PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	WE	SC	GA	UT	PM	OA	HC	HP	DA
J	Schimmel, M				Schimmel, Martin			The 2010 IADR - Geriatric Oral Research Group satellite meeting	GERODONTOLOGY			English	Article						caries; ageing; dental caries; gerodontology; infection; long-term; care		doi: 10.1111/j.1741-2358.2011.00508.x ? The 2010 IADR Geriatric Oral Research Group satellite meeting On 12 and 13 July, the 2010 IADR General Session satellite meeting of the IADR Geriatric Oral Research Group (GORG) was attended by around 60 participants in the beautiful surroundings of Sitges in the outskirts of Barcelona, Spain. The speakers reflected on the main topics Disparities and Expectations in Oral Healthcare: An Elderly Focus and Risks and Benefits of Ageing with a Natural Dentition, which was followed by fruitful discussions in the auditorium and the jointly enjoyed meals. The Sitges meeting comprised lectures of distinguished speakers as well as poster presentations, which discussed and defined the situation of research in the field of gerodontology today as well as the development since the last GORG satellite symposium held on Vancouver Island in 1999. Despite enormous progress over the last 10 years, many important questions concerning economics, regulation, the implementation of oral health care, treatment protocols as well as general health implications of oral disease in the frail and elderly remain still unanswered.	Univ Geneva, Dept Gerodontol & Removable Prosthodont, Sch Dent, Div Gerodontol & Removable Prosthodont, CH-1205 Geneva, Switzerland		Schimmel, M (corresponding author), Univ Geneva, Dept Gerodontol & Removable Prosthodont, Sch Dent, Div Gerodontol & Removable Prosthodont, 19 Rue Barthelemy Menn, CH-1205 Geneva, Switzerland.	martin.schimmel@unige.ch	Schimmel, Martin/F-5694-2011	Schimmel, Martin/0000-0001-9700-5534				0	1	1	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0734-0664			GERODONTOLOGY	Gerodontology	SEP	2012	29	3					171	176		10.1111/j.1741-2358.2011.00508.x			6	Dentistry, Oral Surgery & Medicine; Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine; Geriatrics & Gerontology	989UF	WOS:000307585400002	22591169				2022-03-04	
J	Schimmel, M; Leemann, B; Christou, P; Kiliaridis, S; Schnider, A; Herrmann, FR; Muller, F				Schimmel, Martin; Leemann, Beatrice; Christou, Panagiotis; Kiliaridis, Stavros; Schnider, Armin; Herrmann, Francois R.; Mueller, Frauke			Oral health-related quality of life in hospitalised stroke patients	GERODONTOLOGY			English	Article						oral health-related quality of life; stroke; masticatory efficiency; lip force; Oral Health Impact Profile-EDENT	2-COLOR CHEWING GUM; IMPACT PROFILE; NUTRITIONAL-STATUS; VALIDATION; REHABILITATION; EFFICIENCY; SURVIVORS; DENTURES; VERSION; FORCE	Objective: The aim of this study was to test the hypothesis that impairment of orofacial function following stroke affects the patients' oral health-related quality of life (OHRQoL). Material and methods: From the University Hospitals of Geneva, 31 stroke patients (18 men, 13 women, mean age 69.0 +/- 12.7 years) with unilateral facial and limb palsy were recruited (patient group, PG). In the study, the Oral Health Impact Profile (OHIP)-EDENT was utilised to assess OHRQoL. Further examinations comprised a test of masticatory efficiency and lip force, stroke severity National Institute of Health Stroke Scale and dental state. The control group (CG) consisted of 24 subjects with similar age, gender and dental state. Results: The PG mean OHIP-EDENT sum score was 18.8 +/- 15.5 and proved higher than one of the CG, indicating a lower OHRQoL in the PG (p < 0.01). The score of the sub-domains 'functional limitation' and 'physical pain' were significantly higher in PG (p < 0.03 and p < 0.02, respectively). The masticatory efficiency was significantly lower in the PG (p < 0.0001) and was associated with the OHIP-EDENT sum score and its sub-domains, except for 'physical disability'. This effect was not present in the CG. Conclusion: The OHRQoL is significantly reduced in hospitalised stroke patients whereby functional impairment seems predominant when compared with psychological and psycho-social aspects.	[Schimmel, Martin] Univ Geneva, Div Gerodontol & Removable Prosthodont, Sch Dent, CH-1205 Geneva, Switzerland; [Leemann, Beatrice; Schnider, Armin] Univ Hosp Geneva, Dept Clin Neurosci, Div Rehabil, Geneva, Switzerland; [Christou, Panagiotis; Kiliaridis, Stavros] Univ Geneva, Div Orthodont, CH-1205 Geneva, Switzerland; [Herrmann, Francois R.; Mueller, Frauke] Univ Hosp Geneva, Dept Rehabil & Geriatr, Geneva, Switzerland		Schimmel, M (corresponding author), Univ Geneva, Div Gerodontol & Removable Prosthodont, Sch Dent, 19 Rue Barthelemy Menn, CH-1205 Geneva, Switzerland.	martin.schimmel@unige.ch	Christou, Paul/C-8645-2011; HERRMANN, Francois R/B-6710-2011; HERRMANN, Francois/M-7390-2019; Schimmel, Martin/F-5694-2011; Müller, Frauke/C-3835-2014	Christou, Paul/0000-0001-6358-7396; HERRMANN, Francois R/0000-0003-1312-1517; HERRMANN, Francois/0000-0003-1312-1517; Schimmel, Martin/0000-0001-9700-5534; Müller, Frauke/0000-0003-3981-0134	Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission [3200B0-108239]; European College of Gerodontology GABA	This study was supported by the Swiss National Science Foundation, Grant No. 3200B0-108239. The manuscript received the European College of Gerodontology GABA research award.	Allen F, 2002, INT J PROSTHODONT, V15, P446; Allen PF, 1999, COMMUNITY DENT ORAL, V27, P344, DOI 10.1111/j.1600-0528.1999.tb02031.x; Allison P, 1999, J DENT RES, V78, P643, DOI 10.1177/00220345990780020301; Anastassiadou V, 2001, Gerodontology, V18, P79, DOI 10.1111/j.1741-2358.2001.00079.x; Anderson C, 1996, STROKE, V27, P1812, DOI 10.1161/01.STR.27.10.1812; ANGELERI F, 1993, STROKE, V24, P1478, DOI 10.1161/01.STR.24.10.1478; Atchison K A, 1990, J Dent Educ, V54, P680; Awad MA, 2003, INT J PROSTHODONT, V16, P390; Carod-Artal J, 2000, STROKE, V31, P2995, DOI 10.1161/01.STR.31.12.2995; Chavers LS, 2004, QUAL LIFE RES, V13, P111, DOI 10.1023/B:QURE.0000015289.60595.b1; Chen CCH, 2001, J ADV NURS, V36, P131, DOI 10.1046/j.1365-2648.2001.01950.x; Dennis M, 2000, BRIT MED BULL, V56, P466, DOI 10.1258/0007142001903102; Dewey HM, 1999, CEREBROVASC DIS, V9, P323, DOI 10.1159/000016006; EICHNER K, 1990, Stomatologie der DDR, V40, P321; Frankel MR, 2000, NEUROLOGY, V55, P952, DOI 10.1212/WNL.55.7.952; Gil-Montoya JA, 2008, J PUBLIC HEALTH DENT, V68, P88, DOI 10.1111/j.1752-7325.2007.00082.x; Hagg M, 2004, DYSPHAGIA, V19, P219, DOI 10.1007/s00455-004-0016-3; Hagg M, 2008, DYSPHAGIA, V23, P291, DOI 10.1007/s00455-007-9143-y; Heinisch M., 1991, LEBENSQUALITAT KARDI, P73; HELKIMO E, 1978, ACTA ODONTOL SCAND, V36, P33, DOI 10.3109/00016357809026364; Heydecke G, 2002, ORAL HEALTH-RELATED QUALITY OF LIFE, P139; Heydecke G, 2003, COMMUNITY DENT ORAL, V31, P161, DOI 10.1034/j.1600-0528.2003.00029.x; Hirano K, 2004, J ORAL REHABIL, V31, P199, DOI 10.1111/j.1365-2842.2004.01175.x; Hopman WM, 2003, STROKE, V34, P801, DOI 10.1161/01.STR.0000057978.15397.6F; Hori Kazuhiro, 2005, Gerodontology, V22, P227; John MT, 2002, EUR J ORAL SCI, V110, P425, DOI 10.1034/j.1600-0722.2002.21363.x; Kemppainen P, 1999, J DENT RES, V78, P1810, DOI 10.1177/00220345990780120701; LIEDBERG B, 1995, DYSPHAGIA, V10, P101, DOI 10.1007/BF00440079; Locker D, 1988, Community Dent Health, V5, P3; Locker David, 2002, Community Dent Health, V19, P90; Loesche W J, 1998, Ann Periodontol, V3, P161, DOI 10.1902/annals.1998.3.1.161; MACGREGOR FC, 1990, AESTHET PLAST SURG, V14, P249; MANLY RS, 1950, J DENT RES, V29, P448, DOI 10.1177/00220345500290040701; Mazari A, 2007, DYSPHAGIA, V22, P117, DOI 10.1007/s00455-006-9062-3; Mcgrath C, 2009, J ORAL REHABIL, V36, P264, DOI 10.1111/j.1365-2842.2009.01941.x; McMillan AS, 2005, J ORAL REHABIL, V32, P495, DOI 10.1111/j.1365-2842.2005.01451.x; Muller F, 2001, Gerodontology, V18, P58, DOI 10.1111/j.1741-2358.2001.00058.x; Muller F, 2005, QUINTESSENZ, V56, P1291; Prinz JF, 1999, J ORAL REHABIL, V26, P243, DOI 10.1046/j.1365-2842.1999.00362.x; Sampogna F, 2008, EUR J ORAL SCI, V116, P531, DOI 10.1111/j.1600-0722.2008.00578.x; Schimmel M, 2007, J ORAL REHABIL, V34, P671, DOI 10.1111/j.1365-2842.2007.01773.x; Slade G D, 1994, Community Dent Health, V11, P3; Slade GD, 1997, COMMUNITY DENT ORAL, V25, P284, DOI 10.1111/j.1600-0528.1997.tb00941.x; Tubert-Jeannin S, 2003, COMMUNITY DENT ORAL, V31, P275, DOI 10.1034/j.1600-0528.2003.t01-1-00006.x; Weimar C, 2004, STROKE, V35, P158, DOI 10.1161/01.STR.0000106761.94985.8B; Westergren A, 2001, J CLIN NURS, V10, P257, DOI 10.1046/j.1365-2702.2001.00479.x; Wolfe CDA, 2000, BRIT MED BULL, V56, P275, DOI 10.1258/0007142001903120	47	36	36	0	9	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	0734-0664			GERODONTOLOGY	Gerodontology	MAR	2011	28	1					3	11		10.1111/j.1741-2358.2009.00330.x			9	Dentistry, Oral Surgery & Medicine; Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine; Geriatrics & Gerontology	721NQ	WOS:000287362000002	20337725				2022-03-04	
J	Chebib, N; Waldburger, TC; Boire, S; Prendki, V; Maniewicz, S; Philippe, M; Muller, F				Chebib, Najla; Waldburger, Talina Clizia; Boire, Sandrine; Prendki, Virginie; Maniewicz, Sabrina; Philippe, Mojon; Mueller, Frauke			Oral care knowledge, attitude and practice: Caregivers' survey and observation	GERODONTOLOGY			English	Article						caregivers; dependent elder; geriatric ward; hospitalised patients; oral care; oral hygiene	NURSING-HOMES; HYGIENE CARE; HEALTH-CARE; NURSES KNOWLEDGE; PNEUMONIA; PROTOCOL; PROGRAM	Objectives This study aims to assess caregivers' knowledge, perception and perceived barriers as well as their daily usual practice concerning oral care provision in a geriatric hospital. Methods A semi-structured questionnaire was developed and administered to caregivers in a geriatric ward. Furthermore, oral care delivery to dependent and independent patients was clinically observed. Results One hundred and fifty-two caregivers (60% nurses, 40% nursing aids) completed the survey (78% response rate). Clinical oral care was observed in 97 inpatients. Observations revealed that brushing was done in 94% of opportunities in independent patients but in only 55% of dependent patients. This corresponded to the frequency indicated in the questionnaire for independent elders (97%, n.s.), whereas it was significantly different for dependent elders (89%,P < .001). 95% of caregivers stated in the questionnaire never verifying self-administered oral care, whereas 12.3% were actually observed verifying intraorally its efficiency (P = .07 chi-squared test). 71% of the respondents stated storing the prostheses dry, and 8% stated that they reinserted it after cleaning. Caregivers' observation revealed that 35.1% of prostheses were reinserted in the mouth, indicating a significantly higher rate than in the questionnaire (P < .05). Respondents felt that their training to perform oral hygiene measures was suboptimal (VAS 48 +/- 34.4). Patients verbally refusing oral care were stated as a barrier by 14% of respondents and were witnessed in 15.6% of observation opportunities (n.s). Conclusion Various measures, such as hospital health policy, improved logistics or advanced hands-on training, might help to converge the clinical practice towards the theoretical knowledge.	[Chebib, Najla; Maniewicz, Sabrina; Philippe, Mojon; Mueller, Frauke] Univ Geneva, Univ Clin Dent Med, Div Gerodontol & Removable Prosthodont, Geneva, Switzerland; [Waldburger, Talina Clizia] Univ Geneva, Univ Clin Dent Med, Geneva, Switzerland; [Boire, Sandrine; Prendki, Virginie] Univ Hosp Geneva, Div Internal Med Aged, Dept Rehabil & Geriatr, Thonex, Switzerland; [Mueller, Frauke] Univ Hosp Geneva, Div Geriatr, Dept Rehabil & Geriatr, Thonex, Switzerland		Chebib, N (corresponding author), Univ Geneva, Univ Clin Dent Med, Div Gerodontol & Removable Prosthodont, Geneva, Switzerland.	Najla.Chebib@unige.ch	Maniewicz, Sabrina/X-9934-2018; Maniewicz, Sabrina/ABB-3416-2021; Müller, Frauke/C-3835-2014; Prendki, Virginie/ABI-1378-2020	Maniewicz, Sabrina/0000-0002-3343-787X; Maniewicz, Sabrina/0000-0002-3343-787X; Müller, Frauke/0000-0003-3981-0134; Chebib, Najla/0000-0002-4094-6955			Ab Malik N, 2018, J CLIN NURS, V27, P1913, DOI 10.1111/jocn.14241; Abe S, 2008, ARCH GERONTOL GERIAT, V47, P267, DOI 10.1016/j.archger.2007.08.005; Addor V, 2016, THE NURSES AT WORK S; Albrecht M, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010535.pub2; Binkley C, 2004, AM J INFECT CONTROL, V32, P161, DOI 10.1016/j.ajic.2003.05.001; Chan EY, 2012, APPL NURS RES, V25, P197, DOI 10.1016/j.apnr.2010.12.002; Clave P, 2015, NAT REV GASTRO HEPAT, V12, P259, DOI 10.1038/nrgastro.2015.49; Coker E, 2017, GERIATR NURS, V38, P17, DOI 10.1016/j.gerinurse.2016.06.018; Coker E, 2013, J ADV NURS, V69, P2360, DOI 10.1111/jan.12107; Costello Thomas, 2008, Br J Nurs, V17, P264; de Visschere L, 2011, COMMUNITY DENT ORAL, V39, P416, DOI 10.1111/j.1600-0528.2011.00610.x; Dickson RP, 2014, LANCET RESP MED, V2, P238, DOI 10.1016/S2213-2600(14)70028-1; Gibney J, 2015, SPEC CARE DENT, V35, P285, DOI 10.1111/scd.12131; Iinuma T, 2015, J DENT RES, V94, p28S, DOI 10.1177/0022034514552493; Jablonski RA, 2018, GERODONTOLOGY, V35, P365, DOI 10.1111/ger.12357; Jablonski RA, 2011, RES THEOR NURS PRACT, V25, P163, DOI 10.1891/1541-6577.25.3.163; Janssens B, 2018, CLIN ORAL INVEST, V22, P281, DOI 10.1007/s00784-017-2110-6; Janssens B, 2016, GERODONTOLOGY, V33, P275, DOI 10.1111/ger.12164; Kwok C, 2015, J ORAL REHABIL, V42, P65, DOI 10.1111/joor.12229; Labeau S, 2008, AM J CRIT CARE, V17, P65; Landelle C, 2018, INTENS CARE MED, V44, P1777, DOI 10.1007/s00134-018-5227-4; Metsini A., 2018, SWISS MED WKLY, V148; Meyer S, 2017, CLIN ORAL IMPLAN RES, V28, P1005, DOI 10.1111/clr.12912; Minakuchi S, 2018, GERODONTOLOGY, V35, P317, DOI 10.1111/ger.12347; Mitchell BG, 2019, INFECT DIS HEALTH, V24, P229, DOI 10.1016/j.idh.2019.06.002; Nitschke I, 2001, Gerodontology, V18, P114, DOI 10.1111/j.1741-2358.2001.00114.x; Peltola Petteri, 2004, Gerodontology, V21, P93, DOI 10.1111/j.1741-2358.2004.00012.x; Portella FF, 2015, GERODONTOLOGY, V32, P28, DOI 10.1111/ger.12049; Prendki V, 2018, EUR RESPIR J, V51, DOI 10.1183/13993003.02375-2017; Scannapieco FA, 1999, J PERIODONTOL, V70, P793, DOI 10.1902/jop.1999.70.7.793; Schimmel M, 2013, CLIN ORAL INVEST, V17, P867, DOI 10.1007/s00784-012-0769-2; Sjogren P, 2008, J AM GERIATR SOC, V56, P2124, DOI 10.1111/j.1532-5415.2008.01926.x; Srinivasan M, 2019, GERODONTOLOGY, V36, P125, DOI 10.1111/ger.12388; Stewardson AJ, 2016, LANCET INFECT DIS, V16, P1345, DOI 10.1016/S1473-3099(16)30256-0; Swissethics, 2020, QUAL ASS RES PROJ SU	35	1	1	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0734-0664	1741-2358		GERODONTOLOGY	Gerodontology	MAR	2021	38	1					95	103		10.1111/ger.12502		OCT 2020	9	Dentistry, Oral Surgery & Medicine; Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Dentistry, Oral Surgery & Medicine; Geriatrics & Gerontology	QG7LE	WOS:000579849900001	33073432				2022-03-04	
J	Muller, F; Salem, K; Barbezat, C; Herrmann, FR; Schimmel, M				Mueller, Frauke; Salem, Kamel; Barbezat, Cindy; Herrmann, Francois R.; Schimmel, Martin			Knowledge and attitude of elderly persons towards dental implants	GERODONTOLOGY			English	Article						knowledge; attitude; age; risk factor analysis; dental implants	SUPPORTED MANDIBULAR OVERDENTURES; ORAL-HEALTH; PATIENT SATISFACTION; MASTICATORY FUNCTION; AUSTRIAN POPULATION; SWEDISH POPULATION; INFORMATION; DENTURES; IMPACT; NEED	Knowledge and attitude of elderly persons towards dental implants Background: Despite their unrivalled place in restorative treatment, dental implants are still scarcely used in elderly patients. Introduction: The aim of this survey was therefore to identify potential barriers for accepting an implant treatment. Materials and methods: Participants were recruited from a geriatric hospital, two long-term-care facilities and a private clinic. The final study sample comprised 92 persons, 61 women and 31 men with an average age of 81.2 +/- 8.0 years. In a semi-structured interview, the participants' knowledge of implants and attitude towards a hypothetical treatment with dental implants were evaluated. Results: Twenty-seven participants had never heard of dental implants, and another 13 participants could not describe them. The strongest apprehensions against implants were cost, lack of perceived necessity and old age. Univariate and multiple linear regression analysis identified being women, type and quality of denture, having little knowledge on implants and being hospitalised as the risk factors for refusing implants. However, old age as such was not associated with a negative attitude. Conclusion: The acceptance of dental implants in the elderly population might be increased by providing further information and promoting oral health in general. Regardless of the age, dental implants should be placed when patients are still in good health and live independently.	[Mueller, Frauke] Univ Geneva, Dent Sect, Div Gerodontol & Removable Prosthodont, Fac Med, CH-1205 Geneva, Switzerland; [Mueller, Frauke; Herrmann, Francois R.] Univ Hosp Geneva, Dept Rehabil & Geriatr, Geneva, Switzerland		Muller, F (corresponding author), Univ Geneva, Dent Sect, Div Gerodontol & Removable Prosthodont, Fac Med, 19 Rue Barthelemy Menn, CH-1205 Geneva, Switzerland.	frauke.mueller@unige.ch	Müller, Frauke/C-3835-2014; HERRMANN, Francois/M-7390-2019; HERRMANN, Francois R/B-6710-2011; Schimmel, Martin/F-5694-2011	Müller, Frauke/0000-0003-3981-0134; HERRMANN, Francois/0000-0003-1312-1517; HERRMANN, Francois R/0000-0003-1312-1517; Schimmel, Martin/0000-0001-9700-5534			Allison P, 1999, J DENT RES, V78, P643, DOI 10.1177/00220345990780020301; Awad M, 2008, COMMUNITY DENT ORAL, V36, P12, DOI 10.1111/j.1600-0528.2006.00364.x; Bakke M, 2002, INT J PROSTHODONT, V15, P575; Berge TI, 2000, CLIN ORAL IMPLAN RES, V11, P401, DOI 10.1034/j.1600-0501.2000.011005401.x; Bergendal B, 2009, OSSEOINTEGRATION DEN, P43; Cehreli MC, 2010, INT J ORAL MAX IMPL, V25, P266; de Baat C, 2000, Gerodontology, V17, P45; Ellis JS, 2011, GERODONTOLOGY, V28, P62, DOI 10.1111/j.1741-2358.2009.00348.x; Emami E, 2009, CLIN ORAL IMPLAN RES, V20, P533, DOI 10.1111/j.1600-0501.2008.01693.x; GUILLEY E, 2005, AGES GENERATIONS VIE, P117; Heft MW, 2007, COMMUNITY DENT ORAL, V35, P421, DOI 10.1111/j.1600-0528.2006.00344.x; Hugoson A, 2005, SWED DENT J, V29, P139; Marxkors R, 1994, SCHRIFTENRREIHE BUND, P267; Muller T, 2007, CLIN ORAL IMPLAN RES, V18, P2, DOI 10.1111/j.1600-0501.2007.01459.x; Muller F, 1994, Gerodontology, V11, P7, DOI 10.1111/j.1741-2358.1994.tb00096.x; Narby B, 2008, INT J PROSTHODONT, V21, P481; Nitschke I, 2001, Gerodontology, V18, P114, DOI 10.1111/j.1741-2358.2001.00114.x; Osterberg T, 2010, ACTA ODONTOL SCAND, V68, P360, DOI 10.3109/00016357.2010.514721; Palmvist S, 1991, CLIN ORAL IMPLAN RES, V2, P99, DOI 10.1034/j.1600-0501.1991.020301.x; Rizzoli R, 2009, CURR MED RES OPIN, V25, P2373, DOI 10.1185/03007990903169262; Rustemeyer J, 2007, INT J ORAL MAX SURG, V36, P814, DOI 10.1016/j.ijom.2007.05.003; SALONEN MAM, 1994, COMMUNITY DENT ORAL, V22, P130, DOI 10.1111/j.1600-0528.1994.tb01588.x; Shulman KI, 2000, INT J GERIATR PSYCH, V15, P548, DOI 10.1002/1099-1166(200006)15:6<548::AID-GPS242>3.0.CO;2-U; Slade G D, 1994, Community Dent Health, V11, P3; Tepper G, 2003, CLIN ORAL IMPLAN RES, V14, P621, DOI 10.1034/j.1600-0501.2003.00916.x; Tepper G, 2003, CLIN ORAL IMPLAN RES, V14, P634, DOI 10.1034/j.1600-0501.2003.00917.x; van der Bilt A, 2010, CLIN ORAL IMPLAN RES, V21, P1209, DOI 10.1111/j.1600-0501.2010.01915.x; van Kampen FMC, 2004, J DENT RES, V83, P708, DOI 10.1177/154405910408300910; Visser A, 2011, GERODONTOLOGY, V28, P76, DOI 10.1111/j.1741-2358.2009.00314.x; Walton JN, 2005, INT J PROSTHODONT, V18, P483; Zekry D, 2008, AGE AGEING, V37, P83, DOI 10.1093/ageing/afm132; Zekry D, 2010, J CLIN EPIDEMIOL, V63, P1036, DOI 10.1016/j.jclinepi.2009.11.013; Zimmer C M, 1992, Int J Oral Maxillofac Implants, V7, P228; Zitzmann NU, 2008, EUR J ORAL SCI, V116, P52, DOI 10.1111/j.1600-0722.2007.00512.x; Zitzmann NU, 2007, CLIN ORAL IMPLAN RES, V18, P20, DOI 10.1111/j.1600-0501.2007.01435.x	35	32	32	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0734-0664	1741-2358		GERODONTOLOGY	Gerodontology	JUN	2012	29	2					E914	E923		10.1111/j.1741-2358.2011.00586.x			10	Dentistry, Oral Surgery & Medicine; Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine; Geriatrics & Gerontology	002QK	WOS:000308547000129	22073988	Bronze, Green Accepted			2022-03-04	
J	Muller, F				Mueller, Frauke			Interventions for edentate elders - what is the evidence?	GERODONTOLOGY			English	Article						complete dentures; implant - over dentures; edentate elders	SUPPORTED MANDIBULAR OVERDENTURES; RANDOMIZED CLINICAL-TRIAL; MASSETER MUSCLE THICKNESS; ORAL IMPLANTS; PATIENT SATISFACTION; EDENTULOUS PATIENTS; COMPLETE DENTURES; TOOTH LOSS; PROSTHESES; HEALTH	Demographic developments indicate an increasing proportion of elderly persons in the population as well as longer life expectancies. Furthermore, the prevalence of edentulism is decreasing, and natural teeth are being retained until later in life. Geriatric patients are more frequently fragile with multiple co-morbidities, including frequent medication-related side effects such as xerostomia. Cognitive impairment also increases with age and presents a considerable challenge to oral hygiene and dental treatment. Edentulous patients present a particular challenge, as muscle skill and the ability to adapt to a new denture diminish with age. Duplication techniques reduce the adaptation of replacement dentures, and implants are increasingly used to stabilise lower complete dentures, significantly improving chewing efficiency and preventing peri-implant bone loss. Implant overdentures may reverse some of the functional, psychological and psychosocial effects of tooth loss and thus increase the oral health-related quality of life until late in life. Evidence from RCTs exists on the 10-year survival of implants and implant overdentures, but few studies have investigated the problems and survival rates when the patient loses autonomy. The standard of care in geriatric patients has to be adapted to the patient's motivation, functional and cognitive impairment, and medical condition as well as his/her socio-economic context.	[Mueller, Frauke] Univ Geneva, Div Gerodontol & Removable Prosthodont, CH-1205 Geneva, Switzerland; [Mueller, Frauke] Univ Hosp Geneva, Dept Internal Med Rehabil & Geriatr, Geneva, Switzerland		Muller, F (corresponding author), Univ Geneva, Div Gerodontol & Removable Prosthodont, 19 Rue Barthelemy Menn, CH-1205 Geneva, Switzerland.	frauke.mueller@unige.ch	Müller, Frauke/C-3835-2014	Müller, Frauke/0000-0003-3981-0134			Allen PF, 2006, J DENT RES, V85, P547, DOI 10.1177/154405910608500613; Andreiotelli M, 2010, INT J PROSTHODONT, V23, P195; Arora A, 2005, AGE AGEING, V34, P519, DOI 10.1093/ageing/afi124; Bradbury J, 2006, J DENT RES, V85, P463, DOI 10.1177/154405910608500513; Brill N, 1959, J PROSTHET DENT, V9, P761; Brubacher D, 2004, INT J OBESITY, V28, P1163, DOI 10.1038/sj.ijo.0802721; Bryant SR, 2003, J PROSTHET DENT, V89, P589, DOI 10.1016/S0022-3913(03)00199-9; Buser D, 1990, CLIN ORAL IMPLAN RES, V1, P33, DOI 10.1034/j.1600-0501.1990.010105.x; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; Davis DM, 2000, BRIT DENT J, V188, P503, DOI 10.1038/sj.bdj.4800522a; Deniz DA, 2013, J ORAL REHABIL, V40, P91, DOI 10.1111/joor.12015; Douglass CW, 2002, J PROSTHET DENT, V87, P5, DOI 10.1067/mpr.2002.121203; Ellis Janice S, 2007, J Prosthodont, V16, P37, DOI 10.1111/j.1532-849X.2006.00152.x; Ellis JS, 2011, GERODONTOLOGY, V28, P62, DOI 10.1111/j.1741-2358.2009.00348.x; Emami E, 2009, CLIN ORAL IMPLAN RES, V20, P533, DOI 10.1111/j.1600-0501.2008.01693.x; Engfors Ingela, 2004, Clin Implant Dent Relat Res, V6, P190, DOI 10.1111/j.1708-8208.2004.tb00035.x; Feine J S, 2002, Gerodontology, V19, P3; Fontijn-Tekamp FA, 2000, J DENT RES, V79, P1519, DOI 10.1177/00220345000790071501; Goldspink G, 1998, Gerodontology, V15, P35, DOI 10.1111/j.1741-2358.1998.00035.x; Graves AB, 1996, AM J EPIDEMIOL, V144, P760, DOI 10.1093/oxfordjournals.aje.a009000; Hamdan N, 2013, J DENT RES, V92, P231; Heydecke G, 2005, J DENT, V33, P649, DOI 10.1016/j.jdent.2005.01.003; Hugoson A, 2005, SWED DENT J, V29, P139; Lind Sven, 2005, Pflege Z, V58, P778; Locker David, 2003, Spec Care Dentist, V23, P86, DOI 10.1111/j.1754-4505.2003.tb01667.x; Luraschi J, 2013, J OROFAC PAIN, V27, P206, DOI 10.11607/jop.1097; Meijer HJA, 2004, CLIN ORAL IMPLAN RES, V15, P421, DOI 10.1111/j.1600-0501.2004.01024.x; Meijer HJA, 2001, INT J ORAL MAX IMPL, V16, P522; Millwood J, 2000, Gerodontology, V17, P25, DOI 10.1111/j.1741-2358.2000.00025.x; Mojon P, 2003, IMPLANT OVERDENTURES: THE STANDARD OF CARE FOR EDENTULOUS PATIENTS, P3; Mojon P, 2004, INT J PROSTHODONT, V17, P434; Muller F, 2010, EUR GERIATR MED, V1, P239, DOI 10.1016/j.eurger.2010.06.001; Muller F, 2012, GERODONTOLOGY, V29, pE914, DOI 10.1111/j.1741-2358.2011.00586.x; Muller F, 2012, CLIN ORAL IMPLAN RES, V23, P144, DOI 10.1111/j.1600-0501.2011.02213.x; Muller T, 2007, CLIN ORAL IMPLAN RES, V18, P2, DOI 10.1111/j.1600-0501.2007.01459.x; Muller F, 1994, Gerodontology, V11, P7, DOI 10.1111/j.1741-2358.1994.tb00096.x; MULLER F, 1995, J ORAL REHABIL, V22, P501, DOI 10.1111/j.1365-2842.1995.tb01195.x; Muller F, 2002, INT J PROSTHODONT, V15, P553; Muller F, 1993, Gerodontology, V10, P23, DOI 10.1111/j.1741-2358.1993.tb00075.x; Naert I, 2004, INT J ORAL MAX IMPL, V19, P695; Newton J P, 1993, Gerodontology, V10, P16, DOI 10.1111/j.1741-2358.1993.tb00074.x; Rashid F, 2011, J ORAL REHABIL, V38, P176, DOI 10.1111/j.1365-2842.2010.02143.x; Riesen M, 2002, MED HYG, V2414, P2178; Schimmel M, 2013, INT J ORAL IN PRESS; Schimmel M, 2010, INT J PROSTHODONT, V23, P418; Sheiham A, 2001, J DENT RES, V80, P408, DOI 10.1177/00220345010800020201; Suominen-Taipale AL, 1999, COMMUNITY DENT ORAL, V27, P353, DOI 10.1111/j.1600-0528.1999.tb02032.x; Sutton AF, 2007, J PROSTHET DENT, V97, P292, DOI 10.1016/j.prosdent.2007.03.003; Taji T, 2005, INT J PROSTHODONT, V18, P146; TALLGREN A, 1972, J PROSTHET DENT, V27, P120, DOI 10.1016/0022-3913(72)90188-6; Tamura BK, 2013, J AM MED DIR ASSOC, V14, P649, DOI 10.1016/j.jamda.2013.02.022; Thomason JM, 2009, BRIT DENT J, V207, P185, DOI 10.1038/sj.bdj.2009.728; Thomason JM, 2003, INT J PROSTHODONT, V16, P467; Tokmakidis SP, 2009, CLIN PHYSIOL FUNCT I, V29, P316, DOI 10.1111/j.1475-097X.2009.00866.x; van Kampen FMC, 2004, J DENT RES, V83, P708, DOI 10.1177/154405910408300910; Walton JN, 2005, INT J PROSTHODONT, V18, P483; Weiss A, 2008, J GEN INTERN MED, V23, P19, DOI 10.1007/s11606-007-0429-4; Wismeijer D, 1997, INT J ORAL MAX SURG, V26, P263, DOI 10.1016/S0901-5027(97)80864-8; Zitzmann NU, 2008, EUR J ORAL SCI, V116, P52, DOI 10.1111/j.1600-0722.2007.00512.x	59	34	34	1	28	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0734-0664	1741-2358		GERODONTOLOGY	Gerodontology	FEB	2014	31			1	SI		44	51		10.1111/ger.12083			8	Dentistry, Oral Surgery & Medicine; Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine; Geriatrics & Gerontology	AA5AZ	WOS:000331109200007	24446979	Bronze			2022-03-04	
J	Annen, M; Peterson, C; Humphreys, BK				Annen, Michele; Peterson, Cynthia; Humphreys, B. Kim			Comparison of Treatment Outcomes in Nonspecific Low-Back Pain Patients With and Without Modic Changes Who Receive Chiropractic Treatment	JOURNAL OF MANIPULATIVE AND PHYSIOLOGICAL THERAPEUTICS			English	Article						Diagnostic Imaging; Chiropractic; Outcome Assessment (Health Care); Manipulation; Spinal	LUMBAR DISC HERNIATION; AMPLITUDE SPINAL MANIPULATION; INTERVERTEBRAL DISC; HIGH-VELOCITY; FOLLOW-UP; STEROID INJECTION; SUBCHONDRAL BONE; MRI FINDINGS; TYPE-1; DEGENERATION	Objective: The aim of this study was to determine if there was a difference in outcomes in patients with nonspecific low back pain, both with and without Modic changes (MCs), who received chiropractic care. Methods: This prospective outcomes study included 112 patients with low back pain without disc herniation on magnetic resonance imaging. All patients were treated with spinal manipulative therapy. At baseline, the numerical rating scale (NRS) and Bournemouth Questionnaire (BQ) for disability were collected. The NRS, BQ, and Patient's Global Impression of Change (primary outcome) were collected at the follow-up time points of 1 week, 1 month, and 3 months to assess overall improvement. Magnetic resonance imaging scans were analyzed for the presence of MCs and, if present, classified as Modic I or II. The chi(2) test was used to compare the proportion of patients reporting clinically relevant "improvement" between patients with and without MCs and between Modic I and Modic II patients. The unpaired Student t test was used to compare NRS and BQ at baseline and change scores at all follow-up time points. Results: For the primary outcome measure, the proportion of patients reporting relevant "improvement" (Patient's Global Impression of Change), and for the secondary outcome measures (NRS and BQ change scores), there were no significant differences between Modic positive and Modic negative patients or between Modic I and Modic II patients. Conclusion: Neither the presence nor absence of MCs nor the Modic change category were related to treatment outcomes for patients with low back pain without disc hemiation who received chiropractic care.	[Annen, Michele; Peterson, Cynthia; Humphreys, B. Kim] Univ Zurich, Chiropract Med Dept, Fac Med, Orthopaed Univ Hosp Balgrist, Zurich, Switzerland		Annen, M (corresponding author), Univ Zurich, Chiropract Med Dept, Fac Med, Orthopaed Univ Hosp Balgrist, CH-6987 Caslano, Switzerland.	miky.annen@gmail.com			European Chiropractors' Union; Balgrist Foundation; Uniscientia Foundation	Funding for this study was received from the European Chiropractors' Union, The Balgrist Foundation, and Uniscientia Foundation. No conflicts of interest were reported for this study.	Adams MA, 2000, SPINE, V25, P1625, DOI 10.1097/00007632-200007010-00005; Albert HB, 2007, EUR SPINE J, V16, P977, DOI 10.1007/s00586-007-0336-8; Albert HB, 2013, EUR SPINE J, V22, P690, DOI 10.1007/s00586-013-2674-z; Albert HB, 2013, EUR SPINE J, V22, P697, DOI 10.1007/s00586-013-2675-y; Annen M, 2016, J MANIP PHYSIOL THER, V39, P200, DOI 10.1016/j.jmpt.2016.02.012; Beaudreuil J., 2012, Annals of Physical and Rehabilitation Medicine, V55, P139, DOI 10.1016/j.rehab.2012.01.004; Bianchi M, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0688-x; Brinjikji W, 2015, AM J NEURORADIOL, V36, P2394, DOI 10.3174/ajnr.A4498; Buttermann Glenn R, 2004, Spine J, V4, P495, DOI 10.1016/j.spinee.2004.03.024; Carragee Eugene J, 2005, Spine J, V5, P24, DOI 10.1016/j.spinee.2004.05.250; Chataigner H, 1998, REV CHIR ORTHOP, V84, P583; CROCK HV, 1986, SPINE, V11, P650, DOI 10.1097/00007632-198607000-00028; Djurasovic M, 2012, EUR SPINE J, V21, P1616, DOI 10.1007/s00586-012-2244-9; Ehrler M, 2016, J MANIP PHYSIOL THER, V39, P192, DOI 10.1016/j.jmpt.2016.02.013; Esposito P, 2006, NEUROCHIRURGIE, V52, P315, DOI 10.1016/S0028-3770(06)71225-5; Fayad F, 2007, EUR SPINE J, V16, P925, DOI 10.1007/s00586-006-0301-y; Hutton MJ, 2011, SPINE, V36, P2304, DOI 10.1097/BRS.0b013e31821604b6; Jarvinen J, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0540-3; Jensen OK, 2014, SPINE J, V14, P2568, DOI 10.1016/j.spinee.2014.02.018; Jensen RK, 2012, EUR SPINE J, V21, P2271, DOI 10.1007/s00586-012-2309-9; Jensen TS, 2010, EUR SPINE J, V19, P129, DOI 10.1007/s00586-009-1184-5; Kerttula L, 2012, EUR SPINE J, V21, P1135, DOI 10.1007/s00586-012-2147-9; Kuisma M, 2006, SPINE, V31, P1714, DOI 10.1097/01.brs.0000224167.18483.14; Lee JW, 2013, EUR RADIOL, V23, P205, DOI 10.1007/s00330-012-2566-3; Leemann S, 2014, J MANIP PHYSIOL THER, V37, P155, DOI 10.1016/j.jmpt.2013.12.011; Luoma K, 2009, SKELETAL RADIOL, V38, P237, DOI 10.1007/s00256-008-0611-8; Lurie JD, 2013, SPINE, V38, P1216, DOI 10.1097/BRS.0b013e31828ce66d; Mann E, 2011, SPINE, V36, P1081, DOI 10.1097/BRS.0b013e3181ef6a1e; Melloh M, 2011, OCCUP MED-OXFORD, V61, P127, DOI 10.1093/occmed/kqq194; Mitra D, 2004, EUR RADIOL, V14, P1574, DOI 10.1007/s00330-004-2314-4; MODIC MT, 1988, RADIOLOGY, V166, P193, DOI 10.1148/radiology.166.1.3336678; Neubauer E, 2006, EUR J PAIN, V10, P559, DOI 10.1016/j.ejpain.2005.08.002; Nguyen C, 2012, OSTEOPOROSIS INT, V23, pS857, DOI 10.1007/s00198-012-2164-x; Nguyen C, 2015, ANN RHEUM DIS, V74, P1488, DOI 10.1136/annrheumdis-2015-207317; Ohtori S, 2010, SPINE, V35, P1231, DOI 10.1097/BRS.0b013e3181bde562; Palazzo C, 2017, JOINT BONE SPINE, V84, P507, DOI 10.1016/j.jbspin.2016.08.001; Peterson CK, 2014, EUR J RADIOL, V83, P1786, DOI 10.1016/j.ejrad.2014.06.008; Schistad EI, 2014, SKELETAL RADIOL, V43, P1271, DOI 10.1007/s00256-014-1928-0; Shan Z, 2014, SPINE, V39, P736, DOI 10.1097/BRS.0000000000000259; Siepe CJ, 2006, SPINE, V31, P1923, DOI 10.1097/01.brs.0000228780.06569.e8; Teraguchi M, 2015, SPINE J, V15, P622, DOI 10.1016/j.spinee.2014.11.012; Thompson KJ, 2009, RADIOLOGY, V250, P849, DOI 10.1148/radiol.2503080474; ULMER JL, 1995, AM J ROENTGENOL, V164, P429, DOI 10.2214/ajr.164.2.7839983; Villarreal-Arroyo M, 2012, Acta Ortop Mex, V26, P180; Vital JM, 2003, SPINE, V28, P715; Wedderkopp N, 2009, ACTA RADIOL, V50, P65, DOI 10.1080/02841850802524485; Zhuang Cheng-yu, 2009, Zhonghua Yi Xue Za Zhi, V89, P2490	47	0	0	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0161-4754			J MANIP PHYSIOL THER	J. Manip. Physiol. Ther.	SEP	2018	41	7					561	570		10.1016/j.jmpt.2018.01.008			10	Health Care Sciences & Services; Integrative & Complementary Medicine; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services; Integrative & Complementary Medicine; Rehabilitation	HA2RW	WOS:000450090700002	30442355				2022-03-04	
J	Peterson, CK; Schmid, C; Leemann, S; Anklin, B; Humphreys, BK				Peterson, Cynthia K.; Schmid, Christof; Leemann, Serafin; Anklin, Bernard; Humphreys, B. Kim			OUTCOMES FROM MAGNETIC RESONANCE IMAGING-CONFIRMED SYMPTOMATIC CERVICAL DISK HERNIATION PATIENTS TREATED WITH HIGH-VELOCITY, LOW-AMPLITUDE SPINAL MANIPULATIVE THERAPY: A PROSPECTIVE COHORT STUDY WITH 3-MONTH FOLLOW-UP	JOURNAL OF MANIPULATIVE AND PHYSIOLOGICAL THERAPEUTICS			English	Article						Spine; Neck Pain; Manipulation; Chiropractic; Intervertebral Disk Displacement	LOW-BACK-PAIN; CHIROPRACTIC CARE; NECK PAIN; STEROID INJECTIONS; RADICULOPATHY; HEALTH; SAFETY; MRI	Objective: The purpose of this study was to investigate outcomes of patients with cervical radiculopathy from cervical disk herniation (CDH) who are treated with spinal manipulative therapy. Methods: Adult Swiss patients with neck pain and dermatomal arm pain; sensory, motor, or reflex changes corresponding to the involved nerve root; and at least 1 positive orthopaedic test for cervical radiculopathy were included. Magnetic resonance imaging-confirmed CDH linked with symptoms was required. Baseline data included 2 pain numeric rating scales (NRSs), for neck and arm, and the Neck Disability Index (NDI). At 2 weeks, 1 month, and 3 months after initial consultation, patients were contacted by telephone, and the NDI, NRSs, and patient's global impression of change data were collected. High-velocity, low-amplitude spinal manipulations were administered by experienced doctors of chiropractic. The proportion of patients responding "better" or "much better" on the patient's global impression of change scale was calculated. Pretreatment and posttreatment NRSs and NDIs were compared using the Wilcoxon test. Acute vs subacute/chronic patients' NRSs and NDIs were compared using the Mann-Whitney U test. Results: Fifty patients were included. At 2 weeks, 55.3% were "improved," 68.9% at 1 month and 85.7% at 3 months. Statistically significant decreases in neck pain, arm pain, and NDI scores were noted at 1 and 3 months compared with baseline scores (P < .0001). Of the subacute/chronic patients, 76.2% were improved at 3 months. Conclusions: Most patients in this study, including subacute/chronic patients, with symptomatic magnetic resonance imaging-confirmed CDH treated with spinal manipulative therapy, reported significant improvement with no adverse events.	[Peterson, Cynthia K.; Humphreys, B. Kim] Univ Zurich, Orthoped Univ Hosp Balgrist, Fac Med, Dept Chiropract Med, Zurich, Switzerland		Peterson, CK (corresponding author), Univ Zurich, Orthoped Univ Hosp Balgrist, Fac Med, Dept Chiropract Med, Zurich, Switzerland.	xraydcpeterson@yahoo.ca			Uniscientia Foundation; European Academy for Chiropractic; Balgrist Hospital Foundation	The Uniscientia Foundation, the European Academy for Chiropractic, and the Balgrist Hospital Foundation provided funding support for this study. No conflicts of interest were reported for this study.	BenEliyahu D J, 1996, J Manipulative Physiol Ther, V19, P597; Bronfort Gert, 2004, Spine J, V4, P335, DOI 10.1016/j.spinee.2003.06.002; Casey E, 2011, PHYS MED REH CLIN N, V22, P1, DOI 10.1016/j.pmr.2010.10.001; Cassidy JD, 2008, SPINE, V33, pS176, DOI 10.1097/BRS.0b013e3181644600; Dietl M, 2011, HEALTH TECHNOL ASSES, V7; Ernst CW, 2005, EUR J RADIOL, V55, P409, DOI 10.1016/j.ejrad.2004.11.003; Fischer D, 1999, JAMA-J AM MED ASSOC, V282, P1157, DOI 10.1001/jama.282.12.1157; Gore M, 2012, SPINE, V37, pE668, DOI 10.1097/BRS.0b013e318241e5de; Gross AR, 2004, SPINE, V29, P1541, DOI 10.1097/01.BRS.0000131218.35875.ED; Healy JF, 1996, J COMPUT ASSIST TOMO, V20, P107, DOI 10.1097/00004728-199601000-00019; Hurst H, 2004, J MANIP PHYSIOL THER, V27, P26, DOI 10.1016/j.jmpt.2003.11.003; Johnson C, 2012, J MANIP PHYSIOL THER, V35, P493, DOI 10.1016/j.jmpt.2012.09.001; Kolstad F, 2005, ACTA NEUROCHIR, V147, P1065, DOI 10.1007/s00701-005-0542-2; Lin EL, 2006, J SPINAL DISORD TECH, V19, P183, DOI 10.1097/01.bsd.0000190558.13248.e1; Matsumoto M, 1998, J BONE JOINT SURG BR, V80B, P19, DOI 10.1302/0301-620X.80B1.7929; Murphy DR, 2006, J MANIP PHYSIOL THER, V29, P279, DOI 10.1016/j.jmpt.2006.03.005; Murphy Donald R, 2006, Spine J, V6, P459, DOI 10.1016/j.spinee.2006.01.019; Newell D, 2010, SPINE, V35, P1801, DOI 10.1097/BRS.0b013e3181cc006b; Peterson C, 2012, CHIROPR MAN THER, V20, DOI 10.1186/2045-709X-20-27; Peterson CK, 2012, J MANIP PHYSIOL THER, V35, P525, DOI 10.1016/j.jmpt.2012.06.003; Powers JR, 2005, AUST NZ J PUBL HEAL, V29, P149, DOI 10.1111/j.1467-842X.2005.tb00065.x; RADHAKRISHNAN K, 1994, BRAIN, V117, P325, DOI 10.1093/brain/117.2.325; Rao R, 2002, J BONE JOINT SURG AM, V84A, P1872, DOI 10.2106/00004623-200210000-00021; Rubinstein SM, 2007, J MANIP PHYSIOL THER, V30, P408, DOI 10.1016/j.jmpt.2007.04.013; Teasell R, PAIN RES MANAGE, V15, P313; Thiel HW, 2007, SPINE, V32, P2375, DOI 10.1097/BRS.0b013e3181557bb1; Vernon H, 2008, J MANIP PHYSIOL THER, V31, P491, DOI 10.1016/j.jmpt.2008.08.006; Vernon HT, 2005, J MANIP PHYSIOL THER, V28, P443, DOI 10.1016/j.jmpt.2005.06.011; Wainner RS, 2003, SPINE, V28, P52, DOI 10.1097/00007632-200301010-00014	29	15	16	0	12	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0161-4754			J MANIP PHYSIOL THER	J. Manip. Physiol. Ther.	OCT	2013	36	8					461	467		10.1016/j.jmpt.2013.07.002			7	Health Care Sciences & Services; Integrative & Complementary Medicine; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services; Integrative & Complementary Medicine; Rehabilitation	231YU	WOS:000325455100001	23948425				2022-03-04	
J	Imholz, B; Becker, M; Lombardi, T; Scolozzi, P				Imholz, B.; Becker, M.; Lombardi, T.; Scolozzi, P.			Septic thrombosis of the cavernous sinus secondary to a Streptococcus milleri oral infection	DENTOMAXILLOFACIAL RADIOLOGY			English	Article						cavernous sinus thrombosis; oral infection; Streptococcus milleri		Septic thrombosis of the cavernous sinus (STCS) is an uncommon and potentially lethal disease. Sphenoid and ethmoid sinusitis followed by facial cutaneous infections represents the most common aetiologies, with Staphylococcus aureus as the main responsible organism followed by the Streptococcus pneumoniae. Although all infectious foci of the head and neck area can potentially spread to the cavernous sinus, STCS from oral infection is an exceptionally rare occurrence. We report the unusual case of a patient who presented with an acute STCS secondary to a generalized Streptococcus milleri periodontitis. This case highlights the importance of systematically performing a detailed examination of the oral cavity in patients presenting with intracranial infections caused by uncommon pathogens such as the Streptococcus milled group. Dentomaxillofacial Radiology (2012) 41, 525-528. doi: 10.1259/dmfr/33011853	[Imholz, B.; Scolozzi, P.] Hop Cantonal Univ Geneva, Serv Oral & Maxillofacial Surg, Dept Surg, Fac Med, CH-1211 Geneva, Switzerland; [Becker, M.] Hop Cantonal Univ Geneva, Fac Med, Div Radiol, CH-1211 Geneva, Switzerland; [Lombardi, T.] Hop Cantonal Univ Geneva, Fac Med, Div Stomatol, Lab Oral Histopathol, CH-1211 Geneva, Switzerland		Scolozzi, P (corresponding author), Hop Cantonal Univ Geneva, Serv Oral & Maxillofacial Surg, Dept Surg, Fac Med, CH-1211 Geneva, Switzerland.	paolo.scolozzi@hcuge.ch					Al-Qamachi LH, 2010, BRIT J ORAL MAX SURG, V48, P37, DOI 10.1016/j.bjoms.2008.12.007; Bhatia K, 2002, J LARYNGOL OTOL, V116, P667, DOI 10.1258/002221502760237920; Ebright JR, 2001, ARCH INTERN MED, V161, P2671, DOI 10.1001/archinte.161.22.2671; Han JK, 2001, ARCH OTOLARYNGOL, V127, P650, DOI 10.1001/archotol.127.6.650; LEVINE SR, 1988, NEUROLOGY, V38, P517, DOI 10.1212/WNL.38.4.517; Pavlovich P, 2006, ORBIT, V25, P39, DOI 10.1080/01676830500506077; Schuknecht B, 1998, AM J NEURORADIOL, V19, P617; Socransky SS, 2009, CLIN PERIODONTOLOGY, P207; Watkins LM, 2003, OPHTHALMOLOGY, V110, P569, DOI 10.1016/S0161-6420(02)01765-7; YARINGTON C, 1961, ANN OTO RHINOL LARYN, V70, P263, DOI 10.1177/000348946107000122	10	6	6	0	2	BRITISH INST RADIOLOGY	LONDON	36 PORTLAND PLACE, LONDON W1N 4AT, ENGLAND	0250-832X			DENTOMAXILLOFAC RAD	Dentomaxillofac. Radiol.	SEP	2012	41	6					525	528		10.1259/dmfr/33011853			4	Dentistry, Oral Surgery & Medicine; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine; Radiology, Nuclear Medicine & Medical Imaging	006WI	WOS:000308850000014	22241881	Green Published			2022-03-04	
J	Schimmel, M; Schoeni, P; Zulian, GB; Muller, F				Schimmel, Martin; Schoeni, Patricia; Zulian, Gilbert B.; Mueller, Frauke			Utilisation of dental services in a university hospital palliative and long-term care unit in Geneva	GERODONTOLOGY			English	Article						treatment demand; utilisation; dental care; palliative care; long-term care	ILL CANCER-PATIENTS; DISEASE; HEALTH	Objectives: Dental care plays an important role in the multidisciplinary approach, which is used in palliative and long-term care to address the complex needs of terminally ill patients. The aim of this study was to assess the utilisation of dental services in a University Hospital Palliative and Long-term Care Unit. Material and method: Over an observation period of 13 months, structured questionnaires were filled in after each dental appointment. The survey covered three main topics: the initiation and incentive from the dental consultation, particular difficulties because of the patient's health or the hospital's organisation as well as the accomplished treatment. Results: Two hundred and seventy-five questionnaires from a total of 102 patients were available for analysis. The patients' median age was 83 years (SD 10.3, range 49-101 years), 63 were female, 39 male. A majority of first appointments were initiated by a physician (n = 49 of 102), mainly because of pain (n = 62 of 275). 10.5% of the appointments were cancelled on the same day. Only one-fifth of the patients were able to reach the practice on foot. Six used a walking stick and 54 relied on a wheelchair. Eighteen patients needed to be seen in their bed. The most frequently performed procedures were extractions and removal of denture sore spots (n = 67 of 275) followed by the manufacturing of new dentures (n = 38 of 275). In more than 17% of the appointments, no particular treatment was performed. Conclusion: The utilisation of dental services in terminally ill and severely compromised elderly patients shown justifies a dental service in a palliative care or geriatric hospital setting. The particular dental work profile requires a practitioner with empathy and professional experience.	[Schimmel, Martin; Mueller, Frauke] Univ Geneva, Div Gerodontol & Removable Prosthodont, Geneva, Switzerland; [Zulian, Gilbert B.] Univ Hosp Geneva, Dept Rehabil & Geriatr, Cesco, Geneva, Switzerland		Schimmel, M (corresponding author), Div Gerodontol & Prosthese Adjointe, Sect Med Dent, 19 Rue Barthelemy Menn, CH-1205 Geneva, Switzerland.	martin.schimmel@medecine.unige.ch	Müller, Frauke/C-3835-2014; Schimmel, Martin/F-5694-2011	Müller, Frauke/0000-0003-3981-0134; Schimmel, Martin/0000-0001-9700-5534			Aldred M J, 1991, Spec Care Dentist, V11, P59; Chiodo G T, 1998, Gen Dent, V46, P560; Ettinger R L, 2000, Gerodontology, V17, P8; JOBBINS J, 1992, BRIT MED J, V304, P1612, DOI 10.1136/bmj.304.6842.1612; Kinley Julie, 2004, Int J Palliat Nurs, V10, P580; *KZBV, 2004, STAT BAS VERTR VERS; Lapeer G L, 1990, J Can Dent Assoc, V56, P205; LARUE L, 1994, J PALLIAT CARE, V10, P95; Lefebvre-Chapiro S, 1999, Rev Prat, V49, P1077; Miller M, 2001, CANCER NURS, V24, P241, DOI 10.1097/00002820-200108000-00001; Muller F, 2005, Z GERONTOL GERIATR, V38, P334, DOI 10.1007/s00391-005-0329-3; PAUNOVICH ED, 2000, ORAL DIS UP, V6, P4; Pushpangadan M, 1996, BRIT MED J, V313, P805; Sweeney M P, 1995, Dent Update, V22, P424; Sweeney MP, 1998, ORAL ONCOL, V34, P123, DOI 10.1016/S1368-8375(97)00076-6; Vainio A, 1996, J PAIN SYMPTOM MANAG, V12, P3, DOI 10.1016/0885-3924(96)00042-5; WHO, WHO DEF PALL CAR; Wiseman M A, 2000, Gerodontology, V17, P49, DOI 10.1111/j.1741-2358.2000.00049.x; Wiseman M, 2006, J CAN DENT ASSOC, V72, P453	19	15	16	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0734-0664	1741-2358		GERODONTOLOGY	Gerodontology	JUN	2008	25	2					107	112		10.1111/j.1741-2358.2007.00212.x			6	Dentistry, Oral Surgery & Medicine; Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine; Geriatrics & Gerontology	301VB	WOS:000255922700006	18380782				2022-03-04	
J	Elsig, F; Schimmel, M; Duvernay, E; Giannelli, SV; Graf, CE; Carlier, S; Herrmann, FR; Michel, JP; Gold, G; Zekry, D; Muller, F				Elsig, Fanny; Schimmel, Martin; Duvernay, Elena; Giannelli, Sandra V.; Graf, Christoph E.; Carlier, Sabrina; Herrmann, Francois R.; Michel, Jean-Pierre; Gold, Gabriel; Zekry, Dina; Mueller, Frauke			Tooth loss, chewing efficiency and cognitive impairment in geriatric patients	GERODONTOLOGY			English	Article						elderly; chewing; dementia; geriatrics; mild cognitive impairment; risk factor	NUTRITIONAL ASSESSMENT MNA; ORAL-HEALTH; ALZHEIMERS-DISEASE; OLDER-PEOPLE; NURSING-HOME; WEIGHT-LOSS; DEMENTIA; COMMUNITY; EDENTULISM; REHABILITATION	BackgroundPatients with dementia have poorer oral health and fewer teeth than their peers without cognitive impairment. ObjectiveThe hypothesis of this study is that the number of natural teeth and the chewing efficiency are associated with cognitive functioning. MethodsThis cross-sectional study included 29 patients diagnosed with dementia aged 75years or older and 22 controls who were either cognitively normal (n=19) or with mild cognitive impairment (n=3). Neuropsychological, nutritional and dental assessments were performed. The chewing efficiency was evaluated with a two-colour mixing test. ResultsDemented patients and controls presented with a mean of 4.9 and 6.5 teeth, respectively (n.s.). The number of natural teeth was not associated with dementia (p=0.553). Same results were found for age (p=0.746) and sex (p=0.901). The chewing efficiency by visual inspection proved worse in participants with dementia than in the controls (p<0.011) and explained 9.3% of the variance in the diagnosis of dementia. Neither dental state nor chewing efficiency was related to the nutritional state. ConclusionChewing efficiency seems stronger associated with cognitive impairment than the number of teeth. Hence, in a more holistic approach for the geriatric assessment, the dental examination may be complemented by a chewing efficiency test.	[Elsig, Fanny; Schimmel, Martin; Duvernay, Elena; Mueller, Frauke] Univ Geneva, Sch Dent, Div Gerodontol & Removable Prosthodont, Geneva, Switzerland; [Giannelli, Sandra V.; Graf, Christoph E.; Carlier, Sabrina; Herrmann, Francois R.; Michel, Jean-Pierre; Gold, Gabriel; Zekry, Dina; Mueller, Frauke] Univ Hosp Geneva, Dept Internal Med Rehabil & Geriatr, Thonex, Switzerland		Muller, F (corresponding author), Sch Dent Med, Div Gerodontol & Removable Prosthodont, 19 Rue Barthelemy Menn, CH-1205 Geneva, Switzerland.	Frauke.Mueller@unige.ch	HERRMANN, Francois/M-7390-2019; Müller, Frauke/C-3835-2014; Graf, Christophe/E-8635-2011; HERRMANN, Francois R/B-6710-2011; Schimmel, Martin/F-5694-2011	HERRMANN, Francois/0000-0003-1312-1517; Müller, Frauke/0000-0003-3981-0134; HERRMANN, Francois R/0000-0003-1312-1517; Schimmel, Martin/0000-0001-9700-5534; Graf, Christophe/0000-0002-0235-5046	Swiss Dental Society for Disabled and Elderly Persons (SGZBB); Swiss Society of Odontostomatology (SSO) research funds; Swiss National Research Fund (SNF)Swiss National Science Foundation (SNSF) [102069]	This study was supported by the Swiss Dental Society for Disabled and Elderly Persons (SGZBB), the Swiss Society of Odontostomatology (SSO) research funds, and original study was supported by the Swiss National Research Fund (SNF No 102069).	Adam Helen, 2006, Gerodontology, V23, P99, DOI 10.1111/j.1741-2358.2006.00118.x; Bergdahl M, 2007, SCAND J PSYCHOL, V48, P557, DOI 10.1111/j.1467-9450.2007.00610.x; Bradbury J, 2008, J DENT RES, V87, P720, DOI 10.1177/154405910808700815; Chalmers J, 2005, J ADV NURS, V52, P410, DOI 10.1111/j.1365-2648.2005.03605.x; Chalmers JM, 2002, AUST DENT J, V47, P123, DOI 10.1111/j.1834-7819.2002.tb00315.x; Ellefsen B, 2009, J AM DENT ASSOC, V140, P1392, DOI 10.14219/jada.archive.2009.0076; Farella M, 1999, ARCH ORAL BIOL, V44, P835, DOI 10.1016/S0003-9969(99)00074-6; Ghezzi EM, 2000, ORAL SURG ORAL MED O, V89, P2, DOI 10.1016/S1079-2104(00)80003-7; Gordon S R, 1991, Spec Care Dentist, V11, P49, DOI 10.1111/j.1754-4505.1991.tb00813.x; Grabe HJ, 2009, J CLIN PERIODONTOL, V36, P550, DOI 10.1111/j.1600-051X.2009.01426.x; Hirano Y, 2008, NEUROSCI LETT, V436, P189, DOI 10.1016/j.neulet.2008.03.033; Jensen PM, 2008, J AM GERIATR SOC, V56, P711, DOI 10.1111/j.1532-5415.2008.01631.x; JETTE AM, 1993, J AM GERIATR SOC, V41, P1102, DOI 10.1111/j.1532-5415.1993.tb06459.x; Jones J A, 1993, Gerodontology, V10, P76, DOI 10.1111/j.1741-2358.1993.tb00086.x; Kaiser MJ, 2011, J AM GERIATR SOC, V59, P2124, DOI 10.1111/j.1532-5415.2011.03659.x; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Kimoto K, 2011, J PROSTHODONT RES, V55, P89, DOI 10.1016/j.jpor.2010.09.006; LOESCHE WJ, 1995, ORAL SURG ORAL MED O, V80, P43, DOI 10.1016/S1079-2104(95)80015-8; Matsuo R, 1997, J PHYSIOL-LONDON, V498, P797, DOI 10.1113/jphysiol.1997.sp021903; Millwood J, 2000, Gerodontology, V17, P25, DOI 10.1111/j.1741-2358.2000.00025.x; Miyamoto I, 2005, CLIN ORAL IMPLAN RES, V16, P723, DOI 10.1111/j.1600-0501.2005.01171.x; Miyamoto K, 2011, ASIA PAC J CLIN NUTR, V20, P9; Mojon P, 2004, INT J PROSTHODONT, V17, P434; Morokuma Masakazu, 2008, Nihon Hotetsu Shika Gakkai Zasshi, V52, P194; Moynihan PJ, 2011, ORAL HEALTHCARE FRAI, P73; Nordenram G, 1996, Gerodontology, V13, P9, DOI 10.1111/j.1741-2358.1996.tb00145.x; Okamoto N, 2010, BRAIN RES, V1349, P68, DOI 10.1016/j.brainres.2010.06.054; Ono Takahiro, 2003, Gerodontology, V20, P24, DOI 10.1111/j.1741-2358.2003.00024.x; Ono T, 2007, J NEUROL, V254, P1427, DOI 10.1007/s00415-007-0570-3; Ono Y, 2010, J ORAL REHABIL, V37, P624, DOI 10.1111/j.1365-2842.2010.02079.x; Onozuka M, 2002, BEHAV BRAIN RES, V133, P197, DOI 10.1016/S0166-4328(02)00006-2; Onozuka M, 2002, J DENT RES, V81, P743, DOI 10.1177/154405910208101104; Onozuka M, 2003, J DENT RES, V82, P657, DOI 10.1177/154405910308200817; Onyper SV, 2011, APPETITE, V57, P321, DOI 10.1016/j.appet.2011.05.313; Peltola Petteri, 2004, Gerodontology, V21, P93, DOI 10.1111/j.1741-2358.2004.00012.x; Polzer I, 2010, INT DENT J, V60, P143, DOI 10.1922/IDJ_2184Polzer13; Rubenstein LZ, 2001, J GERONTOL A-BIOL, V56, pM366, DOI 10.1093/gerona/56.6.M366; Schimmel M, 2007, J ORAL REHABIL, V34, P671, DOI 10.1111/j.1365-2842.2007.01773.x; Sheiham A, 2001, J DENT RES, V80, P408, DOI 10.1177/00220345010800020201; SHIP JA, 1994, J AM GERIATR SOC, V42, P57, DOI 10.1111/j.1532-5415.1994.tb06074.x; Simunkovic S Kraljevic, 2005, Gerodontology, V22, P238, DOI 10.1111/j.1741-2358.2005.00086.x; Smith Karen L., 2008, Journal of Nutrition for the Elderly, V27, P381, DOI 10.1080/01639360802265939; Starr JM, 2010, CURR OPIN CLIN NUTR, V13, P19, DOI 10.1097/MCO.0b013e328333aa37; Stewart R, 2007, J AM GERIATR SOC, V55, P1410, DOI 10.1111/j.1532-5415.2007.01298.x; Vidoni ED, 2012, J NEUROL PHYS THER, V36, P8, DOI 10.1097/NPT.0b013e3182462ea6; Vischer UM, 2012, CLIN NUTR, V31, P113, DOI 10.1016/j.clnu.2011.09.010; Weijenberg RAF, 2011, NEUROSCI BIOBEHAV R, V35, P483, DOI 10.1016/j.neubiorev.2010.06.002; Zekry D, 2008, AGE AGEING, V37, P83, DOI 10.1093/ageing/afm132; Zekry D, 2011, DEMENT GERIATR COGN, V32, P103, DOI 10.1159/000326950; Zekry D, 2010, REJUV RES, V13, P675, DOI 10.1089/rej.2010.1037; Zekry D, 2010, J CLIN EPIDEMIOL, V63, P1036, DOI 10.1016/j.jclinepi.2009.11.013; Zekry D, 2010, NEUROBIOL AGING, V31, P719, DOI 10.1016/j.neurobiolaging.2008.05.016; Zekry D, 2009, INT J GERIATR PSYCH, V24, P283, DOI 10.1002/gps.2104; Zhang MY, 2012, DEMENT GER COGN D EX, V2, P200, DOI 10.1159/000338410	54	54	56	0	27	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0734-0664	1741-2358		GERODONTOLOGY	Gerodontology	JUN	2015	32	2					149	156		10.1111/ger.12079			8	Dentistry, Oral Surgery & Medicine; Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine; Geriatrics & Gerontology	CI2GZ	WOS:000354565200010	24128078				2022-03-04	
J	James, RW; Kalix, B; Bioletto, S; Brulhart-Meynet, MC				James, RW; Kalix, B; Bioletto, S; Brulhart-Meynet, MC			Paraoxonase-1 promoter polymorphism C-107T and serum apolipoprotein AI interact to modulate serum paraoxonase-1 status	PHARMACOGENETICS AND GENOMICS			English	Article						oxidative stress; lipoprotein; atherosclerosis; polymorphism; organophosphate	HIGH-DENSITY-LIPOPROTEINS; ANTIOXIDANT ENZYME; STATUS REQUIRES; PON1 GENE; SMOKING; ATHEROGENESIS; PHENOTYPE; DISEASE; MEN	Objectives The objective was to examine the hypothesis that modifications to paraoxonase-1 specific activity (SP, activity per unit mass peptide) could contribute to serum paraoxonase-1 status, a determinant of the clinical efficacy of the enzyme. Methods Enzyme activities and concentrations were determined in a large population (n = 912) of patients and controls. SP were subsequently examined as a function of paraoxonase-1 gene polymorphisms, plasma lipids and lipoproteins, and physiological and pathophysiological parameters. Results Pathophysiological parameters (diabetes, metabolic syndrome, smoking, aging) did not promote variations in paraoxonase-1 SP, whilst coronary disease lowered SP (P < 0.003). No serum lipid, apolipoprotein or lipoprotein component had an impact on specific activity, with the exception of apolipoprotein Al (P < 0.005, both substrates). The paraoxonase-1 promoter C - 107T and Q192R polymorphisms influenced SP and, together with apolipoprotein Al, were highly significant, independent determinants in regression models. There was an interaction between apolipoprotein Al and the C - 107T polymorphism, which significantly modulated SP and serum paraoxonase-1 status. Conclusions Enzyme inactivation giving rise to modulated activity per unit mass of peptide is not a major contributor to pathological effects of disease on serum paraoxonase-1 status. The C - 107T polymorphism and serum apolipoprotein Al have major impacts individually on SP and also provide an example of gene-environment interaction to modulate such activities. These effects accentuate the differences between - 107C and - 107T allele carriers in terms of serum paraoxonase-1 status. The data underline the complexity of the factors that determine serum paraoxonase-1 status and suggest that the latter would benefit from therapeutic modulation of serum high density lipoproteins. (c) 2005 Lippincott Williams & Wilkins.	Univ Hosp, Clin Diabet Unit, Div Endocrinol Diabet & Nutr, CH-1211 Geneva, Switzerland		James, RW (corresponding author), Univ Hosp, Clin Diabet Unit, Div Endocrinol Diabet & Nutr, CH-1211 Geneva, Switzerland.	Richard.James@hcuge.ch					ABBOTT CA, 1995, ARTERIOSCL THROM VAS, V15, P1812, DOI 10.1161/01.ATV.15.11.1812; Ansell BJ, 2004, REV ENDOCR METAB DIS, V5, P351, DOI 10.1023/B:REMD.0000045107.71895.b2; Araki S, 2000, DIABETOLOGIA, V43, P1540, DOI 10.1007/s001250051566; Aviram M, 1999, FREE RADICAL BIO MED, V26, P892, DOI 10.1016/S0891-5849(98)00272-X; Aviram M, 1998, ATHEROSCLEROSIS, V138, P271, DOI 10.1016/S0021-9150(98)00032-X; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; Blatter-Garin MC, 2003, DIABETOLOGIA, V46, P593, DOI 10.1007/s00125-003-1065-0; Boemi M, 2001, ATHEROSCLEROSIS, V155, P229, DOI 10.1016/S0021-9150(00)00556-6; Boemi M, 2004, DIABETIC MED, V21, P423, DOI 10.1111/j.1464-5491.2004.01163.x; Brophy VH, 2000, PHARMACOGENETICS, V10, P453, DOI 10.1097/00008571-200007000-00008; Brophy VH, 2001, AM J HUM GENET, V68, P1428, DOI 10.1086/320600; Brophy VH, 2001, PHARMACOGENETICS, V11, P77, DOI 10.1097/00008571-200102000-00009; Costa LG, 2005, BIOCHEM PHARMACOL, V69, P541, DOI 10.1016/j.bcp.2004.08.027; Dantoine TF, 1998, J AM SOC NEPHROL, V9, P2082; Deakin S, 2002, J BIOL CHEM, V277, P4301, DOI 10.1074/jbc.M107440200; Deakin SP, 2004, CLIN SCI, V107, P435, DOI 10.1042/CS20040187; Durrington PN, 2001, ARTERIOSCL THROM VAS, V21, P473, DOI 10.1161/01.ATV.21.4.473; Garin MCB, 1997, J CLIN INVEST, V99, P62, DOI 10.1172/JCI119134; GARIN MCB, 1994, BIOCHEM J, V304, P549, DOI 10.1042/bj3040549; Hansel B, 2004, J CLIN ENDOCR METAB, V89, P4963, DOI 10.1210/jc.2004-0305; Harel M, 2004, NAT STRUCT MOL BIOL, V11, P412, DOI 10.1038/nsmb767; Hebert R, 2000, STROKE, V31, P1487, DOI 10.1161/01.STR.31.7.1487; JAMES RW, 1990, DIABETES, V39, P1158, DOI 10.2337/diabetes.39.10.1158; James RW, 2000, CIRCULATION, V101, P2252, DOI 10.1161/01.CIR.101.19.2252; Jarvik GP, 2000, ARTERIOSCL THROM VAS, V20, P2441, DOI 10.1161/01.ATV.20.11.2441; Jarvik GP, 2002, ARTERIOSCL THROM VAS, V22, P1329, DOI 10.1161/01.ATV.0000027101.40323.3A; Jarvik GP, 2003, PHARMACOGENETICS, V13, P291, DOI 10.1097/00008571-200305000-00009; Josse D, 2002, J BIOL CHEM, V277, P33386, DOI 10.1074/jbc.M200108200; La Du B, 1992, PHARMACOGENETICS DRU, P51; Leviev I, 2000, ARTERIOSCL THROM VAS, V20, P516, DOI 10.1161/01.ATV.20.2.516; Leviev N, 2001, J MOL MED, V79, P457, DOI 10.1007/s001090100240; Mackness B, 2001, ARTERIOSCL THROM VAS, V21, P1451, DOI 10.1161/hq0901.094247; Marsh JB, 2000, CURR OPIN LIPIDOL, V11, P261, DOI 10.1097/00041433-200006000-00006; MORROW JD, 1995, NEW ENGL J MED, V332, P1198, DOI 10.1056/NEJM199505043321804; Navab M, 2004, J LIPID RES, V45, P993, DOI 10.1194/jlr.R400001-JLR200; Nofer JR, 2001, J BIOL CHEM, V276, P34480, DOI 10.1074/jbc.M103782200; Oda MN, 2001, BIOCHEMISTRY-US, V40, P1710, DOI 10.1021/bi001922h; Richter RJ, 1999, PHARMACOGENETICS, V9, P745, DOI 10.1097/00008571-199912000-00009; Senti M, 2000, GENET EPIDEMIOL, V18, P276, DOI 10.1002/(SICI)1098-2272(200003)18:3<276::AID-GEPI6>3.0.CO;2-J; Shih DM, 1996, J CLIN INVEST, V97, P1630, DOI 10.1172/JCI118589; Spieker LE, 2002, CIRCULATION, V105, P1399, DOI 10.1161/01.CIR.0000013424.28206.8F; Suehiro T, 2000, ATHEROSCLEROSIS, V150, P295, DOI 10.1016/S0021-9150(99)00379-2; van der Gaag MS, 1999, ATHEROSCLEROSIS, V147, P405, DOI 10.1016/S0021-9150(99)00243-9; Vlassara H, 2004, REV ENDOCR METAB DIS, V5, P181, DOI 10.1023/B:REMD.0000032406.84813.f6; von Eckardstein A, 2001, ARTERIOSCL THROM VAS, V21, P13, DOI 10.1161/01.ATV.21.1.13	45	5	5	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1744-6872	1744-6880		PHARMACOGENET GENOM	Pharmacogenet. Genomics	JUN	2005	15	6					441	446		10.1097/01213011-200506000-00011			6	Biotechnology & Applied Microbiology; Genetics & Heredity; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity; Pharmacology & Pharmacy	939WE	WOS:000230102500011	15900219				2022-03-04	
J	Muehlemann, MB; Peterson, CK; Humphreys, BK				Muehlemann, Malin B.; Peterson, Cynthia K.; Humphreys, B. Kim			Differences in Outcomes of Patients Treated by Male vs Female Chiropractors	JOURNAL OF MANIPULATIVE AND PHYSIOLOGICAL THERAPEUTICS			English	Article						Patient Outcome Assessment; Chiropractic	LOW-BACK-PAIN; BOURNEMOUTH QUESTIONNAIRE; GERMAN VERSION; DISABILITY; HEALTH; CARE; VALIDATION; PROGRAM; GENDER; MODE	Objective: The purpose of this study was to compare treatment outcomes of low back pain patients depending on the sex of the treating doctor of chiropractic (DC). Methods: For this study, 1095 adult patients with no manual therapy in the prior 3 months were recruited. Pretreatment pain levels (Numeric Rating Scale for pain [NRS]), Oswestry Disability Index (ODI), and patient demographic details were recorded. The NRS and Patient Global Impression of Change were assessed after 1 week and 1, 3, 6, and 12 months. The ODI was completed up to 3 months. The. 2 test compared sex of the DC with the proportion of patients "improved" at all time points and with baseline categorical variables. The unpaired t test compared changes in NRS and ODI scores between patients of male and female DCs. Results: Female DCs saw proportionally more acute patients (P = .012). Patients of male DCs presented more often with radiculopathy (P = .007). There were no differences in NRS and ODI baseline scores between male and female DCs' patients. At 1 week and 3 and 12 months, significantly more patients of female DCs reported improvement and they had greater decreases in NRS and ODI scores at 1 week. Removing acute patients from the data, there were no longer differences in outcome. Conclusions: Significant differences in treatment outcome in favor of female DCs was no longer present on removal of the acute subgroup from the data. This suggests that patient outcome is influenced by other factors, such as chronicity, rather than sex of the treating DC.	[Muehlemann, Malin B.; Humphreys, B. Kim] Univ Zurich, Chiropract Med, Fac Med, Zurich, Switzerland; [Peterson, Cynthia K.] Univ Hosp Balgrist, Orthoped Chiropract Med, Fac Med, Zurich, Switzerland		Muehlemann, MB (corresponding author), Beustweg 8, CH-8032 Zurich, Switzerland.	malin.muehlemann@gmx.ch		Muhlemann, Malin/0000-0002-3669-1689	European Chiropractor's Union; Balgrist Foundation; Uniscientia Foundation	This study was funded by the European Chiropractor's Union, The Balgrist Foundation, and Uniscientia Foundation. No conflicts of interest were reported for this study.	Anonymous, 2008, Annales de Readaptation et de Medecine Physique, V51, P379, DOI 10.1016/j.annrmp.2008.03.006; Axen I, 2002, J MANIP PHYSIOL THER, V25, P450, DOI 10.1067/mmt.2002.126473; Bell RA, 2002, J GEN INTERN MED, V17, P817, DOI 10.1046/j.1525-1497.2002.10319.x; Bertakis Klea D, 2003, J Am Med Womens Assoc (1972), V58, P69; Blum-Fowler C, 2013, CHIROPR MAN THER, V21, DOI 10.1186/2045-709X-21-32; Bolton JE, 1999, J MANIP PHYSIOL THER, V22, P503, DOI 10.1016/S0161-4754(99)70001-1; Buddeberg-Fischer B, 2003, SWISS MED WKLY, V133, P535; Buddeberg-Fischer B, 2009, DEUT MED WOCHENSCHR, V134, P2451, DOI 10.1055/s-0029-1243027; Buddeberg-Fischer Barbara, 2010, Swiss Med Wkly, V140, pw13134, DOI 10.4414/smw.2010.13134; Buddeberg-Fischer B, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-120; Childs JD, 2004, ANN INTERN MED, V141, P920, DOI 10.7326/0003-4819-141-12-200412210-00008; Cousin G, 2012, PATIENT EDUC COUNS, V87, P193, DOI 10.1016/j.pec.2011.08.004; Fischer D, 1999, JAMA-J AM MED ASSOC, V282, P1157, DOI 10.1001/jama.282.12.1157; George SZ, 2006, J OCCUP REHABIL, V16, P95, DOI 10.1007/s10926-005-9007-y; Hall JA, 2015, HEALTH COMMUN, V30, P894, DOI 10.1080/10410236.2014.900892; Hanmer J, 2007, MED CARE, V45, P1171, DOI 10.1097/MLR.0b013e3181354828; Hays RD, 2009, VALUE HEALTH, V12, P1035, DOI 10.1111/j.1524-4733.2009.00566.x; Heiligers PJM, 2000, SOC SCI MED, V50, P1235, DOI 10.1016/S0277-9536(99)00363-9; Humphreys BK, 2010, J MANIP PHYSIOL THER, V33, P519, DOI 10.1016/j.jmpt.2010.08.003; Kongsted Alice, 2010, Chiropr Osteopat, V18, P8, DOI 10.1186/1746-1340-18-8; Kongsted Alice, 2010, Chiropr Osteopat, V18, P2, DOI 10.1186/1746-1340-18-2; Kraft E, 2008, SCHWEIZERISCHE ARZTE, V90, P455; Kraft E, 2009, SCHWEIZERISCHE ARZTE, V90, P1733; Linton SJ, 2011, EUR J PAIN, V15, P416, DOI 10.1016/j.ejpain.2010.08.009; Malmqvist Stefan, 2009, Chiropr Osteopat, V17, P7, DOI 10.1186/1746-1340-17-7; Mannion AF, 2006, EUR SPINE J, V15, P55, DOI 10.1007/s00586-004-0815-0; Mercado AC, 2005, PAIN, V117, P51, DOI 10.1016/j.pain.2005.05.014; Newell D, 2010, SPINE, V35, P1801, DOI 10.1097/BRS.0b013e3181cc006b; Peterson CK, 2012, J MANIP PHYSIOL THER, V35, P525, DOI 10.1016/j.jmpt.2012.06.003; Pincus T, 2013, SPINE, V38, P2118, DOI 10.1097/BRS.0b013e3182a8c5d6; Pinheiro MB, 2016, SPINE J, V16, P105, DOI 10.1016/j.spinee.2015.10.037; Powers JR, 2005, AUST NZ J PUBL HEAL, V29, P149, DOI 10.1111/j.1467-842X.2005.tb00065.x; Ramond A, 2011, FAM PRACT, V28, P12, DOI 10.1093/fampra/cmq072; Roland M, 2000, SPINE, V25, P3115, DOI 10.1097/00007632-200012150-00006; WADDELL G, 1992, BAILLIERE CLIN RHEUM, V6, P523, DOI 10.1016/S0950-3579(05)80126-8; Woby SR, 2007, EUR J PAIN, V11, P711, DOI 10.1016/j.ejpain.2006.10.009	36	0	0	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0161-4754			J MANIP PHYSIOL THER	J. Manip. Physiol. Ther.	JUL-AUG	2017	40	6					420	426		10.1016/j.jmpt.2017.05.001			7	Health Care Sciences & Services; Integrative & Complementary Medicine; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Integrative & Complementary Medicine; Rehabilitation	FM2JH	WOS:000414810500007	28645451	Bronze			2022-03-04	
J	Knecht, C; Humphreys, BK; Wirth, B				Knecht, Christina; Humphreys, Barry Kim; Wirth, Brigitte			An Observational Study on Recurrences of Low Back Pain During the First 12 Months After Chiropractic Treatment	JOURNAL OF MANIPULATIVE AND PHYSIOLOGICAL THERAPEUTICS			English	Article						Chiropractic; Low Back Pain; Recurrence	LATENT CLASS ANALYSIS; OF-THE-LITERATURE; PRIMARY-CARE; COMPARING OUTCOMES; PROGNOSTIC-FACTORS; DISABILITY; COHORT; POPULATION; RECOVERY; EPISODE	Objectives: The purpose of this study was to investigate recurrence rate and prognostic factors in a large population of patients with low back pain (LBP) up to 1 year after chiropractic care using standardized definitions. Methods: In Switzerland, 722 patients with LBP (375 male; mean age = 44.5 +/- 13.8 years) completed the Numeric Rating Scale for pain (NRS) and the Oswestry Disability Index (ODI) before treatment and 1, 3, 6, and 12months later (ODI up to 3 months). Based on NRS values, patients were categorized as "fast recovery," "slow recovery," "recurrent," "chronic," and "others." In multivariable logistic regression models, age, sex, work status, duration of complaint (subacute: >= 14 days to <3 months; chronic: >= 3 months), previous episodes, baseline NRS, and baseline ODI were investigated as predictors. Results: Based on NRS values, 13.4% of the patients were categorized as recurrent. The recurrent pattern significantly differed from fast recovery in duration of complaint (subacute: odds ratio [OR] = 3.3; chronic: OR = 10.1). The recurrent and chronic pattern significantly differed in duration of complaint (chronic: OR = 0.14) and baseline NRS (OR = 0.75). Conclusion: Recurrence rate was low in this LBP patient population. The duration of complaint before treatment was the main predictor for recurrence. The fact that even subacute duration significantly increased the odds for an unfavorable course of LBP is of clinical relevance.	Univ Zurich, Chiropract Med Dept, Fac Med, Zurich, Switzerland; [Wirth, Brigitte] Univ Hosp Balgrist, Forchstr 340, CH-8008 Zurich, Switzerland		Wirth, B (corresponding author), Univ Hosp Balgrist, Forchstr 340, CH-8008 Zurich, Switzerland.	brigitte.wirth@balgrist.ch			Balgrist Hospital Foundation; Chirosuisse Foundation; Uniscientia Foundation; European Academy for Chiropractic	The following were funding sources for this study: Balgrist Hospital Foundation, Chirosuisse Foundation, Uniscientia Foundation, and European Academy for Chiropractic. No conflicts of interest were reported for this study.	Anonymous, 2008, Annales de Readaptation et de Medecine Physique, V51, P379, DOI 10.1016/j.annrmp.2008.03.006; Bekkering GE, 2005, SPINE, V30, P1881, DOI 10.1097/01.brs.0000173901.64181.db; Boonstra AM, 2014, PAIN, V155, P2545, DOI 10.1016/j.pain.2014.09.014; Burton AK, 1999, SPINE, V24, P2484, DOI 10.1097/00007632-199912010-00010; Carey TS, 2000, SPINE, V25, P115, DOI 10.1097/00007632-200001010-00019; Chou R, 2010, JAMA-J AM MED ASSOC, V303, P1295, DOI 10.1001/jama.2010.344; Dionne CE, 2006, AGE AGEING, V35, P229, DOI 10.1093/ageing/afj055; Donelson R, 2012, PM&R, V4, P394, DOI 10.1016/j.pmrj.2011.10.015; Downie AS, 2016, PAIN, V157, P225, DOI 10.1097/j.pain.0000000000000351; Dunn KM, 2006, AM J EPIDEMIOL, V163, P754, DOI 10.1093/aje/kwj100; Enthoven P, 2006, PAIN, V122, P137, DOI 10.1016/j.pain.2006.01.022; Field A., 2009, DISCOVERING STAT USI; Hancock MJ, 2015, SPINE J, V15, P2360, DOI 10.1016/j.spinee.2015.07.007; Heymans MW, 2010, SPINE J, V10, P847, DOI 10.1016/j.spinee.2010.06.005; Hoy D, 2014, ANN RHEUM DIS, V73, P968, DOI 10.1136/annrheumdis-2013-204428; Kamper SJ, 2011, EUR SPINE J, V20, P9, DOI 10.1007/s00586-010-1477-8; Kent Peter M, 2005, Chiropr Osteopat, V13, P13, DOI 10.1186/1746-1340-13-13; Kongsted A, 2015, SPINE J, V15, P885, DOI 10.1016/j.spinee.2015.02.012; Kovacs FM, 2005, SPINE, V30, P1786, DOI 10.1097/01.brs.0000172159.47152.dc; Mannion AF, 2006, EUR SPINE J, V15, P55, DOI 10.1007/s00586-004-0815-0; Mantel KE, 2016, J MANIP PHYSIOL THER, V39, P141, DOI 10.1016/j.jmpt.2016.02.005; Maughan EF, 2010, EUR SPINE J, V19, P1484, DOI 10.1007/s00586-010-1353-6; Pengel LHM, 2003, BMJ-BRIT MED J, V327, P323, DOI 10.1136/bmj.327.7410.323; Shaw WS, 2001, DISABIL REHABIL, V23, P815; Stanton TR, 2011, EUR SPINE J, V20, P744, DOI 10.1007/s00586-010-1671-8; Stanton TR, 2009, SPINE, V34, pE316, DOI 10.1097/BRS.0b013e318198d073; Stanton TR, 2008, SPINE, V33, P2923, DOI 10.1097/BRS.0b013e31818a3167; Steenstra IA, 2005, OCCUP ENVIRON MED, V62, P851, DOI 10.1136/oem.2004.015842; Tape T., INTERPRETING DIAGNOS; Teichtahl AJ, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0629-y; Thelin A, 2008, J REHABIL MED, V40, P555, DOI 10.2340/16501977-0205; Verkerk K, 2015, EUR J PAIN, V19, P1101, DOI 10.1002/ejp.633	32	0	0	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0161-4754			J MANIP PHYSIOL THER	J. Manip. Physiol. Ther.	JUL-AUG	2017	40	6					427	433		10.1016/j.jmpt.2017.03.005			7	Health Care Sciences & Services; Integrative & Complementary Medicine; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services; Integrative & Complementary Medicine; Rehabilitation	FM2JH	WOS:000414810500008	28822475	Bronze			2022-03-04	
J	Ehrler, M; Peterson, C; Leemann, S; Schmid, C; Anklin, B; Humphreys, BK				Ehrler, Marco; Peterson, Cynthia; Leemann, Serafin; Schmid, Christof; Anklin, Bernard; Humphreys, B. Kim			SYMPTOMATIC, MRI CONFIRMED, LUMBAR DISC HERNIATIONS: A COMPARISON OF OUTCOMES DEPENDING ON THE TYPE AND ANATOMICAL AXIAL LOCATION OF THE HERNIA IN PATIENTS TREATED WITH HIGH-VELOCITY, LOW-AMPLITUDE SPINAL MANIPULATION	JOURNAL OF MANIPULATIVE AND PHYSIOLOGICAL THERAPEUTICS			English	Article						Magnetic Resonance Imaging; Spine; Lumbar Vertebrae; Intervertebral Disc Displacement; Manipulation; Spinal	LOW-BACK-PAIN; CHIROPRACTIC TREATMENT; RISK-FACTORS; DEGENERATION; IMPROVEMENT; POPULATION; PREDICTORS	Objective: The purpose of this study was to evaluate whether specific MRI features, such as axial location and type of herniation, are associated with outcomes of symptomatic lumbar disc herniation patients treated with spinal manipulation therapy (SMT). Methods: MRI and treatment outcome data from 68 patients were included in this prospective outcomes study. Pain numerical rating scale (NRS) and Oswestry physical disability questionnaire (OPDQ) levels were measured at baseline. The Patients Global Impression of Change scale, the NRS and the OPDQ were collected at 2 weeks, 1, 3, 6 months and 1 year. One radiologist and 2 chiropractic medicine master's degree students analyzed the MRI scans blinded to treatment outcomes. kappa statistics assessed inter-rater reliability of MRI diagnosis. The proportion of patients reporting relevant improvement at each time point was compared based on MRI findings using the chi-square test. The t test and ANOVA compared the NRS and OPDQ change scores between patients with various MRI abnormalities. Results: A higher proportion of patients with disc sequestration reported relevant improvement at each time point but this did not quite reach statistical significance. Patients with disc sequestration had significantly higher reduction in leg pain at 1 month compared to those with extrusion (P=.02). Reliability of MRI diagnosis ranged from substantial to perfect (K=.733-1.0). Conclusions: Patients with sequestered herniations treated with SMT to the level of herniation reported significantly higher levels of leg pain reduction at 1 month and a higher proportion reported improvement at all data collection time points but this did not reach statistical significance.	[Ehrler, Marco; Peterson, Cynthia; Humphreys, B. Kim] Univ Zurich, Orthopaed Univ Hosp Balgrist, Fac Med, Chiropract Med Dept, Zurich, Switzerland		Peterson, C (corresponding author), Uniklin Balgrist, Forchstr 340, CH-8004 Zurich, Switzerland.	xraydcpeterson@yahoo.ca			European Chiropractors' Union; Balgrist Foundation; Uniscientia Foundation	The European Chiropractors' Union, the Balgrist Foundation, and the Uniscientia Foundation for providing funding for this study. No conflicts of interest were reported for this study.	Axen I, 2005, J MANIP PHYSIOL THER, V28, P381, DOI 10.1016/j.jmpt.2005.06.008; Bajpai J, 2013, J CRANIOVERTEBRAL JU, V4, P16, DOI 10.4103/0974-8237.121619; Battie MC, 2007, PAIN, V131, P272, DOI 10.1016/j.pain.2007.01.010; Bensler S, 2015, EUR RADIOL, V25, P3405, DOI 10.1007/s00330-015-3758-4; Blum-Fowler C, 2013, CHIROPR MAN THER, V21, DOI 10.1186/2045-709X-21-32; BODEN SD, 1990, J BONE JOINT SURG AM, V72A, P403, DOI 10.2106/00004623-199072030-00013; Endean A, 2011, SPINE, V36, P160, DOI 10.1097/BRS.0b013e3181cd9adb; Fardon DF, 2014, SPINE J, V14, P2525, DOI 10.1016/j.spinee.2014.04.022; Gore M, 2012, SPINE, V37, pE668, DOI 10.1097/BRS.0b013e318241e5de; Kerr D, 2015, CLIN ORTHOP RELAT R, V473, P1920, DOI 10.1007/s11999-014-3803-7; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Leemann S, 2014, J MANIP PHYSIOL THER, V37, P155, DOI 10.1016/j.jmpt.2013.12.011; Masui T, 2005, J SPINAL DISORD TECH, V18, P121, DOI 10.1097/01.bsd.0000154452.13579.b2; McMorland G, 2010, J MANIP PHYSIOL THER, V33, P576, DOI 10.1016/j.jmpt.2010.08.013; Peterson CK, 2012, J MANIP PHYSIOL THER, V35, P525, DOI 10.1016/j.jmpt.2012.06.003; Pfirrmann CWA, 2004, RADIOLOGY, V230, P583, DOI 10.1148/radiol.2302021289; Santilli Valter, 2006, Spine J, V6, P131, DOI 10.1016/j.spinee.2005.08.001; Sutheerayongprasert Chaiyuth, 2012, Journal of the Medical Association of Thailand, V95, P674; Teraguchi M, 2015, SPINE J, V15, P622, DOI 10.1016/j.spinee.2014.11.012; van Tulder M, 2002, BEST PRACT RES CL RH, V16, P761, DOI 10.1053/berh.2002.0267; Vucetic N, 1996, CLIN ORTHOP RELAT R, P192; Zhang YG, 2013, AM J PATHOL, V182, P56, DOI 10.1016/j.ajpath.2012.09.013; Zhang YG, 2009, SPINE, V34, pE918, DOI 10.1097/BRS.0b013e3181a3c2de	23	9	9	0	17	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0161-4754			J MANIP PHYSIOL THER	J. Manip. Physiol. Ther.	MAR-APR	2016	39	3					192	199		10.1016/j.jmpt.2016.02.013			8	Health Care Sciences & Services; Integrative & Complementary Medicine; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services; Integrative & Complementary Medicine; Rehabilitation	DK8NV	WOS:000375184500007	27034106				2022-03-04	
J	Leemann, S; Peterson, CK; Schmid, C; Anklin, B; Humphreys, BK				Leemann, Serafin; Peterson, Cynthia K.; Schmid, Christof; Anklin, Bernard; Humphreys, B. Kim			OUTCOMES OF ACUTE AND CHRONIC PATIENTS WITH MAGNETIC RESONANCE IMAGING-CONFIRMED SYMPTOMATIC LUMBAR DISC HERNIATIONS RECEIVING HIGH-VELOCITY, LOW-AMPLITUDE, SPINAL MANIPULATIVE THERAPY: A PROSPECTIVE OBSERVATIONAL COHORT STUDY WITH ONE-YEAR FOLLOW-UP	JOURNAL OF MANIPULATIVE AND PHYSIOLOGICAL THERAPEUTICS			English	Article						Intervertebral Disc Displacement; Lumbar Vertebrae Manipulation; Spinal; Chiropractic	LOW-BACK-PAIN; OF-THE-LITERATURE; CHIROPRACTIC TREATMENT; CONTROLLED-TRIAL; SCIATICA; IMPROVEMENT; VALIDATION	Objective: The purposes of this study were to evaluate patients with low-back pain (LBP) and leg pain due to magnetic resonance imaging-confirmed disc herniation who are treated with high-velocity, low-amplitude spinal manipulation in terms of their short-, medium-, and long-term outcomes of self-reported global impression of change and pain levels at various time points up to 1 year and to determine if outcomes differ between acute and chronic patients using a prospective, cohort design. Methods: This prospective cohort outcomes study includes 148 patients (between ages of 18 and 65 years) with LBP, leg pain, and physical examination abnormalities with concordant lumbar disc herniations. Baseline numerical rating scale (NRS) data for LBP, leg pain, and the Oswestry questionnaire were obtained. The specific lumbar spinal manipulation was dependent upon whether the disc herniation was intraforaminal or paramedian as seen on the magnetic resonance images and was performed by a doctor of chiropractic. Outcomes included the patient's global impression of change scale for overall improvement, the NRS for LBP, leg pain, and the Oswestry questionnaire at 2 weeks, 1, 3, and 6 months, and 1 year after the first treatment. The proportion of patients reporting "improvement" on the patient's global impression of change scale was calculated for all patients and acute vs chronic patients. Pretreatment and posttreatment NRS scores were compared using the paired t test. Baseline and follow-up Oswestry scores were compared using the Wilcoxon test. Numerical rating scale and Oswestry scores for acute vs chronic patients were compared using the unpaired t test for NRS scores and the Mann-Whitney U test for Oswestry scores. Logistic regression analysis compared baseline variables with "improvement." Results: Significant improvement for all outcomes at all time points was reported (P < .0001). At 3 months, 90.5% of patients were "improved" with 88.0% "improved" at 1 year. Although acute patients improved faster by 3 months, 81.8% of chronic patients reported "improvement" with 89.2% "improved" at 1 year. There were no adverse events reported. Conclusions: A large percentage of acute and importantly chronic lumbar disc herniation patients treated with chiropractic spinal manipulation reported clinically relevant improvement.	[Peterson, Cynthia K.] Univ Zurich, Orthopaed Univ Hosp Balgrist, Chiropract Med Dept, Zurich, Switzerland; [Peterson, Cynthia K.] Univ Zurich, Orthopaed Univ Hosp Balgrist, Dept Radiol, Zurich, Switzerland; [Humphreys, B. Kim] Univ Zurich, Orthopaed Univ Hosp Balgrist, Chiropract Med Dept, Fac Med, Zurich, Switzerland		Peterson, CK (corresponding author), Orthopaed Univ Hosp Balgrist, Dept Chiropract Med, Forchstr 340, CH-8008 Zurich, Switzerland.	cynthia.peterson@balgrist.ch			European Academy for Chiropractic; Uniscientia Foundation; Balgrist Hospital Foundation	The European Academy for Chiropractic, the Uniscientia Foundation, and the Balgrist Hospital Foundation for providing grants for this research. No conflicts of interest were reported for this study.	Assendelft WJJ, 2003, ANN INTERN MED, V138, P871, DOI 10.7326/0003-4819-138-11-200306030-00008; Axen I, 2005, J MANIP PHYSIOL THER, V28, P381, DOI 10.1016/j.jmpt.2005.06.008; CASSIDY JD, 1993, J MANIP PHYSIOL THER, V16, P96; Childs JD, 2004, ANN INTERN MED, V141, P920, DOI 10.7326/0003-4819-141-12-200412210-00008; Gore M, 2012, SPINE, V37, pE668, DOI 10.1097/BRS.0b013e318241e5de; HELIOVAARA M, 1991, SPINE, V16, P608, DOI 10.1097/00007632-199106000-00002; HELIOVAARA M, 1987, J EPIDEMIOL COMMUN H, V41, P251, DOI 10.1136/jech.41.3.251; Lawrence DJ, 2008, J MANIP PHYSIOL THER, V31, P659, DOI 10.1016/j.jmpt.2008.10.007; Leininger B, 2011, PHYS MED REH CLIN N, V22, P105, DOI 10.1016/j.pmr.2010.11.002; Lisi AJ, 2005, J MANIP PHYSIOL THER, V28, P429, DOI 10.1016/j.jmpt.2005.06.013; Luijsterburg PAJ, 2007, EUR SPINE J, V16, P881, DOI 10.1007/s00586-007-0367-1; McMorland G, 2010, J MANIP PHYSIOL THER, V33, P576, DOI 10.1016/j.jmpt.2010.08.013; Oiphant D, 2004, J MANIP PHYSIOL THER, V27, P197; Petersen T, 2011, SPINE, V36, P1999, DOI 10.1097/BRS.0b013e318201ee8e; Peterson CK, 2013, J MANIP PHYSIOL THER, V36, P461, DOI 10.1016/j.jmpt.2013.07.002; Peterson CK, 2013, J MANIP PHYSIOL THER, V36, P218, DOI 10.1016/j.jmpt.2013.04.005; Peterson CK, 2012, J MANIP PHYSIOL THER, V35, P525, DOI 10.1016/j.jmpt.2012.06.003; Peul WC, 2007, NEW ENGL J MED, V356, P2245, DOI 10.1056/NEJMoa064039; Santilli Valter, 2006, Spine J, V6, P131, DOI 10.1016/j.spinee.2005.08.001; Scholz J, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000047; Tamburrelli FC, 2011, EUR SPINE J, V20, P128, DOI 10.1007/s00586-011-1745-2; Tinetti ME, 2011, NEW ENGL J MED, V364, P2478, DOI 10.1056/NEJMp1100535; Van Spall HGC, 2007, JAMA-J AM MED ASSOC, V297, P1233, DOI 10.1001/jama.297.11.1233; van Tulder M, 2002, BEST PRACT RES CL RH, V16, P761, DOI 10.1053/berh.2002.0267; Vroomen PCAJ, 2002, BRIT J GEN PRACT, V52, P119; WEBER H, 1993, SPINE, V18, P1433, DOI 10.1097/00007632-199309010-00006	26	15	15	0	19	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0161-4754			J MANIP PHYSIOL THER	J. Manip. Physiol. Ther.	MAR-APR	2014	37	3					155	163		10.1016/j.jmpt.2013.12.011			9	Health Care Sciences & Services; Integrative & Complementary Medicine; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services; Integrative & Complementary Medicine; Rehabilitation	AE2KS	WOS:000333802400002	24636109	hybrid			2022-03-04	
J	Mantel, KE; Peterson, CK; Humphreys, BK				Mantel, Karin E.; Peterson, Cynthia K.; Humphreys, B. Kim			EXPLORING THE DEFINITION OF ACUTE LOW BACK PAIN: A PROSPECTIVE OBSERVATIONAL COHORT STUDY COMPARING OUTCOMES OF CHIROPRACTIC PATIENTS WITH 0-2, 2-4, AND 4-12 WEEKS OF SYMPTOMS	JOURNAL OF MANIPULATIVE AND PHYSIOLOGICAL THERAPEUTICS			English	Article						Low Back Pain; Chiropractic; Treatment Outcome	QUALITY-OF-LIFE; PRIMARY-CARE; SUBPOPULATION PROGRAM; INCEPTION COHORT; PROGNOSTIC-FACTORS; GENERAL-PRACTICE; CLINICAL-COURSE; GUIDELINES; MANAGEMENT; IMPROVEMENT	Objective: The purpose of this study was to compare improvement rates in patients with low back pain (LBP) undergoing chiropractic treatment with 0-2 weeks vs 2-4 and 4-12 weeks of symptoms. Methods: This was a prospective cohort outcome study with 1-year follow-up including adult acute (symptoms 0-4 weeks) LBP patients. The numerical rating scale for pain (NRS) and Oswestry questionnaire were completed at baseline, 1 week, 1 month, and 3 months after starting treatment. The Patient Global Impression of Change (PGIC) scale was completed at all follow-up time points. At 6 months and 1 year, NRS and PGIC data were collected. The proportion of patients reporting relevant "improvement" (PGIC scale) was compared between patients having 0-2 and 2-4 weeks of symptoms using the chi(2) test at all data collection time points. The unpaired t test compared NRS and Oswestry change scores between these 2 groups. Results: Patients with 0-2 weeks of symptoms were significantly more likely to "improve" at 1 week, 1 month, and 6 months compared with those with 2-4 weeks of symptoms (P < .015). Patients with 0-2 weeks of symptoms reported significantly higher NRS and Oswestry change scores at all data collection time points. Outcomes for patients with 2-4 weeks of symptoms were similar to patients having 4-12 weeks of symptoms. Conclusion: The time period 0-4 weeks as the definition of "acute" should be challenged. Patients with 2-4 weeks of symptoms had outcomes similar to patients with subacute (4-12 weeks) symptoms and not with patients reporting 0-2 weeks of symptoms.	[Mantel, Karin E.; Humphreys, B. Kim] Univ Zurich, Fac Med, Chiropract Med Dept, CH-8006 Zurich, Switzerland; [Peterson, Cynthia K.] Univ Zurich, Orthoped Univ Hosp Balgrist, Dept Chiropract Med, CH-8006 Zurich, Switzerland; [Peterson, Cynthia K.] Univ Zurich, Orthoped Univ Hosp Balgrist, Dept Radiol, CH-8006 Zurich, Switzerland		Peterson, CK (corresponding author), Orthopaed Univ Hosp Balgrist, Forchstr 340, CH-8008 Zurich, Switzerland.	xraydcpeterson@yahoo.ca			European Academy of Chiropractic; Balgrist Hospital Stiftung	Funding for this study was provided from the European Academy of Chiropractic and Balgrist Hospital Stiftung. No conflicts of interest were reported for this study.	Anonymous, 2008, Annales de Readaptation et de Medecine Physique, V51, P379, DOI 10.1016/j.annrmp.2008.03.006; Axen I, 2005, J MANIP PHYSIOL THER, V28, P381, DOI 10.1016/j.jmpt.2005.06.008; Axen I, 2005, J MANIP PHYSIOL THER, V28, P153, DOI 10.1016/j.jmpt.2005.02.007; Becker A, 2010, SPINE, V35, P1714, DOI 10.1097/BRS.0b013e3181cd656f; Bensler S, 2015, EUR RADIOL, V25, P3405, DOI 10.1007/s00330-015-3758-4; Bevan S, 2009, FIT WORK MUSCULOSKEL; Blum-Fowler C, 2013, CHIROPR MAN THER, V21, DOI 10.1186/2045-709X-21-32; Bouter LM, 1998, SPINE, V23, P2014, DOI 10.1097/00007632-199809150-00019; Bouter LM, 2003, SPINE, V28, P1215, DOI 10.1097/00007632-200306150-00002; Brennan GP, 2006, SPINE, V31, P623, DOI 10.1097/01.brs.0000202807.72292.a8; Bronfort Gert, 2010, Chiropr Osteopat, V18, P3, DOI 10.1186/1746-1340-18-3; Carey TS, 2000, SPINE, V25, P115, DOI 10.1097/00007632-200001010-00019; COSTE J, 1994, BRIT MED J, V308, P577, DOI 10.1136/bmj.308.6928.577; Croft PR, 1998, BRIT MED J, V316, P1356, DOI 10.1136/bmj.316.7141.1356; de Vet HCW, 2002, SPINE, V27, P2409, DOI 10.1097/00007632-200211010-00016; Deyo RA, 2014, J PAIN, V15, P569, DOI 10.1016/j.jpain.2014.03.005; Dunn KM, 2006, AM J EPIDEMIOL, V163, P754, DOI 10.1093/aje/kwj100; Ferreira ML, 2003, J MANIP PHYSIOL THER, V26, P593, DOI 10.1016/j.jmpt.2003.08.010; Fersum KV, 2010, BRIT J SPORT MED, V44, P1054, DOI 10.1136/bjsm.2009.063289; Fischer D, 1999, JAMA-J AM MED ASSOC, V282, P1157, DOI 10.1001/jama.282.12.1157; Flynn T, 2002, SPINE, V27, P2835, DOI 10.1097/00007632-200212150-00021; Gabel CP, 2011, EUR SPINE J, V20, P449, DOI 10.1007/s00586-010-1509-4; Grotle M, 2005, SPINE, V30, P976, DOI 10.1097/01.brs.0000158972.34102.6f; HADLER NM, 1987, SPINE, V12, P703, DOI 10.1097/00007632-198709000-00012; Hall H, 2009, SPINE J, V9, P648, DOI 10.1016/j.spinee.2009.04.017; Hancock M, 2009, PHYS THER, V89, P698, DOI 10.2522/ptj.20080351; Hanmer J, 2007, MED CARE, V45, P1171, DOI 10.1097/MLR.0b013e3181354828; Hays RD, 2009, VALUE HEALTH, V12, P1035, DOI 10.1111/j.1524-4733.2009.00566.x; Henschke N, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-54; Hestbaek L, 2003, J MANIP PHYSIOL THER, V26, P213, DOI 10.1016/S0161-4754(03)00006-X; Hestbaek L, 2003, EUR SPINE J, V12, P149, DOI 10.1007/s00586-002-0508-5; Hill JC, 2010, EUR J PAIN, V14, P83, DOI 10.1016/j.ejpain.2009.01.003; Humphreys BK, 2010, J MANIP PHYSIOL THER, V33, P519, DOI 10.1016/j.jmpt.2010.08.003; Hush JM, 2009, ARTHRIT RHEUM-ARTHR, V61, P124, DOI 10.1002/art.24162; Jellema P, 2007, BRIT J GEN PRACT, V57, P15; Kent Peter M, 2005, Chiropr Osteopat, V13, P13, DOI 10.1186/1746-1340-13-13; Koes BW, 2001, SPINE, V26, P2504, DOI 10.1097/00007632-200111150-00022; Kongsted Alice, 2010, Chiropr Osteopat, V18, P2, DOI 10.1186/1746-1340-18-2; Kongsted Alice, 2009, Chiropr Osteopat, V17, P11, DOI 10.1186/1746-1340-17-11; Leboeuf-Yde C, 2005, J MANIP PHYSIOL THER, V28, P472, DOI 10.1016/j.jmpt.2005.07.003; Leboeuf-Yde C, 2001, J MANIP PHYSIOL THER, V24, P63, DOI 10.1067/mmt.2001.112009; LeboeufYde C, 1997, SPINE, V22, P877, DOI 10.1097/00007632-199704150-00010; MACDONALD RS, 1990, SPINE, V15, P364, DOI 10.1097/00007632-199005000-00005; Mannion AF, 2006, EUR SPINE J, V15, P55, DOI 10.1007/s00586-004-0815-0; Marras WS, 2007, SPINE, V32, P2387, DOI 10.1097/BRS.0b013e3181557be9; McGuirk B, 2001, SPINE, V26, P2615, DOI 10.1097/00007632-200112010-00017; Costa LDM, 2013, SPINE, V38, P148, DOI 10.1097/BRS.0b013e318267a92f; Newell D, 2010, SPINE, V35, P1801, DOI 10.1097/BRS.0b013e3181cc006b; Pengel LHM, 2003, BMJ-BRIT MED J, V327, P323, DOI 10.1136/bmj.327.7410.323; Peterson CK, 2012, J MANIP PHYSIOL THER, V35, P525, DOI 10.1016/j.jmpt.2012.06.003; Schmidt CO, 2005, Z ORTHOP GRENZGEB, V143, P292, DOI 10.1055/s-2005-836631; SPITZER WO, 1995, SPINE, V20, pS1; Stanton TR, 2011, EUR SPINE J, V20, P744, DOI 10.1007/s00586-010-1671-8; Stanton TR, 2008, SPINE, V33, P2923, DOI 10.1097/BRS.0b013e31818a3167; van Tulder M, 2006, EUR SPINE J, V15, pS169, DOI 10.1007/s00586-006-1071-2; VONKORFF M, 1994, SPINE, V19, pS2041; Waddell G, 2001, OCCUP MED-OXFORD, V51, P124, DOI 10.1093/occmed/51.2.124; Wasiak R, 2009, SPINE, V34, P970, DOI 10.1097/BRS.0b013e3181a01b63; Wenig CM, 2009, EUR J PAIN, V13, P280, DOI 10.1016/j.ejpain.2008.04.005	59	5	5	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0161-4754			J MANIP PHYSIOL THER	J. Manip. Physiol. Ther.	MAR-APR	2016	39	3					141	149		10.1016/j.jmpt.2016.02.005			9	Health Care Sciences & Services; Integrative & Complementary Medicine; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services; Integrative & Complementary Medicine; Rehabilitation	DK8NV	WOS:000375184500001	27034105	Bronze			2022-03-04	
J	Peterson, CK; Pfirrmann, CWA; Hodler, J; Leemann, S; Schmid, C; Anklin, B; Humphreys, BK				Peterson, Cynthia K.; Pfirrmann, Christian W. A.; Hodler, Jurg; Leemann, Serafin; Schmid, Christof; Anklin, Bernard; Humphreys, B. Kim			SYMPTOMATIC, MAGNETIC RESONANCE IMAGING-CONFIRMED CERVICAL DISK HERNIATION PATIENTS: A COMPARATIVE-EFFECTIVENESS PROSPECTIVE OBSERVATIONAL STUDY OF 2 AGE- AND SEX-MATCHED COHORTS TREATED WITH EITHER IMAGING-GUIDED INDIRECT CERVICAL NERVE ROOT INJECTIONS OR SPINAL MANIPULATIVE THERAPY	JOURNAL OF MANIPULATIVE AND PHYSIOLOGICAL THERAPEUTICS			English	Article						Cervical Spine; Disk Herniation; Nerve Root; Injections; Manipulation, Spinal; Outcomes Assessment; Comparative-Effectiveness Research; Radiculopathy	EPIDURAL STEROID INJECTIONS; HIGH-VELOCITY; NECK PAIN; RADICULOPATHY; MRI; OUTCOMES	Objective: The purpose of this study was to compare the outcomes of overall improvement, pain reduction, and treatment costs in matched patients with symptomatic, magnetic resonance imaging-confirmed cervical disk herniations treated with either spinal manipulative therapy (SMT) or imaging-guided cervical nerve root injection blocks (CNRI). Methods: This prospective cohort comparative-effectiveness study included 104 patients with magnetic resonance imaging-confirmed symptomatic cervical disk herniation. Fifty-two patients treated with CNRI were age and sex matched with 52 patients treated with SMT. Baseline numerical rating scale (NRS) pain data were collected. Three months after treatment, NRS pain levels were recorded and overall "improvement" was assessed using the Patient Global Impression of Change scale. Only responses "much better" or "better" were considered "improved." The proportion of patients "improved" was calculated for each treatment method and compared using the. 2 test. The NRS and NRS change scores for the 2 groups were compared at baseline and 3 months using the unpaired t test. Acute and subacute/chronic patients in the 2 groups were compared for "improvement" using the. 2 test. Results: "Improvement" was reported in 86.5% of SMT patients and 49.0% of CNRI patients (P=.0001). Significantly more CNRI patients were in the subacute/chronic category (77%) compared with SMT patients (46%). A significant difference between the proportion of subacute/chronic CNRI patients (37.5%) and SMT patients (78.3%) reporting "improvement" was noted (P=.002). Conclusion: Subacute/chronic patients treated with SMT were significantly more likely to report relevant "improvement" compared with CNRI patients. There was no difference in outcomes when comparing acute patients only.	[Peterson, Cynthia K.; Pfirrmann, Christian W. A.] Univ Zurich, Orthopaed Univ Hosp Balgrist, Dept Radiol, CH-8006 Zurich, Switzerland; [Peterson, Cynthia K.] Univ Zurich, Orthopaed Univ Hosp Balgrist, Chiropract Med Dept, CH-8006 Zurich, Switzerland; [Hodler, Jurg] Univ Zurich, Univ Hosp, Dept Radiol, CH-8006 Zurich, Switzerland; [Humphreys, B. Kim] Univ Zurich, Orthopaed Univ Hosp Balgrist, Fac Med, Chiropract Med, CH-8006 Zurich, Switzerland		Peterson, CK (corresponding author), Uniklin Balgrist, Forchstr 340, CH-8008 Zurich, Switzerland.	xraydcpeterson@yahoo.ca	Pfirrmann, Christian/E-6032-2012	Pfirrmann, Christian/0000-0003-0091-9650	Vontobel Stiftung, Zurich, Switzerland; European Chiropractor's Union; Balgrist Foundation; Uniscientia Foundation	The following provided funding for this study: Vontobel Stiftung, Zurich, Switzerland; European Chiropractor's Union; The Balgrist Foundation; and Uniscientia Foundation. No conflicts of interest were reported for this study.	BenEliyahu D J, 1996, J Manipulative Physiol Ther, V19, P597; Bronfort Gert, 2004, Spine J, V4, P335, DOI 10.1016/j.spinee.2003.06.002; Cassidy JD, 2008, SPINE, V33, pS176, DOI 10.1097/BRS.0b013e3181644600; Engel A, 2014, PAIN MED, V15, P386, DOI 10.1111/pme.12304; Ernst CW, 2005, EUR J RADIOL, V55, P409, DOI 10.1016/j.ejrad.2004.11.003; Fischer D, 1999, JAMA-J AM MED ASSOC, V282, P1157, DOI 10.1001/jama.282.12.1157; Gross AR, 2004, SPINE, V29, P1541, DOI 10.1097/01.BRS.0000131218.35875.ED; Healy JF, 1996, J COMPUT ASSIST TOMO, V20, P107, DOI 10.1097/00004728-199601000-00019; Hodler J, 2013, EUR SPINE J, V22, pS466, DOI 10.1007/s00586-012-2642-z; Klessinger S, 2014, PAIN MED, V15, P929, DOI 10.1111/pme.12415; Kolstad F, 2005, ACTA NEUROCHIR, V147, P1065, DOI 10.1007/s00701-005-0542-2; Lin EL, 2006, J SPINAL DISORD TECH, V19, P183, DOI 10.1097/01.bsd.0000190558.13248.e1; Matsumoto M, 1998, J BONE JOINT SURG BR, V80B, P19, DOI 10.1302/0301-620X.80B1.7929; Murphy DR, 2006, J MANIP PHYSIOL THER, V29, P279, DOI 10.1016/j.jmpt.2006.03.005; Murphy Donald R, 2006, Spine J, V6, P459, DOI 10.1016/j.spinee.2006.01.019; Neumann PJ, 2013, NEW ENGL J MED, V369, P209, DOI 10.1056/NEJMp1300312; Peterson CK, 2014, SKELETAL RADIOL, V43, P979, DOI 10.1007/s00256-014-1881-y; Peterson CK, 2013, J MANIP PHYSIOL THER, V36, P461, DOI 10.1016/j.jmpt.2013.07.002; Peterson CK, 2013, J MANIP PHYSIOL THER, V36, P218, DOI 10.1016/j.jmpt.2013.04.005; RADHAKRISHNAN K, 1994, BRAIN, V117, P325, DOI 10.1093/brain/117.2.325; Rao R, 2002, J BONE JOINT SURG AM, V84A, P1872, DOI 10.2106/00004623-200210000-00021; Scanlon GC, 2007, SPINE, V32, P1249, DOI 10.1097/BRS.0b013e318053ec50; Sutter R, 2011, SKELETAL RADIOL, V40, P1603, DOI 10.1007/s00256-011-1288-y; Thiel HW, 2007, SPINE, V32, P2375, DOI 10.1097/BRS.0b013e3181557bb1; Tinetti ME, 2011, NEW ENGL J MED, V364, P2478, DOI 10.1056/NEJMp1100535; Vernon HT, 2005, J MANIP PHYSIOL THER, V28, P443, DOI 10.1016/j.jmpt.2005.06.011; Wainner RS, 2003, SPINE, V28, P52, DOI 10.1097/00007632-200301010-00014	27	6	7	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0161-4754			J MANIP PHYSIOL THER	J. Manip. Physiol. Ther.	MAR-APR	2016	39	3					210	217		10.1016/j.jmpt.2016.02.004			8	Health Care Sciences & Services; Integrative & Complementary Medicine; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services; Integrative & Complementary Medicine; Rehabilitation	DK8NV	WOS:000375184500009	27040033	Bronze			2022-03-04	
J	Annen, M; Peterson, C; Leemann, S; Schmid, C; Anklin, B; Humphreys, BK				Annen, Michele; Peterson, Cynthia; Leemann, Serafin; Schmid, Christof; Anklin, Bernard; Humphreys, B. Kim			COMPARISON OF OUTCOMES IN MRI CONFIRMED LUMBAR DISC HERNIATION PATIENTS WITH AND WITHOUT MODIC CHANGES TREATED WITH HIGH VELOCITY, LOW AMPLITUDE SPINAL MANIPULATION	JOURNAL OF MANIPULATIVE AND PHYSIOLOGICAL THERAPEUTICS			English	Article						Modic Changes; Disc Herniation; Lumbar Spine; Outcomes Assessment; Manipulation, Spinal	LOW-BACK-PAIN; FOLLOW-UP; ASSOCIATION; PREDICTORS; THERAPY; COHORT; DEGENERATION; POPULATION; SYMPTOMS; DISEASE	Objective: The purpose of this study was to determine if there is a difference in outcomes between Modic positive and negative lumbar disc herniation (LDH) patients treated with spinal manipulative therapy (SMT). Methods: This prospective outcomes study includes 72 MRI confirmed symptomatic LDH patients treated with SMT. Numerical rating scale (NRS) pain and Oswestry disability data were collected at baseline. NRS, patient global impression of change to assess overall improvement, and Oswestry data were collected at 2 weeks, 1, 3, 6 months and 1 year. MRI scans were analyzed for Modic change present/absent and classified as Modic I or II when present. Chi-squared test compared the proportion of patients reporting relevant 'improvement' between patients with and without Modic changes and those with Modic I vs. II. NRS and Oswestry scores were compared at baseline and change scores at all follow-up time points using the unpaired Student t test. Results: 76.5% of Modic positive patients reported 'improvement' compared to 53.3% of Modic negative patients (P=.09) at 2 weeks. Modic positive patients had larger decreases in leg pain (P=.02) and disability scores (P=.012) at 2 weeks. Modic positive patients had larger reductions in disability levels at 3 (P=.049) and 6 months (P=.001). A significant difference (P=.001) between patients with Modic I vs. Modic II was found at 1 year, where Modic II patients did significantly better. Conclusion: Modic positive patients reported higher levels of clinically relevant improvement 2 weeks, 3 and 6 months compared to Modic negative patients. However, at 1 year Modic I patients were significantly less likely to report 'improvement', suggesting they may be prone to relapse.	[Annen, Michele; Peterson, Cynthia; Humphreys, B. Kim] Univ Zurich, Orthopaed Univ Hosp Balgrist, Fac Med, Chiropract Med Dept, Zurich, Switzerland		Peterson, C (corresponding author), Uniklin Balgrist, Forchstr 340, CH-8004 Zurich, Switzerland.	xraydcpeterson@yahoo.ca	Craven, Beverley Catharine/D-5001-2015	Craven, Beverley Catharine/0000-0001-8234-6803	European Chiropractor's Union; Balgrist Foundation; Uniscientia Foundation	The following provided funding for this study: European Chiropractor's Union; The Balgrist Foundation; and Uniscientia Foundation. No conflicts of interest were reported for this study.	Albert HB, 2013, EUR SPINE J, V22, P690, DOI 10.1007/s00586-013-2674-z; Braithwaite I, 1998, Eur Spine J, V7, P363, DOI 10.1007/s005860050091; Djurasovic M, 2012, EUR SPINE J, V21, P1616, DOI 10.1007/s00586-012-2244-9; Fayad F, 2007, EUR SPINE J, V16, P925, DOI 10.1007/s00586-006-0301-y; Han Chao, 2009, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V23, P1409; Hutton MJ, 2011, SPINE, V36, P2304, DOI 10.1097/BRS.0b013e31821604b6; Jarvinen J, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0540-3; Jensen RK, 2012, EUR SPINE J, V21, P2271, DOI 10.1007/s00586-012-2309-9; Jensen TS, 2010, EUR SPINE J, V19, P129, DOI 10.1007/s00586-009-1184-5; Jensen TS, 2008, EUR SPINE J, V17, P1407, DOI 10.1007/s00586-008-0770-2; Kerttula L, 2012, EUR SPINE J, V21, P1135, DOI 10.1007/s00586-012-2147-9; Kuisma M, 2006, SPINE, V31, P1714, DOI 10.1097/01.brs.0000224167.18483.14; Leemann S, 2014, J MANIP PHYSIOL THER, V37, P155, DOI 10.1016/j.jmpt.2013.12.011; Luoma K, 2009, SKELETAL RADIOL, V38, P237, DOI 10.1007/s00256-008-0611-8; Lurie JD, 2013, SPINE, V38, P1216, DOI 10.1097/BRS.0b013e31828ce66d; Ma Zheng, 2013, Zhonghua Wai Ke Za Zhi, V51, P610; Mann E, 2011, SPINE, V36, P1081, DOI 10.1097/BRS.0b013e3181ef6a1e; Marshman LAG, 2007, J NEUROSURG-SPINE, V6, P152, DOI 10.3171/spi.2007.6.2.152; Mitra D, 2004, EUR RADIOL, V14, P1574, DOI 10.1007/s00330-004-2314-4; Modic MT, 2007, RADIOLOGY, V245, P43, DOI 10.1148/radiol.2451051706; MODIC MT, 1988, RADIOLOGY, V166, P193, DOI 10.1148/radiology.166.1.3336678; Mulconrey Daniel S, 2006, Spine J, V6, P177, DOI 10.1016/j.spinee.2005.08.011; Nguyen C, 2012, OSTEOPOROSIS INT, V23, pS857, DOI 10.1007/s00198-012-2164-x; Oztekin O, 2010, RADIOL ONCOL, V44, P97, DOI 10.2478/v10019-010-0006-z; Pawl Ron, 2013, Surg Neurol Int, V4, pS373, DOI 10.4103/2152-7806.120780; Peterson CK, 2014, EUR J RADIOL, V83, P1786, DOI 10.1016/j.ejrad.2014.06.008; Peterson CK, 2013, J MANIP PHYSIOL THER, V36, P461, DOI 10.1016/j.jmpt.2013.07.002; Peterson CK, 2013, J MANIP PHYSIOL THER, V36, P218, DOI 10.1016/j.jmpt.2013.04.005; Peterson CK, 2012, J MANIP PHYSIOL THER, V35, P525, DOI 10.1016/j.jmpt.2012.06.003; Schistad EI, 2014, SKELETAL RADIOL, V43, P1271, DOI 10.1007/s00256-014-1928-0; Shan Z, 2014, SPINE, V39, P736, DOI 10.1097/BRS.0000000000000259; Teraguchi M, 2015, SPINE J, V15, P622, DOI 10.1016/j.spinee.2014.11.012; Thompson KJ, 2009, RADIOLOGY, V250, P849, DOI 10.1148/radiol.2503080474; ULMER JL, 1995, AM J ROENTGENOL, V164, P429, DOI 10.2214/ajr.164.2.7839983; Villarreal-Arroyo M, 2012, Acta Ortop Mex, V26, P180; Zhuang Cheng-yu, 2009, Zhonghua Yi Xue Za Zhi, V89, P2490	36	10	10	1	15	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0161-4754			J MANIP PHYSIOL THER	J. Manip. Physiol. Ther.	MAR-APR	2016	39	3					200	209		10.1016/j.jmpt.2016.02.012			10	Health Care Sciences & Services; Integrative & Complementary Medicine; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services; Integrative & Complementary Medicine; Rehabilitation	DK8NV	WOS:000375184500008	27046146	Bronze			2022-03-04	
J	Humphreys, BK				Humphreys, B. Kim			Cervical outcome measures: Testing for postural stability and balance	JOURNAL OF MANIPULATIVE AND PHYSIOLOGICAL THERAPEUTICS			English	Article						posture; musculoskeletal equilibrium; neck pain; outcome assessment (health care); spine; cervical vertebrae	CERVICOCEPHALIC KINESTHETIC SENSIBILITY; WHIPLASH-ASSOCIATED DISORDERS; JOINT POSITION ERROR; NECK TORSION TEST; VERTICALITY PERCEPTION; PERSISTENT WHIPLASH; MUSCLE-SPINDLES; FRAME ILLUSION; PAIN; INJURY	Background: Clinical tests assessing a correlation between structural pathology and cervical pain have been unsuccessful, leading the way for file development of functionally based tests. The Purpose of this narrative is to review 4 promising functional tests for the assessment of sensorimotor dysfunction in patients with neck pain. The Joint Position Error/Head Repositioning Accuracy tests, and the Rod and Frame Test were reviewed. Special Features: The SPNTT was developed to test proprioceptive mechanisms in the neck by applying torsion to mainly mechanoreceptors in the cervical spine. The Joint Position Error and Head Repositioning Accuracy test cervicocephalic kinesthesia or the ability to perceive both movement and position of the head in space related to file trunk. The Rod and Frame Test assesses patients' perception of the vertical orientation of their head in 3-dimensional space. All of these tests evaluate important mechanisms responsible for maintaining postural stability and balance and are thought to be applicable for use in mechanical neck pain patients. Summary: All of the reviewed tests show clinical promise because they are able to distinguish patients with neck pain, particularly those with whiplash trauma and dizziness from asymptomatic controls. All of the tests assess cervical sensorimotor dysfunction, although considerably more research is needed to more clearly establish the psychometric properties for each test including minimal clinical important difference. Although these tests call be used in routine clinical practice, they Should be used in combination with other related tests.	[Humphreys, B. Kim] Canadian Mem Chiropract Coll, Toronto, ON, Canada		Humphreys, BK (corresponding author), Univ Zurich, Fac Med, Balgrist Hosp, CH-8006 Zurich, Switzerland.	kim.humphreys@balgrist.ch					AMONOOKUOFI HS, 1982, J ANAT, V135, P585; ANTONUCCI G, 1995, PERCEPTION, V24, P1119, DOI 10.1068/p241119; APPLEBAUM H, 1968, PERCEPT MOTOR SKILL, V26, P1055; Bagust J, 2005, ARCH PHYS MED REHAB, V86, P1062, DOI 10.1016/j.apmr.2004.05.022; Bagust J., 2005, CLIN CHIROPRACTIC, V8, P134, DOI [10.1016/j.clch.2005.07.001, DOI 10.1016/j.clch.2005.07.001, DOI 10.1016/J.CLCH.2005.07.001]; Bolton PS, 1998, J MANIP PHYSIOL THER, V21, P553; Boyd-Clark LC, 2002, SPINE, V27, P694, DOI 10.1097/00007632-200204010-00005; GANDEVIA SC, 1992, TRENDS NEUROSCI, V15, P62, DOI 10.1016/0166-2236(92)90028-7; Grod JP, 2002, ARCH PHYS MED REHAB, V83, P412, DOI 10.1053/apmr.2002.29660; Heikkila H, 1996, SCAND J REHABIL MED, V28, P133; Heikkila HV, 1998, ARCH PHYS MED REHAB, V79, P1089, DOI 10.1016/S0003-9993(98)90176-9; HINOKI M, 1985, ACTA OTO-LARYNGOL, P9; Hogg-Johnson S, 2008, SPINE, V33, pS39, DOI 10.1097/BRS.0b013e31816454c8; Humphreys BK, 2002, J WHIPLASH RELATED D, V1, P99, DOI DOI 10.3109/J180V0LN01_09; HUMPHREYS BK, 2002, J WHIPLASH REL DISOR, V1, P63; Jull G, 2007, J ORTHOP RES, V25, P404, DOI 10.1002/jor.20220; KARLBERG M, 2001, ACTA OTO-LARYNGOL, V11, P664; KARLBERG M, 1991, ARCH PHYSICAL MED RE, V72, P288; Keshner EA, 2000, GAIT POSTURE, V11, P1, DOI 10.1016/S0966-6362(99)00046-6; Liu JX, 2003, J HISTOCHEM CYTOCHEM, V51, P175, DOI 10.1177/002215540305100206; Marchiori DM, 1996, SPINE, V21, P2747, DOI 10.1097/00007632-199612010-00007; Michaelson P, 2003, J REHABIL MED, V35, P229, DOI 10.1080/16501970306093; MORN, 2005, CHIROPR OSTEOPAT; Owens Edward F Jr, 2006, Chiropr Osteopat, V14, P5, DOI 10.1186/1746-1340-14-5; Peterson BW, 2004, PROG BRAIN RES, V143, P369, DOI 10.1016/S0079-6123(03)43035-5; Peterson CK, 2000, SPINE, V25, P218, DOI 10.1097/00007632-200001150-00013; Pinney SJ, 2001, J BONE JOINT SURG AM, V83A, P1317, DOI 10.2106/00004623-200109000-00004; Reid SA, 2005, MANUAL THER, V10, P4, DOI 10.1016/j.math.2004.03.006; REVEL M, 1991, ARCH PHYS MED REHAB, V72, P288; Rix GD, 2001, ARCH PHYS MED REHAB, V82, P911, DOI 10.1053/apmr.2001.23300; RUBIN AM, 1995, AM J OTOL, V16, P216; SMITH MV, 1991, J NEUROPHYSIOL, V66, P83, DOI 10.1152/jn.1991.66.1.83; SPINELLI D, 1995, PERCEPTION, V24, P1105, DOI 10.1068/p241105; Sterling M, 2004, SPINE, V29, P182, DOI 10.1097/01.BRS.0000105535.12598.AE; Sterling M, 2003, PAIN, V103, P65, DOI 10.1016/S0304-3959(02)00420-7; Swait G, 2007, SPINE, V32, pE692, DOI 10.1097/BRS.0b013e31815a5a1b; TANG CC, 2007, MAN THER, V12, P22; Tjell C, 1998, AM J OTOL, V19, P76; Tjell C, 2003, J WHIPLASH ASS DISOR, V1, P9; Treleaven J, 2006, MANUAL THER, V11, P99, DOI 10.1016/j.math.2005.04.003; Treleaven J, 2005, J REHABIL MED, V37, P219, DOI 10.1080/16501970410024299; Treleaven J, 2003, J REHABIL MED, V35, P36, DOI 10.1080/16501970306109; Treleaven J, 2008, ARCH PHYS MED REHAB, V89, P522, DOI 10.1016/j.apmr.2007.11.002; Treleaven J, 2008, MANUAL THER, V13, P2, DOI 10.1016/j.math.2007.06.003; Weinstein SL, 2000, J BONE JOINT SURG AM, V82A, P1; WHITKIN HA, 1954, PERSONALITY PERCEPTI, P24	46	31	32	0	10	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0161-4754			J MANIP PHYSIOL THER	J. Manip. Physiol. Ther.	SEP	2008	31	7			SI		540	546		10.1016/j.jmpt.2008.08.007			7	Health Care Sciences & Services; Integrative & Complementary Medicine; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services; Integrative & Complementary Medicine; Rehabilitation	354JJ	WOS:000259635600008	18804005				2022-03-04	
J	Birchler, FA; Kiliaridis, S; Combescure, C; Vazquez, L				Birchler, Flavia A.; Kiliaridis, Stavros; Combescure, Christophe; Vazquez, Lydia			Dental age assessment on panoramic radiographs in a Swiss population: a validation study of two prediction models	DENTOMAXILLOFACIAL RADIOLOGY			English	Article						age determination by teeth; tooth calcification; panoramic radiography; meta-analysis as topic; forensic dentistry	3RD MOLAR; CHRONOLOGICAL AGE; ROOT DEVELOPMENT; MATURITY CURVES; ACCURACY; MINERALIZATION; INDICATOR; AGREEMENT; PRECISION; EVALUATE	Objectives: Dental age assessment methods are widely used for age estimation. This study aimed to analyse the accuracy of a meta-analysis method to estimate dental age in Swiss individuals and to detect potential limitations of the method. Precision of repeated tooth staging using Demirjian's classification on maxillary and mandibular teeth was also assessed. Methods: Panoramic radiographs of 50 Swiss white healthy children were analysed. Developing teeth on the left maxilla and mandible and all third permanent molars were staged following Demirjian's classification. Dental age was calculated for each subject, using a random effects model and a fixed effect model, and compared with chronological age. Results: The mean error of the dental age ranged between -3 and +1 months for both the calculation models. Dental age calculated with the fixed effect model overestimated the age of the subjects (average +0.10 y, ranging from -1.95 y to +2.16 y) compared with their chronological age, whereas the random effects model underestimated the age (average -0.32 y, ranging from -2.24 y to +1.61 y). Conclusions: Demirjian's method allowed a precise repeated staging of maxillary and mandibular developing teeth. For both calculation models, dental age correlated well, on average, with chronological age of Swiss subjects younger than 12 years. The random effects model showed a better accuracy for these subjects than the fixed effect model. However, both models underestimated the chronological age in subjects older than 12 years.	[Birchler, Flavia A.; Kiliaridis, Stavros] Univ Geneva, Univ Clin Dent Med, Dept Orthodont, Geneva, Switzerland; [Combescure, Christophe] Univ Hosp Geneva, Div Clin Epidemiol, Geneva, Switzerland; [Vazquez, Lydia] Univ Geneva, Univ Clin Dent Med, Dept Orofacial Rehabil Oral & Maxillofacial Radio, Geneva, Switzerland		Birchler, FA (corresponding author), Univ Geneva, Univ Clin Dent Med, Dept Orthodont, Geneva, Switzerland.	flavia.birchler@unige.ch	Vazquez, Lydia/AAX-8097-2020	Vazquez, Lydia/0000-0003-1871-4178; Birchler, Flavia/0000-0001-6044-1156			Azrak B, 2007, J FORENSIC SCI, V52, P146, DOI 10.1111/j.1556-4029.2006.00300.x; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Braga J, 2005, INT J LEGAL MED, V119, P260, DOI 10.1007/s00414-004-0494-8; Chaillet N, 2004, J FORENSIC SCI, V49, P1324; Chudasama PN, 2012, J FORENSIC LEG MED, V19, P22, DOI 10.1016/j.jflm.2011.09.008; Cruz-Landeira A, 2010, INT J LEGAL MED, V124, P105, DOI 10.1007/s00414-009-0380-5; DEMIRJIAN A, 1973, HUM BIOL, V45, P211; DEMIRJIAN A, 1985, AM J ORTHOD DENTOFAC, V88, P433, DOI 10.1016/0002-9416(85)90070-3; Dhanjal KS, 2006, FORENSIC SCI INT, V159, pS74, DOI 10.1016/j.forsciint.2006.02.020; Feijoo G, 2012, FORENSIC SCI INT, V214, DOI 10.1016/j.forsciint.2011.08.024; Flood SJ, 2011, J FORENSIC SCI, V56, P1604, DOI 10.1111/j.1556-4029.2011.01884.x; GARN SM, 1965, J DENT RES, V44, P228, DOI 10.1177/00220345650440011901; Gunst K, 2003, FORENSIC SCI INT, V136, P52, DOI 10.1016/S0379-0738(03)00263-9; HAGG U, 1985, EUR J ORTHODONT, V7, P25; Jayaraman J, 2013, J FORENSIC LEG MED, V20, P373, DOI 10.1016/j.jflm.2013.03.015; KULLMAN L, 1992, SWED DENT J, V16, P161; Kullman L, 1996, DENTOMAXILLOFAC RAD, V25, P173, DOI 10.1259/dmfr.25.4.9084269; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Liversidge HM, 2006, ANN HUM BIOL, V33, P454, DOI 10.1080/03014460600802387; Liversidge HM, 2010, FORENSIC SCI INT, V201, P95, DOI 10.1016/j.forsciint.2010.02.032; Liversidge HM, 2003, FORENSIC SCI INT, V131, P22, DOI 10.1016/S0379-0738(02)00373-0; Maret D, 2011, MED HYPOTHESES, V76, P700, DOI 10.1016/j.mehy.2011.01.039; Meinl A, 2007, FORENSIC SCI INT, V169, P161, DOI 10.1016/j.forsciint.2006.08.014; Mitchell JC, 2009, FORENSIC SCI INT, V189, P19, DOI 10.1016/j.forsciint.2009.04.002; Olze A, 2005, INT J LEGAL MED, V119, P22, DOI 10.1007/s00414-004-0489-5; Peiris TS, 2009, INT J PAEDIATR DENT, V19, P367, DOI 10.1111/j.1365-263X.2009.00984.x; Pelsmaekers B, 1997, J DENT RES, V76, P1337, DOI 10.1177/00220345970760070201; Roberts GJ, 2008, BRIT DENT J, V204, DOI 10.1038/bdj.2008.21; Rothstein HR, 2009, INTRO META ANAL; Rozylo-Kalinowska I, 2008, FORENSIC SCI INT, V174, P207, DOI 10.1016/j.forsciint.2007.04.219; Schmeling A, 2001, LANCET, V358, P89, DOI 10.1016/S0140-6736(01)05379-X; THORSON J, 1991, SWED DENT J, V15, P15; Urzel V, 2013, J FORENSIC SCI, V58, P1341, DOI 10.1111/1556-4029.12221; Willems G, 2001, J Forensic Odontostomatol, V19, P9; Willershausen B, 2001, EUR J MED RES, V6, P377; Yadava M, 2011, INT J LEGAL MED, V125, P651, DOI 10.1007/s00414-010-0491-z	36	11	11	1	11	BRITISH INST RADIOLOGY	LONDON	36 PORTLAND PLACE, LONDON W1N 4AT, ENGLAND	0250-832X	1476-542X		DENTOMAXILLOFAC RAD	Dentomaxillofac. Radiol.		2016	45	1							20150137	10.1259/dmfr.20150137			9	Dentistry, Oral Surgery & Medicine; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine; Radiology, Nuclear Medicine & Medical Imaging	DE8HZ	WOS:000370878300004	26250402	Green Published			2022-03-04	
J	Momjian, A; Courvoisier, D; Kiliaridis, S; Scolozzi, P				Momjian, A.; Courvoisier, D.; Kiliaridis, S.; Scolozzi, P.			Reliability of computational measurement of the condyles on digital panoramic radiographs	DENTOMAXILLOFACIAL RADIOLOGY			English	Article						panoramic radiograph; computer-aided measurements; reliability	IMAGE DISTORTION; TEMPOROMANDIBULAR-JOINT; ORTHOPANTOMOGRAMS; PRECISION	Objective: The aim of this study was to evaluate the reliability of a computational method for assessing three condylar measurements on digital panoramic radiographs: condylar height, area and perimeter. Methods: A computer calculation of the area, the perimeter and the height of 34 condyles was determined on digital panoramic radiographs taken from 17 patients. The test-retest precision of measurements calculation was estimated using an intraclass correlation coefficient (ICC) and Dahlberg's formula at 2 week intervals on the same radiograph to assess intraobserver precision and on two radiographs (RX1 and RX2) to assess the radiographic procedure precision. Changes between measurements on RX1 and RX2 were estimated using paired t-tests to detect systematic errors. Results: Precision of all indices was very high when measurements were made on the same radiograph, thus confirming good reliability for the present computational measuring method. The precision was lower when two different radiographs were compared but was still within an acceptable range of tolerance. There were no statistically significant changes in condylar area, perimeter or height values between RX1 and RX2. Conclusions: This study has demonstrated that (1) the height of the condyle can be rapidly and reliably assessed using a specific computer system directly on digital panoramic radiographs; (2) although less reliable, area and perimeter can also be acceptably evaluated; and (3) this method has the potential for being routinely used to monitor changes in clinical follow-up as well as for research purposes. Dentomaxillofacial Radiology (2011) 40, 444-450. doi: 10.1259/dmfr/83507370	[Momjian, A.; Scolozzi, P.] Univ Hosp, Dept Surg, Serv Oral & Maxillofacial Surg, CH-1211 Geneva, Switzerland; [Kiliaridis, S.] Fac Med Geneva, Dept Orthodont, CH-1211 Geneva, Switzerland; [Courvoisier, D.] Univ Hosp, Serv Clin Epidemiol, CH-1211 Geneva, Switzerland		Scolozzi, P (corresponding author), Univ Hosp, Dept Surg, Serv Oral & Maxillofacial Surg, CH-1211 Geneva, Switzerland.	paolo.scolozzi@hcuge.ch	Courvoisier, Delphine/H-6054-2011	Courvoisier, Delphine/0000-0002-1956-2607			BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brooks SL, 1997, ORAL SURG ORAL MED O, V83, P609, DOI 10.1016/S1079-2104(97)90128-1; Bulut E, 2009, J CRANIOFAC SURG, V20, P2020, DOI 10.1097/SCS.0b013e3181bd302e; Catic A, 1998, ORAL SURG ORAL MED O, V86, P242; Gungor K, 2006, DENTOMAXILLOFAC RAD, V35, P442, DOI 10.1259/dmfr/25346328; HABETS LLMH, 1987, J ORAL REHABIL, V14, P475, DOI 10.1111/j.1365-2842.1987.tb00742.x; Hazan-Molina H, 2011, ORTHOD CRANIOFAC RES, V14, P25, DOI 10.1111/j.1601-6343.2010.01504.x; Kambylafkas P, 2006, ANGLE ORTHOD, V76, P388; KJELLBERG H, 1994, ACTA ODONTOL SCAND, V52, P43, DOI 10.3109/00016359409096375; LARHEIM TA, 1986, AM J ORTHOD DENTOFAC, V90, P45, DOI 10.1016/0889-5406(86)90026-0; Lewis Emma L, 2008, Dent Clin North Am, V52, P875, DOI 10.1016/j.cden.2008.06.001; Mawani F, 2005, ORAL SURG ORAL MED O, V99, P341, DOI 10.1016/j.tripleo.2004.07.011; Ongkosuwito EM, 2009, CLEFT PALATE-CRAN J, V46, P147, DOI 10.1597/07-123.1; Schulze R, 2000, DENTOMAXILLOFAC RAD, V29, P52, DOI 10.1038/sj.dmfr.4600500; TRONJE G, 1981, ACTA RADIOL DIAGN, V22, P449, DOI 10.1177/028418518102200409; TRONJE G, 1981, ACTA RADIOL DIAGN, V22, P689, DOI 10.1177/028418518102200613; TRONJE G, 1981, Acta Radiologica Diagnosis, V22, P295; TRONJE G, 1981, ACTA RADIOL DIAGN, V22, P585, DOI 10.1177/028418518102200513	18	7	7	0	3	BRITISH INST RADIOLOGY	LONDON	36 PORTLAND PLACE, LONDON W1N 4AT, ENGLAND	0250-832X	1476-542X		DENTOMAXILLOFAC RAD	Dentomaxillofac. Radiol.	OCT	2011	40	7					444	450		10.1259/dmfr/83507370			7	Dentistry, Oral Surgery & Medicine; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine; Radiology, Nuclear Medicine & Medical Imaging	826PN	WOS:000295366200007	21960403	Green Published			2022-03-04	
J	Patel, RN; Antonarakis, GS				Patel, Reena N.; Antonarakis, Gregory S.			Factors influencing the adoption and implementation of teledentistry in the UK, with a focus on orthodontics	COMMUNITY DENTISTRY AND ORAL EPIDEMIOLOGY			English	Article						diffusion of innovation theory; orthodontics; stakeholder groups; teledentistry	PART 1; TELEMEDICINE; REFERRALS; SERVICE; SATISFACTION; BENEFITS; ADVICE	ObjectivesUtilizing Rogers' diffusion of innovation theory, this study aims to develop a better understanding of the challenges faced in teledental projects, and outline the factors that impact upon the adoption and implementation of teledental projects, with a focus on orthodontics, thus attempting to provide an explanation for the low uptake in the UK, as well as to suggest factors to encourage success. MethodsA literature search was carried out to obtain information concerning teledentistry (and telemedicine) from both primary and secondary research sources. Using the relevant information obtained, Rogers' diffusion of innovation theory was used as a framework, which was subsequently applied to the key stakeholder groups of a healthcare organization. ResultsThe model describes five characteristics of an innovation: relative advantage, compatibility, complexity, trialability and observability. These attributes are discussed in the context of key stakeholder groups within a healthcare organization: clinicians, patients, hospital managers, and healthcare decision-makers and funders. Each stakeholder group is motivated by different values and experiences, which in turn influence their decision to adopt a new technology. ConclusionsImplementing teledental applications necessitates full comprehension and consideration of the healthcare environment and also a commitment to completely integrate teledentistry within that environment. This is a process that demands strategic alignment with clinical and organizational goals, clinical engagement and strong political support. The challenges within each stakeholder group must be specifically targeted.	[Patel, Reena N.] Mottingham Special Care Dent Clin, London SE9 4EB, England; [Antonarakis, Gregory S.] Univ Geneva, Sch Dent, Dept Orthodont, Geneva, Switzerland		Patel, RN (corresponding author), Mottingham Special Care Dent Clin, Kimmeridge Rd, London SE9 4EB, England.	ernee_tap@hotmail.com	Antonarakis, Gregory/ABA-1855-2020	Antonarakis, Gregory/0000-0001-6741-6922			Al-Qirim N, 2007, INT J MED INFORM, V76, P42, DOI 10.1016/j.ijmedinf.2006.02.001; Benson T, 2002, BRIT MED J, V325, P1086, DOI 10.1136/bmj.325.7372.1086; Brebner EM, 2004, J TELEMED TELECARE, V10, P16, DOI 10.1258/135763304322764130; Bynum AB, 2006, J TELEMED TELECARE, V12, P39, DOI 10.1258/135763306775321407; Chen JW, 2003, J AM DENT ASSOC, V134, P342, DOI 10.14219/jada.archive.2003.0164; Cook J, 2000, BRIT DENT J, V188, P67; Cook J, 2001, J TELEMED TELECARE, V7, P334, DOI 10.1258/1357633011936967; Cook J, 2001, J TELEMED TELECARE, V7, P324, DOI 10.1258/1357633011936958; Currell R., 2000, COCHRANE DATABASE SY; Darkins A, 1996, J Telemed Telecare, V2, P93, DOI 10.1258/1357633961929853; Dick PT, 1999, J PEDIATR SURG, V34, P137, DOI 10.1016/S0022-3468(99)90244-0; Doolittle GC, 2006, J TELEMED TELECARE, V12, P276, DOI 10.1258/135763306778558150; Finch TL, 2003, BMJ-BRIT MED J, V327, P1205, DOI 10.1136/bmj.327.7425.1205; Gibson John, 2007, Health Informatics J, V13, P267, DOI 10.1177/1460458207082977; Greenhalgh T, 2008, BMJ-BRIT MED J, V336, P1290, DOI 10.1136/bmj.a114; Harno K, 2000, J TELEMED TELECARE, V6, P320, DOI 10.1258/1357633001935996; Hjelm NM, 2005, J TELEMED TELECARE, V11, P60, DOI 10.1258/1357633053499886; Jennett PA, 2003, J TELEMED TELECARE, V9, P311, DOI 10.1258/135763303771005207; King G, 2007, J TELEMED TELECARE, V13, P382, DOI 10.1258/135763307783064430; Lobley D, 1997, J Telemed Telecare, V3, P117, DOI 10.1258/1357633971930977; Mair F, 2000, BMJ-BRIT MED J, V320, P1517, DOI 10.1136/bmj.320.7248.1517; Mandall NA, 2005, BRIT DENT J, V199, P727, DOI 10.1038/sj.bdj.4812969; Mandall NA, 2005, BRIT DENT J, V199, P659, DOI 10.1038/sj.bdj.4812930; Menachemi Nir, 2004, J Med Syst, V28, P617, DOI 10.1023/B:JOMS.0000044964.49821.df; Nicholson P, 2000, ROYAL COLL SURG ENGL, V13, P11; Parfitt A A, 1996, Br J Orthod, V23, P359; Paul DL, 1999, IEEE T ENG MANAGE, V46, P279, DOI 10.1109/17.775280; Rayner WJ, 2008, BRIT DENT J, V204, P493, DOI 10.1038/sj.bdj.2008.348; RICHMOND S, 1993, BRIT DENT J, V174, P315, DOI 10.1038/sj.bdj.4808166; Rogers EM, 1995, DIFFUSION INNOVATION; Scuffham PA, 2002, J TELEMED TELECARE, V8, P165, DOI 10.1258/135763302320118915; Stephens C D, 2002, J Orthod, V29, P137, DOI 10.1093/ortho/29.2.137; Walker J, 2002, J TELEMED TELECARE, V8, P73, DOI 10.1258/13576330260440934; Wallace S, 1998, POSTGRAD MED J, V74, P721, DOI 10.1136/pgmj.74.878.721; Whitten P, 2001, J TELEMED TELECARE, V7, P288, DOI 10.1258/1357633011936552; Whitten PS, 2002, BRIT MED J, V324, P1434, DOI 10.1136/bmj.324.7351.1434; Willmot D R, 1995, Br J Orthod, V22, P53; Wootton R, 1998, J R Soc Med, V91, P614; Wootton R, 1999, J TELEMED TELECARE, V5, pS27; Yellowlees P, 1997, J Telemed Telecare, V3, P215, DOI 10.1258/1357633971931192; Yellowlees P, 1996, J Telemed Telecare, V2, P205, DOI 10.1258/1357633961930086	41	9	9	0	23	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0301-5661	1600-0528		COMMUNITY DENT ORAL	Community Dentist. Oral Epidemiol.	OCT	2013	41	5					424	431		10.1111/cdoe.12029			8	Dentistry, Oral Surgery & Medicine; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine; Public, Environmental & Occupational Health	225YS	WOS:000325001800005	23240902				2022-03-04	
J	Srinivasan, M; Delavy, J; Schimmel, M; Duong, S; Zekry, D; Trombert, V; Gold, G; Muller, F				Srinivasan, Murali; Delavy, Joris; Schimmel, Martin; Duong, Stephan; Zekry, Dina; Trombert, Veronique; Gold, Gabriel; Mueller, Frauke			Prevalence of oral hygiene tools amongst hospitalised elders: A cross-sectional survey	GERODONTOLOGY			English	Article						aged 75+; cognitive status; geriatric dentistry; gerodontology; hospitalised elders; MMSE; oral hygiene; oral hygiene tools	SUBSTANTIAL SUPPORTIVE CARE; RANDOMIZED CLINICAL-TRIAL; PLAQUE REMOVAL EFFICACY; COGNITIVE IMPAIRMENT; NURSING-HOMES; RISK-FACTORS; HEALTH; DEMENTIA; CARIES; TOOTHBRUSHES	Objective This study aimed to evaluate the prevalence of various oral hygiene tools amongst hospitalised elders and to associate their cognitive status with the prevalence of tools and oral hygiene status. Materials and method Elderly hospitalised participants were included in the study and underwent a brief clinical intra-oral examination. A semi-structured questionnaire evaluated the awareness and personal possession of the various oral hygiene tools. Participants' personal information and various clinical parameters including DMF (T) index, plaque index, CPITN index, denture plaque and calculus index were collected. Mini-Mental State Examination (MMSE) scores were retrieved from the medical records. Linear regression models were applied for statistical analyses (P < 0.05). Results A total of 100 hospitalised elders (age = 84.5 +/- 6.9 years; female = 72, age = 84.9 +/- 7.2 years; male = 28, age = 83.3 +/- 5.8 years) participated in this study. Awareness was high for manual toothbrush (100%), electric toothbrush (86%), dental floss (79%), interdental brush (44%), interdental stick (55%) and mouthwash (75%), but was low for tongue scraper (9%), while the prevalence of use was 93%, 17%, 27%, 21%, 29%, 39% and 4%, respectively. Linear regression models revealed plaque scores were lower when more hygiene tools were used by the participants (P = 0.0059). Participants with high MMSE scores had lower plaque scores (P = 0.0004) and possessed more oral hygiene tools (P = 0.0203). Conclusion Poor oral hygiene is often noticed in institutionalised elders and might be related to a lack of knowledge about existing oral hygiene tools. These may help optimising oral hygiene, especially in cognitively impaired elders. Oral hygiene tools should be prescribed according to the patient's need, functional and cognitive status.	[Srinivasan, Murali; Delavy, Joris; Schimmel, Martin; Duong, Stephan; Mueller, Frauke] Univ Geneva, Univ Clin Dent Med, Div Gerodontol & Removable Prosthodont, Geneva, Switzerland; [Schimmel, Martin] Univ Bern, Div Gerodontol, Bern, Switzerland; [Zekry, Dina; Gold, Gabriel; Mueller, Frauke] Geneva Univ Hosp, Dept Internal Med Rehabil & Geriatr, Serv Geriatr, Thonex, Switzerland; [Trombert, Veronique] Geneva Univ Hosp, Dept Internal Med & Rehabil Trois Chene, Geneva, Switzerland		Muller, F (corresponding author), Univ Geneva, Univ Clin Dent Med, Div Gerodontol & Removable Prosthodont, Geneva, Switzerland.	frauke.mueller@unige.ch	Müller, Frauke/C-3835-2014; Srinivasan, Murali/B-5159-2013; Schimmel, Martin/F-5694-2011	Müller, Frauke/0000-0003-3981-0134; Srinivasan, Murali/0000-0003-3365-576X; Schimmel, Martin/0000-0001-9700-5534			Abe S, 2008, ARCH GERONTOL GERIAT, V47, P267, DOI 10.1016/j.archger.2007.08.005; Adam Helen, 2006, Gerodontology, V23, P99, DOI 10.1111/j.1741-2358.2006.00118.x; AMBJORNSEN E, 1982, ACTA ODONTOL SCAND, V40, P203, DOI 10.3109/00016358209019813; Andersson P, 2017, COMMUNITY DENT HLTH, V34, P203, DOI 10.1922/CDH_4100Andersson05; Ashwath B, 2014, QUINTESSENCE INT, V45, P577, DOI 10.3290/j.qi.a31960; Baumgartner Willy, 2015, Swiss Dent J, V125, P417; Blanck M, 2007, J Clin Dent, V18, P1; Chu CH, 2015, ORAL HLTH PREV DENT, V13, P51, DOI 10.3290/j.ohpd.a32343; Cutress T W, 1987, Int Dent J, V37, P222; Daly B, 2017, BRIT DENT J, V223; de Visschere L, 2011, COMMUNITY DENT ORAL, V39, P416, DOI 10.1111/j.1600-0528.2011.00610.x; Duyck J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145837; Ellefsen B, 2009, J AM DENT ASSOC, V140, P1392, DOI 10.14219/jada.archive.2009.0076; Estrada I, 2018, SPEC CARE DENT, V38, P3, DOI 10.1111/scd.12265; Felton DA, 2011, J PROSTHODONT, V20, P1, DOI 10.1111/j.1532-849X.2010.00674.x; Fjeld KG, 2014, EUR J ORAL SCI, V122, P142, DOI 10.1111/eos.12113; Fjeld KG, 2017, ACTA ODONTOL SCAND, P1; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gil-Montoya JA, 2015, J PERIODONTOL, V86, P244, DOI 10.1902/jop.2014.140340; Gil-Montoya JA, 2017, J AM GERIATR SOC, V65, P642, DOI 10.1111/jgs.14697; Graves AB, 1996, AM J EPIDEMIOL, V144, P760, DOI 10.1093/oxfordjournals.aje.a009000; Hatipoglu MG, 2011, GERODONTOLOGY, V28, P302, DOI 10.1111/j.1741-2358.2010.00401.x; Heo SM, 2008, CLIN INFECT DIS, V47, P1562, DOI 10.1086/593193; Holmen A, 2012, GERODONTOLOGY, V29, pE503, DOI 10.1111/j.1741-2358.2011.00507.x; Ikeda T, 2016, SPEC CARE DENT, V36, P13, DOI 10.1111/scd.12141; Ildarabadi Es-Hagh, 2017, Mater Sociomed, V29, P263, DOI 10.5455/msm.2017.29.263-267; Imsand M, 2002, Gerodontology, V19, P66, DOI 10.1111/j.1741-2358.2002.00066.x; Isaksson R, 2000, Spec Care Dentist, V20, P109, DOI 10.1111/j.1754-4505.2000.tb00012.x; Klukowska M, 2014, AM J DENT, V27, P179; Larmas M, 2010, CARIES RES, V44, P81, DOI 10.1159/000279327; Liao YM, 2015, NURS CRIT CARE, V20, P89, DOI 10.1111/nicc.12037; Zuluaga DJM, 2012, GERODONTOLOGY, V29, pE420, DOI 10.1111/j.1741-2358.2011.00490.x; Mojon P, 2004, INT J PROSTHODONT, V17, P434; Muller F, 2015, J DENT RES, V94, p14S, DOI 10.1177/0022034514552494; Pritchard AB, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00336; Quagliarello V, 2005, CLIN INFECT DIS, V40, P1, DOI 10.1086/426023; Rosema NAM, 2016, INT J DENT HYG, V14, P29, DOI 10.1111/idh.12115; Schneider C, 2017, EUR J ORAL SCI, V125, P55, DOI 10.1111/eos.12327; SILNESS J, 1964, Acta Odontol Scand, V22, P121, DOI 10.3109/00016356408993968; Slade GD, 2014, J DENT RES, V93, P959, DOI 10.1177/0022034514546165; Stromberg E, 2012, COMMUNITY DENT ORAL, V40, P221, DOI 10.1111/j.1600-0528.2011.00653.x; United Nations Department of Economic and Social Affairs Population Division, 2017, ESAPWP248 POP DIV; Van der Sluijs E, 2018, INT J DENT HYG, V16, P85, DOI 10.1111/idh.12262; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI [10.1016/S0140-6736(07)61602-X, 10.1016/j.jclinepi.2007.11.008, 10.1371/journal.pmed.0040296]; Whitmyer CC, 1998, GERIATR NURS, V19, P29, DOI 10.1016/S0197-4572(98)90024-6; Willumsen T, 2012, GERODONTOLOGY, V29, pE748, DOI 10.1111/j.1741-2358.2011.00554.x; Yoneyama T, 1999, LANCET, V354, P515, DOI 10.1016/S0140-6736(05)75550-1; Yoneyama T, 2002, J AM GERIATR SOC, V50, P430, DOI 10.1046/j.1532-5415.2002.50106.x; Zitzmann NU, 2008, EUR J ORAL SCI, V116, P52, DOI 10.1111/j.1600-0722.2007.00512.x	49	7	7	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0734-0664	1741-2358		GERODONTOLOGY	Gerodontology	JUN	2019	36	2					125	133		10.1111/ger.12388			9	Dentistry, Oral Surgery & Medicine; Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine; Geriatrics & Gerontology	HZ6NP	WOS:000468969800006	30623472				2022-03-04	
J	Kressig, M; Peterson, CK; McChurch, K; Schmid, C; Leemann, S; Anklin, B; Humphreys, BK				Kressig, Michel; Peterson, Cynthia K.; McChurch, Kyle; Schmid, Christof; Leemann, Serafin; Anklin, Bernard; Humphreys, B. Kim			Relationship of Modic Changes, Disk Herniation Morphology, and Axial Location to Outcomes in Symptomatic Cervical Disk Herniation Patients Treated With High-Velocity, Low-Amplitude Spinal Manipulation: A Prospective Study	JOURNAL OF MANIPULATIVE AND PHYSIOLOGICAL THERAPEUTICS			English	Article						Cervical Spine; Disk Herniation; Chiropractic Manipulation; MRI; Outcomes; Modic Changes	LOW-BACK-PAIN; VERTEBRAL END-PLATE; NECK-DISABILITY-INDEX; NERVE ROOT BLOCKS; LUMBAR SPINE; CHIROPRACTIC MANIPULATION; PROPIONIBACTERIUM-ACNES; GENERAL-POPULATION; FOLLOW-UP; RADICULOPATHY	Objective: The purpose of this study was to evaluate whether cervical disk herniation (CDH) location, morphology, or Modic changes (MCs) are related to treatment outcomes. Methods: Magnetic resonance imaging (MRI) and outcome data from 44 patients with CDH treated with spinal manipulative therapy were evaluated. MRI scans were assessed for CDH axial location, morphology, and MCs. Pain (0-10 for neck and arm) and Neck Disability Index (NDI) data were collected at baseline; 2 weeks; 1, 3, and 6 months; and 1 year. The Patient's Global Impression of Change data were collected at all time points and dichotomized into "improved," yes or no. Fischer's exact test compared the proportion improved with MRI abnormalities. Numerical rating scale and NDI scores were compared with MRI abnormalities at baseline and change scores at all time points using the t test or Mann-Whitney U test. Results: Patients who were Modic positive had higher baseline NDI scores (P = .02); 77.8% of patients who were Modic positive and 53.3% of patients who were Modic negative reported improvement at 2 weeks (P = .21). Fifty percent of Modic I and 83.3% of Modic II patients were improved at 2 weeks (P = .07). At 3 months and 1 year, all patients with MCs were improved. Patients who were Modic positive had higher NRS and NDI change scores. Patients with central herniations were more likely to improve only at the 2-week time point (P = .022). Conclusions: Although patients who were Modic positive had higher baseline NDI scores, the proportion of these patients improved was higher for all time points up to 6 months. Patients with Modic I changes did worse than patients with Modic II changes at only 2 weeks.	[Kressig, Michel; McChurch, Kyle] Swiss Acad Chiropract, Postgrad Program, Bern, Switzerland; [Kressig, Michel; Peterson, Cynthia K.; Humphreys, B. Kim] Univ Zurich, Chiropract Med Dept, Fac Med, Orthopaed Univ Hosp Balgrist, Zurich, Switzerland		Peterson, CK (corresponding author), Orthopaed Univ Hosp Balgrist, Forchstr 340, CH-8008 Zurich, Switzerland.	cynthia.peterson@balgrist.ch			European Chiropractors Union; Balgrist Foundation; Uniscientia Foundation	This study was funded by the European Chiropractors Union, Balgrist Foundation, and Uniscientia Foundation. No conflicts of interest were reported for this study.	Albert HB, 2008, MED HYPOTHESES, V70, P361, DOI 10.1016/j.mehy.2007.05.014; Albert HB, 2007, EUR SPINE J, V16, P977, DOI 10.1007/s00586-007-0336-8; Alentado VJ, 2014, GLOB SPINE J, V4, P279, DOI 10.1055/s-0034-1387807; Annen M, 2016, J MANIP PHYSIOL THER, V39, P200, DOI 10.1016/j.jmpt.2016.02.012; Bensler S, 2015, EUR RADIOL, V25, P3405, DOI 10.1007/s00330-015-3758-4; Bianchi M, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0688-x; BODEN SD, 1990, J BONE JOINT SURG AM, V72A, P1178, DOI 10.2106/00004623-199072080-00008; BROWN BM, 1988, AM J ROENTGENOL, V151, P1205, DOI 10.2214/ajr.151.6.1205; Carricajo A, 2007, J HOSP INFECT, V66, P275, DOI 10.1016/j.jhin.2007.04.007; Carrino JA, 2009, RADIOLOGY, V250, P161, DOI 10.1148/radiol.2493071999; Cassidy JD, 2008, SPINE, V33, pS176, DOI 10.1097/BRS.0b013e3181644600; CHABOT MC, 1995, SEMIN SPINE SURG, V7, P2; Cleland JA, 2008, ARCH PHYS MED REHAB, V89, P69, DOI 10.1016/j.apmr.2007.08.126; Cote P, 1998, SPINE, V23, P1689, DOI 10.1097/00007632-199808010-00015; Decker RC, 2011, PHYS MED REH CLIN N, V22, P179, DOI 10.1016/j.pmr.2010.12.001; Ehrler M, 2016, J MANIP PHYSIOL THER, V39, P192, DOI 10.1016/j.jmpt.2016.02.013; Fardon DF, 2014, SPINE J, V14, P2525, DOI 10.1016/j.spinee.2014.04.022; Fejer R, 2006, EUR SPINE J, V15, P834, DOI 10.1007/s00586-004-0864-4; Finneran MT, 2003, SPINE, V28, P1447; HENDERSON CM, 1983, NEUROSURGERY, V13, P504, DOI 10.1227/00006123-198311000-00004; Hurst H, 2004, J MANIP PHYSIOL THER, V27, P26, DOI 10.1016/j.jmpt.2003.11.003; Hutton MJ, 2011, SPINE, V36, P2304, DOI 10.1097/BRS.0b013e31821604b6; Jarvinen J, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0540-3; Jensen RK, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-183; Jensen TS, 2010, EUR SPINE J, V19, P129, DOI 10.1007/s00586-009-1184-5; Jensen TS, 2008, EUR SPINE J, V17, P1407, DOI 10.1007/s00586-008-0770-2; Kaapa E, 2012, SPINE, V37, P134, DOI 10.1097/BRS.0b013e3182188a90; Kolstad F, 2005, ACTA NEUROCHIR, V147, P1065, DOI 10.1007/s00701-005-0542-2; Kovacs FM, 2009, ACTA RADIOL, V50, P497, DOI 10.1080/02841850902838074; Kuisma M, 2007, SPINE, V32, P1116, DOI 10.1097/01.brs.0000261561.12944.ff; LANDIS JR, 1977, BIOMETRICS, V33, P363, DOI 10.2307/2529786; LEE KP, 1995, NEUROLOGY, V45, P1213, DOI 10.1212/WNL.45.6.1213; Malanga GA, 1997, MED SCI SPORT EXER, V29, pS236; Mann E, 2014, EUR SPINE J, V23, P584, DOI 10.1007/s00586-013-2882-6; Mitra D, 2004, EUR RADIOL, V14, P1574, DOI 10.1007/s00330-004-2314-4; MODIC MT, 1988, RADIOLOGY, V166, P193, DOI 10.1148/radiology.166.1.3336678; Morio Y, 2001, SPINE, V26, P1238, DOI 10.1097/00007632-200106010-00012; Mulconrey Daniel S, 2006, Spine J, V6, P177, DOI 10.1016/j.spinee.2005.08.011; Murphy DR, 2006, J MANIP PHYSIOL THER, V29, P279, DOI 10.1016/j.jmpt.2006.03.005; Paciaroni M, 2009, EUR NEUROL, V61, P112, DOI 10.1159/000180314; Peterson CK, 2014, EUR J RADIOL, V83, P1786, DOI 10.1016/j.ejrad.2014.06.008; Peterson CK, 2013, J MANIP PHYSIOL THER, V36, P461, DOI 10.1016/j.jmpt.2013.07.002; Pickar Joel G, 2002, Spine J, V2, P357, DOI 10.1016/S1529-9430(02)00400-X; RADHAKRISHNAN K, 1994, BRAIN, V117, P325, DOI 10.1093/brain/117.2.325; Rao R, 2002, J BONE JOINT SURG AM, V84A, P1872, DOI 10.2106/00004623-200210000-00021; Schistad EI, 2014, SKELETAL RADIOL, V43, P1271, DOI 10.1007/s00256-014-1928-0; Schmid G, 2004, RADIOLOGY, V231, P352, DOI 10.1148/radiol.2312021708; Shan Z, 2014, SPINE, V39, P736, DOI 10.1097/BRS.0000000000000259; Stirling A, 2001, LANCET, V357, P2024, DOI 10.1016/S0140-6736(00)05109-6; Thiel HW, 2007, SPINE, V32, P2375, DOI 10.1097/BRS.0b013e3181557bb1; Vallee JN, 2001, RADIOLOGY, V218, P886, DOI 10.1148/radiology.218.3.r01mr17886; van Dieen JH, 1999, MED HYPOTHESES, V53, P246, DOI 10.1054/mehy.1998.0754; Vernon H, 2008, J MANIP PHYSIOL THER, V31, P491, DOI 10.1016/j.jmpt.2008.08.006; Wainner RS, 2003, SPINE, V28, P52, DOI 10.1097/00007632-200301010-00014; Webb R, 2003, SPINE, V28, P1195, DOI 10.1097/00007632-200306010-00021; Wedderkopp N, 2009, ACTA RADIOL, V50, P65, DOI 10.1080/02841850802524485	56	4	4	1	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0161-4754			J MANIP PHYSIOL THER	J. Manip. Physiol. Ther.	OCT	2016	39	8					565	575		10.1016/j.jmpt.2016.08.004			11	Health Care Sciences & Services; Integrative & Complementary Medicine; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services; Integrative & Complementary Medicine; Rehabilitation	EE3QZ	WOS:000389512400002	27687057	Bronze			2022-03-04	
J	Peterson, CK; Bolton, J; Humphreys, BK				Peterson, Cynthia K.; Bolton, Jennifer; Humphreys, B. Kim			PREDICTORS OF IMPROVEMENT IN PATIENTS WITH ACUTE AND CHRONIC LOW BACK PAIN UNDERGOING CHIROPRACTIC TREATMENT	JOURNAL OF MANIPULATIVE AND PHYSIOLOGICAL THERAPEUTICS			English	Article						Low Back Pain; Chiropractic; Treatment Outcome; Manipulation	QUALITY-OF-LIFE; SUBPOPULATION PROGRAM; SPINAL MANIPULATION; HEALTH; VALIDATION; MANAGEMENT; CONSENSUS; EFFICACY; SCORES; MODE	Objectives: The purpose of this study was to investigate outcomes and prognostic factors in patients with acute or chronic low back pain (LBP) undergoing chiropractic treatment. Methods: This was a prognostic cohort study with medium-term outcomes. Adult patients with LBP of any duration who had not received chiropractic or manual therapy in the prior 3 months were recruited from multiple chiropractic practices in Switzerland. Participating doctors of chiropractic were allowed to use their typical treatment methods (such as chiropractic manipulation, soft tissue mobilization, or other methods) because the purpose of the study was to evaluate outcomes from routine chiropractic practice. Patients completed a numerical pain rating scale and Oswestry disability questionnaire immediately before treatment and at 1 week, 1 month, and 3 months after the start of treatment, together with self-reported improvement using the Patient Global Impression of Change. Results: Patients with acute (<4 weeks; n = 523) and chronic (>3 months; n = 293) LBP were included. Baseline mean pain and disability scores were significantly (P < .001) higher in patients with acute LBP. In both groups of patients, there were significant (P < .0001) improvements in mean scores of pain and disability at 1 week, 1 month, and 3 months, although these change scores were significantly greater in the acute group. Similarly, a greater proportion of patients in the acute group reported improvement at each follow-up. The most consistent predictor was self-reported improvement at 1 week, which was independently associated with improvement at 1 month (adjusted odds ratio [OR], 2.4 [95% confidence interval, 1.3-4.5] and 5.0 [2.4-10.6]) and at 3 months (2.9 [1.3-6.6] and 3.3 [1.3-8.7]) in patients with acute and chronic pain, respectively. The presence of radiculopathy at baseline was not a predictor of outcome. Conclusions: Patients with chronic and acute pain reporting that they were "much better" or "better" on the Patient Global Impression of Change scale at 1 week after the first chiropractic visit were 4 to 5 times more likely to be improved at both 1 and 3 months compared with patients who were not improved at 1 week. Patients with acute pain reported more severe pain and disability initially but recovered faster. Patients with chronic and acute back pain both reported good outcomes, and most patients with radiculopathy also improved. (J Manipulative Physiol Ther 2012;35:525-533)	[Peterson, Cynthia K.; Humphreys, B. Kim] Univ Zurich, Fac Med, Chiropract Dept, Zurich, Switzerland; [Bolton, Jennifer] Angloeuropean Coll Chiropract, Bournemouth, Dorset, England		Peterson, CK (corresponding author), Orthopaed Univ Hosp Balgrist, Chiropract Dept, Forchstr 340, CH-8008 Zurich, Switzerland.	Cynthia.peterson@balgrist.ch			European Academy of Chiropractic; Balgrist Hospital Stiftung	The European Academy of Chiropractic and Balgrist Hospital Stiftung provided funding for this study. No conflicts of interest were reported for this study.	Anonymous, 2008, Annales de Readaptation et de Medecine Physique, V51, P379, DOI 10.1016/j.annrmp.2008.03.006; Assendelft WJ, 2004, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD000447.PUB2; Axen I, 2005, J MANIP PHYSIOL THER, V28, P381, DOI 10.1016/j.jmpt.2005.06.008; Axen I, 2002, J MANIP PHYSIOL THER, V25, P450, DOI 10.1067/mmt.2002.126473; Becker A, 2010, SPINE, V35, P1714, DOI 10.1097/BRS.0b013e3181cd656f; Brennan GP, 2006, SPINE, V31, P623, DOI 10.1097/01.brs.0000202807.72292.a8; Bronfort Gert, 2004, Spine J, V4, P335, DOI 10.1016/j.spinee.2003.06.002; Childs JD, 2004, ANN INTERN MED, V141, P920, DOI 10.7326/0003-4819-141-12-200412210-00008; Ferreira ML, 2003, J MANIP PHYSIOL THER, V26, P593, DOI 10.1016/j.jmpt.2003.08.010; Fischer D, 1999, JAMA-J AM MED ASSOC, V282, P1157, DOI 10.1001/jama.282.12.1157; Flynn T, 2002, SPINE, V27, P2835, DOI 10.1097/00007632-200212150-00021; Fritz JM, 2004, PHYS THER, V84, P173, DOI 10.1093/ptj/84.2.173; Globe GA, 2008, J MANIP PHYSIOL THER, V31, P651, DOI 10.1016/j.jmpt.2008.10.006; Haas Mitchell, 2004, Spine J, V4, P574, DOI 10.1016/j.spinee.2004.02.008; Hanmer J, 2007, MED CARE, V45, P1171, DOI 10.1097/MLR.0b013e3181354828; Hays RD, 2009, VALUE HEALTH, V12, P1035, DOI 10.1111/j.1524-4733.2009.00566.x; Humphreys BK, 2010, J MANIP PHYSIOL THER, V33, P519, DOI 10.1016/j.jmpt.2010.08.003; Kent Peter M, 2005, Chiropr Osteopat, V13, P13, DOI 10.1186/1746-1340-13-13; Khorsan R, 2008, J MANIP PHYSIOL THER, V31, P355, DOI 10.1016/j.jmpt.2008.04.007; Kongsted Alice, 2010, Chiropr Osteopat, V18, P8, DOI 10.1186/1746-1340-18-8; Kongsted Alice, 2010, Chiropr Osteopat, V18, P2, DOI 10.1186/1746-1340-18-2; Kongsted Alice, 2009, Chiropr Osteopat, V17, P11, DOI 10.1186/1746-1340-17-11; Lawrence DJ, 2008, J MANIP PHYSIOL THER, V31, P659, DOI 10.1016/j.jmpt.2008.10.007; Leboeuf-Yde C, 2005, J MANIP PHYSIOL THER, V28, P90, DOI 10.1016/j.jmpt.2005.01.010; Leboeuf-Yde C, 2004, J MANIP PHYSIOL THER, V27, P493, DOI 10.1016/j.jmpt.2004.08.001; Malmqvist Stefan, 2008, Chiropr Osteopat, V16, P13, DOI 10.1186/1746-1340-16-13; Mannion AF, 2006, EUR SPINE J, V15, P55, DOI 10.1007/s00586-004-0815-0; Martin BI, 2008, JAMA-J AM MED ASSOC, V299, P656, DOI 10.1001/jama.299.6.656; Nakipoglu GF, 2008, PAIN PHYSICIAN, V11, P505; Ostelo RWJG, 2008, SPINE, V33, P90, DOI 10.1097/BRS.0b013e31815e3a10; Pengel LHM, 2003, BMJ-BRIT MED J, V327, P323, DOI 10.1136/bmj.327.7410.323; Powers JR, 2005, AUST NZ J PUBL HEAL, V29, P149, DOI 10.1111/j.1467-842X.2005.tb00065.x; SPRATT KF, 1993, SPINE, V18, P1839, DOI 10.1097/00007632-199310000-00020	33	30	31	2	14	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0161-4754			J MANIP PHYSIOL THER	J. Manip. Physiol. Ther.	SEP	2012	35	7					525	533		10.1016/j.jmpt.2012.06.003			9	Health Care Sciences & Services; Integrative & Complementary Medicine; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services; Integrative & Complementary Medicine; Rehabilitation	029OA	WOS:000310503900003	22858233				2022-03-04	
J	Soudet, J; Gill, JK; Stutz, F				Soudet, Julien; Gill, Jatinder Kaur; Stutz, Francoise			Noncoding transcription influences the replication initiation program through chromatin regulation	GENOME RESEARCH			English	Article							RNA-POLYMERASE-II; GENOME-WIDE ANALYSIS; PERVASIVE TRANSCRIPTION; BIDIRECTIONAL PROMOTERS; EARLY TERMINATION; GENE-EXPRESSION; YEAST; ORIGIN; DNA; PROFILES	In eukaryotic organisms, replication initiation follows a temporal program. Among the parameters that regulate this program in Saccharomyces cerevisiae, chromatin structure has been at the center of attention without considering the contribution of transcription. Here, we revisit the replication initiation program in the light of widespread genomic noncoding transcription. We find that noncoding RNA transcription termination in the vicinity of autonomously replicating sequences (ARSs) shields replication initiation from transcriptional readthrough. Consistently, high natural nascent transcription correlates with low ARS efficiency and late replication timing. High readthrough transcription is also linked to increased nucleosome occupancy and high levels of H3K36me3. Moreover, forcing ARS readthrough transcription promotes these chromatin features. Finally, replication initiation defects induced by increased transcriptional readthrough are partially rescued in the absence of H3K36 methylation. Altogether, these observations indicate that natural noncoding transcription into ARSs influences replication initiation through chromatin regulation.	[Soudet, Julien; Gill, Jatinder Kaur; Stutz, Francoise] Univ Geneva, Dept Cell Biol, CH-1211 Geneva 4, Switzerland		Soudet, J; Stutz, F (corresponding author), Univ Geneva, Dept Cell Biol, CH-1211 Geneva 4, Switzerland.	julien.soudet@unige.ch; francoise.stutz@unige.ch	Stutz, Françoise C/N-4329-2017		Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission [31003A 153331]; Canton of Geneva; Polish Swiss Research Programme (PSRP) [Core 183/2010]; iGE3	We thank O. Aparicio, D. MacAlpine, and P. Cramer for sharing data and reagents and M. Strubin, F. Steiner, M. Shyian, G. Canal, T. Halazonetis, and all members from the Stutz lab for comments on the manuscript. We also thank D. Libri for communication of unpublished results. This work was funded by the Swiss National Science Foundation (31003A 153331), iGE3, and the Canton of Geneva, as well as a Polish Swiss Research Programme (PSRP NoCore 183/2010).	Aparicio JG, 2004, MOL CELL BIOL, V24, P4769, DOI 10.1128/MCB.24.11.4769-4780.2004; Aparicio OM, 2013, GENE DEV, V27, P117, DOI 10.1101/gad.209999.112; Arigo JT, 2006, MOL CELL, V23, P841, DOI 10.1016/j.molcel.2006.07.024; Baejen C, 2017, MOL CELL, V66, P38, DOI 10.1016/j.molcel.2017.02.009; BELL SP, 1995, CURR OPIN GENET DEV, V5, P162, DOI 10.1016/0959-437X(95)80003-4; Belsky JA, 2015, GENE DEV, V29, P212, DOI 10.1101/gad.247924.114; Blitzblau HG, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002643; Bresson S, 2017, MOL CELL, V65, P787, DOI 10.1016/j.molcel.2017.01.005; Camblong J, 2007, CELL, V131, P706, DOI 10.1016/j.cell.2007.09.014; Candelli T, 2018, BIORXIV, DOI [10.1101/384859, DOI 10.1101/384859]; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Castelnuovo M, 2014, NUCLEIC ACIDS RES, V42, P4348, DOI 10.1093/nar/gku100; Castelnuovo M, 2013, NAT STRUCT MOL BIOL, V20, P851, DOI 10.1038/nsmb.2598; Churchman LS, 2011, NATURE, V469, P368, DOI 10.1038/nature09652; Czajkowsky DM, 2008, J MOL BIOL, V375, P12, DOI 10.1016/j.jmb.2007.10.046; Das SP, 2015, GENOME RES, V25, P1886, DOI 10.1101/gr.195305.115; David MZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092760; Deegan TD, 2016, CURR OPIN STRUC BIOL, V37, P145, DOI 10.1016/j.sbi.2016.01.014; Dellino GI, 2013, GENOME RES, V23, P1, DOI 10.1101/gr.142331.112; Eaton ML, 2010, GENE DEV, V24, P748, DOI 10.1101/gad.1913210; Fraser HB, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r111; Gros J, 2015, MOL CELL, V60, P797, DOI 10.1016/j.molcel.2015.10.022; Haruki H, 2008, MOL CELL, V31, P925, DOI 10.1016/j.molcel.2008.07.020; Hawkins M, 2013, CELL REP, V5, P1132, DOI 10.1016/j.celrep.2013.10.014; Heichinger C, 2006, EMBO J, V25, P5171, DOI 10.1038/sj.emboj.7601390; Hoggard T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003798; Jensen TH, 2013, MOL CELL, V52, P473, DOI 10.1016/j.molcel.2013.10.032; Kim M, 2004, NATURE, V432, P517, DOI 10.1038/nature03041; Knott SRV, 2012, CELL, V148, P99, DOI 10.1016/j.cell.2011.12.012; Knott SRV, 2009, GENE DEV, V23, P1077, DOI 10.1101/gad.1784309; Kubik S, 2015, MOL CELL, V60, P422, DOI 10.1016/j.molcel.2015.10.002; Looke M, 2013, EMBO REP, V14, P191, DOI 10.1038/embor.2012.196; Looke M, 2010, J BIOL CHEM, V285, P40004, DOI 10.1074/jbc.M110.148924; Luo WF, 2006, GENE DEV, V20, P954, DOI 10.1101/gad.1409106; Malabat C, 2015, ELIFE, V4, DOI 10.7554/eLife.06722; Mayan MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053405; Mayer A, 2015, CELL, V161, P541, DOI 10.1016/j.cell.2015.03.010; McGuffee SR, 2013, MOL CELL, V50, P123, DOI 10.1016/j.molcel.2013.03.004; Miotto B, 2016, P NATL ACAD SCI USA, V113, pE4810, DOI 10.1073/pnas.1609060113; Mori S, 2007, J BIOL CHEM, V282, P4447, DOI 10.1074/jbc.M609671200; Neil H, 2009, NATURE, V457, P1038, DOI 10.1038/nature07747; Nieduszynski CA, 2005, NUCLEIC ACIDS RES, V33, P2410, DOI 10.1093/nar/gki539; Nieduszynski CA, 2006, GENE DEV, V20, P1874, DOI 10.1101/gad.385306; Nojima T, 2015, CELL, V161, P526, DOI 10.1016/j.cell.2015.03.027; Peace JM, 2016, GENOME RES, V26, P365, DOI 10.1101/gr.196857.115; Petryk N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10208; Porrua O, 2016, TRENDS GENET, V32, P508, DOI 10.1016/j.tig.2016.05.007; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Pryde F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005882; Raghuraman MK, 2001, SCIENCE, V294, P115, DOI 10.1126/science.294.5540.115; Rodriguez J, 2017, GENOME RES, V27, P269, DOI 10.1101/gr.209940.116; Rundlett SE, 1996, P NATL ACAD SCI USA, V93, P14503, DOI 10.1073/pnas.93.25.14503; Schaughency P, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004632; Schulz D, 2013, CELL, V155, P1075, DOI 10.1016/j.cell.2013.10.024; Segal E, 2009, CURR OPIN STRUC BIOL, V19, P65, DOI 10.1016/j.sbi.2009.01.004; Sequeira-Mendes J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000446; SNYDER M, 1988, MOL CELL BIOL, V8, P2184, DOI 10.1128/MCB.8.5.2184; Soriano I, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-791; Soudet J, 2014, MOL CELL, V53, P954, DOI 10.1016/j.molcel.2014.02.030; Steinmetz EJ, 2001, NATURE, V413, P327, DOI 10.1038/35095090; STINCHCOMB DT, 1979, NATURE, V282, P39, DOI 10.1038/282039a0; Tudek A, 2014, MOL CELL, V55, P467, DOI 10.1016/j.molcel.2014.05.031; Unnikrishnan A, 2010, NAT STRUCT MOL BIOL, V17, P430, DOI 10.1038/nsmb.1780; Uwimana N, 2017, NUCLEIC ACIDS RES, V45, P6417, DOI 10.1093/nar/gkx242; van Dijk EL, 2011, NATURE, V475, P114, DOI 10.1038/nature10118; Van Nues R, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00025-5; Vogelauer M, 2002, MOL CELL, V10, P1223, DOI 10.1016/S1097-2765(02)00702-5; Weiner A, 2015, MOL CELL, V58, P371, DOI 10.1016/j.molcel.2015.02.002; Wittmann S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14861; Woo H, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.19; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728; Yang SCH, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.61; Yoshida K, 2014, MOL CELL, V54, P691, DOI 10.1016/j.molcel.2014.04.032; Yoshida K, 2013, J MOL BIOL, V425, P4696, DOI 10.1016/j.jmb.2013.09.020	75	9	9	1	6	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	DEC	2018	28	12					1882	1893		10.1101/gr.239582.118			12	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	HC6LR	WOS:000451913800010	30401734	Green Published, hybrid, Green Submitted			2022-03-04	
J	Surget-Groba, Y; Montoya-Burgos, JI				Surget-Groba, Yann; Montoya-Burgos, Juan I.			Optimization of de novo transcriptome assembly from next-generation sequencing data	GENOME RESEARCH			English	Article							RNA-SEQ; MODEL ORGANISMS; GENE DISCOVERY; LARGE SETS; GENOME; RESOLUTION; ALLPATHS; PROGRAM; PROTEIN; FISHES	Transcriptome analysis has important applications in many biological fields. However, assembling a transcriptome without a known reference remains a challenging task requiring algorithmic improvements. We present two methods for substantially improving transcriptome de novo assembly. The first method relies on the observation that the use of a single k-mer length by current de novo assemblers is suboptimal to assemble transcriptomes where the sequence coverage of transcripts is highly heterogeneous. We present the Multiple-k method in which various k-mer lengths are used for de novo transcriptome assembly. We demonstrate its good performance by assembling de novo a published next-generation transcriptome sequence data set of Aedes aegypti, using the existing genome to check the accuracy of our method. The second method relies on the use of a reference proteome to improve the de novo assembly. We developed the Scaffolding using Translation Mapping (STM) method that uses mapping against the closest available reference proteome for scaffolding contigs that map onto the same protein. In a controlled experiment using simulated data, we show that the STM method considerably improves the assembly, with few errors. We applied these two methods to assemble the transcriptome of the non-model catfish Loricaria gr. cataphracta. Using the Multiple-k and STM methods, the assembly increases in contiguity and in gene identification, showing that our methods clearly improve quality and can be widely used. The new methods were used to assemble successfully the transcripts of the core set of genes regulating tooth development in vertebrates, while classic de novo assembly failed.	[Surget-Groba, Yann; Montoya-Burgos, Juan I.] Univ Geneva, Dept Zool & Anim Biol, CH-1211 Geneva 4, Switzerland		Montoya-Burgos, JI (corresponding author), Univ Geneva, Dept Zool & Anim Biol, CH-1211 Geneva 4, Switzerland.	Juan.Montoya@unige.ch	; Surget-Groba, Yann/K-4917-2012	Montoya-Burgos, Juan/0000-0001-9080-9820; Surget-Groba, Yann/0000-0001-7612-4892	funds from the Canton de Geneve; Swiss National Research FundSwiss National Science Foundation (SNSF) [3100A0-122303/1]; G & A Claraz Foundation	We thank Antonis Rokas for sharing with us his Ae. aegypti next-generation short-read data set. We thank Ilham Bahechar for her help with laboratory work, and Marta Burgos and Alison R. Davis for revising the manuscript. We thank Patrick Descombes, Laurent Farinelli, and three anonymous reviewers for their useful discussions and comments. This work was supported by funds fromthe Canton de Geneve, the Swiss National Research Fund (Number 3100A0-122303/1), and the G & A Claraz Foundation.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arslan AN, 2001, BIOINFORMATICS, V17, P327, DOI 10.1093/bioinformatics/17.4.327; Barbazuk WB, 2007, PLANT J, V51, P910, DOI 10.1111/j.1365-313X.2007.03193.x; Burki F, 2008, BIOL LETTERS, V4, P366, DOI 10.1098/rsbl.2008.0224; Butler J, 2008, GENOME RES, V18, P810, DOI 10.1101/gr.7337908; Carninci P, 2008, NAT METHODS, V5, P587, DOI 10.1038/nmeth0708-587; Chaisson MJ, 2008, GENOME RES, V18, P324, DOI 10.1101/gr.7088808; Collins LJ, 2008, GENOME INFORM SER, V21, P3; Disset A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007779; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Elling AA, 2009, PLANT SIGNAL BEHAV, V4, P760, DOI 10.1105/tpc.109.065714; Fraser GJ, 2009, PLOS BIOL, V7, P233, DOI 10.1371/journal.pbio.1000031; Gibbons JG, 2009, MOL BIOL EVOL, V26, P2731, DOI 10.1093/molbev/msp188; Hahn DA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-234; Hale MC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-203; Hegedus Z, 2009, MOL IMMUNOL, V46, P2918, DOI 10.1016/j.molimm.2009.07.002; Hernandez D, 2008, GENOME RES, V18, P802, DOI 10.1101/gr.072033.107; HUANG XQ, 1992, GENOMICS, V14, P18, DOI 10.1016/S0888-7543(05)80277-0; Hughes J, 2006, MOL BIOL EVOL, V23, P268, DOI 10.1093/molbev/msj041; Levin JZ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r115; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; MacCallum I, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r103; Main BJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-422; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Montoya-Burgos JI, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-126; Morrissy AS, 2009, GENOME RES, V19, P1825, DOI 10.1101/gr.094482.109; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Pevzner PA, 2001, P NATL ACAD SCI USA, V98, P9748, DOI 10.1073/pnas.171285098; Porreca GJ, 2007, NAT METHODS, V4, P931, DOI 10.1038/NMETH1110; Reinhardt JA, 2009, GENOME RES, V19, P294, DOI 10.1101/gr.083311.108; Salzberg SL, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000186; Schuster SC, 2008, NAT METHODS, V5, P16, DOI 10.1038/NMETH1156; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Sire JY, 2001, EVOL DEV, V3, P104, DOI 10.1046/j.1525-142x.2001.003002104.x; Smith AD, 2009, BIOINFORMATICS, V25, P2841, DOI 10.1093/bioinformatics/btp533; Steinke D, 2006, J MOL EVOL, V62, P772, DOI 10.1007/s00239-005-0170-8; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Torres TT, 2008, GENOME RES, V18, P172, DOI 10.1101/gr.6984908; Toth AL, 2007, SCIENCE, V318, P441, DOI 10.1126/science.1146647; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Yamanoue Y, 2006, GENES GENET SYST, V81, P29, DOI 10.1266/ggs.81.29; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	48	265	272	0	87	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	OCT	2010	20	10					1432	1440		10.1101/gr.103846.109			9	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	656XS	WOS:000282375000013	20693479	Green Published, Bronze			2022-03-04	
J	Reinders, J; Vivier, CD; Theiler, G; Chollet, D; Descombes, P; Paszkowski, J				Reinders, Jon; Vivier, Celine Delucinge; Theiler, Gregory; Chollet, Didier; Descombes, Patrick; Paszkowski, Jerzy			Genome-wide, high-resolution DNA methylation profiling using bisulfate-mediated cytosine conversion	GENOME RESEARCH			English	Article							ARABIDOPSIS-THALIANA; EPIGENETIC ALLELES; CPG METHYLATION; CG METHYLATION; BINDING-SITES; HETEROCHROMATIN; CHROMOSOME; PATTERNS; GENE; HYPERMETHYLATION	Methylation of cytosines (C-m) is essential for epigenetic gene regulation in plants and mammals. Aberrant C-m patterns are associated with heritable developmental abnormalities in plants and with cancer in mammals. We have developed a genome-wide DNA methylation profiling technology employing a novel amplification step for DNA subjected to bisulfate-mediated cytosine conversion. The methylation patterns detected are not only consistent with previous results obtained with C-m immunoprecipitation (mCIP) techniques, but also demonstrated improved resolution and sensitivity. The technology, named BiMP (for Bisulfite Methylation Profiling), is more cost-effective than mCIP and requires as little as 100 ng of Arabidopsis DNA.	[Reinders, Jon; Theiler, Gregory; Paszkowski, Jerzy] Univ Geneva, Lab Plant Genet, Dept Plant Biol, CH-1211 Geneva 4, Switzerland; [Vivier, Celine Delucinge; Chollet, Didier; Descombes, Patrick] Univ Geneva, CMU, Natl Ctr Competence Res Frontiers Genet, CH-1211 Geneva, Switzerland		Reinders, J (corresponding author), Univ Geneva, Lab Plant Genet, Dept Plant Biol, CH-1211 Geneva 4, Switzerland.	jon.reinders@bioveg.unige.ch					Bao N, 2004, DEV CELL, V7, P653, DOI 10.1016/j.devcel.2004.10.003; Baroux C, 2002, ADV GENET, V46, P165; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Borevitz JO, 2003, GENOME RES, V13, P513, DOI 10.1101/gr.541303; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; Dupont JM, 2004, ANAL BIOCHEM, V333, P119, DOI 10.1016/j.ab.2004.05.007; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Finnegan EJ, 2000, CURR OPIN GENET DEV, V10, P217, DOI 10.1016/S0959-437X(00)00061-7; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Gitan RS, 2002, GENOME RES, V12, P158, DOI 10.1101/gr.202801; Henderson IR, 2006, NAT GENET, V38, P721, DOI 10.1038/ng1804; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; Jacobsen SE, 2000, CURR BIOL, V10, P179, DOI 10.1016/S0960-9822(00)00324-9; Jacobsen SE, 1997, SCIENCE, V277, P1100, DOI 10.1126/science.277.5329.1100; Jorgensen HF, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl527; Keshet I, 2006, NAT GENET, V38, P149, DOI 10.1038/ng1719; Kishimoto N, 2001, PLANT MOL BIOL, V46, P171, DOI 10.1023/A:1010636222327; LEUTWILER LS, 1984, MOL GEN GENET, V194, P15, DOI 10.1007/BF00383491; Lindroth AM, 2001, SCIENCE, V292, P2077, DOI 10.1126/science.1059745; Lippman Z, 2005, NAT METHODS, V2, P219, DOI 10.1038/nmeth0305-219; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Mathieu O, 2007, CELL, V130, P851, DOI 10.1016/j.cell.2007.07.007; Mockler TC, 2005, GENOMICS, V85, P1, DOI 10.1016/j.ygeno.2004.10.005; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Olek A, 1996, NUCLEIC ACIDS RES, V24, P5064, DOI 10.1093/nar/24.24.5064; RAIZIS AM, 1995, ANAL BIOCHEM, V226, P161, DOI 10.1006/abio.1995.1204; Reik W, 2005, NAT REV GENET, V6, P403, DOI 10.1038/nrg1602; Saze H, 2003, NAT GENET, V34, P65, DOI 10.1038/ng1138; Saze H, 2007, EMBO J, V26, P3641, DOI 10.1038/sj.emboj.7601788; Singer T, 2006, PLOS GENET, V2, P1352, DOI 10.1371/journal.pgen.0020144; Soppe WJJ, 2002, EMBO J, V21, P6549, DOI 10.1093/emboj/cdf657; Soppe WJJ, 2000, MOL CELL, V6, P791, DOI 10.1016/S1097-2765(05)00090-0; Tariq M, 2003, P NATL ACAD SCI USA, V100, P8823, DOI 10.1073/pnas.1432939100; Tran RK, 2005, CURR BIOL, V15, P154, DOI 10.1016/j.cub.2005.01.008; Warnecke PM, 2002, METHODS, V27, P101, DOI 10.1016/S1046-2023(02)00060-9; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zhu T, 2000, PLANT PHYSIOL, V124, P1472, DOI 10.1104/pp.124.4.1472	38	51	55	2	16	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	WOODBURY	500 SUNNYSIDE BLVD, WOODBURY, NY 11797-2924 USA	1088-9051			GENOME RES	Genome Res.	MAR	2008	18	3					469	476		10.1101/gr.7073008			8	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	271CO	WOS:000253766700013	18218979	Green Published, Bronze			2022-03-04	
J	Strobino, M; Wenda, JM; Padayachy, L; Steiner, FA				Strobino, Maude; Wenda, Joanna M.; Padayachy, Laura; Steiner, Florian A.			Loss of histone H3.3 results in DNA replication defects and altered origin dynamics in C. elegans	GENOME RESEARCH			English	Article							FORK PROGRESSION; BINDING-SITES; CELL-DIVISION; HUMAN GENOME; TRANSCRIPTION; DAMAGE; CHROMATIN; CHECKPOINT; ACTIVATION; KINETICS	Histone H3.3 is a replication-independent variant of histone H3 with important roles in development, differentiation, and fertility. Here, we show that loss of H3.3 results in replication defects in Caenorhabditis elegans embryos at elevated temperatures. To characterize these defects, we adapt methods to determine replication timing, map replication origins, and examine replication fork progression. Our analysis of the spatiotemporal regulation of DNA replication shows that despite the very rapid embryonic cell cycle, the genome is replicated from early and late firing origins and is partitioned into domains of early and late replication. We find that under temperature stress conditions, additional replication origins become activated. Moreover, loss of H3.3 results in altered replication fork progression around origins, which is particularly evident at stress-activated origins. These replication defects are accompanied by replication checkpoint activation, a delayed cell cycle, and increased lethality in checkpoint-compromised embryos. Our comprehensive analysis of DNA replication in C. elegans reveals the genomic location of replication origins and the dynamics of their firing, and uncovers a role of H3.3 in the regulation of replication origins under stress conditions.	[Steiner, Florian A.] Univ Geneva, Fac Sci, Dept Mol Biol, CH-1211 Geneva, Switzerland; Univ Geneva, Fac Sci, Dept Mol Biol, Inst Genet & Genom Geneva,Sect Biol, CH-1211 Geneva, Switzerland		Steiner, FA (corresponding author), Univ Geneva, Fac Sci, Dept Mol Biol, CH-1211 Geneva, Switzerland.	florian.steiner@unige.ch		Wenda, Joanna/0000-0002-7312-6777; Strobino, Maude/0000-0001-9193-0630; Steiner, Florian/0000-0002-0514-5060	National Institutes of Health Office of Research Infrastructure Programs [P40 OD010440]; Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission [31003A_156774, 31003A_175606]; Republic and Canton of Geneva	We thank Morgane Macheret and Thanos Halazonetis for sharing unpublished protocols, Jonathan Mailler for discussion, Dario Menendez for help with strain generation, Caroline Gabus and Marina Berti for reagent preparation, Nicolas Roggli for help with data analysis and image processing, Florian Huber and Ioannis Xenarios for help with the data analysis, and Uli Laemmli and Gabriel Zentner for reagents and advice when establishing the ChEC method. We thank all the Steiner laboratory members for discussion and comments on the manuscript. We thank Thanos Halazonetis, Damien Hermand, Jonathan Mailler, Reinier Prosee, David Shore, and Maksym Shyian for comments on the manuscript. Some strains were provided by the Caenorhabditis Genetics Center (CGC), which is funded by National Institutes of Health Office of Research Infrastructure Programs (P40 OD010440). We are grateful to the Genomics Platform of the iGE3, the Bioimaging Center of the Faculty of Sciences, and the Flow Cytometry platform of the Medical Faculty at the University of Geneva. The work was funded by the Swiss National Science Foundation (Grants 31003A_156774 and 31003A_175606) and the Republic and Canton of Geneva.	Adam S, 2013, CELL, V155, P94, DOI 10.1016/j.cell.2013.08.029; Begasse ML, 2015, CELL REP, V10, P647, DOI 10.1016/j.celrep.2015.01.006; Besnard E, 2012, NAT STRUCT MOL BIOL, V19, P837, DOI 10.1038/nsmb.2339; Bester AC, 2011, CELL, V145, P435, DOI 10.1016/j.cell.2011.03.044; Boos D, 2019, GENES-BASEL, V10, DOI 10.3390/genes10030199; Brauchle M, 2003, CURR BIOL, V13, P819, DOI 10.1016/S0960-9822(03)00295-1; Bruck I, 2015, P NATL ACAD SCI USA, V112, P11223, DOI 10.1073/pnas.1509608112; Cedergreen N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0140277; Chari S, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.177402; Clement C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05697-1; Costantino L, 2014, SCIENCE, V343, P88, DOI 10.1126/science.1243211; Deal RB, 2010, SCIENCE, V328, P1161, DOI 10.1126/science.1186777; Delaney K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10404-9; Delaney K, 2018, GENETICS, V209, P551, DOI 10.1534/genetics.118.300909; Dellino GI, 2013, GENOME RES, V23, P1, DOI 10.1101/gr.142331.112; Desprat R, 2009, GENOME RES, V19, P2288, DOI 10.1101/gr.094060.109; Dileep V, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02800-w; Eaton ML, 2011, GENOME RES, V21, P164, DOI 10.1101/gr.116038.110; Ekundayo B, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008320; Farkash-Amar S, 2008, GENOME RES, V18, P1562, DOI 10.1101/gr.079566.108; Fragkos M, 2015, NAT REV MOL CELL BIO, V16, P360, DOI 10.1038/nrm4002; Frey A, 2014, CURR BIOL, V24, P2195, DOI 10.1016/j.cub.2014.07.077; Gaggioli V, 2020, BIORXIV, DOI [10.1101/2020.06.24.168708, DOI 10.1101/2020.06.24.168708]; Groth A, 2007, SCIENCE, V318, P1928, DOI 10.1126/science.1148992; Hansen RS, 2010, P NATL ACAD SCI USA, V107, P139, DOI 10.1073/pnas.0912402107; Hiratani I, 2008, PLOS BIOL, V6, P2220, DOI 10.1371/journal.pbio.0060245; Hodl M, 2009, CURR BIOL, V19, P1221, DOI 10.1016/j.cub.2009.05.048; Holway AH, 2006, J CELL BIOL, V172, P999, DOI 10.1083/jcb.200512136; Huang WC, 2013, BIOINFORMATICS, V29, P3097, DOI 10.1093/bioinformatics/btt520; Hyun M, 2016, CELL SIGNAL, V28, P214, DOI 10.1016/j.cellsig.2015.12.006; Jang CW, 2015, GENE DEV, V29, P1377, DOI 10.1101/gad.264150.115; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kanemaki M, 2006, EMBO J, V25, P1753, DOI 10.1038/sj.emboj.7601063; Kumagai A, 2010, CELL, V140, P349, DOI 10.1016/j.cell.2009.12.049; Labib K, 2001, CURR OPIN GENET DEV, V11, P64, DOI 10.1016/S0959-437X(00)00158-1; Langley AR, 2016, NUCLEIC ACIDS RES, V44, P10230, DOI 10.1093/nar/gkw760; Liu QH, 2000, GENE DEV, V14, P1448; MacAlpine DM, 2004, GENE DEV, V18, P3094, DOI 10.1101/gad.1246404; MacAlpine HK, 2010, GENOME RES, V20, P201, DOI 10.1101/gr.097873.109; Macheret M, 2019, NAT PROTOC, V14, P51, DOI 10.1038/s41596-018-0081-y; Macheret M, 2018, NATURE, V555, P112, DOI 10.1038/nature25507; Mantiero D, 2011, EMBO J, V30, P4805, DOI 10.1038/emboj.2011.404; Marchal C, 2019, NAT REV MOL CELL BIO, V20, P721, DOI 10.1038/s41580-019-0162-y; Matsuba C, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.0334; Mesner LD, 2013, GENOME RES, V23, P1774, DOI 10.1101/gr.155218.113; Michalet X, 1997, SCIENCE, V277, P1518, DOI 10.1126/science.277.5331.1518; Miotto B, 2016, P NATL ACAD SCI USA, V113, pE4810, DOI 10.1073/pnas.1609060113; Moiseeva TN, 2019, P NATL ACAD SCI USA, V116, P13374, DOI 10.1073/pnas.1903418116; Neves A, 2015, ELIFE, V4, DOI 10.7554/eLife.04810; Paranjape NP, 2016, G3-GENES GENOM GENET, V6, P1661, DOI 10.1534/g3.116.028068; Petryk N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10208; Phanstiel DH, 2014, BIOINFORMATICS, V30, P2808, DOI 10.1093/bioinformatics/btu379; Pourkarimi E, 2016, ELIFE, V5, DOI [10.7554/elife.21728, 10.7554/eLife.21728]; Prioleau MN, 2016, GENE DEV, V30, P1683, DOI 10.1101/gad.285114.116; R Core Team, 2017, R: A Language and Environment for Statistical Computing; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Richards JL, 2013, DEV BIOL, V374, P12, DOI 10.1016/j.ydbio.2012.11.034; Rodriguez-Martinez M, 2017, NAT STRUCT MOL BIOL, V24, P290, DOI 10.1038/nsmb.3363; Sakai A, 2009, CURR BIOL, V19, P1816, DOI 10.1016/j.cub.2009.09.021; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schmid M, 2004, MOL CELL, V16, P147, DOI 10.1016/j.molcel.2004.09.007; Sonneville R, 2012, J CELL BIOL, V196, P233, DOI 10.1083/jcb.201110080; Stevens K, 2016, IMPLEMENT SCI, V11; Stroud H, 2012, P NATL ACAD SCI USA, V109, P5370, DOI 10.1073/pnas.1203145109; Takahashi S, 2019, NAT GENET, V51, P529, DOI 10.1038/s41588-019-0347-5; Tanaka S, 2011, CURR BIOL, V21, P2055, DOI 10.1016/j.cub.2011.11.038; Tang MCW, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004964; Techer H, 2017, NAT REV GENET, V18, P535, DOI 10.1038/nrg.2017.46; Wollmann H, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1221-3; Woodward AM, 2006, J CELL BIOL, V173, P673, DOI 10.1083/jcb.200602108; Zentner GE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9733; Zhong WW, 2003, NATURE, V423, P885, DOI 10.1038/nature01747; 2006, INT HDB IND POL, P1	73	2	2	2	2	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	DEC	2020	30	12								10.1101/gr.260794.120			13	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	PB1FS	WOS:000596075800005	33172964	hybrid, Green Submitted, Green Published			2022-03-04	
J	Borel, C; Deutsch, S; Letourneau, A; Migliavacca, E; Montgomery, SB; Dimas, AS; Vejnar, CE; Attar, H; Gagnebin, M; Gehrig, C; Falconnet, E; Dupre, Y; Dermitzakis, ET; Antonarakis, SE				Borel, Christelle; Deutsch, Samuel; Letourneau, Audrey; Migliavacca, Eugenia; Montgomery, Stephen B.; Dimas, Antigone S.; Vejnar, Charles E.; Attar, Homa; Gagnebin, Maryline; Gehrig, Corinne; Falconnet, Emilie; Dupre, Yann; Dermitzakis, Emmanouil T.; Antonarakis, Stylianos E.			Identification of cis- and trans- regulatory variation modulating microRNA expression levels in human fibroblasts	GENOME RESEARCH			English	Article							HUMAN GENE-EXPRESSION; WHOLE-GENOME ASSOCIATION; POPULATION; PHENOTYPES; NUCLEOTIDE; MECHANISM; DISEASE; IMPACT; TARGET	MicroRNAs (miRNAs) are regulatory noncoding RNAs that affect the production of a significant fraction of human mRNAs via post-transcriptional regulation. Interindividual variation of the miRNA expression levels is likely to influence the expression of miRNA target genes and may therefore contribute to phenotypic differences in humans, including susceptibility to common disorders. The extent to which miRNA levels are genetically controlled is largely unknown. In this report, we assayed the expression levels of miRNAs in primary fibroblasts from 180 European newborns of the GenCord project and performed association analysis to identify eQTLs (expression quantitative traits loci). We detected robust expression for 121 miRNAs out of 365 interrogated. We have identified significant cis-(10%) and trans-(11%) eQTLs. Furthermore, we detected one genomic locus (rs1522653) that influences the expression levels of five miRNAs, thus unraveling a novel mechanism for coregulation of miRNA expression.	[Borel, Christelle; Deutsch, Samuel; Letourneau, Audrey; Migliavacca, Eugenia; Montgomery, Stephen B.; Dimas, Antigone S.; Vejnar, Charles E.; Attar, Homa; Gagnebin, Maryline; Gehrig, Corinne; Falconnet, Emilie; Dupre, Yann; Dermitzakis, Emmanouil T.; Antonarakis, Stylianos E.] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland		Antonarakis, SE (corresponding author), Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland.	stylianos.antonarakis@unige.ch	Dermitzakis, Emmanouil/B-7687-2013; borel, christelle/AAC-9645-2019; Antonarakis, Stylianos E/N-8866-2014	Antonarakis, Stylianos E/0000-0001-8907-5823; Vejnar, Charles/0000-0002-7132-4534; Montgomery, Stephen/0000-0002-5200-3903; Deutsch, Samuel/0000-0001-9456-7101	Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission; National Center for Competence in Research (NCCR) "Frontiers in Genetics,''Swiss National Science Foundation (SNSF); European UnionEuropean Commission; Infectigen, ChildCare, and J. Lejeune foundations	We thank P. Descombes and the members of the genomics platform of the University of Geneva for their assistance, A.J. Sharp for comments on the manuscript, and Vital-IT for computational support. This study was funded by the Swiss National Science Foundation, the National Center for Competence in Research (NCCR) "Frontiers in Genetics,'' the European Union FP6 "AnEUploidy'' integrated project, and the Infectigen, ChildCare, and J. Lejeune foundations.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; Cheung VG, 2003, NAT GENET, V33, P422, DOI 10.1038/ng1094; Dermitzakis ET, 2008, NAT GENET, V40, P492, DOI 10.1038/ng0508-492; Deutsch S, 2005, HUM MOL GENET, V14, P3741, DOI 10.1093/hmg/ddi404; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Ge DL, 2008, GENOME RES, V18, P640, DOI 10.1101/gr.071571.107; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hull J, 2007, PLOS GENET, V3, P1009, DOI 10.1371/journal.pgen.0030099; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Kwan T, 2008, NAT GENET, V40, P225, DOI 10.1038/ng.2007.57; Kwan T, 2007, GENOME RES, V17, P1210, DOI 10.1101/gr.6281007; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Prandini P, 2007, AM J HUM GENET, V81, P252, DOI 10.1086/519248; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Saini HK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-564; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sethupathy P, 2007, AM J HUM GENET, V81, P405, DOI 10.1086/519979; Spielman RS, 2007, NAT GENET, V39, P226, DOI 10.1038/ng1955; Storey JD, 2007, AM J HUM GENET, V80, P502, DOI 10.1086/512017; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Zhang W, 2009, HUM GENET, V125, P81, DOI 10.1007/s00439-008-0601-x	32	52	55	0	1	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	JAN	2011	21	1					68	73		10.1101/gr.109371.110			6	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	702BC	WOS:000285868300007	21147911	Green Published, Bronze			2022-03-04	
J	Tran, PL; Benski, C; Viviano, M; Petignat, P; Combescure, C; Jinoro, J; Herinianasolo, JL; Vassilakos, P				Phuong Lien Tran; Benski, Caroline; Viviano, Manuela; Petignat, Patrick; Combescure, Christophe; Jinoro, Jeromine; Herinianasolo, Josea Lea; Vassilakos, Pierre			PERFORMANCE OF SMARTPHONE-BASED DIGITAL IMAGES FOR CERVICAL CANCER SCREENING IN A LOW-RESOURCE CONTEXT	INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE			English	Article						Sensitivity; Specificity; Digital images; Smartphone; Cervical cancer	COLPOSCOPY; TESTS	Objectives:Colposcopes are expensive, heavy, and need specialized technical service, which may outreach the capacity of low-resource settings. Our aim was to assess the performance of smartphone-based digital images for the detection of cervical intraepithelial neoplasia grade 2 or worse (CIN2+).Methods:Human papillomavirus (HPV)-positive women recruited through a cervical cancer screening campaign had VIA/VILI assessment (visual inspection after application of acetic acid/lugol's iodine). Cervical digital images were captured with a smartphone camera, randomly coded with no prior selection and distributed on an online database (Google Forms) for evaluation. Healthcare providers were invited to evaluate the images and identify CIN2+. The gold standard was the histopathological diagnosis. The sensitivity and specificity for the detection of CIN2+ was assessed for each reader and reported with the 95 percent confidence interval (Clopper-Pearson method).Results:One hundred twenty-five consecutive HPV-positive women were included, with 19 CIN2+ (15.2 percent). Forty-five gynecologists completed the assessment, one-third were considered as experts (>50 colposcopies) and two-thirds as novices (<50 colposcopies). The sensitivity and specificity for CIN 2+ detection was 71.3 percent (67.0-75.7 percent) and 62.4 percent (57.5-67.4 percent), respectively. The performance of novices and experts was similar. The readers assessed 73.1 percent of images as acceptable for diagnostic.Conclusion:Smartphone-based digital images, with its high portability, have a great potential for the diagnosis of CIN2+ in low-resource context.	[Phuong Lien Tran; Benski, Caroline; Viviano, Manuela; Petignat, Patrick] Geneva Univ Hosp, Dept Gynecol & Obstet, Gynecol Div, Geneva, Switzerland; [Combescure, Christophe] Geneva Univ Hosp, Div Clin Epidemiol, Geneva, Switzerland; [Jinoro, Jeromine; Herinianasolo, Josea Lea] St Damien Healthcare Ctr, Geneva, Switzerland; [Vassilakos, Pierre] Geneva Fdn Med Educ & Res, Geneva, Switzerland		Tran, PL (corresponding author), Geneva Univ Hosp, Dept Gynecol & Obstet, Gynecol Div, Geneva, Switzerland.	phuong_lien_tran@yahoo.com		Petignat, Patrick/0000-0002-6835-533X; TRAN, Phuong Lien/0000-0003-3283-1450			[Anonymous], 2016, Obstet Gynecol, V127, pe1, DOI 10.1097/AOG.0000000000001263; Apgar BS, 2009, AM FAM PHYSICIAN, V80, P147; Catarino R, 2016, CANCER EPIDEMIOL, V42, P159, DOI 10.1016/j.canep.2016.04.013; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Ferris DG, 2004, AM J OBSTET GYNECOL, V191, P1934, DOI 10.1016/j.ajog.2004.06.107; Fokom-Domgue J, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3084; Gallas BD, 2007, J OPT SOC AM A, V24, pB70, DOI 10.1364/JOSAA.24.000B70; Isidean SD, 2017, CANCER EPIDEM BIOMAR, V26, P923, DOI 10.1158/1055-9965.EPI-16-0705; LaFleur BJ, 2009, J CLIN CHILD ADOLESC, V38, P286, DOI 10.1080/15374410902740411; Liu AH, 2016, J LOW GENIT TRACT DI, V20, P154, DOI 10.1097/LGT.0000000000000194; Schadel D, 2005, J TELEMED TELECARE, V11, P103, DOI 10.1258/1357633053499831; Shastri SS, 2005, B WORLD HEALTH ORGAN, V83, P186; Wagner RF, 2007, ACAD RADIOL, V14, P723, DOI 10.1016/j.acra.2007.03.001; World health Organization World health Organization, GUID SCREEN TREATM P	14	10	10	1	4	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0266-4623	1471-6348		INT J TECHNOL ASSESS	Int. J. Technol. Assess. Health Care		2018	34	3					337	342		10.1017/S0266462318000260			6	Health Care Sciences & Services; Public, Environmental & Occupational Health; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services; Public, Environmental & Occupational Health; Medical Informatics	GM7OL	WOS:000438378700012	29921339				2022-03-04	
J	Suppan, M; Gartner, B; Golay, E; Stuby, L; White, M; Cottet, P; Abbas, M; Iten, A; Harbarth, S; Suppan, L				Suppan, Melanie; Gartner, Birgit; Golay, Eric; Stuby, Loric; White, Marion; Cottet, Philippe; Abbas, Mohamed; Iten, Anne; Harbarth, Stephan; Suppan, Laurent			Teaching Adequate Prehospital Use of Personal Protective Equipment During the COVID-19 Pandemic: Development of a Gamified e-Learning Module	JMIR SERIOUS GAMES			English	Article						personal protective equipment; electronic learning; gamification; prehospital; COVID-19	BEHAVIOR	Background: The coronavirus disease (COVID-19) pandemic has led to increased use of personal protective equipment (PPE). Adequate use of this equipment is more critical than ever because the risk of shortages must be balanced against the need to effectively protect health care workers, including prehospital personnel. Specific training is therefore necessary; however, the need for social distancing has markedly disrupted the delivery of continuing education courses. Electronic learning (e-learning) may provide significant advantages because it requires neither the physical presence of learners nor the repetitive use of equipment for demonstration. Objective: Inclusion of game mechanics, or "gamification," has been shown to increase knowledge and skill acquisition. The objective of this research was to develop a gamified e-learning module to interactively deliver concepts and information regarding the correct choice and handling of PPE. Methods: The SERES framework was used to define and describe the development process, including scientific and design foundations. After we defined the target audience and learning objectives by interviewing the stakeholders, we searched the scientific literature to establish relevant theoretical bases. The learning contents were validated by infection control and prehospital experts. Learning mechanics were then determined according to the learning objectives, and the content that could benefit from the inclusion of game mechanics was identified. Results: The literature search resulted in the selection and inclusion of 12 articles. In addition to gamification, pretesting, feedback, avoiding content skipping, and demonstrations using embedded videos were used as learning mechanics. Gamification was used to enhance the interactivity of the PPE donning and doffing sequences, which presented the greatest learning challenges. The module was developed with Articulate Storyline 3 to ensure that it would be compatible with a wide array of devices, as this software generates HTML5-compatible output that can be accessed on smartphones, tablets, and regular computers as long as a recent browser is available. Conclusions: A gamified e-learning module designed to promote better knowledge and understanding of PPE use among prehospital health care workers was created by following the SERES framework. The impact of this module should now be assessed by means of a randomized controlled trial.	[Suppan, Melanie; White, Marion] Univ Geneva Hosp & Fac Med, Div Anesthesiol, Dept Anesthesiol Clin Pharmacol Intens Care & Eme, Rue Gabrielle Perret Gentil 4, CH-1211 Geneva, Switzerland; [Gartner, Birgit; Golay, Eric; Cottet, Philippe; Suppan, Laurent] Univ Geneva Hosp & Fac Med, Div Emergency Med, Dept Anesthesiol Clin Pharmacol Intens Care & Eme, Geneva, Switzerland; [Stuby, Loric] Geneve TEAM Ambulances, Geneva, Switzerland; [Abbas, Mohamed; Iten, Anne; Harbarth, Stephan] Univ Geneva Hosp & Fac Med, Infect Control Program, Geneva, Switzerland; [Abbas, Mohamed; Iten, Anne; Harbarth, Stephan] Univ Geneva Hosp & Fac Med, WHO Collaborating Ctr Patient Safety, Geneva, Switzerland		Suppan, M (corresponding author), Univ Geneva Hosp & Fac Med, Div Anesthesiol, Dept Anesthesiol Clin Pharmacol Intens Care & Eme, Rue Gabrielle Perret Gentil 4, CH-1211 Geneva, Switzerland.	melanie.bochet@hcuge.ch	Abbas, Mohamed/M-1724-2019; Suppan, Laurent/AAU-1562-2020; Stuby, Loric/AAS-9043-2021; Suppan, Melanie/AAZ-8097-2020	Abbas, Mohamed/0000-0002-7265-1887; Suppan, Laurent/0000-0001-6989-6421; Stuby, Loric/0000-0003-1663-5249; Suppan, Melanie/0000-0002-8807-9619; White, Marion Jill/0000-0003-2184-7270; Gartner, Birgit/0000-0003-0726-3201; Harbarth, Stephan/0000-0002-3551-1025; Cottet, Philippe/0000-0001-6029-8548			Ahmed H, 2020, LANCET INFECT DIS, V20, pE79, DOI 10.1016/S1473-3099(20)30252-8; [Anonymous], 2020, GAMIFIED E LEARNING; Arnab S, 2015, BRIT J EDUC TECHNOL, V46, P391, DOI 10.1111/bjet.12113; Bakkay MC, 2019, J COMPUT EDUC, V6, P257, DOI 10.1007/s40692-019-00136-6; Brame CJ, 2016, CBE-LIFE SCI EDUC, V15, DOI 10.1187/cbe.16-03-0125; Buffel C, 2019, JMIR SERIOUS GAMES, V7, DOI 10.2196/12431; Chan M, 2020, J CLIN MED, V9, DOI 10.3390/jcm9010238; Clavier T, 2019, JMIR MHEALTH UHEALTH, V7, DOI 10.2196/12825; Cook DA, 2010, ACAD MED, V85, P909, DOI 10.1097/ACM.0b013e3181d6c319; Creative Commons, ATTR NONCOMMERCIAL S; Crewdson K, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1603-7; Davids MR, 2013, ADV PHYSIOL EDUC, V37, P242, DOI 10.1152/advan.00043.2013; Deterding S., 2011, P 15 INT AC MINDTREK, P9, DOI [10.1145/2181037.2181040, DOI 10.1145/2181037.2181040]; Drummond David, 2017, Adv Simul (Lond), V2, P3, DOI 10.1186/s41077-017-0036-3; Federal Council of the Swiss Government, 2011, FED ACT RES INV HUM; Fouh E, 2014, COMPUT HUM BEHAV, V41, P478, DOI 10.1016/j.chb.2014.09.061; Gentry SV, 2019, J MED INTERNET RES, V21, DOI 10.2196/12994; Gray MM, 2021, AM J PERINAT, V38, pE187, DOI 10.1055/s-0040-1709145; Jebraeily Mohamad, 2017, Acta Inform Med, V25, P232, DOI 10.5455/aim.2017.25.232-235; Koka A, 2020, J MED INTERNET RES, V22, DOI 10.2196/18358; Kopp V, 2008, MED EDUC, V42, P823, DOI 10.1111/j.1365-2923.2008.03122.x; Krathwohl DR, 2002, THEOR PRACT, V41, P212, DOI 10.1207/s15430421tip4104_2; Latimier A, 2019, NPJ SCI LEARN, V4, DOI 10.1038/s41539-019-0053-1; Livingston E, 2020, JAMA-J AM MED ASSOC, V323, P1912, DOI 10.1001/jama.2020.5317; Looyestyn J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173403; Oh HS, 2016, AM J INFECT CONTROL, V44, P647, DOI 10.1016/j.ajic.2015.12.022; Ortega-Arranz A, 2019, UNIVERSAL ACCESS INF, V18, P533, DOI 10.1007/s10209-019-00677-8; Raina S, 2016, IEEE INTERNATIONAL CONFERENCE ON INTELLIGENCE AND SECURITY INFORMATICS: CYBERSECURITY AND BIG DATA, P261, DOI 10.1109/ISI.2016.7745486; Ranney ML, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMp2006141; Rose S, 2020, JAMA-J AM MED ASSOC, V323, P2131, DOI 10.1001/jama.2020.5227; Tang Brandon, 2018, JMIR Med Educ, V4, pe11, DOI 10.2196/mededu.9091; Teter J, 2015, PREHOSP EMERG CARE, V19, P313, DOI 10.3109/10903127.2014.967427; Valdez MK, 2015, AM J INFECT CONTROL, V43, P606, DOI 10.1016/j.ajic.2015.02.025; Verschueren S, 2019, JMIR SERIOUS GAMES, V7, DOI 10.2196/12429; Verschueren S, 2019, JMIR SERIOUS GAMES, V7, DOI 10.2196/11565; Wheeler S, 2012, ENCY SCI LEARNING, P1111; Wittich CM, 2017, BMC MED EDUC, V17, DOI 10.1186/s12909-017-0953-9; Wood L, 2014, GAMIFICATION ED BUSI, P1, DOI [10.1007/978-3-319-10208-5_1, DOI 10.1007/978-3-319-10208-5]	38	21	22	5	10	JMIR PUBLICATIONS, INC	TORONTO	130 QUEENS QUAY E, STE 1102, TORONTO, ON M5A 0P6, CANADA	2291-9279			JMIR SERIOUS GAMES	JMIR Serious Games	APR-JUN	2020	8	2							e20173	10.2196/20173			23	Health Care Sciences & Services; Public, Environmental & Occupational Health; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health; Medical Informatics	MM1AM	WOS:000549890800020	32516115	Green Published, gold			2022-03-04	
J	Bousquet, F; Bousquet, P; Vazquez, L				Bousquet, F.; Bousquet, P.; Vazquez, L.			Transtomography for implant placement guidance in non-invasive surgical procedures	DENTOMAXILLOFACIAL RADIOLOGY			English	Article						dental implants; tomography; distortion; mandible	SPIRAL TOMOGRAPHY; RADIOGRAPHY; SURGERY; NAVIGATION; ACCURACY; CRITERIA	Objectives: To illustrate the use of transtomography for the placement of implants using a radiopaque radiographic guide and to evaluate the accuracy of transtomography. Methods: The study included 11 implants inserted with minimally invasive procedures. Pre-operative, intraoperative and post-operative examinations were performed with a ProMax panoramic unit implemented with transtomographic technique (Planmeca Oy, Helsinki, Finland). At each implant site, cross-sectional and longitudinal intraoperative transtomograms were taken through a radiopaque reference guide to control and adjust the drilling axis. The effective axis on post-operative transtomograms was compared with the planned axis correction estimated on intraoperative images. Radiopaque guides, used as the gold standard, were measured on intraoperative cross-sectional slices to evaluate image distortion. Results: Intraoperative transtomograms, with the reference guide inserted in the bone, gave clear images of the cortical plates and accurate information of drilling length and axis, which allowed the surgeon to adjust pilot drilling axis in 6 sites (54.5%) out of 11 sites, including sites with narrow bone ridges. The implant axis on the post-operative tomogram compared with the planned axis correction showed an angle difference ranging from 0.8 degrees to 3.4 degrees. The image distortion on cross-sectional slices ranged from 0.03 mm to 0.52 mm, resulting in a distortion ratio ranging from 0% to 6% when expressed in percentages. Conclusions: Transtomographic examination performed with a radiographic reference guide during implant surgery can provide the necessary and accurate information for implant placement. Transtomography distortion appears to be less important than in other conventional tomographic systems and comparable with CT scan distortion.	Univ Montpellier, Dept Perio Implantol, F-34059 Montpellier, France; Univ Geneva, Dept Stomatol Oral Surg & Dentomaxillofacial Radi, Geneva, Switzerland		Bousquet, F (corresponding author), 82 Ave Assas, F-34000 Montpellier, France.	bousquet.frederic@libertysurf.fr	Bousquet, Jean/O-4221-2019	BOUSQUET, Philippe/0000-0003-0124-2514			Campelo LD, 2002, INT J ORAL MAX IMPL, V17, P271; Casap N, 2005, INT J ORAL MAX IMPL, V20, P92; Casap N, 2004, J ORAL MAXIL SURG, V62, P116, DOI 10.1016/j.joms.2004.06.028; Dula K, 2001, ORAL SURG ORAL MED O, V91, P735, DOI 10.1067/moe.2001.113591; Dula K, 2001, INT J ORAL MAX IMPL, V16, P80; Ekestubbe A, 2004, DENTOMAXILLOFAC RAD, V33, P87, DOI 10.1259/dmfr/24877187; Fortin T, 2000, J Oral Implantol, V26, P300, DOI 10.1563/1548-1336(2000)026<0300:PDIPIB>2.3.CO;2; Fortin Thomas, 2004, Clin Implant Dent Relat Res, V6, P111, DOI 10.1111/j.1708-8208.2004.tb00033.x; Hahn J, 2000, J Oral Implantol, V26, P193, DOI 10.1563/1548-1336(2000)026<0193:SILAFS>2.3.CO;2; Kan J Y, 2000, Pract Periodontics Aesthet Dent, V12, P467; Kobayashi K, 2004, INT J ORAL MAX IMPL, V19, P228; Lecomber AR, 2001, DENTOMAXILLOFAC RAD, V30, P255, DOI 10.1038/sj.dmfr.4600627; Peltola J, 2004, DENTOMAXILLOFAC RAD, V33, P295, DOI 10.1259/dmfr/14606317; RAMFJORD SF, 1968, J PERIODONTOL, V39, P199, DOI 10.1902/jop.1968.39.4.199; Serhal CB, 2001, CLIN ORAL IMPLAN RES, V12, P230, DOI 10.1034/j.1600-0501.2001.012003230.x; Thunthy Kavas H, 2003, J Oral Implantol, V29, P91, DOI 10.1563/1548-1336(2003)029<0091:AISOTR>2.3.CO;2; Tyndall DA, 2000, ORAL SURG ORAL MED O, V89, P630; Welander U, 2004, DENTOMAXILLOFAC RAD, V33, P188, DOI 10.1259/dmfr/55001955; WOOD DL, 1972, J PERIODONTOL, V43, P141, DOI 10.1902/jop.1972.43.3.141	19	5	5	0	1	BRITISH INST RADIOLOGY	LONDON	36 PORTLAND PLACE, LONDON W1N 4AT, ENGLAND	0250-832X			DENTOMAXILLOFAC RAD	Dentomaxillofac. Radiol.	MAY	2007	36	4					229	233		10.1259/dmfr/91082519			5	Dentistry, Oral Surgery & Medicine; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine; Radiology, Nuclear Medicine & Medical Imaging	181JB	WOS:000247431900008	17536091				2022-03-04	
J	Terzic, A; Becker, M; Wissmeyer, M; Scolozzi, P				Terzic, A.; Becker, M.; Wissmeyer, M.; Scolozzi, P.			F-18-DOPA PET/CT unravels malignant paraganglioma mimicking temporomandibular joint disorder	DENTOMAXILLOFACIAL RADIOLOGY			English	Article						malignant paraganglioma; temporomandibular joint disorder; DOPA PET/CT	HEAD; NECK	This report presents a 29-year-old patient with severe temporomandibular joint (TMJ) pain. Anamnesis and clinical examination led us to the diagnosis of TMJ disorder. He was also in control for a malignant paraganglioma originating from the right carotid body. After initial surgery 8.5 years ago and the removal of metastases 2 years ago he was deemed disease free. An F-18-3,4-dihydroxyphenylalanine(DOPA) positron emission tomography (PET)/CT scan was obtained during follow-up 6 months before he was presented to our clinic. Suspicious of a connection between the actual pain and the tumour, we scrutinized these images. We found a tiny pathological tracer uptake in the right jugular foramen but no correlating finding in the matching CT. We repeated the DOPA PET/CT and found several metastases including the previously detected lesion. Further thin-slice CT and MRI showed a 5 mm paraganglioma located anteriorly to the jugular bulb within the jugular foramen. The lesion was in close relation to the Arnold's nerve, a branch of the vagus nerve which carries sensory information from the external tympanic membrane, external auditory canal and the external ear and explained the severe pain in our patient. He then underwent radiotherapy (45 Gy) during which the pain diminished considerably. In a variety of neuroendocrine tumours, including paraganglioma, DOPA PET/CT allows primary diagnosis, staging and restaging with a higher detection rate than conventional radiological imaging. Owing to low anatomical resolution however, high resolution contrast-enhanced CT and MRI are necessary to complete the investigations. Dentomaxillofacial Radiology (2011) 40, 315-319. doi: 10.1259/dmfr/22707693	[Terzic, A.; Scolozzi, P.] Univ Geneva Hosp, Serv Maxillofacial & Oral Surg, Dept Surg, CH-1211 Geneva 14, Switzerland; [Terzic, A.; Becker, M.; Wissmeyer, M.; Scolozzi, P.] Fac Med, CH-1211 Geneva 14, Switzerland; [Becker, M.] Univ Geneva Hosp, Geneva Univ Hosp, Dept Radiol, CH-1211 Geneva 14, Switzerland; [Wissmeyer, M.] Univ Geneva Hosp, Div Nucl Med, CH-1211 Geneva 14, Switzerland		Terzic, A (corresponding author), Univ Geneva Hosp HUG, Serv Maxillofacial & Oral Surg, Dept Surg, Rue Gabrielle Perret Gentil 4, CH-1211 Geneva 14, Switzerland.	andrej.terzic@hcuge.ch					BATSAKIS JG, 1979, TUMORS HEAD NECK CLI, P280; CHAKERES DW, 1984, RADIOLOGY, V150, P749, DOI 10.1148/radiology.150.3.6320257; Hoegerle S, 2003, EUR J NUCL MED MOL I, V30, P689, DOI 10.1007/s00259-003-1115-3; Lee JH, 2002, CANCER, V94, P730, DOI 10.1002/cncr.10252; Minn H, 2009, J NUCL MED, V50, P1915, DOI 10.2967/jnumed.109.065664; Pellitteri PK, 2004, ORAL ONCOL, V40, P563, DOI 10.1016/j.oraloncology.2003.09.004; Policeni BA, 2008, NEUROIMAG CLIN N AM, V18, P347, DOI 10.1016/j.nic.2007.12.012; Rinaldo A, 2004, ORAL ONCOL, V40, P458, DOI 10.1016/j.oraloncology.2003.08.018; Roistacher SL, 1997, ORAL SURG ORAL MED O, V83, P10, DOI 10.1016/S1079-2104(97)90083-4; Timmers HJLM, 2009, J CLIN ENDOCR METAB, V94, P4757, DOI 10.1210/jc.2009-1248; Vogl TJ, 2009, SKULL BASE-INTERD AP, V19, P3, DOI 10.1055/s-0028-1103121; ZBAREN P, 1985, LARYNGOSCOPE, V95, P450	12	1	1	0	0	BRITISH INST RADIOLOGY	LONDON	36 PORTLAND PLACE, LONDON W1N 4AT, ENGLAND	0250-832X			DENTOMAXILLOFAC RAD	Dentomaxillofac. Radiol.	JUL	2011	40	5					315	319		10.1259/dmfr/22707693			5	Dentistry, Oral Surgery & Medicine; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine; Radiology, Nuclear Medicine & Medical Imaging	781IL	WOS:000291924000008	21697158	Green Published			2022-03-04	
J	Stimec, BV; Dash, J; Assal, M; Stern, R; Fasel, JHD				Stimec, Bojan V.; Dash, Jeremy; Assal, Mathieu; Stern, Richard; Fasel, Jean H. D.			Additional muscular slip of the flexor digitorum longus muscle to the fifth toe	SURGICAL AND RADIOLOGIC ANATOMY			English	Article						Flexor digitorum longus; Anatomic variations; Muscles; Fifth toe	ACCESSORIUS; MORPHOLOGY	Despite the fact that there are numerous reports on muscular variations in the sole of the foot, routine dissection in a formaldehyde-fixed cadaver revealed an accessory flexor digiti quinti muscle, which to the best of our knowledge is a very unusual variant. This was in the form of a slender, 38 mm long muscular slip, with a proximal and distal tendon extending from the common flexor digitorum longus tendinous plate out to the distal phalanx of the fifth toe. An associated finding was the absence of the musculotendinous portion of the flexor digitorum brevis to the same toe. A developmental explanation for this variation is presented. Clinical implications with regard to this anatomical condition may result in clawing of the fifth toe.	[Stimec, Bojan V.; Dash, Jeremy; Fasel, Jean H. D.] Univ Geneva, Anat Sect, Dept Cell Physiol & Metab, Rue Michel Servet 1, CH-1211 Geneva, Switzerland; [Assal, Mathieu; Stern, Richard] Hirslanden Clin La Colline, Ctr Foot & Ankle Surg, Geneva, Switzerland		Stimec, BV (corresponding author), Univ Geneva, Anat Sect, Dept Cell Physiol & Metab, Rue Michel Servet 1, CH-1211 Geneva, Switzerland.	bojan.stimec@unige.ch		Stimec, Bojan/0000-0002-4488-9812			Al-Himdani S, 2013, Foot (Edinb), V23, P154, DOI 10.1016/j.foot.2013.08.002; Athavale SA, 2012, SURG RADIOL ANAT, V34, P367, DOI 10.1007/s00276-011-0909-4; Bergman RA, 1988, COMPENDIUM HUMAN ANA, p[27, 318]; Claassen H, 2003, ANN ANAT, V185, P81, DOI 10.1016/S0940-9602(03)80017-1; FASEL J, 1984, Z ORTHOP GRENZGEB, V122, P835, DOI 10.1055/s-2008-1045075; Humphry G M, 1873, Br Med J, V2, P78; Kopuz C, 1999, CELLS TISSUES ORGANS, V164, P174, DOI 10.1159/000016655; LEWIS OJ, 1962, J ANAT, V96, P321; Lobo S W, 2008, Nepal Med Coll J, V10, P230; NATHAN H, 1974, Anatomischer Anzeiger, V135, P295; PETERSON DA, 1995, FOOT ANKLE INT, V16, P637, DOI 10.1177/107110079501601010; Saar William E, 2011, Foot Ankle Spec, V4, P379, DOI 10.1177/1938640011418496; Testut L., 1911, TRAITE ANATOMIE HUMA TRAITE ANATOMIE HUMA, V6	13	0	0	0	0	SPRINGER FRANCE	PARIS	22 RUE DE PALESTRO, PARIS, 75002, FRANCE	0930-1038	1279-8517		SURG RADIOL ANAT	Surg. Radiol. Anat.	MAY	2018	40	5					533	535		10.1007/s00276-018-1991-7			3	Anatomy & Morphology; Radiology, Nuclear Medicine & Medical Imaging; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anatomy & Morphology; Radiology, Nuclear Medicine & Medical Imaging; Surgery	GE8QR	WOS:000431496800008	29473094				2022-03-04	
J	Fasel, JHD; Aguiar, D; Kiss-Bodolay, D; Montet, X; Kalangos, A; Stimec, BV; Ratib, O				Fasel, Jean H. D.; Aguiar, Diego; Kiss-Bodolay, Daniel; Montet, Xavier; Kalangos, Afksendiyos; Stimec, Bojan V.; Ratib, Osman			Adapting anatomy teaching to surgical trends: a combination of classical dissection, medical imaging, and 3D-printing technologies	SURGICAL AND RADIOLOGIC ANATOMY			English	Article						Additive manufacturing; Surgical anatomy training; Whole-body computed tomography	COMPUTED-TOMOGRAPHY; GENERAL-SURGERY; DIAMETER; STUDENTS; CAREER; VEINS; SELECTION; IMPACT; AORTA; CT	Many regions worldwide report difficulties in recruiting applicants to surgery. One strategy proposed to reverse this trend consists of early exposure of medical students to the field. Against this backdrop, the present study presents an innovative approach for anatomy teaching, integrating a surgically relevant trend: 3D printing. Whole-body computed tomography (CT) was made of two cadavers. Twelve students performed measurements and 3D reconstructions of selected anatomical structures (Osirix, Mimics). 3D printed (3DP) models were obtained (ZPrinter 310 Plus), and the students completed the analogous measurements on these replicas. Finally, classical anatomical dissection was performed and the same parameters were measured. The differences between the values obtained by the three modalities were submitted to standard statistical analysis (Wilcoxon two-tail paired test). Qualitative comparison of the digital 3D reconstructions based on the students' manual CT segmentation and the anatomical reality showed excellent correlation. Quantitatively, the values measured on the CT images and the physical models created by 3D printing differed from those measured on the cadavers by less than 2 mm. Students were highly appreciative of the approach (CT, 3DP, cadaver). Their average satisfaction score was 5.8 on a 1-6 scale. This study shows that the approach proposed can be achieved. The results obtained also show that CT-based 3D printed models are close to the authentic anatomic reality. The program allows early and interactive exposure of medical students to a surgically relevant trend-in this case 3D printing.	[Fasel, Jean H. D.; Aguiar, Diego; Kiss-Bodolay, Daniel; Stimec, Bojan V.] Ctr Med Univ Geneva, Dept Cellular Physiol & Metab, Div Anat, 1 Rue M Servet, CH-1211 Geneva, Switzerland; [Montet, Xavier; Ratib, Osman] Univ Hosp Geneva, Dept Radiol, Geneva, Switzerland; [Kalangos, Afksendiyos] Univ Hosp Geneva, Dept Cardiovasc Surg, Geneva, Switzerland		Fasel, JHD (corresponding author), Ctr Med Univ Geneva, Dept Cellular Physiol & Metab, Div Anat, 1 Rue M Servet, CH-1211 Geneva, Switzerland.	jean.fasel@unige.ch	Kalangos, Afksendiyos/AAM-8202-2021; Aguiar, Diego/AAH-6260-2021	Kalangos, Afksendiyos/0000-0002-4537-8336; Montet, Xavier/0000-0003-2442-5866			Alsaif H. A., 2010, JKAU MED SCI, V17, P37, DOI DOI 10.4197/Med.17-2.4; Angelini P, 2007, CIRCULATION, V115, P1296, DOI 10.1161/CIRCULATIONAHA.106.618082; Are C, 2010, J SURG EDUC, V67, P320, DOI 10.1016/j.jsurg.2010.07.016; Babademez MA, 2013, J CRANIOFAC SURG, V24, pE190, DOI 10.1097/SCS.0b013e3182801edd; Bezerra AS, 2005, AM J ROENTGENOL, V184, P1510, DOI 10.2214/ajr.184.5.01841510; Bland KI, 2002, ARCH SURG-CHICAGO, V137, P259, DOI 10.1001/archsurg.137.3.259; Cesmebasi A, 2014, CLIN ANAT, V27, P1253, DOI 10.1002/ca.22374; Chae MP, 2015, FRONT SURG, V2, DOI 10.3389/fsurg.2015.00025; Deedar-Ali-Khawaja R, 2010, J SURG EDUC, V67, P237, DOI 10.1016/j.jsurg.2010.05.006; DODGE JT, 1992, CIRCULATION, V86, P232, DOI 10.1161/01.CIR.86.1.232; FANUCCI A, 1988, SCAND J GASTROENTERO, V23, P574, DOI 10.3109/00365528809093914; Fasel J, 1995, CLIN ANATOMY RES GRO; Fasel JHD, 2014, EUR J ANAT, V18, P49; Fasel JHD, 2005, LANCET, V365, P754, DOI 10.1016/S0140-6736(05)17981-1; Gawad N, 2013, J SURG EDUC, V70, P487, DOI 10.1016/j.jsurg.2013.03.006; Hager A, 2002, J THORAC CARDIOV SUR, V123, P1060, DOI 10.1067/mtc.2002.122310; Insull PJ, 2006, ANZ J SURG, V76, P1056, DOI 10.1111/j.1445-2197.2006.03942.x; Kahn D, 2006, S AFR J SURG, V44, P108; Kang KY, 2007, NEPHROL DIAL TRANSPL, V22, P2322, DOI 10.1093/ndt/gfm192; Krejza J, 2006, STROKE, V37, P1103, DOI 10.1161/01.STR.0000206440.48756.f7; Malik HH, 2015, J SURG RES, V199, P512, DOI 10.1016/j.jss.2015.06.051; Mashiko T, 2015, WORLD NEUROSURG, V83, P351, DOI 10.1016/j.wneu.2013.10.032; OHSU (Oregon Health and Science University), GASTR MEAS; PATTERSON NW, 1985, COMPUT RADIOL, V9, P61, DOI 10.1016/0730-4862(85)90105-2; Rengier F, 2010, INT J COMPUT ASS RAD, V5, P335, DOI 10.1007/s11548-010-0476-x; Salik E, 2007, J VASC INTERV RADIOL, V18, P361, DOI 10.1016/j.jvir.2006.12.721; Seyfer Alan E, 2007, Bull Am Coll Surg, V92, P8; Shabana W, 2006, AM J ROENTGENOL, V186, P234, DOI 10.2214/AJR.04.0816; Stanford School of Medicine, 2015, CLIN AN DEP SURG; Tartiere D, 2009, CRIT CARE, V13, DOI 10.1186/cc8200; Wanhainen A, 2002, EUR J VASC ENDOVASC, V24, P428, DOI 10.1053/ejvs.2002.1748; Watson RA, 2014, J SURG EDUC, V71, pA2	32	38	42	1	19	SPRINGER FRANCE	PARIS	22 RUE DE PALESTRO, PARIS, 75002, FRANCE	0930-1038	1279-8517		SURG RADIOL ANAT	Surg. Radiol. Anat.	APR	2016	38	3					361	367		10.1007/s00276-015-1588-3			7	Anatomy & Morphology; Radiology, Nuclear Medicine & Medical Imaging; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anatomy & Morphology; Radiology, Nuclear Medicine & Medical Imaging; Surgery	DI7OY	WOS:000373692100015	26553051				2022-03-04	
J	Vazquez, L; Nizamaldin, Y; Combescure, C; Nedir, R; Bischof, M; Ehrenfest, DMD; Carrel, JP; Belser, UC				Vazquez, L.; Nizamaldin, Y.; Combescure, C.; Nedir, R.; Bischof, M.; Ehrenfest, D. M. Dohan; Carrel, J-P; Belser, U. C.			Accuracy of vertical height measurements on direct digital panoramic radiographs using posterior mandibular implants and metal balls as reference objects	DENTOMAXILLOFACIAL RADIOLOGY			English	Article						digital dental radiography; panoramic radiography; dental implant; radiographic magnification	BEAM COMPUTED-TOMOGRAPHY; SCANNERS; POSITION; QUALITY; CBCT; CT	Objectives: Conventional panoramic radiography, a widely used radiographic examination tool in implant treatment planning, allows evaluation of the available bone height before inserting posterior mandibular implants. Image distortion and vertical magnification due to projection geometry is well described for rotational panoramic radiographs. To assess the accuracy of vertical height measurements on direct digital panoramic radiographs, implants and metal balls positioned in the posterior mandible were used as radio-opaque reference objects. The reproducibility of the measuring method was assessed by the inter- and intraobserver agreements. Methods: Direct digital panoramic radiographs, performed using a Kodak 8000C (Eastman Kodak Company, Rochester, NY), of 17 partially edentulous patients (10 females, 7 males, mean age 65 years) were selected from an X-ray database gathered during routine clinical evaluation of implant sites. Proprietary software and a mouse-driven calliper were used to measure the radiological length of 25 implants and 18 metal reference balls, positioned in mandibular posterior segments. The distortion ratio (DR) was calculated by dividing the radiological implant length by the implant's real length and the radiological ball height by the ball's real height. Results: Mean vertical DR was 0.99 for implants and 0.97 for balls, and was unrelated to mandibular sites, side, age, gender or observer. Inter- and intraobserver agreements were acceptable for both reference objects. Conclusions: Vertical measurements had acceptable accuracy and reproducibility when a software-based calibrated measurement tool was used, confirming that digital panoramic radiography can be reliably utilized to determine the pre-operative implant length in premolar and molar mandibular segments. Dentomaxillofacial Radiology (2013) 42, 20110429. doi: 10.1259/dmfr.20110429	[Vazquez, L.; Nizamaldin, Y.; Ehrenfest, D. M. Dohan; Carrel, J-P] Univ Geneva, Sch Dent Med, Dept Oral Surg Oral Med & Dentomaxillofacial Radi, CH-1205 Geneva, Switzerland; [Combescure, C.] Univ Hosp Geneva, Div Clin Epidemiol, Geneva, Switzerland; [Nedir, R.; Bischof, M.] Ardentis Clin Dentaire, Swiss Dent Clin Grp, Vevey, Switzerland; [Belser, U. C.] Univ Geneva, Sch Dent Med, Dept Fixed Prosthodont & Occlus, Geneva, Switzerland		Vazquez, L (corresponding author), Univ Geneva, Sch Dent Med, Dept Oral Surg Oral Med & Dentomaxillofacial Radi, Rue Barthelemy Menn 19, CH-1205 Geneva, Switzerland.	lydia.vazquez@unige.ch	Bischof, Mark B/A-1060-2015; Vazquez, Lydia/AAX-8097-2020; Buser, Daniel/D-3971-2011	Vazquez, Lydia/0000-0003-1871-4178; 			Batenburg RHK, 1997, ORAL SURG ORAL MED O, V84, P430, DOI 10.1016/S1079-2104(97)90044-5; Buser D, 2000, CLIN ORAL IMPLAN RES, V11, P83, DOI 10.1034/j.1600-0501.2000.011S1083.x; Dula K, 2001, INT J ORAL MAX IMPL, V16, P80; Frei C, 2004, CLIN ORAL IMPLAN RES, V15, P490, DOI 10.1111/j.1600-0501.2004.01032.x; Gerlach NL, 2012, J ORAL MAXILLOFAC SU, V68, P811; Gomez-Roman G, 1999, INT J ORAL MAX IMPL, V14, P248; Gotfredsen E, 2005, INT CONGR SER, V1281, P1414, DOI 10.1016/j.ics.2005.03.363; Guerrero ME, 2006, CLIN ORAL INVEST, V10, P1, DOI 10.1007/s00784-005-0031-2; Harris D, 2002, CLIN ORAL IMPLAN RES, V13, P566, DOI 10.1034/j.1600-0501.2002.130518.x; Kim YK, 2011, DENTOMAXILLOFAC RAD, V40, P76, DOI 10.1259/dmfr/20544408; Kobayashi K, 2004, INT J ORAL MAX IMPL, V19, P228; Lascala C, 2004, DENTOMAXILLOFAC RAD, V33, P291, DOI 10.1259/dmfr/25500850; LINDH C, 1995, CLIN ORAL IMPLAN RES, V6, P96, DOI 10.1034/j.1600-0501.1995.060205.x; Loubele M, 2009, EUR J RADIOL, V71, P461, DOI 10.1016/j.ejrad.2008.06.002; Loubele M, 2006, ORAL SURG ORAL MED O, V102, P225, DOI 10.1016/j.tripleo.2005.10.039; Ludlow JB, 2008, J AM DENT ASSOC, V139, P1237, DOI 10.14219/jada.archive.2008.0339; Machtei EE, 2010, J PERIODONTOL, V81, P1051, DOI 10.1902/jop.2010.090621; Marmulla R, 2005, DENTOMAXILLOFAC RAD, V34, P28, DOI 10.1259/dmfr/31342245; MCDAVID WD, 1993, ORAL SURG ORAL MED O, V75, P523, DOI 10.1016/0030-4220(93)90182-4; Nedir R, 2004, CLIN ORAL IMPLAN RES, V15, P150, DOI 10.1111/j.1600-0501.2004.00978.x; Park JB, 2010, MED ORAL PATOL ORAL, V15, pE663, DOI 10.4317/medoral.15.e663; Scarfe WC, 1998, DENTOMAXILLOFAC RAD, V27, P51, DOI 10.1038/sj.dmfr.4600310; Scarfe WC, 2006, J CAN DENT ASSOC, V72, P75; Schropp L, 2009, CLIN ORAL INVEST, V13, P375, DOI 10.1007/s00784-009-0257-5; Schulze R, 2000, DENTOMAXILLOFAC RAD, V29, P52, DOI 10.1038/sj.dmfr.4600500; Schulze RKW, 2001, CLIN ORAL IMPLAN RES, V12, P364, DOI 10.1034/j.1600-0501.2001.012004364.x; Serhal CB, 2000, CLIN ORAL IMPLAN RES, V11, P242, DOI 10.1034/j.1600-0501.2000.011003242.x; Stramotas S, 2002, EUR J ORTHODONT, V24, P43, DOI 10.1093/ejo/24.1.43; Suomalainen A, 2009, DENTOMAXILLOFAC RAD, V38, P367, DOI 10.1259/dmfr/15779208; Tal H, 1991, Dentomaxillofac Radiol, V20, P40; TRONJE G, 1981, ACTA RADIOL DIAGN, V22, P449, DOI 10.1177/028418518102200409; TRONJE G, 1981, Acta Radiologica Diagnosis, V22, P295; Tyndall DA, 2000, ORAL SURG ORAL MED O, V89, P630; Vazquez L, 2008, CLIN ORAL IMPLAN RES, V19, P81, DOI 10.1111/j.1600-0501.2007.01402.x; Vazquez L, 2011, CLIN ORAL IMPLAN RES, V22, P1420, DOI 10.1111/j.1600-0501.2010.02131.x	35	26	26	0	11	BRITISH INST RADIOLOGY	LONDON	36 PORTLAND PLACE, LONDON W1N 4AT, ENGLAND	0250-832X	1476-542X		DENTOMAXILLOFAC RAD	Dentomaxillofac. Radiol.	FEB	2013	42	2							20110429	10.1259/dmfr.20110429			9	Dentistry, Oral Surgery & Medicine; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine; Radiology, Nuclear Medicine & Medical Imaging	102FC	WOS:000315829100004	23360688	Green Published			2022-03-04	
J	Murphy, AE				Murphy, AE			Cancer genetics	EUROPEAN JOURNAL OF CANCER CARE			English	Article							BREAST-CANCER; MANAGEMENT		Univ Hosp Geneva, Geneva, Switzerland		Murphy, AE (corresponding author), Univ Hosp Geneva, Geneva, Switzerland.						Bradley ANM, 1999, EUR J CANCER CARE, V8, P97; Bredart A, 1998, Eur J Cancer Care (Engl), V7, P174; Eisinger F, 1998, ANN ONCOL, V9, P939, DOI 10.1023/A:1008389021382; LERMAN C, 1993, J NATL CANCER I, V85, P1074, DOI 10.1093/jnci/85.13.1074; MUELLER R, 1995, EMERYS ELEMENTS MED; Watson M, 1996, PSYCHO-ONCOL, V5, P233	6	0	0	0	0	BLACKWELL SCIENCE LTD	OXFORD	P O BOX 88, OSNEY MEAD, OXFORD OX2 0NE, OXON, ENGLAND	0961-5423			EUR J CANCER CARE	Eur. J. Cancer Care	MAR	2001	10	1					66	68					3	Oncology; Health Care Sciences & Services; Nursing; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Health Care Sciences & Services; Nursing; Rehabilitation	443QZ	WOS:000169353000022	11827271				2022-03-04	
J	Katsoulis, J; Schimmel, M; Avrampou, M; Stuck, AE; Mericske-Stern, R				Katsoulis, Joannis; Schimmel, Martin; Avrampou, Marianna; Stuck, Andreas E.; Mericske-Stern, Regina			Oral and general health status in patients treated in a dental consultation clinic of a geriatric ward in Bern, Switzerland	GERODONTOLOGY			English	Article						edentulism; geriatric ward; elderly adults; ASA classification; dental and physical status; cognitive impairment	QUALITY-OF-LIFE; TREATMENT NEEDS; PHYSICAL STATUS; OLDER-PEOPLE; TOOTH LOSS; CARE; NUTRITION; RISK; CLASSIFICATION; PERIODONTITIS	Introduction: This audit reports on the oral and general health of patients who were treated in a dental consultation clinic of a geriatric hospital. Material and Methods: Dental and medical records were obtained from 112 female and 80 male patients (mean age, 83.7 +/- 8.2 years) who attended a dental consultation. Data analysis included the general health [American Society of Anesthesiologists (ASA) classification, number of diagnoses, cognitive function] and dental state in the age strata 60-69, 70-79, 80-89 and 90-99 years. Results: Seventy-four per cent of patients were aged over 80 years. The prevalence of ASA-P4 and P3 varied between age groups. Most patients (>86%) had more than three chronic diseases. Cognitive impairment was present in almost half of both older age cohorts (43 and 50%). Half of the patients (52%) were edentulous. In dentate patients, the average number of teeth was 12 +/- 6 and differed in the maxilla significantly between age groups (p = 0.005). There was no significant association between dental state, ASA classification and systemic conditions. Conclusions: The profile of this cohort reflects a poor oral and general health status. The results underline the importance	[Katsoulis, Joannis; Avrampou, Marianna; Mericske-Stern, Regina] Univ Bern, Sch Dent Med, Dept Prosthodont, CH-3010 Bern, Switzerland; [Schimmel, Martin] Univ Geneva, Div Gerodontol & Removable Prosthodont, Geneva, Switzerland; [Stuck, Andreas E.] Univ Hosp Bern, Inselspital, Dept Gen Internal Med, Div Geriatr, CH-3010 Bern, Switzerland		Katsoulis, J (corresponding author), Univ Bern, Sch Dent Med, Dept Prosthodont, Freiburgstr 7, CH-3010 Bern, Switzerland.	joannis.katsoulis@zmk.unibe.ch	Schimmel, Martin/F-5694-2011	Schimmel, Martin/0000-0001-9700-5534			AINAMO J, 1982, INT DENT J, V32, P281; ANGELILLO IF, 1990, COMMUNITY DENT ORAL, V18, P216, DOI 10.1111/j.1600-0528.1990.tb00061.x; Bellomo Fleurange, 2005, Gerodontology, V22, P24, DOI 10.1111/j.1741-2358.2004.00047.x; Besimo Christian E, 2007, Schweiz Monatsschr Zahnmed, V117, P749; Binkley CJ, 2009, ORAL SURG ORAL MED O, V108, P722, DOI 10.1016/j.tripleo.2009.06.027; Borreani E, 2010, GERODONTOLOGY, V27, P11, DOI 10.1111/j.1741-2358.2009.00274.x; Budtz-Jorgensen E, 2001, BEST PRACT RES CL GA, V15, P885, DOI 10.1053/bega.2001.0247; Chen CCH, 2001, J ADV NURS, V36, P131, DOI 10.1046/j.1365-2648.2001.01950.x; Davenport DL, 2006, ANN SURG, V243, P636, DOI 10.1097/01.sla.0000216508.95556.cc; Dion N, 2007, NUTRITION, V23, P301, DOI 10.1016/j.nut.2007.01.009; Dolan T A, 1993, J Dent Educ, V57, P876; Dormenval V, 1995, Gerodontology, V12, P73, DOI 10.1111/j.1741-2358.1995.tb00134.x; Dowell P, 2002, Dent Update, V29, P352; Felton DA, 2009, J PROSTHODONT, V18, P88, DOI 10.1111/j.1532-849X.2009.00437.x; Gluhak C, 2010, GERODONTOLOGY, V27, P47, DOI 10.1111/j.1741-2358.2009.00281.x; Gueiros LA, 2009, GERODONTOLOGY, V26, P297, DOI 10.1111/j.1741-2358.2009.00284.x; Gunday M, 2009, ARCH GERONTOL GERIAT, V49, P172, DOI 10.1016/j.archger.2008.07.003; Hujoel PP, 2005, PERIODONTOL 2000, V39, P22, DOI 10.1111/j.1600-0757.2005.00114.x; Corchero AMI, 2008, MED ORAL PATOL ORAL, V13, pE523; Imsand M, 2002, Gerodontology, V19, P66, DOI 10.1111/j.1741-2358.2002.00066.x; Janket SJ, 2003, ORAL SURG ORAL MED O, V95, P559, DOI 10.1067/moe.2003.107; Karkazis H C, 1993, Eur J Prosthodont Restor Dent, V1, P157; Katsoulis Joannis, 2009, Schweiz Monatsschr Zahnmed, V119, P688; Katsoulis Joannis, 2009, Schweiz Monatsschr Zahnmed, V119, P12; KEATS AS, 1978, ANESTHESIOLOGY, V49, P233, DOI 10.1097/00000542-197810000-00001; Khader YS, 2006, J DIABETES COMPLICAT, V20, P59, DOI 10.1016/j.jdiacomp.2005.05.006; Locker D, 2000, J DENT RES, V79, P970, DOI 10.1177/00220345000790041301; Locker David, 2003, Spec Care Dentist, V23, P86, DOI 10.1111/j.1754-4505.2003.tb01667.x; LUKE DA, 1985, BRIT DENT J, V159, P401, DOI 10.1038/sj.bdj.4805742; Matear DW, 2006, J R SOC PROMO HEALTH, V126, P79, DOI 10.1177/1466424006063183; Mericske-Stern R, 1989, Schweiz Monatsschr Zahnmed, V99, P1245; Millwood J, 2000, Gerodontology, V17, P25, DOI 10.1111/j.1741-2358.2000.00025.x; Miyazaki Haruyo, 2005, Gerodontology, V22, P206, DOI 10.1111/j.1741-2358.2005.00076.x; Muller T, 2007, CLIN ORAL IMPLAN RES, V18, P2, DOI 10.1111/j.1600-0501.2007.01459.x; OSTERBERG T, 1995, J ORAL REHABIL, V22, P653, DOI 10.1111/j.1365-2842.1995.tb01063.x; Paley GA, 2009, GERODONTOLOGY, V26, P97, DOI 10.1111/j.1741-2358.2008.00230.x; Peltola Petteri, 2004, Gerodontology, V21, P93, DOI 10.1111/j.1741-2358.2004.00012.x; Persson GR, 2008, J CLIN PERIODONTOL, V35, P362, DOI 10.1111/j.1600-051X.2008.01281.x; Samson H, 2008, ACTA ODONTOL SCAND, V66, P368, DOI 10.1080/00016350802378654; Schimmel M, 2008, GERODONTOLOGY, V25, P107, DOI 10.1111/j.1741-2358.2007.00212.x; Schimmel M, 2011, GERODONTOLOGY, V28, P3, DOI 10.1111/j.1741-2358.2009.00330.x; Sheiham A, 2001, J DENT RES, V80, P408, DOI 10.1177/00220345010800020201; Simons D, 2003, BRIT DENT J, V194, P137, DOI 10.1038/sj.bdj.4809893; Starr JM, 2010, CURR OPIN CLIN NUTR, V13, P19, DOI 10.1097/MCO.0b013e328333aa37; STUCK AE, 1989, COMMUNITY DENT ORAL, V17, P267, DOI 10.1111/j.1600-0528.1989.tb00631.x; SULLIVAN DH, 1995, CLIN GERIATR MED, V11, P661, DOI 10.1016/S0749-0690(18)30264-7; Taylor GW, 1996, J PERIODONTOL, V67, P1085, DOI 10.1902/jop.1996.67.10s.1085; Thorstensson H, 2010, GERODONTOLOGY, V27, P19, DOI 10.1111/j.1741-2358.2009.00297.x; Tramini P, 2007, GERODONTOLOGY, V24, P196, DOI 10.1111/j.1741-2358.2007.00183.x; Tsakos G, 2009, EUR J ORAL SCI, V117, P286, DOI 10.1111/j.1600-0722.2009.00619.x; Unluer S, 2007, GERODONTOLOGY, V24, P22, DOI 10.1111/j.1741-2358.2007.00136.x; Wyatt CCL, 2009, GERODONTOLOGY, V26, P282, DOI 10.1111/j.1741-2358.2009.00305.x	52	13	14	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0734-0664	1741-2358		GERODONTOLOGY	Gerodontology	JUN	2012	29	2					E602	E610		10.1111/j.1741-2358.2011.00529.x			9	Dentistry, Oral Surgery & Medicine; Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine; Geriatrics & Gerontology	002QK	WOS:000308547000085	21726274	Bronze			2022-03-04	
J	Etter, JF				Etter, JF			Combining psychological theory and new information technology to disseminate smoking-cessation interventions at population level	NICOTINE & TOBACCO RESEARCH			English	Meeting Abstract									Univ Geneva, Fac Med, Inst Social & Prevent Med, CH-1211 Geneva, Switzerland									0	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1462-2203			NICOTINE TOB RES	Nicotine Tob. Res.	AUG	2005	7	4					663	663					1	Substance Abuse; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Substance Abuse; Public, Environmental & Occupational Health	972SY	WOS:000232474700055					2022-03-04	
J	Wolffgramm, J; Galli, G; Heyne, A				Wolffgramm, J; Galli, G; Heyne, A			Neuronal nicotinic acetylcholine receptors from variant genes and their effects on functional outcomes	NICOTINE & TOBACCO RESEARCH			English	Meeting Abstract									CMU, Dept Physiol, Geneva, Switzerland									0	0	0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1462-2203	1469-994X		NICOTINE TOB RES	Nicotine Tob. Res.	AUG	2005	7	4					654	654					1	Substance Abuse; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Substance Abuse; Public, Environmental & Occupational Health	972SY	WOS:000232474700033					2022-03-04	
J	Etter, JF				Etter, Jean-Francois			A list of the most popular smoking cessation Web sites and a comparison of their quality	NICOTINE & TOBACCO RESEARCH			English	Article							INTERNET; INTERVENTION; PROGRAMS; ONLINE; TRIAL; MAIL	To identify the most popular smoking cessation Web sites and to compare their quality, we conducted an Internet survey of 706 U.S. current and former smokers who had already visited such a Web site. Participants cited 133 different sites and rated their quality. Surprisingly, two of the three most frequently visited Web sites were owned by tobacco companies: Philipmorrisusa.com and its information resource Quit Assist (cited by 15.9% of participants) and the R. J. Reynolds site (5.9%). However, these two sites were not perceived as helpful. The other most frequently visited sites were QuitNet.com (10.1%, of all participants), the site of the American Lung Association (5.2%), and Webmd.eom (4.4%). All the nine most frequently visited sites, which together attracted 56% of all visitors, ranked at or below average for quality or helpfulness, and together, the three sites with the highest quality ratings received only 7% of all visitors. Only one-third of participants received follow-up e-mails. Thirteen of the 18 most popular Web sites were for-profit, and several sites promoted unproven methods. Two sites ranked above average for quality, and both were nonprofit: Smokefree.gov and Anti-smoking.org. Quitsmoking.About.com ranked above average for helpfulness. Direct competition radically distinguishes Web sites from other smoking cessation services. However, competition resulted in the selection of tobacco companies sites and commercial sites rather than sites of the best quality. In general, users were not very satisfied with smoking cessation Web sites, and they had difficulty finding the best Web sites. Resources were scattered over dozens of Web sites of often mediocre quality that duplicated each other.	Univ Geneva, Inst Social & Prevent Med, CH-1211 Geneva 4, Switzerland		Etter, JF (corresponding author), Univ Geneva, Inst Social & Prevent Med, CMU,1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland.	Jean-Francois.Etter@imsp.unige.ch		ETTER, Jean-Francois/0000-0002-1426-3157			Anderson JE, 2002, CHEST, V121, P932, DOI 10.1378/chest.121.3.932; Bock BC, 2004, NICOTINE TOB RES, V6, P207, DOI 10.1080/14622200410001676332; Cheh Julie A, 2003, Health Promot Pract, V4, P278, DOI 10.1177/1524839903004003012; Cobb NK, 2005, NICOTINE TOB RES, V7, P207, DOI 10.1080/14622200500055319; Dzewaltowski DA, 2004, ANN BEHAV MED, V28, P75, DOI 10.1207/s15324796abm2802_1; Etter JF, 2006, INT J MED INFORM, V75, P110, DOI 10.1016/j.ijmedinf.2005.06.014; Etter JF, 2005, J MED INTERNET RES, V7, DOI 10.2196/jmir.7.1.e2; Etter JF, 2001, INT J EPIDEMIOL, V30, P521, DOI 10.1093/ije/30.3.521; Eysenbach G, 2004, BMJ-BRIT MED J, V328, P1166, DOI 10.1136/bmj.328.7449.1166; Feil EG, 2003, NICOTINE TOB RES, V5, P189, DOI 10.1080/1462220031000073694; Fox S., 2003, INTERNET HLTH RESOUR; Fox S, 2005, HLTH INFORM ONLINE; Frisby G, 2002, J MED INTERNET RES, V4, DOI 10.2196/jmir.4.2.e8; Lawrance KAG, 2001, CAN J PUBLIC HEALTH, V92, P423, DOI 10.1007/BF03404532; Leatherdale ST, 2005, ADDICT BEHAV, V30, P1614, DOI 10.1016/j.addbeh.2005.02.004; Lenert L, 2004, J AM MED INFORM ASSN, V11, P235, DOI 10.1197/jamia.M1464; SCHNEIDER SJ, 1990, COMPUT HUM BEHAV, V6, P141, DOI 10.1016/0747-5632(90)90002-X; Strecher VJ, 2005, ADDICTION, V100, P682, DOI 10.1111/j.1360-0443.2005.01093.x; Wang J, 2004, PREV MED, V39, P962, DOI 10.1016/j.ypmed.2004.03.038; 2005, CA CANC, V55, P6; 2005, MORBIDITY MORTALITY, V54, P509	21	33	33	0	6	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1462-2203			NICOTINE TOB RES	Nicotine Tob. Res.	DEC	2006	8			1			S27	S34		10.1080/14622200601039923			8	Substance Abuse; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Substance Abuse; Public, Environmental & Occupational Health	132ZJ	WOS:000243981100005	17491168				2022-03-04	
J	Etter, JF				Etter, JF			A self-administered questionnaire to measure cigarette withdrawal symptoms: The cigarette withdrawal scale	NICOTINE & TOBACCO RESEARCH			English	Article							TOBACCO WITHDRAWAL; SMOKING; ABSTINENCE; SMOKERS; NUMBER; COMPONENTS; SEVERITY; MOOD	Because few tobacco withdrawal scales have been submitted to appropriate validity analyses, we sought to develop and assess the validity of a new, self-administered scale measuring cigarette withdrawal symptoms. We generated the instrument content by conducting a qualitative survey of 404 smokers and ex-smokers. Then we tested 61 items on the Internet in 3,050 smokers and ex-smokers. Subsamples provided comprehensive retest data after 17 days (n=1218) and smoking status after 41 days (n=673). The study resulted in a 21-item, six-dimension scale labeled the Cigarette Withdrawal Scale (CWS-21). The six subscales cover the main components of nicotine or tobacco withdrawal in the Diagnostic and Statistical Manual of Mental Disorders and International Statistical Classification of Diseases and Related Health Problems and in qualitative data: Depression-anxiety, craving, irritability-impatience, appetite-weight gain, insomnia, and difficulty concentrating. The six scores had a satisfactory test-retest reliability (r=.60-.71) and a high internal consistency (Cronbach's alpha=.83-.96). The factor structure of the scale was robust in a bootstrap resampling procedure. In ex-smokers, all scores except appetite-weight gain and insomnia predicted relapse at 41-day follow-up. In recent ex-smokers who had quit smoking less than 14 days before baseline, all scores except appetite-weight gain decreased between baseline and the 17-day retest. In baseline ex-smokers who relapsed to smoking at the 17-day retest, appetite-weight gain decreased and craving increased between baseline and retest. CWS-21 is a reliable, valid, multidimensional measure of cigarette withdrawal symptoms that is sensitive to change over time and predicts relapse to smoking.	Univ Geneva, Inst Social & Prevent Med, CMU, CH-1211 Geneva, Switzerland		Etter, JF (corresponding author), Univ Geneva, Inst Social & Prevent Med, CMU, 1 Rue Michel Servet, CH-1211 Geneva, Switzerland.	jean-francois.etter@imsp.unige.ch		ETTER, Jean-Francois/0000-0002-1426-3157			American Psychiatric Association, 1994, Diagnostic and Statistical Manual of Mental Disorders, V4th; EFRON B, 1991, SCIENCE, V253, P390, DOI 10.1126/science.253.5018.390; Etter JF, 1997, PREV MED, V26, P580, DOI 10.1006/pmed.1997.0179; Etter JF, 2001, ARCH INTERN MED, V161, P2596, DOI 10.1001/archinte.161.21.2596; Etter JF, 2001, INT J EPIDEMIOL, V30, P521, DOI 10.1093/ije/30.3.521; FIORE MC, 2000, TREATING TOBACCO USE; Gilbert DG, 1998, PERS INDIV DIFFER, V25, P399, DOI 10.1016/S0191-8869(98)00003-8; Gilbert DG, 2002, J CONSULT CLIN PSYCH, V70, P142, DOI 10.1037//0022-006X.70.1.142; Hajek P, 2003, ADDICTION, V98, P1563, DOI 10.1046/j.1360-0443.2003.00497.x; HENNINGFIELD JE, 1993, J CONSULT CLIN PSYCH, V61, P743, DOI 10.1037/0022-006X.61.5.743; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF02289447; Hughes JR, 1998, NICOTINE SAFETY AND TOXICITY, P147; HUGHES JR, 1986, ARCH GEN PSYCHIAT, V43, P289; HUGHES JR, 1992, J CONSULT CLIN PSYCH, V60, P689, DOI 10.1037/0022-006X.60.5.689; Jarvik ME, 2000, PHARMACOL BIOCHEM BE, V66, P553, DOI 10.1016/S0091-3057(00)00261-6; Johnson EO, 1996, ADDICTION, V91, P583, DOI 10.1111/j.1360-0443.1996.tb02315.x; MARTIN JE, 1980, PSYCHOPHYSIOLOGY, V17, P431, DOI 10.1111/j.1469-8986.1980.tb00179.x; Nunnally J., 1994, PSYCHOL THEORY; O'Connor BP, 2000, BEHAV RES METH INS C, V32, P396, DOI 10.3758/BF03200807; Patten CA, 1996, J SUBST ABUSE, V8, P93, DOI 10.1016/S0899-3289(96)90115-7; PERKINS KA, 1993, J CONSULT CLIN PSYCH, V61, P768, DOI 10.1037/0022-006X.61.5.768; Piasecki TM, 2002, ADDICTION, V97, P1093, DOI 10.1046/j.1360-0443.2002.00216.x; Piasecki TM, 2000, J ABNORM PSYCHOL, V109, P74, DOI 10.1037/0021-843X.109.1.74; Sayette MA, 2000, ADDICTION, V95, pS189; SCHNEIDER NG, 1984, PSYCHOPHARMACOLOGY, V82, P143; SHIFFMAN SM, 1976, PSYCHOPHARMACOLOGY, V50, P35, DOI 10.1007/BF00634151; Streiner DL, 1995, HLTH MEASUREMENT SCA; Ussher M, 2003, TOB CONTROL, V12, P86, DOI 10.1136/tc.12.1.86; Ustun B, 1997, DRUG ALCOHOL DEPEN, V47, P161, DOI 10.1016/S0376-8716(97)00087-2; van den Eijnden RJJM, 2003, ADDICT BIOL, V8, P463, DOI 10.1080/13556210310001646457; VELICER WF, 1976, PSYCHOMETRIKA, V41, P321, DOI 10.1007/BF02293557; Ward MM, 2001, ADDICT BEHAV, V26, P311, DOI 10.1016/S0306-4603(00)00107-6; Welsch SK, 1999, EXP CLIN PSYCHOPHARM, V7, P354, DOI 10.1037/1064-1297.7.4.354; WEST R, 2004, PSYCHOPHARMACOLOGY B; WEST RJ, 1985, PSYCHOPHARMACOLOGY, V87, P334, DOI 10.1007/BF00432717; WEST RJ, 1989, PSYCHOL MED, V19, P981, DOI 10.1017/S0033291700005705; World Health Organization, 2004, ICD 10 INT STAT CLAS, V2nd; World Health Organization, 1996, GUID CONTR MON TOB E; 1996, HARAPS SHORTER DICT	39	43	43	2	7	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1462-2203	1469-994X		NICOTINE TOB RES	Nicotine Tob. Res.	FEB	2005	7	1					47	57		10.1080/14622200412331328501			11	Substance Abuse; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Substance Abuse; Public, Environmental & Occupational Health	919UE	WOS:000228642300005	15804677				2022-03-04	
J	Etter, JF				Etter, Jean-Francois			Electronic Cigarette: A Longitudinal Study of Regular Vapers	NICOTINE & TOBACCO RESEARCH			English	Article							SMOKING-CESSATION; UNITED-STATES; NICOTINE; DEPENDENCE; TOBACCO; ADULTS; ALCOHOL; COOCCURRENCE; PREVALENCE; QUESTIONS	Introduction: It is unclear how vaping behavior changes over time in regular vapers, and what occurs when vapers relapse to smoking or when they stop vaping. We assessed change in vaping and smoking behaviors over 12 months in regular vapers. Methods: A longitudinal study of 3868 regular vapers enrolled on the Internet in 2012-2015 ("base-line"), followed after one (n = 1631, 42%), three (n = 1337, 35%), six (n= 1148, 30%), and 12 months (n = 893, 23%). Results: Participants had been vaping for a median of five months at baseline. Most (77%) were former smokers, who had not smoked for a median of three months at baseline. Over 12 months, enjoyment gradually became the most frequently cited reason to vape (93%), and vaping to deal with craving for tobacco gradually decreased (from 87% to 56%). In exclusive vapers (ex-smokers), nicotine concentration in e-liquids decreased over time (from 12 to 9 mg/mL), but puffs/day remained stable (200 puffs/day). After 12 months, 9% of 687 former smokers relapsed to smoking and 28% of 64 daily smokers (dual users) stopped smoking. After 12 months, when participants stopped vaping, they tended to relapse to smoking (+18% daily smokers among those who stopped vaping versus -2% in permanent vapers, p < .001). When ex-smokers relapsed to smoking, they tended to stop vaping. Conclusions: After 12 months, enjoyment and relapse prevention were the most important reasons to vape. Rates of relapse to smoking were low in former smokers and quit rates were high in current smokers. Stopping vaping was associated with relapsing to smoking.	[Etter, Jean-Francois] Univ Geneva, Fac Med, Inst Global Hlth, Geneva, Switzerland		Etter, JF (corresponding author), Univ Geneva, CMU, Inst Global Hlth, CH-1211 Geneva 4, Switzerland.	Jean-Francois.Etter@unige.ch			Swiss Tobacco Prevention Fund (Swiss Federal Office of Public Health) [12.001189]; University of Geneva	Swiss Tobacco Prevention Fund (Swiss Federal Office of Public Health), grant 12.001189. The Tobacco Prevention Fund had no role in the design and conduct of the study. JFE's salary is paid by the University of Geneva.	Adkison SE, 2013, AM J PREV MED, V44, P207, DOI 10.1016/j.amepre.2012.10.018; Adriaens K, 2014, INT J ENV RES PUB HE, V11, P11220, DOI 10.3390/ijerph111111220; Agrawal A, 2012, ADDICTION, V107, P1221, DOI 10.1111/j.1360-0443.2012.03837.x; Berg Carla J, 2014, Open J Prev Med, V4, P789; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Chapman SLC, 2014, J PSYCHIATR RES, V54, P43, DOI 10.1016/j.jpsychires.2014.03.005; Cummins SE, 2014, TOB CONTROL, V23, P48, DOI 10.1136/tobaccocontrol-2013-051511; Dawkins L, 2013, ADDICTION, V108, P1115, DOI 10.1111/add.12150; Dockrell M, 2013, NICOTINE TOB RES, V15, P1737, DOI 10.1093/ntr/ntt057; Douptcheva N, 2013, J EPIDEMIOL COMMUN H, V67, P1075, DOI 10.1136/jech-2013-203152; Etter JF, 2011, EUR RESPIR J, V38, P1219, DOI 10.1183/09031936.00066011; Etter JF, 2008, DRUG ALCOHOL DEPEN, V95, P152, DOI 10.1016/j.drugalcdep.2008.01.017; Etter JF, 2006, TOB CONTROL, V15, DOI 10.1136/tc.2005.015487; Etter JF, 2016, DRUG ALCOHOL DEPEN, V160, P218, DOI 10.1016/j.drugalcdep.2016.01.003; Etter JF, 2014, ADDICT BEHAV, V39, P491, DOI 10.1016/j.addbeh.2013.10.028; Etter JF, 2013, ADDICTION, V108, P50, DOI 10.1111/j.1360-0443.2012.03981.x; Etter JF, 2011, ADDICTION, V106, P2017, DOI 10.1111/j.1360-0443.2011.03505.x; Etter JF, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-231; Etter JF, 2006, ADDICTION, V101, P362, DOI 10.1111/j.1360-0443.2005.01289.x; Etter JF, 2003, NEUROPSYCHOPHARMACOL, V28, P359, DOI 10.1038/sj.npp.1300030; Farrell M, 2001, BRIT J PSYCHIAT, V179, P432, DOI 10.1192/bjp.179.5.432; Farsalinos KE, 2013, SUBST ABUS-RES TREAT, V7, P139, DOI 10.4137/SART.S12756; Foulds J, 2011, INT J CLIN PRACT, V65, P1037, DOI 10.1111/j.1742-1241.2011.02751.x; Glover M, 2016, NICOTINE TOB RES, DOI [10.1093/ntr/ntw278, DOI 10.1093/NTR/NTW278.]; Grant BF, 2004, ARCH GEN PSYCHIAT, V61, P1107, DOI 10.1001/archpsyc.61.11.1107; HARTMANNBOYCE J, 2016, COCHRANE DB SYST REV; Healton CG, 2006, BRIT MED J, V333, P25, DOI 10.1136/bmj.38840.608704.80; Hughes JR, 2004, ADDICTION, V99, P29, DOI 10.1111/j.1360-0443.2004.00540.x; Kasza KA, 2017, NEW ENGL J MED, V376, P342, DOI 10.1056/NEJMsa1607538; King BA, 2013, NICOTINE TOB RES, V15, P1623, DOI 10.1093/ntr/ntt013; Lasser K, 2000, JAMA-J AM MED ASSOC, V284, P2606, DOI 10.1001/jama.284.20.2606; Malas M, 2016, NICOTINE TOB RES, V18, P1926, DOI 10.1093/ntr/ntw119; Manzoli L, 2017, TOB CONTROL, V26, P284, DOI 10.1136/tobaccocontrol-2015-052822; McRobbie H, 2015, CANCER PREV RES, V8, P873, DOI 10.1158/1940-6207.CAPR-15-0058; Pacifici R, 2015, INT J ENV RES PUB HE, V12, P7638, DOI 10.3390/ijerph120707638; Perkins KA, 2001, CNS DRUGS, V15, P391, DOI 10.2165/00023210-200115050-00005; van Staden S R, 2013, SAMJ, S. Afr. med. j., V103, P865, DOI 10.7196/samj.6887; Weitzman ER, 2005, DRUG ALCOHOL DEPEN, V80, P377, DOI 10.1016/j.drugalcdep.2005.05.008; West R, 2004, PSYCHOPHARMACOLOGY, V177, P195, DOI 10.1007/s00213-004-1923-6; Whooley MA, 1997, J GEN INTERN MED, V12, P439, DOI 10.1046/j.1525-1497.1997.00076.x; Zhuang YL, 2016, TOB CONTROL, V25, pi90, DOI 10.1136/tobaccocontrol-2016-053096	41	19	19	0	8	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1462-2203	1469-994X		NICOTINE TOB RES	Nicotine Tob. Res.	AUG	2018	20	8					912	922		10.1093/ntr/ntx132			11	Substance Abuse; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Substance Abuse; Public, Environmental & Occupational Health	GM6PE	WOS:000438292400002	28591788	Bronze			2022-03-04	
J	Etter, JF				Etter, Jean-Francois			Smoking and Cloninger's Temperament and Character Inventory	NICOTINE & TOBACCO RESEARCH			English	Article							SUBSTANCE USE; PSYCHOBIOLOGICAL MODEL; CIGARETTE DEPENDENCE; TOBACCO WITHDRAWAL; 5-FACTOR MODEL; FRENCH VERSION; PERSONALITY; DIMENSIONS; METAANALYSIS; INTERNET	Cloninger's neuropsychopharmacological theory identifies four temperament traits and three character traits that are largely heritable and are associated with addictions. We tested whether these personality traits were associated with smoking behavior and predicted smoking cessation and tobacco withdrawal symptoms. We conducted an Internet cohort study in 2005-2009. The Temperament and Character Inventory (TCI, 226 items, French version) was assessed in 2,993 people (1,593 current, 969 former, and 419 never-smokers). Subsets of participants indicated their smoking status after 30 days (n = 1,452, 48.5%) and answered the TCI again and reported tobacco withdrawal symptoms after 61 days (n = 644, 21.5%). Compared with never- and former smokers, daily smokers had higher scores of Harm Avoidance (HA) and lower scores of Persistence and Self-Directedness (SD). Daily smokers had higher scores of Novelty Seeking than never-smokers. In daily smokers, the level of tobacco dependence was associated with higher scores of HA and lower scores of SD. In the 60 daily smokers who had stopped smoking after 61 days, after adjustment for tobacco dependence level and baseline tobacco withdrawal ratings, SD predicted lower scores of depressed mood and anxiety at 61-day follow-up and HA predicted higher scores of depressed mood at 61-day follow-up. Personality ratings did not predict smoking cessation at follow-up in daily smokers or relapse in former smokers. A consistent association was found between smoking and high HA and low SD. Knowledge about these associations may be useful to clinicians to tailor counseling.	Univ Geneva, CMU, Inst Social & Prevent Med, Fac Med, CH-1211 Geneva 4, Switzerland		Etter, JF (corresponding author), Univ Geneva, CMU, Inst Social & Prevent Med, Fac Med, 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland.	jean-francois.etter@unige.ch		ETTER, Jean-Francois/0000-0002-1426-3157			Ando J, 2004, J PERS DISORD, V18, P379, DOI 10.1521/pedi.18.4.379.40345; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975, DOI 10.1001/archpsyc.1993.01820240059008; Cook C, 2000, EDUC PSYCHOL MEAS, V60, P821, DOI 10.1177/00131640021970934; De Fruyt F, 2000, PERS INDIV DIFFER, V29, P441, DOI 10.1016/S0191-8869(99)00204-4; Downey KK, 1996, J SUBST ABUSE, V8, P129, DOI 10.1016/S0899-3289(96)90139-X; Etter JF, 2003, NICOTINE TOB RES, V5, P401, DOI 10.1080/1462220031000094240; Etter JF, 2006, ADDICTION, V101, P362, DOI 10.1111/j.1360-0443.2005.01289.x; Etter JF, 2006, INT J MED INFORM, V75, P110, DOI 10.1016/j.ijmedinf.2005.06.014; Etter JF, 2005, DRUG ALCOHOL DEPEN, V77, P259, DOI 10.1016/j.drugalcdep.2004.08.015; Etter JF, 2003, NEUROPSYCHOPHARMACOL, V28, P359, DOI 10.1038/sj.npp.1300030; Etter JF, 2001, INT J EPIDEMIOL, V30, P521, DOI 10.1093/ije/30.3.521; Etter JF, 2000, ADDICT BEHAV, V25, P523, DOI 10.1016/S0306-4603(00)00068-X; Gillespie NA, 2003, PERS INDIV DIFFER, V35, P1931, DOI 10.1016/S0191-8869(03)00042-4; Gurpegui M, 2007, PROG NEURO-PSYCHOPH, V31, P997, DOI 10.1016/j.pnpbp.2007.02.006; HEATH AC, 1995, BEHAV GENET, V25, P103, DOI 10.1007/BF02196921; HEATH AC, 1994, J PERS SOC PSYCHOL, V66, P762, DOI 10.1037/0022-3514.66.4.762; Howard MO, 1997, J STUD ALCOHOL, V58, P48, DOI 10.15288/jsa.1997.58.48; Hughes JR, 2007, NICOTINE TOB RES, V9, P315, DOI 10.1080/14622200701188919; Hughes JR, 2007, NICOTINE TOB RES, V9, P329, DOI 10.1080/14622200701188927; HUGHES JR, 1992, J CONSULT CLIN PSYCH, V60, P689, DOI 10.1037/0022-006X.60.5.689; JENSEN HH, 1999, COGNITIVE BEHAV THER, V28, P70; Johnson JG, 2000, JAMA-J AM MED ASSOC, V284, P2348, DOI 10.1001/jama.284.18.2348; Kassel JD, 1997, HEALTH PSYCHOL, V16, P359, DOI 10.1037/0278-6133.16.4.359; Leventhal AM, 2007, ADDICT BEHAV, V32, P2976, DOI 10.1016/j.addbeh.2007.06.014; Madden PAF, 1997, ADDICTION, V92, P889, DOI 10.1111/j.1360-0443.1997.tb02957.x; Malouff JM, 2006, J DRUG EDUC, V36, P47, DOI 10.2190/9EP8-17P8-EKG7-66AD; Masse LC, 1997, ARCH GEN PSYCHIAT, V54, P62; Munafo MR, 2007, NICOTINE TOB RES, V9, P405, DOI 10.1080/14622200701188851; Nunnally J., 1994, PSYCHOL THEORY; Pelissolo A, 1997, ANN MED-PSYCHOL, V155, P497; Pelissolo A, 2000, PSYCHIAT RES, V94, P67, DOI 10.1016/S0165-1781(00)00127-X; Pomerleau C S, 1992, J Subst Abuse, V4, P143, DOI 10.1016/0899-3289(92)90014-O; Ravaja N, 2001, J STUD ALCOHOL, V62, P98, DOI 10.15288/jsa.2001.62.98; Tercyak KP, 2003, SUBST USE MISUSE, V38, P1953, DOI 10.1081/JA-120025121; vanAmmers EC, 1997, J NERV MENT DIS, V185, P283, DOI 10.1097/00005053-199705000-00001; Wang J, 2004, PREV MED, V39, P962, DOI 10.1016/j.ypmed.2004.03.038; West R, 1997, AM J PSYCHIAT, V154, P1589, DOI 10.1176/ajp.154.11.1589; WILLIAMS A, 1994, NUTR FOOD SCI, V1, P20, DOI DOI 10.1108/00346659410048965; Wills TA, 1998, J PERS SOC PSYCHOL, V74, P387, DOI 10.1037/0022-3514.74.2.387	39	27	27	0	17	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1462-2203			NICOTINE TOB RES	Nicotine Tob. Res.	SEP	2010	12	9					919	926		10.1093/ntr/ntq116			8	Substance Abuse; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Substance Abuse; Public, Environmental & Occupational Health	644BS	WOS:000281346000007	20639284	Green Published			2022-03-04	
J	Schwappach, D				Schwappach, David L. B.			Smoking behavior, intention to quit, and preferences toward cessation programs among gay men in Zurich, Switzerland	NICOTINE & TOBACCO RESEARCH			English	Article							CIGARETTE-SMOKING; INTERVENTION; BISEXUALS; LESBIANS; RISK	International data show that the prevalence of smoking is high among gay males. The need for tailored smoking cessation support has been widely acknowledged, but little is known about gay men's preferences toward culturally-adopted interventions. We investigated preferences toward tailored group programs in a survey study among a sample of gay smokers living in the urban community of Zurich, Switzerland. Preferences were assessed using vignettes describing alternative services randomized over participants. Men that self-defined as gay or bisexual completed the survey (N=379). Responders smoked on average 20 cigarettes per day (CI 18.9-21.5) and the mean nicotine dependence score was 4.6 (CI 4.3-4.9). Men strongly preferred group cessation programs for gay men over generic programs, and services provided by the local gay health care provider over those offered by the traditional course provider. The data suggest that offering tailored programs will increase participation in cessation services. Results emphasize the need for culturally-adopted cessation interventions that provide men strategies for participating in recreational activities as nonsmokers. Gay health care organizations serve as important door openers to communicate the serious health threats for gay men caused by smoking, and may play an important role in attracting men to cessation services.	[Schwappach, David L. B.] Univ Witten Herdecke, Fac Med, Zurich, Switzerland; [Schwappach, David L. B.] Univ Witten Herdecke, Res Inst Publ Hlth & Addict, Zurich, Switzerland		Schwappach, D (corresponding author), Konradstr 31, CH-8032 Zurich, Switzerland.	David.Schwappach@isgf.uzh.ch	Schwappach, David L.B./L-8378-2018	Schwappach, David L.B./0000-0001-8668-3065	Swiss Tobacco Control [07.005411]	This study was funded by the Swiss Tobacco Control Fund grant 07.005411. The funding source had no influence on study design, in the collection, analysis, and interpretation of the data, in the writing of the manuscript, and in the decision to submit the manuscript for publication. The contents are solely the responsibility of the author and do not necessarily represent the official views of the Swiss Tobacco Control Fund. The author has no competing interests to declare.; The author thanks Benedikt Zahno, Zurich AIDS Federation, for his valuable support in study design and his efforts throughout the field phase. The author also acknowledges the support of individuals, organizations, and institutions for assistance in recruiting subjects for survey participation, and the men who participated in the study.	Center for Substance Abuse Treatment, 2001, PROV INTR SUBST AB T; Doolan DM, 2006, NURS RES, V55, pS29, DOI 10.1097/00006199-200607001-00005; *GAY LESB MED ASS, 2001, HLTH PEOPL 2010 COMP; Gruskin EP, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-241; Gruskin EP, 2007, AM J PUBLIC HEALTH, V97, P1496, DOI 10.2105/AJPH.2006.090258; Harding R, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-43; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Hensher D.A., 2005, APPL CHOICE ANAL PRI; McKirnan DJ, 2006, SUBST USE MISUSE, V41, P1197, DOI 10.1080/10826080500514503; Phillips KA, 2002, HEALTH SERV RES, V37, P1681, DOI 10.1111/1475-6773.01115; Prochaska JO, 1997, AM J HEALTH PROMOT, V12, P38, DOI 10.4278/0890-1171-12.1.38; Rossi P., 1982, MEASURING SOCIAL JUD; Ryan H, 2001, AM J PREV MED, V21, P142, DOI 10.1016/S0749-3797(01)00331-2; Ryan M, 2004, HEALTH ECON, V13, P397, DOI 10.1002/hec.821; Schwappach DLB, 2007, J EVAL CLIN PRACT, V13, P259, DOI 10.1111/j.1365-2753.2006.00688.x; StataCorp, 2007, STAT STAT SOFTW REL; Tang H, 2004, CANCER CAUSE CONTROL, V15, P797, DOI 10.1023/B:CACO.0000043430.32410.69; TIMMERMANS H, 1992, PROF GEOGR, V44, P406, DOI 10.1111/j.0033-0124.1992.00406.x; Urama KC, 2006, ECOL ECON, V59, P24, DOI 10.1016/j.ecolecon.2005.09.022; US Department of Health and Human Services, 2000, HLTH PEOPL 2010, V1; WANG J, 2006, PREV MED, V44, P70; WATSON V, 2005, IHEA 5 WORLD C HLTH; 2006, ANN INTERN MED, V145, P839	23	15	15	0	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1462-2203	1469-994X		NICOTINE TOB RES	Nicotine Tob. Res.		2008	10	12					1783	1787	PII 905750718	10.1080/14622200802443502			5	Substance Abuse; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Substance Abuse; Public, Environmental & Occupational Health	376OZ	WOS:000261194200011	19023829				2022-03-04	
J	Dayer, R; Peter, R				Dayer, Romain; Peter, Robin			Percutaneous cementoplasty complicating the treatment of a pathologic subtrochanteric fracture: A case report	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article							RENAL-CELL CARCINOMA; LONG BONES; OSSEOUS METASTASES; FEMORAL NAIL; ZICKEL-NAIL; FEMUR; FIXATION; DISEASE; LESIONS; METHYLMETHACRYLATE		[Dayer, Romain; Peter, Robin] Univ Hosp Geneva, Dept Orthopaed, CH-1211 Geneva 14, Switzerland		Dayer, R (corresponding author), Univ Hosp Geneva, Dept Orthopaed, CH-1211 Geneva 14, Switzerland.	romain.dayer@hcuge.ch					Althausen P, 1997, CANCER, V80, P1103; Assal M, 2000, J ORTHOP TRAUMA, V14, P394, DOI 10.1097/00005131-200008000-00003; BARLOW IW, 1994, INJURY, V25, P426, DOI 10.1016/0020-1383(94)90266-6; BOUMA WH, 1983, CLIN EXP METASTAS, V1, P205, DOI 10.1007/BF00736404; Chang SW, 2005, J VASC INTERV RADIOL, V16, P889, DOI 10.1016/S1051-0443(07)60698-8; Cotten A, 1999, RADIOGRAPHICS, V19, P647, DOI 10.1148/radiographics.19.3.g99ma04647; Deramond H., 1997, Semin Musculoskelet Radiol, V1, P285, DOI 10.1055/s-2008-1080150; Dijkstra PDS, 1997, ARCH ORTHOP TRAUM SU, V116, P221, DOI 10.1007/BF00393714; FIDLER M, 1981, ACTA ORTHOP SCAND, V52, P623, DOI 10.3109/17453678108992157; Gangi A, 1996, RADIOGRAPHICS, V16, P1289, DOI 10.1148/radiographics.16.6.8946536; Gangi A, 1996, RADIOGRAPHICS, V16; Gangi Afshin, 2003, Radiographics, V23, pe10, DOI 10.1148/rg.e10; Giannoudis PV, 1999, ACTA ORTHOP SCAND, V70, P29, DOI 10.3109/17453679909000953; HABERMANN ET, 1989, ORTHOP CLIN N AM, V20, P469; HARRINGTON KD, 1976, J BONE JOINT SURG AM, V58, P1047, DOI 10.2106/00004623-197658080-00001; Harty JA, 2003, SURG-J R COLL SURG E, V1, P48, DOI 10.1016/S1479-666X(03)80010-0; KAEMMERLEN P, 1989, Journal de Radiologie (Paris), V70, P557; KARACHALIOS T, 1993, J BONE JOINT SURG BR, V75, P119, DOI 10.1302/0301-620X.75B1.8421007; Kelekis A, 2005, J VASC INTERV RADIOL, V16, P81, DOI 10.1097/01.RVI.00001417.84515.92; KERR PS, 1993, J BONE JOINT SURG BR, V75, P972, DOI 10.1302/0301-620X.75B6.8245094; Lin PP, 2007, J BONE JOINT SURG AM, V89A, P1794, DOI 10.2106/JBJS.F.00603; MICKELSON MR, 1976, J BONE JOINT SURG AM, V58, P1067, DOI 10.2106/00004623-197658080-00004; MIRELS H, 1989, CLIN ORTHOP RELAT R, P256; Mow VC., 1997, BASIC ORTHOPAEDIC BI; Murphy KJ, 2000, NEUROIMAG CLIN N AM, V10, P535; PETER RE, 1993, INJURY, V24, pS48, DOI 10.1016/0020-1383(93)90007-S; Peter RE, 1997, J ORTHOP TRAUMA, V11, P233, DOI 10.1097/00005131-199704000-00018; Piatek S, 2003, ZBL CHIR, V128, P131, DOI 10.1055/s-2003-37767; RYDELL NW, 1966, ACTA ORTHOP SCAN S88, V37, P1; SIM FH, 1974, J BONE JOINT SURG AM, VA 56, P40, DOI 10.2106/00004623-197456010-00004; SIM FH, 1988, DIAGNOSIS MANAGEMENT; THOMAS WG, 1986, J BONE JOINT SURG BR, V68, P255, DOI 10.1302/0301-620X.68B2.3958011; Toyota N, 2005, CARDIOVASC INTER RAD, V28, P578, DOI 10.1007/s00270-004-0208-0; WEIKERT DR, 1991, J BONE JOINT SURG BR, V73, P668, DOI 10.1302/0301-620X.73B4.2071657; ZICKEL RE, 1976, J BONE JOINT SURG AM, V58, P1061, DOI 10.2106/00004623-197658080-00003	35	13	14	0	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383			INJURY	Injury-Int. J. Care Inj.	JUL	2008	39	7					801	804		10.1016/j.injury.2008.01.009			4	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	329AH	WOS:000257838800017	18539281				2022-03-04	
J	Stern, R				Stern, Richard			Are there advances in the treatment of extracapsular hip fractures in the elderly?	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						pertrochanteric fracture; sliding compression hip screw; hip intramedullary nail; reverse intertrochanteric fracture	UNSTABLE INTERTROCHANTERIC FRACTURES; TROCHANTERIC FEMORAL FRACTURES; MEDOFF SLIDING PLATE; OSTEOPOROTIC PERTROCHANTERIC FRACTURES; PERCUTANEOUS COMPRESSION PLATE; BIPOLAR PROSTHETIC REPLACEMENT; DYNAMIC SCREW-PLATE; TIP-APEX DISTANCE; GAMMA-NAIL; INTRAMEDULLARY NAIL	While the rate of failure following hip fracture surgery for extracapsular hip fractures in the elderly is low, an incidence of implant cutout from the femoral head remains regardless of whether fixation is by sliding hip screw or intramedullary nail. In general, a well-executed osteosynthesis is the best assurance of a good outcome with few complications, and typically a less than ideal placement of the implant in the femoral head is the reason for cut-out and failure of the operation. It is clear that there is no difference in the incidence of complications or functional outcome between a sliding hip screw and an intramedullary nail for pertrochanteric fractures (AO/OTA 31-A1 and A2), while the implant of choice in the elderly for the true intertrochanteric fracture (AO/OTA 31-A3; reverse intertrochanteric) is a nail. However, what is less clear is whether there are newer ideas and/or implant designs that represent true advances in the treatment of extracapsular fractures in the elderly. The following review focuses on just this issue.	Univ Hosp Geneva, Orthopaed Surg Serv, Geneva, Switzerland		Stern, R (corresponding author), Univ Hosp Geneva, Orthopaed Surg Serv, Geneva, Switzerland.	richard.stern@hcuge.ch					Adams CI, 2001, J ORTHOP TRAUMA, V15, P394, DOI 10.1097/00005131-200108000-00003; APEL DM, 1989, CLIN ORTHOP RELAT R, V246, P156; Audige L, 2003, INT ORTHOP, V27, P197, DOI 10.1007/s00264-003-0457-6; Babst R, 1998, J ORTHOP TRAUMA, V12, P392, DOI 10.1097/00005131-199808000-00005; Baixauli F, 1999, CLIN ORTHOP RELAT R, P205; BARTUCCI EJ, 1985, J BONE JOINT SURG AM, V67A, P1094, DOI 10.2106/00004623-198567070-00014; BAUMGAERTNER MR, 1995, J BONE JOINT SURG AM, V77A, P1058, DOI 10.2106/00004623-199507000-00012; Baumgaertner MR, 1997, J BONE JOINT SURG BR, V79B, P969, DOI 10.1302/0301-620X.79B6.7949; BAUMGAERTNER MR, 1998, CLIN ORTHOP RELAT R, V348, P87; Bess R J, 1997, J South Orthop Assoc, V6, P173; Bong MR, 2004, J TRAUMA, V56, P791, DOI 10.1097/01.TA.0000046265.44785.0C; Brandt SE, 2002, INJURY, V33, P413, DOI 10.1016/S0020-1383(02)00080-3; BRIDLE SH, 1991, J BONE JOINT SURG BR, V73, P330, DOI 10.1302/0301-620X.73B2.2005167; Broos P L, 1991, J Orthop Trauma, V5, P446, DOI 10.1097/00005131-199112000-00010; Buciuto R, 1998, ACTA ORTHOP SCAND, V69, P25, DOI 10.3109/17453679809002350; BUTT MS, 1995, INJURY, V26, P615, DOI 10.1016/0020-1383(95)00126-T; CALVERT PT, 1992, J BONE JOINT SURG BR, V74, P329, DOI 10.1302/0301-620X.74B3.1587869; Chirodian N, 2005, INJURY, V36, P793, DOI 10.1016/j.injury.2005.01.017; CLAES H, 1985, INJURY, V16, P261, DOI 10.1016/S0020-1383(85)80016-4; CLAWSON D K, 1964, J Trauma, V4, P737, DOI 10.1097/00005373-196411000-00001; Crawford CH, 2006, J TRAUMA, V60, P325, DOI 10.1097/01.ta.0000197872.87439.f9; Elder S, 2000, J ORTHOP TRAUMA, V14, P386, DOI 10.1097/00005131-200008000-00002; EVANS EM, 1949, J BONE JOINT SURG BR, V31, P190, DOI 10.1302/0301-620X.31B2.190; FORNANDER P, 1992, ACTA ORTHOP SCA S248, V63, P90; Fritz T, 1999, ARCH ORTHOP TRAUM SU, V119, P1, DOI 10.1007/s004020050345; Giraud B, 2005, REV CHIR ORTHOP, V91, P732, DOI 10.1016/S0035-1040(05)84484-8; GOLDHAGEN PR, 1994, J ORTHOP TRAUMA, V8, P367, DOI 10.1097/00005131-199410000-00001; Goodman SB, 1998, CLIN ORTHOP RELAT R, P42; Gotfried Y, 2000, J ORTHOP TRAUMA, V14, P490, DOI 10.1097/00005131-200009000-00005; Gotfried Y, 2004, CLIN ORTHOP RELAT R, P82, DOI 10.1097/01.blo.0000132264.14046.c2; GREEN S, 1987, CLIN ORTHOP RELAT R, P169; GUYER P, 1992, HELV CHIR ACTA, V58, P697; Haentjens P, 2005, DISABIL REHABIL, V27, P1167, DOI 10.1080/09638280500055966; Haidukewych GT, 2001, J BONE JOINT SURG AM, V83A, P643, DOI 10.2106/00004623-200105000-00001; Hardy DCR, 1998, J BONE JOINT SURG AM, V80A, P618, DOI 10.2106/00004623-199805000-00002; HARWIN SF, 1990, ORTHOPEDICS, V13, P1131; HERSCHE O, 1989, HELV CHIR ACTA, V56, P577; Hoffman CW, 1996, AUST NZ J SURG, V66, P151, DOI 10.1111/j.1445-2197.1996.tb01144.x; Hoffmann R, 1999, UNFALLCHIRURG, V102, P182, DOI 10.1007/s001130050391; Im GI, 2005, J ORTHOP TRAUMA, V19, P5, DOI 10.1097/00005131-200501000-00002; Janzing HMJ, 2002, J TRAUMA, V52, P293, DOI 10.1097/00005373-200202000-00015; JENSEN JS, 1975, ACTA ORTHOP SCAND, V46, P795, DOI 10.3109/17453677508989266; JENSEN JS, 1980, ACTA ORTHOP SCAND, V51, P803, DOI 10.3109/17453678008990877; Jones HW, 2006, INT ORTHOP, V30, P69, DOI 10.1007/s00264-005-0028-0; Kim SY, 2005, J BONE JOINT SURG AM, V87A, P2186, DOI 10.2106/JBJS.D.02768; Kosygan KP, 2002, J BONE JOINT SURG BR, V84B, P19, DOI 10.1302/0301-620X.84B1.11919; LAU HK, 1983, INJURY, V15, P129, DOI 10.1016/0020-1383(83)90041-4; Lunsjo K, 2001, ACTA ORTHOP SCAND, V72, P133, DOI 10.1080/000164701317323372; Madsen JE, 1998, J ORTHOP TRAUMA, V12, P241, DOI 10.1097/00005131-199805000-00005; Magyar G, 1997, J BONE JOINT SURG BR, V79B, P487, DOI 10.1302/0301-620X.79B3.7190; Mattsson P, 2005, J BONE JOINT SURG BR, V87B, P1203, DOI 10.1302/0301-620X.87B9.15792; MEDOFF RJ, 1991, J BONE JOINT SURG AM, V73A, P1192, DOI 10.2106/00004623-199173080-00008; Moroni A, 2005, J BONE JOINT SURG AM, V87A, P42, DOI 10.2106/JBJS.E.00437; Moroni A, 2005, J BONE JOINT SURG AM, V87A, P753, DOI 10.2106/JBJS.D.01789; Moroni A, 2004, CLIN ORTHOP RELAT R, P87, DOI 10.1097/01.blo.0000132405.30139.bb; Moroni A, 1998, J BONE JOINT SURG AM, V80A, P547, DOI 10.2106/00004623-199804000-00011; MUHR G, 1979, CLIN ORTHOP RELAT R, P41; Muller M, 1987, COMPREHENSIVE CLASSI, P120; OBrien PJ, 1995, CAN J SURG, V38, P516; Olsson O, 2001, J BONE JOINT SURG BR, V83B, P572, DOI 10.1302/0301-620X.83B4.11302; Palm H, 2007, J BONE JOINT SURG AM, V89A, P470, DOI 10.2106/JBJS.F.00679; Parker MJ, 1996, INT ORTHOP, V20, P163, DOI 10.1007/s002640050055; PARKER MJ, 2005, COCHRANE DB SYST REV, V4; RADFORD PJ, 1993, J BONE JOINT SURG BR, V75, P789, DOI 10.1302/0301-620X.75B5.8376441; Rodop O, 2002, INT ORTHOP, V26, P233, DOI 10.1007/s00264-002-0358-0; Rokito Andrew S., 1993, Contemporary Orthopaedics, V26, P349; ROSSO R, 1993, HELV CHIR ACTA, V59, P955; Sadowski C, 2002, J BONE JOINT SURG AM, V84A, P372, DOI 10.2106/00004623-200203000-00007; Saudan M, 2002, J ORTHOP TRAUMA, V16, P386, DOI 10.1097/00005131-200207000-00004; SCHATZKER J, 1978, J TRAUMA, V18, P732, DOI 10.1097/00005373-197810000-00011; SCHUMPELICK W, 1955, J BONE JOINT SURG AM, V37, P693, DOI 10.2106/00004623-195537040-00003; SIMPSON AHRW, 1989, INJURY, V20, P227, DOI 10.1016/0020-1383(89)90120-4; Sommers MB, 2004, J ORTHOP TRAUMA, V18, P361, DOI 10.1097/00005131-200407000-00006; STERN MB, 1979, INT ORTHOP, V3, P67, DOI 10.1007/BF00266327; Strauss E, 2006, INJURY, V37, P984, DOI 10.1016/j.injury.2006.06.008; Szpalski M, 2004, J ORTHOP TRAUMA, V18, P34, DOI 10.1097/00005131-200401000-00007; Utrilla AL, 2005, J ORTHOP TRAUMA, V19, P229, DOI 10.1097/01.bot.0000151819.95075.ad; Watson JT, 1998, CLIN ORTHOP RELAT R, P79; WHITELAW GP, 1990, CLIN ORTHOP RELAT R, V252, P238; 1996, J ORTHOP TRAUMA S1, V10, P31	80	27	30	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	SEP	2007	38			3			77	87		10.1016/j.injury.2007.08.015			11	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	221LT	WOS:000250230000012					2022-03-04	
J	Peter, RE				Peter, Robin E.			Open reduction and internal fixation of osteoporotic acetabular fractures through the ilio-inguinal approach: use of buttress plates to control medial displacement of the quadrilateral surface	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Acetabular fracture; Osteoporotic fracture; Acetabulum fracture fixation; Geriatric fracture	TOTAL HIP-ARTHROPLASTY; STOPPA APPROACH; ELDERLY-PATIENTS; CABLE FIXATION	The number of acetabular fractures in the geriatric population requiring open reduction and internal fixation is increasing. Fractures with medial or anterior displacement are the most frequent types, and via the ilio-inguinal approach buttress plates have proved helpful to maintain the quadrilateral surface or medial acetabular wall. Seven to ten hole 3.5 mm reconstruction plates may be used as buttress plates, placed underneath the usual pelvic brim plate. This retrospective study presents our results with this technique in 13 patients at a minimum follow-up of 12 months (average, 31 months). 85% of the patients had a good result. The early onset of post-traumatic osteoarthritis necessitated total hip arthroplasty in two patients (15%) at 12 and 18 months follow-up, respectively. This treatment option should be considered in the surgeon's armamentarium when fixing these challenging cases. (C) 2015 Elsevier Ltd. All rights reserved.	Univ Hosp Geneva, Div Orthopaed & Trauma Surg, CH-1211 Geneva, Switzerland		Peter, RE (corresponding author), Univ Hosp Geneva, Div Orthopaed & Trauma Surg, Rue Gabrielle Perret Gentil 4, CH-1211 Geneva, Switzerland.	robin.peter@unige.ch					Archdeacon MT, 2011, J AM ACAD ORTHOP SUR, V19, P170, DOI 10.5435/00124635-201103000-00006; Boraiah S, 2009, J ORTHOP TRAUMA, V23, P243, DOI 10.1097/BOT.0b013e3181923fb8; Carroll EA, 2010, J ORTHOP TRAUMA, V24, P637, DOI 10.1097/BOT.0b013e3181ceb685; Chana-Rodriguez F, 2012, INJURY, V43, pS28, DOI 10.1016/S0020-1383(13)70176-1; COLE JD, 1994, CLIN ORTHOP RELAT R, P112; Culemann U, 2010, INJURY, V41, P405, DOI 10.1016/j.injury.2009.12.001; DAUBIGNE RM, 1954, J BONE JOINT SURG AM, V36-A, P451, DOI 10.2106/00004623-195436030-00001; Giannoudis PV, 2007, J BONE JOINT SURG BR, V89B, P503, DOI 10.1302/0301-620X.89B4.18380; Giannoudis PV, 2013, BONE JOINT J, V95B, P230, DOI 10.1302/0301-620X.95B2.30548; Giannoudis PV, 2011, J BONE JOINT SURG BR, V93B, P970, DOI 10.1302/0301-620X.93B7.26105; Giannoudis PV, 2005, J BONE JOINT SURG BR, V87B, P2, DOI 10.1302/0301-620X.87B1.15605; Guerado E, 2012, INJURY, V43, pS33, DOI 10.1016/S0020-1383(13)70177-3; Herscovici D, 2010, J ORTHOP TRAUMA, V24, P291, DOI 10.1097/BOT.0b013e3181b1d22a; Hoellen IP, 1997, ORTHOPADE, V26, P348, DOI 10.1007/PL00003390; JUDET R, 1964, J BONE JOINT SURG AM, V46, P1615, DOI 10.2106/00004623-196446080-00001; Kang CS, 2002, ACTA ORTHOP SCAND, V73, P619, DOI 10.1080/000164702321039561; Khoury A, 2012, OPER ORTHOP TRAUMATO, V24, P439, DOI 10.1007/s00064-011-0093-z; Laflamme GY, 2011, INJURY, V42, P1130, DOI 10.1016/j.injury.2010.11.060; LETOURNEL E, 1993, CLIN ORTHOP RELAT R, P62; Letournel E, 1993, FRACTURES ACETABULUM, V2; Marintschev I, 2012, INJURY, V43, P470, DOI 10.1016/j.injury.2011.11.009; Mast J, 1989, PLANNING REDUCTION T; Matta JM, 1996, J BONE JOINT SURG AM, V78A, P1632, DOI 10.2106/00004623-199611000-00002; MATTA JM, 1988, CLIN ORTHOP RELAT R, P83; MAYO KA, 1994, CLIN ORTHOP RELAT R, P31; Mears DC, 2002, J BONE JOINT SURG AM, V84A, P1; Mears DC, 1998, J ARTHROPLASTY, V13, P104, DOI 10.1016/S0883-5403(98)90084-5; Mears DC, 2003, CLIN ORTHOP RELAT R, P173, DOI 10.1097/01.blo.0000043057.62337.3a; Mouhsine E, 2004, J ARTHROPLASTY, V19, P344, DOI 10.1016/j.arth.2003.08.020; Pohlemann T, 1998, UNFALLCHIRURG, V101, P201, DOI 10.1007/s001130050254; Ponsen KJ, 2006, J TRAUMA, V61, P662, DOI 10.1097/01.ta.0000219693.95873.24; Qureshi AA, 2004, J ORTHOP TRAUMA, V18, P175, DOI 10.1097/00005131-200403000-00009; Rosset A, 2004, J DIGIT IMAGING, V17, P205, DOI 10.1007/s10278-004-1014-6; Sagi HC, 2010, J ORTHOP TRAUMA, V24, P263, DOI 10.1097/BOT.0b013e3181dd0b84; Schopfer A, 1993, J Orthop Trauma, V7, P236, DOI 10.1097/00005131-199306000-00007; Tidermark J, 2003, J ORTHOP TRAUMA, V17, P193, DOI 10.1097/00005131-200303000-00007; Tornetta P 3rd, 2001, J Am Acad Orthop Surg, V9, P18; White G, 2013, INJURY, V44, P159, DOI 10.1016/j.injury.2012.10.010	38	29	42	0	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	JAN	2015	46			1			S2	S7		10.1016/S0020-1383(15)70003-3			6	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	AZ3LL	WOS:000348128800002	26528936				2022-03-04	
J	Pasricha, J; Harbarth, S; Koessler, T; Camus, V; Schrenzel, J; Cohen, G; Pittet, D; Perrier, A; Iten, A				Pasricha, Janet; Harbarth, Stephan; Koessler, Thibaud; Camus, Veronique; Schrenzel, Jacques; Cohen, Gilles; Pittet, Didier; Perrier, Arnaud; Iten, Anne			Methicillin-resistant Staphylococcus aureus risk profiling: who are we missing?	ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL			English	Article						Carrier state; Epidemiology; MRSA; Prevalence; Probability; Predictive value of tests; Staphylococcal infection; Switzerland	ACTIVE SURVEILLANCE CULTURES; CARRIAGE; ADMISSION; PREVALENCE; SHEA	Background: Targeted screening of patients at high risk for methicillin-resistant Staphylococcus aureus (MRSA) carriage is an important component of MRSA control programs, which rely on prediction tools to identify those high-risk patients. Most previous risk studies reported a substantial rate of patients who are eligible for screening, but failed to be enrolled. The characteristics of these missed patients are seldom described. We aimed to determine the rate and characteristics of patients who were missed by a MRSA screening programme at our institution to see how the failure to include these patients might impact the accuracy of clinical prediction tools. Findings: From March-June 2010 all patients admitted to 13 internal medicine wards at the University of Geneva Hospital (HUG) were prospectively screened for MRSA carriage. Of 1968 patients admitted to the ward, 267 patients (13.6%) failed to undergo appropriate MRSA screening. Forty-one (2.4%) screened patients were MRSA carriers at admission. On multivariate regression, patients who were missed by screening were more likely to be aged < 50 years (OR 2.4 [1.4-3.9]), transferred to internal medicine from another ward in the hospital (OR 2.8 [1.1-7.1]), and have a history of malignancy (OR 3.2[2.1-5.1]). There was no significant difference in the rate of previous MRSA carriage between screened and unscreened patients. Conclusions: Our findings highlight the potential bias that "missed" patients may introduce into MRSA risk scores. Reporting on the proportions and characteristics of missed patients is essential for accurate interpretation of MRSA prediction tools.	[Pasricha, Janet; Harbarth, Stephan; Camus, Veronique; Pittet, Didier; Iten, Anne] Univ Hosp Geneva, Infect Control Program, CH-1211 Geneva, Switzerland; [Pasricha, Janet; Harbarth, Stephan; Koessler, Thibaud; Camus, Veronique; Schrenzel, Jacques; Cohen, Gilles; Pittet, Didier; Perrier, Arnaud; Iten, Anne] Fac Med, CH-1211 Geneva, Switzerland; [Koessler, Thibaud; Perrier, Arnaud] Univ Hosp Geneva, Dept Gen Internal Med, CH-1211 Geneva, Switzerland; [Schrenzel, Jacques] Univ Hosp Geneva, Cent Lab Bacteriol, CH-1211 Geneva, Switzerland; [Cohen, Gilles] Univ Hosp Geneva, Direct Medicoecon Anal, CH-1211 Geneva, Switzerland		Harbarth, S (corresponding author), Univ Hosp Geneva, Infect Control Program, 4 Rue Gabrielle Perret Gentil, CH-1211 Geneva, Switzerland.	stephan.harbarth@hcuge.ch	Kössler, Thibaud/AAZ-9734-2020; Schrenzel, Jacques/AAC-5685-2021; Schrenzel, Jacques/P-8525-2017	Schrenzel, Jacques/0000-0001-5464-7764; Schrenzel, Jacques/0000-0001-5464-7764	European Community, 6th Framework Programme (MOSAR network) [ISHP-CT-2007-037941]	We would like to extend our thanks to F. Maitre, J. Maurin, and G. Renzi for their help with this study, and Rosemary Sudan for editorial assistance. During this study, research activities on MRSA by SH were supported by the European Community, 6th Framework Programme (MOSAR network contract ISHP-CT-2007-037941).	BOYCE JM, 1983, J INFECT DIS, V148, P763, DOI 10.1093/infdis/148.4.763; Eveillard M, 2002, J HOSP INFECT, V50, P122, DOI 10.1053/jhin.2001.1152; Francois P, 2003, J CLIN MICROBIOL, V41, P254, DOI 10.1128/JCM.41.1.254-260.2003; Furuno JP, 2006, ARCH INTERN MED, V166, P580, DOI 10.1001/archinte.166.5.580; Gastmeier P, 2008, J HOSP INFECT, V70, P11, DOI 10.1016/S0195-6701(08)60005-5; Harbarth S, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2005.04.042; Harbarth S, 2008, J AM COLL SURGEONS, V207, P683, DOI 10.1016/j.jamcollsurg.2008.05.023; Haustein T, 2011, LANCET INFECT DIS, V11, P471, DOI 10.1016/S1473-3099(10)70315-7; Lucet JC, 2003, ARCH INTERN MED, V163, P181, DOI 10.1001/archinte.163.2.181; McGinigle KL, 2008, CLIN INFECT DIS, V46, P1717, DOI 10.1086/587901; Muto CA, 2003, INFECT CONT HOSP EP, V24, P362, DOI 10.1086/502213; Nishikawa M, 2009, ARCH GERONTOL GERIAT, V49, P242, DOI 10.1016/j.archger.2008.08.012; Shitrit P, 2006, INFECT CONT HOSP EP, V27, P1004, DOI 10.1086/507914; Weber SG, 2007, INFECT CONT HOSP EP, V28, P249, DOI 10.1086/512261	14	6	7	0	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2047-2994			ANTIMICROB RESIST IN	Antimicrob. Resist. Infect. Control		2013	2								17	10.1186/2047-2994-2-17			4	Public, Environmental & Occupational Health; Infectious Diseases; Microbiology; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Infectious Diseases; Microbiology; Pharmacology & Pharmacy	V41MQ	WOS:000209550700016	23721630	gold, Green Published			2022-03-04	
J	Menetrey, J; Laumonier, T; Garavaglia, G; Hoffmeyer, P; Fritschy, D; Gabbiani, G; Bochaton-Piallat, ML				Menetrey, Jacques; Laumonier, Thomas; Garavaglia, Guido; Hoffmeyer, Pierre; Fritschy, Daniel; Gabbiani, Giulio; Bochaton-Piallat, Marie-Luce			alpha-Smooth muscle actin and TGF-beta receptor I expression in the healing rabbit medial collateral and anterior cruciate ligaments	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Ligament injury; Ligament healing; Myofibroblasts; Rabbit	TRANSFORMING GROWTH-FACTOR-BETA-1; INTRINSIC-PROPERTIES; TISSUE-REPAIR; CELLS; INJURY; TENDON; KNEE; MYOFIBROBLASTS; MULTIDISCIPLINARY; DIFFERENTIATION	The aim of our study was to advance the knowledge about the biological differences in the healing of the anterior cruciate ligament (ACL) versus the medial collateral ligament (MCL). We quantified alpha-smooth muscle actin (alpha-SMA) expression and TGF-beta receptor I (TGF-beta RI) expression in experimentally injured rabbit ligaments (from day 3 to 12 weeks post-injury). Myofibroblasts (alpha-SMA positive cells) were identified as early as the third day post-injury in MCL and their density increased steadily up to day 21. Myofibroblasts were also detected in injured ACL but their density remained very low at all time points. The percentage of positive TGF-beta RI area significantly increased in both injured ligaments compared to controls, with a peak expression at day 21; however, it remained constantly lower in ACL compared to MCL. A significant correlation was found between the percentage of TGF-beta RI positive cells and the percentage of alpha-SMA expression only in injured MCL. These results provide evidence that myofibroblasts are important players in MCL remodelling after injury. The combined presence of myofibroblasts and TGF-beta RI in the first 3 weeks post-MCL injury may partially explain the difference in the MCL and ACL healing process. (C) 2010 Elsevier Ltd. All rights reserved.	[Menetrey, Jacques; Laumonier, Thomas; Garavaglia, Guido; Hoffmeyer, Pierre; Fritschy, Daniel] Univ Geneva, Orthopaed Surg Serv, Univ Hosp Geneva, CH-1211 Geneva 14, Switzerland; [Gabbiani, Giulio; Bochaton-Piallat, Marie-Luce] Univ Geneva, Fac Med, Dept Pathol & Immunol, CH-1211 Geneva 14, Switzerland		Menetrey, J (corresponding author), Univ Geneva, Orthopaed Surg Serv, Univ Hosp Geneva, 4 Rue Gabrielle Perret Gentil, CH-1211 Geneva 14, Switzerland.	jacques.menetrey@hcuge.ch	Menetrey, Jacques/AAX-1151-2020; Hoffmeyer, Pierre/X-4491-2019; Laumonier, Thomas/AAA-4656-2019; hoffmeyer, pierre/AAY-1392-2021	Laumonier, Thomas/0000-0002-8662-2972; Hoffmeyer, Pierre/0000-0001-9736-828X	Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission [32-116595/1]	This study was supported by the Swiss National Science Foundation (Grant No. #32-116595/1). The authors would like to thank Stephanie Coutant-Zimmerli, Philippe Henchoz and Manuel Jorge for their technical assistance.	AMIEL D, 1995, MED SCI SPORT EXER, V27, P844; BARLOW Y, 1992, BRIT MED BULL, V48, P698, DOI 10.1093/oxfordjournals.bmb.a072572; Bray RC, 2003, J ORTHOP RES, V21, P1118, DOI 10.1016/S0736-0266(03)00078-0; Bray RC, 2002, J ORTHOPAED RES, V20, P984, DOI 10.1016/S0736-0266(02)00012-8; DARBY I, 1990, LAB INVEST, V63, P21; ELLISON AE, 1985, ORTHOP CLIN N AM, V16, P3; Faryniarz DA, 1996, J ORTHOP RES, V14, P228, DOI 10.1002/jor.1100140210; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Frank, 1996, J Am Acad Orthop Surg, V4, P74; FRANK C, 1983, AM J SPORT MED, V11, P379, DOI 10.1177/036354658301100602; FRANK C, 1983, ACTA ORTHOP SCAND, V54, P917, DOI 10.3109/17453678308992934; FRANK C, 1983, Journal of Orthopaedic Research, V1, P179, DOI 10.1002/jor.1100010209; Hao H, 2006, ARTERIOSCL THROM VAS, V26, P326, DOI 10.1161/01.ATV.0000199393.74656.4c; Hinz B, 2001, MOL BIOL CELL, V12, P2730, DOI 10.1091/mbc.12.9.2730; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; INOUE M, 1990, CONNECT TISSUE RES, V25, P13, DOI 10.3109/03008209009009809; IPPOLITO E, 1980, J BONE JOINT SURG AM, V62, P583, DOI 10.2106/00004623-198062040-00014; IPPOLITO E, 1977, CLIN ORTHOP RELAT R, P282; Kanaya A, 2007, ARTHROSCOPY, V23, P610, DOI 10.1016/j.arthro.2007.01.013; Le Graverand MPH, 2000, MATRIX BIOL, V19, P431, DOI 10.1016/S0945-053X(00)00093-7; Murray MM, 2007, J ORTHOP RES, V25, P1007, DOI 10.1002/jor.20367; Murray MM, 1999, J ORTHOP RES, V17, P18, DOI 10.1002/jor.1100170105; Murray MM, 2000, J BONE JOINT SURG AM, V82A, P1387, DOI 10.2106/00004623-200010000-00004; NAGINENI CN, 1992, J ORTHOP RES, V10, P465, DOI 10.1002/jor.1100100402; POSTACCHINI F, 1977, EXPERIENTIA, V33, P957, DOI 10.1007/BF01951303; ROBERTS AB, 1986, P NATL ACAD SCI USA, V83, P4167, DOI 10.1073/pnas.83.12.4167; RONNOVJESSEN L, 1993, LAB INVEST, V68, P696; SKALLI O, 1986, J CELL BIOL, V103, P2787, DOI 10.1083/jcb.103.6.2787; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Vaughan MB, 2000, EXP CELL RES, V257, P180, DOI 10.1006/excr.2000.4869; WALLACE CD, 1991, J ORTHOP RES, V9, P787, DOI 10.1002/jor.1100090603; Weiler A, 2002, J ORTHOPAED RES, V20, P310, DOI 10.1016/S0736-0266(01)00109-7; WEISS JA, 1991, J ORTHOPAED RES, V9, P516, DOI 10.1002/jor.1100090407; Woo S L, 2000, J Am Acad Orthop Surg, V8, P364; WOO SLY, 1987, AM J SPORT MED, V15, P22, DOI 10.1177/036354658701500104; Woo SLY, 2006, J BIOMECH, V39, P1, DOI 10.1016/j.jbiomech.2004.10.025; Yoshida M, 1999, J Orthop Sci, V4, P293, DOI 10.1007/s007760050106; Zhou D, 2005, J ORTHOP RES, V23, P949, DOI 10.1016/j.orthres.2005.01.022	38	14	16	0	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383			INJURY	Injury-Int. J. Care Inj.	AUG	2011	42	8					735	741		10.1016/j.injury.2010.07.246			7	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	786DS	WOS:000292284100003	20800229				2022-03-04	
J	Peters, A; Palomo, R; Pittet, D				Peters, Alexandra; Palomo, Rafael; Pittet, Didier			The great nursing brain drain and its effects on patient safety	ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL			English	Editorial Material						Infection prevention and control; Infection control; Hand hygiene; Nurses; Midwives; World Health Organization		The World Health Organization (WHO) has declared 2020 the "Year of the Nurse and Midwife". On May 5th of this year, for the annual celebration of the SAVE LIVES: Clean Your Hands campaign, the WHO will focus on the critical role of nurses and midwives in promoting public health. The brain drain of healthcare workers (HCWs) leads to unequal distribution of nurses and midwives around the world, which affects the quality of care provided to patients. This phenomenon should be addressed as a global problem as it highlights staff shortages in the health system.	[Peters, Alexandra; Pittet, Didier] Univ Geneva Hosp & Fac Med, Infect Control Programme, Geneva, Switzerland; [Palomo, Rafael] Univ Geneva, Geneva, Switzerland		Pittet, D (corresponding author), Univ Geneva Hosp & Fac Med, Infect Control Programme, Geneva, Switzerland.	didier.pittet@hcuge.ch			WHO, Geneva, SwitzerlandWorld Health Organization; Infection Control Program, University of Geneva Hospitals and Faculty of Medicine, Geneva, Switzerland; Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission [32003B_163262]	This work is supported by WHO, Geneva, Switzerland, and the Infection Control Program, University of Geneva Hospitals and Faculty of Medicine, Geneva, Switzerland; hand hygiene research activities at the SPCI/WCC are also supported by the Swiss National Science Foundation (grant number 32003B_163262). Potential conflicts of interest.	Carayon P., 2008, NURSING WORKLOAD PAT; Kollar Eszter, 2013, Swiss Med Wkly, V143, pw13845, DOI 10.4414/smw.2013.13845; Lang TA, 2004, J NURS ADMIN, V34, P326, DOI 10.1097/00005110-200407000-00005; OECD, INT MIGR HLTH WORK; WHO, WHO HLTH WORKF REQ U	5	2	2	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2047-2994			ANTIMICROB RESIST IN	Antimicrob. Resist. Infect. Control	APR 30	2020	9	1							57	10.1186/s13756-020-00719-4			3	Public, Environmental & Occupational Health; Infectious Diseases; Microbiology; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Infectious Diseases; Microbiology; Pharmacology & Pharmacy	LK0GJ	WOS:000530536500001	32354346	gold, Green Published			2022-03-04	
J	Vaudaux, P; Lew, DP				Vaudaux, Pierre; Lew, Daniel P.			Tolerance of staphylococci to bactericidal antibiotics	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						staphylococci; Staphylococcus aureus; bactericidal antibiotics; tolerance; implant-associated infections; rat model	FOREIGN-BODY INFECTION; AUREUS; FIBRONECTIN; SUSCEPTIBILITY; PROPHYLAXIS; RESISTANCE; VANCOMYCIN; THERAPY; MODEL	Antibiotic therapy for deep-seated staphylococcal infections, especially when they are associated with artificial devices used for orthopedic surgery is often associated with failure. Standard anti-staphylococcal bactericidal antibiotics, such as semi-synthetic penicillins, cephalosporins, or glycopeptides, are effective when given prophylactically in clinical conditions or experimental trials of implant-related infections. However, the efficacy of all anti-staphylococcal agents is seriously diminished on already established implant-related deep-seated infections, which then frequently require surgical implant removal to obtain a cure. The failure of antibiotic therapy to cure established staphylococcal foreign-body infections may arise in part from a broad-spectrum phenotypic tolerance expressed in vivo to different classes of antimicrobial agents. The molecular and physiological mechanisms of this in vivo tolerance remain poorly understood.	Univ Klinikum Genf, HUG, Abt Infect Krankheiten, CH-1211 Geneva 14, Switzerland		Vaudaux, P (corresponding author), Univ Klinikum Genf, HUG, Abt Infect Krankheiten, 24 Rue Micheli du Crest, CH-1211 Geneva 14, Switzerland.	pierre.vaudaux@hcuge.ch					Bernard L, 2004, J ANTIMICROB CHEMOTH, V53, P127, DOI 10.1093/jac/dkh033; CAGNI A, 1995, ANTIMICROB AGENTS CH, V39, P1655, DOI 10.1128/AAC.39.8.1655; CHUARD C, 1993, ANTIMICROB AGENTS CH, V37, P625, DOI 10.1128/AAC.37.4.625; CHUARD C, 1991, J INFECT DIS, V163, P1369; Chuard C, 1997, J ANTIMICROB CHEMOTH, V39, P603, DOI 10.1093/jac/39.5.603; CHUARD C, 1991, ANTIMICROB AGENTS CH, V35, P2611, DOI 10.1128/AAC.35.12.2611; Fischer B, 1996, J ORTHOPAED RES, V14, P914, DOI 10.1002/jor.1100140611; Fux CA, 2005, TRENDS MICROBIOL, V13, P34, DOI 10.1016/j.tim.2004.11.010; Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x; Keel M, 2005, INJURY, V36, P691, DOI 10.1016/j.injury.2004.12.037; Lew DP, 2004, LANCET, V364, P369, DOI 10.1016/S0140-6736(04)16727-5; Lowy FD, 2003, J CLIN INVEST, V111, P1265, DOI [10.1172/JC1200318535, 10.1172/JCI200318535]; LUCET JC, 1990, ANTIMICROB AGENTS CH, V34, P2312, DOI 10.1128/AAC.34.12.2312; PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101; SCHAAD HJ, 1994, J ANTIMICROB CHEMOTH, V33, P1191, DOI 10.1093/jac/33.6.1191; SCHAAD HJ, 1994, ANTIMICROB AGENTS CH, V38, P1703, DOI 10.1128/AAC.38.8.1703; VAUDAUX P, 1981, J ANTIMICROB CHEMOTH, V8, P17, DOI 10.1093/jac/8.suppl_A.17; Vaudaux P, 1998, DRUG RESIST UPDATE, V1, P352, DOI 10.1016/S1368-7646(98)80011-3; VAUDAUX P, 1992, J INFECT DIS, V166, P58, DOI 10.1093/infdis/166.1.58; VAUDAUX P, 2000, HDB BACTERIAL ADHESI, P397; Vaudaux P., 2000, INFECT ASS INDWELLIN, P1; Waldvogel F., 2000, INFECT ASS INDWELLIN; ZIMMERLI W, 1982, J INFECT DIS, V146, P487, DOI 10.1093/infdis/146.4.487	23	6	6	0	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	MAY	2006	37			2			15	19		10.1016/j.injury.2006.04.004			5	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	063JX	WOS:000239015600003					2022-03-04	
J	Stern, R				Stern, Richard			Are there advances in the treatment of extracapsular hip fractures in the elderly? (vol 38, pg S77, 2007)	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Correction									[Stern, Richard] Univ Hosp Geneva, Orthopaed Surg Serv, Geneva, Switzerland		Stern, R (corresponding author), Univ Hosp Geneva, Orthopaed Surg Serv, Geneva, Switzerland.	richard.stern@hcuge.ch					Stern R, 2007, INJURY, V38, P77, DOI 10.1016/j.injury.2007.08.015	1	2	2	0	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	JAN	2008	39	1					140	140		10.1016/j.injury.2007.09.015			1	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	264GE	WOS:000253274700024					2022-03-04	
J	Brugger, U; Ruckstuhl, A; Horisberger, B; Gratwohl, A				Bruegger, Urs; Ruckstuhl, Andreas; Horisberger, Bruno; Gratwohl, Alois			DEVELOPMENT OF COVERAGE WITH EVIDENCE DEVELOPMENT FOR MEDICAL TECHNOLOGIES IN SWITZERLAND FROM 1996 TO 2012	INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE			English	Article						Decision making; Evidence-based health care; Health technology assessment; Conditional coverage; Coverage with evidence development	STEM-CELL TRANSPLANTATION; ACCESS	Objectives: The aim of this study was to assess incidence, time frame, and outcome of "Coverage with Evidence Development" (CED) decisions in the Swiss Basic Health Insurance scheme. Methods: Analysis of all controversial medical technologies submitted to review by the Swiss Federal Office of Public Health (FOPH) from 1996 to 2012 with focus on decisions with constraints. Description of types of technology, type of initial decision, duration of evaluation period, final decision, and search for potential factors associated with changes over time. Results: Forty-five (37.5 percent) of 120 controversial health technologies were classified as "yes, in evaluation, reimbursed" for a certain period of time and thirty-five (29.2 percent) as "no, in evaluation, not reimbursed" by the Federal Department of Home Affairs from 1996 to 2012. The rate of CED decisions ranged between zero and nine per year and was influenced by type of technology and calendar year. Forty-four of forty-five decisions were subject to further restrictions, to a "center or a specialist" (76 percent), "indications" (49 percent), "registry" (31 percent), or "other" (49 percent). The time to a final decision ranged from 1.5 to 11 years (median, 6 years). No factors associated with initial decision and final outcome could be identified. Conclusions: CED as a reality in Switzerland might have enabled patients to obtain access to promising technologies early in their life cycle. CED might have acted as a trigger to a successful implementation of a comprehensive national registry. The lack of qualitative data stresses the urgent need for evaluation of the HTA decisions and their impact on patient outcome and costs.	[Bruegger, Urs; Ruckstuhl, Andreas] Zurich Univ Appl Sci, Winterthur, Switzerland; [Horisberger, Bruno; Gratwohl, Alois] Univ Basel, Fac Med, Basel, Switzerland		Brugger, U (corresponding author), Zurich Univ Appl Sci, Winterthur, Switzerland.	brgu@zhaw.ch; rkst@zhaw.ch; horisbruno5@bluewin.ch; alois.gratwohl@unibas.ch			Bangerter Foundation	The study was in part supported by a grant of the Bangerter Foundation.	Aghayev E, 2010, EUR SPINE J, V19, P2190, DOI 10.1007/s00586-010-1550-3; Agresti, 2007, INTRO CATEGORICAL DA; Diel P, 2010, SPINE J, V10, P961, DOI 10.1016/j.spinee.2009.08.452; Gooley TA, 1999, STAT MED, V18, P695, DOI 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O; Gratwohl A, 2011, J CLIN ONCOL, V29, P1980, DOI 10.1200/JCO.2010.30.4121; Gratwohl A, 2010, JAMA-J AM MED ASSOC, V303, P1617, DOI 10.1001/jama.2010.491; Ljungman P, 2010, BONE MARROW TRANSPL, V45, P219, DOI 10.1038/bmt.2009.141; Menon D, 2010, PHARMACOECONOMICS, V28, P109, DOI 10.2165/11530860-000000000-00000; Mohr PE, 2010, PHARMACOECONOMICS, V28, P153, DOI 10.2165/11531050-000000000-00000; Passweg J, 2010, SWISS MED WKLY, V140, P326, DOI smw-12978; Passweg JR, 2013, SWISS MED W IN PRESS; R Development Core Team, 2011, R LANG ENV STAT COMP; Roder C, 2005, EUR SPINE J, V14, P920, DOI 10.1007/s00586-005-1023-2; Schluessmann E, 2010, SPINE, V35, P1397, DOI 10.1097/BRS.0b013e3181e0e871; Stafinski T, 2010, PHARMACOECONOMICS, V28, P113, DOI 10.2165/11530820-000000000-00000; Swiss Federal Office of Public Health (FOPH), 2008, HDB ANTR KOST BEI NE; Swiss Federal Office of Public Health (FOPH), 2009, ANTR KOST DURCH OBL; Swiss Federal Office Of Social Security, 1998, MAN STAND CLIN EC EV; Tunis SR, 2006, HEALTH AFFAIR, V25, P1218, DOI 10.1377/hlthaff.25.5.1218	19	5	6	0	2	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0266-4623	1471-6348		INT J TECHNOL ASSESS	Int. J. Technol. Assess. Health Care	JUL	2014	30	3					253	259		10.1017/S0266462314000233			7	Health Care Sciences & Services; Public, Environmental & Occupational Health; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services; Public, Environmental & Occupational Health; Medical Informatics	AR9CE	WOS:000343868000005	25100035	Green Accepted, Green Submitted, Green Published, hybrid			2022-03-04	
J	Kucinska, M; Murias, M; Nowak-Sliwinska, P				Kucinska, Malgorzata; Murias, Marek; Nowak-Sliwinska, Patrycja			Beyond mouse cancer models: Three-dimensional human-relevant in vitro and non-mammalian in vivo models for photodynamic therapy	MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH			English	Review						3D cell culture model; Non-mammalian model; Photodynamic therapy; Drug discovery; Cancer research	CHICK CHORIOALLANTOIC MEMBRANE; 3D CELL-CULTURE; TRANSEPITHELIAL CALCIUM-TRANSPORT; DROSOPHILA-MELANOGASTER; DRUG DISCOVERY; XENOPUS-LAEVIS; CAENORHABDITIS-ELEGANS; MICROFLUIDIC PLATFORM; TUMOR SPHEROIDS; TISSUE-CULTURE	The proper design of experiments is a critical step for each study in order to obtain reproducible and reliable data. Taking into account constant competitiveness in the quickly developing biomedical sciences and the availability of sophisticated techniques, the choice and establishment of an experimental model system are essential for a successful research project. Currently, various sophisticated in vitro and in vivo models are being designed and developed in order to replace the use of mammalian models to investigate the mechanisms of action, activity and properties of novel compounds or treatment modalities. After the clinical success of photodynamic therapy (PDT) used against neovascular eye disorders, clinically approved PDT protocols for cancer are still being developed. Since several aspects of PDT should be examined, it is crucial to define the possible models that would guide the principle of the 3Rs (Reduction, Refinement, Replacement) practice, which is known as the fundamental strategy for designing more ethical animal studies. This review is focused on the usefulness of alternative in vivo as well as in vitro models to study important aspects of PDT, especially in the context of cancer research. 3D human-relevant cell culture models, followed by non-mammalian models such as the nematode (Caenorhabditis elegans), fly (Drosophila melanogaster), zebrafish (Danio rerio), frog (Xenopus laevis), or chicken chorioallantoic membrane (Gallus gallus), are discussed as an alternative to the widely used but ethically controversial mammalian models. (C) 2016 Elsevier B.V. All rights reserved.	[Kucinska, Malgorzata; Murias, Marek] Poznan Univ Med Sci, Dept Toxicol, Poznan, Poland; [Nowak-Sliwinska, Patrycja] Univ Geneva UNIGE, Sch Pharmaceut Sci, Geneva, Switzerland		Murias, M (corresponding author), Poznan Univ Med Sci, Dept Toxicol, Poznan, Poland.; Nowak-Sliwinska, P (corresponding author), Univ Geneva UNIGE, Sch Pharmaceut Sci, Geneva, Switzerland.	marek.murias@ump.edu.pl; patrycja.nowak-sliwinska@unige.ch	Murias, Marek/A-3776-2015; Nowak-Sliwinska, Patrycja/T-7663-2018	Murias, Marek/0000-0002-2903-4912; Nowak-Sliwinska, Patrycja/0000-0002-8299-0444; , Malgorzata/0000-0002-3606-3623	Polish National Science Centre [UMO-2014/15/B/NZ5/01488]; Union for International Cancer Control [ICR/2015/328429]	The authors acknowledge financial support obtained from the Polish National Science Centre, grant number: UMO-2014/15/B/NZ5/01488 and thank to theUnion for International Cancer Control for UICC Fellowship Number ICR/2015/328429, granted to M.K.	Abaci HE, 2015, LAB CHIP, V15, P882, DOI 10.1039/c4lc00999a; Abedini F, 2012, INT J NANOMED, V7, P4159, DOI [10.2147/IJN.S29823, 10.2147/IJN.S30434]; Abu-Yousif Adnan O, 2009, J Vis Exp, DOI 10.3791/1692; Achilli TM, 2012, EXPERT OPIN BIOL TH, V12, P1347, DOI 10.1517/14712598.2012.707181; AKINS RE, 1993, J CELL SCI, V105, P369; AKINS RE, 1993, J CELL SCI, V105, P381; Akiyama N, 2013, INT J NANOMED, V8, P2629, DOI 10.2147/IJN.S47279; Alemany-Ribes M, 2014, ADV DRUG DELIVER REV, V79-80, P40, DOI 10.1016/j.addr.2014.06.004; Alemany-Ribes M, 2013, TISSUE ENG PT A, V19, P1665, DOI [10.1089/ten.tea.2012.0661, 10.1089/ten.TEA.2012.0661]; Ali S, 2011, BIRTH DEFECTS RES C, V93, P115, DOI 10.1002/bdrc.20206; Anderson CMH, 2010, J PHARMACOL EXP THER, V332, P220, DOI 10.1124/jpet.109.159822; Antoni D, 2015, INT J MOL SCI, V16, P5517, DOI 10.3390/ijms16035517; Asghar W, 2015, MATER TODAY, V18, P539, DOI 10.1016/j.mattod.2015.05.002; Azzouzi AR, 2013, BJU INT, V112, P766, DOI 10.1111/bju.12265; Bae Y. K., 2012, PLOS ONE, V7; Bal U, 2013, MICROSC MICROANAL, V19, P201, DOI 10.1017/S1431927612014080; Barbugli PA, 2015, EXP DERMATOL, V24, P970, DOI 10.1111/exd.12815; Barriuso J, 2015, CLIN CANCER RES, V21, P969, DOI 10.1158/1078-0432.CCR-14-2921; Benayoun L, 2013, CANCER BIOL THER, V14, P64, DOI 10.4161/cbt.22630; Benton G, 2014, ADV DRUG DELIVER REV, V79-80, P3, DOI 10.1016/j.addr.2014.06.005; Berghmans S, 2005, BIOTECHNIQUES, V39, P227, DOI 10.2144/05392RV02; Bersini S, 2014, BIOMATERIALS, V35, P2454, DOI 10.1016/j.biomaterials.2013.11.050; Bhattacharya D, 2015, DEV BIOL, V408, P196, DOI 10.1016/j.ydbio.2015.11.003; Bhuvaneswari R, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-56; Bianchi J.I., 2015, PLOS ONE, V10; Bigelow CE, 2001, BRIT J CANCER, V85, P727, DOI 10.1054/bjoc.2001.1977; Bischel LL, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1007-5; Bjork JK, 2016, ONCOGENE, V35, P1770, DOI 10.1038/onc.2015.241; Blackburn JS, 2011, NAT PROTOC, V6, P229, DOI 10.1038/nprot.2010.170; Blitz IL, 2006, SEMIN CELL DEV BIOL, V17, P133, DOI 10.1016/j.semcdb.2005.11.002; Blythe SA, 2009, DEV DYNAM, V238, P1422, DOI 10.1002/dvdy.21931; Boyd WA, 2010, TOXICOL APPL PHARM, V245, P153, DOI 10.1016/j.taap.2010.02.014; Boyd WA, 2010, NEUROTOXICOL TERATOL, V32, P68, DOI 10.1016/j.ntt.2008.12.004; Bray LJ, 2015, BIOMATERIALS, V53, P609, DOI 10.1016/j.biomaterials.2015.02.124; Breslin S, 2013, DRUG DISCOV TODAY, V18, P240, DOI 10.1016/j.drudis.2012.10.003; Bruce A., 2015, PLOS ONE, V10; Bulina ME, 2006, NAT BIOTECHNOL, V24, P95, DOI 10.1038/nbt1175; Burch, 1959, PRINCIPLES HUMANE EX; Burden N, 2015, TOXICOLOGY, V330, P62, DOI 10.1016/j.tox.2015.01.014; Bussard KM, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0740-2; Caesar L, 2015, PHOTODIAGN PHOTODYN, V12, P414, DOI 10.1016/j.pdpdt.2015.06.001; Caliari SR, 2016, NAT METHODS, V13, P405, DOI 10.1038/nmeth.3839; Casas A, 2011, CURR MED CHEM, V18, P2486, DOI 10.2174/092986711795843272; Cassereau L, 2015, J BIOTECHNOL, V193, P66, DOI 10.1016/j.jbiotec.2014.11.008; Celli JP, 2014, SCI REP-UK, V4, DOI 10.1038/srep03751; Celli JP, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3483903; Celli JP, 2010, CHEM REV, V110, P2795, DOI 10.1021/cr900300p; Chakraborty C, 2009, CURR DRUG METAB, V10, P116, DOI 10.2174/138920009787522197; Chambers KF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111029; Chang CJ, 2007, PHOTODIAGN PHOTODYN, V4, P95, DOI 10.1016/j.pdpdt.2007.03.003; Chang SF, 2008, P NATL ACAD SCI USA, V105, P3927, DOI 10.1073/pnas.0712353105; Charpentier G, 2014, ENVIRON SCI TECHNOL, V48, P4096, DOI 10.1021/es405331c; Chatzinikolaidou M., 2016, DRUG DISCOV TODAY; Chen B, 2005, INT J RADIAT ONCOL, V61, P1216, DOI 10.1016/j.ijrobp.2004.08.006; Chen YT, 2015, SCI REP-UK, V5, DOI 10.1038/srep12893; Chi MY, 2015, BIOMED MICRODEVICES, V17, DOI 10.1007/s10544-015-9966-5; Chin William W. L., 2007, BMC Pharmacology, V7, P15, DOI 10.1186/1471-2210-7-15; Chin WWL, 2007, CANCER LETT, V245, P127, DOI 10.1016/j.canlet.2005.12.041; Chin Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097894; Choi SH, 2014, NATURE, V515, P274, DOI 10.1038/nature13800; Chung S, 2009, LAB CHIP, V9, P269, DOI 10.1039/b807585a; Corsi AK, 2006, ANAL BIOCHEM, V359, P1, DOI 10.1016/j.ab.2006.07.033; Coutier S, 2001, PHOTOCHEM PHOTOBIOL, V73, P297, DOI 10.1562/0031-8655(2001)073<0297:EOFROC>2.0.CO;2; Coviello T, 2007, J CONTROL RELEASE, V119, P5, DOI 10.1016/j.jconrel.2007.01.004; Dai YJ, 2014, ENVIRON TOXICOL CHEM, V33, P11, DOI 10.1002/etc.2406; Daquinag AC, 2013, TISSUE ENG PART C-ME, V19, P336, DOI [10.1089/ten.tec.2012.0198, 10.1089/ten.TEC.2012.0198]; Datar A, 2015, BIOSENSORS-BASEL, V5, P647, DOI 10.3390/bios5040647; de Freitas LM, 2014, J PHOTOCH PHOTOBIO B, V140, P365, DOI 10.1016/j.jphotobiol.2014.08.021; de Groot TE, 2016, LAB CHIP, V16, P334, DOI 10.1039/c5lc01353d; de la Puente P, 2014, EXP CELL RES, V322, P1, DOI 10.1016/j.yexcr.2013.12.017; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Deng H, 2013, DYES PIGMENTS, V99, P930, DOI 10.1016/j.dyepig.2013.06.037; Deng XZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127862; Di Corato R, 2015, ACS NANO, V9, P2904, DOI 10.1021/nn506949t; Drabsch Y, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3573; Duchi S, 2016, NANOMED-NANOTECHNOL, V12, P1885, DOI 10.1016/j.nano.2016.04.014; Dwyer AR, 2016, J BIOL METHODS, V3; Edholm ES, 2013, RESOURCES-BASEL, V2, P167, DOI 10.3390/resources2030167; Edmondson R, 2014, ASSAY DRUG DEV TECHN, V12, P207, DOI 10.1089/adt.2014.573; Evans CL, 2015, FRONT PHYS, V3, DOI 10.3389/fphy.2015.00015; Evans CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023434; Everaert N, 2011, RESP PHYSIOL NEUROBI, V178, P118, DOI 10.1016/j.resp.2011.04.023; Feinbaum RL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002813; Fennema E, 2013, TRENDS BIOTECHNOL, V31, P108, DOI 10.1016/j.tibtech.2012.12.003; Ferdowsian HR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024059; Ferrario A, 2005, CANCER RES, V65, P9473, DOI 10.1158/0008-5472.CAN-05-1659; Ferrario A, 2004, CANCER RES, V64, P2328, DOI 10.1158/0008-5472.CAN-04-0071; Fessart D, 2013, EUR RESPIR J, V42, P1345, DOI 10.1183/09031936.00118812; Festing S, 2007, EMBO REP, V8, P526, DOI 10.1038/sj.embor.7400993; Finlay JC, 2004, PHYS MED BIOL, V49, P4837, DOI 10.1088/0031-9155/49/21/001; Flecknell P, 2002, ALTEX-ALTERN TIEREXP, V19, P73; FOSTER TH, 1993, CANCER RES, V53, P1249; Frey O, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5250; Friberg EG, 2003, CANCER LETT, V195, P73, DOI 10.1016/S0304-3835(03)00150-2; Gaio E., 2016, J PHOTOCH B IN PRESS; Garcia-Alcover I, 2014, DIS MODEL MECH, V7, P1297, DOI 10.1242/dmm.016592; Ghosh S, 2016, CELL PROLIFERAT, V49, P134, DOI 10.1111/cpr.12234; Giannaccini M, 2014, NANOMED-NANOTECHNOL, V10, P703, DOI 10.1016/j.nano.2013.09.010; Glidden MD, 2012, THERANOSTICS, V2, P827, DOI 10.7150/thno.4334; Gong X., 2015, PLOS ONE, V10; Guenette SA, 2007, VET ANAESTH ANALG, V34, P164, DOI 10.1111/j.1467-2995.2006.00316.x; Haisler WL, 2013, NAT PROTOC, V8, P1940, DOI 10.1038/nprot.2013.125; Haldi Maryann, 2006, Angiogenesis, V9, P139, DOI 10.1007/s10456-006-9040-2; Halldorsson S, 2015, BIOSENS BIOELECTRON, V63, P218, DOI 10.1016/j.bios.2014.07.029; Hammer-Wilson MJ, 1999, J PHOTOCH PHOTOBIO B, V53, P44, DOI 10.1016/S1011-1344(99)00124-4; Hardwick LJA, 2015, DEV BIOL, V408, P180, DOI 10.1016/j.ydbio.2015.02.003; Harland RM, 2011, TRENDS GENET, V27, P507, DOI 10.1016/j.tig.2011.08.003; Hauser CAE, 2010, CHEM SOC REV, V39, P2780, DOI 10.1039/b921448h; Hayashi S, 2014, DEV BIOL, V396, P31, DOI 10.1016/j.ydbio.2014.09.018; He J, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/41/415101; He YM, 2012, INT J MED SCI, V9, P627, DOI 10.7150/ijms.4865; Heckenkamp J, 2004, EUR J VASC ENDOVASC, V28, P651, DOI 10.1016/j.ejvs.2004.08.013; Hempstead J, 2015, SCI REP-UK, V5, DOI 10.1038/srep10093; Herroon MK, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00084; Hickman JA, 2014, BIOTECHNOL J, V9, P1115, DOI 10.1002/biot.201300492; Hirotsu T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118699; Horie M, 2015, JOVE-J VIS EXP, DOI 10.3791/52469; Huang CP, 2009, LAB CHIP, V9, P1740, DOI 10.1039/b818401a; Huggett MT, 2014, BRIT J CANCER, V110, P1698, DOI 10.1038/bjc.2014.95; Huh D, 2010, SCIENCE, V328, P1662, DOI 10.1126/science.1188302; Hussain A, 2013, BIOTECHNOL BIOENG, V110, P637, DOI 10.1002/bit.24727; Huygens A, 2003, PHOTOCHEM PHOTOBIOL, V78, P607, DOI 10.1562/0031-8655(2003)078<0607:AAPOHA>2.0.CO;2; Ichikawa K, 2004, CANCER LETT, V205, P39, DOI 10.1016/j.canlet.2003.10.001; Ichikawa Y, 2014, ANGEW CHEM INT EDIT, V53, P6772, DOI 10.1002/anie.201403221; Illiano P., 2016, EUR J NEUROSCI; Ito S, 2014, BIOCHEM BIOPH RES CO, V451, P548, DOI 10.1016/j.bbrc.2014.08.015; Jager T, 2014, ENVIRON SCI TECHNOL, V48, P7026, DOI 10.1021/es501306t; Jamieson LE, 2015, ANALYST, V140, P3910, DOI 10.1039/c5an00524h; Jang KJ, 2010, LAB CHIP, V10, P36, DOI 10.1039/b907515a; Jastrzebska E, 2016, BIOMICROFLUIDICS, V10, DOI 10.1063/1.4941681; Jedrych E, 2011, BIOMICROFLUIDICS, V5, DOI 10.1063/1.3658842; Jedrych E, 2011, ANAL CHIM ACTA, V683, P149, DOI 10.1016/j.aca.2010.10.005; Jewhurst Kyle, 2014, J Cell Death, V7, P25, DOI 10.4137/JCD.S18368; Jiang KQ, 2016, RSC ADV, V6, P26863, DOI 10.1039/c6ra05691a; Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858; Junttila MR, 2013, NATURE, V501, P346, DOI 10.1038/nature12626; Kaletta T, 2006, NAT REV DRUG DISCOV, V5, P387, DOI 10.1038/nrd2031; Katt ME, 2016, FRONT BIOENG BIOTECH, V4, DOI 10.3389/fbioe.2016.00012; Kenny HA, 2007, INT J CANCER, V121, P1463, DOI 10.1002/ijc.22874; Kenny HA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7220; Kenny HA, 2014, J CLIN INVEST, V124, P4614, DOI 10.1172/JCI74778; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Kim H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039556; King EG, 2014, GENETICS, V198, P31, DOI 10.1534/genetics.114.161968; Kirienko NV, 2010, DEV DYNAM, V239, P1413, DOI 10.1002/dvdy.22247; Klemm F, 2015, TRENDS CELL BIOL, V25, P198, DOI 10.1016/j.tcb.2014.11.006; Klingenberg M, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-339; Klueh U, 2003, J BIOMED MATER RES A, V67A, P838, DOI 10.1002/jbm.a.10059; Knight Eleanor, 2015, J Anat, V227, P746, DOI 10.1111/joa.12257; Konantz M, 2012, ANN NY ACAD SCI, V1266, P124, DOI 10.1111/j.1749-6632.2012.06575.x; Kong Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137432; Kue CS, 2015, EXP ANIM TOKYO, V64, P129, DOI 10.1538/expanim.14-0059; Kuzyniak W., 2015, PHOTODIAGN PHOTODYN; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Lee SLC, 2009, P NATL ACAD SCI USA, V106, P19485, DOI 10.1073/pnas.0909228106; Lei Y, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-21; Leung MCK, 2008, TOXICOL SCI, V106, P5, DOI 10.1093/toxsci/kfn121; Li SPY, 2013, BIOMATERIALS, V34, P7519, DOI 10.1016/j.biomaterials.2013.06.028; Li XJ, 2012, BIOANALYSIS, V4, P1509, DOI [10.4155/bio.12.133, 10.4155/BIO.12.133]; Li Y., 2013, TOXICOL RES, V2; Liao ZX, 2014, BIOMATERIALS, V35, P500, DOI 10.1016/j.biomaterials.2013.09.075; Lilienblum W, 2008, ARCH TOXICOL, V82, P211, DOI 10.1007/s00204-008-0279-9; Lim KS, 2015, MACROMOL BIOSCI, V15, P1423, DOI 10.1002/mabi.201500121; Lim SH, 2010, J MED CHEM, V53, P2865, DOI 10.1021/jm901823u; Lim SH, 2010, PHOTOCHEM PHOTOBIOL, V86, P397, DOI 10.1111/j.1751-1097.2009.00684.x; Lin Ruei-Zhen, 2008, Biotechnology Journal, V3, P1172, DOI 10.1002/biot.200700228; Linde N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040058; Liu K, 2015, NANOSCALE, V7, P1596, DOI 10.1039/c4nr05638h; Liu PF, 2015, ONCOTARGET, V6, P37695, DOI 10.18632/oncotarget.6070; Liu XQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156268; Lokman NA, 2012, INT J MOL SCI, V13, P9959, DOI 10.3390/ijms13089959; Lombardot B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121287; Lottner C, 2004, CANCER LETT, V215, P167, DOI 10.1016/j.canlet.2004.06.035; Lou X, 2014, LAB CHIP, V14, P892, DOI 10.1039/c3lc51077h; Mabry KM, 2015, BIOMATERIALS, V49, P47, DOI 10.1016/j.biomaterials.2015.01.047; Manoto SL, 2015, INT J MOL SCI, V16, P10185, DOI 10.3390/ijms160510185; Marsano A, 2016, LAB CHIP, V16, P599, DOI 10.1039/c5lc01356a; Martinez-Sanchez E, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002157; Maude S, 2013, NANOMEDICINE-UK, V8, P823, DOI [10.2217/NNM.13.65, 10.2217/nnm.13.65]; Meeker ND, 2008, DEV COMP IMMUNOL, V32, P745, DOI 10.1016/j.dci.2007.11.011; Mehling M, 2014, CURR OPIN BIOTECH, V25, P95, DOI 10.1016/j.copbio.2013.10.005; Meisslitzer-Ruppitsch C, 2009, J MICROSC-OXFORD, V235, P322, DOI 10.1111/j.1365-2818.2009.03220.x; Mendler M, 2015, DIABETOLOGIA, V58, P393, DOI 10.1007/s00125-014-3415-5; Merkx-Jacques A, 2013, APPL ENVIRON MICROB, V79, P2435, DOI 10.1128/AEM.03501-12; Mhatre SD, 2014, EXP NEUROL, V261, P772, DOI 10.1016/j.expneurol.2014.08.021; Sanabria LM, 2013, BBA-REV CANCER, V1835, P36, DOI 10.1016/j.bbcan.2012.10.001; Miroshnikova YA, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/2/026013; Mohr JC, 2006, BIOMATERIALS, V27, P6032, DOI 10.1016/j.biomaterials.2006.07.012; Montanez-Sauri SI, 2015, CELL MOL LIFE SCI, V72, P237, DOI 10.1007/s00018-014-1738-5; Moors EHM, 2014, DRUG DISCOV TODAY, V19, P1711, DOI 10.1016/j.drudis.2014.03.004; Morton CA, 2013, J EUR ACAD DERMATOL, V27, P536, DOI 10.1111/jdv.12031; Moshal Karni S, 2011, Cancers (Basel), V3, P4102, DOI 10.3390/cancers3044102; Motta-Mena LB, 2014, NAT CHEM BIOL, V10, P196, DOI [10.1038/NCHEMBIO.1430, 10.1038/nchembio.1430]; Mouche I, 2011, METHODS MOL BIOL, V691, P257, DOI 10.1007/978-1-60761-849-2_15; Moutray T, 2011, THER ADV CHRONIC DIS, V2, P325, DOI 10.1177/2040622311415895; Mueller D, 2014, TOXICOL IN VITRO, V28, P104, DOI 10.1016/j.tiv.2013.06.024; Muragaki Y, 2013, J NEUROSURG, V119, P845, DOI 10.3171/2013.7.JNS13415; Nagai Y, 2012, BIOMATERIALS, V33, P1044, DOI 10.1016/j.biomaterials.2011.10.049; Nakano A, 2011, J EUR ACAD DERMATOL, V25, P475, DOI 10.1111/j.1468-3083.2010.03757.x; Nakayama T, 2015, DEV BIOL, V408, P328, DOI 10.1016/j.ydbio.2015.02.012; Nakayama T, 2013, GENESIS, V51, P835, DOI 10.1002/dvg.22720; Nath S, 2016, PHARMACOL THERAPEUT, V163, P94, DOI 10.1016/j.pharmthera.2016.03.013; NICHOLS MG, 1994, PHYS MED BIOL, V39, P2161, DOI 10.1088/0031-9155/39/12/003; Nicolaou KC, 2014, ANGEW CHEM INT EDIT, V53, P9128, DOI 10.1002/anie.201404761; Nonaka Y, 2013, J SURG RES, V181, P234, DOI 10.1016/j.jss.2012.06.047; Nowak-Sliwinska P, 2014, ANGIOGENESIS, V17, P779, DOI 10.1007/s10456-014-9440-7; Nowak-Sliwinska P, 2013, PROG RETIN EYE RES, V37, P182, DOI 10.1016/j.preteyeres.2013.09.003; Nowak-Sliwinska P, 2012, J CELL MOL MED, V16, P1553, DOI 10.1111/j.1582-4934.2011.01440.x; Nowak-Sliwinska P, 2010, ANGIOGENESIS, V13, P281, DOI 10.1007/s10456-010-9185-x; Ny A, 2006, EXP CELL RES, V312, P684, DOI 10.1016/j.yexcr.2005.10.018; Ong C, 2015, NANOTOXICOLOGY, V9, P396, DOI 10.3109/17435390.2014.940405; Pandey UB, 2011, PHARMACOL REV, V63, P411, DOI 10.1124/pr.110.003293; Park JW, 2013, LAB CHIP, V13, P509, DOI 10.1039/c2lc41081h; Pavesi A, 2016, SCI REP-UK, V6, DOI 10.1038/srep26584; Pegaz B, 2005, PHOTOCHEM PHOTOBIOL, V81, P1505, DOI 10.1562/2005-02-23-RA-448; Peters EB, 2016, CELL MOL BIOENG, V9, P38, DOI 10.1007/s12195-015-0423-6; Pimentel E., 2013, OPEN J ANIM SCI, V3; Plaetzer K, 2009, LASER MED SCI, V24, P259, DOI 10.1007/s10103-008-0539-1; Podratz JL, 2011, NEUROBIOL DIS, V43, P330, DOI 10.1016/j.nbd.2011.03.022; Pogue BW, 2003, CANCER RES, V63, P1025; Polacheck WJ, 2014, P NATL ACAD SCI USA, V111, P2447, DOI 10.1073/pnas.1316848111; Polacheck WJ, 2013, LAB CHIP, V13, P2252, DOI 10.1039/c3lc41393d; Polacheck WJ, 2011, P NATL ACAD SCI USA, V108, P11115, DOI 10.1073/pnas.1103581108; Polesello C, 2011, PROG MOL BIOL TRANSL, V100, P51, DOI 10.1016/B978-0-12-384878-9.00002-9; Poon K.L., 2016, ARCH TOXICOL; Prussing K, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-35; Pruvot B, 2011, HAEMATOL-HEMATOL J, V96, P612, DOI 10.3324/haematol.2010.031401; Punzon I, 2013, MOL CELL ENDOCRINOL, V374, P1, DOI 10.1016/j.mce.2013.04.004; Qi YCB, 2012, P NATL ACAD SCI USA, V109, P7499, DOI 10.1073/pnas.1204096109; Rai P, 2010, ADV DRUG DELIVER REV, V62, P1094, DOI 10.1016/j.addr.2010.09.002; Ramis JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000213; Ravi M, 2015, J CELL PHYSIOL, V230, P16, DOI 10.1002/jcp.24683; Ray A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.513; Rennert K, 2015, BIOMATERIALS, V71, P119, DOI 10.1016/j.biomaterials.2015.08.043; Ribatti D, 2002, ANAT REC, V268, P85, DOI 10.1002/ar.10123; Ribatti D, 2014, EXP CELL RES, V328, P314, DOI 10.1016/j.yexcr.2014.06.010; Richards SM, 2006, ECOTOXICOLOGY, V15, P647, DOI 10.1007/s10646-006-0102-4; Rizvi I, 2013, PHOTOCHEM PHOTOBIOL, V89, P942, DOI 10.1111/php.12065; Rizvi I, 2013, P NATL ACAD SCI USA, V110, pE1974, DOI 10.1073/pnas.1216989110; Rizvi I, 2010, CANCER RES, V70, P9319, DOI 10.1158/0008-5472.CAN-10-1783; ROBERTS WG, 1992, CANCER RES, V52, P924; Rodriguez M, 2013, TRENDS GENET, V29, P367, DOI 10.1016/j.tig.2013.01.010; Rossi F, 2015, NAT PROTOC, V10, P1525, DOI 10.1038/nprot.2015.096; Roth A, 2014, ADV DRUG DELIVER REV, V69, P179, DOI 10.1016/j.addr.2013.12.005; Ruck A, 2005, PHOTODIAGN PHOTODYN, V2, P79, DOI 10.1016/S1572-1000(05)00006-2; Ryumina AP, 2013, BBA-GEN SUBJECTS, V1830, P5059, DOI 10.1016/j.bbagen.2013.07.015; Sabino LG, 2014, PROC SPIE, V8931, DOI 10.1117/12.2040659; Saw CLL, 2006, CANCER LETT, V238, P104, DOI 10.1016/j.canlet.2005.06.026; Schmitt SM, 2014, ADV DRUG DELIVER REV, V69, P225, DOI 10.1016/j.addr.2014.02.004; Schuitmaker JJ, 1998, J PHOTOCH PHOTOBIO B, V47, P211, DOI 10.1016/S1011-1344(99)00005-6; Schumacher B, 2001, CURR BIOL, V11, P1722, DOI 10.1016/S0960-9822(01)00534-6; Schweizer PM, 1997, LASER MED SCI, V12, P280, DOI 10.1007/BF02765110; Seano G, 2013, BLOOD, V121, pE129, DOI 10.1182/blood-2012-08-452292; Shemesh J, 2015, LAB CHIP, V15, P4114, DOI 10.1039/c5lc00633c; Shibuya T, 2012, J PHOTOCH PHOTOBIO B, V117, P1, DOI 10.1016/j.jphotobiol.2012.08.005; Shields JD, 2007, CANCER CELL, V11, P526, DOI 10.1016/j.ccr.2007.04.020; Shimizu K, 2013, J BIOSCI BIOENG, V115, P695, DOI 10.1016/j.jbiosc.2012.12.017; Shin MK, 2011, LAB CHIP, V11, P3880, DOI 10.1039/c1lc20671k; Shirmanova MV, 2013, J BIOPHOTONICS, V6, P283, DOI 10.1002/jbio.201200056; Shokry H, 2015, NANOSCALE, V7, P14434, DOI 10.1039/c5nr03983e; Shu XK, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001041; Smijs TGM, 2004, PHOTOCHEM PHOTOBIOL, V79, P332, DOI 10.1562/2003-12-03-RA.1; Smolina M, 2016, ANALYST, V141, P620, DOI 10.1039/c5an01997d; Souza GR, 2010, NAT NANOTECHNOL, V5, P291, DOI 10.1038/nnano.2010.23; Spring BQ, 2015, PHOTOCH PHOTOBIO SCI, V14, P1476, DOI 10.1039/c4pp00495g; Staal FJT, 2016, STEM CELLS DEV, V25, P360, DOI 10.1089/scd.2015.0195; Stern CD, 2005, DEV CELL, V8, P9, DOI 10.1016/j.devcel.2004.11.018; Stiehler M, 2008, J BIOMED MATER RES A, V86A, P448, DOI 10.1002/jbm.a.31602; Stockert JC, 2003, TOXICOLOGY, V192, P211, DOI 10.1016/S0300-483X(03)00334-2; Stoletov K, 2008, ONCOGENE, V27, P4509, DOI 10.1038/onc.2008.95; Straka H, 2012, DEV NEUROBIOL, V72, P649, DOI 10.1002/dneu.20965; Su GN, 2013, BIOMATERIALS, V34, P3215, DOI 10.1016/j.biomaterials.2013.01.044; Sukardi H, 2011, EXPERT OPIN DRUG MET, V7, P579, DOI 10.1517/17425255.2011.562197; SUTHERLAND RM, 1971, JNCI-J NATL CANCER I, V46, P113; Sys G, 2012, CANCER LETT, V326, P69, DOI 10.1016/j.canlet.2012.07.023; Szkolar L, 2014, J PEPT SCI, V20, P578, DOI 10.1002/psc.2666; Tan IB, 2010, HEAD NECK-J SCI SPEC, V32, P1597, DOI 10.1002/hed.21368; Tapias LF, 2015, ANN THORAC SURG, V100, P414, DOI 10.1016/j.athoracsur.2015.04.035; Tatar O, 2006, AM J OPHTHALMOL, V142, P95, DOI 10.1016/j.ajo.2006.01.085; Taylor AM, 2009, ZEBRAFISH, V6, P339, DOI 10.1089/zeb.2009.0607; Teh C, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-110; Teng Y, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-453; Thomas MA, 2005, BRAIN RES PROTOC, V14, P107, DOI 10.1016/j.brainresprot.2004.12.002; Tian H, 2010, BIOMATERIALS, V31, P870, DOI 10.1016/j.biomaterials.2009.10.001; Timmins NE, 2007, TISSUE ENG, V13, P2021, DOI 10.1089/ten.2006.0158; Tokarska K., 2016, J PHARM BIOMED ANAL; Tseng H, 2015, SCI REP-UK, V5, DOI 10.1038/srep13987; Ullah F, 2015, MAT SCI ENG C-MATER, V57, P414, DOI 10.1016/j.msec.2015.07.053; van Beijnum JR, 2013, ONCOGENE, V32, P363, DOI 10.1038/onc.2012.49; van Duinen V, 2015, CURR OPIN BIOTECH, V35, P118, DOI 10.1016/j.copbio.2015.05.002; van Ham TJ, 2010, FASEB J, V24, P4336, DOI 10.1096/fj.10-161018; van Zutphen LFM, 2002, ALTEX-ALTERN TIEREXP, V19, P140; Vargas A, 2004, INT J PHARMACEUT, V286, P131, DOI 10.1016/j.ijpharm.2004.07.029; Vargas A, 2007, ADV DRUG DELIVER REV, V59, P1162, DOI 10.1016/j.addr.2007.04.019; Vellonen KS, 2014, J CONTROL RELEASE, V190, P94, DOI 10.1016/j.jconrel.2014.06.044; Verbridge SS, 2013, J BIOMED MATER RES A, V101, P2948, DOI 10.1002/jbm.a.34587; Vinci M, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-29; Wagner CA, 2000, CELL PHYSIOL BIOCHEM, V10, P1, DOI 10.1159/000016341; Wagner DS, 2010, BIOMATERIALS, V31, P7567, DOI 10.1016/j.biomaterials.2010.06.031; Wan HY, 2002, MAR BIOTECHNOL, V4, P146, DOI 10.1007/s10126-001-0085-3; Wang BK, 2014, BIOMATERIALS, V35, P1954, DOI 10.1016/j.biomaterials.2013.11.066; Wang HW, 2013, LASER SURG MED, V45, P296, DOI 10.1002/lsm.22142; Wang P, 2012, P NATL ACAD SCI USA, V109, P17669, DOI 10.1073/pnas.1205748109; Wang XL, 2010, BIOMATERIALS, V31, P3920, DOI 10.1016/j.biomaterials.2010.01.118; Wang YL, 2015, Q REV BIOPHYS, V48, P488, DOI 10.1017/S0033583515000190; Watson E, 2013, CELL, V153, P253, DOI 10.1016/j.cell.2013.02.050; Weiss A, 2015, SCI REP-UK, V5, DOI 10.1038/srep08990; Weiss A, 2014, J CELL MOL MED, V18, P480, DOI 10.1111/jcmm.12199; WEST CML, 1989, PHOTOCHEM PHOTOBIOL, V50, P665, DOI 10.1111/j.1751-1097.1989.tb04324.x; WEST CML, 1989, BRIT J CANCER, V59, P510, DOI 10.1038/bjc.1989.105; White R, 2013, NAT REV CANCER, V13, P624, DOI 10.1038/nrc3589; Willecke M, 2011, ONCOGENE, V30, P4067, DOI 10.1038/onc.2011.125; Willoughby LF, 2013, DIS MODEL MECH, V6, P521, DOI 10.1242/dmm.009985; Worthington P, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00092; Wright KE, 2009, BRIT J CANCER, V101, P658, DOI 10.1038/sj.bjc.6605197; Wright KE, 2012, PHOTOCHEM PHOTOBIOL, V88, P1539, DOI 10.1111/j.1751-1097.2012.01185.x; Xiao X., 2015, PLOS ONE, V10; Xu F, 2011, BIOTECHNOL J, V6, P204, DOI 10.1002/biot.201000340; Xu JW, 2014, J AM CHEM SOC, V136, P4105, DOI 10.1021/ja4130862; Xue G, 2015, J RADIAT RES, V56, P656, DOI 10.1093/jrr/rrv018; Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006; Yamamoto S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103502; Yan CQ, 2010, CHEM SOC REV, V39, P3528, DOI 10.1039/b919449p; Yang XBB, 2004, TISSUE ENG, V10, P1037, DOI 10.1089/1076327041887718; Yang XJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0061801, 10.1371/journal.pone.0062181]; Yang YM, 2015, LAB CHIP, V15, P735, DOI 10.1039/c4lc01065e; Ye AA, 2016, JOVE-J VIS EXP, DOI 10.3791/53594; Yen J, 2014, CURR OPIN GENET DEV, V24, P38, DOI 10.1016/j.gde.2013.11.003; Yoho JS, 2014, GENESIS, V52, P309, DOI 10.1002/dvg.22760; Yonekawa Y, 2015, J CLIN MED, V4, P343, DOI 10.3390/jcm4020343; Yoon HE, 2014, ONCOL REP, V31, P137, DOI 10.3892/or.2013.2856; Yoon JH, 2012, LASER SURG MED, V44, P76, DOI 10.1002/lsm.21154; Yoon S, 2013, LAB CHIP, V13, P1522, DOI 10.1039/c3lc41322e; Young JJ, 2011, P NATL ACAD SCI USA, V108, P7052, DOI 10.1073/pnas.1102030108; Yu Y., 2015, PLOS ONE, V10; Yuan A, 2015, ACTA BIOMATER, V21, P63, DOI 10.1016/j.actbio.2015.04.014; Zala D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060162; Zang LQ, 2011, ZEBRAFISH, V8, P203, DOI 10.1089/zeb.2011.0726; Zanoni M, 2016, SCI REP-UK, V6, DOI 10.1038/srep19103; Zeitlin BD, 2012, LAB INVEST, V92, P988, DOI 10.1038/labinvest.2012.77; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zervantonakis IK, 2012, P NATL ACAD SCI USA, V109, P13515, DOI 10.1073/pnas.1210182109; ZHANG Q, 2015, CELL DEATH DIS, V6; Zhang Z, 2013, BIOMED MICRODEVICES, V15, P595, DOI 10.1007/s10544-012-9734-8; Zhou M, 2009, BIOMATERIALS, V30, P2523, DOI 10.1016/j.biomaterials.2009.01.010; Zhu G., 2015, INTEGR BIOL	346	15	15	2	25	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1383-5742	1388-2139		MUTAT RES-REV MUTAT	Mutat. Res.-Rev. Mutat. Res.	JUL-SEP	2017	773						242	262		10.1016/j.mrrev.2016.09.002			21	Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology	FJ0DI	WOS:000412378300016	28927532				2022-03-04	
J	Lombardi, T; Samson, J; Kuffer, R				Lombardi, T.; Samson, J.; Kueffer, R.			Low-grade myofibroblastic sarcoma of the tongue	JOURNAL OF ORAL PATHOLOGY & MEDICINE			English	Meeting Abstract									Univ Geneva, CH-1211 Geneva 4, Switzerland									0	0	0	0	0	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	0904-2512			J ORAL PATHOL MED	J. Oral Pathol. Med.	AUG	2006	35	7				225	422	423					2	Dentistry, Oral Surgery & Medicine; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine; Pathology	061RN	WOS:000238890200035					2022-03-04	
J	Meier, ML; Hotz-Boendermaker, S; Boendermaker, B; Luechinger, R; Humphreys, BK				Meier, Michael L.; Hotz-Boendermaker, Sabina; Boendermaker, Bart; Luechinger, Roger; Humphreys, Barry Kim			NEURAL RESPONSES OF POSTERIOR TO ANTERIOR MOVEMENT ON LUMBAR VERTEBRAE: A FUNCTIONAL MAGNETIC RESONANCE IMAGING STUDY	JOURNAL OF MANIPULATIVE AND PHYSIOLOGICAL THERAPEUTICS			English	Article						Magnetic Resonance Imaging Functional; Low Back Pain; Chronic Pain; Manual Therapies; Chiropractic	LOW-BACK-PAIN; DUAL SOMATOSENSORY INPUT; CHIROPRACTIC MANAGEMENT; SUBPOPULATION PROGRAM; MANIPULATIVE THERAPY; CENTRAL INTEGRATION; STIMULATION; MOTION; CORTEX; MRI	Objective: The purpose of this study was to develop and test a clinically relevant method to mechanically stimulate lumbar functional spinal units while recording brain activity by means of functional magnetic resonance imaging (MRI). Methods: Subjects were investigated in the prone position with their face lying on a modified stabilization pillow. To minimize head motion, the pillow was fixed to the MRI headrest, and supporting straps were attached around the shoulders. An experienced manual therapist applied controlled, nonpainful pressure stimuli to 10 healthy subjects at 3 different lumbar vertebrae (L1, L3, and L5). Pressure applied to the thumb was used as a control. The stimulation consisted of posterior to anterior (PA) pressure movement. The therapist followed a randomized stimulation protocol projected onto a screen in the MRI room. Blood oxygenation level-dependent responses were analyzed in relation to the lumbar and the thumb stimulations. The study was conducted by the Chiropractic Department, Faculty of Medicine, University of Zurich, Switzerland. Results: No participant reported any discomfort due to the prone-lying position or use of the pillow. Importantly, PA-induced pressure produced only minimal head movements. Stimulation of the lumbar spinous processes revealed bilateral neural responses in medial parts of the postcentral gyrus (S1). Additional activity was observed in the secondary somatosensory cortex (S2), posterior parts of the insular cortex, different parts of the cingulate cortex, and the cerebellum. Thumb stimulations revealed activation only in lateral parts of the contralateral S1. Conclusion: The current study demonstrates the feasibility of the application of PA pressure on lumbar spinous processes in an MRI environment. This approach may serve as a promising tool for further investigations regarding neuroplastic changes in chronic low back pain subjects.	[Meier, Michael L.; Hotz-Boendermaker, Sabina; Humphreys, Barry Kim] Univ Zurich, Fac Med, Chiropract Dept, Zurich, Switzerland; [Boendermaker, Bart] Vrije Univ Brussel, Fac Med & Pharm, Brussels, Belgium; [Luechinger, Roger] Swiss Fed Inst Technol, Inst Biomed Engn, Zurich, Switzerland; [Luechinger, Roger] Univ Zurich, Zurich, Switzerland		Meier, ML (corresponding author), Ziegelfeldstr 109, CH-4600 Olten, Switzerland.	Michael.meier@uzh.ch	Luechinger, Roger/AAD-5192-2019; Hotz, S/AAL-7043-2020	Luechinger, Roger/0000-0002-7365-0421; Hotz, S/0000-0001-9455-6074; Meier, Michael/0000-0001-6004-8338			Bakkum BW, 2007, J MANIP PHYSIOL THER, V30, P336, DOI 10.1016/j.jmpt.2007.04.007; Baliki MN, 2012, NAT NEUROSCI, V15, P1117, DOI 10.1038/nn.3153; Baliki MN, 2011, J NEUROSCI, V31, P13981, DOI 10.1523/JNEUROSCI.1984-11.2011; Bingel U, 2004, NEUROIMAGE, V23, P224, DOI 10.1016/j.neuroimage.2004.05.021; Boal RW, 2004, J MANIP PHYSIOL THER, V27, P314, DOI 10.1016/j.jmpt.2004.04.005; Bogduk N, 1985, Aust Fam Physician, V14, P1168; BOGDUK N, 1983, SPINE, V8, P286, DOI 10.1097/00007632-198304000-00009; Bogduk N, 1985, AUST FAM PHYSICIAN, V14, P72; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Bronfort Gert, 2004, Spine J, V4, P335, DOI 10.1016/j.spinee.2003.06.002; BROWNING JE, 1991, J CAN CHIRO ASS, V35, P149; Christodoulou AG, 2013, MAGN RESON IMAGING, V31, P707, DOI 10.1016/j.mri.2012.11.007; Derbyshire SWG, 2002, NEUROIMAGE, V16, P158, DOI 10.1006/nimg.2002.1066; Durston S, 2006, BIOL PSYCHIAT, V60, P1062, DOI 10.1016/j.biopsych.2005.12.020; Evans A C, 1992, Neuroimage, V1, P43, DOI 10.1016/1053-8119(92)90006-9; Ferreira ML, 2003, J MANIP PHYSIOL THER, V26, P593, DOI 10.1016/j.jmpt.2003.08.010; Ferretti A, 2004, NEUROIMAGE, V23, P1217, DOI 10.1016/j.neuroimage.2004.08.003; Flor H, 1997, NEUROSCI LETT, V224, P5, DOI 10.1016/S0304-3940(97)13441-3; Flynn T, 2002, SPINE, V27, P2835, DOI 10.1097/00007632-200212150-00021; Globe GA, 2008, J MANIP PHYSIOL THER, V31, P651, DOI 10.1016/j.jmpt.2008.10.006; Haas Mitchell, 2004, Spine J, V4, P574, DOI 10.1016/j.spinee.2004.02.008; HAJNAL JV, 1994, MAGNET RESON MED, V31, P283, DOI 10.1002/mrm.1910310307; Humphreys K., 2005, CHIROPRACTIC MANIPUL, P208; Johansen-Berg H, 2000, NEUROREPORT, V11, P1237, DOI 10.1097/00001756-200004270-00019; Johnstone T, 2006, HUM BRAIN MAPP, V27, P779, DOI 10.1002/hbm.20219; Jull G, 2002, AUST J PHYSIOTHER, V48, P189, DOI 10.1016/S0004-9514(14)60223-3; Khorsan R, 2008, J MANIP PHYSIOL THER, V31, P355, DOI 10.1016/j.jmpt.2008.04.007; Kobayashi Yoshitaka, 2009, Spine (Phila Pa 1976), V34, P2431, DOI 10.1097/BRS.0b013e3181b1fb76; Kuehn E, 2014, BRAIN STRUCT FUNCT, V219, P119, DOI 10.1007/s00429-012-0489-z; Kulig K, 2004, J ORTHOP SPORT PHYS, V34, P57, DOI 10.2519/jospt.2004.34.2.57; Lawrence DJ, 2008, J MANIP PHYSIOL THER, V31, P659, DOI 10.1016/j.jmpt.2008.10.007; Leboeuf-Yde C, 2005, J MANIP PHYSIOL THER, V28, P90, DOI 10.1016/j.jmpt.2005.01.010; Leboeuf-Yde C, 2004, J MANIP PHYSIOL THER, V27, P493, DOI 10.1016/j.jmpt.2004.08.001; Lloyd D, 2008, SPINE, V33, P1372, DOI 10.1097/BRS.0b013e3181734a8a; MacIntosh BJ, 2008, NEUROREHAB NEURAL RE, V22, P728, DOI 10.1177/1545968308316386; Maihofner C, 2003, NEUROLOGY, V61, P1707, DOI 10.1212/01.WNL.0000098939.02752.8E; Mazzola L, 2006, CEREB CORTEX, V16, P960, DOI 10.1093/cercor/bhj038; McGlone F, 2002, BEHAV BRAIN RES, V135, P147, DOI 10.1016/S0166-4328(02)00144-4; McGregor AH, 2001, CLIN BIOMECH, V16, P926, DOI 10.1016/S0268-0033(01)00091-2; Moeller FG, 2004, PSYCHOPHARMACOLOGY, V177, P185, DOI 10.1007/s00213-004-1908-5; Penfield W, 1937, BRAIN, V60, P389, DOI 10.1093/brain/60.4.389; Peterson CK, 2012, J MANIP PHYSIOL THER, V35, P525, DOI 10.1016/j.jmpt.2012.06.003; Peyron R, 2000, NEUROPHYSIOL CLIN, V30, P263, DOI 10.1016/S0987-7053(00)00227-6; Rothman E, 2005, PRINCIPLES PRACTICE; Rubinstein SM, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008112.pub2; Taylor HH, 2010, J MANIP PHYSIOL THER, V33, P261, DOI 10.1016/j.jmpt.2010.03.004; Taylor HH, 2010, J MANIP PHYSIOL THER, V33, P178, DOI 10.1016/j.jmpt.2010.01.005; Van der El A. L. P., 1983, MANUELE THERAPIE; White A. A., 1990, CLIN BIOMECHANICS SP; Wylie GR, 2014, HUM BRAIN MAPP, V35, P1, DOI 10.1002/hbm.22150	50	13	13	0	8	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0161-4754			J MANIP PHYSIOL THER	J. Manip. Physiol. Ther.	JAN	2014	37	1					32	41		10.1016/j.jmpt.2013.09.004			10	Health Care Sciences & Services; Integrative & Complementary Medicine; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services; Integrative & Complementary Medicine; Rehabilitation	281MQ	WOS:000329106100004	24229849				2022-03-04	
J	Kuffer, R; Husson, C; Plantier, F; Samson, J; Lombardi, T				Kuffer, R.; Husson, C.; Plantier, F.; Samson, J.; Lombardi, T.			Rare cases of multiple retention cysts of minor salivary glands	JOURNAL OF ORAL PATHOLOGY & MEDICINE			English	Meeting Abstract									Univ Geneva, CH-1211 Geneva 4, Switzerland									0	0	0	0	0	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	0904-2512			J ORAL PATHOL MED	J. Oral Pathol. Med.	AUG	2006	35	7				223	422	422					1	Dentistry, Oral Surgery & Medicine; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine; Pathology	061RN	WOS:000238890200033					2022-03-04	
J	Scolozzi, P; Momjian, A; Courvoisier, DS; Kiliaridis, S				Scolozzi, P.; Momjian, A.; Courvoisier, D. S.; Kiliaridis, S.			Evaluation of condylar morphology following orthognathic surgery on digital panoramic radiographs. Could methodology influence the range of "normality" in condylar changes?	DENTOMAXILLOFACIAL RADIOLOGY			English	Article						panoramic radiograph; condylar morphology; orthognathic surgery; computer-aided measurements	TEMPOROMANDIBULAR-JOINT PROBLEMS; SPLIT ADVANCEMENT OSTEOTOMIES; RISK-FACTORS; RESORPTION; ORTHOPANTOMOGRAM; DIAGNOSIS; AID	Objectives: To evaluate the morphological condylar changes following orthognathic surgery by using a rapid and reliable computational method on panoramic radiographs. Methods: Digital panoramic radiographs of 45 patients who underwent bilateral sagittal split osteotomy (alone or associated with a Le Fort I osteotomy) between 2007 and 2010 were analysed. Calculation of the area, perimeter and height of 90 condyles was performed by using a specific computational method. Measurements were taken before surgery (m(1)), 1 day after surgery (m(2)) and 1 year after surgery (m(3)). The evolution of each index was analysed using paired t-tests between measures before and 1 day after surgery (m(1) - m(2)) and measures before and 1 year after surgery (m(1) - m(3)). The changes in the condylar area, perimeter and height were examined using the Bland and Altman plotting method. Results: There were no statistically significant changes in the mean condylar area, perimeter or height between m(1) and m(2) or between m(1) and m(3). The Bland and Altman plots for each index showed that a very limited number of condyles increased or decreased in area, perimeter and/or height outside the boundaries of the measurement error. Given the impossibility for a condyle to increase in size, these results are considered to represent the limits of the computational method used. Conclusions: This study demonstrated that there were no significant morphological condylar changes at the 1-year follow-up following surgery and that the range of normality in condylar changes could be influenced by the methodology used.	[Scolozzi, P.; Momjian, A.] Univ Hosp Geneva, Serv Oral & Maxillofacial Surg, Dept Surg, CH-1211 Geneva, Switzerland; [Scolozzi, P.; Momjian, A.] Fac Med Geneva, CH-1211 Geneva, Switzerland; [Courvoisier, D. S.] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; [Kiliaridis, S.] Fac Med Geneva, Dept Orthodont, CH-1211 Geneva, Switzerland		Scolozzi, P (corresponding author), Univ Hosp Geneva, Serv Oral & Maxillofacial Surg, Dept Surg, CH-1211 Geneva, Switzerland.	paolo.scolozzi@hcuge.ch					Arnett G.W., 1990, ORAL MAXILLOFAC SURG, V2, P699; Arnett GW, 1996, AM J ORTHOD DENTOFAC, V110, P117, DOI 10.1016/S0889-5406(96)70099-9; Arnett GW, 1996, AM J ORTHOD DENTOFAC, V110, P8, DOI 10.1016/S0889-5406(96)70081-1; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Borstlap WA, 2004, INT J ORAL MAX SURG, V33, P649, DOI 10.1016/j.ijom.2004.01.018; BOUWMAN JPB, 1994, ORAL SURG ORAL MED O, V78, P138, DOI 10.1016/0030-4220(94)90135-X; CRAWFORD JG, 1994, J ORAL MAXIL SURG, V52, P460, DOI 10.1016/0278-2391(94)90341-7; Cutbirth M, 1998, J ORAL MAXIL SURG, V56, P178, DOI 10.1016/S0278-2391(98)90863-1; De Clercq C A, 1994, Int J Adult Orthodon Orthognath Surg, V9, P233; De Mol Van Otterloo J. J., 1993, British Journal of Oral and Maxillofacial Surgery, V31, P83, DOI 10.1016/0266-4356(93)90166-T; ECKERDAL O, 1986, INT J ORAL MAX SURG, V15, P233, DOI 10.1016/S0300-9785(86)80079-5; HABETS LLMH, 1988, J ORAL REHABIL, V15, P465, DOI 10.1111/j.1365-2842.1988.tb00182.x; HABETS LLMH, 1987, J ORAL REHABIL, V14, P475, DOI 10.1111/j.1365-2842.1987.tb00742.x; Hoppenreijs TJM, 1998, INT J ORAL MAX SURG, V27, P81, DOI 10.1016/S0901-5027(98)80301-9; Hwang SJ, 2004, J CRANIO MAXILL SURG, V32, P103, DOI 10.1016/j.jcms.2003.09.007; Hwang SJ, 2000, ORAL SURG ORAL MED O, V89, P542, DOI 10.1067/moe.2000.105239; Katsumata A, 2006, ORAL SURG ORAL MED O, V101, P505, DOI 10.1016/j.tripleo.2005.07.028; KERSTENS HCJ, 1990, ORAL SURG ORAL MED O, V69, P274, DOI 10.1016/0030-4220(90)90286-2; Kim YI, 2011, ORAL SURG ORAL MED O, V111, P681, DOI 10.1016/j.tripleo.2010.08.001; MERKX MAW, 1994, J CRANIO MAXILL SURG, V22, P53, DOI 10.1016/S1010-5182(05)80297-5; MILLER RI, 1986, J ORAL MAXIL SURG, V44, P1008, DOI 10.1016/S0278-2391(86)80057-X; Momjian A, 2011, DENTOMAXILLOFAC RAD, V40, P444, DOI 10.1259/dmfr/83507370; MONGINI F, 1980, J PROSTHET DENT, V43, P568, DOI 10.1016/0022-3913(80)90333-9; MOORE KE, 1991, J ORAL MAXIL SURG, V49, P448, DOI 10.1016/0278-2391(91)90166-J; Park SB, 2012, J ORAL MAXIL SURG, V70, P1951, DOI 10.1016/j.joms.2011.08.017; SCHEERLINCK JPO, 1994, INT J ORAL MAX SURG, V23, P127, DOI 10.1016/S0901-5027(05)80285-1; Vidra MAL, 2002, ORAL SURG ORAL MED O, V93, P399, DOI 10.1067/moe.2002.121706; Wolford LM, 2003, J ORAL MAXIL SURG, V61, P655, DOI 10.1053/joms.2003.50131	28	6	6	1	4	BRITISH INST RADIOLOGY	LONDON	36 PORTLAND PLACE, LONDON W1N 4AT, ENGLAND	0250-832X	1476-542X		DENTOMAXILLOFAC RAD	Dentomaxillofac. Radiol.	JUL	2013	42	7							20120463	10.1259/dmfr.20120463			5	Dentistry, Oral Surgery & Medicine; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine; Radiology, Nuclear Medicine & Medical Imaging	183DU	WOS:000321795100008	23625066	Green Published			2022-03-04	
J	Negro, F				Negro, F.			HCV and insulin resistance	JOURNAL OF VIRAL HEPATITIS			English	Meeting Abstract	Viral Hepatitis Congress	OCT 09-11, 2014	Frankfurt, GERMANY						[Negro, F.] Univ Hosp Geneva, Geneva, Switzerland				Negro, Francesco/E-2183-2012					0	0	0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1352-0504	1365-2893		J VIRAL HEPATITIS	J. Viral Hepatitis	OCT	2014	21			2	SI	O321	19	19		10.1111/jvh.12332_22			1	Gastroenterology & Hepatology; Infectious Diseases; Virology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Gastroenterology & Hepatology; Infectious Diseases; Virology	AR7DA	WOS:000343738800027		Bronze			2022-03-04	
J	Borel, C; Antonarakis, SE				Borel, Christelle; Antonarakis, Stylianos E.			Functional genetic variation of human miRNAs and phenotypic consequences	MAMMALIAN GENOME			English	Article							ACAA-INSERTION/DELETION POLYMORPHISM; MICRORNA-BINDING-SITES; ANGIOTENSIN-II; COPY-NUMBER; MICROPROCESSOR COMPLEX; DROSHA-DGCR8 COMPLEX; INSULIN-RESISTANCE; ANIMAL MICRORNAS; MESSENGER-RNAS; TARGET SITES	A large number of human protein-coding genes are finely regulated by one or more microRNAs. Members of this small noncoding RNA family have emerged as important post-transcriptional regulators of gene expression and are involved in a number of disease phenotypes. Variability in the human genome is extensive and includes the common and rare single nucleotide polymorphisms (SNPs) and copy number variations (CNVs). The functional significance of the genome's variability is under intense investigation. In this article we review the emerging literature on how human genomic variation influences the outcome of microRNA targeting and the associated phenotypic effects. Illustrative examples are discussed that demonstrate the biological importance of functional polymorphisms affecting miRNA-mediated gene regulation.	[Borel, Christelle; Antonarakis, Stylianos E.] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Borel, Christelle; Antonarakis, Stylianos E.] Univ Hosp Geneva, CH-1211 Geneva, Switzerland		Antonarakis, SE (corresponding author), Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland.	stylianos.antonarakis@medecine.unige.ch	borel, christelle/AAC-9645-2019; Antonarakis, Stylianos E/N-8866-2014	Antonarakis, Stylianos E/0000-0001-8907-5823	Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission; NCCR Frontiers in GeneticsSwiss National Science Foundation (SNSF); European UnionEuropean Commission; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; Lejeune and ChildCare Foundations	The authors' lab is supported by the Swiss National Science Foundation, the NCCR Frontiers in Genetics, The European Union, the NIH, and the Lejeune and ChildCare Foundations. We thank our laboratory colleagues for discussions, critical reading, and numerous suggestions.	Abelson JF, 2005, SCIENCE, V310, P317, DOI 10.1126/science.1116502; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bao L, 2007, NUCLEIC ACIDS RES, V35, pD51, DOI 10.1093/nar/gkl797; BAR M, 2008, STEM CELLS; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beckmann JS, 2007, NAT REV GENET, V8, P639, DOI 10.1038/nrg2149; Berezikov E, 2007, MOL CELL, V28, P328, DOI 10.1016/j.molcel.2007.09.028; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Burnier M, 2000, LANCET, V355, P637, DOI 10.1016/S0140-6736(99)10365-9; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chang S, 2004, NATURE, V430, P785, DOI 10.1038/nature02752; Chen K, 2006, NAT GENET, V38, P1452, DOI 10.1038/ng1910; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Draheim CC, 2002, AM J MENT RETARD, V107, P201, DOI 10.1352/0895-8017(2002)107<0201:DICDRB>2.0.CO;2; Duan RH, 2007, HUM MOL GENET, V16, P1124, DOI 10.1093/hmg/ddm062; Duggirala R, 2001, AM J HUM GENET, V68, P1149, DOI 10.1086/320100; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Georges M, 2007, CURR OPIN GENET DEV, V17, P166, DOI 10.1016/j.gde.2007.04.005; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Glazov EA, 2008, GENOME RES, V18, P957, DOI 10.1101/gr.074740.107; GOOSSENS M, 1980, P NATL ACAD SCI-BIOL, V77, P518, DOI 10.1073/pnas.77.1.518; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Gupta A, 2006, NATURE, V442, P82, DOI 10.1038/nature04836; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Hwang HW, 2007, SCIENCE, V315, P97, DOI 10.1126/science.1136235; Iwai N, 2005, BIOCHEM BIOPH RES CO, V331, P1439, DOI 10.1016/j.bbrc.2005.04.051; JACKSON RJ, 2007, SCI STKE, pRE1, DOI DOI 10.1126/STKE.3672007RE1; Jazdzewski K, 2008, P NATL ACAD SCI USA, V105, P7269, DOI 10.1073/pnas.0802682105; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; Johnston RJ, 2005, P NATL ACAD SCI USA, V102, P12449, DOI 10.1073/pnas.0505530102; KAN YW, 1975, NATURE, V258, P162, DOI 10.1038/258162a0; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kiriakidou M, 2004, GENE DEV, V18, P1165, DOI 10.1101/gad.1184704; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Landthaler M, 2004, CURR BIOL, V14, P2162, DOI 10.1016/j.cub.2004.11.001; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Lv K, 2008, BIOCHEM BIOPH RES CO, V374, P101, DOI 10.1016/j.bbrc.2008.06.102; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; Martin MM, 2006, J BIOL CHEM, V281, P18277, DOI 10.1074/jbc.M601496200; Mishra PJ, 2007, P NATL ACAD SCI USA, V104, P13513, DOI 10.1073/pnas.0706217104; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Morrison RA, 1996, HYPERTENSION, V28, P569, DOI 10.1161/01.HYP.28.4.569; Nielsen CB, 2007, RNA, V13, P1894, DOI 10.1261/rna.768207; Nilsen TW, 2007, TRENDS GENET, V23, P243, DOI 10.1016/j.tig.2007.02.011; Okamura K, 2007, CELL, V130, P89, DOI 10.1016/j.cell.2007.06.028; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Ruby JG, 2007, NATURE, V448, P83, DOI 10.1038/nature05983; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Saunders MA, 2007, P NATL ACAD SCI USA, V104, P3300, DOI 10.1073/pnas.0611347104; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Sethupathy P, 2007, AM J HUM GENET, V81, P405, DOI 10.1086/519979; Song JC, 2002, CLIN PHARMACOKINET, V41, P207, DOI 10.2165/00003088-200241030-00005; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Sunkar R, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-25; Tan Z, 2007, AM J HUM GENET, V81, P829, DOI 10.1086/521200; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van Geel PP, 2000, HYPERTENSION, V35, P717, DOI 10.1161/01.HYP.35.3.717; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Villuendas G, 2006, EUR J ENDOCRINOL, V155, P331, DOI 10.1530/eje.1.02217; WAIKAN Y, 1978, P NATL ACAD SCI USA, V75, P5631, DOI 10.1073/pnas.75.11.5631; Wang G, 2008, AM J HUM GENET, V82, P283, DOI 10.1016/j.ajhg.2007.09.021; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Wong KK, 2007, AM J HUM GENET, V80, P91, DOI 10.1086/510560; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Zeng Y, 2003, RNA, V9, P112, DOI 10.1261/rna.2780503; Zeng Y, 2005, EMBO J, V24, P138, DOI 10.1038/sj.emboj.7600491; Zeng Y, 2005, J BIOL CHEM, V280, P27595, DOI 10.1074/jbc.M504714200	84	67	73	0	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0938-8990	1432-1777		MAMM GENOME	Mamm. Genome	AUG	2008	19	7-8					503	509		10.1007/s00335-008-9137-6			7	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	376JV	WOS:000261180800004	18787897	Green Submitted, Green Accepted			2022-03-04	
J	Antonarakis, GS; Herzog, G; Kiliaridis, S				Antonarakis, G. S.; Herzog, G.; Kiliaridis, S.			Vertical relapse after orthodontic and orthognathic surgical treatment in a patient with myotonic dystrophy	EUROPEAN JOURNAL OF PAEDIATRIC DENTISTRY			English	Article						Myotonic Dystrophy; Myotonia; Open bite; Vertical Growth	DUCHENNE MUSCULAR-DYSTROPHY; BITE FORCE; CRANIOFACIAL MORPHOLOGY; MUSCLE INVOLVEMENT; MASSETER MUSCLE; SELF-CONCEPT; DIAGNOSIS; SURGERY	Patients with myotonic dystrophy (MD), a neuromuscular multisystem disease characterised by progressive muscular weakness, often present with an anterior open bite associated with excessive facial vertical development. These aberrations in vertical craniofacial growth may be due to the reduced function of the masticatory muscles and the lowered position of the tongue. Well-planned and executed treatment of these patients, with orthodontics and orthognathic surgery, can provide satisfactory results. The long-term stability of these treatment results however remains undocumented. This paper describes a case of severe anterior open bite in a patient with MD treated with orthodontics and orthognathic surgery, with an acceptable post-treatment result. Long-term follow-up however revealed a highly unstable outcome. Reasons for this include the continued overeruption of posterior teeth due to the weakened masticatory musculature, mandibular posture, or problems with TMJ adaptation and remodeling. Possible ways to minimise this instability are discussed, namely lifelong skeletal retention or postponing treatment until a later age.	[Antonarakis, G. S.; Herzog, G.; Kiliaridis, S.] Univ Geneva, Univ Clin Dent Med, Div Orthodont, Geneva, Switzerland		Antonarakis, GS (corresponding author), Univ Geneva, Univ Clin Dent Med, Div Orthodont, Geneva, Switzerland.	gregory.antonarakis@unige.ch	Antonarakis, Gregory/ABA-1855-2020	Antonarakis, Gregory/0000-0001-6741-6922			Balasubramaniam R, 2008, SPEC CARE DENT, V28, P243, DOI 10.1111/j.1754-4505.2008.00047.x; Bezak BJ, 2016, J ORAL MAXIL SURG, V74, P601, DOI 10.1016/j.joms.2015.07.023; Georgiakaki I, 1998, J DENT RES, V77, P1018; Guimaraes AS, 2007, J ORAL REHABIL, V34, P195, DOI 10.1111/j.1365-2842.2006.01665.x; Harper PS, 2001, MYOTONIC DYSTROPHY; He TL, 2013, ACTA ODONTOL SCAND, V71, P863, DOI 10.3109/00016357.2012.734411; INGERVALL B, 1987, EUR J ORTHODONT, V9, P15, DOI 10.1093/ejo/9.1.15; KAUFMAN J, 1983, J ORAL MAXIL SURG, V41, P667, DOI 10.1016/0278-2391(83)90022-8; KAWAZOE Y, 1982, J NEUROL NEUROSUR PS, V45, P343, DOI 10.1136/jnnp.45.4.343; KILIARIDIS S, 1995, AM J ORTHOD DENTOFAC, V107, P372, DOI 10.1016/S0889-5406(95)70089-7; KILIARIDIS S, 1989, EUR J ORTHODONT, V11, P131, DOI 10.1093/oxfordjournals.ejo.a035975; Kiliaridis S, 1998, ACTA ODONTOL SCAND, V56, P369, DOI 10.1080/000163598428347; KILIARIDIS S, 1995, J ORAL REHABIL, V22, P619, DOI 10.1111/j.1365-2842.1995.tb01059.x; Kiliaridis S, 2000, INT J PROSTHODONT, V13, P480; Liou EJ, 1998, AM J ORTHOD DENTOFAC, V113, P278; Manzon S, 2007, J ORAL MAXIL SURG, V65, P2575, DOI 10.1016/j.joms.2006.03.047; Marik PK, 2012, PEDIATR DERMATOL, V29, P549, DOI 10.1111/j.1525-1470.2012.01758.x; Mercier J., 1995, Revue de Stomatologie et de Chirurgie Maxillo-Faciale, V96, P74; MULLER H, 1982, J MAXILLOFAC SURG, V10, P224, DOI 10.1016/S0301-0503(82)80044-1; Nozaki S, 2010, Acta Myol, V29, P392; Odman C, 1996, J ORAL REHABIL, V23, P5, DOI 10.1111/j.1365-2842.1996.tb00804.x; Phillips C, 2009, ANGLE ORTHOD, V79, P12, DOI 10.2319/071307-328.1; Portelli M, 2009, EUR J PAEDIATR DENT, V10, P19; RUSSELL SH, 1994, BRIT J ANAESTH, V72, P210, DOI 10.1093/bja/72.2.210; Solano-Hernandez B, 2013, J ORAL MAXIL SURG, V71, P98, DOI 10.1016/j.joms.2012.03.016; STALEY RN, 1992, CLEFT PALATE-CRAN J, V29, P456, DOI 10.1597/1545-1569(1992)029<0456:CDIMD>2.3.CO;2; Suda N, 2004, Orthod Craniofac Res, V7, P55, DOI 10.1046/j.1601-6335.2003.00271.x; Thind Bikram Singh, 2015, Int J Orthod Milwaukee, V26, P55; Tieleman AA, 2012, NEUROMUSCULAR DISORD, V22, P492, DOI 10.1016/j.nmd.2012.01.006; Turner C, 2014, CURR OPIN NEUROL, V27, P599, DOI 10.1097/WCO.0000000000000128; Umemoto G, 2009, SPEC CARE DENT, V29, P210, DOI 10.1111/j.1754-4505.2009.00093.x; van Bruggen HW, 2015, J CHILD NEUROL, V30, P1625, DOI 10.1177/0883073815575575; Zanoteli E, 2002, ORAL SURG ORAL MED O, V94, P262, DOI 10.1067/moe.2002.124580	33	0	0	0	3	ARIESDUE SRL	CARIMATE	VIA AIROLDI, CARIMATE, 11-22060, ITALY	1591-996X	2035-648X		EUR J PAEDIATR DENT	Eur. J. Paediatr. Dent.		2019	20	1					53	58		10.23804/ejpd.2019.20.01.11			6	Dentistry, Oral Surgery & Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine; Pediatrics	JI3ZM	WOS:000493407400011	30919646				2022-03-04	
J	Santoni, FA; Makrythanasis, P; Nikolaev, S; Guipponi, M; Robyr, D; Bottani, A; Antonarakis, SE				Santoni, Federico A.; Makrythanasis, Periklis; Nikolaev, Sergey; Guipponi, Michel; Robyr, Daniel; Bottani, Armand; Antonarakis, Stylianos E.			Simultaneous identification and prioritization of variants in familial, de novo, and somatic genetic disorders with VariantMaster	GENOME RESEARCH			English	Article							ADENYLOSUCCINATE LYASE DEFICIENCY; MENTAL-RETARDATION; HUMAN COLON; MUTATIONS; DISCOVERY; CANCER	There is increasing interest in clinical genetics pertaining to the utilization of high-throughput sequencing data for accurate diagnoses of monogenic diseases. Moreover, massive whole-exome sequencing of tumors has provided significant advances in the understanding of cancer development through the recognition of somatic driver variants. To improve the identification of the variants from HTS, we developed VariantMaster, an original program that accurately and efficiently extracts causative variants in familial and sporadic genetic diseases. The algorithm takes into account predicted variants (SNPs and indels) in affected individuals or tumor samples and utilizes the row (BAM) data to robustly estimate the conditional probability of segregation in a family, as well as the probability of it being de novo or somatic. In familial cases, various modes of inheritance are considered: X-linked, autosomal dominant, and recessive (homozygosity or compound heterozygosity). Moreover, VariantMaster integrates phenotypes and genotypes, and employs Annovar to produce additional information such as allelic frequencies in the general population and damaging scores to further reduce the number of putative variants. As a proof of concept, we successfully applied VariantMaster to identify (1) de novo mutations in a previously described data set, (2) causative variants in a rare Mendelian genetic disease, and (3) known and new "driver'' mutations in previously reported cancer data sets. Our results demonstrate that VariantMaster is considerably more accurate in terms of precision and sensitivity compared with previously published algorithms.	[Santoni, Federico A.; Makrythanasis, Periklis; Nikolaev, Sergey; Robyr, Daniel; Antonarakis, Stylianos E.] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva 4, Switzerland; [Santoni, Federico A.; Guipponi, Michel; Bottani, Armand; Antonarakis, Stylianos E.] HUG, Serv Genet Med, CH-1211 Geneva 4, Switzerland; [Antonarakis, Stylianos E.] Univ Geneva, iGE3 Inst Genet & Genom Geneva, CH-1211 Geneva 4, Switzerland		Santoni, FA (corresponding author), Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva 4, Switzerland.	federico.santoni@unige.ch	Antonarakis, Stylianos E/N-8866-2014; Makrythanasis, Periklis/AAD-7180-2019	Antonarakis, Stylianos E/0000-0001-8907-5823; Santoni, Federico/0000-0002-3258-4747	SNF [144082]; ERCEuropean Research Council (ERC)European Commission [249968]; ChildCare Foundation; Gebert Foundation; Bodossaki Foundation	We thank Ximena Bonilla, Teresa Didonna, and Sam Lukowsky for useful comments and discussions. This study is supported by grants from the SNF (144082), ERC (249968), and ChildCare and Gebert Foundations to S.E.A., and a grant from the Bodossaki Foundation to P.M.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Chun S, 2009, GENOME RES, V19, P1553, DOI 10.1101/gr.092619.109; Conrad DF, 2011, NAT GENET, V43, P712, DOI 10.1038/ng.862; Cooper GM, 2011, NAT REV GENET, V12, P628, DOI 10.1038/nrg3046; Edery P, 2003, AM J MED GENET A, V120A, P185, DOI 10.1002/ajmg.a.20176; Gilfillan GD, 2008, AM J HUM GENET, V82, P1003, DOI 10.1016/j.ajhg.2008.01.013; Jurecka A, 2008, J INHERIT METAB DIS, V31, pS329, DOI 10.1007/s10545-008-0904-z; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Li BS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002944; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li MX, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1257; Makrythanasis P, 2012, MOL SYNDROMOL, V3, P197, DOI 10.1159/000343941; Marie S, 2000, ADV EXP MED BIOL, V486, P79; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Moore DJ, 2013, AM J HUM GENET, V93, P346, DOI 10.1016/j.ajhg.2013.07.009; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nikolaev SI, 2012, CANCER RES, V72, P6279, DOI 10.1158/0008-5472.CAN-12-3869; Peng G, 2013, P NATL ACAD SCI USA, V110, P3985, DOI 10.1073/pnas.1222158110; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Race V, 2000, HUM MOL GENET, V9, P2159, DOI 10.1093/hmg/9.14.2159; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Tarpey PS, 2009, NAT GENET, V41, P535, DOI 10.1038/ng.367; 2012, NAT BIOTECHNOL, V30, P1009	26	28	28	0	15	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	FEB	2014	24	2					349	355		10.1101/gr.163832.113			7	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	303TG	WOS:000330696800017	24389049	Green Submitted, hybrid, Green Published			2022-03-04	
J	Combescure, C; Courvoisier, DS; Haller, G; Perneger, TV				Combescure, C.; Courvoisier, D. S.; Haller, G.; Perneger, T. V.			Meta-analysis of binary outcomes from two-by-two tables when the length of follow-up varies and hazards are proportional	STATISTICAL METHODS IN MEDICAL RESEARCH			English	Article							HETEROGENEITY; RATIO; RISK	Odds ratios (ORs) and relative risks (RRs) are sensitive to the length of follow-up. In meta-analyses, pooling such results from studies with different lengths of follow-up may lead to an artificial heterogeneity and discrepancy caused by the choice of the summary index. In this article, we explore the utility of a meta-analysis method that uses the ratio of logarithms of survival probability as the measure of association, and that avoids the problems mentioned above when hazards are proportional. Meta-analyses of ORs, RRs and ratios of logarithms of survival probability are compared through a simulation study, in which data are simulated from a proportional hazard model and the length of follow-up varies across studies using realistic patterns of variability. Results show that the heterogeneity increases with the variability of length of follow-up for OR and RR, but not for the ratio of the logarithms of survival probability. A published meta-analysis is used to illustrate the method.	[Combescure, C.; Courvoisier, D. S.; Haller, G.; Perneger, T. V.] Univ Hosp Geneva, Div Clin Epidemiol, Fac Med Geneva, CH-1211 Geneva 14, Switzerland		Combescure, C (corresponding author), Univ Hosp Geneva, Div Clin Epidemiol, Fac Med Geneva, Rue Gabrielle Perret Gentil 4, CH-1211 Geneva 14, Switzerland.	Christophe.Combescure@hcuge.ch	Courvoisier, Delphine/H-6054-2011	Courvoisier, Delphine/0000-0002-1956-2607; haller, guy/0000-0001-7367-7029			Cunningham D, 1998, LANCET, V352, P1413, DOI 10.1016/S0140-6736(98)02309-5; D'Amico R, 1999, BRIT MED J, V319, P1200; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DUFFY SW, 1990, AM J EPIDEMIOL, V132, P198, DOI 10.1093/oxfordjournals.aje.a115636; Falagas ME, 2009, EPIDEMIOLOGY, V20, P930, DOI 10.1097/EDE.0b013e3181ba40eb; Fleiss J L, 1993, Stat Methods Med Res, V2, P121, DOI 10.1177/096228029300200202; Glasziou PP, 2002, STAT MED, V21, P1503, DOI 10.1002/sim.1183; GREENLAND S, 1990, AM J EPIDEMIOL, V132, P585, DOI 10.1093/oxfordjournals.aje.a115697; Higgins JPT, 2004, STAT MED, V23, P1663, DOI 10.1002/sim.1752; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Katz KA, 2006, ARCH DERMATOL, V142, P761, DOI 10.1001/archderm.142.6.761; Moodie PF, 2004, STAT MED, V23, P1075, DOI 10.1002/sim.1696; Perneger TV, 2008, CONTEMP CLIN TRIALS, V29, P762, DOI 10.1016/j.cct.2008.06.002; Pocock S, 1993, Stat Methods Med Res, V2, P117, DOI 10.1177/096228029300200201; Simmonds P C, 2000, BMJ, V321, P531; Sutton AJ, 2008, STAT MED, V27, P625, DOI 10.1002/sim.2934; Sweeting MJ, 2004, STAT MED, V23, P1351, DOI 10.1002/sim.1761; Symons MJ, 2002, J CLIN EPIDEMIOL, V55, P893, DOI 10.1016/S0895-4356(02)00443-2; Thompson S G, 1993, Stat Methods Med Res, V2, P173, DOI 10.1177/096228029300200205; Thornton A, 2000, J CLIN EPIDEMIOL, V53, P207, DOI 10.1016/S0895-4356(99)00161-4; 2000, COCHRANE DATABASE SY	21	7	7	0	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0962-2802			STAT METHODS MED RES	Stat. Methods Med. Res.	OCT	2011	20	5					531	540		10.1177/0962280210379172			10	Health Care Sciences & Services; Mathematical & Computational Biology; Medical Informatics; Statistics & Probability	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services; Mathematical & Computational Biology; Medical Informatics; Mathematics	837XV	WOS:000296245700006	20716589				2022-03-04	
J	Onisor, I; Pecie, R; Chaskelis, I; Krejci, I				Onisor, I.; Pecie, R.; Chaskelis, I.; Krejci, I.			Cutting and coagulation during intraoral soft tissue surgery using Er:YAG laser	EUROPEAN JOURNAL OF PAEDIATRIC DENTISTRY			English	Article						Chewing cycles; Deep bite; EMG activity; Functional appliance; masticatory muscles	ER-YAG LASER; DENTISTRY; ACCEPTANCE; THERAPY; HARD	Aim To find the optimal techniques and parameters that enables Er:YAG laser to be used successfully for small intraoral soft tissue interventions, in respect to its cutting and coagulation abilities. Case report In vitro pre-tests: 4 different Er:YAG laser units and one CO, unit as the control were used for incision and coagulation on porcine lower jaws and optimal parameters were established for each type of intervention and each laser unit: energy, frequency, type, pulse duration and distance. Case series: 3 different types of intervention using Er:YAG units are presented: crown lengthening, gingivoplasty and maxillary labial frenectomy with parameters found in the in vitro pre-tests. Results The results showed a great decrease of the EMG activity of masseter and anterior temporalis muscles. Moreover, the height and width of the chewing cycles in the frontal plane increased after therapy. Conclusion Er:YAG is able to provide good cutting and coagulation effects on soft tissues. Specific parameters have to be defined for each laser unit in order to obtain the desired effect. Reduced or absent water spray, defocused light beam, local anaesthesia and the most effective use of long pulses are methods to obtain optimal coagulation and bleeding control.	[Onisor, I.; Pecie, R.; Chaskelis, I.; Krejci, I.] Univ Geneva, Div Cariol & Endodont, Sch Dent, Geneva, Switzerland		Onisor, I (corresponding author), Univ Geneva, Div Cariol & Endodont, Sch Dent, Geneva, Switzerland.	iona.onisor@unige.ch					Boj J., 2005, J ORAL LASER APPL, V5, P85; Boj JR, 2011, EUR ARCH PAEDIATR DE, V12, P113, DOI 10.1007/BF03262790; Boj JR, 2011, EUR ARCH PAEDIATR DE, V12, P100, DOI 10.1007/BF03262788; Cercadillo-Ibarguren I, 2010, MED ORAL PATOL ORAL, V15, pE912, DOI 10.4317/medoral.15.e912; Deppe H, 2007, LASER MED SCI, V22, P217, DOI 10.1007/s10103-007-0440-3; Gaspirc B, 2007, J PERIODONTOL, V78, P1864, DOI 10.1902/jop.2007.070054; Genovese MD, 2008, EUR J PAEDIATR DENT, V9, P13; Gontijo I, 2005, J DENT CHILD, V72, P10; HIBST R, 1989, LASER SURG MED, V9, P338, DOI 10.1002/lsm.1900090405; Hibst R, 2002, J ORAL LASER APPL, V2, P203; Keller U, 1998, J DENT, V26, P649, DOI 10.1016/S0300-5712(97)00036-5; Lanigan SW, 2002, LASERS DERMATOLOGY; Martens LC, 2011, EUR ARCH PAEDIATR DE, V12, P61, DOI 10.1007/BF03262781; Olivi G, 2009, EUR J PAEDIATR DENT, V10, P29; Olivi G, 2010, GEN DENT, V58, pe126; Stock M, 1997, P SOC PHOTO-OPT INS, V3192, P88, DOI 10.1117/12.297864; van As Glenn, 2004, Dent Clin North Am, V48, P1017, DOI 10.1016/j.cden.2004.06.001; Venugopalan V., 1995, P SOC PHOTO-OPT INS, V2381, P184; Watanabe H, 1996, J Clin Laser Med Surg, V14, P67; White JM, 2002, PROC SPIE, V4610, P39, DOI 10.1117/12.469331	20	7	8	0	26	ARIESDUE SRL	CARIMATE	VIA AIROLDI, CARIMATE, 11-22060, ITALY	1591-996X	2035-648X		EUR J PAEDIATR DENT	Eur. J. Paediatr. Dent.	JUN	2013	14	2					140	145					6	Dentistry, Oral Surgery & Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine; Pediatrics	161UT	WOS:000320219500012	23758465				2022-03-04	
J	Mast, P; Tapia, MTR; Daeniker, L; Krejci, I				Mast, P.; Tapia, M. T. Rodriguez; Daeniker, L.; Krejci, I.			Understanding MIH: definition, epidemiology, differential diagnosis and new treatment guidelines	EUROPEAN JOURNAL OF PAEDIATRIC DENTISTRY			English	Article						Diagnosis; Enamel disorders; Glass ionomer cement; Molar-Incisor Hypomineralisation	PERMANENT MOLARS; PHOSPHOPEPTIDE; ENAMEL; CASEIN	Molar-Incisor Hypomineralisation (MIH) is a congenital disease which increases in prevalence. It affects permanent first molars and, often to a lesser degree, permanent incisors with variable severity The aetiology is unknown, but different hypotheses have been advanced. Differential diagnosis is mandatory not to confound MIH with other diseases. Treatment consists in a minimally invasive approach by reinforcing and protecting the existing dental structure. In more severe cases, restorative treatment may be indicated.	[Mast, P.; Tapia, M. T. Rodriguez; Daeniker, L.; Krejci, I.] Univ Geneva, Div Cariol & Endodontol, CH-1211 Geneva 4, Switzerland		Mast, P (corresponding author), Univ Geneva, Div Cariol & Endodontol, CH-1211 Geneva 4, Switzerland.	ivo.krejci@unige.ch					Cross KJ, 2005, J BIOL CHEM, V280, P15362, DOI 10.1074/jbc.M413504200; Fitzpatrick Laura, 2007, J Ir Dent Assoc, V53, P32; Gotler M, 2010, VEHASHINAYIM RH, V27, P10; JACKSON D, 1961, ARCH ORAL BIOL, V5, P212, DOI 10.1016/0003-9969(61)90059-0; Kellerhoff Nadja-Marina, 2004, Schweiz Monatsschr Zahnmed, V114, P243; KOCH G, 1987, COMMUNITY DENT ORAL, V15, P279, DOI 10.1111/j.1600-0528.1987.tb00538.x; Lasfargues JJ, 1987, REV ODONTOSTOMATOL, P16403; Leppaniemi A, 2001, CARIES RES, V35, P36; Ostertag S, 2009, ZAHNARZT PRAXIS, V2-3, P4; REEVES RE, 1958, SCIENCE, V128, P472, DOI 10.1126/science.128.3322.472; Reich E, 2005, ZM, V22, p[52, 59]; Rodd HD, 2007, PEDIATR DENT, V29, P514; Schroeder HE., 1991, ORAL STRUCTURAL BIOL; VANAMERONGEN WE, 1995, J DENT CHILD, V62, P266; Weerheijm K L, 2003, Eur J Paediatr Dent, V4, P114; Weerheijm KL, 2001, CARIES RES, V35, P390, DOI 10.1159/000047479	16	19	21	0	21	ARIESDUE SRL	CARIMATE	VIA AIROLDI, CARIMATE, 11-22060, ITALY	1591-996X			EUR J PAEDIATR DENT	Eur. J. Paediatr. Dent.	SEP	2013	14	3					204	208					5	Dentistry, Oral Surgery & Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine; Pediatrics	230BC	WOS:000325310600008	24295005				2022-03-04	
J	Negro, F				Negro, F.			Epidemiology: risk of transmission in various regions of the world and prevention of routes of transmission	JOURNAL OF VIRAL HEPATITIS			English	Meeting Abstract	Viral Hepatitis Congress	SEP 26-28, 2013	Frankfurt, GERMANY						[Negro, F.] Univ Geneva, Geneva, Switzerland				Negro, Francesco/E-2183-2012					0	0	0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1352-0504			J VIRAL HEPATITIS	J. Viral Hepatitis	SEP	2013	20			3	SI		2	2					1	Gastroenterology & Hepatology; Infectious Diseases; Virology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Gastroenterology & Hepatology; Infectious Diseases; Virology	225XI	WOS:000324998100004					2022-03-04	
J	Lyle, R; Gehrig, C; Neergaard-Henrichsen, C; Deutsch, S; Antonarakis, SE				Lyle, R; Gehrig, C; Neergaard-Henrichsen, C; Deutsch, S; Antonarakis, SE			Gene expression from the aneuploid chromosome in a trisomy mouse model of down syndrome	GENOME RESEARCH			English	Article							TS65DN; TRANSCRIPTOME; LOCALIZATION; SEQUENCE; PCR	Trisomy 21 is the prototype of human aneuploidies. Since its discovery in 1959, the hypothesis has been that overexpression of the similar to230 human chromosome 21 (Hsa21) genes result in the complex phenotype. However, the level of overexpression of Hsa21 genes in trisomic individuals is presently unknown. We have used Taqman real-time quantitative PCR to accurately measure expression of the mouse orthologs of Hsa21 in the partial trisomy mouse model Ts65Dn. The transcript levels of 78 protein-coding genes present in three copies in Ts65Dn and 21 control genes were compared between Ts65Dn and normal mouse littermates. The mean overexpression of the aneuploid genes is very close to the expected 1.5-fold in all Six tissues studied. However, only approximately a third of the genes (37%) are expressed at the theoretical value of 1.5-fold. On average, 45% of the genes are expressed at significantly lower than 1.5-fold, and 9% are not significantly different from I.O. Interestingly, 18% of the aneuploid genes were expressed at levels significantly greater than 1.5-fold. These data provide candidate genes that might be involved in the phenotypes of Down syndrome, and reveal a complex regulation of gene expression that is not only related to gene copy number.	Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; Univ Hosp Geneva, CH-1211 Geneva, Switzerland		Lyle, R (corresponding author), Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland.	Robert.Lyle@medicine.unige.ch	Hor, Charlotte/AAB-4850-2020; Antonarakis, Stylianos E/N-8866-2014; Hor, Charlotte/H-5908-2015	Hor, Charlotte/0000-0002-5361-2372; Antonarakis, Stylianos E/0000-0001-8907-5823; Hor, Charlotte/0000-0002-5361-2372; Deutsch, Samuel/0000-0001-9456-7101			Akeson EC, 2001, CYTOGENET CELL GENET, V93, P270, DOI 10.1159/000056997; Barlow GM, 2001, GENET MED, V3, P91, DOI 10.1097/00125817-200103000-00002; Baxter LL, 2000, HUM MOL GENET, V9, P195, DOI 10.1093/hmg/9.2.195; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Cheung VG, 2002, NAT GENET, V32, P522, DOI 10.1038/ng1036; Cheung VG, 2003, NAT GENET, V33, P422, DOI 10.1038/ng1094; Chrast R, 2000, GENOME RES, V10, P2006, DOI 10.1101/gr.10.12.2006; DAVISSON MT, 1990, PROG CLIN BIOL RES, V360, P263; Davisson MT, 2001, GENOMICS, V78, P99, DOI 10.1006/geno.2001.6639; Epstein CJ., 2001, METABOLIC MOL BASES, P1223; FitzPatrick DR, 2002, HUM MOL GENET, V11, P3249, DOI 10.1093/hmg/11.26.3249; Hattori M, 2000, NATURE, V405, P311, DOI 10.1038/35012518; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mao R, 2003, GENOMICS, V81, P457, DOI 10.1016/S0888-7543(03)00035-1; Pletcher MT, 2001, GENOMICS, V74, P45, DOI 10.1006/geno.2001.6533; Pritchard MA, 1999, J NEURAL TRANSM-SUPP, P293; REEVES RH, 1995, NAT GENET, V11, P177, DOI 10.1038/ng1095-177; Reeves RH, 2001, TRENDS GENET, V17, P83, DOI 10.1016/S0168-9525(00)02172-7; Reymond A, 2002, GENOMICS, V79, P824, DOI 10.1006/geno.2002.6781; Reymond A, 2002, NATURE, V420, P582, DOI 10.1038/nature01178; Reymond A, 2001, GENOMICS, V78, P46, DOI 10.1006/geno.2001.6640; Richtsmeier JT, 2000, DEV DYNAM, V217, P137, DOI 10.1002/(SICI)1097-0177(200002)217:2<137::AID-DVDY1>3.0.CO;2-N; Saran NG, 2003, HUM MOL GENET, V12, P2013, DOI 10.1093/hmg/ddg217; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Shapiro BL, 1997, HUM GENET, V99, P421, DOI 10.1007/s004390050383; Sokal RR, 1995, BIOMETRY, V3rd; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034	27	147	151	0	6	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	JUL	2004	14	7					1268	1274		10.1101/gr.2090904			7	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	834TQ	WOS:000222434200006	15231743	Green Published, Bronze			2022-03-04	
J	Savatier, L; Curnier, F; Krejci, I				Savatier, L.; Curnier, F.; Krejci, I.			Micro-CT evaluation of cavities prepared with with different Er:YAG hand pieces	EUROPEAN JOURNAL OF PAEDIATRIC DENTISTRY			English	Article						Cavity preparation; Cavity shape; Er: YAG laser; Micro-computer tomography (Micro-CT); Minimally invasive dentistry	ER-YAG LASER; CARIES REMOVAL; DENTISTRY; ABLATION	Aim The aim of the study was to compare several cavity shapes after application using different handpieces and tips of Er:YAG laser. Materials and methods Firstly, this in vitro investigation was performed on two upper molars. Their crowns were cut horizontally underneath the occlusal fissures in order to obtain a flat dentin surface. Afterwards, minimal cavities were prepared by using an Er:YAG laser device with a variety of handpieces and tips (Kavo KEY Laser Plus). All cavities were prepared using the following parameters: 250 mJ and 10 Hz during 30s, and were scanned using Micro-CT Secondly, thirteen caries-free, human upper Molars were prepared according to the same protocol. Five cavities were prepared on each tooth, using five different tips and the same laser settings as step one. The cavities' depths were measured with a digital micrometer. The width and morphology were controlled under scanning electron microscope (SEM). Results Noticeable differences in the dimensions of the cavities were observed; even if the same laser parameters were used for all preparations. Two main shapes were registered:, triangle and rectangle. Conclusion None of the cavities presented an adheSive configuration, rounded shape often found in hidden caries; they were straighter (rectangle) or focusing (triangle). For the moment, there is no ideal Er:YAG laser handpiece/tip in order to prepare conservative adhesive cavity.	[Savatier, L.; Curnier, F.; Krejci, I.] Univ Geneva, Div Cariol & Endodontol, Geneva, Switzerland		Savatier, L (corresponding author), Univ Geneva, Div Cariol & Endodontol, Geneva, Switzerland.	ivo.krejci@unige.ch					Bader C, 2006, AM J DENT, V19, P178; Banerjee A, 2013, BRIT DENT J, V214, P107, DOI 10.1038/sj.bdj.2013.106; De Moor RJG, 2009, J ADHES DENT, V11, P427, DOI [10.3290/j.jad.a17528, 10.3290/j.jad.a18136]; Delme K., 2006, J ORAL LASER APPL, V6, P43; Dommisch H, 2008, EUR J ORAL SCI, V116, P170, DOI 10.1111/j.1600-0722.2008.00521.x; Eberhard J, 2008, CLIN ORAL INVEST, V12, P311, DOI 10.1007/s00784-008-0203-y; Eberhard J, 2005, CARIES RES, V39, P496, DOI 10.1159/000088186; Firoozmand L, 2008, BR DENT J, V205, pE1; Firoozmand L, 2008, BR DENT J, V205, P28; Furtando Messias DC, 2006, J ORAL LASER APPL, V6, P181; George R., 2007, J ORAL LASER APPL, V7, p225 ; Harashima T, 2005, PHOTOMED LASER SURG, V23, P52, DOI 10.1089/pho.2005.23.52; HIBST R, 1989, LASER SURG MED, V9, P338, DOI 10.1002/lsm.1900090405; Hibst R, 2002, J ORAL LASER APPL, V2, P203; Iaria Giuseppe, 2008, General Dentistry, V56, P636; Keller U, 1998, J DENT, V26, P649, DOI 10.1016/S0300-5712(97)00036-5; Komblit R, 2009, EUR J PAERDIATR DENT, V10, P75; Komblit R, 2008, EUR J PAEDIATR DENT, V9, P81; Oelgiesser D, 2003, AM J DENT, V16, P96; Schoop U, 2004, LASER SURG MED, V35, P111, DOI 10.1002/lsm.20026; Sela M., 2003, J ORAL LASER APPL, V3, P153	21	2	2	0	2	ARIESDUE SRL	CARIMATE	VIA AIROLDI, CARIMATE, 11-22060, ITALY	1591-996X	2035-648X		EUR J PAEDIATR DENT	Eur. J. Paediatr. Dent.	JUN	2014	15	2					95	100					6	Dentistry, Oral Surgery & Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine; Pediatrics	AJ3FK	WOS:000337551700002	25102455				2022-03-04	
J	Suarez, C; Antonarakis, GS; Pham, D				Suarez, C.; Antonarakis, G. S.; Pham, D.			Occlusal characteristics in subjects with or without the ability to roll the tongue	EUROPEAN JOURNAL OF PAEDIATRIC DENTISTRY			English	Article						Malocclusion; Occlusal characteristics; Tongue: Tongue rolling	MALOCCLUSION; CHILDREN; POSTURE; FORM	Aim The tongue represents an important intraoral muscular force which is in direct contact with the dental arches. The objective of the current study was to compare occlusal characteristics of patients who have the ability to roll their tongue (TR+) to those who cannot (TR-). Materials and methods A hundred consecutive patients under orthodontic treatment were classified as TR+ (n=73) or TR- (n=27). Pre-treatment orthodontic study Casts were used to measure intercanine and intermolar widths, arch lengths, space deficiency, overjet, overbite, presence or absence of posterior crossbite and the molar Angle class. For continuous variables, independent sample t-tests and Mann-Whitney U tests were used to examine differences between the groups. For dichotomous variables, chi-square tests were Used to examine differences between groups, Results TR+ patients showed larger mandibular intermolar widths (1 mm, p<0.05) and less,mandibular space deficiency (1.9 mm, p<0.05) than TR- patients. Mandibular space deficiency was present in the Mandibular arch in 18.5% of TR+ compared to 49.3% in Tif-patients (p<0.05). Conclusions The ability to toll the tongue may lead to differences in occlusal characteristics, namely an inerease in mandibular ihtermolar width and a less mandibular space deficiency	[Suarez, C.; Antonarakis, G. S.; Pham, D.] Univ Geneva, Sch Dent, Dept Orthodont & Pediat Dent, CH-1211 Geneva 4, Switzerland		Suarez, C (corresponding author), Univ Geneva, Sch Dent, Dept Orthodont & Pediat Dent, CH-1211 Geneva 4, Switzerland.	carlos.suarezmartinez@unige.ch	Antonarakis, Gregory/ABA-1855-2020	Antonarakis, Gregory/0000-0001-6741-6922			ANDRIANOPOULOS MV, 1987, ANGLE ORTHOD, V57, P121; CLEALL JF, 1965, AMER J ORTHODONTICS, V51, P566, DOI 10.1016/0002-9416(65)90028-X; Dahlberg G., 1940, STAT METHODS MED BIO; GHAFARI J, 1988, AM J ORTHOD DENTOFAC, V93, P126, DOI 10.1016/0889-5406(88)90289-2; HANSON ML, 1973, AM J ORTHOD DENTOFAC, V64, P63, DOI 10.1016/0002-9416(73)90281-9; HARVOLD EP, 1968, AMER J ORTHODONTICS, V54, P883, DOI 10.1016/0002-9416(68)90241-8; HSU TC, 1948, J HERED, V39, P187, DOI 10.1093/oxfordjournals.jhered.a105848; KOMAI T, 1951, J HERED, V42, P293, DOI 10.1093/oxfordjournals.jhered.a106237; LIU TT, 1949, J HERED, V40, P19, DOI 10.1093/oxfordjournals.jhered.a105945; Melsen B, 1979, Eur J Orthod, V1, P271; Pachi F, 2009, ANGLE ORTHOD, V79, P873, DOI 10.2319/060708-595.1; Proffit W.R., 2007, CONT ORTHODONTICS; PROFFIT WR, 1978, ANGLE ORTHOD, V48, P175; Saccomanno S, 2012, EUR J PAEDIATR DENT, V13, P321; Saccomanno S, 2012, EUR J PAEDIATR DENT, V13, P241; STRAUB WJ, 1962, AM J ORTHOD DENTOFAC, V48, P486, DOI 10.1016/0002-9416(62)90128-8; Sturtevant AH, 1940, P NATL ACAD SCI USA, V26, P100, DOI 10.1073/pnas.26.2.100; SUBTELNY JD, 1970, ANGLE ORTHOD, V40, P170; Thilander Birgit, 2002, J Orofac Orthop, V63, P371, DOI 10.1007/s00056-002-0210-6; Tomes C. S., 1873, DENT COSMOS, V15, P292; URBANOWSKI A, 1947, J HERED, V38, P365; Volk J, 2010, AM J ORTHOD DENTOFAC, V138, P608, DOI 10.1016/j.ajodo.2008.12.028; Weinstein Sam, 1963, ANGLE ORTHOD, V33, P1	23	1	1	0	5	ARIESDUE SRL	CARIMATE	VIA AIROLDI, CARIMATE, 11-22060, ITALY	1591-996X	2035-648X		EUR J PAEDIATR DENT	Eur. J. Paediatr. Dent.	JUN	2014	15	2					147	150					4	Dentistry, Oral Surgery & Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine; Pediatrics	AJ3FK	WOS:000337551700012	25102465				2022-03-04	
J	Epars, JF; Mavropoulos, A; Kiliaridis, S				Epars, Jean-Francois; Mavropoulos, Anestis; Kiliaridis, Stavros			Influence of Age and Vertical Facial Type on the Location of the Mandibular Foramen	PEDIATRIC DENTISTRY			English	Article						MANDIBULAR NERVE BLOCK; CEPHALOMETRY; VERTICAL DIMENSION; DENTAL OCCLUSION; AGE FACTORS	POSITION; GROWTH; CHILDREN; FACE	Purpose: A successful inferior alveolar nerve block anesthesia necessitates knowledge of the exact location of the mandibular foramen. The aim of this study was to determine whether the location of the mandibular foramen is related to the age or the vertical facial morphology of the patient. Methods: Lateral cephalometric radiographs from 145 patients (average age 10.4 years; range 63 to 14.5 year's) were collected. The position of the mandibular foramen was investigated both antero-posteriorely and vertically in relation to the occlusal plane. Pearson's correlation and multiple regression analysis were performed between the variables under study. Results: The mandibular foramen was horizontally located at 50 percent of the ramus width from its anterior border. The vertical distance of the mandibular foramen from the occlusal plane was significantly correlated to all examined variables, especially to the patient's age (r=0.69, P<0.001), the inter-maxillary angle (r=-0.60, P<0.001), and the lower facial anterior soft tissue ratio (r=-0.76, P<0.001). Multiple regression analysis explained more than 70 percent of the variation of the vertical position of the mandibular foramen. Conclusions: Taking into consideration the age and the facial morphology of the patient may help better locate the mandibular foramen, which is a prerequisite for a successful and safe inferior alveolar nerve block.	[Epars, Jean-Francois; Mavropoulos, Anestis; Kiliaridis, Stavros] Univ Geneva, Sch Dent, Dept Orthodont, Geneva, Switzerland		Epars, JF (corresponding author), Univ Geneva, Sch Dent, Dept Orthodont, Geneva, Switzerland.	ifepars@gmail.com					Afsar A, 1998, ORAL SURG ORAL MED O, V86, P234, DOI 10.1016/S1079-2104(98)90131-7; Arat ZM, 2005, ANGLE ORTHOD, V75, P69; BENHAM NR, 1976, J DENT CHILD, V43, P17; Bennett CR, 1978, MONHEIMS LOCAL ANEST; BJORK A, 1972, AMER J ORTHODONTICS, V62, P339, DOI 10.1016/S0002-9416(72)90277-1; FIELDS HW, 1984, AM J ORTHOD DENTOFAC, V85, P217, DOI 10.1016/0002-9416(84)90061-7; HAYWARD J, 1977, ORAL SURG ORAL MED O, V44, P837, DOI 10.1016/0030-4220(77)90027-5; HOUSTON WJB, 1983, AM J ORTHOD DENTOFAC, V83, P382, DOI 10.1016/0002-9416(83)90322-6; Hwang T J, 1990, Zhonghua Ya Yi Xue Hui Za Zhi, V9, P98; ISAACSON JR, 1971, ANGLE ORTHOD, V41, P219; Jerolimov V, 1998, COLLEGIUM ANTROPOL, V22, P169; Kanno CM, 2005, J DENT CHILD, V72, P56; Keros J, 2001, COLLEGIUM ANTROPOL, V25, P327; KILIARIDIS S, 1993, ACTA ODONTOL SCAND, V51, P323, DOI 10.3109/00016359309040583; Malamed SF, 2004, HDB LOCAL ANESTHESIA; Mavropoulos A, 2010, BONE, V47, P687, DOI 10.1016/j.bone.2010.06.025; Mbajiorgu E. F., 2000, Central African Journal of Medicine, V46, P184; Movahhed T, 2011, Journal of Applied Sciences, V11, P573, DOI 10.3923/jas.2011.573.578; MWANIKI DL, 1992, E AFR MED J, V69, P210; Narayana K, 2004, Indian J Dent Res, V15, P99; NICHOLSON ML, 1985, ANAT REC, V212, P110, DOI 10.1002/ar.1092120116; OLSEN N H, 1956, J Am Dent Assoc, V53, P548; OPDEBEECK H, 1978, AM J ORTHOD DENTOFAC, V73, P499, DOI 10.1016/0002-9416(78)90240-3; Pinkham JR, 2005, PEDIAT DENT INFANCY, P447; Prado FB, 2010, CLIN ANAT, V23, P394, DOI 10.1002/ca.20973; PROFFIT WR, 1983, J DENT RES, V62, P566, DOI 10.1177/00220345830620051201; SCHENDEL SA, 1976, AM J ORTHOD DENTOFAC, V70, P398, DOI 10.1016/0002-9416(76)90112-3; Steiner RB, 1977, ORAL SURG ANESTHESIA; Thoma KH, 1958, ORAL SURG; Trost O, 2010, SURG RADIOL ANAT, V32, P927, DOI 10.1007/s00276-010-0645-1; WONG MKS, 1992, J AM DENT ASSOC, V123, P69, DOI 10.14219/jada.archive.1992.0004	31	5	5	0	0	AMER ACAD PEDIATRIC DENTISTRY	CHICAGO	211 E CHICAGO AVENUE SUITE 1036, CHICAGO, IL 60611-2616 USA	0164-1263	1942-5473		PEDIATR DENT	Pediatr. Dent.	JUL-AUG	2013	35	4					369	373					5	Dentistry, Oral Surgery & Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine; Pediatrics	AS8TM	WOS:000344520900012	23930639				2022-03-04	
J	Khouja, F; Abdelaziz, M; Bortolotto, T; Krejci, I				Khouja, F.; Abdelaziz, M.; Bortolotto, T.; Krejci, I.			Intra-pulpal and subsurface temperature rise during tooth irradiation with 808 nm diode laser: an in vitro study	EUROPEAN JOURNAL OF PAEDIATRIC DENTISTRY			English	Review						Diode laser; Dental tissues; Laser irradiation; Temperature changes	PULP CHAMBER; ROOT SURFACE; TEETH; LESIONS; TISSUE	Aim This in vitro study evaluated the pulpal and subsurface temperatures during proximal tooth surface irradiation with different settings of an 808 nm diode laser. Materials and methods The elevation of pulpal and subsurface temperature during irradiation was measured using thermocouples positioned in the centre of the pulp chamber (n=30) and in the centre of a prepared 1.5 mm deep coronal cavity (n=30). Each sample was irradiated 3 times within one-week interval using different exposure settings. A temperature increase of 3.5 degrees C was regarded as critical value for pulpal heath. Results were analysed with one-way ANOVA and Duncan post hoc tests. Micromorphological investigation by digital microscopy was carried out for the irradiated and non-irradiated tooth surface. Results Measurable temperature increase within the pulp chamber (Delta PT) and the subsurface (Delta ST) were observed with all laser settings tested. The highest recorded Delta PT and Delta ST were 3.1 degrees C and 8.5 degrees C, respectively. Delivery mode, beam diameter, and exposure time influenced the temperature rise. No alterations on the enamel surface were observed when inspected by the digital microscope after undergoing irradiation with the tested parameters. Conclusion From the thermal point of view, under the conditions of the present study the application of an 808 nm diode laser on the outer surface of the tooth at 1W in the continuous mode and at 5W in the pulsed mode for two cycles of 30 s each proved to be safe.	[Khouja, F.; Abdelaziz, M.; Bortolotto, T.; Krejci, I.] Univ Geneva, Fac Med, Div Cariol & Endodontol, Sect Dent Med, Geneva, Switzerland		Khouja, F (corresponding author), Univ Geneva, Fac Med, Div Cariol & Endodontol, Sect Dent Med, Geneva, Switzerland.	firas.khouja@unige.ch	Abdelaziz, Marwa/AAZ-9817-2020; Bortolotto, Tissiana/AAE-2796-2021	Abdelaziz, Marwa/0000-0002-9715-879X; Bortolotto, Tissiana/0000-0002-3231-9097			Alfredo E, 2008, J DENT, V36, P529, DOI 10.1016/j.jdent.2008.03.009; Coluzzi DJ, 2011, PRINCIPLES PRACTICE, P12; Gutknecht N, 2004, J CLIN LASER MED SUR, V22, P9, DOI 10.1089/104454704773660912; HUSSEY DL, 1995, J DENT, V23, P267, DOI 10.1016/0300-5712(95)91149-H; Isman E, 2014, SCI WORLD J, DOI 10.1155/2014/589461; Jukic Krmek S, 2009, PHOTOMED LASER SURG, V27, P351, DOI 10.1089/pho.2008.2247; Klinke T, 1997, J Clin Laser Med Surg, V15, P29; Kreisler M, 2002, ORAL SURG ORAL MED O, V93, P730, DOI 10.1067/moe.2002.124766; Moritz A, 1998, LASER SURG MED, V22, P302; Mount GJ, 2000, QUINTESSENCE INT, V31, P535; Odor TM, 1999, INT ENDOD J, V32, P296, DOI 10.1046/j.1365-2591.1999.00224.x; Parirokh Masoud, 2007, Iran Endod J, V2, P37; Parker S, 2007, BRIT DENT J, V202, P445, DOI 10.1038/bdj.2007.294; Parker S, 2007, BRIT DENT J, V202, P73, DOI 10.1038/bdj.2007.24; Ramskold LO, 1997, J ENDODONT, V23, P96, DOI 10.1016/S0099-2399(97)80253-1; SATO K, 1983, CARIES RES, V17, P490, DOI 10.1159/000260708; SCHUCHARD A, 1975, J PROSTHET DENT, V34, P644, DOI 10.1016/0022-3913(75)90062-1; VAARKAMP J, 1995, PHYS MED BIOL, V40, P1375, DOI 10.1088/0031-9155/40/8/006; Yazici AR, 2006, OPER DENT, V31, P261, DOI 10.2341/05-26; Yu D, 1993, J Clin Laser Med Surg, V11, P119; ZACH L, 1965, ORAL SURG ORAL MED O, V19, P515, DOI 10.1016/0030-4220(65)90015-0	21	3	4	0	2	ARIESDUE SRL	CARIMATE	VIA AIROLDI, CARIMATE, 11-22060, ITALY	1591-996X	2035-648X		EUR J PAEDIATR DENT	Eur. J. Paediatr. Dent.		2017	18	1					56	60					5	Dentistry, Oral Surgery & Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine; Pediatrics	FU8DO	WOS:000424083100012	28494605				2022-03-04	
J	Morabia, A; Lash, TL				Morabia, A; Lash, TL			Breast cancer, passive and active cigarette smoking and N-acetyltransferase 2 genotype	PHARMACOGENETICS			English	Letter							N-ACETYLTRANSFERASE-2 GENOTYPE; RISK		Univ Hosp Geneva, Div Clin Epidemiol, CH-1211 Geneva 14, Switzerland; Boston Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Boston, MA USA		Morabia, A (corresponding author), Univ Hosp Geneva, Div Clin Epidemiol, CH-1211 Geneva 14, Switzerland.						CHANGCLAUDE J, 2001, AACR; Delfino RJ, 2000, PHARMACOGENETICS, V10, P461, DOI 10.1097/00008571-200007000-00009; Johnson KC, 2000, CANCER CAUSE CONTROL, V11, P211, DOI 10.1023/A:1008906105790; Lash TL, 1999, AM J EPIDEMIOL, V149, P5; Millikan RC, 1998, CANCER EPIDEM BIOMAR, V7, P371; Morabia A, 2000, AM J EPIDEMIOL, V152, P226, DOI 10.1093/aje/152.3.226; Morabia A, 1996, AM J EPIDEMIOL, V143, P918, DOI 10.1093/oxfordjournals.aje.a008835	7	3	4	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0960-314X			PHARMACOGENETICS	Pharmacogenetics	JAN	2002	12	1					85	86		10.1097/00008571-200201000-00013			2	Biotechnology & Applied Microbiology; Genetics & Heredity; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity; Pharmacology & Pharmacy	515KC	WOS:000173493500013	11773870				2022-03-04	
J	Deakin, S; Guernier, S; James, RW				Deakin, Sara; Guernier, Sophie; James, Richard W.			Pharmacogenetic interaction between paraoxonase-1 gene promoter polymorphism C-107T and statin	PHARMACOGENETICS AND GENOMICS			English	Article						HDL; oxidative stress; pharmacogenetic; promoter; transcription factor	SERUM PARAOXONASE; TRANSGENIC MICE; PON1 GENE; BINDING; EXPRESSION; PROTEINS; ENZYME; SP1	Objective The aims of this study were to compare the impact of transcription factors, together with statin, on the paraoxonase promoter alleles defined by the C(- 107T) polymorphism and to more clearly define regions of the paraoxonase promoter implicated in the actions of transcription factors. Methods Expression studies of promoter alleles were performed with reporter gene cassettes transfected into HepG2 cells, complemented by nuclease protection assays, electrophoretic mobility shift assays and statin therapy in patients. Results One region only of the minimal promoter fragment that up-regulates activity was protected by transcription factors and nuclear extracts. It spanned nucleoticles - 119 to - 100, encompassing the C(- 107)T polymorphism. Sp1 was effective alone in protecting this region, with its effect greatly enhanced by SREBP-2. The protective effect was much stronger for the C vs. T promoter allele. Expression studies confirmed the stimulatory influence of SREBP-2 was significantly stronger for the C promoter. Simvastatin up-regulated promoter activity of the C allele, but had a minor effect on the T allele. Hypercholesterolemic patients homozygous for the C allele showed a significant increase in serum paraoxonase-1 activity and mass during treatment with simvastatin, whereas patients homozygous for the T allele showed no increase. Conclusions The study has delimited the region responsive to transcription factors to a sequence surrounding the C(- 107)T polymorphism of the paraoxonase-1 gene, and demonstrated an interaction at this sequence between Sp1 and SREBP-2. SREBP-2 and statin strongly up-regulated the C, but not the T allele. The results suggest a pharmacogenetic interaction between the promoter and simvastatin, which can influence serum paraoxonase in patients.	Univ Hosp Geneva, Serv Endocrinol Diabet & Nutr, Clin Diabet Unit, CH-1211 Geneva 14, Switzerland; Univ Lausanne, CIG, Lausanne, Switzerland		James, RW (corresponding author), Univ Hosp Geneva, Serv Endocrinol Diabet & Nutr, Clin Diabet Unit, 24,Rue Micheli du Crest, CH-1211 Geneva 14, Switzerland.	Richard.James@hcuge.ch					Brophy VH, 2001, AM J HUM GENET, V68, P1428, DOI 10.1086/320600; Brophy VH, 2001, PHARMACOGENETICS, V11, P77, DOI 10.1097/00008571-200102000-00009; Castellani LW, 1997, J CLIN INVEST, V100, P464, DOI 10.1172/JCI119554; Deakin S, 2003, ARTERIOSCL THROM VAS, V23, P2083, DOI 10.1161/01.ATV.0000096207.01487.36; DEAKIN S, 2003, BIOCH J; Deakin SP, 2004, CLIN SCI, V107, P435, DOI 10.1042/CS20040187; Durrington PN, 2002, ARTERIOSCL THROM VAS, V22, P1248, DOI 10.1161/01.ATV.0000027414.34728.1F; Getz GS, 2004, CURR OPIN LIPIDOL, V15, P261, DOI 10.1097/00041433-200406000-00005; Gouedard C, 2003, MOL PHARMACOL, V63, P945, DOI 10.1124/mol.63.4.945; GOUEDARD C, 2004, REGULATION EXPRESSIO, P127; Haslinger B, 2003, KIDNEY INT, V63, P2065, DOI 10.1046/j.1523-1755.2003.t01-2-00004.x; Horton JD, 1999, CURR OPIN LIPIDOL, V10, P143, DOI 10.1097/00041433-199904000-00008; JAMES RW, 1990, DIABETES, V39, P1158, DOI 10.2337/diabetes.39.10.1158; Leviev I, 2000, ARTERIOSCL THROM VAS, V20, P516, DOI 10.1161/01.ATV.20.2.516; Leviev N, 2001, J MOL MED, V79, P457, DOI 10.1007/s001090100240; Li L, 2004, BIOCHEM CELL BIOL, V82, P460, DOI 10.1139/O04-045; Mackness B, 2003, CIRCULATION, V107, P2775, DOI 10.1161/01.CIR.0000070954.00271.13; Mackness MI, 1998, CURR OPIN LIPIDOL, V9, P319, DOI 10.1097/00041433-199808000-00006; Morel Y, 1998, J BIOL CHEM, V273, P26969, DOI 10.1074/jbc.273.41.26969; Ota K, 2005, METABOLISM, V54, P142, DOI 10.1016/j.metabol.2004.06.018; SANCHEZ HB, 1995, J BIOL CHEM, V270, P1161, DOI 10.1074/jbc.270.3.1161; Shih DM, 1998, NATURE, V394, P284, DOI 10.1038/28406; Shimomura L, 1999, P NATL ACAD SCI USA, V96, P13656, DOI 10.1073/pnas.96.24.13656; Tward A, 2002, CIRCULATION, V106, P484, DOI 10.1161/01.CIR.0000023623.87083.4F; van Himbergen TM, 2005, J LIPID RES, V46, P445, DOI 10.1194/jlr.M400052-JLR200; VanLenten BJ, 1995, J CLIN INVEST, V96, P2758, DOI 10.1172/JCI118345; WAGNER S, 1993, SCIENCE, V262, P395, DOI 10.1126/science.8211160	27	28	29	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1744-6872	1744-6880		PHARMACOGENET GENOM	Pharmacogenet. Genomics	JUN	2007	17	6					451	457		10.1097/FPC.0b013e3280925716			7	Biotechnology & Applied Microbiology; Genetics & Heredity; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity; Pharmacology & Pharmacy	174HD	WOS:000246931900008	17502837				2022-03-04	
J	Delacretaza, A; Santos, PL; Morgui, NS; Vandenberghe, F; Glatard, A; Gholam-Rezaee, M; von Gunten, A; Conus, P; Eap, CB				Delacretaza, Aurelie; Santos, Patricia Lagares; Morgui, Nuria Saigi; Vandenberghe, Frederik; Glatard, Anais; Gholam-Rezaee, Mehdi; von Gunten, Armin; Conus, Philippe; Eap, Chin B.			Influence of polygenic risk scores on lipid levels and dyslipidemia in a psychiatric population receiving weight gain-inducing psychotropic drugs	PHARMACOGENETICS AND GENOMICS			English	Article						lipid traits; polygenic risk score; psychiatry; psychotropic drugs	BODY-MASS INDEX; CARDIOVASCULAR-DISEASE; CRTC1 POLYMORPHISMS; ASSOCIATION; SCHIZOPHRENIA; PREDICTION; VARIANTS; GENETICS; MARKERS; PEOPLE	Objectives Dyslipidemia represents a major health issue in psychiatry. We determined whether weighted polygenic risk scores (wPRSs) combining multiple single-nucleotide polymorphisms (SNPs) associated with lipid levels in the general population are associated with lipid levels [high-density lipoprotein (HDL), low-density lipoprotein (LDL), total cholesterol (TC), and triglycerides] and/or dyslipidemia in patients receiving weight gain-inducing psychotropic drugs. We also determined whether genetics improve the predictive power of dyslipidemia. Patients and methods The influence of wPRS on lipid levels was firstly assessed in a discovery psychiatric sample (n=332) and was then tested for replication in an independent psychiatric sample (n=140). The contribution of genetic markers to predict dyslipidemia was evaluated in the combined psychiatric sample. Results wPRSs were significantly associated with the four lipid traits in the discovery (P=0.02) and in the replication sample (P=0.03). Patients whose wPRS was higher than the median wPRS had significantly higher LDL, TC, and triglyceride levels (0.20, 0.32 and 0.26 mmol/l, respectively; P <= 0.004) and significantly lower HDL levels (0.13 mmol/l; P < 0.0001) compared with others. Adding wPRS to clinical data significantly improved dyslipidemia prediction of HDL (P=0.03) and a trend for improvement was observed for the prediction of TC dyslipidemia (P=0.08). Conclusion Population-based wPRSs have thus significant effects on lipid levels in the psychiatric population. As genetics improved the predictive power of dyslipidemia development, only 24 patients need to be genotyped to prevent the development of one case of HDL hypocholesterolemia. If confirmed by further prospective investigations, the present results could be used for individualizing psychotropic treatment. Copyright (c) 2017 Wolters Kluwer Health, Inc. All rights reserved.	[Delacretaza, Aurelie; Santos, Patricia Lagares; Morgui, Nuria Saigi; Vandenberghe, Frederik; Glatard, Anais; Eap, Chin B.] Lausanne Univ Hosp, Ctr Psychiat Neurosci, Dept Psychiat, Unit Pharmacogenet & Clin Psychopharmacol, Prilly, Switzerland; [Gholam-Rezaee, Mehdi] Lausanne Univ Hosp, Ctr Psychiat Epidemiol & Psychopathol, Dept Psychiat, Prilly, Switzerland; [von Gunten, Armin] Lausanne Univ Hosp, Dept Psychiat, Serv Old Age Psychiat, Prilly, Switzerland; [Conus, Philippe] Lausanne Univ Hosp, Dept Psychiat, Serv Gen Psychiat, Prilly, Switzerland; [Eap, Chin B.] Univ Geneva Lausanne, Sch Pharmaceut Sci, Geneva, Switzerland		Eap, CB (corresponding author), Hop Cery, CH-1008 Lausanne, Switzerland.	chin.eap@chuv.ch		Conus, Philippe/0000-0002-5832-1910; Eap, Chin/0000-0002-5439-0230; Saigi, Nuria/0000-0003-2503-1818; von Gunten, Armin/0000-0001-7852-3803; Vandenberghe, Frederik/0000-0002-8964-2047	Swiss National Research FoundationSwiss National Science Foundation (SNSF) [320030-120686, 324730-144064, 320030-173211]	This work has been funded in part by the Swiss National Research Foundation (C.B.E. and P.C.: 320030-120686, 324730-144064 and 320030-173211).	Al-Mawali Adhra, 2015, Oman Med J, V30, P227, DOI 10.5001/omj.2015.47; Balt SL, 2011, CLIN PHARMACOL THER, V90, P179, DOI 10.1038/clpt.2011.97; Belsky DW, 2013, BIODEMOGR SOC BIOL, V59, P85, DOI 10.1080/19485565.2013.774628; Buscot MJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146081; Cai HL, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.161; Choong E, 2008, Rev Med Suisse, V4, P1994; Choong E, 2013, JAMA PSYCHIAT, V70, P1011, DOI 10.1001/jamapsychiatry.2013.187; Choy PC, 2004, BIOCHEM CELL BIOL, V82, P212, DOI 10.1139/o03-085; Correll CU, 2015, WORLD PSYCHIATRY, V14, P119, DOI 10.1002/wps.20204; Correll CU, 2014, JAMA PSYCHIAT, V71, P1350, DOI 10.1001/jamapsychiatry.2014.1314; Damen JAAG, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2416; de Graaff LCG, 2013, NETH J MED, V71, P145; Hert M, 2012, NAT REV ENDOCRINOL, V8, P114, DOI 10.1038/nrendo.2011.156; Delacretaz A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139155; Ferno J, 2005, PHARMACOGENOMICS J, V5, P298, DOI 10.1038/sj.tpj.6500323; Graham I, 2012, CURR CARDIOL REP, V14, P709, DOI 10.1007/s11886-012-0313-7; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Helgadottir A, 2016, NAT GENET, V48, P634, DOI 10.1038/ng.3561; Hirsch AT, 2002, VASC MED, V7, P323, DOI 10.1191/1358863x02vm453ra; Hung CF, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0334-3; Janssens ACJW, 2007, GENET MED, V9, P528, DOI 10.1097/GIM.0b013e31812eece0; Justesen JM, 2015, CIRC-CARDIOVASC GENE, V8, P465, DOI 10.1161/CIRCGENETICS.114.000637; Kim SF, 2007, P NATL ACAD SCI USA, V104, P3456, DOI 10.1073/pnas.0611417104; KUO PT, 1994, CLIN CARDIOL, V17, P519; Lauressergues E, 2010, N-S ARCH PHARMACOL, V381, P427, DOI 10.1007/s00210-010-0499-4; Lett TAP, 2012, MOL PSYCHIATR, V17, P242, DOI 10.1038/mp.2011.109; Lin X, 2009, DIABETOLOGIA, V52, P600, DOI 10.1007/s00125-008-1254-y; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; MacNeil Raymond R, 2016, Mol Neuropsychiatry, V2, P61, DOI 10.1159/000445802; Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc; Manjunath C N, 2013, Indian J Endocrinol Metab, V17, P969, DOI 10.4103/2230-8210.122600; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Muller B, 2016, HUM GENET, V135, P259, DOI 10.1007/s00439-016-1636-z; Quteineh L, 2016, J AFFECT DISORDERS, V198, P43, DOI 10.1016/j.jad.2016.03.031; R Development Core Team, 2013, R LANG ENV STAT COMP; Ramasamy I, 2016, CLIN CHIM ACTA, V454, P143, DOI 10.1016/j.cca.2015.10.033; Reynolds Gavin P, 2006, J Psychopharmacol, V20, P15, DOI 10.1177/1359786806066040; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Roffeei SN, 2014, PHARMACOGENOMICS, V15, P477, DOI 10.2217/pgs.13.220; Saigi-Morgui N, 2016, PHARMACOGENET GENOM, V26, P208, DOI 10.1097/FPC.0000000000000210; Strong A, 2010, CURR CARDIOVASC RISK, V4, P461, DOI 10.1007/s12170-010-0131-7; Surakka I, 2015, NAT GENET, V47, P589, DOI 10.1038/ng.3300; Thanassoulis G, 2012, CIRC-CARDIOVASC GENE, V5, P113, DOI 10.1161/CIRCGENETICS.111.961342; Toalson Patrick, 2004, Prim Care Companion J Clin Psychiatry, V6, P152; Tse L, 2014, INT CLIN PSYCHOPHARM, V29, P125, DOI 10.1097/YIC.0000000000000014; Vandenberghe F, 2015, J CLIN PSYCHIAT, V76, pE1417, DOI 10.4088/JCP.14m09358; Vehof J, 2011, PSYCHOPHARMACOLOGY, V216, P257, DOI 10.1007/s00213-011-2211-x; Wang CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043834; Wang K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018939; Warrington NM, 2015, INT J EPIDEMIOL, V44, P700, DOI 10.1093/ije/dyv077; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Wofford Marion R, 2006, J Clin Hypertens (Greenwich), V8, P114, DOI 10.1111/j.1524-6175.2006.04751.x	52	3	3	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1744-6872	1744-6880		PHARMACOGENET GENOM	Pharmacogenet. Genomics	DEC	2017	27	12					464	472		10.1097/FPC.0000000000000313			9	Biotechnology & Applied Microbiology; Genetics & Heredity; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biotechnology & Applied Microbiology; Genetics & Heredity; Pharmacology & Pharmacy	FQ4XR	WOS:000418362600005	28945215	Green Accepted			2022-03-04	
J	Fasel, JHD; Majno, PE; Peitgen, HO				Fasel, Jean H. D.; Majno, Pietro E.; Peitgen, Heinz-Otto			Liver segments: an anatomical rationale for explaining inconsistencies with Couinaud's eight-segment concept	SURGICAL AND RADIOLOGIC ANATOMY			English	Article						Liver; Human; Segments; Couinaud; 1-2-20 Concept	SURGICAL ANATOMY; PORTAL-VEIN; CT; LESIONS; SECTOR	Background and purpose An increasing number of surgical and radiological observations call Couinaud's concept of eight liver segments into question and such inconsistencies are commonly explained with anatomical variations. This paper was intended to demonstrate that, beyond variability, another anatomical principle may allow to understand supposedly differing concepts on liver segmentation. Materials and methods The study was performed on 25 portal vein casts scanned by helical CT. The branches of the right and left portal vein and their corresponding territories were determined both anatomically and mathematically (MEVIS LiverAnalyzer, MEVISLab). Results The number of branches coming-off the right and left portal vein was never 8, but many more (mean number 20, range 9-44). Different combinations of these branches and their respective territories, carried out in this study, yielded larger entities and supposedly contradictory subdivisions (including Couinaud's eight segments), without calling upon anatomical variability. Conclusions We suggest the human liver to be considered as corresponding to 1 portal venous territory at the level of the portal vein, to 2 territories at the level of the right and left branch of the portal vein, and to 20 at the level of the rami of the right and left branch. This "1-2-20-concept" is a rationale for reconciling apparent discrepancies with the eight-segment concept. On a pragmatic level, in cases in which imaging or surgical observations do not fit with Couinaud's scheme, we propose clinicians not to autonomically conclude to the presence of an anatomical variation, but to become aware of the presence of an average of 20 (and not 8) second-order portal venous territories within the human liver.	[Fasel, Jean H. D.] Univ Med Ctr, Clin Anat Res Grp, Dept Cellular Physiol & Metab, CH-1211 Geneva 4, Switzerland; [Majno, Pietro E.] Univ Hosp, Dept Visceral Surg, Geneva, Switzerland; [Peitgen, Heinz-Otto] Med Visualisat Ctr, Fraunhofer MEVIS, Bremen, Germany		Fasel, JHD (corresponding author), Univ Med Ctr, Clin Anat Res Grp, Dept Cellular Physiol & Metab, Rue M Servet 1, CH-1211 Geneva 4, Switzerland.	jean.fasel@unige.ch	Peitgen, Heinz-Otto/ABG-2100-2021				Abdalla Eddie K, 2002, Surg Oncol Clin N Am, V11, P835, DOI 10.1016/S1055-3207(02)00035-2; BISMUTH H, 1982, WORLD J SURG, V6, P3, DOI 10.1007/BF01656368; Cervone A, 2000, AM SURGEON, V66, P611; Cho A, 2004, WORLD J SURG, V28, P8, DOI 10.1007/s00268-003-7038-0; Couinaud C, 1998, Chirurgie, V123, P8, DOI 10.1016/S0001-4001(98)80033-0; Couinaud C, 1957, FOIE ETUDES ANATOMIQ; DODD GD, 1993, AM J ROENTGENOL, V161, P574, DOI 10.2214/ajr.161.3.8352108; ELIAS H, 1952, AM J ANAT, V90, P59, DOI 10.1002/aja.1000900104; Fasel JHD, 2008, ANAT REC, V291, P636, DOI 10.1002/ar.20658; Fasel JHD, 1998, RADIOLOGY, V206, P151, DOI 10.1148/radiology.206.1.9423665; Filipponi F, 2000, HEPATO-GASTROENTEROL, V47, P1726; Fischer L, 2002, J COMPUT ASSIST TOMO, V26, P962, DOI 10.1097/00004728-200211000-00019; GOLDSMITH NA, 1957, SURG GYNECOL OBSTET, V105, P310; Hahn HK, 2003, FRACTALS, V11, P53, DOI 10.1142/S0218348X03001422; HJORTSJO CH, 1951, ACTA ANAT, V11, P599; HORSFILED K, 1990, Journal of Applied Physiology, V68, P457; Ko S, 2004, WORLD J SURG, V28, P13, DOI 10.1007/s00268-003-7294-z; KOQURE K, 2002, ARCH SURG-CHICAGO, V137, P1118; MAKUUCHI M, 1985, SURG GYNECOL OBSTET, V161, P346; Ohashi I, 1996, RADIOLOGY, V200, P779, DOI 10.1148/radiology.200.3.8756931; PLATZER W, 1966, ACTA ANAT, V63, P8; Rieker O, 2000, ROFO-FORTSCHR RONTG, V172, P147, DOI 10.1055/s-2000-10505; Skandalakis JE, 2004, SURG CLIN N AM, V84, P413, DOI 10.1016/j.suc.2003.12.002; Strunk H, 2003, EUR RADIOL, V13, P2472, DOI 10.1007/s00330-003-1885-9	24	19	23	0	3	SPRINGER FRANCE	PARIS	22 RUE DE PALESTRO, PARIS, 75002, FRANCE	1279-8517			SURG RADIOL ANAT	Surg. Radiol. Anat.	OCT	2010	32	8					761	765		10.1007/s00276-010-0626-4			5	Anatomy & Morphology; Radiology, Nuclear Medicine & Medical Imaging; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anatomy & Morphology; Radiology, Nuclear Medicine & Medical Imaging; Surgery	654ZX	WOS:000282211400009	20111966	Green Submitted			2022-03-04	
J	Potera, C				Potera, Carol			Animal-Free Toxicity Testing and Drug Screening	GENETIC ENGINEERING & BIOTECHNOLOGY NEWS			English	Article									[Potera, Carol] Univ Geneva, CH-1211 Geneva 4, Switzerland		Potera, C (corresponding author), Univ Geneva, CH-1211 Geneva 4, Switzerland.							0	0	0	0	1	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1935-472X			GENET ENG BIOTECHN N	Genet. Eng. Biotechnol. News	NOV 1	2010	30	19					14	14					1	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	683TR	WOS:000284498600005					2022-03-04	
J	Wenger, Y; Galliot, B				Wenger, Yvan; Galliot, Brigitte			RNAseq versus genome-predicted transcriptomes: a large population of novel transcripts identified in an Illumina-454 Hydra transcriptome	BMC GENOMICS			English	Article						Illumina and 454 RNAseq transcriptome assembly; Hydra transcriptome; Reciprocal Best Hits (RBH); Next generation sequencing; Genome-predicted transcriptome; Human orthologs in Hydra; Pseudogenes	DNA-SEQUENCES; CELL-DIFFERENTIATION; SEQ; PHYLOGENY; EMERGENCE; ALIGNMENT; BLAST; QUANTIFICATION; ARABIDOPSIS; ALGORITHMS	Background: Evolutionary studies benefit from deep sequencing technologies that generate genomic and transcriptomic sequences from a variety of organisms. Genome sequencing and RNAseq have complementary strengths. In this study, we present the assembly of the most complete Hydra transcriptome to date along with a comparative analysis of the specific features of RNAseq and genome-predicted transcriptomes currently available in the freshwater hydrozoan Hydra vulgaris. Results: To produce an accurate and extensive Hydra transcriptome, we combined Illumina and 454 Titanium reads, giving the primacy to Illumina over 454 reads to correct homopolymer errors. This strategy yielded an RNAseq transcriptome that contains 48' 909 unique sequences including splice variants, representing approximately 24' 450 distinct genes. Comparative analysis to the available genome-predicted transcriptomes identified 10' 597 novel Hydra transcripts that encode 529 evolutionarily-conserved proteins. The annotation of 170 human orthologs points to critical functions in protein biosynthesis, FGF and TOR signaling, vesicle transport, immunity, cell cycle regulation, cell death, mitochondrial metabolism, transcription and chromatin regulation. However, a majority of these novel transcripts encodes short ORFs, at least 767 of them corresponding to pseudogenes. This RNAseq transcriptome also lacks 11' 270 predicted transcripts that correspond either to silent genes or to genes expressed below the detection level of this study. Conclusions: We established a simple and powerful strategy to combine Illumina and 454 reads and we produced, with genome assistance, an extensive and accurate Hydra transcriptome. The comparative analysis of the RNAseq transcriptome with genome-predicted transcriptomes lead to the identification of large populations of novel as well as missing transcripts that might reflect Hydra-specific evolutionary events.	[Wenger, Yvan; Galliot, Brigitte] Univ Geneva, Dept Genet & Evolut, Inst Genet & Genom Geneva iGE3, Geneva, Switzerland		Galliot, B (corresponding author), Univ Geneva, Dept Genet & Evolut, Inst Genet & Genom Geneva iGE3, Geneva, Switzerland.	Brigitte.Galliot@unige.ch	Galliot, Brigitte/I-7051-2013	Galliot, Brigitte/0000-0001-7596-8284	Canton of Geneva; Swiss National FoundationSwiss National Science Foundation (SNSF); NCCR "Frontiers in Genetics"Swiss National Science Foundation (SNSF); G. & A. Claraz donation	The authors thank Wanda Buzgariu for making available unpublished data, Joana Cruz for technical help, Juan Montoya-Burgos, Sven Bergmann, Patrick Descombes, Christian Iseli and Laurent Farinelli (Fasteris SA) for helpful advices, Patricia Bossert for reading the final manuscript. The computations were performed at the Vital-IT (http://www.vital-it.ch) Center for high-performance computing of the SIB Swiss Institute of Bioinformatics. This work was supported by the Canton of Geneva, the Swiss National Foundation, the NCCR "Frontiers in Genetics" and the G. & A. Claraz donation.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Barker MS, 2010, EVOL BIOINFORM, V6, P143, DOI 10.4137/EBO.S5861; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Biamonti G, 2009, TRENDS BIOCHEM SCI, V34, P146, DOI 10.1016/j.tibs.2008.11.004; Campbell MA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-327; Chapman JA, 2010, NATURE, V464, P592, DOI 10.1038/nature08830; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Derelle R, 2010, RNA, V16, P696, DOI 10.1261/rna.1975210; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Foret S, 2010, TRENDS GENET, V26, P154, DOI 10.1016/j.tig.2010.01.003; Fujisawa T, 2008, DEV GROWTH DIFFER, V50, pS257, DOI 10.1111/j.1440-169X.2008.00997.x; Galliot B, 2012, INT J DEV BIOL, V56, P411, DOI 10.1387/ijdb.120086bg; Gauchat D, 2004, DEV BIOL, V275, P104, DOI 10.1016/j.ydbio.2004.07.037; Grigoriev IV, 2012, NUCLEIC ACIDS RES, V40, pD26, DOI 10.1093/nar/gkr947; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Haas BJ, 2003, NUCLEIC ACIDS RES, V31, P5654, DOI 10.1093/nar/gkg770; Haas BJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r7; Hemmrich G, 2008, BIOESSAYS, V30, P1010, DOI 10.1002/bies.20813; Hemmrich G, 2012, MOL BIOL EVOL, V29, P3267, DOI 10.1093/molbev/mss134; Hwang JS, 2007, P NATL ACAD SCI USA, V104, P14735, DOI 10.1073/pnas.0703331104; Itzkovitz S, 2007, GENOME RES, V17, P405, DOI 10.1101/gr.5987307; Kawaida H, 2010, GENE, V468, P30, DOI 10.1016/j.gene.2010.08.002; Kircher M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r83; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lassmann T, 2009, BIOINFORMATICS, V25, P2839, DOI 10.1093/bioinformatics/btp527; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Luo CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030087; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Martinez DE, 2010, MOL PHYLOGENET EVOL, V57, P403, DOI 10.1016/j.ympev.2010.06.016; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Moreno-Hagelsieb G, 2008, BIOINFORMATICS, V24, P319, DOI 10.1093/bioinformatics/btm585; Moya A, 2012, MOL ECOL, V21, P2440, DOI 10.1111/j.1365-294X.2012.05554.x; Peterson KJ, 2008, PHILOS T R SOC B, V363, P1435, DOI 10.1098/rstb.2007.2233; Philippe H, 2009, CURR BIOL, V19, P706, DOI 10.1016/j.cub.2009.02.052; Pink RC, 2011, RNA, V17, P792, DOI 10.1261/rna.2658311; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Shalchian-Tabrizi K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002098; Shinzato C, 2011, NATURE, V476, P320, DOI 10.1038/nature10249; Soza-Ried J, 2010, FEBS J, V277, P197, DOI 10.1111/j.1742-4658.2009.07474.x; Stover NA, 2001, P NATL ACAD SCI USA, V98, P5693, DOI 10.1073/pnas.101049998; Swalla BJ, 2008, PHILOS T R SOC B, V363, P1557, DOI 10.1098/rstb.2007.2246; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wurm Y, 2011, P NATL ACAD SCI USA, V108, P5679, DOI 10.1073/pnas.1009690108; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	52	50	51	1	70	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2164			BMC GENOMICS	BMC Genomics	MAR 25	2013	14								204	10.1186/1471-2164-14-204			17	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	123TO	WOS:000317414100002	23530871	Green Published, gold			2022-03-04	
J	Lazarevic, V; Whiteson, K; Hernandez, D; Francois, P; Schrenzel, J				Lazarevic, Vladimir; Whiteson, Katrine; Hernandez, David; Francois, Patrice; Schrenzel, Jacques			Study of inter- and intra-individual variations in the salivary microbiota	BMC GENOMICS			English	Article							MULTIPLE SEQUENCE ALIGNMENT; DIVERSITY; PERIODONTITIS; MICROARRAY; BIOSPHERE	Background: Oral bacterial communities contain species that promote health and others that have been implicated in oral and/or systemic diseases. Culture-independent approaches provide the best means to assess the diversity of oral bacteria because most of them remain uncultivable. Results: The salivary microbiota from five adults was analyzed at three time-points by means of the 454 pyrosequencing technology. The V1-V3 region of the bacterial 16S rRNA genes was amplified by PCR using saliva lysates and broad-range primers. The bar-coded PCR products were pooled and sequenced unidirectionally to cover the V3 hypervariable region. Of 50,708 obtained sequences, 31,860 passed the quality control. Non-bacterial sequences (2.2%) were removed leaving 31,170 reads. Samples were dominated by seven major phyla: members of Firmicutes, Proteobacteria, Actinobacteria, Bacteroidetes and candidate division TM7 were identified in all samples; Fusobacteria and Spirochaetes were identified in all individuals, but not at all time-points. The dataset was represented by 3,011 distinct sequences (100%-ID phylotypes) of similar to 215 nucleotides and 583 phylotypes defined at >= 97% identity (97%-ID phylotypes). We compared saliva samples from different individuals in terms of the phylogeny of their microbial communities. Based on the presence and absence of phylotypes defined at 100% or 97% identity thresholds, samples from each subject formed separate clusters. Among individual taxa, phylum Bacteroidetes and order Clostridiales (Firmicutes) were the best indicators of intraindividual similarity of the salivary flora over time. Fifteen out of 81 genera constituted 73 to 94% of the total sequences present in different samples. Of these, 8 were shared by all time points of all individuals, while 15-25 genera were present in all three timepoints of different individuals. Representatives of the class Sphingobacteria, order Sphingobacteriales and family Clostridiaceae were found only in one subject. Conclusions: The salivary microbial community appeared to be stable over at least 5 days, allowing for subject-specific grouping using UniFrac. Inclusion of all available samples from more distant time points (up to 29 days) confirmed this observation. Samples taken at closer time intervals were not necessarily more similar than samples obtained across longer sampling times. These results point to the persistence of subject-specific taxa whose frequency fluctuates between the time points. Genus Gemella, identified in all time-points of all individuals, was not defined as a core-microbiome genus in previous studies of salivary bacterial communities. Human oral microbiome studies are still in their infancy and larger-scale projects are required to better define individual and universal oral microbiome core.	[Lazarevic, Vladimir; Whiteson, Katrine; Hernandez, David; Francois, Patrice; Schrenzel, Jacques] Univ Hosp Geneva, Genom Res Lab, CH-1211 Geneva 14, Switzerland		Lazarevic, V (corresponding author), Univ Hosp Geneva, Genom Res Lab, Rue Gabrielle Perret Gentil 4, CH-1211 Geneva 14, Switzerland.	vladimir.lazarevic@genomic.ch	Schrenzel, Jacques/P-8525-2017; francois, patrice/AAL-5583-2020; Schrenzel, Jacques/AAC-5685-2021	Schrenzel, Jacques/0000-0001-5464-7764; Schrenzel, Jacques/0000-0001-5464-7764; francois, patrice/0000-0002-0540-750X; Whiteson, Katrine/0000-0002-5423-6014; Lazarevic, Vladimir/0000-0002-6839-2536	Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission [3100A0-112370/1, 3100A0-116075]	We thank for Antoine Huyghe for help with Microsoft Excel and Bernard Berger for advice and assistance in the 454 sequencing. JS and PF are supported by the Swiss National Science Foundation grants 3100A0-112370/1 and 3100A0-116075, respectively.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Colombo APV, 2009, J PERIODONTOL, V80, P1421, DOI 10.1902/jop.2009.090185; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Dawes C, 2003, ARCH ORAL BIOL, V48, P329, DOI 10.1016/S0003-9969(03)00014-1; Droege M, 2008, J BIOTECHNOL, V136, P3, DOI 10.1016/j.jbiotec.2008.03.021; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Faveri M, 2008, ORAL MICROBIOL IMMUN, V23, P112, DOI 10.1111/j.1399-302X.2007.00397.x; Fierer N, 2010, P NATL ACAD SCI USA, V107, P6477, DOI 10.1073/pnas.1000162107; Galand PE, 2009, P NATL ACAD SCI USA, V106, P22427, DOI 10.1073/pnas.0908284106; Hamady M, 2008, NAT METHODS, V5, P235, DOI [10.1038/nmeth.1184, 10.1038/NMETH.1184]; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Huyghe A, 2008, APPL ENVIRON MICROB, V74, P1876, DOI 10.1128/AEM.01722-07; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Keijser BJF, 2008, J DENT RES, V87, P1016, DOI 10.1177/154405910808701104; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Lazarevic V, 2009, J MICROBIOL METH, V79, P266, DOI 10.1016/j.mimet.2009.09.012; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Mager DL, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-27; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Nasidze I, 2009, ANAL BIOCHEM, V391, P64, DOI 10.1016/j.ab.2009.04.034; Nasidze I, 2009, GENOME RES, V19, P636, DOI 10.1101/gr.084616.108; Nawrocki EP, 2007, PLOS COMPUT BIOL, V3, P540, DOI 10.1371/journal.pcbi.0030056; Paster BJ, 2006, PERIODONTOL 2000, V42, P80, DOI 10.1111/j.1600-0757.2006.00174.x; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Siqueira JF, 2009, J DENT RES, V88, P969, DOI 10.1177/0022034509346549; Stackebrandt E, 2006, MICROBIOL TODAY, V33, P152; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259; Zoetendal EG, 2008, GUT, V57, P1605, DOI 10.1136/gut.2007.133603	35	146	153	0	37	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2164			BMC GENOMICS	BMC Genomics	SEP 28	2010	11								523	10.1186/1471-2164-11-523			11	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	662FI	WOS:000282792400001	20920195	gold, Green Accepted, Green Published			2022-03-04	
J	Reymond, A; Friedli, M; Henrichsen, CN; Chapot, F; Deutsch, S; Ucla, C; Rossier, C; Lyle, R; Guipponi, M; Antonarakis, SE				Reymond, A; Friedli, M; Henrichsen, CN; Chapot, F; Deutsch, S; Ucla, C; Rossier, C; Lyle, R; Guipponi, M; Antonarakis, SE			From PREDs and open reading frames to cDNA isolation: Revisiting the human chromosome 21 transcription map	GENOMICS			English	Article						human chromosome 21; transcription map; genomic sequences annotation; gene prediction; gene prediction; C21orf; Down syndrome; trisomy 21	EXPRESSED SEQUENCE TAGS; HUMAN-CHROMOSOME 22; SIGNAL-TRANSDUCTION; DNA-SEQUENCE; TAK1 MAPKKK; PROTEIN; DATABASE; PATHWAY; LAYILIN; DOMAIN	A supernumerary copy of human chromosome 21 (HC21) causes Down syndrome. To understand the molecular pathogenesis of Down syndrome, it is necessary to identify all HC21 genes. The first annotation of the sequence of 21q confirmed 127 genes, and predicted an additional 98 previously unknown "anonymous" genes (predictions (PREDs) and open reading frames (C21orfs)), which were foreseen by exon prediction programs and/or spliced expressed sequence tags. These putative gene models still need to be confirmed as bona fide transcripts. Here we report the characterization and expression pattern of the putative transcripts C21orf7, C21orf11, C21orf15, C21orf18, C21orf19, C21orf22, C21orf42, C21orf50, C21orf51, C21orf57, and C21orf58, the GC-rich sequence DNA-binding factor candidate GCFC (also known as C21orf66), PRED12, PRED31, PRED34, PRED44, PRED54, and PRED56. Our analysis showed that most of the C21orfs originally defined by matching spliced expressed sequence tags were correctly predicted, whereas many of the PREDs, defined solely by computer prediction, do not correspond to genuine genes. Four of the six PREDs were incorrectly predicted: PRED44 and C21orf11 are portions of the same transcript, PRED31 is a pseudogene, and PRED54 and PRED56 were wrongly predicted. In contrast, PRED12 (now called C21orf68) and PRED34 (C21orf63) are now confirmed transcripts. We identified three new genes, C21orf67, C21orf69, and C21orf70, not previously predicted by any programs. This revision of the HC21 transcriptome has consequences for the entire genome regarding the quality of previous annotations and the total number of transcripts. It also provides new candidates for genes involved in Down syndrome and other genetic disorders that map to HC21.	Univ Geneva, Sch Med, Dept Med Genet, CH-1211 Geneva, Switzerland; Univ Geneva, Sch Med, Grad Program Mol & Cellular Biol, CH-1211 Geneva, Switzerland		Antonarakis, SE (corresponding author), Univ Geneva, Sch Med, Dept Med Genet, CH-1211 Geneva, Switzerland.	Stylianos.Antonarakis@medecine.unige.ch	Hor, Charlotte/AAB-4850-2020; Antonarakis, Stylianos E/N-8866-2014; Hor, Charlotte/H-5908-2015	Hor, Charlotte/0000-0002-5361-2372; Antonarakis, Stylianos E/0000-0001-8907-5823; Hor, Charlotte/0000-0002-5361-2372; Deutsch, Samuel/0000-0001-9456-7101; Reymond, Alexandre/0000-0003-1030-8327			Antonarakis SE, 2001, CURR OPIN GENET DEV, V11, P241, DOI 10.1016/S0959-437X(00)00185-4; Aravind L, 1999, TRENDS BIOCHEM SCI, V24, P342, DOI 10.1016/S0968-0004(99)01437-1; Bliskovskii V. V., 1992, Molekulyarnaya Biologiya (Moscow), V26, P807; BOGUSKI MS, 1993, NAT GENET, V4, P332, DOI 10.1038/ng0893-332; Bono P, 2001, MOL BIOL CELL, V12, P891, DOI 10.1091/mbc.12.4.891; Borowsky ML, 1998, J CELL BIOL, V143, P429, DOI 10.1083/jcb.143.2.429; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Corcoran MM, 1999, ONCOGENE, V18, P6271, DOI 10.1038/sj.onc.1203033; de Souza SJ, 2000, P NATL ACAD SCI USA, V97, P12690, DOI 10.1073/pnas.97.23.12690; Deutsch S, 2001, GENOME RES, V11, P300; Drabkin HA, 1999, ONCOGENE, V18, P2589, DOI 10.1038/sj.onc.1202601; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Epstein C.J., 1995, METABOLIC MOL BASES, P749; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Gardiner K., 2000, GENOME BIOL, V1, P1; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Hattori M, 2000, NATURE, V405, P311, DOI 10.1038/35012518; Khachigian LM, 1999, CIRC RES, V84, P1258, DOI 10.1161/01.RES.84.11.1258; Kikuno R, 1999, DNA Res, V6, P197, DOI 10.1093/dnares/6.3.197; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; MATTIONI T, 1992, CHROMOSOMA, V101, P618, DOI 10.1007/BF00360539; Michaud J, 2000, GENOMICS, V68, P71, DOI 10.1006/geno.2000.6258; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Pletcher MT, 2001, GENOMICS, V74, P45, DOI 10.1006/geno.2001.6533; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Ryter JM, 1998, EMBO J, V17, P7505, DOI 10.1093/emboj/17.24.7505; Shibuya H, 1996, SCIENCE, V272, P1179, DOI 10.1126/science.272.5265.1179; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040	30	31	53	0	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0888-7543	1089-8646		GENOMICS	Genomics	NOV	2001	78	1-2					46	54		10.1006/geno.2001.6640			9	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	491RD	WOS:000172121700009	11707072				2022-03-04	
J	Lazarevic, V; Francois, P				Lazarevic, Vladimir; Francois, Patrice			Functional genomics of microbial pathogens	BRIEFINGS IN FUNCTIONAL GENOMICS			English	Editorial Material									[Lazarevic, Vladimir; Francois, Patrice] Univ Hosp Geneva, Genom Res Lab, Geneva, Switzerland		Lazarevic, V (corresponding author), Univ Hosp Geneva, Genom Res Lab, Geneva, Switzerland.		francois, patrice/AAL-5583-2020	francois, patrice/0000-0002-0540-750X				0	2	2	0	8	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	2041-2649			BRIEF FUNCT GENOMICS	Brief. Funct. Genomics	JUL	2013	12	4			SI		289	290		10.1093/bfgp/elt032			2	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	204CW	WOS:000323343600001	23946479	Bronze			2022-03-04	
J	McKenna, G; Allen, F; Schimmel, M; Muller, F				McKenna, Gerald; Allen, Finbarr; Schimmel, Martin; Mueller, Frauke			Who's picking up the bill?	GERODONTOLOGY			English	Editorial Material							ORAL-HEALTH; DENTURES; REHABILITATION		[McKenna, Gerald] Queens Univ Belfast, Nutr & Metab Res Grp, Ctr Publ Hlth, Belfast, Antrim, North Ireland; [Allen, Finbarr] Cork Univ, Dent Sch & Hosp, Univ Coll Cork, Cork, Ireland; [Schimmel, Martin] Univ Bern, Div Gerodontol, Sch Dent Med, Bern, Switzerland; [Mueller, Frauke] Univ Geneva, Dept Gerodontol & Removable Prosthodont, Geneva, Switzerland		McKenna, G (corresponding author), Queens Univ Belfast, Inst Clin Sci, Ctr Publ Hlth, Royal Victoria Hosp,Restorative Dent, Block B, Belfast BT12 6BA, Antrim, North Ireland.	g.mckenna@qub.ac.uk	Allen, P. Finbarr/ABC-7491-2020; Müller, Frauke/C-3835-2014; Schimmel, Martin/F-5694-2011	Allen, P. Finbarr/0000-0002-5873-2728; Müller, Frauke/0000-0003-3981-0134; Schimmel, Martin/0000-0001-9700-5534; McKenna, Gerald/0000-0001-8478-1673	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MC_CF023241] Funding Source: researchfish		Calache H, 2012, J PUBLIC HEALTH DENT, V72, P19, DOI 10.1111/j.1752-7325.2011.00279.x; Listl S, 2011, J DENT RES, V90, P717, DOI 10.1177/0022034511399907; MacEntee MI, 1998, J PROSTHET DENT, V79, P24, DOI 10.1016/S0022-3913(98)70189-1; Marcenes W, 2013, J DENT RES, V92, P592, DOI 10.1177/0022034513490168; McKenna G, 2015, J DENT, V43, P66, DOI 10.1016/j.jdent.2014.06.006; McKenna G, 2014, COMMUNITY DENT ORAL, V42, P366, DOI 10.1111/cdoe.12085; Mejia G, 2014, J DENT RES, V93, P966, DOI 10.1177/0022034514545516; Petersen PE, 2010, COMMUNITY DENT HLTH, V27, P257, DOI 10.1922/CDH_2711Petersen11; Shariati B, 2013, COMMUNITY DENT ORAL, V41, P385, DOI 10.1111/cdoe.12047; Walton JN, 2005, INT J PROSTHODONT, V18, P483; Xie Q, 2015, J ORAL REHABIL, V42, P234, DOI 10.1111/joor.12246; Yao CS, 2014, J CAN DENT ASSOC, V80	12	3	3	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0734-0664	1741-2358		GERODONTOLOGY	Gerodontology	SEP	2015	32	3					161	162		10.1111/ger.12205			2	Dentistry, Oral Surgery & Medicine; Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine; Geriatrics & Gerontology	CP7DM	WOS:000360047400001	26285792	Green Accepted			2022-03-04	
J	Burki, F; Nikolaev, SI; Bolivar, I; Guiard, J; Pawlowski, J				Burki, Fabien; Nikolaev, Sergey I.; Bolivar, Ignacio; Guiard, Jackie; Pawlowski, Jan			Analysis of expressed sequence tags from a naked foraminiferan Reticulomyxa filosa	GENOME			English	Article						Rhizaria; Foraminifera; cDNA library; annotation	FRESH-WATER FORAMINIFERANS; RNA GENE-SEQUENCES; MOLECULAR EVOLUTION; ACTIN PHYLOGENY; FOSSIL RECORD; DIVERSITY; EUKARYOTES; CERCOZOA; PROTEIN; ORIGIN	Foraminifers are a major component of modern marine ecosystems and one of the most important oceanic producers of calcium carbonate. They are a key phylogenetic group among amoeboid protists, but our knowledge of their genome is still mostly limited to a few conserved genes. Here, we report the first study of expressed genes by means of expressed sequence tag (EST) from the freshwater naked foraminiferan Reticulomyxa filosa. Cluster analysis of 1630 valid ESTs enabled the identification of 178 groups of related sequences and 871 singlets. Approximately 50% of the putative unique 1059 ESTs could be annotated using Blast searches against the protein database SwissProt + TrEMBL. The EST database described here is the first step towards gene discovery in Foraminifera and should provide the basis for new insights into the genomic and transcriptomic characteristics of these interesting but poorly understood protists.	Univ Geneva, Dept Zool & Anim Biol, CH-1211 Geneva 4, Switzerland		Burki, F (corresponding author), Univ Geneva, Dept Zool & Anim Biol, 30 Quai Ernest Ansermet, CH-1211 Geneva 4, Switzerland.	Fabien.Burki@zoo.unige.ch	Burki, Fabien/F-4818-2010; Nikolaev, Sergey/F-3148-2012				Abu SM, 2004, FEMS MICROBIOL LETT, V233, P205, DOI 10.1111/j.1574-6968.2004.tb09484.x; Archibald JM, 2004, J EUKARYOT MICROBIOL, V51, P113, DOI 10.1111/j.1550-7408.2004.tb00172.x; Barker S, 2003, PHILOS T R SOC A, V361, P1977, DOI 10.1098/rsta.2003.1238; BREUKER RN, 1997, THESIS RUHR U BOCHUM; BURKI F, 2006, MOL BIOL EVOL; deVargas C, 1997, J MOL EVOL, V45, P285, DOI 10.1007/PL00006232; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Falquet L, 2003, NUCLEIC ACIDS RES, V31, P3782, DOI 10.1093/nar/gkg547; Flakowski J, 2005, J FORAMIN RES, V35, P93, DOI 10.2113/35.2.93; Gooday AJ, 2002, J FORAMIN RES, V32, P384, DOI 10.2113/0320384; Green P., 1996, PHRAP DOCUMENTATION; Habura A, 2005, MOL BIOL EVOL, V22, P2000, DOI 10.1093/molbev/msi190; Habura A, 2004, J EUKARYOT MICROBIOL, V51, P173, DOI 10.1111/j.1550-7408.2004.tb00542.x; Hackett JD, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-80; Holzmann M, 2003, J EUKARYOT MICROBIOL, V50, P135, DOI 10.1111/j.1550-7408.2003.tb00248.x; Holzmann M, 2002, J FORAMIN RES, V32, P344, DOI 10.2113/0320344; HULSMANN N, 1984, J PROTOZOOL, V31, pA55; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Jouannic S, 2005, FEBS LETT, V579, P2709, DOI 10.1016/j.febslet.2005.03.093; Keeling PJ, 2001, MOL BIOL EVOL, V18, P1551, DOI 10.1093/oxfordjournals.molbev.a003941; Keon J, 2005, FUNGAL GENET BIOL, V42, P376, DOI 10.1016/j.fgb.2004.12.005; KOONCE MP, 1985, J CELL BIOL, V100, P322, DOI 10.1083/jcb.100.1.322; Koski LB, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-151; LEE J, 1991, BIOL FORMAMINIFERA; Longet D, 2003, INT J SYST EVOL MICR, V53, P1735, DOI 10.1099/ijs.0.02597-0; Meisterfeld R, 2001, PROTIST, V152, P185, DOI 10.1078/1434-4610-00058; NAUSS RUTH N., 1949, BULL TORREY BOT CLUB, V76, P161, DOI 10.2307/2482203; Nikolaev SI, 2004, P NATL ACAD SCI USA, V101, P8066, DOI 10.1073/pnas.0308602101; OZKAYNAK E, 1990, EMBO J, V9, P2085, DOI 10.1002/j.1460-2075.1990.tb07376.x; Pawlowski J, 1999, J EUKARYOT MICROBIOL, V46, P612, DOI 10.1111/j.1550-7408.1999.tb05137.x; PAWLOWSKI J, 1994, MOL BIOL EVOL, V11, P929; Pawlowski J, 1996, MOL BIOL EVOL, V13, P445, DOI 10.1093/oxfordjournals.molbev.a025605; Pawlowski J, 1997, MOL BIOL EVOL, V14, P498, DOI 10.1093/oxfordjournals.molbev.a025786; Pawlowski J, 2002, POLAR BIOL, V25, P96, DOI 10.1007/s003000100317; Ribichich KF, 2005, EUKARYOT CELL, V4, P455, DOI 10.1128/EC.4.2.455-464.2005; Sen Gupta B.K., 1999, MODERN FORAMINIFERA; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Todo Y, 2005, SCIENCE, V307, P689, DOI 10.1126/science.1105407	38	11	11	2	11	NATL RESEARCH COUNCIL CANADA-N R C RESEARCH PRESS	OTTAWA	BUILDING M 55, OTTAWA, ON K1A 0R6, CANADA	0831-2796			GENOME	Genome	AUG	2006	49	8					882	887		10.1139/G06-048			6	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	108AJ	WOS:000242211800004	17036062				2022-03-04	
J	Cubizolles, F; Gasser, SM				Cubizolles, Fabien; Gasser, Susan M.			The nucleosome: from wallflower to Queen of the Ball	GENOME BIOLOGY			English	Editorial Material									[Cubizolles, Fabien; Gasser, Susan M.] Univ Geneva, Dept Mol Biol, 30 Quai Ernest Ansermet, CH-1211 Geneva 4, Switzerland		Gasser, SM (corresponding author), Univ Geneva, Dept Mol Biol, 30 Quai Ernest Ansermet, CH-1211 Geneva 4, Switzerland.	susan.Gasser@molbio.unige.ch		Cubizolles, Fabien/0000-0002-9822-4074				0	3	3	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.		2001	2	10							4023.1				4	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	VI5VC	WOS:000497524000002					2022-03-04	
J	Montoya-Burgos, JI; Foulon, A; Bahechar, I				Montoya-Burgos, Juan I.; Foulon, Aurelia; Bahechar, Ilham			Transcriptome screen for fast evolving genes by Inter-Specific Selective Hybridization (ISSH)	BMC GENOMICS			English	Article							GEL COMPETITIVE REASSOCIATION; HISTORICAL BIOGEOGRAPHY; HOUSEKEEPING GENES; DROSOPHILA; EVOLUTION; GENOME; SILURIFORMES; LORICARIIDAE; EXPRESSION; SPECIATION	Background: Fast evolving genes are targets of an increasing panel of biological studies, from cancer research to population genetics and species specific adaptations. Yet, their identification and isolation are still laborious, particularly for non-model organisms. We developed a method, named the Inter-Specific Selective Hybridization (ISSH) method, for generating cDNA libraries enriched in fast evolving genes. It utilizes transcripts of homologous tissues of distinct yet related species. Experimental hybridization conditions are monitored in order to discard transcripts that do not find their homologous counterparts in the two species sets as well as transcripts that display a strong complementarity between the two species. Only heteroduplexes that disanneal at low stringency are used for constructing the resulting cDNA library. Results: We demonstrate the efficiency of the ISSH method by generating a brain cDNA library enriched in fast evolving transcripts of a non-model catfish species as well as a control, non-enriched library. Our results indicate that the enriched library contains effectively more fast evolving sequences than the control library. Gene annotation analyses also indicate enrichment in genes with low expression levels and non-ubiquitously expressed genes, both categories encompassing the majority of fast evolving genes. Furthermore, most of the identified transcripts show higher sequence divergence between two closely related catfish species as compared to recognized fast evolving DNA markers. Conclusions: The ISSH method offers a simple, inexpensive and efficient way to screen the transcriptome for isolating fast evolving genes. This method opens new opportunities in the investigation of biological mechanisms that include fast evolving genes, such as the evolution of lineage specific processes and traits responsible for species adaptation to their environment.	[Montoya-Burgos, Juan I.; Foulon, Aurelia; Bahechar, Ilham] Univ Geneva, Dept Zool & Anim Biol, CH-1211 Geneva 4, Switzerland		Montoya-Burgos, JI (corresponding author), Univ Geneva, Dept Zool & Anim Biol, 30 Quai Ernest Ansermet, CH-1211 Geneva 4, Switzerland.	juan.montoya@unige.ch		Montoya-Burgos, Juan/0000-0001-9080-9820	Canton de Geneve; Swiss National Research FundSwiss National Science Foundation (SNSF) [3100A0-122303/1]; G & A Claraz Foundation	We thank Dr. L. Falquet who performed the Blast calculations against the zebrafish transcript databases on the Vital-IT high-performance computing facility of the Swiss Institute of Bioinformatics http://www.vital-it.ch. We acknowledge P.-Y. Pettina and A. Coulot for their help in preliminary laboratory tests of feasibility. We thank Dr. Y. Surget-Groba for bioinformatic advises and for revising the manuscript, and two anonymous reviewers for helpful comments and suggestions. This work was supported by funds from the Canton de Geneve; the Swiss National Research Fund [grant number 3100A0-122303/1]; and the G & A Claraz Foundation.	Ali F, 2008, MOL BIOL EVOL, V25, P2247, DOI 10.1093/molbev/msn184; Barbash DA, 2003, P NATL ACAD SCI USA, V100, P5302, DOI 10.1073/pnas.0836927100; Brcic-Kostic K, 2005, GENET RES, V86, P53, DOI 10.1017/S0016672305007688; Cardoso YP, 2009, MOL ECOL, V18, P947, DOI 10.1111/j.1365-294X.2008.04068.x; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Chiachio MC, 2008, MOL PHYLOGENET EVOL, V49, P606, DOI 10.1016/j.ympev.2008.08.013; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; Garrick RC, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-11; Gibbons JG, 2009, MOL BIOL EVOL, V26, P2731, DOI 10.1093/molbev/msp188; Gotoh K, 2003, GENOME RES, V13, P492, DOI 10.1101/gr.434103; Haerty W, 2007, GENETICS, V177, P1321, DOI 10.1534/genetics.107.078865; Inoue S, 1996, GENOMICS, V31, P271, DOI 10.1006/geno.1996.0048; Karn RC, 2008, MOL BIOL EVOL, V25, P2301, DOI 10.1093/molbev/msn182; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Meyer M, 2008, NAT PROTOC, V3, P267, DOI 10.1038/nprot.2007.520; Montoya-Burgos JI, 2003, MOL ECOL, V12, P1855, DOI 10.1046/j.1365-294X.2003.01857.x; MORENOESTRADA A, 2009, MOL BIOL EVOL, P134; Nicod JC, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng019; Nielsen R, 2005, PLOS BIOL, V3, P976, DOI 10.1371/journal.pbio.0030170; Orr HA, 2004, CURR OPIN GENET DEV, V14, P675, DOI 10.1016/j.gde.2004.08.009; Pollard KS, 2006, NATURE, V443, P167, DOI 10.1038/nature05113; ROWEKAMP W, 1980, DEV BIOL, V79, P409, DOI 10.1016/0012-1606(80)90126-8; Schluter D, 2009, P NATL ACAD SCI USA, V106, P9955, DOI 10.1073/pnas.0901264106; Schmid KJ, 1997, P NATL ACAD SCI USA, V94, P9746, DOI 10.1073/pnas.94.18.9746; SCHUTZBANK T, 1982, CELL, V30, P481, DOI 10.1016/0092-8674(82)90245-8; SCOTT MRD, 1983, CELL, V34, P557, DOI 10.1016/0092-8674(83)90388-4; Smith RF, 1996, GENOME RES, V6, P454, DOI 10.1101/gr.6.5.454; Subramanian S, 2004, GENETICS, V168, P373, DOI 10.1534/genetics.104.028944; Sunnucks P, 2000, TRENDS ECOL EVOL, V15, P199, DOI 10.1016/S0169-5347(00)01825-5; Tripathi N, 2009, P ROY SOC B-BIOL SCI, V276, P2195, DOI 10.1098/rspb.2008.1930; Tuller T, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r142; Zhang LQ, 2004, MOL BIOL EVOL, V21, P236, DOI 10.1093/molbev/msh010	33	7	7	0	1	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2164			BMC GENOMICS	BMC Genomics	FEB 22	2010	11								126	10.1186/1471-2164-11-126			10	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	569VB	WOS:000275629300003	20175901	Green Published, gold			2022-03-04	
J	Michel, JP				Michel, J. -P.			Frailty : Successful clinical practice implementation	JOURNAL OF NUTRITION HEALTH & AGING			English	Editorial Material									Univ Geneva, CH-1211 Geneva 4, Switzerland		Michel, JP (corresponding author), Univ Geneva, CH-1211 Geneva 4, Switzerland.	Jean-Pierre.Michel@hcuge.ch					Borrat-Besson C, 2013, Active Ageing and Solidarity between Generations in Europe: First Results from SHARE After the Economic Crisis, P175; Borsch-Supana B.M., 2014, ACTIVE AGEING SOLIDA; Bugat MER, 2012, J AM MED DIR ASSOC, V13, P669, DOI 10.1016/j.jamda.2012.07.015; Mazya AL, 2013, EUR GERIATR MED, V4, P242, DOI 10.1016/j.eurger.2013.05.004; Morley JE, 2013, EUR GERIATR MED, V4, P215, DOI 10.1016/j.eurger.2013.08.006; Morley JE, 2013, J AM MED DIR ASSOC, V14, P392, DOI 10.1016/j.jamda.2013.03.022; Subra J, 2012, J NUTR HEALTH AGING, V16, P714, DOI 10.1007/s12603-012-0391-7; Tavassoli N, 2014, J NUTR HEALTH AGING, V18, P457, DOI 10.1007/s12603-014-0462-z; Vellas B, 2013, J NUTR HEALTH AGING, V17, P629, DOI 10.1007/s12603-013-0363-6; Vellas B, 2012, J NUTR HEALTH AGING, V16, P599, DOI 10.1007/s12603-012-0096-y; Xue QL, 2011, CLIN GERIATR MED, V27, P1, DOI 10.1016/j.cger.2010.08.009	11	1	1	0	0	SPRINGER FRANCE	PARIS	22 RUE DE PALESTRO, PARIS, 75002, FRANCE	1279-7707	1760-4788		J NUTR HEALTH AGING	J. Nutr. Health Aging	MAY	2014	18	5					470	470		10.1007/s12603-014-0453-0			1	Geriatrics & Gerontology; Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology; Nutrition & Dietetics	AI1KI	WOS:000336609400007	24886732	Bronze, Green Submitted			2022-03-04	
J	Kaya, G				Kaya, G.			New therapeutic targets in dermatoporosis	JOURNAL OF NUTRITION HEALTH & AGING			English	Article						Dermatoporosis; CD44; hyaluronate; hyalurosome; filopodia; HAFi; RAL; corticosteroids	TOPICAL RETINOIDS; HYALURONATE; SKIN; CD44; EXPRESSION; MOUSE; EPIDERMIS	Dermatoporosis is a novel term proposed to describe the chronic cutaneous insufficiency/fragility syndrome characterized by an extreme skin atrophy. Dermatoporosis is principally due to chronological aging and long-term and unprotected sun exposure, but it may also result from the chronic use of topical and systemic corticosteroids. We have recently proposed a membrane organelle, hyalurosome, composed of molecules involved in hyaluronate (HA) metabolism and cell signaling in the keratinocytes, such as principal HA receptor CD44, heparin-binding epidermal growth factor (HB-EGF), HB-EGF receptor erbB1 and HA synthase 3 (HAS3), which is functionally defective in dermatoporosis and may be a target for intervention. Several lines of evidence suggest that hyalurosome is located in keratinocyte filopodia, thin, actin-rich plasma membrane protrusions implicated in cell motility. We have recently shown that keratinocyte filopodia are downregulated by corticosteroids in vitro. Intermediate size HA fragments (HAFi) inhibited the downregulation of filopodia induced by corticosteroids. Topical HAFi prevented the skin atrophy induced by topical corticosteroids in mice without interfering with their anti-inflammatory effect. Topical treatment with HAFi 1% of atrophic forearm skin of dermatoporosis patients for 1 month resulted in a significant clinical improvement and induced the expression of hyalurosome molecules. Topical retinaldehyde (RAL) and HAFi showed a synergy in HA production and pro-HB-EGF expression in mouse skin and in the correction of skin atrophy in dermatoporosis patients. Uncovering the molecular mechanisms implicating hyalurosome seems to be crucial to better understand the pathogenesis of dermatoporosis and to develop new therapeutic strategies.	Univ Hosp Geneva, Dept Dermatol, Geneva, Switzerland		Kaya, G (corresponding author), Univ Hosp Geneva, Dept Dermatol, Geneva, Switzerland.						ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; Barnes L, 2012, J INVEST DERMATOL, V132, P736, DOI 10.1038/jid.2011.384; Barnes L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014372; Calikoglu E, 2006, PHOTOCHEM PHOTOBIOL, V82, P1342, DOI 10.1562/2006-02-10-RA-801; Kaya G, 2007, J INVEST DERMATOL, V127, pS55; Kaya G, 2005, J INVEST DERMATOL, V124, P284, DOI 10.1111/j.0022-202X.2004.23579.x; Kaya G, 2010, EUR GERIATR MED, V1, P216, DOI 10.1016/j.eurger.2010.06.002; Kaya G, 1997, GENE DEV, V11, P996, DOI 10.1101/gad.11.8.996; Kaya G, 2004, J INVEST DERMATOL, V123, pS189; Kaya G, 2008, ARCH DERMATOL, V144, P1303, DOI 10.1001/archderm.144.10.1303; Kaya G, 2006, PLOS MED, V3, P2291, DOI 10.1371/journal.pmed.0030493; Kaya G, 2007, DERMATOLOGY, V215, P284, DOI 10.1159/000107621; Kultti A, 2006, J BIOL CHEM, V281, P15821, DOI 10.1074/jbc.M512840200; LAURENT TC, 1992, FASEB J, V6, P2397, DOI 10.1096/fasebj.6.7.1563592; Loitto VM, 2007, EXP CELL RES, V313, P1295, DOI 10.1016/j.yexcr.2007.01.023; Mengeaud V, 2012, BRIT J DERMATOL, V166, P442, DOI 10.1111/j.1365-2133.2011.10534.x; Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010; Saurat JH, 2007, DERMATOLOGY, V215, P271, DOI 10.1159/000107618; SAURAT JH, 1994, J INVEST DERMATOL, V103, P770, DOI 10.1111/1523-1747.ep12412861; WEST DC, 1985, SCIENCE, V228, P1324, DOI 10.1126/science.2408340	20	12	12	1	5	SPRINGER FRANCE	PARIS	22 RUE DE PALESTRO, PARIS, 75002, FRANCE	1279-7707			J NUTR HEALTH AGING	J. Nutr. Health Aging	APR	2012	16	4					285	288		10.1007/s12603-012-0041-0			4	Geriatrics & Gerontology; Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology; Nutrition & Dietetics	943OT	WOS:000304134500002	22499444	Green Published, Green Submitted			2022-03-04	
J	Michel, JP				Michel, Jean-Pierre			Urbanization and Ageing Health Outcomes	JOURNAL OF NUTRITION HEALTH & AGING			English	Editorial Material						Urbanization; rural-urban migrants; pollution; health inequities; aged	MENTAL-HEALTH; ENVIRONMENT		[Michel, Jean-Pierre] Med Univ Geneva, Geneva, Switzerland		Michel, JP (corresponding author), Med Univ Geneva, Geneva, Switzerland.	Jean-pierre.michel@unige.ch					Cornwell EY, 2015, CITY COMMUNITY, V14, P311, DOI 10.1111/cico.12124; Falkingham J, 2017, SSM-POPUL HLTH, V3, P352, DOI 10.1016/j.ssmph.2017.03.008; Fougere B, 2014, ROLE AGING SMOKING M; Gao S, 2019, AGEING SOC, P1; Giles-Corti B, 2016, LANCET, V388, P2912, DOI 10.1016/S0140-6736(16)30066-6; Hau B, 2019, HEALTH PLACE, V58, DOI 10.1016/j.healthplace.2019.01.003; Johnson MTJ, 2017, SCIENCE, V358, DOI 10.1126/science.aam8327; Landrigan PJ, 2018, LANCET, V391, P462, DOI 10.1016/S0140-6736(17)32345-0; Li XH, 2016, ENVIRON HEALTH-GLOB, V15, DOI 10.1186/s12940-016-0104-5; Lien WC, 2015, J NUTR HEALTH AGING, V19, P575, DOI 10.1007/s12603-015-0473-4; Lu YL, 2015, ENVIRON INT, V77, P5, DOI 10.1016/j.envint.2014.12.010; Luciano M, 2016, INT J SOC PSYCHIATR, V62, P252, DOI 10.1177/0020764016629694; Okkels N, 2018, CURR OPIN PSYCHIATR, V31, P258, DOI 10.1097/YCO.0000000000000413; Sha F, 2017, INJURY PREV, V23, P40, DOI 10.1136/injuryprev-2016-042006; UN Data, POPULATION; United Nations Department of Economic and Social Affairs, 2019, WORLD URB PROSP 2018; United Nations General Assembly, 2016, UN C HOUS SUST URB D; Wham C, 2011, J NUTR HEALTH AGING, V15, P253, DOI 10.1007/s12; World Health Organization (WHO), 2010, HIDD CIT UNM OV HLTH; Wu YT, 2017, J AFFECT DISORDERS, V218, P359, DOI 10.1016/j.jad.2017.05.001; Wyka J, 2010, J NUTR HEALTH AGING, V14, P67, DOI 10.1007/s12603-010-0012-2; Xu FR, 2018, J NUTR HEALTH AGING, V22, P1072, DOI 10.1007/s12603-018-1050-4; Zhu Q, 2019, J NUTR HEALTH AGING, V23, P883, DOI 10.1007/s12603-019-1239-1	23	0	0	2	3	SPRINGER FRANCE	PARIS	22 RUE DE PALESTRO, PARIS, 75002, FRANCE	1279-7707	1760-4788		J NUTR HEALTH AGING	J. Nutr. Health Aging	MAY	2020	24	5					463	465		10.1007/s12603-020-1360-1		APR 2020	3	Geriatrics & Gerontology; Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology; Nutrition & Dietetics	LK0FK	WOS:000526465300001	32346681	Bronze			2022-03-04	
J	Zingg, W; Soulake, I; Baud, D; Huttner, B; Pfister, R; Renzi, G; Pittet, D; Schrenzel, J; Francois, P				Zingg, Walter; Soulake, Isabelle; Baud, Damien; Huttner, Benedikt; Pfister, Riccardo; Renzi, Gesuele; Pittet, Didier; Schrenzel, Jacques; Francois, Patrice			Management and investigation of a Serratia marcescens outbreak in a neonatal unit in Switzerland - the role of hand hygiene and whole genome sequencing (vol 6, 125, 2017)	ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL			English	Correction									[Zingg, Walter; Soulake, Isabelle; Huttner, Benedikt; Pittet, Didier] Univ Geneva Hosp, Infect Control Program, 4 Rue Gabrielle Perret Gentil, CH-1211 Geneva 14, Switzerland; [Zingg, Walter; Soulake, Isabelle; Huttner, Benedikt; Pittet, Didier] Univ Geneva Hosp, WHO Collaborating Ctr Patient Safety, 4 Rue Gabrielle Perret Gentil, CH-1211 Geneva 14, Switzerland; [Baud, Damien; Schrenzel, Jacques; Francois, Patrice] Univ Geneva Hosp, Genom Res Lab, Div Infect Dis, Geneva, Switzerland; [Huttner, Benedikt] Univ Geneva Hosp, Div Infect Dis, Geneva, Switzerland; [Huttner, Benedikt] Fac Med, Geneva, Switzerland; [Pfister, Riccardo] Univ Geneva Hosp, Dept Paediat, Neonatal Intens Care Unit, Geneva, Switzerland; [Renzi, Gesuele; Schrenzel, Jacques; Francois, Patrice] Univ Geneva Hosp, Dept Genet & Lab Med, Bacteriol Lab, Geneva, Switzerland		Zingg, W (corresponding author), Univ Geneva Hosp, Infect Control Program, 4 Rue Gabrielle Perret Gentil, CH-1211 Geneva 14, Switzerland.; Zingg, W (corresponding author), Univ Geneva Hosp, WHO Collaborating Ctr Patient Safety, 4 Rue Gabrielle Perret Gentil, CH-1211 Geneva 14, Switzerland.	walter.zingg@hcuge.ch	Schrenzel, Jacques/AAC-5685-2021; Huttner, Benedikt/M-5616-2014; Schrenzel, Jacques/P-8525-2017; francois, patrice/AAL-5583-2020; Pfister, Riccardo/N-7082-2014	Schrenzel, Jacques/0000-0001-5464-7764; Huttner, Benedikt/0000-0002-1749-9464; Schrenzel, Jacques/0000-0001-5464-7764; Pfister, Riccardo/0000-0002-7395-0512; Pittet, Didier/0000-0002-3667-7131; francois, patrice/0000-0002-0540-750X			Zingg W, 2017, ANTIMICROB RESIST IN, V6, DOI 10.1186/s13756-017-0285-x	1	1	1	0	2	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	2047-2994			ANTIMICROB RESIST IN	Antimicrob. Resist. Infect. Control	JAN 16	2018	7								6	10.1186/s13756-017-0295-8			1	Public, Environmental & Occupational Health; Infectious Diseases; Microbiology; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Infectious Diseases; Microbiology; Pharmacology & Pharmacy	FT4MH	WOS:000423128700001	29377022	gold, Green Published			2022-03-04	
J	Davat, M; Wuarin, L; Stafylakis, D; Abbas, M; Harbarth, S; Hannouche, D; Uckay, I				Davat, Marie; Wuarin, Lydia; Stafylakis, Dimitrios; Abbas, Mohamed; Harbarth, Stephan; Hannouche, Didier; Uckay, Ilker			Should antibiotic prophylaxis before orthopedic implant surgery depend on the duration of pre-surgical hospital stay?	ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL			English	Article						Perioperative antibiotic prophylaxis; Implant orthopedic surgery; Length of hospital stay; Surgical site infections	RESISTANT STAPHYLOCOCCUS-AUREUS; SURGICAL SITE INFECTIONS; ACUTE KIDNEY INJURY; HIP-ARTHROPLASTY; JOINT ARTHROPLASTY; RISK; VANCOMYCIN; PREVENTION; FRACTURES; MULTICENTER	BackgroundProlonged hospital stay before surgery is a risk for colonization with antibiotic-resistant microorganisms and possible antibiotic-resistant surgical site infections (SSI), which lacks acknowledgement in international guidelines for perioperative antibiotic prophylaxis.MethodRetrospective cohort study focusing on prophylaxis-resistant SSI in adult orthopedic implant patients; with emphasis on length of hospital stay prior to the index surgery.ResultsWe enrolled 611cases of SSI (median age, 65years; 241 females and 161 immune-suppressed) in four large implant groups: arthroplasties (n=309), plates (n=127), spondylodeses (n=31), and nails (n=46).The causative pathogen was resistant to the perioperative antibiotic prophylaxis regimen in 307 cases (307/611; 50%), but the length of pre-surgical hospitalization did not influence the incidences of prophylaxis-resistant SSIs. These incidences were (107/211;51%) for the admission day, (170/345;49%) within 10days of delay, (19/35;54%) between 10 and 20days, and (11/20; 55%) beyond 20days of hospital stay before surgery. The corresponding incidences of methicillin-resistant staphylococci were 13%, 14%, 17%, and 5%, respectively. In adjusted group comparisons, the length of prior hospital stay was equally unrelated to future prophylaxis-resistant SSI (odds ratio 1.0, 95% confidence interval 0.99-1.01).ConclusionsIn our retrospective cohort of orthopedic implant SSI, the length of pre-surgical hospital stay was unrelated to the incidence of prophylaxis-resistant pathogens.	[Davat, Marie; Wuarin, Lydia; Stafylakis, Dimitrios; Hannouche, Didier] Geneva Univ Hosp, Orthoped Surg Serv, Geneva, Switzerland; [Abbas, Mohamed; Harbarth, Stephan] Geneva Univ Hosp, Infect Control Program, Geneva, Switzerland; [Uckay, Ilker] Balgrist Univ Hosp, Infectiol, Forchstr 340, CH-8008 Zurich, Switzerland		Uckay, I (corresponding author), Balgrist Univ Hosp, Infectiol, Forchstr 340, CH-8008 Zurich, Switzerland.	ilker.uckay@balgrist.ch	Abbas, Mohamed/M-1724-2019	Abbas, Mohamed/0000-0002-7265-1887; Hannouche, Didier/0000-0003-2060-2394			Agostinho A, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-91; Al-Mayahi M, 2015, J INFECTION, V71, P518, DOI 10.1016/j.jinf.2015.08.002; Al-Mayahi M, 2013, INT ORTHOP, V37, P2253, DOI 10.1007/s00264-013-2092-1; Baraboutis IG, 2011, BRAZ J INFECT DIS, V15, P426, DOI 10.1016/S1413-8670(11)70223-9; Bell S, 2014, J AM SOC NEPHROL, V25, P2625, DOI 10.1681/ASN.2014010035; Billieres Julien, 2016, J Spine Surg, V2, P128, DOI 10.21037/jss.2016.06.06; Bosco JA, 2016, J ARTHROPLASTY, V31, P616, DOI 10.1016/j.arth.2015.09.051; Branch-Elliman W, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002340; Bratzler Dale W, 2013, Am J Health Syst Pharm, V70, P195, DOI 10.2146/ajhp120568; Burger JR, 2018, J ARTHROPLASTY, V33, pS213, DOI 10.1016/j.arth.2018.03.009; Chotai S, 2017, NEUROSURGERY, V80, P746, DOI 10.1093/neuros/nyw097; Clinical and Laboratory Standards Institute, 2007, PERF STAND ANT SUSC; Courtney PM, 2015, CLIN ORTHOP RELAT R, V473, P2197, DOI 10.1007/s11999-014-4062-3; Cranny G, 2008, HEALTH TECHNOL ASSES, V12, pXI; Crawford T, 2012, CLIN INFECT DIS, V54, P1474, DOI 10.1093/cid/cis027; Cuerel Celine, 2017, Eur J Orthop Surg Traumatol, V27, P229, DOI 10.1007/s00590-016-1879-3; Dunkel N, 2012, J ORTHOP SCI, V17, P588, DOI 10.1007/s00776-012-0245-5; Engesaeter LB, 2003, ACTA ORTHOP SCAND, V74, P644, DOI 10.1080/00016470310018135; European Committee on Antimicrobial Susceptibility Testing, BREAKP TABL INT MICS; Gonzalez A, 2014, INT ORTHOP, V38, P2323, DOI 10.1007/s00264-014-2395-x; Jamei Omid, 2017, J Bone Jt Infect, V2, P73, DOI 10.7150/jbji.17171; Jugun K, 2013, INT ORTHOP, V37, P1375, DOI 10.1007/s00264-013-1856-y; Landelle C, 2014, INFECT CONT HOSP EP, V35, P527, DOI 10.1086/675825; Lebowitz D, 2017, INFECT DIS-NOR, V49, P137, DOI 10.1080/23744235.2016.1225979; Lubbeke A, 2016, ACTA ORTHOP, V87, P132, DOI 10.3109/17453674.2015.1126157; Mangram AJ, 1999, AM J INFECT CONTROL, V27, P97, DOI 10.1016/S0196-6553(99)70088-X; Mini E, 1997, DRUGS, V54, P39, DOI 10.2165/00003495-199700546-00008; Mohamad M, 2018, INFECT DIS-NOR, V50, P223, DOI 10.1080/23744235.2017.1374553; Nadeem RD, 2015, J PAK MED ASSOC, V65, P136; O'Toole RV, 2017, J ORTHOP TRAUMA, V31, pS18, DOI [10.1097/BOT.0000000000000801, 10.1097/bot.0000000000000801]; Parvizi J, 2013, BONE JOINT J, V95B, P1450, DOI 10.1302/0301-620X.95B11.33135; Sendi P, 2011, J HOSP INFECT, V79, P64, DOI 10.1016/j.jhin.2011.04.022; Tan TL, 2016, CLIN ORTHOP RELAT R, V474, P1601, DOI 10.1007/s11999-015-4672-4; Teterycz D, 2010, INT J INFECT DIS, V14, pE913, DOI 10.1016/j.ijid.2010.05.014; Uckay I, 2013, J HOSP INFECT, V84, P5, DOI 10.1016/j.jhin.2012.12.014; Uckay I, 2011, J HOSP INFECT, V79, P248, DOI 10.1016/j.jhin.2011.06.014; Uckay I, 2008, ANN MED, V41, P1; Uckay I, 2008, INFECT CONT HOSP EP, V29, P1077, DOI 10.1086/591452; Uckay I, 2017, J INFECTION, V75, P309, DOI 10.1016/j.jinf.2017.06.008; Uckay I, 2012, ANN MED, V44, P360, DOI 10.3109/07853890.2010.550932; Uckay I, 2009, J INFECTION, V59, P337, DOI 10.1016/j.jinf.2009.08.015; Walker H, 2016, J ANTIMICROB CHEMOTH, V71, P2598, DOI 10.1093/jac/dkw166; Westberg M, 2015, CLIN INFECT DIS, V60, P1752, DOI 10.1093/cid/civ162; WHO, 2016, WHO GLOB GUID PREV S	44	2	2	0	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2047-2994			ANTIMICROB RESIST IN	Antimicrob. Resist. Infect. Control	NOV 8	2018	7								131	10.1186/s13756-018-0421-2			7	Public, Environmental & Occupational Health; Infectious Diseases; Microbiology; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Infectious Diseases; Microbiology; Pharmacology & Pharmacy	HA0VZ	WOS:000449930400001	30455869	gold, Green Published, Green Accepted			2022-03-04	
J	Winssinger, N				Winssinger, Nicolas			Biography of Professor Nicolaou: a journey to the extremes of molecular complexity	JOURNAL OF ANTIBIOTICS			English	Editorial Material									[Winssinger, Nicolas] Univ Geneva, Organ Chem, Geneva, Switzerland		Winssinger, N (corresponding author), Univ Geneva, Organ Chem, Geneva, Switzerland.		Winssinger, Nicolas/B-6710-2017	Winssinger, Nicolas/0000-0003-1636-7766				0	0	0	0	1	JAPAN ANTIBIOTICS RESEARCH ASSOC	TOKYO	2 20 8 KAMIOSAKI SHINAGAWA KU, TOKYO, 141, JAPAN	0021-8820			J ANTIBIOT	J. Antibiot.	FEB	2018	71	2					149	150		10.1038/ja.2017.144			2	Biotechnology & Applied Microbiology; Immunology; Microbiology; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Immunology; Microbiology; Pharmacology & Pharmacy	FU8PU	WOS:000424117000001	29375134	Bronze			2022-03-04	
J	Lagoutte, R; Serba, C; Winssinger, N				Lagoutte, Roman; Serba, Christelle; Winssinger, Nicolas			Synthesis of deoxyelephantopin analogues	JOURNAL OF ANTIBIOTICS			English	Article							OLEFIN-METATHESIS CATALYSTS; RESORCYLIC ACID LACTONES; NATURAL-PRODUCTS; SESQUITERPENE LACTONES; KINASE INHIBITORS; DRUG DESIGN; PPAR-GAMMA; ALDEHYDES; RING; IDENTIFICATION	Deoxyelephantopin is a sesquiterpene lactone that was reported to be as effective in the treatment of mammary tumours and lung metastasis as taxol based on a murine orthotopic cancer model. Its germacrene skeleton harbours three Michael acceptors that can potentially engage a target covalently. Its strained 10-membered ring is densely functionalised and represents an important synthetic challenge. We herein describe our studies towards deoxyelephantopins using a ring-closing metathesis approach and report some unexpected observations.	[Lagoutte, Roman; Serba, Christelle; Winssinger, Nicolas] Univ Geneva, Dept Organ Chem, Fac Sci, NCCR Chem Biol, 30 Quai Ernest Ansermet, CH-1205 Geneva, Switzerland		Winssinger, N (corresponding author), Univ Geneva, Dept Organ Chem, Fac Sci, NCCR Chem Biol, 30 Quai Ernest Ansermet, CH-1205 Geneva, Switzerland.	nicolas.winssinger@unige.com	Winssinger, Nicolas/B-6710-2017	Winssinger, Nicolas/0000-0003-1636-7766	Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission	We thank the Swiss National Science Foundation for generous support.	Bae H, 2016, CHEM SCI, V7, P5523, DOI 10.1039/c6sc01279e; Baillie TA, 2016, ANGEW CHEM INT EDIT, V55, P13408, DOI 10.1002/anie.201601091; Barluenga S, 2010, CHEMBIOCHEM, V11, P1692, DOI 10.1002/cbic.201000205; BROWN HC, 1987, J ORG CHEM, V52, P319, DOI 10.1021/jo00378a042; Chany AC, 2011, CHEM-EUR J, V17, P14413, DOI 10.1002/chem.201102542; Chatterjee AK, 2003, J AM CHEM SOC, V125, P11360, DOI 10.1021/ja0214882; Daguer JP, 2015, ANGEW CHEM INT EDIT, V54, P6057, DOI 10.1002/anie.201412276; Dakas PY, 2007, ANGEW CHEM INT EDIT, V46, P6899, DOI 10.1002/anie.200702406; Dakas PY, 2009, CHEM-EUR J, V15, P11490, DOI 10.1002/chem.200901373; Drahl C, 2005, ANGEW CHEM INT EDIT, V44, P5788, DOI 10.1002/anie.200500900; Duplan V, 2014, ORG BIOMOL CHEM, V12, P370, DOI 10.1039/c3ob42049c; Foo K, 2012, ANGEW CHEM INT EDIT, V51, P11491, DOI 10.1002/anie.201206904; Fournier J, 2013, ANGEW CHEM INT EDIT, V52, P1257, DOI 10.1002/anie.201206368; Fournier J, 2012, ANGEW CHEM INT EDIT, V51, P7562, DOI 10.1002/anie.201202486; Fujioka H, 2004, J AM CHEM SOC, V126, P11800, DOI 10.1021/ja046103p; Furstner A, 1997, SYNLETT, P1010; Gao YZ, 2012, ORG BIOMOL CHEM, V10, P3991, DOI 10.1039/c2ob25397f; GRIECO PA, 1977, J ORG CHEM, V42, P1717, DOI 10.1021/jo00430a010; Hoye TR, 2010, J ORG CHEM, V75, P7052, DOI 10.1021/jo101598y; Hoye TR, 2004, J AM CHEM SOC, V126, P10210, DOI 10.1021/ja046385t; Huang CC, 2010, BRIT J PHARMACOL, V159, P856, DOI 10.1111/j.1476-5381.2009.00581.x; Ichikawa H, 2006, CLIN CANCER RES, V12, P5910, DOI 10.1158/1078-0432.CCR-06-0916; Itoh T, 2008, NAT STRUCT MOL BIOL, V15, P924, DOI 10.1038/nsmb.1474; Jogireddy R, 2009, CHEM-EUR J, V15, P11498, DOI 10.1002/chem.200901375; Kingsbury JS, 1999, J AM CHEM SOC, V121, P791, DOI 10.1021/ja983222u; Kitson RRA, 2009, ANGEW CHEM INT EDIT, V48, P9426, DOI 10.1002/anie.200903108; Lagoutte R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12470; Lee WL, 2010, J PROTEOME RES, V9, P237, DOI 10.1021/pr900543e; Leproult E, 2011, J MED CHEM, V54, P1347, DOI 10.1021/jm101396q; Long J, 2014, J MED CHEM, V57, P7098, DOI 10.1021/jm5009456; MARSHALL JA, 1987, J ORG CHEM, V52, P3883, DOI 10.1021/jo00226a031; Merfort I, 2011, CURR DRUG TARGETS, V12, P1560, DOI 10.2174/138945011798109437; Nicolaou KC, 2012, CHEM SOC REV, V41, P5185, DOI 10.1039/c2cs35116a; Nicolaou K.C., 2008, MOL CHANGED WORLD; Nicolaou KC, 2005, ANGEW CHEM INT EDIT, V44, P1012, DOI 10.1002/anie.200460864; Nicolaou KC, 2000, ANGEW CHEM INT EDIT, V39, P44; Nicolaou KC, 2005, ANGEW CHEM INT EDIT, V44, P4490, DOI 10.1002/anie.200500369; Occhipinti G, 2011, ORGANOMETALLICS, V30, P3522, DOI 10.1021/om200181y; Potashman MH, 2009, J MED CHEM, V52, P1231, DOI 10.1021/jm8008597; Pye CR, 2017, P NATL ACAD SCI USA, V114, P5601, DOI 10.1073/pnas.1614680114; Ren YL, 2016, CURR MED CHEM, V23, P2397, DOI 10.2174/0929867323666160510123255; Rodrigues T, 2016, NAT CHEM, V8, P531, DOI [10.1038/NCHEM.2479, 10.1038/nchem.2479]; Romero PE, 2004, ANGEW CHEM INT EDIT, V43, P6161, DOI 10.1002/anie.200461374; Schulte ML, 2013, CHEM-EUR J, V19, P11847, DOI 10.1002/chem.201302669; SEMMELHACK MF, 1981, J ORG CHEM, V46, P1723, DOI 10.1021/jo00321a040; Sen SE, 1997, J ORG CHEM, V62, P6684, DOI 10.1021/jo970509l; Su MX, 2009, NAT PROD COMMUN, V4, P1025; TAKAHASHI T, 1987, HETEROCYCLES, V25, P139, DOI 10.3987/S-1987-01-0139; Trnka TM, 2001, ACCOUNTS CHEM RES, V34, P18, DOI 10.1021/ar000114f; Trost BM, 2009, J AM CHEM SOC, V131, P18343, DOI 10.1021/ja9053948; WENDER PA, 1980, J AM CHEM SOC, V102, P6340, DOI 10.1021/ja00540a029; Zou G, 2008, BIOCHEM PHARMACOL, V75, P1381, DOI 10.1016/j.bcp.2007.11.021	52	6	6	1	14	JAPAN ANTIBIOTICS RESEARCH ASSOC	TOKYO	2 20 8 KAMIOSAKI SHINAGAWA KU, TOKYO, 141, JAPAN	0021-8820			J ANTIBIOT	J. Antibiot.	FEB	2018	71	2					248	256		10.1038/ja.2017.132			9	Biotechnology & Applied Microbiology; Immunology; Microbiology; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Biotechnology & Applied Microbiology; Immunology; Microbiology; Pharmacology & Pharmacy	FU8PU	WOS:000424117000009	29089602	Green Accepted			2022-03-04	
J	Zingg, W; Soulake, I; Baud, D; Huttner, B; Pfister, R; Renzi, G; Pittet, D; Schrenzel, J; Francois, P				Zingg, Walter; Soulake, Isabelle; Baud, Damien; Huttner, Benedikt; Pfister, Riccardo; Renzi, Gesuele; Pittet, Didier; Schrenzel, Jacques; Francois, Patrice			Management and investigation of a Serratia marcescens outbreak in a neonatal unit in Switzerland - the role of hand hygiene and whole genome sequencing-R1, ARIC-D-17-00143	ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL			English	Article						Neonates; Neonatal intensive care unit; Serratia Marcescens; Outbreak; Hand hygiene; Isolation; Infection control; Whole genome sequencing; Cross-transmission; Healthcare-associated infection	INTENSIVE-CARE-UNIT; FIELD GEL-ELECTROPHORESIS; NOSOCOMIAL INFECTIONS; CONTAMINATION	Background: Many outbreaks due to Serratia marcescens among neonates have been described in the literature but little is known about the role of whole genome sequencing in outbreak analysis and management. Methods: Between February and March 2013, 2 neonates and 2 infants previously hospitalised in the neonatal unit of a tertiary care centre in Switzerland, were found to be colonised with S. marcescens. An investigation was launched with extensive environmental sampling and neonatal screening in four consecutive point prevalence surveys between April and May 2013. All identified isolates were first investigated by fingerprinting and later by whole genome sequencing. Audits of best practices were performed and a hand hygiene promotion programme was implemented. Results: Twenty neonates were colonised with S. marcescens. No invasive infection due to S. marcescens occurred. All 231 environmental samples were negative. Hand hygiene compliance improved from 51% in April 2013 to 79% in May 2013 and remained high thereafter. No S. marcescens was identified in point prevalence surveys in June and October 2013. All strains were identical in the fingerprinting analysis and closely related according to whole genome sequencing. Conclusions: Improving best practices and particularly hand hygiene proved effective in terminating the outbreak. Whole genome sequencing is a helpful tool for genotyping because it allows both sufficient discrimination of strains and comparison to other outbreaks through the use of an emerging international database.	[Zingg, Walter; Soulake, Isabelle; Huttner, Benedikt; Pittet, Didier] Univ Geneva Hosp, Infect Control Program, 4 Rue Gabrielle Perret Gentil, CH-1211 Geneva 14, Switzerland; [Zingg, Walter; Soulake, Isabelle; Huttner, Benedikt; Pittet, Didier] Univ Geneva Hosp, WHO Collaborating Ctr Patient Safety, 4 Rue Gabrielle Perret Gentil, CH-1211 Geneva 14, Switzerland; [Baud, Damien; Schrenzel, Jacques; Francois, Patrice] Univ Geneva Hosp, Div Infect Dis, Genom Res Lab, Geneva, Switzerland; [Huttner, Benedikt] Univ Geneva Hosp, Div Infect Dis, Geneva, Switzerland; [Huttner, Benedikt] Fac Med, Geneva, Switzerland; [Pfister, Riccardo] Univ Geneva Hosp, Dept Paediat, Neonatal Intens Care Unit, Geneva, Switzerland; [Renzi, Gesuele; Schrenzel, Jacques; Francois, Patrice] Univ Geneva Hosp, Dept Genet & Lab Med, Bacteriol Lab, Geneva, Switzerland		Zingg, W (corresponding author), Univ Geneva Hosp, Infect Control Program, 4 Rue Gabrielle Perret Gentil, CH-1211 Geneva 14, Switzerland.; Zingg, W (corresponding author), Univ Geneva Hosp, WHO Collaborating Ctr Patient Safety, 4 Rue Gabrielle Perret Gentil, CH-1211 Geneva 14, Switzerland.	walter.zingg@hcuge.ch	Pfister, Riccardo/N-7082-2014; Schrenzel, Jacques/P-8525-2017; Schrenzel, Jacques/AAC-5685-2021; Huttner, Benedikt/M-5616-2014; francois, patrice/AAL-5583-2020	Pfister, Riccardo/0000-0002-7395-0512; Schrenzel, Jacques/0000-0001-5464-7764; Schrenzel, Jacques/0000-0001-5464-7764; Huttner, Benedikt/0000-0002-1749-9464; Pittet, Didier/0000-0002-3667-7131; francois, patrice/0000-0002-0540-750X			Al Jarousha AMK, 2008, J HOSP INFECT, V70, P119, DOI 10.1016/j.jhin.2008.06.028; ANAGNOSTAKIS D, 1981, AM J DIS CHILD, V135, P413, DOI 10.1001/archpedi.1981.02130290011005; Archibald LK, 1997, INFECT CONT HOSP EP, V18, P704; Assadian O, 2002, INFECT CONT HOSP EP, V23, P457, DOI 10.1086/502085; Aujoulat F, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0325-0; Bates CJ, 2005, J HOSP INFECT, V61, P364, DOI 10.1016/j.jhin.2005.05.003; BRAVER DJ, 1987, J HOSP INFECT, V10, P129, DOI 10.1016/0195-6701(87)90138-1; Buffet-Bataillon S, 2009, J HOSP INFECT, V72, P17, DOI 10.1016/j.jhin.2009.01.010; Casolari C, 2005, J HOSP INFECT, V61, P312, DOI 10.1016/j.jhin.2005.03.005; David MD, 2006, J HOSP INFECT, V63, P27, DOI 10.1016/j.jhin.2005.11.006; Drell T, 2014, GUT MICROBES, V5, P304, DOI 10.4161/gmic.28849; DUGGAN TG, 1984, PATHOLOGY, V16, P189, DOI 10.3109/00313028409059103; Gastmeier P, 2007, AM J INFECT CONTROL, V35, P172, DOI 10.1016/j.ajic.2006.07.007; Gastmeier Petra, 2014, Front Microbiol, V5, P81, DOI 10.3389/fmicb.2014.00081; Gillespie EE, 2007, J PERINAT MED, V35, P227, DOI 10.1515/JPM.2007.043; Jang TN, 2001, J HOSP INFECT, V48, P13, DOI 10.1053/jhin.2001.0947; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Moles L, 2015, Clin Microbiol Infect, V21, DOI 10.1016/j.cmi.2015.06.003; Moles L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066986; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Pessoa-Silva CL, 2007, PEDIATRICS, V120, pE382, DOI 10.1542/peds.2006-3712; Raymond J, 2000, INFECT CONT HOSP EP, V21, P260, DOI 10.1086/501755; Sarvikivi E, 2004, INFECT CONT HOSP EP, V25, P723, DOI 10.1086/502467; Schwab F, 2014, INFECTION, V42, P73, DOI 10.1007/s15010-013-0516-x; Steppberger K, 2002, INFECTION, V30, P277, DOI 10.1007/s15010-002-2141-y; Stone SP, 2007, LANCET INFECT DIS, V7, P282, DOI 10.1016/S1473-3099(07)70082-8; Voelz A, 2010, INT J HYG ENVIR HEAL, V213, P79, DOI 10.1016/j.ijheh.2009.09.003; Von Dach E, 2016, J INFECT DIS, V213, P1370, DOI 10.1093/infdis/jiv489	28	12	13	0	7	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	2047-2994			ANTIMICROB RESIST IN	Antimicrob. Resist. Infect. Control	DEC 11	2017	6								125	10.1186/s13756-017-0285-x			6	Public, Environmental & Occupational Health; Infectious Diseases; Microbiology; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Infectious Diseases; Microbiology; Pharmacology & Pharmacy	FP4RN	WOS:000417604200001	29238572	Green Published, gold			2022-03-04	
J	Rached, MAKB; Gaudet, JG; Delhumeau, C; Walder, B				Rached, Mohamed A. K. B.; Gaudet, John G.; Delhumeau, Cecile; Walder, Bernhard			Comparison of two simple models for prediction of short term mortality in patients after severe traumatic brain injury	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Head injury; Prognosis; Discrimination; Calibration; Age; Pupil reactivity; Glasgow Coma Scale; Abbreviated Injury Score	GLASGOW COMA SCALE; OLDER-ADULTS; HEAD-INJURY; SCORE; EPIDEMIOLOGY; MODERATE; IMPACT	Introduction: The subscale motor score of Glasgow Coma Scale (msGCS) and the Abbreviated Injury Score of head region (HAIS) are validated prognostic factors in traumatic brain injury (TBI). The aim was to compare the prognostic performance of a HAIS-based prediction model including HAIS, pupil reactivity and age, and the reference prediction model including msGCS in emergency department (ED), pupil reactivity and age. Methods: Secondary analysis of a prospective epidemiological study including patients after severe TBI (HAIS> 3) with follow-up from the time of accident until 14 days or earlier death was performed in Switzerland. Performance of prediction, based on accuracy of discrimination [area under the receiver-operating curve (AUROC)], calibration (Hosmer-Lemeshow test) and validity (bootstrapping with 2000 repetitions to correct) for optimism of the two prediction models were investigated. A non-inferiority approach was performed and an a priori threshold for important differences was established. Results: The cohort included 808 patients [median age 56 {inter-quartile range (IQR) 33-71}, median motor part of GCS in ED 1 (1-6), abnormal pupil reactivity 29.0%] with a death rate of 29.7% at 14 days. The accuracy of discrimination was similar (AUROCHAIS-based prediction model: 0.839; AUROC msGCS-based prediction model: 0.826, difference of the 2 AUROC 0.013 (-0.007 to 0.037). A similar calibration was observed (Hosmer-Lemeshow X-2 11.64, p = 0.168 vs. Hosmer-Lemeshow X-2 8.66, p = 0.372). Internal validity of HAIS-based prediction model was high (optimism corrected AUROC: 0.837). Conclusions: Performance of prediction for short-term mortality after severe TBI with HAIS-based prediction model was non-inferior to reference prediction model using msGCS as predictor. (C) 2018 Elsevier Ltd. All rights reserved.	[Rached, Mohamed A. K. B.; Gaudet, John G.; Delhumeau, Cecile; Walder, Bernhard] Univ Hosp Geneva HUG, Div Anaesthesiol, Geneva, Switzerland		Rached, MAKB (corresponding author), Univ Hosp Geneva, Dept APSI, Div Anaesthesiol, Rue Gabrielle Perret Gentil 4, CH-1211 Geneva, Switzerland.	mohk@hcuge.ch			Swiss Accident Insurance Foundation (SUVA, Switzerland)	The authors have no conflict of interest to declare. This study was partially funded by the Swiss Accident Insurance Foundation (SUVA, Switzerland). The funding agency had no role in the study design, data collection, data analysis, data interpretation or writing of the report.	Andelic N, 2012, NEUROEPIDEMIOLOGY, V38, P259, DOI 10.1159/000338032; Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; [Anonymous], 1971, JAMA, V215, P277; Ashkenazi I, 2016, JAMA SURG, V151, P954, DOI 10.1001/jamasurg.2016.1742; Beskind DL, 2014, PREHOSP EMERG CARE, V18, P68, DOI 10.3109/10903127.2013.844870; Collins GS, 2015, ANN INTERN MED, V162, P55, DOI [10.7326/M14-0697, 10.1136/bmj.g7594, 10.1186/s12916-014-0241-z, 10.1002/bjs.9736]; Demetriades D, 2004, J AM COLL SURGEONS, V199, P216, DOI 10.1016/j.jamcollsurg.2004.02.030; Demetriades D, 2006, J TRAUMA, V61, P868, DOI 10.1097/01.ta.0000219135.33398.f3; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; Gennarelli TA, 2006, INJURY, V37, P1083, DOI 10.1016/j.injury.2006.07.009; Gill M, 2005, ANN EMERG MED, V45, P37, DOI 10.1016/j.annemergmed.2004.07.429; Grote S, 2011, J NEUROTRAUM, V28, P527, DOI 10.1089/neu.2010.1433; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hendrickson CM, 2016, J TRAUMA ACUTE CARE, V80, P989, DOI 10.1097/TA.0000000000000982; Holmes M, 2014, J AM COLL SURGEONS, V219, P631, DOI 10.1016/j.jamcollsurg.2014.05.014; Hosmer DW, 1997, STAT MED, V16, P965; Kehoe A, 2015, EMERG MED J, V32, P613, DOI 10.1136/emermed-2013-203488; Kesinger MR, 2015, J TRAUMA ACUTE CARE, V78, P396, DOI 10.1097/TA.0000000000000526; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lannoo E, 2000, J NEUROTRAUM, V17, P403, DOI 10.1089/neu.2000.17.403; Majdan M, 2015, J NEUROTRAUM, V32, P101, DOI 10.1089/neu.2014.3438; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Ogundimu EO, 2016, J CLIN EPIDEMIOL, V76, P175, DOI 10.1016/j.jclinepi.2016.02.031; Pepe MS, 2009, STATA J, V9, P1; Reith FCM, 2016, INTENS CARE MED, V42, P3, DOI 10.1007/s00134-015-4124-3; Ringdal KG, 2013, INJURY, V44, P691, DOI 10.1016/j.injury.2012.06.032; Roozenbeek B, 2012, J NEUROTRAUM, V29, P1306, DOI 10.1089/neu.2011.1988; Salottolo K, 2014, JAMA SURG, V149, P727, DOI 10.1001/jamasurg.2014.13; Savitsky B, 2016, BRAIN INJURY, V30, P1194, DOI 10.1080/02699052.2016.1187290; Staples JA, 2016, J HEAD TRAUMA REHAB, V31, pE8, DOI 10.1097/HTR.0000000000000195; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; TEASDALE G, 1974, LANCET, V2, P81; Timmons SD, 2011, J TRAUMA, V71, P1172, DOI 10.1097/TA.0b013e31822b0f4b; Tohme S, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/1757-7241-22-1; van Leeuwen N, 2012, NEUROSURGERY, V70, P811, DOI 10.1227/NEU.0b013e318235d640; von Elm E, 2008, SWISS MED WKLY, V138, P327, DOI 2008/23/smw-12025; Walder B, 2013, J NEUROTRAUM, V30, P1934, DOI 10.1089/neu.2013.2955; Zador Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158762; Zuercher M, 2009, BRAIN INJURY, V23, P371, DOI 10.1080/02699050902926267	40	4	5	0	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	JAN	2019	50	1					65	72		10.1016/j.injury.2018.08.022			8	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	HG1LR	WOS:000454717700013	30213562				2022-03-04	
J	Dornier, C; Dorsaz-Brossa, L; Thevenaz, P; Casagni, F; Brochut, P; Mombelli, A; Vallee, J				Dornier, C; Dorsaz-Brossa, L; Thevenaz, P; Casagni, F; Brochut, P; Mombelli, A; Vallee, J			Geometric alignment and chromatic calibration of serial radiographic images	DENTOMAXILLOFACIAL RADIOLOGY			English	Article						image registration; bone density; intensity calibration; dental radiographs	SUBTRACTION RADIOGRAPHY; PARALLELING INSTRUMENT; DIGITAL SUBTRACTION; CLINICAL-ASSESSMENT; OSSEOUS REPAIR; REGISTRATION; DEFECTS; BONE	Objective: To develop software for automated registration and intensity calibration of serial dental radiographs for the analysis of longitudinal changes in bone density. Methods: Serial dental radiographs were acquired using a positioning device designed to minimize projection divergence. Each radiograph included an image of a standardized aluminium wedge. The radiographs were scanned on a flatbed scanner (AGFA Duo Scan) with a spatial resolution of 300 dpi, and pixel intensity coded in 16-bit grey scale. The intensity was calibrated using serial images of selected areas with defined thickness of the aluminium wedge. A robust B-splines multiresolution registration algorithm was implemented to overcome the acquisition misalignment. Radiographs, taken before and after periodontal therapy, were subtracted to assess bone density evolution. Results: The intensity calibration decreased the maximum intensity variations between serial radiographs from 30 +/- 17% to 1 +/- 1% (mean +/- standard deviation), and improved the visual comparison between the radiographs. The registration stage allowed correcting the misalignment of the radiographs on the scanner screen and superimposing the radiography contents. The observed residual motion was about 0.02 +/- 0.01 mm. Conclusion: Very user-friendly software was developed. The manipulator needs to scan the radiographs only one time. The software performs all subsequent processing steps.	Univ Hosp Geneva, Dept Radiol, Div Med Comp, Digital Imaging Unit, Geneva, Switzerland; Ecole Polytech Fed Lausanne, BM Ecublens, Biomed Imaging Grp, CH-1015 Lausanne, Switzerland; Univ Geneva, Sch Dent Med, Dept Periodontol, Geneva, Switzerland		Dornier, C (corresponding author), CO Voirets, Chemin Voirets 22,Case Postale 605, CH-1212 Grand Lancy 1, Switzerland.	christophe.dornier@edu.ge.ch		Vallee, Jean-Paul/0000-0001-7546-2013			Benn D K, 1990, Dentomaxillofac Radiol, V19, P97; BRAGGER D, 1988, J CLIN PERIODONTOL, V15, P27, DOI 10.1111/j.1600-051X.1988.tb01551.x; DUBREZ B, 1990, J PERIODONTOL, V61, P725, DOI 10.1902/jop.1990.61.12.725; DUBREZ B, 1995, ORAL SURG ORAL MED O, V80, P358, DOI 10.1016/S1079-2104(05)80395-6; DURWIN A, 1985, J CLIN PERIODONTOL, V12, P525, DOI 10.1111/j.1600-051X.1985.tb01387.x; ETTINGER GJ, 1994, J CLIN PERIODONTOL, V21, P540, DOI 10.1111/j.1600-051X.1994.tb01170.x; FROUM SJ, 1982, J PERIODONTOL, V53, P8, DOI 10.1902/jop.1982.53.1.8; GRAF JM, 1988, ORAL SURG ORAL MED O, V66, P502, DOI 10.1016/0030-4220(88)90278-2; HAUSMANN E, 1990, J PERIODONTOL, V61, P149, DOI 10.1902/jop.1990.61.3.149; JEFFCOAT MK, 1995, PERIODONTOL 2000, V7, P54, DOI 10.1111/j.1600-0757.1995.tb00036.x; LEE SH, 1994, P 10 INT C DENT RAD, P371; Lehmann T, 1997, COMPUT BIOL MED, V27, P151, DOI 10.1016/S0010-4825(97)83769-9; Lehmann T, 2001, DENTOMAXILLOFAC RAD, V30, P64, DOI 10.1038/sj.dmfr.4600589; Lehmann TM, 2000, DENTOMAXILLOFAC RAD, V29, P323, DOI 10.1038/sj.dmfr.4600558; POLSON AM, 1978, J CLIN PERIODONTOL, V5, P13, DOI 10.1111/j.1600-051X.1978.tb01902.x; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Thevenaz P, 2000, IEEE T MED IMAGING, V19, P739, DOI 10.1109/42.875199; THEVENAZ P, INTRAMODAL REGISTRAT; Unser M, 1999, IEEE SIGNAL PROC MAG, V16, P22, DOI 10.1109/79.799930; Webber RL, 1996, ORAL SURG ORAL MED O, V81, P480, DOI 10.1016/S1079-2104(96)80029-1; Webber RL, 1997, DENTOMAXILLOFAC RAD, V26, P53, DOI 10.1038/sj.dmfr.4600201	21	8	8	0	0	BRITISH INST RADIOLOGY	LONDON	36 PORTLAND PLACE, LONDON W1N 4AT, ENGLAND	0250-832X	1476-542X		DENTOMAXILLOFAC RAD	Dentomaxillofac. Radiol.	JUL	2004	33	4					220	225		10.1259/dmfr/71716997			6	Dentistry, Oral Surgery & Medicine; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine; Radiology, Nuclear Medicine & Medical Imaging	874UM	WOS:000225375600002	15533974				2022-03-04	
J	Burri, M; Baujard, V; Etter, JF				Burri, Mafalda; Baujard, Vincent; Etter, Jean-Francois			A qualitative analysis of an Internet discussion forum for recent ex-smokers	NICOTINE & TOBACCO RESEARCH			English	Article							SMOKING-CESSATION TREATMENT; SOCIAL SUPPORT; MENTAL-HEALTH; ONLINE; INTERVENTIONS; TRIAL; WORLD	We conducted a qualitative analysis of all messages posted in April 2005 on an online discussion forum aimed at recent ex-smokers, on the smoking cessation Web site Stop-tabac.ch. We analyzed only the forum aimed at recent ex-smokers because it was far more active than forums aimed at current smokers. Participants were 97 people who posted a total of 1,033 messages (mean=10.6 messages per participant). Most (76%) participants were women, the median age was 40 years, and participants had quit smoking for a median of 2 months. Each initial message generated on average 2.7 replies. The most frequent categories of messages covered providing emotional support and encouragements (24% of all messages), stories and opinions (14%), congratulations to other quitters (14%)), commonplace remarks (13%), "thank you" messages (11%), giving practical advice and tips (8%), and nicotine replacement therapy (6%). Women were more likely than men to post messages on nicotine replacement therapy, congratulations and emotional support. Men were more likely to post general commentaries and practical advice. No individual participant or group of participants had a clear leadership role. The 10 most active participants posted half (49.8%) of all messages. Of these 10 participants, six were still among the 10 most active in May and 3 in June 2005. Thus, this online discussion forum was used mainly by women as a source of emotional support and encouragement during the first few weeks after a quit attempt. The forum was used less frequently as a source of practical information and quitting tips.	Univ Geneva, Inst Social & Prevent Med, CH-1211 Geneva 4, Switzerland; Hlth Net Fdn, Geneva, Switzerland		Etter, JF (corresponding author), Univ Geneva, Inst Social & Prevent Med, CMU,1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland.	Jean-Francois.Etter@imsp.unige.ch		ETTER, Jean-Francois/0000-0002-1426-3157			Anderson JE, 2002, CHEST, V121, P932, DOI 10.1378/chest.121.3.932; Bansal MA, 2004, NICOTINE TOB RES, V6, P303, DOI 10.1080/14622200412331320707; Bock BC, 2004, NICOTINE TOB RES, V6, P207, DOI 10.1080/14622200410001676332; Centers for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V54, P509; Des Jarlais DC, 2004, AM J PUBLIC HEALTH, V94, P361, DOI 10.2105/AJPH.94.3.361; Etter JF, 2001, CLIN PHARMACOL THER, V69, P175, DOI 10.1067/mcp.2001.113722; Etter JF, 2005, J MED INTERNET RES, V7, DOI 10.2196/jmir.7.1.e2; ETTER JF, 2005, INT J MED INFORM; Eysenbach G, 2004, BMJ-BRIT MED J, V328, P1166, DOI 10.1136/bmj.328.7449.1166; Fox S, 2005, HLTH INFORM ONLINE; Johnsen JAK, 2002, SCAND J PSYCHOL, V43, P445, DOI 10.1111/1467-9450.00313; Klemm P, 1999, COMPUT NURS, V17, P65; Kummervold PE, 2002, NORD J PSYCHIAT, V56, P59, DOI 10.1080/08039480252803945; Lasker Judith N, 2005, J Med Internet Res, V7, pe10, DOI 10.2196/jmir.7.1.e10; May S, 2000, TOB CONTROL, V9, P415, DOI 10.1136/tc.9.4.415; Owen JE, 2004, J BEHAV MED, V27, P491, DOI 10.1023/B:JOBM.0000047612.81370.f7; Ramos JD, 2004, BRIT MED J, V328, P1177, DOI 10.1136/bmj.328.7449.1177; SCHNEIDER SJ, 1986, COMPUT BIOMED RES, V19, P274, DOI 10.1016/0010-4809(86)90022-4; SCHNEIDER SJ, 1990, COMPUT HUM BEHAV, V6, P141, DOI 10.1016/0747-5632(90)90002-X; Strecher VJ, 2005, ADDICTION, V100, P682, DOI 10.1111/j.1360-0443.2005.01093.x; Taylor SE, 2000, PSYCHOL REV, V107, P411, DOI 10.1037/0033-295X.107.3.411; Woodruff SI, 2001, J ADOLESCENT HEALTH, V29, P239, DOI 10.1016/S1054-139X(01)00262-2; Zrebiec JF, 2001, DIABETIC MED, V18, P154, DOI 10.1046/j.1464-5491.2001.00443.x	23	47	48	0	4	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1462-2203	1469-994X		NICOTINE TOB RES	Nicotine Tob. Res.	DEC	2006	8			1			S13	S19		10.1080/14622200601042513			7	Substance Abuse; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Substance Abuse; Public, Environmental & Occupational Health	132ZJ	WOS:000243981100003	17491166				2022-03-04	
J	Hauke, C; Meisser, A; Perren, SM				Hauke, C; Meisser, A; Perren, SM			Methodology of clinical trials focusing on the PC-Fix clinical trials	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						prospective clinical trials; methodology; trauma surgery; orthopaedic device; PC-Fix; Good Clinical Practice	RANDOMIZED CONTROLLED-TRIALS; COMPRESSION-PLATE FIXATION; INTERNAL-FIXATION; DIAPHYSEAL FRACTURES; CONSORT; SURGERY; RADIUS; ARTHROPLASTY; DRAINAGE; SCREW	Once development and mechanical and biological laboratory testing have been completed, new technologies to be used in orthopaedic and trauma surgery must be investigated in humans before they can be used routinely. Prospective clinical investigations with or without randomization to standard treatments conducted according to the current standards and guidelines for Good Clinical Practice must be performed to prove the safety and efficacy of the new device. Furthermore, these tests serve to determine the specific indications, contraindications, tips and tricks as well as the pitfalls and how to avoid them. Last, but not least, the study must result in improved teaching of the use of the device and in improved follow-up of patients. The basis of every conclusion drawn from such a study is the complete documentation of each single use of the new device. We present the modalities and methodology for conducting a prospective clinical multicentre investigation in trauma surgery, focusing on the clinical trials carried out on the Point Contact Fixator (PC-Fix), a device for the internal fixation of long bone fractures developed as part of the scientific evolution towards the Less Invasive Stabilization Systems (LISS) now being introduced into clinical practice. Four prospective multicentre clinical investigations with an overall number of 1,229 PC-Fixators implanted from October 1993 to May 1998 were performed. To our knowledge this is the largest prospective series ever reported in orthopaedic trauma surgery to test a new device before market introduction. Due to a special documentation and implant replacement procedure, every PC-Fix implantation was documented. Very few patients were lost to long-term follow-up due to the personal commitment of the study monitors. Regular personal visits of the study monitor to the investigating hospitals and close communication between the surgeons, the engineers responsible for development, the study monitor, and the study sponsor meant that problems were identified and dealt with professionally without compromising the health of the patient. Case report forms were concise and had to be transmitted without delay. Handling of radiographs has become easier thanks to the transmission of digital images to the study centre via the internet. There are some aspects specific to trauma surgery which require special consideration and planning is essential, but clinical trials can be performed effectively.	AO ASIF Dev Clin Invest, CH-7270 Davos, Switzerland		Hauke, C (corresponding author), Hop Univ Geneve, Clin & Policlin Orthoped & Chirurgie Appareil Mot, Rue Micheli Du Crest 24, CH-1211 Geneva 14, Switzerland.	Christian.Hauke@hcuge.ch					Altman DG, 1996, BRIT MED J, V313, P570; Amadio PC, 1996, J HAND SURG-AM, V21A, P925, DOI 10.1016/S0363-5023(96)80219-X; ANDERSON LD, 1975, J BONE JOINT SURG AM, VA 57, P287, DOI 10.2106/00004623-197557030-00001; Barrack RL, 1997, J BONE JOINT SURG AM, V79A, P1121, DOI 10.2106/00004623-199708000-00002; Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; Bell PRF, 1997, BRIT J SURG, V84, P737, DOI 10.1002/bjs.1800840602; BERMAN AT, 1990, ORTHOPEDICS, V13, P309; BONCHEK LI, 1979, NEW ENGL J MED, V301, P44, DOI 10.1056/NEJM197907053010110; CHALMERS TC, 1983, NEW ENGL J MED, V309, P1358, DOI 10.1056/NEJM198312013092204; CHAPMAN MW, 1989, J BONE JOINT SURG AM, V71A, P159, DOI 10.2106/00004623-198971020-00001; Clark CR, 1997, J BONE JOINT SURG AM, V79A, P1119, DOI 10.2106/00004623-199708000-00001; CURRAN WJ, 1979, NEW ENGL J MED, V300, P1273, DOI 10.1056/NEJM197905313002213; GERBER C, 1990, ARCH ORTHOP TRAUM SU, V109, P295, DOI 10.1007/BF00636165; GOLDHAGEN PR, 1994, J ORTHOP TRAUMA, V8, P367, DOI 10.1097/00005131-199410000-00001; GOODFELLOW J, 1993, J BONE JOINT SURG BR, V75, P345, DOI 10.1302/0301-620X.75B3.8496195; Grontvedt T, 1996, J BONE JOINT SURG AM, V78A, P159, DOI 10.2106/00004623-199602000-00001; GROSS M, 1993, J BONE JOINT SURG BR, V75, P351, DOI 10.1302/0301-620X.75B3.8496198; GROSS M, 1988, J BONE JOINT SURG AM, V70A, P1364, DOI 10.2106/00004623-198870090-00014; Haas N, 2001, INJURY, V32, pSB51; Hertel R, 2001, INJURY, V32, pSB10; Hertel R, 1996, INJURY, V27, P545, DOI 10.1016/S0020-1383(96)00091-5; Hofer HP, 2001, INJURY, V32, pSB15; Horne J G, 1990, J Orthop Trauma, V4, P30; Jacobsen MB, 1996, J HAND SURG-BRIT EUR, V21B, P202, DOI 10.1016/S0266-7681(96)80097-0; JAZRAWI LM, 2000, CLIN ORTHOP RELAT R, V377, P235; Kolodziej P, 1998, CLIN ORTHOP RELAT R, P79; Lang GJ, 1998, J ORTHOP TRAUMA, V12, P348, DOI 10.1097/00005131-199806000-00009; LIEBERGALL M, 1995, ISRAEL J MED SCI, V31, P62; Liem MSL, 1997, BRIT J SURG, V84, P769, DOI 10.1046/j.1365-2168.1997.02782.x; Maffulli N, 1998, J BONE JOINT SURG AM, V80A, P923, DOI 10.2106/00004623-199806000-00017; MAFFULLI N, 1993, J BONE JOINT SURG AM, V75A, P700, DOI 10.2106/00004623-199305000-00009; MULLER ME, 1990, MANUAL INT FIXATION; Muller ME, 1990, COMPREHENSIVE CLASSI; MURALIKUTTAN KP, 1992, SPINE, V17, P381, DOI 10.1097/00007632-199204000-00001; PERREN SM, 1995, INJURY S2, V26; RUDICEL S, 1985, J BONE JOINT SURG AM, V67A, P1284, DOI 10.2106/00004623-198567080-00026; Simon JA, 1999, J ORTHOP TRAUMA, V13, P196, DOI 10.1097/00005131-199903000-00007; SKINNER P, 1989, INJURY, V20, P291, DOI 10.1016/0020-1383(89)90171-X; SOLOMON MJ, 1994, SURGERY, V115, P707; Swiontkowski MF, 2001, J ORTHOP TRAUMA, V15, P86, DOI 10.1097/00005131-200102000-00002; TAYLOR KM, 1984, NEW ENGL J MED, V310, P1363, DOI 10.1056/NEJM198405243102106; Tepic S, 1997, J ORTHOP TRAUMA, V11, P14, DOI 10.1097/00005131-199701000-00005; VANDERLINDEN W, 1980, SURGERY, V87, P258; Wehbe MA, 1998, J BONE JOINT SURG AM, V80A, P1395, DOI 10.2106/00004623-199809000-00022; 1996, ICH HARMONISED TRIPA; 1980, LANCET, V1, P1229	46	0	1	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	SEP	2001	32			2			SB26	SB37					12	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	487KG	WOS:000171873800005					2022-03-04	
J	Srour, ML; Baratti-Mayer, D				Srour, M. Leila; Baratti-Mayer, Denise			Why is noma a neglected-neglected tropical disease?	PLOS NEGLECTED TROPICAL DISEASES			English	Article								Noma is an orofacial gangrene affecting primarily children living in extreme poverty in remote parts of subtropical and tropical countries. Mortality and disability are high, and survivors often have physical and functional deformities resulting in stigma and isolation. Many healthcare professionals and primary healthcare workers where noma risk factors exist have no knowledge about noma and its implications. Public health measures to improve nutrition, immunizations, sanitation, and access to healthcare and measures to eliminate extreme poverty can lead to the eradication of noma. Research allocation has been insufficient to study the epidemiology, treatment, and prevention of noma. In a recent editorial by Hotez and colleagues in PLOS Neglected Tropical Diseases (NTDs), "What constitutes an NTD?" Noma is not included. The exclusion of noma from NTDs constitutes this preventable childhood disease as a neglected neglected disease. The purpose of this article is the inclusion of noma with the PLOS NTDs. Increased awareness and attention to noma can lead to the eradication of this disease affecting the world's most vulnerable.	[Srour, M. Leila] Hlth Frontiers, Viangchan, Laos; [Baratti-Mayer, Denise] Univ Geneva, Inst Global Hlth, Geneva, Switzerland		Srour, ML (corresponding author), Hlth Frontiers, Viangchan, Laos.	leila@butterflychildren.org		Srour, Margaret Leila/0000-0003-4706-440X			ADELSBERGER L, 1946, LANCET, V250, P317; [Anonymous], 2012, AHRCAC87 UN GEN ASS; Baratti-Mayer D, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16224587; Brattstrom-Stolt L, 2019, INT HEALTH, V11, P290, DOI 10.1093/inthealth/ihy088; Enwonwu CO, 2006, LANCET, V368, P147, DOI 10.1016/S0140-6736(06)69004-1; Farley E, 2020, INT HEALTH, V12, P28, DOI 10.1093/inthealth/ihz066; Fieger A, 2003, TROP MED INT HEALTH, V8, P402, DOI 10.1046/j.1365-3156.2003.01036.x; Haesen S, 2013, 23 ANN C INT SOC EXP; Hotez PJ, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008001; Hotez PJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002865; Huyghe A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002453; Marck, 2003, NOMA FACE POVERTY; Srour ML, 2017, AM J TROP MED HYG, V96, P268, DOI 10.4269/ajtmh.16-0718; Srour ML, 2015, INT HEALTH, V7, P149, DOI 10.1093/inthealth/ihv001; World Health Organization, 1998, WORLD HLTH REP 1998	15	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	AUG	2020	14	8							e0008435	10.1371/journal.pntd.0008435			4	Infectious Diseases; Parasitology; Tropical Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Infectious Diseases; Parasitology; Tropical Medicine	NG6EN	WOS:000564075100007	32817617	gold, Green Published			2022-03-04	
J	Sacconnay, L; Angleviel, M; Randazzo, GM; Queiroz, MMF; Queiroz, EF; Wolfender, JL; Carrupt, PA; Nurisso, A				Sacconnay, Lionel; Angleviel, Melissa; Randazzo, Giuseppe Marco; Queiroz, Marcos Marcal Ferreira; Queiroz, Emerson Ferreira; Wolfender, Jean-Luc; Carrupt, Pierre-Alain; Nurisso, Alessandra			Computational Studies on Sirtuins from Trypanosoma cruzi: Structures, Conformations and Interactions with Phytochemicals	PLOS NEGLECTED TROPICAL DISEASES			English	Article							ANTIPROTOZOAL ACTIVITY; NATURAL-PRODUCTS; IN-VITRO; NAPHTHYLISOQUINOLINE ALKALOIDS; TRYPANOCIDAL CONSTITUENTS; MOLECULAR DOCKING; CRYSTAL-STRUCTURE; CHAGAS-DISEASE; SIR2 FAMILY; DNA-REPAIR	Background The silent-information regulator 2 proteins, otherwise called sirtuins, are currently considered as emerging anti-parasitic targets. Nicotinamide, a pan-sirtuin inhibitor, is known to cause kinetoplast alterations and the arrested growth of T. cruzi, the protozoan responsible for Chagas disease. These observations suggested that sirtuins from this parasite (TcSir2rp1 and TcSir2rp3) could play an important role in the regulation of the parasitic cell cycle. Thus, their inhibition could be exploited for the development of novel anti-trypanosomal compounds. Methods Homology modeling was used to determine the three-dimensional features of the sirtuin TcSir2rp1 from T. cruzi. The apo-form of human SIRT2 and the same structure solved in complex with its co-substrate NAD(+) allowed the modeling of TcSir2rp1 in the open and closed conformational states. Molecular docking studies were then carried out. A library composed of fifty natural and diverse compounds that are known to be active against this parasite, was established based on the literature and virtually screened against TcSir2rp1 and TcSir2rp3, which was previously modeled by our group. Results In this study, two conformational states of TcSir2rp1 were described for the first time. The molecular docking results of compounds capable of binding sirtuins proved to be meaningful when the closed conformation of the protein was taken into account for calculations. This specific conformation was then used for the virtual screening of antritrypanosomal phytochemicals against TcSir2rp1 and TcSir2rp3. The calculations identified a limited number of scaffolds extracted from Vismia orientalis, Cussonia zimmermannii, Amomum aculeatum and Anacardium occidentale that potentially interact with both proteins. Conclusions The study provided reliable models for future structure-based drug design projects concerning sirtuins from T. cruzi. Molecular docking studies highlighted not only the advantages of performing in silico interaction studies on their closed conformations but they also suggested the potential mechanism of action of four phytochemicals known for their anti-trypanosomal activity in vitro. Author SummaryT. cruzi is a protozoan pathogen responsible for Chagas disease. Current therapies rely only on a very small number of drugs, most of which are inadequate because of their severe host toxicity or because of their susceptibility to drug-resistance mechanisms. To determine efficient therapeutic alternatives, the identification of new biotargets and detailed knowledge of their structures are essential. Sirtuins from T. cruzi have been recently considered as promising targets for the development of new treatments for Chagas disease. Inhibition of their activity has been shown to significantly interfere with the life cycle of the parasite. T. cruzi possesses genes encoding two sirtuin-like proteins, TcSIR2rp1 and TcSIR2rp3. The structures of these enzymes were theoretically elucidated in this work, which also focused on the impact of their possible conformational states on computational interaction studies. A small library of phytochemicals that are active against the parasite was built and screened against the most meaningful conformations, identifying a restricted number of scaffolds that potentially interact with the modeled proteins. For these hits, a mechanism of action related to interactions with sirtuins was proposed.	[Sacconnay, Lionel; Angleviel, Melissa; Randazzo, Giuseppe Marco; Queiroz, Marcos Marcal Ferreira; Queiroz, Emerson Ferreira; Wolfender, Jean-Luc; Carrupt, Pierre-Alain; Nurisso, Alessandra] Univ Lausanne, Univ Geneva, Sch Pharmaceut Sci, Geneva, Switzerland		Sacconnay, L (corresponding author), Univ Lausanne, Univ Geneva, Sch Pharmaceut Sci, Geneva, Switzerland.	alessandra.nurisso@unige.ch	Randazzo, Giuseppe Marco/J-8810-2019; Queiroz, Emerson Ferreira/AAU-6235-2020; Jean-Luc, Wolfender JLW/O-2163-2018	Randazzo, Giuseppe Marco/0000-0003-1585-0019; Jean-Luc, Wolfender JLW/0000-0002-0125-952X; Ferreira Queiroz, Emerson/0000-0001-9567-1664	Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission	The authors are grateful to the Swiss National Science Foundation for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe F, 2003, BIOL PHARM BULL, V26, P1730, DOI 10.1248/bpb.26.1730; Abegaz BM, 2002, J NAT PROD, V65, P1117, DOI 10.1021/np0201218; Alsford S, 2007, MOL MICROBIOL, V63, P724, DOI 10.1111/j.1365-2958.2006.05553.x; ALVES TMA, 1995, PLANTA MED, V61, P85, DOI 10.1055/s-2006-958011; Ambrozin ARP, 2005, J BRAZIL CHEM SOC, V16, P434, DOI 10.1590/S0103-50532005000300018; Andrews KT, 2012, IMMUNOL CELL BIOL, V90, P66, DOI 10.1038/icb.2011.97; Avalos JL, 2005, MOL CELL, V17, P855, DOI 10.1016/j.molcel.2005.02.022; Bastos JK, 1999, PLANTA MED, V65, P541, DOI 10.1055/s-1999-14012; Bringmann G, 2002, PHYTOCHEMISTRY, V61, P195, DOI 10.1016/S0031-9422(02)00217-0; Bringmann G, 2013, PHYTOCHEMISTRY, V91, P220, DOI 10.1016/j.phytochem.2012.02.017; Bringmann G, 2011, PHYTOCHEMISTRY, V72, P89, DOI 10.1016/j.phytochem.2010.10.006; Buck SW, 2004, J LEUKOCYTE BIOL, V75, P939, DOI 10.1189/jlb.0903424; Castrignano T, 2006, NUCLEIC ACIDS RES, V34, pD306, DOI 10.1093/nar/gkj105; CLARK M, 1989, J COMPUT CHEM, V10, P982, DOI 10.1002/jcc.540100804; da Silva AA, 2004, J PHARM PHARMACOL, V56, P1195, DOI 10.1211/0022357044067; Dali-Youcef N, 2007, ANN MED, V39, P335, DOI 10.1080/07853890701408194; De Carvalho EAB, 2005, MICRON, V36, P155, DOI 10.1016/j.micron.2004.09.003; Ferreira ME, 2010, PHYTOMEDICINE, V17, P375, DOI 10.1016/j.phymed.2009.09.009; Erosa-Rejon GJ, 2010, PHYTOCHEM LETT, V3, P9, DOI 10.1016/j.phytol.2009.10.002; Finnin MS, 2001, NAT STRUCT BIOL, V8, P621, DOI 10.1038/89668; Fournet A, 1997, COMP BIOCHEM PHYS C, V116, P51, DOI 10.1016/S0742-8413(96)00127-2; Fournet A, 2007, FITOTERAPIA, V78, P382, DOI 10.1016/j.fitote.2007.03.003; Freitas RF, 2009, BIOORGAN MED CHEM, V17, P2476, DOI 10.1016/j.bmc.2009.01.079; Freitas-Junior LH, 2005, CELL, V121, P25, DOI 10.1016/j.cell.2005.01.037; Garcia-Salcedo JA, 2003, EMBO J, V22, P5851, DOI 10.1093/emboj/cdg553; GOODFORD PJ, 1985, J MED CHEM, V28, P849, DOI 10.1021/jm00145a002; Grael CFF, 2005, FITOTERAPIA, V76, P73, DOI 10.1016/j.fitote.2004.10.013; Grozinger CM, 2001, J BIOL CHEM, V276, P38837, DOI 10.1074/jbc.M106779200; Hay AE, 2007, J NAT PROD, V70, P9, DOI 10.1021/np0680230; Heilmann J, 2001, PHYTOCHEMISTRY, V57, P1281, DOI 10.1016/S0031-9422(01)00174-1; Hotez PJ, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000300; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Izumi E, 2008, EXP PARASITOL, V118, P324, DOI 10.1016/j.exppara.2007.08.015; Izumi E, 2011, NAT PROD REP, V28, P809, DOI 10.1039/c0np00069h; Jones E., 2001, SCIPY OPEN SOURCE SC; Kadam RU, 2006, BIOORG MED CHEM LETT, V16, P6013, DOI 10.1016/j.bmcl.2006.08.128; Kappagoda S, 2011, MAYO CLIN PROC, V86, P561, DOI 10.4065/mcp.2011.0203; Karioti A, 2009, PHYTOMEDICINE, V16, P783, DOI 10.1016/j.phymed.2008.12.008; Kaur S, 2010, MOL DIVERS, V14, P169, DOI 10.1007/s11030-009-9147-7; Kaya GI, 2011, PHYTOCHEM LETT, V4, P301, DOI 10.1016/j.phytol.2011.05.008; Kayser O, 2003, PARASITOL RES, V90, pS55, DOI 10.1007/s00436-002-0768-3; Kelly K, 2013, 3D BIOINFORMATICS CO, P1; Kelly K, 2013, MULTIPLE SEQUENCE ST, P1; Kelly K, 2013, A SEARCH APPL SEQUEN, V4; Landrum G., 2013, RELEASE, V1, P1; Lawson M, 2010, BBA-GENE REGUL MECH, V1799, P726, DOI 10.1016/j.bbagrm.2010.06.003; LEVITT M, 1992, J MOL BIOL, V226, P507, DOI 10.1016/0022-2836(92)90964-L; Marcucci MC, 2001, J ETHNOPHARMACOL, V74, P105, DOI 10.1016/S0378-8741(00)00326-3; Marmorstein R, 2004, BIOCHEM SOC T, V32, P904, DOI 10.1042/BST0320904; Matsuo Kenji, 2003, Natural Medicines, V57, P253; Maurer B, 2012, ACS MED CHEM LETT, V3, P1050, DOI 10.1021/ml3002709; Mbwambo ZH, 2006, J NAT PROD, V69, P369, DOI 10.1021/np050406v; Mbwambo ZH, 2004, PLANTA MED, V70, P706, DOI 10.1055/s-2004-827199; Menezes C, 2011, DRUG DEVELOP RES, V72, P471, DOI 10.1002/ddr.20454; Menna-Barreto RFS, 2008, PARASITOL RES, V103, P111, DOI 10.1007/s00436-008-0937-0; Merrick CJ, 2012, J INFECT DIS, V205, P1593, DOI 10.1093/infdis/jis239; Moniot S, 2013, J STRUCT BIOL, V182, P136, DOI 10.1016/j.jsb.2013.02.012; Moretti C, 1998, J NAT PROD, V61, P1390, DOI 10.1021/np9800654; Newman JC, 2012, J BIOL CHEM, V287, P42436, DOI 10.1074/jbc.R112.404863; Ogungbe IV, 2009, MOLECULES, V14, P1513, DOI 10.3390/molecules14041513; Outeiro TF, 2007, SCIENCE, V317, P516, DOI 10.1126/science.1143780; Paveto C, 2004, ANTIMICROB AGENTS CH, V48, P69, DOI 10.1128/AAC.48.1.69-74.2004; Petter M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001292; Pontius A, 2008, J NAT PROD, V71, P1579, DOI 10.1021/np800294q; Ramirez I, 2003, PHYTOCHEMISTRY, V64, P645, DOI 10.1016/S0031-9422(03)00241-3; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; Religa AA, 2012, MOL BIOCHEM PARASIT, V185, P71, DOI 10.1016/j.molbiopara.2012.08.003; Ribeiro TS, 2004, BIOORG MED CHEM LETT, V14, P3555, DOI 10.1016/j.bmcl.2004.04.019; Rogers D, 2010, J CHEM INF MODEL, V50, P742, DOI 10.1021/ci100050t; Sacconnay L, 2013, MOL BIOSYST, V9, P2223, DOI 10.1039/c3mb70180h; Sakkiah S, 2012, CHEM BIOL DRUG DES, V80, P315, DOI 10.1111/j.1747-0285.2012.01406.x; Satoskar AR, 2009, MED PARASITOLOGY; Schmidt TJ, 2002, PLANTA MED, V68, P750, DOI 10.1055/s-2002-33799; Senn M, 2007, J NAT PROD, V70, P1565, DOI 10.1021/np0702133; Setzer WN, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001727; Silvestre R, 2006, IMMUNOLOGY, V119, P529, DOI 10.1111/j.1365-2567.2006.02468.x; Silvestre R, 2009, IMMUNOLOGY, V128, P484, DOI 10.1111/j.1365-2567.2009.03132.x; Soares MBP, 2012, ACTA TROP, V122, P224, DOI 10.1016/j.actatropica.2012.01.001; Tarus PK, 2002, PHYTOCHEMISTRY, V60, P375, DOI 10.1016/S0031-9422(02)00078-X; Tasdemir D, 2006, ANTIMICROB AGENTS CH, V50, P1352, DOI 10.1128/AAC.50.4.1352-1364.2006; Tasdemir D, 2005, PHYTOCHEMISTRY, V66, P355, DOI 10.1016/j.phytochem.2004.11.013; Uchiyama N, 2006, TETRAHEDRON, V62, P4355, DOI 10.1016/j.tet.2006.02.067; Vergnes B, 2005, GENE, V363, P85, DOI 10.1016/j.gene.2005.06.047; Wilkinson SR, 2008, P NATL ACAD SCI USA, V105, P5022, DOI 10.1073/pnas.0711014105; Wright AD, 2005, J NAT PROD, V68, P459, DOI 10.1021/np049640w; Zhao X, 2013, J MED CHEM, V56, P963, DOI 10.1021/jm301431y; Zheng WP, 2013, EUR J MED CHEM, V59, P132, DOI 10.1016/j.ejmech.2012.11.014; Zuleta LMC, 2003, PHYTOCHEMISTRY, V64, P549, DOI 10.1016/S0031-9422(03)00153-5	88	23	23	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	FEB	2014	8	2							e2689	10.1371/journal.pntd.0002689			11	Infectious Diseases; Parasitology; Tropical Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Infectious Diseases; Parasitology; Tropical Medicine	AB8CK	WOS:000332017500002	24551254	Green Published, Green Submitted, gold			2022-03-04	
J	Jackson, Y; Santos, L; Arm-Vernez, I; Mauris, A; Wolff, H; Chappuis, F; Getaz, L				Jackson, Yves; Santos, Lilian; Arm-Vernez, Isabelle; Mauris, Anne; Wolff, Hans; Chappuis, Francois; Getaz, Laurent			Prevalence of chronic infections and susceptibility to measles and varicella-zoster virus in Latin American immigrants	INFECTIOUS DISEASES OF POVERTY			English	Article						Immigrants; Europe; Chronic infection; Co-infection; Trypanosma cruzi; Strongyloides stercoralis; HIV	STRONGYLOIDES-STERCORALIS INFECTION; TRYPANOSOMA-CRUZI INFECTION; CHAGAS-DISEASE; ADULT IMMIGRANTS; VIRAL-HEPATITIS; SPAIN; HIV; TRANSMISSION; POPULATION; CATALONIA	Background: Large numbers of Latin American immigrants recently arrived in Western Europe. Curative and preventive programmes need to take account of their risk of suffering and transmitting imported chronic infections and of their susceptibility to cosmopolitan infections. We aimed to assess the prevalence and co-occurrence of imported chronic infections among Latin American immigrants, and their susceptibility to highly prevalent cosmopolitan infections. Methods: Adult participants were recruited in the community and in a primary health centre in Geneva in 2008. Serological tests were performed on stored sera for HIV, HBV, syphilis, Strongyloides stercoralis, Trypanosoma cruzi, varicella and measles. We considered only chronic active infections in the analysis. Results and discussion: The 1 012 participants, aged 37.2 (SD 11.3) years, were mostly female (82.5 %) and Bolivians (48 %). Overall, 209 (20.7 %) had at least one and 27 (2.7 %) two or more chronic infections. T. cruzi (12.8 %) and S. stercoralis (8.4 %) were the most prevalent chronic active infections compared to syphilis (0.4 %), HBV (0.4 %) and HIV (1.4 %). Concomitant infections affected 28.2 and 18.5 % of T. cruzi and S. stercoralis infected cases. Bolivian origin (aOR: 13.6; 95 % CI: 3.2-57.9) was associated with risk of multiple infections. Susceptibilities for VZV and measles were 0.7 and 1.4 %, respectively. Latin American immigrants are at risk of complications and possible reactivation of chronic parasitic infections but have overall low risks of chronic viral and syphilitic active infections. Conclusions: Systematic screening for chronic active parasitic infections is therefore necessary especially among Bolivians. The high protection rate against measles and VZV doesn't require specific preventive interventions.	[Jackson, Yves] Univ Hosp Geneva, Div Primary Care Med, Rue Gabrielle Perret Gentil 6, CH-1211 Geneva, Switzerland; [Jackson, Yves; Santos, Lilian; Arm-Vernez, Isabelle; Mauris, Anne; Wolff, Hans; Chappuis, Francois; Getaz, Laurent] Univ Geneva, Fac Med, Rue Gabrielle Perret Gentil 6, CH-1211 Geneva, Switzerland; [Jackson, Yves] Univ Geneva, Inst Global Hlth, Geneva, Switzerland; [Santos, Lilian; Chappuis, Francois; Getaz, Laurent] Univ Hosp Geneva, Div Trop & Humanitarian Med, Geneva, Switzerland; [Arm-Vernez, Isabelle; Mauris, Anne] Univ Hosp Geneva, Dept Genet & Lab Med, Geneva, Switzerland; [Wolff, Hans; Getaz, Laurent] Univ Hosp Geneva, Div Correct Med & Psychiat, Geneva, Switzerland		Jackson, Y (corresponding author), Univ Hosp Geneva, Div Primary Care Med, Rue Gabrielle Perret Gentil 6, CH-1211 Geneva, Switzerland.; Jackson, Y (corresponding author), Univ Geneva, Fac Med, Rue Gabrielle Perret Gentil 6, CH-1211 Geneva, Switzerland.; Jackson, Y (corresponding author), Univ Geneva, Inst Global Hlth, Geneva, Switzerland.	yves.jackson@hcuge.ch	Wolff, Hans/F-2122-2015	Wolff, Hans/0000-0002-4978-2176; GETAZ, LAURENT/0000-0002-8724-861X			Andrus JK, 2011, VACCINE, V29, pD91, DOI 10.1016/j.vaccine.2011.04.059; Angheben A, 2011, EUR C TROP MED INT H; Basile L, 2011, EUROSURVEILLANCE, V16, P16; Bisoffi Z, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002640; Bocanegra C, 2014, AM J TROP MED HYG, V91, P1277, DOI 10.4269/ajtmh.14-0206; Buonfrate D, 2015, EPIDEMIOL INFECT, V143, P452, DOI 10.1017/S0950268814001563; Delaporte E, 2011, EUROSURVEILLANCE, V16, P2; Getaz L, 2014, Rev Med Suisse, V10, P827; Getaz L, 2010, SCAND J INFECT DIS, V42, P936, DOI 10.3109/00365548.2010.511259; Gobbi F, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003361; Greenaway C, 2007, ANN INTERN MED, V146, P20, DOI 10.7326/0003-4819-146-1-200701020-00005; Hochberg NS, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001034; IOM, 2012, RUT DIN MIGR ENTR PA; Jackson Y, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000592; Kempf W, 2007, SWISS MED WKLY, V137, P239; KJERSEM H, 1990, SCAND J SOC MED, V18, P171, DOI 10.1177/140349489001800303; Lemos C, 2004, Euro Surveill, V9, P9, DOI 10.2807/esm.09.04.00463-en; Llenas-Garcia J, 2013, AIDS CARE, V25, P980, DOI 10.1080/09540121.2012.748881; Lopez-Velez R, 2003, AM J TROP MED HYG, V69, P115, DOI 10.4269/ajtmh.2003.69.115; Manzardo Christian, 2008, Travel Med Infect Dis, V6, P4, DOI 10.1016/j.tmaid.2007.11.002; Mascarello M, 2011, ANN TROP MED PARASIT, V105, P617, DOI 10.1179/2047773211Y.0000000006; Monge-Maillo B, 2015, AM J TROP MED HYG, V92, P848, DOI 10.4269/ajtmh.14-0520; Munoz J, 2009, ACTA TROP, V111, P51, DOI 10.1016/j.actatropica.2009.02.005; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Ramos JM, 2015, T ROY SOC TROP MED H, V109, P447, DOI 10.1093/trstmh/trv043; Requena-Mendez A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003245; Salvador F, 2013, AM J TROP MED HYG, V88, P1196, DOI 10.4269/ajtmh.12-0714; Sampedro A, 2010, ENFERM INFEC MICR CL, V28, P694, DOI 10.1016/j.eimc.2010.04.007; Schar F, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002288; Sharma S, 2015, J HEPATOL, V63, P515, DOI 10.1016/j.jhep.2015.04.026; Trepo C, 2014, LANCET, V384, P2053, DOI 10.1016/S0140-6736(14)60220-8; UNAIDS, 2013, UNAIDS REP GLOB AIDS; Valerio L, 2009, EUROSURVEILLANCE, V14, P18; Valerio LI, 2008, REV CLIN ESP, V208, P426, DOI 10.1157/13127602; van Rijckevorsel GGC, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-140	35	5	5	0	3	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	2049-9957			INFECT DIS POVERTY	Infect. Dis. Poverty	MAY 11	2016	5								41	10.1186/s40249-016-0136-7			6	Infectious Diseases; Parasitology; Tropical Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Infectious Diseases; Parasitology; Tropical Medicine	DS8MS	WOS:000381038100001	27164954	gold, Green Published			2022-03-04	
J	Vandenberghe, F; Saigi-Morgui, N; Delacretaz, A; Quteineh, L; Crettol, S; Ansermot, N; Gholam-Rezaee, M; von Gunten, A; Conus, P; Eap, CB				Vandenberghe, Frederik; Saigi-Morgui, Nuria; Delacretaz, Aurelie; Quteineh, Lina; Crettol, Severine; Ansermot, Nicolas; Gholam-Rezaee, Mehdi; von Gunten, Armin; Conus, Philippe; Eap, Chin B.			Prediction of early weight gain during psychotropic treatment using a combinatorial model with clinical and genetic markers	PHARMACOGENETICS AND GENOMICS			English	Article						atypical antipsychotics; genetic risk prediction; mirtazapine; mood stabilizers; weight gain; weight monitoring	ATYPICAL ANTIPSYCHOTICS; OBESITY RISK; ASSOCIATION; POLYMORPHISMS; SUSCEPTIBILITY; SCHIZOPHRENIA; GUIDELINES; IMPACT; MASS	Background Psychotropic drugs can induce significant (>5%) weight gain (WG) already after 1 month of treatment, which is a good predictor for major WG at 3 and 12 months. The large interindividual variability of drug-induced WG can be explained in part by genetic and clinical factors. Aim The aim of this study was to determine whether extensive analysis of genes, in addition to clinical factors, can improve prediction of patients at risk for more than 5% WG at 1 month of treatment. Methods Data were obtained from a 1-year naturalistic longitudinal study, with weight monitoring during weight-inducing psychotropic treatment. A total of 248 Caucasian psychiatric patients, with at least baseline and 1-month weight measures, and with compliance ascertained were included. Results were tested for replication in a second cohort including 32 patients. Results Age and baseline BMI were associated significantly with strong WG. The area under the curve (AUC) of the final model including genetic (18 genes) and clinical variables was significantly greater than that of the model including clinical variables only (AUC(final): 0.92, AUC(clinical): 0.75, P<0.0001). Predicted accuracy increased by 17% with genetic markers (Accuracy(final): 87%), indicating that six patients must be genotyped to avoid one misclassified patient. The validity of the final model was confirmed in a replication cohort. Patients predicted before treatment as having more than 5% WG after 1 month of treatment had 4.4% more WG over 1 year than patients predicted to have up to 5% WG (P <= 0.0001). Conclusion These results may help to implement genetic testing before starting psychotropic drug treatment to identify patients at risk of important WG. Copyright (C) 2016 Wolters Kluwer Health, Inc. All rights reserved.	[Vandenberghe, Frederik; Saigi-Morgui, Nuria; Delacretaz, Aurelie; Quteineh, Lina; Crettol, Severine; Ansermot, Nicolas; Eap, Chin B.] Hosp Cery, Univ Lausanne Hosp, Unit Pharmacogenet & Clin Psychopharmacol, Dept Psychiat,Ctr Psychiat Neurosci, Prilly, Switzerland; [Gholam-Rezaee, Mehdi] Hosp Cery, Univ Lausanne Hosp, Dept Psychiat, Ctr Psychiat Epidemiol & Psychopathol, Prilly, Switzerland; [von Gunten, Armin] Hosp Cery, Univ Lausanne Hosp, Dept Psychiat, Serv Old Age Psychiat, Prilly, Switzerland; [Conus, Philippe] Hosp Cery, Univ Lausanne Hosp, Dept Psychiat, Serv Gen Psychiat, Prilly, Switzerland; [Eap, Chin B.] Univ Lausanne, Univ Geneva, Sch Pharm, Dept Pharmaceut Sci, Geneva, Switzerland		Eap, CB (corresponding author), Hosp Cery, CH-1008 Lausanne, Switzerland.	chin.eap@chuv.ch		Conus, Philippe/0000-0002-5832-1910; von Gunten, Armin/0000-0001-7852-3803; Saigi, Nuria/0000-0003-2503-1818; Eap, Chin/0000-0002-5439-0230; Vandenberghe, Frederik/0000-0002-8964-2047	TakedaTakeda Pharmaceutical Company Ltd; Roche Transplantation Research Foundation; Swiss National Research FoundationSwiss National Science Foundation (SNSF) [320030-120686, 324730-144064]	C.B.E. has received research support from Takeda and The Roche Transplantation Research Foundation in the past 3 years.; This work has been funded in part by the Swiss National Research Foundation (C.B.E. and P.C.: 320030-120686 and 324730-144064).	Albayrak O, 2013, AM J MED GENET B, V162B, P295, DOI 10.1002/ajmg.b.32144; Allison DB, 1999, AM J PSYCHIAT, V156, P1686; Ando T, 2014, MOL GENET GENOM MED, V2, P313, DOI 10.1002/mgg3.69; Choong E, 2008, Rev Med Suisse, V4, P1994; Choong E, 2013, JAMA PSYCHIAT, V70, P1011, DOI 10.1001/jamapsychiatry.2013.187; Choong E, 2012, J PSYCHIATR RES, V46, P540, DOI 10.1016/j.jpsychires.2012.01.014; Correll CU, 2009, JAMA-J AM MED ASSOC, V302, P1765, DOI 10.1001/jama.2009.1549; DAVISON AC, 1997, BOOTSTRAP METHODS TH, P1, DOI DOI 10.1017/CBO9780511802843.002; De Hert M, 2011, EUR PSYCHIAT, V26, P144, DOI 10.1016/j.eurpsy.2010.09.011; De Hert M, 2009, EUR PSYCHIAT, V24, P412, DOI 10.1016/j.eurpsy.2009.01.005; Hert M, 2012, NAT REV ENDOCRINOL, V8, P114, DOI 10.1038/nrendo.2011.156; Delacretaz A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139155; Gebhardt S, 2010, J CLIN PHARM THER, V35, P207, DOI 10.1111/j.1365-2710.2009.01084.x; Goff DC, 2005, J CLIN PSYCHIAT, V66, P183, DOI 10.4088/JCP.v66n0205; Grarup N, 2014, DIABETOLOGIA, V57, P1528, DOI 10.1007/s00125-014-3270-4; Han LY, 2011, DIABETOLOGIA; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Hiemke C, 2011, PHARMACOPSYCHIATRY, V44, P195, DOI 10.1055/s-0031-1286287; Hivert MF, 2008, DIABETES, V57, P3353, DOI 10.2337/db08-0700; Hoffmann VP, 2010, J CLIN PSYCHOPHARM, V30, P656, DOI 10.1097/JCP.0b013e3181faf670; Janssens ACJW, 2007, GENET MED, V9, P528, DOI 10.1097/GIM.0b013e31812eece0; Klein TE, 2009, NEW ENGL J MED, V360, P753, DOI 10.1056/NEJMoa0809329; Laimer M, 2006, J CLIN PSYCHIAT, V67, P421, DOI 10.4088/JCP.v67n0313; Lett TAP, 2012, MOL PSYCHIATR, V17, P242, DOI 10.1038/mp.2011.109; Li A, 2013, INT J OBESITY, V37, P559, DOI 10.1038/ijo.2012.82; Lipkovich I, 2006, J CLIN PSYCHOPHARM, V26, P316, DOI 10.1097/01.jcp.0000219916.88810.1c; Lipkovich I, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-78; Lu JF, 2014, HUM IMMUNOL, V75, P1062, DOI 10.1016/j.humimm.2014.09.004; Monteleone P, 2010, J CLIN PSYCHOPHARM, V30, P441, DOI 10.1097/JCP.0b013e3181e742c5; Monteleone P, 2010, PHARMACOL RES, V61, P400, DOI 10.1016/j.phrs.2010.01.002; Ogden C.L., 2011, NCHS DATA BRIEF, V2013, P1; Pinheiro J., 2020, PACKAGE NLME LINEAR; Pinheiro J, 2006, MIXED EFFECTS MODELS; Quteineh L, 2015, PHARMACOGENET GENOM, V25, P246, DOI 10.1097/FPC.0000000000000131; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Russell JM, 2001, CNS DRUGS, V15, P537, DOI 10.2165/00023210-200115070-00004; Saigi-Morgui N, 2015, J CLIN PSYCHOPHARM, V35, P544, DOI 10.1097/JCP.0000000000000388; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Vandenberghe F, 2015, J CLIN PSYCHIAT, V76, pE1417, DOI 10.4088/JCP.14m09358; Venables W.N., 2002, MODERN APPL STAT S; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; World Health Organization, 2015, CHALL OB QUICK STAT; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011	43	7	7	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1744-6872	1744-6880		PHARMACOGENET GENOM	Pharmacogenet. Genomics	DEC	2016	26	12					547	557		10.1097/FPC.0000000000000249			11	Biotechnology & Applied Microbiology; Genetics & Heredity; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biotechnology & Applied Microbiology; Genetics & Heredity; Pharmacology & Pharmacy	EB6CR	WOS:000387469100003	27741037	Green Accepted			2022-03-04	
J	Agoritsas, T; Deom, M; Perneger, TV				Agoritsas, Thomas; Deom, Marie; Perneger, Thomas V.			Study design attributes influenced patients' willingness to participate in clinical research: a randomized vignette-based study	JOURNAL OF CLINICAL EPIDEMIOLOGY			English	Article						Willingness to participate; Recruitment; Inpatient attitudes; Research methods; Study design; Clinical trials; Funding source	CONFLICTS-OF-INTEREST; CONTROLLED-TRIALS; PHYSICIAN PRACTICE; RANDOM ALLOCATION; INFORMED-CONSENT; PATIENTS ENTER; ATTITUDES; RECRUITMENT; EXPERIENCE; ONCOLOGY	Objective: To identify characteristics of clinical research projects that influence patients' willingness to participate in research. Study Design and Setting: We surveyed all patients discharged during 1 month from a Swiss public teaching hospital. We described four hypothetical studies and asked patients whether they would agree to participate. We randomly manipulated three study attributes in each vignette, using a factorial design. Results: All studies were not equally acceptable to the 1,277 respondents. A higher willingness to participate was found when a new drug had no side effects, no additional visit was required, balanced information was given, results were in the public domain, and the project was approved by a research ethics committee. In contrast, destruction of blood samples at the end of the project, use of placebo controls, and random allocation to study arms were associated with a lower likelihood of participation. The origin of funds, financial reward, the need to complete a questionnaire, and clinical vs. economic purpose of the study did not influence willingness to participate. Conclusion: Patients valued safety, convenience, oversight, and open communication in research. However, they were put off by some aspects that are valued by health care professionals. Educating the public about research methods may improve participation. (C) 2011 Elsevier Inc. All rights reserved.	[Agoritsas, Thomas; Deom, Marie; Perneger, Thomas V.] Univ Hosp Geneva, Div Clin Epidemiol, CH-1211 Geneva 14, Switzerland		Agoritsas, T (corresponding author), Univ Hosp Geneva, Div Clin Epidemiol, Gabrielle Perret Gentil 6, CH-1211 Geneva 14, Switzerland.	thomas.agoritsas@hcuge.ch	Agoritsas, Thomas/F-4321-2014	Agoritsas, Thomas/0000-0002-6182-9969	Quality of Care Service; University Hospitals of Geneva	This study had no external funding source. The patient survey was funded by the Quality of Care Service, University Hospitals of Geneva, to which Dr Perneger and Dr Agoritsas were previously affiliated.	[Anonymous], 2000, JAMA, V284, P3043; [Anonymous], GUID GOOD CLIN PRACT; ANTMAN K, 1985, J CLIN ONCOL, V3, P1142, DOI 10.1200/JCO.1985.3.8.1142; Bekelman JE, 2003, JAMA-J AM MED ASSOC, V289, P454, DOI 10.1001/jama.289.4.454; CASSILETH BR, 1982, JAMA-J AM MED ASSOC, V248, P968, DOI 10.1001/jama.248.8.968; CHARLSON ME, 1984, BRIT MED J, V289, P1281, DOI 10.1136/bmj.289.6454.1281; Cleopas A, 2006, QUAL SAF HEALTH CARE, V15, P136, DOI 10.1136/qshc.2005.015602; Ding EL, 2007, ARCH INTERN MED, V167, P905, DOI 10.1001/archinte.167.9.905; DUNN LB, 2008, SCHIZOPHR B; EASTERBROOK PJ, 1992, J ROY SOC MED, V85, P71; Edwards P, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000008.pub3; Edwards SJL, 1998, SOC SCI MED, V47, P1825, DOI 10.1016/S0277-9536(98)00235-4; Eggly S, 2008, PATIENT EDUC COUNS, V70, P143, DOI 10.1016/j.pec.2007.09.019; Ellis PM, 2001, J CLIN ONCOL, V19, P3554, DOI 10.1200/JCO.2001.19.15.3554; Ellis PM, 2000, ANN ONCOL, V11, P939, DOI 10.1023/A:1008342222205; Fallowfield LJ, 1998, EUR J CANCER, V34, P1554, DOI 10.1016/S0959-8049(98)00193-2; Featherstone K, 1998, BRIT MED J, V317, P1177, DOI 10.1136/bmj.317.7167.1177; Halpern SD, 2003, AM HEART J, V146, P985, DOI 10.1016/S0002-8703(03)00507-6; Hampson LA, 2006, NEW ENGL J MED, V355, P2330, DOI 10.1056/NEJMsa064160; Henderson M, 2005, J PAIN SYMPTOM MANAG, V29, P116, DOI 10.1016/j.jpainsymman.2004.12.001; Jenkinson C, 2002, INT J QUAL HEALTH C, V14, P353, DOI 10.1093/intqhc/14.5.353; Jenkinson C, 1999, J EPIDEMIOL COMMUN H, V53, P46, DOI 10.1136/jech.53.1.46; Jordhoy MS, 1999, PALLIATIVE MED, V13, P299, DOI 10.1191/026921699668963873; Kerr C, 2004, J MED ETHICS, V30, P80, DOI 10.1136/jme.2002.001123; Kim SYH, 2004, J MED ETHICS, V30, P73, DOI 10.1136/jme.2002.001461; Lee KP, 2006, MED J AUSTRALIA, V184, P621, DOI 10.5694/j.1326-5377.2006.tb00418.x; Leplege A, 1998, J CLIN EPIDEMIOL, V51, P1013, DOI 10.1016/S0895-4356(98)00093-6; Madsen S, 1999, J INTERN MED, V245, P571, DOI 10.1046/j.1365-2796.1999.00502.x; Mapstone J, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000013.pub3; Meropol Neal J, 2007, J Natl Compr Canc Netw, V5, P655; Peabody JW, 2004, ANN INTERN MED, V141, P771, DOI 10.7326/0003-4819-141-10-200411160-00008; Perneger TV, 2005, MED CARE, V43, P374, DOI 10.1097/01.mlr.0000156856.36901.40; Robinson EJ, 2004, SOC SCI MED, V58, P811, DOI 10.1016/S0277-9536(03)00255-7; Ross S, 1999, J CLIN EPIDEMIOL, V52, P1143, DOI 10.1016/S0895-4356(99)00141-9; Ryan M, 2000, BMJ-BRIT MED J, V320, P1530, DOI 10.1136/bmj.320.7248.1530; STREINER DL, 2003, HLTH MEASUREMENT SCA; Trauth J M, 2000, J Health Soc Policy, V12, P23; van Wonderen KE, 2008, J CLIN EPIDEMIOL, V61, P971, DOI 10.1016/j.jclinepi.2008.05.008; Veloski J, 2005, AM J MED QUAL, V20, P151, DOI 10.1177/1062860605274520; Verheggen FWSM, 1998, PATIENT EDUC COUNS, V35, P111, DOI 10.1016/S0738-3991(98)00060-3; Watson Judith M, 2006, BMC Med Res Methodol, V6, P34, DOI 10.1186/1471-2288-6-34; Weinfurt KP, 2008, J GEN INTERN MED, V23, P860, DOI 10.1007/s11606-008-0590-4; Welton AJ, 1999, BRIT MED J, V318, P1114, DOI 10.1136/bmj.318.7191.1114; Wendler D, 2002, ARCH INTERN MED, V162, P1457, DOI 10.1001/archinte.162.13.1457; Wright JR, 2004, J CLIN ONCOL, V22, P4312, DOI 10.1200/JCO.2004.01.187	45	38	39	1	21	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0895-4356	1878-5921		J CLIN EPIDEMIOL	J. Clin. Epidemiol.	JAN	2011	64	1					107	115		10.1016/j.jclinepi.2010.02.007			9	Health Care Sciences & Services; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health	705QS	WOS:000286153600017	20558036				2022-03-04	
J	Leuchter, RHV; Darque, A; Hueppi, PS				Leuchter, Russia Ha-Vinh; Darque, Alexandra; Hueppi, Petra Susan			Brain Maturation, Early Sensory Processing, and Infant Colic	JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION			English	Article							PRENATAL STRESS; SPINAL-CORD; FEEDING PROBLEMS; CRYING INFANTS; HUMAN NEWBORNS; HUMAN FETUSES; MELATONIN; PAIN; BEHAVIOR; SLEEP		[Leuchter, Russia Ha-Vinh; Darque, Alexandra; Hueppi, Petra Susan] Univ Geneva, Dept Pediat, Div Dev & Growth, CH-1211 Geneva, Switzerland		Leuchter, RHV (corresponding author), Univ Geneva, Dept Pediat, Div Dev & Growth, CH-1211 Geneva, Switzerland.		Ha-Vinh Leuchter, Russia/AAA-5924-2022				Afif A, 2007, BRAIN STRUCT FUNCT, V212, P335, DOI 10.1007/s00429-007-0161-1; Ambriz-Tututi M, 2009, LIFE SCI, V84, P489, DOI 10.1016/j.lfs.2009.01.024; Ardura J, 2003, HORM RES, V59, P66, DOI 10.1159/000068571; Azoulay R, 2006, PEDIATR RADIOL, V36, P97, DOI 10.1007/s00247-005-0030-0; Barr R G, 1998, Pediatrics, V102, P1282; Barr RC, 1999, PEDIATRICS, V103, part. no., DOI 10.1542/peds.103.5.e68; Barr RG, 2005, J DEV BEHAV PEDIATR, V26, P14; Barr RG, 2002, ARCH PEDIAT ADOL MED, V156, P1172, DOI 10.1001/archpedi.156.12.1172; BARR RG, 1991, PEDIATRICS, V87, P623; Beggs S, 2002, EUR J NEUROSCI, V16, P1249, DOI 10.1046/j.1460-9568.2002.02185.x; Berger MA, 2002, NEUROCHEM RES, V27, P1525, DOI 10.1023/A:1021656607278; Bolten MI, 2012, J PEDIATR-US, V161, P104, DOI 10.1016/j.jpeds.2011.12.044; Brand S, 2011, NEUROPSYCHOBIOLOGY, V64, P15, DOI 10.1159/000322456; Brzezinski A, 2005, SLEEP MED REV, V9, P41, DOI 10.1016/j.smrv.2004.06.004; Brzezinski Amnon, 1997, New England Journal of Medicine, V336, P186; CHARNAY Y, 1984, J COMP NEUROL, V223, P415, DOI 10.1002/cne.902230307; CHI JG, 1977, ANN NEUROL, V1, P86, DOI 10.1002/ana.410010109; Coe CL, 2003, BIOL PSYCHIAT, V54, P1025, DOI 10.1016/S0006-3223(03)00698-X; Craig ADB, 2003, TRENDS NEUROSCI, V26, P303, DOI 10.1016/S0166-2236(03)00123-1; Day JC, 1998, J NEUROSCI, V18, P1886; de Graaf-Peters VB, 2006, EARLY HUM DEV, V82, P257, DOI 10.1016/j.earlhumdev.2005.10.013; DEGANGI GA, 1993, INF MENTAL HLTH J, V14, P330, DOI 10.1002/1097-0355(199324)14:4<330::AID-IMHJ2280140407>3.0.CO;2-K; Derbyshire SWG, 2006, BRIT MED J, V332, P909, DOI 10.1136/bmj.332.7546.909; Dubois J, 2008, CEREB CORTEX, V18, P1444, DOI 10.1093/cercor/bhm180; Dubois J, 2012, NEUROPHYSIOL CLIN, V42, P1, DOI 10.1016/j.neucli.2011.08.001; Engler AC, 2012, EUR J PEDIATR, V171, P729, DOI 10.1007/s00431-011-1659-3; Erberich SG, 2006, NEUROIMAGE, V29, P155, DOI 10.1016/j.neuroimage.2005.07.024; Fabrizi L, 2011, CURR BIOL, V21, P1552, DOI 10.1016/j.cub.2011.08.010; Fitzgerald M, 1999, P NATL ACAD SCI USA, V96, P7719, DOI 10.1073/pnas.96.14.7719; Fitzgerald M, 2005, NAT REV NEUROSCI, V6, P507, DOI 10.1038/nrn1701; FITZGERALD M, 1991, BRIT MED BULL, V47, P667, DOI 10.1093/oxfordjournals.bmb.a072499; Gagnier J J, 2001, Altern Med Rev, V6, P383; Goubet N, 2007, J DEV BEHAV PEDIATR, V28, P189, DOI 10.1097/dbp.0b013e31802d0b8d; Hathway GJ, 2009, J PHYSIOL-LONDON, V587, P2927, DOI 10.1113/jphysiol.2008.168013; Hemmi MH, 2011, ARCH DIS CHILD, V96, P622, DOI 10.1136/adc.2010.191312; Huhtala V, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.6.e84; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; Jacobson L, 2005, ENDOCRIN METAB CLIN, V34, P271, DOI 10.1016/j.ecl.2005.01.003; Jansen J, 2010, PSYCHONEUROENDOCRINO, V35, P329, DOI 10.1016/j.psyneuen.2009.07.008; Jenni OG, 2006, CURR OPIN PSYCHIATR, V19, P282, DOI 10.1097/01.yco.0000218599.32969.03; Juberg DR, 2001, PEDIATRICS, V107, P135, DOI 10.1542/peds.107.1.135; Kanabar D, 2001, J HUM NUTR DIET, V14, P359, DOI 10.1046/j.1365-277X.2001.00304.x; Kennaway DJ, 1996, J CLIN ENDOCR METAB, V81, P1525, DOI 10.1210/jc.81.4.1525; Kimata H, 2007, J PSYCHOSOM RES, V62, P699, DOI 10.1016/j.jpsychores.2006.12.007; Kirjavainen J, 2004, PEDIATRICS, V114, P592, DOI 10.1542/peds.2003-0651-L; Korszun A, 1999, J RHEUMATOL, V26, P2675; KOSTOVIC I, 1990, J COMP NEUROL, V297, P441, DOI 10.1002/cne.902970309; Kostovic I, 2010, ACTA PAEDIATR, V99, P1119, DOI 10.1111/j.1651-2227.2010.01811.x; Kumral A, 2009, MED HYPOTHESES, V72, P103, DOI 10.1016/j.mehy.2008.08.005; Kurtoglu S, 1997, ACTA PAEDIATR, V86, P764, DOI 10.1111/j.1651-2227.1997.tb08583.x; LEHTONEN L, 1994, J DEV BEHAV PEDIATR, V15, P416; Lodygensky GA, 2010, J ANAT, V217, P418, DOI 10.1111/j.1469-7580.2010.01280.x; Marsh DF, 1997, BRIT J ANAESTH, V79, P787, DOI 10.1093/bja/79.6.787; McGraw K, 1999, SLEEP, V22, P303, DOI 10.1093/sleep/22.3.303; Ment LR, 2009, LANCET NEUROL, V8, P1042, DOI 10.1016/S1474-4422(09)70257-1; MILLER AR, 1993, PEDIATRICS, V92, P551; Moore E. R., 2007, COCHRANE DATABASE SY, V3; Perlman SB, 2010, SOC NEUROSCI-UK, V5, P533, DOI 10.1080/17470911003683219; Peyron R, 2000, NEUROPHYSIOL CLIN, V30, P263, DOI 10.1016/S0987-7053(00)00227-6; Rao MR, 2004, ARCH DIS CHILD, V89, P989, DOI 10.1136/adc.2003.039198; REPPERT SM, 1988, SCIENCE, V242, P78, DOI 10.1126/science.2845576; Rivkees Scott A, 2003, Pediatr Endocrinol Rev, V1, P38; Romantshik O, 2007, ACTA PAEDIATR, V96, P372, DOI 10.1111/j.1651-2227.2006.00106.x; Sadeh A, 1997, SLEEP, V20, P185; Saha L, 2007, J CLIN GASTROENTEROL, V41, P29, DOI 10.1097/MCG.0b013e31802df84c; Savino F, 2007, ACTA PAEDIATR, V96, P1259, DOI 10.1111/j.1651-2227.2007.00428.x; Schaal B, 2000, CHEM SENSES, V25, P729, DOI 10.1093/chemse/25.6.729; SCHAAL B, 1991, CR ACAD SCI III-VIE, V313, P319; Schmid G, 2011, CHILD CARE HLTH DEV, V37, P493, DOI 10.1111/j.1365-2214.2010.01201.x; Schmid G, 2010, ACTA PAEDIATR, V99, P286, DOI 10.1111/j.1651-2227.2009.01572.x; Schwartz CE, 2010, ARCH GEN PSYCHIAT, V67, P78, DOI 10.1001/archgenpsychiatry.2009.171; Sivan Y, 2001, PEDIATR RES, V49, P63, DOI 10.1203/00006450-200101000-00015; Slater R, 2010, EUR J PAIN, V14, P321, DOI 10.1016/j.ejpain.2009.05.005; SMOTHERMAN WP, 1991, PHYSIOL BEHAV, V50, P47, DOI 10.1016/0031-9384(91)90496-B; St James-Roberts I, 2003, DEV MED CHILD NEUROL, V45, P400, DOI 10.1017/S0012162203000756; St James-Roberts I, 2006, PEDIATRICS, V117, pE1146, DOI 10.1542/peds.2005-2387; St James-Roberts I, 2011, ARCH DIS CHILD, V96, P340, DOI 10.1136/adc.2010.200204; Stevens B., 2010, COCHRANE DB SYST REV, V1, P1; StJamesRoberts I, 1997, EARLY HUM DEV, V48, P143, DOI 10.1016/S0378-3782(96)01845-2; StJamesRoberts I, 1995, EARLY DEV PARENTING, V4, P177; Taylor MJ, 1996, EVOKED POTENTIAL, V100, P448; Thor PJ, 2007, J PHYSIOL PHARMACOL, V58, P97; Tollenaar MS, 2011, STRESS, V14, P53, DOI 10.3109/10253890.2010.499485; Underdown A., 2006, COCHRANE DATABASE SY, V4; Vanhatalo S, 2000, BRAIN DEV-JPN, V22, P145, DOI 10.1016/S0387-7604(00)00089-9; Vanhatalo S, 2006, SEMIN FETAL NEONAT M, V11, P464, DOI 10.1016/j.siny.2006.07.009; Varendi H, 1998, EARLY HUM DEV, V51, P47, DOI 10.1016/S0378-3782(97)00082-0; WESSEL MA, 1954, PEDIATRICS, V14, P421; White BP, 2000, CHILD DEV, V71, P862, DOI 10.1111/1467-8624.00196; Whittle S, 2006, NEUROSCI BIOBEHAV R, V30, P511, DOI 10.1016/j.neubiorev.2005.09.003; Winberg J, 1998, ACTA PAEDIATR, V87, P6, DOI 10.1080/08035259850157787; Wolke D, 2002, PEDIATRICS, V109, P1054, DOI 10.1542/peds.109.6.1054; Wolke D, 2009, J DEV BEHAV PEDIATR, V30, P226, DOI 10.1097/DBP.0b013e3181a85973; Wurmser H, 2006, EARLY HUM DEV, V82, P341, DOI 10.1016/j.earlhumdev.2005.09.016; Zero to Three, 2005, DIAGNOSTIC CLASSIFIC	95	6	7	1	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0277-2116	1536-4801		J PEDIATR GASTR NUTR	J. Pediatr. Gastroenterol. Nutr.	DEC	2013	57			1			S18	S25		10.1097/01.mpg.0000441929.05684.78			8	Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics	277NK	WOS:000328826100007					2022-03-04	
J	de la Fuente, IG; McLin, VA; Rimensberger, PC; Wildhaber, BE				de la Fuente, I. Garcia; McLin, V. A.; Rimensberger, P. C.; Wildhaber, B. E.			Amanita Poisoning and Liver Transplantation: Do We Have the Right Decision Criteria?	JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION			English	Article							FULMINANT HEPATIC-FAILURE; PROGNOSTIC-FACTORS; AMATOXIN; INDICATORS; CHILDHOOD		[de la Fuente, I. Garcia; McLin, V. A.; Rimensberger, P. C.; Wildhaber, B. E.] Univ Hosp Geneva, Dept Pediat, CH-1211 Geneva, Switzerland		de la Fuente, IG (corresponding author), Univ Hosp Geneva, Dept Pediat, 6 Willy Donze, CH-1211 Geneva, Switzerland.						BERNUAU J, 1986, SEMIN LIVER DIS, V6, P97, DOI 10.1055/s-2008-1040593; Bhaduri BR, 1996, SEMIN LIVER DIS, V16, P349, DOI 10.1055/s-2007-1007248; BISMUTH H, 1995, ANN SURG, V222, P109, DOI 10.1097/00000658-199508000-00002; Broussard CN, 2001, AM J GASTROENTEROL, V96, P3193; Bucuvalas John, 2006, Clin Liver Dis, V10, P149, DOI 10.1016/j.cld.2005.10.006; Ciocca M, 2008, ARCH DIS CHILD, V93, P48, DOI 10.1136/adc.2006.115113; Dhawan A, 2004, PEDIATR TRANSPLANT, V8, P584, DOI 10.1111/j.1399-3046.2004.00292.x; Enjalbert F, 2002, J TOXICOL-CLIN TOXIC, V40, P715, DOI 10.1081/CLT-120014646; Escudie L, 2007, J HEPATOL, V46, P466, DOI 10.1016/j.jhep.2006.10.013; Ganzert M, 2005, J HEPATOL, V42, P202, DOI 10.1016/j.jhep.2004.10.023; Jan Mohammad Ali, 2008, J Ayub Med Coll Abbottabad, V20, P99; Krenova M, 2007, HUM EXP TOXICOL, V26, P955, DOI 10.1177/0960327107085832; Lee WS, 2005, J PEDIATR GASTR NUTR, V40, P575, DOI 10.1097/01.MPG.0000158524.30294.E2; Miloh T, 2010, PEDIATR TRANSPLANT, V14, P863, DOI 10.1111/j.1399-3046.2010.01356.x; OGRADY JG, 1989, GASTROENTEROLOGY, V97, P439, DOI 10.1016/0016-5085(89)90081-4; Panaro F, 2006, TRANSPLANT INT, V19, P344, DOI 10.1111/j.1432-2277.2006.00275.x; PINSON CW, 1990, AM J SURG, V159, P493, DOI 10.1016/S0002-9610(05)81254-1; PSACHAROPOULOS HT, 1980, ARCH DIS CHILD, V55, P252, DOI 10.1136/adc.55.4.252; Yamada EC, 1998, WESTERN J MED, V169, P380; Yildiz BD, 2008, PEDIATR TRANSPLANT, V12, P105, DOI 10.1111/j.1399-3046.2007.00838.x	20	8	8	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0277-2116	1536-4801		J PEDIATR GASTR NUTR	J. Pediatr. Gastroenterol. Nutr.	OCT	2011	53	4					459	462		10.1097/MPG.0b013e318216f2c7			4	Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics	826HA	WOS:000295344000022	21970997				2022-03-04	
J	Anastaze, K; Belli, D; Parvex, P; Girardin, E; Giroud, A; Wildhaber, B; Mclin, V				Anastaze, K.; Belli, D.; Parvex, P.; Girardin, E.; Giroud, A.; Wildhaber, B.; McLin, V.			GLOMERULAR AND TUBULAR FUNCTION FOLLOWING ORTHOTOPIC LIVER TRANSPLANTATION IN CHILDREN TREATED WITH TACROLIMUS	JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION			English	Meeting Abstract									[Anastaze, K.; Belli, D.; Giroud, A.; McLin, V.] Childrens Hosp, Gastroenterol Unit, Geneva, Switzerland; [Parvex, P.; Girardin, E.] Childrens Hosp, Nephrol Unit, Geneva, Switzerland; [Wildhaber, B.] Childrens Hosp, Pediat Surg Serv, Geneva, Switzerland				Parvex, Paloma/AAJ-1396-2020					0	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0277-2116			J PEDIATR GASTR NUTR	J. Pediatr. Gastroenterol. Nutr.	JUN	2010	50			2			E167	E167					1	Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics	608AJ	WOS:000278550100342					2022-03-04	
J	Perneger, TV				Perneger, Thomas V.			Citation analysis of identical consensus statements revealed journal-related bias	JOURNAL OF CLINICAL EPIDEMIOLOGY			English	Article						Research assessment; Research evaluation; Impact factor; Citations; Consensus statements; Bias	RANDOMIZED CONTROLLED-TRIAL; IMPACT FACTOR; ARTICLES; PUBLICATION; QUALITY; COUNTS; RATES; ASSOCIATION; INDICATORS	Objective: To examine whether the prestige of a journal, measured by its impact factor, influences the numbers of citations obtained by published articles, independently of their scientific merit. Study Design and Setting: In this cohort study, citation counts were retrieved for articles describing consensus statements that were published in multiple journals and were correlated with the impact factors of the source journals. Results: Four consensus statements were published in multiple copies: QUOROM (QUality Of Reporting Of Meta-analyses) was published in three journals, CONSORT (CONsolidated Standards Of Reporting Trials) in eight journals, STARD (STAndards for Reporting of Diagnostic accuracy) in 14 journals, and STROBE (STrengthening the Reporting of OBservational studies in Epidemiology) in eight journals. For each consensus statement, the impact factor of the source journal and the number of citations were highly correlated (Spearman correlation coefficients: QUOROM, 1.00; CONSORT, 0.88; STARD, 0.65; and STROBE, 0.81-all P < 0.02). When adjusted for time since publication, each logarithm unit of impact factor predicted an increase of 1.0 logarithm unit of citations (95% confidence interval: 0.7-1.3, P < 0.001), and the variance explained was 66% (adjusted r(2) = 0.66). Conclusions: The prominence of the journal where an article is published, measured by its impact factor, influences the number of citations that the article will gather over time. Citation counts are not purely a reflection of scientific merit. (C) 2010 Elsevier Inc. All rights reserved.	Univ Hosp Geneva, Div Clin Epidemiol, CH-1211 Geneva, Switzerland		Perneger, TV (corresponding author), Univ Hosp Geneva, Div Clin Epidemiol, 2 Rue Gabrielle Perret Gentil, CH-1211 Geneva, Switzerland.	thomas.perneger@hcuge.ch					Aksnes DW, 2006, J AM SOC INF SCI TEC, V57, P169, DOI 10.1002/asi.20262; Bain CR, 2005, ANAESTH INTENS CARE, V33, P567, DOI 10.1177/0310057X0503300503; Baldi S, 1998, AM SOCIOL REV, V63, P829, DOI 10.2307/2657504; Barbui C, 2006, J CLIN PSYCHIAT, V67, P37, DOI 10.4088/JCP.v67n0106; Bhandari M, 2007, CAN J SURG, V50, P119; Bornmann L, 2008, J DOC, V64, P45, DOI 10.1108/00220410810844150; Callaham M, 2002, JAMA-J AM MED ASSOC, V287, P2847, DOI 10.1001/jama.287.21.2847; Cronin B, 1998, SCIENTOMETRICS, V43, P45, DOI 10.1007/BF02458393; Davis PM, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a568; Etter JF, 2009, J CLIN EPIDEMIOL, V62, P831, DOI 10.1016/j.jclinepi.2008.09.015; Eysenbach G, 2006, PLOS BIOL, V4, P692, DOI 10.1371/journal.pbio.0040157; Figg WD, 2006, PHARMACOTHERAPY, V26, P759, DOI 10.1592/phco.26.6.759; Filion Kristian B, 2008, Epidemiol Perspect Innov, V5, P3, DOI 10.1186/1742-5573-5-3; FRANK E, 1994, JAMA-J AM MED ASSOC, V272, P163, DOI 10.1001/jama.272.2.163; Grange RI, 1999, BJU INT, V84, P601; Hendrix D, 2008, J MED LIBR ASSOC, V96, P324, DOI 10.3163/1536-5050.96.4.007; Huang Y, 2008, SCIENTOMETRICS, V77, P177, DOI 10.1007/s11192-007-1899-1; KASSIRER JP, 1995, NEW ENGL J MED, V333, P449, DOI 10.1056/NEJM199508173330709; Lee KP, 2002, JAMA-J AM MED ASSOC, V287, P2805, DOI 10.1001/jama.287.21.2805; Lokker C, 2008, BMJ-BRIT MED J, V336, P655, DOI 10.1136/bmj.39482.526713.BE; Moed H, 2005, CITATION ANAL RES EV; Nieminen Pentti, 2006, BMC Med Res Methodol, V6, P42, DOI 10.1186/1471-2288-6-42; Nieminen P, 2007, J CLIN EPIDEMIOL, V60, P939, DOI 10.1016/j.jclinepi.2006.11.014; Patsopoulos NA, 2005, JAMA-J AM MED ASSOC, V293, P2362, DOI 10.1001/jama.293.19.2362; Perneger TV, 2004, BRIT MED J, V329, P546, DOI 10.1136/bmj.329.7465.546; Saha S, 2003, J MED LIBR ASSOC, V91, P42; SEGLEN PO, 1994, J AM SOC INFORM SCI, V45, P1, DOI 10.1002/(SICI)1097-4571(199401)45:1<1::AID-ASI1>3.0.CO;2-Y; Seglen PO, 1997, BRIT MED J, V314, P498; SHADISH WR, 1995, SOC STUD SCI, V25, P477, DOI 10.1177/030631295025003003	29	30	31	0	9	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0895-4356			J CLIN EPIDEMIOL	J. Clin. Epidemiol.	JUN	2010	63	6					660	664		10.1016/j.jclinepi.2009.09.012			5	Health Care Sciences & Services; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health	596DH	WOS:000277663900014	20097531				2022-03-04	
J	Cleopas, A; Kolly, V; Perneger, TV				Cleopas, Agatta; Kolly, Veronique; Perneger, Thomas V.			Longer response scales improved the acceptability and performance of the Nottingham Health Profile	JOURNAL OF CLINICAL EPIDEMIOLOGY			English	Article						Nottingham Health Profile instrument; health status measurement; response format; patient survey; psychometrics	PATIENT SATISFACTION; VERSION; SF-36; POPULATION; MANAGEMENT; VALIDITY; WEIGHTS; NUMBER; CARE	Objective: To test alternative response formats for the Nottingham Health Profile (NHP), in terms of acceptability, score distributions, and measurement proper-ties. Study Design and Settings: Randomized trial of four response formats for the NHP: original "yes/no" format, a 3-point similarity format ("applies completely/in part/not at all"), a 5-point intensity format ("completely true" to "completely false"), and a 5-point frequency format ("all the time" to "never"). Respondents were patients discharged from a hospital. We compared scores distributions, reliability coefficients, correlations with dimension-specific numerical scales, and patient ratings of the instrument. Results: Response rates were similar for the four versions. The original response format had the fewest fully completed questionnaires, and the largest ceiling effects. Internal consistency and test-retest coefficients were acceptable for all versions, but were higher for the two 5-point formats. Correlations reflecting convergent and discriminant validity were higher for the longer response formats than for the original version. The frequency format received the highest ratings from patients, particularly from the sicker and older subgroups. Conclusions: The psychometric performance and patient acceptability of the NHP can be improved by using a 5-point frequency response format instead of the original dichotomous response format. (C) 2006 Elsevier Inc. All rights reserved.	Univ Hosp Geneva, Qual Care Unit, CH-1204 Geneva, Switzerland		Perneger, TV (corresponding author), Univ Hosp Geneva, Qual Care Unit, 24 Micheli du Crest, CH-1204 Geneva, Switzerland.	thomas.perneger@hcuge.ch					Bovier PA, 2004, AM J MED, V117, P569, DOI 10.1016/j.amjmed.2004.05.020; BRAZIER JE, 1992, BMJ-BRIT MED J, V305, P160, DOI 10.1136/bmj.305.6846.160; Bruera E, 1991, J Palliat Care, V7, P6; BUCQUET D, 1990, SOC SCI MED, V30, P829, DOI 10.1016/0277-9536(90)90207-9; Clancy CM, 1998, SCIENCE, V282, P245, DOI 10.1126/science.282.5387.245; DONOVAN JL, 1993, J EPIDEMIOL COMMUN H, V47, P158, DOI 10.1136/jech.47.2.158; ELLWOOD PM, 1988, NEW ENGL J MED, V318, P1549, DOI 10.1056/NEJM198806093182329; Hendriks AAJ, 2004, PATIENT EDUC COUNS, V55, P142, DOI 10.1016/j.pec.2003.11.006; Hendriks AAJ, 2001, MED CARE, V39, P270, DOI 10.1097/00005650-200103000-00007; Hinz A, 2003, PSYCHOTHER PSYCH MED, V53, P353; HUNT SM, 1980, J EPIDEMIOL COMMUN H, V34, P281, DOI 10.1136/jech.34.4.281; HUNT SM, 1981, SOC SCI MED-MED SOC, V15, P221, DOI 10.1016/0271-7123(81)90005-5; JENKINSON C, 1991, SOC SCI MED, V32, P1413, DOI 10.1016/0277-9536(91)90202-N; Jenkinson C, 1999, J EPIDEMIOL COMMUN H, V53, P46, DOI 10.1136/jech.53.1.46; Kucukdeveci AA, 2000, INT J REHABIL RES, V23, P31, DOI 10.1097/00004356-200023010-00004; Lamarca R, 2001, J CLIN EPIDEMIOL, V54, P127, DOI 10.1016/S0895-4356(00)00283-3; Lovas K, 2003, HEALTH POLICY, V63, P49, DOI 10.1016/S0168-8510(02)00078-7; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/h0043158; Nagata C, 1996, J Epidemiol, V6, P192; Nishimura K, 2004, INTERNAL MED, V43, P35, DOI 10.2169/internalmedicine.43.35; Nunnally J., 1994, PSYCHOL THEORY; Perneger TV, 2005, MED CARE, V43, P374, DOI 10.1097/01.mlr.0000156856.36901.40; Perneger TV, 2003, MED CARE, V41, P1343, DOI 10.1097/01.MLR.0000100580.94559.AD; Preston CC, 2000, ACTA PSYCHOL, V104, P1, DOI 10.1016/S0001-6918(99)00050-5; Prieto L, 1996, J CLIN EPIDEMIOL, V49, P31, DOI 10.1016/0895-4356(95)00064-X; Stober J, 2002, J PERS ASSESS, V78, P370, DOI 10.1207/S15327752JPA7802_10; STREINER D, 1991, HLTH MEASUREMENT SCA; Thorsen Hanne, 1993, Scandinavian Journal of Primary Health Care, V11, P124, DOI 10.3109/02813439308994914; Uutela T, 2003, RHEUMATOLOGY, V42, P841, DOI 10.1093/rheumatology/keg229; WARE JE, 1988, MED CARE, V26, P393, DOI 10.1097/00005650-198804000-00008; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002	31	12	12	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0895-4356	1878-5921		J CLIN EPIDEMIOL	J. Clin. Epidemiol.	NOV	2006	59	11					1183	1190		10.1016/j.jclinepi.2006.02.014			8	Health Care Sciences & Services; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health	096IE	WOS:000241370000009	17027429				2022-03-04	
J	Semeraro, L; Lenaud, AV; McLin, VA				Semeraro, Laura; Lenaud, Anne-Valerie; McLin, Valerie A.			Cardiovascular Dysphagia	JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION			English	Editorial Material									[Semeraro, Laura; Lenaud, Anne-Valerie; McLin, Valerie A.] Hop Univ Geneve, Dept Pediat, Geneva 14, Switzerland		McLin, VA (corresponding author), Hop Univ Geneve, Dept Pediat, Geneva 14, Switzerland.	valerie.mclin@hcuge.ch					CAPPELL MS, 1995, DIGEST DIS SCI, V40, P166, DOI 10.1007/BF02063961; Gotsman I, 1999, POSTGRAD MED J, V75, P629, DOI 10.1136/pgmj.75.888.629; Newman LA, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.6.e106	3	0	0	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0277-2116	1536-4801		J PEDIATR GASTR NUTR	J. Pediatr. Gastroenterol. Nutr.	JUL	2012	55	1					1	1		10.1097/MPG.0b013e318244a30b			1	Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics	959TR	WOS:000305337000001	22167018				2022-03-04	
J	Mclin, VA				McLin, Valerie A.			Summary of "Genomic and Genetic Deletions of the FOX Gene Cluster on 16q24.1 and Inactivating Mutations of FOXF1 Cause Alveolar Capillary Dysplasia and Other Malformations"	JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION			English	Editorial Material							VISCERAL MESODERM; GUT DEVELOPMENT; HAPLOINSUFFICIENCY; DIFFERENTIATION; PROLIFERATION; LUNG		Hop Cantonal Univ Geneva, Dept Enfant & Adolescent, Unite Gastroenterol Pediat, CH-1211 Geneva 14, Switzerland		McLin, VA (corresponding author), Hop Cantonal Univ Geneva, Dept Enfant & Adolescent, Unite Gastroenterol Pediat, CH-1211 Geneva 14, Switzerland.						Beh J, 2007, DEVELOPMENT, V134, P3297, DOI 10.1242/dev.010140; Kaestner KH, 1997, GENE DEV, V11, P1583, DOI 10.1101/gad.11.12.1583; Kalinichenko VV, 2004, AM J PHYSIOL-LUNG C, V286, pL521, DOI 10.1152/ajplung.00212.2003; Kalinichenko VV, 2002, J BIOL CHEM, V277, P12369, DOI 10.1074/jbc.M112162200; Madison BB, 2009, J BIOL CHEM, V284, P5936, DOI 10.1074/jbc.M808103200; Mahlapuu M, 1998, DEV BIOL, V202, P183, DOI 10.1006/dbio.1998.9010; Mahlapuu M, 2001, DEVELOPMENT, V128, P2397; Mahlapuu M, 2001, DEVELOPMENT, V128, P155; Mclin VA, 2009, GASTROENTEROLOGY, V136, P2074, DOI 10.1053/j.gastro.2009.03.001; Ormestad M, 2006, DEVELOPMENT, V133, P833, DOI 10.1242/dev.02252; Ormestad M, 2004, DEV DYNAM, V229, P328, DOI 10.1002/dvdy.10426; Tseng HT, 2004, DEVELOPMENT, V131, P3637, DOI 10.1242/dev.01234; Zaffran S, 2001, GENE DEV, V15, P2900	13	1	2	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0277-2116			J PEDIATR GASTR NUTR	J. Pediatr. Gastroenterol. Nutr.	MAR	2010	50	3					350	351		10.1097/MPG.0b013e3181c15f30			2	Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics	562WH	WOS:000275085500022	20118801				2022-03-04	
J	Brulhart-Meynet, MC; Deakin, SP; Sgroi, A; Buhler, L; James, RW				Brulhart-Meynet, Marie-Claude; Deakin, Sara P.; Sgroi, Antonino; Buhler, Leo; James, Richard William			Expression of the hepatic Niemann-Pick C1 like 1 protein gene is sensitive to rosuvastatin treatment of primary human hepatocytes	PHARMACOGENETICS AND GENOMICS			English	Article						cardiovascular risk; cholesterol homeostasis; gene expression; liver	SIMVASTATIN; LIVER	Statins act by reducing hepatic cholesterol synthesis, thus stimulating uptake of serum cholesterol. Statin therapy modulates a number of genes involved in hepatic cholesterol homeostasis. These have rarely been analyzed simultaneously in the same experimental setting, with virtually no studies of primary human hepatocytes. This study analyzed the efficacy of rosuvastatin in the coordinated regulation of a number of genes implicated in cholesterol metabolism in primary human hepatocytes. Expression of five cholesterol-related genes were significantly upregulated, notably the Niemann-Pick C1 like 1 protein, for whom functional studies have been essentially limited to the intestine. Two genes were significantly downregulated, including sterol recognition element binding protein-1 gene that is implicated in control of hepatic lipogenesis. The results show the coordinated regulation of several genes implicated in hepatic cholesterol homeostasis and suggest therapeutic targets that could complement that clinical action of statins. Pharmacogenetics and Genomics 20: 455-458 (C) 2010 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.	[Brulhart-Meynet, Marie-Claude; Deakin, Sara P.; James, Richard William] Cantonal Hosp, Dept Internal Med, Geneva, Switzerland; [Sgroi, Antonino; Buhler, Leo] Cantonal Hosp, Dept Surg, Geneva, Switzerland; [Deakin, Sara P.; Sgroi, Antonino; Buhler, Leo; James, Richard William] Univ Geneva, Fac Med, Geneva, Switzerland		James, RW (corresponding author), Univ Hosp, Dept Internal Med, Clin Diabet Unit, 24 Rue Micheli du Crest, CH-1211 Geneva 14, Switzerland.	Richard.James@hcuge.ch		Buhler, Leo/0000-0002-9461-8498	Swiss National Research FoundationSwiss National Science Foundation (SNSF); Astra-Zeneca AG, SwitzerlandAstraZeneca	The study was supported by grants from the Swiss National Research Foundation (to R.W.J.) and Astra-Zeneca AG, Switzerland.	Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; Deakin S, 2003, ARTERIOSCL THROM VAS, V23, P2083, DOI 10.1161/01.ATV.0000096207.01487.36; Dubuc G, 2004, ARTERIOSCL THROM VAS, V24, P1454, DOI 10.1161/01.ATV.0000134621.14315.43; Ferre P, 2007, HORM RES, V68, P72, DOI 10.1159/000100426; Lally S, 2006, DIABETOLOGIA, V49, P1008, DOI 10.1007/s00125-006-0177-8; Mai G, 2005, XENOTRANSPLANTATION, V12, P457, DOI 10.1111/j.1399-3089.2005.00248.x; Rader DJ, 2007, AM J CARDIOL, V100, p15N, DOI 10.1016/j.amjcard.2007.08.008; SHENG ZQ, 1995, P NATL ACAD SCI USA, V92, P935, DOI 10.1073/pnas.92.4.935; Stender S, 2005, DIABETES OBES METAB, V7, P430, DOI 10.1111/j.1463-1326.2004.00450.x; Telford DE, 2007, J LIPID RES, V48, P699, DOI 10.1194/jlr.M600439-JLR200; Yu LQ, 2008, CURR OPIN LIPIDOL, V19, P263, DOI 10.1097/MOL.0b013e3282f9b563	11	3	3	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1744-6872			PHARMACOGENET GENOM	Pharmacogenet. Genomics	JUL	2010	20	7					455	458		10.1097/FPC.0b013e32833a9328			4	Biotechnology & Applied Microbiology; Genetics & Heredity; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity; Pharmacology & Pharmacy	612EK	WOS:000278879400007	20461026				2022-03-04	
J	Morabia, A				Morabia, A			The controversial controversy of a passionate controversialist	JOURNAL OF CLINICAL EPIDEMIOLOGY			English	Article						Feinstein; tobacco industry; epidemiologic studies	ENVIRONMENTAL TOBACCO-SMOKE; GENERALS EPIDEMIOLOGIC CRITERIA; PUBLIC-HEALTH CONSPIRACY; OCCUPATIONAL LUNG-CANCER; CORONARY HEART-DISEASE; OF-EVIDENCE ANALYSIS; PASSIVE SMOKING; UNITED-STATES; CIGARETTE-SMOKING; SCIENTIFIC STANDARDS	Alvan Feinstein was among the pioneers who perceived the need to apply epidemiologic principles and methods to clinical medicine. In his attempt to convert his peers to his own views, he was very liberal in criticizing the work of others. Epidemiologists still recall his 1988 article in Science entitled "Scientific Standards in Epidemiologic Studies of the Menace of Daily Life," in which he criticized observational epidemiology for its lack of scientific rigor. In this context, Feinstein's work has also been the center of controversies. One in particular, related to the fact that he carried out research and consulted for industries, in particular the tobacco industry, has tainted the last years of Feinstein's career. My purpose in this article is to discuss Feinstein's relationship with the tobacco industry. It is not to judge the validity of his work. Against this background, a question of historic relevance, one that can be discussed on the basis of some evidence, is whether Feinstein, world-reknowned epidemiologist and editor of this journal from 1982 until his recent death, helped the tobacco industry to publish articles minimizing the deleterious effects of smoking in the Journal of Chronic Diseases and (since 1988) the Journal of Clinical Epidemiology. To address this question I have searched the articles related to the effects of tobacco that were published in the Journal since 1978. The tobacco industry has had the opportunity, via its consultants, to defend its own ideas in the "Variance and Dissent" section. Perhaps in hindsight Feinstein could be criticized for not having clearly indicated the sponsorship of the tobacco industry behind these publications, of which he was fully aware. However, this does not suffice to infer that he was the tobacco industry's, "man." Feinstein's attitude in matters of publication appears balanced. (C) 2002 Elsevier Science Inc. All rights reserved.	Univ Hosp, Div Clin Epidemiol, CH-1211 Geneva 14, Switzerland		Morabia, A (corresponding author), Univ Hosp, Div Clin Epidemiol, CH-1211 Geneva 14, Switzerland.	alfredo.morabia@hcuge.ch					BERLIN NI, 1984, J CHRON DIS, V37, P809, DOI 10.1016/0021-9681(84)90012-2; BERLIN NI, 1984, AM REV RESPIR DIS, V130, P545; BURCH PR, 1984, J CHRON DIS, V37, P813; BURCH PRJ, 1985, J CHRON DIS, V38, P469, DOI 10.1016/0021-9681(85)90029-3; BURCH PRJ, 1988, J CLIN EPIDEMIOL, V41, P373, DOI 10.1016/0895-4356(88)90145-X; BURCH PRJ, 1978, J ROY STAT SOC A STA, V141, P437, DOI 10.2307/2344483; BURCH PRJ, 1980, J CHRON DIS, V33, P221, DOI 10.1016/0021-9681(80)90067-3; BURCH PRJ, 1984, J CHRON DIS, V37, P325, DOI 10.1016/0021-9681(84)90095-X; BURCH PRJ, 1983, J CHRON DIS, V36, P821, DOI 10.1016/0021-9681(83)90003-6; BURCH PRJ, 1981, J CHRON DIS, V34, P87, DOI 10.1016/0021-9681(81)90054-0; BURCH PRJ, 1984, J CHRON DIS, V37, P793, DOI 10.1016/0021-9681(84)90011-0; Curtin F, 1999, J CLIN EPIDEMIOL, V52, P1055, DOI 10.1016/S0895-4356(99)00089-X; Enstrom JE, 1999, J CLIN EPIDEMIOL, V52, P813; FARLAND W, 1994, J CLIN EPIDEMIOL, V47, P335, DOI 10.1016/0895-4356(94)90153-8; Feinstein A R, 1991, Epidemiology, V2, P72, DOI 10.1097/00001648-199101000-00012; Feinstein A R, 1990, Epidemiology, V1, P170, DOI 10.1097/00001648-199003000-00017; FEINSTEIN AR, 1988, SCIENCE, V242, P1257, DOI 10.1126/science.3057627; FEINSTEIN AR, 1983, J CHRON DIS, V36, P299, DOI 10.1016/0021-9681(83)90112-1; FEINSTEIN AR, 1987, AM J CLIN NUTR, V45, P1080, DOI 10.1093/ajcn/45.5.1080; Feinstein AR, 1996, J CLIN EPIDEMIOL, V49, P615, DOI 10.1016/0895-4356(96)00040-6; FEINSTEIN AR, 1992, TOXICOL PATHOL, V20, P303; FLEISS JL, 1991, J CLIN EPIDEMIOL, V44, P127, DOI 10.1016/0895-4356(91)90261-7; FORSYTH BW, 1989, JAMA-J AM MED ASSOC, V261, P2517, DOI 10.1001/jama.261.17.2517; FOWLER NO, 1992, J CLIN EPIDEMIOL, V45, P1032, DOI 10.1016/0895-4356(92)90122-4; GLANTZ SA, 1992, J CLIN EPIDEMIOL, V45, P815, DOI 10.1016/0895-4356(92)90063-S; GLANTZ SA, 1993, J CLIN EPIDEMIOL, V46, P410, DOI 10.1016/0895-4356(93)90161-S; GORI GB, 1994, J CLIN EPIDEMIOL, V47, P325, DOI 10.1016/0895-4356(94)90152-X; GORI GB, 1994, J CLIN EPIDEMIOL, V47, P351; GRANIERI S, 1978, J CHRON DIS, V31, P499, DOI 10.1016/0021-9681(78)90035-8; GREENLAND S, 1991, EPIDEMIOLOGY, V2, P387, DOI 10.1097/00001648-199109000-00015; GROSS AJ, 1995, J CLIN EPIDEMIOL, V48, P603, DOI 10.1016/0895-4356(95)90024-1; GROSS AJ, 1995, J CLIN EPIDEMIOL, V48, P587, DOI 10.1016/0895-4356(94)00166-N; HARDY DR, COMMUNICATION; HELIOVAARA M, 1981, J CHRON DIS, V34, P305, DOI 10.1016/0021-9681(81)90068-0; HICKEY RJ, 1986, J CHRON DIS, V39, P407, DOI 10.1016/0021-9681(86)90127-X; HIGGINS ITT, 1983, J CHRON DIS, V36, P677, DOI 10.1016/0021-9681(83)90159-5; HILL P, 1983, J CHRON DIS, V36, P439, DOI 10.1016/0021-9681(83)90136-4; IDLE JR, 1990, J CLIN EPIDEMIOL, V43, P313, DOI 10.1016/0895-4356(90)90117-8; JINOT J, 1994, J CLIN EPIDEMIOL, V47, P339, DOI 10.1016/0895-4356(94)90154-6; Keil U, 1999, J CLIN EPIDEMIOL, V52, P91; KRISTEIN MM, 1984, J CHRON DIS, V37, P317, DOI 10.1016/0021-9681(84)90094-8; KRISTEIN MM, 1984, J CHRON DIS, V37, P333; KRISTEIN MM, 1985, J CHRON DIS, V38, P471, DOI 10.1016/0021-9681(85)90030-X; KRISTEIN MM, 1986, J CHRON DIS, V39, P409, DOI 10.1016/0021-9681(86)90128-1; KRISTENSEN TS, 1991, J CLIN EPIDEMIOL, V44, P99, DOI 10.1016/0895-4356(91)90206-O; KULLER LH, 1991, J CLIN EPIDEMIOL, V44, P877, DOI 10.1016/0895-4356(91)90048-E; LEE PN, 1993, J CLIN EPIDEMIOL, V46, P409, DOI 10.1016/0895-4356(93)90160-3; Levois M, 1998, J CLIN EPIDEMIOL, V51, P37, DOI 10.1016/S0895-4356(97)00224-2; LILIENFELD AM, 1983, J CHRON DIS, V36, P837, DOI 10.1016/0021-9681(83)90004-8; MANTEL N, 1992, J CLIN EPIDEMIOL, V45, P809, DOI 10.1016/0895-4356(92)90062-R; MCFARLANE MJ, 1987, JAMA-J AM MED ASSOC, V258, P331, DOI 10.1001/jama.258.3.331; Ong EK, 2000, LANCET, V355, P1253, DOI 10.1016/S0140-6736(00)02098-5; Ong EK, 2001, AM J PUBLIC HEALTH, V91, P1749, DOI 10.2105/AJPH.91.11.1749; PERSKE M, 1993, J CLIN EPIDEMIOL, V46, P408, DOI 10.1016/0895-4356(93)90159-X; Samet JM, 2001, AM J PUBLIC HEALTH, V91, P1742, DOI 10.2105/AJPH.91.11.1742; Savitz D A, 1991, Epidemiology, V2, P61, DOI 10.1097/00001648-199101000-00010; Savitz D A, 1990, Epidemiology, V1, P78, DOI 10.1097/00001648-199001000-00017; SCHACHTER EN, 1983, J CHRON DIS, V36, P681, DOI 10.1016/0021-9681(83)90160-1; SELTZER CC, 1989, J CLIN EPIDEMIOL, V42, P743, DOI 10.1016/0895-4356(89)90070-X; Seltzer CC, 1997, J CLIN EPIDEMIOL, V50, P627, DOI 10.1016/S0895-4356(96)00372-1; SELTZER CC, 1991, J CLIN EPIDEMIOL, V44, P871, DOI 10.1016/0895-4356(91)90047-D; SELTZER CC, 1985, J CHRON DIS, V38, P17, DOI 10.1016/0021-9681(85)90004-9; SMITH CJ, 1992, TOXICOL PATHOL, V20, P289, DOI 10.1177/019262339202000217; STERLING TD, 1984, J CHRON DIS, V37, P227, DOI 10.1016/0021-9681(84)90150-4; STERLING TD, 1983, J CHRON DIS, V36, P683; STERLING TD, 1990, J CLIN EPIDEMIOL, V43, P141, DOI 10.1016/0895-4356(90)90177-Q; STERLING TD, 1992, J CLIN EPIDEMIOL, V45, P223, DOI 10.1016/0895-4356(92)90082-X; STERLING TD, 1983, J CHRON DIS, V36, P669, DOI 10.1016/0021-9681(83)90158-3; Sterling TD, 1996, J CLIN EPIDEMIOL, V49, P803, DOI 10.1016/0895-4356(96)00032-7; THORNTON A, 1994, J CLIN EPIDEMIOL, V47, P1143, DOI 10.1016/0895-4356(94)90101-5; VANLEEUWEN FE, 1995, J CLIN EPIDEMIOL, V48, P599, DOI 10.1016/0895-4356(94)00167-O; WEINKAM JJ, 1990, J CLIN EPIDEMIOL, V43, P133, DOI 10.1016/0895-4356(90)90176-P; Weiss N S, 1990, Epidemiology, V1, P85, DOI 10.1097/00001648-199001000-00019; Yach D, 2001, AM J PUBLIC HEALTH, V91, P1745, DOI 10.2105/AJPH.91.11.1745	74	2	2	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0895-4356	1878-5921		J CLIN EPIDEMIOL	J. Clin. Epidemiol.	DEC	2002	55	12					1207	1213	PII S0895-4356(02)00526-7	10.1016/S0895-4356(02)00526-7			7	Health Care Sciences & Services; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services; Public, Environmental & Occupational Health	631VQ	WOS:000180187900011	12547451				2022-03-04	
J	Kuffer, R; Lombardi, T				Kuffer, R; Lombardi, T			Premalignant lesions of the oral mucosa. A discussion about the place of oral intraepithelial neoplasia (OIN)	ORAL ONCOLOGY			English	Review						oral mucosa; precancerous lesions; Intraepithelial neoplasia; epithelial dysplasia; squamous cell carcinoma	UPPER AERODIGESTIVE TRACT; SQUAMOUS-CELL CARCINOMA; LEUKOPLAKIA; DYSPLASIA	Oral precancerous lesions are traditionally classified as leukoplakia, erythroplakia, erythroleukoplakia, and distinguished from precancerous conditions. Major attention is focused on leukoplakia, and no distinction made whether dysplasia is or not present. Malignant transformation is a multistep process that should be approached also from the histological, and not merely from the chinical standpoint. Intraepithelial neoplasia, a notion created for the uterine cervix and already extended to other mucosae, should be adapted to the oral mucosa and used as diagnostic term. OIN (oral intraepithelial neoplasia) is not only a change in terminology, but also a progress in the unifying concept of precursors of squamous cell carcinoma, suppressing the useless discussion between severe dysplasia and carcinoma in situ. Furthermore, grading lesions as low or high grade OIN increases diagnostic consistency. OIN is suspected on three clinical patterns reflecting histological changes: mosaic, irregular keratosis, erythroplakia (or intermediate aspects), but dysplastic mucosa may also appear normal clinically. (C) 2002 Elsevier Science Ltd. All rights reserved.	Fac Med, Div Stomatol, Lab Oral Histopathol, CH-1211 Geneva 4, Switzerland		Kuffer, R (corresponding author), Fac Med, Div Stomatol, Lab Oral Histopathol, 19 Rue Barthelemy Menn, CH-1211 Geneva 4, Switzerland.						Axell T, 1996, J ORAL PATHOL MED, V25, P49, DOI 10.1111/j.1600-0714.1996.tb00191.x; Badaracco G, 2000, ANTICANCER RES, V20, P1301; Broders AC, 1932, J AMER MED ASSOC, V99, P1670, DOI 10.1001/jama.1932.02740720024007; COLLIN A, 1986, GYNECOLOGIE, V38, P190; CRISSMAN JD, 1987, PATHOL ANNU, V22, P311; CRISSMAN JD, 1989, AM J SURG PATHOL, V13, P5; CRUM CP, 1993, GYNECOL ONCOL, P182; Ephros H, 1997, ORAL SURG ORAL MED O, V83, P187, DOI 10.1016/S1079-2104(97)90001-9; EPSTEIN JB, 1992, J ORAL PATHOL MED, V21, P160, DOI 10.1111/j.1600-0714.1992.tb00094.x; GRICOUROFF G, 1952, PRESSE MED, V60, P743; Hart WR, 2001, INT J GYNECOL PATHOL, V20, P16, DOI 10.1097/00004347-200101000-00003; KRUTCHKOFF DJ, 1985, ORAL SURG ORAL MED O, V60, P308, DOI 10.1016/0030-4220(85)90315-9; Liu SC, 2000, ORAL ONCOL, V36, P145, DOI 10.1016/S1368-8375(99)00076-7; LUMERMAN H, 1995, ORAL SURG ORAL MED O, V79, P321, DOI 10.1016/S1079-2104(05)80226-4; Mashberg A, 2000, ORAL ONCOL, V36, P253, DOI 10.1016/S1368-8375(00)00006-3; McLaren KM, 2000, HISTOPATHOLOGY, V37, P460, DOI 10.1046/j.1365-2559.2000.00998.x; MONTEIL RA, 1983, ANN PATHOL, V3, P257; PINDBORG JJ, 1977, ORAL SURG ORAL MED O, V43, P383, DOI 10.1016/0030-4220(77)90325-5; PINDBORG JJ, 1980, ORAL CANC PRECANCER; REAGAN JW, 1953, CANCER, V6, P224, DOI 10.1002/1097-0142(195303)6:2<224::AID-CNCR2820060203>3.0.CO;2-H; Richart RM, 1967, CLIN OBSTET GYNECOL, V10, P748, DOI 10.1097/00003081-196712000-00002; Rubin IC, 1910, AM J OBSTET GYNECOL, V62, P668; SCULLY C, 1993, J ORAL PATHOL MED, V22, P337, DOI 10.1111/j.1600-0714.1993.tb01086.x; Silverman S, 1997, ORAL SURG ORAL MED O, V84, P154, DOI 10.1016/S1079-2104(97)90062-7; SOLOMON D, 1989, JAMA-J AM MED ASSOC, V262, P931; Speight PM., 1996, CURR DIAGN PATHOL, V3, P165; SPRAGUE W G, 1963, Oral Surg Oral Med Oral Pathol, V16, P1067, DOI 10.1016/0030-4220(63)90222-6; van der Waal I, 2000, ORAL ONCOL, V36, P264, DOI 10.1016/S1368-8375(99)00092-5; VANOORTMARSSEN GJ, 1991, BRIT J CANCER, V64, P559, DOI 10.1038/bjc.1991.350; Warnakulasuriya KAAS, 1996, J ORAL PATHOL MED, V25, P97, DOI 10.1111/j.1600-0714.1996.tb00201.x; *WHO, 1975, INT HIST CLASS TUM, V13; WHO Collaborating Centre for Oral Precancerous Lesions, 1978, ORAL SURG ORAL MED O, V46, P518; WILLIAMSON J. J., 1964, ORAL SURG ORAL MED AND ORAL PATHOL, V17, P308, DOI 10.1016/0030-4220(64)90499-2; Woodhouse SL, 1999, ARCH PATHOL LAB MED, V123, P1079	34	54	55	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1368-8375	1879-0593		ORAL ONCOL	Oral Oncol.	FEB	2002	38	2					125	130	PII S1368-8375(01)00050-1	10.1016/S1368-8375(01)00050-1			6	Oncology; Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Dentistry, Oral Surgery & Medicine	533XD	WOS:000174554800001	11854058				2022-03-04	
J	Costanza, MC; Wolff, H; James, RW; Morabia, A				Costanza, MC; Wolff, H; James, RW; Morabia, A			In a quasi-simultaneous assessment, imprecise cholesterol monitoring and screening tests were improved	JOURNAL OF CLINICAL EPIDEMIOLOGY			English	Article						clinical decision makings; gold standard tests; dry-chemistry tests; hypercholesterolemia; prediction limits; receiver operating characteristic (ROC) curve	PRECISION; VARIABILITY; REFLOTRON	Objective: To calibrate Reflotron-measured capillary total cholesterol (cTC) relative to a laboratory-measured venous total cholesterol (vTC) criterion standard for monitoring and screening hypercholesterolemia. Study Design and Setting: Quasi-simultaneous assessment in 1999-2002 of Reflotron cTC and laboratory vTC in a random sample of 4,269 adult residents of Geneva, Switzerland (calibration development subsample n = 3,067; validation subsample n = 1,172), by means of bias, precision, correlation, sensitivity, and false positive percentage (calculated as 100 - specificity) analyses of Reflotron cTC vs. laboratory vTC measures for predicting hypercholesterolemia. Results: Total bias was small (-0.26 ramol/L), but there was substantial negative drift in Reflotron cTC (annual biases +0.08, -0.17, -0.27, and -0.60 mmol/L in 1999-2002). Overall, 57% of Reflotron cTC measurements for 894 hypercholesterolemic patients underestimated laboratory vTC (2%, 57%, 71%, and 98% in 1999-2002). Prior to calibration, sensitivity was 73% for the development and 35% for the validation subsample, with false positive at 4% (development) and 0.1% (validation). After calibration, sensitivity was 78% for the development and 37% for the validation subsample, with false positive at 5% (development) and 0.2% (validation). Using 95% upper prediction limits (UPL) for individual vTC values increased sensitivity to 99% and 83% and false positive percentage to 30% and 7% for the development and validation subsamples, respectively. Conclusion: Crude results of Reflotron-measured cTC have poor sensitivity. Instead, 95% UPL can be used for monitoring and screening. Simply adding 0.8 mmol/L to a patient's observed Reflotron cTC value provides a very good approximation to the 95% UPL. (c) 2005 Elsevier Inc. All rights reserved.	Univ Hosp Geneva, Div Clin Epidemiol, CH-1211 Geneva, Switzerland; Univ Hosp Geneva, Lipid Lab, Clin Diabet Unit, CH-1211 Geneva, Switzerland		Costanza, MC (corresponding author), Univ Hosp Geneva, Div Clin Epidemiol, 25 Rue Micheli du Crest, CH-1211 Geneva, Switzerland.	Michael.Costanza@hcuge.ch	Wolff, Hans/F-2122-2015; Costanza, Michael C/A-9129-2009	Wolff, Hans/0000-0002-4978-2176; 			BACHORIK PS, 1989, CLIN CHEM, V35, P1734; BACHORIK PS, 1990, CLIN CHEM, V36, P255; BELSEY R, 1990, JAMA-J AM MED ASSOC, V263, P1250, DOI 10.1001/jama.263.9.1250; Cooper GR, 1997, JAMA-J AM MED ASSOC, V278, P478; COOPER GR, 1992, JAMA-J AM MED ASSOC, V267, P1652, DOI 10.1001/jama.267.12.1652; DeWilde S, 2003, HEART, V89, P417, DOI 10.1136/heart.89.4.417; Galobardes B, 2003, AM J PUBLIC HEALTH, V93, P1302, DOI 10.2105/AJPH.93.8.1302; GREGORY LC, 1994, CLIN CHEM, V40, P579; HAVAS S, 1992, AM J PUBLIC HEALTH, V82, P458, DOI 10.2105/AJPH.82.3.458; KAUFMAN HW, 1990, JAMA-J AM MED ASSOC, V263, P1245, DOI 10.1001/jama.263.9.1245; KOCH TR, 1987, CLIN CHEM, V33, P2262; Law MR, 2002, BMJ-BRIT MED J, V324, P1570, DOI 10.1136/bmj.324.7353.1570; Majeed A, 2000, J PUBLIC HEALTH MED, V22, P275, DOI 10.1093/pubmed/22.3.275; MILLER WG, 1993, CLIN CHEM, V39, P297; ROEBACK JR, 1993, J CLIN EPIDEMIOL, V46, P1159, DOI 10.1016/0895-4356(93)90115-H; Seber G.A.F., 2003, LINEAR REGRESSION AN, V2nd edn; THOMPSON SG, 1990, J CLIN EPIDEMIOL, V43, P783, DOI 10.1016/0895-4356(90)90238-K; *US PREV SERV TASK, 2003, GUID CLIN PREV SERV; WEISSFELD JL, 1992, J CLIN EPIDEMIOL, V45, P971, DOI 10.1016/0895-4356(92)90113-2; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837	20	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0895-4356	1878-5921		J CLIN EPIDEMIOL	J. Clin. Epidemiol.	AUG	2005	58	8					841	848		10.1016/j.jclinepi.2005.01.009			8	Health Care Sciences & Services; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services; Public, Environmental & Occupational Health	952ML	WOS:000231007500014	16086475				2022-03-04	
J	Montet, X; Eberlin, JL; Bianchi, S; Fasel, J				Montet, X; Eberlin, JL; Bianchi, S; Fasel, J			Assessment of intra-articular volume of the wrist: a comparative study between CT-arthrography and dissection	SURGICAL AND RADIOLOGIC ANATOMY			English	Article						wrist; arthrography; CT-arthrography; anatomy; ligaments	KINEMATICS	The aim of this study was to compare the intra-articular volumes of the wrist's joint measured by CT-arthrography and by dissection on ten cadavers. A good correlation was found between CT-arthrography and dissection in the assessment of the intra-articular volume of both wrist joints. A volume of 1.34 (+/- 0.46) milliliter and 0.97 (+/- 0.32) milliliter were found by Ct-arthrography for the radiocarpal and midcarpal joints, respectively. Dissection of the same wrists gives a volume of 1.24 (+/- 0.33) and 0.90 (+/- 0.21) for the radiocarpal and midcarpal joints, respectively. The knowledge of normal wrist-joint volume is a major prerequisite to evaluate carpal instability without ligaments' tears. We believe that CT-arthrography could be helpful in evaluating patients with suspected carpal instability.	Hop Univ Geneve, Div Radiodiagnost & Radiol Intervent, Unite Imagerie Numer, CH-1211 Geneva, Switzerland; FMH Chirurg Plast Reconstruct & Esthet, CH-2900 Porrentruym, Switzerland; Fdn Grangettes, CH-1224 Chene Bougeries, Switzerland; Ctr Med Univ Geneva, Dept Morphol, Geneva, Switzerland		Montet, X (corresponding author), Hop Univ Geneve, Div Radiodiagnost & Radiol Intervent, Unite Imagerie Numer, 24 Rue Micheli du Crest, CH-1211 Geneva, Switzerland.	xavier.montet@hcuge.ch		Montet, Xavier/0000-0003-2442-5866			FAHRER M, 1980, TRAIE CHIRURGIE MAIN, V1, P166; KAPANJI IA, 1998, MAIN, V4, P417; Klein HM, 2002, ROFO-FORTSCHR RONTG, V174, P177, DOI 10.1055/s-2002-20103; KUHLMANN N, 1977, REV ESPAGNOLA CIRURG, V5, P12; Linkous MD, 1998, RADIOL CLIN N AM, V36, P651, DOI 10.1016/S0033-8389(05)70054-3; Meier R, 2002, Handchir Mikrochir Plast Chir, V34, P381, DOI 10.1055/s-2002-37475; NEWBERG AH, 1985, RADIOLOGY, V155, P605, DOI 10.1148/radiology.155.3.4001360; Sennwald G, 1999, J HAND SURG-AM, V24A, P1344; SENNWALD GR, 1993, J HAND SURG-AM, V18A, P805, DOI 10.1016/0363-5023(93)90046-6; VIEGAS SF, 1993, J HAND SURG-AM, V18A, P463, DOI 10.1016/0363-5023(93)90094-J	10	6	6	0	0	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013 USA	1279-8517			SURG RADIOL ANAT	Surg. Radiol. Anat.	DEC	2005	27	5					444	449		10.1007/s00276-005-0017-4			6	Anatomy & Morphology; Radiology, Nuclear Medicine & Medical Imaging; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anatomy & Morphology; Radiology, Nuclear Medicine & Medical Imaging; Surgery	990EI	WOS:000233725600014	16132197	Green Submitted			2022-03-04	
J	Mclin, VA; Barbe, RP; Wetterwald, R; Belli, DC; Posfay-Barbe, KM				McLin, V. A.; Barbe, R. P.; Wetterwald, R.; Belli, D. C.; Posfay-Barbe, K. M.			PSYCHOMOTOR EVALUATION OF PEDIATRIC LIVER TRANSPLANT RECIPIENTS AND PARENTAL ASSESSMENT BEFORE AND AFTER TRANSPLANTATION	JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION			English	Meeting Abstract									[Barbe, R. P.; Wetterwald, R.; Posfay-Barbe, K. M.] Univ Hosp Geneva, Dept Pediat, Geneva, Switzerland				Posfay-Barbe, Klara M/E-9131-2013; BARBE, Remy P/B-3433-2008; Posfay-Barbe, Klara M./AAV-2515-2021	Posfay-Barbe, Klara M/0000-0001-9464-5704; BARBE, Remy P/0000-0002-1851-1787; Posfay-Barbe, Klara M./0000-0001-9464-5704				0	0	0	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0277-2116			J PEDIATR GASTR NUTR	J. Pediatr. Gastroenterol. Nutr.	JUN	2010	50			2			E33	E34					2	Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics	608AJ	WOS:000278550100067					2022-03-04	
J	Dobrinas, M; Cornuz, J; Pedrido, L; Eap, CB				Dobrinas, Maria; Cornuz, Jacques; Pedrido, Leticia; Eap, Chin B.			Influence of cytochrome P450 oxidoreductase genetic polymorphisms on CYP1A2 activity and inducibility by smoking	PHARMACOGENETICS AND GENOMICS			English	Article						cytochrome P4501A2; cytochrome P450 oxidoreductase; genetic polymorphism; inducibility; POR; smoking	ANTLEY-BIXLER-SYNDROME; P450 OXIDOREDUCTASE; MUTATIONS; STEROIDOGENESIS; METABOLISM; CLOZAPINE; CESSATION; VARIANTS; GENOTYPE; HUMANS	Background Cytochrome P4501A2 (CYP1A2) presents a high interindividual variability in its activity and also in its inducibility by smoking. Cytochrome P450 oxidoreductase (POR) is an electron transfer protein that catalyzes the activity of several cytochromes P450. We aimed to study the influence of POR genetic polymorphisms on CYP1A2 activity while smoking and after smoking cessation, as well as on CYP1A2 inducibility. Methods CYP1A2 activity was determined by the paraxanthine/caffeine ratio in 184 smokers and in 113 of these smokers who were abstinent during a 4-week period. Participants were genotyped for POR rs17148944G > A, rs10239977C > T, rs3815455C > T, rs2286823G > A, rs2302429G > A, and rs1057868C > T (POR*28) polymorphisms. Results While smoking, none of the tested POR polymorphisms showed a significant influence on CYP1A2 activity. After smoking cessation, significantly higher CYP1A2 activity was found in POR rs2302429A carriers (P = 0.038) and in carriers of rs17148944G-rs10239977C-rs3815455T-rs2286823Grs2302429A-rs1057868T haplotype (P = 0.038), whereas carriers of POR rs2286823A (P = 0.031) and of the rs17148944G-rs10239977C-rs3815455C-rs2286823Ars2302429G-rs1057868C haplotype (P = 0.031) had decreased CYP1A2 activity. In the complete regression model, only POR rs2302429G > A showed a significant effect (P = 0.017). No influence of POR genotypes or haplotypes was observed on the inducibility of CYP1A2. Conclusion POR genetic polymorphisms influence CYP1A2 basal but not induced activity and do not seem to influence CYP1A2 inducibility. Future work is warranted to identify other clinical and genetic factors that may explain the variability in CYP1A2 activity and inducibility by smoking. Pharmacogenetics and Genomics 22: 143-151 (C) 2012 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.	[Dobrinas, Maria; Pedrido, Leticia; Eap, Chin B.] Univ Lausanne, Hosp Cery, CHUV, Ctr Psychiat Neurosci,Dept Psychiat,Unit Pharmaco, Prilly, Switzerland; [Cornuz, Jacques] Univ Lausanne, Dept Ambulatory Care & Community Med, Lausanne, Switzerland; [Eap, Chin B.] Univ Lausanne, Univ Geneva, Sch Pharmaceut Sci, Geneva, Switzerland		Eap, CB (corresponding author), Hosp Cery, CHUV, Ctr Psychiat Neurosci, Dept Psychiat,Unit Pharmacogenet & Clin Psychopha, CH-1008 Lausanne, Switzerland.	chin.eap@chuv.ch		Eap, Chin/0000-0002-5439-0230	Swiss Federal Office of Public Health [06.004879]	This work was supported by a grant from the Swiss Federal Office of Public Health (06.004879 to CB Eap).	Agrawal V, 2008, PHARMACOGENET GENOM, V18, P569, DOI 10.1097/FPC.0b013e32830054ac; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 2011, NAT CTR BIOT INF DBS; Bondolfi G, 2005, THER DRUG MONIT, V27, P539, DOI 10.1097/01.ftd.0000164609.14808.93; Carrillo JA, 2003, J CLIN PSYCHOPHARM, V23, P119, DOI 10.1097/00004714-200304000-00003; Dobrinas M, 2011, CLIN PHARMACOL THER, V90, P117, DOI 10.1038/clpt.2011.70; Eap CB, 2004, J CLIN PSYCHOPHARM, V24, P214, DOI 10.1097/01.jcp.0000116646.91923.2f; Faber MS, 2005, BASIC CLIN PHARMACOL, V97, P125, DOI 10.1111/j.1742-7843.2005.pto_973160.x; Fluck CE, 2011, ENDOCR DEV, V20, P63, DOI 10.1159/000321221; Fluck CE, 2010, BIOCHEM BIOPH RES CO, V401, P149, DOI 10.1016/j.bbrc.2010.09.035; FUHR U, 1994, PHARMACOGENETICS, V4, P109, DOI 10.1097/00008571-199406000-00001; Fukami M, 2005, J CLIN ENDOCR METAB, V90, P414, DOI 10.1210/jc.2004-0810; Ghotbi R, 2007, EUR J CLIN PHARMACOL, V63, P537, DOI 10.1007/s00228-007-0288-2; Gomes AM, 2009, PHARMACOGENOMICS, V10, P579, DOI 10.2217/PGS.09.7; Gunes A, 2008, PHARMACOGENOMICS, V9, P625, DOI 10.2217/14622416.9.5.625; Gunes A, 2009, PHARMACOGENOMICS, V10, P769, DOI [10.2217/pgs.09.22, 10.2217/PGS.09.22]; Hart SN, 2008, PHARMACOGENET GENOM, V18, P11, DOI 10.1097/FPC.0b013e3282f2f121; Henderson CJ, 2003, J BIOL CHEM, V278, P13480, DOI 10.1074/jbc.M212087200; Huang N, 2008, P NATL ACAD SCI USA, V105, P1733, DOI 10.1073/pnas.0711621105; Huang NW, 2005, AM J HUM GENET, V76, P729, DOI 10.1086/429417; Hubbard PA, 2001, J BIOL CHEM, V276, P29163, DOI 10.1074/jbc.M101731200; Kroon LA, 2007, AM J HEALTH-SYST PH, V64, P1917, DOI 10.2146/ajhp060414; Masters BSS, 2005, BIOCHEM BIOPH RES CO, V338, P507, DOI 10.1016/j.bbrc.2005.09.165; Miller WL, 2011, MOL CELL ENDOCRINOL, V336, P174, DOI 10.1016/j.mce.2010.10.022; Nakajima M, 1999, J BIOCHEM-TOKYO, V125, P803, DOI 10.1093/oxfordjournals.jbchem.a022352; Oneda B, 2009, PHARMACOGENET GENOM, V19, P877, DOI 10.1097/FPC.0b013e32833225e7; Otto DME, 2003, MOL CELL BIOL, V23, P6103, DOI 10.1128/MCB.23.17.6103-6116.2003; Sachse C, 1999, BRIT J CLIN PHARMACO, V47, P445, DOI 10.1046/j.1365-2125.1999.00898.x; Sandee D, 2010, PHARMACOGENET GENOM, V20, P677, DOI 10.1097/FPC.0b013e32833f4f9b; Shen AL, 2002, J BIOL CHEM, V277, P6536, DOI 10.1074/jbc.M111408200; SPIGSET O, 1995, CLIN PHARMACOL THER, V58, P399, DOI 10.1016/0009-9236(95)90052-7; Zhou SF, 2010, DRUG METAB REV, V42, P268, DOI 10.3109/03602530903286476	32	27	29	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1744-6872	1744-6880		PHARMACOGENET GENOM	Pharmacogenet. Genomics	FEB	2012	22	2					143	151		10.1097/FPC.0b013e32834e9e1a			9	Biotechnology & Applied Microbiology; Genetics & Heredity; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity; Pharmacology & Pharmacy	879DT	WOS:000299310600006	22246422				2022-03-04	
J	Rutschmann, OT; Kossovsky, M; Geissbuhler, A; Perneger, TV; Vermeulen, B; Simon, J; Sarasin, FP				Rutschmann, OT; Kossovsky, M; Geissbuhler, A; Perneger, TV; Vermeulen, B; Simon, J; Sarasin, FP			Interactive triage simulator revealed important variability in both process and outcome of emergency triage	JOURNAL OF CLINICAL EPIDEMIOLOGY			English	Article						computer simulation; emergency service; hospital; process assessment (health care); triage	DEPARTMENT TRIAGE; SEVERITY INDEX; NURSE TRIAGE; RELIABILITY; AGREEMENT; VALIDITY; SCALE	Background and Objectives: (1) to evaluate the performance of emergency department triage; (2) to explore the variability of the triage process: and (3) to examine the reliability of a four-level triage scale, using an interactive triage simulator. Methods: We developed 22 interactive computerized vignettes describing patients presenting at the Emergency Department. Each vignette displayed the presenting complaint and offered the possibility to ask questions and obtain vital signs before deciding on the triage severity rating. The vignettes were rated twice by 45 nurses and 8 physicians. Results: (1) The concordance between the observed triage decision and an expert-attributed emergency level was perfect in 58% of the situations. Triage acuity was overestimated in 11%, and underestimated in 31%. (2) There was a wide variability in the triage process across observers and vignettes. The mean number of questions varied from 1.77 to 18.95 across individuals, and from 3.96 to 11.60 across vignettes. (3) Finally. the test-retest reliability of our instrument was good (weighted kappa = 0.82) but the interrater reliability was moderate (weighted kappa = 0.41). Conclusions: The computerized triage simulator is an innovative tool to evaluate the process and the performance of triage and to evaluate the reliability of a triage instrument. (C) 2006 Elsevier Inc. All rights reserved.	Univ Hosp Geneva, Dept Med, Emergency Med Unit, CH-1211 Geneva 14, Switzerland; Univ Hosp Geneva, Serv Med Informat, Dept Radiol & Med Informat, CH-1211 Geneva, Switzerland; Univ Hosp Geneva, Qual Care Unit, CH-1211 Geneva 14, Switzerland; Univ Hosp Geneva, Ctr Emergency Med, CH-1211 Geneva 14, Switzerland		Rutschmann, OT (corresponding author), Univ Hosp Geneva, Dept Med, Emergency Med Unit, 24 Rue Micheli Crest, CH-1211 Geneva 14, Switzerland.	olivier.rutschmann@hcuge.ch					Australasian College for Emergency Medicine, 2002, Emerg Med (Fremantle), V14, P335; Beveridge R, 1998, J Emerg Med, V16, P507; Beveridge R, 1999, ANN EMERG MED, V34, P155, DOI 10.1016/S0196-0644(99)70223-4; Considine J, 2004, ANN EMERG MED, V44, P516, DOI 10.1016/j.annemergmed.2004.04.007; Cooper RJ, 2004, ANN EMERG MED, V44, P524, DOI 10.1016/j.annemergmed.2004.07.432; Cooper RJ, 2002, ANN EMERG MED, V39, P223, DOI 10.1067/mem.2002.121524; Derlet RW, 2002, ANN EMERG MED, V39, P430, DOI 10.1067/mem.2002.122707; Derlet RW, 2000, ANN EMERG MED, V35, P63, DOI 10.1016/S0196-0644(00)70105-3; Eitel DR, 2003, ACAD EMERG MED, V10, P1070, DOI 10.1197/S1069-6563(03)00350-6; Fernandes CMB, 1999, ANN EMERG MED, V34, P141, DOI 10.1016/S0196-0644(99)70248-9; GEORGE S, 1992, BRIT MED J, V304, P876, DOI 10.1136/bmj.304.6831.876; GEORGE S, 1995, BRIT MED J, V311, P1305, DOI 10.1136/bmj.311.7015.1305a; JELINEK GA, 1996, EMERGEN MED, V8, P226; Mackway-Jones K, 1997, EMERGENCY TRIAGE; MANOS D, 2002, CAN J EMERG MED, V4; Murray Michael, 2004, CJEM, V6, P421; Nakagawa J, 2003, ANN EMERG MED, V41, P191, DOI 10.1067/mem.2003.47; Shapiro MJ, 2000, ANN EMERG MED, V36, P71; Tanabe P, 2004, ACAD EMERG MED, V11, P59, DOI 10.1197/S1069-6563(03)00585-2; Travers Debbie A, 2002, J Emerg Nurs, V28, P395, DOI 10.1067/men.2002.127184; Washington DL, 2000, ANN EMERG MED, V36, P15, DOI 10.1067/mem.2000.107003; Williams RM, 1996, ANN EMERG MED, V27, P506, DOI 10.1016/S0196-0644(96)99999-0; Wuerz R, 1998, ANN EMERG MED, V32, P431, DOI 10.1016/S0196-0644(98)70171-4; Wuerz R, 2001, ACAD EMERG MED, V8, P61; Wuerz RC, 2001, ACAD EMERG MED, V8, P170, DOI 10.1111/j.1553-2712.2001.tb01283.x; Wuerz RC, 2000, ACAD EMERG MED, V7, P236, DOI 10.1111/j.1553-2712.2000.tb01066.x	26	38	39	1	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0895-4356			J CLIN EPIDEMIOL	J. Clin. Epidemiol.	JUN	2006	59	6					615	621		10.1016/j.jclinepi.2005.11.003			7	Health Care Sciences & Services; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services; Public, Environmental & Occupational Health	049CD	WOS:000237992200009	16713524				2022-03-04	
J	Jannot, AS; Ehret, G; Perneger, T				Jannot, Anne-Sophie; Ehret, Georg; Perneger, Thomas			P < 5 x 10(-8) has emerged as a standard of statistical significance for genome-wide association studies	JOURNAL OF CLINICAL EPIDEMIOLOGY			English	Article						Genome-wide association study; Validation studies; Evaluation studies as topic; Significance thresholds; False discovery rate; Multiple testing	REPLICATION	Objectives: In genome-wide association studies (GWASs), the practice regarding the choice of thresholds of significance and of thresholds used to include single nucleotide polymorphisms (SNPs) in a further validation stage is not well known. Here, we performed a systematic analysis of all GWASs published in two recent but nonconsecutive periods to assess whether any consensus was emerging regarding the choice of these thresholds. Study Design and Setting: We identified 167 GWASs published during the first semester of 2011 and 105 published in the third trimester of 2012 and retrieved the genome-wide threshold of significance and the thresholds to include SNPs in a replication stage if applicable. Results: The proportion of studies using 5 x 10(-8) as a genome-wide significance threshold increased between 2011 and 2012(40% vs. 64%, P < 0.001), whereas the proportion of articles that gave a justification for this threshold decreased. The distribution of thresholds used to include SNPs in the replication stage remained stable over time (median 10(-5)), and the variance remained large [interquartile range (10(-6), 10(-4))]. Conclusion: Although 5 x 10(-8) has become the de facto standard genome-wide threshold, practice regarding the choice of inclusion threshold for the replication step remains heterogeneous and did not ensure the best trade-off between power and type 1 error. (C) 2015 Elsevier Inc. All rights reserved.	[Jannot, Anne-Sophie; Perneger, Thomas] Univ Hosp Geneva, Div Clin Epidemiol, CH-1211 Geneva, Switzerland; [Ehret, Georg] Univ Hosp Geneva, Div Cardiol, CH-1211 Geneva, Switzerland		Jannot, AS (corresponding author), Univ Hosp Geneva, Div Clin Epidemiol, Rue Gabrielle Perret Gentil 4, CH-1211 Geneva, Switzerland.	jannot_as@hotmail.com	EHRET, Georg B/A-9532-2009	EHRET, Georg B/0000-0002-5730-0675; Jannot, Anne-Sophie/0000-0002-8001-8539	University Hospitals of Geneva	This work was funded by the University Hospitals of Geneva.	Barsh GS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002812; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cantor RM, 2010, AM J HUM GENET, V86, P6, DOI 10.1016/j.ajhg.2009.11.017; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Cichon S, 2009, AM J PSYCHIAT, V166, P540, DOI 10.1176/appi.ajp.2008.08091354; Dudbridge F, 2008, GENET EPIDEMIOL, V32, P227, DOI 10.1002/gepi.20297; Efron B, 2002, GENET EPIDEMIOL, V23, P70, DOI 10.1002/gepi.1124; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hoggart CJ, 2008, GENET EPIDEMIOL, V32, P179, DOI 10.1002/gepi.20292; Iglesias AI, 2014, J CLIN EPIDEMIOL, V67, P487, DOI 10.1016/j.jclinepi.2013.10.006; Ioannidis JPA, 2010, J CLIN EPIDEMIOL, V63, P945, DOI 10.1016/j.jclinepi.2010.04.002; Ioannidis JPA, 2009, NAT REV GENET, V10, P318, DOI 10.1038/nrg2544; Li A, 2013, INT J OBESITY, V37, P559, DOI 10.1038/ijo.2012.82; Little J, 2009, J CLIN EPIDEMIOL, V62, P597, DOI 10.1016/j.jclinepi.2008.12.004; Panagiotou OA, 2012, INT J EPIDEMIOL, V41, P273, DOI 10.1093/ije/dyr178; Pe'er I, 2008, GENET EPIDEMIOL, V32, P381, DOI 10.1002/gepi.20303; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029	20	34	34	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0895-4356	1878-5921		J CLIN EPIDEMIOL	J. Clin. Epidemiol.	APR	2015	68	4					460	465		10.1016/j.jclinepi.2015.01.001			6	Health Care Sciences & Services; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services; Public, Environmental & Occupational Health	CE9QU	WOS:000352179300014	25666886				2022-03-04	
J	Siebert, JN; Ehrler, F; Gervaix, A; Haddad, K; Lacroix, L; Schrurs, P; Sahin, A; Lovis, C; Manzano, S				Siebert, Johan N.; Ehrler, Frederic; Gervaix, Alain; Haddad, Kevin; Lacroix, Laurence; Schrurs, Philippe; Sahin, Ayhan; Lovis, Christian; Manzano, Sergio			Adherence to AHA Guidelines When Adapted for Augmented Reality Glasses for Assisted Pediatric Cardiopulmonary Resuscitation: A Randomized Controlled Trial	JOURNAL OF MEDICAL INTERNET RESEARCH			English	Article						resuscitation; emergency medicine; pediatrics; biomedical technologies; equipment and supplies; eyeglasses	HEART-ASSOCIATION GUIDELINES; HOSPITAL CARDIAC-ARREST; GOOGLE GLASS; DEFIBRILLATION; OUTCOMES; EPIDEMIOLOGY; TECHNOLOGY; RETENTION; SURVIVAL; IMPROVES	Background: The American Heart Association (AHA) guidelines for cardiopulmonary resuscitation (CPR) are nowadays recognized as the world's most authoritative resuscitation guidelines. Adherence to these guidelines optimizes the management of critically ill patients and increases their chances of survival after cardiac arrest. Despite their availability, suboptimal quality of CPR is still common. Currently, the median hospital survival rate after pediatric in-hospital cardiac arrest is 36%, whereas it falls below 10% for out-of-hospital cardiac arrest. Among emerging information technologies and devices able to support caregivers during resuscitation and increase adherence to AHA guidelines, augmented reality (AR) glasses have not yet been assessed. In order to assess their potential, we adapted AHA Pediatric Advanced Life Support (PALS) guidelines for AR glasses. Objective: The study aimed to determine whether adapting AHA guidelines for AR glasses increased adherence by reducing deviation and time to initiation of critical life-saving maneuvers during pediatric CPR when compared with the use of PALS pocket reference cards. Methods: We conducted a randomized controlled trial with two parallel groups of voluntary pediatric residents, comparing AR glasses to PALS pocket reference cards during a simulation-based pediatric cardiac arrest scenario-pulseless ventricular tachycardia (pVT). The primary outcome was the elapsed time in seconds in each allocation group, from onset of pVT to the first defibrillation attempt. Secondary outcomes were time elapsed to (1) initiation of chest compression, (2) subsequent defibrillation attempts, and (3) administration of drugs, as well as the time intervals between defibrillation attempts and drug doses, shock doses, and number of shocks. All these outcomes were assessed for deviation from AHA guidelines. Results: Twenty residents were randomized into 2 groups. Time to first defibrillation attempt (mean: 146 s) and adherence to AHA guidelines in terms of time to other critical resuscitation endpoints and drug dose delivery were not improved using AR glasses. However, errors and deviations were significantly reduced in terms of defibrillation doses when compared with the use of the PALS pocket reference cards. In a total of 40 defibrillation attempts, residents not wearing AR glasses used wrong doses in 65% (26/40) of cases, including 21 shock overdoses >100 J, for a cumulative defibrillation dose of 18.7 Joules per kg. These errors were reduced by 53% (21/40, P<.001) and cumulative defibrillation dose by 37% (5.14/14, P=.001) with AR glasses. Conclusions: AR glasses did not decrease time to first defibrillation attempt and other critical resuscitation endpoints when compared with PALS pocket cards. However, they improved adherence and performance among residents in terms of administering the defibrillation doses set by AHA.	[Siebert, Johan N.; Gervaix, Alain; Haddad, Kevin; Lacroix, Laurence; Manzano, Sergio] Univ Hosp Geneva, Dept Pediat Emergency Med, Geneva Childrens Hosp, Ave Roseraie 47, CH-1205 Geneva, Switzerland; [Ehrler, Frederic; Lovis, Christian] Univ Hosp Geneva, Dept Radiol & Med Informat, Div Med Informat Sci, Geneva, Switzerland; [Schrurs, Philippe; Sahin, Ayhan] Univ Hosp Geneva, Geneva Med Ctr, Geneva, Switzerland		Siebert, JN (corresponding author), Univ Hosp Geneva, Dept Pediat Emergency Med, Geneva Childrens Hosp, Ave Roseraie 47, CH-1205 Geneva, Switzerland.	Johan.Siebert@hcuge.ch	Lacroix, Laurence/ABF-5052-2021; Lovis, Christian/D-2634-2012; Lovis, Christian/T-5364-2019; Ehrler, Frederic/ABE-8600-2020; Siebert, Johan/ABF-6115-2020; Ehrler, Frederic/S-5156-2016; Manzano, Sergio/ABG-6281-2020	Lacroix, Laurence/0000-0002-6636-3344; Lovis, Christian/0000-0002-2681-8076; Lovis, Christian/0000-0002-2681-8076; Ehrler, Frederic/0000-0001-9734-3242; Siebert, Johan/0000-0002-2871-3382; Ehrler, Frederic/0000-0001-9734-3242; Manzano, Sergio/0000-0001-9603-5520; Gervaix, Alain/0000-0002-8925-5936			[Anonymous], 1986, JAMA, V255, P2905; Atkins DL, 2009, CIRCULATION, V119, P1484, DOI 10.1161/CIRCULATIONAHA.108.802678; Aungst TD, 2015, INT J CLIN PRACT, V69, P1179, DOI 10.1111/ijcp.12688; CDC, 2011, NAT HOSP AMB MED CAR; Chaballout Basil, 2016, JMIR Med Educ, V2, pe2; Chai PR, 2015, JAMA DERMATOL, V151, P794, DOI 10.1001/jamadermatol.2015.0248; Chan PS, 2008, NEW ENGL J MED, V358, P9, DOI 10.1056/NEJMoa0706467; Chang JYC, 2016, SURG INNOV, V23, P422, DOI 10.1177/1553350616646477; Cheng A, 2014, PEDIATRICS, V133, P1091, DOI 10.1542/peds.2013-3267; de Caen AR, 2015, CIRCULATION, V132, pS526, DOI 10.1161/CIR.0000000000000266; Dilley SJ, 2015, TEACH LEARN MED, V27, P71, DOI 10.1080/10401334.2014.979182; Ehrler F, 2016, STUD HEALTH TECHNOL, V224, P141, DOI 10.3233/978-1-61499-653-8-141; Field LC, 2014, RESUSCITATION, V85, P138, DOI 10.1016/j.resuscitation.2013.09.013; Gerein RB, 2006, ACAD EMERG MED, V13, P653, DOI 10.1197/j.aem.2005.12.025; Girotra S, 2012, NEW ENGL J MED, V367, P1912, DOI 10.1056/NEJMoa1109148; Hazinski MF, 2015, CIRCULATION, V132, pS2, DOI 10.1161/CIR.0000000000000270; Hunt EA, 2014, RESUSCITATION, V85, P945, DOI 10.1016/j.resuscitation.2014.02.025; Hunt EA, 2009, RESUSCITATION, V80, P819, DOI 10.1016/j.resuscitation.2009.03.020; Iqbal MH, 2016, INT J SURG, V36, P293, DOI 10.1016/j.ijsu.2016.11.013; Jayaram N, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002122; Jeffers J, 2016, PEDIATR EMERG CARE, V32, P210, DOI 10.1097/PEC.0000000000000765; JSTOR, MIS Q; Kamarainen Antti, 2010, J Emerg Trauma Shock, V3, P273, DOI 10.4103/0974-2700.66531; Kleinman ME, 2010, CIRCULATION, V122, pS876, DOI 10.1161/CIRCULATIONAHA.110.971101; Knudson JD, 2012, CRIT CARE MED, V40, P2940, DOI 10.1097/CCM.0b013e31825feb3f; KUISMA M, 1995, RESUSCITATION, V30, P141, DOI 10.1016/0300-9572(95)00888-Z; Labrosse M, 2015, AM J EMERG MED, V33, P1516, DOI 10.1016/j.ajem.2015.07.049; Liebert CA, 2016, SURG INNOV, V23, P366, DOI 10.1177/1553350616630142; Low D, 2011, ANAESTHESIA, V66, P255, DOI 10.1111/j.1365-2044.2011.06649.x; Matos RI, 2013, CIRCULATION, V127, P442, DOI 10.1161/CIRCULATIONAHA.112.125625; McEvoy MD, 2014, RESUSCITATION, V85, P82, DOI 10.1016/j.resuscitation.2013.09.019; Meaney PA, 2013, CIRCULATION, V128, P417, DOI 10.1161/CIR.0b013e31829d8654; Meaney PA, 2011, PEDIATRICS, V127, pE16, DOI 10.1542/peds.2010-1617; Merchant RM, 2010, ANN EMERG MED, V55, P538, DOI 10.1016/j.annemergmed.2010.01.020; Mitrasinovic S, 2015, TECHNOL HEALTH CARE, V23, P381, DOI 10.3233/THC-150910; Nadkarni VM, 2006, JAMA-J AM MED ASSOC, V295, P50, DOI 10.1001/jama.295.1.50; Ross Joshua C, 2013, J Grad Med Educ, V5, P613, DOI 10.4300/JGME-D-12-00343.1; Samson RA, 2006, NEW ENGL J MED, V354, P2328, DOI 10.1056/NEJMoa052917; Semeraro F, 2013, RESUSCITATION, V84, P501, DOI 10.1016/j.resuscitation.2012.12.006; Sirbaugh PE, 1999, ANN EMERG MED, V33, P174, DOI 10.1016/S0196-0644(99)70391-4; Smith KK, 2008, RESUSCITATION, V78, P59, DOI 10.1016/j.resuscitation.2008.02.007; Stetler J, 2016, INT J CARDIOL, V204, P147, DOI 10.1016/j.ijcard.2015.11.144; Tarantinos K, 2014, AM J EMERG MED, V32, P1143, DOI 10.1016/j.ajem.2014.06.017; Thomas L, 2000, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD000349; Topjian AA, 2008, PEDIATRICS, V122, P1086, DOI 10.1542/peds.2007-3313; Yang CW, 2012, RESUSCITATION, V83, P1055, DOI 10.1016/j.resuscitation.2012.02.027	46	23	23	0	11	JMIR PUBLICATIONS, INC	TORONTO	59 WINNERS CIRCLE, TORONTO, ON M4L 3Y7, CANADA	1438-8871			J MED INTERNET RES	J. Med. Internet Res.	MAY 29	2017	19	5							e183	10.2196/jmir.7379			13	Health Care Sciences & Services; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services; Medical Informatics	VH7US	WOS:000454806500001	28554878	gold, Green Published			2022-03-04	
J	Mhawech, P; Dutguerov, P; Assaly, M; Ares, C; Allal, AS				Mhawech, P; Dutguerov, P; Assaly, M; Ares, C; Allal, AS			EB-D fibronectin expression in squamous cell carcinoma of the head and neck	ORAL ONCOLOGY			English	Article						ED-B fibronectin expression; head and neck squamous cell carcinoma; immunohistochemistry; prognostic value	IN-SITU HYBRIDIZATION; B ONCOFETAL DOMAIN; PROGNOSTIC VALUE; ANGIOGENESIS; MARKER; TUMOR; ISOFORMS; TISSUES; CANCER; HYPOPHARYNX	ED-B fibronectin (ED-B FN), a glycoprotein involved in cell adhesion and migration, is expressed in fetal and neoplastic tissues and absent in their normal counterparts. The aim of this study is to evaluate the expression of this glycoprotein in relation to the histological and clinical data and to determine whether it has a prognostic value in patients with head and neck squamous cell carcinoma (HNSCC). Ninety-five cases were assessed for ED-B FN expression using immunohistochemistry. Positive ED-B FN expression was significantly associated with tumor grade (p = 0.06) and primary tumor site (p = 0.02). The larynx was the tumor site associated with the least ED-B FN expression. In univariate analysis, there was no association with disease-free survival (p = 0.48), but the mean time to progression was clearly shorter in tumors with positive ED-B FN expression than in those with negative expression (6 vs. 11 months). Patients having tumors expressing the ED-B FN had a trend to a significant lower overall survival in the multivariate analysis (p = 0.06). Our study showed that ED-B FN expression might have a prognostic value in patients with HNSCC. (C) 2004 Elsevier Ltd. All rights reserved.	Univ Hosp Geneva, Dept Pathol, CH-1211 Geneva, Switzerland; Univ Hosp Geneva, Div Head & Neck Surg, CH-1211 Geneva, Switzerland; Univ Hosp Geneva, Div Radiat Oncol, CH-1211 Geneva, Switzerland		Mhawech, P (corresponding author), Univ Hosp Geneva, Dept Pathol, CMU Michel Servet 1, CH-1211 Geneva, Switzerland.	pmhawech1@yahoo.com	Dulguerov, Pavel/AAO-2899-2020; Dulguerov, Pavel/I-7325-2015	Dulguerov, Pavel/0000-0001-5863-3933			Allal AS, 1999, HEAD NECK-J SCI SPEC, V21, P217; Allal AS, 1999, INT J RADIAT ONCOL, V45, P41, DOI 10.1016/S0360-3016(99)00138-8; Berndt A, 1998, HISTOCHEM CELL BIOL, V109, P249, DOI 10.1007/s004180050224; Birchler M, 1999, NAT BIOTECHNOL, V17, P984, DOI 10.1038/13679; Birchler MT, 2003, LARYNGOSCOPE, V113, P1231, DOI 10.1097/00005537-200307000-00023; BORSI L, 1992, EXP CELL RES, V199, P98, DOI 10.1016/0014-4827(92)90466-L; CARNEMOLLA B, 1989, J CELL BIOL, V108, P1139, DOI 10.1083/jcb.108.3.1139; CASTELLANI P, 1994, INT J CANCER, V59, P612, DOI 10.1002/ijc.2910590507; Chen WS, 1996, EXP CELL RES, V223, P9, DOI 10.1006/excr.1996.0053; CRISSMAN JD, 1984, CANCER-AM CANCER SOC, V54, P2995, DOI 10.1002/1097-0142(19841215)54:12<2995::AID-CNCR2820541230>3.0.CO;2-R; De Stefani A, 1997, Acta Otorhinolaryngol Ital, V17, P219; HYNES R, 1985, ANNU REV CELL BIOL, V1, P67, DOI 10.1146/annurev.cb.01.110185.000435; INFUSA H, 1995, CANCER, V75, P2802; KACZMAREK J, 1994, INT J CANCER, V59, P11, DOI 10.1002/ijc.2910590104; Khademi B, 2002, CANCER LETT, V184, P223, DOI 10.1016/S0304-3835(02)00242-2; Khan AJ, 2002, CLIN CANCER RES, V8, P540; Kosmehl H, 1999, BRIT J CANCER, V81, P1071, DOI 10.1038/sj.bjc.6690809; Landis SH, 1999, CA-CANCER J CLIN, V49, P8, DOI 10.3322/canjclin.49.1.8; Liu M, 2003, EUR ARCH OTO-RHINO-L, V260, P28, DOI 10.1007/s00405-002-0512-8; Lyons AJ, 2001, BRIT J ORAL MAX SURG, V39, P471, DOI 10.1054/bjom.2001.0702; MANDEL U, 1994, APMIS, V102, P695, DOI 10.1111/j.1699-0463.1994.tb05222.x; Midulla M, 2000, CANCER RES, V60, P164; Nilsson F, 2001, CANCER RES, V61, P711; PERA E, 1986, CANCER, V58, P928, DOI 10.1002/1097-0142(19860815)58:4<928::AID-CNCR2820580421>3.0.CO;2-J; Pujuguet P, 1996, AM J PATHOL, V148, P579; RUOSLAHTI E, 1988, ANNU REV BIOCHEM, V57, P375, DOI 10.1146/annurev.bi.57.070188.002111; Santimaria M, 2003, CLIN CANCER RES, V9, P571; WIERNIK G, 1991, HISTOPATHOLOGY, V19, P411, DOI 10.1111/j.1365-2559.1991.tb00230.x	28	28	29	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1368-8375			ORAL ONCOL	Oral Oncol.	JAN	2005	41	1					82	88		10.1016/j.oraloncology.2004.07.003			7	Oncology; Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Dentistry, Oral Surgery & Medicine	894RA	WOS:000226808100012	15598590	Green Published			2022-03-04	
J	Suppan, M; Catho, G; Nunes, TR; Sauvan, V; Perez, M; Graf, C; Pittet, D; Harbarth, S; Abbas, M; Suppan, L				Suppan, Melanie; Catho, Gaud; Nunes, Tomas Robalo; Sauvan, Valerie; Perez, Monique; Graf, Christophe; Pittet, Didier; Harbarth, Stephan; Abbas, Mohamed; Suppan, Laurent			A Serious Game Designed to Promote Safe Behaviors Among Health Care Workers During the COVID-19 Pandemic: Development of "Escape COVID-19"	JMIR SERIOUS GAMES			English	Article						COVID-19; transmission; serious games; infection prevention; health care workers; SARS-COV-2; infectious disease; safety; behavior; hospital	TRANSMISSION	Background: As many countries fear and even experience the emergence of a second wave of COVID-19, reminding health care workers (HCWs) and other hospital employees of the critical role they play in preventing SARS-CoV-2 transmission is more important than ever. Building and strengthening the intrinsic motivation of HCWs to apply infection prevention and control (IPC) guidelines to avoid contaminating their colleagues, patients, friends, and relatives is a goal that must be energetically pursued. A high rate of nosocomial infections during the first COVID-19 wave was detected by IPC specialists and further cemented their belief in the need for an engaging intervention that could improve compliance with COVID-19 safe behaviors. Objective: Our aim was to develop a serious game that would promote IPC practices with a specific focus on COVID-19 among HCWs and other hospital employees. Methods: The first 3 stages of the SERES framework were used to develop this serious game. A brainswarming session between developers and IPC specialists was used to identify the target audience and acquisition objectives. Nicholson's RECIPE mnemonic (reflection, engagement, choice, information, play, exposition) for meaningful gamification was used to guide the general design. A common and simple terminology was used to suit the broad target audience. The game was tested on various platforms (smartphones, tablets, laptops, desktop computers) by different users during each development loop and before its final release. Results: The game was designed to target all hospital staff who could be in direct contact with patients within the Geneva University Hospitals. In total, 10 acquisition objectives were defined by IPC specialists and implemented into the game according to the principles of meaningful gamification. A simple storyboard was first created using Microsoft PowerPoint and was progressively refined through multiple iteration loops. Articulate Storyline was then used to create two successive versions of the actual game. In the final version, a unique graphic atmosphere was created with help from a professional graphic designer. Feedback mechanisms were used extensively throughout the game to strengthen key IPC messages. Conclusions: The SERES framework was successfully used to create "Escape COVID-19," a serious game designed to promote safe IPC practices among HCWs and other hospital employees during the COVID-19 pandemic. This game can be obtained free of charge for research and educational purposes. A SCORM (shareable content object reference model) package is available to facilitate results and completion tracking on most current learning management systems.	[Suppan, Melanie] Univ Geneva Hosp, Dept Anesthesiol Clin Pharmacol Intens Care & Eme, Div Anesthesiol, Rue Gabrielle Perret Gentil 4, CH-1211 Geneva, Switzerland; [Suppan, Melanie; Catho, Gaud; Nunes, Tomas Robalo; Sauvan, Valerie; Perez, Monique; Pittet, Didier; Harbarth, Stephan; Abbas, Mohamed] Fac Med, Rue Gabrielle Perret Gentil 4, CH-1211 Geneva, Switzerland; [Catho, Gaud; Nunes, Tomas Robalo; Sauvan, Valerie; Pittet, Didier; Harbarth, Stephan; Abbas, Mohamed] Univ Geneva Hosp, WHO Collaborating Ctr Patient Safety, Infect Control Program, Geneva, Switzerland; [Nunes, Tomas Robalo] Hosp Garcia Orta, EPE, Infectious Dis Dept, Almada, Portugal; [Graf, Christophe] Geneva Univ Hosp, Dept Rehabil & Geriatr, Geneva, Switzerland; [Suppan, Laurent] Univ Geneva Hosp, Dept Anesthesiol Clin Pharmacol Intens Care & Eme, Div Emergency Med, Geneva, Switzerland		Suppan, M (corresponding author), Univ Geneva Hosp, Dept Anesthesiol Clin Pharmacol Intens Care & Eme, Div Anesthesiol, Rue Gabrielle Perret Gentil 4, CH-1211 Geneva, Switzerland.; Suppan, M (corresponding author), Fac Med, Rue Gabrielle Perret Gentil 4, CH-1211 Geneva, Switzerland.	melanie.bochet@hcuge.ch	Abbas, Mohamed/M-1724-2019; Suppan, Melanie/AAZ-8097-2020; Suppan, Laurent/AAU-1562-2020	Abbas, Mohamed/0000-0002-7265-1887; Suppan, Melanie/0000-0002-8807-9619; Suppan, Laurent/0000-0001-6989-6421; Graf, Christophe/0000-0002-0235-5046; CATHO, Gaud/0000-0002-4948-0944; Harbarth, Stephan/0000-0002-3551-1025; Robalo Nunes/0000-0001-8780-7760			Ahmed W, 2020, J MED INTERNET RES, V22, DOI 10.2196/22374; Ali KF, 2020, J MED INTERNET RES, V22, DOI 10.2196/19913; [Anonymous], 2020, COR REC PROF SANT HO; [Anonymous], 2020, ESCAPE COVID 19 SERI; [Anonymous], 2020, NOUV COR INF PROF SA; [Anonymous], 2020, ENV SCI POLLUT RES I; Arnab S, 2015, BRIT J EDUC TECHNOL, V46, P391, DOI 10.1111/bjet.12113; Arons MM, 2020, NEW ENGL J MED, V382, P2081, DOI 10.1056/NEJMoa2008457; Bartsch SM, 2020, HEALTH AFFAIR, V39, P927, DOI 10.1377/hlthaff.2020.00426; Barycka K, 2021, AM J EMERG MED, V46, P751, DOI 10.1016/j.ajem.2020.09.055; Bhagavathula Akshaya Srikanth, 2020, JMIR Public Health Surveill, V6, pe19160, DOI 10.2196/19160; BrainSwarming McCaffrey T., 2014, BRAINSWARMING BRAINS; Casanova L, 2008, EMERG INFECT DIS, V14, P1291, DOI 10.3201/eid1408.080085; Caserman P, 2020, JMIR SERIOUS GAMES, V8, DOI 10.2196/19037; Chou R, 2020, ANN INTERN MED, V173, P120, DOI 10.7326/M20-1632; Cook DA, 2010, ACAD MED, V85, P909, DOI 10.1097/ACM.0b013e3181d6c319; Coronavirus Resource Center, 2020, J HOPK U MED; Csikszentmihalyi M., 1997, FINDING FLOW; Danis K, 2020, EUROSURVEILLANCE, V25, P14, DOI 10.2807/1560-7917.ES.2020.25.22.2000956; Davids MR, 2013, ADV PHYSIOL EDUC, V37, P242, DOI 10.1152/advan.00043.2013; Deci E. L., 2002, HDB SELF DETERMINATI; Drummond David, 2017, Adv Simul (Lond), V2, P3, DOI 10.1186/s41077-017-0036-3; Fagan JJ, 2020, SAMJ S AFR MED J, V110, P335, DOI [10.7196/SAMJ.2020.v110i5.14774, 10.7196/samj.2020.v110i5.14774]; Fouh E, 2014, COMPUT HUM BEHAV, V41, P478, DOI 10.1016/j.chb.2014.09.061; Freeman D, 2022, PSYCHOL MED, V52, P251, DOI 10.1017/S0033291720001890; Gentry SV, 2019, J MED INTERNET RES, V21, DOI 10.2196/12994; Gesser-Edelsburg A, 2020, ANTIMICROB RESIST IN, V9, DOI 10.1186/s13756-020-00812-8; Godlee F, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1324; Guo CY, 2020, BASIC CLIN PHARMACOL, V127, P6; Hassanian-Moghaddam H, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02938-y; Houghton C, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013582; Iacobucci G, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m3806; Kaxiras E, 2020, J MED INTERNET RES, V22, DOI 10.2196/20912; Kohn A., 1993, TROUBLE GOLD STARS I; Koka A, 2020, J MED INTERNET RES, V22, DOI 10.2196/18358; Kopp V, 2008, MED EDUC, V42, P823, DOI 10.1111/j.1365-2923.2008.03122.x; Lapolla P, 2021, INFECT CONT HOSP EP, V42, P364, DOI 10.1017/ice.2020.241; Latimier A, 2019, NPJ SCI LEARN, V4, DOI 10.1038/s41539-019-0053-1; Li X, 2020, CURR OPIN HIV AIDS, V15, P328, DOI 10.1097/COH.0000000000000650; Maqbool A, 2020, DIABETES METAB SYND, V14, P887, DOI 10.1016/j.dsx.2020.06.024; McMichael TM, 2020, NEW ENGL J MED, V382, P2005, DOI 10.1056/NEJMoa2005412; Payne HE, 2015, JMIR SERIOUS GAMES, V3, DOI 10.2196/games.4187; Raina S, 2016, IEEE INTERNATIONAL CONFERENCE ON INTELLIGENCE AND SECURITY INFORMATICS: CYBERSECURITY AND BIG DATA, P261, DOI 10.1109/ISI.2016.7745486; Ravyse WS, 2017, VIRTUAL REAL-LONDON, V21, P31, DOI 10.1007/s10055-016-0298-4; Remtulla Ridhaa, 2020, JMIR Med Educ, V6, pe20190, DOI 10.2196/20190; Rhee C, 2020, INFECT CONT HOSP EP, V41, P1323, DOI 10.1017/ice.2020.211; Roxby AC, 2020, JAMA INTERN MED, V180, P1101, DOI 10.1001/jamainternmed.2020.2233; Sharma SK, 2020, J EDUC HEALTH PROMOT, V9, DOI 10.4103/jehp.jehp_533_20; Snodgrass JG, 2011, CULT MED PSYCHIAT, V35, P26, DOI 10.1007/s11013-010-9197-4; Sommerstein R, 2020, ANTIMICROB RESIST IN, V9, DOI 10.1186/s13756-020-00763-0; Stock AD, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00471; Suppan L, 2020, ANTIMICROB RESIST IN, V9, DOI 10.1186/s13756-020-00849-9; Suppan L, 2020, J MED INTERNET RES, V22, DOI 10.2196/21265; Suppan M, 2020, JMIR SERIOUS GAMES, V8, DOI 10.2196/20173; Szczerbinska K, 2020, EUR GERIATR MED, V11, P639, DOI 10.1007/s41999-020-00362-7; Tan JW, 2019, JMIR SERIOUS GAMES, V7, DOI 10.2196/14620; Tian WJ, 2020, J MED VIROL, V92, P1875, DOI 10.1002/jmv.26050; Verschueren S, 2019, JMIR SERIOUS GAMES, V7, DOI 10.2196/12429; Verschueren S, 2019, JMIR SERIOUS GAMES, V7, DOI 10.2196/11565; Wheeler S., 2012, ENCY SCI LEARNING, P1109; Wood L, 2014, GAMIFICATION ED BUSI, P1, DOI [10.1007/978-3-319-10208-5_1, DOI 10.1007/978-3-319-10208-5]; Xiao J, 2020, J INFECT PUBLIC HEAL, V13, P843, DOI 10.1016/j.jiph.2020.05.019; Xu SQ, 2020, LANCET, V395, P1321, DOI 10.1016/S0140-6736(20)30845-X; Yin Guosheng, 2020, JMIR Public Health Surveill, V6, pe19464, DOI 10.2196/19464; Zhang ZR, 2020, FRONT MED-PRC, V14, P229, DOI 10.1007/s11684-020-0765-x; Zhao JJ, 2020, CLIN INFECT DIS, V71, P2027, DOI 10.1093/cid/ciaa344; Zheng C, 2020, J HOSP INFECT, V106, P325, DOI 10.1016/j.jhin.2020.07.025	67	7	7	7	8	JMIR PUBLICATIONS, INC	TORONTO	130 QUEENS QUAY E, STE 1102, TORONTO, ON M5A 0P6, CANADA	2291-9279			JMIR SERIOUS GAMES	JMIR Serious Games	OCT-DEC	2020	8	4							e24986	10.2196/24986			19	Health Care Sciences & Services; Public, Environmental & Occupational Health; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health; Medical Informatics	QX1VF	WOS:000629136000004	33242312	Green Published, gold			2022-03-04	
J	Kuffer, R; Lombardi, T				Kuffer, R; Lombardi, T			In reply to: When is an oral leukoplakia malignant	ORAL ONCOLOGY			English	Letter									Univ Geneva, Fac Med, Div Stomatol, Lab Oral Histopathol, CH-1211 Geneva 4, Switzerland		Kuffer, R (corresponding author), Univ Geneva, Fac Med, Div Stomatol, Lab Oral Histopathol, 19 Rue Barthelemy Menn, CH-1211 Geneva 4, Switzerland.							0	0	0	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0964-1955			ORAL ONCOL	Oral Oncol.	DEC	2002	38	8					811	812	PII S1368-8375(02)00024-6	10.1016/S1368-8375(02)00024-6			2	Oncology; Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Dentistry, Oral Surgery & Medicine	611XX	WOS:000179044100015					2022-03-04	
J	Seppey, M; Manni, M; Zdobnov, EM				Seppey, Mathieu; Manni, Mose; Zdobnov, Evgeny M.			LEMMI: a continuous benchmarking platform for metagenomics classifiers	GENOME RESEARCH			English	Article							CLASSIFICATION	Studies of microbiomes are booming, along with the diversity of computational approaches to make sense out of the sequencing data and the volumes of accumulated microbial genotypes. A swift evaluation of newly published methods and their improvements against established tools is necessary to reduce the time between the methods' release and their adoption in microbiome analyses. The LEMMI platform offers a novel approach for benchmarking software dedicated to metagenome composition assessments based on read classification. It enables the integration of newly published methods in an independent and centralized benchmark designed to be continuously open to new submissions. This allows developers to be proactive regarding comparative evaluations and guarantees that any promising methods can be assessed side by side with established tools quickly after their release. Moreover, LEMMI enforces an effective distribution through software containers to ensure long-term availability of all methods. Here, we detail the LEMMI workflow and discuss the performances of some previously unevaluated tools. We see this platform eventually as a community-driven effort in which method developers can showcase novel approaches and get unbiased benchmarks for publications, and users can make informed choices and obtain standardized and easy-to-use tools.	[Seppey, Mathieu; Manni, Mose; Zdobnov, Evgeny M.] Univ Geneva, Dept Genet Med & Dev, Med Sch, CH-1211 Geneva, Switzerland; [Seppey, Mathieu; Manni, Mose; Zdobnov, Evgeny M.] Swiss Inst Bioinformat, CH-1211 Geneva, Switzerland		Zdobnov, EM (corresponding author), Univ Geneva, Dept Genet Med & Dev, Med Sch, CH-1211 Geneva, Switzerland.	evgeny.zdobnov@unige.ch	Zdobnov, Evgeny/AAB-2745-2022	Zdobnov, Evgeny/0000-0002-5178-1498; Seppey, Mathieu/0000-0003-3248-011X	Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission [31003A_ 166483, 310030_189062]	We thank all members of the Zdobnov group for discussions and feedback and Maxime Arbez for his help. This work was supported by the Swiss National Science Foundation funding 31003A_ 166483 and 310030_189062 to E.M.Z.	Belmann P, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0087-0; Bokulich NA, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00062-16; Bremges A, 2018, MSYSTEMS, V3, DOI 10.1128/mSystems.00103-18; Capella-Gutierrez S, 2017, 181677 BIORXIV, V49, DOI [10.1101/181677, DOI 10.1101/181677]; Federhen S, 2012, NUCLEIC ACIDS RES, V40, pD136, DOI 10.1093/nar/gkr1178; Gardner PP, 2019, PEERJ, V7, DOI 10.7717/peerj.6160; Huerta-Cepas J, 2016, MOL BIOL EVOL, V33, P1635, DOI 10.1093/molbev/msw046; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Johnson S, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S9-S14; Keegan KP, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002541; Kim D, 2016, GENOME RES, V26, P1721, DOI 10.1101/gr.210641.116; Koster J, 2012, BIOINFORMATICS, V28, P2520, DOI 10.1093/bioinformatics/bts480; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Leprevost FD, 2017, BIOINFORMATICS, V33, P2580, DOI 10.1093/bioinformatics/btx192; Lindgreen S, 2016, SCI REP-UK, V6, DOI 10.1038/srep19233; Lu J, 2017, PEERJ COMPUT SCI, DOI 10.7717/peerj-cs.104; Maier-Hein L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07619-7; Mangul S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09406-4; Mangul S, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1649-8; Marcais G, 2011, BIOINFORMATICS, V27, P764, DOI 10.1093/bioinformatics/btr011; Marcelino VR, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-02014-2; McIntyre ABR, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1299-7; McKinney W., 2010, P 9 PYTH SCI C AUST, V445, P51, DOI 10.25080/majora-92bf1922-00a; Menzel P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11257; Meyer F, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1646-y; Meyer F, 2018, GIGASCIENCE, V7, DOI 10.1093/gigascience/giy069; Muller A, 2017, BIOINFORMATICS, V33, P3740, DOI 10.1093/bioinformatics/btx520; Nasko DJ, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1554-6; Norel R, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.70; O'Leary NA, 2016, NUCLEIC ACIDS RES, V44, pD733, DOI 10.1093/nar/gkv1189; Oliphant Travis E, 2015, GUIDE NUMPY, Vsecond; Paez-Espino D, 2019, NUCLEIC ACIDS RES, V47, pD678, DOI 10.1093/nar/gky1127; Parks DH, 2020, NAT BIOTECHNOL, V38, P1079, DOI 10.1038/s41587-020-0501-8; Parks DH, 2018, NAT BIOTECHNOL, V36, P996, DOI 10.1038/nbt.4229; Peabody MA, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0788-5; Piro VC, 2020, BIOINFORMATICS, V36, P12, DOI 10.1093/bioinformatics/btaa458; Sczyrba A, 2017, NAT METHODS, V14, P1063, DOI [10.1038/NMETH.4458, 10.1038/nmeth.4458]; Truong DT, 2015, NAT METHODS, V12, P902, DOI 10.1038/nmeth.3589; Wood DE, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1891-0; Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46; Ye SH, 2019, CELL, V178, P779, DOI 10.1016/j.cell.2019.07.010	41	4	4	2	2	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	AUG	2020	30	8					1208	1216		10.1101/gr.260398.119			9	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	NU2QN	WOS:000573487300003	32616517	Green Accepted, Green Published, hybrid			2022-03-04	
J	Etter, JF				Etter, JF			Comparing the efficacy of two Internet-based, computer-tailored smoking cessation programs: A randomized trial	JOURNAL OF MEDICAL INTERNET RESEARCH			English	Article						tobacco dependence; Internet; randomized controlled trials; smoking cessation; behaviour change	INTERVENTION; SMOKERS; VALIDATION; PEOPLE; INFORMATION; DEPENDENCE; COTININE; RATES; QUIT	Background: Online computer-tailored smoking cessation programs have not yet been compared directly. Objective: To compare the efficacy of two Internet-based, computer-tailored smoking cessation programs. Methods: Randomized controlled trial conducted in 2003-2004. Visitors to a smoking cessation website were randomly assigned to either an original online, interactive smoking cessation program or to a modified program. Both programs consisted of tailored, personalized counseling letters based on participants' characteristics, followed by monthly email reminders. The original program was based on psychological and addiction theory, and on preliminary research conducted in the same population. The modified program was shorter and contained more information on nicotine replacement therapy and nicotine dependence, and less information on health risks and coping strategies. In both programs, 1 month and 2 months after entering the study, participants were invited by email to answer the same tailoring questionnaire again in order to receive a second counseling letter. Participants in both programs obtained, on average, 1.2 feedback counseling letters over 2.5 months, and 84% received only 1 feedback letter. The outcome was self-reported smoking abstinence (no puff of tobacco in the previous 7 days), assessed 2.5 months after entry in the program. We report results from intention-to-treat (ITT) analyses, where all non-respondents at follow-up were counted as smokers. Results: The baseline questionnaire was answered by a total of 11969 current (74%) and former (26%) smokers, and the follow-up survey by 4237 people (35%). In an ITT analysis, abstinence rates in baseline current smokers were respectively 10.9% and 8.9% (odds ratio [OR]=1.24, 95% confidence interval [CI]1.08-1.43, P=.003) in the original and modified programs, and 25.2% and 15.7% (OR=1.81, CI 1.51-2.16, P < .001) in baseline former smokers. While we found statistically significant differences in quit rates in smokers in the contemplation stage favoring the original program (OR=1.54, CI 1.18-2.02, P=.002), no between-group differences in quit rates were observed in smokers in the precontemplation (OR=1.07, CI 0.36-3.14, P=.91) and preparation (OR=1.15, CI 0.97-1.37,P=.10) stages of change. Conclusions: In smokers in the contemplation stage of change and in former smokers, the original program produced higher smoking abstinence rates than the modified program.	Univ Geneva, CMU, Inst Social & Prevent Med, CH-1211 Geneva, Switzerland		Etter, JF (corresponding author), Univ Geneva, CMU, Inst Social & Prevent Med, 1 Rue Michel Servet, CH-1211 Geneva, Switzerland.	jean-francois.etter@imsp.unige.ch		Graham, Amanda/0000-0003-3036-9653; ETTER, Jean-Francois/0000-0002-1426-3157	NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01 CA104836, P50 CA84719, 1 R01 CA10483-01A1, P50 CA084719, R01 CA104836-02] Funding Source: Medline		Anderson JE, 2002, CHEST, V121, P932, DOI 10.1378/chest.121.3.932; Aveyard P, 1999, BRIT MED J, V319, P948, DOI 10.1136/bmj.319.7215.948; BENOWITZ NL, 1992, MED CLIN N AM, V76, P415, DOI 10.1016/S0025-7125(16)30360-1; Blondal T, 1999, BRIT MED J, V318, P285, DOI 10.1136/bmj.318.7179.285; Bock BC, 2004, NICOTINE TOB RES, V6, P207, DOI 10.1080/14622200410001676332; Brug J, 1996, PREV MED, V25, P236, DOI 10.1006/pmed.1996.0052; Cook C, 2000, EDUC PSYCHOL MEAS, V60, P821, DOI 10.1177/00131640021970934; de Vries H, 1999, PATIENT EDUC COUNS, V36, P99; Dijkstra A, 1998, HEALTH PSYCHOL, V17, P513, DOI 10.1037/0278-6133.17.6.513; Etter JF, 2004, J EPIDEMIOL COMMUN H, V58, P849, DOI 10.1136/jech.2003.017103; Etter JF, 2000, ADDICTION, V95, P613, DOI 10.1046/j.1360-0443.2000.95461312.x; Etter JF, 1997, PREV MED, V26, P580, DOI 10.1006/pmed.1997.0179; Etter JF, 1998, AM J EPIDEMIOL, V147, P141; Etter JF, 1999, ADDICTION, V94, P269, DOI 10.1046/j.1360-0443.1999.94226910.x; Etter JF, 2000, AM J EPIDEMIOL, V151, P251; Etter JF, 2002, RESPIRATION, V69, P111, DOI 10.1159/000056311; Etter JF, 2001, ARCH INTERN MED, V161, P2596, DOI 10.1001/archinte.161.21.2596; Etter JF, 2000, ADDICTION, V95, P901, DOI 10.1046/j.1360-0443.2000.9569017.x; Etter JF, 2000, ADDICT BEHAV, V25, P523, DOI 10.1016/S0306-4603(00)00068-X; Fiore MC, 1996, JAMA-J AM MED ASSOC, V275, P1270, DOI 10.1001/jama.1996.03530400058039; Fishbein M, 1980, UNDERSTANDING ATTITU; GLASGOW RE, 1993, ADDICT BEHAV, V18, P511, DOI 10.1016/0306-4603(93)90068-K; Lancaster T, 2000, BRIT MED J, V321, P355, DOI 10.1136/bmj.321.7257.355; LANCASTER T, 2002, COCHRANE DB SYST REV, V3; Lenert L, 2004, J AM MED INFORM ASSN, V11, P235, DOI 10.1197/jamia.M1464; Marlatt GA, 1985, RELAPSE PREVENTION M; MURRAY RP, 1993, AM J PUBLIC HEALTH, V83, P1251, DOI 10.2105/AJPH.83.9.1251; PROCHASKA JO, 1993, HEALTH PSYCHOL, V12, P399, DOI 10.1037/0278-6133.12.5.399; PROCHASKA JO, 1992, AM PSYCHOL, V47, P1102, DOI 10.1037/0003-066X.47.9.1102; SCHNEIDER SJ, 1990, COMPUT HUM BEHAV, V6, P141, DOI 10.1016/0747-5632(90)90002-X; SRNT Subcommittee on Biochemical Verification, 2002, Nicotine Tob Res, V4, P149, DOI 10.1080/14622200210123581; STRECHER V, 2004, P 6 ANN C SOC RES NI; Strecher VJ, 1999, PATIENT EDUC COUNS, V36, P107, DOI 10.1016/S0738-3991(98)00128-1; VELICER WF, 1992, PSYCHOL BULL, V111, P23, DOI 10.1037/0033-2909.111.1.23; Wang J, 2004, PREV MED, V39, P962, DOI 10.1016/j.ypmed.2004.03.038; 2005, CA CANC J CLIN, V55, P6	36	182	185	0	16	JMIR PUBLICATIONS, INC	TORONTO	130 QUEENS QUAY E, STE 1102, TORONTO, ON M5A 0P6, CANADA	1438-8871			J MED INTERNET RES	J. Med. Internet Res.	JAN-MAR	2005	7	1							e2	10.2196/jmir.7.1.e2			10	Health Care Sciences & Services; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Medical Informatics	907DC	WOS:000227694500002	15998617	Green Published, gold			2022-03-04	
J	Powell, JE; Henders, AK; McRae, AF; Wright, MJ; Martin, NG; Dermitzakis, ET; Montgomery, GW; Visscher, PM				Powell, Joseph E.; Henders, Anjali K.; McRae, Allan F.; Wright, Margaret J.; Martin, Nicholas G.; Dermitzakis, Emmanouil T.; Montgomery, Grant W.; Visscher, Peter M.			Genetic control of gene expression in whole blood and lymphoblastoid cell lines is largely independent	GENOME RESEARCH			English	Article							QUANTITATIVE TRAIT LOCI; GENOME-WIDE ASSOCIATION; NORMAL HUMAN TISSUES; HOUSEKEEPING GENES; CDNA MICROARRAY; DISEASE; HERITABILITY; PROFILES; NORMALIZATION; ARCHITECTURE	The degree to which the level of genetic variation for gene expression is shared across multiple tissues has important implications for research investigating the role of expression on the etiology of complex human traits and diseases. In the last few years, several studies have been published reporting the extent of overlap in expression quantitative trait loci (eQTL) identified in multiple tissues or cell types. Although these studies provide important information on the regulatory control of genes across tissues, their limited power means that they can typically only explain a small proportion of genetic variation for gene expression. Here, using expression data from monozygotic twins (MZ), we investigate the genetic control of gene expression in lymphoblastoid cell lines (LCL) and whole blood (WB). We estimate the genetic correlation that represents the combined effects of all causal loci across the whole genome and is a measure of the level of common genetic control of gene expression between the two RNA sources. Our results show that, when averaged across the genome, mean levels of genetic correlation for gene expression in LCL and WB samples are close to zero. We support our results with evidence from gene expression in an independent sample of LCL, T-cells, and fibroblasts. In addition, we provide evidence that housekeeping genes, which maintain basic cellular functions, are more likely to have high genetic correlations between the RNA sources than non-housekeeping genes, implying a relationship between the transcript function and the degree to which a gene has tissue-specific genetic regulatory control.	[Powell, Joseph E.; Henders, Anjali K.; McRae, Allan F.; Wright, Margaret J.; Martin, Nicholas G.; Montgomery, Grant W.; Visscher, Peter M.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Dermitzakis, Emmanouil T.] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland		Powell, JE (corresponding author), Queensland Inst Med Res, Brisbane, Qld 4006, Australia.	joseph.powell@qimr.edu.au	Visscher, Peter/ABB-6151-2020; Wright, Margaret J/H-3308-2014; Dermitzakis, Emmanouil/B-7687-2013; Martin, Nicholas/R-9235-2019; McRae, Allan F/J-2644-2014; Powell, Joseph/G-3027-2014; Montgomery, Grant W/B-7148-2008; Wright, Margaret Jane/A-4560-2016; Henders, Anjali/E-3126-2017	Visscher, Peter/0000-0002-2143-8760; Martin, Nicholas/0000-0003-4069-8020; McRae, Allan F/0000-0001-5286-5485; Powell, Joseph/0000-0001-9031-6356; Montgomery, Grant W/0000-0002-4140-8139; Wright, Margaret Jane/0000-0001-7133-4970; Henders, Anjali/0000-0003-3672-1451	Australian National Health and Medical Research Council (NHMRC)National Health and Medical Research Council of Australia [241944, 339462, 389927, 389875, 389891, 389892, 389938, 442915, 442981, 496739, 552485, 552498, 496667, 613601]; Australian Research CouncilAustralian Research Council [A7960034, A79906588, A79801419, DP0770096, DP0212016, DP0343921]; Louis-Jeantet Foundation	We gratefully acknowledge the participation of the individuals sampled in this work. We acknowledge funding by Australian National Health and Medical Research Council (NHMRC) grants 241944, 339462, 389927, 389875, 389891, 389892, 389938, 442915, 442981, 496739, 552485, and 552498, and Australian Research Council grants A7960034, A79906588, A79801419, DP0770096, DP0212016, and DP0343921 for building and maintaining the adolescent twin family resource through which samples were collected. We thank Anthony Caracella, Megan Campbell, Kalpana Patel, and Sara Smith for their technical assistance with the microarray hybridizations; and Alison Mackenzie, Marlene Grace, and Ann Eldridge for data collection. This research was supported by NHMRC grants 389892, 496667, and 613601. ARM., G.W.M., and P.M.V. are supported by the NHMRC Fellowship Scheme. E.T.D. acknowledges funds from the Louis-Jeantet Foundation. We thank Mike Goddard for helpful comments on the manuscript.	Alba MM, 2005, MOL BIOL EVOL, V22, P598, DOI 10.1093/molbev/msi045; Altschuler SJ, 2010, CELL, V141, P559, DOI 10.1016/j.cell.2010.04.033; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bullaughey K, 2009, HUM MOL GENET, V18, P4296, DOI 10.1093/hmg/ddp382; Butte AJ, 2001, PHYSIOL GENOMICS, V7, P95, DOI 10.1152/physiolgenomics.2001.7.2.95; Caliskan M, 2011, HUM MOL GENET, V20, P1643, DOI 10.1093/hmg/ddr041; Carter KL, 2002, J VIROL, V76, P10427, DOI 10.1128/JVI.76.20.10427-10436.2002; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; Cheung VG, 2003, NAT GENET, V33, P422, DOI 10.1038/ng1094; Cheung VG, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000480; Cheung VG, 2009, NAT REV GENET, V10, P595, DOI 10.1038/nrg2630; CHEVERUD JM, 1988, EVOLUTION, V42, P958, DOI 10.1111/j.1558-5646.1988.tb02514.x; Choy E, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000287; Cookson W, 2009, NAT REV GENET, V10, P184, DOI 10.1038/nrg2537; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Ding J, 2010, AM J HUM GENET, V87, P779, DOI 10.1016/j.ajhg.2010.10.024; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Duan S, 2008, AM J HUM GENET, V82, P1101, DOI 10.1016/j.ajhg.2008.03.006; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Farre D, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r140; Gilad Y, 2008, TRENDS GENET, V24, P408, DOI 10.1016/j.tig.2008.06.001; Gilmour AR, 1995, BIOMETRICS, V51, P1440, DOI 10.2307/2533274; Gilmour AR, 2007, ASREML USER GUIDE; Goring HHH, 2007, NAT GENET, V39, P1208, DOI 10.1038/ng2119; Heinzen EL, 2008, PLOS BIOL, V6, P2869, DOI 10.1371/journal.pbio.1000001; Hill WG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000008; Hubner N, 2005, NAT GENET, V37, P243, DOI 10.1038/ng1522; Idaghdour Y, 2010, NAT GENET, V42, P62, DOI 10.1038/ng.495; Jacox E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012274; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kwan T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000608; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; McGregor B, 1999, GENET EPIDEMIOL, V16, P40, DOI 10.1002/(SICI)1098-2272(1999)16:1<40::AID-GEPI4>3.0.CO;2-1; Mcrae AF, 2007, HUM MOL GENET, V16, P364, DOI 10.1093/hmg/ddl456; Min JL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-96; Monks SA, 2004, AM J HUM GENET, V75, P1094, DOI 10.1086/426461; Montgomery SB, 2011, NAT REV GENET, V12, P277, DOI 10.1038/nrg2969; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; NEITZEL H, 1986, HUM GENET, V73, P320, DOI 10.1007/BF00279094; Nica AC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002003; Petretto E, 2006, PLOS GENET, V2, P1625, DOI 10.1371/journal.pgen.0020172; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Price AL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001317; Price AL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000294; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Saito-Hisaminato A, 2002, DNA RES, V9, P35, DOI 10.1093/dnares/9.2.35; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Spielman RS, 2007, NAT GENET, V39, P226, DOI 10.1038/ng1955; Storey JD, 2007, AM J HUM GENET, V80, P502, DOI 10.1086/512017; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Visscher PM, 2008, NAT REV GENET, V9, P255, DOI 10.1038/nrg2322; Visscher PM, 2006, PLOS GENET, V2, P316, DOI 10.1371/journal.pgen.0020041; Visscher PM, 2004, TWIN RES, V7, P505, DOI 10.1375/1369052042335250; Whitney AR, 2003, P NATL ACAD SCI USA, V100, P1896, DOI 10.1073/pnas.252784499; Williams RBH, 2007, GENOME RES, V17, P1707, DOI 10.1101/gr.6981507; Yanai I, 2005, BIOINFORMATICS, V21, P650, DOI 10.1093/bioinformatics/bti042; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693; Zhang LQ, 2004, MOL BIOL EVOL, V21, P236, DOI 10.1093/molbev/msh010; Zheng Q, 2008, NUCLEIC ACIDS RES, V36, pW358, DOI 10.1093/nar/gkn276; Zhu J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-172; Zhu J, 2008, TRENDS GENET, V24, P481, DOI 10.1016/j.tig.2008.08.004	63	61	63	0	11	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051			GENOME RES	Genome Res.	MAR	2012	22	3					456	466		10.1101/gr.126540.111			11	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	901JG	WOS:000300962600005	22183966	Green Published, Bronze			2022-03-04	
J	Nikolaev, SI; Deutsch, S; Genolet, R; Borel, C; Parand, L; Ucla, C; Schutz, F; Sail, GD; Dupre, Y; Jaquier-Gubler, P; Araud, T; Conne, B; Descombes, P; Vassalli, JD; Curran, J; Antonarakis, SE				Nikolaev, Sergey I.; Deutsch, Samuel; Genolet, Raphael; Borel, Christelle; Parand, Leila; Ucla, Catherine; Schuetz, Frederic; Sail, Genevieve Duriaux; Dupre, Yann; Jaquier-Gubler, Pascale; Araud, Tanguy; Conne, Beatrice; Descombes, Patrick; Vassalli, Jean-Dominique; Curran, Joseph; Antonarakis, Stylianos E.			Transcriptional and post-transcriptional profile of human chromosome 21	GENOME RESEARCH			English	Article							CONSERVED NONCODING SEQUENCES; IRON-RESPONSIVE ELEMENT; MESSENGER-RNAS; 5'-UNTRANSLATED REGION; ENCODE REGIONS; HUMAN GENOME; TRANSLATIONAL REGULATION; GENE-EXPRESSION; PROTEIN; IDENTIFICATION	Recent studies have demonstrated extensive transcriptional activity across the human genome, a substantial fraction of which is not associated with any functional annotation. However, very little is known regarding the post-transcriptional processes that operate within the different classes of RNA molecules. To characterize the post-transcriptional properties of expressed sequences from human chromosome 21 (HSA21), we separated RNA molecules from three cell lines (GM06990, HeLa S3, and SK-N-AS) according to their ribosome content by sucrose gradient fractionation. Polyribosomal-associated RNA and total RNA were subsequently hybridized to genomic tiling arrays. We found that similar to 50% of the transcriptional signals were located outside of annotated exons and were considered as TARs (transcriptionally active regions). Although TARs were observed among polysome-associated RNAs, RT-PCR and RACE experiments revealed that similar to 40% were likely to represent nonspecific cross-hybridization artifacts. Bioinformatics discrimination of TARs according to conservation and sequence complexity allowed us to identify a set of high-confidence TARs. This set of TARs was significantly depleted in the polysomes, suggesting that it was not likely to be involved in translation. Analysis of polysome representation of RefSeq exons showed that at least 15% of RefSeq transcripts undergo significant post-transcriptional regulation in at least two of the three cell lines tested. Among the regulated transcripts, enrichment analysis revealed an over-representation of genes involved in Alzheimer's disease (AD), including APP and the BACE1 protease that cleaves APP to produce the pathogenic beta 42 peptide. We demonstrate that the combination of RNA fractionation and tiling arrays is a powerful method to assess the transcriptional and post-transcriptional properties of genomic regions.	[Nikolaev, Sergey I.; Deutsch, Samuel; Borel, Christelle; Parand, Leila; Ucla, Catherine; Sail, Genevieve Duriaux; Dupre, Yann; Conne, Beatrice; Vassalli, Jean-Dominique; Antonarakis, Stylianos E.] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Genolet, Raphael; Jaquier-Gubler, Pascale; Araud, Tanguy; Curran, Joseph] Univ Geneva, Sch Med, Dept Microbiol & Mol Med, CH-1211 Geneva, Switzerland; [Schuetz, Frederic] Swiss Bioinformat Inst, CH-1015 Lausanne, Switzerland		Antonarakis, SE (corresponding author), Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland.	Stylianos.Antonarakis@unige.ch	borel, christelle/AAC-9645-2019; Nikolaev, Sergey/F-3148-2012; Antonarakis, Stylianos E/N-8866-2014	Antonarakis, Stylianos E/0000-0001-8907-5823; Schutz, Frederic/0000-0001-7048-7692; Deutsch, Samuel/0000-0001-9456-7101	Lejeune Foundation [ME7430]; Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission; NCCR "Frontiers in Genetics''Swiss National Science Foundation (SNSF); La Ligue Genevoise Contre le Cancer; EUEuropean Commission	This work was supported by the Lejeune Foundation grant number ME7430 to S. N., the Swiss National Science Foundation, NCCR "Frontiers in Genetics'' to S. E. A. and J. D. V., La Ligue Genevoise Contre le Cancer to J. C., and the EU FP6 Integrated project AnEUploidy and Biosapiens grants to S. E. A.	Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Borel C, 2008, AM J HUM GENET, V82, P971, DOI 10.1016/j.ajhg.2008.02.016; Campo PA, 2002, CELL GROWTH DIFFER, V13, P409; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Denoeud F, 2007, GENOME RES, V17, P746, DOI 10.1101/gr.5660607; Dermitzakis ET, 2003, SCIENCE, V302, P1033, DOI 10.1126/science.1087047; Dermitzakis ET, 2002, NATURE, V420, P578, DOI 10.1038/nature01251; Deutsch S, 2005, HUM MOL GENET, V14, P3741, DOI 10.1093/hmg/ddi404; Drake JA, 2006, NAT GENET, V38, P223, DOI 10.1038/ng1710; Felsenstein J, 1996, MOL BIOL EVOL, V13, P93, DOI 10.1093/oxfordjournals.molbev.a025575; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Graber TE, 2007, MOL BIOSYST, V3, P825, DOI 10.1039/b708867a; Gray NK, 1998, ANNU REV CELL DEV BI, V14, P399, DOI 10.1146/annurev.cellbio.14.1.399; Grolleau A, 2002, J BIOL CHEM, V277, P22175, DOI 10.1074/jbc.M202014200; Harrow J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s4; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Iacono M, 2005, GENE, V349, P97, DOI 10.1016/j.gene.2004.11.041; Imataka H, 1997, EMBO J, V16, P817, DOI 10.1093/emboj/16.4.817; JACKSON RJ, 1988, NATURE, V334, P292, DOI 10.1038/334292a0; Johannes G, 1999, P NATL ACAD SCI USA, V96, P13118, DOI 10.1073/pnas.96.23.13118; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lammich S, 2004, EMBO REP, V5, P620, DOI 10.1038/sj.embor.7400166; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; MACEJAK DG, 1991, NATURE, V353, P90, DOI 10.1038/353090a0; Marash L, 2005, CELL DEATH DIFFER, V12, P554, DOI 10.1038/sj.cdd.4401609; Mignone F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews0004; Mihailovich M, 2007, NUCLEIC ACIDS RES, V35, P2975, DOI 10.1093/nar/gkm191; Morgulis A, 2006, J COMPUT BIOL, V13, P1028, DOI 10.1089/cmb.2006.13.1028; Numata K, 2007, GENE, V392, P134, DOI 10.1016/j.gene.2006.12.005; Patel N, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-10; Patterson SD, 2003, NAT BIOTECHNOL, V21, P221, DOI 10.1038/nbt0303-221; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Prabhakar S, 2006, GENOME RES, V16, P855, DOI 10.1101/gr.4717506; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Rinn JL, 2003, GENE DEV, V17, P529, DOI 10.1101/gad.1055203; Rogers JT, 2002, J BIOL CHEM, V277, P45518, DOI 10.1074/jbc.M207435200; Rozowsky JS, 2007, GENOME RES, V17, P732, DOI 10.1101/gr.5696007; Sakakibara S, 1996, DEV BIOL, V176, P230, DOI 10.1006/dbio.1996.0130; SARNOW P, 1989, P NATL ACAD SCI USA, V86, P5795, DOI 10.1073/pnas.86.15.5795; Schratt GM, 2004, J NEUROSCI, V24, P7366, DOI 10.1523/JNEUROSCI.1739-04.2004; Serikawa KA, 2003, MOL CELL PROTEOMICS, V2, P191, DOI 10.1074/mcp.D200002-MCP200; Shendure J, 2004, NAT REV GENET, V5, P335, DOI 10.1038/nrg1325; Sherrill KW, 2008, MOL CELL BIOL, V28, P2011, DOI 10.1128/MCB.01446-07; Shoemaker DD, 2001, NATURE, V409, P922, DOI 10.1038/35057141; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; TING J, 1988, DNA-J MOLEC CELL BIO, V7, P275, DOI 10.1089/dna.1988.7.275; Tsuritani K, 2007, GENOME RES, V17, P1005, DOI 10.1101/gr.6030107; Venti A, 2004, ANN NY ACAD SCI, V1035, P34, DOI 10.1196/annals.1332.003; Wang HD, 2005, J CELL BIOL, V171, P811, DOI 10.1083/jcb.200506006; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wickens M, 1997, CURR OPIN GENET DEV, V7, P220, DOI 10.1016/S0959-437X(97)80132-3; Wilkins MR, 2006, PROTEOMICS, V6, P4, DOI 10.1002/pmic.200500856; Wu JQ, 2008, GENOME BIOL, V9, DOI [10.1186/gb-2008-9-5-220, 10.1186/gb-2008-9-1-r3]; Zeng Y, 2002, MOL CELL, V9, P1327, DOI 10.1016/S1097-2765(02)00541-5; Zhu YY, 2001, BIOTECHNIQUES, V30, P892, DOI 10.2144/01304pf02	61	1	1	0	8	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	AUG	2009	19	8					1471	1479		10.1101/gr.089425.108			9	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	478OM	WOS:000268597600015	19581486	Bronze, Green Published, Green Submitted			2022-03-04	
J	Turelli, P; Castro-Diaz, N; Marzetta, F; Kapopoulou, A; Raclot, C; Duc, J; Tieng, V; Quenneville, S; Trono, D				Turelli, Priscilla; Castro-Diaz, Nathaly; Marzetta, Flavia; Kapopoulou, Adamandia; Raclot, Charlene; Duc, Julien; Tieng, Vannary; Quenneville, Simon; Trono, Didier			Interplay of TRIM28 and DNA methylation in controlling human endogenous retroelements	GENOME RESEARCH			English	Article							EMBRYONIC STEM-CELLS; TRANSPOSABLE ELEMENTS; HUMAN GENOME; BINDING; RETROVIRUSES; TRANSCRIPTION; METHYLTRANSFERASE; RETROTRANSPOSONS; PLURIPOTENCY; CONTRIBUTES	Reverse transcription-derived sequences account for at least half of the human genome. Although these retroelements are formidable motors of evolution, they can occasionally cause disease, and accordingly are inactivated during early embryogenesis through epigenetic mechanisms. In the mouse, at least for endogenous retroviruses, important mediators of this process are the tetrapod-specific KRAB-containing zinc finger proteins (KRAB-ZFPs) and their cofactor TRIM28. The present study demonstrates that KRAB/TRIM28-mediated regulation is responsible for controlling a very broad range of human-specific endogenous retroelements (EREs) in human embryonic stem (ES) cells and that it exerts, as a consequence, a marked effect on the transcriptional dynamics of these cells. It further reveals reciprocal dependence between TRIM28 recruitment at specific families of EREs and DNA methylation. It finally points to the importance of persistent TRIM28-mediated control of ERE transcriptional impact beyond their presumed inactivation by DNA methylation.	[Turelli, Priscilla; Castro-Diaz, Nathaly; Marzetta, Flavia; Kapopoulou, Adamandia; Raclot, Charlene; Duc, Julien; Quenneville, Simon; Trono, Didier] Ecole Polytech Fed Lausanne, Sch Life Sci, CH-1015 Lausanne, Switzerland; [Turelli, Priscilla; Castro-Diaz, Nathaly; Marzetta, Flavia; Kapopoulou, Adamandia; Raclot, Charlene; Duc, Julien; Quenneville, Simon; Trono, Didier] Ecole Polytech Fed Lausanne, Frontiers Genet Program, CH-1015 Lausanne, Switzerland; [Tieng, Vannary] Univ Geneva, Dept Pathol, Fac Med, CH-1211 Geneva, Switzerland		Trono, D (corresponding author), Ecole Polytech Fed Lausanne, Sch Life Sci, CH-1015 Lausanne, Switzerland.	didier.trono@epfl.ch			Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission; European Research CouncilEuropean Research Council (ERC)European Commission [ERC 268721]	We thank J. Marquis for help with the ChIP protocol, Evarist Planet for the bioinformatics support, the staff of the CIG Technologies facility for library preparation and sequencing, and Vital-IT for computing. This work was financed through grants from the Swiss National Science Foundation and the European Research Council to D.T. (ERC 268721).	Bourque G, 2008, GENOME RES, V18, P1752, DOI 10.1101/gr.080663.108; Buzdin A, 2006, J VIROL, V80, P10752, DOI 10.1128/JVI.00871-06; Cammas F, 2000, DEVELOPMENT, V127, P2955; Chuong EB, 2013, NAT GENET, V45, P325, DOI 10.1038/ng.2553; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; de Koning APJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002384; Finnegan DJ, 2012, CURR BIOL, V22, pR432, DOI 10.1016/j.cub.2012.04.025; Frietze S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015082; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; Ivanov AV, 2007, MOL CELL, V28, P823, DOI 10.1016/j.molcel.2007.11.012; Iyengar S, 2011, MOL CELL BIOL, V31, P1833, DOI 10.1128/MCB.01331-10; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kaer K, 2013, GENE, V518, P231, DOI 10.1016/j.gene.2013.01.008; Karimi MM, 2011, CELL STEM CELL, V8, P676, DOI 10.1016/j.stem.2011.04.004; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leitch HG, 2013, NAT STRUCT MOL BIOL, V20, P311, DOI 10.1038/nsmb.2510; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Macfarlan TS, 2012, NATURE, V487, P57, DOI 10.1038/nature11244; Macfarlan TS, 2011, GENE DEV, V25, P594, DOI 10.1101/gad.2008511; Mager DLM, 2005, ENCY LIFE SCI; Matsui T, 2010, NATURE, V464, P927, DOI 10.1038/nature08858; MCCLINTOCK B, 1956, COLD SPRING HARB SYM, V21, P197, DOI 10.1101/SQB.1956.021.01.017; Messerschmidt DM, 2012, SCIENCE, V335, P1499, DOI 10.1126/science.1216154; Mey A, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-21; Quenneville S, 2012, CELL REP, V2, P766, DOI 10.1016/j.celrep.2012.08.043; Quenneville S, 2011, MOL CELL, V44, P361, DOI 10.1016/j.molcel.2011.08.032; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rebollo R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002301; Rowe HM, 2013, GENOME RES, V23, P452, DOI 10.1101/gr.147678.112; Rowe HM, 2013, DEVELOPMENT, V140, P519, DOI 10.1242/dev.087585; Rowe HM, 2011, VIROLOGY, V411, P273, DOI 10.1016/j.virol.2010.12.007; Rowe HM, 2010, NATURE, V463, P237, DOI 10.1038/nature08674; Schmidt D, 2012, CELL, V148, P335, DOI 10.1016/j.cell.2011.11.058; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Seki Y, 2010, P NATL ACAD SCI USA, V107, P10926, DOI 10.1073/pnas.0907601107; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Wang H, 2005, J MOL BIOL, V354, P994, DOI 10.1016/j.jmb.2005.09.085; Wang T, 2007, P NATL ACAD SCI USA, V104, P18613, DOI 10.1073/pnas.0703637104; Wolf D, 2008, P NATL ACAD SCI USA, V105, P12521, DOI 10.1073/pnas.0805540105; Wolf D, 2007, CELL, V131, P46, DOI 10.1016/j.cell.2007.07.026; Wolf D, 2009, NATURE, V458, P1201, DOI 10.1038/nature07844; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zuo XP, 2012, J BIOL CHEM, V287, P2107, DOI 10.1074/jbc.M111.322644	45	101	103	2	13	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	AUG	2014	24	8					1260	1270		10.1101/gr.172833.114			11	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	AM4XT	WOS:000339860200002	24879559	hybrid, Green Published			2022-03-04	
J	Di-Poi, N; Montoya-Burgos, JI; Duboule, D				Di-Poi, Nicolas; Montoya-Burgos, Juan I.; Duboule, Denis			Atypical relaxation of structural constraints in Hox gene clusters of the green anole lizard	GENOME RESEARCH			English	Article							TRANSPOSON-FREE REGIONS; TEMPORAL COLINEARITY; REGULATORY ELEMENTS; LIMB DEVELOPMENT; EVOLUTION; VERTEBRATE; EXPRESSION; GENOMES; ORGANIZATION; MURINE	Hox genes control many aspects of embryonic development in metazoans. Previous analyses of this gene family revealed a surprising diversity in terms of gene number and organization between various animal species. In vertebrates, Hox genes are grouped into tightly organized clusters, claimed to be devoid of repetitive sequences. Here, we report the genomic organization of the four Hox loci present in the green anole lizard and show that they have massively accumulated retrotransposons, leading to gene clusters larger in size when compared to other vertebrates. In addition, similar repeats are present in many other development-related gene-containing regions, also thought to be refractory to such repetitive elements. Transposable elements are major sources of genetic variations, including alterations of gene expression, and hence this situation, so far unique among vertebrates, may have been associated with the evolution of the spectacular realm of morphological variations in the body plans of Squamata. Finally, sequence alignments highlight some divergent evolution in highly conserved DNA regions between vertebrate Hox clusters, which may coincide with the emergence of mammalian-specific features.	[Di-Poi, Nicolas; Montoya-Burgos, Juan I.; Duboule, Denis] Univ Geneva, Dept Zool & Anim Biol, Natl Res Ctr Frontiers Genet, CH-1211 Geneva 4, Switzerland; [Duboule, Denis] Swiss Fed Inst Technol, Sch Life Sci, CH-1015 Lausanne, Switzerland		Duboule, D (corresponding author), Univ Geneva, Dept Zool & Anim Biol, Natl Res Ctr Frontiers Genet, CH-1211 Geneva 4, Switzerland.	denis.duboule@unige.ch	Di-Poi, Nicolas/O-6256-2019; Di-Poi, Nicolas/O-2378-2015	Di-Poi, Nicolas/0000-0002-3313-3016; Di-Poi, Nicolas/0000-0002-3313-3016; Montoya-Burgos, Juan/0000-0001-9080-9820; duboule, denis/0000-0001-9961-2960	Canton de Geneve; Louis- Jeantet Foundation; Claraz Foundation; Swiss National Research FundSwiss National Science Foundation (SNSF); National Center (NCCR) "Frontiers in Genetics,'' and the EU programs "Cells into Organs''Swiss National Science Foundation (SNSF)	We thank the Broad Institute at MIT and Harvard for releasing lizard and horse genome data ahead of publication, and J. Woltering for sharing information. This work was supported by funds from the Canton de Geneve, the Louis- Jeantet Foundation, the Claraz Foundation, the Swiss National Research Fund, the National Center (NCCR) "Frontiers in Genetics,'' and the EU programs "Cells into Organs'' and "Crescendo.''	Amemiya CT, 2008, J EXP ZOOL PART B, V310B, P465, DOI 10.1002/jez.b.21213; Belancio VP, 2008, GENOME RES, V18, P343, DOI 10.1101/gr.5558208; BROWN WM, 1994, INT J BIOCHEM, V26, P1403, DOI 10.1016/0020-711X(94)90184-8; Cameron RA, 2006, J EXP ZOOL PART B, V306B, P45, DOI 10.1002/jez.b.21070; Castillo-Davis CI, 2002, NAT GENET, V31, P415, DOI 10.1038/ng940; Cohn MJ, 1999, NATURE, V399, P474, DOI 10.1038/20944; de Rosa R, 1999, NATURE, V399, P772, DOI 10.1038/21631; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Deschamps J, 2005, DEVELOPMENT, V132, P2931, DOI 10.1242/dev.01897; Di-Poi N, 2007, PLOS GENET, V3, P2500, DOI 10.1371/journal.pgen.0030232; DUBOULE D, 1989, EMBO J, V8, P1497, DOI 10.1002/j.1460-2075.1989.tb03534.x; DUBOULE D, 1994, DEVELOPMENT, P135; Duboule D, 2007, DEVELOPMENT, V134, P2549, DOI 10.1242/dev.001065; Evgen'ev MB, 2005, CYTOGENET GENOME RES, V110, P510, DOI 10.1159/000084984; Ferrier DEK, 2002, MOL PHYLOGENET EVOL, V24, P412, DOI 10.1016/S1055-7903(02)00204-X; Feschotte C, 2007, ANNU REV GENET, V41, P331, DOI 10.1146/annurev.genet.40.110405.090448; Fried C, 2004, J EXP ZOOL PART B, V302B, P165, DOI 10.1002/jez.b.20007; Garcia-Fernandez J, 2005, HEREDITY, V94, P145, DOI 10.1038/sj.hdy.6800621; Garcia-Gasca A, 2000, DEV DYNAM, V219, P261, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1048>3.0.CO;2-3; Gaunt SJ, 2000, INT J DEV BIOL, V44, P109; Gazave E, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r21; Gentles AJ, 2007, GENOME RES, V17, P992, DOI 10.1101/gr.6070707; Godwin AR, 1998, GENE DEV, V12, P11, DOI 10.1101/gad.12.1.11; GRAHAM A, 1989, CELL, V57, P367, DOI 10.1016/0092-8674(89)90912-4; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Herault Y, 1999, DEV BIOL, V208, P157, DOI 10.1006/dbio.1998.9179; Hoegg S, 2005, TRENDS GENET, V21, P421, DOI 10.1016/j.tig.2005.06.004; Kim CB, 2000, P NATL ACAD SCI USA, V97, P1655, DOI 10.1073/pnas.030539697; Kmita M, 2003, SCIENCE, V301, P331, DOI 10.1126/science.1085753; Kohany O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; Lemons D, 2006, SCIENCE, V313, P1918, DOI 10.1126/science.1132040; Margulies EH, 2008, NAT REV GENET, V9, P303, DOI 10.1038/nrg2185; Meyer A, 1998, NATURE, V391, P225, DOI 10.1038/34530; Montavon T, 2008, GENE DEV, V22, P346, DOI 10.1101/gad.1631708; Mungpakdee S, 2008, MOL BIOL EVOL, V25, P1333, DOI 10.1093/molbev/msn097; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Piskurek O, 2006, J MOL EVOL, V62, P630, DOI 10.1007/s00239-005-0201-5; Richardson MK, 2007, CYTOGENET GENOME RES, V117, P110, DOI 10.1159/000103171; RIJLI FM, 1994, DEV DYNAM, V201, P366, DOI 10.1002/aja.1002010408; Santini S, 2003, GENOME RES, V13, P1111, DOI 10.1101/gr.700503; Simons C, 2006, GENOME RES, V16, P164, DOI 10.1101/gr4624306; Simons C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-470; Sinibaldi-Vallebona P, 2006, GENE CHROMOSOME CANC, V45, P1, DOI 10.1002/gcc.20266; Tanzer A, 2005, J EXP ZOOL PART B, V304B, P75, DOI 10.1002/jez.b.21021; Tarchini B, 2006, DEV CELL, V10, P93, DOI 10.1016/j.devcel.2005.11.014; Zakany J, 2001, CELL, V106, P207, DOI 10.1016/S0092-8674(01)00436-6; Zakany J, 2007, CURR OPIN GENET DEV, V17, P359, DOI 10.1016/j.gde.2007.05.011	48	38	38	0	7	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	APR	2009	19	4					602	610		10.1101/gr.087932.108			9	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	427LX	WOS:000264781900009	19228589	Bronze, Green Published			2022-03-04	
J	Hernandez, D; Francois, P; Farinelli, L; Osteras, M; Schrenzel, J				Hernandez, David; Francois, Patrice; Farinelli, Laurent; Osteras, Magne; Schrenzel, Jacques			De novo bacterial genome sequencing: Millions of very short reads assembled on a desktop computer	GENOME RESEARCH			English	Article							STAPHYLOCOCCUS-AUREUS; MULTIDRUG-RESISTANCE; ALGORITHMS; ARRAYS	Novel high-throughput DNA sequencing technologies allow researchers to characterize a bacterial genome during a single experiment and at a moderate cost. However, the increase in sequencing throughput that is allowed by using such platforms is obtained at the expense of individual sequence read length, which must be assembled into longer contigs to be exploitable. This study focuses on the Illumina sequencing platform that produces millions of very short sequences that are 35 bases in length. We propose a de novo assembler software that is dedicated to process such data. Based on a classical overlap graph representation and on the detection of potentially spurious reads, our software generates a set of accurate contigs of several kilobases that cover most of the bacterial genome. The assembly results were validated by comparing data sets that were obtained experimentally for Staphylococcus aureus strain MW2 and Helicobacter acinonychis strain Sheeba with that of their published genomes acquired by conventional sequencing of 1.5- to 3.0-kb fragments. We also provide indications that the broad coverage achieved by high-throughput sequencing might allow for the detection of clonal polymorphisms in the set of DNA molecules being sequenced.	[Hernandez, David; Francois, Patrice; Schrenzel, Jacques] Univ Hosp Geneva, Genom REs Lab, Infect Dis Serv, CH-1211 Geneva, Switzerland; [Hernandez, David; Francois, Patrice; Schrenzel, Jacques] Univ Geneva, CH-1211 Geneva, Switzerland; [Farinelli, Laurent; Osteras, Magne] Fasteris SA, CH-1228 Plan Les Ouates, Switzerland		Hernandez, D (corresponding author), Univ Hosp Geneva, Genom REs Lab, Infect Dis Serv, CH-1211 Geneva, Switzerland.	david.hernandez@genomic.ch	Schrenzel, Jacques/AAC-5685-2021; Schrenzel, Jacques/P-8525-2017; francois, patrice/AAL-5583-2020	Schrenzel, Jacques/0000-0001-5464-7764; Schrenzel, Jacques/0000-0001-5464-7764; francois, patrice/0000-0002-0540-750X			Audic S, 2007, PLOS GENET, V3, P1454, DOI 10.1371/journal.pgen.0030138; Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5; Bentley DR, 2006, CURR OPIN GENET DEV, V16, P545, DOI 10.1016/j.gde.2006.10.009; Brenner S, 2000, NAT BIOTECHNOL, V18, P630, DOI 10.1038/76469; Chongtrakool P, 2006, ANTIMICROB AGENTS CH, V50, P1001, DOI 10.1128/AAC.50.3.1001-1012.2006; Dohm JC, 2007, GENOME RES, V17, P1697, DOI 10.1101/gr.6435207; Eisen JA, 2007, PLOS BIOL, V5, P384, DOI 10.1371/journal.pbio.0050082; Eppinger M, 2006, PLOS GENET, V2, P1097, DOI 10.1371/journal.pgen.0020120; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Fournier PE, 2006, PLOS GENET, V2, P62, DOI 10.1371/journal.pgen.0020007; Handelsman J, 1998, CHEM BIOL, V5, pR245, DOI 10.1016/S1074-5521(98)90108-9; Idury R M, 1995, J Comput Biol, V2, P291, DOI 10.1089/cmb.1995.2.291; KEANE T, 2007, 15 ANN INT C INT SYS; KECECIOGLU JD, 1995, ALGORITHMICA, V13, P7, DOI 10.1007/BF01188580; LANDER E S, 1988, Genomics, V2, P231; MANBER U, 1993, SIAM J COMPUT, V22, P935, DOI 10.1137/0222058; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mitra RD, 1999, NUCLEIC ACIDS RES, V27, DOI 10.1093/nar/27.24.e34; Mullikin JC, 2003, GENOME RES, V13, P81, DOI 10.1101/gr.731003; Mwangi MM, 2007, P NATL ACAD SCI USA, V104, P9451, DOI 10.1073/pnas.0609839104; Myers EW, 2005, BIOINFORMATICS, V21, P79, DOI 10.1093/bioinformatics/bti1114; Pevzner PA, 2001, P NATL ACAD SCI USA, V98, P9748, DOI 10.1073/pnas.171285098; Pop M, 2004, BRIEF BIOINFORM, V5, P237, DOI 10.1093/bib/5.3.237; Pop M, 2002, COMPUTER, V35, P47, DOI 10.1109/MC.2002.1016901; Service RF, 2006, SCIENCE, V311, P1544, DOI 10.1126/science.311.5767.1544; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Sommer DD, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-64; Sundquist A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000484; Warren RL, 2007, BIOINFORMATICS, V23, P500, DOI 10.1093/bioinformatics/btl629; Wendl MC, 2002, GENOME RES, V12, P1943, DOI 10.1101/gr.655102; Whiteford N, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni170	32	434	446	2	55	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	MAY	2008	18	5					802	809		10.1101/gr.072033.107			8	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	295WK	WOS:000255504600012	18332092	Green Published, Bronze			2022-03-04	
J	Ciman, M; Wac, K				Ciman, Matteo; Wac, Katarzyna			iSenseSleep: Using Smartphones as Sleep Duration Sensors	JMIR MHEALTH AND UHEALTH			English	Article						mobile phone use; mobile health; behavioral research; well being	LIFE	Background: Smartphones are becoming increasingly ubiquitous every day; they are becoming more assimilated into our everyday life, being the last thing used before going to sleep and the first one after waking up. This strong correlation between our lifestyle choices and smartphone interaction patterns enables us to use them as sensors for sleep duration assessment to understand individuals' lifestyle and sleep patterns. Objectives: The objective of this study was to estimate sleep duration based on the analysis of the users' ON-OFF interaction with their smartphone alone using the iSenseSleep algorithm. Methods: We used smartwatch sleep assessment data as the ground truth. Results were acquired with 14 different subjects collecting smartwatch and smartphone interaction data for up to 6 months each. Results: Results showed that based on the smartphone ON-OFF patterns, individual's sleep duration can be estimated with an average error of 7% (24/343) [SD 4% (17/343)] min of the total duration), enabling an estimate of sleep start and wake-up times as well as sleep deprivation patterns. Conclusions: It is possible to estimate sleep duration patterns using only data related to smartphone screen interaction.	[Ciman, Matteo; Wac, Katarzyna] Univ Geneva, Qual Life Technol Lab, Carouge, Switzerland		Wac, K (corresponding author), Univ Geneva, Qual Life Technol Lab, UNIGE, Route Drize 7,Battelle A, CH-1227 Carouge, Switzerland.	katarzyna.wac@unige.ch	Wac, Katarzyna/C-7856-2013	Wac, Katarzyna/0000-0002-8060-399X	AAL CoME [7-127, 769765]	The authors wish to thank AAL CoME (Caregivers and Me, 7-127) and H2020 WellCo (769765) projects.	Abdullah S, 2014, CIRCADIAN COMPUTING; ASCHOFF J, 1965, SCIENCE, V148, P1427, DOI 10.1126/science.148.3676.1427; Blatter K, 2007, PHYSIOL BEHAV, V90, P196, DOI 10.1016/j.physbeh.2006.09.009; Buysse DJ, 2014, SLEEP, V37, P9, DOI 10.5665/sleep.3298; Carinci G, 2016, SPRINGER MATH PHYS, P7, DOI 10.1007/978-3-319-33370-0_2; Carney CE, 2012, SLEEP, V35, P287, DOI 10.5665/sleep.1642; Chen Z., 2013, 7 INT C PERV COMP TE; Ciman M, 2018, IEEE T AFFECT COMPUT, V9, P51, DOI 10.1109/TAFFC.2016.2592504; Ciman M, 2016, PERS UBIQUIT COMPUT, V20, P1015, DOI 10.1007/s00779-016-0968-y; Dey AK, 2011, P 13 INT C UB COMP 2; Flurry Analytics Blog, MEDIA PRODUCTIVITY E; Foley D, 2004, J PSYCHOSOM RES, V56, P497, DOI 10.1016/j.jpsychores.2004.02.010; Hamermesh DS, 2015, ILR REV, V68, P1007, DOI 10.1177/0019793915592375; Hao Tian, 2013, P 11 ACM C EMB NETW, DOI DOI 10.1145/2517351.2517359; Hirshkowitz M, 2015, SLEEP HEALTH, V1, P233, DOI 10.1016/j.sleh.2015.10.004; Kahneman D, 2004, SCIENCE, V306, P1776, DOI 10.1126/science.1103572; Lane ND, 2014, MOBILE NETW APPL, V19, P345, DOI 10.1007/s11036-013-0484-5; Min J.-K., 2014, P SIGCHI C HUM FACT, P477, DOI DOI 10.1145/2556288.2557220; Miyata S, 2010, NEUROSCI LETT, V469, P229, DOI 10.1016/j.neulet.2009.12.001; MONK TH, 1994, J SLEEP RES, V3, P111, DOI 10.1111/j.1365-2869.1994.tb00114.x; Oulasvirta A, 2012, PERS UBIQUIT COMPUT, V16, P105, DOI 10.1007/s00779-011-0412-2; Patel S., 2014, BASIS SCI; Patel S, 2006, 2006 INT C UB COMP S, P17, DOI [10.1007/11853565_8, DOI 10.1007/11853565_8]; Pew Research Center, DO YOU SLEEP CELL PH; Prensky M., 2009, INNOV J ONLINE ED, V5, P3; Roenneberg T, 2003, J BIOL RHYTHM, V18, P80, DOI 10.1177/0748730402239679; Shirazi AS, 2013, INT J HUM-COMPUT ST, V71, P878, DOI 10.1016/j.ijhcs.2013.03.001; Silva PA, 2015, P ANN HICSS, P3237, DOI 10.1109/HICSS.2015.390; Veldi M, 2005, SLEEP MED, V6, P269, DOI 10.1016/j.sleep.2004.12.003; Winkelman JW, 2003, SLEEP MED, V4, P243, DOI 10.1016/S1389-9457(03)00060-1	30	4	4	2	2	JMIR PUBLICATIONS, INC	TORONTO	130 QUEENS QUAY E, STE 1102, TORONTO, ON M5A 0P6, CANADA	2291-5222			JMIR MHEALTH UHEALTH	JMIR mHealth uHealth	MAY 21	2019	7	5							e11930	10.2196/11930			12	Health Care Sciences & Services; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services; Medical Informatics	IC1PH	WOS:000470730900001	31115341	Green Published, gold			2022-03-04	
J	Dietrich, D; Dekova, R; Davy, S; Fahrni, G; Geissbuhler, A				Dietrich, Damien; Dekova, Ralitza; Davy, Stephan; Fahrni, Guillaume; Geissbuehler, Antoine			Applications of Space Technologies to Global Health: Scoping Review	JOURNAL OF MEDICAL INTERNET RESEARCH			English	Review						satellite imagery; satellite communications; public health; remote sensing technology; global positioning system; geographic information systems; telemedicine; spaceflight; space medicine; global health	GEOGRAPHIC INFORMATION-SYSTEMS; RESOLUTION SATELLITE IMAGERY; CHLOROPHYLL-A CONCENTRATION; CLINICAL ULTRASOUND ABOARD; REMOTE-SENSING TECHNIQUES; MOSQUITO LARVAL HABITATS; AEROSOL OPTICAL DEPTH; LONG-TERM EXPOSURE; PARTICULATE MATTER; PHYSICAL-ACTIVITY	Background: Space technology has an impact on many domains of activity on earth, including in the field of global health. With the recent adoption of the United Nations' Sustainable Development Goals that highlight the need for strengthening partnerships in different domains, it is useful to better characterize the relationship between space technology and global health. Objective: The aim of this study was to identify the applications of space technologies to global health, the key stakeholders in the field, as well as gaps and challenges. Methods: We used a scoping review methodology, including a literature review and the involvement of stakeholders, via a brief self-administered, open-response questionnaire. A distinct search on several search engines was conducted for each of the four key technological domains that were previously identified by the UN Office for Outer Space Affairs' Expert Group on Space and Global Health (Domain A: remote sensing; Domain B: global navigation satellite systems; Domain C: satellite communication; and Domain D: human space flight). Themes in which space technologies are of benefit to global health were extracted. Key stakeholders, as well as gaps, challenges, and perspectives were identified. Results: A total of 222 sources were included for Domain A, 82 sources for Domain B, 144 sources for Domain C, and 31 sources for Domain D. A total of 3 questionnaires out of 16 sent were answered. Global navigation satellite systems and geographic information systems are used for the study and forecasting of communicable and noncommunicable diseases; satellite communication and global navigation satellite systems for disaster response; satellite communication for telemedicine and tele-education; and global navigation satellite systems for autonomy improvement, access to health care, as well as for safe and efficient transportation. Various health research and technologies developed for inhabited space flights have been adapted for terrestrial use. Conclusions: Although numerous examples of space technology applications to global health exist, improved awareness, training, and collaboration of the research community is needed.	[Dietrich, Damien; Dekova, Ralitza; Davy, Stephan; Fahrni, Guillaume; Geissbuehler, Antoine] Hop Univ Geneve, eHlth & Telemed Div, Rue Gabrielle Perret Gentil 4, CH-1205 Geneva, Switzerland		Dietrich, D (corresponding author), Hop Univ Geneve, eHlth & Telemed Div, Rue Gabrielle Perret Gentil 4, CH-1205 Geneva, Switzerland.	Damien.Dietrich@hcuge.ch		Davy, Stephan/0000-0001-7321-7452; Dietrich, Damien/0000-0001-6554-7160			Achee NL, 2006, J MED ENTOMOL, V43, P382, DOI 10.1603/0022-2585(2006)043[0382:UORSAG]2.0.CO;2; Adde A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164685; Adde A, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004681; Adimi F, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-125; Ageep TB, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-123; Agroyannis B, 1999, INT J ARTIF ORGANS, V22, P679, DOI 10.1177/039139889902201005; Al-Hamdan MZ, 2014, GEOCARTO INT, V29, P85, DOI 10.1080/10106049.2012.715209; Algaet MA, 2014, WIRELESS PERS COMMUN, V78, P375, DOI 10.1007/s11277-014-1758-3; Ali Mohammad, 2004, Int J Health Geogr, V3, P20; Alisky JM, 2006, MED HYPOTHESES, V66, P1161, DOI 10.1016/j.mehy.2005.11.045; Almanza E, 2012, HEALTH PLACE, V18, P46, DOI 10.1016/j.healthplace.2011.09.003; Almeida AS, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-13; Anderson HR, 2012, ENVIRON HEALTH PERSP, V120, P1333, DOI 10.1289/ehp.1104724; Angood PB, 2000, TELEMED J E-HEALTH, V6, P315, DOI 10.1089/153056200750040174; Anno S, 2015, GEOSPATIAL HEALTH, V10, P376, DOI 10.4081/gh.2015.376; Anogianakis G, 1998, IEEE Trans Inf Technol Biomed, V2, P254, DOI 10.1109/4233.737580; Anogianakis G, 1997, Stud Health Technol Inform, V39, P298; Anogianakis G, 1997, Stud Health Technol Inform, V39, P264; [Anonymous], 1998, ACAD RADIOL, V5, pS484, DOI [10.1016/S1076-6332(98)80316-4, DOI 10.1016/S1076-6332(98)80316-4]; [Anonymous], 2013, WHAT IS DIFFERENCE G; Anscombe DL, 2010, TELEMED J E-HEALTH, V16, P659, DOI 10.1089/tmj.2010.9957; Arbeille P, 2003, ULTRASOUND MED BIOL, V29, P993, DOI 10.1016/S0301-5629(03)00063-2; Arbeille P, 2001, J Gravit Physiol, V8, pP143; Arbeille Ph, 2007, J Gravit Physiol, V14, pP139; Arbeille Ph, 2004, J Gravit Physiol, V11, pP233; Arboleda S, 2009, INT J ENV RES PUB HE, V6, P3040, DOI 10.3390/ijerph6123040; Armstrong I J, 1997, J Telemed Telecare, V3, P27, DOI 10.1258/1357633971930166; Asadi S S, 2007, Int J Environ Res Public Health, V4, P45, DOI 10.3390/ijerph2007010008; Assare RK, 2015, GEOSPATIAL HEALTH, V10, P69, DOI 10.4081/gh.2015.345; Ausseresses A D, 1995, J Med Syst, V19, P143, DOI 10.1007/BF02257065; Aziz S, 2014, J VECTOR DIS, V51, P91; BABU PM, 2014, INT J ENG RES, V3, P476, DOI DOI 10.17950/IJER/V3S8/801; Badland Hannah M., 2010, Environmental Health and Preventive Medicine, V15, P327, DOI 10.1007/s12199-010-0138-1; Baeza A, 2013, P NATL ACAD SCI USA, V110, P15157, DOI 10.1073/pnas.1305728110; Bagshaw M, 1996, J Telemed Telecare, V2 Suppl 1, P36, DOI 10.1258/1357633961929213; Bandaru V, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13060606; Barau I, 2014, J INFECT DIS, V210, pS102, DOI 10.1093/infdis/jiu010; Beck LR, 2000, EMERG INFECT DIS, V6, P217, DOI 10.3201/eid0603.000301; Bediang G, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00180; Bennie J, 2014, SCI REP-UK, V4, DOI 10.1038/srep03789; Berek B, 1994, Hosp Technol Ser, V13, P1; Bhaskaranarayana A, 2009, TELEMED J E-HEALTH, V15, P586, DOI 10.1089/tmj.2009.0060; Bhaskaranarayana A, 2009, SPACE TECHNOLOGIES B; Bhunia GS, 2010, GEOSPATIAL HEALTH, V4, P155, DOI 10.4081/gh.2010.197; Black N., 2001, STUDYING ORG DELIVER, P188; Bo YC, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-358; Bonner MR, 2003, EPIDEMIOLOGY, V14, P408, DOI 10.1097/01.EDE.0000073121.63254.c5; Boruff BJ, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-22; Boulos MNK, 2001, J BIOMED INFORM, V34, P195, DOI 10.1006/jbin.2001.1015; Brauer M, 2012, ENVIRON SCI TECHNOL, V46, P652, DOI 10.1021/es2025752; Brooker S, 2000, ADV PARASIT, V47, P245, DOI 10.1016/S0065-308X(00)47011-9; Brooker S, 2002, B WORLD HEALTH ORGAN, V80, P783; Brown ME, 2014, POPUL ENVIRON, V36, P48, DOI 10.1007/s11111-013-0201-0; Brown-Connolly NE, 2014, TELEMED E-HEALTH, V20, P18, DOI 10.1089/tmj.2013.0080; Buczak AL, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-124; Burgi R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142223; Cappelle J, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-60; Casalino NAD, 2005, EUR C INF SYST MAY 1; Ceccato P., 2005, Parassitologia (Rome), V47, P81; Cermack M, 2006, BRIT J ANAESTH, V97, P107, DOI 10.1093/bja/ael132; Chaix B, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/s12966-014-0124-x; Chaix B, 2013, HEALTH PLACE, V21, P46, DOI 10.1016/j.healthplace.2013.01.003; Chan LS, 2004, J TRAVEL MED, V11, P273, DOI 10.2310/7060.2004.19102; Chen YY, 2012, INT J ENV RES PUB HE, V9, P1874, DOI 10.3390/ijerph9051874; Cheng CM, 2013, INT J ENV RES PUB HE, V10, P2979, DOI 10.3390/ijerph10072979; Chevalier A, 2016, DATA BRIEF, V8, P136, DOI 10.1016/j.dib.2016.05.016; Chiang MF, 2008, J FORMOS MED ASSOC, V107, P937, DOI 10.1016/S0929-6646(09)60017-6; Chiao L, 2005, J TRAUMA, V58, P885, DOI 10.1097/01.TA.0000162456.37962.01; Chonin A, 1998, Life Support Biosph Sci, V5, P433; Chronaki CE, 2007, STUD HEALTH TECHNOL, V129, P87; CLARKE KC, 1991, PREV VET MED, V11, P229, DOI 10.1016/S0167-5877(05)80007-8; Clennon JA, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-58; Coker E, 2015, ENVIRON RES, V142, P354, DOI 10.1016/j.envres.2015.06.044; Corner RJ, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-13; COVA G, 2009, INT S IT MED ED 14 1, P76, DOI DOI 10.1109/ITIME.2009.5236457; Croner CM, 1996, STAT MED, V15, P1961, DOI 10.1002/(SICI)1097-0258(19960930)15:18<1961::AID-SIM408>3.0.CO;2-L; Crump A, 2006, GEOSPATIAL HEALTH, V1, P7, DOI 10.4081/gh.2006.276; Cui P, 2010, CHINA J ORNITHOL, V152, P83; Dambach P, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-8; Dambach P, 2009, GLOBAL HEALTH ACTION, V2, P149, DOI 10.3402/gha.v2i0.2094; Danda Jacek, 2003, Polish Journal of Pathology, V54, P197; Dasgupta Aparajita, 2008, Indian J Community Med, V33, P3, DOI 10.4103/0970-0218.39234; de Andrade VS, 2013, REV SAUDE PUBL, V47, P239, DOI 10.1590/S0034-8910.2013047004011; De Castro MC, 2004, AM J TROP MED HYG, V71, P103, DOI 10.4269/ajtmh.2004.71.103; de Oliveira EC, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-420; de Oliveira EF, 2012, MEM I OSWALDO CRUZ, V107, P396, DOI 10.1590/S0074-02762012000300015; De Roeck E, 2014, GEOSPATIAL HEALTH, V8, pS671, DOI 10.4081/gh.2014.296; de Savigny D, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-27; Dias MCFD, 2007, LEPROSY REV, V78, P261; Debakey ME, 1995, TELEMED J E HLTH, V1, P3, DOI [DOI 10.1089/tmj.1.1995.1.3, DOI 10.1089/TMJ.1.1995.1.3]; Delgorge C, 2005, IEEE T INF TECHNOL B, V9, P50, DOI 10.1109/TITB.2004.840062; Dijkers M., 2015, KNOWLEDGE TRANSLATIO, V4, P1, DOI DOI 10.1179/2047480615Z.000000000329; Diuk-Wasser MA, 2006, INT J REMOTE SENS, V27, P535, DOI 10.1080/01431160500104350; Dlamini SN, 2015, GEOSPATIAL HEALTH, V10, P88, DOI 10.4081/gh.2015.302; Doarn CR, 1998, TELEMED J, V4, P19, DOI 10.1089/tmj.1.1998.4.19; Doarn CR, 2003, STUD HEALTH TECHNOL, V97, P35; Duplaga M, 2006, HLTH INFORMAT SER, P1; Durrani H, 2009, J TELEMED TELECARE, V15, P175, DOI 10.1258/jtt.2009.080605; Ebhuoma O, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13060584; Edwards N, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0178-4; Ehlkes L, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-35; Ehrlich AI, 2007, J TELEMED TELECARE, V13, P4, DOI 10.1258/135763307779701211; Eisele TP, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-44; Eisenberg MC, 2013, EPIDEMICS-NETH, V5, P197, DOI 10.1016/j.epidem.2013.09.004; Elainne Christine De Souza G, 2012, INT J HEALTH GEOGR, V11, P51, DOI DOI 10.1186/1476-072X-11-51; Elgethun K, 2003, ENVIRON HEALTH PERSP, V111, P115, DOI 10.1289/ehp.5350; Elliott CT, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-11; Ernst RD, 1999, J DIGIT IMAGING, V12, P195, DOI 10.1007/BF03168799; Espinosa M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004621; Estrada-Pena A, 2002, ENVIRON HEALTH PERSP, V110, P635, DOI 10.1289/ehp.02110635; Feliciani F, 2003, ESA BULL-EUR SPACE, P54; Fiadjoe J, 2009, ANESTH ANALG, V108, P1212, DOI 10.1213/ane.0b013e318198f786; Foale CM, 2005, AVIAT SPACE ENVIR MD, V76, P594; Franke J, 2015, GEOSPATIAL HEALTH, V10, P117, DOI 10.4081/gh.2015.335; Frassy F, 2014, SENSORS-BASEL, V14, P15900, DOI 10.3390/s140915900; Friedman D S, 1991, Med Des Mater, V1, P54; Fuentes MV, 2006, GEOSPATIAL HEALTH, V1, P59, DOI 10.4081/gh.2006.281; Gammino VM, 2014, J INFECT DIS, V210, pS98, DOI 10.1093/infdis/jit285; Ganapathy K, 2004, Stud Health Technol Inform, V104, P178; Garawi S. A., 2004, Fifth IEE International Conference on 3G Mobile Communication Technologies (3G 2004) The Premier Technical Conference for 3G and Beyond, P118, DOI 10.1049/cp:20040647; GARSHNEK V, 1991, SPACE COMMUN, V8, P311; GARSHNEK V, 1989, SPACE POLICY, V5, P330, DOI 10.1016/0265-9646(89)90053-2; Garshnek V, 1999, ANN EMERG MED, V34, P213, DOI 10.1016/S0196-0644(99)70231-3; Gebreslasie MT, 2015, GEOSPATIAL HEALTH, V10, P239, DOI 10.4081/gh.2015.328; Geddes JA, 2016, ENVIRON HEALTH PERSP, V124, P281, DOI 10.1289/ehp.1409567; Geissbuhler A, 2007, INT J MED INFORM, V76, P351, DOI 10.1016/j.ijmedinf.2007.01.012; Giardina F, 2015, GEOSPATIAL HEALTH, V10, P232, DOI 10.4081/gh.2015.333; Gilbert M, 2010, ECOHEALTH, V7, P448, DOI 10.1007/s10393-010-0672-8; Goetz SJ, 2000, ADV PARASIT, V47, P289, DOI 10.1016/S0065-308X(00)47012-0; Gomez E, 1996, Telemed J, V2, P201, DOI 10.1089/tmj.1.1996.2.201; Gortzis LG, 2007, IEEE T INF TECHNOL B, V11, P597, DOI 10.1109/TITB.2007.894724; Graham DJ, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00066; Graham S, 1999, REMOTE SENSING FEATU; Grant Iain C, 2004, Int J Circumpolar Health, V63, P356; Graschew G, 2007, 2007 9 INT C E HLTH, P19; Graschew G, 2006, WORLD C MED PHYS BIO, P358; Graschew G, 2006, STUD HEALTH TECHNOL, V121, P168; Graschew Georgi, 2004, Stud Health Technol Inform, V103, P150; Graschew G, 2008, STUD HEALTH TECHNOL, V131, P67; Graschew Georgi, 2002, Biomed Tech (Berl), V47 Suppl 1 Pt 1, P330, DOI 10.1515/bmte.2002.47.s1a.330; Grigoriev AI, 1997, ACTA ASTRONAUT, V41, P531, DOI 10.1016/S0094-5765(98)00053-8; Grigoriev AI, 2002, AVIAT SPACE ENVIR MD, V73, P688; Grimes DJ, 2014, MICROB ECOL, V67, P489, DOI 10.1007/s00248-013-0363-4; Groves T, 1996, BRIT MED J, V313, P1606, DOI 10.1136/bmj.313.7072.1606; Guo C, 2015, COMPUT INTEL NEUROSC, V2015, DOI 10.1155/2015/531321; Guo JG, 2005, ACTA TROP, V96, P213, DOI 10.1016/j.actatropica.2005.07.029; Guo Tiffany W, 2015, Methods Mol Biol, V1256, P3, DOI 10.1007/978-1-4939-2172-0_1; Gupta P, 2006, ATMOS ENVIRON, V40, P5880, DOI 10.1016/j.atmosenv.2006.03.016; Haenssgen MJ, 2015, EMERG THEMES EPIDEMI, V12, DOI 10.1186/s12982-015-0041-8; Haidegger T, 2011, SURG ENDOSC, V25, P681, DOI 10.1007/s00464-010-1243-3; Hanari-Bojd AA, 2012, J VECTOR DIS, V49, P91; Haque U, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-120; Hartvigsen G, 2007, STUD HEALTH TECHNOL, V129, P82; Hassan Ali N., 2004, Journal of the Egyptian Society of Parasitology, V34, P367; Hay SI, 1999, TROP MED INT HEALTH, V4, P58, DOI 10.1046/j.1365-3156.1999.00355.x; Hay SI, 1997, INT J REMOTE SENS, V18, P2899, DOI 10.1080/014311697217125; Hay SI, 2000, ADV PARASIT, V47, P1, DOI 10.1016/S0065-308X(00)47005-3; HAYES RO, 1985, B WORLD HEALTH ORGAN, V63, P361; Herbreteau V., 2005, Parassitologia (Rome), V47, P63; Herbreteau V, 2007, HEALTH PLACE, V13, P400, DOI 10.1016/j.healthplace.2006.03.003; Hertzfeld Henry R, 2002, J Technol Transf, V27, P311, DOI 10.1023/A:1020207506064; Higgs G, 2015, ENVIRON HEALTH INSIG, V9, DOI 10.4137/EHI.S15665; Hightower AW, 1998, AM J TROP MED HYG, V58, P266, DOI 10.4269/ajtmh.1998.58.266; Hillson R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112241; Hines JW, 1996, ACTA ASTRONAUT, V38, P261, DOI 10.1016/0094-5765(96)00025-2; Hjort J, 2016, ENVIRON HEALTH PERSP, V124, P619, DOI 10.1289/ehp.1509761; Hoff RM, 2009, J AIR WASTE MANAGE, V59, P645, DOI 10.3155/1047-3289.59.6.645; Hu Y, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003470; Hudson HE, 2005, TELEMED J E-HEALTH, V11, P460, DOI 10.1089/tmj.2005.11.460; Hughes S, 2007, AUSTRALAS PHYS ENG S, V30, P292, DOI 10.1007/BF03178440; HUGHJONES M, 1989, PARASITOL TODAY, V5, P244, DOI 10.1016/0169-4758(89)90256-1; Hunter PD, 2010, REMOTE SENS ENVIRON, V114, P2705, DOI 10.1016/j.rse.2010.06.006; Hunter PD, 2009, ENVIRON SCI TECHNOL, V43, P2627, DOI 10.1021/es802977u; Hwang SC, 2000, IEEE T INF TECHNOL B, V4, P212, DOI 10.1109/4233.870031; Hwang SC, 2000, J TELEMED TELECARE, V6, P91, DOI 10.1258/1357633001935103; Hystad P, 2014, ENVIRON HEALTH PERSP, V122, P1095, DOI 10.1289/ehp.1308049; Igarashi T, 2014, GEOSPATIAL HEALTH, V8, pS603, DOI 10.4081/gh.2014.299; Ippoliti C, 2013, GEOSPATIAL HEALTH, V8, P267, DOI 10.4081/gh.2013.72; Jacob BG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002342; Jagai JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038168; James Peter, 2015, Curr Epidemiol Rep, V2, P131; Jarvis-Selinger S, 2008, TELEMED J E-HEALTH, V14, P720, DOI 10.1089/tmj.2007.0108; Jerrett M, 2017, ENVIRON HEALTH PERSP, V125, P552, DOI 10.1289/EHP575; Jia P, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0763-9; Johnson D, 2011, GEOGR COMPASS, V5, P767, DOI 10.1111/j.1749-8198.2011.00442.x; Johnson DP, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-57; Jones JA, 2009, ULTRASOUND MED BIOL, V35, P1059, DOI 10.1016/j.ultrasmedbio.2009.01.002; Jones R, 2006, J ADV NURS, V56, P99, DOI 10.1111/j.1365-2648.2006.03984.x; Jones RW, 2000, J TELEMED TELECARE, V6, P32, DOI 10.1258/1357633001933961; Jossif A, 2007, METHOD INFORM MED, V46, P84; JOVANOVIC P, 1987, ACTA ASTRONAUT, V15, P951, DOI 10.1016/0094-5765(87)90056-7; Junejo ZA, 2007, 3 INT C REC ADV SPAC, DOI [10.1109/RAST.2007.4284074, DOI 10.1109/RAST.2007.4284074]; Jutla A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137828; Jutla A, 2015, FRONT PUBLIC HEALTH, V3, DOI 10.3389/fpubh.2015.00010; Jutla A, 2013, REMOTE SENS LETT, V4, P822, DOI 10.1080/2150704X.2013.802097; Jutla AS, 2012, REMOTE SENS ENVIRON, V123, P196, DOI 10.1016/j.rse.2012.03.005; Jutla AS, 2010, J AM WATER RESOUR AS, V46, P651, DOI 10.1111/j.1752-1688.2010.00448.x; Kabaria CW, 2016, INT J HEALTH GEOGR, V15, DOI 10.1186/s12942-016-0051-y; Kaewwaen Wuthichai, 2015, Interdiscip Perspect Infect Dis, V2015, P909106, DOI 10.1155/2015/909106; Kalluri S, 2007, PLOS PATHOG, V3, P1361, DOI 10.1371/journal.ppat.0030116; Kaminska IA, 2004, ANN AGR ENV MED, V11, P181; Kanthraj GR, 2009, J EUR ACAD DERMATOL, V23, P865, DOI 10.1111/j.1468-3083.2009.03136.x; Kanthraj GR, 2007, INDIAN J DERMATOL VE, V73, P5, DOI 10.4103/0378-6323.30643; Karimi A., 2015, J ADV PARASITOL, V2, P1, DOI [10.14737/journal.jap/201, DOI 10.14737/JOURNAL.JAP/201, 10.14737/JOURNAL. JAP/2014/2.1.1.4]; Kasitipradith N, 2001, INT J MED INFORM, V61, P113, DOI 10.1016/S1386-5056(01)00133-2; Kayser K, 1996, WIEN KLIN WOCHENSCHR, V108, P532; Kayser K., 1995, Archives d'Anatomie et de Cytologie Pathologiques, V43, P196; Kerr J, 2011, AM J PREV MED, V41, P532, DOI 10.1016/j.amepre.2011.07.017; Kesari S, 2013, MEM I OSWALDO CRUZ, V108, P197, DOI 10.1590/0074-0276108022013012; Khan MF, 2012, INNOV SYST SOFTW ENG, V8, P293, DOI 10.1007/s11334-012-0191-6; Kiewra Dorota, 2012, Annals of Parasitology, V58, P181; Kirpich A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004153; Kishi Yuichiro, 2007, Rinsho Byori, V55, P460; Kistemann T, 2002, INT J HYG ENVIR HEAL, V205, P169, DOI 10.1078/1438-4639-00145; Kiuchi T, 2000, METHOD INFORM MED, V39, P353; Kleiner K, 2000, NEW SCI, V165, P7; Kloog I, 2013, EPIDEMIOLOGY, V24, P555, DOI 10.1097/EDE.0b013e318294beaa; Kloog I, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-40; Kocian A, 2011, P IEEE AER C 2011 BI, DOI [10.1109/AERO.2011.5747335, DOI 10.1109/AER0.2011.5747335]; Koike Kenichi, 2003, Igaku Butsuri, V23, P44; Komnakos D, 2007, 18 INT S PERS IND MO; Kondo MC, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-338; Konkel L, 2015, ENVIRON HEALTH PERSP, V123, pA43, DOI 10.1289/ehp.123-A43; Kozlovskaya IB, 2003, ACTA ASTRONAUT, V53, P269, DOI 10.1016/S0094-5765(03)80004-8; Krech T, 2002, INT J MED MICROBIOL, V291, P30, DOI 10.1016/S1438-4221(02)80006-6; Krishnamurthy Ramesh, 2006, AMIA Annu Symp Proc, P991; KUKKONEN CA, 1995, J MED SYST, V19, P263, DOI 10.1007/BF02257177; Kutser T, 2004, LIMNOL OCEANOGR, V49, P2179, DOI 10.4319/lo.2004.49.6.2179; Kutser T, 2006, ESTUAR COAST SHELF S, V67, P303, DOI 10.1016/j.ecss.2005.11.024; Kyriacou E, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-7; Kzar AA, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13010092; Labrador V, SATELLITE COMMUNICAT; Lafaye M, 2013, GEOSPATIAL HEALTH, V8, P279, DOI 10.4081/gh.2013.73; Lai YS, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-359; Lamminen H, 1999, J TELEMED TELECARE, V5, P71, DOI 10.1258/1357633991933323; Larson KM, 2013, GEOPHYS RES LETT, V40, P2657, DOI 10.1002/grl.50556; Lary DJ, 2015, ENVIRON HEALTH INSIG, V9, DOI 10.4137/EHI.S15664; Lary DJ, 2014, GEOSPATIAL HEALTH, V8, pS611, DOI 10.4081/gh.2014.292; LATHERS CM, 1990, J CLIN PHARMACOL, V30, P223, DOI 10.1002/j.1552-4604.1990.tb03465.x; Latifi R, 2008, STUD HEALTH TECHNOL, V131, P1; Latifi R., 2005, EUR SURG, V37, P293; Lauer A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111921; Lee HJ, 2014, ENVIRON RES, V133, P103, DOI 10.1016/j.envres.2014.04.006; Lee HJ, 2012, ENVIRON RES, V118, P8, DOI 10.1016/j.envres.2012.06.011; Lee SJ, 2012, ENVIRON HEALTH PERSP, V120, P1727, DOI 10.1289/ehp.1205006; Li RT, 2016, SPORTS HEALTH, V8, P74, DOI 10.1177/1941738115616917; Li ZQ, 2014, SENSORS-BASEL, V14, P21117, DOI 10.3390/s141121117; Li ZC, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8040319; Lin CF, 2009, 9 WSEAS INT C APPL I; Lin CF, 2012, J MED SYST, V36, P511, DOI 10.1007/s10916-010-9496-x; Lin CC, 2006, IEEE T INF TECHNOL B, V10, P696, DOI 10.1109/TITB.2006.874196; Lin G, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/684618; Lin YZ, 2016, MATER TODAY COMMUN, V6, P44, DOI 10.1016/j.mtcomm.2015.12.001; Liss A, 2014, GEOSPATIAL HEALTH, V8, pS647, DOI 10.4081/gh.2014.294; Liu HY, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-93; Liu JC, 2015, ENVIRON RES, V136, P120, DOI 10.1016/j.envres.2014.10.015; Liu Y, 2005, ENVIRON SCI TECHNOL, V39, P3269, DOI 10.1021/es049352m; Liu Y, 2009, ENVIRON HEALTH PERSP, V117, P886, DOI 10.1289/ehp.0800123; Lobitz B, 2000, P NATL ACAD SCI USA, V97, P1438, DOI 10.1073/pnas.97.4.1438; Louis VR, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-50; Lowther SA, 2009, TROP MED INT HEALTH, V14, P70, DOI 10.1111/j.1365-3156.2008.02185.x; Machault V, 2008, J TRAVEL MED, V15, P216, DOI 10.1111/j.1708-8305.2008.00202.x; Machault V, 2014, ISPRS INT J GEO-INF, V3, P1352, DOI 10.3390/ijgi3041352; Machault V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050674; Machault V, 2011, GEOSPATIAL HEALTH, V5, P151, DOI 10.4081/gh.2011.167; Machault V, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-252; MacKerron G, 2013, GLOBAL ENVIRON CHANG, V23, P992, DOI 10.1016/j.gloenvcha.2013.03.010; Mackie S, 2014, J GEOPHYS RES-ATMOS, V119, P2409, DOI 10.1002/2013JD021077; Maglaveras N, 2003, AMIA Annu Symp Proc, P415; Mahapatra AK, 2009, TELEMED J E-HEALTH, V15, P592, DOI 10.1089/tmj.2009.0057; Maheu M., 2002, E HLTH TELEHEALTH TE; Malik AZ, 2007, HEALTHCOM 2007: Ubiquitous Healthcare in Aging Societies, P90, DOI 10.1109/HEALTH.2007.381611; Manyangadze T, 2015, GEOSPATIAL HEALTH, V10, P99, DOI 10.4081/gh.2015.326; Marani Roberto, 2010, Open Biomed Eng J, V4, P250, DOI 10.2174/1874120701004010250; Marcantonio M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121158; Masic Z, 2005, ST HEAL T, V116, P267; Masimalai, 2014, INT J MED SCI PUBLIC, V3, P1430, DOI [DOI 10.5455/IJMSPH.2014.081020141, 10.5455/ijmsph.2014.081020141]; Massone C, 2009, SEMIN CUTAN MED SURG, V28, P203, DOI 10.1016/j.sder.2009.06.002; Mattikalli NM, 1996, J ENVIRON MANAGE, V48, P263, DOI 10.1006/jema.1996.0077; Maxwell SK, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-46; Maynard Nancy G, 2007, Alaska Med, V49, P78; McCrorie PRW, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/s12966-014-0093-0; McGuinn LA, 2016, ENVIRON RES, V145, P9, DOI 10.1016/j.envres.2015.10.026; Meade K, 2007, TELEMED J E-HEALTH, V13, P331, DOI 10.1089/tmj.2006.0040; Mendez-Lazaro P, 2014, INT J ENV RES PUB HE, V11, P9409, DOI 10.3390/ijerph110909409; Merrell RC, 2005, TELEMED J E-HEALTH, V11, P511, DOI 10.1089/tmj.2005.11.511; Merrell RC, 2006, J TELEMED TELECARE, V12, P321, DOI 10.1258/135763306778558105; Merrell RC, 2008, STUD HEALTH TECHNOL, V131, P99; Meystre S, 2005, TELEMED J E-HEALTH, V11, P63, DOI 10.1089/tmj.2005.11.63; Midekisa A, 2014, WATER RESOUR RES, V50, P8791, DOI 10.1002/2014WR015634; Midekisa A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-165; Milne H, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-160; Min Z, 2006, CNKI J           MAR; Mishra SK, 2009, TELEMED J E-HEALTH, V15, P568, DOI 10.1089/tmj.2009.0059; Mitka M, 1998, JAMA-J AM MED ASSOC, V280, P1296, DOI 10.1001/jama.280.15.1296; Miyashita T, 2003, CIRC J, V67, P562; Moahi KH, 1999, LIBRI, V49, P43, DOI 10.1515/libr.1999.49.1.43; Mohr M, 2008, STUD HEALTH TECHNOL, V131, P255; Moloney JM, 1998, AM J TROP MED HYG, V59, P261, DOI 10.4269/ajtmh.1998.59.261; Morabito M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127277; Moss WJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-163; Mougiakakou SG, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-49; Mupela Evans N, 2011, Philos Ethics Humanit Med, V6, P9, DOI 10.1186/1747-5341-6-9; Mushinzimana E, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-13; Myers MF, 2000, ADV PARASIT, V47, P309, DOI 10.1016/S0065-308X(00)47013-2; Nagatuma Hideaki, 2003, J Med Syst, V27, P225, DOI 10.1023/A:1022522810200; Nakajima I, 1999, J Med Syst, V23, P425, DOI 10.1023/A:1020512813780; Nakajima I, 2006, 8 INT C E HLTH NETW; Nakajima I, 2011, J MED SYST, V35, P215, DOI 10.1007/s10916-009-9358-6; Newman SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030636; Nicogossian AE, 2001, TELEMED J E-HEALTH, V7, P1, DOI 10.1089/153056201300093813; Niyato D, 2007, IEEE WIREL COMMUN, V14, P72, DOI 10.1109/MWC.2007.314553; Noury-Desvaux B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023027; Nuckols JR, 2004, ENVIRON HEALTH PERSP, V112, P1007, DOI 10.1289/ehp.6738; Nygren D, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-231; O'Connor TM, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-707; O'Sullivan UM, 1999, ST HEAL T, V64, P230; Ohno G, 2012, J TELEMED TELECARE, V18, P473, DOI 10.1258/jtt.2012.GTH111; Okada Y, 2000, METHOD INFORM MED, V39, P343; Olaguer EP, 2015, ENVIRON HEALTH INSIG, V9, P1, DOI 10.4137/EHI.S15654; Oliver M, 2010, J PHYS ACT HEALTH, V7, P102, DOI 10.1123/jpah.7.1.102; OMalley, 2005, INT J SOC RES METHOD, V8, P19, DOI [10.1080/1364557032000119616, DOI 10.1080/1364557032000119616]; Omumbo JA, 2002, PHOTOGRAMM ENG REM S, V68, P161; Oreskovic NM, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1596-6; OTSU Y, 1986, ACTA ASTRONAUT, V13, P459, DOI 10.1016/0094-5765(86)90099-8; Otto C, 1999, ST HEAL T, V64, P270; Ozdenerol E, 2015, INT J ENV RES PUB HE, V12, P15182, DOI 10.3390/ijerph121214971; Pager D, 2002, BIOMED SCI INSTRUM, V38, P283; Pak HS, 2008, TELEMED J E-HEALTH, V14, P389, DOI 10.1089/tmj.2008.0030; Pascal M, 2015, 1 M EXP GROUP SPAC G; Pascal M, 2016, 2 M EXP GROUP SPAC G; Patz J, 2005, ENVIRON HEALTH PERSP, V113, pA84, DOI 10.1289/ehp.113-a84; Paul N L, 1997, J Telemed Telecare, V3 Suppl 1, P52, DOI 10.1258/1357633971930364; Pereira G, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-466; Perry B, 2000, SOC SCI MED, V50, P1177, DOI 10.1016/S0277-9536(99)00364-0; Polo G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143736; POPE KO, 1994, ECOL APPL, V4, P81, DOI 10.2307/1942117; Prosser DJ, 2009, IBIS, V151, P568, DOI 10.1111/j.1474-919X.2009.00932.x; Pyke J, 2007, P ANN INT IEEE EMBS, P3094, DOI 10.1109/IEMBS.2007.4352982; Rahman A, 2006, AM J TROP MED HYG, V74, P17, DOI 10.4269/ajtmh.2006.74.17; Rahman A, 2010, AM J TROP MED HYG, V82, P1004, DOI 10.4269/ajtmh.2010.09-0201; Rai Praveen Kumar, 2013, Inform Prim Care, V21, P43, DOI 10.14236/jhi.v21i1.38; Rakotomanana F, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-173; Ramesh Masthi N R, 2012, Indian J Med Sci, V66, P13; Carvalho LFR, 2012, PREV VET MED, V103, P74, DOI 10.1016/j.prevetmed.2011.08.006; Rao U R, 1995, J Med Syst, V19, P295, DOI 10.1007/BF02257181; Rashidi M, 2013, J RES MED SCI, V18, P1074; Rayman R, 2007, INT J MED ROBOT COMP, V3, P111, DOI 10.1002/rcs.133; Rayman R, 2005, LECT NOTES COMPUT SC, V3750, P57; Reith A, 2008, STUD HEALTH TECHNOL, V134, P209; Richardson DB, 2013, SCIENCE, V339, P1390, DOI 10.1126/science.1232257; Ricke J, 1995, J Telemed Telecare, V1, P224; Rizou D, 2009, IEEE ENG MED BIO, P1254, DOI 10.1109/IEMBS.2009.5333908; Rob, 2011, HOW GNSS WORKS; Robinson TP, 2000, ADV PARASIT, V47, P81, DOI 10.1016/S0065-308X(00)47007-7; Roelfsema CM, 2006, HARMFUL ALGAE, V5, P45, DOI 10.1016/j.hal.2005.05.001; Ronga L. S., 2012, IEEE International Conference on Communications (ICC 2012), P3286, DOI 10.1109/ICC.2012.6363952; Ross MD, 2001, ACTA ASTRONAUT, V49, P441, DOI 10.1016/S0094-5765(01)00118-7; ROUSE DJ, 1981, MED INSTRUM, V15, P234; ROUSE DJ, 1991, ACTA ASTRONAUT, V25, P103, DOI 10.1016/0094-5765(91)90067-F; Sadiq MA, 2006, HLTH COM 2006 8 INT, DOI 10.1109/HEALTH.2006.246414; Samothrakis S, 1997, INT J MED INFORM, V47, P69, DOI 10.1016/S1386-5056(97)00078-6; Samson DM, 2015, J VECTOR ECOL, V40, P46, DOI 10.1111/jvec.12131; Sarfraz MS, 2014, GEOSPATIAL HEALTH, V8, pS685, DOI 10.4081/gh.2014.297; Sargsyan AE, 2005, J TRAUMA, V58, P35, DOI 10.1097/01.TA.0000145083.47032.78; Satava R, 2000, TELEMED J E-HEALTH, V6, P303, DOI 10.1089/153056200750040165; Satyanarayana K, 2013, J Med Eng, V2013, P363508, DOI 10.1155/2013/363508; Sawai T, 2000, Rinsho Byori, V48, P458; Saxena R, 2014, J VECTOR DIS, V51, P276; Saxena R, 2014, J VECTOR DIS, V51, P211; Scholte RGC, 2013, GEOSPATIAL HEALTH, V8, P97, DOI 10.4081/gh.2013.58; Schuster G, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-8; Seltenrich N, 2014, ENVIRON HEALTH PERSP, V122, pA268, DOI 10.1289/ehp.122-A268; Sewe MO, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154204; Shi WZ, 2012, SENSORS-BASEL, V12, P6825, DOI 10.3390/s120606825; Shimizu K, 1999, IEEE ENG MED BIOL, V18, P32, DOI 10.1109/51.775487; Shin JH, 2016, AVIAN DIS, V60, P311, DOI 10.1637/11096-042015-Reg; Shirayama Y, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-217; Sibert K, 2008, TELEMED J E-HEALTH, V14, P266, DOI 10.1089/tmj.2007.0050; Silue KD, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-111; Simis SGH, 2007, REMOTE SENS ENVIRON, V106, P414, DOI 10.1016/j.rse.2006.09.008; Simmons SC, 2003, J AM MED INFORM ASSN, V10, P166, DOI 10.1197/jamia.M1205; Simmons S, 2008, TELEMED J E-HEALTH, V14, P968, DOI 10.1089/tmj.2008.0117; Simoonga C, 2009, PARASITOLOGY, V136, P1683, DOI 10.1017/S0031182009006222; Singh IP, 2008, TELEMED J E-HEALTH, V14, P846, DOI 10.1089/tmj.2008.0095; Sithiprasasna Ratana, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P14; Smith LR, 2014, SKELET MUSCLE, V4, DOI 10.1186/2044-5040-4-21; Song DP, 2013, INT J ENV RES PUB HE, V10, P5163, DOI 10.3390/ijerph10105163; Song YQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep17628; Sood S, 2007, TELEMED J E-HEALTH, V13, P573, DOI 10.1089/tmj.2006.0073; Soti V, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-10; Sotoudeheian S, 2014, J ENVIRON HEALTH SCI, V12, DOI 10.1186/s40201-014-0122-6; Guimaraes RJDS, 2010, MEM I OSWALDO CRUZ, V105, P524, DOI 10.1590/S0074-02762010000400030; Spear RC, 2004, AM J TROP MED HYG, V70, P48, DOI 10.4269/ajtmh.2004.70.48; Spear RC, 2002, ENVIRON HEALTH PERSP, V110, P907, DOI 10.1289/ehp.02110907; Sprigg W, 2009, SPIE NEWSROOM, P1, DOI [10.1117/2.1200902.1488, DOI 10.1117/2.1200902.1488]; Srivastava S, 2015, COMPUT MATH METHOD M, V2015, DOI 10.1155/2015/894171; Stadler H, 2003, WATER SCI TECHNOL, V47, P197, DOI 10.2166/wst.2003.0119; Stefani A, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-192; Stefani A, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-65; Stoloff PH, 1998, TELEMED J, V4, P293, DOI 10.1089/tmj.1.1998.4.293; Stothard JR, 2011, T ROY SOC TROP MED H, V105, P500, DOI 10.1016/j.trstmh.2011.05.007; Sudhamony S, 2008, IET COMMUN, V2, P231, DOI 10.1049/iet-com:20060701; Tachakra S, 2003, TELEMED J E-HEALTH, V9, P247, DOI 10.1089/153056203322502632; Takahashi T, 2001, INT J MED INFORM, V61, P131, DOI 10.1016/S1386-5056(01)00135-6; Takizawa M, 1998, J TELEMED TELECARE, V4, P146; Takizawa Masaomi, 2003, Igaku Butsuri, V23, P51; Tan J, 2016, J COMPUTER INFORM SY, V42, P7, DOI [10.1080/08874417.2002.11647605, DOI 10.1080/08874417.2002.11647605]; Tangalos E G, 1997, J Telemed Telecare, V3, P40, DOI 10.1258/1357633971930184; Tassetto D, 2011, INT J SATELL COMM N, V29, P461, DOI 10.1002/sat.984; Tatem AJ, 2004, J URBAN HEALTH, V81, P363, DOI 10.1093/jurban/jth124; Tatem AJ, 2004, REMOTE SENS ENVIRON, V93, P42, DOI 10.1016/j.rse.2004.06.014; Tenbrink T, 2014, REPRESENTING SPACE C; Texier G, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-87; Thanapongtharm W, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0390-0; Thanapongtharm W, 2013, GEOSPATIAL HEALTH, V8, P193, DOI 10.4081/gh.2013.66; Thierry B, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-14; Thomas CJ, 2000, T ROY SOC TROP MED H, V94, P159, DOI 10.1016/S0035-9203(00)90257-8; Thomson DR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093925; Tian HY, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0770-x; Torbick N, 2015, INT J ENV RES PUB HE, V12, P11560, DOI 10.3390/ijerph120911560; Torbick N, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-1; Tourre YM, 2009, GLOBAL HEALTH ACTION, V2, P133, DOI 10.3402/gha.v2i0.2053; Townshend AD, 2008, MED SCI SPORT EXER, V40, P124, DOI 10.1249/mss.0b013e3181590bc2; Tran A, 2013, INT J ENV RES PUB HE, V10, P1698, DOI 10.3390/ijerph10051698; Tran A, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-9; Tulu B, 2007, TELEMED J E-HEALTH, V13, P349, DOI 10.1089/tmj.2006.0055; Tymms PB, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009318; Tyrer H W, 2001, Biomed Sci Instrum, V37, P417; Tyrer H W, 1999, Biomed Sci Instrum, V35, P111; van Donkelaar A, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006996; van Donkelaar A, 2015, ENVIRON HEALTH PERSP, V123, P135, DOI 10.1289/ehp.1408646; VandenBos GR, 2000, PROF PSYCHOL-RES PR, V31, P490, DOI 10.1037/0735-7028.31.5.490; Vargas A, 2014, REV PANAM SALUD PUBL, V35, P359; Varshney U, 2007, MOBILE NETW APPL, V12, P113, DOI 10.1007/s11036-007-0017-1; Vieyres P, 2003, IND ROBOT, V30, P77, DOI 10.1108/01439910310457742; Vouyioukas D, 2007, J MED SYST, V31, P237, DOI 10.1007/s10916-007-9061-4; Walsh SJ, 2010, J LAT AM GEOGR, V9, P137, DOI 10.1353/lag.2010.0024; Walz Y, 2015, GEOSPATIAL HEALTH, V10, P271, DOI 10.4081/gh.2015.398; Walz Y, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004217; Walz Y, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0732-6; Wang YC, 2013, GEOSPATIAL HEALTH, V8, P111, DOI 10.4081/gh.2013.59; Wang Y, 2015, INT J ENV RES PUB HE, V12, P15843, DOI 10.3390/ijerph121215025; Wang ZX, 2013, ENVIRON INT, V51, P150, DOI 10.1016/j.envint.2012.10.011; Ward MH, 2005, EPIDEMIOLOGY, V16, P542, DOI 10.1097/01.ede.0000165364.54925.f3; Ward MH, 2000, ENVIRON HEALTH PERSP, V108, P5, DOI 10.2307/3454289; WASHINO RK, 1994, AM J TROP MED HYG, V50, P134, DOI 10.4269/ajtmh.1994.50.134; WATSON DS, 1989, MED J AUSTRALIA, V151, P62, DOI 10.5694/j.1326-5377.1989.tb101162.x; Watson DS, 1989, MED J AUSTRALIA, V151, P71; Wei L, 2011, AM J TROP MED HYG, V84, P497, DOI 10.4269/ajtmh.2011.10-0314; Wieters KM, 2012, J PHYS ACT HEALTH, V9, P913, DOI 10.1123/jpah.9.7.913; Wilke D, 1999, ACTA ASTRONAUT, V44, P579, DOI 10.1016/S0094-5765(99)00065-X; WINFIELD D, 1994, INVEST RADIOL, V29, P507, DOI 10.1097/00004424-199404000-00021; Winfield DL, 1997, ACTA ASTRONAUT, V41, P515, DOI 10.1016/S0094-5765(98)00054-X; Witheetrirong Y, 2011, INT J ENV RES PUB HE, V8, P3416, DOI 10.3390/ijerph8083416; Wood BL, 2000, ADV PARASIT, V47, P331, DOI 10.1016/S0065-308X(00)47014-4; Woodall J, 1997, INT J MED INFORM, V47, P31, DOI 10.1016/S1386-5056(97)00079-8; WU J, 2013, ENVIRON HEALTH GLOB, V12; Wu J, 2010, ENVIRON HEALTH INSIG, V4, P93, DOI 10.4137/EHI.S6246; Wynne TT, 2015, TOXINS, V7, P1649, DOI 10.3390/toxins7051649; Xu LY, 2014, INT J ENV RES PUB HE, V11, P12368, DOI 10.3390/ijerph111212368; Xu M, 2015, INT J ENV RES PUB HE, V12, P354, DOI 10.3390/ijerph120100354; Xu ZW, 2014, SCI REP-UK, V4, DOI 10.1038/srep05389; Yamaguchi T, 1997, J Telemed Telecare, V3, P78, DOI 10.1258/1357633971930904; Yamashita S, 1999, THYROID, V9, P969, DOI 10.1089/thy.1999.9.969; Yamauchi K, 2000, Nagoya J Med Sci, V63, P19; Yan L, 2007, EMERG INFECT DIS, V13, P1301, DOI 10.3201/eid1309.061481; Yang GJ, 2005, ACTA TROP, V96, P117, DOI 10.1016/j.actatropica.2005.07.006; Yang GJ, 2006, GEOSPATIAL HEALTH, V1, P85, DOI 10.4081/gh.2006.283; Yang K, 2008, WASTE MANAGE, V28, P2750, DOI 10.1016/j.wasman.2008.01.021; Yao JY, 2014, J EXPO SCI ENV EPID, V24, P328, DOI 10.1038/jes.2013.87; Yao JY, 2013, ENVIRON HEALTH PERSP, V121, P1142, DOI 10.1289/ehp.1306768; Yao L, 2014, INT J ENV RES PUB HE, V11, P5241, DOI 10.3390/ijerph110505241; Yokota K, 2001, ST HEAL T, V84, P866; Watanabe FSY, 2015, INT J ENV RES PUB HE, V12, P10391, DOI 10.3390/ijerph120910391; Zaidan BB, 2011, INT J PHARMACOL, V7, P382, DOI 10.3923/ijp.2011.382.387; Zhang F, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/s12940-015-0026-7; Zhang ZJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069447; Zhang ZJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-11; Zhao JP, 2010, TELEMED J E-HEALTH, V16, P634, DOI 10.1089/tmj.2009.0159; Zhu HR, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004028; Ziadlou D, 2008, 2008 3 INT C BROADB; Zou L, 2006, J MED ENTOMOL, V43, P1034, DOI 10.1603/0022-2585(2006)43[1034:MLHMUR]2.0.CO;2	483	10	10	3	21	JMIR PUBLICATIONS, INC	TORONTO	130 QUEENS QUAY E, STE 1102, TORONTO, ON M5A 0P6, CANADA	1438-8871			J MED INTERNET RES	J. Med. Internet Res.	JUN	2018	20	6							e230	10.2196/jmir.9458			35	Health Care Sciences & Services; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Medical Informatics	GL8TR	WOS:000437499500003	29950289	Green Published, gold, Green Submitted			2022-03-04	
J	Lombardi, T; Philippeaux, MM; Hadengue, A; Samson, J; Borisch, B; Rubbia-Brandt, L				Lombardi, T; Philippeaux, MM; Hadengue, A; Samson, J; Borisch, B; Rubbia-Brandt, L			Absence of leukocyte microchimerism in oral lichen planus (OLP): an in situ hybridisation study	JOURNAL OF ORAL PATHOLOGY & MEDICINE			English	Article						in situ hybridisation; lichen planus; microchimerism; mouth mucosa	PRIMARY BILIARY-CIRRHOSIS; HEPATITIS-C VIRUS; LUPUS-ERYTHEMATOSUS; MATERNAL BLOOD; FETAL MICROCHIMERISM; PERIPHERAL-BLOOD; CELL SUBSETS; Y-CHROMOSOME; ANTIBODIES; LESIONS	Oral lichen planus (OLP) is a relatively common chronic inflammatory disease. The majority of patients are between 30 and 50 years of age with a higher incidence in females. The aetiology is unknown and various hypotheses on the pathogenic mechanisms, including autoimmunity, have been proposed over the years. In the present study, we investigated whether leukocyte microchimerism, a biological situation implicated in the aetiology of some autoimmune diseases, might play a role in the pathogenesis of OLP. We used in situ hybridisation to identify Y chromosome DNA in a series of formalin-fixed paraffin-mbedded oral mucosa biopsies of women with established clinical and histological disease who had given birth to a male child. The positive control, two mucosal specimens from a man with OLP, showed over 90% of keratinocytes and cells within the inflammatory infiltrate, a positive nuclear signal. The negative control, biopsies from three women having carried only female foetuses and one nulliparous woman, all with OLP, did not show any nuclear signal. In the fifteen selected cases of OLP biopsies from women who had on ly ma le offspring, nucleated cells containing the Y chromosome were not detected within the chronic inflammatory infiltrate. These results suggest that unlike some other immunologically mediated diseases, leukocyte microchimerism does not seems to be involved in the pathogenesis of OLP.	Univ Geneva, Div Stomatol & Oral Surg, CH-1211 Geneva 4, Switzerland; Univ Geneva, Div Clin Pathol, CH-1211 Geneva 4, Switzerland; Univ Geneva, Div Gastroenterol & Hepatol, CH-1211 Geneva 4, Switzerland		Lombardi, T (corresponding author), Div Stomatol, Oral Histopathol Lab, 19 Rue Barthelemy Menn, CH-1211 Geneva 4, Switzerland.	Tommaso.Lombardi@Medecine.unige.ch	Borisch, Bettina/AAG-8212-2019	Borisch, Bettina/0000-0002-9902-324X			ARONSON IK, 1978, ARCH DERMATOL, V114, P255, DOI 10.1001/archderm.114.2.255; Artlett CM, 1998, NEW ENGL J MED, V338, P1186, DOI 10.1056/NEJM199804233381704; AXELL T, 1976, ODONTOL REVY, V27, P1; Bermejo Fenoll A, 1991, AV ODONTOESTOMATOL, V7, P38; Bianchi DW, 1996, P NATL ACAD SCI USA, V93, P705, DOI 10.1073/pnas.93.2.705; BIANCHI DW, 1995, J PEDIATR-US, V127, P847, DOI 10.1016/S0022-3476(95)70018-8; Blomgren J, 1996, J ORAL PATHOL MED, V25, P311, DOI 10.1111/j.1600-0714.1996.tb00268.x; BOUQUOT JE, 1986, ORAL SURG ORAL MED O, V61, P373, DOI 10.1016/0030-4220(86)90422-6; Bramanti TE, 1995, ORAL SURG ORAL MED O, V80, P698, DOI 10.1016/S1079-2104(05)80254-9; BROWN RS, 1993, J ORAL PATHOL MED, V22, P69, DOI 10.1111/j.1600-0714.1993.tb00046.x; Camisa C, 1999, CUTIS, V63, P189; Carrizosa AM, 1997, EXP DERMATOL, V6, P54, DOI 10.1111/j.1600-0625.1997.tb00146.x; Carrozzo M, 1999, J ORAL PATHOL MED, V28, P16; Chaiyarit P, 1999, J ORAL PATHOL MED, V28, P210; Chung MS, 1999, AM J OPHTHALMOL, V128, P364, DOI 10.1016/S0002-9394(99)00141-5; DAVIES MG, 1977, BRIT J DERMATOL, V96, P145, DOI 10.1111/j.1365-2133.1977.tb12536.x; Evans PC, 1999, BLOOD, V93, P2033, DOI 10.1182/blood.V93.6.2033.406k18_2033_2037; Farmer E R, 1986, Adv Dermatol, V1, P173; FENOLL AB, 1991, AV ODONTOESTOMATOL, V7, P29; FENOLL AB, 1991, AV ODONTOESTOMATOL, V7, P36; GART GS, 1994, CUTIS, V53, P249; ISHII T, 1987, J ORAL PATHOL MED, V16, P356, DOI 10.1111/j.1600-0714.1987.tb00708.x; JONTELL M, 1990, J ORAL PATHOL MED, V19, P273, DOI 10.1111/j.1600-0714.1990.tb00841.x; Koch P, 1999, J AM ACAD DERMATOL, V41, P422, DOI 10.1016/S0190-9622(99)70116-7; Laine J, 1997, CONTACT DERMATITIS, V36, P141, DOI 10.1111/j.1600-0536.1997.tb00396.x; Larsson A, 1995, Oral Dis, V1, P152; LIN SC, 1992, J AM ACAD DERMATOL, V26, P943, DOI 10.1016/0190-9622(92)70138-6; LO YMD, 1990, LANCET, V335, P1463, DOI 10.1016/0140-6736(90)91491-R; Lodi G, 1997, J ORAL PATHOL MED, V26, P36, DOI 10.1111/j.1600-0714.1997.tb00007.x; LUNDSTROM IMC, 1985, INT J ORAL MAXILLOF, V14, P259, DOI 10.1016/S0300-9785(85)80037-5; Maloney S, 1999, J CLIN INVEST, V104, P41, DOI 10.1172/JCI6611; McCartan B, 1998, ORAL SURG ORAL MED O, V85, P493, DOI 10.1016/S1079-2104(98)90278-5; McCartan B E, 1997, Oral Dis, V3, P58; Nelson JL, 1999, LUPUS, V8, P370, DOI 10.1177/096120339900800508; Nelson JL, 1998, LANCET, V351, P559, DOI 10.1016/S0140-6736(97)08357-8; OLEAGA JM, 1995, ACTA DERM-VENEREOL, V75, P87; Ostman PO, 1996, ORAL SURG ORAL MED O, V81, P459, DOI 10.1016/S1079-2104(96)80024-2; Rubbia-Brandt L, 1999, HEPATOLOGY, V30, P821, DOI 10.1002/hep.510300322; SCHIODT M, 1983, ACTA PATH MICRO IM C, V91, P59; Scully C, 1998, CRIT REV ORAL BIOL M, V9, P86, DOI 10.1177/10454411980090010501; SILVERMAN S, 1985, ORAL SURG ORAL MED O, V60, P30, DOI 10.1016/0030-4220(85)90210-5; SILVERMAN S, 1991, ORAL SURG ORAL MED O, V72, P665, DOI 10.1016/0030-4220(91)90007-Y; STINGL G, 1975, BRIT J DERMATOL, V93, P313, DOI 10.1111/j.1365-2133.1975.tb06497.x; STRAUSS RA, 1989, ORAL SURG ORAL MED O, V68, P406, DOI 10.1016/0030-4220(89)90137-0; Sugerman P B, 1993, Australas J Dermatol, V34, P63; Tanaka A, 1999, HEPATOLOGY, V30, P833, DOI 10.1002/hep.510300410; Tanei Ryoji, 1997, Journal of Dermatology (Tokyo), V24, P20; THOMAS MR, 1994, LANCET, V343, P413, DOI 10.1016/S0140-6736(94)91248-3; THORN JJ, 1988, J ORAL PATHOL MED, V17, P213, DOI 10.1111/j.1600-0714.1988.tb01527.x; WALSH LJ, 1990, J ORAL PATHOL MED, V19, P389, DOI 10.1111/j.1600-0714.1990.tb00866.x; WHO Collaborating Centre for Oral Precancerous Lesions, 1978, ORAL SURG ORAL MED O, V46, P518; Woo SB, 1997, CRIT REV ORAL BIOL M, V8, P201, DOI 10.1177/10454411970080020701	52	6	7	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0904-2512	1600-0714		J ORAL PATHOL MED	J. Oral Pathol. Med.	AUG	2001	30	7					398	401		10.1034/j.1600-0714.2001.300703.x			4	Dentistry, Oral Surgery & Medicine; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine; Pathology	452XJ	WOS:000169884700003	11488416				2022-03-04	
J	Bischof, P				Bischof, P			Cellular and molecular aspects of human implantation	PLACENTA			English	Meeting Abstract	Joint Meeting of the 2nd Latinamerican Symposium on Fetal-Mateanal Interaction and Placenta/19th Annual Meeting of the Chilean-Society-of-Physiological-Sciences	NOV 06-09, 2005	Santiago, CHILE	Chilean Soc Physiol Sci					Univ Geneva, Dept Obstet & Gynaecol, Geneva, Switzerland									0	0	0	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0143-4004			PLACENTA	Placenta	JAN	2006	27	1					A20	A20					1	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	993YM	WOS:000233996200071					2022-03-04	
J	Cohen, M; Bischof, P				Cohen, M.; Bischof, P.			Involvement of p53 and its partners in regulating trophoblastic invasiveness	PLACENTA			English	Meeting Abstract	14th Meeting of the International-Federation-of-Placental-Associations/12th Meeting of the European-Placenta-Group (IFPA/EPG)	SEP 10-13, 2008	Seggau Castle, AUSTRIA	Int Federat Placenta Assoc, European Placenta Grp					[Cohen, M.; Bischof, P.] Fac Med, Geneva, Switzerland									0	0	0	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0143-4004			PLACENTA	Placenta	AUG	2008	29	8					A91	A91					1	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	345XM	WOS:000259031100334					2022-03-04	
J	Cohen, M; Meisser, A; Bischof, P				Cohen, M.; Meisser, A.; Bischof, P.			Metalloproteinases and human placental invasiveness	PLACENTA			English	Review						metalloproteinases; invasion; trophoblast	TUMOR-NECROSIS-FACTOR; TYPE-1 MATRIX-METALLOPROTEINASE; HUMAN NEUTROPHIL PROCOLLAGENASE; STEPWISE ACTIVATION MECHANISMS; HUMAN CYTOTROPHOBLAST CELLS; LEUKEMIA INHIBITORY FACTOR; IV COLLAGENASE EXPRESSION; GELATINASE-A MMP-2; GROWTH-FACTOR-BETA; TISSUE INHIBITOR	Matrix metalloproteinases (MMPs) are the main mediators of extracellular matrix degradation. This confers an important role to these enzymes in the invasion of the trophoblast cells where their expression are spatiotemporally regulated. The regulation of MMPs activity is complex and is established at different levels. Their expressions depend on various cis-elements in their gene promoter, and are induced or repressed by various soluble factors. After expression and secretion, the proMMPs must be activated through an activation network. Then, the enzyme activity is regulated by inhibition or stabilization. In this review, we shall focus on the expression, the role in invasion and the regulation of MMPs in the human placenta.	Univ Geneva, Hormone Lab, Dept Obstet & Gynaecol Matern, CH-1211 Geneva 14, Switzerland		Bischof, P (corresponding author), Univ Geneva, Hormone Lab, Dept Obstet & Gynaecol Matern, 32 Blvd Cluse, CH-1211 Geneva 14, Switzerland.	paul.bischof@hcuge.ch		cohen, marie/0000-0003-4621-5464			AGARWAL C, 1994, CANCER RES, V54, P943; Ala-Aho R, 2002, ONCOGENE, V21, P1187, DOI 10.1038/sj/onc/1205198; Bai SX, 2005, REPRODUCTION, V129, P103, DOI 10.1530/rep.1.00283; Baker AH, 2002, J CELL SCI, V115, P3719, DOI 10.1242/jcs.00063; Bannikov GA, 2002, J BIOL CHEM, V277, P16022, DOI 10.1074/jbc.M110931200; Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; Bian JH, 1997, MOL CELL BIOL, V17, P6330, DOI 10.1128/MCB.17.11.6330; Bischof P, 2000, BEST PRACT RES CL OB, V14, P801, DOI 10.1053/beog.2000.0120; Bischof P, 1995, Early Pregnancy, V1, P263; BISCHOF P, 1995, AM J REPROD IMMUNOL, V34, P225, DOI 10.1111/j.1600-0897.1995.tb00945.x; Bischof P, 2003, PLACENTA, V24, P155, DOI 10.1053/plac.2002.0890; BISCHOF P, 1991, AM J OBSTET GYNECOL, V165, P1791, DOI 10.1016/0002-9378(91)90034-O; Bjorn SF, 2000, PLACENTA, V21, P170, DOI 10.1053/plac.1999.0447; Bode W, 1999, CELL MOL LIFE SCI, V55, P639, DOI 10.1007/s000180050320; Booth NA, 1999, BEST PRACT RES CL HA, V12, P423, DOI 10.1053/beha.1999.0034; Boyd RS, 1999, BRIT J CANCER, V80, P315, DOI 10.1038/sj.bjc.6690357; Brew K, 2000, BBA-PROTEIN STRUCT M, V1477, P267, DOI 10.1016/S0167-4838(99)00279-4; Castellucci M, 2000, MOL HUM REPROD, V6, P951, DOI 10.1093/molehr/6.10.951; Chakraborty C, 2002, CAN J PHYSIOL PHARM, V80, P116, DOI 10.1139/Y02-016; Cho A, 2000, ARTERIOSCL THROM VAS, V20, P2527, DOI 10.1161/01.ATV.20.12.2527; Chou CS, 2003, J CLIN ENDOCR METAB, V88, P4781, DOI 10.1210/jc.2003-030659; CONESE M, 1995, BAILLIERE CLIN HAEM, V8, P365, DOI 10.1016/S0950-3536(05)80273-2; Cossins J, 1996, BIOCHEM BIOPH RES CO, V228, P494, DOI 10.1006/bbrc.1996.1688; CRABBE T, 1994, BIOCHEMISTRY-US, V33, P14419, DOI 10.1021/bi00252a007; CRABBE T, 1993, EUR J BIOCHEM, V218, P431, DOI 10.1111/j.1432-1033.1993.tb18393.x; CURRY VA, 1992, BIOCHEM J, V285, P143, DOI 10.1042/bj2850143; d'Ortho MP, 1997, EUR J BIOCHEM, V250, P751, DOI 10.1111/j.1432-1033.1997.00751.x; DAMSKY CH, 1992, J CLIN INVEST, V89, P210, DOI 10.1172/JCI115565; Dano K, 1999, APMIS, V107, P120, DOI 10.1111/j.1699-0463.1999.tb01534.x; de Coignac AB, 2000, EUR J BIOCHEM, V267, P3323; DONEHOWER LA, 1993, BIOCHIM BIOPHYS ACTA, V1155, P181, DOI 10.1016/0304-419X(93)90004-V; Dong JC, 2002, REPRODUCTION, V123, P621, DOI 10.1530/reprod/123.5.621; Dong Z, 2001, INT J CANCER, V93, P507, DOI 10.1002/ijc.1358; Douglas DA, 1997, J PROTEIN CHEM, V16, P237, DOI 10.1023/A:1026348808069; Doyle GAR, 1997, J BIOL CHEM, V272, P11840, DOI 10.1074/jbc.272.18.11840; EECKHOUT Y, 1977, BIOCHEM J, V166, P21, DOI 10.1042/bj1660021; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Ellis V, 1999, BIOCHEMISTRY-US, V38, P651, DOI 10.1021/bi981714d; EMONARD H, 1990, INVAS METAST, V10, P170; EMONARD H, 1990, MATRIX, V10, P373, DOI 10.1016/S0934-8832(11)80144-7; FEINBERG RF, 1994, J CLIN ENDOCR METAB, V78, P1241, DOI 10.1210/jc.78.5.1241; Ferry G, 1997, FEBS LETT, V402, P111, DOI 10.1016/S0014-5793(96)01508-6; Freitas S, 1999, BIOL REPROD, V61, P1070, DOI 10.1095/biolreprod61.4.1070; FRIDMAN R, 1995, CANCER RES, V55, P2548; Gomez DE, 1997, EUR J CELL BIOL, V74, P111; GRAHAM CH, 1991, J CELL PHYSIOL, V148, P228, DOI 10.1002/jcp.1041480207; GRUBER BL, 1989, J CLIN INVEST, V84, P1657, DOI 10.1172/JCI114344; Gu ZZ, 2002, SCIENCE, V297, P1186, DOI 10.1126/science.1073634; Gum R, 1997, ONCOGENE, V14, P1481, DOI 10.1038/sj.onc.1200973; Hamilton GS, 1998, EXP CELL RES, V244, P147, DOI 10.1006/excr.1998.4195; Han VKM, 1996, J CLIN ENDOCR METAB, V81, P2680, DOI 10.1210/jc.81.7.2680; Hills FA, 2004, J ENDOCRINOL, V183, P487, DOI 10.1677/joe.1.05867; Himelstein BP, 1998, CLIN EXP METASTAS, V16, P169; HOWARD EW, 1991, J BIOL CHEM, V266, P13064; Hurskainen T, 1998, J HISTOCHEM CYTOCHEM, V46, P221, DOI 10.1177/002215549804600211; Hurskainen T, 1996, J HISTOCHEM CYTOCHEM, V44, P1379, DOI 10.1177/44.12.8985130; IMAI K, 1995, J BIOL CHEM, V270, P6691, DOI 10.1074/jbc.270.12.6691; Isaka K, 2003, PLACENTA, V24, P53, DOI 10.1053/plac.2002.0867; Karmakar S, 2004, J BIOL CHEM, V279, P55297, DOI 10.1074/jbc.M407013200; KNAUPER V, 1993, BIOCHEM J, V295, P581; Knauper V, 1996, J BIOL CHEM, V271, P17124, DOI 10.1074/jbc.271.29.17124; Knauper V, 1996, EUR J BIOCHEM, V235, P187, DOI 10.1111/j.1432-1033.1996.00187.x; Knauper V, 1997, EUR J BIOCHEM, V248, P369, DOI 10.1111/j.1432-1033.1997.00369.x; KNAUPER V, 1990, EUR J BIOCHEM, V189, P295, DOI 10.1111/j.1432-1033.1990.tb15489.x; Kolkenbrock H, 1997, BIOL CHEM, V378, P71, DOI 10.1515/bchm.1997.378.2.71; Lee JS, 1996, MOL CELL BIOL, V16, P4312; Lewis TS, 1998, ADV CANCER RES, V74, P49, DOI 10.1016/S0065-230X(08)60765-4; LIBRACH CL, 1994, J BIOL CHEM, V269, P17125; LIBRACH CL, 1991, J CELL BIOL, V113, P437, DOI 10.1083/jcb.113.2.437; Llano E, 1999, CANCER RES, V59, P2570; Lochter A, 1999, MOL BIOL CELL, V10, P271, DOI 10.1091/mbc.10.2.271; LOHI J, 1992, J CELL BIOCHEM, V50, P337, DOI 10.1002/jcb.240500402; Maruo T, 1995, Early Pregnancy, V1, P54; Massova I, 1998, FASEB J, V12, P1075, DOI 10.1096/fasebj.12.12.1075; McKinnon T, 2001, J CLIN ENDOCR METAB, V86, P3665, DOI 10.1210/jc.86.8.3665; McLaughlin B, 1996, BIOCHEM J, V317, P739, DOI 10.1042/bj3170739; Meisser A, 1999, MOL HUM REPROD, V5, P1055, DOI 10.1093/molehr/5.11.1055; Meissner A, 1999, MOL HUM REPROD, V5, P252, DOI 10.1093/molehr/5.3.252; MILES LA, 1991, BIOCHEMISTRY-US, V30, P1682, DOI 10.1021/bi00220a034; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; NAGASE H, 1990, BIOCHEMISTRY-US, V29, P5783, DOI 10.1021/bi00476a020; NAGASE H, 1991, BIOMED BIOCHIM ACTA, V50, P749; Nagase H, 1997, BIOL CHEM, V378, P151; Nakamura H, 1998, EUR J BIOCHEM, V253, P67, DOI 10.1046/j.1432-1327.1998.2530067.x; Nawrocki B, 1996, PLACENTA, V17, P565, DOI 10.1016/S0143-4004(96)80073-7; NICHOLSON R, 1989, BIOCHEMISTRY-US, V28, P5195, DOI 10.1021/bi00438a042; Novaro V, 2001, REPROD FERT DEVELOP, V13, P411, DOI 10.1071/RD01036; OGATA Y, 1992, J BIOL CHEM, V267, P3581; Ohuchi E, 1997, J BIOL CHEM, V272, P2446, DOI 10.1074/jbc.272.4.2446; OKADA Y, 1989, FEBS LETT, V249, P353, DOI 10.1016/0014-5793(89)80657-X; Oki N, 2004, J CLIN ENDOCR METAB, V89, P5213, DOI 10.1210/jc.2004-0352; OVERALL CM, 1991, J BIOL CHEM, V266, P14064; Parsons SL, 1997, BRIT J SURG, V84, P160, DOI 10.1046/j.1365-2168.1997.02719.x; PEI DQ, 1995, NATURE, V375, P244, DOI 10.1038/375244a0; PEKONEN F, 1988, J CLIN ENDOCR METAB, V67, P1250, DOI 10.1210/jcem-67-6-1250; Pendas AM, 1997, J BIOL CHEM, V272, P4281, DOI 10.1074/jbc.272.7.4281; Philip S, 2001, J BIOL CHEM, V276, P44926, DOI 10.1074/jbc.M103334200; POLETTE M, 1994, LAB INVEST, V71, P838; Qiu Q, 2004, REPRODUCTION, V128, P355, DOI 10.1530/rep.1.00234; Qiu W, 2005, BIOL REPROD, V72, P954, DOI 10.1095/biolreprod.104.036772; Ramos DM, 2002, MATRIX BIOL, V21, P297, DOI 10.1016/S0945-053X(02)00002-1; RICE A, 1995, BIOCHEMISTRY-US, V34, P9249, DOI 10.1021/bi00028a038; Rice A, 1998, CYTOKINE GROWTH F R, V9, P287, DOI 10.1016/S1359-6101(98)00020-3; Robinson M, 2001, HEALTH SOC CARE COMM, V9, P180, DOI 10.1046/j.1365-2524.2001.00288-4.x; Roth I, 1999, DEV BIOL, V205, P194, DOI 10.1006/dbio.1998.9122; SAARINEN J, 1994, J BIOL CHEM, V269, P18134; Salamonsen Lois A, 2002, Rev Endocr Metab Disord, V3, P133, DOI 10.1023/A:1015407012559; SALO T, 1991, J BIOL CHEM, V266, P11436; SANG QX, 1995, BBA-PROTEIN STRUCT M, V1251, P99, DOI 10.1016/0167-4838(95)00086-A; Sang QXA, 1996, J PROTEIN CHEM, V15, P243, DOI 10.1007/BF01887112; Sato H, 1996, FEBS LETT, V393, P101, DOI 10.1016/0014-5793(96)00861-7; SATO H, 1993, ONCOGENE, V8, P395; Schroen DJ, 1996, GENE EXPRESSION, V6, P197; Sharkey AM, 1999, BIOL REPROD, V60, P355, DOI 10.1095/biolreprod60.2.355; Sharrocks AD, 1997, INT J BIOCHEM CELL B, V29, P1371, DOI 10.1016/S1357-2725(97)00086-1; SHIMONOVITZ S, 1994, AM J OBSTET GYNECOL, V171, P832, DOI 10.1016/0002-9378(94)90107-4; Shimonovitz S, 1998, AM J OBSTET GYNECOL, V178, P457, DOI 10.1016/S0002-9378(98)70420-X; Sorsa T, 1997, J BIOL CHEM, V272, P21067, DOI 10.1074/jbc.272.34.21067; Staun-Ram Elsebeth, 2004, Reprod Biol Endocrinol, V2, P59, DOI 10.1186/1477-7827-2-59; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; SUBLER MA, 1992, J VIROL, V66, P4757, DOI 10.1128/JVI.66.8.4757-4762.1992; Sun YB, 2004, J CELL BIOCHEM, V92, P258, DOI 10.1002/jcb.20044; Sun YB, 2000, J BIOL CHEM, V275, P11327, DOI 10.1074/jbc.275.15.11327; Sun YB, 1999, J BIOL CHEM, V274, P11535, DOI 10.1074/jbc.274.17.11535; SUZUKI K, 1995, BIOCHEM J, V305, P301, DOI 10.1042/bj3050301; SUZUKI K, 1990, BIOCHEMISTRY-US, V29, P10261, DOI 10.1021/bi00496a016; Szony BJ, 1999, MOL HUM REPROD, V5, P1059, DOI 10.1093/molehr/5.11.1059; TAKINO T, 1995, J BIOL CHEM, V270, P23013, DOI 10.1074/jbc.270.39.23013; Tarrade A, 2002, BIOL REPROD, V67, P1628, DOI 10.1095/biolreprod.101.001925; Uria JA, 2000, CANCER RES, V60, P4745; Van den Steen PE, 2001, BBA-GEN SUBJECTS, V1528, P61, DOI 10.1016/S0304-4165(01)00190-8; Van den Steen PE, 2002, CRIT REV BIOCHEM MOL, V37, P375, DOI 10.1080/10409230290771546; VASSALLI JD, 1991, J CLIN INVEST, V88, P1067, DOI 10.1172/JCI115405; Vettraino IM, 1996, PLACENTA, V17, P557, DOI 10.1016/S0143-4004(96)80072-5; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Wang HB, 2003, FERTIL STERIL, V80, P736, DOI 10.1016/S0015-0282(03)00782-9; WERB Z, 1977, NEW ENGL J MED, V296, P1017, DOI 10.1056/NEJM197705052961801; Werner H, 1996, P NATL ACAD SCI USA, V93, P8318, DOI 10.1073/pnas.93.16.8318; Westermarck J, 1997, ONCOGENE, V14, P2651, DOI 10.1038/sj.onc.1201111; Westermarck J, 1999, FASEB J, V13, P781, DOI 10.1096/fasebj.13.8.781; Wiehler S, 2004, BIOCHEM BIOPH RES CO, V315, P463, DOI 10.1016/j.bbrc.2004.01.078; WINDSOR LJ, 1993, J BIOL CHEM, V268, P17341; Xu P, 2000, BIOL REPROD, V62, P988, DOI 10.1095/biolreprod62.4.988; Xu P, 2001, BIOL REPROD, V65, P240, DOI 10.1095/biolreprod65.1.240; Yamamoto H, 1998, GENE DEV, V12, P1315, DOI 10.1101/gad.12.9.1315; Zhang J, 2002, MOL HUM REPROD, V8, P659, DOI 10.1093/molehr/8.7.659; Zhao YG, 2003, J BIOL CHEM, V278, P15056, DOI 10.1074/jbc.M210975200; Zygmunt M, 1998, AM J REPROD IMMUNOL, V40, P326	148	153	165	0	17	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0143-4004	1532-3102		PLACENTA	Placenta	AUG	2006	27	8					783	793		10.1016/j.placenta.2005.08.006			11	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Science Citation Index Expanded (SCI-EXPANDED)	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	062XU	WOS:000238981000001	16249026				2022-03-04	
J	Arvanitidou, S; Martinelli-Klay, CP; Samson, J; Lobrinus, JA; Dulguerov, N; Lombardi, T				Arvanitidou, Souzana; Martinelli-Klay, Carla P.; Samson, Jacky; Lobrinus, Johannes A.; Dulguerov, Nicolas; Lombardi, Tommaso			HSP105 expression in oral squamous cell carcinoma: Correlation with clinicopathological features and outcomes	JOURNAL OF ORAL PATHOLOGY & MEDICINE			English	Article						heat shock protein 105; immunohistochemistry; oral cancer; oral squamous cell carcinoma	SHOCK-PROTEIN 105; PROGNOSTIC-SIGNIFICANCE; HEAT-SHOCK-PROTEIN-105; APOPTOSIS	Background Heat shock proteins (HSPs) are released in response to stress situations, such as heat, inflammation, and infection. They are also involved in the tumor cell proliferation and prevention of apoptosis. Heat shock protein 105 (Hsp105/110) is a high-molecular-weight protein, which has been reported in many cancer types but few studies have been carried out on oral squamous cell carcinoma (OSCC). In the current study, we have focused on HSP105 expression on OSCC and evaluated their correlation with tumor clinicopathological parameters and patients' survival. Methods A retrospective study included 70 patients with OSCC of which 50 patients (71.4%) were male and 20 (28.6%) were female. The patient's information, including age, location, TNM stage, histological grade, regional metastasis, recurrence, and survival, were collected. Immunohistochemical staining for HSP105 was performed. The healthy oral mucosa (n = 10) was used as a control. The staining intensity and percentage of stained cells were semi-quantitatively evaluated, and HSP105 expression was correlated with tumor clinicopathological features and patient survival. Results Statistical analysis for HSP105 showed that there was no significant correlation with tumor clinicopathological features. However, HSP105 overexpression was associated with a decrease in the duration of patients' survival (P = .042). Conclusion This result suggests that the increased expression of the HSP105 in the OSCC could be a prognostic factor for malignancy.	[Arvanitidou, Souzana; Martinelli-Klay, Carla P.; Samson, Jacky; Lombardi, Tommaso] Univ Geneva, Univ Hosp Geneva, Lab Oral & Maxillofacial Pathol,Dept Surg, Oral Med & Oral & Maxillofacial Pathol Unit,Div O, Geneva, Switzerland; [Lobrinus, Johannes A.] Univ Geneva, Univ Hosp Geneva, Div Clin Pathol, Geneva, Switzerland; [Dulguerov, Nicolas] Univ Geneva, Univ Hosp Geneva, Dept Otorhinolaryngol Head & Neck Surg, Geneva, Switzerland		Lombardi, T (corresponding author), Oral Med & Oral & Maxillofacial Pathol Unit, Lab Oral & Maxillofacial Pathol, Rue Michel Servet 1, CH-1211 Geneva 4, Switzerland.	tommaso.lombardi@unige.ch					Calderwood SK, 2013, SCIENTIFICA, V2013, DOI 10.1155/2013/217513; Duval A, 2006, HAEMATOLOGICA, V91, P713; Gao HJ, 2014, CANCER LETT, V344, P54, DOI 10.1016/j.canlet.2013.10.007; Hosaka S, 2006, CANCER SCI, V97, P623, DOI 10.1111/j.1349-7006.2006.00217.x; Hwang TS, 2003, J GASTROEN HEPATOL, V18, P690, DOI 10.1046/j.1440-1746.2003.03011.x; Kai M, 2003, ONCOL REP, V10, P1777; Kampinga HH, 2009, CELL STRESS CHAPERON, V14, P105, DOI 10.1007/s12192-008-0068-7; Kawai T, 2014, MOL CLIN ONCOL, V2, P38, DOI 10.3892/mco.2013.203; Kimura A, 2016, ONCOTARGET, V7, P18415, DOI 10.18632/oncotarget.7821; Kumagai J, 2000, EUR J BIOCHEM, V267, P3073, DOI 10.1046/j.1432-1033.2000.01336.x; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mohtasham N, 2011, MED ORAL PATOL ORAL, V16, pE730, DOI 10.4317/medoral.17007; Muchemwa FC, 2006, BRIT J DERMATOL, V155, P582, DOI 10.1111/j.1365-2133.2006.07362.x; Oda T, 2009, MOL MED REP, V2, P603, DOI 10.3892/mmr_00000144; Oh HJ, 2017, APMIS, V125, P1076, DOI 10.1111/apm.12770; Park HS, 2009, J CUTAN PATHOL, V36, P511, DOI 10.1111/j.1600-0560.2008.01085.x; Popli DB, 2015, BIOMED PAP, V159, P366, DOI 10.5507/bp.2015.004; Saito Y, 2009, J BIOCHEM, V145, P185, DOI 10.1093/jb/mvn155; Slaby O, 2009, ONCOL REP, V21, P1235, DOI 10.3892/or_00000346; Sobin LH, 1997, TNM CLASSIFICATION M; Ullmann R, 2004, J PATHOL, V203, P798, DOI 10.1002/path.1584; Yamagishi N, 2006, EXP CELL RES, V312, P3215, DOI 10.1016/j.yexcr.2006.06.007; Yu N, 2015, MOL CELL BIOL, V35, P1390, DOI 10.1128/MCB.01307-14; Zuo DM, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00075	24	3	3	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0904-2512	1600-0714		J ORAL PATHOL MED	J. Oral Pathol. Med.	AUG	2020	49	7					665	671		10.1111/jop.13007		MAR 2020	7	Dentistry, Oral Surgery & Medicine; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine; Pathology	NG3EL	WOS:000522719500001	32128880	Green Accepted			2022-03-04	
J	Bischof, P; Meisser, A; Haenggeli, L; Cohen, M				Bischof, P; Meisser, A; Haenggeli, L; Cohen, M			Transcriptional repression of the human metalloproteinase-9 promoter by wild-type p53 in human cytotrophoblastic cells	PLACENTA			English	Meeting Abstract									Univ Geneva, Dept Obstet & Gynecol, Geneva, Switzerland									0	0	0	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0143-4004			PLACENTA	Placenta	SEP-OCT	2005	26	8-9				P1301	A57	A57					1	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Science Citation Index Expanded (SCI-EXPANDED)	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	959DG	WOS:000231496500214					2022-03-04	
J	Cohen, M				Cohen, Marie			INVOLVEMENT OF MEMBRANE GRP78 IN TROPHOBLASTIC CELL FUSION	PLACENTA			English	Meeting Abstract	International-Federation-of-Placenta-Associations (IFPA)/EPG Meeting	SEP 09-12, 2014	Paris, FRANCE	Int Federat Placenta Assoc, EPG					[Cohen, Marie] Univ Geneva, Geneva, Switzerland									0	0	0	0	2	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0143-4004	1532-3102		PLACENTA	Placenta	SEP	2014	35	9				P2.151	A107	A107		10.1016/j.placenta.2014.06.350			1	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	AQ6ZC	WOS:000342961400363		Green Published			2022-03-04	
J	Cohen, M; Meisser, A; Haenggeli, L; Bischof, P				Cohen, M; Meisser, A; Haenggeli, L; Bischof, P			Involvement of MAPK pathway in TNF-alpha induced MMP-9 expression in human cytotrophoblastic cells	PLACENTA			English	Meeting Abstract									Univ Geneva, Dept Obstet & Gynecol, Geneva, Switzerland									0	0	0	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0143-4004			PLACENTA	Placenta	SEP-OCT	2005	26	8-9				P1311	A59	A59					1	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Science Citation Index Expanded (SCI-EXPANDED)	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	959DG	WOS:000231496500223					2022-03-04	
J	Gex-Fabry, M; Balant-Gorgia, AE; Balant, LP				Gex-Fabry, M; Balant-Gorgia, AE; Balant, LP			Therapeutic drug monitoring of olanzapine: The combined effect of age, gender, smoking, and comedication	THERAPEUTIC DRUG MONITORING			English	Article						olanzapine; therapeutic drug monitoring; intraindividual variability; interindividual variability factors; drug-drug interactions	PLASMA-CONCENTRATIONS; SCHIZOPHRENIC-PATIENTS; CLINICAL-RESPONSE; PHARMACOKINETICS; METABOLISM; PSYCHOPHARMACOLOGY; GLUCURONIDATION; VENLAFAXINE; MANAGEMENT; HUMANS	Therapeutic drug monitoring (TDM) data for the antipsychotic drug olanzapine were investigated with respect to concentration versus dose relationship, intra-individual versus interindividual variability, and the combined influence of patient characteristics on steady-state concentration. The study included 250 patients, with daily doses ranging from 2.5 to 30 mg. Median concentration to dose ratio was 2.1 (ng/mL)/(mg/d), with 90% of the distribution in a fivefold range. In the first subgroup of patients with two measurements at different doses (n = 21), data were in keeping with linear concentration versus dose relationship. In the second subgroup of patients with repeated measurements at a constant daily dose (n = 40), estimates of within-patient and between-patient variabilities were 30.5% and 49.4%, respectively. In the whole sample, multiple regression analysis of dose-normalized concentration revealed significant effects of time postdose (-18% per 12 hours delay, P < 0.05), age greater than or equal to 60 years (+27%, P < 0.005), cigarette smoking (-12%, P < 0.05), and comedication with fluvoxamine (+74%, P < 0.001), paroxetine, fluoxetine, or sertraline (considered together, +32%, P < 0.05), venlafaxine (+27%, P < 0.05), and inducers of P450 enzymes (-40%, P < 0.001). The final model included a tendency for higher concentration associated with female gender (+11%, P = 0.07) and accounted for 27% of observed interindividual variability. When considering a worst-case scenario, an elderly, nonsmoking woman prescribed fluvoxamine comedication was predicted to reach a 4.6-fold higher olanzapine concentration than a young male smoker coadministered carbamazepine. The current study suggests that patients characterized by a combination of factors associated with altered metabolism may benefit from olanzapine TDM.	Univ Hosp Geneva, Clin Res Unit, Dept Psychiat, CH-1225 Chene Bourg, Switzerland		Gex-Fabry, M (corresponding author), Univ Hosp Geneva, Clin Res Unit, Dept Psychiat, 2,Chem Petit Bel Air, CH-1225 Chene Bourg, Switzerland.						Albers LJ, 2000, PSYCHIAT RES, V96, P235, DOI 10.1016/S0165-1781(00)00213-4; Amchin J, 1999, J CLIN PHARMACOL, V39, P297; Aravagiri M, 1997, THER DRUG MONIT, V19, P307, DOI 10.1097/00007691-199706000-00011; Bhana N, 2001, DRUGS, V61, P111, DOI 10.2165/00003495-200161010-00011; Callaghan JT, 1999, CLIN PHARMACOKINET, V37, P177, DOI 10.2165/00003088-199937030-00001; Christensen M, 2002, CLIN PHARMACOL THER, V71, P141, DOI 10.1067/mcp.2002.121788; Desai HD, 2001, CNS DRUGS, V15, P469, DOI 10.2165/00023210-200115060-00005; DeVane CL, 1999, CELL MOL NEUROBIOL, V19, P443, DOI 10.1023/A:1006934807375; Ereshefsky L, 1996, J CLIN PSYCHIAT, V57, P12; ERESHEFSKY L, 1996, J CLIN PSYCHOPHAR S2, V16, P37; Fulton B, 1997, DRUGS, V53, P281, DOI 10.2165/00003495-199753020-00007; Glue P, 1996, HUM PSYCHOPHARM CLIN, V11, P97, DOI 10.1002/(SICI)1099-1077(199603)11:2<97::AID-HUP759>3.0.CO;2-7; Kassahun K, 1997, DRUG METAB DISPOS, V25, P81; Kelly DL, 1999, SCHIZOPHR RES, V40, P101, DOI 10.1016/S0920-9964(99)00053-5; LeMarchand L, 1997, PHARMACOGENETICS, V7, P11, DOI 10.1097/00008571-199702000-00002; Linnet K, 2002, THER DRUG MONIT, V24, P512, DOI 10.1097/00007691-200208000-00009; Liston HL, 2001, J CLIN PSYCHOPHARM, V21, P500, DOI 10.1097/00004714-200110000-00008; Lucas RA, 1998, EUR J CLIN PHARMACOL, V54, P639, DOI 10.1007/s002280050527; MINERS JO, 1991, PHARMACOL THERAPEUT, V51, P347, DOI 10.1016/0163-7258(91)90065-T; Olesen OV, 1999, THER DRUG MONIT, V21, P87, DOI 10.1097/00007691-199902000-00013; Perry PJ, 1997, J CLIN PSYCHOPHARM, V17, P472, DOI 10.1097/00004714-199712000-00006; Perry PJ, 2001, J CLIN PSYCHOPHARM, V21, P14, DOI 10.1097/00004714-200102000-00004; Ring BJ, 1996, J PHARMACOL EXP THER, V276, P658; Robertson MD, 2000, J FORENSIC SCI, V45, P418; Simon T, 2001, BRIT J CLIN PHARMACO, V52, P601, DOI 10.1046/j.0306-5251.2001.01494.x; Skogh E, 2002, THER DRUG MONIT, V24, P518, DOI 10.1097/00007691-200208000-00010; Tollefson GD, 2001, BIOL PSYCHIAT, V49, P52, DOI 10.1016/S0006-3223(00)01026-X; Volavka J, 2002, AM J PSYCHIAT, V159, P255, DOI 10.1176/appi.ajp.159.2.255; Weigmann H, 2001, THER DRUG MONIT, V23, P410, DOI 10.1097/00007691-200108000-00015	29	114	116	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0163-4356			THER DRUG MONIT	Ther. Drug Monit.	FEB	2003	25	1					46	53		10.1097/00007691-200302000-00007			8	Medical Laboratory Technology; Pharmacology & Pharmacy; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology; Pharmacology & Pharmacy; Toxicology	639DN	WOS:000180612500007	12548144				2022-03-04	
J	Cohen, M; Meisser, A; Haenggeli, L; Irminger-Finger, I; Bischof, P				Cohen, M.; Meisser, A.; Haenggeli, L.; Irminger-Finger, I.; Bischof, P.			Status of p53 in first-trimester cytotrophoblastic cells	MOLECULAR HUMAN REPRODUCTION			English	Article						complex; CTB; cytoplasm; nucleus; p53	TUMOR-SUPPRESSOR GENE; WILD-TYPE P53; HUMAN PLACENTA; IN-VITRO; PROTEIN; BINDING; DNA; DEGRADATION; ANTIBODIES; STABILITY	p53 has been called the cellular gatekeeper of the genome because it can induce cell-cycle arrest in G1, apoptosis or affect DNA replication in response to DNA damage. As p53 has been observed in first-trimester cytotrophoblastic cells (CTB), but its expression in normal cells is generally not detectable because of its short half-life, p53 could play an important role in cellular differentiation and/or in the control of the invasion of trophoblastic cells; therefore, p53 status was investigated in these cells. Using different antibodies recognizing different epitopes of p53 protein, abundant p53 expression was observed both in nuclear and in cytoplasmic compartments of first-trimester CTB. Whereas p53 was detected in the nuclei of few trophoblastic cells with an antibody recognizing the N-terminal epitope of the protein, high expression level of p53 in the cytoplasm of CTB was detected with an antibody recognizing the middle part of p53. The lack of immunoreactivity of p53 with antibodies recognizing the epitopes located at the N-terminus of p53 and the high level of p53 protein observed in the cytoplasm of CTB suggest that the N-terminus of p53 is involved in the formation of complexes. These cytoplasmic complexes were detected under non-reducing conditions in western blot analysis and had apparent molecular weights (MW) of 195, 167 or 125 kDa. These complexes could prolong the half-life of p53 in the cytoplasm of CTBs. By contrast, in the nuclei of CTBs, p53 seems to be present as a tetramer.	Univ Geneva, Lab Hormonol, Dept Obstet & Gynaecol, CH-1211 Geneva 14, Switzerland		Bischof, P (corresponding author), Univ Geneva, Lab Hormonol, Dept Obstet & Gynaecol, 32 Blvd Cluse, CH-1211 Geneva 14, Switzerland.	paul.bischof@hcuge.ch		cohen, marie/0000-0003-4621-5464			Aladjem MI, 1998, CURR BIOL, V8, P145, DOI 10.1016/S0960-9822(98)70061-2; ALMOG N, 1997, BIOCHIM BIOPHYS ACTA, V1333, P1; Bian JH, 1997, MOL CELL BIOL, V17, P6330, DOI 10.1128/MCB.17.11.6330; Bischof P, 1995, Early Pregnancy, V1, P263; Bonsing BA, 1997, CYTOMETRY, V28, P11, DOI 10.1002/(SICI)1097-0320(19970501)28:1<11::AID-CYTO2>3.3.CO;2-H; Bourdon JC, 2005, GENE DEV, V19, P2122, DOI 10.1101/gad.1339905; Cohen M, 2006, PLACENTA, V27, P783, DOI 10.1016/j.placenta.2005.08.006; Courtois S, 2002, ONCOGENE, V21, P6722, DOI 10.1038/sj.onc.1205874; Courtois S, 2004, ONCOGENE, V23, P631, DOI 10.1038/sj.onc.1206929; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Flaman JM, 1996, ONCOGENE, V12, P813; GRAHAM JM, 1993, BIOMEMBRANE PROTOCOL, V19, P1; HAIDACHER S, 1995, HUM REPROD, V10, P983, DOI 10.1093/oxfordjournals.humrep.a136082; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Maier B, 2004, GENE DEV, V18, P306, DOI 10.1101/gad.1162404; MARZUSCH K, 1995, PLACENTA, V16, P101, DOI 10.1016/0143-4004(95)90086-1; Matsumoto M, 2006, MED MOL MORPHOL, V39, P79, DOI 10.1007/s00795-006-0320-0; Nickels A, 1997, INT J CANCER, V73, P613, DOI 10.1002/(SICI)1097-0215(19971114)73:4<613::AID-IJC25>3.0.CO;2-8; Quenby S, 1998, MOL HUM REPROD, V4, P477, DOI 10.1093/molehr/4.5.477; Royds JA, 2006, CELL DEATH DIFFER, V13, P1017, DOI 10.1038/sj.cdd.4401913; Weinberg RL, 2004, J MOL BIOL, V342, P801, DOI 10.1016/j.jmb.2004.07.042; WesierskaGadek J, 1996, BIOCHEM BIOPH RES CO, V224, P96, DOI 10.1006/bbrc.1996.0990; WU Y, 1994, EMBO J, V13, P4823, DOI 10.1002/j.1460-2075.1994.tb06808.x; Yin YL, 2002, NAT CELL BIOL, V4, P462, DOI 10.1038/ncb801; Zaika A, 1999, J BIOL CHEM, V274, P27474, DOI 10.1074/jbc.274.39.27474	28	13	13	0	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND		1460-2407		MOL HUM REPROD	Mol. Hum. Reprod.	FEB	2007	13	2					111	116		10.1093/molehr/gal105			6	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Science Citation Index Expanded (SCI-EXPANDED)	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	127MP	WOS:000243590700004	17158854	Green Published, Bronze			2022-03-04	
J	Marchetti, T; de Moerloose, P; Cohen, M				Marchetti, Tess; de Moerloose, Philippe; Cohen, Marie			PATHOLOGICAL MECHANISMS OF ANTIPHOSPHOLIPID ANTIBODIES IN TROPHOBLASTIC CELL FUSION	PLACENTA			English	Meeting Abstract	International-Federation-of-Placenta-Associations (IFPA)/EPG Meeting	SEP 09-12, 2014	Paris, FRANCE	Int Federat Placenta Assoc, EPG					[Marchetti, Tess; Cohen, Marie] Univ Hosp Geneva, Lab Hormonol, Geneva, Switzerland; [Marchetti, Tess; de Moerloose, Philippe] Univ Hosp Geneva, Haemostasis Unit, Geneva, Switzerland									0	0	0	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0143-4004	1532-3102		PLACENTA	Placenta	SEP	2014	35	9				P1.149-N	A57	A57		10.1016/j.placenta.2014.06.185			1	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	AQ6ZC	WOS:000342961400198					2022-03-04	
J	Bastida-Ruiz, D; Yart, L; Cohen, M				Bastida-Ruiz, Daniel; Yart, Lucile; Cohen, Marie			ROLE OF THE UNFOLDED PROTEIN RESPONSE IN TROPHOBLASTIC CELL FUSION	PLACENTA			English	Meeting Abstract	Meeting of the International-Federation-of-Placenta-Associations (IFPA)	AUG 30-SEP 02, 2017	Manchester, ENGLAND	Int Federat Placenta Assoc					[Bastida-Ruiz, Daniel; Yart, Lucile; Cohen, Marie] Univ Geneva, Geneva, Switzerland					Yart, Lucile/0000-0002-5700-0883; cohen, marie/0000-0003-4621-5464				0	0	0	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0143-4004	1532-3102		PLACENTA	Placenta	SEP	2017	57					P1.29	257	258		10.1016/j.placenta.2017.07.118			2	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	FH9OL	WOS:000411541500129					2022-03-04	
J	Bischof, P; Cohen, M				Bischof, P.; Cohen, M.			The tumour-suppressor p53 and trophoblast invasion	PLACENTA			English	Meeting Abstract	12th Meeting of the International-Federation-of-Placenta-Association/14th Meeting of the Japan-Plancenta-Association/24th Meeting of Japan Trophoblast Disease Study Group	SEP 06-09, 2006	Kobe, JAPAN	Int Federat Placenta Assoc, Japan Placenta Assoc					Univ Geneva, Dept Obstet & Gynaecol, Geneva, Switzerland									0	0	0	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0143-4004	1532-3102		PLACENTA	Placenta	SEP-OCT	2006	27	9-10					A6	A6					1	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	081IX	WOS:000240312200033					2022-03-04	
J	Bischof, P				Bischof, P			Regulation of trophoblast invasion during embryo implantation and placentation	PLACENTA			English	Meeting Abstract	Joint Meeting of the 2nd Latinamerican Symposium on Fetal-Maternal Interaction and Placenta/19th Annual Meeting of the Chilean-Society-of-Physiological-Sciences	NOV 06-09, 2005	Santiago, CHILE	Chilean Soc Physiol Sci					Univ Geneva, Dept Obstet & Gynaecol, Geneva, Switzerland									0	0	0	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0143-4004	1532-3102		PLACENTA	Placenta	JAN	2006	27	1					A6	A6					1	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	993YM	WOS:000233996200029					2022-03-04	
J	Bischof, P; Truong, K; Campana, A				Bischof, P; Truong, K; Campana, A			Regulation of trophoblastic gelatinases by proto-oncogenes	PLACENTA			English	Article							COLLAGENASE GENE-EXPRESSION; IV COLLAGENASE; METALLOPROTEINASE EXPRESSION; MATRIX-METALLOPROTEINASE; UROKINASE RECEPTOR; INVASION; TUMOR; INHIBITOR; SECRETION; MECHANISM	During the first trimester of pregnancy, certain cytotrophoblastic cells (CTB) of anchoring villi invade the underlying decidua. Regulation of this invasive behaviour depends on cytokines and growth factors secreted by decidua and trophoblast, which modulate metalloproteinase (MMP) secretion of CTB. Since MMP-9 expression by CTB is a prerequisite for matrigel invasion and since the promoter region of the MMP-9 gene contains two AP-1 binding sites, we hypothesized, that transient activation of c-jun and c-fos oncogenes (which bind to form AP-1) by turnour necrosis factor (TNFalpha), or the phorbol ester TPA will promote the invasive phenotype of CTB and induce the production of MMP-9. TNFalpha or TPA when added to primary cultures of CTB increase MMP-9 activity and MMP-9 mRNA. This effect is inhibited by cycloheximide indicating the necessity of protein synthesis. TPA or TNFa. induces also the binding of nuclear proteins (extracted from treated CTB) to a radiolabelled oligonucleotide corresponding to the consensus sequence of the TPA responsive element. Antibodies to Jun and Fos can displace this binding. Transient transfection of antisense mRNA to jun or fos into CTB inhibits the immunoreactivity and gelatinolytic activity of MMP-9. We conclude that AP-1 is necessary but may not be sufficient for transactivation of the MMP-9 gene in human CTB. (C) 2002 Elsevier Science Ltd. All rights reserved.	Univ Geneva, Dept Obstet & Gynaecol, CH-1211 Geneva 14, Switzerland		Bischof, P (corresponding author), Univ Geneva, Dept Obstet & Gynaecol, CH-1211 Geneva 14, Switzerland.	paul.bischof@hcuge.ch					Bischof P, 1995, Early Pregnancy, V1, P263; BISCHOF P, 1995, HUM REPROD, V10, P734, DOI 10.1093/oxfordjournals.humrep.a136024; BISCHOF P, 1991, AM J OBSTET GYNECOL, V165, P1791, DOI 10.1016/0002-9378(91)90034-O; BISCHOF P, 2000, IMPLANTATION MISCARR, V14; BRENNER DA, 1989, NATURE, V337, P661, DOI 10.1038/337661a0; Chakraborty C, 2002, CAN J PHYSIOL PHARM, V80, P116, DOI 10.1139/Y02-016; Feng Q, 2000, PLACENTA, V21, P184, DOI 10.1053/plac.1999.0446; GRAHAM CH, 1992, BIOCHEM CELL BIOL, V70, P867, DOI 10.1139/o92-135; Graham CH, 1998, BLOOD, V91, P3300, DOI 10.1182/blood.V91.9.3300.3300_3300_3307; He C, 1996, CANCER LETT, V106, P185, DOI 10.1016/0304-3835(96)04318-2; Himelstein BP, 1998, CLIN EXP METASTAS, V16, P169; Hu ZY, 1999, J ANAT, V194, P183, DOI 10.1046/j.1469-7580.1999.19420183.x; HUHTALA P, 1990, GENOMICS, V6, P554, DOI 10.1016/0888-7543(90)90486-E; HUHTALA P, 1991, J BIOL CHEM, V266, P16485; LALA PK, 1994, P ANN M AM ASS CANC, V35, pA3658; LIBRACH CL, 1994, J BIOL CHEM, V269, P17125; LIBRACH CL, 1991, J CELL BIOL, V113, P437, DOI 10.1083/jcb.113.2.437; MACKAY AR, 1992, INVAS METAST, V12, P168; MARTELLI M, 1993, J REPROD FERTIL, V98, P67; Matrisian LM, 2000, CURR BIOL, V10, pR692, DOI 10.1016/S0960-9822(00)00720-X; Meisser A, 1999, MOL HUM REPROD, V5, P1055, DOI 10.1093/molehr/5.11.1055; Meissner A, 1999, MOL HUM REPROD, V5, P252, DOI 10.1093/molehr/5.3.252; PIJNENBORG R, 1980, PLACENTA, V1, P3, DOI 10.1016/S0143-4004(80)80012-9; Sambrook J., 1989, MOL CLONING; SATO H, 1993, ONCOGENE, V8, P395; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; TREMBLE P, 1995, J CELL BIOL, V129, P1707, DOI 10.1083/jcb.129.6.1707; VANSTRAATEN F, 1983, P NATL ACAD SCI-BIOL, V80, P3183; Westermarck J, 1999, FASEB J, V13, P781, DOI 10.1096/fasebj.13.8.781	29	28	31	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0143-4004	1532-3102		PLACENTA	Placenta	FEB-MAR	2003	24	2-3					155	163		10.1053/plac.2002.0890			9	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Science Citation Index Expanded (SCI-EXPANDED)	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	645HU	WOS:000180970800005	12566242				2022-03-04	
J	Toti, P; Barone, A; Marconcini, S; Menchini-Fabris, GB; Martuscelli, R; Covani, U				Toti, Paolo; Barone, Antonio; Marconcini, Simone; Menchini-Fabris, Giovanni Battista; Martuscelli, Ranieri; Covani, Ugo			Pose determination of a blade implant in three dimensions from a single two-dimensional radiograph	DENTOMAXILLOFACIAL RADIOLOGY			English	Article						tissue-implant interactions; dental digital radiography; algorithms; radiographic image interpretation; blade-form implant	CREST	The aim of the study was to introduce a mathematical method to estimate the correct pose of a blade by evaluating the radiographic features obtained from a single two-dimensional image. Blade-form implant bed preparation was performed using the piezosurgery device, and placement was attained with the use of magnetic mallet. The pose determination of the blade was described by means of three consecutive rotations defined by three angles of orientation (triplet phi, theta and psi). Retrospective analysis on periapical radiographs was performed. This method was used to compare implant (axial length along the marker, i.e. the implant structure) vs angular correction factor (a trigonometric function of the triplet). The accuracy of the method was tested by generating two-dimensional radiographic simulations of the blades, which were then compared with the images of the implants as appearing on the real radiographs. Two patients had to be excluded from further evaluation because the values of the estimated pose angles showed a too-wide range to be effective for a good standardization of serial radiographs: intrapatient range from baseline to 1-year survey was > of a threshold determined by the clinicians (30 degrees). The linear dependence between implant (CF degrees) and angular correction factor (CF boolean AND) was estimated by a robust linear regression, yielding the following coefficients: slope, 0.908; intercept, -0.092; and coefficient of determination, 0.924. The absolute error in accuracy was -0.29 +/- 4.35, 0.23 +/- 3.81 and 0.64 +/- 1.18 degrees, respectively, for the angles phi, theta and psi. The present theoretical and experimental study established the possibility of determining, a posteriori, a unique triplet of angles (phi, theta and psi) which described the pose of a blade upon a single two-dimensional radiograph, and of suggesting a method to detect cases in which the standardized geometric projection failed. The angular correction of the bone level yielded results very close to those obtained with an internal marker related to the implant length.	[Toti, Paolo; Marconcini, Simone; Menchini-Fabris, Giovanni Battista; Covani, Ugo] Univ Pisa, Dept Surg Med Mol & Crit Area Pathol, Pisa, Italy; [Toti, Paolo; Marconcini, Simone; Menchini-Fabris, Giovanni Battista; Covani, Ugo] Fortis Dent Ctr, Tuscan Dent Inst, Forte Dei Marmi, Italy; [Barone, Antonio] Univ Geneva, Dept Surg, Rue Barthelemy Menn, Geneva, Switzerland; [Martuscelli, Ranieri] Univ Naples Federico II, Sch Med, Dept Neurosci Reprod & Odontostomatol Sci, Naples, Italy		Toti, P (corresponding author), Univ Pisa, Dept Surg Med Mol & Crit Area Pathol, Pisa, Italy.; Toti, P (corresponding author), Fortis Dent Ctr, Tuscan Dent Inst, Forte Dei Marmi, Italy.	capello.totipaolo@tiscali.it	Covani, Ugo/AAE-7084-2019; Fabris, Giovanni Battista Menchini/AAZ-9866-2020; Barone, Antonio/O-2738-2013	Fabris, Giovanni Battista Menchini/0000-0001-9542-0160; Barone, Antonio/0000-0003-1226-7565; COVANI, UGO/0000-0002-1267-6345	Tuscan Stomatologic Institute	The present study was supported in part by the Tuscan Stomatologic Institute. No external funding was available for this study.	Albrektsson T, 1986, Int J Oral Maxillofac Implants, V1, P11; Crespi R, 2014, ORAL MAXILLOFAC SURG, V18, P59, DOI 10.1007/s10006-013-0389-2; Economopotilos T, 2008, DENTOMAXILLOFAC RAD, V37, P185, DOI 10.1259/dmfr/26553364; Eickholz P, 1998, ORAL SURG ORAL MED O, V85, P99, DOI 10.1016/S1079-2104(98)90406-1; Fernandez-Formoso N, 2011, DENTOMAXILLOFAC RAD, V40, P385, DOI 10.1259/dmfr/45365752; Jemt T, 1990, INT J PERIODONT REST, V10, P341; Mol A, 2003, ORAL SURG ORAL MED O, V96, P373, DOI 10.1016/S1079-2104(03)00357-3; Roeder F, 2010, CLIN ORAL INVEST, V14, P645, DOI 10.1007/s00784-009-0350-9; Schropp L, 2009, CLIN ORAL INVEST, V13, P375, DOI 10.1007/s00784-009-0257-5; Schulze RKW, 2010, DENTOMAXILLOFAC RAD, V39, P33, DOI 10.1259/dmfr/12523158; Schulze RKW, 2005, DENTOMAXILLOFAC RAD, V34, P205, DOI 10.1259/dmfr/56357032; Sewerin LP, 1991, CLIN ORAL IMPLAN RES, V2, P20, DOI 10.1034/j.1600-0501.1991.020102.x; Strecha J, 2010, INT J ORAL SCI, V2, P105, DOI 10.4248/IJOS10030; VineshKamath K, 2014, J DENT HERALD, V1, P34; Wu JC, 2005, ORAL SURG ORAL MED O, V100, P99, DOI 10.1016/j.tripleo.2004.12.011	15	4	4	0	1	BRITISH INST RADIOLOGY	LONDON	36 PORTLAND PLACE, LONDON W1N 4AT, ENGLAND	0250-832X	1476-542X		DENTOMAXILLOFAC RAD	Dentomaxillofac. Radiol.		2018	47	4							20170258	10.1259/dmfr.20170258			13	Dentistry, Oral Surgery & Medicine; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine; Radiology, Nuclear Medicine & Medical Imaging	GG2TI	WOS:000432545200009	29227154	Green Published			2022-03-04	
J	Veuthey, JL; Souverain, S; Rudaz, S				Veuthey, JL; Souverain, S; Rudaz, S			Column-switching procedures for the fast analysis of drugs in biologic samples	THERAPEUTIC DRUG MONITORING			English	Article; Proceedings Paper	8th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology	SEP 07-11, 2003	BASEL, SWITZERLAND	Int Assoc Therapeut Drug Monitoring & Clin Toxicol		column switching; fast drug analysis; liquid chromatography-mass spectrometry	PERFORMANCE LIQUID-CHROMATOGRAPHY; MASS-SPECTROMETRY; HUMAN PLASMA; METHADONE; PRECIPITATION; METABOLITES; SUPPORTS	Liquid chromatography coupled with mass spectrometry in single and dual mode (LC-MS and LC-MS/MS) is the method of choice for the quantification of drugs and their metabolites in biologic fluids. Following the new challenges encountered in the process of drug development, liquid chromatography-mass spectrometry has been found to achieve high-throughput analysis. With this impressive tool, the sample preparation step before analysis is simplified, and the analytic process speeded up. Several generic approaches have recently been developed for the sample extraction coupled on line with a LC-MS system. In this paper, different extraction supports allowing the direct injection of biologic fluids were investigated, namely, restricted-access media, large-size particle, and monolithic phases. In the column-switching configuration, these supports, coupled with microbore analytic columns, were found suitable for the fast analysis (total analysis time of less than 10 minutes) of different drugs and their metabolites in biologic matrices at the nanogram per milliliter level.	Univ Geneva, Sch Pharm, Lab Pharmaceut Analyt Chem, CH-1211 Geneva 4, Switzerland		Veuthey, JL (corresponding author), Univ Geneva, Sch Pharm, Lab Pharmaceut Analyt Chem, 20 Blvd Yvoy, CH-1211 Geneva 4, Switzerland.	jean-luc.veuthey@pharm.unige.ch	Rudaz, Serge/AAB-2861-2021	Rudaz, Serge/0000-0002-4180-5417			Boos KS, 1997, LC GC-MAG SEP SCI, V15, P602; Brignol N, 2000, RAPID COMMUN MASS SP, V14, P141, DOI 10.1002/(SICI)1097-0231(20000215)14:3&lt;141::AID-RCM856&gt;3.0.CO;2-I; Cabrera K, 2000, HRC-J HIGH RES CHROM, V23, P93; Dawidowicz AL, 1998, CHROMATOGRAPHIA, V47, P523, DOI 10.1007/BF02467489; HAGESTAM IH, 1985, ANAL CHEM, V57, P1757, DOI 10.1021/ac00285a058; Hopfgartner G, 2003, MASS SPECTROM REV, V22, P195, DOI 10.1002/mas.10050; Jemal M, 2000, BIOMED CHROMATOGR, V14, P422, DOI 10.1002/1099-0801(200010)14:6<422::AID-BMC25>3.0.CO;2-I; Jemal M, 1999, RAPID COMMUN MASS SP, V13, P2125, DOI 10.1002/(SICI)1097-0231(19991115)13:21<2125::AID-RCM763>3.0.CO;2-H; Jemal M, 1999, RAPID COMMUN MASS SP, V13, P97, DOI 10.1002/(SICI)1097-0231(19990130)13:2<97::AID-RCM461>3.0.CO;2-T; Marquet P, 2002, THER DRUG MONIT, V24, P255, DOI 10.1097/00007691-200204000-00008; Ortelli D, 2002, J SEP SCI, V25, P222, DOI 10.1002/1615-9314(20020301)25:4<222::AID-JSSC222>3.0.CO;2-#; Plumb R, 2001, RAPID COMMUN MASS SP, V15, P986, DOI 10.1002/rcm.329; POWELL ML, 2001, AM PHARM REV, V4, P63; QUINN HM, 1997, Patent No. 9716724; Racaityte K, 2000, J CHROMATOGR A, V890, P135; Rouan MC, 2001, J PHARMACEUT BIOMED, V25, P995, DOI 10.1016/S0731-7085(01)00349-1; Souverain S, 2003, CLIN CHEM LAB MED, V41, P1615, DOI 10.1515/CCLM.2003.245; Souverain S, 2003, CHROMATOGRAPHIA, V57, P569, DOI 10.1007/BF02491731; Souverain S, 2003, J CHROMATOGR B, V784, P117, DOI 10.1016/S1570-0232(02)00783-3; SOUVERAIN S, 2003, GIT LAB J, V2, P80; Tanaka N, 2000, HRC-J HIGH RES CHROM, V23, P111	21	42	43	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0163-4356	1536-3694		THER DRUG MONIT	Ther. Drug Monit.	APR	2004	26	2					161	166		10.1097/00007691-200404000-00013			6	Medical Laboratory Technology; Pharmacology & Pharmacy; Toxicology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Medical Laboratory Technology; Pharmacology & Pharmacy; Toxicology	844GW	WOS:000223147100014	15228158				2022-03-04	
J	Aelami, MH; Lotfi, M; Zingg, W				Aelami, Mohammad Hassan; Lotfi, Mojtaba; Zingg, Walter			Ventilator-associated pneumonia in neonates, infants and children	ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL			English	Review						Ventilator-associated pneumonia; Children; Neonates; Healthcare-associated infection	INTENSIVE-CARE-UNIT; DEVICE-ASSOCIATED INFECTIONS; CONTROL CONSORTIUM INICC; HOSPITAL-ACQUIRED INFECTION; CRITICALLY-ILL CHILDREN; NETWORK NHSN REPORT; NOSOCOMIAL INFECTIONS; RISK-FACTORS; SAFETY NETWORK; PEDIATRIC-PATIENTS	Ventilator-associated pneumonia (VAP) is relatively common in mechanically-ventilated children, but there is a wide variation in reported VAP rates, depending on settings and geographical regions. Surveillance definitions in children are challenging. Although these are provided by the German nosocomial infection surveillance system and an independent Dutch group, the combination of clinical and radiologic signs leaves room for interpretation. Of note, the United States Centers for Disease Prevention and Control guidelines do not offer algorithms for neonates. Despite the fact that most experts agree on the low sensitivity and specificity of existing definitions, little has changed over the past years. However, the number of studies reporting on VAP prevention programs has increased in recent years. Single interventions, such as chlorhexidine mouth wash or stress ulcer prophylaxis, were not effective. Successful prevention programs combined multiple interventions, such as hand hygiene, glove and gown use for endotracheal tube manipulation, backrest elevation, oral care with chlorhexidine, stress ulcer prophylaxis, cuff pressure maintenance where appropriate, use of orogastric tubes, avoidance of gastric overdistension, and elimination of non-essential tracheal suction. These multimodal strategies have proved to be successful among neonates, infants, and children. Importantly, they are applicable in high-as well as in low-and middle-income countries. This review provides an update of VAP incidence rates and summarizes current knowledge on its epidemiology, risk factors, surveillance definitions, and prevention programs in the pediatric setting.	[Aelami, Mohammad Hassan] Mashhad Univ Med Sci, Sch Med, Imam Reza Hosp, Dept Pediat, Mashhad, Iran; [Aelami, Mohammad Hassan] Mashhad Univ Med Sci, Sch Med, Imam Reza Hosp, Infect Control & Hand Hyg Res Ctr, Mashhad, Iran; [Lotfi, Mojtaba] Mashhad Univ Med Sci, Sch Med, Dept Pediat, Mashhad, Iran; [Zingg, Walter] Univ Hosp Geneva, Infect Control Program, CH-1211 Geneva 14, Switzerland; [Zingg, Walter] Univ Hosp Geneva, WHO Collaborating Ctr Patient Safety, CH-1211 Geneva 14, Switzerland		Zingg, W (corresponding author), Univ Hosp Geneva, Infect Control Program, 4 Rue Gabrielle Perret Gentil, CH-1211 Geneva 14, Switzerland.	walter.zingg@hcuge.ch					Abdel-Gawad TA, 2009, CRIT CARE, V13, DOI 10.1186/cc8134; Abramczyk Marcelo L., 2003, Braz J Infect Dis, V7, P375, DOI 10.1590/S1413-86702003000600004; Afjeh SA, 2012, ARCH IRAN MED, V15, P568; Almuneef M, 2004, INFECT CONT HOSP EP, V25, P753, DOI 10.1086/502472; [Anonymous], 2009, SURVEILLANCE; [Anonymous], 2014, CDC NHSN SURV DEF SP; Apisarnthanarak A, 2003, PEDIATRICS, V112, P1283, DOI 10.1542/peds.112.6.1283; da Silva ARA, 2012, INFECT CONT HOSP EP, V33, P845, DOI 10.1086/666627; Avila-Figueroa C, 1999, SALUD PUBLICA MEXICO, V41, pS18; Awasthi S, 2013, J CLIN EPIDEMIOL, V66, P62, DOI 10.1016/j.jclinepi.2012.06.006; Badr MA, 2011, IRAN J PEDIATR, V21, P418; Becerra MR, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-66; Ben Jaballah N, 2006, MED MALADIES INFECT, V36, P379, DOI 10.1016/j.medmal.2006.05.004; Bigham MT, 2009, J PEDIATR-US, V154, P582, DOI 10.1016/j.jpeds.2008.10.019; Brierley J, 2012, EUR J PEDIATR, V171, P323, DOI 10.1007/s00431-011-1538-y; Brilli RJ, 2008, JT COMM J QUAL PATIE, V34, P629, DOI 10.1016/S1553-7250(08)34080-X; Broughton EI, 2012, INT J PEDIAT, V2012, P359; Cai Xiao-Di, 2010, Zhongguo Dang Dai Er Ke Za Zhi, V12, P81; Casado RJA, 2011, CRIT CARE MED, V39, P1968, DOI 10.1097/CCM.0b013e31821b840d; Ceballos K, 2013, ADV NEONAT CARE, V13, P154, DOI 10.1097/ANC.0b013e318285fe70; Cernada M, 2013, PEDIATR CRIT CARE ME, V14, P55, DOI 10.1097/PCC.0b013e318253ca31; Citak A, 2000, TURKISH J PEDIATR, V42, P39; COTTON MF, 1989, PEDIATR INFECT DIS J, V8, P676, DOI 10.1097/00006454-198910000-00003; Couto RC, 2006, INFECT CONT HOSP EP, V27, P571, DOI 10.1086/504931; da Silva PS, 2010, PEDIATR INT, V52, P438, DOI 10.1111/j.1442-200X.2010.03104.x; Diaz-Ramos RD, 1999, SALUD PUBLICA MEXICO, V41, pS12; Dudeck MA, 2013, AM J INFECT CONTROL, V41, P286, DOI 10.1016/j.ajic.2013.01.002; Duennas L, 2011, J INFECT DEV COUNTR, V5, P445, DOI 10.3855/jidc.1319; Edwards JR, 2008, AM J INFECT CONTROL, V36, P609, DOI 10.1016/j.ajic.2008.08.001; Edwards JR, 2007, AM J INFECT CONTROL, V35, P290, DOI 10.1016/j.ajic.2007.04.001; El-Kholy A, 2012, AM J INFECT CONTROL, V40, pE216, DOI 10.1016/j.ajic.2011.12.010; El-Nawawy AA, 2006, J TROP PEDIATRICS, V52, P185, DOI 10.1093/tropej/fmi091; Elster T, 2009, GINEKOL POL, V80, P609; Elward AM, 2002, PEDIATRICS, V109, P758, DOI 10.1542/peds.109.5.758; Esteban E, 2013, PEDIATR CRIT CARE ME, V14, P525, DOI 10.1097/PCC.0b013e31828a87cc; Fayon MJ, 1997, AM J RESP CRIT CARE, V155, P162, DOI 10.1164/ajrccm.155.1.9001306; Jonusas SF, 2011, ARCH ARGENT PEDIATR, V109, P398, DOI [10.5546/aap.2011.398, 10.1590/S0325-00752011000500005]; Garland JS, 2009, CLIN PERINATOL, V36, P1, DOI 10.1016/j.clp.2008.09.005; Gastmeier P, 2002, J HOSP INFECT, V52, P161, DOI 10.1053/jhin.2002.1292; Gautam A, 2012, CRIT CARE RESUSC, V14, P283; Geffers C, 2008, J HOSP INFECT, V68, P214, DOI 10.1016/j.jhin.2008.01.016; Grisaru-Soen G, 2009, PEDIATR CRIT CARE ME, V10, P202, DOI 10.1097/PCC.0b013e31819a37c5; Grohskopf LA, 2002, J PEDIATR-US, V140, P432, DOI 10.1067/mpd.2002.122499; Guardia Cami M T, 2008, An Pediatr (Barc), V69, P34; Gupta A, 2014, AM J INFECT CONTROL, V42, P111, DOI 10.1016/j.ajic.2013.09.026; Gurskis V, 2009, MEDICINA-LITHUANIA, V45, P203, DOI 10.3390/medicina45030027; Helwich Ewa, 2013, Med Wieku Rozwoj, V17, P224; Hentschel J, 2005, INFECTION, V33, P350, DOI 10.1007/s15010-005-5052-x; Hocevar SN, 2012, INFECT CONT HOSP EP, V33, P1200, DOI 10.1086/668425; Jacomo ADN, 2011, INFECT CONT HOSP EP, V32, P591, DOI 10.1086/660018; Garcia IJ, 2014, AN PEDIATR, V80, P28, DOI 10.1016/j.anpedi.2010.09.010; Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205; Kusahara DM, 2012, INT J NURS STUD, V49, P1354, DOI 10.1016/j.ijnurstu.2012.06.005; Langley Joanne M, 2005, Pediatr Crit Care Med, V6, pS9, DOI 10.1097/01.PCC.0000161932.73262.D7; Leistner R, 2013, KLIN PADIATR, V225, P75, DOI 10.1055/s-0033-1334886; Liu B, 2013, J THORAC DIS, V5, P525, DOI 10.3978/j.issn.2072-1439.2013.08.31; Lopes JMM, 2002, AM J INFECT CONTROL, V30, P1, DOI 10.1067/mic.2002.117039; Lopriore E, 2002, INTENS CARE MED, V28, P763, DOI 10.1007/s00134-002-1289-3; da Silva PSL, 2014, J CRIT CARE, V29, P545, DOI 10.1016/j.jcrc.2014.01.010; Magill SS, 2013, AM J CRIT CARE, V22, P469, DOI 10.4037/ajcc2013893; Mahfouz A. A., 2010, Eastern Mediterranean Health Journal, V16, P40; Maltezou HC, 2013, PEDIATR INFECT DIS J, V32, pE151, DOI 10.1097/INF.0b013e3182804b49; Martinez-Aguilar G, 2001, SALUD PUBLICA MEXICO, V43, P515, DOI 10.1590/S0036-36342001000600001; Moradi M., 2013, Tehran University Medical Journal, V71, P373; Muszynski JA, 2013, PEDIATR CRIT CARE ME, V14, P533, DOI 10.1097/PCC.0b013e31828a897f; Navoa-Ng JA, 2011, AM J INFECT CONTROL, V39, P548, DOI 10.1016/j.ajic.2010.10.018; Oygur N, 2010, TURKISH J PEDIATR, V52, P50; Ozdemir H, 2011, TURKISH J PEDIATR, V53, P255; Patel JC, 2000, CRIT CARE MED, V28, P3530, DOI 10.1097/00003246-200010000-00030; Patria MF, 2013, WORLD J PEDIATR, V9, P365, DOI 10.1007/s12519-013-0444-y; Pessoa-Silva CL, 2004, INFECT CONT HOSP EP, V25, P772, DOI 10.1086/502475; Pittet D, 2010, CRIT CARE MED, V38, P983, DOI 10.1097/CCM.0b013e3181c8fd0c; Rasslan Ossama, 2012, J Infect Public Health, V5, P394, DOI 10.1016/j.jiph.2012.07.002; Raymond J, 2000, INFECT CONT HOSP EP, V21, P260, DOI 10.1086/501755; Roeleveld PP, 2011, INTENS CARE MED, V37, P1656, DOI 10.1007/s00134-011-2349-3; Rogers E, 2010, J MATERN-FETAL NEO M, V23, P1039, DOI 10.3109/14767050903387029; Rosenthal VD, 2011, INFECTION, V39, P439, DOI 10.1007/s15010-011-0136-2; Rosenthal VD, 2012, AM J INFECT CONTROL, V40, P497, DOI 10.1016/j.ajic.2011.08.005; Rosenthal VD, 2012, PEDIATR CRIT CARE ME, V13, P399, DOI 10.1097/PCC.0b013e318238b260; Rosenthal VD, 2012, INFECT CONT HOSP EP, V33, P704, DOI 10.1086/666342; Rosenthal VD, 2010, AM J INFECT CONTROL, V38, P95, DOI 10.1016/j.ajic.2009.12.004; Samransamruajkit R, 2010, J CRIT CARE, V25, P56, DOI 10.1016/j.jcrc.2009.03.005; Sebastian MR, 2012, PEDIATR CRIT CARE ME, V13, pE305, DOI 10.1097/PCC.0b013e31824ea119; Shaath GA, 2014, PEDIATR CARDIOL, V35, P627, DOI 10.1007/s00246-013-0830-1; Srinivasan R, 2009, PEDIATRICS, V123, P1108, DOI 10.1542/peds.2008-1211; Stover BH, 2001, AM J INFECT CONTROL, V29, P152, DOI 10.1067/mic.2001.115407; Su BH, 2007, AM J INFECT CONTROL, V35, P190, DOI 10.1016/j.ajic.2006.07.004; Tekin R, 2013, PEDIATR NEONATOL, V54, P303, DOI 10.1016/j.pedneo.2013.03.011; van der Zwet WC, 2005, J HOSP INFECT, V61, P300, DOI 10.1016/j.jhin.2005.03.014; Venkatachalam V, 2011, PEDIATR CRIT CARE ME, V12, P286, DOI 10.1097/PCC.0b013e3181fe2ffb; Weber JM, 1997, AM J INFECT CONTROL, V25, P195, DOI 10.1016/S0196-6553(97)90004-3; Xu Jin-Hua, 2007, Zhonghua Pifuke Zazhi, V40, P437; Xu XF, 2010, J PERINAT MED, V38, P431, DOI [10.1515/JPM.2010.063, 10.1515/jpm.2010.063]; Yalaz M, 2012, TURKISH J PEDIATR, V54, P128; Yapicioglu H, 2011, J TROP PEDIATRICS, V57, P157, DOI 10.1093/tropej/fmq060; Yuan TM, 2007, J PERINAT MED, V35, P334, DOI 10.1515/JPM.2007.065; Zhang De-Shuang, 2013, Sichuan Da Xue Xue Bao Yi Xue Ban, V44, P584; Zhang De-Shuang, 2013, Zhongguo Dang Dai Er Ke Za Zhi, V15, P14; Zhou Q, 2013, AM J INFECT CONTROL, V41, P1059, DOI 10.1016/j.ajic.2013.06.007	99	18	18	131	143	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2047-2994			ANTIMICROB RESIST IN	Antimicrob. Resist. Infect. Control	SEP 30	2014	3								30	10.1186/2047-2994-3-30			10	Public, Environmental & Occupational Health; Infectious Diseases; Microbiology; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Infectious Diseases; Microbiology; Pharmacology & Pharmacy	CZ7OH	WOS:000367288200001		gold			2022-03-04	
J	Fathi, M; Fornerone, S; Hughes, S; Viette, V; Hochstrasser, D				Fathi, Marc; Fornerone, Samuel; Hughes, Severine; Viette, Veronique; Hochstrasser, Denis			A LC-MS method for the determination of duloxetine in serum	THERAPEUTIC DRUG MONITORING			English	Meeting Abstract	10th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology	SEP 09-14, 2007	Nice, FRANCE						Univ Hosp Geneva, Lab Med Serv, Geneva, Switzerland									0	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0163-4356			THER DRUG MONIT	Ther. Drug Monit.	AUG	2007	29	4				189	518	519					2	Medical Laboratory Technology; Pharmacology & Pharmacy; Toxicology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology; Pharmacology & Pharmacy; Toxicology	194QP	WOS:000248359200202					2022-03-04	
J	Suppan, L; Stuby, L; Gartner, B; Larribau, R; Iten, A; Abbas, M; Harbarth, S; Suppan, M				Suppan, Laurent; Stuby, Loric; Gartner, Birgit; Larribau, Robert; Iten, Anne; Abbas, Mohamed; Harbarth, Stephan; Suppan, Melanie			Impact of an e-learning module on personal protective equipment knowledge in student paramedics: a randomized controlled trial	ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL			English	Article						Covid-19; e-learning; Personal protective equipment; Student paramedics; Emergency medical services; Randomized controlled trial	COVID-19; SERVICES	Background Prehospital professionals such as emergency physicians or paramedics must be able to choose and adequately don and doff personal protective equipment (PPE) in order to avoid COVID-19 infection. Our aim was to evaluate the impact of a gamified e-learning module on adequacy of PPE in student paramedics. Methods This was a web-based, randomized 1:1, parallel-group, triple-blind controlled trial. Student paramedics from three Swiss schools were invited to participate. They were informed they would be presented with both an e-learning module and an abridged version of the current regional prehospital COVID-19 guidelines, albeit not in which order. After a set of 22 questions designed to assess baseline knowledge, the control group was shown the guidelines before answering a set of 14 post-intervention questions. The e-learning group was shown the gamified e-learning module right after the guidelines, and before answering post-intervention questions. The primary outcome was the difference in the percentage of adequate choices of PPE before and after the intervention. Results The participation rate was of 71% (98/138). A total of 90 answer sets was analyzed. Adequate choice of PPE increased significantly both in the control (50% [33;83] vs 25% [25;50], P = .013) and in the e-learning group (67% [50;83] vs 25% [25;50], P = .001) following the intervention. Though the median of the difference was higher in the e-learning group, there was no statistically significant superiority over the control (33% [0;58] vs 17% [- 17;42], P = .087). The e-learning module was of greatest benefit in the subgroup of student paramedics who were actively working in an ambulance company (42% [8;58] vs 25% [- 17;42], P = 0.021). There was no significant effect in student paramedics who were not actively working in an ambulance service (0% [- 25;33] vs 17% [- 8;50], P = .584). Conclusions The use of a gamified e-learning module increases the rate of adequate choice of PPE only among student paramedics actively working in an ambulance service. In this subgroup, combining this teaching modality with other interventions might help spare PPE and efficiently protect against COVID-19 infection.	[Suppan, Laurent; Gartner, Birgit; Larribau, Robert] Univ Geneva Hosp, Dept Anesthesiol Clin Pharmacol Intens Care & Eme, Div Emergency Med, Rue Gabrielle Perret Gentil 4, CH-1211 Geneva 14, Switzerland; [Suppan, Laurent; Gartner, Birgit; Larribau, Robert; Iten, Anne; Abbas, Mohamed; Harbarth, Stephan; Suppan, Melanie] Fac Med, Rue Gabrielle Perret Gentil 4, CH-1211 Geneva 14, Switzerland; [Stuby, Loric] Geneve TEAM Ambulances, Geneva, Switzerland; [Iten, Anne; Abbas, Mohamed; Harbarth, Stephan] Univ Geneva Hosp, Infect Control Program, Geneva, Switzerland; [Iten, Anne; Abbas, Mohamed; Harbarth, Stephan] Univ Geneva Hosp, WHO Collaborating Ctr Patient Safety, Geneva, Switzerland; [Suppan, Melanie] Univ Geneva Hosp, Div Anesthesiol, Dept Anesthesiol Clin Pharmacol Intens Care & Eme, Geneva, Switzerland		Suppan, L (corresponding author), Univ Geneva Hosp, Dept Anesthesiol Clin Pharmacol Intens Care & Eme, Div Emergency Med, Rue Gabrielle Perret Gentil 4, CH-1211 Geneva 14, Switzerland.; Suppan, L (corresponding author), Fac Med, Rue Gabrielle Perret Gentil 4, CH-1211 Geneva 14, Switzerland.	laurent.suppan@hcuge.ch	Stuby, Loric/AAS-9043-2021; Suppan, Laurent/AAU-1562-2020; Abbas, Mohamed/M-1724-2019; Larribau, Robert/AAT-7988-2021; Suppan, Melanie/AAZ-8097-2020	Stuby, Loric/0000-0003-1663-5249; Suppan, Laurent/0000-0001-6989-6421; Abbas, Mohamed/0000-0002-7265-1887; Larribau, Robert/0000-0002-5200-4199; Suppan, Melanie/0000-0002-8807-9619; Gartner, Birgit/0000-0003-0726-3201; Harbarth, Stephan/0000-0002-3551-1025			[Anonymous], **NON-TRADITIONAL**; Bakkay MC, 2019, J COMPUT EDUC, V6, P257, DOI 10.1007/s40692-019-00136-6; Brigade Sanitaire Cantonale, 2020, COR MAL COVID 19 PRI, P1; Eysenbach G, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1923; Fouh E, 2014, COMPUT HUM BEHAV, V41, P478, DOI 10.1016/j.chb.2014.09.061; Gentry SV, 2019, J MED INTERNET RES, V21, DOI 10.2196/12994; Ghazali DA, 2020, PREHOSPITAL DISASTER, V35, P451, DOI 10.1017/S1049023X20000783; Holmes JL, 2020, LANCET, V395, pE93, DOI 10.1016/S0140-6736(20)31031-X; Klasen JM, 2020, MED ED; Koka A, 2020, J MED INTERNET RES, V22, DOI 10.2196/18358; Kopp V, 2008, MED EDUC, V42, P823, DOI 10.1111/j.1365-2923.2008.03122.x; Krathwohl DR, 2002, THEOR PRACT, V41, P212, DOI 10.1207/s15430421tip4104_2; Latimier A, 2019, NPJ SCI LEARN, V4, DOI 10.1038/s41539-019-0053-1; Li S, 2020, J MED INTERNET RES, V22, DOI 10.2196/16233; Lynch JB, 2020, CLIN INFECT DIS, DOI [10.1093/cid/ciaa1063/5876809, DOI 10.1093/CID/CIAA1063/5876809]; Mann DM, 2020, J AM MED INFORM ASS; Northington WE, 2007, ACAD EMERG MED, V14, P846, DOI 10.1197/j.aem.2007.06.034; Perez Sust Pol, 2020, JMIR Public Health Surveill, V6, pe19106, DOI 10.2196/19106; Raina S, 2016, IEEE INTERNATIONAL CONFERENCE ON INTELLIGENCE AND SECURITY INFORMATICS: CYBERSECURITY AND BIG DATA, P261, DOI 10.1109/ISI.2016.7745486; Sommerstein R, 2020, ANTIMICROB RESIST IN, V9, DOI 10.1186/s13756-020-00763-0; Suppan L, 2020, COVID 19 STUDENT PAR, V6, P257, DOI [10.1007/s40692-019-00136-6, DOI 10.1007/S40692-019-00136-6]; Suppan L, 2020, J MED INTERNET RES, V22, DOI 10.2196/21265; Suppan M, 2020, COVID 19 PREHOSPITAL; Suppan M, 2020, JMIR SERIOUS GAMES, V8, DOI 10.2196/20173; Ting DSW, 2020, NAT MED, V26, P459, DOI 10.1038/s41591-020-0824-5; Vilendrer S, 2020, J AM MED INFORM ASS	26	8	8	4	6	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2047-2994			ANTIMICROB RESIST IN	Antimicrob. Resist. Infect. Control	NOV 10	2020	9	1							185	10.1186/s13756-020-00849-9			9	Public, Environmental & Occupational Health; Infectious Diseases; Microbiology; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Infectious Diseases; Microbiology; Pharmacology & Pharmacy	OU9TI	WOS:000591865400002	33168097	gold, Green Published			2022-03-04	
J	Negro, F				Negro, F.			Steatosis and insulin resistance in response to treatment of chronic hepatitis C	JOURNAL OF VIRAL HEPATITIS			English	Article						hepatitis C; insulin resistance; standard of care; steatosis	SUSTAINED VIROLOGICAL RESPONSE; VIRUS CORE PROTEIN; COMBINATION THERAPY; RECEPTOR SUBSTRATE-1; TNF-ALPHA; RHEUMATOID-ARTHRITIS; INTERFERON THERAPY; SOCS3 EXPRESSION; LIVER FIBROSIS; PEGINTERFERON	. This review will focus on the impact of steatosis and insulin resistance on the response to antiviral therapy for chronic hepatitis C. Hepatitis C virus (HCV) infection is known to have direct and/or indirect effects on lipid and glucose metabolism, leading to, among other disturbances, steatosis and insulin resistance, respectively. Some of these disturbances have a marked HCV genotype distribution. For example, on average, patients with HCV genotype 3 have the highest prevalence and severity of viral fatty liver. On the other hand, the current global spread of the metabolic syndrome represents a formidable cofactor of morbidity in HCV-related chronic liver disease. Thus, the pathogenesis of steatosis and insulin resistance in patients with chronic hepatitis C may often be dual, i.e. viral and metabolic. This distinction is relevant because the effect (if any) of steatosis or insulin resistance on the response to antiviral agents seems to depend on their pathogenesis. Accumulating data suggest that viral fatty liver may not impact on response to therapy, while metabolic steatosis does. Similarly, viral insulin resistance may not reduce the rate of response to therapy to the same extent that metabolic insulin resistance does. Some implications for patient management are discussed.	[Negro, F.] Univ Hosp, Div Gastroenterol & Hepatol, Geneva, Switzerland; [Negro, F.] Univ Hosp, Div Clin Pathol, Geneva, Switzerland		Negro, F (corresponding author), Univ Geneva, Dept Internal Med, Med Ctr, 1 Rue Michel Servet, CH-1205 Geneva, Switzerland.	Francesco.Negro@hcuge.ch	Negro, Francesco/E-2183-2012		Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission [314730-130498]; RocheRoche Holding; MerckMerck & Company; AbbottAbbott Laboratories; NovartisNovartis; JanssenJohnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc	The author's experimental work cited in the present article is supported by grant number 314730-130498 from the Swiss National Science Foundation. The author has received fees for serving as advisory board member for Roche, Merck, Abbott, Novartis and Janssen.	Alberti A, 2009, LIVER INT, V29, P15, DOI 10.1111/j.1478-3231.2008.01945.x; Arase Y, 2009, HEPATOLOGY, V49, P739, DOI 10.1002/hep.22703; Asselah T, 2006, GUT, V55, P123, DOI 10.1136/gut.2005.069757; Aytug S, 2003, HEPATOLOGY, V38, P1384, DOI 10.1016/j.hep.2003.09.012; Banerjee S, 2008, J VIROL, V82, P2606, DOI 10.1128/JVI.01672-07; Bernsmeier C, 2008, J HEPATOL, V49, P429, DOI 10.1016/j.jhep.2008.04.007; Bochud PY, 2009, J HEPATOL, V51, P655, DOI 10.1016/j.jhep.2009.05.016; Bortoletto G, 2010, J VIRAL HEPATITIS, V17, P475, DOI 10.1111/j.1365-2893.2009.01204.x; Bugianesi E, 2006, HEPATOLOGY, V44, P1648, DOI 10.1002/hep.21429; Chu CJ, 2009, ALIMENT PHARM THER, V29, P46, DOI 10.1111/j.1365-2036.2008.03823.x; Conjeevaram H, 2008, HEPATOLOGY, V48, p384A; Cuchacovich R, 2009, CLIN RHEUMATOL, V28, P1217, DOI 10.1007/s10067-009-1208-x; D'Souza R, 2005, AM J GASTROENTEROL, V100, P1509, DOI 10.1111/j.1572-0241.2005.41403.x; Dai CY, 2009, J HEPATOL, V50, P712, DOI 10.1016/j.jhep.2008.12.017; Durante-Mangoni E, 2009, CLIN INFECT DIS, V49, P498, DOI 10.1086/600887; Elgouhari HM, 2008, HEPATOLOGY, V48, p383A; Fattovich G, 2011, LIVER INT, V31, P66, DOI 10.1111/j.1478-3231.2010.02343.x; Gadina M, 2001, CURR OPIN IMMUNOL, V13, P363, DOI 10.1016/S0952-7915(00)00228-4; Gonzalez-Gay MA, 2010, ANN NY ACAD SCI, V1193, P153, DOI 10.1111/j.1749-6632.2009.05287.x; Grasso A, 2009, J HEPATOL, V51, P984, DOI 10.1016/j.jhep.2009.07.008; Harrison S, 2010, J HEPATOL, V52, pS129, DOI 10.1016/S0168-8278(10)60310-8; Hickman IJ, 2003, J HEPATOL, V39, P1042, DOI 10.1016/S0168-8278(03)00463-X; Huang Y, 2007, GASTROENTEROLOGY, V132, P733, DOI 10.1053/j.gastro.2006.11.045; Hui JM, 2003, GASTROENTEROLOGY, V125, P1695, DOI 10.1053/j.gastro.2003.08.032; Hung CH, 2011, INT J CANCER, V128, P2344, DOI 10.1002/ijc.25585; Kawaguchi T, 2004, AM J PATHOL, V165, P1499, DOI 10.1016/S0002-9440(10)63408-6; Kawaguchi T, 2007, AM J GASTROENTEROL, V102, P570, DOI 10.1111/j.1572-0241.2006.01038.x; Kawamura Y, 2010, AM J MED, V123, P951, DOI 10.1016/j.amjmed.2010.05.013; Khattab M, 2010, AM J GASTROENTEROL, V105, P1970, DOI 10.1038/ajg.2010.110; Khattab M, 2010, LIVER INT, V30, P447, DOI 10.1111/j.1478-3231.2009.02171.x; Kim KA, 2009, J HEPATOL, V50, P705, DOI 10.1016/j.jhep.2008.12.021; Knobler H, 2005, QJM-INT J MED, V98, P1, DOI 10.1093/qjmed/hci001; Knobler H, 2003, AM J GASTROENTEROL, V98, P2751, DOI 10.1016/j.amjgastroenterol.2003.06.002; Leandro G, 2006, GASTROENTEROLOGY, V130, P1636, DOI 10.1053/j.gastro.2006.03.014; Mehta SH, 2000, ANN INTERN MED, V133, P592, DOI 10.7326/0003-4819-133-8-200010170-00009; Milner KL, 2010, GASTROENTEROLOGY, V138, P932, DOI 10.1053/j.gastro.2009.11.050; Mitsuyoshi H, 2008, HEPATOL RES, V38, P348, DOI 10.1111/j.1872-034X.2007.00280.x; Miyaaki H, 2009, HEPATOL RES, V39, P850, DOI 10.1111/j.1872-034X.2009.00529.x; Moucari R, 2009, GUT, V59, P1694; Moucari R, 2008, GASTROENTEROLOGY, V134, P416, DOI 10.1053/j.gastro.2007.11.010; Muzzi A, 2005, J HEPATOL, V42, P41, DOI 10.1016/j.jhep.2004.09.022; Nasta P, 2008, AIDS, V22, P857, DOI 10.1097/QAD.0b013e3282fbd1c4; Negro F, 2010, GUT, V59, P1279, DOI 10.1136/gut.2009.192732; Negro F, 2009, WORLD J GASTROENTERO, V15, P1537, DOI 10.3748/wjg.15.1537; Overbeck K, 2008, J HEPATOL, V49, P295, DOI 10.1016/j.jhep.2008.03.033; Patton HM, 2004, J HEPATOL, V40, P484, DOI 10.1016/j.jhep.2003.11.004; Pazienza V, 2007, HEPATOLOGY, V45, P1164, DOI 10.1002/hep.21634; Pazienza V, 2010, J GEN VIROL, V91, P1678, DOI 10.1099/vir.0.020644-0; Persico M, 2007, HEPATOLOGY, V46, P1009, DOI 10.1002/hep.21782; Poustchi H, 2008, J HEPATOL, V48, P28, DOI 10.1016/j.jhep.2007.07.026; Poynard T, 2003, HEPATOLOGY, V38, P75, DOI 10.1053/jhep.2003.50267; Ratziu V, 2003, J HEPATOL, V39, P1049, DOI 10.1016/S0168-8278(03)00456-2; Romero-Gomez M, 2005, GASTROENTEROLOGY, V128, P636, DOI 10.1053/j.gastro.2004.12.049; Romero-Gomez M, 2008, J HEPATOL, V48, P721, DOI 10.1016/j.jhep.2007.11.022; Romero-Gomez M, 2009, HEPATOLOGY, V50, P1702, DOI 10.1002/hep.23206; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Shintani Y, 2004, GASTROENTEROLOGY, V126, P840, DOI 10.1053/j.gastro.2003.11.056; Ursni F, 2010, INT J IMMUNOPATH PH, V23, P961, DOI 10.1177/039463201002300334; Vanni E, 2009, HEPATOLOGY, V50, P697, DOI 10.1002/hep.23031; Veldt BJ, 2008, HEPATOLOGY, V47, P1856, DOI 10.1002/hep.22251; Walsh MJ, 2006, GUT, V55, P529, DOI 10.1136/gut.2005.069674; Wascher TC, 2011, MOL MED, V17, P189, DOI 10.2119/molmed.2010.00221; Westin J, 2007, J VIRAL HEPATITIS, V14, P29, DOI 10.1111/j.1365-2893.2006.00777.x; White DL, 2008, J HEPATOL, V49, P831, DOI 10.1016/j.jhep.2008.08.006	65	29	33	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1352-0504	1365-2893		J VIRAL HEPATITIS	J. Viral Hepatitis	JAN	2012	19			1	SI		42	47		10.1111/j.1365-2893.2011.01523.x			6	Gastroenterology & Hepatology; Infectious Diseases; Virology	Science Citation Index Expanded (SCI-EXPANDED)	Gastroenterology & Hepatology; Infectious Diseases; Virology	874WC	WOS:000298987800008	22233413				2022-03-04	
J	Peters, A; Borzykowski, T; Tartari, E; Kilpatrick, C; Mai, SHC; Allegranzi, B; Pittet, D				Peters, Alexandra; Borzykowski, Tcheun; Tartari, Ermira; Kilpatrick, Claire; Mai, Safiah Hwai Chuen; Allegranzi, Benedetta; Pittet, Didier			"Clean care for all-it's in your hands": the May 5th, 2019 World Health Organization SAVE LIVES: Clean Your Hands campaign	ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL			English	Editorial Material						Infection prevention and control; Infection control; Hand hygiene; Universal health coverage; Antimicrobial resistance; World Health Organization; Healthcare-associated infection; Global health; Survey			[Peters, Alexandra; Borzykowski, Tcheun; Tartari, Ermira; Pittet, Didier] Univ Geneva Hosp, Infect Control Programme, 4 Rue Gabrielle Perret Gentil, CH-1211 Geneva 14, Switzerland; [Peters, Alexandra; Borzykowski, Tcheun; Tartari, Ermira; Pittet, Didier] Univ Geneva Hosp, WHO Collaborating Ctr Patient Safety, 4 Rue Gabrielle Perret Gentil, CH-1211 Geneva 14, Switzerland; [Peters, Alexandra; Borzykowski, Tcheun; Tartari, Ermira; Pittet, Didier] Fac Med, 4 Rue Gabrielle Perret Gentil, CH-1211 Geneva 14, Switzerland; [Kilpatrick, Claire; Mai, Safiah Hwai Chuen; Allegranzi, Benedetta] WHO, Dept Serv Delivery & Safety, Infect Prevent & Control Global Unit, Geneva, Switzerland		Pittet, D (corresponding author), Univ Geneva Hosp, Infect Control Programme, 4 Rue Gabrielle Perret Gentil, CH-1211 Geneva 14, Switzerland.; Pittet, D (corresponding author), Univ Geneva Hosp, WHO Collaborating Ctr Patient Safety, 4 Rue Gabrielle Perret Gentil, CH-1211 Geneva 14, Switzerland.; Pittet, D (corresponding author), Fac Med, 4 Rue Gabrielle Perret Gentil, CH-1211 Geneva 14, Switzerland.	Didier.pittet@hcuge.ch	Tartari, Ermira/AAC-6804-2021	Kilpatrick, Claire/0000-0002-5680-8549; Pittet, Didier/0000-0002-3667-7131	World Health Organization (WHO), Geneva, SwitzerlandWorld Health Organization; Infection Control Programme and WHO Collaborating Centre on Patient Safety (SPCI/WCC), University of Geneva Hospitals and Faculty of Medicine, Geneva, Switzerland; Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission [32003B_163262]	This work is supported by the World Health Organization (WHO), Geneva, Switzerland, and the Infection Control Programme and WHO Collaborating Centre on Patient Safety (SPCI/WCC), University of Geneva Hospitals and Faculty of Medicine, Geneva, Switzerland; hand hygiene research activities at the SPCI/WCC are also supported by the Swiss National Science Foundation (grant no. 32003B_163262).	Allegranzi B, 2014, AM J INFECT CONTROL, V42, P224, DOI 10.1016/j.ajic.2013.11.015; Kilpatrick C, 2018, J HOSP INFECT, V100, P202, DOI 10.1016/j.jhin.2018.07.036; World Health Organization, WHAT IS UN COV; World Health Organization, SAVE LIVES CLEAN YOU; World Health Organization, WHO HAND HYG SELF AS	5	1	1	0	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2047-2994			ANTIMICROB RESIST IN	Antimicrob. Resist. Infect. Control	APR 17	2019	8								64	10.1186/s13756-019-0513-7			3	Public, Environmental & Occupational Health; Infectious Diseases; Microbiology; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Infectious Diseases; Microbiology; Pharmacology & Pharmacy	HU0GM	WOS:000464949400001	31016014	Green Published, gold			2022-03-04	
J	Fathi, M; Duparc, MT; Morch, F; Jayo, M; Martin, C; Hochstrasser, D				Fathi, M; Duparc, MT; Morch, F; Jayo, M; Martin, C; Hochstrasser, D			Simultaneous determination of fluoxetine, norfluoxetine, paroxetine, sertraline and reboxetine in serum as acetvlated derivatives by gas chromatography-selected ion monitoring mass spectrometry (GC-SIM-MS)	THERAPEUTIC DRUG MONITORING			English	Meeting Abstract	9th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology	APR 23-28, 2005	Louisville, KY						Univ Hosp Geneva, Cent Lab Clin Chem, Geneva, Switzerland									0	2	2	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0163-4356			THER DRUG MONIT	Ther. Drug Monit.	APR	2005	27	2				29	217	218		10.1097/00007691-200504000-00045			2	Medical Laboratory Technology; Pharmacology & Pharmacy; Toxicology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology; Pharmacology & Pharmacy; Toxicology	912YH	WOS:000228115500046					2022-03-04	
J	Phan, HT; Zingg, W; Tran, HTT; Dinh, APP; Pittet, D				Hang Thi Phan; Zingg, Walter; Hang Thi Thuy Tran; Anh Pham Phuong Dinh; Pittet, Didier			Sustained effects of a multimodal campaign aiming at hand hygiene improvement on compliance and healthcare-associated infections in a large gynaecology/obstetrics tertiary-care centre in Vietnam	ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL			English	Article						Hand hygiene; Compliance; Healthcare-associated infection; Surgical site infection; Incidence; Vietnam; Lower-middle-income country; Multimodal; Behaviour change; Intervention; Alcohol-based handrub; Hand sanitizer	ALCOHOL-BASED HANDRUB; CESAREAN-SECTION; STRATEGY; IMPLEMENTATION; ORGANIZATION; PROMOTION; PROGRAM; SURVEILLANCE; PREVENTION; FEEDBACK	Background Hung Vuong Hospital (HVH) is a 900-bed maternity hospital in Ho-Chi-Minh-City, Vietnam. Due to low compliance, a quasi-experimental, observational study was conducted with the aim to improve hand hygiene. Methods A multimodal promotion strategy was established in 2010 and further developed towards ongoing, repetitive and inventive campaigns including patient participation. Hand hygiene compliance was monitored by direct observation and healthcare-associated infections (HAIs) by applying standard definitions. Results Between 2010 and 2018, a total of 43,711 hand hygiene opportunities were observed. Compliance improved from 21.5% (95%CI: 20.2-22.8%) in 2010 to 75.1% (73.9-76.2%) in 2018 (incidence rate ratio, IRR , 1.10; 95%CI, 1.10-1.11). This was achieved through increasing recourse to alcohol-based hand rubbing. A total of 554,720 women were admitted to HVH during the study period for 353,919 deliveries (198,679 vaginal; 155,240 by C-section) and 257,127 surgical procedures. The HAI-incidence decreased significantly from 1.10 episodes per 1000 patient-days in 2010 to 0.45 per 1000 patient-days in 2018 (IRR 0.85; 95%CI, 0.79-0.90). Significant improvement was observed also for surgical site infections after gynaecological surgery (IRR 0.95; 95%CI, 0.92-0.99) and endometritis after abortion (IRR 0.80; 95%CI, 0.68-0.93). Conclusions A multimodal strategy aiming at behaviour change significantly improved and sustained hand hygiene, which contributed to the reduction of healthcare-associated infections.	[Hang Thi Phan; Hang Thi Thuy Tran; Anh Pham Phuong Dinh] Hung Vuong Hosp, Infect Control Programme, Ho Chi Minh City, Vietnam; [Zingg, Walter; Pittet, Didier] Univ Geneva Hosp, Infect Control Programme, 4 Rue Gabrielle Perret Gentil, CH-1205 Geneva, Switzerland; [Zingg, Walter; Pittet, Didier] Univ Geneva Hosp, WHO Collaborating Ctr Patient Safety, 4 Rue Gabrielle Perret Gentil, CH-1205 Geneva, Switzerland; [Zingg, Walter; Pittet, Didier] Fac Med, 4 Rue Gabrielle Perret Gentil, CH-1205 Geneva, Switzerland		Zingg, W (corresponding author), Univ Geneva Hosp, Infect Control Programme, 4 Rue Gabrielle Perret Gentil, CH-1205 Geneva, Switzerland.; Zingg, W (corresponding author), Univ Geneva Hosp, WHO Collaborating Ctr Patient Safety, 4 Rue Gabrielle Perret Gentil, CH-1205 Geneva, Switzerland.; Zingg, W (corresponding author), Fac Med, 4 Rue Gabrielle Perret Gentil, CH-1205 Geneva, Switzerland.	walter.zingg@hcuge.ch			Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission [32003B_163262]; Hung Vuong Hospital (HVH); Infection Control Program & WHO Collaborating Centre on Patient Safety (SPCI/WCC) at the University of Geneva Hospitals, Geneva, Switzerland	Hung Vuong Hospital (HVH) and the Infection Control Program & WHO Collaborating Centre on Patient Safety (SPCI/WCC) at the University of Geneva Hospitals, Geneva, Switzerland; hand hygiene research activities at the SPCI/WCC are supported by the Swiss National Science Foundation (32003B_163262).	Albright J, 2018, AM J INFECT CONTROL, V46, P1104, DOI 10.1016/j.ajic.2018.04.205; Allegranzi B, 2017, HAND HYGIENE HDB MED, P144; Allegranzi B, 2017, HAND HYGIENE HDB MED, P299, DOI 10.1002/9781118846810.ch41; Allegranzi B, 2017, HAND HYGIENE HDB MED, P230, DOI [10.1002/9781118846810.ch33, DOI 10.1002/9781118846810.CH33]; Allegranzi B, 2014, AM J INFECT CONTROL, V42, P224, DOI 10.1016/j.ajic.2013.11.015; Allegranzi B, 2013, LANCET INFECT DIS, V13, P843, DOI 10.1016/S1473-3099(13)70163-4; Allegranzi B, 2010, INFECT CONT HOSP EP, V31, P133, DOI 10.1086/649796; Anh Thu T, 2009, PHIL 47 INF DIS SOC; Arise K, 2016, AM J INFECT CONTROL, V44, pE211, DOI 10.1016/j.ajic.2016.07.011; Balkhy HH, 2003, AM J INFECT CONTROL, V31, P288, DOI 10.1067/mic.2003.14; Barrera L, 2011, AM J INFECT CONTROL, V39, P633, DOI 10.1016/j.ajic.2010.11.004; Bion J, 2013, BMJ QUAL SAF, V22, P110, DOI 10.1136/bmjqs-2012-001325; Cunningham D, 2018, J PATIENT SAF, V14, P107, DOI 10.1097/PTS.0000000000000172; Damani N, 2017, HAND HYGIENE HDB MED, P357; Edwards JR, 2009, AM J INFECT CONTROL, V37, P783, DOI 10.1016/j.ajic.2009.10.001; Farret TCF, 2015, BRAZ J INFECT DIS, V19, P113, DOI 10.1016/j.bjid.2014.09.009; Grayson ML, 2011, MED J AUSTRALIA, V195, P615, DOI 10.5694/mja11.10747; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Hugonnet S, 2002, ARCH INTERN MED, V162, P1037, DOI 10.1001/archinte.162.9.1037; Lebovic G, 2013, J HOSP INFECT, V83, P276, DOI 10.1016/j.jhin.2013.01.001; Luangasanatip N, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3728; Moro ML, 2017, EUROSURVEILLANCE, V22, P25, DOI 10.2807/1560-7917.ES.2017.22.23.30546; Nguyen KV, 2008, TROP MED INT HEALTH, V13, P1297, DOI 10.1111/j.1365-3156.2008.02141.x; Pittet D, 2000, LANCET, V356, P1307, DOI 10.1016/S0140-6736(00)02814-2; Pittet D, 1999, ANN INTERN MED, V130, P126, DOI 10.7326/0003-4819-130-2-199901190-00006; Pittet D, 2004, INFECT CONT HOSP EP, V25, P264, DOI 10.1086/502389; Rosenthal VD, 2013, INFECT CONT HOSP EP, V34, P597, DOI 10.1086/670626; Saito H, 2017, ANTIMICROB RESIST IN, V6, DOI 10.1186/s13756-017-0287-8; Salmon S, 2011, BIOMED CENTRAL P S6, V5, pO22, DOI DOI 10.1186/1753-6561-5-S6-O22; Salmon S, 2014, AM J INFECT CONTROL, V42, P71, DOI 10.1016/j.ajic.2013.07.011; Sax H, 2007, J HOSP INFECT, V67, P9, DOI 10.1016/j.jhin.2007.06.004; Sax H, 2017, HAND HYGIENE HDB MED, P162; Stewardson AJ, 2013, J HOSP INFECT, V83, P30, DOI 10.1016/j.jhin.2012.05.017; Stewardson AJ, 2016, LANCET INFECT DIS, V16, P1345, DOI 10.1016/S1473-3099(16)30256-0; Stone SP, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3005; Storr J, 2017, ANTIMICROB RESIST IN, V6, DOI 10.1186/s13756-016-0149-9; Thu LTA, 2007, INFECT CONT HOSP EP, V28, P583, DOI 10.1086/516661; van der Kooi T, 2018, INTENS CARE MED, V44, P48, DOI 10.1007/s00134-017-5007-6; von Elm E, 2007, BMJ-BRIT MED J, V335, P806; Zingg W, 2015, LANCET INFECT DIS, V15, P212, DOI 10.1016/S1473-3099(14)70854-0	40	3	3	1	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2047-2994			ANTIMICROB RESIST IN	Antimicrob. Resist. Infect. Control	APR 10	2020	9	1							51	10.1186/s13756-020-00712-x			9	Public, Environmental & Occupational Health; Infectious Diseases; Microbiology; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Infectious Diseases; Microbiology; Pharmacology & Pharmacy	LD0HK	WOS:000525714000001	32276646	Green Published, gold			2022-03-04	
J	Pires, D; Prendki, V; Renzi, G; Fankhauser, C; Sauvan, V; Huttner, B; Schrenzel, J; Harbarth, S				Pires, Daniela; Prendki, Virginie; Renzi, Gesuele; Fankhauser, Carolina; Sauvan, Valerie; Huttner, Benedikt; Schrenzel, Jacques; Harbarth, Stephan			Low frequency of asymptomatic carriage of toxigenic Clostridium difficile in an acute care geriatric hospital: prospective cohort study in Switzerland	ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL			English	Article						Clostridium difficile; Asymptomatic; Colonization	COLONIZATION; CARRIERS; UNIT; TRANSMISSION; PREVALENCE; INFECTION	Background: The role of asymptomatic carriers of toxigenic Clostridium difficile (TCD) in nosocomial cross-transmission remains debatable. Moreover, its relevance in the elderly has been sparsely studied. Objectives: To assess asymptomatic TCD carriage in an acute care geriatric population. Methods: We performed a prospective cohort study at the 296-bed geriatric hospital of the Geneva University Hospitals. We consecutively recruited all patients admitted to two 15-bed acute-care wards. Patients with C. difficile infection (CDI) or diarrhoea at admission were excluded. First bowel movement after admission and every two weeks thereafter were sampled. C. difficile toxin B gene was identified using real-time polymerase chain-reaction (BD MAX (TM) Cdiff). Asymptomatic TCD carriage was defined by the presence of the C. difficile toxin B gene without diarrhoea. Results: A total of 102 patients were admitted between March and June 2015. Two patients were excluded. Among the 100 patients included in the study, 63 were hospitalized and 1 had CDI in the previous year, and 36 were exposed to systemic antibiotics within 90 days prior to admission. Overall, 199 stool samples were collected (median 2 per patient, IQR 1-3). Asymptomatic TCD carriage was identified in two patients (2 %). Conclusions: We found a low prevalence of asymptomatic TCD carriage in a geriatric population frequently exposed to antibiotics and healthcare. Our findings suggest that asymptomatic TCD carriage might contribute only marginally to nosocomial TCD cross-transmission in our and similar healthcare settings.	[Pires, Daniela; Fankhauser, Carolina; Sauvan, Valerie; Huttner, Benedikt; Harbarth, Stephan] Univ Hosp Geneva, Infect Control Program, 4 Rue Gabrielle Perret Gentil, CH-1211 Geneva, Switzerland; [Pires, Daniela] Univ Lisbon, Dept Infect Dis, Ctr Hosp Lisboa Norte, P-1699 Lisbon, Portugal; [Pires, Daniela] Univ Lisbon, Fac Med, P-1699 Lisbon, Portugal; [Prendki, Virginie] Univ Hosp Geneva, Dept Geriatr, Geneva, Switzerland; [Renzi, Gesuele; Schrenzel, Jacques] Univ Hosp Geneva, Cent Lab Bacteriol, Geneva, Switzerland; [Huttner, Benedikt; Schrenzel, Jacques; Harbarth, Stephan] Univ Hosp Geneva, Dept Infect Dis, Geneva, Switzerland; [Huttner, Benedikt; Schrenzel, Jacques; Harbarth, Stephan] Univ Geneva, Fac Med, Geneva, Switzerland		Pires, D (corresponding author), Univ Hosp Geneva, Infect Control Program, 4 Rue Gabrielle Perret Gentil, CH-1211 Geneva, Switzerland.; Pires, D (corresponding author), Univ Lisbon, Dept Infect Dis, Ctr Hosp Lisboa Norte, P-1699 Lisbon, Portugal.; Pires, D (corresponding author), Univ Lisbon, Fac Med, P-1699 Lisbon, Portugal.	danicpires@gmail.com	Schrenzel, Jacques/AAC-5685-2021; Schrenzel, Jacques/P-8525-2017; Huttner, Benedikt/M-5616-2014; Prendki, Virginie/ABI-1378-2020	Schrenzel, Jacques/0000-0001-5464-7764; Schrenzel, Jacques/0000-0001-5464-7764; Huttner, Benedikt/0000-0002-1749-9464; Prendki, Virginie/0000-0003-1315-2938	Fundacao para a Ciencia e TecnologiaPortuguese Foundation for Science and TechnologyEuropean Commission [SFRH/SINT/95317/2013]; European CommissionEuropean CommissionEuropean Commission Joint Research Centre [282512]	DP was partially supported by Fundacao para a Ciencia e Tecnologia (SFRH/SINT/95317/2013). CF and BH were supported by the European Commission under the Life Science Health Priority of the 7th Framework Program (RGNOSIS grant agreement 282512).	[Anonymous], 2012, XPERT C DIFF PACK IN; [Anonymous], 2008, BD GENOHMTM CDIF ASS; BD MAXTM Cdiff Assay, 2013, BD MAXTM CDIFF ASS P; Burnham CAD, 2013, CLIN MICROBIOL REV, V26, P604, DOI 10.1128/CMR.00016-13; Corrado OJ, 1990, J INFECTION, V21, P187; Curry SR, 2013, CLIN INFECT DIS, V57, P1094, DOI 10.1093/cid/cit475; Donskey CJ, 2015, INFECT DIS CLIN N AM, V29, P13, DOI 10.1016/j.idc.2014.11.001; Donskey CJ, 2014, J CLIN MICROBIOL, V52, P315, DOI 10.1128/JCM.01852-13; Furuya-Kanamori L, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1258-4; Furuya-Kanamori L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120730; Harbarth S, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001171; Hung YP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042415; Kong LY, 2015, AM J INFECT CONTROL, V43, P248, DOI 10.1016/j.ajic.2014.11.024; Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801; McCoubrey J, 2003, J MED MICROBIOL, V52, P573, DOI 10.1099/jmm.0.05179-0; Riggs MM, 2007, CLIN INFECT DIS, V45, P992, DOI 10.1086/521854; RUDENSKY B, 1993, POSTGRAD MED J, V69, P45, DOI 10.1136/pgmj.69.807.45; Schoevaerdts D, 2011, J AM GERIATR SOC, V59, P2179, DOI 10.1111/j.1532-5415.2011.03685.x; Tschudin-Sutter S, 2015, INFECT CONT HOSP EP, V36, P1324, DOI 10.1017/ice.2015.177	19	4	4	0	5	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	2047-2994			ANTIMICROB RESIST IN	Antimicrob. Resist. Infect. Control	JUN 8	2016	5								24	10.1186/s13756-016-0123-6			5	Public, Environmental & Occupational Health; Infectious Diseases; Microbiology; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Infectious Diseases; Microbiology; Pharmacology & Pharmacy	DP4NV	WOS:000378473500001	27280019	Green Published, gold			2022-03-04	
J	Negro, F; Clement, S				Negro, F.; Clement, S.			Impact of obesity, steatosis and insulin resistance on progression and response to therapy of hepatitis C	JOURNAL OF VIRAL HEPATITIS			English	Review						cirrhosis; hepatitis C virus; interferon-alpha; metabolic syndrome	RIBAVIRIN COMBINATION THERAPY; PEGINTERFERON PLUS RIBAVIRIN; SUSTAINED VIROLOGICAL RESPONSE; TRIGLYCERIDE TRANSFER PROTEIN; PEGYLATED-INTERFERON THERAPY; INDEPENDENT RISK-FACTOR; BODY-MASS INDEX; GROWTH-FACTOR-I; HEPATOCELLULAR-CARCINOMA; FIBROSIS PROGRESSION	Clinical progression of chronic hepatitis C depends on several cofactors, which also have a negative affect on the rate of response to interferon-alpha-based therapy. Given the current worldwide prevalence of the metabolic syndrome, the impact of obesity and insulin resistance, and of their histopathological correlate, hepatic steatosis, on the natural history and management of chronic hepatitis C is undoubtedly very important. We will review some of the current knowledge on the clinical consequences of overweight/obesity, steatosis and insulin resistance on chronic hepatitis C, and discuss how this issue may be dealt with in clinical practice.	[Negro, F.] Univ Hosp, Div Gastroenterol & Hepatol, Geneva, Switzerland; [Negro, F.; Clement, S.] Univ Hosp, Div Clin Pathol, Geneva, Switzerland		Negro, F (corresponding author), Ctr Med Univ Geneva, Div Clin Pathol, 1 Rue Michel Servet, CH-1206 Geneva, Switzerland.	francesco.negro@hcuge.ch	Negro, Francesco/E-2183-2012		Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission [320000-116544]; Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission; Leenaards Foundation (Lausanne, Switzerland)	The Authors' experimental and clinical work cited in the text is supported by research grant no. 320000-116544 from the Swiss National Science Foundation and by a research award from the Leenaards Foundation (Lausanne, Switzerland).	Adinolfi LE, 2001, HEPATOLOGY, V33, P1358, DOI 10.1053/jhep.2001.24432; Akuta N, 2006, J MED VIROL, V78, P83, DOI 10.1002/jmv.20507; Alberti A, 2009, LIVER INT, V29, P15, DOI 10.1111/j.1478-3231.2008.01945.x; Argo CK, 2009, J HEPATOL, V51, P371, DOI 10.1016/j.jhep.2009.03.019; BOCHUD PY, 2009, J HEPATOL IN PRESS; Bongiovanni M, 2008, JAIDS-J ACQ IMM DEF, V47, P258, DOI 10.1097/QAI.0b013e318158befd; Bortoletto G, 2007, HEPATOLOGY, V46, p361A; Bressler BL, 2003, HEPATOLOGY, V38, P639, DOI 10.1053/jhep.2003.50350; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Camma C, 2009, HEPATOLOGY, V49, P195, DOI 10.1002/hep.22655; Cancello R, 2006, DIABETES, V55, P1554, DOI 10.2337/db06-0133; Charlton MR, 2006, HEPATOLOGY, V43, P1177, DOI 10.1002/hep.21239; Chen CL, 2008, GASTROENTEROLOGY, V135, P111, DOI 10.1053/j.gastro.2008.03.073; Chu CJ, 2009, ALIMENT PHARM THER, V29, P46, DOI 10.1111/j.1365-2036.2008.03823.x; Conjeevaram H, 2008, HEPATOLOGY, V48, p384A; Conjeevaram HS, 2007, HEPATOLOGY, V45, P80, DOI 10.1002/hep.21455; CONOVER A, 1989, HORM METAB RES, V21, P59, DOI 10.1055/s-2007-1009151; D'Souza R, 2005, AM J GASTROENTEROL, V100, P1509, DOI 10.1111/j.1572-0241.2005.41403.x; Eguchi Y, 2006, WORLD J GASTROENTERO, V12, P556, DOI 10.3748/wjg.v12.i4.556; Elgouhari HM, 2008, HEPATOLOGY, V48, p383A; Everhart JE, 2009, GASTROENTEROLOGY, V137, P549, DOI 10.1053/j.gastro.2009.05.007; Fabris P, 2005, ALIMENT PHARM THER, V21, P1173, DOI 10.1111/j.1365-2036.2005.02452.x; Fartoux L, 2005, GUT, V54, P1003, DOI 10.1136/gut.2004.050302; Ford ES, 2004, DIABETES CARE, V27, P2444, DOI 10.2337/diacare.27.10.2444; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Gad RR, 2008, LIVER INT, V28, P1112, DOI 10.1111/j.1478-3231.2008.01750.x; Gadina M, 2001, CURR OPIN IMMUNOL, V13, P363, DOI 10.1016/S0952-7915(00)00228-4; Glue P, 2000, CLIN PHARMACOL THER, V68, P556, DOI 10.1067/mcp.2000.110973; GOLDSTEIN RH, 1989, ENDOCRINOLOGY, V124, P964, DOI 10.1210/endo-124-2-964; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Hanouneh IA, 2008, CLIN GASTROENTEROL H, V6, P584, DOI 10.1016/j.cgh.2008.02.034; Hickman IJ, 2004, GUT, V53, P413, DOI 10.1136/gut.2003.027581; Hourigan LF, 1999, HEPATOLOGY, V29, P1215, DOI 10.1002/hep.510290401; Hu SX, 2009, J CLIN GASTROENTEROL, V43, P758, DOI 10.1097/MCG.0b013e31818be17c; Huang JF, 2007, HEPATOLOGY, V46, p349A; Huang PL, 2009, DIS MODEL MECH, V2, P231, DOI 10.1242/dmm.001180; Hui JM, 2003, GASTROENTEROLOGY, V125, P1695, DOI 10.1053/j.gastro.2003.08.032; Jacobson IM, 2007, HEPATOLOGY, V46, P971, DOI 10.1002/hep.21932; Kamal SM, 2002, GASTROENTEROLOGY, V123, P1070, DOI 10.1053/gast.2002.36045; Kawaguchi T, 2004, AM J PATHOL, V165, P1499, DOI 10.1016/S0002-9440(10)63408-6; Khuroo MS, 2004, ALIMENT PHARM THER, V20, P931, DOI 10.1111/j.1365-2036.2004.02208.x; Koike K, 2009, J GASTROENTEROL, V44, P82, DOI 10.1007/s00535-008-2276-4; Konishi I, 2009, LIVER INT, V29, P1194, DOI 10.1111/j.1478-3231.2009.02043.x; Kumar D, 2002, HEPATOLOGY, V36, P1266, DOI 10.1053/jhep.2002.36370; Lavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x; Leandro G, 2006, GASTROENTEROLOGY, V130, P1636, DOI 10.1053/j.gastro.2006.03.014; Lord GM, 1998, NATURE, V394, P897, DOI 10.1038/29795; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Martin SS, 2008, J AM COLL CARDIOL, V52, P1201, DOI 10.1016/j.jacc.2008.05.060; Mirandola S, 2006, GASTROENTEROLOGY, V130, P1661, DOI 10.1053/j.gastro.2006.02.035; Monto A, 2005, HEPATOLOGY, V42, P310, DOI 10.1002/hep.20805; Moucari R, 2008, GASTROENTEROLOGY, V134, P416, DOI 10.1053/j.gastro.2007.11.010; Muzzi A, 2005, J HEPATOL, V42, P41, DOI 10.1016/j.jhep.2004.09.022; Nasta P, 2008, AIDS, V22, P857, DOI 10.1097/QAD.0b013e3282fbd1c4; Negro F, 2009, LIVER INT, V29, P26, DOI 10.1111/j.1478-3231.2008.01950.x; Ohata K, 2003, CANCER-AM CANCER SOC, V97, P3036, DOI 10.1002/cncr.11427; Overbeck K, 2008, J HEPATOL, V49, P295, DOI 10.1016/j.jhep.2008.03.033; Paradis V, 2001, HEPATOLOGY, V34, P738, DOI 10.1053/jhep.2001.28055; Patton HM, 2004, J HEPATOL, V40, P484, DOI 10.1016/j.jhep.2003.11.004; Pekow JR, 2007, CANCER-AM CANCER SOC, V109, P2490, DOI 10.1002/cncr.22701; Perlemuter G, 2002, FASEB J, V16, P185, DOI 10.1096/fj.01-0396com; Perry CM, 2001, DRUGS, V61, P2263, DOI 10.2165/00003495-200161150-00013; Persico M, 2007, HEPATOLOGY, V46, P1009, DOI 10.1002/hep.21782; Petta S, 2008, AM J GASTROENTEROL, V103, P1136, DOI 10.1111/j.1572-0241.2008.01813.x; Piodi A, 2008, HEPATOLOGY, V48, P16, DOI 10.1002/hep.22288; Poustchi H, 2008, J HEPATOL, V48, P28, DOI 10.1016/j.jhep.2007.07.026; Poynard T, 2003, HEPATOLOGY, V38, P75, DOI 10.1053/jhep.2003.50267; Rodriguez-Torres M, 2009, LIVER INT, V29, P237, DOI 10.1111/j.1478-3231.2008.01859.x; Romero-Gomez M, 2005, GASTROENTEROLOGY, V128, P636, DOI 10.1053/j.gastro.2004.12.049; Romero-Gomez M, 2008, HEPATOLOGY, V48, p380A; Rubbia-Brandt L, 2000, J HEPATOL, V33, P106, DOI 10.1016/S0168-8278(00)80166-X; Ryan CK, 2002, LIVER TRANSPLANT, V8, P1114, DOI 10.1053/jlts.2002.36740; Serfaty L, 2001, J HEPATOL, V34, P428, DOI 10.1016/S0168-8278(00)00036-2; Spahr L, 2001, J HEPATOL, V35, P308, DOI 10.1016/S0168-8278(01)00082-4; Sulkowski M, 2008, J HEPATOL, V48, pS370, DOI 10.1016/S0168-8278(08)60993-9; Svegliati-Baroni G, 1999, HEPATOLOGY, V29, P1743, DOI 10.1002/hep.510290632; Thomopoulos KC, 2006, EUR J GASTROEN HEPAT, V18, P233, DOI 10.1097/00042737-200603000-00002; Veldt BJ, 2009, AM J TRANSPLANT, V9, P1406, DOI 10.1111/j.1600-6143.2009.02642.x; Veldt BJ, 2008, HEPATOLOGY, V47, P1856, DOI 10.1002/hep.22251; Walsh MJ, 2006, GUT, V55, P529, DOI 10.1136/gut.2005.069674; Westin J, 2007, J VIRAL HEPATITIS, V14, P29, DOI 10.1111/j.1365-2893.2006.00777.x; Zeuzem S, 2004, J HEPATOL, V40, P993, DOI [10.1016/j.jhep.2004.02.007, 10.1016/S0168-8278(04)00060-1]; Ziol M, 1996, J HEPATOL, V25, P833, DOI 10.1016/S0168-8278(96)80286-8	85	51	53	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1352-0504	1365-2893		J VIRAL HEPATITIS	J. Viral Hepatitis	OCT	2009	16	10					681	688		10.1111/j.1365-2893.2009.01186.x			8	Gastroenterology & Hepatology; Infectious Diseases; Virology	Science Citation Index Expanded (SCI-EXPANDED)	Gastroenterology & Hepatology; Infectious Diseases; Virology	495FY	WOS:000269877200001	19732324				2022-03-04	
J	O'Donoghue, M; Ho, JMC; Pittet, D; Suen, LKP				O'Donoghue, Margaret; Ho, Jacqueline M. C.; Pittet, Didier; Suen, Lorna K. P.			Acceptability and tolerability of alcohol-based hand hygiene products for elderly residents in long-term care: a crossover study	ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL			English	Article						Hand hygiene; Alcohol-based hand rub; Long-term care facility; Elderly hand hygiene; Tolerability; Acceptability; World Health Organization	CONTAMINATED SURFACES; TRANSMISSION; EFFICACY; GEL; INFECTIONS; PREVALENCE; PATHOGENS; TIMES; FOAM	Background: Hand hygiene is a critical component of infection control. Much of the focus on improving hand hygiene in healthcare settings has been directed towards healthcare worker compliance but its importance for patients, including those in long-term care facilities (LTCFs), is increasingly being recognised. Alcohol-based hand rub (ABHR) can lead to improved compliance. We aimed to determine acceptability and tolerability of two ABHRs for hand hygiene of elderly LTCF residents using a modified version of the WHO protocol. Methods: Thirty six elderly LTCF residents participated in this crossover study. A modified and translated (Chinese) version of the WHO protocol for evaluation of two or more ABHRs was used to determine product acceptability and tolerability for one gel (bottle with reclosable cap) and one foam (pump). During the 3-day testing period, participants were provided with their own portable bottle of ABHR. A research nurse objectively assessed the skin integrity of the hands at baseline and throughout the study. Skin moisture content was determined using a Scalar Moisture Checker Probe (Science Technology Resources, Ca, USA). Participants rated ABHR tolerability and acceptability using the WHO checklist at the end of each test period. Results: Both products passed the WHO criteria for acceptability and tolerability. The foam (86%) scored higher than the gel (51%) for ease of use possibly because some participants found the cap of the gel bottle difficult to open due to finger stiffness. No evidence of damage to skin integrity was observed. Overall, skin moisture content had improved by the end of the study. Residents preferred either of the test products to the liquid formulation currently in use by the LTCF. Conclusions: Overall, the elderly were willing to use ABHR for hand hygiene. Both products were well tolerated and preferred over the usual product provided by the LTCF. However, forgetfulness and difficulty rubbing the product over the hands due to finger stiffness posed a challenge for some residents. This could be overcome by using healthcare worker-assisted hand hygiene at specified times each day and prompts to serve as reminders to perform hand hygiene.	[O'Donoghue, Margaret; Ho, Jacqueline M. C.; Suen, Lorna K. P.] Hong Kong Polytech Univ, Squina Int Ctr Infect Control, Sch Nursing, Hung Hom,Kowloon, Hong Kong, Peoples R China; [Pittet, Didier] Univ Geneva Hosp & Fac Med, Infect Control Program, Geneva, Switzerland; [Pittet, Didier] Univ Geneva Hosp & Fac Med, World Hlth Org Collaborating Ctr Patient Safety, Geneva, Switzerland		O'Donoghue, M (corresponding author), Hong Kong Polytech Univ, Squina Int Ctr Infect Control, Sch Nursing, Hung Hom,Kowloon, Hong Kong, Peoples R China.	Margaret.o.donoghue@polyu.edu.hk		O'DONOGHUE, Margaret/0000-0003-3577-747X; Pittet, Didier/0000-0002-3667-7131	School of Nursing, The Hong Kong Polytechnic UniversityHong Kong Polytechnic University	This study was funded by a research grant provided by the School of Nursing, The Hong Kong Polytechnic University.	Cao J, 2016, JAMA INTERN MED, V176, P705, DOI 10.1001/jamainternmed.2016.0142; Denkinger CM, 2013, ARCH GERONTOL GERIAT, V56, P227, DOI 10.1016/j.archger.2012.05.006; Dharan S, 2003, INFECT CONT HOSP EP, V24, P160, DOI 10.1086/502182; Dumyati G, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0576-7; Greenaway RE, 2018, J HOSP INFECT, V100, P195, DOI 10.1016/j.jhin.2018.07.011; Haverstick S, 2017, CRIT CARE NURSE, V37, pE1, DOI 10.4037/ccn2017694; Istenes N, 2013, AM J INFECT CONTROL, V41, P793, DOI 10.1016/j.ajic.2012.11.012; Kahvecioglu D, 2014, INFECT CONT HOSP EP, V35, pS48, DOI 10.1086/677835; Kampf G, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-78; Kramer A, 2002, LANCET, V359, P1489, DOI 10.1016/S0140-6736(02)08426-X; Landers T, 2012, AM J INFECT CONTROL, V40, pS11, DOI 10.1016/j.ajic.2012.02.006; Larson EL, 2012, AM J INFECT CONTROL, V40, P806, DOI 10.1016/j.ajic.2011.10.016; Mody L, 2019, CLIN INFECT DIS, V69, P1837, DOI 10.1093/cid/ciz092; O'Donnell M, 2015, AM J INFECT CONTROL, V43, P162, DOI 10.1016/j.ajic.2014.10.018; Otter JA, 2013, AM J INFECT CONTROL, V41, pS6, DOI 10.1016/j.ajic.2012.12.004; Otter JA, 2011, INFECT CONT HOSP EP, V32, P687, DOI 10.1086/660363; Patel PK, 2017, INFECT CONT HOSP EP, V38, P1110, DOI 10.1017/ice.2017.133; Pineles L, 2019, INFECT CONT HOSP EP, V40, P815, DOI 10.1017/ice.2019.117; Pittet D, 2007, INFECT CONT HOSP EP, V28, P1344, DOI 10.1086/523272; Schweon SJ, 2011, AM J INFECT CONTROL, V39, P336, DOI 10.1016/j.ajic.2010.09.013; Sunkesula V, 2015, INFECT CONT HOSP EP, V36, P229, DOI 10.1017/ice.2014.34; Tanner Judith, 2011, Nurs Times, V107, P16; The World Health Organisation, 2009, TOOLS EVALUATION FEE; Tschudin-Sutter S, 2017, CLIN MICROBIOL INFEC, V23, DOI 10.1016/j.cmi.2016.12.030; Wilkinson MAC, 2018, J HOSP INFECT, V98, P359, DOI 10.1016/j.jhin.2017.09.024; World Health Organization, 2009, HAND HYG WHY	26	2	2	2	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2047-2994			ANTIMICROB RESIST IN	Antimicrob. Resist. Infect. Control	OCT 29	2019	8	1							165	10.1186/s13756-019-0610-7			10	Public, Environmental & Occupational Health; Infectious Diseases; Microbiology; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Infectious Diseases; Microbiology; Pharmacology & Pharmacy	JT1QQ	WOS:000500772900001	31673354	Green Published, gold			2022-03-04	
J	Cordey, S; Roux, L				Cordey, S; Roux, L			Transcribing paramyxovirus RNA polymerase engages the template at its 3 ' extremity	JOURNAL OF GENERAL VIROLOGY			English	Article							VESICULAR STOMATITIS-VIRUS; RESPIRATORY SYNCYTIAL VIRUS; DEFECTIVE INTERFERING PARTICLES; SENDAI-VIRUS; ANTIGENOMIC PROMOTERS; REPLICATION; TRANSCRIPTION; GENOME; NUCLEOCAPSIDS; TERMINUS	For the non-segmented, negative-stranded RNA viruses, the mechanism controlling transcription or replication is still a matter of debate. To gain information about this mechanism and about the nature of the RNA polymerase involved, the length of an intervening sequence separating the 3' end of Sendai virus minigenomes and a downstream transcription-initiation signal was increased progressively. It was found that transcription, as measured by green fluorescent protein (GFP) expression, decreased progressively in proportion to the increase in length of the intervening sequence. GFP expression correlated well with the levels of GFP mRNA in the cells, as measured by quantitative primer extension and by RNase protection. Thus, mRNA transcription was inversely proportional to the length of the inserted sequence. These data are evidence that the RNA polymerase initiating transcription at the downstream transcription signal somehow sees the distance separating this signal and the template 3' extremity. Implication of this observation for the nature of the Sendai virus RNA polymerase and for the mechanism by which it synthesizes mRNAs or replication products is presented.	Univ Geneva, Sch Med, Dept Microbiol & Mol Med, CH-1211 Geneva 4, Switzerland		Roux, L (corresponding author), Univ Geneva, Sch Med, Dept Microbiol & Mol Med, 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland.	laurent.roux@medecine.unige.ch	Cordey, Samuel/C-9240-2018	Cordey, Samuel/0000-0002-2684-5680			Bhella D, 2004, J MOL BIOL, V340, P319, DOI 10.1016/j.jmb.2004.05.015; Buchholz UJ, 1999, J VIROL, V73, P251, DOI 10.1128/JVI.73.1.251-259.1999; CALAIN P, 1995, VIROLOGY, V212, P163, DOI 10.1006/viro.1995.1464; CALAIN P, 1993, J VIROL, V67, P4822, DOI 10.1128/JVI.67.8.4822-4830.1993; EGELMAN EH, 1989, J VIROL, V63, P2233, DOI 10.1128/JVI.63.5.2233-2243.1989; Fearns R, 1999, J VIROL, V73, P388, DOI 10.1128/JVI.73.1.388-397.1999; Fearns R, 2000, J VIROL, V74, P6006, DOI 10.1128/JVI.74.13.6006-6014.2000; Fearns R, 2002, J VIROL, V76, P1663, DOI 10.1128/JVI.76.4.1663-1672.2002; Hoffman MA, 2000, VIROLOGY, V269, P201, DOI 10.1006/viro.2000.0223; Iseni F, 2002, RNA, V8, P1056, DOI 10.1017/S1355838202029977; JOHNSON LD, 1979, VIROLOGY, V99, P203, DOI 10.1016/0042-6822(79)90056-4; Kolakofsky D, 2004, VIROLOGY, V318, P463, DOI 10.1016/j.virol.2003.10.031; Le Mercier P, 2003, J VIROL, V77, P9147, DOI 10.1128/JVI.77.17.9147-9155.2003; Le Mercier P, 2002, J VIROL, V76, P5492, DOI 10.1128/JVI.76.11.5492-5502.2002; Li T, 1999, J VIROL, V73, P444, DOI 10.1128/JVI.73.1.444-452.1999; Li T, 1997, VIROLOGY, V232, P248, DOI 10.1006/viro.1997.8571; Marcos F, 2005, VIROLOGY, V331, P396, DOI 10.1016/j.virol.2004.10.040; McGivern DR, 2005, J VIROL, V79, P2449, DOI 10.1128/JVI.79.4.2449-2460.2005; MOTTET G, 1989, VIRUS RES, V14, P175, DOI 10.1016/0168-1702(89)90037-3; Murphy SK, 1998, J VIROL, V72, P10, DOI 10.1128/JVI.72.1.10-19.1998; PATTNAIK AK, 1995, VIROLOGY, V206, P760, DOI 10.1016/S0042-6822(95)80005-0; Qanungo KR, 2004, P NATL ACAD SCI USA, V101, P5952, DOI 10.1073/pnas.0401449101; Schoehn G, 2004, J MOL BIOL, V339, P301, DOI 10.1016/j.jmb.2004.03.073; SEMLER BL, 1978, P NATL ACAD SCI USA, V75, P4704, DOI 10.1073/pnas.75.10.4704; Smallwood S, 2002, VIROLOGY, V304, P235, DOI 10.1006/viro.2002.1720; Stillman EA, 1998, J VIROL, V72, P5565, DOI 10.1128/JVI.72.7.5565-5572.1998; Tapparel C, 1998, J VIROL, V72, P3117, DOI 10.1128/JVI.72.4.3117-3128.1998; Vulliemoz D, 2005, J GEN VIROL, V86, P171, DOI 10.1099/vir.0.80435-0; Vulliemoz D, 2002, J VIROL, V76, P7987, DOI 10.1128/JVI.76.16.7987-7995.2002; Vulliemoz D, 2001, J VIROL, V75, P4506, DOI 10.1128/JVI.75.10.4506-4518.2001; Walpita P, 2004, VIRUS RES, V100, P199, DOI 10.1016/j.virusres.2003.12.025; Whelan SPJ, 2002, P NATL ACAD SCI USA, V99, P9178, DOI 10.1073/pnas.152155599	32	10	11	0	0	MICROBIOLOGY SOC	LONDON	CHARLES DARWIN HOUSE, 12 ROGER ST, LONDON WC1N 2JU, ERKS, ENGLAND	0022-1317	1465-2099		J GEN VIROL	J. Gen. Virol.	MAR	2006	87		3				665	672		10.1099/vir.0.81353-0			8	Biotechnology & Applied Microbiology; Virology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Virology	018DM	WOS:000235744000021	16476989	Bronze			2022-03-04	
J	Cordey, S; Roux, L				Cordey, Samuel; Roux, Laurent			Further characterization of a paramyxovirus transcription initiation signal: search for required nucleotides upstream and importance of the N phase context	JOURNAL OF GENERAL VIROLOGY			English	Article							RESPIRATORY SYNCYTIAL VIRUS; ACCESSORY C-PROTEINS; SENDAI-VIRUS; RNA-POLYMERASE; MESSENGER-RNA; GENOME LENGTH; ANTIGENOMIC PROMOTERS; INFECTIOUS PARTICLES; MEASLES-VIRUS; REPLICATION	Paramyxovirus genomes contain a linear array of five to ten genes sequentially transcribed by the viral RNA polymerase. rnRNA synthesis initiates at a nucleotide signal (gs1) within the genomic promoter located at the genome 3' end. To gain information about the mechanism involved in transcription initiation, a search was carried out for upstream nucleotides required for gs1 and the effects of the gs1 nucleocapsid protein (N) phase context on transcription regulation were determined. For both purposes, tandem promoter mini-genomes carrying a transcription signal ectopically positioned downstream of a replication-only signal were used. The requirement for hygromycin resistance gene expression was used in an attempt to select essential nucleotides within randomized stretches of nucleotides. Nucleotide insertions or deletions were also made on either side of the transcription signal to change its original N phase context in the five remaining possibilities and GFP expression from these modified signals was assessed. Cell cultures resistant to hygromycin treatment were readily obtained following amplification of mini-genomes harbouring randomized sequences. However, selected nucleotides upstream of gs1 could not be identified under conditions where nucleotides within gs1 were selected. In contrast, it was observed that changing the gs1 N phase context progressively decreased transcription by five- to tenfold. These results are discussed in relation to two different mechanisms of transcription initiation.	Univ Geneva, Sch Med, Dept Microbiol & Mol Med, CMU, CH-1211 Geneva 4, Switzerland		Roux, L (corresponding author), Univ Geneva, Sch Med, Dept Microbiol & Mol Med, CMU, 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland.	laurent.roux@medecine.unige.ch	Cordey, Samuel/C-9240-2018	Cordey, Samuel/0000-0002-2684-5680			Bontron S, 1997, MOL CELL BIOL, V17, P4249, DOI 10.1128/MCB.17.8.4249; Buchholz UJ, 1999, J VIROL, V73, P251, DOI 10.1128/JVI.73.1.251-259.1999; Cadd T, 1996, J VIROL, V70, P5067, DOI 10.1128/JVI.70.8.5067-5074.1996; CALAIN P, 1995, VIROLOGY, V212, P163, DOI 10.1006/viro.1995.1464; CALAIN P, 1993, J VIROL, V67, P4822, DOI 10.1128/JVI.67.8.4822-4830.1993; Chappell SA, 2000, P NATL ACAD SCI USA, V97, P1536, DOI 10.1073/pnas.97.4.1536; Chappell SA, 2004, P NATL ACAD SCI USA, V101, P9590, DOI 10.1073/pnas.0308759101; CONZELMANN KK, 1990, VIROLOGY, V175, P485, DOI 10.1016/0042-6822(90)90433-R; Cordey S, 2006, J GEN VIROL, V87, P665, DOI 10.1099/vir.0.81353-0; Cowton VM, 2006, J GEN VIROL, V87, P1805, DOI 10.1099/vir.0.81786-0; Cowton VM, 2005, J VIROL, V79, P11311, DOI 10.1128/JVI.79.17.11311-11322.2005; Fearns R, 2002, J VIROL, V76, P1663, DOI 10.1128/JVI.76.4.1663-1672.2002; Hoffman MA, 2006, J VIROL, V80, P5388, DOI 10.1128/JVI.00204-06; Iseni F, 2002, RNA, V8, P1056, DOI 10.1017/S1355838202029977; Kolakofsky D, 1998, J VIROL, V72, P891, DOI 10.1128/JVI.72.2.891-899.1998; KOLAKOFSKY D, 1982, VIRUS PERSISTENCE, P203; Kolakofsky D., 2001, FIELDS VIROLOGY, V3, P1305; Le Mercier P, 2003, J VIROL, V77, P9147, DOI 10.1128/JVI.77.17.9147-9155.2003; Le Mercier P, 2002, J VIROL, V76, P5492, DOI 10.1128/JVI.76.11.5492-5502.2002; Murphy SK, 1999, J VIROL, V73, P805, DOI 10.1128/JVI.73.1.805-809.1999; PATTNAIK AK, 1995, VIROLOGY, V206, P760, DOI 10.1016/S0042-6822(95)80005-0; Qanungo KR, 2004, P NATL ACAD SCI USA, V101, P5952, DOI 10.1073/pnas.0401449101; Rager M, 2002, EMBO J, V21, P2364, DOI 10.1093/emboj/21.10.2364; ROUX L, 1979, VIROLOGY, V93, P91, DOI 10.1016/0042-6822(79)90278-2; Skiadopoulos MH, 2003, J VIROL, V77, P270, DOI 10.1128/JVI.77.1.270-279.2003; Tapparel C, 1998, J VIROL, V72, P3117, DOI 10.1128/JVI.72.4.3117-3128.1998; Tapparel C, 1997, J VIROL, V71, P9588, DOI 10.1128/JVI.71.12.9588-9599.1997; Vulliemoz D, 2005, J GEN VIROL, V86, P171, DOI 10.1099/vir.0.80435-0; Vulliemoz D, 2002, J VIROL, V76, P7987, DOI 10.1128/JVI.76.16.7987-7995.2002; Walpita P, 2004, VIRUS RES, V100, P199, DOI 10.1016/j.virusres.2003.12.025; Whelan SPJ, 1999, J VIROL, V73, P307, DOI 10.1128/JVI.73.1.307-315.1999; Whelan SPJ, 2002, P NATL ACAD SCI USA, V99, P9178, DOI 10.1073/pnas.152155599	32	5	5	0	0	SOC GENERAL MICROBIOLOGY	READING	MARLBOROUGH HOUSE, BASINGSTOKE RD, SPENCERS WOODS, READING RG7 1AG, BERKS, ENGLAND	0022-1317			J GEN VIROL	J. Gen. Virol.	MAY	2007	88		5				1555	1564		10.1099/vir.0.82701-0			10	Biotechnology & Applied Microbiology; Virology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Virology	168NW	WOS:000246532300021	17412986	Bronze			2022-03-04	
J	Bampi, C; Rasga, L; Roux, L				Bampi, Carole; Rasga, Lara; Roux, Laurent			Antagonism to human BST-2/tetherin by Sendai virus glycoproteins	JOURNAL OF GENERAL VIROLOGY			English	Article							MOLECULAR-MECHANISM; PARTICLE-PRODUCTION; PROTEINS; VPU; HN; TETHERIN; RELEASE; FORMS; MOTIF; BETA	Tetherin is an interferon-inducible factor that restricts viral particle production. We show here that Sendai virus (SeV) induces a drastic decrease in tetherin levels in infected He La cells. Using ectopic expression of tetherin in Madin-Darby canine kidney cells, we find that infectious SeV production is sensitive to restriction by tetherin, suggesting that SeV downregulates tetherin to counter this form of cellular restriction. By using radioactive tetherin in pulse-chase experiments, applying conditions that limit protein degradation, and by estimating tetherin mRNA levels, we find that tetherin degradation is the mechanism of downregulation. Suppression of the virus envelope proteins matrix, fusion (F) or haemagglutinin-neuraminidase protein (HN) during the course of infection demonstrates that F and HN, in concert, are responsible for tetherin degradation. The mechanism(s) by which these two viral glycoproteins participate in degrading tetherin remains to be determined.	[Bampi, Carole; Rasga, Lara; Roux, Laurent] Univ Geneva, Dept Microbiol & Mol Med, Fac Med, Geneva, Switzerland		Roux, L (corresponding author), Univ Geneva, Dept Microbiol & Mol Med, Fac Med, Geneva, Switzerland.	laurent.roux@unige.ch			Swiss National Foundation for Scientific ResearchSwiss National Science Foundation (SNSF)	The authors are indebted to Bastien Mangeat and Dominique Garcin for helpful discussions and technical advice and support, to Genevieve Mottet-Osman for constant technical support and to Daniel Kolakofsky for critical editing of the manuscript. Priscilla Turelli made available a generous supply of anti-tetherin antibodies. L.R. is supported by grants from the Swiss National Foundation for Scientific Research.	Burke E, 1998, VIROLOGY, V252, P137, DOI 10.1006/viro.1998.9471; Diaz E, 1998, CELL, V93, P433, DOI 10.1016/S0092-8674(00)81171-X; Douglas JL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000913; Douglas JL, 2009, J VIROL, V83, P7931, DOI 10.1128/JVI.00242-09; Evans DT, 2010, TRENDS MICROBIOL, V18, P388, DOI 10.1016/j.tim.2010.06.010; Fouillot-Coriou N, 2000, VIROLOGY, V270, P464, DOI 10.1006/viro.2000.0291; Fritz JV, 2012, VIROLOGY, V424, P33, DOI 10.1016/j.virol.2011.12.008; Ganley IG, 2004, MOL BIOL CELL, V15, P5420, DOI 10.1091/mbc.E04-08-0747; Garcin D, 1999, J VIROL, V73, P6559, DOI 10.1128/JVI.73.8.6559-6565.1999; Garcin D, 2001, J VIROL, V75, P6800, DOI 10.1128/JVI.75.15.6800-6807.2001; Gosselin-Grenet AS, 2010, VIROLOGY, V405, P439, DOI 10.1016/j.virol.2010.06.030; Gosselin-Grenet AS, 2006, VIROLOGY, V344, P296, DOI 10.1016/j.virol.2005.09.035; Grigorov B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024135; Jia B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000429; Jouvenet N, 2009, J VIROL, V83, P1837, DOI 10.1128/JVI.02211-08; Kupzig S, 2003, TRAFFIC, V4, P694, DOI 10.1034/j.1600-0854.2003.00129.x; Le Tortorec A, 2009, J VIROL, V83, P11966, DOI 10.1128/JVI.01515-09; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Mangeat B, 2012, J BIOL CHEM, V287, P22015, DOI 10.1074/jbc.M111.319996; Mansouri M, 2009, J VIROL, V83, P9672, DOI 10.1128/JVI.00597-09; MAXFIELD FR, 1982, J CELL BIOL, V95, P676, DOI 10.1083/jcb.95.2.676; Mitchell RS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000450; MOTTET G, 1986, J VIROL, V59, P132, DOI 10.1128/JVI.59.1.132-141.1986; Mottet-Osman G, 2007, J VIROL, V81, P2861, DOI 10.1128/JVI.02291-06; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Pardieu C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000843; Radoshitzky SR, 2010, J VIROL, V84, P10569, DOI 10.1128/JVI.00103-10; Rollason R, 2007, J CELL SCI, V120, P3850, DOI 10.1242/jcs.003343; ROUX L, 1979, VIROLOGY, V93, P91, DOI 10.1016/0042-6822(79)90278-2; Sakuma T, 2009, J VIROL, V83, P2382, DOI 10.1128/JVI.01607-08; Schubert U, 1996, J VIROL, V70, P809, DOI 10.1128/JVI.70.2.809-819.1996; Strahle L, 2006, VIROLOGY, V351, P101, DOI 10.1016/j.virol.2006.03.022; Takimoto T, 2004, VIRUS RES, V106, P133, DOI 10.1016/j.virusres.2004.08.010; Weidner JM, 2010, J VIROL, V84, P12646, DOI 10.1128/JVI.01328-10; Yondola MA, 2011, J VIROL, V85, P2480, DOI 10.1128/JVI.02188-10; Zhang FW, 2009, CELL HOST MICROBE, V6, P54, DOI 10.1016/j.chom.2009.05.008	36	16	18	0	0	SOC GENERAL MICROBIOLOGY	READING	MARLBOROUGH HOUSE, BASINGSTOKE RD, SPENCERS WOODS, READING RG7 1AG, BERKS, ENGLAND	0022-1317			J GEN VIROL	J. Gen. Virol.	JUN	2013	94		6				1211	1219		10.1099/vir.0.051771-0			9	Biotechnology & Applied Microbiology; Virology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Virology	170GJ	WOS:000320838100009	23468424	Green Accepted, Green Published, Green Submitted, hybrid			2022-03-04	
J	Vulliemoz, D; Cordey, S; Mottet-Osman, G; Roux, L				Vulliemoz, D; Cordey, S; Mottet-Osman, G; Roux, L			Nature of a paramyxovirus replication promoter influences a nearby transcription signal	JOURNAL OF GENERAL VIROLOGY			English	Article							RESPIRATORY SYNCYTIAL VIRUS; SENDAI-VIRUS; RNA-POLYMERASE; ANTIGENOMIC PROMOTERS; GENOME LENGTH; RULE; NUCLEOCAPSIDS; INITIATION; REQUIRES; REGIONS	The genomic and antigenomic 3' ends of the Sendai virus replication promoters are bi-partite in nature. They are symmetrically composed of leader or trailer sequences, a gene start (gs) or gene end (ge) site, respectively, and a simple hexameric repeat. Studies of how mRNA synthesis initiates from the first gene start site (gs1) have been hampered by the fact that gs1 is located between two essential elements of the replication promoter. Transcription initiation, then, is separated from the replication initiation site by only 56 nt on the genome, so that transcription and replication may sterically interfere with each other. In order to study the initiation of Sendai virus mRNAs without this possible interference, Sendai virus mini-genomes were prepared having tandem promoters in which replication takes place from the external one, whereas mRNA synthesis occurs from the internal one. Transcription now initiates at position 146 rather than position 56 relative to the genome 3' end. Under these conditions, it was found that the frequency with which mRNA synthesis initiates depends, in an inverse fashion, on the strength of the external replication promoter. It was also found that the sequences essential for replication are not required for basic mRNA synthesis as long as there is an external replication promoter at which viral RNA polymerase can enter the nucleocapsid template. The manner in which transcription and replication initiations influence each other is discussed.	Univ Geneva, Sch Med, Dept Microbiol & Mol Med, CMU, CH-1211 Geneva, Switzerland		Roux, L (corresponding author), Univ Geneva, Sch Med, Dept Microbiol & Mol Med, CMU, 1 Rue Michel Servet, CH-1211 Geneva, Switzerland.	Laurent.Roux@medecine.unige.ch	Cordey, Samuel/C-9240-2018	Cordey, Samuel/0000-0002-2684-5680			Bhella D, 2002, J GEN VIROL, V83, P1831, DOI 10.1099/0022-1317-83-8-1831; Buchholz UJ, 1999, J VIROL, V73, P251, DOI 10.1128/JVI.73.1.251-259.1999; CALAIN P, 1995, VIROLOGY, V212, P163, DOI 10.1006/viro.1995.1464; CALAIN P, 1992, VIROLOGY, V191, P62, DOI 10.1016/0042-6822(92)90166-M; CALAIN P, 1993, J VIROL, V67, P4822, DOI 10.1128/JVI.67.8.4822-4830.1993; EGELMAN EH, 1989, J VIROL, V63, P2233, DOI 10.1128/JVI.63.5.2233-2243.1989; Fearns R, 1999, J VIROL, V73, P388, DOI 10.1128/JVI.73.1.388-397.1999; Hoffman MA, 2000, VIROLOGY, V269, P201, DOI 10.1006/viro.2000.0223; Iseni F, 2002, RNA, V8, P1056, DOI 10.1017/S1355838202029977; Kolakofsky D., 2001, FIELDS VIROLOGY, V3, P1305; Le Mercier P, 2003, J VIROL, V77, P9147, DOI 10.1128/JVI.77.17.9147-9155.2003; Le Mercier P, 2002, J VIROL, V76, P5492, DOI 10.1128/JVI.76.11.5492-5502.2002; MOTTET G, 1989, VIRUS RES, V14, P175, DOI 10.1016/0168-1702(89)90037-3; Murphy SK, 1998, J VIROL, V72, P10, DOI 10.1128/JVI.72.1.10-19.1998; Pelet T, 1996, VIROLOGY, V224, P405, DOI 10.1006/viro.1996.0547; Rager M, 2002, EMBO J, V21, P2364, DOI 10.1093/emboj/21.10.2364; Skiadopoulos MH, 2003, J VIROL, V77, P270, DOI 10.1128/JVI.77.1.270-279.2003; Stillman EA, 1999, J VIROL, V73, P7199, DOI 10.1128/JVI.73.9.7199-7209.1999; Stillman EA, 1998, J VIROL, V72, P5565, DOI 10.1128/JVI.72.7.5565-5572.1998; Tapparel C, 1998, J VIROL, V72, P3117, DOI 10.1128/JVI.72.4.3117-3128.1998; Vulliemoz D, 2002, J VIROL, V76, P7987, DOI 10.1128/JVI.76.16.7987-7995.2002; Vulliemoz D, 2001, J VIROL, V75, P4506, DOI 10.1128/JVI.75.10.4506-4518.2001; Whelan SPJ, 2002, P NATL ACAD SCI USA, V99, P9178, DOI 10.1073/pnas.152155599	23	16	16	0	0	MICROBIOLOGY SOC	LONDON	CHARLES DARWIN HOUSE, 12 ROGER ST, LONDON WC1N 2JU, ERKS, ENGLAND	0022-1317	1465-2099		J GEN VIROL	J. Gen. Virol.	JAN	2005	86		1				171	180		10.1099/vir.0.80435-0			10	Biotechnology & Applied Microbiology; Virology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Virology	888QT	WOS:000226390000020	15604444	Bronze			2022-03-04	
J	Kyle, UG; Kossovsky, MP; Genton, L; Pichard, C				Kyle, Ursula G.; Kossovsky, Michel P.; Genton, Laurence; Pichard, Claude			Overweight and obesity in a Swiss city: 10-year trends	PUBLIC HEALTH NUTRITION			English	Article						body composition; leisure-time activity; long-term trends; fat-free mass; fat moss	FAT-FREE MASS; BIOELECTRICAL-IMPEDANCE ANALYSIS; PHYSICAL-ACTIVITY; BODY-MASS; WEIGHT CHANGE; FOLLOW-UP; INDEX; MORTALITY; HEALTH; MEN	Background: Increased rates of overweight/obesity have been reported in recent years in developed countries. This population study of healthy subjects evaluated the changes in overweight/obesity prevalence in 2003, compared with 1993, and determined the association of age, sex and leisure-time activity with body mass index (BMI), fat-free mass index (FFMI) and fat mass index (FMI). Design: Two transversal samples of convenience. Paricipants: Healthy volunteers (1993, n = 802; 2003, n = 1631). Methods: Fat-free mass was determined using the bioelectrical impedance multiple regression equation. Multivariable linear regression, including confounding variables (age, sex, leisure-time activity), was used to model the body composition evolution between the 1993 and the 2003 subjects. Results: BMI and FMI were higher in 2003 than in 1993, P < 0.001. FFMI was not higher in 2003 than in 1993, P = 0.38. More subjects were overweight/obese in 2003 than in 1993 (27.5 versus 17.2%, chi-square P < 0.001), and had a high FFMI (30.2 versus 21.8%, chi-square P < 0.001) and high FMI (28.0 versus 20.3%, chi-square P < 0.001). Multivariate linear regressions showed that leisure-time activity was negatively, and sex, age and inclusion year were positively associated with BMI, FFMI and FMI (the exception was a negative association with sex) (P < 0.001). Conclusion: Overweight prevalence increased between 1993 and 2003 in a Swiss city, and was associated with a higher fat mass. This observation remained statistically significant after adjustment for age, sex and leisure-time activity.	Univ Hosp Geneva, Hosp Care Syst Res & Anal Grp, CH-1211 Geneva, Switzerland		Pichard, C (corresponding author), Univ Hosp Geneva, Hosp Care Syst Res & Anal Grp, CH-1211 Geneva, Switzerland.	claude.pichard@medecine.unige.ch		Genton Graf, Laurence/0000-0002-0037-5203			Allison DB, 1997, INT J OBESITY, V21, P424, DOI 10.1038/sj.ijo.0800423; Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755, DOI 10.1093/oxfordjournals.aje.a009520; CORNONIHUNTLEY JC, 1991, J CLIN EPIDEMIOL, V44, P743, DOI 10.1016/0895-4356(91)90126-T; EICHHOLZER M, 2005, SCHWEIZ RUNDSCH MED, V94, P1713, DOI DOI 10.1024/0369-8394.94.44.1713; Gallagher D, 2000, AM J PHYSIOL-ENDOC M, V279, pE366, DOI 10.1152/ajpendo.2000.279.2.E366; Gaolbardes B, 2003, ANN EPIDEMIOL, V13, P537, DOI 10.1016/S1047-2797(03)00055-3; Goulenok C, 2004, CHEST, V125, P1441, DOI 10.1378/chest.125.4.1441; GROSCURTH A, 2003, SCHWEIZ RUNDSCH MED, V92, P2191, DOI DOI 10.1024/0369-8394.92.51.2191; Haapanen N, 1997, INT J OBESITY, V21, P288, DOI 10.1038/sj.ijo.0800403; Heithoff KA, 1997, CLIN THER, V19, P811, DOI 10.1016/S0149-2918(97)80104-X; Heitmann BL, 2002, AM J CLIN NUTR, V75, P840, DOI 10.1093/ajcn/75.5.840; Heitmann BL, 2000, INT J OBESITY, V24, P33, DOI 10.1038/sj.ijo.0801082; Houtkooper LB, 1996, AM J CLIN NUTR, V64, P436, DOI 10.1093/ajcn/64.3.436S; Hughes VA, 2002, AM J CLIN NUTR, V76, P473, DOI 10.1093/ajcn/76.2.473; James PT, 2004, EUR J CARDIOV PREV R, V11, P3, DOI 10.1097/01.hjr.0000114707.27531.48; Kesaniemi YA, 2001, MED SCI SPORT EXER, V33, pS351; Kyle UG, 2004, NUTRITION, V20, P255, DOI 10.1016/j.nut.2003.11.019; Kyle UG, 2004, CLIN NUTR, V23, P79, DOI 10.1016/S0261-5614(03)00092-X; Kyle UG, 2003, ACTA DIABETOL, V40, pS258, DOI 10.1007/s00592-003-0080-4; Kyle UG, 2003, NUTRITION, V19, P597, DOI 10.1016/S0899-9007(03)00061-3; Kyle UG, 2001, BRIT J NUTR, V86, P725, DOI 10.1079/BJN2001470; Kyle UG, 2001, NUTRITION, V17, P248, DOI 10.1016/S0899-9007(00)00553-0; Kyle UG, 2001, MED SCI SPORT EXER, V33, P576; KYLE UG, 2003, CLIN NUTR, V22, pS3; Lee CD, 1998, INT J OBESITY, V22, pS2; LUKASKI HC, 1986, J APPL PHYSIOL, V60, P1327, DOI 10.1152/jappl.1986.60.4.1327; Mataix J, 2005, J AM COLL NUTR, V24, P456, DOI 10.1080/07315724.2005.10719491; Mensink G B M, 2005, Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, V48, P1348, DOI 10.1007/s00103-005-1163-x; *NCHS, 2002, PREV OV OB AD US; Ogden CL, 2003, ENDOCRIN METAB CLIN, V32, P741, DOI 10.1016/S0889-8529(03)00074-4; RISSANEN AM, 1991, EUR J CLIN NUTR, V45, P419; SEGAL KR, 1988, AM J CLIN NUTR, V47, P7, DOI 10.1093/ajcn/47.1.7; Silventoinen K, 2004, INT J OBESITY, V28, P710, DOI 10.1038/sj.ijo.0802614; Stolarczyk LM, 1997, AM J CLIN NUTR, V66, P8, DOI 10.1093/ajcn/66.1.8; Tager IB, 2004, EPIDEMIOLOGY, V15, P479, DOI 10.1097/01.ede.0000128401.55545.c6; TAYLOR HL, 1978, J CHRON DIS, V31, P741, DOI 10.1016/0021-9681(78)90058-9; Tremblay A, 2003, CHEST, V123, P1202, DOI 10.1378/chest.123.4.1202; VANITALLIE TB, 1990, AM J CLIN NUTR, V52, P953, DOI 10.1093/ajcn/52.6.953; WILLIAMSON DF, 1993, INT J OBESITY, V17, P279	39	8	8	0	1	CAMBRIDGE UNIV PRESS	CAMBRIDGE	EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND	1368-9800	1475-2727		PUBLIC HEALTH NUTR	Public Health Nutr.	SEP	2007	10	9					914	919		10.1017/S136898000765798X			6	Public, Environmental & Occupational Health; Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Nutrition & Dietetics	205FL	WOS:000249099300011	17381938	Green Submitted, Bronze			2022-03-04	
J	Hede, V; Froment, C; Aubry, JM; Rutschmann, O; Desmeules, J; Besson, M				Hede, V.; Froment, C.; Aubry, J. -M.; Rutschmann, O.; Desmeules, J.; Besson, M.			Role of Adverse Drug Reaction in Transfers from Psychiatric Wards to Emergency Unit in Geneva University Hospitals	DRUG SAFETY			English	Meeting Abstract	18th ISoP Annual Meeting on Pharmacovigilance without Borders	NOV 11-14, 2018	Geneva, SWITZERLAND	Int Soc Pharmacovigilance			EPIDEMIOLOGY		[Hede, V.; Aubry, J. -M.] Geneva Univ Hosp, Serv Psychiat Specialties, Dept Mental Hlth & Psychiat, Geneva, Switzerland; [Hede, V.; Froment, C.; Besson, M.] Geneva Univ Hosp, Psychopharmacol Unit, Clin Pharmacol & Toxicol Dept, Geneva, Switzerland; [Rutschmann, O.] Geneva Univ Hosp, Emergency Dept, Geneva, Switzerland; [Desmeules, J.] Geneva Univ Hosp, Clin Pharmacol & Toxicol Dept, Geneva, Switzerland				Besson, Marie/AAG-3253-2019				Ayani N, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-1009-0; Bouvy JC, 2015, DRUG SAFETY, V38, P437, DOI 10.1007/s40264-015-0281-0; Lucca JM, 2014, J RES PHARM PRACT, V3, P46, DOI 10.4103/2279-042X.137063; Rothschild JM, 2007, GEN HOSP PSYCHIAT, V29, P156, DOI 10.1016/j.genhosppsych.2006.12.002; Thomas M, 2010, ANN PHARMACOTHER, V44, P819, DOI 10.1345/aph.1M746	5	0	0	0	0	ADIS INT LTD	NORTHCOTE	5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND	0114-5916	1179-1942		DRUG SAFETY	Drug Saf.	NOV	2018	41	11				ISoP18-148	1254	1254					1	Public, Environmental & Occupational Health; Pharmacology & Pharmacy; Toxicology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	Public, Environmental & Occupational Health; Pharmacology & Pharmacy; Toxicology	GV9IT	WOS:000446470800314					2022-03-04	
J	Lorenzini, KI; Wainstein, L; Bovet, L; Ramlawi, M; Khan, R; Spechbach, H; Desmeules, J; Piguet, V				Lorenzini, K. Ing; Wainstein, L.; Bovet, L.; Ramlawi, M.; Khan, R.; Spechbach, H.; Desmeules, J.; Piguet, V.			The Epidemic of Opioid Misuse, a Threat for Switzerland? A Pilot Study at the Geneva University Hospitals	DRUG SAFETY			English	Meeting Abstract	18th ISoP Annual Meeting on Pharmacovigilance without Borders	NOV 11-14, 2018	Geneva, SWITZERLAND	Int Soc Pharmacovigilance			UNITED-STATES; OVERDOSE; DEATHS; PAIN		[Lorenzini, K. Ing; Wainstein, L.; Bovet, L.; Desmeules, J.; Piguet, V.] Univ Hosp Geneva, Clin Pharmacol & Toxicol, Geneva, Switzerland; [Ramlawi, M.; Khan, R.; Spechbach, H.] Univ Hosp Geneva, Emergency Med, Geneva, Switzerland								Everdingen MHJVDBV, 2007, ANN ONCOL, V18, P1437, DOI 10.1093/annonc/mdm056; Helmerhorst GTT, 2017, BONE JOINT J, V99B, P856, DOI 10.1302/0301-620X.99B7.BJJ-2016-1350.R1; IASP, 2013, UNR PAIN IS MAJ GLOB; Pain and Policy Studies Group, OP CONS DAT; Seth P, 2018, MMWR-MORBID MORTAL W, V67, P349, DOI 10.15585/mmwr.mm6712a1; Volkow ND, 2016, NEW ENGL J MED, V374, P1253, DOI 10.1056/NEJMra1507771	6	0	0	0	1	ADIS INT LTD	NORTHCOTE	5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND	0114-5916	1179-1942		DRUG SAFETY	Drug Saf.	NOV	2018	41	11				ISoP18-132	1214	1215					2	Public, Environmental & Occupational Health; Pharmacology & Pharmacy; Toxicology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Public, Environmental & Occupational Health; Pharmacology & Pharmacy; Toxicology	GV9IT	WOS:000446470800231					2022-03-04	
J	Jallon, P; Picard, F				Jallon, P; Picard, F			Bodyweight gain and anticonvulsants - A comparative review	DRUG SAFETY			English	Review							ADD-ON THERAPY; WEIGHT-GAIN; EPILEPTIC PATIENTS; DOUBLE-BLIND; GABAPENTIN MONOTHERAPY; PALMITATE BINDING; SODIUM VALPROATE; PARTIAL SEIZURES; SERUM-ALBUMIN; BODY-WEIGHT	Bodyweight gain is a common and frequent undesirable effect associated with the use of anticonvulsant drugs. This has been observed for many years with valproic acid (sodium valproate) and carbamazepine, and also, more recently, with some of the newer anticonvulsants such as vigabatrin and gabapentin. Very often bodyweight gain in children, adolescents and adults with epilepsy taking such anticonvulsants results in cosmetic adverse effects. On the other hand, bodyweight gain is disturbing to general health, with a possible increase in the risk of diabetes mellitus or heart disease. Other potential adverse effects, such as the association of obesity with polycystic ovaries, have been reported with the use of valproic acid. Potential mechanisms of anticonvulsant-associated bodyweight gain are not yet clear and differ between drugs used. The involvement of lowered blood glucose level, which may stimulate eating through an effect on the hypothalamus, constitutes one of the possible mechanisms. Lowered blood glucose levels may result from a competition between the binding of the drug and long chain fatty acids. An increased availability of the latter stimulates insulin production and lowers the serum glucose levels. Another possible explanation for lowered blood glucose may be a deficiency in carnitine directly caused by the drug, that would result in a reduction of fatty acid metabolism and an increase in glucose consumption. An enhancing effect of gamma -aminobutyric acid-mediated neurotransmission may increase appetite for carbohydrates and reduce! energy expenditure. An antidiuretic hormone-like effect or effects on norepinephrine (noradrenaline) or serotonin-mediated neurotransmission are more rarely considered. Many studies on anticonvulsant-associated bodyweight gain illustrate how we could better define the risk factors for the development of anticonvulsant-induced bodyweight gain and uncover the mechanisms behind it.	Hop Cantonal Geneva, Epilepsy Unit, CH-1211 Geneva 14, Switzerland		Jallon, P (corresponding author), Hop Cantonal Geneva, Epilepsy Unit, CH-1211 Geneva 14, Switzerland.	pierre.jallon@hcuge.ch					ANGEL I, 1990, CLIN NEUROPHARMACOL, V13, P361, DOI 10.1097/00002826-199010000-00001; Arch JRS, 1998, INT J OBESITY, V22, P1159, DOI 10.1038/sj/ijo/0800779; Bauer J, 2000, EPILEPSY RES, V41, P163, DOI 10.1016/S0920-1211(00)00139-X; Baulac M, 1998, SEIZURE-EUR J EPILEP, V7, P55, DOI 10.1016/S1059-1311(98)90009-7; Beydoun A, 1997, NEUROLOGY, V49, P746, DOI 10.1212/WNL.49.3.746; BOURGEOIS B, 1987, EPILEPSIA, V28, pS8, DOI 10.1111/j.1528-1157.1987.tb05769.x; BREUM L, 1992, METABOLISM, V41, P666, DOI 10.1016/0026-0495(92)90061-E; BRODERSEN R, 1990, MOL PHARMACOL, V37, P704; CARMEL PW, 1985, ACTA NEUROCHIR, V75, P113, DOI 10.1007/BF01406331; Chadwick D, 1999, LANCET, V354, P13, DOI 10.1016/S0140-6736(98)10531-7; Chadwick DW, 1998, NEUROLOGY, V51, P1282, DOI 10.1212/WNL.51.5.1282; Corman CL, 1997, CAN J NEUROL SCI, V24, P240, DOI 10.1017/S0317167100021879; COVANIS A, 1982, EPILEPSIA, V23, P693, DOI 10.1111/j.1528-1157.1982.tb05085.x; DAM M, 1981, VALPROATE TREATMENT, P83; DeToledo JC, 1997, THER DRUG MONIT, V19, P394, DOI 10.1097/00007691-199708000-00006; Devinsky O, 2000, NEUROLOGY, V54, P973, DOI 10.1212/WNL.54.4.973; DINESEN H, 1984, ACTA NEUROL SCAND, V70, P65; Easter D, 1997, SEIZURE, V6, P121, DOI 10.1016/S1059-1311(97)80065-9; EGGER J, 1981, BMJ-BRIT MED J, V283, P577, DOI 10.1136/bmj.283.6291.577; Eke T, 1997, BRIT MED J, V314, P180, DOI 10.1136/bmj.314.7075.180; FEUERSTEIN J, 1981, ACTUAL PSYCHIATR, V5, P126; Genton P, 2001, EPILEPSIA, V42, P295, DOI 10.1046/j.1528-1157.2001.28899.x; GOLDMAN CK, 1985, EUR J PHARMACOL, V115, P11, DOI 10.1016/0014-2999(85)90578-3; Greenwood RS, 2000, EPILEPSIA, V41, pS42, DOI 10.1111/j.1528-1157.2000.tb01523.x; Guberman A, 2000, SEIZURE-EUR J EPILEP, V9, P112, DOI 10.1053/seiz.2000.0382; HASSAN MN, 1976, ACTA NEUROL SCAND, V54, P209, DOI 10.1111/j.1600-0404.1976.tb04797.x; HENRY DA, 1977, BMJ-BRIT MED J, V1, P83, DOI 10.1136/bmj.1.6053.83-a; Herzog AG, 2001, EPILEPSIA, V42, P311, DOI 10.1046/j.1528-1157.2001.33500.x; Hogan RE, 2000, EPILEPSY RES, V41, P23, DOI 10.1016/S0920-1211(00)00125-X; ISJOARVI JIT, 2001, EPILEPSIA, V42, P305; Isojarvi JIT, 1998, ANN NEUROL, V43, P446, DOI 10.1002/ana.410430406; Isojarvi JIT, 1996, ANN NEUROL, V39, P579, DOI 10.1002/ana.410390506; ISOJARVI JIT, 1993, NEW ENGL J MED, V329, P1383, DOI 10.1056/NEJM199311043291904; JANSKY L, 1995, PHYSIOL REV, V75, P237, DOI 10.1152/physrev.1995.75.2.237; KIMURA T, 1974, J CLIN ENDOCR METAB, V38, P356, DOI 10.1210/jcem-38-3-356; LALJEE HCK, 1980, PLACE SODIUM VALPROA, P141; LAMPL Y, 1991, CLIN NEUROPHARMACOL, V14, P251, DOI 10.1097/00002826-199106000-00009; LEIBOWITZ SF, 1992, TRENDS NEUROSCI, V15, P491, DOI 10.1016/0166-2236(92)90101-D; LEIBOWITZ SF, 1989, BRAIN RES, V503, P132, DOI 10.1016/0006-8993(89)91713-7; MATTSON RH, 1992, NEW ENGL J MED, V327, P765, DOI 10.1056/NEJM199209103271104; Murialdo G, 1997, J ENDOCRINOL INVEST, V20, P519, DOI 10.1007/BF03348013; Murialdo G, 1998, CLIN NEUROPHARMACOL, V21, P52; Novak GP, 1999, J CHILD NEUROL, V14, P490, DOI 10.1177/088307389901400802; PERUCCA E, 1978, J NEUROL NEUROSUR PS, V41, P713, DOI 10.1136/jnnp.41.8.713; Pijl H, 1996, DRUG SAFETY, V14, P329, DOI 10.2165/00002018-199614050-00005; RALL TW, 1990, PHARMACOL BASIS THER, P436; Rattya J, 1999, PEDIATRICS, V103, P588, DOI 10.1542/peds.103.3.588; REMY C, 1989, BRIT J CLIN PHARMACO, V27, pS125, DOI 10.1111/j.1365-2125.1989.tb03473.x; RICHENS A, 1994, J NEUROL NEUROSUR PS, V57, P682, DOI 10.1136/jnnp.57.6.682; RUSS MJ, 1988, APPETITE, V10, P103, DOI 10.1016/0195-6663(88)90062-1; SCHMIDT D, 1984, EPILEPSIA, V25, pS44, DOI 10.1111/j.1528-1157.1984.tb05636.x; TARTARA A, 1992, ACTA NEUROL SCAND, V86, P247, DOI 10.1111/j.1600-0404.1992.tb05079.x; Tritos NA, 1997, DIABETOLOGIA, V40, P1371, DOI 10.1007/s001250050838; Verrotti A, 1999, NEUROLOGY, V53, P230, DOI 10.1212/WNL.53.1.230; VOLZKE E, 1973, EPILEPSIA, V14, P185, DOI 10.1111/j.1528-1157.1973.tb03955.x; VORUM H, 1993, EPILEPSY RES, V16, P55, DOI 10.1016/0920-1211(93)90040-E	56	129	133	0	11	ADIS INT LTD	NORTHCOTE	5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND	0114-5916	1179-1942		DRUG SAFETY	Drug Saf.		2001	24	13					969	978		10.2165/00002018-200124130-00004			10	Public, Environmental & Occupational Health; Pharmacology & Pharmacy; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Pharmacology & Pharmacy; Toxicology	494ZF	WOS:000172315200004	11735653				2022-03-04	
J	Bianchi-Demicheli, F; Ludicke, F; Chardonnens, D				Bianchi-Demicheli, F; Ludicke, F; Chardonnens, D			Imaginary pregnancy 10 years after abortion and sterilization in a menopausal woman: a case report	MATURITAS			English	Article									Univ Hosp Geneva, Dept Obstet & Gynaecol, Clin Infertil & Gynaecol Endocrinol, CH-1211 Geneva 14, Switzerland		Bianchi-Demicheli, F (corresponding author), Univ Hosp Geneva, Dept Obstet & Gynaecol, Clin Infertil & Gynaecol Endocrinol, 32 Blvd Cluse, CH-1211 Geneva 14, Switzerland.	francesco.bianchi-demicheli@hcuge.ch					ADLER NE, 1990, SCIENCE, V248, P41, DOI 10.1126/science.2181664; *DSM 4, 1996, DIAGN STAT MAN MENT; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; KAPLAN HI, 1997, SYNOPSIS PSYCHIAT	4	6	6	0	0	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0378-5122			MATURITAS	Maturitas	AUG 20	2004	48	4					479	481		10.1016/j.maturitas.2003.09.030			3	Geriatrics & Gerontology; Obstetrics & Gynecology	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology; Obstetrics & Gynecology	848CZ	WOS:000223446200018	15283942				2022-03-04	
J	Rollason, V; Samer, C; Lorenzini, KI; Besson, M; Escher, M; Piguet, V; Desmeules, JA				Rollason, V.; Samer, C.; Lorenzini, K. Ing; Besson, M.; Escher, M.; Piguet, V.; Desmeules, J. A.			Drug Exposure During Pregnancy: The Importance of Follow-Up in the Evaluation of Risks	DRUG SAFETY			English	Meeting Abstract	13th Annual Meeting of the International-Society-of-Pharmacovigilance (ISoP) - The Renaissance of Pharmacovigilance	OCT 01-04, 2013	Pisa, ITALY	Int Soc Pharmacovigilance					[Rollason, V.; Samer, C.; Lorenzini, K. Ing; Besson, M.; Escher, M.; Piguet, V.; Desmeules, J. A.] Univ Hosp Geneva, Div Clin Pharmacol & Toxicol, Geneva, Switzerland				Samer, Caroline/ABB-2447-2021; Samer, Caroline F/M-4544-2016; Besson, Marie/AAG-3253-2019	Samer, Caroline/0000-0001-8178-0616; Samer, Caroline F/0000-0001-8178-0616; 				0	0	0	0	1	ADIS INT LTD	AUCKLAND	41 CENTORIAN DR, PRIVATE BAG 65901, MAIRANGI BAY, AUCKLAND 1311, NEW ZEALAND	0114-5916	1179-1942		DRUG SAFETY	Drug Saf.		2013	36	9					931	931					1	Public, Environmental & Occupational Health; Pharmacology & Pharmacy; Toxicology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Public, Environmental & Occupational Health; Pharmacology & Pharmacy; Toxicology	221NA	WOS:000324664400314					2022-03-04	
J	Rodieux, F; Ing-Lorenzini, K; Rollason, V				Rodieux, F.; Ing-Lorenzini, K.; Rollason, V.			Importance of Pharmacovigilance in ihe Pediatric Population	DRUG SAFETY			English	Meeting Abstract	18th ISoP Annual Meeting on Pharmacovigilance without Borders	NOV 11-14, 2018	Geneva, SWITZERLAND	Int Soc Pharmacovigilance					[Rodieux, F.; Ing-Lorenzini, K.; Rollason, V.] Geneva Univ Hosp, Div Clin Pharmacol & Toxicol, Geneva, Switzerland									0	0	0	0	0	ADIS INT LTD	NORTHCOTE	5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND	0114-5916	1179-1942		DRUG SAFETY	Drug Saf.	NOV	2018	41	11				ISoP18-146	1249	1249					1	Public, Environmental & Occupational Health; Pharmacology & Pharmacy; Toxicology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Public, Environmental & Occupational Health; Pharmacology & Pharmacy; Toxicology	GV9IT	WOS:000446470800304					2022-03-04	
J	Lorenzini, KI; Vernaz, N; Girardin, F; Tirone, F; Rollason, V; Desmeules, J; Samer, C				Lorenzini, K. Ing; Vernaz, N.; Girardin, F.; Tirone, F.; Rollason, V.; Desmeules, J.; Samer, C.			Extra Costs Related to Serious Adverse Drug Reactions in Hospitalized Patients, the Example of Long Qt and Agranulocytosis	DRUG SAFETY			English	Meeting Abstract	18th ISoP Annual Meeting on Pharmacovigilance without Borders	NOV 11-14, 2018	Geneva, SWITZERLAND	Int Soc Pharmacovigilance			FREQUENCY		[Lorenzini, K. Ing; Girardin, F.; Tirone, F.; Rollason, V.; Desmeules, J.; Samer, C.] Univ Hosp Geneva, Clin Pharmacol & Toxicol, Geneva, Switzerland; [Vernaz, N.; Girardin, F.] Univ Hosp Geneva, Med Direct, Geneva, Switzerland; [Vernaz, N.] Univ Hosp Geneva, Finance Direct, Geneva, Switzerland				Samer, Caroline/ABB-2447-2021	Samer, Caroline/0000-0001-8178-0616			Bordet R, 2001, EUR J CLIN PHARMACOL, V56, P935, DOI 10.1007/s002280000260; Girardin FR, 2019, PHARMACOGENOMICS J, V19, P211, DOI 10.1038/s41397-017-0004-2; Khan LM, 2013, EUR J CLIN PHARMACOL, V69, P1985, DOI 10.1007/s00228-013-1563-z; Miguel A, 2012, PHARMACOEPIDEM DR S, V21, P1139, DOI 10.1002/pds.3309; Moore N, 1998, BRIT J CLIN PHARMACO, V45, P301, DOI 10.1046/j.1365-2125.1998.00667.x; Poncet A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127213	6	0	0	0	1	ADIS INT LTD	NORTHCOTE	5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND	0114-5916	1179-1942		DRUG SAFETY	Drug Saf.	NOV	2018	41	11				ISoP18-149	1257	1258					2	Public, Environmental & Occupational Health; Pharmacology & Pharmacy; Toxicology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Public, Environmental & Occupational Health; Pharmacology & Pharmacy; Toxicology	GV9IT	WOS:000446470800321					2022-03-04	
J	D'incau, S; Jaafar, J; Ing-Lorenzini, R; Calmy, A				D'incau, S.; Jaafar, J.; Ing-Lorenzini, R.; Calmy, A.			Iatrogenic Adrenal Insufficiency Following Use of Corticosteroids in HIV Infected Patients Receiving Cobicistat-Based Antiretroviral Regimen	DRUG SAFETY			English	Meeting Abstract	18th ISoP Annual Meeting on Pharmacovigilance without Borders	NOV 11-14, 2018	Geneva, SWITZERLAND	Int Soc Pharmacovigilance			CUSHING SYNDROME; TRIAMCINOLONE; SUPPRESSION		[D'incau, S.; Calmy, A.] Hop Univ Geneva, HIV Unit, Div Infect Dis, Geneva, Switzerland; [Jaafar, J.] Hop Univ Geneva, Div Endocrinol Diabetol Hypertens & Nutr, Geneva, Switzerland; [Ing-Lorenzini, R.] Hop Univ Geneva, Div Clin Pharmacol & Toxicol, Geneva, Switzerland								John G., 2013, J ANTIVIR ANTIRETROV, V5, P180; Lewis J, 2014, AIDS, V28, P2636, DOI 10.1097/QAD.0000000000000462; Ramanathan R, 2008, CLIN INFECT DIS, V47, pE97, DOI 10.1086/593314; Schwarze-Zander C, 2013, INFECTION, V41, P1183, DOI 10.1007/s15010-013-0506-z; Wassner Chanie, 2017, J Int Assoc Provid AIDS Care, V16, P535, DOI 10.1177/2325957417729748	5	0	0	0	0	ADIS INT LTD	NORTHCOTE	5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND	0114-5916	1179-1942		DRUG SAFETY	Drug Saf.	NOV	2018	41	11				ISoP18-146	1248	1249					2	Public, Environmental & Occupational Health; Pharmacology & Pharmacy; Toxicology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Public, Environmental & Occupational Health; Pharmacology & Pharmacy; Toxicology	GV9IT	WOS:000446470800303					2022-03-04	
J	Gex-Fabry, M; Balant-Gorgia, AE; Balant, LP				Gex-Fabry, M; Balant-Gorgia, AE; Balant, LP			Therapeutic drug monitoring databases for postmarketing surveillance of drug-drug interactions	DRUG SAFETY			English	Article							CLINICAL PHARMACOKINETIC DATA; POPULATION PHARMACOKINETICS; SERUM CONCENTRATIONS; VARIABILITY FACTORS; RELATIVE CLEARANCE; PATIENT CHARACTERISTICS; CONCOMITANT TREATMENT; PSYCHIATRIC-PATIENTS; DIGOXIN-QUINIDINE; JAPANESE PATIENTS	Drug-drug interactions can be associated with patient morbidity due to either increased toxicity or a potentially ineffective concentration. Because interactions cannot always be anticipated during drug development and actual patients receiving a drug for therapeutic use often differ from those included in clinical trials, postmarketing surveillance is essential. Therapeutic drug monitoring (TDM) databases offer a unique opportunity in this respect. Prerequisites for TDM databases to provide valid information in a pharmacoepidemiological perspective include the following: precise description of exposure to the potentially interacting drugs; measurement of parent compound and active metabolites through accurate and precise analytical techniques; documentation of relevant patient characteristics that may act as confounding factors (e.g. gender, age, smoking habits); repeated assessments over time if possible; and sound pharmacokinetic framework for data selection, analysis and interpretation. The contribution of TDM to the documentation of drug-drug interactions takes advantage of different possible study designs, discussed on the basis of recently published studies. The single case report plays an important role as an alert signal. It is illustrated for a patient on long-term treatment, who displayed an unexpectedly high clozapine concentration rafter the introduction of ciprofloxacin comedication. The prospective on and off comedication panel study shows advantages in terms of carefully selected inclusion criteria and control of treatment modalities. A study of the thioridazine-fluvoxamine interaction is presented, with patients followed on thioridazine monotherapy, after introduction of fluvoxamine and after its discontinuation. The main advantage of the retrospective large-scale TDM database screen is representativeness of patients actually treated, whereas drawbacks are related to quality of data and suitability for valid interpretation. Such an approach is illustrated by a review of data collected over 10 years of routine TDM that allowed documenting induction of nortriptyline metabolism by carbamazepine and inhibition by several phenothiazines. Finally, population pharmacokinetics is well suited to observational data collected for TDM purpose, provided quality is ascertained. Focus is placed on interindividual variability and relationship between pharmacokinetic parameters and patient characteristics, including comedication. The population approach is discussed with respect to a study that documented a 32% increase of haloperidol clearance associated with anticonvulsant comedication, in addition to effects of age and bodyweight. Among factors to consider for improved effectiveness in the use of TDM databases for postmarketing surveillance of drug-drug interactions, integration of efficacy and safety data in future studies and communication of expert recommendations to prescribing physicians are essential.	Univ Hosp Geneva, Dept Psychiat, Clin Res Unit, CH-1225 Chene Bourg, Switzerland; Univ Hosp Geneva, Dept Psychiat, Therapeut Drug Monitoring Unit, CH-1225 Chene Bourg, Switzerland		Gex-Fabry, M (corresponding author), Univ Hosp Geneva, Dept Psychiat, Clin Res Unit, 2 Shemin Petit Bel Air, CH-1225 Chene Bourg, Switzerland.						Aarons L, 1999, CLIN PHARMACOKINET, V36, P255, DOI 10.2165/00003088-199936040-00001; ANTAL EJ, 1989, CLIN PHARMACOL THER, V46, P552, DOI 10.1038/clpt.1989.185; Back DJ, 2000, THER DRUG MONIT, V22, P122, DOI 10.1097/00007691-200002000-00026; Balant-Gorgia AE, 1999, THER DRUG MONIT, V21, P105, DOI 10.1097/00007691-199902000-00017; BalantGorgia AE, 1996, THERAPIE, V51, P399; BalantGorgia AE, 1996, PHARMACOPSYCHIATRY, V29, P38, DOI 10.1055/s-2007-979541; BALANTGORGIA AE, 1997, J SUBST MISUSE, V2, P5; Bates DW, 1998, THER DRUG MONIT, V20, P550, DOI 10.1097/00007691-199810000-00018; Bauer LA, 1996, THER DRUG MONIT, V18, P46, DOI 10.1097/00007691-199602000-00008; BERTSCHY G, 1991, EUR J CLIN PHARMACOL, V40, P119, DOI 10.1007/BF00315151; Bjerrum L, 1997, EUR J CLIN PHARMACOL, V53, P7, DOI 10.1007/s002280050329; Bottiger Y, 1999, THER DRUG MONIT, V21, P171, DOI 10.1097/00007691-199904000-00006; Brosen K, 1996, THER DRUG MONIT, V18, P393, DOI 10.1097/00007691-199608000-00014; Buur-Rasmussen B, 1999, EUR NEUROPSYCHOPHARM, V9, P453, DOI 10.1016/S0924-977X(99)00033-4; Carrillo JA, 1999, J CLIN PSYCHOPHARM, V19, P494, DOI 10.1097/00004714-199912000-00002; CENTORRINO F, 1994, J CLIN PSYCHOPHARM, V14, P119; Dahl ML, 2000, THER DRUG MONIT, V22, P114, DOI 10.1097/00007691-200002000-00024; DANIEL DG, 1994, J CLIN PSYCHOPHARM, V14, P340; DEVANE CL, 1993, CLIN PHARMACOL THER, V53, P521, DOI 10.1038/clpt.1993.65; Eap CB, 1997, J CLIN PSYCHOPHARM, V17, P113, DOI 10.1097/00004714-199704000-00010; ERESHEFSKY L, 1991, J CLIN PSYCHOPHARM, V11, P296; ERESHEFSKY L, 1988, CLIN CHEM, V34, P863; *EUR AG EV MED PRO, NOT GUID INV DRUG IN; GexFabry M, 1997, THER DRUG MONIT, V19, P1, DOI 10.1097/00007691-199702000-00001; GEXFABRY M, 1995, THER DRUG MONIT, V17, P39, DOI 10.1097/00007691-199502000-00007; GEXFABRY M, 1990, CLIN PHARMACOKINET, V19, P241, DOI 10.2165/00003088-199019030-00007; Glue P, 1996, HUM PSYCHOPHARM CLIN, V11, P97, DOI 10.1002/(SICI)1099-1077(199603)11:2<97::AID-HUP759>3.0.CO;2-7; Grasela TH, 1999, J CLIN PHARMACOL, V39, P373, DOI 10.1177/00912709922007949; Greenblatt DJ, 1998, J CLIN PSYCHIAT, V59, P19; Gronroos PE, 1997, EUR J CLIN PHARMACOL, V53, P13, DOI 10.1007/s002280050330; Gross AS, 1998, BRIT J CLIN PHARMACO, V46, P95, DOI 10.1046/j.1365-2125.1998.00770.x; Haffen E, 1999, PHARMACOPSYCHIATRY, V32, P232, DOI 10.1055/s-1999-7960; Hirokane G, 1999, THER DRUG MONIT, V21, P82, DOI 10.1097/00007691-199902000-00012; Hollister Leo E., 1994, P217; Hubner GI, 1999, THER DRUG MONIT, V21, P536, DOI 10.1097/00007691-199910000-00008; Islam SI, 1996, THER DRUG MONIT, V18, P624, DOI 10.1097/00007691-199610000-00017; JANN MW, 1985, J CLIN PSYCHOPHARM, V5, P106, DOI 10.1097/00004714-198504000-00010; Jelliffe RW, 1998, CLIN PHARMACOKINET, V34, P57, DOI 10.2165/00003088-199834010-00003; JERLING M, 1994, THER DRUG MONIT, V16, P1, DOI 10.1097/00007691-199402000-00001; Jerling M, 1996, EUR J DRUG METAB PH, V21, P113, DOI 10.1007/BF03190259; JERLING M, 1995, J CLIN PSYCHOPHARM, V15, P435, DOI 10.1097/00004714-199512000-00008; JERLING M, 1994, THER DRUG MONIT, V16, P368, DOI 10.1097/00007691-199408000-00006; JERLING M, 1994, BRIT J CLIN PHARMACO, V38, P453, DOI 10.1111/j.1365-2125.1994.tb04382.x; Johannessen SI, 1997, CNS DRUGS, V7, P349, DOI 10.2165/00023210-199707050-00003; Keyler DE, 1998, POSTGRAD MED, V103, P209, DOI 10.3810/pgm.1998.03.422; Leinonen E, 1996, THER DRUG MONIT, V18, P111, DOI 10.1097/00007691-199604000-00001; LIU H, 1994, THER DRUG MONIT, V16, P132, DOI 10.1097/00007691-199404000-00004; Loonen AJM, 1999, EUR NEUROPSYCHOPHARM, V10, P51, DOI 10.1016/S0924-977X(99)00054-1; LUDDEN TM, 1997, POPULATION APPROACH, P40; Lundmark J, 2000, THER DRUG MONIT, V22, P446, DOI 10.1097/00007691-200008000-00014; McLellan RA, 1996, DRUG METAB DISPOS, V24, P1134; McLeod HL, 1997, PHARMACOL THERAPEUT, V74, P39, DOI 10.1016/S0163-7258(96)00201-X; Mitchell PB, 2000, BRIT J CLIN PHARMACO, V49, P303, DOI 10.1046/j.1365-2125.2000.00174.x; Morris RG, 1998, BRIT J CLIN PHARMACO, V46, P547, DOI 10.1046/j.1365-2125.1998.00835.x; MULLER HJ, 1994, INT J CLIN PHARM TH, V32, P269; Olesen OV, 1999, THER DRUG MONIT, V21, P87, DOI 10.1097/00007691-199902000-00013; Perry PJ, 2000, CNS DRUGS, V13, P167, DOI 10.2165/00023210-200013030-00003; Perucca E, 2000, CLIN PHARMACOKINET, V38, P191, DOI 10.2165/00003088-200038030-00001; Raaska K, 2000, EUR J CLIN PHARMACOL, V56, P585, DOI 10.1007/s002280000192; SEIFRITZ E, 1994, EUR NEUROPSYCHOPHARM, V4, P15, DOI 10.1016/0924-977X(94)90310-7; Seymour RM, 1998, DRUG AGING, V12, P485, DOI 10.2165/00002512-199812060-00006; SHAPIRO S, 1989, CLIN PHARMACOL THER, V46, P371, DOI 10.1038/clpt.1989.154; SHEINER LB, 1977, J PHARMACOKINET BIOP, V5, P445, DOI 10.1007/BF01061728; SHEINER LB, 1992, ANNU REV PHARMACOL, V32, P185, DOI 10.1146/annurev.pa.32.040192.001153; Spina E, 2000, THER DRUG MONIT, V22, P481, DOI 10.1097/00007691-200008000-00019; SPINA E, 1993, THER DRUG MONIT, V15, P247; STEINIJANS VW, 1991, INT J CLIN PHARM TH, V29, P323; STROM BL, 1989, CLIN PHARMACOL THER, V46, P390, DOI 10.1038/clpt.1989.156; Thomson AH, 1996, THER DRUG MONIT, V18, P245, DOI 10.1097/00007691-199606000-00005; *US FDA, GUID IND IN VIV DRUG; VANDEL S, 1995, PHARMACOL RES, V31, P347, DOI 10.1016/1043-6618(95)80088-3; VAUGHAN DA, 1988, AM J PSYCHIAT, V145, P1478; VOZEH S, 1985, CLIN PHARMACOKINET, V10, P457; Walson PD, 1998, CLIN CHEM, V44, P415; Warner A, 2000, THER DRUG MONIT, V22, P93, DOI 10.1097/00007691-200002000-00020; WHITING B, 1986, CLIN PHARMACOKINET, V11, P387, DOI 10.2165/00003088-198611050-00004; WILLIAMS PJ, 1992, CLIN PHARMACOKINET, V22, P66, DOI 10.2165/00003088-199222010-00006; Yew WW, 1998, THER DRUG MONIT, V20, P469, DOI 10.1097/00007691-199810000-00004; Yukawa E, 2000, J CLIN PSYCHOPHARM, V20, P685, DOI 10.1097/00004714-200012000-00016; Yukawa E, 1996, J CLIN PHARMACOL, V36, P752, DOI 10.1002/j.1552-4604.1996.tb04246.x; Yukawa E, 1997, J CLIN PHARMACOL, V37, P92, DOI 10.1002/j.1552-4604.1997.tb04766.x; Yukawa E, 1997, J CLIN PHARMACOL, V37, P1160, DOI 10.1002/j.1552-4604.1997.tb04301.x; YUKAWA E, 1993, THER DRUG MONIT, V15, P75, DOI 10.1097/00007691-199304000-00002; Yukawa E, 1998, EUR J CLIN PHARMACOL, V54, P69, DOI 10.1007/s002280050423	84	18	18	0	5	ADIS INTERNATIONAL LTD	AUCKLAND	41 CENTORIAN DR, PRIVATE BAG 65901, MAIRANGI BAY, AUCKLAND 10, NEW ZEALAND	0114-5916			DRUG SAFETY	Drug Saf.		2001	24	13					947	959		10.2165/00002018-200124130-00002			13	Public, Environmental & Occupational Health; Pharmacology & Pharmacy; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Pharmacology & Pharmacy; Toxicology	494ZF	WOS:000172315200002	11735651				2022-03-04	
J	Barnes, L; Kaya, G; Rollason, V				Barnes, Laurent; Kaya, Gurkan; Rollason, Victoria			Topical Corticosteroid-Induced Skin Atrophy: A Comprehensive Review	DRUG SAFETY			English	Review							HALOBETASOL PROPIONATE OINTMENT; 0.1-PERCENT TACROLIMUS OINTMENT; CHRONIC ECZEMATOUS DERMATOSES; INDUCED EPIDERMAL ATROPHY; ATOPIC-DERMATITIS; CLOBETASOL PROPIONATE; DOUBLE-BLIND; PLAQUE PSORIASIS; RETINOIC ACID; CLOBETASOL-17-PROPIONATE OINTMENT	Skin atrophy is an adverse effect of topical corticosteroids (TCs) which, as an established non-life-threatening effect, has been poorly reported by trials involving these drugs. Atopic dermatitis and psoriasis are example of disorders that require repeated therapies with TCs; however, assessing the atrophogenic activity of TCs is still an issue. This study aims to review clinical data on skin atrophy induced by TCs. Searches of the PubMed, EMBASE, and Cochrane (Central) databases from 1965 to May 2013 were undertaken using the keywords 'corticosteroid', 'skin', and 'atrophy'. Skin and epidermal thickness values were retrieved from trials on healthy skin, and studies including skin atrophy as a safety endpoint in trials testing the efficacy of TCs were analyzed. Overall, 60 articles were retrieved. Whole skin and epidermal thickness were relevant parameters to measure early skin atrophy on healthy skin before it becomes clinically obvious. Epidermis thickness also seems to be more sensitive than whole skin thickness in detecting early atrophy; however, measuring skin atrophy still requires standardization. Further clinical trials on the atrophic effects of each TC are required to better evaluate their respective atrophic risks and their risk/benefit ratios. However, measuring epidermal or whole skin thickness will not be relevant in acute phases of inflammatory skin disorders treated with TCs because of the thickening induced by inflammation. In addition, skin atrophy seems to be induced by chronic TC use rather than by acute treatments. Long-term safety studies may be more relevant to evaluate atrophic activity.	[Barnes, Laurent; Kaya, Gurkan] Univ Geneva, Univ Hosp Geneva, Div Dermatol, Geneva, Switzerland; [Rollason, Victoria] Univ Geneva, Univ Hosp Geneva, Div Clin Pharmacol & Toxicol, Geneva, Switzerland		Barnes, L (corresponding author), Univ Geneva, Univ Hosp Geneva, Div Dermatol, Geneva, Switzerland.	Laurent.Barnes@unige.ch					Andres Philippe, 2006, J Drugs Dermatol, V5, P328; Arkwright PD, 2013, J ALLER CL IMM-PRACT, V1, P142, DOI 10.1016/j.jaip.2012.09.002; Babamiri K, 2010, AESTHET SURG J, V30, P74, DOI 10.1177/1090820X09360704; Baer R L, 1970, Arch Belg Dermatol Syphiligr, V26, P129; Barnes L, 2013, J INVEST DERMATOL, V133, P1017, DOI 10.1038/jid.2012.439; Barnes PJ, 2011, BRIT J PHARMACOL, V163, P29, DOI 10.1111/j.1476-5381.2010.01199.x; Belge Katharina, 2014, F1000Prime Rep, V6, P4, DOI 10.12703/P6-4; BJERKE JR, 1990, CLIN TRIALS J, V27, P94; Breneman DL, 1992, J DERMATOL TREAT, V3, P19; Cossmann M, 2006, BRIT J DERMATOL, V155, P700, DOI 10.1111/j.1365-2133.2006.07369.x; Dolle S, 2010, ALLERGY, V65, P1158, DOI 10.1111/j.1398-9995.2010.02341.x; DYKES PJ, 1977, J INVEST DERMATOL, V69, P275, DOI 10.1111/1523-1747.ep12507488; Dykes PJ, 1996, CLIN EXP DERMATOL, V21, P180, DOI 10.1111/j.1365-2230.1996.tb00058.x; El Madani HA, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.2.026009; Farage M. A., 2008, International Journal of Cosmetic Science, V30, P87, DOI 10.1111/j.1468-2494.2007.00415.x; Feldman SR, 2009, CUTIS, V84, P25; Fisher GJ, 1996, FASEB J, V10, P1002, DOI 10.1096/fasebj.10.9.8801161; FROSCH PJ, 1981, BRIT J DERMATOL, V104, P57; Gans EH, 2008, J DRUGS DERMATOL, V7, P28; Gebhardt C, 2010, J INVEST DERMATOL, V130, P141, DOI 10.1038/jid.2009.210; GOETTE DK, 1973, SOUTH MED J, V66, P542; Groeneweg FL, 2011, J ENDOCRINOL, V209, P153, DOI 10.1530/JOE-10-0472; Guillot B, 2013, REV MED INTERNE, V34, P310, DOI 10.1016/j.revmed.2012.12.004; GUZZO CA, 1991, J AM ACAD DERMATOL, V25, P1179, DOI 10.1016/0190-9622(91)70322-S; Haapasaari KM, 1997, SKIN PHARMACOL, V10, P261; Hengge UR, 2006, J AM ACAD DERMATOL, V54, P1, DOI 10.1016/j.jaad.2005.01.010; HERZ G, 1991, J AM ACAD DERMATOL, V25, P1166, DOI 10.1016/0190-9622(91)70319-W; HERZ G, 1983, J INT MED RES, V11, P21; Hoffmann K, 1998, J EUR ACAD DERMATOL, V10, P137, DOI 10.1016/S0926-9959(97)00151-7; Hoon TS, 2004, J DERMATOL TREAT, V15, P141; JABLONSKA S, 1979, BRIT J DERMATOL, V100, P193, DOI 10.1111/j.1365-2133.1979.tb05561.x; Jarratt MT, 2006, CUTIS, V78, P348; Jensen JM, 2009, J ALLERGY CLIN IMMUN, V123, P1124, DOI 10.1016/j.jaci.2009.03.032; Joly P, 2009, J INVEST DERMATOL, V129, P1681, DOI 10.1038/jid.2008.412; Josse G, 2009, SKIN RES TECHNOL, V15, P35, DOI 10.1111/j.1600-0846.2008.00326.x; Kaidbey K, 2001, INT J DERMATOL, V40, P468, DOI 10.1046/j.1365-4362.2001.01234.x; KATZ HI, 1991, J AM ACAD DERMATOL, V25, P1175; Kaya G, 2007, DERMATOLOGY, V215, P284, DOI 10.1159/000107621; Kim JE, 2010, J DERMATOL, V37, P448, DOI 10.1111/j.1346-8138.2010.00808.x; Kirkup M E, 2003, J Dermatolog Treat, V14, P141, DOI 10.1080/09546630310013388; Kolbe L, 2001, SKIN RES TECHNOL, V7, P73, DOI 10.1034/j.1600-0846.2001.70203.x; Korting HC, 2002, SKIN PHARMACOL APPL, V15, P85, DOI 10.1159/000049394; Kragballe K, 2006, BRIT J DERMATOL, V154, P1155, DOI 10.1111/j.1365-2133.2006.07236.x; Kragballe K, 2009, BRIT J DERMATOL, V161, P159, DOI 10.1111/j.1365-2133.2009.09116.x; KRAGBALLE K, 1991, ACTA DERM-VENEREOL, V71, P540; Kwon Hyok Bu, 2013, J Drugs Dermatol, V12, pe63; Kyllonen H, 2004, BRIT J DERMATOL, V150, P1174, DOI 10.1111/j.1365-2133.2004.06017.x; LAVKER RM, 1992, J AM ACAD DERMATOL, V26, P535, DOI 10.1016/0190-9622(92)70076-R; Lebwohl MG, 1998, J AM ACAD DERMATOL, V39, P590, DOI 10.1016/S0190-9622(98)70008-8; Lebwohl MG, 2001, J AM ACAD DERMATOL, V44, P77, DOI 10.1067/mjd.2001.110046; LEHMANN P, 1983, J INVEST DERMATOL, V81, P169, DOI 10.1111/1523-1747.ep12543603; LEVY J, 1994, SKIN PHARMACOL, V7, P231, DOI 10.1159/000211299; Lotti T, 2008, DERMATOL THER, V21, pS20, DOI 10.1111/j.1529-8019.2008.00198.x; LUBACH D, 1992, DERMATOLOGY, V185, P44, DOI 10.1159/000247402; LUBACH D, 1995, DERMATOLOGY, V190, P51, DOI 10.1159/000246635; Maloney JM, 1998, INT J DERMATOL, V37, P142, DOI 10.1046/j.1365-4362.1998.00394.x; MARKS R, 1976, DERMATOLOGICA, V152, P117, DOI 10.1159/000257872; MARKS R, 1975, ARCH DERMATOL FORSCH, V253, P93, DOI 10.1007/BF00582060; Mcmichael AJ, 1996, BRIT J DERMATOL, V135, P60; Mengeaud V, 2012, BRIT J DERMATOL, V166, P442, DOI 10.1111/j.1365-2133.2011.10534.x; MUNRO DD, 1975, BRIT MED J, V3, P626, DOI 10.1136/bmj.3.5984.626; Nakagawa H, 2006, CLIN DRUG INVEST, V26, P235, DOI 10.2165/00044011-200626050-00001; Naylor EC, 2011, MATURITAS, V69, P249, DOI 10.1016/j.maturitas.2011.04.011; Pariser D, 2009, AM J THER, V16, P264, DOI 10.1097/MJT.0b013e31818a975c; Pasonen-Seppanen SM, 2008, J INVEST DERMATOL, V128, P797, DOI 10.1038/sj.jid.5701098; Pauporte M, 2004, J Dermatolog Treat, V15, P360; Pels R, 2008, DRUG TODAY, V44, P547, DOI 10.1358/dot.2008.44.7.1122221; POLANO MK, 1982, ACTA DERM-VENEREOL, V62, P361; Reitamo S, 2005, BRIT J DERMATOL, V152, P1282, DOI 10.1111/j.1365-2133.2005.06592.x; Reygagne P, 2005, J DERMATOL TREAT, V16, P31, DOI 10.1080/09546630410024853; Rigopoulos D, 2004, BRIT J DERMATOL, V151, P1071, DOI 10.1111/j.1365-2133.2004.06208.x; Rosso JQ, 2009, J CLIN AESTHET DERMA, V2, P24; Saurat JH, 2007, DERMATOLOGY, V215, P271, DOI 10.1159/000107618; Schacke H, 2002, PHARMACOL THERAPEUT, V96, P23, DOI 10.1016/S0163-7258(02)00297-8; SCHMIED C, 1993, DERMATOLOGY, V187, P263, DOI 10.1159/000247260; Schoepe S, 2006, EXP DERMATOL, V15, P406, DOI 10.1111/j.0906-6705.2006.00435.x; SERUP J, 1985, DERMATOLOGICA, V170, P189, DOI 10.1159/000249529; SNYDER DS, 1977, J INVEST DERMATOL, V69, P279, DOI 10.1111/1523-1747.ep12507493; SOMERMA S, 1984, ACTA DERM-VENEREOL, V64, P41; Sorg O, 2006, DERMATOL THER, V19, P289, DOI 10.1111/j.1529-8019.2006.00086.x; SPARKES CG, 1974, BRIT J DERMATOL, V90, P197, DOI 10.1111/j.1365-2133.1974.tb06385.x; Stern R, 2008, CLIN DERMATOL, V26, P106, DOI 10.1016/j.clindermatol.2007.09.013; STEVANOVIC DV, 1972, BRIT J DERMATOL, V87, P548, DOI 10.1111/j.1365-2133.1972.tb07444.x; SULZBERGER MB, 1952, J INVEST DERMATOL, V19, P101, DOI 10.1038/jid.1952.72; Svensson A, 2011, CURR MED RES OPIN, V27, P1395, DOI 10.1185/03007995.2011.582483; Tan MH, 2002, INT J DERMATOL, V41, P804, DOI 10.1046/j.1365-4362.2002.01571.x; TANNER JM, 1959, P NUTR SOC, V18, P148, DOI 10.1079/PNS19590038; Terra JB, 2014, J EUR ACAD DERMATOL, V28, P712, DOI 10.1111/jdv.12153; Uliasz A, 2008, CUTIS, V81, P517; van der Vleuten CJM, 1999, ARCH DERMATOL RES, V291, P390, DOI 10.1007/s004030050427; WARRENFELTZ A, 1975, AM FAM PHYSICIAN, V11, P74; YAWALKAR SJ, 1983, J INT MED RES, V11, P1; Yazdanparast P, 2006, THYROID, V16, P1157, DOI 10.1089/thy.2006.16.1157; Zackheim HS, 1998, ARCH DERMATOL, V134, P949, DOI 10.1001/archderm.134.8.949	94	43	48	2	16	ADIS INT LTD	NORTHCOTE	5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND	0114-5916	1179-1942		DRUG SAFETY	Drug Saf.	MAY	2015	38	5					493	509		10.1007/s40264-015-0287-7			17	Public, Environmental & Occupational Health; Pharmacology & Pharmacy; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Pharmacology & Pharmacy; Toxicology	CG7WH	WOS:000353516700006	25862024				2022-03-04	
J	Oneda, B; Crettola, S; Sirot, EJ; Bochud, M; Ansermot, N; Eap, CB				Oneda, Beatrice; Crettola, Severine; Sirot, Evelyne Jaquenoud; Bochud, Murielle; Ansermot, Nicolas; Eap, Chin B.			The P450 oxidoreductase genotype is associated with CYP3A activity in vivo as measured by the midazolam phenotyping test	PHARMACOGENETICS AND GENOMICS			English	Article						cytochrome P4503A; genotyping; midazolam; phenotyping; P450 oxidoreductase	CYTOCHROME-P450 3A; HUMAN LIVER; GENETIC POLYMORPHISMS; EUROPEAN-AMERICAN; AFRICAN-AMERICAN; COMMON CYP3A4; DRUG; EXPRESSION; METABOLISM; VARIANTS	Background CYP3A4, CYP3A5 and CYP3A7 are hepatic enzymes that metabolize about 50% of drugs on the market, with a large overlap in their specificities. We investigated the genetic bases that contribute to the variation of CYP3A activity. Methods We phenotyped 251 individuals from two independent studies (182 patients treated with methadone and 69 patients with clozapine) for CYP3A activity using the midazolam phenotyping test and genotyped them for CYP3A4, CYP3A5, and CYP3A7 genetic variants, including the single nucleotide polymorphism (SNP) rs4646437C>T in intron 7 of CYP3A4. Owing to the fact that CYP enzymes require electron transfer through the P450 oxidoreductase (POR), and functional impairment has been shown for the POR*28 SNP, this polymorphism was also analysed. Results We show that CYP3A4, CYP3A5 and CYP3A7 genotypes, including the SNP rs4646437C>T, do not reflect the inter-individual variability of CYP3A activity (P>0.1). In contrast POR*28 TT genotype presents a 1.6-fold increase in CYP3A activity compared with POR*28C carriers (n = 182, P = 0.004). This finding was replicated in the second independent dataset (n = 69, P = 0.04). Conclusion The SNP POR*28 seems to be a better genetic marker of the variability of total CYP3A activity in vivo than CYP3A4, CYP3A5 and CYP3A7 genetic variants. Pharmacogenetics and Genomics 19:877-883 (C) 2009 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.	[Oneda, Beatrice; Crettola, Severine; Ansermot, Nicolas; Eap, Chin B.] Univ Lausanne, Hosp Cery, Dept Psychia CHUV, Ctr Psychiat Neurosci,Unit Biochem & Clin Psychop, CH-1008 Prilly, Switzerland; [Sirot, Evelyne Jaquenoud] Klin Konigsfelden, MediQ, Psychiat Dienste Aargau AG, Brugg, Switzerland; [Bochud, Murielle] CHU Vaudois, Inst Univ Med Sociale & Prevent, Geneva, Switzerland; [Eap, Chin B.] Univ Lausanne, Univ Geneva, Sch Pharmaceut Sci, Geneva, Switzerland		Eap, CB (corresponding author), Univ Lausanne, Hosp Cery, Dept Psychia CHUV, Ctr Psychiat Neurosci,Unit Biochem & Clin Psychop, CH-1008 Prilly, Switzerland.	Chin.Eap@chuv.ch	Bochud, Murielle/A-3981-2010	Bochud, Murielle/0000-0002-5727-0218; Eap, Chin/0000-0002-5439-0230	Unit of Biochemistry and Clinical Psychopharmacology; Department of Psychiatry, University of Lausanne	The authors thank V Sari, K. Powell Golay (editorial assistance), E. Ponce (bibliographical help); N. Cochard, M. Delessert, M. Jonzier-Perey, M. Brawand, A.C. Aubert, C. Brogli (sample analysis). This study has been supported by internal funds from the Unit of Biochemistry and Clinical Psychopharmacology and from the Department of Psychiatry, University of Lausanne.	Agrawal V, 2008, PHARMACOGENET GENOM, V18, P569, DOI 10.1097/FPC.0b013e32830054ac; Aichhorn W, 2006, INT CLIN PSYCHOPHARM, V21, P81, DOI 10.1097/01.yic.0000188213.46667.f1; Ball SE, 1999, CLIN PHARMACOL THER, V66, P288, DOI 10.1016/S0009-9236(99)70037-8; Burk O, 2002, J BIOL CHEM, V277, P24280, DOI 10.1074/jbc.M202345200; Crettol S, 2006, CLIN PHARMACOL THER, V80, P668, DOI 10.1016/j.clpt.2006.09.012; Crettol S, 2008, THER DRUG MONIT, V30, P689, DOI 10.1097/FTD.0b013e31818a2a60; Dai D, 2001, J PHARMACOL EXP THER, V299, P825; Dally H, 2004, CANCER LETT, V207, P95, DOI 10.1016/j.canlet.2003.12.011; Daly AK, 2006, CLIN PHARMACOKINET, V45, P13, DOI 10.2165/00003088-200645010-00002; de Wildt SN, 1999, CLIN PHARMACOKINET, V37, P485, DOI 10.2165/00003088-199937060-00004; Dobrinas M, 2007, HIV PGX, V2, P1; Eap CB, 2004, EUR J CLIN PHARMACOL, V60, P231, DOI 10.1007/s00228-004-0767-7; Eap CB, 2004, EUR J CLIN PHARMACOL, V60, P237, DOI 10.1007/s00228-004-0762-z; Eiselt R, 2001, PHARMACOGENETICS, V11, P447, DOI 10.1097/00008571-200107000-00008; Evans WE, 1999, SCIENCE, V286, P487, DOI 10.1126/science.286.5439.487; Evans WE, 2003, NEW ENGL J MED, V348, P538, DOI 10.1056/NEJMra020526; Felix CA, 1998, P NATL ACAD SCI USA, V95, P13176, DOI 10.1073/pnas.95.22.13176; Floyd MD, 2003, PHARMACOGENETICS, V13, P595, DOI 10.1097/00008571-200310000-00003; Fukuda T., 2004, Pharmacogenomics Journal, V4, P34, DOI 10.1038/sj.tpj.6500218; Gomes AM, 2009, PHARMACOGENOMICS, V10, P579, DOI 10.2217/PGS.09.7; Gomes LG, 2008, J CLIN ENDOCR METAB, V93, P2913, DOI 10.1210/jc.2008-0304; Guengrich FP, 1999, ANNU REV PHARMACOL, V39, P1, DOI 10.1146/annurev.pharmtox.39.1.1; Hart SN, 2008, PHARMACOGENET GENOM, V18, P11, DOI 10.1097/FPC.0b013e3282f2f121; He P, 2005, CLIN PHARMACOL THER, V77, P373, DOI 10.1016/j.clpt.2004.11.112; Henderson CJ, 2003, J BIOL CHEM, V278, P13480, DOI 10.1074/jbc.M212087200; Huang N, 2008, P NATL ACAD SCI USA, V105, P1733, DOI 10.1073/pnas.0711621105; Huang NW, 2005, AM J HUM GENET, V76, P729, DOI 10.1086/429417; Huang P, 2003, EUR J CLIN PHARMACOL, V59, P471, DOI 10.1007/s00228-003-0649-4; Hubbard PA, 2001, J BIOL CHEM, V276, P29163, DOI 10.1074/jbc.M101731200; Hustert E, 2001, PHARMACOGENETICS, V11, P773, DOI 10.1097/00008571-200112000-00005; Ingelman-Sundberg M, 2007, PHARMACOL THERAPEUT, V116, P496, DOI 10.1016/j.pharmthera.2007.09.004; Kuehl P, 2001, NAT GENET, V27, P383, DOI 10.1038/86882; Lamba JK, 2002, PHARMACOGENETICS, V12, P121, DOI 10.1097/00008571-200203000-00006; Lepper ER, 2005, CLIN CANCER RES, V11, P7398, DOI 10.1158/1078-0432.CCR-05-0520; Lin YS, 2002, MOL PHARMACOL, V62, P162, DOI 10.1124/mol.62.1.162; Masters BSS, 2005, BIOCHEM BIOPH RES CO, V338, P507, DOI 10.1016/j.bbrc.2005.09.165; Otto DME, 2003, MOL CELL BIOL, V23, P6103, DOI 10.1128/MCB.23.17.6103-6116.2003; Ozdemir V, 2000, PHARMACOGENETICS, V10, P373, DOI 10.1097/00008571-200007000-00001; Perera MA, 2009, PHARMACOGENOMICS J, V9, P49, DOI 10.1038/tpj.2008.13; Rebbeck TR, 1998, J NATL CANCER I, V90, P1225, DOI 10.1093/jnci/90.16.1225; Schirmer M, 2007, PHARMACOGENOMICS, V8, P443, DOI 10.2217/14622416.8.5.443; SCHUETZ EG, 1992, ARCH BIOCHEM BIOPHYS, V294, P206, DOI 10.1016/0003-9861(92)90159-T; Scott RR, 2007, J CLIN ENDOCR METAB, V92, P2318, DOI 10.1210/jc.2006-2345; Shen AL, 2002, J BIOL CHEM, V277, P6536, DOI 10.1074/jbc.M111408200; Shen LX, 2004, DRUG METAB DISPOS, V32, P186, DOI 10.1124/dmd.32.2.186; Shih PS, 2002, DRUG METAB DISPOS, V30, P1491, DOI 10.1124/dmd.30.12.1491; Sim SC, 2005, PHARMACOGENET GENOM, V15, P625, DOI 10.1097/01.fpc.0000171516.84139.89; Sirot EJ, 2009, J CLIN PSYCHOPHARM, V29, P319, DOI 10.1097/JCP.0b013e3181acc372; Streetman DS, 2000, PHARMACOGENETICS, V10, P187, DOI 10.1097/00008571-200004000-00001; Thummel KE, 1998, ANNU REV PHARMACOL, V38, P389, DOI 10.1146/annurev.pharmtox.38.1.389; Tirona RG, 2003, NAT MED, V9, P220, DOI 10.1038/nm815; Villeneuve JP, 2000, CLIN PHARMACOL THER, V67, P242, DOI 10.1067/mcp.2000.104642; Wandel C, 2000, CLIN PHARMACOL THER, V68, P82, DOI 10.1067/mcp.2000.108506; Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411; Wang YH, 2005, DRUG METAB DISPOS, V33, P664, DOI 10.1124/dmd.104.001834; Watanabe A, 2007, DRUG METAB DISPOS, V35, P1232, DOI 10.1124/dmd.107.015016; WATKINS PB, 1994, PHARMACOGENETICS, V4, P171, DOI 10.1097/00008571-199408000-00001; Westlind A, 2001, BIOCHEM BIOPH RES CO, V281, P1349, DOI 10.1006/bbrc.2001.4505; Wilkinson GR, 1996, J PHARMACOKINET BIOP, V24, P475, DOI 10.1007/BF02353475; Wojnowski L, 2004, THER DRUG MONIT, V26, P192, DOI 10.1097/00007691-200404000-00019; Wolbold R, 2003, HEPATOLOGY, V38, P978, DOI 10.1053/jhep.2003.50393; WRIGHTON SA, 1992, CRIT REV TOXICOL, V22, P1, DOI 10.3109/10408449209145319; Wrighton SA, 2000, DRUG METAB REV, V32, P339, DOI 10.1081/DMR-100102338; WRIGHTON SA, 2000, METABOLIC DRUG INTER, P115; Xie HG, 2004, PHARMACOGENOMICS, V5, P243, DOI 10.1517/phgs.5.3.243.29833; Yu KS, 2004, CLIN PHARMACOL THER, V76, P104, DOI 10.1016/j.clpt.2004.03.009; Zhu B, 2003, BRIT J CLIN PHARMACO, V55, P264, DOI 10.1046/j.1365-2125.2003.01728.x; HOME PAGE HUMAN CYTO	68	92	98	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1744-6872	1744-6880		PHARMACOGENET GENOM	Pharmacogenet. Genomics	NOV	2009	19	11					877	883		10.1097/FPC.0b013e32833225e7			7	Biotechnology & Applied Microbiology; Genetics & Heredity; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity; Pharmacology & Pharmacy	517HB	WOS:000271602800006	19801957				2022-03-04	
J	Fagerstrom, K; Etter, JF; Unger, JB				Fagerstrom, Karl; Etter, Jean-Francois; Unger, Jennifer B.			E-Cigarettes: A Disruptive Technology That Revolutionizes Our Field?	NICOTINE & TOBACCO RESEARCH			English	Editorial Material									[Etter, Jean-Francois] Univ Geneva, Inst Global Hlth, CH-1211 Geneva 4, Switzerland; [Unger, Jennifer B.] Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA		Fagerstrom, K (corresponding author), Framnasvagen 8, S-18531 Vaxholm, Sweden.	kark.fagerstrom@swipnet.se		Unger, Jennifer/0000-0001-9064-6603			Berg CJ, 2015, NICOTINE TOB RES, V17, P245, DOI 10.1093/ntr/ntu103; Biener L, 2015, NICOTINE TOB RES, V17, P127, DOI 10.1093/ntr/ntu200; Bowker KA, 2014, NICOTINE TOB RES, V16, DOI 10.1093/ntr/ntu029; Bullen C, 2010, TOB CONTROL, V19, P98, DOI 10.1136/tc.2009.031567; Bunnell RE, 2015, NICOTINE TOB RES, V17, P228, DOI 10.1093/ntr/ntu166; Davis B, 2015, NICOTINE TOB RES, V17, P134, DOI 10.1093/ntr/ntu080; European Union, 2014, TOB HLTH DIR; Farsalinos KE, 2015, NICOTINE TOB RES, V17, P163, DOI 10.1093/ntr/ntu207; Farsalinos KE, 2015, NICOTINE TOB RES, V17, P168, DOI 10.1093/ntr/ntu176; Foulds J, 2015, NICOTINE TOB RES, V17, P186, DOI 10.1093/ntr/ntu204; Goniewicz ML, 2015, NICOTINE TOB RES, V17, P256, DOI 10.1093/ntr/ntu152; Hajek P, 2015, NICOTINE TOB RES, V17, P175, DOI 10.1093/ntr/ntu153; Harrell PT, 2015, NICOTINE TOB RES, V17, P193, DOI 10.1093/ntr/ntu149; Herzog B., 2014, US TOBACCO TRENDS DI; King BA, 2015, NICOTINE TOB RES, V17, P219, DOI 10.1093/ntr/ntu191; Lechner WV, 2015, NICOTINE TOB RES, V17, P180, DOI 10.1093/ntr/ntu061; Ordonez JE, 2015, NICOTINE TOB RES, V17, P209, DOI 10.1093/ntr/ntu223; Rigotti NA, 2015, NICOTINE TOB RES, V17, P236, DOI 10.1093/ntr/ntu138; Shihadeh A, 2015, NICOTINE TOB RES, V17, P158, DOI 10.1093/ntr/ntu175; Spindle TR, 2015, NICOTINE TOB RES, V17, P142, DOI 10.1093/ntr/ntu186; Talih S, 2015, NICOTINE TOB RES, V17, P150, DOI 10.1093/ntr/ntu174; Walton KM, 2015, NICOTINE TOB RES, V17, P259, DOI 10.1093/ntr/ntu214; Williams M, 2015, NICOTINE TOB RES, V17, P201, DOI 10.1093/ntr/ntu118	23	29	29	0	18	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1462-2203	1469-994X		NICOTINE TOB RES	Nicotine Tob. Res.	FEB	2015	17	2			SI		125	126		10.1093/ntr/ntu240			2	Substance Abuse; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Substance Abuse; Public, Environmental & Occupational Health	CC1YW	WOS:000350142300001	25609846	Green Published			2022-03-04	
J	Crettol, S; Venetz, JP; Fontana, M; Aubert, JD; Ansermot, N; Fathi, M; Pascual, M; Eap, CB				Crettol, Severine; Venetz, Jean-Pierre; Fontana, Massimiliano; Aubert, John-David; Ansermot, Nicolas; Fathi, Marc; Pascual, Manuel; Eap, Chin B.			Influence of ABCB1 genetic polymorphisms on cyclosporine intracellular concentration in transplant recipients	PHARMACOGENETICS AND GENOMICS			English	Article						ABCB1; cyclosporine; genetic polymorphism; P-glycoprotein; therapeutic drug monitoring	P-GLYCOPROTEIN EXPRESSION; PERIPHERAL-BLOOD LYMPHOCYTES; MULTIDRUG-RESISTANCE GENE; EFFLUX TRANSPORT ACTIVITY; KIDNEY GRAFT-REJECTION; HUMAN MDR1 GENE; MONONUCLEAR-CELLS; MASS-SPECTROMETRY; EPITHELIAL-CELLS; DRUG-RESISTANCE	Objective The expression on lymphocytes of P-glycoprotein, an efflux transporter encoded by the ABCB1 gene, might influence cyclosporine intracellular concentration. Methods ABCB1 genotypes, cyclosporine intracellular and blood concentrations were determined in 64 stable renal, liver or lung transplant recipients. Results Cyclosporine intracellular concentration correlated moderately with blood concentration (r(2) =0.30, P < 0.00005). The ABCB1 1199A carriers presented a 1.8-fold decreased cyclosporine intracellular concentration (P=0.04), whereas the 3435Tcarriers presented a 1.7-fold increase (P = 0.02) as well as a 1.2-fold increased blood concentration (P=0.04). In contrast, ABCB1 61A > G, 1236C > Tand 2677G > Tpolymorphisms did not influence cyclosporine intracellular and blood concentrations. Conclusion This is the first report demonstrating that ABCB1 polymorphisms influence cyclosporine intracellular concentration. Interestingly, its influence on intracellular concentration is significantly higher than on blood concentration (P < 0.002). This may therefore modulate cyclosporine immunosuppressive activity. Pharmacogenetics and Genomics 18:307-315 (c) 2008 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.	[Crettol, Severine; Eap, Chin B.] Univ Lausanne, Hop Cer, Dept Psychiat,Unit Biochem & Clin Psychopharmacol, Ctr Psychiat Neurosci,CHUV, CH-1008 Prilly, Switzerland; [Venetz, Jean-Pierre; Fontana, Massimiliano; Aubert, John-David; Pascual, Manuel] Univ Lausanne, Geneva, Switzerland; [Venetz, Jean-Pierre; Fontana, Massimiliano; Aubert, John-David; Pascual, Manuel] Transplantat Ctr, CHUV, Geneva, Switzerland; [Ansermot, Nicolas; Fathi, Marc] Univ Hosp Geneva, Lab Med Serv, Geneva, Switzerland		Eap, CB (corresponding author), Univ Lausanne, Hop Cer, Dept Psychiat,Unit Biochem & Clin Psychopharmacol, Ctr Psychiat Neurosci,CHUV, CH-1008 Prilly, Switzerland.	Chin.Eap@chuv.ch	Aubert, John-David/H-5561-2019	Aubert, John-David/0000-0001-8856-4000; Eap, Chin/0000-0002-5439-0230; Pascual, Manuel A./0000-0001-7747-1693			Akalin E, 2006, CLIN J AM SOC NEPHRO, V1, P433, DOI 10.2215/CJN.01751105; Ansermot N, 2007, J CHROMATOGR B, V857, P92, DOI 10.1016/j.jchromb.2007.07.001; Balayssac D, 2005, TOXICOL LETT, V156, P319, DOI 10.1016/j.toxlet.2004.12.008; Barnard JB, 2006, TRANSPLANTATION, V82, P1677, DOI 10.1097/01.tp.0000250724.09996.bd; Calado RT, 2002, HAEMATOLOGICA, V87, P564; CHAUDHARY PM, 1992, BLOOD, V80, P2735; Coller JK, 2006, CLIN PHARMACOL THER, V80, P682, DOI 10.1016/j.clpt.2006.09.011; Colombo S, 2005, J CHROMATOGR B, V819, P259, DOI 10.1016/j.jchromb.2005.02.010; COON JS, 1991, HUM IMMUNOL, V32, P134, DOI 10.1016/0198-8859(91)90110-U; Crettol S, 2006, CLIN PHARMACOL THER, V80, P668, DOI 10.1016/j.clpt.2006.09.012; Crouthamel MH, 2006, J PHARM SCI-US, V95, P2767, DOI 10.1002/jps.20743; DRACH D, 1992, BLOOD, V80, P2729; Drescher S, 2002, BRIT J CLIN PHARMACO, V53, P526, DOI 10.1046/j.1365-2125.2002.01591.x; Eap CB, 2004, PHARMACOGENETICS, V14, P255, DOI 10.1097/00008571-200404000-00005; Fakata KL, 1998, LIFE SCI, V62, P2441, DOI 10.1016/S0024-3205(98)00227-6; Farrell RJ, 2002, ALIMENT PHARM THERAP, V16, P1021, DOI 10.1046/j.1365-2036.2002.01238.x; Fellay J, 2002, LANCET, V359, P30, DOI 10.1016/S0140-6736(02)07276-8; GOTZL M, 1995, NEPHRON, V69, P277, DOI 10.1159/000188470; Hitzl M, 2001, PHARMACOGENETICS, V11, P293, DOI 10.1097/00008571-200106000-00003; Hoffmeyer S, 2000, P NATL ACAD SCI USA, V97, P3473, DOI 10.1073/pnas.050585397; KEMNITZ J, 1991, J HEART LUNG TRANSPL, V10, P201; Kimchi-Sarfaty C, 2002, MOL PHARMACOL, V62, P1, DOI 10.1124/mol.62.1.1; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; KRONBACH T, 1988, CLIN PHARMACOL THER, V43, P630, DOI 10.1038/clpt.1988.87; Marzolini C, 2004, CLIN PHARMACOL THER, V75, P13, DOI 10.1016/j.clpt.2003.09.012; Masuda S, 2006, PHARMACOL THERAPEUT, V112, P184, DOI 10.1016/j.pharmthera.2006.04.006; Melk A, 1999, TRANSPLANT INT, V12, P10, DOI 10.1007/s001470050179; Oselin K, 2003, FUND CLIN PHARMACOL, V17, P463, DOI 10.1046/j.1472-8206.2003.00163.x; Oselin K, 2003, EUR J CLIN INVEST, V33, P261, DOI 10.1046/j.1365-2362.2003.01133.x; SAEKI T, 1993, J BIOL CHEM, V268, P6077; SCHINKEL AH, 1995, J CLIN INVEST, V96, P1698, DOI 10.1172/JCI118214; Singh D, 2004, TRANSPLANTATION, V77, P557, DOI 10.1097/01.TP.0000114594.21317.A5; Vergara E, 1998, TRANSPLANT P, V30, P2425, DOI 10.1016/S0041-1345(98)00673-3; Wang DX, 2005, PHARMACOGENET GENOM, V15, P693, DOI 10.1097/01.fpc.0000178311.02878.83; Woodahl EL, 2005, AIDS, V19, P1617, DOI 10.1097/01.aids.0000183626.74299.77; Woodahl EL, 2004, J PHARMACOL EXP THER, V310, P1199, DOI 10.1124/jpet.104.065383; YOUSEM SA, 1993, J HEART LUNG TRANSPL, V12, P20; Zanker B, 1997, TRANSPL P, V29, P1507, DOI 10.1016/S0041-1345(96)00651-3	38	74	78	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1744-6872			PHARMACOGENET GENOM	Pharmacogenet. Genomics	APR	2008	18	4					307	315		10.1097/FPC.0b013e3282f7046f			9	Biotechnology & Applied Microbiology; Genetics & Heredity; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity; Pharmacology & Pharmacy	281KR	WOS:000254496300004	18334915				2022-03-04	
J	Lorenzini, KI; Foufi, V; Tirone, F; Rollason, V; Gaudet-Blavignac, C; Desmeules, J; Lovis, C; Samer, C				Lorenzini, K. Ing; Foufi, V.; Tirone, F.; Rollason, V.; Gaudet-Blavignac, C.; Desmeules, J.; Lovis, C.; Samer, C.			Screening of Discharge Letters to Detect Adverse Drug Reactions. Can Natural Language Processing Tools be Helpful?	DRUG SAFETY			English	Meeting Abstract	18th ISoP Annual Meeting on Pharmacovigilance without Borders	NOV 11-14, 2018	Geneva, SWITZERLAND	Int Soc Pharmacovigilance			HOSPITALIZED-PATIENTS; METAANALYSIS		[Lorenzini, K. Ing; Tirone, F.; Rollason, V.; Desmeules, J.; Samer, C.] Univ Hosp Geneva, Clin Pharmacol & Toxicol, Geneva, Switzerland; [Foufi, V.; Gaudet-Blavignac, C.; Lovis, C.] Univ Hosp Geneva, Med Informat Sci Div, Geneva, Switzerland				Lovis, Christian/D-2634-2012; Samer, Caroline/ABB-2447-2021; Lovis, Christian/T-5364-2019; Gaudet-Blavignac, Christophe/M-5334-2015	Lovis, Christian/0000-0002-2681-8076; Samer, Caroline/0000-0001-8178-0616; Lovis, Christian/0000-0002-2681-8076; Gaudet-Blavignac, Christophe/0000-0001-6527-5898			Hakkarainen KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033236; Lazarou J, 1998, JAMA-J AM MED ASSOC, V279, P1200, DOI 10.1001/jama.279.15.1200; Miguel A, 2012, PHARMACOEPIDEM DR S, V21, P1139, DOI 10.1002/pds.3309; Thurmann PA, 2001, DRUG SAFETY, V24, P961; Trifiro G, 2009, PHARMACOEPIDEM DR S, V18, P1176, DOI 10.1002/pds.1836; Warrer P, 2012, BRIT J CLIN PHARMACO, V73, P674, DOI 10.1111/j.1365-2125.2011.04153.x	6	0	0	0	3	ADIS INT LTD	NORTHCOTE	5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND	0114-5916	1179-1942		DRUG SAFETY	Drug Saf.	NOV	2018	41	11				ISoP18-135	1222	1222					1	Public, Environmental & Occupational Health; Pharmacology & Pharmacy; Toxicology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Public, Environmental & Occupational Health; Pharmacology & Pharmacy; Toxicology	GV9IT	WOS:000446470800248					2022-03-04	
J	Tognon, M; Kohler, T; Luscher, A; van Delden, C				Tognon, Mikael; Kohler, Thilo; Luscher, Alexandre; van Delden, Christian			Transcriptional profiling of Pseudomonas aeruginosa and Staphylococcus aureus during in vitro co-culture	BMC GENOMICS			English	Article						Pseudomonas aeruginosa; Staphylococcus aureus; Transcriptome; RNAseq; Bacterial competition	CYSTIC-FIBROSIS; MEXGHI-OPMD; EFFLUX PUMP; ANTIBIOTIC-RESISTANCE; GENE-EXPRESSION; GROWTH; VIRULENCE; SUSCEPTIBILITY; METABOLISM; PROTEINS	BackgroundCo-colonization by Pseudomonas aeruginosa and Staphylococcus aureus is frequent in cystic fibrosis patients. Polymicrobial infections involve both detrimental and beneficial interactions between different bacterial species. Such interactions potentially indirectly impact the human host through virulence, antibiosis and immunomodulation.ResultsHere we explored the responses triggered by the encounter of these two pathogens to identify early processes that are important for survival when facing a potential competitor. Transcriptional profiles of both bacteria were obtained after 3h co-culture and compared to the respective mono-culture using RNAseq. Global responses in both bacteria included competition for nitrogen sources, amino acids and increased tRNA levels. Both organisms also induced lysogenic mechanisms related to prophage induction (S. aureus) and R- and F- pyocin synthesis (P. aeruginosa), possibly as a response to stress resulting from nutrient limitation or cell damage. Specific responses in S. aureus included increased expression of de novo and salvation pathways for purine and pyrimidine synthesis, a switch to glucose fermentation, and decreased expression of major virulence factors and global regulators.ConclusionsTaken together, transcriptomic data indicate that early responses between P. aeruginosa and S. aureus involve competition for resources and metabolic adaptations, rather than the expression of bacteria- or host-directed virulence factors.	[Tognon, Mikael; Kohler, Thilo; Luscher, Alexandre; van Delden, Christian] Univ Hosp Geneva, Transplant Infect Dis Unit, Geneva, Switzerland; [Tognon, Mikael; Kohler, Thilo; Luscher, Alexandre; van Delden, Christian] Univ Geneva, Dept Microbiol & Mol Med, 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland		Kohler, T (corresponding author), Univ Hosp Geneva, Transplant Infect Dis Unit, Geneva, Switzerland.; Kohler, T (corresponding author), Univ Geneva, Dept Microbiol & Mol Med, 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland.	thilo.kohler@unige.ch	Köhler, Thilo/AAN-9498-2021		Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission [140929, 159523]	This research was conducted with the financial support of the Swiss National Science Foundation (grants no 140929 and no 159523).	Aendekerk S, 2005, MICROBIOL-SGM, V151, P1113, DOI 10.1099/mic.0.27631-0; Aendekerk S, 2002, MICROBIOL-SGM, V148, P2371, DOI 10.1099/00221287-148-8-2371; Ahlgren HG, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0062-7; Aledo JC, 2004, BIOESSAYS, V26, P778, DOI 10.1002/bies.20063; Alvarez-Ortega C, 2007, MOL MICROBIOL, V65, P153, DOI 10.1111/j.1365-2958.2007.05772.x; Antonic Vlado, 2013, Infect Drug Resist, V6, P175, DOI 10.2147/IDR.S49039; Arias AA, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv080; Baba T, 2008, J BACTERIOL, V190, P300, DOI 10.1128/JB.01000-07; Baldan R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089614; Barnabie PM, 2015, J BACTERIOL, V197, P2250, DOI 10.1128/JB.00303-15; Brazas MD, 2005, ANTIMICROB AGENTS CH, V49, P3222, DOI 10.1128/AAC.49.8.3222-3227.2005; Brunskill EW, 1997, MICROBIOL-UK, V143, P2877, DOI 10.1099/00221287-143-9-2877; Buckner MMC, 2011, NATURE, V472, P179, DOI 10.1038/472179a; Cornforth DM, 2013, NAT REV MICROBIOL, V11, P285, DOI 10.1038/nrmicro2977; Cowley ES, 2015, MBIO, V6, DOI 10.1128/mBio.00767-15; Dalton T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027317; DeLeon S, 2014, INFECT IMMUN, V82, P4718, DOI 10.1128/IAI.02198-14; Dickson RP, 2015, AM J PHYSIOL-LUNG C, V309, pL1047, DOI 10.1152/ajplung.00279.2015; Dumas JL, 2006, FEMS MICROBIOL LETT, V254, P217, DOI 10.1111/j.1574-6968.2005.00008.x; EMMETT M, 1975, CAN J MICROBIOL, V21, P729, DOI 10.1139/m75-107; Filkins LM, 2015, J BACTERIOL, V197, P2252, DOI 10.1128/JB.00059-15; Folkesson A, 2012, NAT REV MICROBIOL, V10, P841, DOI 10.1038/nrmicro2907; Fu HH, 2015, ARCH BIOCHEM BIOPHYS, V584, P28, DOI 10.1016/j.abb.2015.08.012; Fugere A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086705; Gardner PR, 2000, J BIOL CHEM, V275, P31581, DOI 10.1074/jbc.M004141200; He JX, 2004, P NATL ACAD SCI USA, V101, P2530, DOI 10.1073/pnas.0304622101; Hervas AB, 2008, J BACTERIOL, V190, P416, DOI 10.1128/JB.01230-07; Hibbing ME, 2010, NAT REV MICROBIOL, V8, P15, DOI 10.1038/nrmicro2259; Hoffman LR, 2006, P NATL ACAD SCI USA, V103, P19890, DOI 10.1073/pnas.0606756104; KESSLER E, 1993, J BIOL CHEM, V268, P7503; Khemici V, 2015, PLOS GENET, V11, DOI [10.1371/journal.pgen.1005577, 10.1371/journal.pgen.1006320]; Kinkel TL, 2013, MBIO, V4, DOI 10.1128/mBio.00696-13; Kumar A, 2015, ENVIRON MICROBIOL, V17, P4459, DOI 10.1111/1462-2920.12890; Li XZ, 2015, CLIN MICROBIOL REV, V28, P337, DOI 10.1128/CMR.00117-14; Lightbown JW, 1954, BIOCHEM J, V58, P49; Maliniak ML, 2016, J CYST FIBROS, V15, P350, DOI 10.1016/j.jcf.2015.10.014; Mashburn LM, 2005, J BACTERIOL, V187, P554, DOI 10.1128/JB.187.2.554-566.2005; Michelsen CF, 2014, J BACTERIOL, V196, P3903, DOI 10.1128/JB.02006-14; Miller CL, 2017, MICROBIOLOGYOPEN, V6, DOI 10.1002/mbo3.427; Nuxoll AS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003033; Patton TG, 2005, MOL MICROBIOL, V56, P1664, DOI 10.1111/j.1365-2958.2005.04653.x; Ranjit DK, 2011, J BACTERIOL, V193, P2468, DOI 10.1128/JB.01545-10; Rice KC, 2007, P NATL ACAD SCI USA, V104, P8113, DOI 10.1073/pnas.0610226104; RUDIN L, 1974, J BACTERIOL, V118, P155, DOI 10.1128/JB.118.1.155-164.1974; Sakhtah H, 2016, P NATL ACAD SCI USA, V113, pE3538, DOI 10.1073/pnas.1600424113; Selva L, 2009, P NATL ACAD SCI USA, V106, P1234, DOI 10.1073/pnas.0809600106; Serra R, 2015, EXPERT REV ANTI-INFE, V13, P605, DOI 10.1586/14787210.2015.1023291; Sharma V, 2006, APPL ENVIRON MICROB, V72, P695, DOI 10.1128/AEM.72.1.695-701.2006; Sibley CD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000184; Tanabe T, 2012, MICROBIOL-SGM, V158, P2039, DOI 10.1099/mic.0.059568-0; Tay WH, 2016, J MOL BIOL, V428, P3355, DOI 10.1016/j.jmb.2016.05.006; Thomas VC, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004205; Tognon M, 2017, ISME J, V11, P2233, DOI 10.1038/ismej.2017.83; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; West SA, 2003, P ROY SOC B-BIOL SCI, V270, P37, DOI 10.1098/rspb.2002.2209; West SA, 2007, ANNU REV ECOL EVOL S, V38, P53, DOI 10.1146/annurev.ecolsys.38.091206.095740; Yang LA, 2011, INT J ORAL SCI, V3, P74, DOI 10.4248/IJOS11027; Zhang Z, 2015, INT FORUM ALLERGY RH, V5, P724, DOI 10.1002/alr.21532	58	30	30	4	16	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2164			BMC GENOMICS	BMC Genomics	JAN 10	2019	20								30	10.1186/s12864-018-5398-y			15	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	HH1FV	WOS:000455465600002	30630428	Green Published, gold			2022-03-04	
J	Etter, JF; Hughes, JR				Etter, JF; Hughes, JR			A comparison of the psychometrics of three cigarette withdrawal scales	NICOTINE & TOBACCO RESEARCH			English	Meeting Abstract									Univ Geneva, CH-1211 Geneva, Switzerland; Univ Vermont, Dept Psychiat & Psychol, Burlington, VT 05405 USA				Hughes, John/H-9687-2013	Hughes, John/0000-0002-0092-9309				0	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1462-2203			NICOTINE TOB RES	Nicotine Tob. Res.	AUG	2005	7	4					649	649					1	Substance Abuse; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Substance Abuse; Public, Environmental & Occupational Health	972SY	WOS:000232474700022					2022-03-04	
J	Siegrist, CA; Ambrosioni, J; Bel, M; Combescure, C; Hadaya, K; Martin, PY; Soccal, PM; Berney, T; Noble, S; Meier, S; Posfay-Barbe, K; Grillet, S; Kaiser, L; van Delden, C				Siegrist, Claire-Anne; Ambrosioni, Juan; Bel, Michael; Combescure, Christophe; Hadaya, Karine; Martin, Pierre-Yves; Soccal, Paola M.; Berney, Thierry; Noble, Stephane; Meier, Sara; Posfay-Barbe, Klara; Grillet, Stephane; Kaiser, Laurent; van Delden, Christian		H1N1 Study Grp	Responses of solid organ transplant recipients to the AS03-adjuvanted pandemic influenza vaccine	ANTIVIRAL THERAPY			English	Article							HUMORAL IMMUNE-RESPONSE; MYCOPHENOLATE-MOFETIL; ANTIBODY-RESPONSE; INFECTION; MECHANISMS; PROGRESS; DRUGS; H1N1	Background: Solid organ transplant (SOT) recipients are a priority group for influenza vaccination and strategies enhancing immunogenicity are needed. Methods: We determined adverse reactions, changes in biomarkers of graft function and immune responses to two doses of the AS03-adjuvanted influenza A/09/H1N1 vaccine in 216 SOT recipients and in 138 controls after one dose. Antibody responses were measured by haemagglutination inhibition and confirmed by microneutralization. We calculated geometric mean titres (GMT) and seroprotection rates (GMT >= 40). Results: Adverse reactions were fewer than in controls and graft function remained unaffected. Seroprotection was achieved by only 70.3% of SOT recipients, with significant differences between groups (lung 43.6%, heart 72.0%, kidney 83.3%, liver 83.3% and pancreas 85%), compared to 87% of controls (P<0.001). The weakest responses (seroprotection 43.5%) were elicited in lung transplant recipients. GMT remained threefold lower (115 versus 340) in SOT recipients than controls. Multivariate analyses identified increasing age, type of transplant and increasing blood levels of mycophenolate as independently associated to weaker responses. In contrast, even high blood levels of calcineurin inhibitors remained without significant influence on vaccine responses. Conclusions: The squalene-based adjuvanted A/09/H1N1 vaccine was safe in SOT recipients. However, even two doses of this adjuvanted influenza vaccine did not provide adequate protection for lung transplant recipients and those with high mycophenolate blood levels. Additional prophylactic measures should, therefore, be considered for these high-risk groups.	[Ambrosioni, Juan; Berney, Thierry; van Delden, Christian] Univ Hosp Geneva, Dept Surg, Serv Transplantat, Geneva, Switzerland; [Siegrist, Claire-Anne; Bel, Michael; Meier, Sara; Posfay-Barbe, Klara; Grillet, Stephane] Univ Hosp Geneva, Ctr Vaccinol, Geneva, Switzerland; [Combescure, Christophe] Univ Hosp Geneva, Clin Res Ctr, Geneva, Switzerland; [Hadaya, Karine; Martin, Pierre-Yves] Univ Hosp Geneva, Serv Nephrol, Geneva, Switzerland; [Soccal, Paola M.] Univ Hosp Geneva, Serv Pneumol, Geneva, Switzerland; [Noble, Stephane] Univ Hosp Geneva, Serv Cardiol, Geneva, Switzerland; [Kaiser, Laurent] Univ Hosp Geneva, Lab Virol, Geneva, Switzerland		van Delden, C (corresponding author), Univ Hosp Geneva, Dept Surg, Serv Transplantat, Geneva, Switzerland.	Christian.vandelden@hcuge.ch	Posfay-Barbe, Klara M/E-9131-2013; Posfay-Barbe, Klara M./AAV-2515-2021; Berney, Thierry/ABE-9450-2021	Posfay-Barbe, Klara M/0000-0001-9464-5704; Posfay-Barbe, Klara M./0000-0001-9464-5704; Berney, Thierry/0000-0002-4230-9378; Passweg, Jakob R/0000-0001-7092-3351	Ligue genevoise contre le cancer; Swiss Federal Office of Public Health; Center for Clinical Research; Center for Vaccinology (Geneva University Hospitals and Medical School, Geneva, Switzerland)	Funding sources were the Center for Clinical Research and Center for Vaccinology (Geneva University Hospitals and Medical School, Geneva, Switzerland) and Ligue genevoise contre le cancer. MB's salary was supported by a grant from the Swiss Federal Office of Public Health.	Ademokun A, 2010, BIOGERONTOLOGY, V11, P125, DOI 10.1007/s10522-009-9256-9; Allison AC, 2005, TRANSPLANTATION, V80, pS181, DOI 10.1097/01.tp.0000186390.10150.66; Barraclough KA, 2010, TRANSPLANTATION, V90, P44, DOI 10.1097/TP.0b013e3181e06584; Blumberg EA, 1996, CLIN INFECT DIS, V22, P295, DOI 10.1093/clinids/22.2.295; Clark TW, 2009, NEW ENGL J MED, V361, P2424, DOI 10.1056/NEJMoa0907650; Fishman JA, 2007, NEW ENGL J MED, V357, P2601, DOI 10.1056/NEJMra064928; Gabay C, 2011, ARTHRITIS RHEUM-US, V63, P1486, DOI 10.1002/art.30325; Hayney Mary S, 2004, Prog Transplant, V14, P346; Ison MG, 2010, CURR OPIN INFECT DIS, V23, P365, DOI 10.1097/QCO.0b013e32833bc1c3; Kumar D, 2010, AM J TRANSPLANT, V10, P18, DOI 10.1111/j.1600-6143.2009.02960.x; Kumar D, 2010, LANCET INFECT DIS, V10, P521, DOI 10.1016/S1473-3099(10)70133-X; Kunisaki KM, 2009, LANCET INFECT DIS, V9, P493, DOI 10.1016/S1473-3099(09)70175-6; Ljungman P, 2010, LANCET INFECT DIS, V10, P506, DOI 10.1016/S1473-3099(10)70136-5; Lopez-Medrano F, 2007, TRANSPLANTATION, V84, P851, DOI 10.1097/01.tp.0000282788.70383.8b; Madan RP, 2008, CLIN INFECT DIS, V46, P712, DOI 10.1086/527391; Mazzone PJ, 2001, EUR RESPIR J, V18, P971, DOI 10.1183/09031936.01.00215201; Rentenaar RJ, 2002, KIDNEY INT, V62, P319, DOI 10.1046/j.1523-1755.2002.00425.x; Ritter ML, 2009, TRANSPL INFECT DIS, V11, P290, DOI 10.1111/j.1399-3062.2009.00407.x; Salles MJC, 2010, CLIN TRANSPLANT, V24, pE17, DOI 10.1111/j.1399-0012.2009.01095.x; Scharpe J, 2008, AM J TRANSPLANT, V8, P332, DOI 10.1111/j.1600-6143.2007.02066.x; Schwarz TF, 2009, VACCINE, V27, P6284, DOI 10.1016/j.vaccine.2009.01.040; Seville MTA, 2010, TRANSPLANTATION, V90, P571, DOI 10.1097/TP.0b013e3181e86af0; Smith KGC, 1998, NEPHROL DIAL TRANSPL, V13, P160, DOI 10.1093/ndt/13.1.160; Taylor AL, 2005, CRIT REV ONCOL HEMAT, V56, P23, DOI 10.1016/j.critrevonc.2005.03.012; Tett SE, 2011, TRANSPLANT REV-ORLAN, V25, P47, DOI 10.1016/j.trre.2010.06.001; van Gelder T, 2009, AM J TRANSPLANT, V9, P1495, DOI 10.1111/j.1600-6143.2009.02678.x; Zmonarski SC, 2003, TRANSPLANT P, V35, P2205, DOI 10.1016/S0041-1345(03)00764-4	27	33	33	0	9	INT MEDICAL PRESS LTD	LONDON	2-4 IDOL LANE, LONDON EC3R 5DD, ENGLAND	1359-6535			ANTIVIR THER	Antivir. Ther.		2012	17	5					893	903		10.3851/IMP2103			11	Infectious Diseases; Pharmacology & Pharmacy; Virology	Science Citation Index Expanded (SCI-EXPANDED)	Infectious Diseases; Pharmacology & Pharmacy; Virology	037CV	WOS:000311080200014	22544169				2022-03-04	
J	Dobrinas, M; Cornuz, J; Eap, CB				Dobrinas, Maria; Cornuz, Jacques; Eap, Chin B.			Pharmacogenetics of CYP1A2 activity and inducibility in smokers and exsmokers	PHARMACOGENETICS AND GENOMICS			English	Article						CYP1A2; genetic polymorphism; inducibility; nuclear receptors; smoking	CONSTITUTIVE ANDROSTANE RECEPTOR; ARYL-HYDROCARBON RECEPTOR; GENETIC POLYMORPHISMS; SMOKING-CESSATION; DOWN-REGULATION; ASSOCIATION; VARIABILITY; CLOZAPINE; GENOTYPE; PLASMA	Background There is a high interindividual variability in cytochrome P4501A2 (CYP1A2) activity and in its inducibility by smoking, only poorly explained by known CYP1A2 polymorphisms. We aimed to study the contribution of other regulatory pathways, including transcription factors and nuclear receptors, toward this variability. Methods CYP1A2 activity was determined by the paraxanthine/caffeine ratio in 184 smokers and in 113 of them who were abstinent for 4 weeks. Participants were genotyped for 22 polymorphisms in 12 genes. Results A significant influence on CYP1A2 inducibility was observed for the NR1I3 rs2502815 (P = 0.0026), rs4073054 (P=0.029), NR2B1 rs3818740 (P = 0.0045), rs3132297 (P=0.036), AhR rs2282885 (P=0.040), rs2066853 (P=0.019), NR1I1 rs2228570 (P=0.037), and NR1I2 rs1523130 (P=0.044) polymorphisms. Among these, the NR1I3 rs2502815 (P=0.0045), rs4073054 (P=0.048), and NR2B1 rs3818740 (P=0.031) also influenced CYP1A2 basal activity. Conclusion This is the first in-vivo demonstration of the influence of genes involved in CYP1A2 regulatory pathways on its basal activity and inducibility by smoking. These results need to be confirmed by other studies. Pharmacogenetics and Genomics 23:286-292 (C) 2013 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.	[Dobrinas, Maria; Eap, Chin B.] Univ Lausanne Hosp, Ctr Psychiat Neurosci, Dept Psychiat, Unit Pharmacogenet & Clin Psychopharmacol, Prilly, Switzerland; [Cornuz, Jacques] Univ Lausanne, Dept Ambulatory Care & Community Med, Lausanne, Switzerland; [Eap, Chin B.] Univ Lausanne, Univ Geneva, Sch Pharmaceut Sci, Geneva, Switzerland		Eap, CB (corresponding author), Hosp Cery, Ctr Psychiat Neurosci, Dept Psychiat, Unit Pharmacogenet & Clin Psychopharmacol, CH-1008 Lausanne, Switzerland.	chin.eap@chuv.ch		Eap, Chin/0000-0002-5439-0230	Tobacco Prevention Fund, Swiss Federal Office of Public Health [06.004879]	This work was supported by a grant from the Tobacco Prevention Fund, Swiss Federal Office of Public Health (06.004879 to C.B. Eap).	[Anonymous], 2010, R LANG ENV STAT COMP; Bondolfi G, 2005, THER DRUG MONIT, V27, P539, DOI 10.1097/01.ftd.0000164609.14808.93; Carrillo JA, 2003, J CLIN PSYCHOPHARM, V23, P119, DOI 10.1097/00004714-200304000-00003; Chen D, 2009, PHARMACOGENET GENOM, V19, P25, DOI 10.1097/FPC.0b013e328316d8d8; Crawford JH, 2004, CRIT CARE MED, V32, P502, DOI 10.1097/01.CCM.0000109453.57709.E2; Dobrinas M, 2011, CLIN PHARMACOL THER, V90, P117, DOI 10.1038/clpt.2011.70; Dobrinas M, 2012, PHARMACOGENET GENOM, V22, P143, DOI 10.1097/FPC.0b013e32834e9e1a; Eap CB, 2004, J CLIN PSYCHOPHARM, V24, P214, DOI 10.1097/01.jcp.0000116646.91923.2f; Faber MS, 2005, BASIC CLIN PHARMACOL, V97, P125, DOI 10.1111/j.1742-7843.2005.pto_973160.x; FUHR U, 1994, PHARMACOGENETICS, V4, P109, DOI 10.1097/00008571-199406000-00001; Ghotbi R, 2007, EUR J CLIN PHARMACOL, V63, P537, DOI 10.1007/s00228-007-0288-2; Gunes A, 2008, PHARMACOGENOMICS, V9, P625, DOI 10.2217/14622416.9.5.625; Gunes A, 2009, PHARMACOGENOMICS, V10, P769, DOI [10.2217/pgs.09.22, 10.2217/PGS.09.22]; Harper PA, 2002, CHEM-BIOL INTERACT, V141, P161, DOI 10.1016/S0009-2797(02)00071-6; Ikeda S, 2005, MOL GENET METAB, V86, P314, DOI 10.1016/j.ymgme.2005.05.011; Jiang ZW, 2006, PHARMACOGENET GENOM, V16, P359, DOI 10.1097/01.fpc.0000204994.99429.46; Jiang ZW, 2005, HUM MUTAT, V25, P196, DOI 10.1002/humu.20134; Klein K, 2010, FRONT PHARMACOL, V1, DOI 10.3389/fphar.2010.00129; Kroon LA, 2007, AM J HEALTH-SYST PH, V64, P1917, DOI 10.2146/ajhp060414; Lamba JK, 2008, PHARMACOGENOMICS, V9, P71, DOI 10.2217/14622416.9.1.71; Lamba V, 2010, J PHARMACOL EXP THER, V332, P1088, DOI 10.1124/jpet.109.160804; Lubomirov R, 2010, PHARMACOGENET GENOM, V20, P217, DOI 10.1097/FPC.0b013e328336eee4; MacLeod S, 1997, MUTAT RES-FUND MOL M, V376, P135, DOI 10.1016/S0027-5107(97)00036-5; MacLeod S. L., 1998, Proceedings of the American Association for Cancer Research Annual Meeting, V39, P396; Maglich JM, 2002, MOL PHARM, V62, P462; Martinez-Jimenez CP, 2006, MOL PHARMACOL, V70, P1681, DOI 10.1124/mol.106.025403; Narvaez MJ, 2005, J BIOCHEM MOL TOXIC, V19, P78, DOI 10.1002/jbt.20063; Nebert DW, 2004, J BIOL CHEM, V279, P23847, DOI 10.1074/jbc.R400004200; Okey AB, 2005, PHARMACOGENET GENOM, V15, P371, DOI 10.1097/01213011-200506000-00001; Oliver P, 2010, CLIN CHEM LAB MED, V48, P635, DOI 10.1515/CCLM.2010.130; Uitterlinden AG, 2004, GENE, V338, P143, DOI 10.1016/j.gene.2004.05.014; Urano T, 2009, GERIATR GERONTOL INT, V9, P235, DOI 10.1111/j.1447-0594.2009.00527.x; Vieta E, 2010, CURR MED RES OPIN, V26, P1485, DOI 10.1185/03007991003779380; Yoshinari K, 2010, BIOCHEM PHARMACOL, V79, P261, DOI 10.1016/j.bcp.2009.08.008; Zhou M, 2008, INT J MOL MED, V21, P423; Zhou SF, 2010, DRUG METAB REV, V42, P268, DOI 10.3109/03602530903286476	36	13	13	0	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1744-6872	1744-6880		PHARMACOGENET GENOM	Pharmacogenet. Genomics	MAY	2013	23	5					286	292		10.1097/FPC.0b013e3283602e75			7	Biotechnology & Applied Microbiology; Genetics & Heredity; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity; Pharmacology & Pharmacy	123OG	WOS:000317399000005	23492909				2022-03-04	
J	Kossioni, A; Vanobbergen, J; Newton, J; Muller, F; Heath, R				Kossioni, Anastassia; Vanobbergen, Jacques; Newton, James; Mueller, Frauke; Heath, Robin			European College of Gerodontology: undergraduate curriculum guidelines in Gerodontology	GERODONTOLOGY			English	Article						undergraduate dental curriculum; gerodontology; dental education; competences; guidelines	ORAL-HEALTH PROGRAM; MORTALITY; PEOPLE	Effective undergraduate teaching of gerodontology to present and future dental students is important if good oral health care of older people is to be assured. A review of the undergraduate curriculum for gerodontology is presented and indicates the need for a knowledge base from which new graduates can develop a special interest in care of older patients. The aim is improved care of older patients, satisfaction for teaching staff involved and improved professional standing for Dentistry. Motivation of students could also be achieved by the positive match between rising patient awareness and ethical responsibility of the profession for those older patients. As it stands, the undergraduate curriculum should include topics on specific care for the elderly and other patient groups, which extend the competences already agreed by the Association for Dental Education in Europe (ADEE). The logistics of teaching these topics will need co-ordination of those staff with appropriate skill and interest, preferably as a development of existing curriculum content.	[Kossioni, Anastassia] Athens Dent Sch, Dept Prosthodont, Athens, Greece; [Vanobbergen, Jacques] Univ Ghent, Dept Community Dent & Oral Publ Hlth, B-9000 Ghent, Belgium; [Newton, James] Sch Med & Dent, Aberdeen Dent Sch, Aberdeen, Scotland; [Mueller, Frauke] Univ Geneva, Div Gerodontol & Removable Prosthodont, Geneva, Switzerland; [Heath, Robin] Univ London, Barts & London Sch Med & Dent, London, England		Kossioni, A (corresponding author), Univ Athens, Dept Prosthodont, Sch Dent, Thivon 2 Goudi, Athens 11527, Greece.	akossion@dent.uoa.gr	Müller, Frauke/C-3835-2014; Kossioni, Anastassia E/AAA-3193-2020; Vanobbergen, Jacques/S-2284-2016	Müller, Frauke/0000-0003-3981-0134; Kossioni, Anastassia E/0000-0003-0610-6984; 	ECG	The authors wish to acknowledge the support of the President of the ECG, Professor Bernd Wostmann from the University of Giessen, Germany, as well as all members of the ECG who commented on this document.	Appollonio I, 1997, J AM GERIATR SOC, V45, P1315, DOI 10.1111/j.1532-5415.1997.tb02930.x; Chavez Elisa M, 2004, J Dent Educ, V68, P454; Dolan T A, 1996, Gerodontology, V13, P94, DOI 10.1111/j.1741-2358.1996.tb00161.x; *GEN DENT COUNC, 2002, 1 5 YEARS FRAMEWORK; GIANNAKOURIS K, 2008, AGEING CHARACTERISES; Heath R M, 1992, Int Dent J, V42, P399; Hugoson A, 2005, SWED DENT J, V29, P139; Kossioni A E, 2006, Eur J Dent Educ, V10, P131, DOI 10.1111/j.1600-0579.2006.00402.x; Locker D, 2001, COMMUNITY DENT HLTH, V18, P7; Locker David, 2003, Spec Care Dentist, V23, P86, DOI 10.1111/j.1754-4505.2003.tb01667.x; Locker David, 2002, Community Dent Health, V19, P90; Matear D, 1999, J Can Dent Assoc, V65, P289; MATTSSON U, 1990, COMMUNITY DENT ORAL, V18, P219, DOI 10.1111/j.1600-0528.1990.tb00062.x; Nitschke I, 2008, GERODONTOLOGY, V25, P135, DOI 10.1111/j.1741-2358.2008.00222.x; Nitschke Ina, 2004, Gerodontology, V21, P123, DOI 10.1111/j.1741-2358.2004.00031.x; Nitschke Ina, 2004, Oral Health Prev Dent, V2 Suppl 1, P271; Oliver R, 2008, EUR J DENT EDUC, V12, P74, DOI 10.1111/j.1600-0579.2007.00482.x; Osterberg T, 2008, COMMUNITY DENT ORAL, V36, P258, DOI 10.1111/j.1600-0528.2007.00413.x; Petersen PE, 2005, COMMUNITY DENT ORAL, V33, P81, DOI 10.1111/j.1600-0528.2004.00219.x; Petersen PE, 2003, COMMUNITY DENT ORAL, V31, P3, DOI 10.1046/j..2003.com122.x; Plasschaert AJM, 2007, EUR J DENT EDUC, V11, P125, DOI 10.1111/j.1600-0579.2007.00445.x; Plasschaert A J M, 2005, Eur J Dent Educ, V9, P98, DOI 10.1111/j.1600-0579.2005.00369.x; Preshaw P M, 2005, Eur J Dent Educ, V9, P73, DOI 10.1111/j.1600-0579.2004.00357.x; Samson H, 2008, ACTA ODONTOL SCAND, V66, P368, DOI 10.1080/00016350802378654; Sanz M, 2008, EUR J DENT EDUC, V12, P101, DOI 10.1111/j.1600-0579.2007.00492.x; SHAY K, 1994, J PROSTHET DENT, V72, P510, DOI 10.1016/0022-3913(94)90124-4; 1989, J DENT ED, V53, P313	27	32	35	0	5	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	0734-0664			GERODONTOLOGY	Gerodontology	SEP	2009	26	3					165	171		10.1111/j.1741-2358.2009.00296.x			7	Dentistry, Oral Surgery & Medicine; Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine; Geriatrics & Gerontology	482YL	WOS:000268926600002	19371386				2022-03-04	
J	Rodondi, A; Ammann, P; Ghilardi-Beuret, S; Rizzoli, R				Rodondi, A.; Ammann, P.; Ghilardi-Beuret, S.; Rizzoli, R.			Zinc increases the effects of essential amino acids-whey protein supplements in frail elderly	JOURNAL OF NUTRITION HEALTH & AGING			English	Article						Osteoporosis; fracture; bone remodeling; nutrition; ageing	GROWTH-FACTOR-I; BONE-MINERAL DENSITY; ADULT FEMALE RATS; IGF-I; DIETARY-PROTEIN; ENERGY UNDERNUTRITION; PREPUBERTAL CHILDREN; CONTROLLED-TRIAL; PROXIMAL FEMUR; HIP FRACTURE	Protein undernutrition is frequent in the elderly. It contributes to the development of osteoporosis, possibly via lower IGF-I. Dietary zinc can influence IGF-I production. To determine the influence of dietary zinc addition on IGF-I and bone turnover responses to essential amino acids-whey (EAA-W) protein supplements in frail elderly. A daily oral protein supplement was given to hospitalized patients for 4 weeks. On a randomized, double-blind basis, patients received either an additional 30 mg/day of zinc or control. Sixty-one hospitalized elderly aged 66.7 to 105.8, with a mini-nutritional assessment score between 17 and 24 were enrolled. Activities of daily living; dietary intakes; serum IGF-I, IGF-BP3, CrossLaps (TM), osteocalcin and zinc were measured before and after 1, 2 and 4 weeks of protein supplementation. Serum IGF-I rapidly increased in both groups. Zinc accelerated this increase with changes of +48.2 +/- 14.3 and +22.4 +/- 4.7% (p <.05) by 1 week, in the zinc-supplemented and control groups, respectively. Zinc significantly decreased the serum bone resorption marker CrossLaps (TM) by already 1 week. Activities of daily living improved by +27.0 +/- 3.1 and +18.3 +/- 4.5% in zinc-supplemented and control groups, respectively. In the elderly, zinc supplementation accelerated the serum IGF-I response to EAA-W protein by 1 week and decreased a biochemical marker of bone resorption.	[Ammann, P.] Univ Hosp, Dept Rehabil & Geriatr, Div Bone Dis, WHO Collaborating Ctr Osteoporosis Prevent, CH-1211 Geneva 14, Switzerland; Fac Med Geneva, CH-1211 Geneva 14, Switzerland		Ammann, P (corresponding author), Univ Hosp, Dept Rehabil & Geriatr, Div Bone Dis, WHO Collaborating Ctr Osteoporosis Prevent, CH-1211 Geneva 14, Switzerland.	Patrick.Ammann@unige.ch					Amin S, 2004, J BONE MINER RES, V19, P1075, DOI 10.1359/JBMR.040301; Ammann P, 2000, J BONE MINER RES, V15, P683, DOI 10.1359/jbmr.2000.15.4.683; Ammann P, 2002, J BONE MINER RES, V17, pS205; Ammann P, 2003, OSTEOPOROSIS INT, V14, pS13, DOI 10.1007/s00198-002-1345-4; Ammann P, 2002, J BONE MINER RES, V17, P1264, DOI 10.1359/jbmr.2002.17.7.1264; Ammann P, 2001, J BONE MINER RES, V16, pS294; Avenell A, 2003, EUR J CLIN NUTR, V57, P895, DOI 10.1038/sj.ejcn.1601623; BIJVOET OLM, 1969, CLIN SCI, V37, P23; BONJOUR JP, 1988, BONE, V9, P123, DOI 10.1016/8756-3282(88)90001-4; Bonjour JP, 1997, OSTEOPOROSIS INT, V7, P36, DOI 10.1007/BF03194340; Bourrin S, 2000, ENDOCRINOLOGY, V141, P3149, DOI 10.1210/en.141.9.3149; Bourrin S, 2000, J BONE MINER RES, V15, P1555, DOI 10.1359/jbmr.2000.15.8.1555; Brown KH, 2002, AM J CLIN NUTR, V75, P1062, DOI 10.1093/ajcn/75.6.1062; CALHOUN NR, 1974, CLIN ORTHOP RELAT R, P212, DOI 10.1097/00003086-197409000-00084; Corish CA, 2000, BRIT J NUTR, V83, P575, DOI 10.1017/S000711450000074X; Darnton-Hill I, 2005, AM J CLIN NUTR, V81, p1198S; DELMI M, 1990, LANCET, V335, P1013, DOI 10.1016/0140-6736(90)91073-J; Devine A, 1998, AM J CLIN NUTR, V68, P200, DOI 10.1093/ajcn/68.1.200; GEINOZ G, 1993, OSTEOPOROSIS INT, V3, P242, DOI 10.1007/BF01623827; Hampson G, 2003, OSTEOPOROSIS INT, V14, P750, DOI 10.1007/s00198-003-1440-1; Hannan MT, 2000, J BONE MINER RES, V15, P2504, DOI 10.1359/jbmr.2000.15.12.2504; Hengsberger S, 2005, BONE, V36, P134, DOI 10.1016/j.bone.2004.09.013; Holloway WR, 1996, BONE, V19, P137, DOI 10.1016/8756-3282(96)00141-X; Imamoglu S, 2005, J PEDIATR ENDOCR MET, V18, P69; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Kerstetter JE, 2003, AM J CLIN NUTR, V78, p584S, DOI 10.1093/ajcn/78.3.584S; Ma ZJ, 2000, J BONE MINER METAB, V18, P264, DOI 10.1007/PL00010640; Gomez JM, 2006, CURR PHARM BIOTECHNO, V7, P125; MOONGA BS, 1995, J BONE MINER RES, V10, P453; NINH NX, 1995, J ENDOCRINOL, V144, P449, DOI 10.1677/joe.0.1440449; Ninh NX, 1996, AM J CLIN NUTR, V63, P514, DOI 10.1093/ajcn/63.4.514; Ninh NX, 1998, J ENDOCRINOL, V159, P211, DOI 10.1677/joe.0.1590211; Pepersack T, 2001, ARCH GERONTOL GERIAT, V33, P243, DOI 10.1016/S0167-4943(01)00186-8; PRASAD AS, 1985, ANNU REV NUTR, V5, P341, DOI 10.1146/annurev.nu.05.070185.002013; Promislow JHE, 2002, AM J EPIDEMIOL, V155, P636, DOI 10.1093/aje/155.7.636; Rapuri PB, 2003, AM J CLIN NUTR, V77, P1517, DOI 10.1093/ajcn/77.6.1517; Rizzoli R, 2004, J BONE MINER RES, V19, P527, DOI 10.1359/JBMR.040204; Rizzoli R, 2001, JOINT BONE SPINE, V68, P383, DOI 10.1016/S1297-319X(01)00295-0; Schurch MA, 1998, ANN INTERN MED, V128, P801, DOI 10.7326/0003-4819-128-10-199805150-00002; Sollman AT, 2008, METABOLISM, V57, P95, DOI 10.1016/j.metabol.2007.08.011; Sullivan DH, 1999, JAMA-J AM MED ASSOC, V281, P2013, DOI 10.1001/jama.281.21.2013; THISSEN JP, 1994, ENDOCR REV, V15, P80, DOI 10.1210/er.15.1.80; TKATCH L, 1992, J AM COLL NUTR, V11, P519; Vellas B, 1999, NUTRITION, V15, P116, DOI 10.1016/S0899-9007(98)00171-3; Wang YM, 2006, J BONE MINER RES, V21, P1350, DOI 10.1359/JBMR.060610; Yamaguchi M, 2005, J CELL BIOCHEM, V94, P794, DOI 10.1002/jcb.20335	46	31	32	0	14	SPRINGER FRANCE	PARIS	22 RUE DE PALESTRO, PARIS, 75002, FRANCE	1279-7707	1760-4788		J NUTR HEALTH AGING	J. Nutr. Health Aging	JUN	2009	13	6					491	497		10.1007/s12603-009-0099-5			7	Geriatrics & Gerontology; Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology; Nutrition & Dietetics	466SC	WOS:000267681900003	19536417	Green Submitted			2022-03-04	
J	Charbonnier, Y; Gettler, B; Francois, P; Bento, M; Renzoni, A; Vaudaux, P; Schlegel, W; Schrenzel, J				Charbonnier, Y; Gettler, B; Francois, P; Bento, M; Renzoni, A; Vaudaux, P; Schlegel, W; Schrenzel, J			A generic approach for the design of whole-genome oligoarrays, validated for genomotyping, deletion mapping and gene expression analysis on Staphylococcus aureus	BMC GENOMICS			English	Article							OLIGONUCLEOTIDE ARRAYS; MICROARRAY; PROBES; HYBRIDIZATION; RESISTANCE; VIRULENCE	Background: DNA microarray technology is widely used to determine the expression levels of thousands of genes in a single experiment, for a broad range of organisms. Optimal design of immobilized nucleic acids has a direct impact on the reliability of microarray results. However, despite small genome size and complexity, prokaryotic organisms are not frequently studied to validate selected bioinformatics approaches. Relying on parameters shown to affect the hybridization of nucleic acids, we designed freely available software and validated experimentally its performance on the bacterial pathogen Staphylococcus aureus. Results: We describe an efficient procedure for selecting 40 - 60 mer oligonucleotide probes combining optimal thermodynamic properties with high target specificity, suitable for genomic studies of microbial species. The algorithm for filtering probes from extensive oligonucleotides libraries fitting standard thermodynamic criteria includes positional information of predicted target-probe binding regions. This algorithm efficiently selected probes recognizing homologous gene targets across three different sequenced genomes of Staphylococcus aureus. BLAST analysis of the final selection of 5,427 probes yielded > 97%, 93%, and 81% of Staphylococcus aureus genome coverage in strains N315, Mu50, and COL, respectively. A manufactured oligoarray including a subset of control Escherichia coli probes was validated for applications in the fields of comparative genomics and molecular epidemiology, mapping of deletion mutations and transcription profiling. Conclusion: This generic chip-design process merging sequence information from several related genomes improves genome coverage even in conserved regions.	Univ Hosp Geneva, Genom Res Lab, CH-1211 Geneva, Switzerland; Univ Geneva, Fdn Rech Med, CH-1211 Geneva, Switzerland; Univ Hosp Geneva, Infect Dis Serv, CH-1211 Geneva, Switzerland; Univ Hosp Geneva, Clin Microbiol Lab, CH-1211 Geneva, Switzerland		Charbonnier, Y (corresponding author), Univ Hosp Geneva, Genom Res Lab, Rue Micheli Crest 24, CH-1211 Geneva, Switzerland.	yvan.charbonnier@genomic.ch; brian.gettler@genomic.ch; patrice.francois@genomic.ch; manuela.bento@genomic.ch; adriana.renzoni@genomic.ch; pierre.vaudaux@hcuge.ch; werner.schlegel@medecine.unige.ch; jacques.schrenzel@genomic.ch	Schrenzel, Jacques/P-8525-2017; Schrenzel, Jacques/AAC-5685-2021; francois, patrice/AAL-5583-2020	Schrenzel, Jacques/0000-0001-5464-7764; Schrenzel, Jacques/0000-0001-5464-7764; Renzoni, Adriana/0000-0002-4897-5208; francois, patrice/0000-0002-0540-750X			ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5; Barczak A, 2003, GENOME RES, V13, P1775, DOI 10.1101/gr.1048803; Blanchard AP, 1999, NAT BIOTECHNOL, V17, P953, DOI 10.1038/13644; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bozdech Z, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r9; Cramton SE, 1999, INFECT IMMUN, V67, P5427, DOI 10.1128/IAI.67.10.5427-5433.1999; Dubiley S, 1999, NUCLEIC ACIDS RES, V27, DOI 10.1093/nar/27.18.e19; Dunman PM, 2001, J BACTERIOL, V183, P7341, DOI 10.1128/JB.183.24.7341-7353.2001; Eriksson S, 2003, MOL MICROBIOL, V47, P103, DOI 10.1046/j.1365-2958.2003.03313.x; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; Gillenwater JY, 2003, EUR UROL SUPPL, V2, P3, DOI 10.1016/S1569-9056(03)00029-0; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Haas SA, 2003, NUCLEIC ACIDS RES, V31, P5576, DOI 10.1093/nar/gkg752; Hughes TR, 2001, NAT BIOTECHNOL, V19, P342, DOI 10.1038/86730; Ketomaki K, 2003, BIOCONJUGATE CHEM, V14, P811, DOI 10.1021/bc0340058; Kim CC, 2002, GENOME BIOL, V3; Kothapalli R, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-22; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Li J, 2002, TOXICOL SCI, V69, P383, DOI 10.1093/toxsci/69.2.383; Lucchini S, 2001, MICROBIOL-SGM, V147, P1403, DOI 10.1099/00221287-147-6-1403; Nielsen HB, 2003, NUCLEIC ACIDS RES, V31, P3491, DOI 10.1093/nar/gkg622; Novick RP, 2001, MICROBES INFECT, V3, P585, DOI 10.1016/S1286-4579(01)01414-9; Nuwaysir EF, 2002, GENOME RES, V12, P1749, DOI 10.1101/gr.362402; Okamoto T, 2000, NAT BIOTECHNOL, V18, P438, DOI 10.1038/74507; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Ramakrishnan R, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.7.e30; ROSENOW C, 2001, NUCLEIC ACIDS RES, V29, pU35; Rouillard JM, 2003, NUCLEIC ACIDS RES, V31, P3057, DOI 10.1093/nar/gkg426; Rouillard JM, 2002, BIOINFORMATICS, V18, P486, DOI 10.1093/bioinformatics/18.3.486; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; Staudinger BJ, 2002, J CLIN INVEST, V110, P1151, DOI 10.1172/JCI200215268; Talaat AM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf103; Talla E, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-38; Tolstrup N, 2003, NUCLEIC ACIDS RES, V31, P3758, DOI 10.1093/nar/gkg580; Vaudaux P, 2002, INFECT IMMUN, V70, P5428, DOI 10.1128/IAI.70.10.5428-5437.2002; Wang D, 2002, P NATL ACAD SCI USA, V99, P15687, DOI 10.1073/pnas.242579699; Wright MA, 2002, NAT BIOTECHNOL, V20, P1082, DOI 10.1038/nbt1102-1082; Yang IV, 2002, GENOME BIOL, V3; Yershov G, 1996, P NATL ACAD SCI USA, V93, P4913, DOI 10.1073/pnas.93.10.4913	40	87	94	0	4	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2164			BMC GENOMICS	BMC Genomics	JUN 17	2005	6								95	10.1186/1471-2164-6-95			12	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	953IM	WOS:000231069800001	15963225	gold, Green Published			2022-03-04	
J	Keizer, I; Wahl, C; Gex-Fabry, M; Croquette, P; Humair, JP; Aubry, JM; Khan, AN				Keizer, I.; Wahl, C.; Gex-Fabry, M.; Croquette, P.; Humair, J-P; Aubry, J-M; Khan, A. N.			Withdrawal symptoms upon a short motivational 26-hour smoking abstinence program in psychiatric patients	TOBACCO INDUCED DISEASES			English	Meeting Abstract									[Keizer, I.; Gex-Fabry, M.; Croquette, P.; Aubry, J-M; Khan, A. N.] HUG Univ Hosp Geneva, Dept Mental Hlth & Psychiat, Geneva, Switzerland; [Keizer, I.; Gex-Fabry, M.; Aubry, J-M] Univ Geneva, Geneva, Switzerland; [Wahl, C.; Humair, J-P] CIPRET Geneve Carrefour Addict, Geneva, Switzerland; [Humair, J-P] HUG Univ Hosp Geneva, Div Primary Care Med, Geneva, Switzerland			corinne.wahl@cipret.ch						0	0	0	0	0	EUROPEAN PUBLISHING	HERAKLION	SCIENCE & TECHNOLGY PARK CRETE, (STEP-C), N PLASTIRA 100, VASSILIKA VOUTWN, HERAKLION, CRETE 00000, GREECE	1617-9625			TOB INDUC DIS	Tob. Induc. Dis.		2018	16			1		LB-1349-5	202	202		10.18332/tid/84719			1	Substance Abuse; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Substance Abuse; Public, Environmental & Occupational Health	GF3IN	WOS:000431841800531		gold			2022-03-04	
J	Feigl, G; Fuchs, A; Gries, M; Hogan, QH; Weninger, B; Rosmarin, W				Feigl, G.; Fuchs, A.; Gries, M.; Hogan, Q. H.; Weninger, B.; Rosmarin, W.			A supraomohyoidal plexus block designed to avoid complications	SURGICAL AND RADIOLOGIC ANATOMY			English	Article						supraomohyoidal plexus block; supraclavicular plexus blocks; brachial plexus block; anesthetic technique; anesthesiology	BRACHIAL-PLEXUS; INTERSCALENE BLOCK; ANESTHESIA	Interscalene blocks of the brachial plexus are used for surgery of the shoulder and are frequently associated with complications such as temporary phrenic block, Horner syndrome or hematoma. To minimize the risk of these complications, we developed an approach that avoids medially directed needle advancement and favors spread to lateral regions only: the supraomohyoidal block. We tested this procedure in 11 cadavers fixed by Thiel's method. The insertion site is at the lateral margin of the sternocleidomastoid muscle at the level of the cricoid cartilage. The needle is inserted in the axis of the plexus with an angle of approximately 35 degrees to the skin, and advanced in lateral and caudal direction. Distribution of solution was determined in ten cadavers after bilateral injection of colored solution (20 and 30 ml) and followed by dissection. In an eleventh cadaver, computerized tomography and 3D reconstruction after radio contrast injection was performed. In additional five cadavers we performed Winnie's technique with bilateral injection (20 and 30 ml).Concerning the supraomohyoidal block the injection mass reached the infraclavicular region surrounded all trunks of the brachial plexus in the supraclavicular region and the suprascapular nerve in all cases. The solution did not spread medially beyond the lateral margin of the anterior scalene muscle into the scalenovertebral triangle. Therefore, phrenic nerve, stellate ganglion, laryngeal nerve nor the vertebral artery were exposed to the injected solution. Distribution was comparable with the use of 20 and 30 ml of solution. Injections on five cadavers performing the interscalene block of Winnie resulted in an extended spread medially to the anterior scalene muscle. We conclude that our method may be a preferred approach due to its safety, because no structures out of interest were reached. Solution of 20 ml is suggested to be enough for a successful block.	Univ Geneva, CMU, Div Anat, CH-1211 Geneva, Switzerland; Med Univ Graz, Dept Anat, Graz, Austria; Med Univ Graz, Dept Anesthesiol & Intens Care Med, Graz, Austria; Med Coll Wisconsin, Dept Anesthesiol, Milwaukee, WI 53226 USA		Feigl, G (corresponding author), Univ Geneva, CMU, Div Anat, Rue Michel Servet 1, CH-1211 Geneva, Switzerland.	Georg.Feigl@medecine.unige.ch					Benumof JL, 2000, ANESTHESIOLOGY, V93, P1541, DOI 10.1097/00000542-200012000-00033; Bittar DA, 2001, ANESTHESIOLOGY, V95, P1303, DOI 10.1097/00000542-200111000-00051; Borgeat A, 2003, ANESTHESIOLOGY, V99, P436, DOI 10.1097/00000542-200308000-00026; Borgeat Alain, 2002, Best Pract Res Clin Anaesthesiol, V16, P211, DOI 10.1053/bean.2002.0234; Casati A, 1999, ANESTH ANALG, V88, P587, DOI 10.1097/00000539-199903000-00024; DUTTON RP, 1994, ANESTHESIOLOGY, V80, P939, DOI 10.1097/00000542-199404000-00028; Hempel V, 1999, ANAESTHESIST, V48, P341, DOI 10.1007/s001010050712; KILKA HG, 1995, ANAESTHESIST, V44, P339, DOI 10.1007/s001010050162; Kulenkampff D, 1911, ZENTRALBL CHIR, V38, P1337; KUMAR A, 1971, ANESTHESIOLOGY, V35, P650; Long TR, 2002, J CLIN ANESTH, V14, P546, DOI 10.1016/S0952-8180(02)00408-7; Meier G, 1997, ANAESTHESIST, V46, P715, DOI 10.1007/s001010050458; Meier G, 2001, ANAESTHESIST, V50, P333, DOI 10.1007/s001010170018; MOORTHY SS, 1991, ANESTH ANALG, V73, P238; PhamDang C, 1997, ANESTH ANALG, V85, P111, DOI 10.1097/00000539-199707000-00020; Sala-Blanch X, 1999, REGION ANESTH PAIN M, V24, P231, DOI 10.1016/S1098-7339(99)90133-5; SCAMMELL SJ, 1979, ANAESTH INTENS CARE, V7, P56, DOI 10.1177/0310057X7900700109; SELTZER JL, 1977, ANESTH ANALG, V56, P585; THIEL W, 1992, ANN ANAT, V174, P185, DOI 10.1016/S0940-9602(11)80346-8; TUOMINEN MK, 1991, ANESTHESIOLOGY, V75, P356, DOI 10.1097/00000542-199108000-00026; Umfahrer P., 2002, STOMATOLOGIE, V99, P169; URMEY WF, 1991, ANESTH ANALG, V72, P498; VESTERANDERSEN T, 1981, ACTA ANAESTH SCAND, V25, P81, DOI 10.1111/j.1399-6576.1981.tb01612.x; WINNIE AP, 1970, ANESTH ANAL CURR RES, V49, P455	24	15	17	0	3	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013 USA	1279-8517			SURG RADIOL ANAT	Surg. Radiol. Anat.	AUG	2006	28	4					403	408		10.1007/s00276-006-0113-0			6	Anatomy & Morphology; Radiology, Nuclear Medicine & Medical Imaging; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anatomy & Morphology; Radiology, Nuclear Medicine & Medical Imaging; Surgery	081ZB	WOS:000240355000013	16680393	Green Submitted			2022-03-04	
J	Yerly, S; Vora, S; Gunthard, H; Vernazza, P; Furrer, H; Zinkernagel, A; Hirschel, B; Perrin, L				Yerly, S; Vora, S; Gunthard, H; Vernazza, P; Furrer, H; Zinkernagel, A; Hirschel, B; Perrin, L		Swiss HIV Cohort Study (SHCS)	Virological response following switch to atazanavir/ritonavir in relation to baseline genotypic resistance pattern	ANTIVIRAL THERAPY			English	Meeting Abstract	13th International HIV Drug Resistance Workshop	JUN 08-12, 2004	Tenerife, SPAIN						Geneve Hosp, Virol Lab, Geneva, Switzerland				Furrer, Hansjakob/G-6768-2013; Zinkernagel, Annelies S/F-1780-2017	Furrer, Hansjakob/0000-0002-1375-3146; Zinkernagel, Annelies S/0000-0003-4700-1118				0	0	0	0	0	INT MEDICAL PRESS LTD	LONDON	2-4 IDOL LANE, LONDON EC3R 5DD, ENGLAND	1359-6535			ANTIVIR THER	Antivir. Ther.	AUG	2004	9	4					U114	U114					1	Infectious Diseases; Pharmacology & Pharmacy; Virology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Infectious Diseases; Pharmacology & Pharmacy; Virology	960TH	WOS:000231615600173					2022-03-04	
J	Ritter, C; Huynh, CK; Etter, JF; Elger, BS				Ritter, Catherine; Cong Khanh Huynh; Etter, Jean-Francois; Elger, Bernice S.			Exposure to tobacco smoke before and after a partial smoking ban in prison: indoor air quality measures	TOBACCO CONTROL			English	Article								Although exposure to secondhand smoke (SHS) is reportedly high in prison, few studies have measured this in the prison environment, and none have done so in Europe. We measured two indicators of SHS exposure (particulate matter PM10 and nicotine) in fixed locations before (2009) and after (2010) introduction of a partial smoking ban in a Swiss prison. Access to smoking cessation support was available to detainees throughout the study. Objectives To measure SHS before and after the introduction of a partial smoking ban. Methods Assessment of particulate matter PM10 (suspended microparticles of 10 mu m) and nicotine in ambient air, collected by real-time aerosol monitor and nicotine monitoring devices. Results The authors observed a significant improvement of nicotine concentrations in the air after the introduction of the smoking ban (before: 7.0 mu g/m(3), after: 2.1 mu g/m(3), difference 4.9 mu g/m(3), 95% CI for difference: 0.52 to 9.8, p = 0.03) but not in particulate matter PM10 (before: 0.11 mg/m(3), after: 0.06 mg/m(3), difference 0.06 mg/m(3), 95% CI for difference of means: -0.07 to 0.19, p = 0.30). Conclusions The partial smoking ban was followed by a decrease in nicotine concentrations in ambient air. These improvements can be attributed to the introduction of the smoking ban since no other policy change occurred during this period. Although this shows that concentrations of SHS decreased significantly, protection was still incomplete and further action is necessary to improve indoor air quality.	[Ritter, Catherine; Elger, Bernice S.] Univ Ctr Legal Med Geneva & Lausanne, CH-1211 Geneva, Switzerland; [Cong Khanh Huynh] Inst Work & Hlth IST, Lausanne, Switzerland; [Etter, Jean-Francois] Univ Geneva, Fac Med, Inst Social & Prevent Med, Geneva, Switzerland		Ritter, C (corresponding author), Univ Ctr Legal Med Geneva & Lausanne, Rue Michel Servet 1, CH-1211 Geneva, Switzerland.	catherine.ritter@unige.ch	Elger, Bernice Simone/V-7265-2017	Elger, Bernice Simone/0000-0002-4249-7399; ETTER, Jean-Francois/0000-0002-1426-3157	Swiss Federal Office of Public Health	Swiss Federal Office of Public Health (Tobacco Prevention Fund).	[Anonymous], 2009, ORDONNANCE PROTECTIO; Belcher JM, 2006, DRUG ALCOHOL REV, V25, P343, DOI 10.1080/09595230600741198; Butler T, 2007, TOB CONTROL, V16, P291, DOI 10.1136/tc.2007.021600; Cropsey K, 2008, AM J PUBLIC HEALTH, V98, P1894, DOI 10.2105/AJPH.2007.128207; Cropsey KL, 2005, ADDICT BEHAV, V30, P589, DOI 10.1016/j.addbeh.2004.07.003; Eldridge GD, 2009, AM J PREV MED, V37, pS179, DOI 10.1016/j.amepre.2009.05.009; Global Smokefree Partnership, 2009, FCTC ART 8 PLUS SER; Guyon L., 2010, INTERDICTION FUMER E; Hammond SK, 2005, J EXPO ANAL ENV EPID, V15, P205, DOI 10.1038/sj.jea.7500387; Huynh CK, 2010, INT J VENT, V9, P93; Khanh Huynh Cong, 2008, Rev Med Suisse, V4, P430; Narkauskaite L, 2007, MED SCI MONITOR, V13, pCR131; NIPS, 2007, SMOK POL; Patrick S, 2001, SOC SCI J, V38, P27, DOI 10.1016/S0362-3319(00)00108-7; Proescholdbell SK, 2008, TOB CONTROL, V17, DOI 10.1136/tc.2007.022038; U.S. Department of Health and Human Services, 2010, TOB SMOK CAUS DIS BI; US Department of Health and Human Services, 2006, HLTH CONS INV EXP TO; WHO [World Health Organization], 2009, WHO FRAM CONV TOB CO, P11; World Health Organization, 2009, WOMEN AND HEALTH: TODAY'S EVIDENCE TOMORROW'S AGENDA, P1; World Health Organization, EUR TOB CONTR REP 20; World Health Organization, 2009, WHO FRAM CONV TOB CO; World Health Organization Europe. ROf, 2007, HLTH PRIS WHO GUID E; World Health Organization (WHO), 2009, WHO REP GLOB TOB EP, P8	23	24	24	1	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0964-4563	1468-3318		TOB CONTROL	Tob. Control	SEP	2012	21	5					488	491		10.1136/tc.2011.043356			4	Substance Abuse; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Substance Abuse; Public, Environmental & Occupational Health	994PK	WOS:000307943100020	21836161				2022-03-04	
J	Zekry, D; Krause, KH; Irminger-Finger, I; Graf, CE; Genet, C; Vitale, AM; Michel, JP; Gold, G; Herrmann, FR				Zekry, D.; Krause, K. H.; Irminger-Finger, I.; Graf, C. E.; Genet, C.; Vitale, A. -M.; Michel, J. -P.; Gold, G.; Herrmann, F. R.			Telomere length, comorbidity, functional, nutritional and cognitive status as predictors of 5 years post hospital discharge survival in the oldest old	JOURNAL OF NUTRITION HEALTH & AGING			English	Article						Telomere; aging; biomarker; mortality; survival	MORTALITY; DEMENTIA; ASSOCIATION; POPULATION; DISEASE; BLOOD; INDEX; AGE	Telomere length has been considered in many cross-sectional studies as a biomarker of aging. However the association between shorter telomeres with lower survival at advanced ages remains a controversial issue. This association could reflect the impact of other health conditions than a direct biological effect. To test whether leukocyte telomere length is associated with 5-year survival beyond the impact of other risk factors of mortality like comorbidity, functional, nutritional and cognitive status. Prospective study. A population representative sample of 444 patients (mean age 85 years; 74% female) discharged from the acute geriatric hospital of Geneva University Hospitals (January-December 2004), since then 263 (59.2%) had died (December 2009). Telomere length in leukocytes by flow cytometry. In univariate model, telomere length at baseline and cognitive status were not significantly associated with mortality even when adjusting for age (R-2=9.5%) and gender (R-2=1.9%). The best prognostic predictor was the geriatric index of comorbidity (GIC) (R-2=8.8%; HR=3.85) followed by more dependence in instrumental (R-2=5.9%; HR=3.85) and based (R2=2.3%; HR=0.84) activities of daily living and lower albumin levels (R-2=1.5%; HR=0.97). Obesity (BMI > 30: R-2=1.6%; HR=0.55) was significantly associated with a two-fold decrease in the risk of mortality compared to BMI between 20-25. When all independent variables were entered in a full multiple Cox regression model (R-2=21.4%), the GIC was the strongest risk predictor followed by the nutritional and functional variables. Neither telomeres length nor the presence of dementia are predictors of survival whereas the weight of multiple comorbidity conditions, nutritional and functional impairment are significantly associated with 5-year mortality in the oldest old.	[Zekry, D.; Graf, C. E.; Genet, C.; Vitale, A. -M.; Michel, J. -P.; Gold, G.; Herrmann, F. R.] Univ Hosp Geneva, Dept Rehabil & Geriatr, Thonex, Switzerland; [Zekry, D.; Graf, C. E.; Genet, C.; Vitale, A. -M.; Michel, J. -P.; Gold, G.; Herrmann, F. R.] Univ Geneva, Thonex, Switzerland; [Krause, K. H.; Irminger-Finger, I.] Univ Hosp Geneva, Dept Pathol & Immunol, Geneva, Switzerland; [Krause, K. H.; Irminger-Finger, I.] Univ Geneva, Geneva, Switzerland		Zekry, D (corresponding author), Univ Hosp Geneva, Dept Rehabil & Geriatr, 3 Chemin Pont Bochet, Thonex, Switzerland.	dina.zekry@hcuge.ch	HERRMANN, Francois/M-7390-2019; HERRMANN, Francois R/B-6710-2011; Krause, Karl-Heinz/E-8030-2011; Graf, Christophe/E-8635-2011	HERRMANN, Francois/0000-0003-1312-1517; HERRMANN, Francois R/0000-0003-1312-1517; Krause, Karl-Heinz/0000-0002-9033-6768; Graf, Christophe/0000-0002-0235-5046	Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission [3200B0-102069]; Swiss Foundation for Ageing Research (AETAS)	This work was supported by grants from the Swiss National Science Foundation (3200B0-102069) and from the Swiss Foundation for Ageing Research (AETAS).	ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114; American Psychological Association, 2000, DSM 4 DIAGN STAT MAN; Andersen K, 2010, DEMENT GERIATR COGN, V29, P61, DOI 10.1159/000265553; Bakaysa SL, 2007, AGING CELL, V6, P769, DOI 10.1111/j.1474-9726.2007.00340.x; Bischoff C, 2006, EPIDEMIOLOGY, V17, P190, DOI 10.1097/01.ede.0000199436.55248.10; Bischoff C, 2005, TWIN RES HUM GENET, V8, P433, DOI 10.1375/twin.8.5.433; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Covinsky KE, 1997, J GEN INTERN MED, V12, P203, DOI 10.1046/j.1525-1497.1997.012004203.x; Drame M, 2008, J NUTR HEALTH AGING, V12, P599, DOI 10.1007/BF02983207; Espaulellal J, 2007, AGE AGEING, V36, P407, DOI 10.1093/ageing/afm033; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Ganguli M, 2005, ARCH NEUROL-CHICAGO, V62, P779, DOI 10.1001/archneur.62.5.779; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Houben JMJ, 2008, FREE RADICAL BIO MED, V44, P235, DOI 10.1016/j.freeradbiomed.2007.10.001; Hultdin M, 1998, NUCLEIC ACIDS RES, V26, P3651, DOI 10.1093/nar/26.16.3651; Inouye SK, 1998, JAMA-J AM MED ASSOC, V279, P1187, DOI 10.1001/jama.279.15.1187; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; LAWTON MP, 1969, GERONTOLOGIST, V9, P9, DOI 10.1093/geront/9.1.9; LINDSEY J, 1991, MUTAT RES, V256, P45, DOI 10.1016/0921-8734(91)90032-7; Martens UM, 2002, BRIT J HAEMATOL, V119, P810, DOI 10.1046/j.1365-2141.2002.03910.x; Martin-Ruiz CM, 2005, AGING CELL, V4, P287, DOI 10.1111/j.1474-9726.2005.00171.x; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Njajou OT, 2007, P NATL ACAD SCI USA, V104, P12135, DOI 10.1073/pnas.0702703104; Njajou OT, 2009, J GERONTOL A-BIOL, V64, P860, DOI 10.1093/gerona/glp061; Robert PH, 2003, DEMENT GERIATR COGN, V15, P92, DOI 10.1159/000067971; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; Royston P, 2006, STATA J, V6, P83, DOI 10.1177/1536867X0600600105; Rozzini R, 2002, AGE AGEING, V31, P277, DOI 10.1093/ageing/31.4.277; Rubenstein LZ, 2001, J GERONTOL A-BIOL, V56, pM366, DOI 10.1093/gerona/56.6.M366; SLAGBOOM PE, 1994, AM J HUM GENET, V55, P876; Solomon PR, 1998, ARCH NEUROL-CHICAGO, V55, P349, DOI 10.1001/archneur.55.3.349; Terry DF, 2008, J GERONTOL A-BIOL, V63, P809, DOI 10.1093/gerona/63.8.809; Tschanz JT, 2004, NEUROLOGY, V62, P1156, DOI 10.1212/01.WNL.0000118210.12660.C2; Wong JMY, 2003, LANCET, V362, P983, DOI 10.1016/S0140-6736(03)14369-3; Zekry D, 2010, REJ RES         0906; Zekry D, 2008, AGE AGEING, V37, P83, DOI 10.1093/ageing/afm132; Zekry D, 2010, NEUROBIOL AGING, V31, P719, DOI 10.1016/j.neurobiolaging.2008.05.016; Zekry D, 2009, INT J GERIATR PSYCH, V24, P283, DOI 10.1002/gps.2104	38	7	8	0	6	SPRINGER FRANCE	PARIS	22 RUE DE PALESTRO, PARIS, 75002, FRANCE	1279-7707	1760-4788		J NUTR HEALTH AGING	J. Nutr. Health Aging	MAR	2012	16	3					225	230		10.1007/s12603-011-0138-x			6	Geriatrics & Gerontology; Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology; Nutrition & Dietetics	929HD	WOS:000303051000006	22456777	Green Submitted			2022-03-04	
J	Graf, CE; Herrmann, FR; Genton, L				Graf, C. E.; Herrmann, F. R.; Genton, Laurence			Relation of Disease with Standardized Phase Angle Among Older Patients	JOURNAL OF NUTRITION HEALTH & AGING			English	Article						Bioelectrical impendance analysis; cumulative illness rating scale; phase angle; severity of disease; older people	BIOELECTRICAL-IMPEDANCE ANALYSIS; OBSTRUCTIVE PULMONARY-DISEASE; BODY-WATER COMPARTMENTS; HEMODIALYSIS-PATIENTS; LIVER-CIRRHOSIS; MORTALITY; HEALTHY; DETERMINANTS; VALIDATION; PROGNOSIS	A low phase angle (PA) has been associated with negative outcome in specific diseases. However, many patients suffer from several co-morbidities. This study aims at identifying the impact of the type and the severity of diseases on PA in a retrospective cohort study of older people. We included all people ae<yen>65 years who underwent a PA measurement (NutriguardA (R)) between 1990 and 2011 at the Geneva University Hospitals. PA was standardized for gender, age and body mass index according to German reference values. Co-morbidities were reported in form of the Cumulative Illness Rating Scale which considers 14 different organs/systems (disease categories), each rated from 0 (healthy) to 4 (severe illness) (severity grades). The association between the diseases categories and standardized PA was evaluated by a multivariate linear regression. For each significant disease category, we performed univariate regression models. The adjusted R2 was used to identify the best predictors of standardized PA. We considered that the severity grade affected standardized PA if there was a progressive decrease in the regression coefficients. We included 1181 people (37% women). The multivariate regression model showed that the disease categories explain 17% of the variance of standardized PA. Many disease categories affect standardized PA and the ones best associated with standardized PA were the hematopoietic and vascular (R2 7.4%), the musculo-skeletal (R2 5.5%) and the respiratory (R2 4.0%) diseases. The regression coefficients in the univariate linear regression model decreased progressively with higher severity grades in respiratory (-0.15, -0.27, -0.55, -0.67) and musculo-skeletal diseases (-0.09, -0.46, -0.85, -0.86). Many different diseases affect standardized PA. The higher the severity grade in musculo-skeletal and respiratory diseases, the lower is the standardized PA.	[Graf, C. E.] Geneva Univ Hosp, Dept Rehabil & Palliat Care, Geneva, Switzerland; [Herrmann, F. R.] Geneva Univ Hosp, Dept Internal Med Rehabil & Geriatr, Geriatr, Geneva, Switzerland; [Genton, Laurence] Geneva Univ Hosp, Clin Nutr, Rue Gabrielle Perret Gentil 4, CH-1205 Geneva, Switzerland; [Genton, Laurence] Univ Geneva, Geneva, Switzerland		Genton, L (corresponding author), Geneva Univ Hosp, Clin Nutr, Rue Gabrielle Perret Gentil 4, CH-1205 Geneva, Switzerland.	laurence.genton@hcuge.ch	HERRMANN, Francois R/B-6710-2011; HERRMANN, Francois/M-7390-2019	HERRMANN, Francois R/0000-0003-1312-1517; HERRMANN, Francois/0000-0003-1312-1517; Genton Graf, Laurence/0000-0002-0037-5203	Research Fund of the Department of Internal Medicine of the Geneva University Hospitals; Geneva Faculty of Medicine; AstraZeneca SwitzerlandAstraZeneca	This work was partly supported by the Research Fund of the Department of Internal Medicine of the Geneva University Hospitals and the Geneva Faculty of Medicine. This fund receives an unrestricted grant from AstraZeneca Switzerland. Department of Internal Medicine of the Geneva University Hospitals and University of Geneva. For the Swiss National Cohort, Swiss National Science Foundation.	Baarends EM, 1997, AM J CLIN NUTR, V65, P88, DOI 10.1093/ajcn/65.1.88; BARACNIETO M, 1978, AM J CLIN NUTR, V31, P23, DOI 10.1093/ajcn/31.1.23; Barbosa-Silva MCG, 2005, AM J CLIN NUTR, V82, P49, DOI 10.1093/ajcn/82.1.49; Barbosa-Silva MCG, 2005, CURR OPIN CLIN NUTR, V8, P311, DOI 10.1097/01.mco.0000165011.69943.39; Barrea L, 2017, NUTRIENTS, V9; BAUMGARTNER RN, 1988, AM J CLIN NUTR, V48, P16, DOI 10.1093/ajcn/48.1.16; Beberashvilil I, 2014, EUR J CLIN NUTR, V68, P683, DOI 10.1038/ejcn.2014.67; Bosy-Westphal A, 2006, JPEN-PARENTER ENTER, V30, P309, DOI 10.1177/0148607106030004309; Buchholz AC, 2003, AM J CLIN NUTR, V77, P371, DOI 10.1093/ajcn/77.2.371; Cox-Reijven PLM, 2003, AM J CLIN NUTR, V78, P1111, DOI 10.1093/ajcn/78.6.1111; Gonzalez MC, 2016, AM J CLIN NUTR, V103, P712, DOI 10.3945/ajcn.115.116772; Graf CE, 2015, AM J CLIN NUTR, V101, P760, DOI 10.3945/ajcn.114.102566; HAUSSINGER D, 1993, LANCET, V341, P1330, DOI 10.1016/0140-6736(93)90828-5; Kehayias JJ, 2012, J NUTR HEALTH AGING, V16, P35, DOI 10.1007/s12603-011-0079-4; Kyle UG, 2012, CLIN NUTR, V31, P875, DOI 10.1016/j.clnu.2012.04.002; Levitt DG, 2010, J APPL PHYSIOL, V109, P786, DOI 10.1152/japplphysiol.00278.2010; Maddocks M, 2015, CLIN NUTR, V34, P1245, DOI 10.1016/j.clnu.2014.12.020; Maggiore Q, 1996, KIDNEY INT, V50, P2103, DOI 10.1038/ki.1996.535; MILLER ME, 1989, AM J CLIN NUTR, V50, P168, DOI 10.1093/ajcn/50.1.168; Norman K, 2012, CLIN NUTR, V31, P854, DOI 10.1016/j.clnu.2012.05.008; Ritz P, 2008, CLIN NUTR, V27, P740, DOI 10.1016/j.clnu.2008.07.010; Ritz P, 2001, J GERONTOL A-BIOL, V56, pM349, DOI 10.1093/gerona/56.6.M349; Ruiz-Margain A, 2015, DIGEST LIVER DIS, V47, P309, DOI 10.1016/j.dld.2014.12.015; Salvi F, 2008, J AM GERIATR SOC, V56, P1926, DOI 10.1111/j.1532-5415.2008.01935.x; Schols AMWJ, 2005, AM J CLIN NUTR, V82, P53, DOI 10.1093/ajcn/82.1.53; Selberg O, 2002, EUR J APPL PHYSIOL, V86, P509, DOI 10.1007/s00421-001-0570-4; Sergi G, 2004, ANN CLIN LAB SCI, V34, P416; Siervo M, 2010, INT J OBESITY, V34, P908, DOI 10.1038/ijo.2010.9; Silva AM, 2008, AM J CLIN NUTR, V88, P315, DOI 10.1093/ajcn/88.2.315; Stobaus N, 2012, BRIT J NUTR, V107, P1217, DOI 10.1017/S0007114511004028; Thibault R, 2016, INTENSIVE CARE MED; Wilhelm-Leen ER, 2014, J GEN INTERN MED, V29, P147, DOI 10.1007/s11606-013-2585-z; Woodrow G, 2004, PERITON DIALYSIS INT, V24, P169; Zekry D, 2012, J AM MED DIR ASSOC, V13, P272, DOI 10.1016/j.jamda.2010.11.011	34	2	2	0	3	SPRINGER FRANCE	PARIS	22 RUE DE PALESTRO, PARIS, 75002, FRANCE	1279-7707	1760-4788		J NUTR HEALTH AGING	J. Nutr. Health Aging	MAY	2018	22	5					601	607		10.1007/s12603-018-1034-4			7	Geriatrics & Gerontology; Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology; Nutrition & Dietetics	GG3YY	WOS:000432630800008	29717760				2022-03-04	
J	Dubois-Ferriere, V; Gamulin, A; Chowdhary, A; Fasel, J; Stern, R; Assal, M				Dubois-Ferriere, Victor; Gamulin, Axel; Chowdhary, Ashwin; Fasel, Jean; Stern, Richard; Assal, Mathieu			Syndesmosis reduction by computer-assisted orthopaedic surgery with navigation: Feasibility and accuracy in a cadaveric study	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Syndesmosis; Computer-assisted; Reduction; Navigation; Cadaver	ANKLE FRACTURES; TIBIOFIBULAR SYNDESMOSIS; SCREW FIXATION; MALREDUCTION; INJURIES; CT; STABILIZATION; PREDICTORS; ISO-C-3D	Introduction: Syndesmotic disruption may be difficult to reduce and fix, and malreduction is associated with inferior outcomes. Intraoperative computed tomography (CT) can provide accurate assessment of syndesmotic reduction. We hypothesized that three-dimensional (3-D) computer-assisted orthopaedic surgery (CAOS) with navigation of syndesmotic reduction could avoid malreduction. Our goal was to assess feasibility and accuracy of such a technic in a cadaveric study. Method: Eleven through-the-knee cadaveric specimens were used. Ankle CT as control was obtained prior to intervention. The syndesmosis was destabilized by sectioning the tibiofibular ligaments, producing a malreduction temporarily fixed with a Kirschner wire (K-wire). With reference base fixed to the tibia an acquisition scan was made. A K-wire was fixed to the fibula. The K-wire holding the syndesmosis malreduced was removed. The fibula was reduced within the syndesmosis under 3-D CAOS using a navigated K-wire. Once optimal position was obtained by referencing control images, the syndesmosis was fixed with a 3.5 mm screw. A CT scan was performed to assess quality of reduction. Results: Position of the fibula in control and post-reduction CT scans showed a mean anterior-posterior displacement of 0.74 (+/- 0.62) mm. The medial-lateral position measured a mean displacement of 0.68 (+/- 0.76) mm. Rotation of the fibula revealed a mean difference of 0.99 degrees (+/- 0.73). Conclusion: In this cadaveric study, CAOS with navigation allowed for very accurate syndesmosis reduction. This appears to be a promising technique to be confirmed by clinical study. (C) 2016 Elsevier Ltd. All rights reserved.	[Dubois-Ferriere, Victor; Gamulin, Axel] Univ Hosp Geneva, Div Orthopaed & Trauma Surg, Geneva, Switzerland; [Chowdhary, Ashwin; Stern, Richard; Assal, Mathieu] Clin La Colline, Ctr Surg Foot & Ankle, Geneva, Switzerland; [Fasel, Jean] Ctr Med Univ Geneva, Div Anat, Geneva, Switzerland; [Assal, Mathieu] Ctr Med Univ Geneva, Fac Med, Geneva, Switzerland		Dubois-Ferriere, V (corresponding author), Univ Hosp Geneva, Div Orthopaed & Trauma Surg, Dept Surg, Rue Gabrielle Perret Gentil 4, CH-1211 Geneva 14, Switzerland.	victor.dubois-ferriere@hcuge.ch	Gamulin, Axel/AAZ-5342-2021				Atesok K, 2007, INJURY, V38, P1163, DOI 10.1016/j.injury.2007.06.014; Atesok K, 2010, J AM ACAD ORTHOP SUR, V18, P247, DOI 10.5435/00124635-201005000-00001; Beamer A, 2004, CLIN ORTHOP RELAT R, P227, DOI 10.1097/01.blo.0000129152.81015.ad; CHISSELL HR, 1995, J BONE JOINT SURG BR, V77B, P435; Dikos GD, 2012, J ORTHOP TRAUMA, V26, P433, DOI 10.1097/BOT.0b013e3182535f30; Dubois-Ferriere V, 2014, Rev Med Suisse, V10, P562; Eckardt H, 2015, FOOT ANKLE INT, V36, P764, DOI 10.1177/1071100715576518; Egol KA, 2010, J ORTHOP TRAUMA, V24, P7, DOI 10.1097/BOT.0b013e3181b1542c; Franke J, 2014, FOOT ANKLE INT, V35, P1323, DOI 10.1177/1071100714549047; Franke J, 2012, J BONE JOINT SURG AM, V94A, P1386, DOI 10.2106/JBJS.K.01122; Gardner MJ, 2006, FOOT ANKLE INT, V27, P788, DOI 10.1177/107110070602701005; Kendoff D, 2009, J TRAUMA, V66, P232, DOI 10.1097/TA.0b013e31815ede5d; Kotwal R, 2016, SKELET RADIOL, V2015; LEEDS HC, 1984, J BONE JOINT SURG AM, V66A, P490, DOI 10.2106/00004623-198466040-00002; Lepojarvi S, 2014, J ORTHOP TRAUMA, V28, P205, DOI 10.1097/BOT.0b013e3182a59b3c; Miller AN, 2016, J ORTHOP TRAUMA, P2012; Miller AN, 2009, FOOT ANKLE INT, V30, P419, DOI 10.3113/FAI.2009.0419; Naqvi GA, 2012, AM J SPORT MED, V40, P2828, DOI 10.1177/0363546512461480; Nault ML, 2013, J ORTHOP TRAUMA, V27, P638, DOI 10.1097/BOT.0b013e318284785a; Nielson JH, 2005, CLIN ORTHOP RELAT R, P216, DOI 10.1097/01.blo.0000161090.86162.19; Phisitkul P, 2012, J BONE JOINT SURG AM, V94A, P2256, DOI 10.2106/JBJS.K.01726; Richter M, 2005, J ORTHOP TRAUMA, V19, P259, DOI 10.1097/01.bot.0000151822.10254.db; Sagi HC, 2012, J ORTHOP TRAUMA, V26, P439, DOI 10.1097/BOT.0b013e31822a526a; Weening B, 2005, J ORTHOP TRAUMA, V19, P102, DOI 10.1097/00005131-200502000-00006; Westermann RW, 2014, J BONE JOINT SURG AM, V96A, P1732, DOI 10.2106/JBJS.N.00198	25	4	5	0	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	DEC	2016	47	12					2694	2699		10.1016/j.injury.2016.10.009			6	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	EF7XX	WOS:000390543800014	27810152				2022-03-04	
J	Noger, M; Berli, MC; Fasel, JHD; Hoffmeyer, PJ				Noger, M.; Berli, M. C.; Fasel, J. H. D.; Hoffmeyer, P. J.			The risk of injury to neurovascular structures from distal locking screws of the Unreamed Humeral Nail (UHN): A cadaveric study	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Unreamed Humeral Nail; UHN; distal locking bolt; nerve injury; vascular injury	AXILLARY NERVE; INTRAMEDULLARY NAILS; SHAFT FRACTURES; INTERLOCKING; EXPERIENCE	When performing distal interlocking of an intramedullary humeral nail, there is risk of iatrogenic injuring to the neurovascular structures. Our cadaveric study with frozen sections through the distal humerus presents the anatomic relationship of the different neurovascular bundles and the trajectories used for the implantation of the three distal interlocking screws of the AO-UHN. The middle lateromedial pin was in direct contact with the radial nerve in 3 out of 10 cases, with the ulnar nerve in 3 out of 10 cases and with the brachial artery in 1 out of 10 cases. We recommend using only the two anteroposterior screws for distal interlocking, avoiding the lateromedial locking option. If this lateromedial locking screw is needed to gain adequate stability, it should be introduced under visual control. (c) 2007 Elsevier Ltd. All rights reserved.	Univ Hosp Geneva, Dept Orthopaed Surg & Musculoskeletal Traumatol, Geneva, Switzerland; Univ Geneva, Dept Morphol & Surg, CH-1211 Geneva 4, Switzerland		Noger, M (corresponding author), Hop Univ Geneve, Dept Chirurg, Serv Chirurg Orthoped & Traumatol Apparell Moteur, Rue Micheli Crest 24, CH-1211 Geneva, Switzerland.	markus.noger@hcuge.ch	hoffmeyer, pierre/AAY-1392-2021; Hoffmeyer, Pierre/X-4491-2019	Hoffmeyer, Pierre/0000-0001-9736-828X			Albritton MJ, 2003, J ORTHOP TRAUMA, V17, P411, DOI 10.1097/00005131-200307000-00004; Blum J, 2002, UNFALLCHIRURG, V105, P9, DOI 10.1007/s113-002-8158-5; Hems TEJ, 1996, INJURY, V27, P485, DOI 10.1016/0020-1383(96)00056-3; INGMAN AM, 1994, J BONE JOINT SURG BR, V76B, P23, DOI 10.1302/0301-620X.76B1.8300675; Prince EJ, 2004, J ORTHOP TRAUMA, V18, P585, DOI 10.1097/00005131-200410000-00001; Rupp RE, 1996, ORTHOPEDICS, V19, P593; VARLEY GW, 1995, INJURY, V26, P155, DOI 10.1016/0020-1383(95)93492-Z	7	15	18	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	AUG	2007	38	8					954	957		10.1016/j.injury.2007.04.014			4	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	202XG	WOS:000248937100013	17631884				2022-03-04	
J	Hugonnet, S; Dosso, A; Dharan, S; Martin, Y; Herrero, ML; Regnier, C; Pittet, D				Hugonnet, Stephane; Dosso, Andre; Dharan, Sasi; Martin, Yves; Herrero, Maria-Luisa; Regnier, Carole; Pittet, Didier			Outbreak of endophthalmitis after cataract surgery: The importance of the quality of the surgical wound	INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY			English	Article							POSTOPERATIVE ENDOPHTHALMITIS; RISK	Postoperative endophthalmitis is a rare but potentially devastating condition. We investigated an outbreak of 8 cases of endophthalmitis in patients who underwent phakectomy performed by a single surgeon from January through September 2004. The outbreak was traced to damaged surgical blades, and it highlights the importance of the quality of the surgical wound.	Univ Hosp Geneva, Infect Control Program, Dept Internal Med, CH-1211 Geneva 14, Switzerland; Univ Hosp Geneva, Dept Clin Neurosci & Dermatol, Ophtalmol Unit, CH-1211 Geneva, Switzerland		Pittet, D (corresponding author), Univ Hosp Geneva, Infect Control Program, Dept Internal Med, 24 Rue Micheli du Crest, CH-1211 Geneva 14, Switzerland.	didier.pittet@hcuge.ch					Centers for Disease Control and Prevention (CDC), 1996, MMWR Morb Mortal Wkly Rep, V45, P491; Cruciani M, 1998, CLIN INFECT DIS, V26, P330, DOI 10.1086/516292; Fridkin SK, 1996, CLIN INFECT DIS, V22, P222, DOI 10.1093/clinids/22.2.222; Hanscom TA, 2004, CLIN INFECT DIS, V38, P542, DOI 10.1086/381262; Hoffmann KK, 2002, ARCH OPHTHALMOL-CHIC, V120, P90; Kresloff MS, 1998, SURV OPHTHALMOL, V43, P193, DOI 10.1016/S0039-6257(98)00036-8; Li JH, 2004, INVEST OPHTH VIS SCI, V45, P1321, DOI 10.1167/iovs.03-1000; Mandal K, 2004, J CATARACT REFR SURG, V30, P1960, DOI 10.1016/j.jcrs.2004.01.039; Miller JJ, 2005, AM J OPHTHALMOL, V139, P983, DOI 10.1016/j.ajo.2005.01.025; Olson RJ, 2004, SURV OPHTHALMOL, V49, pS55, DOI 10.1016/j.survophthal.2004.01.002; PETTIT TH, 1980, ARCH OPHTHALMOL-CHIC, V98, P1025, DOI 10.1001/archopht.1980.01020031015002; Tabbara KF, 1998, OPHTHALMOLOGY, V105, P522, DOI 10.1016/S0161-6420(98)93037-8	12	5	6	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0899-823X			INFECT CONT HOSP EP	Infect. Control Hosp. Epidemiol.	NOV	2006	27	11					1246	1248		10.1086/508836			3	Public, Environmental & Occupational Health; Infectious Diseases	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Infectious Diseases	205AG	WOS:000249084500017	17080384	Green Published			2022-03-04	
J	Rubinovitch, B; Pittet, D				Rubinovitch, B; Pittet, D			Screening for methicillin-resistant Staphylococcus aureus in the endemic hospital: what have we learned?	JOURNAL OF HOSPITAL INFECTION			English	Review						methicillin-resistant Staphylococcus aureus; endemic MRSA; infection control; admission screening; cost-effectiveness	NOSOCOMIAL INFECTIONS; VIRULENCE FACTORS; NATIONAL-SURVEY; MRSA; BACTEREMIA; VANCOMYCIN; EPIDEMIOLOGY; IMPACT; COLONIZATION; SURVEILLANCE	Control of methicillin-resistant Staphylococcus aureus (MRSA) still generates controversy among infection control practitioners. Opponents claim that once MRSA becomes endemic in an institution, control efforts are no longer justified. This review examines the usefulness, feasibility and cost-effectiveness of control programmes in acute-care hospitals where eradication of MRSA has either failed or has never been attempted; hence, the pathogen has become endemic. High endemicity is associated with increased hospital-acquired infection rates, increased use of glycopeptides and subsequent risk of emergence of antibiotic-resistant cram-positive bacteria, and additional healthcare costs. Thus, MRSA control has many advantages. Indeed, in many institutions the actual benefit of containment efforts was manifested through the resultant decrease in the incidence of hospital-acquired MRSA infections. Successful programmes are based on an early identification of the MRSA reservoir and prompt implementation of contact precautions. The most efficacious strategy to detect occult MRSA carriage is via the screening of high-risk patients on admission to the hospital which has proven to be cost-effective in varied acute-care endemic settings. (C) 2001 The Hospital Infection Society.	Univ Hosp Geneva, Infect Control Programme, CH-1211 Geneva 14, Switzerland		Pittet, D (corresponding author), Univ Hosp Geneva, Infect Control Programme, CH-1211 Geneva 14, Switzerland.	didier.pittet@hcuge.ch					Abramson MA, 1999, INFECT CONT HOSP EP, V20, P408, DOI 10.1086/501641; Adcock PM, 1998, J INFECT DIS, V178, P577, DOI 10.1086/517478; [Anonymous], 1996, Am J Infect Control, V24, P380; ASPINALL SL, 1995, ANN PHARMACOTHER, V29, P694, DOI 10.1177/106002809502907-807; Ayliffe GAJ, 1998, J HOSP INFECT, V39, P253, DOI 10.1016/S0195-6701(98)90293-6; BLUMBERG LH, 1994, EUR J CLIN MICROBIOL, V13, P82, DOI 10.1007/BF02026131; BOYCE JM, 1991, INFECT CONT HOSP EP, V12, P46, DOI 10.2307/30147088; BOYCE JM, 1990, INFECT CONT HOSP EP, V11, P639; BRADLEY SF, 1991, ANN INTERN MED, V115, P417, DOI 10.7326/0003-4819-115-6-417; Chaix C, 1999, JAMA-J AM MED ASSOC, V282, P1745, DOI 10.1001/jama.282.18.1745; Chang FY, 1998, TRANSPLANTATION, V65, P1169, DOI 10.1097/00007890-199805150-00004; Chien JW, 2000, CLIN INFECT DIS, V30, P146, DOI 10.1086/313597; COHEN SH, 1991, AM J MED, V91, pS233, DOI 10.1016/0002-9343(91)90374-7; Cookson B, 1997, BRIT MED J, V314, P664, DOI 10.1136/bmj.314.7081.664; Cosseron-Zerbib M, 1998, J HOSP INFECT, V40, P225, DOI 10.1016/S0195-6701(98)90140-2; CUTLER RR, 1979, J MED MICROBIOL, V12, P55, DOI 10.1099/00222615-12-1-55; DUCKWORTH GJ, 1990, J MED MICROBIOL, V32, P195, DOI 10.1099/00222615-32-3-195; Durmaz B, 1997, J HOSP INFECT, V37, P325, DOI 10.1016/S0195-6701(97)90149-3; Farrington M, 1998, QJM-MON J ASSOC PHYS, V91, P539, DOI 10.1093/qjmed/91.8.539; FOLORUNSO AB, 2000, INFECT CONT HOSP EP, V18, P765; Girou E, 1998, CLIN INFECT DIS, V27, P543, DOI 10.1086/514695; Gorak EJ, 1999, CLIN INFECT DIS, V29, P797, DOI 10.1086/520437; HALEY RW, 1985, AM J EPIDEMIOL, V121, P182, DOI 10.1093/oxfordjournals.aje.a113990; Harbarth S, 1998, ARCH INTERN MED, V158, P182, DOI 10.1001/archinte.158.2.182; Harbarth S, 2000, J HOSP INFECT, V46, P43, DOI 10.1053/jhin.2000.0798; HARTSTEIN AI, 1995, INFECT CONT HOSP EP, V16, P257; Hartstein Alan I., 1999, P347; Herold BC, 1998, JAMA-J AM MED ASSOC, V279, P593, DOI 10.1001/jama.279.8.593; HERSHOW RC, 1992, INFECT CONT HOSP EP, V13, P587, DOI 10.2307/30148461; Herwaldt Loreen A., 1999, American Journal of Medicine, V106, p11S, DOI 10.1016/S0002-9343(98)00350-7; Humphreys H, 1997, J HOSP INFECT, V36, P167, DOI 10.1016/S0195-6701(97)90191-2; Jernigan JA, 1995, INFECT CONT HOSP EP, V16, P686; Jernigan JA, 1996, AM J EPIDEMIOL, V143, P496, DOI 10.1093/oxfordjournals.aje.a008770; JEWELL M, 1994, J CHEMOTHERAPY, V6, P35; JORDENS JZ, 1989, J MED MICROBIOL, V30, P245, DOI 10.1099/00222615-30-4-245; Kallen AJ, 2000, INFECT CONT HOSP EP, V21, P223, DOI 10.1086/501750; KARCHMER AW, 1991, ANN INTERN MED, V115, P739, DOI 10.7326/0003-4819-115-9-739; KHATIB R, 1995, SCAND J INFECT DIS, V27, P529, DOI 10.3109/00365549509047061; LACEY RW, 1987, J HOSP INFECT, V9, P103, DOI 10.1016/0195-6701(87)90046-6; LAW MR, 1988, EPIDEMIOL INFECT, V101, P623, DOI 10.1017/S0950268800029496; Lessing MPA, 1996, J HOSP INFECT, V34, P205, DOI 10.1016/S0195-6701(96)90067-5; LEVINE DP, 1991, ANN INTERN MED, V115, P674, DOI 10.7326/0003-4819-115-9-674; Linden Peter K., 1998, American Journal of Medicine, V104, p24S, DOI 10.1016/S0002-9343(98)00152-1; Lindenmayer JM, 1998, ARCH INTERN MED, V158, P895, DOI 10.1001/archinte.158.8.895; LYE WC, 1993, KIDNEY INT, V43, P1357, DOI 10.1038/ki.1993.191; MAGUIRE GP, 2000, J HOSP INFECT, V28, P273; Morgan M, 2000, J HOSP INFECT, V44, P227, DOI 10.1053/jhin.1999.0695; MUDER RR, 1991, ANN INTERN MED, V114, P107, DOI 10.7326/0003-4819-114-2-1-107; MULLIGAN ME, 1993, AM J MED, V94, P313, DOI 10.1016/0002-9343(93)90063-U; Murray BE, 2000, NEW ENGL J MED, V342, P710, DOI 10.1056/NEJM200003093421007; NETTLEMAN MD, 1991, AM J MED, V91, pS228, DOI 10.1016/0002-9343(91)90373-6; O'Brien FG, 1999, J CLIN MICROBIOL, V37, P2858; PANLILIO AL, 1992, INFECT CONT HOSP EP, V13, P582; Papia G, 1999, INFECT CONT HOSP EP, V20, P473, DOI 10.1086/501655; PEACOCK JE, 1981, J INFECT DIS, V144, P575, DOI 10.1093/infdis/144.6.575; Pittet D, 2000, LANCET, V356, P1307, DOI 10.1016/S0140-6736(00)02814-2; Pittet D, 1996, INFECT CONT HOSP EP, V17, P496; Pittet D, 1997, QJM-MON J ASSOC PHYS, V90, P239, DOI 10.1093/qjmed/90.4.239; Pujol M, 1996, AM J MED, V100, P509, DOI 10.1016/S0002-9343(96)00014-9; ROSDAHL VT, 1991, INFECT CONT HOSP EP, V12, P83; Schmitz FJ, 1997, EUR J EPIDEMIOL, V13, P699, DOI 10.1023/A:1007357206672; Soriano A, 2000, CLIN INFECT DIS, V30, P368, DOI 10.1086/313650; STAMM AM, 1993, AM J INFECT CONTROL, V21, P70, DOI 10.1016/0196-6553(93)90227-U; Struelens MJ, 1996, INFECT CONT HOSP EP, V17, P503; Teare EL, 1997, BRIT MED J, V314, P665, DOI 10.1136/bmj.314.7081.665; THOMPSON RL, 1982, ANN INTERN MED, V97, P309, DOI 10.7326/0003-4819-97-3-309; Troillet N, 1998, INFECT CONT HOSP EP, V19, P181, DOI 10.1086/647791; TURNIDGE J, 1989, MED J AUSTRALIA, V150, P65, DOI 10.5694/j.1326-5377.1989.tb136365.x; VandenbrouckeGrauls CMJE, 1996, INFECT CONT HOSP EP, V17, P512; VAUDAUX P, 1979, J INFECT DIS, V139, P547, DOI 10.1093/infdis/139.5.547; VOSS A, 1994, EUR J CLIN MICROBIOL, V13, P50, DOI 10.1007/BF02026127; Waldvogel FA, 1999, NEW ENGL J MED, V340, P556, DOI 10.1056/NEJM199902183400709; WARD TT, 1992, J INFECT DIS, V166, P400, DOI 10.1093/infdis/166.2.400; WENZEL RP, 1991, AM J MED, V91, pS221, DOI 10.1016/0002-9343(91)90372-5	74	81	82	0	3	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0195-6701	1532-2939		J HOSP INFECT	J. Hosp. Infect.	JAN	2001	47	1					9	18		10.1053/jhin.2000.0873			10	Public, Environmental & Occupational Health; Infectious Diseases	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Infectious Diseases	397ET	WOS:000166680900004	11161895				2022-03-04	
J	Hopf, NB; Bolognesi, C; Danuser, B; Wild, P				Hopf, Nancy B.; Bolognesi, Claudia; Danuser, Brigitta; Wild, Pascal			Biological monitoring of workers exposed to carcinogens using the buccal micronucleus approach: A systematic review and meta-analysis	MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH			English	Review						Occupational exposure; Micronucleus assay; Genotoxicity; Buccal cells; Biomarker	PERIPHERAL-BLOOD LYMPHOCYTES; PETROL STATION ATTENDANTS; BRAZILIAN FOOTWEAR-WORKERS; ORAL EPITHELIAL-CELLS; OCCUPATIONAL-EXPOSURE; GENETIC-DAMAGE; DNA-DAMAGE; CYTOGENETIC DAMAGE; WOOD DUST; NUCLEAR ANOMALIES	A biomarker-based approach using micronucleus (MN) (extranuclear DNA-containing bodies) frequencies in buccal cells has been proposed to monitor workers exposed to aero-digestive carcinogens for early detection of occupational cancer. To assess this non-invasive MN approach, we sought to understand: (A) What is the extent of MN frequency increase in occupationally exposed over non-exposed populations across studies published in the scientific literature for buccal cells; and (B) Which types of occupational exposures give relevant summary MN ratios across studies published in the scientific literature. A systematic literature review was performed, and the MN frequency ratios for buccal cells were calculated for each occupational study. Meta-analytic techniques were applied using the confidence interval or a standard error on the log-transformed ratio. Exposure categories were developed based on similar occupational exposures or jobs. A summary ratio and proportion of variance explained (the I-2 index) were derived assuming a Gaussian random effect model for each exposure category. The meta-analysis of the published literature (n = 96 studies) showed large random variability between studies within each category (I-2 > 90%), except where exposures were to a single carcinogenic substance (e.g. formaldehyde, silica) or similar jobs were performed (e.g. antineoplastic dispensing, gasoline attendants). The greatest summary frequency ratios were for silica (FR 9.02 95%CI 6.83-11.93), formaldehyde (FR 4.81 95%CI 2.19-10.60), and for hairdressers as an exposure category (FR 7.06 95%CI 3.96-12.57). The unexplained between-study variability can be related to exposures to mixtures of carcinogens with unknown mechanisms. If the latter had been measured, the between-study variability may have been explained. We conclude that better exposure assessments are needed to understand the relationship between occupational exposures and MN frequency responses in buccal cells. Nevertheless, our analysis indicates that the buccal cell MN assay is a promising tool for surveying workers exposed to genotcodc agents.	[Hopf, Nancy B.; Danuser, Brigitta; Wild, Pascal] Univ Lausanne, Inst Work & Hlth, IST, Lausanne, Switzerland; [Hopf, Nancy B.; Danuser, Brigitta; Wild, Pascal] Univ Geneva, Inst Work & Hlth, IST, Lausanne, Switzerland; [Bolognesi, Claudia] Osped Policlin San Martino, Environm Carcinogenesis Unit, Genoa, Italy; [Wild, Pascal] French Inst Res & Safety, INRS, Vandoeuvre Les Nancy, France		Hopf, NB (corresponding author), Inst Work & Hlth IST, Route Corn 2, CH-1066 Lausanne, Switzerland.	Nancy.Hopf@chuv.ch; claudiabolognesi@yahoo.it; Brigitta.Danuser@chuv.ch; pascal.wild@inrs.fr	Wild, Pascal/O-9791-2019; Wild, Pascal/A-9585-2012	Wild, Pascal/0000-0003-3165-3808; Wild, Pascal/0000-0003-3165-3808; Hopf, Nancy B/0000-0002-4490-6109	EU-COST Action DiMoPEx travel grant [CA 15129]	This meta-analysis was supported by a EU-COST Action DiMoPEx (CA 15129) travel grant and internal research money at the three institutes: IST (Switzerland), INRS (France), Environmental Carcinogenesis Unit, Ospedale Policlinico San Martino (Italy).	Andrade MC, 2017, ANTICANCER RES, V37, P849, DOI 10.21873/anticanres.11388; Angerer J, 1997, INT ARCH OCC ENV HEA, V70, P365, DOI 10.1007/s004200050231; Aslanturk OS, 2017, ENVIRON SCI POLLUT R, V24, P14700, DOI 10.1007/s11356-017-9075-5; Azhar DA, 2013, DENT MATER J, V32, P519, DOI 10.4012/dmj.2012-322; BAGWE AN, 1993, MUTAT RES, V299, P103, DOI 10.1016/0165-1218(93)90087-T; Benedetti D, 2013, MUTAT RES-GEN TOX EN, V752, P28, DOI 10.1016/j.mrgentox.2013.01.001; Benites CI, 2006, GENET MOL RES, V5, P45; Binazzi A, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1042-2; Bloching M, 2000, ORAL ONCOL, V36, P550, DOI 10.1016/S1368-8375(00)00051-8; Bolognesi C, 2002, CANCER RES, V62, P5418; Bolognesi C, 2015, MUTAT RES-REV MUTAT, V766, P20, DOI 10.1016/j.mrrev.2015.07.002; Bonassi S, 2007, CARCINOGENESIS, V28, P625, DOI 10.1093/carcin/bgl177; Bonassi S, 2011, MUTAT RES-REV MUTAT, V728, P88, DOI 10.1016/j.mrrev.2011.06.005; Bonassi S, 2011, MUTAGENESIS, V26, P93, DOI 10.1093/mutage/geq075; Bruschweiler BJ, 2014, CHIMIA, V68, P710, DOI 10.2533/chimia.2014.710; Bruschweiler ED, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00148; Bruschweiler ED, 2014, MUTAGENESIS, V29, P201, DOI 10.1093/mutage/geu003; Burgaz S, 2002, BIOMARKERS, V7, P151, DOI 10.1080/13547500110113242; Burgaz S, 2002, MUTAT RES-GEN TOX EN, V521, P47, DOI 10.1016/S1383-5718(02)00215-2; Burgaz S, 1999, MUTAT RES-GEN TOX EN, V439, P97, DOI 10.1016/S1383-5718(98)00180-6; Cameron Keyuna S., 2011, Reviews on Environmental Health, V26, P81, DOI 10.1515/REVEH.2011.012; Carbajal-Lopez Y, 2016, ENVIRON SCI POLLUT R, V23, P2513, DOI 10.1007/s11356-015-5474-7; Carlin V, 2013, TOXICOL MECH METHOD, V23, P108, DOI 10.3109/15376516.2012.721810; Casartelli G, 2000, ANAL QUANT CYTOL, V22, P486; Cassini C, 2011, INT J OCCUP MED ENV, V24, P308, DOI 10.2478/s13382-011-0030-2; Cavallo D, 2005, MUTAT RES-GEN TOX EN, V587, P45, DOI 10.1016/j.mrgentox.2005.07.008; Cavallo D, 2006, TOXICOLOGY, V223, P26, DOI 10.1016/j.tox.2006.03.003; Cavallo D, 2009, ENVIRON MOL MUTAGEN, V50, P781, DOI 10.1002/em.20501; Jara-Ettinger AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131548; Celik A, 2003, MUTAGENESIS, V18, P417, DOI 10.1093/mutage/geg022; Celik A, 2006, ENVIRON MOL MUTAGEN, V47, P693, DOI 10.1002/em.20257; Celik A, 2013, ECOTOX ENVIRON SAFE, V92, P265, DOI 10.1016/j.ecoenv.2013.01.030; Celik A, 2010, DNA CELL BIOL, V29, P277, DOI 10.1089/dna.2009.0996; Chandrasekhar M, 2006, MUTAGENESIS, V21, P249, DOI 10.1093/mutage/gel029; Chinde S, 2014, ENVIRON SCI POLLUT R, V21, P11469, DOI 10.1007/s11356-014-3128-9; Da Silva FR, 2012, ENVIRON MOL MUTAGEN, V53, P525, DOI 10.1002/em.21713; Danadevi K, 2004, MUTAGENESIS, V19, P35, DOI 10.1093/mutage/geh001; Danse IR, 1997, ECOTOX ENVIRON SAFE, V38, P71, DOI 10.1006/eesa.1997.1565; de Aquino T, 2016, AN ACAD BRAS CIENC, V88, P227, DOI 10.1590/0001-3765201620150194; de Bortoli GM, 2009, MUTAT RES-GEN TOX EN, V675, P1, DOI 10.1016/j.mrgentox.2009.01.001; Adad LMD, 2015, GENET MOL BIOL, V38, P308, DOI 10.1590/S1415-475738320140336; Galvao MFD, 2017, ENVIRON POLLUT, V220, P659, DOI 10.1016/j.envpol.2016.10.024; de Oliveira Hugo M, 2011, Indian J Occup Environ Med, V15, P52, DOI 10.4103/0019-5278.90374; Demircigil GC, 2010, MUTAGENESIS, V25, P163, DOI 10.1093/mutage/gep057; Diler SB, 2011, DNA CELL BIOL, V30, P821, DOI 10.1089/dna.2011.1216; Driscoll T, 2005, AM J IND MED, V48, P419, DOI 10.1002/ajim.20209; Dutta S, 2016, TOXICOL MECH METHOD, V26, P627, DOI 10.1080/15376516.2016.1230917; Eisenberg S, 2009, J INFUS MURS, V32, P23, DOI 10.1097/NAN.0b013e31819246e0; Eshkoor SA, 2013, BALK J MED GENET, V16, P45, DOI 10.2478/bjmg-2013-0031; Eshkoor SA, 2011, ARH HIG RADA TOKSIKO, V62, P291, DOI 10.2478/10004-1254-62-2011-2088; Espitia-Perez L, 2016, MUTAT RES-GEN TOX EN, V808, P38, DOI 10.1016/j.mrgentox.2016.08.003; Fenech M, 2016, MUTAT RES-REV MUTAT, V770, P12, DOI 10.1016/j.mrrev.2016.04.008; Flanagan ME, 2003, AIHA J, V64, P319, DOI 10.1080/15428110308984823; Gaikwad AS, 2015, J OCCUP MED TOXICOL, V10, DOI 10.1186/s12995-015-0049-6; Garcia PV, 2012, MUTAT RES-GEN TOX EN, V747, P197, DOI 10.1016/j.mrgentox.2012.05.008; Garcia-Leston J, 2012, ENVIRON INT, V43, P29, DOI 10.1016/j.envint.2012.03.001; Goelzer B.I.F., 2008, ILO ENCY OCCUPATIONA; Gomez-Arroyo S, 2000, MUTAT RES-GEN TOX EN, V466, P117, DOI 10.1016/S1383-5718(99)00231-4; Goud KI, 2004, MUTAT RES-GEN TOX EN, V563, P151, DOI 10.1016/j.mrgentox.2004.07.001; Grover P, 2010, INT J HYG ENVIR HEAL, V213, P99, DOI 10.1016/j.ijheh.2010.01.005; Gurel E, 2005, TUBERK TORAK, V53, P225; Halder Ajanta, 2012, Indian J Occup Environ Med, V16, P34, DOI 10.4103/0019-5278.99691; Hallare AV, 2009, ENVIRON MONIT ASSESS, V156, P331, DOI 10.1007/s10661-008-0488-y; Hamid ZA, 2016, GENES ENVIRON, V38, DOI 10.1186/s41021-016-0032-1; Heuser VD, 2007, TOXICOLOGY, V232, P235, DOI 10.1016/j.tox.2007.01.011; Heuser VD, 2005, MUTAT RES-GEN TOX EN, V583, P85, DOI 10.1016/j.mrgentox.2005.03.002; Hou LF, 2012, INT J EPIDEMIOL, V41, P79, DOI 10.1093/ije/dyr154; IARC, 2012, SIL SOM SIL COAL DUS; IARC International Agency for Research on Cancer, 2007, MONOGRAPHS EVALUATIO, V89; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2006, IARC Monogr Eval Carcinog Risks Hum, V87, P1; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2010, IARC Monogr Eval Carcinog Risks Hum, V92, P1; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2006, IARC Monogr Eval Carcinog Risks Hum, V88, P1; Iarmarcovai G, 2008, MUTAT RES-REV MUTAT, V659, P274, DOI 10.1016/j.mrrev.2008.05.006; Javed H, 2017, J PAK MED ASSOC, V67, P275; Castaneda-Yslas IJ, 2016, J TOXICOL-US, V2016, DOI 10.1155/2016/7934257; Karahalil B, 1999, MUTAT RES-GEN TOX EN, V442, P29, DOI 10.1016/S1383-5718(99)00055-8; Karaman A, 2008, WORLD J GASTROENTERO, V14, P6835, DOI 10.3748/wjg.14.6835; Kausar A, 2014, INT J HYG ENVIR HEAL, V217, P169, DOI 10.1016/j.ijheh.2013.04.007; Khan AW, 2015, MUTAGENESIS, V30, P613, DOI 10.1093/mutage/gev022; Khan MR, 2012, IRAN J CANCER PREV, V5, P87; Khan MI, 2010, ENVIRON SCI POLLUT R, V17, P1347, DOI 10.1007/s11356-010-0319-x; Kiilunen M, 1997, ANN OCCUP HYG, V41, P167, DOI 10.1016/S0003-4878(96)00032-4; Kumar A, 2011, ENVIRON TOXICOL PHAR, V32, P128, DOI 10.1016/j.etap.2011.04.002; Ladeira C, 2013, ENVIRON MOL MUTAGEN, V54, P213, DOI 10.1002/em.21755; Ladeira C, 2011, MUTAT RES-GEN TOX EN, V721, P15, DOI 10.1016/j.mrgentox.2010.11.015; Leon-Mejia G, 2014, ECOTOX ENVIRON SAFE, V107, P133, DOI 10.1016/j.ecoenv.2014.05.023; Lewinska D, 2007, INT ARCH OCC ENV HEA, V80, P371, DOI 10.1007/s00420-006-0130-7; Liu MT, 2004, ONCOGENE, V23, P2531, DOI 10.1038/sj.onc.1207375; Loomis D, 2017, LANCET ONCOL, V18, P1574, DOI 10.1016/S1470-2045(17)30832-X; Loomis D, 2013, LANCET ONCOL, V14, P1262, DOI 10.1016/S1470-2045(13)70487-X; Lu K, 2010, J AM CHEM SOC, V132, P3388, DOI 10.1021/ja908282f; Lucero L, 2000, MUTAT RES-GEN TOX EN, V464, P255, DOI 10.1016/S1383-5718(99)00200-4; Luzhna Lidiya, 2013, Frontiers in Genetics, V4, P131, DOI 10.3389/fgene.2013.00131; MACHADOSANTELLI GM, 1994, MUTAT RES-GENET TOX, V322, P203, DOI 10.1016/0165-1218(94)90007-8; Martinez-Valenzuela C, 2015, ENVIRON TOXICOL PHAR, V40, P397, DOI 10.1016/j.etap.2015.07.010; Martino-Roth M G, 2003, Genet Mol Res, V2, P410; Martino-Roth MG, 2002, GENET MOL BIOL, V25, P495, DOI 10.1590/S1415-47572002000400021; Martins RA, 2009, ENVIRON INT, V35, P1062, DOI 10.1016/j.envint.2009.06.001; McHale CM, 2012, CARCINOGENESIS, V33, P240, DOI 10.1093/carcin/bgr297; Metgud R, 2015, J CANCER RES THER, V11, P868, DOI 10.4103/0973-1482.146058; Minasi LB, 2011, GENET MOL RES, V10, P3924, DOI 10.4238/2011.December.12.5; O'Brien TJ, 2003, MUTAT RES-FUND MOL M, V533, P3, DOI 10.1016/j.mrfmmm.2003.09.006; OBE G, 1975, HUMANGENETIK, V30, P143, DOI 10.1007/BF00291947; PARTANEN T, 1985, SCAND J WORK ENV HEA, V11, P409, DOI 10.5271/sjweh.2206; PARTANEN T, 1990, SCAND J WORK ENV HEA, V16, P394, DOI 10.5271/sjweh.1766; Pastor S, 2001, MUTAGENESIS, V16, P539, DOI 10.1093/mutage/16.6.539; Pastor S, 2002, ENVIRON MOL MUTAGEN, V40, P101, DOI 10.1002/em.10100; Pastor S, 2001, MUTAT RES-GEN TOX EN, V495, P147, DOI 10.1016/S1383-5718(01)00206-6; da Silva VHP, 2012, TOXICOL MECH METHOD, V22, P497, DOI 10.3109/15376516.2012.680621; Pinto D, 2000, MUTAT RES-GEN TOX EN, V467, P105, DOI 10.1016/S1383-5718(00)00024-3; Qayyum S, 2012, TOXICOL IND HEALTH, V28, P74, DOI 10.1177/0748233711407237; Ramos MA, 2014, ACTA CYTOL, V58, P582, DOI 10.1159/000366224; RAPPAPORT SM, 1993, AM IND HYG ASSOC J, V54, P654, DOI 10.1202/0002-8894(1993)054<0654:VOEBWI>2.0.CO;2; Rekhadevi PV, 2007, MUTAGENESIS, V22, P395, DOI 10.1093/mutage/gem032; Rekhadevi PV, 2011, ENVIRON MOL MUTAGEN, V52, P310, DOI 10.1002/em.20622; Rekhadevi PV, 2009, MUTAGENESIS, V24, P59, DOI 10.1093/mutage/gen053; RIBEIRO LR, 1994, MUTAT RES-ENVIR MUTA, V313, P81, DOI 10.1016/0165-1161(94)90035-3; Rickes LN, 2010, GENET MOL RES, V9, P1921, DOI 10.4238/vol9-3gmr941; Rohr P, 2013, MUTAT RES-GEN TOX EN, V758, P23, DOI 10.1016/j.mrgentox.2013.08.006; Rohr P, 2013, ENVIRON MOL MUTAGEN, V54, P65, DOI 10.1002/em.21744; Rushton L, 2012, BRIT J CANCER, V107, pS3, DOI 10.1038/bjc.2012.112; Sailaja N, 2006, MUTAT RES-GEN TOX EN, V609, P74, DOI 10.1016/j.mrgentox.2006.06.022; Silveira HCS, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-87; SARTO F, 1990, MUTAT RES, V244, P345, DOI 10.1016/0165-7992(90)90083-V; Sellappa S, 2010, ASIAN PAC J CANCER P, V11, P919; Sellappa S, 2010, IND HEALTH, V48, P852, DOI 10.2486/indhealth.MS1055; Shailey RS, 2012, J CANCER RES THER, V8, P578, DOI 10.4103/0973-1482.106544; Siebel AM, 2010, TOXICOL IND HEALTH, V26, P619, DOI 10.1177/0748233710375948; Singaraju M, 2012, J CYTOL, V29, P1, DOI 10.4103/0970-9371.93208; Singaravelu SR, 2015, ENVIRON SCI POLLUT R, V22, P2721, DOI 10.1007/s11356-014-3543-y; Singh Zorawar, 2013, Toxicol Int, V20, P95, DOI 10.4103/0971-6580.111550; Souza KM, 2016, MUTAT RES-FUND MOL M, V791, P42, DOI 10.1016/j.mrfmmm.2016.09.002; StataCorp, 2013, STAT STAT SOFTW REL; Straif K, 2008, OCCUP ENVIRON MED, V65, P787, DOI 10.1136/oem.2007.038224; Sudha S, 2011, ASIAN PAC J CANCER P, V12, P1041; Takkouche B, 2009, INT J EPIDEMIOL, V38, P1512, DOI 10.1093/ije/dyp283; Torres-Bugarin O, 1998, MUTAT RES-GEN TOX EN, V413, P277, DOI 10.1016/S1383-5718(98)00021-7; Torres-Bugarin O, 2007, BRIT J SPORT MED, V41, DOI 10.1136/bjsm.2006.032474; Turci F, 2016, PART FIBRE TOXICOL, V13, DOI 10.1186/s12989-016-0136-6; Utani K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010089; Venkata RP, 2017, BIOMARKERS, V22, P446, DOI [10.1080/1354750X.2016.1252954, 10.1080/1354750x.2016.1252954]; Viegas S, 2010, J OCCUP MED TOXICOL, V5, DOI 10.1186/1745-6673-5-25; Vuyyuri SB, 2006, ENVIRON MOL MUTAGEN, V47, P562, DOI 10.1002/em.20229; Wang Q, 2013, INT J HYG ENVIR HEAL, V216, P76, DOI 10.1016/j.ijheh.2012.02.008; Waters Martha, 2015, J Occup Environ Hyg, V12 Suppl 1, pS99, DOI 10.1080/15459624.2015.1084421; Wultsch G, 2015, MUTAGENESIS, V30, P701, DOI 10.1093/mutage/gev034; Wultsch G, 2014, INT J HYG ENVIR HEAL, V217, P492, DOI 10.1016/j.ijheh.2013.09.005; Wultsch G, 2013, INT J HYG ENVIR HEAL, V216, P82, DOI 10.1016/j.ijheh.2012.03.007; Xue WL, 2005, TOXICOL APPL PHARM, V206, P73, DOI 10.1016/j.taap.2004.11.006	149	14	16	2	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1383-5742	1388-2139		MUTAT RES-REV MUTAT	Mutat. Res.-Rev. Mutat. Res.	JUL-SEP	2019	781						11	29		10.1016/j.mrrev.2019.02.006			19	Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology	IT5AT	WOS:000482872300002	31416572				2022-03-04	
J	Paoloni-Giacobino, A				Paoloni-Giacobino, A			Genetic testing and self-perception	GENETIC COUNSELING			English	Letter							CARRIER STATUS; CYSTIC-FIBROSIS		Univ Hosp Geneva, Dept Psychiat, CH-1225 Geneva, Switzerland		Paoloni-Giacobino, A (corresponding author), Univ Hosp Geneva, Dept Psychiat, Belle Idee 2,Ch du Petit Bel Air, CH-1225 Geneva, Switzerland.			Giacobino, Ariane/0000-0001-9432-1785			DELAPORTE C, 1996, GENET COUNSEL, V74, P289; Denayer L, 1996, CLIN GENET, V49, P232; EVERSKIEBOOMS G, 1994, CLIN GENET, V46, P336; FANOS JH, 1995, AM J HUM GENET, V57, P431; McConkie-Rosell A, 2000, AM J MED GENET, V92, P336, DOI 10.1002/1096-8628(20000619)92:5<336::AID-AJMG8>3.0.CO;2-L; Sobel SK, 2000, AM J MED GENET, V90, P49, DOI 10.1002/(SICI)1096-8628(20000103)90:1<49::AID-AJMG10>3.0.CO;2-3; TARGUM SD, 1981, AM J MED GENET, V8, P281, DOI 10.1002/ajmg.1320080305	7	0	0	0	0	MEDECINE ET HYGIENE	GENEVA 4	78 AVE ROSERALE, 1211 GENEVA 4, SWITZERLAND	1015-8146			GENET COUNSEL	Genet. Couns.		2001	12	3					303	304					2	Biotechnology & Applied Microbiology; Genetics & Heredity; Medical Ethics; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity; Medical Ethics; Research & Experimental Medicine	482TK	WOS:000171591200014	11693796				2022-03-04	
J	Caburet, S; Conti, C; Schurra, C; Lebofsky, R; Edelstein, SJ; Bensimon, A				Caburet, S; Conti, C; Schurra, C; Lebofsky, R; Edelstein, SJ; Bensimon, A			Human ribosomal RNA gene arrays display a broad range of palindromic structures	GENOME RESEARCH			English	Article							COMPLETE SEQUENCE; MOLECULAR-BASIS; DNA HELICASE; HUMAN RDNA; REPEAT; SGS1; HETEROGENEITY; ORGANIZATION; METHYLATION; PATTERNS	The standard model of eukaryotic ribosomal RNA (rRNA) genes involves tandem arrays with hundreds of units in clusters, the nucleolus organizer regions [NORs). A first genomic overview for human cells is reported here for these regions, which have never been sequenced in their totality, by Using molecular combing. The rRNA-coding regions are examined by fluorescence oil single molecules of DNA with two specific probes that cover their entire length. The standard organization assumed for rDNA units is a transcribed region followed by a nontranscribed spacer. While we confirmed this arrangement in many cases, unorthodox patterns were also observed in normal individuals, with one-third of the rDNA Units rearranged to form apparently palindromic structures (noncanonical Units) independent of the age of the donors. In cells from individuals with a deficiency in the WRN RecQ helicase (Werner syndrome), the proportion of palindromes increased to one-half. These findings, supported by Southern blot analyses, show that rRNA genes are a mosaic of canonical and (presumably nonfunctional) palindromic Units that may be altered by factors associated with genomic instability and pathology.	Inst Pasteur, Unite Stabil Genomes, F-75724 Paris, France; Univ Geneva, Dept Biochem, CH-1211 Geneva, Switzerland		Bensimon, A (corresponding author), Inst Pasteur, Unite Stabil Genomes, F-75724 Paris, France.	abensim@pasteur.fr	Caburet, Sandrine/AAH-3435-2019	Caburet, Sandrine/0000-0002-7404-8213			ARNHEIM N, 1977, CELL, V11, P363, DOI 10.1016/0092-8674(77)90053-8; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; BENSIMON A, 1994, SCIENCE, V265, P2096, DOI 10.1126/science.7522347; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; CABURET S, 2002, THESIS U PARIS 7 PAR; CONCONI A, 1989, CELL, V57, P753, DOI 10.1016/0092-8674(89)90790-3; DAMMANN R, 1995, MOL CELL BIOL, V15, P5294; ELDER JF, 1995, Q REV BIOL, V70, P297, DOI 10.1086/419073; ERICKSON JM, 1985, AM J HUM GENET, V37, P311; ERICKSON JM, 1981, GENE, V16, P1, DOI 10.1016/0378-1119(81)90055-X; Frederiksen S, 1997, CYTOGENET CELL GENET, V76, P101, DOI 10.1159/000134523; French SL, 2003, MOL CELL BIOL, V23, P1558, DOI 10.1128/MCB.23.5.1558-1568.2003; GANGLOFF S, 1994, MOL CELL BIOL, V14, P8391, DOI 10.1128/MCB.14.12.8391; GONZALEZ IL, 1995, GENOMICS, V27, P320, DOI 10.1006/geno.1995.1049; Gonzalez IL, 2001, GENOMICS, V73, P255, DOI 10.1006/geno.2001.6540; Gray MD, 1998, EXP CELL RES, V242, P487, DOI 10.1006/excr.1998.4124; Grozdanov P, 2003, GENOMICS, V82, P637, DOI 10.1016/S0888-7543(03)00199-X; Grummt I, 2003, NAT REV MOL CELL BIO, V4, P641, DOI 10.1038/nrm1171; Hattori M, 2000, NATURE, V405, P311, DOI 10.1038/35012518; HENDERSON AS, 1972, P NATL ACAD SCI USA, V69, P3394, DOI 10.1073/pnas.69.11.3394; Heo SJ, 1999, GENES CELLS, V4, P619, DOI 10.1046/j.1365-2443.1999.00288.x; Howlett NG, 2000, MUTAT RES-FUND MOL M, V454, P53, DOI 10.1016/S0027-5107(00)00097-X; Ji YG, 2000, GENOME RES, V10, P597, DOI 10.1101/gr.10.5.597; Johnson FB, 1999, CELL, V96, P291, DOI 10.1016/S0092-8674(00)80567-X; KRYSTAL M, 1978, J MOL BIOL, V126, P91, DOI 10.1016/0022-2836(78)90281-4; Kuo BA, 1996, NUCLEIC ACIDS RES, V24, P4817, DOI 10.1093/nar/24.23.4817; LABELLA T, 1989, GENOMICS, V5, P752, DOI 10.1016/0888-7543(89)90117-1; Machwe A, 2000, FASEB J, V14, P1715, DOI 10.1096/fj.99-0926com; Marciniak RA, 1998, P NATL ACAD SCI USA, V95, P6887, DOI 10.1073/pnas.95.12.6887; Michalet X, 1997, SCIENCE, V277, P1518, DOI 10.1126/science.277.5331.1518; Mighell AJ, 2000, FEBS LETT, V468, P109, DOI 10.1016/S0014-5793(00)01199-6; Moss T, 2002, CELL, V109, P545, DOI 10.1016/S0092-8674(02)00761-4; NAYLOR S L, 1983, Journal of Molecular and Applied Genetics, V2, P137; NELKIN B, 1980, GENE, V11, P89, DOI 10.1016/0378-1119(80)90089-X; Pasero P, 2002, GENE DEV, V16, P2479, DOI 10.1101/gad.232902; Pikaard CS, 2000, TRENDS GENET, V16, P495, DOI 10.1016/S0168-9525(00)02113-2; Romao-Correa RF, 2004, J DERMATOL SCI, V34, P109, DOI 10.1016/j.jdermsci.2003.11.009; Santoro R, 2002, NAT GENET, V32, P393, DOI 10.1038/ng1010; Schawalder J, 2003, BMC CELL BIOL, V4, DOI 10.1186/1471-2121-4-15; SCHMALENSEE R, 1980, ENERGY J, V1, P1; Schofer C, 1998, HISTOCHEM CELL BIOL, V110, P201, DOI 10.1007/s004180050282; Shen JC, 2001, MECH AGEING DEV, V122, P921, DOI 10.1016/S0047-6374(01)00248-2; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; SYLVESTER JE, 1986, HUM GENET, V73, P193, DOI 10.1007/BF00401226; Watt PM, 1996, GENETICS, V144, P935; WELLAUER PK, 1979, J MOL BIOL, V128, P289, DOI 10.1016/0022-2836(79)90089-5; WORTON RG, 1988, SCIENCE, V239, P64, DOI 10.1126/science.3336775; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258	48	98	102	0	6	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	AUG	2005	15	8					1079	1085		10.1101/gr.3970105			7	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	952UW	WOS:000231032000006	16024823	Bronze, Green Published			2022-03-04	
J	Cartier, V; Haenny, A; Inan, C; Walder, B; Zingg, W				Cartier, V.; Haenny, A.; Inan, C.; Walder, B.; Zingg, W.			No association between ultrasound-guided insertion of central venous catheters and bloodstream infection: a prospective observational study	JOURNAL OF HOSPITAL INFECTION			English	Article						Central line; Central venous catheter; Central-line-associated bloodstream infection; Insertion technique; Ultrasound	INTERNAL JUGULAR-VEIN; CRITICALLY-ILL PATIENTS; INTENSIVE-CARE-UNIT; NOSOCOMIAL INFECTION; CONTROLLED TRIAL; RISK-FACTORS; CANNULATION; PREVENTION; COMPLICATIONS; PLACEMENT	Background: Ultrasound guidance for the insertion of central venous catheters (CVCs) reduces mechanical complications and shortens insertion time, but its effect on CVC-associated bloodstream infection (CABSI) remains controversial. Aim: To test the effect of ultrasound-guided CVC insertion on CABSI in a hospital-wide setting. Methods: A four-year prospective cohort study was conducted at a university-affiliated, tertiary care centre. All patients receiving a non-tunnelled CVC, inserted by an anaesthetist, were enrolled. Catheter surveillance was performed by trained infection control nurses and checked by an infection control doctor. The primary outcome was CABSI as defined by the US Centers for Disease Control and Prevention. The secondary outcome was all-cause mortality up to 28 days after CVC removal. Findings: In total, 2312 patients with 2483 CVCs were included and analysed. Ultrasound guidance was used for 844 CVC insertions (34.0%), with a significant increasing trend over the study period [incidence rate ratio 1.13, 95% confidence interval (CI) 01.11-1.15; P < 0.001]. Forty-seven CABSIs were identified, representing an overall incidence of 2.1 episodes per 1000 catheter-days. No association was detected between ultrasound guidance and CABSI (hazard ratio 0.69, 95% CI 0.36-1.30; P=0.252). All-cause mortality was 11.0% (253/2312), with no significant trend and no association with ultrasound guidance. Conclusion: Ultrasound guidance had no effect on CABSI or mortality. In a hospital-wide setting with baseline CABSI rates at the standard level currently found in high-income countries, the use of ultrasound has no additional benefit for the prevention of CABSI. (C) 2014 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.	[Cartier, V.; Haenny, A.; Inan, C.; Walder, B.] Univ Hosp Geneva, Div Anaesthesiol, CH-1211 Geneva 14, Switzerland; [Zingg, W.] Univ Hosp Geneva, Infect Control Programme, CH-1211 Geneva 14, Switzerland		Zingg, W (corresponding author), Univ Hosp Geneva, Infect Control Programme, 4 Rue Gabrielle Perret Gentil, CH-1211 Geneva 14, Switzerland.	walter.zingg@hcuge.ch			University of Geneva Hospitals	The project was a quality improvement programme financed by the University of Geneva Hospitals.	Airapetian N, 2013, INTENS CARE MED, V39, P1938, DOI 10.1007/s00134-013-3072-z; Berenholtz SM, 2004, CRIT CARE MED, V32, P2014, DOI 10.1097/01.CCM.0000142399.70913.2F; Cavanna L, 2013, ANN ONCOL, V24, P2928, DOI 10.1093/annonc/mdt387; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chittick P, 2013, INFECT CONT HOSP EP, V34, P850, DOI 10.1086/671268; Chuan WX, 2005, PEDIATR ANESTH, V15, P733, DOI 10.1111/j.1460-9592.2004.01547.x; COBB DK, 1992, NEW ENGL J MED, V327, P1062, DOI 10.1056/NEJM199210083271505; COLLIGNON PJ, 1994, MED J AUSTRALIA, V161, P374, DOI 10.5694/j.1326-5377.1994.tb127491.x; Dudeck MA, 2011, AM J INFECT CONTROL, V39, P798, DOI 10.1016/j.ajic.2011.10.001; Eggimann P, 2000, LANCET, V355, P1864, DOI 10.1016/S0140-6736(00)02291-1; Fridkin SK, 1996, INFECT CONT HOSP EP, V17, P150; Gastmeier P, 2006, J HOSP INFECT, V64, P16, DOI 10.1016/j.jhin.2006.04.017; Goetz AM, 1998, INFECT CONT HOSP EP, V19, P842; GUALTIERI E, 1995, CRIT CARE MED, V23, P692, DOI 10.1097/00003246-199504000-00018; HEISELMAN D, 1994, JAMA-J AM MED ASSOC, V272, P1819, DOI 10.1001/jama.272.23.1819; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Hrics P, 1998, AM J EMERG MED, V16, P401, DOI 10.1016/S0735-6757(98)90140-1; Hugonnet S, 2007, CRIT CARE MED, V35, P76, DOI 10.1097/01.CCM.0000251125.08629.3F; Karakitsos D, 2006, CRIT CARE, V10, DOI 10.1186/cc5101; Koll BS, 2008, JT COMM J QUAL PATIE, V34, P713, DOI 10.1016/S1553-7250(08)34094-X; Koroglu M, 2006, ACTA RADIOL, V47, P43, DOI 10.1080/02841850500406845; Lamperti M, 2012, INTENS CARE MED, V38, P1105, DOI 10.1007/s00134-012-2597-x; Leung J, 2006, ANN EMERG MED, V48, P540, DOI 10.1016/j.annemergmed.2006.01.011; Leyvi G, 2005, PEDIATR ANESTH, V15, P953, DOI 10.1111/j.1460-9592.2005.01609.x; Maki DG, 2006, MAYO CLIN PROC, V81, P1159, DOI 10.4065/81.9.1159; MAKI DG, 1986, INFECT CONT HOSP EP, V7, P113, DOI 10.1017/S0195941700065619; Mehta N, 2013, EMERG MED J, V30, P355, DOI 10.1136/emermed-2012-201230; Merrer J, 2001, JAMA-J AM MED ASSOC, V286, P700, DOI 10.1001/jama.286.6.700; Nadig C, 1998, NEPHROL DIAL TRANSPL, V13, P978, DOI 10.1093/ndt/13.4.978; National Institute for Health and Clinical Excellence, 2002, GUID US ULTR LOC DEV; O'Grady NP, 2011, AM J INFECT CONTROL, V39, pS1, DOI 10.1016/j.ajic.2011.01.003; Opilla MT, 2007, JPEN-PARENTER ENTER, V31, P302, DOI 10.1177/0148607107031004302; PITTET D, 1994, JAMA-J AM MED ASSOC, V271, P1598, DOI 10.1001/jama.271.20.1598; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; RAAD II, 1994, INFECT CONT HOSP EP, V15, P231; RICHET H, 1990, J CLIN MICROBIOL, V28, P2520, DOI 10.1128/JCM.28.11.2520-2525.1990; Robert J, 2000, INFECT CONT HOSP EP, V21, P12, DOI 10.1086/501690; Rosenthal VD, 2012, AM J INFECT CONTROL, V40, P396, DOI 10.1016/j.ajic.2011.05.020; Rothschild JM, 2001, ULTRASOUND GUIDANCE; Ruesch S, 2002, CRIT CARE MED, V30, P454, DOI 10.1097/00003246-200202000-00031; Safdar N, 2005, CHEST, V128, P489, DOI 10.1378/chest.128.2.489; Siempos II, 2009, CRIT CARE MED, V37, P2283, DOI 10.1097/CCM.0b013e3181a02a67; Timsit JF, 1998, CHEST, V114, P207, DOI 10.1378/chest.114.1.207; Turker G, 2009, CLINICS, V64, P989, DOI 10.1590/S1807-59322009001000009; Verghese ST, 1999, ANESTHESIOLOGY, V91, P71, DOI 10.1097/00000542-199907000-00013; Yilmaz G, 2007, JPEN-PARENTER ENTER, V31, P284, DOI 10.1177/0148607107031004284; Zingg W, 2011, J HOSP INFECT, V77, P304, DOI 10.1016/j.jhin.2010.11.011; Zingg W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093898; Zingg W, 2011, CURR OPIN INFECT DIS, V24, P377, DOI 10.1097/QCO.0b013e32834811ed; Zingg W, 2008, BEST PRACT RES-CLIN, V22, P407, DOI 10.1016/j.bpa.2008.05.007; Zingg W, 2009, CRIT CARE MED, V37, P2167, DOI 10.1097/CCM.0b013e3181a02d8f; Zurcher M, 2004, ANESTH ANALG, V99, P177, DOI 10.1213/01.ANE.0000118101.94596.A0	53	10	10	0	6	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0195-6701	1532-2939		J HOSP INFECT	J. Hosp. Infect.	JUN	2014	87	2					103	108		10.1016/j.jhin.2014.03.009			6	Public, Environmental & Occupational Health; Infectious Diseases	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Infectious Diseases	AI2BN	WOS:000336661900006	24811115				2022-03-04	
J	Pessoa-Silva, CL; Dharan, S; Hugonnet, S; Touveneau, S; Posfay-Barbe, K; Pfister, R; Pittet, D				Pessoa-Silva, CL; Dharan, S; Hugonnet, S; Touveneau, S; Posfay-Barbe, K; Pfister, R; Pittet, D			Dynamics of bacterial hand contamination during routine neonatal care	INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY			English	Article							HOSPITAL-ACQUIRED INFECTIONS; NOSOCOMIAL INFECTIONS; GLOVES; STAY; UNIT; EPIDEMIOLOGY; PREVALENCE; MORTALITY; PROGRAM; HYGIENE	OBJECTIVE: To evaluate the dynamics of bacterial contamination of healthcare workers' (HCWs) hands during neonatal care. SETTING: The 20-bed neonatal unit of a large acute care teaching hospital in Geneva, Switzerland. METHODS: Structured observation sessions were conducted. A sequence of care began when the HCW performed hand hygiene and ended when the activity changed or hand hygiene was performed again. Alcohol-based handrub was the standard procedure for hand hygiene. An imprint of the five fingertips of the dominant hand was obtained before and after hand hygiene and at the end of a sequence of care. Regression methods were used to model the final bacterial count according to the type and duration of care and the use of gloves. RESULTS: One hundred forty-nine sequences of care were observed. Commensal skin flora comprised 72.4% of all culture-positive specimens (n = 360). Other microorganisms identified were Enterobacteriaceae (n 55, 13.8%); Staphylococcus aureus (n = 10, 2.5%); and fungi (n 7, 1.8%). Skin contact, respiratory care, and diaper change were independently associated with an increased bacterial count; the use of gloves did not fully protect HCWs' hands from bacterial contamination. CONCLUSIONS: These data confirm that hands become progressively contaminated with commensal flora and potential pathogens during neonatal care, and identify activities at higher risk for hand contamination. They also reinforce the need for hand hygiene after a sequence of care, before starting a different task, and after glove removal (Infect Control Hosp Epidemiol 2004;25:192-197).	Univ Geneva Hosp, Dept Internal Med, Infect Control Program, CH-1211 Geneva 14, Switzerland; Univ Geneva Hosp, Dept Pediat, CH-1211 Geneva 14, Switzerland		Pittet, D (corresponding author), Univ Geneva Hosp, Dept Internal Med, Infect Control Program, 24 Rue Micheli Crest, CH-1211 Geneva 14, Switzerland.		Posfay-Barbe, Klara M./AAV-2515-2021; Pfister, Riccardo/N-7082-2014; Posfay-Barbe, Klara M/E-9131-2013	Posfay-Barbe, Klara M./0000-0001-9464-5704; Pfister, Riccardo/0000-0002-7395-0512; Posfay-Barbe, Klara M/0000-0001-9464-5704			[Anonymous], 2001, ANN BOOK ASTM STAND; Boyce JM, 1997, INFECT CONT HOSP EP, V18, P622; Burgner D, 1996, J HOSP INFECT, V34, P163, DOI 10.1016/S0195-6701(96)90062-6; CONLY JM, 1989, AM J INFECT CONTROL, V17, P330, DOI 10.1016/0196-6553(89)90002-3; DASCHNER F, 1983, J HOSP INFECT, V4, P90, DOI 10.1016/0195-6701(83)90073-7; DOEBBELING BN, 1988, ANN INTERN MED, V109, P394, DOI 10.7326/0003-4819-109-5-394; DOEBBELING BN, 1992, NEW ENGL J MED, V327, P88, DOI 10.1056/NEJM199207093270205; Ehrenkranz RA, 1999, PEDIATRICS, V104, P280, DOI 10.1542/peds.104.2.280; FORDJONES EL, 1989, PEDIATR INFECT DIS J, V8, P668, DOI 10.1097/00006454-198910000-00002; FOX MK, 1974, AM J NURS, V74, P1676, DOI 10.2307/3423172; Gaynes RP, 1996, PEDIATRICS, V98, P357; GIRARD R, 1983, J HOSP INFECT, V4, P361, DOI 10.1016/0195-6701(83)90006-3; Harbarth S, 2002, PEDIATR INFECT DIS J, V21, P489, DOI 10.1097/00006454-200206000-00002; Hoogkamp-Korstanje J A, 1982, J Hosp Infect, V3, P275, DOI 10.1016/0195-6701(82)90046-9; LARSON E, 1985, J ADV NURS, V10, P547, DOI 10.1111/j.1365-2648.1985.tb00546.x; LARSON EL, 1995, AM J INFECT CONTROL, V23, P251, DOI 10.1016/0196-6553(95)90070-5; Leroyer A, 1997, J HOSP INFECT, V35, P37, DOI 10.1016/S0195-6701(97)90166-3; Mahieu LM, 2001, J HOSP INFECT, V47, P223, DOI 10.1053/jhin.2000.0852; MCFARLAND LV, 1989, NEW ENGL J MED, V320, P204, DOI 10.1056/NEJM198901263200402; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; OJAJARVI J, 1980, J HYG-CAMBRIDGE, V85, P193, DOI 10.1017/S0022172400063221; OLSEN RJ, 1993, JAMA-J AM MED ASSOC, V270, P350, DOI 10.1001/jama.270.3.350; PATTERSON JE, 1991, AM J MED, V91, P479, DOI 10.1016/0002-9343(91)90183-X; Pessoa-Silva CL, 2002, J PEDIATR-US, V141, P381, DOI 10.1067/mpd.2002.127279; Pessoa-Silva CL, 2001, EUR J EPIDEMIOL, V17, P715, DOI 10.1023/A:1015665810739; Pittet D, 2000, LANCET, V356, P1307, DOI 10.1016/S0140-6736(00)02814-2; Pittet D, 1999, ARCH INTERN MED, V159, P821, DOI 10.1001/archinte.159.8.821; Raymond J, 2000, INFECT CONT HOSP EP, V21, P260, DOI 10.1086/501755; Samore MH, 1996, AM J MED, V100, P32, DOI 10.1016/S0002-9343(96)90008-X; Sohn AH, 2001, J PEDIATR-US, V139, P821, DOI 10.1067/mpd.2001.119442; Tenorio AR, 2001, CLIN INFECT DIS, V32, P826, DOI 10.1086/319214; TOWNSEND TR, 1981, AM J EPIDEMIOL, V114, P73, DOI 10.1093/oxfordjournals.aje.a113176; WELLIVER RC, 1984, AM J DIS CHILD, V138, P131, DOI 10.1001/archpedi.1984.02140400017004; Wendt C, 2001, J HOSP INFECT, V48, pS23, DOI 10.1016/S0195-6701(01)90008-8	34	90	93	2	12	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0899-823X	1559-6834		INFECT CONT HOSP EP	Infect. Control Hosp. Epidemiol.	MAR	2004	25	3					192	197		10.1086/502376			6	Public, Environmental & Occupational Health; Infectious Diseases	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Infectious Diseases	803BD	WOS:000220205700004	15061408				2022-03-04	
J	Dharan, S; Hugonnet, S; Sax, H; Pittet, D				Dharan, S; Hugonnet, S; Sax, H; Pittet, D			Comparison of waterless hand antisepsis agents at short application times: Raising the flag of concern	INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY			English	Article							HYGIENE REGIMENS; PREVENTION; INFECTION; SOAP	OBJECTIVE: Although alcohol-based hand rinses and gels have recommended application times of 30 to 60 seconds, healthcare workers usually take much less time for hand hygiene. We compared the efficacies of four alcohol-based hand rubs produced in Europe (hand rinses A, B, and C and one gel formulation) with the efficacy of the European Norm 1500 (EN 1500) reference waterless hand antisepsis agent (60% 2-propanol) at short application times. DESIGN: Comparative crossover study. SETTING: Infection Control Program laboratory of a large tertiary-care teaching hospital. PARTICIPANTS: Twelve healthy volunteers. INTERVENTION: Measurement of residual bacterial counts and log reduction factors following inoculation of finger- tips with Staphylococcus aureus American Type Culture Collection (ATCC 6538, Pseudomonas aeruginosa ATCC 15442, and a clinical isolate of Enterococcus faecalis. I RESULTS: All hand rinses satisfied EN 1500 standards following a single application for 15 and 30 seconds, but reduction factors for the gel formulation were significantly lower for all tested organisms (all P < .025). CONCLUSIONS: Under stringent conditions similar to clinical practice, all three hand rinses proved to be more efficacious than the marketed alcohol-based gel in reducing bacterial counts on hands. Further studies are necessary to determine the in vivo efficacy of alcohol-based gels and whether they are as efficacious as alcohol-based rinses in reducing the transmission of nosocomial infections.	Univ Hosp Geneva, Dept Internal Med, Infect Control Program, CH-1211 Geneva 14, Switzerland		Pittet, D (corresponding author), Univ Hosp Geneva, Dept Internal Med, Infect Control Program, CH-1211 Geneva 14, Switzerland.		Sax, Hugo S/A-9377-2016	Sax, Hugo S/0000-0002-1532-2198			*ASTM, 2000, ASTM E 117400 STAND; AYLIFFE GAJ, 1978, J CLIN PATHOL, V31, P923, DOI 10.1136/jcp.31.10.923; Boyce JM, 2000, INFECT CONT HOSP EP, V21, P442, DOI 10.1086/501785; Boyce JM, 1999, ANN INTERN MED, V130, P153, DOI 10.7326/0003-4819-130-2-199901190-00011; Boyce JM, 2001, EMERG INFECT DIS, V7, P231, DOI 10.3201/eid0702.010216; *EUR COMM STAND, 1997, EN 1500 CHEM DIS ANT; Frantz SW, 1997, J HOSP INFECT, V37, P157, DOI 10.1016/S0195-6701(97)90185-7; Hugonnet S, 2002, ARCH INTERN MED, V162, P1037, DOI 10.1001/archinte.162.9.1037; Kramer A, 2002, LANCET, V359, P1489, DOI 10.1016/S0140-6736(02)08426-X; Larson E, 1999, CLIN INFECT DIS, V29, P1287, DOI 10.1086/313468; Larson EL, 2001, CRIT CARE MED, V29, P944, DOI 10.1097/00003246-200105000-00007; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Pittet D, 2000, INFECT CONT HOSP EP, V21, P381, DOI 10.1086/501777; Pittet D, 2000, LANCET, V356, P1307, DOI 10.1016/S0140-6736(00)02814-2; Pittet D, 1999, ANN INTERN MED, V130, P126, DOI 10.7326/0003-4819-130-2-199901190-00006; Pittet D, 2002, LANCET, V360, P1511, DOI 10.1016/S0140-6736(02)11447-4; Pittet D, 1999, ARCH INTERN MED, V159, P821, DOI 10.1001/archinte.159.8.821; Pittet D, 2001, EMERG INFECT DIS, V7, P234, DOI 10.3201/eid0702.010217; PITTET D, 1994, JAMA-J AM MED ASSOC, V271, P1598, DOI 10.1001/jama.271.20.1598; Rotter Manfred L., 1999, P1339; ROTTER ML, 1991, J HOSP INFECT, V18, P57, DOI 10.1016/0195-6701(91)90264-9; SEMMELWEIS IP, 1961, AETIOLOGIE BEGRIFF P, P1; SIMMONS B, 1990, INFECT CONT HOSP EP, V11, P589; Trick WE, 2001, CRIT CARE MED, V29, P1083, DOI 10.1097/00003246-200105000-00045; Voss A, 1997, INFECT CONT HOSP EP, V18, P205; Zaragoza M, 1999, AM J INFECT CONTROL, V27, P258, DOI 10.1053/ic.1999.v27.a97622	26	45	47	0	4	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0899-823X	1559-6834		INFECT CONT HOSP EP	Infect. Control Hosp. Epidemiol.	MAR	2003	24	3					160	164		10.1086/502182			5	Public, Environmental & Occupational Health; Infectious Diseases	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Infectious Diseases	656LA	WOS:000181608200002	12683505	Green Submitted			2022-03-04	
J	Zingg, W; Posfay-Barbe, KM; Pfister, RE; Touveneau, S; Pittet, D				Zingg, Walter; Posfay-Barbe, Klara M.; Pfister, Riccardo E.; Touveneau, Sylvie; Pittet, Didier			Individualized Catheter Surveillance among Neonates: A Prospective, 8-Year, Single-Center Experience	INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY			English	Article							BLOOD-STREAM INFECTION; INTENSIVE-CARE-UNIT; NOSOCOMIAL INFECTIONS; RISK-FACTORS; HAND HYGIENE; PREVALENCE; PNEUMONIA; HOSPITALS; IMPACT; RATES	OBJECTIVE. To monitor trends in central line-associated bloodstream infections and clinical sepsis (CLABICS) among neonates and to determine risk factors for infection, especially dwell time. DESIGN. Prospective, single-center cohort study conducted from 2001 through 2008. SETTING. University-affiliated tertiary care center. METHODS. Individualized surveillance of catheter use and CLABICS episodes was conducted. Data were obtained via regular on-site visits made 3 times a week. Trends over time were estimated by Poisson regression, and risk factor analysis was conducted using a Cox proportional hazards model and logistic regression. RESULTS. In all, 1,124 neonates were exposed to 2,210 central lines for a total of 12,746 catheter-days and 11,467 catheter-days at risk. The median duration of catheter use was 8 (interquartile range, 5-11) days for peripherally inserted central catheters (PICCs) and 4 (interquartile range, 2-6) days for umbilical catheters; 102 CLABICS episodes were detected. The median time to infection was 7 days. Incidence densities were 8.5 CLABICS episodes per 1,000 catheter-days at risk and 8.0 CLABICS episodes per 1,000 catheter-days. The highest rates were identified among neonates weighing 750 g or lower (14.9 CLABICS episodes per 1,000 catheter days at risk) and for PICCs (13.2 CLABICS episodes per 1,000 catheter days at risk). Catheter dwell time was associated with CLABICS for all umbilical catheters (odds ratio [OR], 1.2 per day of use [95% confidence interval {CI}, 1.1-1.3]; P < .001) and for PICCs for up to 7 days (OR, 1.2 [95% CI, 1.1-1.4]; P = .041), but not thereafter (OR, 1.0 [95% CI, 0.9-1.1]; P = .90). CONCLUSION. Catheter dwell time is a risk factor for CLABICS during the first 7 days, irrespective of catheter type. After 7 days, PICCs are less likely to become infected.	[Zingg, Walter; Touveneau, Sylvie; Pittet, Didier] Univ Geneva Hosp & Fac Med, Infect Control Program, CH-1211 Geneva, Switzerland; [Posfay-Barbe, Klara M.; Pfister, Riccardo E.] Univ Geneva Hosp & Fac Med, Dept Pediat, CH-1211 Geneva, Switzerland		Pittet, D (corresponding author), Univ Geneva Hosp & Fac Med, Infect Control Program, 4 Rue Gabrielle Perret Gentil, CH-1211 Geneva, Switzerland.	didier.pittet@hcuge.ch	Pfister, Riccardo/N-7082-2014; Posfay-Barbe, Klara M./AAV-2515-2021; Posfay-Barbe, Klara M/E-9131-2013	Pfister, Riccardo/0000-0002-7395-0512; Posfay-Barbe, Klara M./0000-0001-9464-5704; Posfay-Barbe, Klara M/0000-0001-9464-5704	teams of the neonatal unit; pediatric intensive care unit of the University of Geneva Hospitals; University of Geneva Hospitals	We thank the teams of the neonatal unit and the pediatric intensive care unit of the University of Geneva Hospitals for their support and Rosemary Sudan for editorial assistance.; This study was conducted as a qualitative research project and was funded by the University of Geneva Hospitals.	Ainsworth SB, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004219.pub3; APGAR V, 1953, Curr Res Anesth Analg, V32, P260; Mireya UA, 2007, J INFECTION, V54, P212, DOI 10.1016/j.jinf.2006.03.023; Balkhy HH, 2006, INT J INFECT DIS, V10, P326, DOI 10.1016/j.ijid.2005.06.013; Brady MT, 2005, AM J INFECT CONTROL, V33, P268, DOI 10.1016/j.ajic.2004.11.006; CHATHAS MK, 1990, AM J DIS CHILD, V144, P1246, DOI 10.1001/archpedi.1990.02150350078030; Clark Reese, 2004, J Perinatol, V24, P446, DOI 10.1038/sj.jp.7211125; COCKBURN F, 1993, LANCET, V342, P193; Connell TG, 2007, PEDIATRICS, V119, P891, DOI 10.1542/peds.2006-0440; Contreras-Cuellar Germán A., 2007, Rev. salud pública, V9, P439, DOI 10.1590/S0124-00642007000300012; Couto RC, 2007, AM J INFECT CONTROL, V35, P183, DOI 10.1016/j.ajic.2006.06.013; Edwards JR, 2008, AM J INFECT CONTROL, V36, P609, DOI 10.1016/j.ajic.2008.08.001; Eggimann P, 2003, INTENS CARE MED, V29, P2086, DOI 10.1007/s00134-003-1991-9; Eggimann P, 2000, LANCET, V355, P1864, DOI 10.1016/S0140-6736(00)02291-1; El-Nawawy AA, 2006, J TROP PEDIATRICS, V52, P185, DOI 10.1093/tropej/fmi091; Elward AM, 2006, INFECT CONT HOSP EP, V27, P553, DOI 10.1086/505096; FREEMAN J, 1990, NEW ENGL J MED, V323, P301, DOI 10.1056/NEJM199008023230504; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Geffers C, 2008, J HOSP INFECT, V68, P214, DOI 10.1016/j.jhin.2008.01.016; HARBARTH S, 2007, BENNETT BRACHMANS HO, P373; Hentschel J, 2005, INFECTION, V33, P350, DOI 10.1007/s15010-005-5052-x; Hoang V, 2008, PEDIATRICS, V121, pE1152, DOI 10.1542/peds.2007-1962; Holmes A, 2008, J HOSP INFECT, V68, P66, DOI 10.1016/j.jhin.2007.08.019; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Hugonnet S, 2004, EMERG INFECT DIS, V10, P76, DOI 10.3201/eid1001.030407; Jaballah NB, 2007, AM J INFECT CONTROL, V35, P613, DOI 10.1016/j.ajic.2006.09.007; Nagata E, 2002, AM J INFECT CONTROL, V30, P26, DOI 10.1067/mic.2002.119823; Perlman SE, 2007, AM J INFECT CONTROL, V35, P177, DOI 10.1016/j.ajic.2006.01.002; Pessoa-Silva CL, 2007, PEDIATRICS, V120, pE382, DOI 10.1542/peds.2006-3712; Pittet D, 1999, INFECT CONT HOSP EP, V20, P37, DOI 10.1086/501554; Pittet D, 1997, PREVENTION CONTROL N, P711; Posfay-Barbe KM, 2008, LANCET INFECT DIS, V8, P19, DOI 10.1016/S1473-3099(07)70310-9; Raka L, 2006, INFECT CONT HOSP EP, V27, P421, DOI 10.1086/503387; Sax H, 2001, J HOSP INFECT, V48, P27, DOI 10.1053/jhin.2001.0961; Schwab F, 2007, J HOSP INFECT, V65, P319, DOI 10.1016/j.jhin.2006.12.020; Smith PB, 2008, INFECT CONT HOSP EP, V29, P749, DOI 10.1086/589905; Stoll BJ, 2002, PEDIATRICS, V110, P285, DOI 10.1542/peds.110.2.285; Stover BH, 2001, AM J INFECT CONTROL, V29, P152, DOI 10.1067/mic.2001.115407; Zingg W, 2009, J HOSP INFECT, V73, P41, DOI 10.1016/j.jhin.2009.05.015; Zingg W, 2008, CURR OPIN INFECT DIS, V21, P228, DOI 10.1097/QCO.0b013e3282fcec5f; Zingg W, 2009, CRIT CARE MED, V37, P2167, DOI 10.1097/CCM.0b013e3181a02d8f	41	20	20	0	11	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0899-823X	1559-6834		INFECT CONT HOSP EP	Infect. Control Hosp. Epidemiol.	JAN	2011	32	1					42	49		10.1086/657634			8	Public, Environmental & Occupational Health; Infectious Diseases	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Infectious Diseases	694IP	WOS:000285290200006	21121817	Green Published			2022-03-04	
J	Harbarth, S; Pittet, D				Harbarth, S; Pittet, D			Control of nosocomial methicillin-resistant Staphylococcus aureus: Where shall we send our hospital director next time?	INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY			English	Editorial Material							SURVEILLANCE; INFECTIONS; ADMISSION; OUTBREAK; MRSA		Hop Univ Geneva, Dept Internal Med, Infect Control Program, CH-1211 Geneva 14, Switzerland		Harbarth, S (corresponding author), Hop Univ Geneva, Dept Internal Med, Infect Control Program, CH-1211 Geneva 14, Switzerland.						Afif W, 2002, AM J INFECT CONTROL, V30, P430, DOI 10.1067/mic.2002.125174; BARRETT FF, 1968, NEW ENGL J MED, V279, P441, DOI 10.1056/NEJM196808292790901; CAMUS A, 1972, PLAGUE; *CDCP, MRSA INF HLTH CAR PE; Chaix C, 1999, JAMA-J AM MED ASSOC, V282, P1745, DOI 10.1001/jama.282.18.1745; Diekema DJ, 2001, CLIN INFECT DIS, V32, pS114, DOI 10.1086/320184; Farrington M, 1998, QJM-MON J ASSOC PHYS, V91, P539, DOI 10.1093/qjmed/91.8.539; Garner Julia S., 1996, Infection Control and Hospital Epidemiology, V17, P53; Gastmeier P, 2003, WIEN KLIN WOCHENSCHR, V115, P99, DOI 10.1007/BF03040287; Harbarth S, 2001, Lancet Infect Dis, V1, P251, DOI 10.1016/S1473-3099(01)00120-7; Harbarth S, 2000, CLIN INFECT DIS, V30, P990, DOI 10.1086/313793; Harbarth S, 1998, QJM-MON J ASSOC PHYS, V91, P519, DOI 10.1093/qjmed/91.8.519; Hartstein AI, 1997, INFECT CONT HOSP EP, V18, P42; Jernigan JA, 1996, AM J EPIDEMIOL, V143, P496, DOI 10.1093/oxfordjournals.aje.a008770; Kotilainen P, 2003, EMERG INFECT DIS, V9, P169; Lucet JC, 2003, ARCH INTERN MED, V163, P181, DOI 10.1001/archinte.163.2.181; Marshall C, 2003, INFECT CONT HOSP EP, V24, P322, DOI 10.1086/502215; Mermel LA, 2001, CLIN INFECT DIS, V32, P1249, DOI 10.1086/320001; MULLIGAN ME, 1993, AM J MED, V94, P313, DOI 10.1016/0002-9343(93)90063-U; Muto CA, 2003, INFECT CONT HOSP EP, V24, P362, DOI 10.1086/502213; NNIS System, 2002, AM J INFECT CONTROL, V30, P458, DOI 10.1067/mic.2002.130032; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Papia G, 1999, INFECT CONT HOSP EP, V20, P473, DOI 10.1086/501655; *PHLS, 2002, COMMUN DIS REP CDR W, V12, P1; Rubinovitch B, 2001, J HOSP INFECT, V47, P9, DOI 10.1053/jhin.2000.0873; Saiman L, 2003, INFECT CONT HOSP EP, V24, P317, DOI 10.1086/502217; Sievert DM, 2002, JAMA-J AM MED ASSOC, V288, P824; Simor AE, 2001, CAN MED ASSOC J, V165, P21; Teare EL, 1997, BRIT MED J, V314, P665, DOI 10.1136/bmj.314.7081.665; Tenover FC, 2001, EMERG INFECT DIS, V7, P327, DOI 10.3201/eid0702.010237; Vriens M, 2002, EUR J CLIN MICROBIOL, V21, P782, DOI 10.1007/s10096-002-0811-4; Vriens MR, 2002, INFECT CONT HOSP EP, V23, P491, DOI 10.1086/502094	32	14	14	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0899-823X	1559-6834		INFECT CONT HOSP EP	Infect. Control Hosp. Epidemiol.	MAY	2003	24	5					314	316		10.1086/502211			3	Public, Environmental & Occupational Health; Infectious Diseases	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Infectious Diseases	678XV	WOS:000182892700006	12785402	Green Submitted, Bronze			2022-03-04	
J	Pittet, D				Pittet, D			Promotion of hand hygiene: Magic, hype, or scientific challenge?	INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY			English	Editorial Material							CARE UNIT; ALCOHOL; INFECTION		Univ Hosp Geneva, Dept Internal Med, Infect Control Program, CH-1211 Geneva 14, Switzerland		Pittet, D (corresponding author), Univ Hosp Geneva, Dept Internal Med, Infect Control Program, CH-1211 Geneva 14, Switzerland.						Bischoff WE, 2000, ARCH INTERN MED, V160, P1017, DOI 10.1001/archinte.160.7.1017; Bittner MJ, 2002, INFECT CONT HOSP EP, V23, P120, DOI 10.1086/502020; BOYCE J, 2001, FED REG; Boyce JM, 2000, INFECT CONT HOSP EP, V21, P438, DOI 10.1086/501784; HALEY RW, 1982, J INFECT DIS, V145, P875, DOI 10.1093/infdis/145.6.875; Harbarth S, 1999, INFECT CONT HOSP EP, V20, P598, DOI 10.1086/501677; HARBARTH S, IN PRESS PEDIAT INFE; HUGONNET S, IN PRESS ARCH INTERN; Kretzer EK, 1998, AM J INFECT CONTROL, V26, P245, DOI 10.1016/S0196-6553(98)80008-4; Larson E, 1999, CLIN INFECT DIS, V29, P1287, DOI 10.1086/313468; Larson EL, 1997, AM J INFECT CONTROL, V25, P3, DOI 10.1016/S0196-6553(97)90046-8; Larson EL, 2000, BEHAV MED, V26, P14, DOI 10.1080/08964280009595749; Maury E, 2000, AM J RESP CRIT CARE, V162, P324, DOI 10.1164/ajrccm.162.1.9908118; Muto CA, 2000, AM J INFECT CONTROL, V28, P273, DOI 10.1067/mic.2000.103242; Pittet D, 2000, INFECT CONT HOSP EP, V21, P381, DOI 10.1086/501777; Pittet D, 2000, LANCET, V356, P1307, DOI 10.1016/S0140-6736(00)02814-2; Pittet D, 1999, ANN INTERN MED, V130, P126, DOI 10.7326/0003-4819-130-2-199901190-00006; Pittet D, 2001, EMERG INFECT DIS, V7, P234, DOI 10.3201/eid0702.010217; Pittet D, 2001, LANCET, P9; Widmer AF, 2000, CLIN INFECT DIS, V31, P136, DOI 10.1086/313888	20	22	23	0	1	SLACK INC	THOROFARE	6900 GROVE RD, THOROFARE, NJ 08086 USA	0899-823X			INFECT CONT HOSP EP	Infect. Control Hosp. Epidemiol.	MAR	2002	23	3					118	119		10.1086/502019			2	Public, Environmental & Occupational Health; Infectious Diseases	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Infectious Diseases	545ZJ	WOS:000175247200003	11918114	Green Submitted, Bronze			2022-03-04	
J	Harbarth, S; Huttner, B; Gervaz, P; Fankhauser, C; Chraiti, MN; Schrenzel, J; Licker, M; Pittet, D				Harbarth, Stephan; Huttner, Benedikt; Gervaz, Pascal; Fankhauser, Carolina; Chraiti, Marie-Noelle; Schrenzel, Jacques; Licker, Marc; Pittet, Didier			Risk factors for methicillin-resistant Staphylococcus aureus surgical site infection	INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY			English	Article							HOSPITAL ADMISSION; MRSA	We prospectively evaluated 46 possible risk factors for methicillin-resistant Staphylococcus aureus (MRSA) surgical site infection (SSI) among patients with MRSA carriage in a large intervention study. Of 6,130 study patients, 68 (1.1%) developed MRSA SSI, which occurred a median of 14 days after surgery. Risk factors associated with MRSA SSI were receipt of emergency surgery, presence of comorbid condition, receipt of immunosuppressive therapy, receipt of contaminated surgery, and a surgical duration longer than the 75th percentile. MRSA carriage on admission did not predict MRSA SSI.	[Harbarth, Stephan; Huttner, Benedikt; Fankhauser, Carolina; Chraiti, Marie-Noelle; Pittet, Didier] Univ Hosp Geneva & Med Sch, Infect Control Program, CH-1211 Geneva 14, Switzerland; [Gervaz, Pascal] Univ Hosp Geneva & Med Sch, Dept Surg, CH-1211 Geneva 14, Switzerland; [Schrenzel, Jacques] Univ Hosp Geneva & Med Sch, Microbiol Lab, CH-1211 Geneva 14, Switzerland; [Licker, Marc] Univ Hosp Geneva & Med Sch, Dept Anesthesiol Pharmacol & Intens Care, CH-1211 Geneva 14, Switzerland		Harbarth, S (corresponding author), Univ Hosp Geneva & Med Sch, Infect Control Program, 24 Rue Micheli du Crest, CH-1211 Geneva 14, Switzerland.	stephan.harbarth@hcuge.ch	Huttner, Benedikt/M-5616-2014; Schrenzel, Jacques/P-8525-2017; Schrenzel, Jacques/AAC-5685-2021	Huttner, Benedikt/0000-0002-1749-9464; Schrenzel, Jacques/0000-0001-5464-7764; Schrenzel, Jacques/0000-0001-5464-7764; licker, marc/0000-0002-3691-4440	Geneva University Hospitals [CI 70,897, CI 13003]; Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission [4049-40-106294/1]; Infection Control Program; Departments of Surgery and Anesthesiology	We acknowledge the financial support of the Geneva University Hospitals (CI 70,897 and CI 13003) and the Swiss National Science Foundation (grant 4049-40-106294/1). We thank the personnel of the Infection Control Program and the Departments of Surgery and Anesthesiology for their full support and help.; Potential conflicts of interest. All authors report no conflicts of interest relevant to this study.	Anderson DJ, 2007, INFECT CONT HOSP EP, V28, P1047, DOI 10.1086/520731; Davis KA, 2004, CLIN INFECT DIS, V39, P776, DOI 10.1086/422997; Engemann JJ, 2003, CLIN INFECT DIS, V36, P592, DOI 10.1086/367653; Harbarth S, 2008, JAMA-J AM MED ASSOC, V299, P1149, DOI 10.1001/jama.299.10.1149; Mangram AJ, 1999, INFECT CONT HOSP EP, V20, P250, DOI 10.1086/501620; Manian FA, 2003, CLIN INFECT DIS, V36, P863, DOI 10.1086/368195; Marshall C, 2004, J HOSP INFECT, V57, P245, DOI 10.1016/j.jhin.2004.03.024; Morange-Saussier V, 2006, ANN VASC SURG, V20, P767, DOI 10.1007/s10016-006-9088-x; Juan RS, 2007, J THORAC CARDIOV SUR, V134, P670, DOI 10.1016/j.jtcvs.2007.04.010; Shams WE, 2004, ORTHOPEDICS, V27, P565	10	33	33	0	3	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0899-823X	1559-6834		INFECT CONT HOSP EP	Infect. Control Hosp. Epidemiol.	SEP	2008	29	9					890	893		10.1086/590193			4	Public, Environmental & Occupational Health; Infectious Diseases	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Infectious Diseases	348MG	WOS:000259214000016	18785849	Green Published			2022-03-04	
J	Walder, B; Pittet, D; Tramer, MR				Walder, B; Pittet, D; Tramer, MR			Prevention of bloodstream infections with central venous catheters treated with anti-infective agents depends on catheter. type and insertion time: Evidence from a meta-analysis	INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY			English	Article							BLOOD-STREAM INFECTION; SILVER-IMPREGNATED CUFF; PROSPECTIVE RANDOMIZED TRIAL; INTENSIVE-CARE UNIT; BACTERIAL-COLONIZATION; CHLORHEXIDINE; SEPSIS; ACCESS; SULFADIAZINE; EFFICACY	OBJECTIVE: To test the evidence that the risk of infection related to central venous catheters (CVCs) is decreased by anti-infective coating or cuffing. DESIGN: Systematic review of randomized, controlled trials comparing anti-infective with inactive (control) CVCs. INTERVENTIONS: Average insertion times were taken as a measurement of the length of insertion. Dichotomous data were combined using a fixed effect model and expressed as odds ratio (OR) with 95% confidence interval (CI95). RESULTS: Two trials on antibiotic coating (343 CVCs) had an average insertion time of 6 days; the risk of BSI decreased from 5.1% with control to 0% with anti-infective catheters. There were no trials with longer average insertion times. In three trials on silver collagen cuffs (422 CVCs), the average insertion time ranged from 5 to 8.2 days (median, 7 days); the risk of BSI was 5.6% with control and 3.2% with anti-infective catheters. In another trial on silver collagen cuffs (101 CVCs), the average insertion time was 38 days; the risk of BSI was 3.7% with control and 4.3% with anti-infective catheters. In five trials on chlorhexidine-silver sulfadiazine coating (1,269 CVCs), the average insertion time ranged from 5.2 to 7.5 days (median, 6 days); the risk of BSI decreased from 4.1% with control to 1.9% with anti-infective catheters. In five additional trials on chlorhexidine-silver sulfadiazine coating (1,544 CVCs), the average insertion time ranged from 7.8 to 20 days (median, 12 days); the risk of BSI was 4.5% with control and 4.2% with anti-infective catheters. CONCLUSIONS: Antibiotic and chlorhexidine-silver sulfadiazine coatings are anti-infective for short (approximately 1 week) insertion times. For longer insertion times, there are no data on antibiotic coating, and there is evidence of lack of effect for chlorhexidine-silver sulfadiazine coating. For silver-impregnated collagen cuffs, there is evidence of lack of effect for both short- and long-term insertion.	Univ Geneva Hosp, Div Surg Intens Care, CH-1211 Geneva 14, Switzerland; Univ Geneva Hosp, Div Anaesthesiol, Dept APSIC, CH-1211 Geneva, Switzerland; Univ Geneva Hosp, Dept Internal Med, Infect Control Program, CH-1211 Geneva 14, Switzerland		Walder, B (corresponding author), Univ Geneva Hosp, Div Surg Intens Care, 24 Rue Micheli Du Crest, CH-1211 Geneva 14, Switzerland.						ARNOW PM, 1993, CLIN INFECT DIS, V16, P778, DOI 10.1093/clind/16.6.778; BABYCOS CR, 1993, JPEN-PARENTER ENTER, V17, P61, DOI 10.1177/014860719301700161; Bach A, 1996, J ANTIMICROB CHEMOTH, V37, P315, DOI 10.1093/jac/37.2.315; Bach A, 1996, INTENS CARE MED, V22, P1066, DOI 10.1007/s001340050214; Bambauer R, 1996, BLOOD PURIFICAT, V14, P249, DOI 10.1159/000170268; Boswald M, 1999, INFECTION, V27, pS56, DOI 10.1007/BF02561621; Ciresi DL, 1996, AM SURGEON, V62, P641; COBB DK, 1992, NEW ENGL J MED, V327, P1062, DOI 10.1056/NEJM199210083271505; DAHLBERG PJ, 1995, INFECT CONT HOSP EP, V16, P506; Darouiche RO, 1999, NEW ENGL J MED, V340, P1, DOI 10.1056/NEJM199901073400101; Eggimann P, 2000, LANCET, V355, P1864, DOI 10.1016/S0140-6736(00)02291-1; FLOWERS RH, 1989, JAMA-J AM MED ASSOC, V261, P878, DOI 10.1001/jama.261.6.878; Gavaghan DJ, 2000, PAIN, V85, P415, DOI 10.1016/S0304-3959(99)00302-4; George SJ, 1997, EUR J ANAESTH, V14, P428, DOI 10.1046/j.1365-2346.1997.00168.x; Goldschmidt H, 1995, ZBL BAKT-INT J MED M, V283, P215; GROEGER JS, 1993, ANN SURG, V218, P206, DOI 10.1097/00000658-199308000-00014; Hannan M, 1999, ANAESTHESIA, V54, P868; Hasaniya NWMA, 1996, CHEST, V109, P1030, DOI 10.1378/chest.109.4.1030; Haxhe JJ, 1998, J HOSP INFECT, V40, P166, DOI 10.1016/S0195-6701(98)90101-3; Heard SO, 1998, ARCH INTERN MED, V158, P81, DOI 10.1001/archinte.158.1.81; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; JARVIS WR, 1991, AM J MED S3B, V91, P185; KAMAL GD, 1991, JAMA-J AM MED ASSOC, V265, P2364, DOI 10.1001/jama.265.18.2364; LAUPACIS A, 1988, NEW ENGL J MED, V318, P1728, DOI 10.1056/NEJM198806303182605; LEW DP, 1996, HOSP EPIDEMIOLOGY IN, P731; Logghe C, 1997, J HOSP INFECT, V37, P145, DOI 10.1016/S0195-6701(97)90184-5; Loo S, 1997, ANAESTH INTENS CARE, V25, P637, DOI 10.1177/0310057X9702500607; MAKI DG, 1988, AM J MED, V85, P307, DOI 10.1016/0002-9343(88)90579-7; Maki DG, 1997, ANN INTERN MED, V127, P257, DOI 10.7326/0003-4819-127-4-199708150-00001; MAKI DG, 1977, NEW ENGL J MED, V296, P1305, DOI 10.1056/NEJM197706092962301; Maki DG, 1998, HOSP INFECT, P689; Marik PE, 1999, CRIT CARE MED, V27, P1128, DOI 10.1097/00003246-199906000-00034; Moore RA, 1998, BRIT MED J, V316, P333, DOI 10.1136/bmj.316.7128.333; MORRIS JA, 1995, CALCULATING CONFIDEN, P50; Oda T, 1997, ANESTHESIOLOGY, V87, P1242, DOI 10.1097/00000542-199711000-00031; Pearson ML, 1996, AM J INFECT CONTROL, V24, P262; Pearson ML, 1997, ANN INTERN MED, V127, P304, DOI 10.7326/0003-4819-127-4-199708150-00009; Pemberton LB, 1996, ARCH SURG-CHICAGO, V131, P986; PITTET D, 1994, JAMA-J AM MED ASSOC, V271, P1598, DOI 10.1001/jama.271.20.1598; Pittet D, 1997, PREVENTION CONTROL N, P711; Raad I, 1997, ANN INTERN MED, V127, P267, DOI 10.7326/0003-4819-127-4-199708150-00002; Raad I, 1998, LANCET, V351, P893, DOI 10.1016/S0140-6736(97)10006-X; Raad II, 1998, CRIT CARE MED, V26, P219, DOI 10.1097/00003246-199802000-00015; RICHET H, 1990, J CLIN MICROBIOL, V28, P2520, DOI 10.1128/JCM.28.11.2520-2525.1990; Ruesch S, 2002, CRIT CARE MED, V30, P454, DOI 10.1097/00003246-200202000-00031; SIVAJI Y, 1986, J HOSP INFECT, V7, P236, DOI 10.1016/0195-6701(86)90073-3; SMITH HO, 1995, GYNECOL ONCOL, V58, P92, DOI 10.1006/gyno.1995.1189; Tennenberg S, 1997, ARCH SURG-CHICAGO, V132, P1348; Terazawa E, 1998, ANESTHESIOLOGY, V89, P1296, DOI 10.1097/00000542-199811000-00060; Thornton J, 1996, ANAESTHESIA, V51, P1018, DOI 10.1111/j.1365-2044.1996.tb14994.x; vanHeerden PV, 1996, ANAESTH INTENS CARE, V24, P330, DOI 10.1177/0310057X9602400305; Veenstra DL, 1999, JAMA-J AM MED ASSOC, V281, P261, DOI 10.1001/jama.281.3.261; Veenstra DL, 1999, JAMA-J AM MED ASSOC, V282, P554, DOI 10.1001/jama.282.6.554; Wenzel RP, 1999, NEW ENGL J MED, V340, P48, DOI 10.1056/NEJM199901073400109; YUSUF S, 1985, PROG CARDIOVASC DIS, V27, P335, DOI 10.1016/S0033-0620(85)80003-7	55	94	100	0	4	SLACK INC	THOROFARE	6900 GROVE RD, THOROFARE, NJ 08086 USA	0899-823X			INFECT CONT HOSP EP	Infect. Control Hosp. Epidemiol.	DEC	2002	23	12					748	756		10.1086/502005			9	Public, Environmental & Occupational Health; Infectious Diseases	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Infectious Diseases	628HA	WOS:000179986300009	12517018	Green Submitted			2022-03-04	
S	Drepper, VJ		Ronco, C; Crepaldi, C; Rosner, MH		Drepper, Valerie Jotterand			Practical Aspects on Use of Sharesource in Remote Patient Management	REMOTE PATIENT MANAGEMENT IN PERITONEAL DIALYSIS	Contributions to Nephrology		English	Article; Book Chapter							AMBULATORY PERITONEAL-DIALYSIS; RESIDUAL RENAL-FUNCTION; TRANSPORT; FAILURE; WATER	Remote patient management (RPM) has been increasingly implemented in the care of chronic patients in the last decades with significant positive impact on clinical outcomes. Homebased dialysis therapies constitute an attractive alternative to in-center hemodialysis as they offer patients more flexibility and empowerment. Nonetheless, their remote nature and intrinsic problematic visibility to therapy-related issues occurring at home contribute to holding back both patients and nephrologists from adopting them. RPM has recently become available in automated peritoneal dialysis (APD) by means of a new cloud-based platform with a 2-way communication system (Sharesource), offering accurate daily monitoring of the therapy as well as ability to remotely alter the prescription. Its main documented advantage is the early identification of clinically relevant issues such as catheter dysfunction and non-adherence to prescribed PD therapy; its contribution to recognition of an imminent peritonitis has still to be evaluated. RPM is also of particular interest for patients with social, geographical or physical limitations in terms of travel reduction. Moreover, permanent access to data for PD teams may provide reassurance and alleviate anxiety generated by the remote nature of the method for both patients and nephrologists. Finally, RPM offers further advantages such as a more personalized APD prescription, tailored to patients' needs, as well as improved clinical follow-up and a more proactive care. Long-term impacts of RPM in PD on patients' outcomes, healthcare costs, and its potential influence on a greater take-up of the technique, notably through reinforced confidence for both patients and nephrologists through better visibility of the progress of the therapy, have still to be evaluated. Given the positive impact of PD on the preservation of residual renal function and association of the latter with better survival, any tool that may contribute to its broader use is most valuable. (c) 2019 S. Karger AG, Basel	[Drepper, Valerie Jotterand] Geneva Univ Hosp, Div Nephrol, Geneva, Switzerland		Drepper, VJ (corresponding author), Geneva Univ Hosp, Div Nephrol, Geneva, Switzerland.						Albrektsen GE, 2004, AM J KIDNEY DIS, V43, P485, DOI 10.1053/j.ajkd.2003.10.043; Bargman JM, 2001, J AM SOC NEPHROL, V12, P2158, DOI 10.1681/ASN.V12102158; Bechade C, 2014, NEPHROL DIAL TRANSPL, V29, P2127, DOI 10.1093/ndt/gft055; Bernardini J, 2000, AM J KIDNEY DIS, V35, P1104, DOI 10.1016/S0272-6386(00)70047-3; Bernardini J, 1998, AM J KIDNEY DIS, V31, P101, DOI 10.1053/ajkd.1998.v31.pm9428459; Drepper VJ, 2018, PERITON DIALYSIS INT, V38, P76, DOI 10.3747/pdi.2017.00054; Griva K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089001; Jansen MAM, 2002, KIDNEY INT, V62, P1046, DOI 10.1046/j.1523-1755.2002.00505.x; Kolesnyk I, 2010, PERITON DIALYSIS INT, V30, P170, DOI 10.3747/pdi.2008.00277; Kramer A, 2018, CLIN KIDNEY J, V11, P108, DOI 10.1093/ckj/sfx149; KREDIET RT, 1987, EUR J CLIN INVEST, V17, P43, DOI 10.1111/j.1365-2362.1987.tb01224.x; Lee HY, 2003, NEPHROLOGY, V8, pS33, DOI 10.1046/j.1440-1797.8.s.11.x; Manani SM, 2018, BLOOD PURIFICAT, V46, P111, DOI 10.1159/000487703; Mawar S, 2012, INT UROL NEPHROL, V44, P1243, DOI 10.1007/s11255-011-0079-7; Perl J, 2016, PERITON DIALYSIS INT, V36, P297, DOI 10.3747/pdi.2014.00288; Rojas M, 2017, HELP REMOTE PATIENT; Steventon Adam, 2012, BMJ, V344, pe3874, DOI 10.1136/bmj.e3874; Yu ZL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149784	18	0	0	1	3	KARGER	BASEL	POSTFACH, CH-4009 BASEL, SWITZERLAND	0302-5144	1662-2782	978-3-318-06477-3; 978-3-318-06476-6	CONTRIB NEPHROL	Contrib.Nephrol.		2019	197						28	34		10.1159/000496315	10.1159/isbn.978-3-318-06477-3		7	Health Care Sciences & Services; Urology & Nephrology	Book Citation Index – Science (BKCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services; Urology & Nephrology	BO1IJ	WOS:000500332100005	34569510	Bronze			2022-03-04	
J	Wang, JC				Wang, Jiancong			The challenges of antimicrobial resistance surveillance in China	AMERICAN JOURNAL OF INFECTION CONTROL			English	Letter									[Wang, Jiancong] Univ Geneva, Fac Med, Inst Global Hlth, Geneva, Switzerland		Wang, JC (corresponding author), Univ Geneva, Fac Med, Inst Global Hlth, Geneva, Switzerland.	jiancong.wang@outlook.com					Allegranzi B, 2011, LANCET, V377, P228, DOI 10.1016/S0140-6736(10)61458-4; European Centre for Disease Prevention and Control, 2018, ANT RES AMR REP PROT; European Centre for Disease Prevention and Control, 2017, SURV ANT RES EUR; Gasser M, 2019, LANCET INFECT DIS, V19, P17, DOI 10.1016/S1473-3099(18)30708-4; Hu FP, 2018, CLIN INFECT DIS, V67, pS128, DOI 10.1093/cid/ciy657; [胡付品 Hu Fupin], 2018, [中国感染与化疗杂志, Chinese Journal of Infection and Chemotherapy], V18, P241; [胡付品 Hu Fupin], 2018, [中国感染与化疗杂志, Chinese Journal of Infection and Chemotherapy], V18, P331; National Health Commission of the People's Republic of China, 2019, CHIN ANT RES SURV SY; Wang JC, 2018, INFECT CONT HOSP EP, V39, P701, DOI 10.1017/ice.2018.60; Wang JC, 2019, ANTIMICROB RESIST IN, V8, DOI 10.1186/s13756-019-0481-y; WHO, 2017, GLOB ANT RES SURV SY; Zhang YW, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.01882-17	12	3	3	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0196-6553	1527-3296		AM J INFECT CONTROL	Am. J. Infect. Control	NOV	2019	47	11					1403	1404		10.1016/j.ajic.2019.05.017			2	Public, Environmental & Occupational Health; Infectious Diseases	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Infectious Diseases	JJ1AL	WOS:000493892600027	31345616	Bronze			2022-03-04	
J	Longtin, Y; Akakpo, C; Rutschmann, OT; Pittet, D; Sax, H				Longtin, Yves; Akakpo, Christophe; Rutschmann, Olivier T.; Pittet, Didier; Sax, Hugo			Evaluation of Patients' Mask Use after the Implementation of Cough Etiquette in the Emergency Department	INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY			English	Article; Proceedings Paper	48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy/46th Annual Meeting of the Infectious-Diseases-Society-of-America	OCT 25, 2008	Washington, DC	Infect Dis Soc Amer			HEALTH-CARE SETTINGS	We developed a patient-based survey to evaluate the impact of a respiratory hygiene and cough etiquette implementation strategy on infection control practices in the emergency department. The frequency of self-reported mask use by coughing patients was low (27%) and often inconsistent. The frequency of use was highest among patients who presented with myalgia (odds ratio, 14.7; P = .02) and among patients who visited the emergency department during January (odds ratio, 4.1; P = .04). Infect Control Hosp Epidemiol 2009; 30: 904-908	[Longtin, Yves; Akakpo, Christophe; Pittet, Didier; Sax, Hugo] Univ Geneva Hosp & Fac Med, Infect Control Program, CH-1211 Geneva 14, Switzerland; [Rutschmann, Olivier T.] Univ Geneva Hosp & Fac Med, Dept Emergency, CH-1211 Geneva 14, Switzerland		Pittet, D (corresponding author), Univ Geneva Hosp & Fac Med, Infect Control Program, 2 Rue Gabrielle Perret-Gentil, CH-1211 Geneva 14, Switzerland.	didier.pittet@hcuge.ch	Sax, Hugo S/A-9377-2016	Sax, Hugo S/0000-0002-1532-2198			Hogg William, 2006, Can Fam Physician, V52, P1110; Katz MH, 2006, MULTIVARIABLE ANALYSIS: A PRACTICAL GUIDE FOR CLINICIANS, 2ND EDITION, P1, DOI 10.1017/CBO9780511811692; Rothman RE, 2006, ANN EMERG MED, V48, P570, DOI 10.1016/j.annemergmed.2006.05.018; Siegel JD, 2007, AM J INFECT CONTROL, V35, pS65, DOI 10.1016/j.ajic.2007.10.007; Turnberg W, 2009, INFECT CONT HOSP EP, V30, P47, DOI 10.1086/592707; Turnberg W, 2008, AM J INFECT CONTROL, V36, P268, DOI 10.1016/j.ajic.2007.08.004	6	9	9	0	3	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0899-823X	1559-6834		INFECT CONT HOSP EP	Infect. Control Hosp. Epidemiol.	SEP	2009	30	9					904	908		10.1086/605471			5	Public, Environmental & Occupational Health; Infectious Diseases	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Public, Environmental & Occupational Health; Infectious Diseases	479TR	WOS:000268684300015	19622049				2022-03-04	
J	Galliot, B; Ghila, L				Galliot, Brigitte; Ghila, Luiza			Cell Plasticity in Homeostasis and Regeneration	MOLECULAR REPRODUCTION AND DEVELOPMENT			English	Review							PLURIPOTENT STEM-CELLS; URODELE LIMB REGENERATION; ELEMENT-BINDING PROTEIN; SELF-ORGANIZING SYSTEM; CENTRAL-NERVOUS-SYSTEM; PLANARIAN REGENERATION; APOPTOTIC CELLS; GENE-EXPRESSION; XENOPUS-LAEVIS; ADULT HYDRA	Over the past decades, genetic analyses performed in vertebrate and invertebrate organisms deciphered numerous cellular and molecular mechanisms deployed during sexual development and identified genetic circuitries largely shared among bilaterians. In contrast, the functional analysis of the mechanisms that support regenerative processes in species randomly scattered among the animal kingdom, were limited by the lack of genetic tools. Consequently, unifying principles explaining how stress and injury can lead to the reactivation of a complete developmental program with restoration of original shape and function remained beyond reach of understanding. Recent data on cell plasticity suggest that beside the classical developmental approach, the analysis of homeostasis and asexual reproduction in adult organisms provides novel entry points to dissect the regenerative potential of a given species, a given organ or a given tissue. As a clue, both tissue homeostasis and regeneration dynamics rely on the availability of stem cells and/or on the plasticity of differentiated cells to replenish the missing structure. The freshwater Hydra polyp provides us with a unique model system to study the intricate relationships between the mechanisms that regulate the maintenance of homeostasis, even in extreme conditions (starvation and overfeeding) and the reactivation of developmental programs after bisection or during budding. Interestingly head regeneration in Hydra can follow several routes according to the level of amputation, suggesting that indeed the homeostatic background dramatically influences the route taken to bridge injury and regeneration.	[Galliot, Brigitte; Ghila, Luiza] Univ Geneva, Dept Zool & Anim Biol, Fac Sci, Geneva, Switzerland		Galliot, B (corresponding author), 4 Bd Yvoy, CH-1211 Geneva 4, Switzerland.	brigitte.galliot@unige.ch	GHILA, Luiza/N-1372-2014; Galliot, Brigitte/I-7051-2013	GHILA, Luiza/0000-0001-7173-6312; Galliot, Brigitte/0000-0001-7596-8284	Swiss National FoundationSwiss National Science Foundation (SNSF); Geneva State; NCCRSwiss National Science Foundation (SNSF); Claraz Donation; Academic Society of Geneva	We are grateful to Philip Newmark for helpful discussions and to two anonymous reviewers for constructive comments. The work in our laboratory is funded by the Swiss National Foundation, the Geneva State, the NCCR "Frontiers in Genetics" Stem Cells & Regeneration pilot project, the Claraz Donation and the Academic Society of Geneva.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Agata K, 2007, DEV GROWTH DIFFER, V49, P73, DOI 10.1111/j.1440-169x.2007.00919.x; Alvarado AS, 2006, NAT REV GENET, V7, P873, DOI 10.1038/nrg1923; Alvarado AS, 2000, BIOESSAYS, V22, P578, DOI 10.1002/(SICI)1521-1878(200006)22:6<578::AID-BIES11>3.0.CO;2-#; Auger H, 2010, DEV BIOL, V339, P374, DOI 10.1016/j.ydbio.2009.12.040; BACH P, 1969, NATURE, V221, P963, DOI 10.1038/221963a0; Barco A, 2006, J NEUROCHEM, V97, P1520, DOI 10.1111/j.1471-4159.2006.03870.x; Beck CW, 2003, DEV CELL, V5, P429, DOI 10.1016/S1534-5807(03)00233-8; Behra M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000455; Bely AE, 2001, DEVELOPMENT, V128, P2781; Bely AE, 2010, TRENDS ECOL EVOL, V25, P161, DOI 10.1016/j.tree.2009.08.005; BENNETT EL, 1964, SCIENCE, V146, P610, DOI 10.1126/science.146.3644.610; Berlucchi Giovanni, 2002, J Hist Neurosci, V11, P305, DOI 10.1076/jhin.11.3.305.10396; Birnbaum KD, 2008, CELL, V132, P697, DOI 10.1016/j.cell.2008.01.040; Blanpain C, 2007, CELL, V128, P445, DOI 10.1016/j.cell.2007.01.014; BODE H, 1973, ROUX ARCH DEVEL BIOL, V171, P269; Bode HR, 1996, J CELL SCI, V109, P1155; BODE HR, 1977, J CELL SCI, V24, P31; BODE HR, 1992, TRENDS GENET, V8, P279, DOI 10.1016/0168-9525(92)90135-Q; Bottger A, 2007, SEMIN CANCER BIOL, V17, P134, DOI 10.1016/j.semcancer.2006.11.008; BOSCH TCG, 1984, DEV BIOL, V104, P161, DOI 10.1016/0012-1606(84)90045-9; Bosch TCG, 2007, DEV BIOL, V303, P421, DOI 10.1016/j.ydbio.2006.12.012; Bosch TCG, 2009, BIOESSAYS, V31, P478, DOI 10.1002/bies.200800183; Brockes JR, 2008, ANNU REV CELL DEV BI, V24, P525, DOI 10.1146/annurev.cellbio.24.110707.175336; Brockes JP, 2005, SCIENCE, V310, P1919, DOI 10.1126/science.1115200; Brockes JR, 2002, NAT REV MOL CELL BIO, V3, P566, DOI 10.1038/nrm881; BRUNER J, 1965, J Physiol (Paris), V57, P230; Bryant SV, 2002, INT J DEV BIOL, V46, P887; Buzgariu W, 2008, METHOD ENZYMOL, V451, P409, DOI 10.1016/S0076-6879(08)03226-6; CAMPBELL RD, 1976, J CELL SCI, V21, P1; Carnevali MDC, 2006, ISJ-INVERT SURVIV J, V3, P64; Chapman JA, 2010, NATURE, V464, P592, DOI 10.1038/nature08830; Chera S, 2006, J CELL SCI, V119, P846, DOI 10.1242/jcs.02807; Chera S, 2007, BIOSYSTEMS, V87, P191, DOI 10.1016/j.biosystems.2006.09.014; Chera S, 2009, BBA-MOL CELL RES, V1793, P1432, DOI 10.1016/j.bbamcr.2009.03.010; Chera S, 2009, DEV CELL, V17, P279, DOI 10.1016/j.devcel.2009.07.014; CHIU CP, 1984, CELL, V37, P879, DOI 10.1016/0092-8674(84)90423-9; Christensen RN, 2000, DEV DYNAM, V217, P216, DOI 10.1002/(SICI)1097-0177(200002)217:2<216::AID-DVDY8>3.0.CO;2-8; Dahlberg C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004458; DAVID CN, 1972, J CELL SCI, V11, P557; Driesch H, 1900, ARCH ENTWICKLUNG ORG, V10, P361, DOI 10.1007/BF02156642; DUBEL S, 1987, DIFFERENTIATION, V35, P181, DOI 10.1111/j.1432-0436.1987.tb00167.x; Duboule D, 2007, DEVELOPMENT, V134, P2549, DOI 10.1242/dev.001065; Dworkin S, 2007, DEV BIOL, V307, P127, DOI 10.1016/j.ydbio.2007.04.026; Dworkin S, 2009, STEM CELLS, V27, P1347, DOI 10.1002/stem.56; Eberhard D, 2008, CELL MOL LIFE SCI, V65, P33, DOI 10.1007/s00018-007-7428-9; Echeverri K, 2002, SEMIN CELL DEV BIOL, V13, P353, DOI 10.1016/S1084952102000915; Eggan E, 2004, NATURE, V428, P44, DOI 10.1038/nature02375; Eguchi G, 1993, CURR OPIN CELL BIOL, V5, P1023, DOI 10.1016/0955-0674(93)90087-7; Eisenhoffer GT, 2008, CELL STEM CELL, V3, P327, DOI 10.1016/j.stem.2008.07.002; Ettensohn CA, 2007, DEVELOPMENT, V134, P3077, DOI 10.1242/dev.009092; Fabila Y, 2002, MECH DEVELOP, V119, P157, DOI 10.1016/S0925-4773(02)00351-9; Fan Y, 2008, DEV CELL, V14, P399, DOI 10.1016/j.devcel.2008.01.003; Ferretti P, 2008, CELL MOL LIFE SCI, V65, P45, DOI 10.1007/s00018-007-7430-2; FRENCH V, 1976, SCIENCE, V193, P969, DOI 10.1126/science.948762; FUJISAWA T, 1992, DEV BIOL, V150, P185, DOI 10.1016/0012-1606(92)90017-B; Fujisawa T, 2003, DEV DYNAM, V226, P182, DOI 10.1002/dvdy.10221; Galliot B, 2008, CELL MOL LIFE SCI, V65, P3, DOI 10.1007/s00018-007-7424-0; Galliot B, 2006, SEMIN CELL DEV BIOL, V17, P492, DOI 10.1016/j.semcdb.2006.05.005; Galliot B, 2009, DEV BIOL, V332, P2, DOI 10.1016/j.ydbio.2009.05.563; Gallllot B, 2006, AUTOPHAGY, V2, P231, DOI 10.4161/auto.2706; Gauchat D, 1998, DEVELOPMENT, V125, P1637; GERAUDIE J, 1981, AM J ANAT, V162, P73, DOI 10.1002/aja.1001620107; Gonzalez-Estevez C, 2007, P NATL ACAD SCI USA, V104, P13373, DOI 10.1073/pnas.0703588104; Gould SJ, 2000, EVOL DEV, V2, P241, DOI 10.1046/j.1525-142x.2000.00067.x; GREMIGNI V, 1980, J EMBRYOL EXP MORPH, V55, P53; GREMIGNI V, 1980, J EMBRYOL EXP MORPH, V55, P65; Grogg MW, 2006, SEMIN CELL DEV BIOL, V17, P753, DOI 10.1016/j.semcdb.2006.10.001; Guder C, 2006, ONCOGENE, V25, P7450, DOI 10.1038/sj.onc.1210052; Guo TX, 2006, DEV CELL, V11, P159, DOI 10.1016/j.devcel.2006.06.004; GURDON JB, 1958, NATURE, V182, P64, DOI 10.1038/182064a0; Haase A, 2009, CELL STEM CELL, V5, P434, DOI 10.1016/j.stem.2009.08.021; Handberg-Thorsager M, 2008, FRONT BIOSCI-LANDMRK, V13, P6374, DOI 10.2741/3160; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; HAY ED, 1959, DEV BIOL, V1, P555, DOI 10.1016/0012-1606(59)90018-1; Hayashi T, 2006, DEV GROWTH DIFFER, V48, P371, DOI 10.1111/j.1440-169x.2006.00876.x; Hill R, 2009, J BIOL CHEM, V284, P11755, DOI 10.1074/jbc.R800071200; Hochedlinger K, 2009, DEVELOPMENT, V136, P509, DOI 10.1242/dev.020867; HOLSTEIN TW, 1991, DEV BIOL, V148, P602, DOI 10.1016/0012-1606(91)90277-A; HOLSTEIN TW, 1990, DEV BIOL, V142, P401, DOI 10.1016/0012-1606(90)90361-L; HOLSTEIN TW, 1990, DEV BIOL, V142, P392, DOI 10.1016/0012-1606(90)90360-U; Huh JR, 2004, CURR BIOL, V14, P1262, DOI 10.1016/j.cub.2004.06.015; Hwang JS, 2004, GENE, V333, P15, DOI 10.1016/j.gene.2004.02.034; ITEN LE, 1975, DEV BIOL, V44, P119, DOI 10.1016/0012-1606(75)90381-4; KANDEL ER, 1965, J PHYSIOL-LONDON, V181, P1; Kaslin J, 2008, PHILOS T R SOC B, V363, P101, DOI 10.1098/rstb.2006.2015; Kaslin J, 2009, J NEUROSCI, V29, P6142, DOI 10.1523/JNEUROSCI.0072-09.2009; KELEHER GP, 1990, P NATL ACAD SCI USA, V87, P8457, DOI 10.1073/pnas.87.21.8457; KOIZUMI O, 1988, DEV BIOL, V129, P358, DOI 10.1016/0012-1606(88)90383-1; KOIZUMI O, 1986, DEV BIOL, V116, P407, DOI 10.1016/0012-1606(86)90142-9; KOIZUMI O, 1991, J NEUROSCI, V11, P2011; Kragl M, 2009, NATURE, V460, P60, DOI 10.1038/nature08152; Kroiher M, 1999, INT J DEV BIOL, V43, P817; Kumar A, 2007, SCIENCE, V318, P772, DOI 10.1126/science.1147710; Lee TH, 2010, CIRC RES, V106, P120, DOI 10.1161/CIRCRESAHA.109.207902; Lengfeld T, 2009, DEV BIOL, V330, P186, DOI 10.1016/j.ydbio.2009.02.004; Levi BP, 2008, COLD SH Q B, V73, P539, DOI 10.1101/sqb.2008.73.049; Li F, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000634; LO DC, 1993, P NATL ACAD SCI USA, V90, P7230, DOI 10.1073/pnas.90.15.7230; Loh YH, 2008, CELL CYCLE, V7, P885, DOI 10.4161/cc.7.7.5636; Marcum B.A., 1980, P429; Martinez DE, 1998, EXP GERONTOL, V33, P217, DOI 10.1016/S0531-5565(97)00113-7; McClure KD, 2007, INT J BIOCHEM CELL B, V39, P1105, DOI 10.1016/j.biocel.2007.01.007; Melendez A, 2008, DEVELOPMENT, V135, P2347, DOI 10.1242/dev.016105; Metcalf M M, 1906, Science, V23, P786, DOI 10.1126/science.23.594.786; Miljkovic-Licina M, 2007, DEVELOPMENT, V134, P1191, DOI 10.1242/dev.02804; MINOBE S, 1995, DEV BIOL, V172, P170, DOI 10.1006/dbio.1995.0013; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Moreno E, 2004, CELL, V117, P117, DOI 10.1016/S0092-8674(04)00262-4; MORGAN TH, 1901, REGENERATION; Morrison JI, 2006, J CELL BIOL, V172, P433, DOI 10.1083/jcb.200509011; MULLER WA, 1995, DEV BIOL, V167, P175, DOI 10.1006/dbio.1995.1015; MUNEOKA K, 1986, DEV BIOL, V116, P256, DOI 10.1016/0012-1606(86)90062-X; Nakamura T, 2008, CELL MOL LIFE SCI, V65, P64, DOI 10.1007/s00018-007-7432-0; Nechiporuk A, 2003, DEV BIOL, V258, P291, DOI 10.1016/S0012-1606(03)00129-5; Neuschwander-Tetri BA, 2004, PANCREAS, V28, pE104, DOI 10.1097/00006676-200405000-00022; Newmark PA, 2008, COLD SH Q B, V73, P573, DOI 10.1101/sqb.2008.73.022; Newmark PA, 2000, DEV BIOL, V220, P142, DOI 10.1006/dbio.2000.9645; Nye HLD, 2003, DEV DYNAM, V226, P555, DOI 10.1002/dvdy.10237; Nye HLD, 2003, DEV DYNAM, V226, P280, DOI 10.1002/dvdy.10236; Odelberg Shannon J., 2005, Anatomical Record Part B:The New Anatomist, V287, P25, DOI 10.1002/ar.b.20080; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Ohmuraya M, 2005, GASTROENTEROLOGY, V129, P696, DOI 10.1053/j.gastro.2005.05.057; Okada T. S, 1991, TRANSDIFFERENTIATION; OTTO JJ, 1977, J CELL SCI, V28, P117; Oviedo NJ, 2008, DIS MODEL MECH, V1, P131, DOI 10.1242/dmm.000117; Pauly B, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-31; Pearl EJ, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-66; Pearson BJ, 2008, COLD SH Q B, V73, P565, DOI 10.1101/sqb.2008.73.045; PELLETTIERI J, 2009, DEV BIOL; Pellettieri J, 2007, ANNU REV GENET, V41, P83, DOI 10.1146/annurev.genet.41.110306.130244; Perez-Garijo A, 2004, DEVELOPMENT, V131, P5591, DOI 10.1242/dev.01432; Pomerantz J, 2004, NAT CELL BIOL, V6, P810, DOI 10.1038/ncb0904-810; Poss KD, 2007, SEMIN CELL DEV BIOL, V18, P36, DOI 10.1016/j.semcdb.2006.11.009; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; RABES HM, 1976, CELL TISSUE KINET, V9, P517; Raff M, 2003, ANNU REV CELL DEV BI, V19, P1, DOI 10.1146/annurev.cellbio.19.111301.143037; Rando TA, 2006, NATURE, V441, P1080, DOI 10.1038/nature04958; Redd MJ, 2004, PHILOS T R SOC B, V359, P777, DOI 10.1098/rstb.2004.1466; Reddien PW, 2005, SCIENCE, V310, P1327, DOI 10.1126/science.1116110; Reddien PW, 2005, DEV CELL, V8, P635, DOI 10.1016/j.devcel.2005.02.014; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P725, DOI 10.1146/annurev.cellbio.20.010403.095114; Reversade B, 2005, CELL, V123, P1147, DOI 10.1016/j.cell.2005.08.047; Rossi L, 2008, CELL MOL LIFE SCI, V65, P16, DOI 10.1007/s00018-007-7426-y; Rossi L, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r62; Ryoo HD, 2004, DEV CELL, V7, P491, DOI 10.1016/j.devcel.2004.08.019; SALO E, 1985, J EMBRYOL EXP MORPH, V89, P57; SALO E, 1984, J EMBRYOL EXP MORPH, V83, P63; Salo E, 2009, INT J DEV BIOL, V53, P1317, DOI 10.1387/ijdb.072414es; Salvetti A, 2009, DEV BIOL, V328, P305, DOI 10.1016/j.ydbio.2009.01.029; SCHALLER HC, 1989, DEVELOPMENT, V107, P99; SCHMID V, 1995, SEMIN CELL BIOL, V6, P109, DOI 10.1006/scel.1995.0016; SCHMID V, 1984, CELL, V38, P801, DOI 10.1016/0092-8674(84)90275-7; Shaw T, 2009, EMBO REP, V10, P881, DOI 10.1038/embor.2009.102; SHOSTAK S, 1974, Q REV BIOL, V49, P287, DOI 10.1086/408170; Siebert S, 2008, DEV BIOL, V313, P13, DOI 10.1016/j.ydbio.2007.09.007; Simon A, 2009, SEMIN CELL DEV BIOL, V20, P691, DOI 10.1016/j.semcdb.2009.04.015; Slack JMW, 2008, CELL MOL LIFE SCI, V65, P54, DOI 10.1007/s00018-007-7431-1; Slack JMW, 2007, NAT REV MOL CELL BIO, V8, P369, DOI 10.1038/nrm2146; Steele RE, 2002, DEV BIOL, V248, P199, DOI 10.1006/dbio.2002.0744; STOCUM DL, 1968, DEV BIOL, V18, P457, DOI 10.1016/0012-1606(68)90052-3; STOCUM DL, 1968, DEV BIOL, V18, P441, DOI 10.1016/0012-1606(68)90051-1; STOCUM DL, 1975, DEV BIOL, V45, P112, DOI 10.1016/0012-1606(75)90246-8; SUGIYAMA T, 1993, DEV BIOL, V160, P64, DOI 10.1006/dbio.1993.1286; Suh H, 2009, ANNU REV CELL DEV BI, V25, P253, DOI 10.1146/annurev.cellbio.042308.113256; SUMMERBELL D, 1981, J EMBRYOL EXP MORPH, V65, P129; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tanaka EM, 2009, NAT REV NEUROSCI, V10, P713, DOI 10.1038/nrn2707; TASSAVA RA, 1979, J EXP ZOOL, V208, P97, DOI 10.1002/jez.1402080111; Technau U, 1999, DEVELOPMENT, V126, P999; THORNTON CS, 1957, J EXP ZOOL, V134, P357, DOI 10.1002/jez.1401340209; Tseng AS, 2007, DEV BIOL, V301, P62, DOI 10.1016/j.ydbio.2006.10.048; Vaglia JL, 1999, INT J DEV BIOL, V43, P95; Wagers AJ, 2004, CELL, V116, P639, DOI 10.1016/S0092-8674(04)00208-9; Will B, 2008, BEHAV BRAIN RES, V192, P7, DOI 10.1016/j.bbr.2007.11.031; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Wittlieb J, 2006, P NATL ACAD SCI USA, V103, P6208, DOI 10.1073/pnas.0510163103; WOLFF ETIENNE, 1948, REV SUISSE ZOOL, V55, P218; YAROSS MS, 1986, DEV BIOL, V114, P225, DOI 10.1016/0012-1606(86)90398-2; Yin VP, 2008, CURR OPIN GENET DEV, V18, P381, DOI 10.1016/j.gde.2008.06.008; Yoshida K, 2006, GENE, V385, P64, DOI 10.1016/j.gene.2006.06.031; Yun KS, 2003, J COMP NEUROL, V461, P151, DOI 10.1002/cne.10685; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314; Zupanc GKH, 2008, J PHYSIOL-PARIS, V102, P357, DOI 10.1016/j.jphysparis.2008.10.007	185	52	56	0	22	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1040-452X	1098-2795		MOL REPROD DEV	Mol. Reprod. Dev.	OCT	2010	77	10					837	855		10.1002/mrd.21206			19	Biochemistry & Molecular Biology; Cell Biology; Developmental Biology; Reproductive Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Developmental Biology; Reproductive Biology	667OJ	WOS:000283203100005	20602493	Bronze, Green Accepted			2022-03-04	
J	Hugonnet, S; Eggimann, P; Borst, F; Maricot, P; Chevrolet, JC; Pittet, D				Hugonnet, S; Eggimann, P; Borst, F; Maricot, P; Chevrolet, JC; Pittet, D			Impact of ventilator-associated pneumonia on resource utilization and patient outcome	INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY			English	Article							INTENSIVE-CARE-UNIT; NOSOCOMIAL PNEUMONIA; RISK-FACTORS; MECHANICAL VENTILATION; COST-EFFECTIVENESS; INFECTION-CONTROL; EXTRA COSTS; MORTALITY; STAY; PROLONGATION	OBJECTIVE: To assess the effect of ventilator-associated pneumonia on resource utilization, morbidity, and mortality. DESIGN: Retrospective matched cohort study based on prospectively collected data. SETTING: Medical intensive care unit of a university teaching hospital. PATIENTS: Case-patients were all patients receiving mechanical ventilation for 48 hours or more who experienced an episode of ventilator-associated pneumonia. Control-patients were matched for number of discharge diagnoses, duration of mechanical support before the onset of pneumonia among case-patients, age, admission diagnosis, gender, and study period. RESULTS: One hundred six cases of ventilator-associated pneumonia were identified in 452 patients receiving mechanical ventilation. The matching procedure selected 97 pairs. Length of stay in the intensive care unit and duration of mechanical ventilation were greater among case-patients by a mean of 7.2 days (P < .001) and 5.1 days (P < .001), respectively. Median costs were $24,727 (interquartile range, $18,348 to $39,703) among case-patients and $17,438 (interquartile range, $12,261 to $24,226) among control-patients (P < .001). The attributable mortality rate was 7.3% (P = .26). The attributable extra hospital stay was 10 days with an extra cost of $15,986 per episode of pneumonia. CONCLUSION: Ventilator-associated pneumonia negatively affects patient outcome and represents a significant burden on intensive care unit and hospital resources.	Univ Hosp Geneva, Infect Control Program, Dept Internal Med, CH-1211 Geneva 14, Switzerland; Univ Hosp Geneva, Med Intens Care Unit, Dept Internal Med, CH-1211 Geneva 14, Switzerland; Univ Hosp Geneva, Dept Radiol, Medecon Unit, CH-1211 Geneva 14, Switzerland		Pittet, D (corresponding author), Univ Hosp Geneva, Infect Control Program, Dept Internal Med, CH-1211 Geneva 14, Switzerland.						Baker AM, 1996, AM J RESP CRIT CARE, V153, P343, DOI 10.1164/ajrccm.153.1.8542141; Bercault N, 2001, CRIT CARE MED, V29, P2303, DOI 10.1097/00003246-200112000-00012; Borst F, 1999, INT J MED INFORM, V54, P157, DOI 10.1016/S1386-5056(99)00004-0; BORST F, 2000, P 16 PCS E INT WORK, P35; Campbell GD, 1996, AM J RESP CRIT CARE, V153, P1711; Centers for Disease Control and Prevention, 1989, AM REV RESPIR DIS, V139, P1058; Cook D, 2000, INTENS CARE MED, V26, pS31, DOI 10.1007/s001340051116; Cook DJ, 1998, ANN INTERN MED, V129, P433, DOI 10.7326/0003-4819-129-6-199809150-00002; CRAIG CP, 1984, AM J INFECT CONTROL, V12, P233, DOI 10.1016/0196-6553(84)90114-7; CRAVEN DE, 1988, ARCH INTERN MED, V148, P1161, DOI 10.1001/archinte.148.5.1161; Cunnion KM, 1996, AM J RESP CRIT CARE, V153, P158, DOI 10.1164/ajrccm.153.1.8542110; DEVOS N, 2001, REANIMATION S1, V10, pS158; Eggimann P, 2001, CHEST, V120, P2059, DOI 10.1378/chest.120.6.2059; Eggimann P, 2000, LANCET, V355, P1864, DOI 10.1016/S0140-6736(00)02291-1; Esteban A, 2002, JAMA-J AM MED ASSOC, V287, P345, DOI 10.1001/jama.287.3.345; Fagon JY, 2000, ANN INTERN MED, V132, P621, DOI 10.7326/0003-4819-132-8-200004180-00004; Fagon JY, 1996, JAMA-J AM MED ASSOC, V275, P866, DOI 10.1001/jama.275.11.866; FAGON JY, 1993, AM J MED, V94, P281, DOI 10.1016/0002-9343(93)90060-3; FAGON JY, 1989, AM REV RESPIR DIS, V139, P877, DOI 10.1164/ajrccm/139.4.877; Finkelstein R, 2000, J HOSP INFECT, V44, P200, DOI 10.1053/jhin.1999.0682; FINKLER SA, 1982, ANN INTERN MED, V96, P102, DOI 10.7326/0003-4819-96-1-102; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Gerberding J, 2000, AM J INFECT CONTROL, V28, P429, DOI 10.1067/mic.2000.110544; Graves N, 2004, EMERG INFECT DIS, V10, P561, DOI 10.3201/eid1004.020754; HALEY RW, 1991, AM J MED, V91, pS32, DOI 10.1016/0002-9343(91)90341-T; HALEY RW, 1980, J INFECT DIS, V141, P248, DOI 10.1093/infdis/141.2.248; Heyland DK, 1999, AM J RESP CRIT CARE, V159, P1249, DOI 10.1164/ajrccm.159.4.9807050; Hugonnet S, 2002, CRIT CARE MED, V30, P2636, DOI 10.1097/00003246-200212000-00004; Ibrahim EH, 2001, CHEST, V120, P555, DOI 10.1378/chest.120.2.555; Ibrahim EH, 2000, CHEST, V117, P1434, DOI 10.1378/chest.117.5.1434; KAPPSTEIN I, 1992, EUR J CLIN MICROBIOL, V11, P504, DOI 10.1007/BF01960804; KOHN L, 1999, ERR HUMAN BUILDING S; KOLLEF MH, 1993, JAMA-J AM MED ASSOC, V270, P1965, DOI 10.1001/jama.270.16.1965; Kollef MH, 1999, NEW ENGL J MED, V340, P627, DOI 10.1056/NEJM199902253400807; MARTIN MA, 1989, ANN INTERN MED, V110, P9, DOI 10.7326/0003-4819-110-1-9; MEDURI GU, 1992, CHEST, V102, pS551, DOI 10.1016/S0012-3692(16)34868-1; Minei JP, 2000, SHOCK, V14, P331, DOI 10.1097/00024382-200014030-00016; NNIS System, 2001, AM J INFECT CONTROL, V29, P404, DOI 10.1067/mic.2001.119952; Papazian L, 1996, AM J RESP CRIT CARE, V154, P91, DOI 10.1164/ajrccm.154.1.8680705; Pittet D, 2000, LANCET, V356, P874, DOI 10.1016/S0140-6736(00)02675-1; Pittet D, 1999, INFECT CONT HOSP EP, V20, P37, DOI 10.1086/501554; PITTET D, 1994, JAMA-J AM MED ASSOC, V271, P1598, DOI 10.1001/jama.271.20.1598; Rello J, 1996, CLIN INFECT DIS, V23, P973, DOI 10.1093/clinids/23.5.973; Rello J, 2002, CHEST, V122, P2115, DOI 10.1378/chest.122.6.2115; RELLO J, 1991, CHEST, V100, P439, DOI 10.1378/chest.100.2.439; Richards MJ, 2000, INFECT CONT HOSP EP, V21, P510, DOI 10.1086/501795; Russell LB, 1996, JAMA-J AM MED ASSOC, V276, P1172, DOI 10.1001/jama.276.14.1172; Stone PW, 2002, AM J INFECT CONTROL, V30, P145, DOI 10.1067/mic.2002.121099; Timsit JF, 1996, AM J RESP CRIT CARE, V154, P116, DOI 10.1164/ajrccm.154.1.8680666; VINCENT JL, 1995, JAMA-J AM MED ASSOC, V274, P639, DOI 10.1001/jama.274.8.639; Wallace WC, 1999, AM SURGEON, V65, P987; Warren DK, 2003, CRIT CARE MED, V31, P1312, DOI 10.1097/01.CCM.0000063087.93157.06; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; 1992, MMWR, V41, P783	54	63	63	0	3	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0899-823X	1559-6834		INFECT CONT HOSP EP	Infect. Control Hosp. Epidemiol.	DEC	2004	25	12					1090	1096		10.1086/502349			7	Public, Environmental & Occupational Health; Infectious Diseases	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Infectious Diseases	879NS	WOS:000225725100015	15636298	Green Submitted			2022-03-04	
J	Sax, H; Hugonnet, S; Harbarth, S; Herrault, P; Pittet, D				Sax, H; Hugonnet, S; Harbarth, S; Herrault, P; Pittet, D			Variation in nosocomial infection prevalence according to patient care setting: a hospital-wide survey	JOURNAL OF HOSPITAL INFECTION			English	Article						nosocomial infections; prevalence; acquisition; detection; acute care; long-term care facilities	LONG-TERM-CARE; ACQUIRED INFECTIONS; NURSING-HOMES; SURVEILLANCE; PNEUMONIA	A study was performed to estimate the prevalence of nosocomial infections (NI) and assess differences between medical care settings in one hospital complex. A seven-day period-prevalence survey was conducted in May 1998 in a large primary and tertiary healthcare centre in Geneva, Switzerland, that included all patients in acute, sub-acute and chronic care settings. Variables included demography, exposure to invasive devices and antibiotics, surgical history and patients' localization. Overall prevalence of NI was 11.3% (acute, 8.4%; sub-acute, 11.4%; chronic care setting, 16.4%) in the 1928 patients studied, and ranged from 0% in ophthalmology to 23% in critical care units. Odds of infection in sub-acute and chronic care settings were significantly higher than in the acute care setting even after adjustment for case-mix [OR, 2.59; 95% confidence interval (CI95) 1.53-4.41; and OR, 2.34; CI95 1.38-3.95, respectively]. As a distinct group, patients in the geriatric location (belonging to the sub-acute care setting) showed a significant proportion of urinary (39%) and respiratory (21%) tract infections, contrasting with a relatively low exposure to urinary catheters (6.1%) and orotracheal intubation (0%). In conclusion, sub-acute and chronic care settings are associated with high infection prevalence even after case-mix adjustment. Prevalence studies are an easy surveillance (C) 2001 The Hospital Infection Society.	Univ Hosp Geneva, Dept Internal Med, Infect Control Program, CH-1211 Geneva 14, Switzerland		Pittet, D (corresponding author), Univ Hosp Geneva, Dept Internal Med, Infect Control Program, CH-1211 Geneva 14, Switzerland.		Sax, Hugo S/A-9377-2016	Sax, Hugo S/0000-0002-1532-2198			AAVITSLAND P, 1992, SCAND J INFECT DIS, V24, P477, DOI 10.3109/00365549209052634; BECKSAGUE C, 1994, INFECT CONT HOSP EP, V15, P494; DANCHAIVIJITR S, 1988, J MED ASS THAI S2, V72, P1; Danchaivijitr Somwang, 1995, Journal of the Medical Association of Thailand, V78, pS67; Emmerson AM, 1996, J HOSP INFECT, V32, P175, DOI 10.1016/S0195-6701(96)90144-9; Frankart L, 1998, SCHWEIZ MED WSCHR, V128, P1973; FREEMAN J, 1981, REV INFECT DIS, V3, P668; FRENCH GL, 1989, LANCET, V2, P1021; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Gastmeier P, 1998, J HOSP INFECT, V38, P37, DOI 10.1016/S0195-6701(98)90173-6; Gaynes RP, 1996, NNIS E NATL NOSOCOMI, P1017; Gross PA, 1996, INFECT CONT HOSP EP, V17, P675; HALEY RW, 1985, AM J EPIDEMIOL, V121, P182, DOI 10.1093/oxfordjournals.aje.a113990; Hernandez C A, 1996, Can J Nurs Adm, V9, P32; JEPSEN OB, 1993, J HOSP INFECT, V25, P271, DOI 10.1016/0195-6701(93)90113-E; MOJON P, 1997, GERODONTOLOGY, V4, P9; MORO ML, 1986, J HOSP INFECT, V8, P72, DOI 10.1016/0195-6701(86)90107-6; Muder RR, 1996, ARCH INTERN MED, V156, P2365, DOI 10.1001/archinte.156.20.2365; Pittet D, 1999, INFECT CONT HOSP EP, V20, P37, DOI 10.1086/501554; Scannapieco FA, 1996, J PERIODONTOL, V67, P1114, DOI 10.1902/jop.1996.67.10s.1114; Smith PW, 1999, INFECT CONT HOSP EP, V20, P303, DOI 10.1086/501621; Soufir L, 1999, INFECT CONT HOSP EP, V20, P396, DOI 10.1086/501639; SRAMOVA H, 1988, J HOSP INFECT, V11, P328, DOI 10.1016/0195-6701(88)90085-0; STEINMILLER AM, 1991, AM J INFECT CONTROL, V19, P143, DOI 10.1016/0196-6553(91)90020-D; Strausbaugh L., 1996, HOSP EPIDEMIOLOGY IN, P1151; Strausbaugh LJ, 1999, AM J INFECT CONTROL, V27, P1, DOI 10.1016/S0196-6553(99)70067-2; Vaque J, 1996, INFECT CONT HOSP EP, V17, P293; VAQUE J, 1992, J HOSP INFECT, V20, P1, DOI 10.1016/0195-6701(92)90056-R; VINCENT JL, 1995, JAMA-J AM MED ASSOC, V274, P639, DOI 10.1001/jama.274.8.639; Weinstein JW, 1999, INFECT CONT HOSP EP, V20, P543, DOI 10.1086/501675; Wiener J, 1999, JAMA-J AM MED ASSOC, V281, P517, DOI 10.1001/jama.281.6.517	31	42	43	0	1	W B SAUNDERS CO LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0195-6701			J HOSP INFECT	J. Hosp. Infect.	MAY	2001	48	1					27	32		10.1053/jhin.2001.0961			6	Public, Environmental & Occupational Health; Infectious Diseases	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Infectious Diseases	438FB	WOS:000169042000005	11358468				2022-03-04	
J	Graz, B; Willcox, M; Szeless, T; Rougemont, A				Graz, Bertrand; Willcox, Merlin; Szeless, Thomas; Rougemont, Andre			"Test and treat" or presumptive treatment for malaria in high transmission situations? A reflection on the latest WHO guidelines	MALARIA JOURNAL			English	Editorial Material							RAPID DIAGNOSTIC-TESTS; RANDOMIZED-TRIAL; CASE-MANAGEMENT; FEBRILE ILLNESS; BURKINA-FASO; CHILDREN; TANZANIA; ACCURACY; FEVER; AFRICA	Recent WHO guidelines recommend a universal "test and treat" strategy for malaria, mainly by use of rapid diagnostic test (RDT) in all areas. The evidence for this approach is questioned here as there is a risk of over-reliance on parasitological diagnosis in high transmission situations, which still exist. In such areas, when a patient has fever or other malaria symptoms, the presence of Plasmodium spp neither reliably confirms malaria as the cause of the fever, nor excludes the possibility of other diseases. This is because the patient may be an asymptomatic carrier of malaria parasites and suffer from another disease. To allow clinicians to perform their work adequately, local epidemiologic data are necessary. One size does not fit all. If parasite prevalence in the population is low, a diagnostic test is relevant; if the prevalence is high, the test does not provide information of any clinical usefulness, as happens with any test in medicine when the prevalence of the tested characteristic is high in the healthy population. It should also be remembered that, if in some cases anti-malarials are prescribed to parasite-negative patients, this will not increase selection pressure for drug resistance, because the parasite is not there. In high transmission situations at least, other diagnoses should be sought in all patients, irrespective of the presence of malaria parasites. For this, clinical skills (but not necessarily physicians) are irreplaceable, in order to differentiate malaria from other causes of acute fever, such as benign viral infection or potentially dangerous conditions, which can all be present with the parasite co-existing only as a "commensal" or silent undesirable guest.	[Graz, Bertrand; Szeless, Thomas; Rougemont, Andre] Univ Geneva, Inst Social & Prevent Med, CH-1211 Geneva 4, Switzerland; [Willcox, Merlin] Univ Oxford, Dept Primary Hlth Care, Oxford OX1 2JD, England		Graz, B (corresponding author), Univ Geneva, Inst Social & Prevent Med, CH-1211 Geneva 4, Switzerland.	Bertrand.Graz@unige.ch	Willcox, Merlin/I-6255-2019	Willcox, Merlin/0000-0002-5227-3444			Abeku TA, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-202; Ansah EK, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c930; Berkley JA, 1999, QJM-INT J MED, V92, P151, DOI 10.1093/qjmed/92.3.151; Bisoffi Z, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-192; Bisoffi Z, 2009, TROP MED INT HEALTH, V14, P491, DOI 10.1111/j.1365-3156.2009.02246.x; Bouvier P, 1997, AM J EPIDEMIOL, V145, P850, DOI 10.1093/oxfordjournals.aje.a009179; Chandler CIR, 2008, TROP MED INT HEALTH, V13, P1131, DOI 10.1111/j.1365-3156.2008.02118.x; Cheng A, 2006, J TROP PEDIATRICS, V52, P386, DOI 10.1093/tropej/fml037; D'Acremont V, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-240; d'Acremont V, 2010, CLIN INFECT DIS, V51, P506, DOI 10.1086/655688; D'Acremont V, 2009, PLOS MED, V6, P4, DOI 10.1371/journal.pmed.0050252; Delley V, 2000, TROP MED INT HEALTH, V5, P404, DOI 10.1046/j.1365-3156.2000.00566.x; English M, 2009, PLOS MED, V6, P7, DOI 10.1371/journal.pmed.1000015; Graz B, 2010, T ROY SOC TROP MED H, V104, P33, DOI 10.1016/j.trstmh.2009.07.005; Kyabayinze DJ, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-200; Kyabayinze DJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-221; Lubell Y, 2008, BMJ-BRIT MED J, V336, P202, DOI 10.1136/bmj.39395.696065.47; Masanja MI, 2010, AM J TROP MED HYG, V83, P1238, DOI 10.4269/ajtmh.2010.10-0194; McMorrow ML, 2008, AM J TROP MED HYG, V79, P385, DOI 10.4269/ajtmh.2008.79.385; Msellem MI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000070; Njama-Meya D, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-7; Organization WaH, 2010, MAL RAP DIAGN TEST P; Perneger TV, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-81; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Reyburn H, 2007, BRIT MED J, V334, P403, DOI 10.1136/bmj.39073.496829.AE; ROUGEMONT A, 1991, LANCET, V338, P1292, DOI 10.1016/0140-6736(91)92592-P; Shillcutt S, 2008, B WORLD HEALTH ORGAN, V86, P101, DOI 10.2471/BLT.07.042259; Singh N, 2005, AM J TROP MED HYG, V72, P26, DOI 10.4269/ajtmh.2005.72.26; Skarbinski J, 2009, AM J TROP MED HYG, V80, P919; Sserwanga A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016316; Swarthout TD, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-58; SZELESS T, 2009, INFECTION MALADIE PR; Van den Bruel A, 2010, LANCET, V375, P834, DOI 10.1016/S0140-6736(09)62000-6; WHO, 2006, GUID TREATM MAL; WHO, 2010, GUID TREATM MAL, P2; Willcox ML, 2009, ANN TROP MED PARASIT, V103, P3, DOI 10.1179/136485909X384983; World Health Organization, 2000, MAN CHILD SER INF SE; World Health Organization, 2009, PAR CONF MAL DIAGN W; Yukich J, 2010, AM J TROP MED HYG, V83, P61, DOI 10.4269/ajtmh.2010.09-0632; Zarocostas J, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c1402; Zurovac D, 2008, TROP MED INT HEALTH, V13, P784, DOI 10.1111/j.1365-3156.2008.02072.x; Zurovac D, 2008, AM J TROP MED HYG, V78, P884, DOI 10.4269/ajtmh.2008.78.884	42	51	52	0	7	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	MAY 20	2011	10								136	10.1186/1475-2875-10-136			8	Infectious Diseases; Parasitology; Tropical Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Infectious Diseases; Parasitology; Tropical Medicine	784ZI	WOS:000292196800001	21599880	gold, Green Published			2022-03-04	
J	von Dach, E; Landelle, C; Agostinho, A; Haustein, T; Francois, P; Renzi, G; Schrenzel, J; Harbarth, S				von Dach, Elodie; Landelle, Caroline; Agostinho, Americo; Haustein, Thomas; Francois, Patrice; Renzi, Gesuele; Schrenzel, Jacques; Harbarth, Stephan			Determinants of Successful Methicillin-Resistant Staphylococcus aureus Decolonization	INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY			English	Article							INTENSIVE-CARE-UNIT; RISK-FACTORS; CARRIAGE; COLONIZATION; ACQUISITION; CARRIERS		[von Dach, Elodie; Landelle, Caroline; Agostinho, Americo; Haustein, Thomas; Harbarth, Stephan] Geneva Univ Hosp & Fac Med, Infect Control Program, Rue Gabrielle Perret Gentil 4, CH-1211 Geneva 14, Switzerland; [Francois, Patrice; Harbarth, Stephan] Geneva Univ Hosp & Fac Med, Div Infect Dis, Geneva, Switzerland; [Francois, Patrice; Schrenzel, Jacques] Geneva Univ Hosp & Fac Med, Genom Res Lab, Geneva, Switzerland; [Renzi, Gesuele; Schrenzel, Jacques] Geneva Univ Hosp & Fac Med, Clin Microbiol Lab, Geneva, Switzerland		Harbarth, S (corresponding author), Geneva Univ Hosp & Fac Med, Infect Control Program, Rue Gabrielle Perret Gentil 4, CH-1211 Geneva 14, Switzerland.	stephan.harbarth@hcuge.ch	Schrenzel, Jacques/P-8525-2017; francois, patrice/AAL-5583-2020; Schrenzel, Jacques/AAC-5685-2021	Schrenzel, Jacques/0000-0001-5464-7764; Schrenzel, Jacques/0000-0001-5464-7764; francois, patrice/0000-0002-0540-750X	B. Braun Medical AG (Sempach, Switzerland)	This work was supported by B. Braun Medical AG (Sempach, Switzerland) as an investigator-initiated research project. The sponsor had no influence on data analysis and reporting.	Ammerlaan HSM, 2011, J ANTIMICROB CHEMOTH, V66, P2418, DOI 10.1093/jac/dkr250; Bocher S, 2010, CLIN MICROBIOL INFEC, V16, P1427, DOI [10.1111/j.1469-0691.2009.03137.x, 10.1111/j.1469-0691.2010.03137.x]; Buehlmann M, 2008, INFECT CONT HOSP EP, V29, P510, DOI 10.1086/588201; Harbarth S, 2000, CLIN INFECT DIS, V31, P1380, DOI 10.1086/317484; Harbarth S, 2007, J CLIN MICROBIOL, V45, P1072, DOI 10.1128/JCM.02121-06; Kohler P, 2013, INFECTION, V41, P33, DOI 10.1007/s15010-012-0290-1; Landelle C, 2016, J ANTIMICROB CHEMOTH, V71, P531, DOI 10.1093/jac/dkv331; Lee AS, 2011, CLIN INFECT DIS, V52, P1422, DOI 10.1093/cid/cir233; Marschall J, 2006, INFECT CONT HOSP EP, V27, P1206, DOI 10.1086/507917; Merrer J, 2000, INFECT CONT HOSP EP, V21, P718, DOI 10.1086/501721	10	0	0	0	2	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0899-823X	1559-6834		INFECT CONT HOSP EP	Infect. Control Hosp. Epidemiol.	JUN	2016	37	6					732	+		10.1017/ice.2016.34			3	Public, Environmental & Occupational Health; Infectious Diseases	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Infectious Diseases	DM7LO	WOS:000376541900023	26880575				2022-03-04	
J	Dharan, S; Pittet, D				Dharan, S; Pittet, D			Environmental controls in operating theatres	JOURNAL OF HOSPITAL INFECTION			English	Review						surgical wound infection; operating rooms; environmental monitoring; quality control; reference standards; air microbiology	WOUND CONTAMINATION; RELATIVE IMPORTANCE; AIR CONTAMINATION; GENERAL-SURGERY; ROOMS; COUNTS; INFECTION; AIRBORNE; SURFACE; ROUTES	Surgical-site infection is the leading complication of surgery. Normal skin flora of patients or healthcare workers causes more than half all infections following clean surgery, but the importance of airborne bacteria in this setting remains controversial. Modern operating theatres have conventional plenum ventilation with filtered air where particles greater than or equal to5 mum are removed. For orthopaedic and other implant surgery, laminar-flow systems are used with high-efficiency particulate air (HEPA) filters where particles greater than or equal to0.3 mum are removed. The use of ultra-clean air has been shown to reduce infection rates significantly in orthopaedic implant surgery. Few countries have set bacterial threshold limits for conventionally ventilated operating rooms, although most recommend 20 air changes per hour to obtain 50-150 colony forming units/m(3) of air. There are no standardized methods for bacterial air sampling or its frequency. With the use of HEPA filters in operating theatre ventilation, there is a tendency to apply cleanroom technology standards used in industry for hospitals. These are based on measuring the presence of particles of varying sizes and numbers, and are better suited than bacterial sampling. Environmental bacterial sampling in operating theatres should be limited to investigation of epidemics, validation of protocols, or changes made in materials which could influence the microbial content. (C) 2002 The Hospital Infection Society.	Univ Geneva Hosp, Dept Internal Med, Infect Control Programme, CH-1211 Geneva 14, Switzerland		Pittet, D (corresponding author), Univ Geneva Hosp, Dept Internal Med, Infect Control Programme, CH-1211 Geneva 14, Switzerland.	didier.pittet@hcuge.ch					AYLIFFE GAJ, 1991, REV INFECT DIS, V13, pS800; BERMAN BR, 1985, SCAND J INFECT DIS, V17, P421; Bitkover CY, 2000, ANN THORAC SURG, V69, P1110, DOI 10.1016/S0003-4975(99)01432-0; *BRIT STAND I, 1989, 52951 BRIT STAND I; CHARNLEY J, 1969, BRIT J SURG, V56, P641, DOI 10.1002/bjs.1800560902; Chosky SA, 1996, J BONE JOINT SURG BR, V78B, P835, DOI 10.1302/0301-620X.78B5.0780835; FITZGERALD RH, 1979, ARCH SURG-CHICAGO, V114, P772; Friberg B, 1999, J HOSP INFECT, V42, P287, DOI 10.1053/jhin.1998.0598; Friberg B, 1999, J HOSP INFECT, V42, P61, DOI 10.1053/jhin.1998.0542; Friberg B, 2001, J HOSP INFECT, V47, P110, DOI 10.1053/jhin.2000.0909; Friberg BEE, 1996, ACTA ORTHOP SCAND, V67, P578, DOI 10.3109/17453679608997760; Gaspar C, 1997, Enferm Infecc Microbiol Clin, V15, P250; Gosden PE, 1998, J HOSP INFECT, V39, P173, DOI 10.1016/S0195-6701(98)90255-9; Hubble MJ, 1996, J HOSP INFECT, V32, P1, DOI 10.1016/S0195-6701(96)90159-0; Humphreys H, 1999, J HOSP INFECT, V42, P265, DOI 10.1053/jhin.1998.0624; ISO, 1999, 146441 ISO; Johnston IDA., 1984, DESIGN UTILIZATION O; LAUFMAN H, 1979, ARCH SURG-CHICAGO, V114, P826; LEW DP, 1995, HOSPITAL EPIDEMIOLOG, P731; LIDWELL OM, 1982, BRIT MED J, V285, P10, DOI 10.1136/bmj.285.6334.10; MITCHELL NJ, 1978, BMJ-BRIT MED J, V1, P696, DOI 10.1136/bmj.1.6114.696; MITCHELL NJ, 1991, J HOSP INFECT, V18, P239, DOI 10.1016/0195-6701(91)90148-2; Pasquarella C, 2000, J HOSP INFECT, V46, P241, DOI 10.1053/jhin.2000.0820; PITTET D, 1994, INFECT CONT HOSP EP, V15, P456; RITTER MA, 1980, CLIN ORTHOP RELAT R, V153, P204; SCHWAN A, 1977, ACTA ORTHOP SCAND, V48, P86, DOI 10.3109/17453677708985116; SEAL DV, 1990, J APPL BACTERIOL, V68, P225, DOI 10.1111/j.1365-2672.1990.tb02568.x; *US DEP DEF, 1956, 282 US DEP DEF; *US GEN SERV ADM, 1992, 209E FED STAND; VASEY H, 1987, MED HYG, V45, P1646; *VDI, 1995, REINR GRUNDL DEF FES; Verkkala K, 1998, EUR J CARDIO-THORAC, V14, P206, DOI 10.1016/S1010-7940(98)00150-X; Whyte W, 1982, J Hosp Infect, V3, P123, DOI 10.1016/0195-6701(82)90004-4; Whyte W, 1996, PDA J Pharm Sci Technol, V50, P201; WHYTE W, 1992, J HOSP INFECT, V22, P41, DOI 10.1016/0195-6701(92)90129-A; WHYTE W, 1991, J HOSP INFECT, V18, P93, DOI 10.1016/0195-6701(91)90154-Z; WHYTE W, 1973, J HYG-CAMBRIDGE, V71, P559, DOI 10.1017/S0022172400046544; WHYTE W, 1983, J HOSP INFECT, V4, P133, DOI 10.1016/0195-6701(83)90042-7	38	152	156	0	33	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0195-6701	1532-2939		J HOSP INFECT	J. Hosp. Infect.	JUN	2002	51	2					79	84		10.1053/jhin.2002.1217			6	Public, Environmental & Occupational Health; Infectious Diseases	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Infectious Diseases	570YH	WOS:000176687700001	12090793				2022-03-04	
J	Uckay, I; Hugonnet, S; Kaiser, L; Sax, HG; Pittet, D				Uckay, Ilker; Hugonnet, Stephane; Kaiser, Laurent; Sax, Hugo; Pittet, Didier			Age limit does not replace serologic testing for determination of immune status for measles	INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY			English	Article							HEALTH-CARE WORKERS; RUBELLA; MUMPS; VARICELLA; PREVALENCE; ANTIBODIES; SUSCEPTIBILITY; SEROPREVALENCE; VACCINATION; POPULATION	Adults more than 40 years old are not necessarily immune to measles. A measles outbreak that involved healthcare workers occurred after contact with a 44-year-old patient. Results of a hospitalwide program of mass screening revealed that 117 (4.5%) of 2,600 individuals tested seronegative for measles; 31 (26.1%) of these 117 individuals were more than 40 years old.	Univ Hosp Geneva, Infect Control Program, CH-1211 Geneva, Switzerland; Univ Hosp Geneva, Infect Control Program, Virol Lab, Geneva, Switzerland		Pittet, D (corresponding author), Univ Hosp Geneva, Infect Control Program, 24 Rue Micheli-du-Crest, CH-1211 Geneva, Switzerland.	didier.pittet@hcuge.ch	Sax, Hugo S/A-9377-2016	Sax, Hugo S/0000-0002-1532-2198			*ACIP, 1997, MMWR-MORBID MORTAL W, V46, P1; Almuneef MA, 2006, INFECT CONT HOSP EP, V27, P1178, DOI 10.1086/508826; AMMARI LK, 1993, INFECT CONT HOSP EP, V14, P81, DOI 10.2307/30147165; ANDERSON RM, 1990, LANCET, V335, P641, DOI 10.1016/0140-6736(90)90420-A; Asari S, 2003, AM J INFECT CONTROL, V31, P157, DOI 10.1067/mic.2003.16; Celikbas A, 2006, AM J INFECT CONTROL, V34, P583, DOI 10.1016/j.ajic.2006.04.213; Dhiman N, 2005, CLIN EXP IMMUNOL, V142, P498, DOI 10.1111/j.1365-2249.2005.02931.x; Fedeli U, 2002, J HOSP INFECT, V51, P133, DOI 10.1053/jhin.2002.1222; FERSON MJ, 1994, MED J AUSTRALIA, V161, P615, DOI 10.5694/j.1326-5377.1994.tb127643.x; Hatakeyama S, 2004, INFECT CONT HOSP EP, V25, P591, DOI 10.1086/502444; KIM M, 1992, INFECT CONT HOSP EP, V13, P399, DOI 10.1086/646557; KRAUSE PJ, 1994, CLIN INFECT DIS, V18, P431, DOI 10.1093/clinids/18.3.431; Kremer JR, 2006, VACCINE, V24, P2594, DOI 10.1016/j.vaccine.2005.12.015; Ljungman P, 2004, BONE MARROW TRANSPL, V34, P589, DOI 10.1038/sj.bmt.1704634; Masserey E, 1998, Rev Med Suisse Romande, V118, P309; MUHLEMANN K, 2001, SWISS NOSO B, V8, P13; Seo SK, 2002, INFECT CONT HOSP EP, V23, P276, DOI 10.1086/502049; Steingart KR, 1999, INFECT CONT HOSP EP, V20, P115, DOI 10.1086/501595; *SWISS FED OFF PUB, 2006, EIDG KOM IMPFFR EKIF; WILLY ME, 1994, INFECT CONT HOSP EP, V15, P12; WRIGHT LJ, 1994, INFECT CONT HOSP EP, V15, P8; Ziegler E, 2003, OCCUP MED-OXFORD, V53, P398, DOI 10.1093/occmed/kqg077	22	8	8	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0899-823X			INFECT CONT HOSP EP	Infect. Control Hosp. Epidemiol.	SEP	2007	28	9					1117	1120		10.1086/519928			4	Public, Environmental & Occupational Health; Infectious Diseases	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Infectious Diseases	205NT	WOS:000249121600020	17932840	Green Published			2022-03-04	
J	Pittet, D; Sax, H; Hugonnet, S; Harbarth, S				Pittet, D; Sax, H; Hugonnet, S; Harbarth, S			Cost implications of successful hand hygiene promotion	INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY			English	Article							NOSOCOMIAL INFECTIONS; CARE; PREVALENCE	We evaluated the costs associated with a sustained and successful campaign for hand hygiene promotion that emphasized alcohol-based handrubs. The total cost of the hand hygiene promotion corresponded to less than 1% of the costs associated with nosocomial infections. Successful hand hygiene promotion is probably cost-saving (Infect Control Hosp Epidemiol 2004;25:264-266).	Univ Geneva Hosp, Dept Internal Med, Infect Control Program, CH-1211 Geneva 14, Switzerland		Pittet, D (corresponding author), Univ Geneva Hosp, Dept Internal Med, Infect Control Program, 24,Rue Micheli Crest, CH-1211 Geneva 14, Switzerland.		Sax, Hugo S/A-9377-2016	Sax, Hugo S/0000-0002-1532-2198; Pittet, Didier/0000-0002-3667-7131			Boyce JM, 2000, INFECT CONT HOSP EP, V21, P438, DOI 10.1086/501784; Eggimann P, 2000, LANCET, V355, P1864, DOI 10.1016/S0140-6736(00)02291-1; *HOP U GEN, 2004, NEW APPR PREV INF HO; HUGONNET S, 2001, AM SOC MICR INT C AN; Larson EL, 2001, CRIT CARE MED, V29, P944, DOI 10.1097/00003246-200105000-00007; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Pittet D, 2000, LANCET, V356, P1307, DOI 10.1016/S0140-6736(00)02814-2; Pittet D, 1999, INFECT CONT HOSP EP, V20, P37, DOI 10.1086/501554; Sax H, 2001, J HOSP INFECT, V48, P27, DOI 10.1053/jhin.2001.0961; Schulgen G, 2000, J CLIN EPIDEMIOL, V53, P409, DOI 10.1016/S0895-4356(99)00182-1; *SWISS FED STAT OF, 2001, NAT CONS PRIC IND SW; WENZEL RP, 1995, J HOSP INFECT, V31, P79, DOI 10.1016/0195-6701(95)90162-0	12	93	94	0	2	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0899-823X	1559-6834		INFECT CONT HOSP EP	Infect. Control Hosp. Epidemiol.	MAR	2004	25	3					264	266		10.1086/502389			3	Public, Environmental & Occupational Health; Infectious Diseases	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Infectious Diseases	803BD	WOS:000220205700017	15061421				2022-03-04	
J	Pittet, D				Pittet, D			Compliance with hand disinfection and its impact on hospital-acquired infections	JOURNAL OF HOSPITAL INFECTION			English	Article; Proceedings Paper	6th International BODE Hygiene Days	SEP 07-10, 2001	VIENNA, AUSTRIA	BODE		hand hygiene; handwashing; hand-rub; alcohol-based hand disinfection; epidemiology; hospital-acquired infections; MRSA; healthcare workers	INTENSIVE-CARE-UNIT; RESISTANT STAPHYLOCOCCUS-AUREUS; HANDWASHING PRACTICES; BLAND SOAP; HYGIENE; ALCOHOL; SKIN; ANTISEPSIS; FREQUENCY; STAFF	Hand hygiene prevents cross-infection in hospitals, but adherence to guidelines is poor among healthcare workers. Although some interventions to improve compliance have been successful, none had achieved lasting improvement until very recently. Reasons for non-compliance with recommendations occur at individual, group and institutional levels. The complexity of the process of behavioural change would suggest that the application of multimodal, multidisciplinary strategies are necessary. Both easy access to hand hygiene in a timely fashion and skin protection appear necessary prerequisites for satisfactory hand hygiene behaviour. Alcohol-based hand-rub may be superior to traditional handwashing as it requires less time, acts faster, irritates hands less often, and recently proved significantly to contribute to sustained improvement in compliance associated with decreased infection rates. This paper reviews barriers to appropriate hand hygiene and describes the results of the first successful experience of sustained hand hygiene promotion and its effectiveness on hospital-acquired infection. (C) 2001 The Hospital Infection Society.	Univ Hosp Geneva, Infect Control Programme, CH-1211 Geneva 14, Switzerland		Pittet, D (corresponding author), Univ Hosp Geneva, Infect Control Programme, 24 Rue Micheli du Creat, CH-1211 Geneva 14, Switzerland.	didier.pittet@hcuge.ch					ALBERT RK, 1981, NEW ENGL J MED, V304, P1465, DOI 10.1056/NEJM198106113042404; Bischoff WE, 2000, ARCH INTERN MED, V160, P1017, DOI 10.1001/archinte.160.7.1017; Boyce JM, 2000, INFECT CONT HOSP EP, V21, P442, DOI 10.1086/501785; Boyce JM, 1999, ANN INTERN MED, V130, P153, DOI 10.7326/0003-4819-130-2-199901190-00011; Boyce JM, 2000, INFECT CONT HOSP EP, V21, P438, DOI 10.1086/501784; BROUGHALL JM, 1984, J HOSP INFECT, V5, P447, DOI 10.1016/0195-6701(84)90016-1; BUTZ AM, 1990, AM J INFECT CONTROL, V18, P347, DOI 10.1016/0196-6553(90)90248-Q; CASEWELL M, 1977, BRIT MED J, V2, P1315, DOI 10.1136/bmj.2.6098.1315; CONLY JM, 1989, AM J INFECT CONTROL, V17, P330, DOI 10.1016/0196-6553(89)90002-3; Cookson B, 1999, BRIT MED J, V318, P686; DOEBBELING BN, 1988, ANN INTERN MED, V109, P394, DOI 10.7326/0003-4819-109-5-394; DOEBBELING BN, 1992, NEW ENGL J MED, V327, P88, DOI 10.1056/NEJM199207093270205; DONOWITZ LG, 1987, AM J DIS CHILD, V141, P683, DOI 10.1001/archpedi.1987.04460060099044; DUBBERT PM, 1990, INFECT CONT HOSP EP, V11, P191; Early E, 1998, AM J INFECT CONTROL, V26, P263, DOI 10.1016/S0196-6553(98)80011-4; ECKERT DG, 1989, INFECT CONT HOSP EP, V10, P306, DOI 10.1086/646033; EHRENKRANZ NJ, 1991, INFECT CONT HOSP EP, V12, P654, DOI 10.2307/30146898; GOLDMANN D, 1992, NEW ENGL J MED, V327, P120, DOI 10.1056/NEJM199207093270211; GRAHAM M, 1990, AM J INFECT CONTROL, V18, P77, DOI 10.1016/0196-6553(90)90085-7; JARVIS WR, 1994, LANCET, V344, P1311, DOI 10.1016/S0140-6736(94)90687-4; KHAN MU, 1982, T ROY SOC TROP MED H, V76, P164, DOI 10.1016/0035-9203(82)90266-8; Khatib M, 1999, CHEST, V116, P172, DOI 10.1378/chest.116.1.172; Kimel L S, 1996, J Sch Nurs, V12, P14, DOI 10.1177/105984059601200204; Kretzer EK, 1998, AM J INFECT CONTROL, V26, P245, DOI 10.1016/S0196-6553(98)80008-4; LARSON E, 1991, INFECT CONT HOSP EP, V12, P422; LARSON E, 1986, AM J INFECT CONTROL, V14, P51, DOI 10.1016/0196-6553(86)90055-6; Larson E, 1999, CLIN INFECT DIS, V29, P1287, DOI 10.1086/313468; LARSON E, 1995, J HOSP INFECT, V30, P88, DOI 10.1016/0195-6701(95)90010-1; LARSON E, 1982, AM J INFECT CONTROL, V10, P93, DOI 10.1016/0196-6553(82)90019-0; Larson EL, 1997, AM J INFECT CONTROL, V25, P3, DOI 10.1016/S0196-6553(97)90046-8; LARSON EL, 1995, AM J INFECT CONTROL, V23, P251, DOI 10.1016/0196-6553(95)90070-5; MAKI DG, 1989, J CHEMOTHERAPY, V1, P3; MASSANARI RM, 1984, AM J INFECT CONTROL, V12, P247; Master D, 1997, Fam Med, V29, P336; Maury E, 2000, AM J RESP CRIT CARE, V162, P324, DOI 10.1164/ajrccm.162.1.9908118; MCLANE C, 1983, AM J INFECT CONTROL, V11, P178, DOI 10.1016/0196-6553(83)90078-0; Muto CA, 2000, AM J INFECT CONTROL, V28, P273, DOI 10.1067/mic.2000.103242; Pittet D, 2000, INFECT CONT HOSP EP, V21, P381, DOI 10.1086/501777; Pittet D, 2000, LANCET, V356, P1307, DOI 10.1016/S0140-6736(00)02814-2; Pittet D, 1999, ANN INTERN MED, V130, P126, DOI 10.7326/0003-4819-130-2-199901190-00006; Pittet D, 1999, ARCH INTERN MED, V159, P821, DOI 10.1001/archinte.159.8.821; Rotter Manfred L., 1999, P1339; Rotter ML, 1998, CURR OPIN INFECT DIS, V11, P457, DOI 10.1097/00001432-199808000-00011; Rotter ML, 1997, HYG MED, V22, P332, DOI DOI 10.1136/BMJ.319.7208.518; Semmelweis I, 1988, CHALLENGE EPIDEMIOLO, P46; Shahid NS, 1996, J DIARRHOEAL DIS RES, V14, P85; SIMMONS B, 1990, INFECT CONT HOSP EP, V11, P589; SPROAT LJ, 1994, J HOSP INFECT, V26, P137, DOI 10.1016/0195-6701(94)90057-4; STANTON BF, 1987, AM J EPIDEMIOL, V125, P292, DOI 10.1093/oxfordjournals.aje.a114529; Teare EL, 1999, J HOSP INFECT, V43, P1, DOI 10.1053/jhin.1999.0251; Thompson BL, 1997, INFECT CONT HOSP EP, V18, P97; Tibballs J, 1996, MED J AUSTRALIA, V164, P395, DOI 10.5694/j.1326-5377.1996.tb122084.x; Voss A, 1997, INFECT CONT HOSP EP, V18, P205; WEBSTER J, 1994, J PAEDIATR CHILD H, V30, P59, DOI 10.1111/j.1440-1754.1994.tb00568.x; ZAFAR AB, 1995, AM J INFECT CONTROL, V23, P200, DOI 10.1016/0196-6553(95)90042-X	55	171	176	0	13	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0195-6701	1532-2939		J HOSP INFECT	J. Hosp. Infect.	AUG	2001	48			A			S40	S46		10.1016/S0195-6701(01)90012-X			7	Public, Environmental & Occupational Health; Infectious Diseases	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Public, Environmental & Occupational Health; Infectious Diseases	458FB	WOS:000170181600010	11759025				2022-03-04	
J	Carlet, J; Pittet, D				Carlet, Jean; Pittet, Didier			Access to antibiotics: a safety and equity challenge for the next decade	ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL			English	Editorial Material						Antibiotics; Antimicrobial resistance; Antimicrobial resistance surveillance; Antibiotics -use; Multidrug-resistant organisms	RESISTANCE; HOSPITALS; EMERGENCE; PREVENT	Bacterial resistance to antibiotics is increasing worldwide in healthcare settings and in the community. Some microbial pathogens have become resistant to multiple antibiotics, if not all presently available, thus severely compromising treatment success and contributing to enhanced morbidity, mortality, and resource use. The major driver of resistance is misuse of antibiotics in both human and non-human medicine. Both enhanced access and restricted use in many parts of the world is mandatory. There is an urgent need for an international, integrated, multi-level action to preserve antibiotics in the armamentarium of the 21st century and address the global issue of antimicrobial resistance.	[Carlet, Jean] WAAR, F-94000 Creteil, France; [Carlet, Jean] Hop St Joseph, F-75014 Paris, France; [Pittet, Didier] Univ Hosp Geneva, Infect Control Programme, Geneva, Switzerland; [Pittet, Didier] Univ Hosp Geneva, WHO Collaborat Ctr Patient Safety, Geneva, Switzerland; [Pittet, Didier] Fac Med, Geneva, Switzerland		Carlet, J (corresponding author), WAAR, 9 Rue Terrasse, F-94000 Creteil, France.	jeancarlet@gmail.com					Allegranzi B, 2011, LANCET, V377, P228, DOI 10.1016/S0140-6736(10)61458-4; Anthony F, 2001, REV SCI TECH OIE, V20, P829, DOI 10.20506/rst.20.3.1318; Bassetti M, 2011, EXPERT REV ANTI-INFE, V9, P909, DOI [10.1586/eri.11.107, 10.1586/ERI.11.107]; Bush K, 2011, NAT REV MICROBIOL, V9, P894, DOI 10.1038/nrmicro2693; Carlet J, 2012, CLIN MICROBIOL INFEC, V18, P1, DOI 10.1111/j.1469-0691.2011.03702.x; Carlet J, 2011, LANCET, V378, P369, DOI 10.1016/S0140-6736(11)60401-7; Carlet J, 2009, INFECT CONT HOSP EP, V30, P737, DOI 10.1086/598682; Degos L, 2009, BMJ-BRIT MED J, V338, P2585; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; European Centre for Disease Prevention and Control (ECDC), 2009, ECDC EMEA JOINT TECH; European Centre for Duisease Prevention and Control, 2010, ECDC DAIL UPD 2009 I; Goldmann DA, 1996, JAMA-J AM MED ASSOC, V275, P234, DOI 10.1001/jama.275.3.234; Hughes JM, 2011, JAMA-J AM MED ASSOC, V305, P1027, DOI 10.1001/jama.2011.279; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Levy MM, 2010, CRIT CARE MED, V38, P367, DOI 10.1097/CCM.0b013e3181cb0cdc; Loveday HP, 2006, J HOSP INFECT, V63, pS45, DOI 10.1016/j.jhin.2006.01.002; Matthaiou DK, 2008, CRIT CARE MED, V36, P807, DOI 10.1097/CCM.0B013E3181652FAE; Meier S, 2011, INFECTION, V39, P333, DOI 10.1007/s15010-011-0132-6; Ofner-Agostini M, 2007, AM J INFECT CONTROL, V35, P563, DOI 10.1016/j.ajic.2006.12.003; Perez F, 2012, CLIN INFECT DIS, V54, P175, DOI 10.1093/cid/cir793; Piddock LJV, 2012, LANCET INFECT DIS, V12, P249, DOI 10.1016/S1473-3099(11)70316-4; Rossolini GM, 2007, NEW MICROBIOL, V30, P332; Van Gastel E, 2010, J ANTIMICROB CHEMOTH, V65, P576, DOI 10.1093/jac/dkp470; Vlieghe Erika, 2012, Expert Rev Anti Infect Ther, V10, P145, DOI 10.1586/eri.11.162; Wernitz MH, 2005, CLIN MICROBIOL INFEC, V11, P457, DOI 10.1111/j.1469-0691.2005.01152.x; WHO, 2012, EVOLVING THREAT OF ANTIMICROBIAL RESISTANCE: OPTIONS FOR ACTION, P1	27	15	15	0	4	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2047-2994			ANTIMICROB RESIST IN	Antimicrob. Resist. Infect. Control		2013	2								1	10.1186/2047-2994-2-1			4	Public, Environmental & Occupational Health; Infectious Diseases; Microbiology; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Infectious Diseases; Microbiology; Pharmacology & Pharmacy	V41MQ	WOS:000209550700001	23305311	Green Published, gold			2022-03-04	
J	Marimuthu, K; Pittet, D; Harbarth, S				Marimuthu, Kalisvar; Pittet, Didier; Harbarth, Stephan			The effect of improved hand hygiene on nosocomial MRSA control	ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL			English	Review						Hand hygiene; Hand washing; Multimodal strategy; Alcohol-based handrubs; Nosocomial MRSA; MRSA control; MRSA bacteremia	RESISTANT STAPHYLOCOCCUS-AUREUS; INTERRUPTED TIME-SERIES; HEALTH-CARE WORKERS; CLOSTRIDIUM-DIFFICILE; INFECTIONS; TRANSMISSION; PROGRAM; IMPACT; INTERVENTIONS; REDUCTIONS	The purpose of this review is to examine studies that have assessed the association between hand hygiene enhancement and methicillin-resistant Staphylococcus aureus (MRSA) rates and to explore controversies surrounding this association. Many studies have been published confirming the link between improved hand hygiene compliance and reduction in MRSA acquisition and infections, including bacteremia. These studies have also shown the cost-beneficial nature of these programmes. Despite considerable research some issues remain unanswered still, including the temporal relationship between hand hygiene enhancement strategies and decrease in MRSA rates, association between hand hygiene enhancement and MRSA-related surgical site infections, diminishing effect of hand hygiene compliance on MRSA rates after reaching a threshold and the role of instituting contact precautions in the setting of low MRSA rates and sufficient hand hygiene compliance. In conclusion, enhancement of hand hygiene compliance has been shown to reduce MRSA rates; however, some open issues warrant further investigation.	[Marimuthu, Kalisvar] Tan Tock Seng Hosp, Inst Infect Dis & Epidemiol, Singapore, Singapore; [Marimuthu, Kalisvar; Pittet, Didier; Harbarth, Stephan] Univ Hosp Geneva, Infect Control Program, CH-1211 Geneva 14, Switzerland; [Marimuthu, Kalisvar; Pittet, Didier; Harbarth, Stephan] Fac Med, CH-1211 Geneva 14, Switzerland; [Pittet, Didier] Univ Hosp Geneva, WHO Collaborating Ctr Patient Safety, CH-1211 Geneva 14, Switzerland		Harbarth, S (corresponding author), Univ Hosp Geneva, Infect Control Program, CH-1211 Geneva 14, Switzerland.	stephan.harbarth@hcuge.ch		Marimuthu, Kalisvar/0000-0002-0395-5633	Geneva University Hospitals; B. Braun; European Commission (MOSAR network contract) [LSHP-CT-2007-037941]	Stephan Harbarth: Member of the scientific advisory board of Destiny Pharma, DaVolterra and bioMerieux. He has received financial support for MRSA research activities from Geneva University Hospitals, B. Braun and the European Commission (MOSAR network contract LSHP-CT-2007-037941).	Barnett AG, 2014, INFECT CONT HOSP EP, V35, P1029, DOI 10.1086/677160; Beggs CB, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-114; Cooper BS, 1999, J HOSP INFECT, V43, P131, DOI 10.1053/jhin.1998.0647; Dautzenberg MJ, 2014, EUROSURVEILLANCE, V19, P20723; Derde LPG, 2014, LANCET INFECT DIS, V14, P31, DOI 10.1016/S1473-3099(13)70295-0; DiDiodato G, 2013, INFECT CONT HOSP EP, V34, P605, DOI 10.1086/670637; Faetkenheuer G, 2014, LANCET, DOI [10.1016/S0140-6736(14)60660-7, DOI 10.1016/S0140-6736(14)60660-7]; Fisher D, 2013, J HOSP INFECT, V85, P141, DOI 10.1016/j.jhin.2013.07.005; Grayson ML, 2008, MED J AUSTRALIA, V188, P633, DOI 10.5694/j.1326-5377.2008.tb01820.x; Grayson ML, 2011, MED J AUSTRALIA, V195, P615, DOI 10.5694/mja11.10747; Harbarth S, 2006, CLIN MICROBIOL INFEC, V12, P1154, DOI 10.1111/j.1469-0691.2006.01572.x; Johnson PDR, 2005, MED J AUSTRALIA, V183, P509, DOI 10.5694/j.1326-5377.2005.tb07151.x; Kirkland KB, 2012, BMJ QUAL SAF, V21, P1019, DOI 10.1136/bmjqs-2012-000800; Larsen J, 2014, J GLOB ANTIMICROB RE, V2, P260, DOI 10.1016/j.jgar.2014.09.003; Lee AS, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003126; MacKenzie FM, 2007, CLIN MICROBIOL INFEC, V13, P269, DOI 10.1111/j.1469-0691.2006.01592.x; Marimuthu K, 2014, CURR OPIN INFECT DIS, V27, P356, DOI 10.1097/QCO.0000000000000081; McBryde ES, 2007, J THEOR BIOL, V245, P470, DOI 10.1016/j.jtbi.2006.11.008; OLSEN RJ, 1993, JAMA-J AM MED ASSOC, V270, P350, DOI 10.1001/jama.270.3.350; Pittet D, 2000, LANCET, V356, P1307, DOI 10.1016/S0140-6736(00)02814-2; Pittet D, 2004, INFECT CONT HOSP EP, V25, P264, DOI 10.1086/502389; Pittet D, 2009, INFECT CONT HOSP EP, V30, P611, DOI 10.1086/600379; Sroka S, 2010, J HOSP INFECT, V74, P204, DOI 10.1016/j.jhin.2009.08.023; Stone SP, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3005; Tenorio AR, 2001, CLIN INFECT DIS, V32, P826, DOI 10.1086/319214; Vernaz N, 2008, J ANTIMICROB CHEMOTH, V62, P601, DOI 10.1093/jac/dkn199	26	31	31	4	16	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	2047-2994			ANTIMICROB RESIST IN	Antimicrob. Resist. Infect. Control	NOV 26	2014	3								34	10.1186/2047-2994-3-34			6	Public, Environmental & Occupational Health; Infectious Diseases; Microbiology; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Infectious Diseases; Microbiology; Pharmacology & Pharmacy	CZ7OQ	WOS:000367289100001	25937922	Green Published, gold			2022-03-04	
J	Zingg, W; Cartier, V; Walder, B				Zingg, W.; Cartier, V.; Walder, B.			No association between ultrasound-guided insertion of central venous catheters and bloodstream infection: a prospective observational study	JOURNAL OF HOSPITAL INFECTION			English	Letter							INTERNAL JUGULAR-VEIN		[Zingg, W.] Univ Hosp Geneva, Infect Control Programme, CH-1211 Geneva 14, Switzerland; [Cartier, V.; Walder, B.] Univ Hosp Geneva, Div Anaesthesiol, CH-1211 Geneva 14, Switzerland		Zingg, W (corresponding author), Univ Hosp Geneva, Infect Control Programme, 4 Rue Gabrielle Perret Gentil, CH-1211 Geneva 14, Switzerland.	walter.zingg@hcuge.ch					Airapetian N, 2013, INTENS CARE MED, V39, P1938, DOI 10.1007/s00134-013-3072-z; Cartier V, 2014, J HOSP INFECT, V87, P103, DOI 10.1016/j.jhin.2014.03.009; Hrics P, 1998, AM J EMERG MED, V16, P401, DOI 10.1016/S0735-6757(98)90140-1; Karakitsos D, 2006, CRIT CARE, V10, DOI 10.1186/cc5101; Lennon M, 2012, MINERVA ANESTESIOL, V78, P1234	5	1	1	0	1	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0195-6701	1532-2939		J HOSP INFECT	J. Hosp. Infect.	MAY	2015	90	1					82	82		10.1016/j.jhin.2015.01.007			1	Public, Environmental & Occupational Health; Infectious Diseases	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Infectious Diseases	CF6TF	WOS:000352688400015	25698592				2022-03-04	
J	Sax, H; Posfay-Barbe, K; Harbarth, S; Francois, P; Touveneau, S; Pessoa-Silva, CL; Schrenzel, J; Dharan, S; Gervaix, A; Pittet, D				Sax, H.; Posfay-Barbe, K.; Harbarth, S.; Francois, P.; Touveneau, S.; Pessoa-Silva, C. L.; Schrenzel, J.; Dharan, S.; Gervaix, A.; Pittet, D.			Control of a cluster of community-associated, methicillin-resistant Staphylocloccus aureus in neonatology	JOURNAL OF HOSPITAL INFECTION			English	Article						community-associated infections/microbiology/transmission; cross-infection/microbiology/transmission; disease transmission, vertical; intensive care units, neonatal; Methicitlin resistance; Staphytococcal infections/microbiology/transmission	INTENSIVE-CARE-UNIT; PANTON-VALENTINE LEUKOCIDIN; STAPHYLOCOCCUS-AUREUS; EPIDEMIOLOGIC ANALYSIS; BREAST-MILK; TRANSMISSION; OUTBREAK; INFECTIONS; INFANTS; DISEASE	To control an outbreak of community-associated MRSA (CA-MRSA) in a neonatology unit, an investigation was conducted that involved screening neonates and parents, molecular analysis of MRSA isolates and tong-term follow-up of cases. During a two-month period in the summer of 2000, Panton-Valentine leukocidin (PVL)-producing CA-MRSA (strain ST5-MRSA-IV) was detected in five neonates. The mother of the index caseshowed signs of mastitis and wound infection and consequently tested positive for CA-MRSA. A small. cluster of endemic, PVL-negative MRSA strains (ST228-MRSA-I) occurred in parallel. Enhanced hygiene measures, barrier precautions, topical. decolonization of carriers, and cohorting of new admissions terminated the outbreak. Four months after the outbreak, the mother of another neonate developed furunculosis with the epidemic CA-MRSA strain. One infant had persistent CA-MRSA carriage resulting in skin infection in a sibling four years after the outbreak. In conclusion, an epidemic CA-MRSA strain was introduced by the mother of the index case. This spread among neonates and was subsequently transmitted to another mother and a sibling. This is the first report of a successfully controlled neonatology outbreak of genetically distinct PVL-producing CA-MRSA in Europe. (c) 2006 The Hospital Infection Society. Published by Elsevier Ltd. All rights reserved.	Univ Hosp Geneva, Infect Control Programme, CH-1211 Geneva 14, Switzerland; Univ Hosp Geneva, Dept Paediat, CH-1211 Geneva 14, Switzerland; Univ Hosp Geneva, Genom Res Lab, CH-1211 Geneva 14, Switzerland		Harbarth, S (corresponding author), Univ Hosp Geneva, Infect Control Programme, Rue Micheli Crest 24, CH-1211 Geneva 14, Switzerland.	stephan.harbarth@hcuge.ch	Posfay-Barbe, Klara M./AAV-2515-2021; Schrenzel, Jacques/AAC-5685-2021; francois, patrice/AAL-5583-2020; Posfay-Barbe, Klara M/E-9131-2013; Sax, Hugo S/A-9377-2016; Schrenzel, Jacques/P-8525-2017	Posfay-Barbe, Klara M./0000-0001-9464-5704; Schrenzel, Jacques/0000-0001-5464-7764; Posfay-Barbe, Klara M/0000-0001-9464-5704; Sax, Hugo S/0000-0002-1532-2198; Schrenzel, Jacques/0000-0001-5464-7764; francois, patrice/0000-0002-0540-750X			Andersen BM, 2002, J HOSP INFECT, V50, P18, DOI 10.1053/jhin.2001.1128; Baggett HC, 2004, J INFECT DIS, V189, P1565, DOI 10.1086/383247; Behari P, 2004, INFECT CONT HOSP EP, V25, P778, DOI 10.1086/502476; Buescher ES, 2005, CURR OPIN PEDIATR, V17, P67, DOI 10.1097/01.mop.0000147906.30720.4d; Campbell KM, 2004, J CLIN MICROBIOL, V42, P4050, DOI 10.1128/JCM.42.9.4050-4053.2004; Cimolai N, 2003, AM J PERINAT, V20, P125, DOI 10.1055/s-2003-40010; Eckhardt C, 2003, INFECT CONT HOSP EP, V24, P460, DOI 10.1086/502234; Enright MC, 2002, P NATL ACAD SCI USA, V99, P7687, DOI 10.1073/pnas.122108599; FANG FC, 1993, JAMA-J AM MED ASSOC, V270, P1323, DOI 10.1001/jama.270.11.1323; Francois P, 2005, J CLIN MICROBIOL, V43, P3346, DOI 10.1128/JCM.43.7.3346-3355.2005; Francois P, 2004, J CLIN MICROBIOL, V42, P3309, DOI 10.1128/JCM.42.7.3309-3312.2004; HALEY RW, 1995, J INFECT DIS, V171, P614, DOI 10.1093/infdis/171.3.614; Harbarth S, 2005, EMERG INFECT DIS, V11, P962, DOI 10.3201/eid1106.041308; Harbarth S, 2000, J HOSP INFECT, V46, P43, DOI 10.1053/jhin.2000.0798; Huang YC, 2005, INFECT CONT HOSP EP, V26, P157, DOI 10.1086/502520; Kitajima H, 2003, PEDIATR INT, V45, P238, DOI 10.1046/j.1442-200X.2003.01719.x; Le Thomas I, 2001, J CLIN MICROBIOL, V39, P728, DOI 10.1128/JCM.39.2.728-729.2001; MITSUDA T, 1995, J HOSP INFECT, V31, P123, DOI 10.1016/0195-6701(95)90167-1; Mitsuda T, 1999, J HOSP INFECT, V42, P45, DOI 10.1053/jhin.1998.0551; Morel AS, 2002, AM J INFECT CONTROL, V30, P170, DOI 10.1067/mic.2002.119819; Nambiar Sumathi, 2003, Pediatr Crit Care Med, V4, P220, DOI 10.1097/01.PCC.0000059736.20597.75; NOEL GJ, 1992, PEDIATR INFECT DIS J, V11, P184, DOI 10.1097/00006454-199203000-00002; Pan ES, 2003, CLIN INFECT DIS, V37, P1384, DOI 10.1086/379019; Regev-Yochay G, 2005, EMERG INFECT DIS, V11, P453, DOI 10.3201/eid1103.040470; Robinson DA, 2005, LANCET, V365, P1256, DOI 10.1016/S0140-6736(05)74814-5; Sa-Leao R, 1999, J CLIN MICROBIOL, V37, P1913; Saiman L, 2003, INFECT CONT HOSP EP, V24, P317, DOI 10.1086/502217; Saiman L, 2003, CLIN INFECT DIS, V37, P1313, DOI 10.1086/379022; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978; WYSHAM DN, 1957, NEW ENGL J MED, V257, P295, DOI 10.1056/NEJM195708152570701; Zinderman CE, 2004, EMERG INFECT DIS, V10, P941, DOI 10.3201/eid1005.030604	31	66	67	0	8	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0195-6701	1532-2939		J HOSP INFECT	J. Hosp. Infect.	MAY	2006	63	1					93	100		10.1016/j.jhin.2005.11.016			8	Public, Environmental & Occupational Health; Infectious Diseases	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Infectious Diseases	044JK	WOS:000237668200014	16542756				2022-03-04	
J	Schmidt, JS; Kuster, SP; Nigg, A; Dazio, V; Brilhante, M; Rohrbach, H; Bernasconi, OJ; Budel, T; Campos-Madueno, EI; Brawand, SG; Schuller, S; Endimiani, A; Perreten, V; Willi, B				Schmidt, Janne S.; Kuster, Stefan P.; Nigg, Aurelien; Dazio, Valentina; Brilhante, Michael; Rohrbach, Helene; Bernasconi, Odette J.; Budel, Thomas; Campos-Madueno, Edgar, I; Brawand, Stefanie Gobeli; Schuller, Simone; Endimiani, Andrea; Perreten, Vincent; Willi, Barbara			Poor infection prevention and control standards are associated with environmental contamination with carbapenemase-producing Enterobacterales and other multidrug-resistant bacteria in Swiss companion animal clinics	ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL			English	Article						Infection prevention and control; Small animal clinic; Enterobacteriaceae; Antimicrobial resistant pathogens; Multidrug-resistant pathogens; Colonization; Zoonosis	COAGULASE-NEGATIVE STAPHYLOCOCCI; ESCHERICHIA-COLI; ANTIMICROBIAL RESISTANCE; ACINETOBACTER-BAUMANNII; METHICILLIN RESISTANCE; VETERINARY CLINICS; GENETIC DIVERSITY; AUREUS MRSA; PSEUDINTERMEDIUS; CASEOLYTICUS	Background Intensive medical care in companion animal clinics could pose a risk for the selection and dissemination of multidrug-resistant organisms (MDROs). Infection prevention and control (IPC) concepts are key measures to reduce the spread of MDROs, but data on IPC standards in companion animal clinics is sparse. The study assessed IPC standards in seven companion animal clinics and practices in Switzerland by structured IPC audits and combined results with environmental MDRO contamination and MDRO carriage of the personnel. Methods IPC audits were held between August 2018 and January 2019. The observations in 34 IPC areas were scored based on predefined criteria (not fulfilled/partially fulfilled/fulfilled = score 0/1/2). Environmental swabs and nasal and stool samples from veterinary personnel were tested for methicillin-resistant (MR) staphylococci and macrococci and for colistin-resistant, extended-spectrum beta-lactamase- and carbapenemase-producing (CP)Enterobacterales(CPE). Species was identified by MALDI-TOF MS, antimicrobial resistance determined by microdilution and beta-lactam resistance gene detection, and genetic relatedness assessed by REP-/ERIC-PCR and multilocus sequence typing. Results Of a maximum total IPC score of 68, the institutions reached a median (range) score of 33 (19-55). MDROs were detected in median (range) 8.2% (0-33.3%) of the sampling sites. Clinics with low IPC standards showed extensive environmental contamination, i.e. of intensive care units, consultation rooms and utensils. CPE were detected in two clinics; one of them showed extensive contamination with CPKlebsiella pneumoniae(ST11,bla(OXA-48)) and MRStaphylococcus pseudintermedius(ST551,mecA). Despite low IPC scores, environmental contamination with MDROs was low in primary opinion practices. Three employees were colonized withEscherichia coliST131 (bla(CTX-M-15),bla(CTX-M-27),bla(CTX-M-14)). Two employees carried CPE. coliclosely related to environmental (ST410,bla(OXA-181)) and patient-derived isolates (ST167,bla(NDM-5)). MRStaphylococcus aureus(ST225,mecA) and MRS. pseudintermedius(ST551,mecA) of the same sequence types and with similar resistance profiles were found in employees and the environment in two clinics. Conclusions The study indicates that IPC standards in companion animal clinics are variable and that insufficient IPC standards could contribute to the evolution of MDROs which can be transferred between the environment and working personnel. The implementation of IPC concepts in companion animal clinics should urgently be promoted.	[Schmidt, Janne S.; Willi, Barbara] Univ Zurich, Vetsuisse Fac, Clin Small Anim Internal Med, Zurich, Switzerland; [Kuster, Stefan P.] Univ Zurich, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland; [Kuster, Stefan P.] Univ Hosp Zurich, Zurich, Switzerland; [Nigg, Aurelien; Brilhante, Michael; Brawand, Stefanie Gobeli; Perreten, Vincent] Univ Bern, Vetsuisse Fac, Inst Vet Bacteriol, Bern, Switzerland; [Dazio, Valentina; Schuller, Simone] Univ Bern, Vetsuisse Fac, Dept Clin Vet Med, Div Small Anim Internal Med, Bern, Switzerland; [Brilhante, Michael] Univ Bern, Grad Sch Cellular & Biomed Sci, Bern, Switzerland; [Rohrbach, Helene] Univ Bern, Vetsuisse Fac, Dept Clin Vet Med, Small Anim Clin, Bern, Switzerland; [Bernasconi, Odette J.; Budel, Thomas; Campos-Madueno, Edgar, I; Endimiani, Andrea] Univ Bern, Fac Med, Inst Infect Dis, Bern, Switzerland		Willi, B (corresponding author), Univ Zurich, Vetsuisse Fac, Clin Small Anim Internal Med, Zurich, Switzerland.	bwilli@vetclinics.uzh.ch	Campos-Madueno, Edgar I/ABF-8165-2020; Willi, Barbara/AAZ-8136-2021; Bernasconi, Odette Joëlle/AAG-6378-2019; Perreten, Vincent/ABB-1144-2020; Endimiani, Andrea/H-4008-2019; Willi, Barbara/B-7636-2018	Campos-Madueno, Edgar I/0000-0002-1846-9857; Willi, Barbara/0000-0002-8010-1180; Bernasconi, Odette Joëlle/0000-0002-7579-5819; Perreten, Vincent/0000-0001-5722-9445; Endimiani, Andrea/0000-0003-3186-5421; 	Swiss Federal Food Safety and Veterinary Office [1.18.10]; Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission [NRP-72]; Swiss National Science Foundation (SNF)Swiss National Science Foundation (SNSF) [177378]; Institute of Veterinary Bacteriology, University of Bern	The study was supported by the Swiss Federal Food Safety and Veterinary Office (Grant No. 1.18.10 to BW, SS, SPK, AE, VP and SGB), the Swiss National Science Foundation (NRP-72, "National Research Program, Antimicrobial Resistance"; SNF grant No. 177378 to AE and VP), and by internal funds of the Institute of Veterinary Bacteriology, University of Bern. The funding body had no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.	Andersson UG, 2014, SCAND J INFECT DIS, V46, P310, DOI 10.3109/00365548.2013.866267; [Anonymous], 2017, M100S27 CLSI, V27th; [Anonymous], 2019, R LANG ENV STAT COMP; [Anonymous], 2014, ANT RES GLOB REP SUR; Barlow A, 2020, INT J STEM EDUC, V7, P22, DOI 10.1186/s40594-020-00220-9; Boost MV, 2011, ZOONOSES PUBLIC HLTH, V58, P36, DOI 10.1111/j.1863-2378.2009.01286.x; Brawand SG, 2017, INT J SYST EVOL MICR, V67, P621, DOI 10.1099/ijsem.0.001673; Budel T, 2019, J ANTIMICROB CHEMOTH, V74, P2880, DOI 10.1093/jac/dkz296; Bundesamt fur Lebensmittelsicherheit und Veterinarwesen (BLV), 2019, INF ANT VET IS ABV; Cain CL, 2013, VET CLIN N AM-SMALL, V43, P19, DOI 10.1016/j.cvsm.2012.09.003; Canadian Committe on Antibiotic Resistance (CCAR), 2008, INF PREV CONTR BEST; CDC, 2013, ANTIBIOTIC RESISTANC; Chanchaithong P, 2019, J ANTIMICROB CHEMOTH, V74, P2531, DOI 10.1093/jac/dkz260; Chomel BB, 2011, EMERG INFECT DIS, V17, P167, DOI 10.3201/eid1702.101070; Cotting K, 2017, VET DERMATOL, V28, P559, DOI 10.1111/vde.12474; Damborg P, 2016, J Comp Pathol, V155, pS27, DOI 10.1016/j.jcpa.2015.03.004; Donker T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035002; Endimiani A, 2020, J ANTIMICROB CHEMOTH, V75, P766, DOI 10.1093/jac/dkz470; Endimiani A, 2011, J ANTIMICROB CHEMOTH, V66, P2248, DOI 10.1093/jac/dkr289; EUCAST, 2019, BREAKP TABL INT MICS; Ewers C, 2011, BERL MUNCH TIERARZTL, V124, P94, DOI 10.2376/0005-9366-124-94; Faires MC, 2009, JAVMA-J AM VET MED A, V235, P540, DOI 10.2460/javma.235.5.540; Fessler AT, 2018, VET MICROBIOL, V221, P153, DOI 10.1016/j.vetmic.2018.06.001; Francey T, 2000, J VET INTERN MED, V14, P177, DOI 10.1892/0891-6640(2000)014&lt;0177:TROBAA&gt;2.3.CO;2; Gomez-Sanz E, 2015, ANTIMICROB AGENTS CH, V59, P4577, DOI 10.1128/AAC.05064-14; Gronthal T, 2018, EURO SURVEILL, V23; Gronthal T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110084; Guardabassi L, 2004, J ANTIMICROB CHEMOTH, V54, P321, DOI 10.1093/jac/dkh332; Harris PA, 2019, J BIOMED INFORM, V95, DOI 10.1016/j.jbi.2019.103208; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Holmes AH, 2016, LANCET, V387, P176, DOI 10.1016/S0140-6736(15)00473-0; Ishihara K, 2010, APPL ENVIRON MICROB, V76, P5165, DOI 10.1128/AEM.02780-09; Kizerwetter-Swida M, 2017, VET MICROBIOL, V208, P106, DOI 10.1016/j.vetmic.2017.07.025; Kuenzli E, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-528; Ljungquist Oskar, 2016, Infection Ecology & Epidemiology, V6, P31514, DOI 10.3402/iee.v6.31514; Louie L, 2002, J CLIN MICROBIOL, V40, P2786, DOI 10.1128/JCM.40.8.2786-2790.2002; Martins A, 2007, MICROBIOL IMMUNOL, V51, P787, DOI 10.1111/j.1348-0421.2007.tb03968.x; Mathys DA, 2018, VECTOR-BORNE ZOONOT, V18, P620, DOI 10.1089/vbz.2018.2320; Moodley A, 2009, VET MICROBIOL, V137, P397, DOI 10.1016/j.vetmic.2009.01.034; Morris DO, 2010, VET DERMATOL, V21, P400, DOI 10.1111/j.1365-3164.2010.00866.x; Nigg A, 2019, EUROSURVEILLANCE, V24, P13, DOI 10.2807/1560-7917.ES.2019.24.39.1900071; Nordmann P, 2012, CLIN MICROBIOL INFEC, V18, P411, DOI 10.1111/j.1469-0691.2012.03795.x; Overesch G, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-30; Paul NC, 2011, ZOONOSES PUBLIC HLTH, V58, P533, DOI 10.1111/j.1863-2378.2011.01398.x; Peterhans S, 2018, J GLOB ANTIMICROB RE, V15, P226, DOI 10.1016/j.jgar.2018.10.013; Platell JL, 2011, VET MICROBIOL, V153, P99, DOI 10.1016/j.vetmic.2011.05.007; Pomba C, 2017, J ANTIMICROB CHEMOTH, V72, P957, DOI 10.1093/jac/dkw481; Prescott JF, 2002, CAN VET J, V43, P107; Rogers BA, 2011, J ANTIMICROB CHEMOTH, V66, P1, DOI 10.1093/jac/dkq415; Rosenkranz KW, 2014, SCHWEIZ ARCH TIERH, V156, P317, DOI 10.1024/0036-7281/a000601; Sakwinska O, 2009, APPL ENVIRON MICROB, V75, P175, DOI 10.1128/AEM.01860-08; Schmitt K, 2019, BMC VET RES, V15, DOI 10.1186/s12917-019-1821-0; Schwendener S, 2017, SCI REP-UK, V7, DOI 10.1038/srep43797; Sieber S, 2011, MICROB DRUG RESIST, V17, P471, DOI 10.1089/mdr.2010.0188; Smith A, 2019, J VET INTERN MED, V33, P1677, DOI 10.1111/jvim.15522; Storr J, 2017, ANTIMICROB RESIST IN, V6, DOI 10.1186/s13756-016-0149-9; Stull JW, 2018, J AM ANIM HOSP ASSOC, V54, P297, DOI [10.5326/JAAHA-MS-6903, 10.5326/jaaha-ms-6903]; van der Kolk JH, 2019, J GLOB ANTIMICROB RE, V16, P59, DOI 10.1016/j.jgar.2018.08.011; van Duijkeren E, 2011, VET MICROBIOL, V150, P338, DOI 10.1016/j.vetmic.2011.02.012; Walther B, 2017, VET MICROBIOL, V200, P71, DOI 10.1016/j.vetmic.2016.05.017; Weese JS, 2006, VET MICROBIOL, V115, P148, DOI 10.1016/j.vetmic.2006.01.004; Zogg AL, 2018, FRONT VET SCI, V5, DOI 10.3389/fvets.2018.00062; Zurfluh K, 2017, ANTIMICROB RESIST IN, V6, DOI 10.1186/s13756-017-0186-z	63	14	14	2	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2047-2994			ANTIMICROB RESIST IN	Antimicrob. Resist. Infect. Control	JUN 23	2020	9	1							93	10.1186/s13756-020-00742-5			13	Public, Environmental & Occupational Health; Infectious Diseases; Microbiology; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Infectious Diseases; Microbiology; Pharmacology & Pharmacy	ME7YK	WOS:000544870300001		Green Accepted, Green Published, gold, Green Submitted			2022-03-04	
J	Lee, AS; Macedo-Vinas, M; Francois, P; Renzi, G; Vernaz, N; Schrenzel, J; Pittet, D; Harbarth, S				Lee, A. S.; Macedo-Vinas, M.; Francois, P.; Renzi, G.; Vernaz, N.; Schrenzel, J.; Pittet, D.; Harbarth, S.			Trends in mupirocin resistance in meticillin-resistant Staphylococcus aureus and mupirocin consumption at a tertiary care hospital	JOURNAL OF HOSPITAL INFECTION			English	Letter							INTERPRETIVE CRITERIA; LOW-LEVEL		[Lee, A. S.; Macedo-Vinas, M.; Pittet, D.; Harbarth, S.] Univ Hosp Geneva, Infect Control Program, CH-1211 Geneva 14, Switzerland; [Francois, P.; Schrenzel, J.] Univ Hosp Geneva, Genom Res Lab, CH-1211 Geneva 14, Switzerland; [Renzi, G.; Schrenzel, J.] Univ Hosp Geneva, Dept Microbiol, CH-1211 Geneva 14, Switzerland; [Vernaz, N.] Univ Hosp Geneva, Dept Pharm, CH-1211 Geneva 14, Switzerland		Harbarth, S (corresponding author), Univ Hosp Geneva, Infect Control Program, Rue Gabrielle Perret Gentil 4, CH-1211 Geneva 14, Switzerland.	stephan.harbarth@hcuge.ch	francois, patrice/AAL-5583-2020; Schrenzel, Jacques/AAC-5685-2021; Schrenzel, Jacques/P-8525-2017	Schrenzel, Jacques/0000-0001-5464-7764; Schrenzel, Jacques/0000-0001-5464-7764; francois, patrice/0000-0002-0540-750X; Vernaz, Nathalie/0000-0002-1371-5510			Antonio M, 2002, ANTIMICROB AGENTS CH, V46, P438, DOI 10.1128/AAC.46.2.438-442.2002; Finlay JE, 1997, ANTIMICROB AGENTS CH, V41, P1137, DOI 10.1128/AAC.41.5.1137; Jones JC, 2007, CLIN INFECT DIS, V45, P541, DOI 10.1086/520663; LEE AS, 2010, P 50 INT C ANT AG CH; de Oliveira NEM, 2007, J MED MICROBIOL, V56, P937, DOI 10.1099/jmm.0.46965-0; Patel JB, 2009, CLIN INFECT DIS, V49, P935, DOI 10.1086/605495; Thomas CM, 2010, NAT REV MICROBIOL, V8, P281, DOI 10.1038/nrmicro2278; Vivoni AM, 2005, INFECT CONT HOSP EP, V26, P662, DOI 10.1086/502599	8	38	38	0	3	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0195-6701	1532-2939		J HOSP INFECT	J. Hosp. Infect.	APR	2011	77	4					360	362		10.1016/j.jhin.2010.11.002			4	Public, Environmental & Occupational Health; Infectious Diseases	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Infectious Diseases	736PH	WOS:000288506100017	21276638				2022-03-04	
J	Pittet, D				Pittet, D.			Healthcare-associated infection: moving behind headlines to clinical solutions INTRODUCTION	JOURNAL OF HOSPITAL INFECTION			English	Editorial Material									Univ Geneva Hosp & Fac Med, Infect Control Programme, CH-1211 Geneva 14, Switzerland		Pittet, D (corresponding author), Univ Geneva Hosp & Fac Med, Infect Control Programme, 4 Rue Gabrielle Perret Gentil, CH-1211 Geneva 14, Switzerland.	didier.pittet@hcuge.ch					Fletcher M, 2009, J HOSP INFECT, V73, P397, DOI 10.1016/j.jhin.2009.06.029; Lynch P, 2007, J HOSP INFECT, V65, P148, DOI 10.1016/S0195-6701(07)60033-4; Pittet D, 2005, LANCET, V366, P1246, DOI 10.1016/S0140-6736(05)67506-X	3	6	6	0	1	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0195-6701			J HOSP INFECT	J. Hosp. Infect.	DEC	2009	73	4					293	295		10.1016/j.jhin.2009.08.004			3	Public, Environmental & Occupational Health; Infectious Diseases	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Infectious Diseases	522YE	WOS:000272035400001	19819585				2022-03-04	
J	Tartari, E; Pires, D; Pittet, D				Tartari, Ermira; Pires, Daniela; Pittet, Didier			Clean Your Hands 5th May 2017: 'Fight antibiotic resistance - it's in your hands'	ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL			English	Editorial Material									[Tartari, Ermira; Pires, Daniela; Pittet, Didier] Univ Geneva Hosp, Infect Control Programme, 4 Rue Gabrielle Perret Gentil, CH-1211 Geneva, Switzerland; [Tartari, Ermira; Pires, Daniela; Pittet, Didier] Univ Geneva Hosp, WHO Collaborating Ctr Patient Safety Infect Contr, 4 Rue Gabrielle Perret Gentil, CH-1211 Geneva, Switzerland; [Tartari, Ermira; Pires, Daniela; Pittet, Didier] Fac Med, 4 Rue Gabrielle Perret Gentil, CH-1211 Geneva, Switzerland; [Tartari, Ermira] Mater Dei Hosp, Infect Control Unit, Msida, Malta; [Pires, Daniela] Univ Lisbon, Ctr Hosp Lisboa Norte, Dept Infect Dis, Lisbon, Portugal; [Pires, Daniela] Univ Lisbon, Fac Med, Lisbon, Portugal		Pittet, D (corresponding author), Univ Geneva Hosp, Infect Control Programme, 4 Rue Gabrielle Perret Gentil, CH-1211 Geneva, Switzerland.; Pittet, D (corresponding author), Univ Geneva Hosp, WHO Collaborating Ctr Patient Safety Infect Contr, 4 Rue Gabrielle Perret Gentil, CH-1211 Geneva, Switzerland.; Pittet, D (corresponding author), Fac Med, 4 Rue Gabrielle Perret Gentil, CH-1211 Geneva, Switzerland.	didier.pittet@hcuge.ch	Tartari, Ermira/AAC-6804-2021	Pittet, Didier/0000-0002-3667-7131	Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission [32003B_163262]; Fundacao para a Ciencia e a TecnologiaPortuguese Foundation for Science and TechnologyEuropean Commission [SFRH/SINT/95317/2013]	Ermira Tartari and Daniela Pires are partially supported by the Swiss National Science Foundation (32003B_163262) for hand hygiene research activities. Daniela Pires is also supported by Fundacao para a Ciencia e a Tecnologia (SFRH/SINT/95317/2013).	Luangasanatip N, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3728; WHO, 2015, WHO GLOBAL ACTION PL; World Health Organization, 2009; World Health Organization, 2016, GUID COR COMP INF PR; World Health Organization, SAV LIV CLEAN YOUR H	5	0	0	0	0	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	2047-2994			ANTIMICROB RESIST IN	Antimicrob. Resist. Infect. Control	MAY 5	2017	6									10.1186/s13756-017-0196-x			2	Public, Environmental & Occupational Health; Infectious Diseases; Microbiology; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Infectious Diseases; Microbiology; Pharmacology & Pharmacy	ET8VK	WOS:000400581100001	28484592	Green Published, gold			2022-03-04	
J	Kamma, J; Mombelli, A; Tsinidou, K; Vasdekis, V; Giannopoulou, C				Kamma, J.; Mombelli, A.; Tsinidou, K.; Vasdekis, V.; Giannopoulou, C.			Cytokines in gingival crevicular fluid of adolescents and young adults	ORAL MICROBIOLOGY AND IMMUNOLOGY			English	Article						age; cytokines; gingival crevicular fluid	PERIODONTAL-DISEASE; CHILDREN; PLAQUE; AGE; METABOLISM; SECRETION; MEDIATORS; MONOCYTES; RESPONSES; HORMONES	The purpose of this study was to compare the levels of the cytokines interleukin-1 beta (IL-1 beta), IL-4, and IL-8 in the gingival crevicular fluid (GCF) of adolescents and young adults. Twenty-five adolescents aged between 14 and 16 years (Group A) and 20 periodontally healthy young adults aged between 25 and 35 years (Group B) were selected from two private dental clinics limited to pedodontics and periodontics respectively in Piraeus Greece. All subjects were systemically healthy. Clinical examination included probing pocket depth (PPD), presence or absence of plaque, and bleeding on probing (BOP). GCF was collected from four sites per subject. IL-1 beta, IL-4, and IL-8, measured as total amounts (pg/30 s), were evaluated in 180 samples using a commercially available sandwich enzyme-linked immunosorbent assay. IL-1 beta mean levels of Groups A and B were adjusted for BOP and PPD. Differences of IL-1 beta mean levels between the two age groups were statistically significant (F = 50.245, P < 0.001) in favour of Group A. Adolescents showed statistically significantly lower mean levels of IL-4 than young adults in the presence of BOP (F = 10.690, P = 0.001). There was no statistically significant difference between adolescents and adults for the means of IL-8 adjusted for BOP and plaque presence (F = 2.032, P = 0.161). Within the limits of this study the differences reported in mean levels of IL-1 beta and IL-4 may be attributed to the different age status.	[Mombelli, A.; Giannopoulou, C.] Univ Geneva, Dept Periodontol, Geneva, Switzerland; [Kamma, J.; Tsinidou, K.] Private Dent Clin Ltd Periodont, Piraeus, Greece; [Vasdekis, V.] Athens Univ Econ & Business, Athens, Greece		Kamma, J (corresponding author), 6-8 Freattidos St, GR-18537 Piraeus, Greece.	joannakamma@gmail.com	Vasdekis, Vassilis/AAM-4050-2021	Vasdekis, Vassilis/0000-0002-4484-1421	Swiss Society of Odontostomatology (SSO)	The authors declare that they have no conflict of interests. The present work was supported by the Swiss Society of Odontostomatology (SSO).	AINAMO J, 1975, INT DENT J, V25, P229; BHAT M, 1991, J PUBLIC HEALTH DENT, V51, P5, DOI 10.1111/j.1752-7325.1991.tb02168.x; BIRKEDALHANSEN H, 1993, J PERIODONTAL RES, V28, P500, DOI 10.1111/j.1600-0765.1993.tb02113.x; Brown BW, 1997, STAT MED, V16, P2511, DOI 10.1002/(SICI)1097-0258(19971130)16:22<2511::AID-SIM693>3.0.CO;2-4; Chipeta J, 1998, CELL IMMUNOL, V183, P149, DOI 10.1006/cimm.1998.1244; CUROLOVIC Z, 1977, SSO SCHWEIZ MONATSSC, V87, P801; DAHLEN G, 1989, J CLIN PERIODONTOL, V16, P305, DOI 10.1111/j.1600-051X.1989.tb01660.x; Diggle P. J., 1996, ANAL LONGITUDINAL DA; FAGIOLO U, 1993, EUR J IMMUNOL, V23, P2375, DOI 10.1002/eji.1830230950; Gardner EM, 2002, BIOGERONTOLOGY, V3, P271, DOI 10.1023/A:1020151401826; GENCO RJ, 1992, J PERIODONTOL, V63, P338, DOI 10.1902/jop.1992.63.4s.338; Giannopoulou C, 2003, J CLIN PERIODONTOL, V30, P145, DOI 10.1034/j.1600-051X.2003.300201.x; HUGOSON A, 1981, SWED DENT J, V5, P91; JANDINSKI JJ, 1988, J ORAL PATHOL MED, V17, P145, DOI 10.1111/j.1600-0714.1988.tb01515.x; Kabashima H, 1996, J ORAL PATHOL MED, V25, P449, DOI 10.1111/j.1600-0714.1996.tb00295.x; Kamma JJ, 2000, ORAL MICROBIOL IMMUN, V15, P103, DOI 10.1034/j.1399-302x.2000.150206.x; Kowalczyk D, 2002, CLIN EXP IMMUNOL, V127, P507, DOI 10.1046/j.1365-2249.2002.01701.x; LINDHE J, 1975, J PERIODONTAL RES, V10, P243, DOI 10.1111/j.1600-0765.1975.tb00031.x; MADDEN KS, 1995, PHYSIOL REV, V75, P77, DOI 10.1152/physrev.1995.75.1.77; MARIOTTI A, 1994, CRIT REV ORAL BIOL M, V5, P27, DOI 10.1177/10454411940050010201; MOLTENI M, 1994, J BIOL REG HOMEOS AG, V8, P41; Nakashima K, 1996, J CLIN PERIODONTOL, V23, P832, DOI 10.1111/j.1600-051X.1996.tb00620.x; OJANOTKO A, 1982, J PERIODONTAL RES, V17, P196, DOI 10.1111/j.1600-0765.1982.tb01145.x; OLEARY TJ, 1972, J PERIODONTOL, V43, P38, DOI 10.1902/jop.1972.43.1.38; RIANCHO JA, 1994, GERONTOLOGY, V40, P8; RICH EA, 1993, GERONTOLOGY, V39, P93; Scheett TP, 1999, PEDIATR RES, V46, P429, DOI 10.1203/00006450-199910000-00011; SMITH QT, 1992, J PERIODONTAL RES, V27, P466, DOI 10.1111/j.1600-0765.1992.tb01819.x; SUTCLIFFE P, 1972, J PERIODONTAL RES, V7, P52, DOI 10.1111/j.1600-0765.1972.tb00631.x; VITTEK J, 1979, J PERIODONTOL, V50, P254, DOI 10.1902/jop.1979.50.5.254; VOLLER A, 1996, MANUAL CLIN IMMUNOLO, P506; Yakovlev E, 1996, J PERIODONTOL, V67, P788, DOI 10.1902/jop.1996.67.8.788	32	20	23	0	2	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	0902-0055			ORAL MICROBIOL IMMUN	Oral Microbiol. Immunol.	FEB	2009	24	1					7	10		10.1111/j.1399-302X.2008.00466.x			4	Dentistry, Oral Surgery & Medicine; Immunology; Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine; Immunology; Microbiology	383PM	WOS:000261685500002	19121063				2022-03-04	
J	Pasricha, J; Koessler, T; Harbarth, S; Schrenzel, J; Camus, V; Cohen, G; Perrier, A; Pittet, D; Iten, A				Pasricha, Janet; Koessler, Thibaud; Harbarth, Stephan; Schrenzel, Jacques; Camus, Veronique; Cohen, Gilles; Perrier, Arnaud; Pittet, Didier; Iten, Anne			Carriage of extended-spectrum beta-lactamase-producing enterobacteriacae among internal medicine patients in Switzerland	ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL			English	Article						Extended-spectrum beta-lactamase producing enterobacteraciae; Infection control; Antimicrobial resistance		Background: The incidence of extended-spectrum beta-lactamase producing-enterobacteriacae (ESBL-E) infection is rising worldwide. We aimed to determine the prevalence and nosocomial acquisition rate of ESBL-E as well as the risk factors for ESBL-E carriage and acquisition amongst patients consecutively admitted to 13 internal medicine units at our hospital who were not previously known to be ESBL-E carriers. Findings: We screened all patients admitted or transferred to internal medicine units for ESBL-E on admission and discharge using rectal swabs. Of 1072 patients screened, 51 (4.8%) were carriers of an ESBL-E at admission. Of 473 patients who underwent admission and discharge screening, 21 (4.4%) acquired an ESBL-E On multivariate analysis, diabetes mellitus without end-organ complications (OR 2.87 [1.09-7.08]), connective tissue disease (OR 7.22 [1.17-44.59]), and liver failure (OR 8.39 [1.55-45.45]) were independent risk factors for carriage of an ESBL-E upon admission to hospital (area under the ROC curve, 0.68). Receipt of a first- or second-generation cephalosporin (OR 9.25 [222-37.82]), intra-hospital transfer (OR 6.68 [1.71-26.06]), and a hospital stay >21 days (OR 25.17 [4.18-151.68]) were associated with acquisition of an ESBL-E during hospitalisation; whilst admission from home was protective (OR 0.16 [0.06-0.39]) on univariate regression. No risk profile with sufficient accuracy to predict previously unknown carriage on admission or acquisition of ESBL-E could be developed using readily available patient information. Conclusions: ESBL-E carriage is endemic amongst internal medicine patients at our institution. We were unable to develop a clinical risk profile to accurately predict ESBL-E carriage amongst these patients.	[Pasricha, Janet; Harbarth, Stephan; Camus, Veronique; Pittet, Didier; Iten, Anne] Univ Hosp Geneva, Infect Control Program, CH-1211 Geneva 14, Switzerland; [Pasricha, Janet; Koessler, Thibaud; Harbarth, Stephan; Schrenzel, Jacques; Camus, Veronique; Cohen, Gilles; Perrier, Arnaud; Pittet, Didier; Iten, Anne] Fac Med, CH-1211 Geneva 14, Switzerland; [Koessler, Thibaud; Perrier, Arnaud; Iten, Anne] Univ Hosp Geneva, Dept Gen Internal Med, CH-1211 Geneva 14, Switzerland; [Schrenzel, Jacques] Univ Hosp Geneva, Cent Lab Bacteriol, CH-1211 Geneva 14, Switzerland; [Cohen, Gilles] Univ Hosp Geneva, Div Medico Econ Anal, CH-1211 Geneva 14, Switzerland; [Pittet, Didier] Univ Hosp Geneva, WHO Collaborating Ctr Patient Safety, CH-1211 Geneva 14, Switzerland; [Pasricha, Janet] Univ Oxford, Jenner Inst, Oxford, England		Harbarth, S (corresponding author), Univ Hosp Geneva, Infect Control Program, 4 Rue Gabrielle Perret Gentil, CH-1211 Geneva 14, Switzerland.	stephan.harbarth@hcuge.ch	Kössler, Thibaud/AAZ-9734-2020; Schrenzel, Jacques/AAC-5685-2021; Schrenzel, Jacques/P-8525-2017	Schrenzel, Jacques/0000-0001-5464-7764; Schrenzel, Jacques/0000-0001-5464-7764	European CommunityEuropean Commission; IMI Programme	We thank F. Maitre, J. Maurin, and G. Renzi for their help with this study Rosemary Sudan for editorial assistance. Current research on ESBL-E by supported by the European Community, 7th Framework Programme (SATURN, AIDA and R-Gnosis network contracts), and IMI Programme (Rapp-ID network contract).	Azim A, 2010, J MED MICROBIOL, V59, P955, DOI 10.1099/jmm.0.018085-0; Ben-Ami R, 2006, CLIN INFECT DIS, V42, P925, DOI 10.1086/500936; Ben-Ami R, 2009, CLIN INFECT DIS, V49, P682, DOI 10.1086/604713; Bert F, 2012, EMERG INFECT DIS, V18, P908, DOI 10.3201/eid1806.110139; Buke C, 2007, INFECT CONT HOSP EP, V28, P1255, DOI 10.1086/522678; Canton R, 2006, CURR OPIN MICROBIOL, V9, P466, DOI 10.1016/j.mib.2006.08.011; Enoch DA, 2012, J HOSP INFECT, V81, P270, DOI 10.1016/j.jhin.2012.05.006; Fankhauser C, 2009, SWISS MED WKLY, V139, P747, DOI smw-12918; Gardam MA, 2002, J INFECT DIS, V186, P1754, DOI 10.1086/345921; Han JH, 2012, INFECT CONT HOSP EP, V33, P1242, DOI 10.1086/668443; Harris AD, 2007, EMERG INFECT DIS, V13, P1144, DOI 10.3201/eid1308.070071; Harris AD, 2007, AM J INFECT CONTROL, V35, P97, DOI 10.1016/j.ajic.2006.09.011; Johnson SW, 2013, INFECT CONT HOSP EP, V34, P385, DOI 10.1086/669858; Lowe CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062678; Papadomichelakis E, 2008, INTENS CARE MED, V34, P2169; Pena C, 2006, CLIN MICROBIOL INFEC, V12, P279, DOI 10.1111/j.1469-0691.2005.01358.x; Pena C, 1997, J HOSP INFECT, V35, P9, DOI 10.1016/S0195-6701(97)90163-8; Rodriguez-Bano J, 2006, CLIN INFECT DIS, V42, P37, DOI 10.1086/498519; Rooney PJ, 2009, J ANTIMICROB CHEMOTH; Ruppe E, 2012, EUR J CLIN MICROBIOL, V31, P319, DOI 10.1007/s10096-011-1313-z; Snyder GM, 2012, AM J INFECT CONTROL, V40, P474, DOI 10.1016/j.ajic.2011.06.011; Song KH, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-41; Stewardson A, 2013, INFECT CONT HOSP EP, V34, P133, DOI 10.1086/669086; Thouverez M, 2004, INFECT CONT HOSP EP, V25, P838, DOI 10.1086/502305; Weintrob AC, 2010, INFECT CONT HOSP EP, V31, P330, DOI 10.1086/651304; Zahar JR, 2009, CURR OPIN INVEST DR, V10, P172	26	27	29	0	2	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	2047-2994			ANTIMICROB RESIST IN	Antimicrob. Resist. Infect. Control		2013	2								20	10.1186/2047-2994-2-20			7	Public, Environmental & Occupational Health; Infectious Diseases; Microbiology; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Infectious Diseases; Microbiology; Pharmacology & Pharmacy	V41MQ	WOS:000209550700019	23759067	Green Published, gold			2022-03-04	
J	Breckwoldt, J; Knecht, M; Massee, R; Flach, B; Hofmann-Huber, C; Kaap-Frohlich, S; Witt, CM; Aeberhard, R; Sax, H				Breckwoldt, Jan; Knecht, Monika; Massee, Ralph; Flach, Barbara; Hofmann-Huber, Caroline; Kaap-Frohlich, Sylvia; Witt, Claudia M.; Aeberhard, Ruth; Sax, Hugo			Operating room technician trainees teach medical students - an inter-professional peer teaching approach for infection prevention strategies in the operation room	ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL			English	Article						Interprofessional education; Operation room technicians; Medical students; Infection prevention; Simulated operating room; Simulation training	GUIDELINES; CARE; ATTITUDES; EDUCATION; DOCTORS	BackgroundEducation is a cornerstone strategy to prevent health-associated infections. Trainings benefit from being interactive, simulation-based, team-orientated, and early in professional socialization. We conceived an innovative inter-professional peer-teaching module with operating room technician trainees (ORTT) teaching infection prevention behavior in the operating room (OR) to medical students (MDS).MethodsORTT delivered a 2-h teaching module to small groups of MDS in a simulated OR setting with 4 posts: entering OR'; surgical hand disinfection'; dressing up for surgery and preparing a surgical field', debriefing'. MDS and ORTT evaluated module features and teaching quality through 2 specific questionnaires. Structured field notes by education specialist observers were analyzed thematically.ResultsOn Likert scales from -2 to +2, mean overall satisfaction was +1.91 (0.3) for MDS and+1.66 (+/- 0.6 SD) for ORTT while teaching quality was rated +1.89 (+/- 0.3) by MDS and self-rated with +1.34 (+/- 0.5) by ORTT. Students and observers highlighted that the training fostered mutual understanding and provided insight into the corresponding profession.ConclusionsUndergraduate inter-professional teaching among ORTT and MDS in infection prevention and control proved feasible with high educational quality. Inducing early mutual understanding between professional groups might improve professional collaboration and patient safety.	[Breckwoldt, Jan; Kaap-Frohlich, Sylvia; Witt, Claudia M.] Univ Zurich, Fac Med, Off Dean, Sect Res & Dev, Zurich, Switzerland; [Knecht, Monika; Massee, Ralph; Flach, Barbara; Hofmann-Huber, Caroline; Aeberhard, Ruth] Careum Training Ctr, Training Program Operating Room Technicians, Zurich, Switzerland; [Massee, Ralph; Flach, Barbara] Careum raining Ctr, Program Operating Room Technicians, Zurich, Switzerland; [Hofmann-Huber, Caroline; Aeberhard, Ruth] Careum Training Ctr, Zurich, Switzerland; [Kaap-Frohlich, Sylvia] Univ Zurich, Fac Med, Vice Deanery Educ, Zurich, Switzerland; [Witt, Claudia M.] Univ Zurich, Fac Med, Interprof Affairs, Zurich, Switzerland; [Witt, Claudia M.] Univ Zurich, Fac Med, Interprofess Affairs, Zurich, Switzerland; [Aeberhard, Ruth] Careum Training Ctr, Dept Vocat Educ, Zurich, Switzerland; [Sax, Hugo] Univ Hosp Zurich, Infect Prevent & Control Program, Zurich, Switzerland		Breckwoldt, J (corresponding author), Univ Zurich, Fac Med, Off Dean, Pestalozzistr 3-5, CH-8091 Zurich, Switzerland.	jan.breckwoldt@usz.ch	Witt, Claudia M./AAX-2370-2021	Witt, Claudia M./0000-0002-5440-7805; Breckwoldt, Jan/0000-0003-1716-1970			Anderson E, 2009, MED EDUC, V43, P542, DOI 10.1111/j.1365-2923.2009.03328.x; [Anonymous], 2017, GUIDELINES HAND HYGI; Bloom B.S., 1956, TAXONOMY ED OBJECTIV, VI; Boekaerts M., 1998, RES DIALOGUE LEARNIN, V1, P13, DOI [DOI 10.1016/S0959-4752(98)00008-5, 10.1016/S0959-4752(98)00008-5]; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Breckwoldt J, 2007, RESUSCITATION, V74, P158, DOI 10.1016/j.resuscitation.2006.11.017; Brophy J.E, 1999, TEACHING; Burgess A, 2014, BMC MED EDUC, V14, DOI 10.1186/1472-6920-14-115; D'Amour Danielle, 2005, J Interprof Care, V19 Suppl 1, P116, DOI 10.1080/13561820500082529; Fichtner Andreas, 2013, GMS Z Med Ausbild, V30, pDoc24, DOI 10.3205/zma000867; Haddara W, 2013, ACAD MED, V88, P1509, DOI 10.1097/ACM.0b013e3182a31893; Hattie J, 2007, REV EDUC RES, V77, P81, DOI 10.3102/003465430298487; Helmke A, 2007, QUALITY ED DETERMINI; Kaur Rajneesh, 2016, J Infect Prev, V17, P162, DOI 10.1177/1757177416645345; Kirkpatrick DL, 1994, EVALUATING TRAINING, P1994; Knobe M, 2010, MED EDUC, V44, P148, DOI 10.1111/j.1365-2923.2009.03557.x; Leeper Kristine, 2002, Curr Surg, V59, P69, DOI 10.1016/S0149-7944(01)00494-9; Mayer RE, 2002, THEOR PRACT, V41, P226, DOI 10.1207/s15430421tip4104_4; Meyer H, 2007, WHAT IS GOOD TEACHIN; Nicol PW, 2009, J HOSP INFECT, V72, P36, DOI 10.1016/j.jhin.2009.01.021; Oandasan I., 2005, J INTERFPROF CARE S1, V19, P21, DOI [DOI 10.1080/13561820500083550, 10.1080/13561820500083550]; Osborne S, 2003, AM J INFECT CONTROL, V31, P415, DOI 10.1067/mic.2003.68; Quiros D, 2007, HEART LUNG, V36, P287, DOI 10.1016/j.hrtlng.2006.08.005; Raemer DB, 2016, ACAD MED, V91, P530, DOI 10.1097/ACM.0000000000001033; Reeves S, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000072.pub3; Ross MT, 2007, MED TEACH, V29, P527, DOI 10.1080/01421590701665886; Rubinson L, 2005, INFECT CONT HOSP EP, V26, P525, DOI 10.1086/502579; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; Sladek RM, 2008, AM J INFECT CONTROL, V36, P399, DOI 10.1016/j.ajic.2007.11.002; Slavin R.E., 1994, INT J EDUC RES, V21, P141, DOI [10.1016/0883-0355(94)90029-9, DOI 10.1016/0883-0355(94)90029-9]; Stein AD, 2003, J HOSP INFECT, V54, P68, DOI 10.1016/S0195-6701(03)00074-4; Weber U, 2016, GMS J MED EDU, V33, DOI 10.3205/zma001056; Whitehead C, 2007, MED EDUC, V41, P1010, DOI 10.1111/j.1365-2923.2007.02893.x; Williams B, 2016, NURS EDUC TODAY, V42, P23, DOI 10.1016/j.nedt.2016.03.024; Zingg W, 2015, LANCET INFECT DIS, V15, P212, DOI 10.1016/S1473-3099(14)70854-0; Zwarentein M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000072.pub2	36	1	1	0	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2047-2994			ANTIMICROB RESIST IN	Antimicrob. Resist. Infect. Control	MAY 14	2019	8								75	10.1186/s13756-019-0526-2			9	Public, Environmental & Occupational Health; Infectious Diseases; Microbiology; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Infectious Diseases; Microbiology; Pharmacology & Pharmacy	HY4YQ	WOS:000468134200001	31114677	Green Published, gold			2022-03-04	
J	Andres, A; Toso, C				Andres, Axel; Toso, Christian			Liver transplantation for colorectal metastasis: a stepwise approach	HEPATOBILIARY SURGERY AND NUTRITION			English	Editorial Material							RECURRENCE		[Andres, Axel; Toso, Christian] Geneva Univ Hosp, Abdominal Surg & Transplantat, 4 Rue Gabrielle Perret Gentil, CH-1211 Geneva, Switzerland		Andres, A (corresponding author), Geneva Univ Hosp, Abdominal Surg & Transplantat, 4 Rue Gabrielle Perret Gentil, CH-1211 Geneva, Switzerland.	axel.andres@hcuge.ch					Dueland S, 2015, ANN SURG, V261, P956, DOI 10.1097/SLA.0000000000000786; Fong Y, 1999, ANN SURG, V230, P309, DOI 10.1097/00000658-199909000-00004; Grut H, 2018, EUR J NUCL MED MOL I, V45, P218, DOI 10.1007/s00259-017-3843-9; Hagness M, 2013, ANN SURG, V257, P800, DOI 10.1097/SLA.0b013e3182823957; Line PD, 2015, ANN SURG, V262, pE5, DOI 10.1097/SLA.0000000000001165; Mazzaferro V, 1996, NEW ENGL J MED, V334, P693, DOI 10.1056/NEJM199603143341104; Toso C, 2017, LIVER TRANSPLANT, V23, P1073, DOI 10.1002/lt.24791	7	0	0	0	0	AME PUBL CO	SHATIN	FLAT-RM C 16F, KINGS WING PLAZA 1, NO 3 KWAN ST, SHATIN, HONG KONG 00000, PEOPLES R CHINA	2304-3881	2304-389X		HEPATOBIL SURG NUTR	Hepatobil. Surg. Nutr.	JUN	2020	9	3					336	338		10.21037/hbsn.2019.10.20			3	Gastroenterology & Hepatology; Nutrition & Dietetics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Gastroenterology & Hepatology; Nutrition & Dietetics; Surgery	LR6CE	WOS:000535779800010	32509822	Green Published, gold			2022-03-04	
J	Kayser, B; Hulsebosch, R; Bosch, F				Kayser, Bengt; Hulsebosch, Ronald; Bosch, Frank			Low-Dose Acetylsalicylic Acid Analog and Acetazolamide for Prevention of Acute Mountain Sickness : The Authors Reply	HIGH ALTITUDE MEDICINE & BIOLOGY			English	Letter							EFFICACY; TRIAL		[Kayser, Bengt] Univ Geneva, Inst Movement Sci & Sports Med, CH-1205 Geneva, Switzerland		Kayser, B (corresponding author), Univ Geneva, Inst Movement Sci & Sports Med, 10 Rue Conseil Gen, CH-1205 Geneva, Switzerland.	bengt.kayser@unige.ch	Bosch, Frank/AAW-6704-2020; Kayser, Bengt/M-8643-2013	Kayser, Bengt/0000-0002-9776-7501			Basnyat B, 2006, HIGH ALT MED BIOL, V7, P17, DOI 10.1089/ham.2006.7.17; Basnyat B, 2003, HIGH ALT MED BIOL, V4, P45, DOI 10.1089/152702903321488979; Kayser B, 2008, HIGH ALT MED BIOL, V9, P15, DOI 10.1089/ham.2007.1037	3	1	1	0	0	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1527-0297			HIGH ALT MED BIOL	High Alt. Med. Biol.	DEC	2008	9	4					351	352		10.1089/ham.2008.0169			2	Biophysics; Public, Environmental & Occupational Health; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Public, Environmental & Occupational Health; Sport Sciences	389IG	WOS:000262085500018					2022-03-04	
J	Patcas, R; Markic, G; Muller, L; Ullrich, O; Peltomaki, T; Kellenberger, CJ; Karlo, CA				Patcas, R.; Markic, G.; Mueller, L.; Ullrich, O.; Peltomaki, T.; Kellenberger, C. J.; Karlo, C. A.			Accuracy of linear intraoral measurements using cone beam CT and multidetector CT: a tale of two CTs	DENTOMAXILLOFACIAL RADIOLOGY			English	Article						computed tomography; CBCT; image quality; accuracy; soft tissue	MULTISLICE COMPUTED-TOMOGRAPHY; DERIVING HOUNSFIELD UNITS; MASTICATORY MUCOSA; IMAGE QUALITY; RELIABILITY; ARTIFACTS; DOSIMETRY; THICKNESS; IDENTIFICATION; RADIATION	Objectives: The aim was to compare the accuracy of linear bone measurements of cone beam CT (CBCT) with multidetector CT (MDCT) and validate intraoral soft-tissue measurements in CBCT. Methods: Comparable views of CBCT and MDCT were obtained from eight intact cadaveric heads. The anatomical positions of the gingival margin and the buccal alveolar bone ridge were determined. Image measurements (CBCT/MDCT) were performed upon multiplanar reformatted data sets and compared with the anatomical measurements; the number of non-assessable sites (NASs) was evaluated. Results: Radiological measurements were accurate with a mean difference from anatomical measurements of 0.14 mm (CBCT) and 0.23 mm (MDCT). These differences were statistically not significant, but the limits of agreement for bone measurements were broader in MDCT (-1.35 mm; 1.82 mm) than in CBCT (-0.93 mm; 1.21 mm). The limits of agreement for soft-tissue measurements in CBCT were smaller (-0.77 mm; 1.07 mm), indicating a slightly higher accuracy. More NASs occurred in MDCT (14.5%) than in CBCT (8.3%). Conclusions: CBCT is slightly more reliable for linear measurements than MDCT and less affected by metal artefacts. CBCT accuracy of linear intraoral soft-tissue measurements is similar to the accuracy of bone measurements. Dentomaxillofacial Radiology (2012) 41, 637-644. doi: 10.1259/dmfr/21152480	[Patcas, R.; Markic, G.; Mueller, L.] Univ Zurich, Ctr Dent Med, Clin Orthodont & Pediat Dent, CH-8032 Zurich, Switzerland; [Ullrich, O.] Univ Zurich, Fac Med, Inst Anat, CH-8032 Zurich, Switzerland; [Peltomaki, T.] Tampere Univ Hosp, Dent & Oral Dis Outpatient Clin, Tampere, Finland; [Kellenberger, C. J.] Univ Childrens Hosp Zurich, Dept Diagnost Imaging, Zurich, Switzerland; [Karlo, C. A.] Univ Zurich Hosp, Inst Diagnost & Intervent Radiol, CH-8091 Zurich, Switzerland		Patcas, R (corresponding author), Univ Zurich, Ctr Dent Med, Clin Orthodont & Pediat Dent, Plattenstr 2, CH-8032 Zurich, Switzerland.	raphael.patcas@zzm.uzh.ch		Kellenberger, Christian/0000-0001-9122-2431			Abrahams JJ, 2001, RADIOLOGY, V219, P334, DOI 10.1148/radiology.219.2.r01ma33334; Al-Ekrish AA, 2011, DENTOMAXILLOFAC RAD, V40, P67, DOI 10.1259/dmfr/27546065; Arai Y, 1999, DENTOMAXILLOFAC RAD, V28, P245, DOI 10.1038/sj.dmfr.4600448; Araki K, 2004, DENTOMAXILLOFAC RAD, V33, P51, DOI 10.1259/dmfr/54013049; Barriviera M, 2009, J CLIN PERIODONTOL, V36, P564, DOI 10.1111/j.1600-051X.2009.01422.x; BLAND JM, 1995, LANCET, V346, P1085, DOI 10.1016/S0140-6736(95)91748-9; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bryant J, 2011, DENTOMAXILLOFAC RAD, V40, P65, DOI 10.1259/dmfr/34858640; Bryant JA, 2008, DENTOMAXILLOFAC RAD, V37, P365, DOI 10.1259/dmfr/13227258; BURNMURDOCH RA, 1981, ARCH ORAL BIOL, V26, P995, DOI 10.1016/0003-9969(81)90109-6; Carrafiello G, 2010, RADIOL MED, V115, P600, DOI 10.1007/s11547-010-0520-5; de Oliveira AEF, 2009, ORAL SURG ORAL MED O, V107, P256, DOI 10.1016/j.tripleo.2008.05.039; Docquier PL, 2010, ONCOLOGY-BASEL, V78, P115, DOI 10.1159/000306140; Draenert FG, 2007, DENTOMAXILLOFAC RAD, V36, P198, DOI 10.1259/dmfr/32579161; Endo M, 2001, MED PHYS, V28, P469, DOI 10.1118/1.1357457; European Union, 2002, ETS 186, V186; Farman AG, 2009, SEMIN ORTHOD, V15, P2, DOI DOI 10.1053/J.S0D0.2008.09.001; Fourie Z, 2011, CLEFT PALATE-CRAN J, V48, P623, DOI 10.1597/10-076; Fourie Z, 2010, FORENSIC SCI INT, V199, P9, DOI 10.1016/j.forsciint.2010.02.018; Hashimoto K, 2003, ORAL SURG ORAL MED O, V95, P371, DOI 10.1067/moe.2003.120; Hashimoto Koji, 2006, J Oral Sci, V48, P27, DOI 10.2334/josnusd.48.27; Heiland M, 2007, ORAL SURG ORAL MED O, V104, P814, DOI 10.1016/j.tripleo.2007.04.031; Honda K, 2006, DENTOMAXILLOFAC RAD, V35, P152, DOI 10.1259/dmfr/15831361; IMREY PB, 1986, J CLIN PERIODONTOL, V13, P517, DOI 10.1111/j.1600-051X.1986.tb01500.x; Januario AL, 2008, J ESTHET RESTOR DENT, V20, P366, DOI 10.1111/j.1708-8240.2008.00210.x; Katsumata A, 2007, ORAL SURG ORAL MED O, V104, P829, DOI 10.1016/j.tripleo.2006.12.005; Katsumata A, 2009, ORAL SURG ORAL MED O, V107, P420, DOI 10.1016/j.tripleo.2008.05.049; Kobayashi K, 2004, INT J ORAL MAX IMPL, V19, P228; Lascala C, 2004, DENTOMAXILLOFAC RAD, V33, P291, DOI 10.1259/dmfr/25500850; Lee MJ, 2007, RADIOGRAPHICS, V27, P791, DOI 10.1148/rg.273065087; Liang X, 2010, EUR J RADIOL, V75, P265, DOI 10.1016/j.ejrad.2009.03.042; Liang X, 2010, EUR J RADIOL, V75, P270, DOI 10.1016/j.ejrad.2009.04.016; Loubele M, 2008, ORAL SURG ORAL MED O, V105, P512, DOI 10.1016/j.tripleo.2007.05.004; Loubele M, 2007, INT J ORAL MAX IMPL, V22, P446; Loubele M, 2006, ORAL SURG ORAL MED O, V102, P225, DOI 10.1016/j.tripleo.2005.10.039; Ludlow JB, 2006, DENTOMAXILLOFAC RAD, V35, P219, DOI 10.1259/dmfr/14340323; Ludlow JB, 2003, DENTOMAXILLOFAC RAD, V32, P229, DOI 10.1259/dmfr/26310390; Mah P, 2010, DENTOMAXILLOFAC RAD, V39, P323, DOI 10.1259/dmfr/19603304; Mischkowski RA, 2007, ORAL SURG ORAL MED O, V104, P551, DOI 10.1016/j.tripleo.2007.02.021; Mozzo P, 1998, EUR RADIOL, V8, P1558, DOI 10.1007/s003300050586; Muller HP, 2000, J CLIN PERIODONTOL, V27, P431, DOI 10.1034/j.1600-051x.2000.027006431.x; Muller HP, 1999, ORAL SURG ORAL MED O, V88, P248, DOI 10.1016/S1079-2104(99)70123-X; Naitoh M, 2010, ORAL SURG ORAL MED O, V109, pE19, DOI 10.1016/j.tripleo.2009.08.027; Naranjo V, 2011, COMPUT METH PROG BIO, V102, P64, DOI 10.1016/j.cmpb.2010.11.009; Robb R A, 1982, J Med Syst, V6, P539, DOI 10.1007/BF00995505; Schulze D, 2004, DENTOMAXILLOFAC RAD, V33, P83, DOI 10.1259/dmfr/28403350; Seibert J, 1997, ESTHETICS PERIODONTA, P647; Silverman PM, 2001, AM J ROENTGENOL, V176, P1135, DOI 10.2214/ajr.176.5.1761135; Stefan U, 2010, BONE, V47, P1048, DOI 10.1016/j.bone.2010.08.012; Studer SP, 1997, J PERIODONTOL, V68, P145, DOI 10.1902/jop.1997.68.2.145; Sukovic P, 2003, Orthod Craniofac Res, V6 Suppl 1, P31, DOI 10.1034/j.1600-0544.2003.259.x; Suomalainen A, 2008, DENTOMAXILLOFAC RAD, V37, P10, DOI 10.1259/dmfr/14140281; Suomalainen A, 2009, DENTOMAXILLOFAC RAD, V38, P367, DOI 10.1259/dmfr/15779208; Swiss Academy of Medical Science, 2009, SCHWEIZ ARZTEZTG, V90, P102; Trpkova B, 1997, AM J ORTHOD DENTOFAC, V112, P165, DOI 10.1016/S0889-5406(97)70242-7; van Daatselaar AN, 2004, DENTOMAXILLOFAC RAD, V33, P361, DOI 10.1259/dmfr/23496562; Wang YN, 2011, BIOTECH HISTOCHEM, V86, P359, DOI 10.3109/10520295.2010.520275; Yared KFG, 2006, AM J ORTHOD DENTOFAC, V130, DOI 10.1016/j.ajodo.2006.01.015	58	26	28	0	7	BRITISH INST RADIOLOGY	LONDON	36 PORTLAND PLACE, LONDON W1N 4AT, ENGLAND	0250-832X	1476-542X		DENTOMAXILLOFAC RAD	Dentomaxillofac. Radiol.	DEC	2012	41	8					637	644		10.1259/dmfr/21152480			8	Dentistry, Oral Surgery & Medicine; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine; Radiology, Nuclear Medicine & Medical Imaging	056TM	WOS:000312514300003	22554987	Green Published			2022-03-04	
J	Charadram, N; Maniewicz, S; Maggi, S; Petrovic, M; Kossioni, A; Srinivasan, M; Schimmel, M; Mojon, P; Muller, F				Charadram, Nattida; Maniewicz, Sabrina; Maggi, Stefania; Petrovic, Mirko; Kossioni, Anastassia; Srinivasan, Murali; Schimmel, Martin; Mojon, Philippe; Mueller, Frauke		e-Delphi Working grp	Development of a European consensus from dentists, dental hygienists and physicians on a standard for oral health care in care-dependent older people: An e-Delphi study	GERODONTOLOGY			English	Article						care-dependent older adults; e-Delphi study; geriatric oral care; institutionalised older adults	DENTURE CLEANSERS; AMERICAN-COLLEGE; HOME RESIDENTS; ADVANCED LUNG; NURSING-HOME; EFFICACY; DISEASE; PLAQUE; MANAGEMENT; FRAIL	Objectives This study aimed to obtain a consensus on oral health policy, access to dental care, oral hygiene measures and training levels. Background Poor oral health is widespread in care-dependent older people, but no consensus for a minimum standard of oral health care exists yet. Methods The e-Delphi approach was applied to a selected panel of interdisciplinary experts. Data analysis was based on three measurements: (a) >= 70% of experts' opinion fall into category "agree or strongly agree," (b) median score on the 5-point Likert scale >= 4, (c) interquartile range <= 1. Results A total of 31 experts from 17 European countries participated in this survey. Agreement was achieved for a compulsory dental examination when an elder is admitted to a long-term care (LTC) facility. Older people should brush their teeth twice/day and regularly clean interproximal spaces and oral mucosa. Dentures should be rinsed after meals and cleaned twice/day. The use of denture cleansing tablets was considered necessary. Dentures should be removed before sleeping and stored dry. A 5000 ppm fluoride toothpaste should be applied daily in elder with high caries risk. A short report on the oral health status of the elder should be included in the geriatric assessment. All experts concluded that the knowledge and the training in oral health care for caregivers and family members of care-dependent older people were imperative. Conclusions Using the e-Delphi method, multidisciplinary healthcare professionals from different countries agreed on certain cardinal recommendations for a standard oral health care for care-dependent older people.	[Charadram, Nattida; Maniewicz, Sabrina; Mojon, Philippe; Mueller, Frauke] Univ Geneva, Univ Clin Dent Med, Div Gerodontol & Removable Prosthodont, Geneva, Switzerland; [Maggi, Stefania] CNR Inst Neurosci, Aging Branch, Padua, Italy; [Petrovic, Mirko] Univ Ghent, Sect Geriatr, Dept Internal Med & Paediat, Ghent, Belgium; [Kossioni, Anastassia] Natl & Kapodistrian Univ Athens, Dent Sch, Dept Prosthodont, Div Gerodontol, Athens, Greece; [Srinivasan, Murali] Univ Zurich, Ctr Dent Med, Clin Gen Special Care & Geriatr Dent, Zurich, Switzerland; [Schimmel, Martin] Univ Bern, Sch Dent Med, Dept Reconstruct Dent & Gerodontol, Div Gerodontol, Bern, Switzerland		Muller, F (corresponding author), Univ Clin Dent Med, CMU, Div Gerodontol & Removable Prosthodont, 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland.	frauke.mueller@unige.ch	Srinivasan, Murali/B-5159-2013; Müller, Frauke/C-3835-2014; Charadram, Nattida/ABG-6626-2020; Kossioni, Anastassia E/AAA-3193-2020; Schimmel, Martin/F-5694-2011; Maniewicz, Sabrina/X-9934-2018; Maniewicz, Sabrina/ABB-3416-2021	Srinivasan, Murali/0000-0003-3365-576X; Müller, Frauke/0000-0003-3981-0134; Kossioni, Anastassia E/0000-0003-0610-6984; Schimmel, Martin/0000-0001-9700-5534; Maniewicz, Sabrina/0000-0002-3343-787X; Maniewicz, Sabrina/0000-0002-3343-787X; Soiza, Roy/0000-0002-1397-4272; Wardh, Inger/0000-0003-0939-802X; Janssens, Barbara/0000-0003-3490-0114	Universite de Geneve; Division of Gerodontology and Removable Prosthodontics of the University of Geneva	Universite de Geneve, Grant/Award Number: This study was entirely funded by public funds, allocated to the Division of Gerodontology and Removable Prosthodontics of the University of Geneva.	Abdallah Claude, 2015, J Anaesthesiol Clin Pharmacol, V31, P152, DOI 10.4103/0970-9185.155140; Akins Ralitsa B, 2005, BMC Med Res Methodol, V5, P37, DOI 10.1186/1471-2288-5-37; Andersson P, 2017, COMMUNITY DENT HLTH, V34, P203, DOI 10.1922/CDH_4100Andersson05; Gil-Montoya JA, 2015, CLIN INTERV AGING, V10, DOI 10.2147/CIA.S54630; ARIAUDO AA, 1971, J PERIODONTOL, V42, P309, DOI 10.1902/jop.1971.42.5.309; Armstrong D, 2005, CAN J GASTROENTEROL, V19, P15, DOI 10.1155/2005/836030; Atkinson JC, 2000, J AM DENT ASSOC, V131, P345, DOI 10.14219/jada.archive.2000.0178; AUGSBURGER RH, 1982, J PROSTHET DENT, V47, P356, DOI 10.1016/S0022-3913(82)80079-6; Avlund Kirsten, 2004, Gerodontology, V21, P17, DOI 10.1046/j.1741-2358.2003.00003.x; Azarpazhooh A, 2006, J PERIODONTOL, V77, P1465, DOI 10.1902/jop.2006.060010; BALENSEIFEN JW, 1970, J DENT RES, V49, P320, DOI 10.1177/00220345700490022101; Baumgartner Willy, 2015, Swiss Dent J, V125, P417; Beirne P, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004346.pub3; Benn D K, 1999, J Am Coll Dent, V66, P27; Bots-VantSpijker PC, 2014, COMMUNITY DENT ORAL, V42, P113, DOI 10.1111/cdoe.12068; Bouattour Y, 2020, INT J PROSTHODONTICS; Bramanti Ennio, 2012, Dent Res J (Isfahan), V9, P361; Butler-Jones D, 2010, REPORT STATE PUBLIC; Chalmers J M, 2000, Spec Care Dentist, V20, P147, DOI 10.1111/j.1754-4505.2000.tb01152.x; Chapple ILC, 2015, J CLIN PERIODONTOL, V42, pS71, DOI 10.1111/jcpe.12366; Charles L, 2017, CAN GERIATR J, V20, P75, DOI 10.5770/cgj.20.252; Chen X, 2013, J AM DENT ASSOC, V144, P1234, DOI 10.14219/jada.archive.2013.0051; Christina CA, 2005, CAN J PROGRAM EVAL, V20, P272; Christou V, 1998, J PERIODONTOL, V69, P759, DOI 10.1902/jop.1998.69.7.759; Chung J P, 2000, Spec Care Dentist, V20, P12, DOI 10.1111/j.1754-4505.2000.tb00004.x; Claydon NC, 2008, PERIODONTOL 2000, V48, P10, DOI 10.1111/j.1600-0757.2008.00273.x; Cohen-Mansfield Jiska, 2002, Am J Alzheimers Dis Other Demen, V17, P249, DOI 10.1177/153331750201700404; Cohen-Mansfield J, 2012, J CLIN PSYCHIAT, V73, P1255, DOI 10.4088/JCP.12m07918; Crosby G, 2010, MAYO CLIN PROC, V85, P12, DOI 10.4065/mcp.2009.0724; Cruz PC, 2011, J APPL ORAL SCI, V19, P668, DOI 10.1590/S1678-77572011000600021; Cutler CW, 2000, J CLIN PERIODONTOL, V27, P134, DOI 10.1034/j.1600-051x.2000.027002134.x; Dalkey NC, 1969, DELPHI METHOD EXPT S; Danser M M, 2003, Int J Dent Hyg, V1, P151, DOI 10.1034/j.1601-5037.2003.00034.x; Davies R M, 2004, Clin Oral Investig, V8, P2, DOI 10.1007/s00784-003-0234-3; Porta SRD, 2015, GERODONTOLOGY, V32, P260, DOI 10.1111/ger.12104; de Souza RF, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007395.pub2; DeBowes SL, 2013, INT J DENT HYG, V11, P15, DOI 10.1111/j.1601-5037.2012.00548.x; Decker SL, 2011, JAMA-J AM MED ASSOC, V306, P187, DOI 10.1001/jama.2011.956; Deep P, 2000, J Can Dent Assoc, V66, P298; DeRiso A, 1996, CHEST, V109, P1556, DOI 10.1378/chest.109.6.1556; Deschepper M, 2018, INTENS CARE MED, V44, P1017, DOI 10.1007/s00134-018-5171-3; Dharamsi S, 2009, J DENT EDUC, V73, P581; Douglas H, 2017, AUST HEALTH REV, V41, P455, DOI 10.1071/AH16038; Duyck J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145837; Fiske Janice, 2006, Gerodontology, V23 Suppl 1, P5; FLOTRA L, 1971, Scandinavian Journal of Dental Research, V79, P119; Frame PS, 2000, AM J PREV MED, V18, P159, DOI 10.1016/S0749-3797(99)00138-5; Frascella JA, 2000, AM J DENT, V13, P55; Gaszynska E, 2014, CLIN INTERV AGING, V9, P1637, DOI 10.2147/CIA.S69790; Gil-Montoya JA, 2006, GERIATR NURS, V27, P95, DOI 10.1016/j.gerinurse.2005.12.003; Guessous I, 2014, BMC ORAL HEALTH, V14, DOI 10.1186/1472-6831-14-121; Hasson F, 2000, J ADV NURS, V32, P1008, DOI 10.1046/j.1365-2648.2000.01567.x; Heo SM, 2008, CLIN INFECT DIS, V47, P1562, DOI 10.1086/593193; Hoeksema AR, 2017, CLIN ORAL INVEST, V21, P2189, DOI 10.1007/s00784-016-2011-0; Hopcraft MS, 2008, AUST DENT J, V53, P239, DOI 10.1111/j.1834-7819.2008.00055.x; Iinuma T, 2015, J DENT RES, V94, p28S, DOI 10.1177/0022034514552493; Imsand M, 2002, Gerodontology, V19, P66, DOI 10.1111/j.1741-2358.2002.00066.x; Izumi M, 2016, J ORAL REHABIL, V43, P953, DOI 10.1111/joor.12451; Jackson MA, 2006, J PERIODONTOL, V77, P1421, DOI 10.1902/jop.2006.050360; Kawato T., 2019, J CAN DENT ASSOC, V84, pI7; Keeney S., 2011, DELPHI TECHNIQUE NUR, V1; Keyf F, 2003, J BIOMATER APPL, V18, P5, DOI 10.1177/0885328203018001001; Kocak Mustafa Murat, 2009, Eur J Dent, V3, P57; Kossioni AE, 2018, J AM MED DIR ASSOC, V19, P1039, DOI 10.1016/j.jamda.2018.10.007; Kossioni AE, 2018, J AM GERIATR SOC, V66, P609, DOI 10.1111/jgs.15191; Kulak-Ozkan Y, 2002, J ORAL REHABIL, V29, P300, DOI 10.1046/j.1365-2842.2002.00816.x; Levasseur Melanie, 2007, Can J Occup Ther, V74 Spec No., P233; Lewis A, 2015, AUST DENT J, V60, P95, DOI 10.1111/adj.12288; Likert R.A., 1932, TECHNIQUE MEASUREMEN; LOE H, 1979, J CLIN PERIODONTOL, V6, P32, DOI 10.1111/j.1600-051X.1979.tb02116.x; Logan H L, 1991, Spec Care Dentist, V11, P243, DOI 10.1111/j.1754-4505.1991.tb01488.x; Mahler DA, 2010, POL ARCH MED WEWN, V120, P160, DOI 10.20452/pamw.915; Mahler DA, 2010, CHEST, V137, P674, DOI 10.1378/chest.09-1543; Manabe T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140060; Manski RJ, 2002, J AM DENT ASSOC, V133, P1551, DOI 10.14219/jada.archive.2002.0087; Marino R, 2016, J TELEMED TELECARE, V22, P326, DOI 10.1177/1357633X15608991; McKenna H, 2010, RES PROCESS NURSING, P260; Meyer-Lueckel H, 2019, CARIES RES, V53, P599, DOI 10.1159/000501588; Mojon P, 2004, INT J PROSTHODONT, V17, P434; Mulk BS, 2014, J CLIN DIAGN RES, V8, pZE1, DOI 10.7860/JCDR/2014/8898.4427; Najafi Mohammad Hassan, 2012, Dent Res J (Isfahan), V9, P305; Navazesh Mahvash, 2002, Compend Contin Educ Dent, V23, P41; Nikawa H, 1999, INT J PROSTHODONT, V12, P153; Par M, 2014, ACTA CLIN CROAT, V53, P72; Paranhos Helena de Freitas Oliveira, 2004, Braz. oral res., V18, P215, DOI 10.1590/S1806-83242004000300007; Petersen PE, 2005, COMMUNITY DENT ORAL, V33, P81, DOI 10.1111/j.1600-0528.2004.00219.x; Pires CW, 2017, ORAL HLTH PREV DENT, V15, P73, DOI 10.3290/j.ohpd.a37716; Powell C, 2003, J ADV NURS, V41, P376, DOI 10.1046/j.1365-2648.2003.02537.x; Pretty IA, 2014, GERODONTOLOGY, V31, P77, DOI 10.1111/ger.12098; Quagliarello V, 2005, CLIN INFECT DIS, V40, P1, DOI 10.1086/426023; Quirynen M, 2001, J CLIN PERIODONTOL, V28, P1127, DOI 10.1034/j.1600-051X.2001.281207.x; Ragher M, 2017, J PHARM BIOALLIED SC, V9, pS241, DOI 10.4103/jpbs.JPBS_112_17; Rak O S, 1990, Community Dent Health, V7, P295; Ramage G, 2019, J ORAL MICROBIOL, V11, DOI 10.1080/20002297.2018.1538437; Ramos Delfina, 2016, Dyna rev.fac.nac.minas, V83, P14, DOI 10.15446/dyna.v83n196.56603; Ramseier C, ORAL HLTH PREV DENT; RASKIN MS, 1994, J SOC WORK EDUC, V30, P75, DOI 10.1080/10437797.1994.10672215; Ray P. K., 1990, International Journal of Operations & Production Management, V10, P25, DOI 10.1108/01443579010005245; Rayens M. K., 2000, POLICY POLITICS NURS, V1, P308, DOI DOI 10.1177/152715440000100409; Razak P Abdul, 2014, J Int Oral Health, V6, P110; Salzer S, 2015, J CLIN PERIODONTOL, V42, pS92, DOI 10.1111/jcpe.12363; Sambunjak D, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008829.pub2; Schneider C, 2017, EUR J ORAL SCI, V125, P55, DOI 10.1111/eos.12327; Schonlau M, 2015, SURV RES METHODS-GER, V9, P125; Seppi K, 2011, MOVEMENT DISORD, V26, pS42, DOI 10.1002/mds.23884; Sinha M, 2012, RESULTS GEN SOCIAL S; Srinivasan M, 2019, GERODONTOLOGY, V36, P125, DOI 10.1111/ger.12388; Srinivasan M, 2014, COMMUNITY DENT ORAL, V42, P333, DOI 10.1111/cdoe.12090; Stiefel DJ, 2002, SPEC CARE DENT, V22, P26; Sweeney MP, 2007, COMMUNITY DENT HLTH, V24, P37; Torres-Pereira CC, 2013, TELEMED E-HEALTH, V19, P117, DOI 10.1089/tmj.2012.0087; VIGILD M, 1990, ACTA ODONTOL SCAND, V48, P99, DOI 10.3109/00016359009005864; WANG NJ, 1995, COMMUNITY DENT ORAL, V23, P1, DOI 10.1111/j.1600-0528.1995.tb00189.x; Warth J, 2013, TECHNOL FORECAST SOC, V80, P566, DOI 10.1016/j.techfore.2012.04.005; White SM, 2010, ANAESTHESIA, V65, P778, DOI 10.1111/j.1365-2044.2010.06456.x; Wigger-Alberti W, 2010, J BREATH RES, V4, DOI 10.1088/1752-7155/4/1/017102; WILLIAMS PL, 1994, J ADV NURS, V19, P180, DOI 10.1111/j.1365-2648.1994.tb01066.x; Winnier J Jasmin, 2013, Int J Clin Pediatr Dent, V6, P188, DOI 10.5005/jp-journals-10005-1216; Wolden Heidi, 2006, Gerodontology, V23, P106, DOI 10.1111/j.1741-2358.2006.00114.x; Wu B, 2007, AM J PUBLIC HEALTH, V97, P2216, DOI 10.2105/AJPH.2007.109934	120	1	1	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0734-0664	1741-2358		GERODONTOLOGY	Gerodontology	MAR	2021	38	1					41	56		10.1111/ger.12501		OCT 2020	16	Dentistry, Oral Surgery & Medicine; Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Dentistry, Oral Surgery & Medicine; Geriatrics & Gerontology	QG7LE	WOS:000579223200001	33073408	Green Submitted, Green Published			2022-03-04	
J	Dauve, V; McLin, VA				Dauve, Veronique; McLin, Valerie A.			Recent Advances in the Molecular and Genetic Understanding of Congenital Gastrointestinal Malformations	JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION			English	Review						development; gastrointestinal malformations; molecular regulation	ESOPHAGEAL ATRESIA; CHARGE SYNDROME; TRACHEOESOPHAGEAL; ASSOCIATION; PANCREAS; HAPLOINSUFFICIENCY; DISRUPTION; MUTATIONS; EMBRYOS; LUNG	Major developmental paradigms are highly conserved among vertebrates. The contribution of developmental biology to the understanding of human disease and regeneration has soared recently. We review advances in the molecular and genetic understanding of gastrointestinal development using evidence from both mammalian and nonmammalian models. When appropriate, we highlight relevance and applicability to human disease.	Hop Univ Geneve, Dept Pediat, Fac Med, CH-1211 Geneva 14, Switzerland; Univ Geneva, Geneva, Switzerland		McLin, VA (corresponding author), Hop Univ Geneve, Dept Pediat, CH-1211 Geneva 14, Switzerland.	valerie.mclin@hcuge.ch			Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission [31003A-132721]; Gertrude von Meissner Foundation; Hans Wilsdorf Foundation (Geneva, Switzerland)	The present work was supported by the Swiss National Science Foundation (grant 31003A-132721) and the Gertrude von Meissner Foundation to V.A.M. and Hans Wilsdorf Foundation (Geneva, Switzerland) to V.D.	Arsic D, 2004, J PEDIATR SURG, V39, P1747, DOI 10.1016/j.jpedsurg.2004.08.013; Bagnat M, 2007, NAT CELL BIOL, V9, P954, DOI 10.1038/ncb1621; Bianchi D, 2000, FETOLOGY DIAGNOSIS M; Bonal C, 2008, INT J DEV BIOL, V52, P823, DOI 10.1387/ijdb.072444cb; Chung E, 1996, AM J HUM GENET, V58, P363; Chung E, 2008, ARCH DIS CHILD, V93, P1003, DOI 10.1136/adc.2008.141499; Delahaye A, 2007, CLIN GENET, V72, P112, DOI 10.1111/j.1399-0004.2007.00821.x; DORNEY SFA, 1987, J PEDIATR GASTR NUTR, V6, P307, DOI 10.1097/00005176-198703000-00026; Fairbanks TJ, 2004, J PEDIATR SURG, V39, P872, DOI 10.1016/j.jpedsurg.2004.02.026; Feenstra B, 2012, NAT GENET, V44, P334, DOI 10.1038/ng.1067; Filippi L, 2008, EUR J PEDIATR SURG, V18, P195, DOI 10.1055/s-2008-1038503; Hajduk P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027635; Hebrok M, 2000, DEVELOPMENT, V127, P4905; HUANG PL, 1993, CELL, V75, P1273, DOI 10.1016/0092-8674(93)90615-W; Ioannides AS, 2010, DEV BIOL, V337, P351, DOI 10.1016/j.ydbio.2009.11.005; Jongmans MCJ, 2009, CLIN GENET, V75, P65, DOI 10.1111/j.1399-0004.2008.01107.x; Kanard RC, 2005, J PEDIATR SURG, V40, P313, DOI 10.1016/j.jpedsurg.2004.10.057; Louw J H, 1966, S Afr J Surg, V4, P57; LOUW JH, 1955, LANCET, V2, P1065; Mahlapuu M, 2001, DEVELOPMENT, V128, P2397; Matsumoto A, 2002, ANAT EMBRYOL, V205, P53, DOI 10.1007/s00429-001-0226-5; Minoo P, 1999, DEV BIOL, V209, P60, DOI 10.1006/dbio.1999.9234; Mitchell J, 2004, DIABETOLOGIA, V47, P2160, DOI 10.1007/s00125-004-1576-3; Moniot B, 2004, DEVELOPMENT, V131, P3795, DOI 10.1242/dev.01259; Nagendran S, 2009, ANN THORAC SURG, V88, P2040, DOI 10.1016/j.athoracsur.2009.02.070; Nawaz A, 2005, PEDIATR SURG INT, V21, P589, DOI 10.1007/s00383-005-1412-y; Nayci A, 2003, PEDIATR SURG INT, V19, P742, DOI 10.1007/s00383-003-0973-x; Nichol PF, 2011, J GASTROINTEST SURG, V15, P694, DOI 10.1007/s11605-010-1400-y; Noah TK, 2011, EXP CELL RES, V317, P2702, DOI 10.1016/j.yexcr.2011.09.006; Pearl EJ, 2011, DEV BIOL, V351, P135, DOI 10.1016/j.ydbio.2010.12.043; Petrackova I, 2004, EUR J PEDIATR, V163, P333, DOI 10.1007/s00431-004-1424-y; Pumberger W, 2012, SURG TODAY, V42, P589, DOI 10.1007/s00595-012-0123-y; Qi BQ, 2000, DEV GROWTH DIFFER, V42, P145; Ramalho-Santos M, 2000, DEVELOPMENT, V127, P2763; Sanlaville D, 2006, J MED GENET, V43, P211, DOI 10.1136/jmg.2005.036160; Shaw-Smith C, 2006, J MED GENET, V43, P545, DOI 10.1136/jmg.2005.038158; Smith DM, 2000, DEVELOPMENT, V127, P3671; Spiegel R, 2011, AM J MED GENET A, V155A, P2821, DOI 10.1002/ajmg.a.34251; Spitz L, 2006, J PEDIATR SURG, V41, P1635, DOI 10.1016/j.jpedsurg.2006.07.004; Stankiewicz P, 2009, AM J HUM GENET, V84, P780, DOI 10.1016/j.ajhg.2009.05.005; Stern L E, 2000, Semin Pediatr Surg, V9, P135, DOI 10.1053/spsu.2000.7565; Sukegawa A, 2000, DEVELOPMENT, V127, P1971; Tandler J., 1900, MORPH JAHRBUCH, V29, P187; Tongsin Achariya, 2008, J Med Assoc Thai, V91 Suppl 3, pS85; van Bokhoven H, 2005, NAT GENET, V37, P465, DOI 10.1038/ng1546; van Noort M, 2002, DEV BIOL, V244, P1, DOI 10.1006/dbio.2001.0566; VANBEERS B, 1989, J COMPUT ASSIST TOMO, V13, P528; Zhao R, 2005, HEPATOLOGY, V41, P956, DOI 10.1002/hep.20691; Zorn AM, 2009, ANNU REV CELL DEV BI, V25, P221, DOI 10.1146/annurev.cellbio.042308.113344; Zorn AM., 2008, LIVER DEV	50	6	6	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0277-2116	1536-4801		J PEDIATR GASTR NUTR	J. Pediatr. Gastroenterol. Nutr.	JUL	2013	57	1					4	13		10.1097/MPG.0b013e3182922b49			10	Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics	248ZD	WOS:000326744500006	23539045				2022-03-04	
J	Schappi, MG; Meier, S; Bel, M; Siegrist, CA; Posfay-Barbe, KM				Schappi, Michela G.; Meier, Sara; Bel, Michael; Siegrist, Claire-Anne; Posfay-Barbe, Klara M.		H1N1 Study Grp	Protective Antibody Responses to Influenza A/H1N1/09 Vaccination in Children With Celiac Disease	JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION			English	Article						celiac disease; children; influenza; responder; vaccination	HEPATITIS-B-VACCINE	Patients with celiac disease have an increased risk for severe influenza infection and they show less of a response to certain vaccine types. During the influenza A/H1N1/09 pandemic, we prospectively investigated pandemic vaccine responses in 14 pediatric patients with celiac disease and age-/sex-matched controls. All of the children with celiac disease reached protective antibody titers (>= 40) and showed a geometric mean titer comparable with the control group (530 vs 573).	[Schappi, Michela G.; Meier, Sara; Bel, Michael; Siegrist, Claire-Anne; Posfay-Barbe, Klara M.; H1N1 Study Grp] Univ Hosp Geneva, Dept Pediat, Geneva, Switzerland		Schappi, MG (corresponding author), Childrens Hosp Geneva, Pediat Gastroenterol Unit, 6 Rue Willy Donze, CH-1211 Geneva 14, Switzerland.	Michela.Tempia-Caliera@hcuge.ch	Schäppi, Michela/D-5363-2012; Schäppi Tempia-Caliera, Michela/A-7619-2012; Posfay-Barbe, Klara M./AAV-2515-2021; Posfay-Barbe, Klara M/E-9131-2013	Schäppi Tempia-Caliera, Michela/0000-0002-9860-7294; Posfay-Barbe, Klara M./0000-0001-9464-5704; Posfay-Barbe, Klara M/0000-0001-9464-5704; Passweg, Jakob R/0000-0001-7092-3351	Clinical Research Center of the University Hospitals of Geneva; Medical Faculty of Geneva; Center of Vaccinology	This work was supported by an institutional grant of the Clinical Research Center of the University Hospitals of Geneva and Medical Faculty of Geneva and by the Center of Vaccinology.	Ertem D, 2010, EUR J GASTROEN HEPAT, V22, P787, DOI 10.1097/MEG.0b013e32832e9d41; Marild K, 2010, AM J GASTROENTEROL, V105, P2465, DOI 10.1038/ajg.2010.352; MAWHINNEY H, 1975, CLIN EXP IMMUNOL, V21, P399; MCKINLEY M, 1995, J CLIN GASTROENTEROL, V20, P113, DOI 10.1097/00004836-199503000-00008; Meier S, 2011, VACCINE, V29, P3548, DOI 10.1016/j.vaccine.2011.02.094; Nemes E, 2008, PEDIATRICS, V121, pE1570, DOI 10.1542/peds.2007-2446; Park SD, 2007, J PEDIATR GASTR NUTR, V44, P431, DOI 10.1097/MPG.0b013e3180320654; Pettingale KW, 1970, CLIN SCI, V38, P16; Zingone F, 2011, VACCINE, V29, P1005, DOI 10.1016/j.vaccine.2010.11.060	9	6	6	0	29	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0277-2116			J PEDIATR GASTR NUTR	J. Pediatr. Gastroenterol. Nutr.	JUN	2012	54	6					817	819		10.1097/MPG.0b013e318248e7be			3	Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics	943JA	WOS:000304115900022	22228003	Green Published			2022-03-04	
J	Bhatia, M; Platon, A; Khabiri, E; Becker, C; Poletti, PA				Bhatia, Mona; Platon, Alexandra; Khabiri, Ebrahim; Becker, Christoph; Poletti, Pierre-Alexandre			Contrast enhanced ultrasonography versus MR angiography in aortocaval fistula: case report	ABDOMINAL IMAGING			English	Article						Aortocaval fistula; Contrast enhanced ultrasound; Magnetic resonance angiography; CT angiography; Emergency radiology	ABDOMINAL AORTIC-ANEURYSM; ULTRASOUND; DIAGNOSIS	Aortocaval fistula (ACF) is a rare, life threatening complication of abdominal aortic aneurysms. Time to diagnosis is crucial as preoperative diagnosis and early surgical intervention significantly improve the outcome. The clinical spectrum being varied, the challenge of prompt and reliable diagnosis rests on emergency radiology. While the gold standard for detecting ACF today is CT angiography (CTA), frequently complicating renal insufficiency discourages the use of iodinated contrast making MR angiography (MRA) a useful alternative. Contrast enhanced ultrasound (CEUS) provides a promising new diagnostic option allowing rapid, non invasive and bedside diagnosis, especially in hemodynamically unstable patients. We present a case of prompt diagnosis of ACF by CEUS in comparison to modern MRA, thus establishing the new potential role of CEUS.	[Bhatia, Mona; Platon, Alexandra; Becker, Christoph; Poletti, Pierre-Alexandre] Univ Hosp Geneva, Dept Radiol, Geneva, Switzerland; [Khabiri, Ebrahim] Univ Hosp Geneva, Dept Cardiovasc Surg, Geneva, Switzerland		Bhatia, M (corresponding author), Univ Hosp Geneva, Dept Radiol, Geneva, Switzerland.	mona.bhatia@hcuge.ch					Adam DJ, 1998, J VASC SURG, V27, P431, DOI 10.1016/S0741-5214(98)70317-9; Barr R, 2002, EUR J RADIOL, V41, P207, DOI 10.1016/S0720-048X(01)00461-2; Catalano O, 2005, AM J ROENTGENOL, V184, P423, DOI 10.2214/ajr.184.2.01840423; Clevert DA, 2007, EUR RADIOL, V17, P2991, DOI 10.1007/s00330-006-0542-5; Clevert DA, 2007, CARDIOVASC INTER RAD, V30, P480, DOI 10.1007/s00270-006-0143-3; Coulier Bruno, 2004, Emerg Radiol, V11, P100, DOI 10.1007/s10140-004-0375-y; Davidovic LB, 2002, CARDIOVASC SURG, V10, P555, DOI 10.1016/S0967-2109(02)00106-0; Fenster MS, 1996, CATHETER CARDIO DIAG, V38, P75, DOI 10.1002/(SICI)1097-0304(199605)38:1<75::AID-CCD17>3.0.CO;2-R; Gaa J, 1999, EUR RADIOL, V9, P1438, DOI 10.1007/s003300050866; Greis C, 2004, EUR RADIOL, V14, pP11, DOI 10.1007/s10406-004-0076-3; Jones Peter G, 2003, Emerg Med (Fremantle), V15, P54, DOI 10.1046/j.1442-2026.2003.00409.x; Rajmohan B, 2002, J Postgrad Med, V48, P203; Rosenthal D, 1998, ANN VASC SURG, V12, P86, DOI 10.1007/s100169900122; Salerno S, 2007, INT J CARDIOVAS IMAG, V23, P635, DOI 10.1007/s10554-006-9158-8; Syme J, 1831, EDINBURGH MED SURG J, V36, P1045	15	4	4	0	2	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0942-8925	1432-0509		ABDOM IMAGING	Abdom. Imaging	JUN	2010	35	3					376	380		10.1007/s00261-009-9507-x			5	Gastroenterology & Hepatology; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Gastroenterology & Hepatology; Radiology, Nuclear Medicine & Medical Imaging	611IV	WOS:000278809700020	19319592	Green Submitted			2022-03-04	
J	Aurrand-Lions, M; Johnson-Leger, C; Lamagna, C; Ozaki, H; Kita, T; Imhof, BA				Aurrand-Lions, M; Johnson-Leger, C; Lamagna, C; Ozaki, H; Kita, T; Imhof, BA			Junctional adhesion molecules and interendothelial junctions	CELLS TISSUES ORGANS			English	Article; Proceedings Paper	Symposium on Molecular Approaches to Cell-Cell Adhesion	JAN, 2001	ESSEN, GERMANY			endothelial junctions; junctional adhesion molecules; lymphocytes; transmigration; homing	IMMUNOGLOBULIN SUPERFAMILY; MEMBRANE-PROTEIN; TIGHT JUNCTIONS; MIGRATION; LYMPHOCYTES; CLONING; MEMBER; CELLS	Similar to epithelia, endothelial cells are linked to each other via intercellular junctional complexes including gap junctions, adherens junctions and tight junctions. While polarized epithelial cells show a high degree of spatial sorting of junctional complexes, endothelia organize their junctions randomly. For this reason the nature of endothelial contacts may be highly adaptable to the need of permeability and leukocyte transmigration. For instance, high endothelial venules (HEVs) in lymphoid organs, where lymphocytes continuously exit the bloodstream, generally show more leaky contacts than brain with its impermeable blood-brain barrier. We recently identified an Ig superfamily molecule named JAM-2 which is specifically expressed in junctions of lymphatic endothelial cells and HEVs. We showed that JAM-2 belongs to the novel CTX molecular family and we now cloned the human equivalent of JAM-2. The presence of JAM-2 at sites of constitutive lymphocyte circulation argues for a role of this molecule in facilitating transmigration. This is supported by the increased transmigration in vitro across endothelial cells over-expressing JAM-2 at intercellular contacts. Copyright (C) 2002 S. Karger AG, Basel.	Univ Geneva, Dept Pathol, CH-1211 Geneva, Switzerland; Kyoto Univ, Fac Med, Grad Sch Med, Dept Geriatr Med, Kyoto, Japan		Imhof, BA (corresponding author), Univ Geneva, Dept Pathol, 1,Rue Michel Servet, CH-1211 Geneva, Switzerland.	Beat.Imhof@medecine.unige.ch	Aurrand-Lions, Michel/O-9953-2016	Aurrand-Lions, Michel/0000-0002-8361-3034			Allport JR, 2000, J CELL BIOL, V148, P203, DOI 10.1083/jcb.148.1.203; Anderson JM, 1993, CURR OPIN CELL BIOL, V5, P772, DOI 10.1016/0955-0674(93)90024-K; Aurrand-Lions M, 2001, J BIOL CHEM, V276, P2733, DOI 10.1074/jbc.M005458200; Aurrand-Lions MA, 2000, CURR TOP MICROBIOL, V251, P91; AURRANDLIONS M, 2001, IN PRESS BLOOD; Bazzoni G, 2000, J BIOL CHEM, V275, P20520, DOI 10.1074/jbc.M905251199; Beyer Eric C., 1993, V137C, P1; Burns AR, 2000, J CELL SCI, V113, P45; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Craven SE, 1998, CELL, V93, P495, DOI 10.1016/S0092-8674(00)81179-4; DEJANA E, 1995, FASEB J, V9, P910, DOI 10.1096/fasebj.9.10.7615160; DelMaschio A, 1996, J CELL BIOL, V135, P497, DOI 10.1083/jcb.135.2.497; DUPASQUIER L, 1999, P 6 WORKSH MHC EV; Ebnet K, 2000, J BIOL CHEM, V275, P27979; Ebnet K, 2001, EMBO J, V20, P3738, DOI 10.1093/emboj/20.14.3738; Feng D, 1998, J EXP MED, V187, P903, DOI 10.1084/jem.187.6.903; FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; GOWANS JL, 1964, PROC R SOC SER B-BIO, V159, P257, DOI 10.1098/rspb.1964.0001; GUMBINER BM, 1993, J CELL BIOL, V123, P1631, DOI 10.1083/jcb.123.6.1631; Hirata K, 2001, J BIOL CHEM, V276, P16223, DOI 10.1074/jbc.M100630200; Hordijk PL, 1999, J CELL SCI, V112, P1915; HUANG AJ, 1993, J CELL BIOL, V120, P1371, DOI 10.1083/jcb.120.6.1371; IMHOF BA, 1995, ADV IMMUNOL, V58, P345, DOI 10.1016/S0065-2776(08)60623-9; Itoh M, 2001, J CELL BIOL, V154, P491, DOI 10.1083/jcb.200103047; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Johnson-Leger C, 2000, J CELL SCI, V113, P921; KEMLER R, 1993, TRENDS GENET, V9, P317, DOI 10.1016/0168-9525(93)90250-L; Kostrewa D, 2001, EMBO J, V20, P4391, DOI 10.1093/emboj/20.16.4391; Kwak BR, 2001, MOL BIOL CELL, V12, P831, DOI 10.1091/mbc.12.4.831; Lampe PD, 2000, ARCH BIOCHEM BIOPHYS, V384, P205, DOI 10.1006/abbi.2000.2131; LAMPUGNANI MG, 1992, J CELL BIOL, V118, P1511, DOI 10.1083/jcb.118.6.1511; Mackay CR, 2001, NAT IMMUNOL, V2, P95, DOI 10.1038/84298; Martin-Padura I, 1998, J CELL BIOL, V142, P117, DOI 10.1083/jcb.142.1.117; Martinez-Estrada OM, 2001, J BIOL CHEM, V276, P9291, DOI 10.1074/jbc.M006991200; Ozaki H, 1999, J IMMUNOL, V163, P553; Palmeri D, 2000, J BIOL CHEM, V275, P19139, DOI 10.1074/jbc.M003189200; Rubin Lee L., 1992, Current Opinion in Cell Biology, V4, P830, DOI 10.1016/0955-0674(92)90107-N; Salmi M, 1997, ADV IMMUNOL, V64, P139, DOI 10.1016/S0065-2776(08)60889-5; SCHMELZ M, 1993, EUR J CELL BIOL, V61, P274; SIMIONESCU M, 1991, CELL BIOL REV, V25, P5; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Vestweber D, 2000, J PATHOL, V190, P281; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; Wiedle G, 2001, CRIT REV CL LAB SCI, V38, P1, DOI 10.1080/20014091084164; WILLIAMS RL, 1989, CELL, V57, P1053, DOI 10.1016/0092-8674(89)90343-7	47	27	28	0	2	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1422-6405	1422-6421		CELLS TISSUES ORGANS	Cells Tissues Organs		2002	172	3					152	160		10.1159/000066967			9	Anatomy & Morphology; Cell Biology; Developmental Biology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Anatomy & Morphology; Cell Biology; Developmental Biology	634LE	WOS:000180340200002	12476045				2022-03-04	
J	Perneger, TV; Combescure, C				Perneger, Thomas V.; Combescure, Christophe			The distribution of P-values in medical research articles suggested selective reporting associated with statistical significance	JOURNAL OF CLINICAL EPIDEMIOLOGY			English	Article						Statistical tests; P-values; Publication bias; Practice of research	SCIENCE-WISE FALSE; DISCOVERY RATE; PUBLICATION; INFERENCES; ABSTRACTS	Objectives: Published P-values provide a window into the global enterprise of medical research. The aim of this study was to use the distribution of published P-values to estimate the relative frequencies of null and alternative hypotheses and to seek irregularities suggestive of publication bias. Study Design and Setting: This cross-sectional study included P-values published in 120 medical research articles in 2016 (30 each from the BMJ, JAMA, Lancet, and New England Journal of Medicine). The observed distribution of P-values was compared with expected distributions under the null hypothesis (i.e., uniform between 0 and 1) and the alternative hypothesis (strictly decreasing from 0 to 1). P-values were categorized according to conventional levels of statistical significance and in one-percent intervals. Results: Among 4,158 recorded P-values, 26.1% were highly significant (P < 0.001), 9.1% were moderately significant (P > 0.001 to < 0.01), 11.7% were weakly significant (P >= 0.01 to < 0.05), and 53.2% were nonsignificant (P >= 0.05). We noted three irregularities: (1) high proportion of P-values <0.001, especially in observational studies, (2) excess of P-values equal to 1, and (3) about twice as many P-values less than 0.05 compared with those more than 0.05. The latter finding was seen in both randomized trials and observational studies, and in most types of analyses, excepting heterogeneity tests and interaction tests. Under plausible assumptions, we estimate that about half of the tested hypotheses were null and the other half were alternative. Conclusion: This analysis suggests that statistical tests published in medical journals are not a random sample of null and alternative hypotheses but that selective reporting is prevalent. In particular, significant results are about twice as likely to be reported as nonsignificant results. (C) 2017 Elsevier Inc. All rights reserved.	[Perneger, Thomas V.] Univ Geneva, Fac Med, Div Clin Epidemiol, 6 Rue Gabrielle Perret Gentil, CH-1211 Geneva, Switzerland; Geneva Univ Hosp, 6 Rue Gabrielle Perret Gentil, CH-1211 Geneva, Switzerland		Perneger, TV (corresponding author), Univ Geneva, Fac Med, Div Clin Epidemiol, 6 Rue Gabrielle Perret Gentil, CH-1211 Geneva, Switzerland.	thomas.perneger@hcuge.ch					BEGG CB, 1988, J ROY STAT SOC A STA, V151, P419, DOI 10.2307/2982993; Benjamini Y, 2014, BIOSTATISTICS, V15, P13, DOI 10.1093/biostatistics/kxt032; Bland M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076010; Chavalarias D, 2016, JAMA-J AM MED ASSOC, V315, P1141, DOI 10.1001/jama.2016.1952; DICKERSIN K, 1992, JAMA-J AM MED ASSOC, V267, P374, DOI 10.1001/jama.267.3.374; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; Feinstein AR, 1998, J CLIN EPIDEMIOL, V51, P355, DOI 10.1016/S0895-4356(97)00295-3; Gelman A, 2014, BIOSTATISTICS, V15, P18, DOI 10.1093/biostatistics/kxt034; Ginsel Bastiaan, 2015, BMC Res Notes, V8, P721, DOI 10.1186/s13104-015-1691-x; Goodman SN, 1999, ANN INTERN MED, V130, P995, DOI 10.7326/0003-4819-130-12-199906150-00008; Goodman SN, 2014, BIOSTATISTICS, V15, P23, DOI 10.1093/biostatistics/kxt035; Gotzsche PC, 2006, BMJ-BRIT MED J, V333, P231, DOI 10.1136/bmj.38895.410451.79; Head ML, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002106; Hooper R, 2009, J CLIN EPIDEMIOL, V62, P1242, DOI 10.1016/j.jclinepi.2009.02.004; Hung HMJ, 1997, BIOMETRICS, V53, P11, DOI 10.2307/2533093; Ioannidis JPA, 2014, BIOSTATISTICS, V15, P28, DOI 10.1093/biostatistics/kxt036; Jager LR, 2014, BIOSTATISTICS, V15, P1, DOI 10.1093/biostatistics/kxt007; Jannot AS, 2015, J CLIN EPIDEMIOL, V68, P460, DOI 10.1016/j.jclinepi.2015.01.001; Masicampo EJ, 2012, Q J EXP PSYCHOL, V65, P2271, DOI 10.1080/17470218.2012.711335; Murdoch DJ, 2008, AM STAT, V62, P242, DOI 10.1198/000313008X332421; Pounds S, 2003, BIOINFORMATICS, V19, P1236, DOI 10.1093/bioinformatics/btg148; Sellke T, 2001, AM STAT, V55, P62, DOI 10.1198/000313001300339950; STERLING TD, 1959, J AM STAT ASSOC, V54, P30, DOI 10.2307/2282137; Wasserstein RL, 2016, AM STAT, V70, P129, DOI 10.1080/00031305.2016.1154108	24	16	16	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0895-4356	1878-5921		J CLIN EPIDEMIOL	J. Clin. Epidemiol.	JUL	2017	87						70	77		10.1016/j.jclinepi.2017.04.003			8	Health Care Sciences & Services; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services; Public, Environmental & Occupational Health	FG6FY	WOS:000410468800008	28400294				2022-03-04	
J	Schappi, MG; Deffert, C; Rougemont, A; Belli, D; Krause, K				Schaeppi, M. G.; Deffert, C.; Rougemont, A.; Belli, D.; Krause, K.			THE TREATMENT OF COLITIS IN CHRONIC GRANULOMATOUS DISEASE COULD BE PREVENTIVE?	JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION			English	Meeting Abstract									[Rougemont, A.] Univ Hosp Geneva, Geneva, Switzerland; [Krause, K.] Med Univ Geneva, Geneva, Switzerland				Rougemont, Anne-Laure/C-5612-2015; Schäppi, Michela/D-5363-2012; Schäppi Tempia-Caliera, Michela/A-7619-2012	Schäppi Tempia-Caliera, Michela/0000-0002-9860-7294				0	0	0	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0277-2116			J PEDIATR GASTR NUTR	J. Pediatr. Gastroenterol. Nutr.	JUN	2010	50			2			E113	E114					2	Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics	608AJ	WOS:000278550100230					2022-03-04	
J	Courvoisier, DS; Combescure, C; Agoritsas, T; Gayet-Ageron, A; Perneger, TV				Courvoisier, Delphine S.; Combescure, Christophe; Agoritsas, Thomas; Gayet-Ageron, Angele; Perneger, Thomas V.			Performance of logistic regression modeling: beyond the number of events per variable, the role of data structure	JOURNAL OF CLINICAL EPIDEMIOLOGY			English	Letter									[Courvoisier, Delphine S.] Univ Geneva, Fac Med, CH-1211 Geneva 4, Switzerland; Univ Hosp Geneva, Div Clin Epidemiol, CH-1205 Geneva, Switzerland		Courvoisier, DS (corresponding author), Univ Geneva, Fac Med, CH-1211 Geneva 4, Switzerland.	delphine.courvoisier@hcuge.ch	Agoritsas, Thomas/F-4321-2014; Courvoisier, Delphine/H-6054-2011	Agoritsas, Thomas/0000-0002-6182-9969; Courvoisier, Delphine/0000-0002-1956-2607			Courvoisier DS, 2011, J CLIN EPIDEMIOL, V64, P993, DOI 10.1016/j.jclinepi.2010.11.012; Heinze G, 2003, COMPUT METH PROG BIO, V71, P181, DOI 10.1016/S0169-2607(02)00088-3; Heinze G, 2002, STAT MED, V21, P2409, DOI 10.1002/sim.1047; Heinze G, 2006, STAT MED, V25, P4216, DOI 10.1002/sim.2687; Steyerberg EW, 2011, J CLIN EPIDEMIOL, V64, P1464, DOI 10.1016/j.jclinepi.2011.06.016	5	3	3	0	10	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0895-4356			J CLIN EPIDEMIOL	J. Clin. Epidemiol.	DEC	2011	64	12					1463	1464		10.1016/j.jclinepi.2011.06.013			2	Health Care Sciences & Services; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services; Public, Environmental & Occupational Health	847TI	WOS:000296995000026					2022-03-04	
J	Montaruli, E; Pfister, RE; Wildhaber, BE				Montaruli, Ernesto; Pfister, Riccardo E.; Wildhaber, Barbara E.			Sterile Hepatic Abscess Secondary to Administration of Parenteral Fluids Via an Umbilical Venous Catheter in a Premature Baby	JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION			English	Article							VEIN CATHETERIZATION; COMPLICATIONS; INFANT		[Montaruli, Ernesto] Hop Univ Geneve, Hop Enfants, CH-1211 Geneva 14, Switzerland; [Pfister, Riccardo E.] Univ Geneva, Univ Childrens Hosp Geneva, Dept Paediat, Unit Neonatol & Paediat Intens Care, Geneva, Switzerland; [Wildhaber, Barbara E.] Univ Geneva, Univ Childrens Hosp Geneva, Dept Paediat, Unit Paediat Surg, Geneva, Switzerland		Montaruli, E (corresponding author), Hop Univ Geneve, Hop Enfants, Rue Willy Donze 6, CH-1211 Geneva 14, Switzerland.	Ernesto.montaruli@hcuge.ch	Pfister, Riccardo/N-7082-2014	Pfister, Riccardo/0000-0002-7395-0512			Ades Anne, 2003, J Perinatol, V23, P24, DOI 10.1038/sj.jp.7210851; Al-Essa M, 2005, MED PRIN PRACT, V14, P98, DOI 10.1159/000083919; Cohen M, 2006, EUR J PEDIATR SURG, V16, P55, DOI 10.1055/s-2006-923917; Coley BD, 1998, PEDIATR RADIOL, V28, P923, DOI 10.1007/s002470050500; GREENBERG M, 1995, J PEDIATR-US, V126, P633, DOI 10.1016/S0022-3476(95)70366-7; Hermansen MC, 2005, CLIN PERINATOL, V32, P141, DOI 10.1016/j.clp.2004.11.005; INGLIS GDT, 2005, COCHRANE DB SYST REV, V4; Lam HS, 2005, BIOL NEONATE, V88, P54, DOI 10.1159/000084718; OHARA MB, 2006, PEDIATRICS, V118, pE25; TARIQ AA, 1977, CLIN PEDIATR, V16, P577, DOI 10.1177/000992287701600618	10	3	3	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0277-2116			J PEDIATR GASTR NUTR	J. Pediatr. Gastroenterol. Nutr.	NOV	2011	53	5					575	576		10.1097/MPG.0b013e31821c5acf			2	Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics	839QI	WOS:000296383000022	22020540				2022-03-04	
J	Bernier, J				Bernier, J.			Optimizing treatments of locally advanced squamous cell carcinoma: Where to go from here?	ORAL ONCOLOGY			English	Editorial Material							CHEMORADIATION PLUS CETUXIMAB; NECK-CANCER; ADVANCED HEAD; PHASE-II; EXPRESSION; TRIAL		[Bernier, J.] Genolier Swiss Med Network, Dept Radiat Oncol, CH-1272 Geneva, Switzerland; [Bernier, J.] Univ Geneva, CH-1272 Geneva, Switzerland		Bernier, J (corresponding author), Genolier Swiss Med Network, Dept Radiat Oncol, Route Muids 3, CH-1272 Geneva, Switzerland.	jbernier@genolier.net	Bernier, Jacques/AAE-7248-2020	Bernier, Jacques/0000-0002-0138-9906			Ang KK, 2002, CANCER RES, V62, P7350; Ang KK, 2011, J CLIN ONCOL S, V29, p360s; Blumenschein GR, 2011, J CLIN ONCOL, V29, P2312, DOI 10.1200/JCO.2010.31.7875; Bonner JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMoa053422; FAN Z, 1993, CANCER RES, V53, P4637; Kao J, 2011, CANCER-AM CANCER SOC, V117, P318, DOI 10.1002/cncr.25374; Kies MS, 2009, INT J RADIAT ONCOL, V75, pS14, DOI 10.1016/j.ijrobp.2009.07.057; Kies MS, 2010, J CLIN ONCOL, V28, P8, DOI 10.1200/JCO.2009.23.0425; LEFEBVRE JL, 2011, J CLIN ONCOL S, V29, pS360; Merlano M, 2011, ANN ONCOL, V22, P712, DOI 10.1093/annonc/mdq412; Milas L, 2000, CLIN CANCER RES, V6, P701; Seiwert TY, 2011, J CLIN ONCOL S, V29; Vermorken JB, 2008, NEW ENGL J MED, V359, P1116, DOI 10.1056/NEJMoa0802656; WEICHSELBAUM RR, 1989, HEAD NECK-J SCI SPEC, V11, P437, DOI 10.1002/hed.2880110510; Young RJ, 2011, CANCER EPIDEM BIOMAR, V20, P1230, DOI 10.1158/1055-9965.EPI-10-1262	15	1	1	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1368-8375			ORAL ONCOL	Oral Oncol.	OCT	2011	47	10					931	933		10.1016/j.oraloncology.2011.07.026			3	Oncology; Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Dentistry, Oral Surgery & Medicine	841YY	WOS:000296552300001	21856208				2022-03-04	
J	Wildhaber, BE				Wildhaber, Barbara E.			Pediatric Vascular Tumors of the Liver: Beware!	JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION			English	Editorial Material							CHILDREN; ANGIOSARCOMA; TRANSPLANTATION		[Wildhaber, Barbara E.] Univ Geneva, Dept Pediat, Div Pediat Surg, Childrens Hosp, Geneva, Switzerland		Wildhaber, BE (corresponding author), Hop Univ Geneve, Med Cheffe Serv, Hop Enfants, Rue Willy Donze 6, CH-1211 Geneva 4, Switzerland.	Barbara.Wildhaber@hcuge.ch					Ackermann O, 2011, J PEDIATR GASTR NUTR, V53, P615, DOI 10.1097/MPG.0b013e318230146c; Awan S, 1996, J PEDIATR SURG, V31, P1729, DOI 10.1016/S0022-3468(96)90065-2; Bien E, 2009, EUR J CANCER CARE, V18, P411, DOI 10.1111/j.1365-2354.2008.01063.x; Bonaccorsi-Riani E, 2010, TRANSPL INT, V23, P686, DOI 10.1111/j.1432-2277.2010.01107.x; DEHNER LP, 1971, ARCH PATHOL, V92, P101; Karpelowsky JS, 2008, PEDIATR SURG INT, V24, P1171, DOI 10.1007/s00383-008-2239-0; Kassarjian A, 2004, AM J ROENTGENOL, V182, P785, DOI 10.2214/ajr.182.3.1820785; NORONHA R, 1984, AM J SURG PATHOL, V8, P863, DOI 10.1097/00000478-198411000-00007; Otte JB, 2004, PEDIATR BLOOD CANCER, V42, P74, DOI 10.1002/pbc.10376; Prokurat A, 2002, MED PEDIATR ONCOL, V39, P524, DOI 10.1002/mpo.10179	10	1	1	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0277-2116			J PEDIATR GASTR NUTR	J. Pediatr. Gastroenterol. Nutr.	DEC	2011	53	6					588	588		10.1097/MPG.0b013e318230148d			1	Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics	855DB	WOS:000297542700003	21832952				2022-03-04	
J	Benkebil, F; Duvanel, C; Combescure, C; Aubert, V; Salomon, C; Belli, DC; Tempia, MGS				Benkebil, F.; Duvanel, C.; Combescure Ch, C.; Aubert, V.; Salomon, C.; Belli, D. C.; Tempia, M. G. Schaeppi			ASSESSING ACCURACY OF INTERPRETATION OF A RAPID CELIAC ASSAY IN A WARD SETTING	JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION			English	Meeting Abstract									[Duvanel, C.; Combescure Ch, C.; Aubert, V.; Salomon, C.; Belli, D. C.; Tempia, M. G. Schaeppi] Univ Hosp Geneva, Geneva, Switzerland; [Benkebil, F.] Vidymed, Lausanne, Switzerland				Salomon, Carlos F/L-2167-2013	Salomon, Carlos F/0000-0003-4474-0046				0	0	0	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0277-2116			J PEDIATR GASTR NUTR	J. Pediatr. Gastroenterol. Nutr.	JUN	2010	50			2			E76	E76					1	Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics	608AJ	WOS:000278550100153					2022-03-04	
J	Arigoni, F; Bovier, PA; Mermillod, B; Waltz, P; Sappino, AP				Arigoni, Flavia; Bovier, Patrick A.; Mermillod, Bernadette; Waltz, Patricia; Sappino, Andre-Pascal			Prevalence of burnout among Swiss cancer clinicians, paediatricians and general practitioners: who are most at risk?	SUPPORTIVE CARE IN CANCER			English	Article						Burnout; Cancer physicians; Primary care; Workload	MEDICINE RESIDENCY PROGRAM; CROSS-SECTIONAL SURVEY; JOB-SATISFACTION; MENTAL-HEALTH; HOSPITAL CONSULTANTS; PATIENT-CARE; STRESS; COMMUNICATION; PHYSICIANS; ONCOLOGY	Goals of work Increasing economical and administrative constraints and changes in health-care systems constitute a risk for burnout, especially for cancer physicians. However, little is known about differences across medical specialties and the importance of work characteristics. Methods A postal questionnaire addressing burnout, psychiatric morbidity, sociodemographics and work characteristics was administered to 180 cancer physicians, 184 paediatricians and 197 general practitioners in Switzerland. Results A total of 371 (66%) physicians participated in the survey. Overall, one third of the respondents expressed signs indicative of psychiatric morbidity and of burnout, including high levels of emotional exhaustion (33%) and depersonalisation/cynicism (28%) and a reduced feeling of personal accomplishment (20%). Workload (>50 h/week), lack of continuing education (< 6 h/month) and working in a public institution were significantly associated with an increased risk of burnout. After adjustment for these characteristics, general practitioners had a higher risk for emotional exhaustion ( OR: 2.0, 95% CI: 1.1 to 3.6) and depersonalisation ( OR: 2.7, 95% CI: 1.4 to 5.3). Conclusion In this Swiss sample, cancer clinicians had a significant lower risk of burnout, despite a more important workload. Among possible explanations, involvement in research and teaching activities and access to continuing education may have protected them.	[Arigoni, Flavia; Sappino, Andre-Pascal] Univ Hosp Geneva, Div Oncol, Dept Gen Internal Med, CH-1211 Geneva, Switzerland; [Bovier, Patrick A.] Univ Hosp Geneva, Dept Community & Primary Care Med, Div Primary Care Med, CH-1211 Geneva, Switzerland; [Mermillod, Bernadette] Univ Hosp Geneva, Dept Radiol & Med Informat, CH-1211 Geneva, Switzerland; [Waltz, Patricia] Univ Hosp Geneva, Div Emergency & Liaison Psychiat, CH-1211 Geneva, Switzerland		Sappino, AP (corresponding author), Univ Hosp Geneva, Div Oncol, Dept Gen Internal Med, 24 Rue Micheli du Crest, CH-1211 Geneva, Switzerland.	andre-pascal.sappino@hcuge.ch			Division of oncology; Department of internal medicine; Geneva University Hospitals; Amgen SwitzerlandAmgen	This research project was partly supported by research grants partly from the institutional funds of the Division of oncology and the Department of internal medicine, Geneva University Hospitals and from Amgen Switzerland. We would like to thank Mrs. Paola Pirelli for her administrative work and Dr Jill Graham for giving us methodological indications.	Bell DJ, 2006, AM J OBSTET GYNECOL, V195, P1474, DOI 10.1016/j.ajog.2006.05.039; Bettschart W, 1991, PSYCHOL MED, V23, P1059; Bovier PA, 2005, BMC HEALTH SERV RES, V5, DOI 10.1186/1472-6963-5-72; Bragard I, 2006, SUPPORT CARE CANCER, V14, P454, DOI 10.1007/s00520-005-0008-3; Buddeberg-Fischer B, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-98; Catalan J, 1996, J PSYCHOSOM RES, V40, P425, DOI 10.1016/0022-3999(95)00527-7; DION G, 1994, CAN J BEHAV SCI, V26, P210, DOI 10.1037/0008-400X.26.2.210; Favre N, 2007, SUPPORT CARE CANCER, V15, P333, DOI 10.1007/s00520-006-0150-6; Goehring C, 2005, SWISS MED WKLY, V135, P101; Goitein L, 2005, ARCH INTERN MED, V165, P2601, DOI 10.1001/archinte.165.22.2601; Goldberg D., 1991, USERS GUIDE GEN HLTH; Graham J, 2002, LANCET, V360, P1975, DOI 10.1016/S0140-6736(02)11871-X; Graham J, 2000, ONCOLOGY-NY, V14, P1633; Grunfeld E, 2000, CAN MED ASSOC J, V163, P166; Kash KM, 2000, ONCOLOGY-NY, V14, P1621; Kiss A, 1999, ANN ONCOL, V10, P899, DOI 10.1023/A:1008340806731; Libert Y, 2006, SUPPORT CARE CANCER, V14, P230, DOI 10.1007/s00520-005-0871-y; Maslach C, 2001, ANNU REV PSYCHOL, V52, P397, DOI 10.1146/annurev.psych.52.1.397; Maslach C, 1996, MBI MASLACH BURNOUT, V3rd; McManus IC, 2002, LANCET, V359, P2089, DOI 10.1016/S0140-6736(02)08915-8; Merckaert I, 2005, CURR OPIN ONCOL, V17, P319, DOI 10.1097/01.cco.0000167737.72196.f9; RAMIREZ AJ, 1995, BRIT J CANCER, V71, P1263, DOI 10.1038/bjc.1995.244; Ramirez AJ, 1996, LANCET, V347, P724, DOI 10.1016/S0140-6736(96)90077-X; Renzi C, 2005, J EUR ACAD DERMATOL, V19, P153, DOI 10.1111/j.1468-3083.2005.01029.x; Schaufeli W.B., 1998, BURNOUT COMPANION ST; Shanafelt TD, 2002, ANN INTERN MED, V136, P358, DOI 10.7326/0003-4819-136-5-200203050-00008; Taylor C, 2005, LANCET, V366, P742, DOI 10.1016/S0140-6736(05)67178-4; Thomsen S, 1999, PSYCHOTHER PSYCHOSOM, V68, P157, DOI 10.1159/000012325; Travado L, 2005, PSYCHO-ONCOLOGY, V14, P661, DOI 10.1002/pon.890; TRUCHOT D, 2001, RAPPORT RECHERCHE UN; ULLRICH A, 1990, SOC SCI MED, V31, P1013, DOI 10.1016/0277-9536(90)90113-7; Whalley D, 2006, BRIT J GEN PRACT, V56, P87; WHIPPEN DA, 1991, J CLIN ONCOL, V9, P1916, DOI 10.1200/JCO.1991.9.10.1916; Williams AP, 2002, FAM PRACT, V19, P647, DOI 10.1093/fampra/19.6.647	34	75	76	1	9	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-4355	1433-7339		SUPPORT CARE CANCER	Support. Care Cancer	JAN	2009	17	1					75	81		10.1007/s00520-008-0465-6			7	Oncology; Health Care Sciences & Services; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Oncology; Health Care Sciences & Services; Rehabilitation	382AQ	WOS:000261577400010	18528715	Green Submitted, Green Accepted			2022-03-04	
J	Nagy, M; Ozsahin, H; Ansari, M; Preynat-Seauve, O; Cerdan-Bruyere, P; Chalandon, Y; Rigal, E				Nagy, M.; Ozsahin, H.; Ansari, M.; Preynat-Seauve, O.; Cerdan-Bruyere, P.; Chalandon, Y.; Rigal, E.			Effect of dysimmunity on blood group determination after allogeneic stem cell transplantation: a difficult case	BONE MARROW TRANSPLANTATION			English	Meeting Abstract	38th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation (EBMT)	APR 01-04, 2012	Geneva, SWITZERLAND	European Grp Blood & Marrow Transplantat (EBMT)					[Ozsahin, H.; Ansari, M.] Univ Hosp Geneva, Children Hosp, Geneva, Switzerland				Chalandon, Yves/AAF-5125-2019; ANSARI, Marc/V-3334-2017					0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369			BONE MARROW TRANSPL	Bone Marrow Transplant.	APR	2012	47			1			S341	S342					2	Biophysics; Oncology; Hematology; Immunology; Transplantation	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biophysics; Oncology; Hematology; Immunology; Transplantation	925GN	WOS:000302749201534					2022-03-04	
J	Courvoisier, DS; Combescure, C; Agoritsas, T; Gayet-Ageron, A; Perneger, TV				Courvoisier, Delphine S.; Combescure, Christophe; Agoritsas, Thomas; Gayet-Ageron, Angele; Perneger, Thomas V.			Performance of logistic regression modeling: beyond the number of events per variable, the role of data structure	JOURNAL OF CLINICAL EPIDEMIOLOGY			English	Article						Model adequacy; Model building; Type I error; Power; Event per variable; Logistic regression	ASSUMPTIONS; SIMULATION	Objective: Logistic regression is commonly used in health research, and it is important to be sure that the parameter estimates can be trusted. A common problem occurs when the outcome has few events; in such a case, parameter estimates may be biased or unreliable. This study examined the relation between correctness of estimation and several data characteristics: number of events per variable (EPV), number of predictors, percentage of predictors that are highly correlated, percentage of predictors that were non-null, size of regression coefficients, and size of correlations. Study Design: Simulation studies. Results: In many situations, logistic regression modeling may pose substantial problems even if the number of EPV exceeds 10. Moreover, the number of EPV is not the only element that impacts on the correctness of parameter estimation. High regression coefficients and high correlations between the predictors may cause large problems in the estimation process. Finally, power is generally very low, even at 20 EPV. Conclusion: There is no single rule based on EPV that would guarantee an accurate estimation of logistic regression parameters. Instead, the number of predictors, probable size of the regression coefficients based on previous literature, and correlations among the predictors must be taken into account as guidelines to determine the necessary sample size. (C) 2011 Elsevier Inc. All rights reserved.	[Courvoisier, Delphine S.; Combescure, Christophe; Agoritsas, Thomas; Gayet-Ageron, Angele; Perneger, Thomas V.] Univ Hosp Geneva, Div Clin Epidemiol, CH-1205 Geneva, Switzerland; [Courvoisier, Delphine S.; Combescure, Christophe; Agoritsas, Thomas; Gayet-Ageron, Angele; Perneger, Thomas V.] Univ Geneva, Fac Med, CH-1211 Geneva 4, Switzerland		Courvoisier, DS (corresponding author), Univ Hosp Geneva, Div Clin Epidemiol, 6 Rue Perret Gentil, CH-1205 Geneva, Switzerland.	delphine.courvoisier@hcuge.ch	Agoritsas, Thomas/F-4321-2014	Agoritsas, Thomas/0000-0002-6182-9969; Gayet-Ageron, Angele/0000-0002-6164-9693			Altman DG, 2000, STAT MED, V19, P453, DOI 10.1002/(SICI)1097-0258(20000229)19:4<453::AID-SIM350>3.0.CO;2-5; Cepeda MS, 2003, AM J EPIDEMIOL, V158, P280, DOI 10.1093/aje/kwg115; HARRELL FE, 1985, CANCER TREAT REP, V69, P1071; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hsieh FY, 1998, STAT MED, V17, P1623, DOI 10.1002/(SICI)1097-0258(19980730)17:14<1623::AID-SIM871>3.0.CO;2-S; MALDONADO G, 1993, EPIDEMIOLOGY, V4, P310, DOI 10.1097/00001648-199307000-00006; Moons KGM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b375; Ottenbacher KJ, 2004, J CLIN EPIDEMIOL, V57, P1147, DOI 10.1016/j.jclinepi.2003.05.003; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; R CORE TEAM, 2021, R LANG ENV STAT COMP; Steyerberg EW, 2003, J CLIN EPIDEMIOL, V56, P441, DOI 10.1016/S0895-4356(03)00047-7; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052	12	150	152	1	23	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0895-4356			J CLIN EPIDEMIOL	J. Clin. Epidemiol.	SEP	2011	64	9					993	1000		10.1016/j.jclinepi.2010.11.012			8	Health Care Sciences & Services; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services; Public, Environmental & Occupational Health	806MT	WOS:000293813000007	21411281				2022-03-04	
J	Beauverd, Y; Roosnek, E; Simon, A; Tirefort, Y; Grandjean, AP; Tsopra, O; Dantin, C; Masouridi-Levrat, S; Chalandon, Y				Beauverd, Y.; Roosnek, E.; Simon, A.; Tirefort, Y.; Grandjean, A. -P.; Tsopra, O.; Dantin, C.; Masouridi-Levrat, S.; Chalandon, Y.			Impact of FLT3-ITD mutations on the outcome of patients allografted with partial T-cell depleted grafts for AML in first complete remission with normal karyotype	BONE MARROW TRANSPLANTATION			English	Meeting Abstract	41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation	MAR 22-25, 2015	Istanbul, TURKEY	European Soc Blood & Marrow Transplantat					[Beauverd, Y.; Roosnek, E.; Simon, A.; Tirefort, Y.; Grandjean, A. -P.; Tsopra, O.; Dantin, C.; Masouridi-Levrat, S.; Chalandon, Y.] Univ Hosp Geneva, Hematol, Geneva, Switzerland				Chalandon, Yves/AAF-5125-2019					0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369	1476-5365		BONE MARROW TRANSPL	Bone Marrow Transplant.	MAR	2015	50			1		P734	S485	S485					1	Biophysics; Oncology; Hematology; Immunology; Transplantation	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biophysics; Oncology; Hematology; Immunology; Transplantation	CE2GN	WOS:000351632902343					2022-03-04	
J	Nabergoj, M; Mamez, AC; Morin, S; Ortiz, CD; Dantin, C; Pradier, A; Tran, TA; Longval, T; Anastasiou, M; Bounaix, L; Stephan, C; Beauverd, Y; Giannotti, F; Masouridi-Levrat, S; Chalandon, Y				Nabergoj, Mitja; Mamez, Anne-Claire; Morin, Sarah; Ortiz, Carmen de Ramon; Dantin, Carole; Pradier, Amandine; Thien-An Tran; Longval, Thomas; Anastasiou, Maria; Bounaix, Laura; Stephan, Caroline; Beauverd, Yan; Giannotti, Federica; Masouridi-Levrat, Stavroula; Chalandon, Yves			Comparison between two reduced intensity conditioning regimens in patients with a myeloid malignancy: A single center experience comparing FB2 with flumel	BONE MARROW TRANSPLANTATION			English	Meeting Abstract	45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT)	MAR 24-27, 2019	Frankfurt, GERMANY	European Soc Blood & Marrow Transplantat					[Nabergoj, Mitja; Mamez, Anne-Claire; Morin, Sarah; Ortiz, Carmen de Ramon; Dantin, Carole; Pradier, Amandine; Thien-An Tran; Longval, Thomas; Anastasiou, Maria; Bounaix, Laura; Stephan, Caroline; Beauverd, Yan; Giannotti, Federica; Masouridi-Levrat, Stavroula; Chalandon, Yves] Geneva Univ Hosp, Geneva, Switzerland				Chalandon, Yves/AAF-5125-2019					0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369	1476-5365		BONE MARROW TRANSPL	Bone Marrow Transplant.	JUL	2019	54			1		P120	220	220					1	Biophysics; Oncology; Hematology; Immunology; Transplantation	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biophysics; Oncology; Hematology; Immunology; Transplantation	JA3GL	WOS:000487707800249					2022-03-04	
J	Grandjean, AP; Simonetta, F; Masouridi-Levrat, S; Tirefort, Y; Beauverd, Y; Simon, A; Ansari, M; Dantin, C; Roosnek, E; Chalandon, Y				Grandjean, A. P.; Simonetta, F.; Masouridi-Levrat, S.; Tirefort, Y.; Beauverd, Y.; Simon, A.; Ansari, M.; Dantin, C.; Roosnek, E.; Chalandon, Y.			Impact of T-cell depletion techniques on post transplant graft versus host disease after allogeneic HSCT with myeloablative conditionning	BONE MARROW TRANSPLANTATION			English	Meeting Abstract	41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation	MAR 22-25, 2015	Istanbul, TURKEY	European Soc Blood & Marrow Transplantat					[Grandjean, A. P.; Simonetta, F.; Masouridi-Levrat, S.; Tirefort, Y.; Beauverd, Y.; Simon, A.; Dantin, C.; Roosnek, E.; Chalandon, Y.] Univ Hosp Geneva, Hematol, Geneva, Switzerland; [Ansari, M.] Univ Hosp Geneva, Oncohematol Pediat, Geneva, Switzerland				ANSARI, Marc/V-3334-2017; Chalandon, Yves/AAF-5125-2019					0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369	1476-5365		BONE MARROW TRANSPL	Bone Marrow Transplant.	MAR	2015	50			1		P093	S163	S163					1	Biophysics; Oncology; Hematology; Immunology; Transplantation	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biophysics; Oncology; Hematology; Immunology; Transplantation	CE2GN	WOS:000351632901089					2022-03-04	
J	Simonetta, F; Pradier, A; Bosshard, C; Masouridi-Levrat, S; Chalandon, Y; Roosnek, E				Simonetta, F.; Pradier, A.; Bosshard, C.; Masouridi-Levrat, S.; Chalandon, Y.; Roosnek, E.			NK cell functional impairment after allogeneic hematopoietic stem cells transplantation is associated with reduced T-bet and Eomes expression	BONE MARROW TRANSPLANTATION			English	Meeting Abstract	41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation	MAR 22-25, 2015	Istanbul, TURKEY	European Soc Blood & Marrow Transplantat					[Simonetta, F.; Pradier, A.; Bosshard, C.; Masouridi-Levrat, S.; Chalandon, Y.; Roosnek, E.] Univ Hosp Geneva, Div Hematol, Geneva, Switzerland				Chalandon, Yves/AAF-5125-2019					0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369	1476-5365		BONE MARROW TRANSPL	Bone Marrow Transplant.	MAR	2015	50			1		P705	S470	S471					2	Biophysics; Oncology; Hematology; Immunology; Transplantation	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biophysics; Oncology; Hematology; Immunology; Transplantation	CE2GN	WOS:000351632902315					2022-03-04	
J	Kyle, UG; Chalandon, Y; Miralbell, R; Karsegard, VL; Hans, D; Trombetti, A; Rizzoli, R; Helg, C; Pichard, C				Kyle, UG; Chalandon, Y; Miralbell, R; Karsegard, VL; Hans, D; Trombetti, A; Rizzoli, R; Helg, C; Pichard, C			Longitudinal follow-up of body composition in hematopoietic stem cell transplant patients	BONE MARROW TRANSPLANTATION			English	Article						body composition; longitudinal follow-up; fat-free mass; fat mass	BONE-MARROW-TRANSPLANTATION; VERSUS-HOST-DISEASE; X-RAY ABSORPTIOMETRY; ACUTE GRAFT; VENOOCCLUSIVE DISEASE; PREVENTION; PREDNISONE; LEUKEMIA; THERAPY; WEIGHT	Patients with hematological malignancies are well nourished prior to allogeneic hematopoietic stem cell transplantation (HSCT). HSCT and associated complications can affect body composition. The study evaluated cross-sectionally the prevalence and longitudinally the changes in lean body mass index (LBMI) in HSCT patients. Patients ( n = 82) were classified as normal or low LBMI. Logistic regression analyses were used to estimate odds ratios ( OR) for low vs normal LBMI, between healthy volunteers and patients; for limited or extensive vs no chronic graft-versus-host-disease (GVHD); and for decreased ( Karnofsky <80) vs normal functional status (>80). Patients were significantly more likely to have low LBMI at 6, 12 months, 2 - 3, 4 - 6 and 46 years than volunteers. In all, 38% of patients were below pre-HSCT LBMI at 4 - 6 years post-HSCT. Low LBMI was significantly associated with steroid treatment ( OR 2.6, confidence intervals (CI) 1.3 - 5.2, P = 0.008); limited ( OR 5.5, CI 1.7 - 18.5, P = 0.005) or extensive chronic GVHD ( OR 20.3, CI 5.7 - 71.6, P<0.001); and decreased performance status ( Karnofsky scores of <= 80) ( OR 2.7, CI 1.3 - 5.9, P = 0.01). Patients were more likely to have low LBMI than volunteers. Chronic GVHD and low performance status were associated with low LBMI; thus, complications and/or treatment increase the likelihood of low LBMI.	Univ Hosp Geneva, Div Clin Nutr, CH-1211 Geneva, Switzerland; Univ Hosp Geneva, Div Hematol, CH-1211 Geneva, Switzerland; Univ Hosp Geneva, Div Radiat Oncol, CH-1211 Geneva, Switzerland; Univ Hosp Geneva, Div Nucl Med, CH-1211 Geneva, Switzerland; Univ Hosp Geneva, Div Bone Dis, CH-1211 Geneva, Switzerland		Pichard, C (corresponding author), Univ Hosp Geneva, Div Clin Nutr, CH-1211 Geneva, Switzerland.	claude.pichard@medicine.unige.ch	Chalandon, Yves/AAF-5125-2019; Miralbell, Raymond/AAA-1234-2020; Trombetti, Andrea/J-9965-2013; Trombetti, Andrea/F-4575-2011	Trombetti, Andrea/0000-0002-0540-7024; Chalandon, Yves/0000-0001-9341-8104			ATTAL M, 1992, BLOOD, V79, P2834; Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755, DOI 10.1093/oxfordjournals.aje.a009520; Bieri S, 2001, INT J RADIAT ONCOL, V49, P1071, DOI 10.1016/S0360-3016(00)01491-7; BLAKE GM, 1996, J BONE MINER RES  S1, V11, pS157; Buchs N, 2001, OSTEOPOROSIS INT, V12, P880, DOI 10.1007/s001980170041; Chalandon Y, 2004, BIOL BLOOD MARROW TR, V10, P347, DOI 10.1016/j.bbmt.2004.01.002; Couto-Silva AC, 2000, BONE MARROW TRANSPL, V26, P1205, DOI 10.1038/sj.bmt.1702718; DEEG HJ, 1995, BONE MARROW TRANSPL, V15, P461; Dickson T M, 1999, Biol Blood Marrow Transplant, V5, P299, DOI 10.1016/S1083-8791(99)70005-4; EINSELE H, 1995, BLOOD, V86, P2815; Genton L, 2002, NUTRITION, V18, P66, DOI 10.1016/S0899-9007(01)00700-6; GLUCKSBERG H, 1974, TRANSPLANTATION, V18, P295, DOI 10.1097/00007890-197410000-00001; GUIOT HFL, 1987, EUR J HAEMATOL, V38, P187; Herrmann V M, 1993, Nutr Clin Pract, V8, P19, DOI 10.1177/011542659300800119; Hickson R C, 1993, Exerc Sport Sci Rev, V21, P135; HORBER FF, 1991, DIABETES, V40, P141, DOI 10.2337/diabetes.40.1.141; Iestra JA, 1999, BONE MARROW TRANSPL, V23, P933, DOI 10.1038/sj.bmt.1701747; Kauppila M, 1998, BONE MARROW TRANSPL, V22, P331, DOI 10.1038/sj.bmt.1701337; Kinney T, 1997, J CARDIOPULM REHABIL, V17, P76, DOI [10.1097/00008483-199703000-00002, DOI 10.1097/00008483-199703000-00002]; Kottaridis PD, 2000, BLOOD, V96, P2419; Kyle UG, 2003, CURR OPIN CLIN NUTR, V6, P387, DOI 10.1097/01.mco.0000078988.18774.3d; Kyle UG, 2003, NUTRITION, V19, P597, DOI 10.1016/S0899-9007(03)00061-3; Kyle UG, 2001, NUTRITION, V17, P248, DOI 10.1016/S0899-9007(00)00553-0; Laviano A, 1996, NUTRITION, V12, P358, DOI 10.1016/S0899-9007(96)80061-X; LEWIS MK, 1994, OSTEOPOROSIS INT, V4, P11, DOI 10.1007/BF02352255; MAZESS RB, 1984, AM J CLIN NUTR, V40, P834, DOI 10.1093/ajcn/40.4.834; Meloni G, 2001, BONE MARROW TRANSPL, V28, P365, DOI 10.1038/sj.bmt.1703145; MOR V, 1984, CANCER, V53, P2002, DOI 10.1002/1097-0142(19840501)53:9<2002::AID-CNCR2820530933>3.0.CO;2-W; Nysom K, 2001, BONE MARROW TRANSPL, V27, P817, DOI 10.1038/sj.bmt.1703012; Pichard C, 2004, AM J CLIN NUTR, V79, P613; SLOSMAN DO, 1992, RADIOLOGY, V185, P593, DOI 10.1148/radiology.185.2.1410379; STORB R, 1990, BLOOD, V76, P1037; STORB R, 1986, NEW ENGL J MED, V314, P729, DOI 10.1056/NEJM198603203141201; WEISDORF SA, 1983, GASTROENTEROLOGY, V85, P1076	34	55	57	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369	1476-5365		BONE MARROW TRANSPL	Bone Marrow Transplant.	JUN	2005	35	12					1171	1177		10.1038/sj.bmt.1704996			7	Biophysics; Oncology; Hematology; Immunology; Transplantation	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Oncology; Hematology; Immunology; Transplantation	932UG	WOS:000229578400007	15880127	Bronze			2022-03-04	
J	Harnet, JC; Lombardi, T; Lutz, JC; Meyer, P; Kahn, JL				Harnet, J.-Cl.; Lombardi, T.; Lutz, J.-Ch.; Meyer, P.; Kahn, J.-L.			Sagittal craniofacial growth evaluated on children dry skulls using V-2 and V-3 canal openings as references	SURGICAL AND RADIOLOGIC ANATOMY			English	Article						anatomy; craniofacial growth; skull base; craniofacial foramina; cephalometrics	CRANIAL BASE; BASICRANIAL FLEXION; OSSIFICATION; ANATOMY; ANGLE	The purpose of this study was to investigate the relationship between standard cephalometric landmarks and lines and those using ovale, rotundum, greater palatine and infra-orbital foramina as references. Thirty-four children dry skulls, 19 males and 15 females aged 0-6 years, were examined by computed tomography scanning. The classical cephalometric dimensions of skull base were measured from middle sagittal plane crossing over basion, nasion and sella turcica. Those of hard palate (maxilla and palatine bone) were measured from axial plane intersecting posterior nasal spine and anterior nasal spine. The dimensions between ovale and rotundum foramina, rotundum and infra-orbital foramina, greater palatine and infra-orbital foramina were determined by using constructed tomographic planes enclosing these different foramina. Biostatistical analysis using partial correlations showed that the linear variables with nerve canal openings as references are strongly related to length of both the skull base and of the hard palate. The results highlight the importance of the nerve canal openings of skull base and bone facial components in normal or pathologic craniofacial growth investigations.	Hop Univ Strasbourg, Hop Hautepierre, F-67098 Strasbourg, France; Fac Dent, Strasbourg, France; Fac Med, Sch Dent Med, Div Stomatol, Lab Oral & Maxillofacial Pathol, Geneva, Switzerland; Fac Med, Inst Normal Anat, Strasbourg, France; Fac Med, Biostat Lab & Med Informat, Strasbourg, France		Harnet, JC (corresponding author), Hop Univ Strasbourg, Hop Hautepierre, Ave Moliere, F-67098 Strasbourg, France.	jean-claude.harnet@libertysurf.fr					Crocquet M., 1993, Bulletin de l'Association des Anatomistes, V77, P5; GEORGE SL, 1978, AM J PHYS ANTHROPOL, V49, P171, DOI 10.1002/ajpa.1330490204; Guyot L, 2006, SURG RADIOL ANAT, V28, P559, DOI 10.1007/s00276-006-0161-5; Jarvinen S, 1984, Br J Orthod, V11, P209; KERR WJS, 1987, AM J ORTHOD DENTOFAC, V92, P207, DOI 10.1016/0889-5406(87)90413-6; KJAER I, 1989, J CRAN GENET DEV BIO, V9, P257; KJAER I, 1990, J CRAN GENET DEV BIO, V10, P29; KJAER I, 1989, SCAND J DENT RES, V97, P1; KJAER I, 1990, J CRAN GENET DEV BIO, V10, P329; LANG J, 1984, ANAT ANZEIGER, V156, P351; MELSEN B, 1987, ANN PLAS SURG, V19, P16, DOI 10.1097/00000637-198707000-00003; Nie XG, 2005, ACTA ODONTOL SCAND, V63, P127, DOI 10.1080/00016350510019847; RICCIARDELLI EJ, 1995, CLIN PLAST SURG, V22, P361; ROSS C, 1995, AM J PHYS ANTHROPOL, V98, P575, DOI 10.1002/ajpa.1330980413; Ross CF, 2004, J HUM EVOL, V46, P185, DOI 10.1016/j.jhevol.2003.11.001; Sejrsen B, 1996, AM J PHYS ANTHROPOL, V99, P603, DOI 10.1002/(SICI)1096-8644(199604)99:4<603::AID-AJPA6>3.0.CO;2-U; Sejrsen B, 1997, ACTA ODONTOL SCAND, V55, P356, DOI 10.3109/00016359709059200; SPERBER GH, 1989, CRANIOFACIAL EMBRYOL, P101; Tanabe Y, 2002, EUR J ORTHODONT, V24, P175, DOI 10.1093/ejo/24.2.175; VARELLA J, 1990, ACTA ANAT, V138, P208	20	4	4	0	1	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013 USA	1279-8517			SURG RADIOL ANAT	Surg. Radiol. Anat.	OCT	2007	29	7					589	594		10.1007/s00276-007-0237-x			6	Anatomy & Morphology; Radiology, Nuclear Medicine & Medical Imaging; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anatomy & Morphology; Radiology, Nuclear Medicine & Medical Imaging; Surgery	209SX	WOS:000249409400009	17653618				2022-03-04	
J	Montet, X; Lazeyras, F; Howarth, N; Mentha, G; Rubbia-Brandt, L; Becker, CD; Vallee, JP; Terrier, F				Montet, X; Lazeyras, F; Howarth, N; Mentha, G; Rubbia-Brandt, L; Becker, CD; Vallee, JP; Terrier, F			Specificity of SPIO particles for characterization of liver hemangiomas using MRI	ABDOMINAL IMAGING			English	Article						superparamagnetic iron oxide; liver; hemangioma; magnetic resonance imaging; specificity	SUPERPARAMAGNETIC IRON-OXIDE; HEPATIC CAVERNOUS HEMANGIOMA; SPIRAL CT; HEPATOCELLULAR-CARCINOMA; PATHOLOGICAL CORRELATION; MALIGNANT LESIONS; PHASE CT; ENHANCEMENT; ECHO; BENIGN	We investigated the specificity of superparamagnetic iron oxide (SPIO)-enhanced T1-weighted spin-echo (SE) magnetic resonance (MR) images for the characterization of liver hemangiomas. When imaging liver hemangiomas, which are the most frequent benign liver tumors, a method with very high specificity is required, which will obviate other studies, follow-up, or invasive diagnostic procedures such as percutaneous biopsy. Eighty-three lesions were examined by MR imaging at 1.5 T before and after intravenous injection of SPIO particles. Lesions were categorized as follows according to the final diagnosis: 37 hemangiomas, nine focal nodular hyperplasias (FNHs), 19 hepatocellular carcinomas (HCCs), and 18 metastases. Their signal intensity values were normalized to muscle and compared. The only lesions showing a significant increase in signal intensity ratio (lesion to muscle) on postcontrast T1-weighted SE images were hemangiomas (p<0.001). The signal intensity ratio of hemangiomas increased on average by 70%. Based on receiver operating characteristic analysis and using a cutoff level of 50% signal increase, the specificity and sensitivity of SPIO-enhanced MR imaging for the characterization of hemangiomas would be 100% and 70%, respectively. The T1 effect of SPIO particles can help differentiate hemangiomas from other focal liver lesions such as FNHs, HCCs, and metastases and may obviate biopsy. When using SPIO particles for liver imaging, it is useful to add a T1-weighted sequence to T2-weighted images, thereby providing additional information for lesion characterization.	Hop Cantonal Univ Geneva, Div Radiodiagnost & Radiol Intervent, CH-1211 Geneva 14, Switzerland; Hop Cantonal Univ Geneva, Clin & Policlin Chirurg Digest, CH-1211 Geneva, Switzerland; Hop Cantonal Univ Geneva, Div Pathol Clin, CH-1211 Geneva 14, Switzerland		Montet, X (corresponding author), Hop Cantonal Univ Geneva, Div Radiodiagnost & Radiol Intervent, 24 Rue Micheli Crest, CH-1211 Geneva 14, Switzerland.	xavier.montet@hcuge.ch		Vallee, Jean-Paul/0000-0001-7546-2013; Montet, Xavier/0000-0003-2442-5866			Bartolozzi C, 2001, EUR RADIOL, V11, P1374, DOI 10.1007/s003300100845; BELLIN MF, 1994, RADIOLOGY, V193, P657, DOI 10.1148/radiology.193.3.7972804; CHAMBON C, 1993, MAGN RESON IMAGING, V11, P509, DOI 10.1016/0730-725X(93)90470-X; Cieszanowski A, 2002, EUR RADIOL, V12, P2273, DOI 10.1007/s00330-002-1366-6; Clement O, 1998, Top Magn Reson Imaging, V9, P167; DUDA SH, 1994, J MAGN RESON IMAGING, V4, P309, DOI 10.1002/jmri.1880040314; GIBNEY RG, 1987, AM J ROENTGENOL, V149, P953, DOI 10.2214/ajr.149.5.953; GRANGIER C, 1994, J COMPUT ASSIST TOMO, V18, P888, DOI 10.1097/00004728-199411000-00008; HANAFUSA K, 1995, RADIOLOGY, V196, P465, DOI 10.1148/radiology.196.2.7617862; Harvey CJ, 2001, EUR RADIOL, V11, P1578, DOI 10.1007/s003300101002; Horton KM, 1999, RADIOGRAPHICS, V19, P431, DOI 10.1148/radiographics.19.2.g99mr04431; Imai Y, 2000, HEPATOLOGY, V32, P205, DOI 10.1053/jhep.2000.9113; ITAI Y, 1987, ACTA RADIOL, V28, P697; Ito K, 1997, RADIOLOGY, V204, P729, DOI 10.1148/radiology.204.3.9280251; Kato H, 2001, EUR RADIOL, V11, P2510, DOI 10.1007/s003300101110; Kim K W, 2000, Korean J Radiol, V1, P191; Leifer DM, 2000, RADIOLOGY, V214, P167, DOI 10.1148/radiology.214.1.r00ja09167; LESLIE DF, 1995, AM J ROENTGENOL, V164, P625, DOI 10.2214/ajr.164.3.7863883; LOMBARDO DM, 1990, AM J ROENTGENOL, V155, P55, DOI 10.2214/ajr.155.1.2112864; MARSH JI, 1989, GASTROINTEST RADIOL, V14, P262, DOI 10.1007/BF01889211; Marti-Bonmati L, 1999, ABDOM IMAGING, V24, P147, DOI 10.1007/s002619900464; MCFARLAND EG, 1994, RADIOLOGY, V193, P43, DOI 10.1148/radiology.193.1.8090920; McNicholas MMJ, 1996, CLIN RADIOL, V51, P401, DOI 10.1016/S0009-9260(96)80157-7; Mentha G, 1999, Swiss Surg, V5, P122, DOI 10.1024/1023-9332.5.3.122; Muller RD, 1999, ACTA RADIOL, V40, P628; Nino-Murcia M, 2000, RADIOLOGY, V215, P746, DOI 10.1148/radiology.215.3.r00jn03746; OHTOMO K, 1990, J COMPUT ASSIST TOMO, V14, P650, DOI 10.1097/00004728-199007000-00026; Outwater EK, 1997, JMRI-J MAGN RESON IM, V7, P1033, DOI 10.1002/jmri.1880070615; Poeckler-Schoeniger C, 1999, MAGN RESON IMAGING, V17, P383, DOI 10.1016/S0730-725X(98)00180-5; Reimer P, 2000, RADIOLOGY, V217, P152, DOI 10.1148/radiology.217.1.r00oc31152; SHAMSI K, 1993, ROFO FORTSCHR RONTG, V159, P22, DOI 10.1055/s-2008-1032715; SHIMIZU S, 1992, SURG GYNECOL OBSTET, V174, P403; Soyer P, 1997, AM J ROENTGENOL, V168, P461, DOI 10.2214/ajr.168.2.9016227; Soyer P, 1998, CLIN IMAG, V22, P200, DOI 10.1016/S0899-7071(97)00124-1; TAYLOR PM, 1995, CLIN RADIOL, V50, P215, DOI 10.1016/S0009-9260(05)83472-5; Vilgrain V, 2000, RADIOGRAPHICS, V20, P379, DOI 10.1148/radiographics.20.2.g00mc01379; VOGL TJ, 1995, RADIOLOGE, V35, pS258; Ward J, 1999, RADIOLOGY, V210, P459, DOI 10.1148/radiology.210.2.r99fe05459; WHITNEY WS, 1993, RADIOLOGY, V189, P863, DOI 10.1148/radiology.189.3.8234717; Yun EJ, 1999, ABDOM IMAGING, V24, P262, DOI 10.1007/s002619900492	40	20	20	0	0	SPRINGER-VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0942-8925			ABDOM IMAGING	Abdom. Imaging	JAN-FEB	2004	29	1					60	70		10.1007/s00261-003-0092-0			11	Gastroenterology & Hepatology; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Gastroenterology & Hepatology; Radiology, Nuclear Medicine & Medical Imaging	769XG	WOS:000188688100012	15160755	Green Published, Green Submitted			2022-03-04	
J	Luthy, C; Cedraschi, C; Pugliesi, A; Di Silvestro, K; Mugnier-Konrad, B; Rapiti, E; Allaz, AF				Luthy, Christophe; Cedraschi, Christine; Pugliesi, Angela; Di Silvestro, Katie; Mugnier-Konrad, Beatrice; Rapiti, Elisabetta; Allaz, Anne-Francoise			Patients' views about causes and preferences for the management of cancer-related fatigue-a case for non-congruence with the physicians?	SUPPORTIVE CARE IN CANCER			English	Article						Fatigue; Cancer-related fatigue; Supportive care; Patients' views; Treatment preferences; Treatment guidelines	QUALITY-OF-LIFE; MULTIDIMENSIONAL FATIGUE; DEPRESSION; COMMUNICATION; VALIDATION; GUIDELINES; ANXIETY	Cancer-related fatigue (CRF) is frequently overlooked. Adherence to treatment guidelines may be related to the patient's views about illness. This study aimed at exploring patients' views about CRF and determining whether they are congruent with best practice treatments. Data were collected in 160 consecutive patients hospitalized in a supportive care setting. Biological, clinical, and psychological variables were assessed using validated questionnaires. Patients were also asked to complete the Brief Fatigue Inventory (BFI) and a questionnaire investigating their main symptoms and views about CRF and its management. Patients were mainly men (60%); median age was 66 years. Various cancer diagnoses were represented; 17.5% had primary local diseases, 40% local recurrences, and 42.5% metastatic diseases. The majority of the patients experienced moderate or severe CRF (76.3%) on the BFI. Fatigue was the most frequently reported symptom (87.5%). Only anxiety, depression, and dimensions of quality of life were significantly related with CRF. Two thirds of the patients associated CRF with cancer-related morbidities. As for the best treatments, patients first stressed control of adverse effects. Over half of the patients were reluctant to report fatigue, mainly because they considered fatigue as an unavoidable side effect, but also because they feared a change towards less active/aggressive treatments. Patients mostly consider that CRF must be tolerated. Guidelines emphasize activity enhancement strategies as beneficial. The patients' preferences for rest rather than activity may be related to their high level of fatigue, which leads them to disregard activity as a possible treatment.	[Luthy, Christophe; Cedraschi, Christine; Di Silvestro, Katie; Mugnier-Konrad, Beatrice; Allaz, Anne-Francoise] Univ Hosp Geneva, Dept Rehabil & Geriatr, Div Gen Med Rehabil, CH-1211 Geneva 14, Switzerland; [Pugliesi, Angela] Univ Hosp Geneva, Dept Internal Med, Div Oncol, CH-1211 Geneva 14, Switzerland; [Rapiti, Elisabetta] Univ Hosp Geneva, Canc Registry, Inst Social & Prevent Med, CH-1211 Geneva 14, Switzerland		Luthy, C (corresponding author), Univ Hosp Geneva, Dept Rehabil & Geriatr, Div Gen Med Rehabil, 26 Ave Beau Sejour, CH-1211 Geneva 14, Switzerland.	Christophe.Luthy@hcuge.ch					AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Ahlberg K, 2003, LANCET, V362, P640, DOI 10.1016/S0140-6736(03)14186-4; Blank T, 2006, ANN BEHAV MED, V32, P211, DOI 10.1207/s15324796abm3203_6; Brown LF, 2009, PSYCHOSOMATICS, V50, P440, DOI 10.1176/appi.psy.50.5.440; Cella David, 2006, Oncology (Williston Park), V20, P25; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Collins S, 2008, PATIENT EDUC COUNS, V72, P102, DOI 10.1016/j.pec.2008.02.011; Cramp F, 2008, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD006145.PUB2; DONOVAN JL, 1992, SOC SCI MED, V34, P507, DOI 10.1016/0277-9536(92)90206-6; Dy SM, 2008, J CLIN ONCOL, V26, P3886, DOI 10.1200/JCO.2007.15.9525; Echteld MA, 2007, EUR J CANCER, V43, P1030, DOI 10.1016/j.ejca.2007.01.024; Escalante CP, 2003, SUPPORT CARE CANCER, V11, P79, DOI 10.1007/s00520-002-0406-8; Flechtner H, 2003, ONCOLOGIST, V8, P5, DOI 10.1634/theoncologist.8-suppl_1-5; Goedendorp MM, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006953.pub2; Greenfield S, 2007, AM J MED, V120, P3, DOI 10.1016/j.amjmed.2007.02.002; Hay MC, 2008, J EVAL CLIN PRACT, V14, P707, DOI 10.1111/j.1365-2753.2008.01009.x; Haynes RB, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000011.pub2; Higginson IJ, 2008, EUR J CANCER, V44, P1414, DOI 10.1016/j.ejca.2008.02.024; Hofman M, 2007, ONCOLOGIST, V12, P4, DOI 10.1634/theoncologist.12-S1-4; Jacobsen PB, 2004, J PAIN SYMPTOM MANAG, V28, P7, DOI 10.1016/j.jpainsymman.2003.11.002; Lesage P, 2002, ONCOLOGY-NY, V16, P373; Mendoza TR, 1999, CANCER-AM CANCER SOC, V85, P1186, DOI 10.1002/(SICI)1097-0142(19990301)85:5<1186::AID-CNCR24>3.0.CO;2-N; Minton O, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006704.pub2; Mock V, 2000, ONCOLOGY-NY, V14, P151; Morrow GR, 2002, SUPPORT CARE CANCER, V10, P389, DOI 10.1007/s005200100293; National Comprehensive Cancer Network (NCCN), 2009, CLIN PRACT GUID ONC, V1; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Passik SD, 2002, J PAIN SYMPTOM MANAG, V24, P481, DOI 10.1016/S0885-3924(02)00518-3; RAZAVI D, 1989, REV PSYCHOL APPL, V39, P295; Romito F, 2008, SUPPORT CARE CANCER, V16, P943, DOI 10.1007/s00520-007-0357-1; Stasi R, 2003, CANCER-AM CANCER SOC, V98, P1786, DOI 10.1002/cncr.11742; Stone P, 2000, ANN ONCOL, V11, P971, DOI 10.1023/A:1008318932641; Stone PC, 2008, EUR J CANCER, V44, P1097, DOI 10.1016/j.ejca.2008.02.037; Whitehead L, 2009, J PAIN SYMPTOM MANAG, V37, P107, DOI 10.1016/j.jpainsymman.2007.08.019; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	35	21	23	0	6	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-4355	1433-7339		SUPPORT CARE CANCER	Support. Care Cancer	MAR	2011	19	3					363	370		10.1007/s00520-010-0826-9			8	Oncology; Health Care Sciences & Services; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Health Care Sciences & Services; Rehabilitation	728CL	WOS:000287851500006	20169368	Green Published			2022-03-04	
J	Perneger, TV; Rae, AC; Gaspoz, JM; Borst, F; Vitek, O; Heliot, C				Perneger, TV; Rae, AC; Gaspoz, JM; Borst, F; Vitek, O; Heliot, C			Screening for pressure ulcer risk in an acute care hospital: Development of a brief bedside scale	JOURNAL OF CLINICAL EPIDEMIOLOGY			English	Article						pressure ulcers; prediction scales; acute care hospitals; quality of health care	BRADEN SCALE; SORE RISK; VALIDATION; QUALITY	To derive a brief bedside pressure ulcer prediction tool for patients admitted to acute care hospitals, we conducted a prospective study of first pressure ulcer incidence among 1,190 consecutive patients hospitalized in selected wards of a Swiss teaching hospital. Baseline predictors included patient age and items from the Nor-ton and Braden ulcer prediction scales. During follow-up, 170 patients developed new pressure ulcers. The predictive ability of baseline assessments decayed over time. Occurrence of first pressure ulcer in the 5 days after admission ( 129 events) was best predicted by patient age (5 levels), mobility (3 levels), mental status (3 levels), and friction/shear (3 levels). The Fragment score (sum of friction, age, mobility, mental status) was linearly related to pressure ulcer risk, and its area under the receiver operating characteristic curve (0.80) was higher than for the Norton (0.74; P = 0.006) and Braden (0.74; P = 0.004) scores. This brief pressure ulcer prediction scale performed well in an acute care setting. Use of this scale may facilitate the implementation of pressure ulcer prevention interventions. (C) 2002 Elsevier Science Inc. All rights reserved.	Univ Hosp Geneva, Qual Care Unit, CH-1211 Geneva 14, Switzerland; Univ Geneva, Inst Social & Prevent Med, Geneva, Switzerland; Univ Hosp Geneva, Dept Nursing, CH-1211 Geneva 14, Switzerland; Univ Hosp Geneva, Dept Internal Med, CH-1211 Geneva, Switzerland; Univ Hosp Geneva, Div Med Informat, CH-1211 Geneva, Switzerland; Univ Geneva, Dept Stat, Geneva, Switzerland		Perneger, TV (corresponding author), Univ Hosp Geneva, Qual Care Unit, CH-1211 Geneva 14, Switzerland.	thomas.perneger@hcuge.ch					ALLMAN RM, 1986, ANN INTERN MED, V105, P337, DOI 10.7326/0003-4819-105-3-337; ALLMAN RM, 1995, JAMA-J AM MED ASSOC, V273, P865, DOI 10.1001/jama.273.11.865; Baxt WG, 1996, LANCET, V347, P12, DOI 10.1016/S0140-6736(96)91555-X; Bergstrom N, 1996, J AM GERIATR SOC, V44, P22, DOI 10.1111/j.1532-5415.1996.tb05633.x; BERGSTROM N, 1992, J AM GERIATR SOC, V40, P747, DOI 10.1111/j.1532-5415.1992.tb01845.x; BERGSTROM N, 1987, NURS RES, V36, P205, DOI 10.1097/00006199-198707000-00002; BERLOWITZ DR, 1989, J AM GERIATR SOC, V37, P1043, DOI 10.1111/j.1532-5415.1989.tb06918.x; Bours G J, 1999, Ostomy Wound Manage, V45, P28; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Collett D., 1994, MODELLING SURVIVAL D; Defloor T, 1999, J CLIN NURS, V8, P206, DOI 10.1046/j.1365-2702.1999.00254.x; Gunningberg L, 1999, J CLIN NURS, V8, P396, DOI 10.1046/j.1365-2702.1999.00287.x; Haalboom J R, 1999, Ostomy Wound Manage, V45, P20; Halfens RJG, 2000, INT J NURS STUD, V37, P313, DOI 10.1016/S0020-7489(00)00010-9; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; HTOMAS DR, 2001, J GERONTOL MED SCI, V56, pM328; Katz PR, 1996, J AM GERIATR SOC, V44, P1118; Lyder CH, 2001, ARCH INTERN MED, V161, P1549, DOI 10.1001/archinte.161.12.1549; MCNEIL BJ, 1975, NEW ENGL J MED, V293, P211, DOI 10.1056/NEJM197507312930501; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; *NAT PRESS ULC ADV, 1989, DECUBITUS, V2, P24; NHS Centre for Reviews and Dissemination and the Nuffield Institute for Health, 1995, EFFECTIVE HLTH CARE, V2, P1; Norton D, 1996, Adv Wound Care, V9, P38; Norton D, 1962, INVESTIGATION GERIAT; PATTERSON JA, 1995, J AM GERIATR SOC, V43, P919, DOI 10.1111/j.1532-5415.1995.tb05538.x; Perneger TV, 1998, J AM GERIATR SOC, V46, P1282, DOI 10.1111/j.1532-5415.1998.tb04547.x; Perneger TV, 1998, ARCH INTERN MED, V158, P1940, DOI 10.1001/archinte.158.17.1940; Sharp C, 2000, J Qual Clin Pract, V20, P150, DOI 10.1046/j.1440-1762.2000.00384.x; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Tibshirani R.J., 1993, INTRO BOOTSTRAP, VVolume 57, P1; *US DEP HHS, 1992, AHCPR PUB; VOHRA RK, 1994, BMJ-BRIT MED J, V309, P853, DOI 10.1136/bmj.309.6958.853	32	44	46	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0895-4356	1878-5921		J CLIN EPIDEMIOL	J. Clin. Epidemiol.	MAY	2002	55	5					498	504	PII S0895-4356(01)00514-5	10.1016/S0895-4356(01)00514-5			7	Health Care Sciences & Services; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services; Public, Environmental & Occupational Health	550VD	WOS:000175523500011	12007553				2022-03-04	
J	Tirefort, Y; Roosnek, E; Paiano, S; Levrat, E; Casini, A; Mohty, B; Bernimoulin, M; Nagy-Hulliger, M; Grandjean, A; Matthes, T; Chigrinova, E; Samii, K; Ansari, M; Kindler, V; Ozsahin, H; Masouridi, S; Chalandon, Y				Tirefort, Y.; Roosnek, E.; Paiano, S.; Levrat, E.; Casini, A.; Mohty, B.; Bernimoulin, M.; Nagy-Hulliger, M.; Grandjean, A.; Matthes, T.; Chigrinova, E.; Samii, K.; Ansari, M.; Kindler, V.; Ozsahin, H.; Masouridi, S.; Chalandon, Y.			Prognostic significance of EBMT risk score for the outcome of allogeneic haematopoietic stem cell transplantations after T-cell depletion	BONE MARROW TRANSPLANTATION			English	Meeting Abstract	38th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation (EBMT)	APR 01-04, 2012	Geneva, SWITZERLAND	European Grp Blood & Marrow Transplantat (EBMT)					[Tirefort, Y.; Roosnek, E.; Paiano, S.; Levrat, E.; Casini, A.; Mohty, B.; Bernimoulin, M.; Nagy-Hulliger, M.; Grandjean, A.; Matthes, T.; Chigrinova, E.; Samii, K.; Ansari, M.; Kindler, V.; Ozsahin, H.; Masouridi, S.; Chalandon, Y.] Univ Hosp Geneva, Geneva, Switzerland				Chalandon, Yves/AAF-5125-2019; ANSARI, Marc/V-3334-2017					0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369			BONE MARROW TRANSPL	Bone Marrow Transplant.	APR	2012	47			1			S312	S312					1	Biophysics; Oncology; Hematology; Immunology; Transplantation	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biophysics; Oncology; Hematology; Immunology; Transplantation	925GN	WOS:000302749201463					2022-03-04	
J	Rigatou, E; Pause, FG; Mattiello, V; Chalandon, Y; Ansari, M; Ozsahin, H				Rigatou, E.; Pause, F. Gummy; Mattiello, V.; Chalandon, Y.; Ansari, M.; Ozsahin, H.			Update on post transplant immune reconstitution after allogeneic stem cell transplantation in paediatric high-risk leukaemia patients	BONE MARROW TRANSPLANTATION			English	Meeting Abstract	38th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation (EBMT)	APR 01-04, 2012	Geneva, SWITZERLAND	European Grp Blood & Marrow Transplantat (EBMT)					[Rigatou, E.; Pause, F. Gummy; Mattiello, V.; Chalandon, Y.; Ansari, M.; Ozsahin, H.] Univ Hosp Geneva, Geneva, Switzerland				Chalandon, Yves/AAF-5125-2019					0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369			BONE MARROW TRANSPL	Bone Marrow Transplant.	APR	2012	47			1			S366	S367					2	Biophysics; Oncology; Hematology; Immunology; Transplantation	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biophysics; Oncology; Hematology; Immunology; Transplantation	925GN	WOS:000302749201583					2022-03-04	
J	Mohty, B; Thomas, Y; Vukicevic, M; Nagy, M; Levrat, E; Bernimoulin, M; Kaiser, L; Roosnek, E; Passweg, J; Chalandon, Y				Mohty, B.; Thomas, Y.; Vukicevic, M.; Nagy, M.; Levrat, E.; Bernimoulin, M.; Kaiser, L.; Roosnek, E.; Passweg, J.; Chalandon, Y.			Clinical features and outcome of 2009-influenza A (H1N1) after allogeneic hematopoietic SCT	BONE MARROW TRANSPLANTATION			English	Article						influenza A H1N1; infection; allogeneic hematopoietic SCT; swine flu; oseltamivir	INFLUENZA-A H1N1; STEM-CELL TRANSPLANTATION; RESPIRATORY VIRUS-INFECTIONS; VERSUS-HOST-DISEASE; HEMATOLOGIC MALIGNANCIES; VACCINATION; RECIPIENTS; FAILURE; ADULTS; GRAFT	The impact of the 2009 H1N1-Influenza A (H1N1) pandemic in allogeneic hematopoietic SCT recipients (allo-HSCT) is not yet well defined. Between May 2009 and May 2010, all allo-HSCTs who presented with respiratory symptoms were screened for the presence of the H1N1 virus. Oseltamivir resistance was assessed and chart reviews were performed for all cases. In all, 51 of 248 (20%) allo-HSCT recipients followed at our outpatient clinic were screened. We identified 10 patients with H1N1 infection. Close contact with children was the most commonly suspected mode of transmission. Upper and lower respiratory tract infections were present in eight and five patients, respectively. Lymphopenia (<1 G/L) was the most frequent biological abnormality. High immunosuppression was responsible for severe infection requiring mechanical ventilation associated with prolonged viral shedding in three patients who had significant comorbidities and GvHD. Two of them developed an oseltamivir-resistant strain and both patients died subsequently despite intensive therapy, resulting in a case fatality rate of 20%. In conclusion, although most allo-HSCTs had mild symptoms from H1N1 infection, severe immunosuppression and emergence of oseltamivir resistance were likely responsible for a substantial morbidity, further supporting the need for vaccination and monitoring of close contacts, especially children. Bone Marrow Transplantation (2012) 47, 236-242; doi:10.1038/bmt.2011.57; published online 21 March 2011	[Mohty, B.] Univ Hosp Geneva, Serv Hematol, Div Hematol, Blood & Marrow Transplant Program, Rue Gabrielle Perret Gentil 4, CH-1211 Geneva 14, Switzerland; [Thomas, Y.; Kaiser, L.] Univ Hosp Geneva, Virol Lab, CH-1211 Geneva 14, Switzerland; [Thomas, Y.; Kaiser, L.] Univ Hosp Geneva, Swiss Natl Ctr Influenza, CH-1211 Geneva 14, Switzerland; [Kaiser, L.] Univ Hosp Geneva, Div Infect Dis, CH-1211 Geneva 14, Switzerland		Mohty, B (corresponding author), Univ Hosp Geneva, Serv Hematol, Div Hematol, Blood & Marrow Transplant Program, Rue Gabrielle Perret Gentil 4, CH-1211 Geneva 14, Switzerland.	bilal.mohty@hcuge.ch	Souza, Thiago Moreno L./G-2900-2012; passweg, jakob/AAG-3911-2020; Chalandon, Yves/AAF-5125-2019	Souza, Thiago Moreno L./0000-0003-2212-3899; Chalandon, Yves/0000-0001-9341-8104; Passweg, Jakob R/0000-0001-7092-3351			Avetisyan G, 2008, TRANSPLANTATION, V86, P257, DOI 10.1097/TP.0b013e3181772a75; Bastos DA, 2011, BONE MARROW TRANSPL, V46, P467, DOI 10.1038/bmt.2010.133; Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449; Campbell AP, 2010, ANN INTERN MED, V152, P619, DOI 10.7326/0003-4819-152-9-201005040-00022; Cao B, 2009, NEW ENGL J MED, V361, P2507, DOI 10.1056/NEJMoa0906612; Cauchemez S, 2009, NEW ENGL J MED, V361, P2619, DOI 10.1056/NEJMoa0905498; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P467; Chalandon Y, 2006, BIOL BLOOD MARROW TR, V12, P102, DOI 10.1016/j.bbmt.2005.09.010; Chemaly RF, 2006, MEDICINE, V85, P278, DOI 10.1097/01.md.0000232560.22098.4e; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; de la Camara R, 2010, BONE MARROW TRANSPL, V45, pS35; Ditschkowski M, 2011, ANN HEMATOL, V90, P117, DOI 10.1007/s00277-010-0971-8; ENGELHARD D, 1993, BONE MARROW TRANSPL, V11, P1; Englund J., 2009, Morbidity and Mortality Weekly Report, V58, P893; Frangoul H, 2011, BONE MARROW TRANSPL, V46, P152, DOI 10.1038/bmt.2010.66; Garbino J, 2004, CHEST, V125, P1033, DOI 10.1378/chest.125.3.1033; Garland P, BIOL BLOOD MARROW TR; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; George B, 2011, BIOL BLOOD MARROW TR, V17, P147, DOI 10.1016/j.bbmt.2010.07.004; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Khanna N, 2009, TRANSPL INFECT DIS, V11, P100, DOI 10.1111/j.1399-3062.2008.00362.x; Kharfan-Dabaja MA, 2010, INT J HEMATOL, V91, P124, DOI 10.1007/s12185-009-0464-5; Kumar D, 2010, LANCET INFECT DIS, V10, P521, DOI 10.1016/S1473-3099(10)70133-X; Lalayanni C, 2010, J INFECTION, V61, P270, DOI 10.1016/j.jinf.2010.06.013; Ljungman P, 2009, BONE MARROW TRANSPL, V44, P521, DOI 10.1038/bmt.2009.263; Ljungman P, 2001, BONE MARROW TRANSPL, V28, P479, DOI 10.1038/sj.bmt.1703139; Ljungman P., 2010, ICAAC M 2010; Ljungman P, 2010, LANCET INFECT DIS, V10, P506, DOI 10.1016/S1473-3099(10)70136-5; Martino R, 2005, BIOL BLOOD MARROW TR, V11, P781, DOI 10.1016/j.bbmt.2005.07.007; Martino R, 2003, CLIN INFECT DIS, V36, P1, DOI 10.1086/344899; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Nichols WG, 2004, CLIN INFECT DIS, V39, P1300, DOI 10.1086/425004; OFSP, RAPP SIT HEBD OFSP; Patel P, 2010, BONE MARROW TRANSPL, V45, P1756, DOI 10.1038/bmt.2010.57; Pauksen K, 2000, CLIN INFECT DIS, V30, P342, DOI 10.1086/313663; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Plennevaux E, 2010, LANCET, V375, P41, DOI 10.1016/S0140-6736(09)62026-2; Redelman-Sidi G, 2010, J INFECTION, V60, P257, DOI 10.1016/j.jinf.2010.01.009; Rozovski U, 2010, BONE MARROW TRANSPL, V45, P1572, DOI 10.1038/bmt.2009.376; Taplitz R, BIOL BLOOD MARROW TR; Tramontana AR, 2010, EMERG INFECT DIS, V16, P1068, DOI 10.3201/eid1607.091691; World Health Organization, 2009, CDC PROT REALT RTPCR; Zaia J, 2009, BONE MARROW TRANSPL, V44, P471, DOI 10.1038/bmt.2009.258	43	12	12	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369	1476-5365		BONE MARROW TRANSPL	Bone Marrow Transplant.	FEB	2012	47	2					236	242		10.1038/bmt.2011.57			7	Biophysics; Oncology; Hematology; Immunology; Transplantation	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Oncology; Hematology; Immunology; Transplantation	894GM	WOS:000300415100012	21423124	Green Published, Bronze			2022-03-04	
J	Lo Piccolo, R				Lo Piccolo, Rodolfo			Reduce the fear of a three-year-old child during the pose of a Gripper (R) in an implantable port system (PAC (R))	BONE MARROW TRANSPLANTATION			English	Meeting Abstract	6th Meeting of the EBMT Paediatric Diseases Working Party/1st Meeting of the EBMT Paediatric Nurses	JUN 02-04, 2008	Poznan, POLAND	European Grp Blood & Marrow Transplantat, Paediat Dis Working Party					[Lo Piccolo, Rodolfo] Hop Univ Geneve, Geneva, Switzerland									0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369			BONE MARROW TRANSPL	Bone Marrow Transplant.	OCT	2008	42			2			S128	S129					2	Biophysics; Oncology; Hematology; Immunology; Transplantation	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biophysics; Oncology; Hematology; Immunology; Transplantation	377DT	WOS:000261232600084					2022-03-04	
J	Jannot, AS; Agoritsas, T; Gayet-Ageron, A; Perneger, TV				Jannot, Anne-Sophie; Agoritsas, Thomas; Gayet-Ageron, Angele; Perneger, Thomas V.			Citation bias favoring statistically significant studies was present in medical research	JOURNAL OF CLINICAL EPIDEMIOLOGY			English	Article						Systematic bias; Medical literature analysis and retrieval system; Regression analysis; Journal impact factor; Meta-analysis; Publication bias	PUBLICATION BIAS; GOOGLE SCHOLAR; ARTICLES; JOURNALS; COUNTS; BEHAVIOR; NETWORK; SCIENCE; SCOPUS; WEB	Objective: Statistically significant studies may be cited more than negative studies on the same topic. We aimed to assess here whether such citation bias is present across the medical literature. Study Design and Setting: We conducted a cohort study of the association between statistical significance and citations. We selected all therapeutic intervention studies included in meta-analyses published between January and March 2010 in the Cochrane database, and retrieved citation counts of all individual studies using ISI Web of Knowledge. The association between the statistical significance of each study and the number of citations it received between 2008 and 2010 was assessed in mixed Poisson models. Results: We identified 89 research questions addressed in 458 eligible articles. Significant studies were cited twice as often as nonsignificant studies (multiplicative effect of significance: 2.14, 95% confidence interval: 1.38-3.33). This association was partly because of the higher impact factor of journals where significant studies are published (adjusted multiplicative effect of significance: 1.14, 95% confidence interval: 0.87-1.51). Conclusion: A citation bias favoring significant results occurs in medical research. As a consequence, treatments may seem more effective to the readers of medical literature than they really are. (C) 2013 Elsevier Inc. All rights reserved.	[Jannot, Anne-Sophie; Agoritsas, Thomas; Gayet-Ageron, Angele; Perneger, Thomas V.] Univ Geneva, CRC, CH-1211 Geneva 14, Switzerland; [Jannot, Anne-Sophie; Agoritsas, Thomas; Gayet-Ageron, Angele; Perneger, Thomas V.] Univ Geneva, Dept Hlth & Community Med, Div Clin Epidemiol, CH-1211 Geneva 14, Switzerland; [Jannot, Anne-Sophie; Agoritsas, Thomas; Gayet-Ageron, Angele; Perneger, Thomas V.] Univ Hosp Geneva, CH-1211 Geneva 14, Switzerland; [Agoritsas, Thomas] Univ Hosp Geneva, Div Gen Internal Med, Geneva, Switzerland		Jannot, AS (corresponding author), Univ Geneva, CRC, Rue Gabrielle Perret Gentil 6, CH-1211 Geneva 14, Switzerland.	anne-sophie.jannot@hcuge.ch	Agoritsas, Thomas/F-4321-2014	Agoritsas, Thomas/0000-0002-6182-9969; Jannot, Anne-Sophie/0000-0002-8001-8539; Gayet-Ageron, Angele/0000-0002-6164-9693	University Hospitals of Geneva	This work was funded by the University Hospitals of Geneva.	Baldi S, 1998, AM SOCIOL REV, V63, P829, DOI 10.2307/2657504; Bornmann L, 2008, J DOC, V64, P45, DOI 10.1108/00220410810844150; Callaham M, 2002, JAMA-J AM MED ASSOC, V287, P2847, DOI 10.1001/jama.287.21.2847; Case DO, 2000, J AM SOC INFORM SCI, V51, P635, DOI 10.1002/(SICI)1097-4571(2000)51:7<635::AID-ASI6>3.0.CO;2-H; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; Emerson GB, 2010, ARCH INTERN MED, V170, P1934, DOI 10.1001/archinternmed.2010.406; Etter JF, 2009, J CLIN EPIDEMIOL, V62, P831, DOI 10.1016/j.jclinepi.2008.09.015; Eysenbach G, 2006, PLOS BIOL, V4, P692, DOI 10.1371/journal.pbio.0040157; Fu Lawrence D, 2008, AMIA Annu Symp Proc, P222; Greenberg Steven A, 2009, BMJ, V339, pb2680, DOI 10.1136/bmj.b2680; Jadad AR, 1998, JAMA-J AM MED ASSOC, V280, P278, DOI 10.1001/jama.280.3.278; Kjaergard LL, 2002, J CLIN EPIDEMIOL, V55, P407, DOI 10.1016/S0895-4356(01)00513-3; Kulkarni AV, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000403; Kulkarni AV, 2009, JAMA-J AM MED ASSOC, V302, P1092, DOI 10.1001/jama.2009.1307; Leimu R, 2005, TRENDS ECOL EVOL, V20, P28, DOI 10.1016/j.tree.2004.10.010; Lokker C, 2008, BMJ-BRIT MED J, V336, P655, DOI 10.1136/bmj.39482.526713.BE; Meho LI, 2007, J AM SOC INF SCI TEC, V58, P2105, DOI 10.1002/asi.20677; Nieminen P, 2007, J CLIN EPIDEMIOL, V60, P939, DOI 10.1016/j.jclinepi.2006.11.014; Perneger TV, 2010, J CLIN EPIDEMIOL, V63, P660, DOI 10.1016/j.jclinepi.2009.09.012; Schmidt LM, 2005, J FAM PRACTICE, V54, P334; Sobel M.E., 1982, SOCIOLOGICAL METHODO, V13, P290, DOI [10.2307/270723, DOI 10.2307/270723]	21	74	77	3	34	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0895-4356	1878-5921		J CLIN EPIDEMIOL	J. Clin. Epidemiol.	MAR	2013	66	3					296	301		10.1016/j.jclinepi.2012.09.015			6	Health Care Sciences & Services; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health	083SV	WOS:000314486400009	23347853				2022-03-04	
J	Simonetta, F; Pradier, A; Bosshard, C; Masouridi-Levrat, S; Dantin, C; Koutsi, A; Tirefort, Y; Roosnek, E; Chalandon, Y				Simonetta, F.; Pradier, A.; Bosshard, C.; Masouridi-Levrat, S.; Dantin, C.; Koutsi, A.; Tirefort, Y.; Roosnek, E.; Chalandon, Y.			Dynamics of expression of Programmed cell death protein-1 (PD-1) on T cells after allogeneic hematopoietic stem cell transplantation	BONE MARROW TRANSPLANTATION			English	Meeting Abstract	43rd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT)	MAR 26-29, 2017	Marseille, FRANCE	European Soc Blood & Marrow Transplantat					[Simonetta, F.] Geneva Univ Hosp, Div Hematol, Geneva, Switzerland				Chalandon, Yves/AAF-5125-2019				Haverkos, 2016, BLOOD, V128, P1163; Singh AK, 2016, BONE MARROW TRANSPLA; Villasboas, 2016, ONCOTARGET	3	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369	1476-5365		BONE MARROW TRANSPL	Bone Marrow Transplant.	JUL	2017	52			1		O110	S75	S77					3	Biophysics; Oncology; Hematology; Immunology; Transplantation	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biophysics; Oncology; Hematology; Immunology; Transplantation	FV1WK	WOS:000424355300093					2022-03-04	
J	Bieri, S; Helg, C; Roosnek, E; Miralbell, R; Passweg, J; Chapuis, B; Chalandon, Y				Bieri, S; Helg, C; Roosnek, E; Miralbell, R; Passweg, J; Chapuis, B; Chalandon, Y			Health-related quality of life and social issues after allogeneic haematological stem cell transplant for haematological diseases	BONE MARROW TRANSPLANTATION			English	Meeting Abstract	32nd Annual Meeting of the European-Group-for-Blood-and-Morrow-Transplantation/22nd Meeting of the EBMT-Nures-Group/5th Meeting of the EMBT-Data-Management-Group	MAR 19-22, 2006	Hamburg, GERMANY	European Grp Blood & Marrow Transplantat, EBMT Nurses Grp, EBMT Data Management Grp					Univ Hosp Geneva, Geneva, Switzerland				Chalandon, Yves/AAF-5125-2019					0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369			BONE MARROW TRANSPL	Bone Marrow Transplant.	MAR	2006	37			1			S60	S61					2	Biophysics; Oncology; Hematology; Immunology; Transplantation	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Oncology; Hematology; Immunology; Transplantation	028WT	WOS:000236520200150					2022-03-04	
J	Luthy, C; Pugliesi, A; Rapiti, E; Kossovsky, M; Dietrich, PY; Cedraschi, C; Allaz, AF				Luthy, C.; Pugliesi, A.; Rapiti, E.; Kossovsky, M.; Dietrich, P. Y.; Cedraschi, C.; Allaz, A. F.			Aggressiveness of cancer treatment in patients hospitalized in a supportive care unit	SUPPORTIVE CARE IN CANCER			English	Article						Supportive care; Chemotherapy; Advanced cancer; Aggressiveness of care; Integrated care	MULTIDISCIPLINARY TEAM MANAGEMENT; EARLY PALLIATIVE CARE; CELL LUNG-CANCER; COLORECTAL-CANCER; LIFE; CHEMOTHERAPY; END; DEATH	This study aimed at determining the aggressiveness of chemotherapy (CT)in patients hospitalized in a supportive care unit (focusing on mortality, patient profiles, survival, readmissions, and CT near death). In a prospective cohort study, 247 consecutive patients were investigated at the admission (disease, treatments, oncologist's theoretical survival prognosis, internist's clinical global impression (CGI)). A 3-and 6-month follow-upwas performed. Survival was assessed up to 3 years. Various cancer diagnoses were represented in polymorbid patients. Since disease onset, 69.6 % had received a first line of CT only; 147 patients (59.5 %) had CT at the admission; median CGI was 3 (range = 0-10); and theoretical survival prognosis was < 12 months in 65.2 %. In-hospitalmortality rate was 21 %. Odds of receiving CT was inversely associated with age (OR for patients a parts per thousand yen71 years vs. patients < 50 years 0.19; 95 % CI 0.06-0.65; p = 0.02) and number of previous CT lines (OR for patients with 2-4 lines vs. those with 1 line 0.14; 95 % CI 0.06-0.34; p = 0.000). In the multiadjusted model, 6-monthsurvival remained associated with CT at the admission (HR 1.86; 95 % CI 1.31-2.65; p = 0.001), CGI (per point HR 0.84; 95 % CI 0.73-0.96; p = 0.013), and theoretical survival prognosis (per category HR 0.53; 95 % CI 0.44-0.66; p = 0.000). Very few patients needed readmission related to CT's adverse effects. From admission and throughout follow-up, 24 patients (9.7 %) had received CT during their last 14 days of life. This study showed that a supportive care program can benefit a heterogeneous population as it contributes to assess clinical risks and benefits of CT and prevent aggressive care near death.	[Luthy, C.; Kossovsky, M.; Cedraschi, C.; Allaz, A. F.] Univ Geneva, Univ Hosp Geneva, Div Gen Med Rehabil SMIR BS, Dept Rehabil & Geriatr, CH-1211 Geneva 14, Switzerland; [Pugliesi, A.; Dietrich, P. Y.] Univ Geneva, Univ Hosp Geneva, Dept Internal Med, Div Oncol, Geneva, Switzerland; [Rapiti, E.] Univ Geneva, Inst Social & Prevent Med, Geneva Canc Registry, Geneva, Switzerland; [Cedraschi, C.] Univ Geneva, Univ Hosp Geneva, Div Clin Pharmacol & Toxicol, Dept Anesthesiol Pharmacol & Intens Care, Geneva, Switzerland		Luthy, C (corresponding author), Univ Geneva, Univ Hosp Geneva, Div Gen Med Rehabil SMIR BS, Dept Rehabil & Geriatr, 26 Ave Beau Sejour, CH-1211 Geneva 14, Switzerland.	christophe.luthy@hcuge.ch					Aparicio T, 2013, J CLIN ONCOL, V31, P1464, DOI 10.1200/JCO.2012.42.9894; Braga S, 2011, ANN ONCOL, V22, P2345, DOI 10.1093/annonc/mdr416; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Earle CC, 2004, J CLIN ONCOL, V22, P315, DOI 10.1200/JCO.2004.08.136; Earle CC, 2008, J CLIN ONCOL, V26, P3860, DOI 10.1200/JCO.2007.15.8253; ESMO Guidelines Working Group (Eds), 2010, ANN ONC S21; Friedland PL, 2011, BRIT J CANCER, V104, P1246, DOI 10.1038/bjc.2011.92; Greer JA, 2012, J CLIN ONCOL, V30, P394, DOI 10.1200/JCO.2011.35.7996; Leung KMYB, 2012, CUAJ-CAN UROL ASSOC, V6, P367, DOI 10.5489/cuaj.11161; MacDermid E, 2009, COLORECTAL DIS, V11, P291, DOI 10.1111/j.1463-1318.2008.01580.x; Matsuyama R, 2006, J CLIN ONCOL, V24, P3490, DOI 10.1200/JCO.2005.03.6236; Nappa U, 2011, ANN ONCOL, V22, P2375, DOI 10.1093/annonc/mdq778; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Rose C, 2008, CA-CANCER J CLIN, V58, P266, DOI 10.3322/CA.2008.0012; Smith TJ, 2011, NEW ENGL J MED, V364, P2060, DOI 10.1056/NEJMsb1013826; Stephens MR, 2006, DIS ESOPHAGUS, V19, P164, DOI 10.1111/j.1442-2050.2006.00559.x; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678; The AM, 2000, BRIT MED J, V321, P1376, DOI 10.1136/bmj.321.7273.1376	18	0	0	0	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-4355	1433-7339		SUPPORT CARE CANCER	Support. Care Cancer	FEB	2015	23	2					325	331		10.1007/s00520-014-2341-x			7	Oncology; Health Care Sciences & Services; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Health Care Sciences & Services; Rehabilitation	AZ6AB	WOS:000348298700005	25077805	Green Submitted			2022-03-04	
J	Simonetta, F; Pradier, A; Masouridi-Levrat, S; Bosshard, C; Dantin, C; Hogan, C; Matthes, T; Chalandon, Y; Roosnek, E				Simonetta, F.; Pradier, A.; Masouridi-Levrat, S.; Bosshard, C.; Dantin, C.; Hogan, C.; Matthes, T.; Chalandon, Y.; Roosnek, E.			Neutrophil and monocyte CD64 expression provides limited diagnostic value for detection of Graft-versus-Host disease or viral infections in patients after allogeneic Hematopoietic Stem Cell Transplantation	BONE MARROW TRANSPLANTATION			English	Meeting Abstract	41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation	MAR 22-25, 2015	Istanbul, TURKEY	European Soc Blood & Marrow Transplantat					[Simonetta, F.; Pradier, A.; Masouridi-Levrat, S.; Bosshard, C.; Dantin, C.; Hogan, C.; Matthes, T.; Chalandon, Y.; Roosnek, E.] Univ Hosp Geneva, Hematol, Geneva, Switzerland				Chalandon, Yves/AAF-5125-2019	Simonetta, Federico/0000-0002-0399-689X				0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369	1476-5365		BONE MARROW TRANSPL	Bone Marrow Transplant.	MAR	2015	50			1		P114	S175	S175					1	Biophysics; Oncology; Hematology; Immunology; Transplantation	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biophysics; Oncology; Hematology; Immunology; Transplantation	CE2GN	WOS:000351632901110					2022-03-04	
J	Rigatou, E; Pause, FG; Mattiello, V; Chalandon, Y; Ansari, M; Ozsahin, H				Rigatou, E.; Pause, F. Gummy; Mattiello, V.; Chalandon, Y.; Ansari, M.; Ozsahin, H.			Diamond Blackfan anaemia: when to transplant?	BONE MARROW TRANSPLANTATION			English	Meeting Abstract	38th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation (EBMT)	APR 01-04, 2012	Geneva, SWITZERLAND	European Grp Blood & Marrow Transplantat (EBMT)					[Rigatou, E.; Pause, F. Gummy; Mattiello, V.; Chalandon, Y.; Ansari, M.; Ozsahin, H.] Univ Hosp Geneva, Geneva, Switzerland				Chalandon, Yves/AAF-5125-2019; ANSARI, Marc/V-3334-2017					0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369			BONE MARROW TRANSPL	Bone Marrow Transplant.	APR	2012	47			1			S368	S368					1	Biophysics; Oncology; Hematology; Immunology; Transplantation	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biophysics; Oncology; Hematology; Immunology; Transplantation	925GN	WOS:000302749201584					2022-03-04	
J	Petropoulou, A; Nabergoj, M; Mamez, AC; Morin, S; Mahne, E; Ortiz, CD; Stephan, C; Ayer, C; Bruno, B; Bounaix, L; Anastasiou, M; Mappoura, M; Dantin, C; Beauverd, Y; Simonetta, F; Giannotti, F; Masouridi-Levrat, S; Chalandon, Y				Petropoulou, Anna; Nabergoj, Mitja; Mamez, Anne-Claire; Morin, Sarah; Mahne, Elif; Ortiz, Carmen De Ramon; Stephan, Caroline; Ayer, Christian; Bruno, Benjamin; Bounaix, Laura; Anastasiou, Maria; Mappoura, Maria; Dantin, Carole; Beauverd, Yan; Simonetta, Federico; Giannotti, Federica; Masouridi-Levrat, Stavroula; Chalandon, Yves			Efficacy and Toxicity of Ruxolitinib in Patients with steroid-resistant Acute and Chronic graft-versus-host Disease after Hematopoietic Cell Transplantation	BONE MARROW TRANSPLANTATION			English	Meeting Abstract									[Petropoulou, Anna; Nabergoj, Mitja; Mamez, Anne-Claire; Morin, Sarah; Mahne, Elif; Ortiz, Carmen De Ramon; Stephan, Caroline; Ayer, Christian; Bruno, Benjamin; Bounaix, Laura; Anastasiou, Maria; Mappoura, Maria; Dantin, Carole; Beauverd, Yan; Simonetta, Federico; Giannotti, Federica; Masouridi-Levrat, Stavroula; Chalandon, Yves] Geneva Univ Hosp, Geneva, Switzerland									0	0	0	0	0	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0268-3369	1476-5365		BONE MARROW TRANSPL	Bone Marrow Transplant.	DEC	2020	55	SUPPL 1		TEM CELL T		P203	334	335					2	Biophysics; Oncology; Hematology; Immunology; Transplantation	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Oncology; Hematology; Immunology; Transplantation	PH6YT	WOS:000600556201192					2022-03-04	
J	Ghannoo, ME				Ghannoo, M. E.			Introducing intravenous (IV) Morphine PCA (Patient-Controlled Analgesia) for in-patients dealing with mucositis issues	BONE MARROW TRANSPLANTATION			English	Meeting Abstract	42nd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation	APR 03-06, 2016	Valencia, SPAIN	European Soc Blood & Marrow Transplantat					[Ghannoo, M. E.] Univ Hosp Geneva, BMT Ward, Dept Internal Med, Geneva, Switzerland									0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369	1476-5365		BONE MARROW TRANSPL	Bone Marrow Transplant.	MAR	2016	51			1		NP063	S546	S547					2	Biophysics; Oncology; Hematology; Immunology; Transplantation	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biophysics; Oncology; Hematology; Immunology; Transplantation	DI2VR	WOS:000373357601450					2022-03-04	
J	Veronique, C; Soraya, H; Murielle, TL; Laurence, L				Veronique, C.; Soraya, H.; Murielle, T. L.; Laurence, L.			A 100% LIFE AFTER TRANSPLANT: EDUCATION PROGRAM OF PATIENT SUPPORT	BONE MARROW TRANSPLANTATION			English	Meeting Abstract	41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation	MAR 22-25, 2015	Istanbul, TURKEY	European Soc Blood & Marrow Transplantat					[Veronique, C.; Soraya, H.; Murielle, T. L.] Univ Geneva Hop Cantonal, Med, Geneva, Switzerland; [Laurence, L.] Univ Geneva Hop Cantonal, Specialite Med, Geneva, Switzerland									0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369	1476-5365		BONE MARROW TRANSPL	Bone Marrow Transplant.	MAR	2015	50			1		N017	S506	S506					1	Biophysics; Oncology; Hematology; Immunology; Transplantation	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biophysics; Oncology; Hematology; Immunology; Transplantation	CE2GN	WOS:000351632902384					2022-03-04	
J	Bernhard, V; Bouchardy, M; Cristiano, G; Ozsahin, H; Gumy-Pause, F; Ansari, M				Bernhard, V.; Bouchardy, M.; Cristiano, G.; Ozsahin, H.; Gumy-Pause, F.; Ansari, M.			Transdisciplinary project: enhancement of physical activity for long-term hospitalised onco-haematological children	BONE MARROW TRANSPLANTATION			English	Meeting Abstract	38th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation (EBMT)	APR 01-04, 2012	Geneva, SWITZERLAND	European Grp Blood & Marrow Transplantat (EBMT)					[Bernhard, V.; Bouchardy, M.; Cristiano, G.; Ozsahin, H.; Gumy-Pause, F.; Ansari, M.] HUG, Geneva, Switzerland									0	0	0	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369			BONE MARROW TRANSPL	Bone Marrow Transplant.	APR	2012	47			1			S501	S501					1	Biophysics; Oncology; Hematology; Immunology; Transplantation	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biophysics; Oncology; Hematology; Immunology; Transplantation	925GN	WOS:000302749202109					2022-03-04	
J	Fontanet, A; Chalandon, Y; Roosnek, E; Mohty, B; Passweg, JR				Fontanet, A.; Chalandon, Y.; Roosnek, E.; Mohty, B.; Passweg, J. R.			Cotrimoxazole myelotoxicity in hematopoietic SCT recipients: time for reappraisal	BONE MARROW TRANSPLANTATION			English	Letter							STEM-CELL TRANSPLANTATION; TRIMETHOPRIM-SULFAMETHOXAZOLE; JIROVECI PNEUMONIA; PROPHYLAXIS		[Fontanet, A.; Chalandon, Y.; Roosnek, E.; Mohty, B.; Passweg, J. R.] Univ Hosp Geneva, Div Hematol, Geneva, Switzerland		Fontanet, A (corresponding author), Univ Hosp Geneva, Div Hematol, Geneva, Switzerland.	jakob.passweg@hcuge.ch	passweg, jakob/AAG-3911-2020; Chalandon, Yves/AAF-5125-2019	Passweg, Jakob R/0000-0001-7092-3351; Chalandon, Yves/0000-0001-9341-8104			APPERLEY J, 2008, HEMATOPOIETIC STEM C; Copelan EA, 2006, NEW ENGL J MED, V354, P1813, DOI 10.1056/NEJMra052638; De Castro N, 2005, BONE MARROW TRANSPL, V36, P879, DOI 10.1038/sj.bmt.1705149; DEEG HJ, 1979, TRANSPLANTATION, V28, P243, DOI 10.1097/00007890-197909000-00017; DEJONGH CA, 1983, J CLIN ONCOL, V1, P302, DOI 10.1200/JCO.1983.1.5.302; Fuchs M, 2000, BONE MARROW TRANSPL, V26, P815, DOI 10.1038/sj.bmt.1702586; Green H, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858; Lindemulder S, 2007, PEDIATRICS, V120, pE47, DOI 10.1542/peds.2006-1360; PINCHING AJ, 1988, AIDS, V2, P335, DOI 10.1097/00002030-198810000-00002; Stolley P. D., 1982, CASE CONTROL STUDIES	10	15	15	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369	1476-5365		BONE MARROW TRANSPL	Bone Marrow Transplant.	SEP	2011	46	9					1272	1273		10.1038/bmt.2010.285			2	Biophysics; Oncology; Hematology; Immunology; Transplantation	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Oncology; Hematology; Immunology; Transplantation	817HN	WOS:000294662700016	21102496				2022-03-04	
J	Mohty, B; Thomas, Y; Vukicevic, M; Nagy, M; Levrat, E; Bernimoulin, M; Kaiser, L; Roosnek, E; Passweg, J; Chalandon, Y				Mohty, B.; Thomas, Y.; Vukicevic, M.; Nagy, M.; Levrat, E.; Bernimoulin, M.; Kaiser, L.; Roosnek, E.; Passweg, J.; Chalandon, Y.			Clinical features and outcome of 2009-influenza A (H1N1) after allogeneic haematopoietic stem cell transplantation	BONE MARROW TRANSPLANTATION			English	Meeting Abstract	37th European Group for Bone and Marrow Transplantation/27th Meeting of the EBMT Nurses Group/10th Meeting of the EBMT Management Group	APR 03-06, 2011	Paris, FRANCE	European Grp Bone & Marrow Transplantat, European Grp Bone & Marrow Transplantat Nurses Grp, European Grp Bone & Marrow Transplantat Management Grp					[Mohty, B.; Thomas, Y.; Vukicevic, M.; Nagy, M.; Levrat, E.; Bernimoulin, M.; Kaiser, L.; Roosnek, E.; Passweg, J.; Chalandon, Y.] Univ Hosp Geneva, Geneva, Switzerland				Chalandon, Yves/AAF-5125-2019; passweg, jakob/AAG-3911-2020					0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369			BONE MARROW TRANSPL	Bone Marrow Transplant.	APR	2011	46			1			S209	S210					2	Biophysics; Oncology; Hematology; Immunology; Transplantation	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biophysics; Oncology; Hematology; Immunology; Transplantation	745VC	WOS:000289195401319					2022-03-04	
J	Chalandon, Y; Roosnek, E; Helg, C; Verholen, F; Knipp, S; Ozsahin, H; Passweg, J				Chalandon, Y.; Roosnek, E.; Helg, C.; Verholen, F.; Knipp, S.; Ozsahin, H.; Passweg, J.			Efficient prevention of veno-occlusive disease of the liver with defibrotide after allogeneic haematopoietic stem cell transplantation. An extended study	BONE MARROW TRANSPLANTATION			English	Meeting Abstract	33rd Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation	MAR 25-28, 2007	Lyon, FRANCE	European Grp Blood & Marrow Transplantat					Univ Hosp Geneva, Geneva, Switzerland				Chalandon, Yves/AAF-5125-2019					0	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369			BONE MARROW TRANSPL	Bone Marrow Transplant.	APR	2007	39			1			S197	S197					1	Biophysics; Oncology; Hematology; Immunology; Transplantation	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Oncology; Hematology; Immunology; Transplantation	150HU	WOS:000245207400533					2022-03-04	
J	Tirefort, Y; Simonetta, F; Pradier, A; Bosshard, C; Grandjean, AP; Beauverd, Y; Masouridi-Levrat, S; Matthes, T; Roosnek, E; Chalandon, Y				Tirefort, Y.; Simonetta, F.; Pradier, A.; Bosshard, C.; Grandjean, A. -P.; Beauverd, Y.; Masouridi-Levrat, S.; Matthes, T.; Roosnek, E.; Chalandon, Y.			impact of the different approaches of in vivo T cell depletion on NK cell subsets reconstitution after allogeneic Hematopoietic Stem Cell Transplantation	BONE MARROW TRANSPLANTATION			English	Meeting Abstract	41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation	MAR 22-25, 2015	Istanbul, TURKEY	European Soc Blood & Marrow Transplantat					[Tirefort, Y.; Simonetta, F.; Pradier, A.; Bosshard, C.; Grandjean, A. -P.; Beauverd, Y.; Masouridi-Levrat, S.; Matthes, T.; Roosnek, E.; Chalandon, Y.] Univ Hosp Geneva, Hematol, Geneva, Switzerland				Chalandon, Yves/AAF-5125-2019	Simonetta, Federico/0000-0002-0399-689X				0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369	1476-5365		BONE MARROW TRANSPL	Bone Marrow Transplant.	MAR	2015	50			1		P674	S456	S457					2	Biophysics; Oncology; Hematology; Immunology; Transplantation	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biophysics; Oncology; Hematology; Immunology; Transplantation	CE2GN	WOS:000351632902286					2022-03-04	
J	Paiano, S; Roosnek, E; Tirefort, Y; Nagy, M; Masouridi, S; Levrat, E; Bernimoulin, M; Huguet, S; Bosman, LP; Mohty, B; Casini, A; Matthes, T; Samii, K; Passweg, J; Chalandon, Y				Paiano, S.; Roosnek, E.; Tirefort, Y.; Nagy, M.; Masouridi, S.; Levrat, E.; Bernimoulin, M.; Huguet, S.; Bosman, L. Pizzi; Mohty, B.; Casini, A.; Matthes, T.; Samii, K.; Passweg, J.; Chalandon, Y.			A study comparing two types of rabbit ATG as part of pre-transplant conditioning for allogeneic HSCT for haematologic malignancies: earlier relapse with thymoglobulin as compared to ATG-F	BONE MARROW TRANSPLANTATION			English	Meeting Abstract	38th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation (EBMT)	APR 01-04, 2012	Geneva, SWITZERLAND	European Grp Blood & Marrow Transplantat (EBMT)					[Paiano, S.; Roosnek, E.; Tirefort, Y.; Nagy, M.; Masouridi, S.; Levrat, E.; Bernimoulin, M.; Huguet, S.; Bosman, L. Pizzi; Mohty, B.; Casini, A.; Matthes, T.; Samii, K.; Passweg, J.; Chalandon, Y.] HUG, Geneva, Switzerland				passweg, jakob/AAG-3911-2020; Chalandon, Yves/AAF-5125-2019					0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369			BONE MARROW TRANSPL	Bone Marrow Transplant.	APR	2012	47			1			S208	S209					2	Biophysics; Oncology; Hematology; Immunology; Transplantation	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biophysics; Oncology; Hematology; Immunology; Transplantation	925GN	WOS:000302749201251					2022-03-04	
J	Beauverd, Y; Morin, S; Nabergoi, M; Stephan, C; Ortiz, CD; Mamez, AC; Mahne, E; Petropoulou, A; Giannotti, F; Ayer, C; Bruno, B; Bounaix, L; Anastasiou, M; Mappoura, M; Tran, TA; Masouridi-Levrat, S; Chalandon, Y				Beauverd, Yan; Morin, Sarah; Nabergoi, Mitja; Stephan, Caroline; Ortiz, Carmen De Ramon; Mamez, Anne-Claire; Mahne, Elif; Petropoulou, Anna; Giannotti, Federica; Ayer, Christian; Bruno, Benjamin; Bounaix, Laura; Anastasiou, Maria; Mappoura, Maria; Tran, Thien-An; Masouridi-Levrat, Stavroula; Chalandon, Yves			Validation of Disease Risk Comorbidity Index (DRCI) for Overall Survival after Allogeneic Stem Cell Transplantation (HSCT) With Partially T-cell Depleted GRAFT	BONE MARROW TRANSPLANTATION			English	Meeting Abstract									[Beauverd, Yan; Morin, Sarah; Nabergoi, Mitja; Stephan, Caroline; Ortiz, Carmen De Ramon; Mamez, Anne-Claire; Mahne, Elif; Petropoulou, Anna; Giannotti, Federica; Ayer, Christian; Bruno, Benjamin; Bounaix, Laura; Anastasiou, Maria; Mappoura, Maria; Tran, Thien-An; Masouridi-Levrat, Stavroula; Chalandon, Yves] Geneva Univ Hosp, Geneva, Switzerland									0	0	0	0	0	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0268-3369	1476-5365		BONE MARROW TRANSPL	Bone Marrow Transplant.	DEC	2020	55	SUPPL 1		TEM CELL T		P290	401	402					2	Biophysics; Oncology; Hematology; Immunology; Transplantation	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Oncology; Hematology; Immunology; Transplantation	PH6YT	WOS:000600556201278					2022-03-04	
J	Danzer, D; Gervaz, P; Platon, A; Poletti, PA				Danzer, D; Gervaz, P; Platon, A; Poletti, PA			Bleeding Meckel's diverticulum diagnosis: an unusual indication for computed tomography	ABDOMINAL IMAGING			English	Article						Meckel's diverticulum; bleeding; computed tomography; arteriography; imaging		Despite the wide use of modem investigation techniques, the diagnosis of complications related to Meckel's diverticulum (MD) remains difficult. Arteriography is commonly indicated for acute bleeding, and radionuclide scans may help in identifying the site of intestinal hemorrhage. In contrast, computed tomography (CT) is usually considered little use in the diagnosis of bleeding MD. We present the case of a young patient with massive gastrointestinal hemorrhage, in whom the diagnosis of MD bleeding was preoperatively made with contrast-enhanced CT after two negatives arteriographies.	Hop Cantonal Univ Geneva, Clin Digest Surg, CH-1211 Geneva, Switzerland; Hop Cantonal Univ Geneva, Dept Radiol, CH-1211 Geneva, Switzerland		Gervaz, P (corresponding author), Hop Cantonal Univ Geneva, Clin Digest Surg, 24 Rue Micheli du Crest, CH-1211 Geneva, Switzerland.						Chiu EJ, 2000, HEPATO-GASTROENTEROL, V47, P181; DIXON PM, 1987, CLIN RADIOL, V38, P615, DOI 10.1016/S0009-9260(87)80338-0; Groebli Y, 2001, EUR J SURG, V167, P518; KASUMOTO H, 1992, AM J SURG, V164, P382; LEIJONMARCK CE, 1986, BRIT J SURG, V73, P146, DOI 10.1002/bjs.1800730225; Miele V, 2001, Radiol Med, V101, P230; Pinero A, 2002, EUR J SURG, V168, P8; Portnoy O, 2001, Isr Med Assoc J, V3, P982; Rossi P, 1996, AM J ROENTGENOL, V166, P567, DOI 10.2214/ajr.166.3.8623629; Yamamoto A, 2000, NUCL SCI ENG, V136, P247, DOI 10.13182/NSE00-A2155	10	9	10	0	0	SPRINGER-VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0942-8925			ABDOM IMAGING	Abdom. Imaging	SEP-OCT	2003	28	5					631	633		10.1007/s00261-003-0049-3			3	Gastroenterology & Hepatology; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Gastroenterology & Hepatology; Radiology, Nuclear Medicine & Medical Imaging	714WQ	WOS:000184936800006	14628864	Green Submitted			2022-03-04	
J	Griesser, AC; Vlastos, G; Morel, L; Beaume, C; Sappino, AP; Haller, G				Griesser, A. -C.; Vlastos, G.; Morel, L.; Beaume, C.; Sappino, A. -P.; Haller, G.			Socio-demographic predictors of high support needs in newly diagnosed breast cancer patients	EUROPEAN JOURNAL OF CANCER CARE			English	Article						breast cancer; needs assessment; supportive care; health services needs and demand	CARE NEEDS; UNMET NEEDS; PSYCHOLOGICAL DISTRESS; WOMEN; INFORMATION; ANXIETY; EXPERIENCES; MORTALITY; SURVIVORS; AGE	This study aimed to identify high support needs and their socio-demographic predictors to improve supportive care for newly diagnosed breast cancer patients. A cross-sectional study measured patients' needs and unsatisfied support needs by the supportive care needs survey (SCNS-34), administered after surgery, chemotherapy or radiotherapy. Socio-demographic, disease and treatment characteristics completed data collection. A total of 308 questionnaires were completed with a response rate of 88%. The most frequent support needs (73.3% of patients) related to information and the highest unsatisfied support needs to the management of emotions and daily life (36.3-39.6% of patients). Younger age predicted high and dissatisfied support needs (P < 0.05). Patients born outside Switzerland or with a lower level of education had more needs in daily living and psychological domains (P < 0.05). Being born outside Switzerland also predicted dissatisfaction with information provided. Being parent was a predictor of significant needs in the daily living domain after adjusting for disease and treatment characteristics (P = 0.01). Therefore, information, psychological and daily living support for newly diagnosed breast cancer patients should be strongly reinforced, particularly in patients being born outside Switzerland, those with children or being younger. For the latter, support in sexuality domain should also be emphasised.	[Sappino, A. -P.] Univ Hosp Geneva, Breast Canc Care Program, Serv Oncol, Geneva, Switzerland; [Vlastos, G.; Morel, L.] Univ Hosp Geneva, Senol Unit, Geneva, Switzerland; [Haller, G.] Univ Hosp Geneva, Qual Care Unit, Geneva, Switzerland		Griesser, AC (corresponding author), CHU Vaudois, Multidisciplinary Oncol Ctr, Rue Bugnon 46, CH-1011 Lausanne, Switzerland.	anne-claude.griesser@chuv.ch		haller, guy/0000-0001-7367-7029; Griesser, Anne-Claude/0000-0002-5841-4340	Geneva University Hospitals; quality of care fund	Financial support was generously provided by Geneva University Hospitals, as part of the quality of care fund. The funding agreement ensured the authors' complete independence.	Aranda S, 2005, EUR J CANCER CARE, V14, P211, DOI 10.1111/j.1365-2354.2005.00541.x; Barnes J, 2000, BRIT MED J, V321, P479, DOI 10.1136/bmj.321.7259.479; Beesley V, 2008, PSYCHO-ONCOLOGY, V17, P392, DOI 10.1002/pon.1249; Blamey RW, 2006, EUR J CANCER, V42, P1331, DOI 10.1016/j.ejca.2006.04.003; Bonevski B, 2000, CANCER, V88, P217, DOI 10.1002/(SICI)1097-0142(20000101)88:1<217::AID-CNCR29>3.0.CO;2-Y; Booth K, 2005, PATIENT EDUC COUNS, V56, P225, DOI 10.1016/j.pec.2004.02.016; Bouchardy C, 2007, BRIT J CANCER, V96, P1743, DOI 10.1038/sj.bjc.6603783; Boyle P, 2005, ANN ONCOL, V16, P481, DOI 10.1093/annonc/mdi098; Brusilovskiy E, 2009, J PSYCHOSOC ONCOL, V27, P42, DOI 10.1080/07347330802614774; Callahan Daniel, 2009, Health Prog, V90, P29; Connell S, 2006, SUPPORT CARE CANCER, V14, P419, DOI 10.1007/s00520-005-0003-8; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Ferlay J, 2007, ANN ONCOL, V18, P581, DOI 10.1093/annonc/mdl498; Girgis A, 2000, AUST NZ J PUBL HEAL, V24, P166, DOI 10.1111/j.1467-842X.2000.tb00137.x; Grabsch Brenda, 2006, Palliat Support Care, V4, P47; Harrison JD, 2009, SUPPORT CARE CANCER, V17, P1117, DOI 10.1007/s00520-009-0615-5; Helseth S, 2005, J ADV NURS, V52, P38, DOI 10.1111/j.1365-2648.2005.03562.x; Hjerl K, 2002, ACTA PSYCHIAT SCAND, V105, P258, DOI 10.1034/j.1600-0447.2002.9028.x; Iwamitsu Y, 2005, PSYCHOSOMATICS, V46, P19, DOI 10.1176/appi.psy.46.1.19; Janz NK, 2008, CANCER-AM CANCER SOC, V113, P1058, DOI 10.1002/cncr.23660; Li J, 2006, PSYCHO-ONCOL, V15, P509, DOI 10.1002/pon.983; Lintz K, 2003, PSYCHO-ONCOLOGY, V12, P769, DOI 10.1002/pon.702; McDowell ME, 2010, PSYCHO-ONCOLOGY, V19, P508, DOI 10.1002/pon.1604; McKenney Susan A, 2005, Breast Dis, V23, P115; MONTAZERI A, 2008, J EXPT CLIN CANC RES, V2007, P27; Osborne RH, 2003, EUR J CANCER, V39, P755, DOI 10.1016/S0959-8049(02)00814-6; Raupach Jane C A, 2002, Health Expect, V5, P289, DOI 10.1046/j.1369-6513.2002.00191.x; Salminen E, 2004, SUPPORT CARE CANCER, V12, P663, DOI 10.1007/s00520-003-0578-x; Sanson-Fisher R, 2000, CANCER, V88, P226, DOI 10.1002/(SICI)1097-0142(20000101)88:1<226::AID-CNCR30>3.0.CO;2-P; Scholten C, 2001, SUPPORT CARE CANCER, V9, P459, DOI 10.1007/s005200000233; Seidman AD, 2006, ONCOLOGY-NY, V20, P983; SOBIN LH, 2002, TNM CLASSIFICATION M, P272; Soothill K, 2001, SUPPORT CARE CANCER, V9, P597, DOI 10.1007/s005200100278; Thewes B, 2004, PSYCHO-ONCOL, V13, P177, DOI 10.1002/pon.710; Tsuchiya M, 2009, EUR J CANCER CARE, V18, P149, DOI 10.1111/j.1365-2354.2008.00936.x; Veronesi U, 2005, LANCET, V365, P1727, DOI 10.1016/S0140-6736(05)66546-4; Vivar CG, 2005, J ADV NURS, V51, P520, DOI 10.1111/j.1365-2648.2005.03524.x	37	25	28	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-5423	1365-2354		EUR J CANCER CARE	Eur. J. Cancer Care	JUL	2011	20	4					466	474		10.1111/j.1365-2354.2010.01190.x			9	Oncology; Health Care Sciences & Services; Nursing; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Oncology; Health Care Sciences & Services; Nursing; Rehabilitation	774PT	WOS:000291399300006	20477860				2022-03-04	
J	Bieri, S; Roosnek, E; Helg, C; Verholen, F; Robert, D; Chapuis, B; Passweg, J; Miralbell, R; Chalandon, Y				Bieri, S.; Roosnek, E.; Helg, C.; Verholen, F.; Robert, D.; Chapuis, B.; Passweg, J.; Miralbell, R.; Chalandon, Y.			Quality of life and social integration after allogeneic hematopoietic SCT	BONE MARROW TRANSPLANTATION			English	Article						quality of life; allo-SCT; employment status	BONE-MARROW-TRANSPLANTATION; TOTAL-BODY IRRADIATION; VERSUS-HOST-DISEASE; STEM-CELL TRANSPLANTATION; EUROPEAN-ORGANIZATION; FUNCTIONAL ASSESSMENT; CANCER-THERAPY; FACT-BMT; GRAFT; RECIPIENTS	In total, 124 adult patients in remission after allogeneic hematopoietic SCT (HSCT) participated in a cross-sectional study to assess health-related quality of life (HRQL). Assessment of HRQL was carried out using two questionnaires: the (EORTC QLQ-C30) and the Functional Assessment of Cancer Therapy ( FACT) with specific modules for BMT (FACT-BMT). Transplanted patients differed from healthy controls in many HRQL-related dimensions in the EORTC QLQ-C30: social functioning 73.4 versus 85.8, P < 0.0001; role functioning 74.6 versus 83.3, P < 0.004; physical functioning 83.9 versus 89.9, P < 0.001; emotional functioning 72.2 versus 82.8, P < 0.0001 but were not significant for global HRQL 71.2 versus 75.3, P < 0.03. In total, 60% of the patients returned to work after HSCT; 31% part time and 29% full time. Age at HSCT and employment status were significantly associated with HRQL. Other factors such as disease and disease stage and especially the occurrence of late complications did not impact the perception of HRQL. This study suggests that the perception of HRQL after HSCT differs from the general population. Issues to increase work-related capabilities and improve social support need to be addressed.	[Roosnek, E.; Helg, C.; Verholen, F.; Robert, D.; Chapuis, B.; Passweg, J.; Chalandon, Y.] Univ Hosp, Div Hematol, Dept Internal Med, CH-1211 Geneva, Switzerland; [Bieri, S.; Miralbell, R.] Univ Hosp, Dept Radiol, Div Radiat Oncol, CH-1211 Geneva, Switzerland		Chalandon, Y (corresponding author), Univ Hosp, Div Hematol, Dept Internal Med, 24 Rue Micheli du Crest, CH-1211 Geneva, Switzerland.	yves.chalandon@hcuge.ch	Miralbell, Raymond/AAA-1234-2020; Chalandon, Yves/AAF-5125-2019; passweg, jakob/AAG-3911-2020	Chalandon, Yves/0000-0001-9341-8104; Passweg, Jakob R/0000-0001-7092-3351			AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Andrykowski MAA, 2005, J CLIN ONCOL, V23, P599, DOI 10.1200/JCO.2005.03.189; BAKER F, 1994, BONE MARROW TRANSPL, V13, P589; BAROFSKY I, 1989, WORK ILLNESS CANC PA, P3; Bieri S, 2001, INT J RADIAT ONCOL, V49, P1071, DOI 10.1016/S0360-3016(00)01491-7; Bush NE, 2000, BIOL BLOOD MARROW TR, V6, P576, DOI 10.1016/S1083-8791(00)70067-X; Cella D, 1997, MANUAL FUNCTIONAL AS; Chalandon Y, 2006, BIOL BLOOD MARROW TR, V12, P102, DOI 10.1016/j.bbmt.2005.09.010; Chiodi S, 2000, BRIT J HAEMATOL, V110, P614, DOI 10.1046/j.1365-2141.2000.02053.x; COX, 1989, ANAL BINARY DATA; GLUCKSBERG H, 1974, TRANSPLANTATION, V18, P295, DOI 10.1097/00007890-197410000-00001; Hale G, 1998, BLOOD, V92, P4581, DOI 10.1182/blood.V92.12.4581.424k22_4581_4590; Heinonen H, 2001, BONE MARROW TRANSPL, V28, P503, DOI 10.1038/sj.bmt.1703158; Heinonen H, 2001, ANN HEMATOL, V80, P137, DOI 10.1007/s002770000249; Hjermstad MJ, 1998, J CLIN ONCOL, V16, P1188, DOI 10.1200/JCO.1998.16.3.1188; Holzner B, 2004, ACTA ONCOL, V43, P153, DOI 10.1080/02841860310023453; Kopp M, 2000, EUR J HAEMATOL, V65, P97, DOI 10.1034/j.1600-0609.2000.90143.x; Kopp M, 2005, EUR J HAEMATOL, V74, P304, DOI 10.1111/j.1600-0609.2004.00402.x; Kopp M, 1998, ANN HEMATOL, V77, P27, DOI 10.1007/s002770050407; McQuellon RP, 1997, BONE MARROW TRANSPL, V19, P357, DOI 10.1038/sj.bmt.1700672; Miralbell R, 1996, J CLIN ONCOL, V14, P579, DOI 10.1200/JCO.1996.14.2.579; MIRALBELL R, 1994, INT J RADIAT ONCOL, V29, P1167, DOI 10.1016/0360-3016(94)90414-6; MOR V, 1984, CANCER, V53, P2002, DOI 10.1002/1097-0142(19840501)53:9<2002::AID-CNCR2820530933>3.0.CO;2-W; Sutherland HJ, 1997, BONE MARROW TRANSPL, V19, P1129, DOI 10.1038/sj.bmt.1700806; SYRJALA KL, 1993, BONE MARROW TRANSPL, V11, P319; Syrjala KL, 2004, JAMA-J AM MED ASSOC, V291, P2335, DOI 10.1001/jama.291.19.2335; WINGARD JR, 1991, ANN INTERN MED, V114, P113, DOI 10.7326/0003-4819-114-2-113	27	66	72	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369	1476-5365		BONE MARROW TRANSPL	Bone Marrow Transplant.	DEC	2008	42	12					819	827		10.1038/bmt.2008.253			9	Biophysics; Oncology; Hematology; Immunology; Transplantation	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Oncology; Hematology; Immunology; Transplantation	387JX	WOS:000261949600006	18711345	Bronze			2022-03-04	
J	Masouridi-Levrat, S; Simonetta, F; Tirefort, Y; Morin, S; Dantin, C; Stephan, C; Tsopra, O; Beauverd, Y; Mamez, AC; Chalandon, Y				Masouridi-Levrat, Stavroula; Simonetta, Federico; Tirefort, Yordanka; Morin, Sarah; Dantin, Carole; Stephan, Caroline; Tsopra, Olga; Beauverd, Yan; Mamez, Anne-Claire; Chalandon, Yves			Impact of partial T-cell depletion on a composite endpoint associated with clinical benefit after initial treatment of chronic graft-versus- host disease	BONE MARROW TRANSPLANTATION			English	Meeting Abstract	44th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT)	MAR 18-21, 2018	Lisbon, PORTUGAL	European Soc Blood & Marrow Transplantat					[Masouridi-Levrat, Stavroula; Simonetta, Federico; Tirefort, Yordanka; Morin, Sarah; Dantin, Carole; Stephan, Caroline; Tsopra, Olga; Beauverd, Yan; Mamez, Anne-Claire; Chalandon, Yves] Geneva Univ Hosp, Dept Oncol, Div Hematol, Geneva, Switzerland				Chalandon, Yves/AAF-5125-2019					0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369	1476-5365		BONE MARROW TRANSPL	Bone Marrow Transplant.	SEP	2018	53			S		P370	423	424					2	Biophysics; Oncology; Hematology; Immunology; Transplantation	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biophysics; Oncology; Hematology; Immunology; Transplantation	JA3ES	WOS:000487702804065					2022-03-04	
J	Aikaterini, K; Federico, S; Vu, DL; Boely, E; Dantin, C; Pradier, A; Tirefort, Y; Mamez, AC; Tsopra, O; Stephan, C; Beauverd, Y; Roosnek, E; Masouridi-Levrat, S; Van Delden, C; Chalandon, Y				Aikaterini, K.; Federico, S.; Vu, D-L; Boely, E.; Dantin, C.; Pradier, A.; Tirefort, Y.; Mamez, A-C; Tsopra, O.; Stephan, C.; Beauverd, Y.; Roosnek, E.; Masouridi-Levrat, S.; Van Delden, C.; Chalandon, Y.			Impact of different T-cell depletion techniques on the incidence of infectious complications after allogenic hematopoietic stem cell transplantation	BONE MARROW TRANSPLANTATION			English	Meeting Abstract	43rd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT)	MAR 26-29, 2017	Marseille, FRANCE	European Soc Blood & Marrow Transplantat					[Aikaterini, K.; Federico, S.; Dantin, C.; Pradier, A.; Tirefort, Y.; Mamez, A-C; Tsopra, O.; Stephan, C.; Beauverd, Y.; Roosnek, E.; Masouridi-Levrat, S.; Chalandon, Y.] Univ Hosp Geneva, Dept Oncol, Hematol Unit, Geneva, Switzerland; [Vu, D-L; Boely, E.; Van Delden, C.] Univ Hosp Geneva, Infect Dis, Dept Med Specializat, Geneva, Switzerland				Chalandon, Yves/AAF-5125-2019				Chalandon Y, 2006, BIOL BLOOD MARROW TR, V12, P102, DOI 10.1016/j.bbmt.2005.09.010; Finke J, 2009, LANCET ONCOL, V10, P855, DOI 10.1016/S1470-2045(09)70225-6; HOROWITZ MM, 1990, BLOOD, V75, P555; Kroger N, 2016, NEW ENGL J MED, V374, P43, DOI 10.1056/NEJMoa1506002; Soiffer, 2016, BLOOD, V128, P505	5	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369	1476-5365		BONE MARROW TRANSPL	Bone Marrow Transplant.	JUL	2017	52			1		P264	S253	S254					2	Biophysics; Oncology; Hematology; Immunology; Transplantation	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biophysics; Oncology; Hematology; Immunology; Transplantation	FV1WK	WOS:000424355301235					2022-03-04	
J	Perneger, TV				Perneger, Thomas V.			Online accesses to medical research articles on publication predicted citations up to 15 years later	JOURNAL OF CLINICAL EPIDEMIOLOGY			English	Article						Research assessment; Citations; Online usage	ASSOCIATION; QUALITY; COUNTS; IMPACT; INDICATORS; JOURNALS; BIAS	Objectives: To examine whether the number of early online accesses to medical research articles predicts citations in the scientific literature over time. Study Design and Setting: Cohort study of research articles published in the BMJ between January and June 1999. The number of online assesses within 1 week of publication was examined in relation to citation counts in 1999-2004, 2004-2009, and 2009-2014. Results: The 148 included articles were accessed on average 691 times up publication, and each was cited on average 33 times in 1999-2004, 32 times in 2004-2009, and 26 times in 2009-2014. The logarithm of accesses predicted the logarithm of citations for all three subsequent periods, but the association weakened over time (correlation with citations in 1999-2004: 0.54, 2004-2009: 0.49, 2009-2014: 0.39; all P < 0.001). In addition to online accesses, the presence of an abstract also predicted more citations for all periods. Conclusion: Early interest in a medical research article, reflected by online accesses within a week of publication, predicts citations up to 15 years later. This strengthens the validity of online usage as a measure of the scientific merit of publications. (C) 2015 Elsevier Inc. All rights reserved.	[Perneger, Thomas V.] Univ Hosp Geneva, Div Clin Epidemiol, CH-1211 Geneva, Switzerland; [Perneger, Thomas V.] Univ Geneva, Dept Community Hlth & Med, Fac Med, CH-1211 Geneva 4, Switzerland		Perneger, TV (corresponding author), Univ Hosp Geneva, Div Clin Epidemiol, 6 Rue Gabrielle Perret Gentil, CH-1211 Geneva, Switzerland.	thomas.perneger@hcuge.ch					Bornman M, 2007, CAN J SURG, V50, P119; Bornmann L, 2008, J DOC, V64, P45, DOI 10.1108/00220410810844150; Brody T, 2006, J AM SOC INF SCI TEC, V57, P1060, DOI 10.1002/asi.20373; Callaham M, 2002, JAMA-J AM MED ASSOC, V287, P2847, DOI 10.1001/jama.287.21.2847; Etter JF, 2009, J CLIN EPIDEMIOL, V62, P831, DOI 10.1016/j.jclinepi.2008.09.015; Eysenbach G, 2006, PLOS BIOL, V4, P692, DOI 10.1371/journal.pbio.0040157; Eysenbach G, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.2012; Figg WD, 2006, PHARMACOTHERAPY, V26, P759, DOI 10.1592/phco.26.6.759; Filion Kristian B, 2008, Epidemiol Perspect Innov, V5, P3, DOI 10.1186/1742-5573-5-3; Gargouri Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013636; Hendrix D, 2008, J MED LIBR ASSOC, V96, P324, DOI 10.3163/1536-5050.96.4.007; Jannot AS, 2013, J CLIN EPIDEMIOL, V66, P296, DOI 10.1016/j.jclinepi.2012.09.015; Lee KP, 2002, JAMA-J AM MED ASSOC, V287, P2805, DOI 10.1001/jama.287.21.2805; Lokker C, 2008, BMJ-BRIT MED J, V336, P655, DOI 10.1136/bmj.39482.526713.BE; Nieminen Pentti, 2006, BMC Med Res Methodol, V6, P42, DOI 10.1186/1471-2288-6-42; Patel VM, 2011, J ROY SOC MED, V104, P251, DOI 10.1258/jrsm.2011.110005; Patsopoulos NA, 2005, JAMA-J AM MED ASSOC, V293, P2362, DOI 10.1001/jama.293.19.2362; Perneger TV, 2010, J CLIN EPIDEMIOL, V63, P660, DOI 10.1016/j.jclinepi.2009.09.012; Perneger TV, 2004, BRIT MED J, V329, P546, DOI 10.1136/bmj.329.7465.546; Reed DA, 2007, JAMA-J AM MED ASSOC, V298, P1002, DOI 10.1001/jama.298.9.1002; SHADISH WR, 1995, SOC STUD SCI, V25, P477, DOI 10.1177/030631295025003003; Walter G, 2003, MED J AUSTRALIA, V178, P280, DOI 10.5694/j.1326-5377.2003.tb05196.x; Watson AB, 2009, J VISION, V9, DOI 10.1167/9.4.i	23	6	7	1	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0895-4356	1878-5921		J CLIN EPIDEMIOL	J. Clin. Epidemiol.	DEC	2015	68	12					1440	1445		10.1016/j.jclinepi.2015.01.024			6	Health Care Sciences & Services; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services; Public, Environmental & Occupational Health	CY6TR	WOS:000366542200008	25728430				2022-03-04	
J	Charbonnet, P; Toman, J; Buhler, L; Vermeulen, B; Morel, P; Becker, CD; Terrier, F				Charbonnet, P; Toman, J; Buhler, L; Vermeulen, B; Morel, P; Becker, CD; Terrier, F			Treatment of gastrointestinal hemorrhage	ABDOMINAL IMAGING			English	Review						gastrointestinal hemorrhage; selective embolization; surgery	ARTERIAL EMBOLIZATION; MANAGEMENT; DIAGNOSIS; ANGIOGRAPHY; EMBOLOTHERAPY; IMPACT	Background: We assessed the value of selective arteriography in the diagnosis and management of acute gastrointestinal hemorrhage. Methods: We reviewed the records of 107 consecutive patients who had gastrointestinal hemorrhage and underwent selective arteriography between January 1992 and October 2003: 10 had upper gastrointestinal bleeding, 79 had lower gastrointestinal bleeding, and 18 had varicose bleeding with portal hypertension. Selective embolization was attempted in 15 patients to obtain hemostasis. Angiographic findings were reviewed and prospective reports were compared with the final diagnosis and outcome. Results: Of 129 angiographic studies, 36 correctly revealed the bleeding site and 93 were negative. Extravasation was seen in 24 cases at the level of stomach (n = 2), duodenum (n = 1), small bowel (n = 5), or colon (n = 16). Indirect signs of bleeding sources were identified in 12 patients (stomach in one, small bowel in four, large bowel in four, liver in three). Transcatheter embolization induced definitive hemostasis in 11 of 15 patients (73%), namely in the stomach (n = 2), small bowel (n = 3), colon (n = 7), and liver (n = 3). Three patients required surgery after embolization. Conclusion: Abdominal arteriography may localize gastrointestinal bleeding sources in approximately one-third of cases. Selective embolization may provide definitive hemostasis in most instances.	Hop Cantonal Univ Geneva, Div Radiodiagnost & Radiol, CH-1211 Geneva, Switzerland; Hop Cantonal Univ Geneva, Div Urgences Medicochirurg, CH-1211 Geneva, Switzerland; Hop Cantonal Univ Geneva, Clin & Policlin Chirurg Digest, CH-1211 Geneva, Switzerland		Charbonnet, P (corresponding author), Hop Cantonal Univ Geneva, Clin & Policlin Chirurg Digest, 24 Rue Micheli du Crest, CH-1211 Geneva, Switzerland.	pierre.charbonnet@hcuge.ch		Buhler, Leo/0000-0002-9461-8498			Aina R, 2001, J VASC INTERV RADIOL, V12, P195, DOI 10.1016/S1051-0443(07)61825-9; Al Qahtani AR, 2002, WORLD J SURG, V26, P620, DOI 10.1007/s00268-001-0279-x; *AM COLL SURG, 1997, AM COLL SURG ADV TRA, P94; Angtuaco TL, 2001, AM J GASTROENTEROL, V96, P1782, DOI 10.1016/S0002-9270(01)02434-0; BAR AH, 1980, SURG GYNECOL OBSTET, V150, P226; Bloomfeld RS, 2000, CURR OPIN GASTROEN, V16, P89, DOI 10.1097/00001574-200001000-00016; Bonacker MJ, 2003, ROFO-FORTSCHR RONTG, V175, P524, DOI 10.1055/s-2003-38445; Brackman MR, 2003, AM SURGEON, V69, P145; BRITT LG, 1983, AM SURGEON, V49, P121; BROWDER W, 1986, ANN SURG, V204, P530, DOI 10.1097/00000658-198611000-00004; CAREY LS, 1974, J CAN ASSOC RADIOL, V25, P113; COLACCHIO TA, 1982, AM J SURG, V143, P607, DOI 10.1016/0002-9610(82)90175-1; Ghosh S, 2002, POSTGRAD MED J, V78, P4, DOI 10.1136/pmj.78.915.4; GIANTURCO C, 1975, AM J ROENTGENOL, V124, P428, DOI 10.2214/ajr.124.3.428; Gostout CJ, 2000, AM J GASTROENTEROL, V95, P590; Gostout CJ, 2000, NEW ENGL J MED, V342, P125, DOI 10.1056/NEJM200001133420210; KOVAL G, 1987, DIGEST DIS SCI, V32, P248, DOI 10.1007/BF01297049; Lefkovitz Z, 2002, MED CLIN N AM, V86, P1357, DOI 10.1016/S0025-7125(02)00080-9; LEITMAN IM, 1989, ANN SURG, V209, P175, DOI 10.1097/00000658-198902000-00007; Ljungdahl M, 2002, EUR J SURG, V168, P384, DOI 10.1080/110241502320789050; Longstreth GF, 1997, AM J GASTROENTEROL, V92, P419; Nicholson AA, 1998, GUT, V43, P79, DOI 10.1136/gut.43.1.79; NUSBAUM M, 1963, Surg Forum, V14, P374; Okazaki K, 2002, GUT, V51, P1, DOI 10.1136/gut.51.1.1; Pennoyer WP, 1996, INT J COLORECTAL DIS, V11, P279, DOI 10.1007/s003840050062; Podila PV, 2001, AM J GASTROENTEROL, V96, P208; PORTER DH, 1997, GASTROINTESTINAL EME, P163; ROCKALL TA, 1995, BRIT MED J, V311, P22; ROSCH J, 1972, RADIOLOGY, V102, P303, DOI 10.1148/102.2.303; Strate LL, 2003, ARCH INTERN MED, V163, P838, DOI 10.1001/archinte.163.7.838; Vernava AM, 1997, DIS COLON RECTUM, V40, P846, DOI 10.1007/BF02055445; Zuccaro G, 1998, AM J GASTROENTEROL, V93, P1202; Zuckerman GR, 1998, GASTROINTEST ENDOSC, V48, P606, DOI 10.1016/S0016-5107(98)70043-4	33	18	20	0	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0942-8925	1432-0509		ABDOM IMAGING	Abdom. Imaging	DEC	2005	30	6					719	726		10.1007/s00261-005-0314-8			8	Gastroenterology & Hepatology; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Gastroenterology & Hepatology; Radiology, Nuclear Medicine & Medical Imaging	987XJ	WOS:000233550700015	16252149	Green Published, Green Submitted			2022-03-04	
J	Pradier, A; Masouridi-Levrat, S; Bosshard, C; Dantin, C; Vu, DL; Zanella, MC; Boely, E; Tapparel, C; Kaiser, L; Chalandon, Y; Simonetta, F; Roosnek, E				Pradier, Amandine; Masouridi-Levrat, Stavroula; Bosshard, Carine; Dantin, Carole; Vu, Diem-Lan; Zanella, Marie-Celine; Boely, Elsa; Tapparel, Caroline; Kaiser, Laurent; Chalandon, Yves; Simonetta, Federico; Roosnek, Eddy			Torque Teno Virus as Biomarker to Predict Complications and Outcome after Allogeneic Hematopoietic Stem Cell Transplantation	BONE MARROW TRANSPLANTATION			English	Meeting Abstract									[Pradier, Amandine; Masouridi-Levrat, Stavroula; Bosshard, Carine; Dantin, Carole; Vu, Diem-Lan; Zanella, Marie-Celine; Boely, Elsa; Tapparel, Caroline; Kaiser, Laurent; Chalandon, Yves; Simonetta, Federico; Roosnek, Eddy] Geneva Univ Hosp, Geneva, Switzerland									0	0	0	0	0	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0268-3369	1476-5365		BONE MARROW TRANSPL	Bone Marrow Transplant.	DEC	2020	55	SUPPL 1		TEM CELL T		P473	539	540					2	Biophysics; Oncology; Hematology; Immunology; Transplantation	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Oncology; Hematology; Immunology; Transplantation	PH6YT	WOS:000600556202118					2022-03-04	
J	Tirefort, Y; Federico, S; Masouridi-Levrat, S; Pradier, A; Dantin, C; Beauverd, Y; Stephan, C; Polchlopek, K; Chalandon, Y				Tirefort, Y.; Federico, S.; Masouridi-Levrat, S.; Pradier, A.; Dantin, C.; Beauverd, Y.; Stephan, C.; Polchlopek, K.; Chalandon, Y.			G-CSF mobilized versus conventional donor lymphocytes for relapse or mixed chimerism after HSCT: a single center retrospective study	BONE MARROW TRANSPLANTATION			English	Meeting Abstract	42nd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation	APR 03-06, 2016	Valencia, SPAIN	European Soc Blood & Marrow Transplantat					[Tirefort, Y.; Federico, S.; Masouridi-Levrat, S.; Pradier, A.; Dantin, C.; Beauverd, Y.; Stephan, C.; Polchlopek, K.; Chalandon, Y.] Univ Hosp Geneva, Hematol, Geneva, Switzerland				Chalandon, Yves/AAF-5125-2019				Abbi KKS, 2013, BONE MARROW TRANSPL, V48, P357, DOI 10.1038/bmt.2012.144; Frey NV, 2008, BEST PRACT RES CL HA, V21, P205, DOI 10.1016/j.beha.2008.02.007	2	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369	1476-5365		BONE MARROW TRANSPL	Bone Marrow Transplant.	MAR	2016	51			1		P397	S325	S325					1	Biophysics; Oncology; Hematology; Immunology; Transplantation	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biophysics; Oncology; Hematology; Immunology; Transplantation	DI2VR	WOS:000373357601023					2022-03-04	
J	Simon, A; Roosnek, E; Tirefort, Y; Beauverd, Y; Dantin, C; Tsopra, O; Masouridi-Levrat, S; Chalandon, Y				Simon, A.; Roosnek, E.; Tirefort, Y.; Beauverd, Y.; Dantin, C.; Tsopra, O.; Masouridi-Levrat, S.; Chalandon, Y.			LOW INCIDENCE OF ACUTE AND CHRONIC GVHD AFTER REDUCED INTENSITY CONDITIONING AND PARTIAL T-CELL DEPLETION FOR HEMATOLOGICAL MALIGNANCIES	BONE MARROW TRANSPLANTATION			English	Meeting Abstract	40th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation	MAR 30-APR 02, 2014	Milan, ITALY	European Grp Blood & Marrow Transplantat					[Simon, A.; Roosnek, E.; Tirefort, Y.; Beauverd, Y.; Dantin, C.; Tsopra, O.; Masouridi-Levrat, S.; Chalandon, Y.] Hop Cantonal Univ Geneva, Geneva, Switzerland				Chalandon, Yves/AAF-5125-2019					0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369	1476-5365		BONE MARROW TRANSPL	Bone Marrow Transplant.	MAR	2014	49			1		PH-AB250	S545	S545					1	Biophysics; Oncology; Hematology; Immunology; Transplantation	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biophysics; Oncology; Hematology; Immunology; Transplantation	CP5RP	WOS:000359941902369					2022-03-04	
J	Bernhard, V; Jeantet, V				Bernhard, V.; Jeantet, V.			Improving specific paediatric nurse training	BONE MARROW TRANSPLANTATION			English	Meeting Abstract	37th European Group for Bone and Marrow Transplantation/27th Meeting of the EBMT Nurses Group/10th Meeting of the EBMT Management Group	APR 03-06, 2011	Paris, FRANCE	European Grp Bone & Marrow Transplantat, European Grp Bone & Marrow Transplantat Nurses Grp, European Grp Bone & Marrow Transplantat Management Grp					[Bernhard, V.; Jeantet, V.] HUG, Geneva, Switzerland									0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369			BONE MARROW TRANSPL	Bone Marrow Transplant.	APR	2011	46			1			S440	S440					1	Biophysics; Oncology; Hematology; Immunology; Transplantation	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biophysics; Oncology; Hematology; Immunology; Transplantation	745VC	WOS:000289195403125					2022-03-04	
J	Bieri, S; Roosnek, E; Helg, C; Ozsahin, H; Wacker, P; Chapuis, B; Miralbell, R				Bieri, S; Roosnek, E; Helg, C; Ozsahin, H; Wacker, P; Chapuis, B; Miralbell, R			Long-term medical outcome after T-cell depleted allogeneic haematopoietic stem cell transplantation in a single centre	BONE MARROW TRANSPLANTATION			English	Meeting Abstract	31st Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation/21st Meeting of the EBMT-Nurses-Group/4th Meeting of the EBMT-Data-Management-Group	MAR 20-23, 2005	Prague, CZECH REPUBLIC	European Grp Blood & Marrow Transplantat, EBMT Nurses Grp, EBMT Data Management Grp					Univ Hosp Geneva, Geneva, Switzerland									0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369			BONE MARROW TRANSPL	Bone Marrow Transplant.	MAR	2005	35			2			S189	S189					1	Biophysics; Oncology; Hematology; Immunology; Transplantation	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Oncology; Hematology; Immunology; Transplantation	915UE	WOS:000228336001007					2022-03-04	
J	Levrat, SM; Simonetta, F; Tirefort, Y; Tsopra, O; Dantin, C; Beauverd, Y; Simon, A; Polchlopeck, K; Stephan, C; Chalandon, Y				Levrat, S. Masouridi; Simonetta, F.; Tirefort, Y.; Tsopra, O.; Dantin, C.; Beauverd, Y.; Simon, A.; Polchlopeck, K.; Stephan, C.; Chalandon, Y.			Impact of different methods of T-cell depletion on poor graft function incidence after allogeneic hematopoietic stem cell transplantation	BONE MARROW TRANSPLANTATION			English	Meeting Abstract	42nd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation	APR 03-06, 2016	Valencia, SPAIN	European Soc Blood & Marrow Transplantat					[Levrat, S. Masouridi; Simonetta, F.; Tirefort, Y.; Tsopra, O.; Dantin, C.; Beauverd, Y.; Simon, A.; Polchlopeck, K.; Stephan, C.; Chalandon, Y.] Univ Hosp Geneva, Hematol, Geneva, Switzerland				Chalandon, Yves/AAF-5125-2019					0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369	1476-5365		BONE MARROW TRANSPL	Bone Marrow Transplant.	MAR	2016	51			1		P595	S429	S430					2	Biophysics; Oncology; Hematology; Immunology; Transplantation	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biophysics; Oncology; Hematology; Immunology; Transplantation	DI2VR	WOS:000373357601221					2022-03-04	
J	Perneger, TV; Brindel, P; Combescure, C; Gayet-Ageron, A				Perneger, Thomas V.; Brindel, Pauline; Combescure, Christophe; Gayet-Ageron, Angele			Evidence of survival benefit was often ambiguous in randomized trials of cancer treatments	JOURNAL OF CLINICAL EPIDEMIOLOGY			English	Article						Estimation; Uncertainty; Confidence interval; Treatment effectiveness; Randomized trial	CLINICAL BENEFIT; OPEN-LABEL; PHASE-III; MAGNITUDE; THERAPY; DOCTORS	Objectives: The objective of the study is to estimate the proportion of statistically significant survival improvements reported in ran-domized trials of cancer treatments that are also compatible with a clinically negligible benefit. Study Design and Setting: This is a cross-sectional study of reports of randomized clinical trials of cancer treatments that reported a statistically significant increase in overall survival, published in leading journals between 2009 and 2019. The main outcome variable was the hazard ratio (HR) for overall survival and its upper 95% confidence limit. An HR of 0.95 implies an absolute survival gain <= 1.9%, and an HR of 0.90 implies an absolute survival gain <3.8%; we reasoned that such survival gains can be considered clinically negligible, given the potential toxicity of oncologic treatments. Results: Among 234 trial results, the mean point estimate of the HR was 0.664, and all HRs were below 0.90. The mean upper 95% confidence limit for the HR was 0.897, but 37.6% of the values were >= 0.95, and 59.0% were >= 0.90. These proportions were lower when overall survival was the primary outcome of the trial (29.9% >= 0.95 and 51.3% >= 0.90). Conclusions: Considering only point estimates of HRs, all trials reported clinically meaningful improvements in overall survival. However, the upper confidence limits of a large proportion of HRs were also compatible with clinically negligible survival gains. Acknowledging the uncertainty regarding treatment benefits presents a challenge for the reporting of trial results and for clinical decision making. (c) 2020 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http:// creativecommons.org/licenses/by-nc-nd/4.0/).	[Perneger, Thomas V.; Brindel, Pauline; Combescure, Christophe; Gayet-Ageron, Angele] Univ Geneva, Div Clin Epidemiol, Univ Hosp Geneva, Fac Med, CH-1211 Geneva, Switzerland		Perneger, TV (corresponding author), Geneva Univ Hosp, Div Clin Epidemiol, 6 Rue Gabrielle Perret Gentil, CH-1211 Geneva, Switzerland.	thomas.perneger@hcuge.ch		Gayet-Ageron, Angele/0000-0002-6164-9693			Amrhein V, 2019, NATURE, V567, P305, DOI 10.1038/d41586-019-00857-9; Benjamin DJ, 2018, NAT HUM BEHAV, V2, P6, DOI 10.1038/s41562-017-0189-z; Berry DA, 2006, NAT REV DRUG DISCOV, V5, P27, DOI 10.1038/nrd1927; Cherny NI, 2015, ANN ONCOL, V26, P1547, DOI 10.1093/annonc/mdv249; Davis C, 2009, BMJ, V359, P4530, DOI DOI 10.1136/bmj.j4530; Eeles RA, 2015, J CLIN ONCOL, V33, P4138, DOI 10.1200/JCO.2015.60.9719; Eisenberger M, 2017, J CLIN ONCOL, V35, P3198, DOI 10.1200/JCO.2016.72.1076; FARRINGTON CP, 1990, STAT MED, V9, P1447, DOI 10.1002/sim.4780091208; Garcia-del-Muro X, 2011, J CLIN ONCOL, V29, P2528, DOI 10.1200/JCO.2010.33.6107; Gelman A, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l5381; Greenland S, 2016, EUR J EPIDEMIOL, V31, P337, DOI 10.1007/s10654-016-0149-3; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Heinemann V, 2014, LANCET ONCOL, V15, P1065, DOI 10.1016/S1470-2045(14)70330-4; KATZ J, 1984, HASTINGS CENT REP, V14, P35, DOI 10.2307/3560848; Kayama T, 2018, J CLIN ONCOL, V36, P3282, DOI 10.1200/JCO.2018.78.6186; Kim HH, 2019, JAMA ONCOL, V5, P506, DOI 10.1001/jamaoncol.2018.6727; Kitagawa R, 2015, J CLIN ONCOL, V33, P2129, DOI 10.1200/JCO.2014.58.4391; Kravitz RL, 2004, MILBANK Q, V82, P661, DOI 10.1111/j.0887-378X.2004.00327.x; Lee SM, 2017, J CLIN ONCOL, V35, P402, DOI 10.1200/JCO.2016.68.1841; Mehanna H, 2016, NEW ENGL J MED, V374, P1444, DOI 10.1056/NEJMoa1514493; Mejean A, 2018, NEW ENGL J MED, V379, P417, DOI 10.1056/NEJMoa1803675; Perneger TV, 2008, CONTEMP CLIN TRIALS, V29, P762, DOI 10.1016/j.cct.2008.06.002; Perneger TV, 2011, J GEN INTERN MED, V26, P1411, DOI 10.1007/s11606-011-1810-x; Politi MC, 2007, MED DECIS MAKING, V27, P681, DOI 10.1177/0272989x07307270; Robert C, 2015, NEW ENGL J MED, V372, P320, DOI 10.1056/NEJMoa1412082; Rothman KJ, 2016, EUR J EPIDEMIOL, V31, P443, DOI 10.1007/s10654-016-0158-2; ROTHMAN KJ, 1978, NEW ENGL J MED, V299, P1362; Simpkin AL, 2019, J GEN INTERN MED, V34, P2586, DOI 10.1007/s11606-019-04860-8; Slamon D, 2011, NEW ENGL J MED, V365, P1273, DOI 10.1056/NEJMoa0910383; Tibau A, 2018, JNCI-J NATL CANCER I, V110, P486, DOI 10.1093/jnci/djx232; Zipkin DA, 2014, ANN INTERN MED, V161, P270, DOI 10.7326/M14-0295	31	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0895-4356	1878-5921		J CLIN EPIDEMIOL	J. Clin. Epidemiol.	NOV	2020	127						1	8		10.1016/j.jclinepi.2020.06.026			8	Health Care Sciences & Services; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services; Public, Environmental & Occupational Health	OR9QA	WOS:000589799000004	32622900	Green Published, hybrid			2022-03-04	
J	Chalandon, Y; Roosnek, E; Waelchli, L; Helg, C; Chapuis, B				Chalandon, Y; Roosnek, E; Waelchli, L; Helg, C; Chapuis, B			Partial in vitro T-cell depletion with CAMPATH-1H in combination with DLI for CML molecular relapses decreases GVHD with 70% 5-years DFS in HLA-identical sibling PBSC for haematological malignancies	BONE MARROW TRANSPLANTATION			English	Meeting Abstract	30th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation/20th Meeting of the EBMT-Nurses-Group/3rd Meeting of the EBMT-Data-Management-Group	MAR 28-31, 2004	Barcelona, SPAIN	European Grp Blood & Marrow Transplantat, EBMT Nurses Grp, EBMT Data management Grp					Hop Cantonal Univ Geneva, Geneva, Switzerland				Chalandon, Yves/AAF-5125-2019					0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369			BONE MARROW TRANSPL	Bone Marrow Transplant.	MAR	2004	33			1			S92	S92					1	Biophysics; Oncology; Hematology; Immunology; Transplantation	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Oncology; Hematology; Immunology; Transplantation	812PH	WOS:000220850900262					2022-03-04	
J	Flores, P; Vuilloud, C; Cristiano, G; Ozsahin, H; Gumy-Pause, F; Ansari, M; Bernhard, V				Flores, P.; Vuilloud, C.; Cristiano, G.; Ozsahin, H.; Gumy-Pause, F.; Ansari, M.; Bernhard, V.			Schooling of ill children - school social link. Experience in a transplant unit	BONE MARROW TRANSPLANTATION			English	Meeting Abstract	38th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation (EBMT)	APR 01-04, 2012	Geneva, SWITZERLAND	European Grp Blood & Marrow Transplantat (EBMT)					[Flores, P.; Vuilloud, C.; Cristiano, G.; Ozsahin, H.; Gumy-Pause, F.; Ansari, M.; Bernhard, V.] HUG, Geneva, Switzerland									0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369			BONE MARROW TRANSPL	Bone Marrow Transplant.	APR	2012	47			1			S483	S483					1	Biophysics; Oncology; Hematology; Immunology; Transplantation	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biophysics; Oncology; Hematology; Immunology; Transplantation	925GN	WOS:000302749202065					2022-03-04	
J	Ambrosioni, J; van Delden, C; Krause, KH; Bouchuiguir-Wafa, C; Nagy, M; Passweg, J; Chalandon, Y				Ambrosioni, J.; van Delden, C.; Krause, K. H.; Bouchuiguir-Wafa, C.; Nagy, M.; Passweg, J.; Chalandon, Y.			Invasive microsporidiosis in allogeneic haematopoietic SCT recipients	BONE MARROW TRANSPLANTATION			English	Letter							INTESTINAL MICROSPORIDIOSIS; TRANSPLANTATION; INFECTION		[Ambrosioni, J.; van Delden, C.; Krause, K. H.] Univ Hosp Geneva, Dept Med, Infect Dis Serv, Geneva, Switzerland; [Bouchuiguir-Wafa, C.] Univ Hosp Geneva, Dept Genet, Geneva, Switzerland; [Bouchuiguir-Wafa, C.] Univ Hosp Geneva, Microbiol Lab, Geneva, Switzerland; [Nagy, M.; Passweg, J.; Chalandon, Y.] Univ Hosp Geneva, Serv Haematol, Geneva, Switzerland		Ambrosioni, J (corresponding author), Univ Hosp Geneva, Dept Med, Infect Dis Serv, Geneva, Switzerland.	Christian.vandelden@unige.ch	Krause, Karl-Heinz/E-8030-2011; passweg, jakob/AAG-3911-2020; Chalandon, Yves/AAF-5125-2019	Krause, Karl-Heinz/0000-0002-9033-6768; Passweg, Jakob R/0000-0001-7092-3351; Chalandon, Yves/0000-0001-9341-8104			Conteas CN, 1996, ARCH PATHOL LAB MED, V120, P847; Didier ES, 2006, CURR OPIN INFECT DIS, V19, P485, DOI 10.1097/01.qco.0000244055.46382.23; Didier Elizabeth S, 2005, Expert Rev Anti Infect Ther, V3, P419, DOI 10.1586/14787210.3.3.419; Gross U, 2003, PARASITOL RES, V90, pS14, DOI 10.1007/s00436-002-0753-x; Kelkar R, 1997, BONE MARROW TRANSPL, V19, P179, DOI 10.1038/sj.bmt.1700536; Lanternier F, 2009, TRANSPL INFECT DIS, V11, P83, DOI 10.1111/j.1399-3062.2008.00347.x; Molina JM, 2002, NEW ENGL J MED, V346, P1963, DOI 10.1056/NEJMoa012924; MOURA H, 1996, J EUKARYOT MICROBIOL, V43, P94; Novitzky N, 2001, CYTOTHERAPY, V3, P211, DOI 10.1080/146532401753174043; Rabodonirina M, 2003, J EUKARYOT MICROBIOL, V50, P583, DOI 10.1111/j.1550-7408.2003.tb00639.x; Teachey DT, 2004, BONE MARROW TRANSPL, V33, P299, DOI 10.1038/sj.bmt.1704327; Thomarat F, 2004, J MOL EVOL, V59, P780, DOI 10.1007/s00239-004-2673-0; WEBER R, 1994, CLIN MICROBIOL REV, V7, P426, DOI 10.1128/CMR.7.4.426-461.1994	13	13	13	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369			BONE MARROW TRANSPL	Bone Marrow Transplant.	JUL	2010	45	7					1249	1251		10.1038/bmt.2009.315			3	Biophysics; Oncology; Hematology; Immunology; Transplantation	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Oncology; Hematology; Immunology; Transplantation	621WB	WOS:000279614900018	19915628	Bronze			2022-03-04	
J	Grannavel, C; Suva, D; Brouwers, N; Passweg, J; Kindler, V				Grannavel, C.; Suva, D.; Brouwers, N.; Passweg, J.; Kindler, V.			Transmigration and trapping of activated human T-lymphocytes in a closed environment under mesenchymal multipotent stromal cells are required for their inhibition in vitro	BONE MARROW TRANSPLANTATION			English	Meeting Abstract	34th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation/24nd Meeting of the EBMT-Nurses-Group/7th Meeting of the EBMT-Data-Management-Group	MAR 30-APR 02, 2008	Florence, ITALY	European Grp Blood & Marrow Transplantat, EBMT Nurses Grp, EBMT Data Management Grp					[Grannavel, C.; Suva, D.; Brouwers, N.; Passweg, J.; Kindler, V.] Univ Hosp Geneva, Geneva, Switzerland				passweg, jakob/AAG-3911-2020					0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369			BONE MARROW TRANSPL	Bone Marrow Transplant.	MAR	2008	41			1			S216	S216					1	Biophysics; Oncology; Hematology; Immunology; Transplantation	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Oncology; Hematology; Immunology; Transplantation	279ML	WOS:000254359200541					2022-03-04	
J	Repond, B; Cristiano, G; Ozsahin, H; Gumy-Pause, F; Ansari, M; Bernhard, V				Repond, B.; Cristiano, G.; Ozsahin, H.; Gumy-Pause, F.; Ansari, M.; Bernhard, V.			Diet in the onco-haematology paediatric unit of the Geneva university hospital	BONE MARROW TRANSPLANTATION			English	Meeting Abstract	38th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation (EBMT)	APR 01-04, 2012	Geneva, SWITZERLAND	European Grp Blood & Marrow Transplantat (EBMT)					[Repond, B.; Cristiano, G.; Ozsahin, H.; Gumy-Pause, F.; Ansari, M.; Bernhard, V.] HUG, Geneva, Switzerland									0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369			BONE MARROW TRANSPL	Bone Marrow Transplant.	APR	2012	47			1			S460	S460					1	Biophysics; Oncology; Hematology; Immunology; Transplantation	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biophysics; Oncology; Hematology; Immunology; Transplantation	925GN	WOS:000302749202007					2022-03-04	
J	Bernier, J				Bernier, Jacques			Radiotherapy of head-and-neck cancer: From translational research to clinical optimization	ORAL ONCOLOGY			English	Meeting Abstract									[Bernier, Jacques] Genolier Swiss Med Network, Geneva, Switzerland; [Bernier, Jacques] Univ Geneva, Geneva, Switzerland				Bernier, Jacques/AAE-7248-2020	Bernier, Jacques/0000-0002-0138-9906				0	0	0	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1368-8375	1879-0593		ORAL ONCOL	Oral Oncol.	MAY 1	2013	49			1			S2	S2		10.1016/j.oraloncology.2013.03.464			1	Oncology; Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Dentistry, Oral Surgery & Medicine	V40KJ	WOS:000209477200005					2022-03-04	
J	Poletti, PA; Vargas, MI; Becker, CD				Poletti, PA; Vargas, MI; Becker, CD			Successful treatment of a ruptured mycotic aneurysm of the ileocolic artery with transcatheter embolization and antibiotic therapy	ABDOMINAL IMAGING			English	Article						mycotic aneurysm; ileocolic artery aneurysm; embolization	SUPERIOR MESENTERIC-ARTERY; PANCREATICODUODENAL ARTERY; INFECTIOUS ENDOCARDITIS; SELECTIVE EMBOLIZATION	We report a case of mycotic aneurysm of the ileocolic artery due to Streptococcus bovis endocarditis and acute septicemia complicated by active hemorrhage, that was treated successfully with transcatheter embolization and subsequent intravenous antibiotic treatment. This case suggests that a mycotic aneurysm can be treated successfully by percutaneous embolization in an emergent situation (active bleeding, septicemia) even without previous antibiotic therapy.	Univ Hosp Geneva, Div Radiodiagnost & Radiol Intervent, CH-1211 Geneva, Switzerland		Poletti, PA (corresponding author), Univ Hosp Geneva, Div Radiodiagnost & Radiol Intervent, Rue Micheli Crest 24, CH-1211 Geneva, Switzerland.			Vargas, Maria Isabel/0000-0002-6571-5336			CHARLIER P, 1988, ARCH MAL COEUR VAISS, V81, P1269; Chou T F, 1991, J Formos Med Assoc, V90, P853; FRIEDMAN SG, 1987, J VASC SURG, V6, P87, DOI 10.1067/mva.1987.avs0060087; GLANZ S, 1987, CARDIOVASC INTER RAD, V10, P198, DOI 10.1007/BF02593869; Hammer FD, 1996, EUR RADIOL, V6, P514; Majerus B, 1998, DIGEST SURG, V15, P266, DOI 10.1159/000018626; MANSUR AJ, 1986, CLIN CARDIOL, V9, P65, DOI 10.1002/clc.4960090204; MUKERJEE S, 1974, BRIT J SURG, V61, P233, DOI 10.1002/bjs.1800610315; NOSHER JL, 1990, CARDIOVASC INTERVENT, V12, P310; OHMI M, 1990, J CARDIOVASC SURG, V31, P115; Osler W, 1885, Br Med J, V1, P522; PORTER LL, 1979, AM J MED, V67, P697, DOI 10.1016/0002-9343(79)90268-7; Silver SE, 1999, CLIN INFECT DIS, V29, P1573, DOI 10.1086/313517; Staat P, 1996, ARCH MAL COEUR VAISS, V89, P1431; STEWART B, 1991, AUST NZ J SURG, V61, P153, DOI 10.1111/j.1445-2197.1991.tb00194.x	15	6	6	0	0	SPRINGER-VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0942-8925			ABDOM IMAGING	Abdom. Imaging	NOV-DEC	2001	26	6					651	653		10.1007/s00261-001-0008-9			3	Gastroenterology & Hepatology; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Gastroenterology & Hepatology; Radiology, Nuclear Medicine & Medical Imaging	487PR	WOS:000171884900019	11907733				2022-03-04	
J	Simonetta, F; Masouridi-Levrat, S; Beauverd, Y; Tsopra, O; Tirefort, Y; Stephan, C; Polchlopek, K; Favale, R; Dantin, C; Ansari, M; Roosnek, E; Chalandon, Y				Simonetta, F.; Masouridi-Levrat, S.; Beauverd, Y.; Tsopra, O.; Tirefort, Y.; Stephan, C.; Polchlopek, K.; Favale, R.; Dantin, C.; Ansari, M.; Roosnek, E.; Chalandon, Y.			T-cell depletion improves the composite end point graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic stem cell transplantation	BONE MARROW TRANSPLANTATION			English	Meeting Abstract	42nd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation	APR 03-06, 2016	Valencia, SPAIN	European Soc Blood & Marrow Transplantat					[Simonetta, F.; Masouridi-Levrat, S.; Beauverd, Y.; Tsopra, O.; Tirefort, Y.; Stephan, C.; Polchlopek, K.; Favale, R.; Dantin, C.; Roosnek, E.; Chalandon, Y.] Univ Hosp Geneva, Div Hematol, Geneva, Switzerland; [Ansari, M.] Univ Hosp Geneva, Dept Pediat, Oncohematol Unit, Geneva, Switzerland				Chalandon, Yves/AAF-5125-2019; ANSARI, Marc/V-3334-2017				Holtan SG, 2015, BLOOD, V125, P1333, DOI 10.1182/blood-2014-10-609032	1	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369	1476-5365		BONE MARROW TRANSPL	Bone Marrow Transplant.	MAR	2016	51			1		P210	S223	S224					2	Biophysics; Oncology; Hematology; Immunology; Transplantation	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biophysics; Oncology; Hematology; Immunology; Transplantation	DI2VR	WOS:000373357600391					2022-03-04	
J	Levrat, E; Roosnek, E; Mohty, B; Bernimoulin, M; Nagy-Hulliger, M; Tirefort, Y; Paiano, S; Ozsahin, H; Villard, J; Passweg, J; Chalandon, Y				Levrat, E.; Roosnek, E.; Mohty, B.; Bernimoulin, M.; Nagy-Hulliger, M.; Tirefort, Y.; Paiano, S.; Ozsahin, H.; Villard, J.; Passweg, J.; Chalandon, Y.			Evolution of mixed chimerism after allogeneic haematopoietic stem cell transplantation in patients with haematologic malignancies	BONE MARROW TRANSPLANTATION			English	Meeting Abstract	37th European Group for Bone and Marrow Transplantation/27th Meeting of the EBMT Nurses Group/10th Meeting of the EBMT Management Group	APR 03-06, 2011	Paris, FRANCE	European Grp Bone & Marrow Transplantat, European Grp Bone & Marrow Transplantat Nurses Grp, European Grp Bone & Marrow Transplantat Management Grp					[Levrat, E.; Roosnek, E.; Mohty, B.; Bernimoulin, M.; Nagy-Hulliger, M.; Tirefort, Y.; Paiano, S.; Ozsahin, H.; Villard, J.; Passweg, J.; Chalandon, Y.] Univ Hosp Geneva, Geneva, Switzerland				Chalandon, Yves/AAF-5125-2019; passweg, jakob/AAG-3911-2020					0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369			BONE MARROW TRANSPL	Bone Marrow Transplant.	APR	2011	46			1			S199	S199					1	Biophysics; Oncology; Hematology; Immunology; Transplantation	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biophysics; Oncology; Hematology; Immunology; Transplantation	745VC	WOS:000289195401294					2022-03-04	
J	Chalandon, Y; Terraz, S; Kindler, V; Passweg, J; Rubbia-Brandt, L; Hadengue, A; Spahr, L				Chalandon, Y.; Terraz, S.; Kindler, V.; Passweg, J.; Rubbia-Brandt, L.; Hadengue, A.; Spahr, L.			Intrahepatic G-CSF stimulated autologous bone marrow stem cell transplantation versus standard of care in patients with decompensated alcoholic liver disease: a randomised study	BONE MARROW TRANSPLANTATION			English	Meeting Abstract	38th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation (EBMT)	APR 01-04, 2012	Geneva, SWITZERLAND	European Grp Blood & Marrow Transplantat (EBMT)					[Chalandon, Y.; Terraz, S.; Kindler, V.; Passweg, J.; Rubbia-Brandt, L.; Hadengue, A.; Spahr, L.] Univ Hosp Geneva, Geneva, Switzerland				Chalandon, Yves/AAF-5125-2019; huijuan, Cao/A-2427-2014; passweg, jakob/AAG-3911-2020					0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369			BONE MARROW TRANSPL	Bone Marrow Transplant.	APR	2012	47			1			S57	S57					1	Biophysics; Oncology; Hematology; Immunology; Transplantation	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biophysics; Oncology; Hematology; Immunology; Transplantation	925GN	WOS:000302749200122					2022-03-04	
J	Notari, SC; Favez, N; Notari, L; Panes-Ruedin, B; Antonini, T; Delaloye, JF				Notari, S. Cairo; Favez, N.; Notari, L.; Panes-Ruedin, B.; Antonini, T.; Delaloye, J. -F.			Women's experiences of sexual functioning in the early weeks of breast cancer treatment	EUROPEAN JOURNAL OF CANCER CARE			English	Article						breast cancer; early detection; mixed methods; quantitative and qualitative change; sexual functioning	QUALITY-OF-LIFE; LONG-TERM; YOUNG-WOMEN; BODY-IMAGE; ACTIVITY QUESTIONNAIRE; SURVIVORS; HEALTH; IMPACT; DIAGNOSIS; INTIMACY	This study describes women's sexual functioning in the early weeks of breast cancer treatment and the possible sexual changes that women may experience compared with pre-treatment functioning. Seventy-five patients filled out a questionnaire on sexual functioning and participated in a semi-structured interview on changes in sexual life and intimacy after treatment. Sixty-two women were sexually active before treatment; three post-treatment patterns of sexual behaviour were identified: 22.6% of these women were as active as before treatment, 35.5% stopped any sexual activity and 41.9% experienced quantitative and qualitative changes. Analyses showed that each pattern had specific characteristics regarding current sexual functioning, the kinds of changes reported (e.g. decreased frequency and increased tenderness) and the reasons for these changes (e.g. tiredness and sex not a priority). Even in the immediate post-surgical period, women may react in very different ways to treatment in terms of sexual functioning. Most women experience changes, but cessation of sexual activity is not inevitable. Positive changes (growing tenderness and affection) also exist. These important interindividual differences require a person-centred approach when the topic of sexuality is being addressed, and practitioners need to be sensitive to individual perceptions of change. Early detection of sexual changes may prevent the crystallisation of difficulties over time.	[Notari, S. Cairo; Favez, N.; Notari, L.; Antonini, T.] Univ Geneva, Fac Psychol & Educ Sci, Bd Pont Arve 40, CH-1205 Geneva, Switzerland; [Panes-Ruedin, B.; Delaloye, J. -F.] Univ Lausanne Hosp, Senol Unit, Lausanne, Switzerland		Notari, SC (corresponding author), Univ Geneva, Fac Psychol & Educ Sci, Bd Pont Arve 40, CH-1205 Geneva, Switzerland.	sarah.cairo@unige.ch	Favez, Nicolas/ABB-6292-2020	Favez, Nicolas/0000-0003-1744-7602; Cairo Notari, Sarah/0000-0003-2623-2881	Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission	Swiss National Science Foundation.	Ananth H, 2003, PALLIATIVE MED, V17, P202, DOI 10.1191/0269216303pm759oa; Begovic-Juhant A, 2012, J PSYCHOSOC ONCOL, V30, P446, DOI 10.1080/07347332.2012.684856; Bredart A, 2011, PSYCHO-ONCOLOGY, V20, P841, DOI 10.1002/pon.1789; Butler L, 1998, WESTERN J NURS RES, V20, P683, DOI 10.1177/019394599802000603; Cebeci F, 2010, SEX DISABIL, V28, P255, DOI 10.1007/s11195-010-9169-1; Ferreira SMD, 2015, REV LAT-AM ENFERM, V23, P82, DOI 10.1590/0104-1169.3602.2528; DeSimone M, 2014, AM J CLIN ONCOL-CANC, V37, P101, DOI 10.1097/COC.0b013e318248d89d; Emilee G, 2010, MATURITAS, V66, P397, DOI 10.1016/j.maturitas.2010.03.027; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fobair P, 2006, PSYCHO-ONCOL, V15, P579, DOI 10.1002/pon.991; Ganz PA, 2002, JNCI-J NATL CANCER I, V94, P39; Ganz PA, 1998, J CLIN ONCOL, V16, P501, DOI 10.1200/JCO.1998.16.2.501; Ganz PA, 1999, J CLIN ONCOL, V17, P2371, DOI 10.1200/JCO.1999.17.8.2371; Holmberg SK, 2001, CANCER NURS, V24, P53, DOI 10.1097/00002820-200102000-00009; Hordern AJ, 2007, MED J AUSTRALIA, V186, P224, DOI 10.5694/j.1326-5377.2007.tb00877.x; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Klaeson K, 2011, EUR J CANCER CARE, V20, P728, DOI 10.1111/j.1365-2354.2011.01239.x; Kornblith AB, 2003, CANCER-AM CANCER SOC, V98, P679, DOI 10.1002/cncr.11531; Krippendorf K., 2004, CONTENT ANAL INTRO I, V2nd ed.; KUYKEN W, 1995, SOC SCI MED, V41, P1403, DOI 10.1016/0277-9536(95)00112-k; Lam WWT, 2012, BREAST CANCER RES TR, V131, P957, DOI 10.1007/s10549-011-1798-2; Landmark BT, 2008, J CLIN NURS, V17, P192, DOI 10.1111/j.1365-2702.2008.02340.x; Landmark BT, 2002, J ADV NURS, V40, P112, DOI 10.1046/j.1365-2648.2002.02346.x; Liavaag AH, 2008, GYNECOL ONCOL, V108, P348, DOI 10.1016/j.ygyno.2007.10.009; Manne SL, 2006, PSYCHO-ONCOL, V15, P234, DOI 10.1002/pon.941; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; Meyerowitz BE, 1999, J SEX MARITAL THER, V25, P237, DOI 10.1080/00926239908403998; Mols F, 2005, EUR J CANCER, V41, P2613, DOI 10.1016/j.ejca.2005.05.017; Moreira H., 2010, PSICOONCOLOGIA, V7, P61; Neyt M, 2006, J PSYCHOSOC ONCOL, V24, P89, DOI 10.1300/J077v24n03_05; Pelusi J, 2006, CANCER NURS, V29, P32, DOI 10.1097/00002820-200603002-00013; Rogers M, 2002, CANCER NURS, V25, P57, DOI 10.1097/00002820-200202000-00011; Sadovsky R, 2010, J SEX MED, V7, P349, DOI 10.1111/j.1743-6109.2009.01620.x; Safarinejad MR, 2013, PSYCHO-ONCOLOGY, V22, P1242, DOI 10.1002/pon.3130; Schover Leslie R, 2005, Hematology Am Soc Hematol Educ Program, P523; Shands ME, 2006, PSYCHO-ONCOLOGY, V15, P1055, DOI 10.1002/pon.1036; Sheppard LA, 2008, BREAST J, V14, P176, DOI 10.1111/j.1524-4741.2007.00550.x; Speer JJ, 2005, BREAST J, V11, P440, DOI 10.1111/j.1075-122X.2005.00131.x; Stead ML, 1999, BRIT J OBSTET GYNAEC, V106, P50, DOI 10.1111/j.1471-0528.1999.tb08084.x; Takahashi M, 2005, SOC SCI MED, V61, P1278, DOI 10.1016/j.socscimed.2005.01.013; Takahashi M, 2008, PSYCHO-ONCOL, V17, P901, DOI 10.1002/pon.1297; Thirlaway K, 1996, QUAL LIFE RES, V5, P81, DOI 10.1007/BF00435972; Ussher JM, 2013, J ADV NURS, V69, P327, DOI 10.1111/j.1365-2648.2012.06010.x; Ussher JM, 2012, CANCER NURS, V35, P456, DOI 10.1097/NCC.0b013e3182395401; Vieira EM, 2014, REV LAT-AM ENFERM, V22, P408, DOI 10.1590/0104-1169.3258.2431; Vistad I, 2007, J WOMENS HEALTH, V16, P139, DOI 10.1089/jwh.2006.0052	46	7	7	1	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-5423	1365-2354		EUR J CANCER CARE	Eur. J. Cancer Care	JAN	2018	27	1							e12607	10.1111/ecc.12607			10	Oncology; Health Care Sciences & Services; Nursing; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Oncology; Health Care Sciences & Services; Nursing; Rehabilitation	FT8DQ	WOS:000423383300026	29372622				2022-03-04	
J	Levrat, SM; Morin, S; Giannotti, F; Dantin, C; Pradier, A; Tran, TA; Longval, T; Anastasiou, M; Bounaix, L; Stephan, C; Tsopra, O; Beauverd, Y; Nabergoj, M; Ortiz, CD; Mamez, AC; Chalandon, Y				Levrat, Stavroula Masouridi; Morin, Sarah; Giannotti, Federica; Dantin, Carole; Pradier, Amandine; Thien-An Tran; Longval, Thomas; Anastasiou, Maria; Bounaix, Laura; Stephan, Caroline; Tsopra, Olga; Beauverd, Yan; Nabergoj, Mitja; Ortiz, Carmen de Ramon; Mamez, Anne-Claire; Chalandon, Yves			Outcome of patients with chronic myeloid leukemia transplanted with HLA-identical sibling donor and partial T-cell depletion. a single center experience with a very long follow-up	BONE MARROW TRANSPLANTATION			English	Meeting Abstract	45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT)	MAR 24-27, 2019	Frankfurt, GERMANY	European Soc Blood & Marrow Transplantat					[Levrat, Stavroula Masouridi; Morin, Sarah; Giannotti, Federica; Dantin, Carole; Pradier, Amandine; Thien-An Tran; Longval, Thomas; Anastasiou, Maria; Bounaix, Laura; Stephan, Caroline; Tsopra, Olga; Beauverd, Yan; Nabergoj, Mitja; Ortiz, Carmen de Ramon; Mamez, Anne-Claire; Chalandon, Yves] Geneva Univ Hosp, Geneva, Switzerland				Chalandon, Yves/AAF-5125-2019					0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369	1476-5365		BONE MARROW TRANSPL	Bone Marrow Transplant.	JUL	2019	54			1		P097	205	206					2	Biophysics; Oncology; Hematology; Immunology; Transplantation	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biophysics; Oncology; Hematology; Immunology; Transplantation	JA3GL	WOS:000487707800229					2022-03-04	
J	Rigatou, E; Gumy-Pause, F; Mattiello, V; Chalandon, Y; Ansari, M; Ozsahin, H				Rigatou, E.; Gumy-Pause, F.; Mattiello, V.; Chalandon, Y.; Ansari, M.; Ozsahin, H.			Post-transplant immune reconstitution after allogeneic stem cell transplantation in paediatric patients with high-risk leukaemia	BONE MARROW TRANSPLANTATION			English	Meeting Abstract	37th European Group for Bone and Marrow Transplantation/27th Meeting of the EBMT Nurses Group/10th Meeting of the EBMT Management Group	APR 03-06, 2011	Paris, FRANCE	European Grp Bone & Marrow Transplantat, European Grp Bone & Marrow Transplantat Nurses Grp, European Grp Bone & Marrow Transplantat Management Grp					[Rigatou, E.; Gumy-Pause, F.; Mattiello, V.; Chalandon, Y.; Ansari, M.; Ozsahin, H.] Univ Hosp Geneva, Geneva, Switzerland				ANSARI, Marc/V-3334-2017; Chalandon, Yves/AAF-5125-2019					0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369			BONE MARROW TRANSPL	Bone Marrow Transplant.	APR	2011	46			1			S149	S150					2	Biophysics; Oncology; Hematology; Immunology; Transplantation	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biophysics; Oncology; Hematology; Immunology; Transplantation	745VC	WOS:000289195401158					2022-03-04	
J	Thang, NNT; Abdo, G; Martin, JB; Seium-Neberay, Y; Yilmaz, H; Verbist, MC; Rufenacht, D; Sappino, AP; Dietrich, PY				Thang, Nhu Nam Tran; Abdo, German; Martin, Jean-Baptiste; Seium-Neberay, Yodit; Yilmaz, Hasan; Verbist, Marie-Christine; Rufenacht, Daniel; Sappino, Andre-Pascal; Dietrich, Pierre-Yves			Percutaneous cementoplasty in multiple myeloma: a valuable adjunct for pain control and ambulation maintenance	SUPPORTIVE CARE IN CANCER			English	Article						bone metastasis; pain; vertebral compression fracture; vertebroplasty	VERTEBRAL COMPRESSION FRACTURES; CANCER-PATIENTS; OSTEOLYTIC METASTASES; INITIAL-EXPERIENCE; PERFORMANCE STATUS; VERTEBROPLASTY; KYPHOPLASTY; DISEASE; PATIENT; SPINE	Goals of work Bone pain and functional impairment are major concerns for multiple myeloma (MM) patients. The goal of this study was to better define the role of percutaneous cementoplasty (PC) in improving their quality of life. Materials and methods This retrospective analysis included 28 consecutive heavily pretreated MM patients managed at our institution between 1996 and 2002. They underwent a total of 34 PC procedures for the treatment of 117 vertebrae and 2 iliac sites and were evaluated at 1 month. Main results Significant pain reduction of > 50% was obtained after 83% of the procedures, with a mean visual analogous score decreasing from 7.48/10 to 2.1/10 (p < 0.001). It resulted in a complete interruption of opiate analgesic consumption after 59.3% of the procedures, with a mean decrease of 70.4% in the opiate dose. Functional impairment was evaluated with the Eastern Cooperative Oncology Group (ECOG) performance status scale, with mean scores improving from 1.9 to 0.86 after the procedures (p=0.001). There was no major complication. Conclusion PC is a safe, feasible, and efficient approach for the treatment of bone pain and disability in MM patients.	[Thang, Nhu Nam Tran; Seium-Neberay, Yodit; Verbist, Marie-Christine; Sappino, Andre-Pascal; Dietrich, Pierre-Yves] Univ Hosp Geneva, Div Oncol, CH-1211 Geneva 14, Switzerland; [Abdo, German; Martin, Jean-Baptiste; Yilmaz, Hasan; Rufenacht, Daniel] Univ Hosp Geneva, Dept Radiol, CH-1211 Geneva 14, Switzerland		Dietrich, PY (corresponding author), Univ Hosp Geneva, Div Oncol, 21 Rue Micheli du Crest, CH-1211 Geneva 14, Switzerland.	Pierre-Yves.Dietrich@hcuge.ch					Barr JD, 2000, SPINE, V25, P923, DOI 10.1097/00007632-200004150-00005; Bartolozzi B, 2006, EUR J HAEMATOL, V76, P180, DOI 10.1111/j.1600-0609.2005.00573.x; Cotten A, 1998, RADIOGRAPHICS, V18, P311, DOI 10.1148/radiographics.18.2.9536480; Cotten A, 1996, RADIOLOGY, V200, P525, DOI 10.1148/radiology.200.2.8685351; Diamond TH, 2004, BRIT J HAEMATOL, V124, P485, DOI 10.1111/j.1365-2141.2004.04809.x; Dudeney S, 2002, J CLIN ONCOL, V20, P2382, DOI 10.1200/JCO.2002.09.097; DURIE BGM, 1989, EUR J HAEMATOL, V43, P111; Durie Brian G M, 2003, Hematol J, V4, P379; Durr HR, 2002, SPINE, V27, P320; Evans AJ, 2003, RADIOLOGY, V226, P366, DOI 10.1148/radiol.2262010906; Fourney DR, 2003, J NEUROSURG, V98, P21, DOI 10.3171/spi.2003.98.1.0021; GALIBERT P, 1987, NEUROCHIRURGIE, V33, P166; GROSSMAN SA, 1991, J PAIN SYMPTOM MANAG, V6, P53, DOI 10.1016/0885-3924(91)90518-9; Halpin Ryan J, 2004, J Support Oncol, V2, P339; Hentschel SJ, 2004, J SPINAL DISORD TECH, V17, P554, DOI 10.1097/01.bsd.0000112042.70321.53; Hoskin PJ, 2003, CANCER TREAT REV, V29, P321, DOI 10.1016/S0305-7372(03)00013-6; Kallmes DF, 2003, RADIOLOGY, V229, P27, DOI 10.1148/radiol.2291020222; Kaufmann TJ, 2001, AM J NEURORADIOL, V22, P1860; Kelekis A, 2005, J VASC INTERV RADIOL, V16, P81, DOI 10.1097/01.RVI.00001417.84515.92; Kim AK, 2002, RADIOLOGY, V222, P737, DOI 10.1148/radiol.2223010718; Martin JB, 1999, BONE, V25, p11S, DOI 10.1016/S8756-3282(99)00126-X; Martin JB, 2003, RADIOLOGY, V229, P593, DOI 10.1148/radiol.2292020976; Peh WCG, 2003, BRIT J RADIOL, V76, P69, DOI 10.1259/bjr/10254271; Ramos L, 2006, EUR J HAEMATOL, V77, P7, DOI 10.1111/j.0902-4441.2005.t01-1-EJH2355.x; ROILA F, 1991, ANN ONCOL, V2, P437, DOI 10.1093/oxfordjournals.annonc.a057981; SANMILLAN RD, 1999, BONE, V25, pS85; Shimony JS, 2004, RADIOLOGY, V232, P846, DOI 10.1148/radiol.2323030353; Stallmeyer MJB, 2003, J VASC INTERV RADIOL, V14, P683, DOI 10.1097/01.RVI.0000064859.87207.FA; Taylor AE, 1999, SUPPORT CARE CANCER, V7, P332, DOI 10.1007/s005200050271; Walker MP, 2003, CLIN ORTHOP RELAT R, pS165, DOI 10.1097/01.blo.0000092977.12414.f9	30	16	16	0	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-4355	1433-7339		SUPPORT CARE CANCER	Support. Care Cancer	AUG	2008	16	8					891	896		10.1007/s00520-007-0344-6			6	Oncology; Health Care Sciences & Services; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Health Care Sciences & Services; Rehabilitation	330RH	WOS:000257960000004	17960432	Green Accepted, Green Submitted			2022-03-04	
J	Lovis, C				Lovis, Christian			Unlocking the Power of Artificial Intelligence and Big Data in Medicine	JOURNAL OF MEDICAL INTERNET RESEARCH			English	Article						medical informatics; artificial intelligence; big data	ELECTRONIC HEALTH RECORD; COST-EFFECTIVENESS; PRIVACY; DISCRIMINATION; VARIABILITY; REIDENTIFICATION; CLASSIFICATION; GUIDELINES; ANONYMITY; RISKS	Data-driven science and its corollaries in machine learning and the wider field of artificial intelligence have the potential to drive important changes in medicine. However, medicine is not a science like any other: It is deeply and tightly bound with a large and wide network of legal, ethical, regulatory, economical, and societal dependencies. As a consequence, the scientific and technological progresses in handling information and its further processing and cross-linking for decision support and predictive systems must be accompanied by parallel changes in the global environment, with numerous stakeholders, including citizen and society. What can be seen at the first glance as a barrier and a mechanism slowing down the progression of data science must, however, be considered an important asset. Only global adoption can transform the potential of big data and artificial intelligence into an effective breakthroughs in handling health and medicine. This requires science and society, scientists and citizens, to progress together.	[Lovis, Christian] Univ Hosp Geneva, Div Med Informat Sci, Gabrielle Perret Gentil 4, CH-1205 Geneva, Switzerland; [Lovis, Christian] Univ Geneva, Dept Radiol & Med Informat, Geneva, Switzerland		Lovis, C (corresponding author), Univ Hosp Geneva, Div Med Informat Sci, Gabrielle Perret Gentil 4, CH-1205 Geneva, Switzerland.	Christian.Lovis@hcuge.ch	Lovis, Christian/D-2634-2012	Lovis, Christian/0000-0002-2681-8076			Ahmed R, 2019, CELL, V177, P1583, DOI 10.1016/j.cell.2019.05.007; Allen B, 2019, J AM COLL RADIOL, V16, P208, DOI 10.1016/j.jacr.2018.09.007; [Anonymous], 2019, ART INT MACH LEARN S; Bardey D, 2019, J HEALTH ECON, V68, DOI 10.1016/j.jhealeco.2019.102223; Barth-Jones D., 2012, SOC SCI RES NETW, P19; Begoli E, 2019, NAT MACH INTELL, V1, P20, DOI 10.1038/s42256-018-0004-1; Belisle-Pipon JC, 2019, NAT MED, V25, P1198, DOI 10.1038/s41591-019-0534-z; Bellomi M, 2017, EUR J RADIOL, V95, P96, DOI 10.1016/j.ejrad.2017.08.001; Benitez K, 2010, J AM MED INFORM ASSN, V17, P169, DOI 10.1136/jamia.2009.000026; Carli D, 2018, JMIR MED INF, V6, DOI 10.2196/medinform.7170; Chan Kai Siang, 2019, JMIR Med Educ, V5, pe13930, DOI 10.2196/13930; Chevrier R, 2019, J MED INTERNET RES, V21, DOI 10.2196/13484; Dankar FK, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-66; Data Science Institute, TRAIN MED STUD RES A; Dixon P, 2017, HEALTH TECHNOL-GER, V7, P539, DOI 10.1007/s12553-017-0202-6; El Emam K, 2013, J LAW MED ETHICS, V41, P37, DOI 10.1111/jlme.12036; El Emam K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028071; Emam Khaled El, 2009, Can J Hosp Pharm, V62, P307; Faes L, 2019, LANCET DIGIT HEALTH, V1, pE232, DOI 10.1016/S2589-7500(19)30108-6; Giles M., MIT TECHNOLOGY REV; GitHub, 2019, FAIR METR; Godec P, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12397-x; Govindarajulu NS, 2018, STANFORD ENCY PHILOS; Harvard University, 2019, INT FAIR RES DAT MAN; Hersh WR, 2007, AM J MANAG CARE, V13, P277; Hoehndorf R., 2017, DATA SCI, V1, P27, DOI [DOI 10.3233/DS-170004, 10.3233/DS-170004]; Househ Mowafa, 2018, Yearb Med Inform, V27, P29, DOI 10.1055/s-0038-1641197; Hutson M, 2018, SCIENCE, V359, P725, DOI 10.1126/science.359.6377.725; Ienca M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204937; Jiang BH, 2017, ANN THORAC MED, V12, P95, DOI 10.4103/1817-1737.203750; Jung M, 2018, METHOD INFORM MED, V52, P99, DOI [10.1056/NEJMp1612619, DOI 10.1056/NEJMP1612619]; Kerasidou A, 2017, MED HEALTH CARE PHIL, V20, P43, DOI 10.1007/s11019-016-9721-6; Kolachalama VB, 2018, NPJ DIGIT MED, V1, DOI 10.1038/s41746-018-0061-1; Kulynych J, 2017, J LAW BIOSCI, V4, P94, DOI 10.1093/jlb/lsw061; Kurzweil R, 2005, SINGULARITY IS NEAR, P978; Larson HJ, 2018, HUM VACC IMMUNOTHER, V14, P1599, DOI 10.1080/21645515.2018.1459252; Leonelli S, 2019, NATURE, V574, P317, DOI 10.1038/d41586-019-03062-w; Lillehaug SI, 1998, ARTIF INTELL MED, V12, P197, DOI 10.1016/S0933-3657(97)00054-7; Loukides G, 2010, J AM MED INFORM ASSN, V17, P322, DOI 10.1136/jamia.2009.002725; Luger G, 2009, ARTIF INTELL, P978; Malin B, 2011, J AM MED INFORM ASSN, V18, P3, DOI 10.1136/jamia.2010.004622; Malin Bradley, 2006, AMIA Annu Symp Proc, P524; Mascalzoni D, 2014, APPL TRANSL GENOM, V3, P23, DOI 10.1016/j.atg.2014.04.003; Masters K, 2019, MED TEACH, V41, P976, DOI 10.1080/0142159X.2019.1595557; Mokdad AH, 2018, JAMA-J AM MED ASSOC, V319, P1444, DOI 10.1001/jama.2018.0158; Neumann PJ, 2017, NEW ENGL J MED, V376, P203, DOI 10.1056/NEJMp1612619; NIH: U.S. National Library of Medicine, DET IND STAT 1965 20; O'Neill L, 2016, ANESTH ANALG, V122, P2017, DOI 10.1213/ANE.0000000000001331; Olazaran M, 1996, SOC STUD SCI, V26, P611, DOI 10.1177/030631296026003005; Parikh RB, 2019, SCIENCE, V363, P810, DOI 10.1126/science.aaw0029; Pew Research Center: Science & Society, TRUST MISTR AM VIEWS; Rengers JM, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.00320; Sanders GD, 2016, JAMA-J AM MED ASSOC, V316, P1093, DOI 10.1001/jama.2016.12195; Sandhu E, 2012, JT COMM J QUAL PATIE, V38, P34, DOI 10.1016/S1553-7250(12)38005-7; Sbaffi L, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.7579; Seymour L, 2017, LANCET ONCOL, V18, pE143, DOI 10.1016/S1470-2045(17)30074-8; Skevofilakas M, 2010, IEEE ENG MED BIO, P6713, DOI 10.1109/IEMBS.2010.5626245; Stangl AL, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.3.18734; Stausberg J, 2019, GMS MED INFORM BIOM, V15; Thorogood A, 2015, J LAW MED ETHICS, V43, P690, DOI 10.1111/jlme.12312; Union POTE, TURN FAIR REAL FIN R; Wartman Steven A, 2019, AMA J Ethics, V21, pE146, DOI 10.1001/amajethics.2019.146; Weiner MG, 2009, ANN INTERN MED, V151, P359, DOI 10.7326/0003-4819-151-5-200909010-00141; Weiskopf NG, 2013, J AM MED INFORM ASSN, V20, P144, DOI 10.1136/amiajnl-2011-000681; Wilkinson MD, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.18; Yoon SH, 2016, EUR J CANCER, V53, P5, DOI 10.1016/j.ejca.2015.10.014; Zaaijer S, 2017, ELIFE, V6, DOI 10.7554/eLife.27798	67	14	15	6	17	JMIR PUBLICATIONS, INC	TORONTO	130 QUEENS QUAY E, STE 1102, TORONTO, ON M5A 0P6, CANADA	1438-8871			J MED INTERNET RES	J. Med. Internet Res.	NOV 8	2019	21	11							e16607	10.2196/16607			9	Health Care Sciences & Services; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Medical Informatics	JL3YB	WOS:000495467000001	31702565	Green Published, gold			2022-03-04	
J	Beauverd, Y; Roosnek, E; Tirefort, Y; Ansari, M; Dantin, C; Tsopra, O; Masouridi-Levrat, S; Chalandon, Y				Beauverd, Y.; Roosnek, E.; Tirefort, Y.; Ansari, M.; Dantin, C.; Tsopra, O.; Masouridi-Levrat, S.; Chalandon, Y.			VALIDATION OF THE REVISED DISEASE RISK INDEX FOR PATIENTS UNDERGOING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) AFTER PARTIAL T-CELL DEPLETION	BONE MARROW TRANSPLANTATION			English	Meeting Abstract	40th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation	MAR 30-APR 02, 2014	Milan, ITALY	European Grp Blood & Marrow Transplantat					[Beauverd, Y.; Roosnek, E.; Tirefort, Y.; Ansari, M.; Dantin, C.; Tsopra, O.; Masouridi-Levrat, S.; Chalandon, Y.] Univ Hosp Geneva, Blood & Marrow Transplant Program, Geneva, Switzerland				Chalandon, Yves/AAF-5125-2019; ANSARI, Marc/V-3334-2017					0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369	1476-5365		BONE MARROW TRANSPL	Bone Marrow Transplant.	MAR	2014	49			1		PH-P117	S154	S155					2	Biophysics; Oncology; Hematology; Immunology; Transplantation	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biophysics; Oncology; Hematology; Immunology; Transplantation	CP5RP	WOS:000359941901117					2022-03-04	
J	Taraschi, G; Aguiar, D; Tille, JC; Petignat, P; Abdulcadir, J				Taraschi, Gianmarco; Aguiar, Diego; Tille, Jean Christophe; Petignat, Patrick; Abdulcadir, Jasmine			Clitoral leiomyoma in a premenopausal woman: a case report	BMC WOMENS HEALTH			English	Article						Extrauterine leiomyoma; Alport's syndrome; Vulvar lesions	SMOOTH-MUSCLE TUMORS; ALPORT SYNDROME	Background Extrauterine leiomyomata is an uncommon lesion that can lead to several problems of differential diagnosis, especially when localized in the external genitalia. There are few reports in the English literature and a novel association with Alport's syndrome has been investigated since the 1980s. Case presentation Here, we describe the case of a premenopausal woman who presented with an indolent swelling of the right interlabial fossa that resulted in a Bartholin cyst. In addition to this cyst, a benign leiomyoma of the right side of the clitoris was also found and removed. Our patient refused any further examination, although she was informed that genetic counselling could be organized to rule out an association with Alport's syndrome. Conclusions Extrauterine leiomyomata localized in the external genitalia is an uncommon lesion arising from smooth muscle cells around vascular epithelium or erectile tissue. Since an association between extrauterine leiomyomata and Alport's syndrome has been described, genetic testing can be proposed to these patients. Upper intestinal tract symptoms such as dysphagia should prompt a gastroenterological evaluation as an association with an esophageal leiomyomatosis has been described.	[Taraschi, Gianmarco; Petignat, Patrick; Abdulcadir, Jasmine] Geneva Univ Hosp, Dept Obstet & Gynaecol, 30 Bldg Cluse, CH-1211 Geneva, Switzerland; [Aguiar, Diego; Tille, Jean Christophe] Geneva Univ Hosp, Div Clin Pathol, 1 Rue Michel Servet, CH-1205 Geneva, Switzerland		Taraschi, G (corresponding author), Geneva Univ Hosp, Dept Obstet & Gynaecol, 30 Bldg Cluse, CH-1211 Geneva, Switzerland.	Gianmarco.Taraschi@hcuge.ch	Aguiar, Diego/AAH-6260-2021	Taraschi, Gianmarco/0000-0002-8197-3394			Androulaki A, 2007, INT J GYNECOL CANCER, V17, P290, DOI 10.1111/j.1525-1438.2006.00744.x; ANTIGNAC C, 1992, KIDNEY INT, V42, P1178, DOI 10.1038/ki.1992.402; DAHAN K, 1995, KIDNEY INT, V48, P1900, DOI 10.1038/ki.1995.489; Fasih N, 2008, RADIOGRAPHICS, V28, P1931, DOI 10.1148/rg.287085095; KAUFMAN RAYMOND H., 1965, CLIN OBSTET GYNECOL, V8, P953, DOI 10.1097/00003081-196512000-00014; Khunamornpong S, 2007, INT J GYNECOL CANCER, V17, P1333, DOI 10.1111/j.1525-1438.2007.00989.x; Nielsen GP, 1996, AM J SURG PATHOL, V20, P779, DOI 10.1097/00000478-199607000-00001; Sun C, 2018, J INT MED RES, V46, P663, DOI 10.1177/0300060517721796	8	1	1	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1472-6874		BMC WOMENS HEALTH	BMC Womens Health	MAY 1	2020	20	1							89	10.1186/s12905-020-00959-x			4	Public, Environmental & Occupational Health; Obstetrics & Gynecology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Obstetrics & Gynecology	LL0YS	WOS:000531283300002	32357868	Green Published, gold			2022-03-04	
J	Levrat, SM; Pradier, A; Simonetta, F; Kaiser, L; Chalandon, Y; Roosnek, E				Levrat, S. Masouridi; Pradier, A.; Simonetta, F.; Kaiser, L.; Chalandon, Y.; Roosnek, E.			Anti-Torque teno virus immunity in patients undergoing allogeneic hematopoietic stem cell transplantation	BONE MARROW TRANSPLANTATION			English	Meeting Abstract	41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation	MAR 22-25, 2015	Istanbul, TURKEY	European Soc Blood & Marrow Transplantat					[Levrat, S. Masouridi; Pradier, A.; Simonetta, F.; Chalandon, Y.; Roosnek, E.] Univ Hosp Geneva, Hematol, Geneva, Switzerland; [Kaiser, L.] Univ Hosp Geneva, Infect Dis, Geneva, Switzerland				Chalandon, Yves/AAF-5125-2019	Simonetta, Federico/0000-0002-0399-689X				0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369	1476-5365		BONE MARROW TRANSPL	Bone Marrow Transplant.	MAR	2015	50			1		P671	S455	S456					2	Biophysics; Oncology; Hematology; Immunology; Transplantation	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biophysics; Oncology; Hematology; Immunology; Transplantation	CE2GN	WOS:000351632902284					2022-03-04	
J	Kindler, V				Kindler, V.			HUMAN MESENCHYMAL STROMAL CELLS, IN THE PRESENCE OF GAMMA INTERFERON, INHIBIT JURKAT T CELL PROLIFERATION	BONE MARROW TRANSPLANTATION			English	Meeting Abstract	40th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation	MAR 30-APR 02, 2014	Milan, ITALY	European Grp Blood & Marrow Transplantat					[Kindler, V.] Univ Hosp Geneva, Hematol, Geneva 4, Switzerland									0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369	1476-5365		BONE MARROW TRANSPL	Bone Marrow Transplant.	MAR	2014	49			1		PH-P069	S133	S133					1	Biophysics; Oncology; Hematology; Immunology; Transplantation	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biophysics; Oncology; Hematology; Immunology; Transplantation	CP5RP	WOS:000359941901069					2022-03-04	
J	Beauverd, Y; Roosnek, E; Tirefort, Y; Nagy-Hulliger, M; Bernimoulin, M; Tsopra, O; Kindler, V; Ansari, M; Dantin, C; Casini, A; Grandjean, AP; Chigrinova, E; Masouridi-Levrat, S; Chalandon, Y				Beauverd, Y.; Roosnek, E.; Tirefort, Y.; Nagy-Hulliger, M.; Bernimoulin, M.; Tsopra, O.; Kindler, V.; Ansari, M.; Dantin, C.; Casini, A.; Grandjean, A-P; Chigrinova, E.; Masouridi-Levrat, S.; Chalandon, Y.			Is there a difference in the disease risk index for outcome of patients undergoing allogeneic haematopoietic stem cell transplantation after T-cell depletion?	BONE MARROW TRANSPLANTATION			English	Meeting Abstract	39th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation (EBMT)	APR 07-10, 2013	London, ENGLAND	European Grp Blood & Marrow Transplantat (EBMT)					[Beauverd, Y.; Roosnek, E.; Tirefort, Y.; Nagy-Hulliger, M.; Bernimoulin, M.; Tsopra, O.; Kindler, V.; Ansari, M.; Dantin, C.; Casini, A.; Grandjean, A-P; Chigrinova, E.; Masouridi-Levrat, S.; Chalandon, Y.] Hop Cantonal Univ Geneva, Geneva, Switzerland				ANSARI, Marc/V-3334-2017; Chalandon, Yves/AAF-5125-2019					0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369			BONE MARROW TRANSPL	Bone Marrow Transplant.	APR	2013	48			2			S251	S251					1	Biophysics; Oncology; Hematology; Immunology; Transplantation	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biophysics; Oncology; Hematology; Immunology; Transplantation	145OB	WOS:000319025200543					2022-03-04	
J	Chigrinova, E; Roosnek, E; Mohty, B; Grandjean, AP; Casini, A; Ansari, M; Ozsahin, H; Nagy, M; Tirefort, Y; Levrat, E; Bernimoulin, M; Masouridi, S; Chalandon, Y				Chigrinova, E.; Roosnek, E.; Mohty, B.; Grandjean, A-P; Casini, A.; Ansari, M.; Ozsahin, H.; Nagy, M.; Tirefort, Y.; Levrat, E.; Bernimoulin, M.; Masouridi, S.; Chalandon, Y.			Allogeneic haematopoietic stem cell transplantation for non-Hodgkin lymphoma. A single-centre experience	BONE MARROW TRANSPLANTATION			English	Meeting Abstract	38th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation (EBMT)	APR 01-04, 2012	Geneva, SWITZERLAND	European Grp Blood & Marrow Transplantat (EBMT)					[Chigrinova, E.; Roosnek, E.; Mohty, B.; Grandjean, A-P; Casini, A.; Ansari, M.; Ozsahin, H.; Nagy, M.; Tirefort, Y.; Levrat, E.; Bernimoulin, M.; Masouridi, S.; Chalandon, Y.] Univ Hosp Geneva, Geneva, Switzerland				ANSARI, Marc/V-3334-2017; Chalandon, Yves/AAF-5125-2019					0	0	0	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369			BONE MARROW TRANSPL	Bone Marrow Transplant.	APR	2012	47			1			S437	S439					3	Biophysics; Oncology; Hematology; Immunology; Transplantation	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biophysics; Oncology; Hematology; Immunology; Transplantation	925GN	WOS:000302749201720					2022-03-04	
J	Paccot, A; L'Heritier, D				Paccot, A.; L'Heritier, D.			Patients' experience point of view in protective isolation and health care workers' feelings in an allogenic haematopoietic stem cell transplantation unit	BONE MARROW TRANSPLANTATION			English	Meeting Abstract	38th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation (EBMT)	APR 01-04, 2012	Geneva, SWITZERLAND	European Grp Blood & Marrow Transplantat (EBMT)					[Paccot, A.; L'Heritier, D.] Hop Cantonal Univ Geneva, Geneva, Switzerland									0	1	1	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369			BONE MARROW TRANSPL	Bone Marrow Transplant.	APR	2012	47			1			S481	S481					1	Biophysics; Oncology; Hematology; Immunology; Transplantation	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biophysics; Oncology; Hematology; Immunology; Transplantation	925GN	WOS:000302749202059					2022-03-04	
J	Salah-Bernhard, V				Salah-Bernhard, Valerie			Children's satisfaction survey	BONE MARROW TRANSPLANTATION			English	Meeting Abstract	6th Meeting of the EBMT Paediatric Diseases Working Party/1st Meeting of the EBMT Paediatric Nurses	JUN 02-04, 2008	Poznan, POLAND	European Grp Blood & Marrow Transplantat, Paediat Dis Working Party					[Salah-Bernhard, Valerie] Hop Cantonal Univ Geneva, Geneva, Switzerland									0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369			BONE MARROW TRANSPL	Bone Marrow Transplant.	OCT	2008	42			2			S111	S111					1	Biophysics; Oncology; Hematology; Immunology; Transplantation	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biophysics; Oncology; Hematology; Immunology; Transplantation	377DT	WOS:000261232600037					2022-03-04	
J	Terrettaz, M; Verholen, F; Passweg, J; Knipp, S; Burkhard, PR; Chalandon, Y				Terrettaz, M.; Verholen, F.; Passweg, J.; Knipp, S.; Burkhard, P. R.; Chalandon, Y.			Steroid-responsive cauda equina syndrome associated with GVHD after allogeneic hematopoietic stem cell transplantation	BONE MARROW TRANSPLANTATION			English	Letter							BONE-MARROW-TRANSPLANTATION; VERSUS-HOST-DISEASE; NEUROLOGIC COMPLICATIONS; LEUKEMIA; GRAFT; AUTOPSY		[Terrettaz, M.; Verholen, F.; Passweg, J.; Knipp, S.; Chalandon, Y.] HUG, Serv Hematol, Dept Med Interne, Geneva, Switzerland; [Burkhard, P. R.] HUG, Serv Neurol, Dept Clin Neurosci, Geneva, Switzerland		Terrettaz, M (corresponding author), HUG, Serv Hematol, Dept Med Interne, Geneva, Switzerland.	yves.chalandon@hcuge.ch	passweg, jakob/AAG-3911-2020; Chalandon, Yves/AAF-5125-2019	Blum, Sabine/0000-0003-2275-3081; Chalandon, Yves/0000-0001-9341-8104; Passweg, Jakob R/0000-0001-7092-3351			Antonini G, 1998, NEUROLOGY, V50, P1441, DOI 10.1212/WNL.50.5.1441; Bleggi-Torres LF, 2000, BONE MARROW TRANSPL, V25, P301, DOI 10.1038/sj.bmt.1702140; Campbell JN, 2005, AM J NEURORADIOL, V26, P654; Chalandon Y, 2006, BIOL BLOOD MARROW TR, V12, P102, DOI 10.1016/j.bbmt.2005.09.010; Graus F, 1996, NEUROLOGY, V46, P1004, DOI 10.1212/WNL.46.4.1004; Jabbour E, 2007, BLOOD, V109, P3214, DOI 10.1182/blood-2006-08-043646; Kamble RT, 2007, BONE MARROW TRANSPL, V39, P49, DOI 10.1038/sj.bmt.1705540; Kew AK, 2007, BONE MARROW TRANSPL, V40, P183, DOI 10.1038/sj.bmt.1705709; MOHRMANN RL, 1990, HUM PATHOL, V21, P630, DOI 10.1016/S0046-8177(96)90010-6; Takatsuka H, 2000, ACTA HAEMATOL-BASEL, V103, P203, DOI 10.1159/000041050	10	3	3	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369			BONE MARROW TRANSPL	Bone Marrow Transplant.	FEB	2008	41	3					315	316		10.1038/sj.bmt.1705915			2	Biophysics; Oncology; Hematology; Immunology; Transplantation	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Oncology; Hematology; Immunology; Transplantation	261ZH	WOS:000253118000013	17994117	Bronze			2022-03-04	
J	Popowski, Y; Lambert, JF; Passweg, J; Zilli, T; Vlastos, AT; Bonnefoi, H; Chalandon, Y				Popowski, Y.; Lambert, J-F.; Passweg, J.; Zilli, T.; Vlastos, A-T.; Bonnefoi, H.; Chalandon, Y.			Bone marrow derived haematopoietic stem cells for the treatment of radionecrosis of the cervix uteri: a case report	BONE MARROW TRANSPLANTATION			English	Meeting Abstract	33rd Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation	MAR 25-28, 2007	Lyon, FRANCE	European Grp Blood & Marrow Transplantat					Univ Hosp Geneva, Geneva, Switzerland				Chalandon, Yves/AAF-5125-2019					0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369			BONE MARROW TRANSPL	Bone Marrow Transplant.	APR	2007	39			1			S228	S228					1	Biophysics; Oncology; Hematology; Immunology; Transplantation	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Oncology; Hematology; Immunology; Transplantation	150HU	WOS:000245207400618					2022-03-04	
J	Nabergoj, M; Anastasiou, M; Morin, S; Beauverd, Y; Stephan, C; Ortiz, CD; Mahne, E; Petropoulou, A; Giannotti, F; Ayer, C; Bruno, B; Bounaix, L; Mappoura, M; Tran, TA; Bessis, AS; Royston, E; Mamez, AC; Masouridi-Levrat, S; Chalandon, Y				Nabergoj, Mitja; Anastasiou, Maria; Morin, Sarah; Beauverd, Yan; Stephan, Caroline; Ortiz, Carmen De Ramon; Mahne, Elif; Petropoulou, Anna; Giannotti, Federica; Ayer, Christian; Bruno, Benjamin; Bounaix, Laura; Mappoura, Maria; Tran, Thien-An; Bessis, Anne-Sophie; Royston, Eva; Mamez, Anne-Claire; Masouridi-Levrat, Stavroula; Chalandon, Yves			Impact of Donor-recipient Sex Mismatch in Patients Receiving Partial T-cell Depleted Allogeneic Stem Cell Transplantation for Hematological Malignancy: A Retrospective Monocentric Study	BONE MARROW TRANSPLANTATION			English	Meeting Abstract									[Nabergoj, Mitja; Anastasiou, Maria; Morin, Sarah; Beauverd, Yan; Stephan, Caroline; Ortiz, Carmen De Ramon; Mahne, Elif; Petropoulou, Anna; Giannotti, Federica; Ayer, Christian; Bruno, Benjamin; Bounaix, Laura; Mappoura, Maria; Tran, Thien-An; Bessis, Anne-Sophie; Royston, Eva; Mamez, Anne-Claire; Masouridi-Levrat, Stavroula; Chalandon, Yves] Hop Univ Geneve, Geneva, Switzerland									0	0	0	0	0	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0268-3369	1476-5365		BONE MARROW TRANSPL	Bone Marrow Transplant.	DEC	2020	55	SUPPL 1		TEM CELL T		P657	676	676					1	Biophysics; Oncology; Hematology; Immunology; Transplantation	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Oncology; Hematology; Immunology; Transplantation	PH6YT	WOS:000600556202294					2022-03-04	
J	Beauverd, Y; Roosnek, E; Tirefort, Y; Dantin, C; Ansari, M; Tsopra, O; Masouridi-Levrat, S; Chalandon, Y				Beauverd, Y.; Roosnek, E.; Tirefort, Y.; Dantin, C.; Ansari, M.; Tsopra, O.; Masouridi-Levrat, S.; Chalandon, Y.			Outcome of hematopoietic stem cell transplantation is similar for patients with a partial in vitro T-cell-depleted graft compared with a non-T-cell-depleted graft when stratified by the refined disease risk index	BONE MARROW TRANSPLANTATION			English	Article							VERSUS-HOST-DISEASE; COMORBIDITY INDEX; LEUKEMIA; VALIDATION; MORTALITY; SURVIVAL; BLOOD	Comparisons of hematopoietic stem cell transplantation (HSCT) methods in retrospective studies are often hampered by the heterogeneity of comparison groups. The refined disease risk index (DRI) is a potentially interesting tool to compare HSCT protocols as it is based on the disease type and burden at transplant and stratifies patients into four prognostic groups for overall survival (OS). We included 265 patients with partial T-cell-depleted graft (TDEP) and 163 non-TDEP patients in a retrospective study and compared outcomes following stratification using the refined DRI. The 2-year OS rate for TDEP patients was 81.6, 60.9 and 43.3% for the low-, intermediate- and high-risk groups, respectively (P < 0.001). For non-TDEP patients, the 2-year OS rate was 62.9, 48.8, 44.2 and 7.6% for the low-, intermediate-, high- and very-high-risk groups, respectively (P < 0.001). There was no significant difference when comparing OS between TDEP and non-TDEP for the low-, intermediate- and high-risk groups, but TDEP patients had less acute GvHD grades II-IV. In conclusion, we confirm that the refined DRI is a valuable tool to compare the outcomes of different HSCT protocols. We demonstrate also that TDEP did not impact on the outcome of HSCT, but it did reduce the incidence of acute GvHD.	[Beauverd, Y.; Roosnek, E.; Tirefort, Y.; Dantin, C.; Tsopra, O.; Masouridi-Levrat, S.; Chalandon, Y.] Genevas Univ Hosp, Div Hematol, Stem Cell Transplant Unit, 4 Rue Gabrielle Perret Gentil, CH-1205 Geneva, Switzerland; [Ansari, M.] Genevas Univ Hosp, Oncohematol Unit, Dept Pediat, Geneva, Switzerland		Chalandon, Y (corresponding author), Genevas Univ Hosp, Div Hematol, Stem Cell Transplant Unit, 4 Rue Gabrielle Perret Gentil, CH-1205 Geneva, Switzerland.	yves.chalandon@hcuge.ch	ANSARI, Marc/V-3334-2017; Chalandon, Yves/AAF-5125-2019	Chalandon, Yves/0000-0001-9341-8104; ansari, marc/0000-0002-9649-6498			Armand P, 2010, BONE MARROW TRANSPL, V45, P877, DOI 10.1038/bmt.2009.253; Armand P, 2014, BLOOD, V123, P3664, DOI 10.1182/blood-2014-01-552984; Armand P, 2012, BLOOD, V120, P905, DOI 10.1182/blood-2012-03-418202; Armand P, 2012, BIOL BLOOD MARROW TR, V18, P280, DOI 10.1016/j.bbmt.2011.07.024; Barrett AJ, 1996, BRIT J HAEMATOL, V93, P754, DOI 10.1046/j.1365-2141.1996.d01-1713.x; Beauverd Y, 2014, BIOL BLOOD MARROW TR, V20, P1322, DOI 10.1016/j.bbmt.2014.04.023; Bleakley M, 2004, NAT REV CANCER, V4, P371, DOI 10.1038/nrc1365; Bonnett D, 1999, P NATL ACAD SCI USA, V96, P8639, DOI 10.1073/pnas.96.15.8639; Chakrabarti S, 2003, BRIT J HAEMATOL, V121, P109, DOI 10.1046/j.1365-2141.2003.04228.x; Chalandon Y, 2006, BIOL BLOOD MARROW TR, V12, P102, DOI 10.1016/j.bbmt.2005.09.010; Copelan EA, 2006, NEW ENGL J MED, V354, P1813, DOI 10.1056/NEJMra052638; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Gratwohl A, 2009, CANCER-AM CANCER SOC, V115, P4715, DOI 10.1002/cncr.24531; Hahn T, 2013, J CLIN ONCOL, V31, P2437, DOI 10.1200/JCO.2012.46.6193; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Lee SJ, 2002, BLOOD, V100, P406, DOI 10.1182/blood.V100.2.406; Levrat E, 2015, BONE MARROW RES, DOI 10.1155/2015/176526; Remberger M, 2011, BIOL BLOOD MARROW TR, V17, P1688, DOI 10.1016/j.bbmt.2011.05.001; Sorror ML, 2005, BLOOD, V106, P2912, DOI 10.1182/blood-2005-05-2004; Sorror M, 2008, CANCER-AM CANCER SOC, V112, P1992, DOI 10.1002/cncr.23375; Welniak LA, 2007, ANNU REV IMMUNOL, V25, P139, DOI 10.1146/annurev.immunol.25.022106.141606	21	5	5	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369	1476-5365		BONE MARROW TRANSPL	Bone Marrow Transplant.	JUL	2016	51	7					955	960		10.1038/bmt.2016.34			6	Biophysics; Oncology; Hematology; Immunology; Transplantation	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Oncology; Hematology; Immunology; Transplantation	DQ9OW	WOS:000379540200013	26950373	Bronze			2022-03-04	
J	Weber, C; Merminod, T; Herrmann, FR; Zulian, GB				Weber, Catherine; Merminod, Thierry; Herrmann, Francois R.; Zulian, Gilbert B.			Prophylactic anti-coagulation in cancer palliative care: a prospective randomised study	SUPPORTIVE CARE IN CANCER			English	Article						anti-coagulation; cancer; palliative care; thrombosis; bleeding	VENOUS THROMBOEMBOLIC DISEASE; MOLECULAR-WEIGHT HEPARIN; THERAPY; CHEMOTHERAPY; PREVENTION; DALTEPARIN; MANAGEMENT; THROMBOSIS; CARCINOMA; SURVIVAL	Goals The objective of this study was to determine utility of prophylactic anti-coagulation in cancer patients hospitalised for palliative care in a specialised centre. Materials and methods Prospective 1:1 open randomised study was designed. Twenty patients aged 55 to 88 years with advanced cancer and an estimated life expectancy of less than 6 months were assigned to either receive treatment with 2,850/3,800 U (< 70/> 70 kg) of daily subcutaneous nadroparin or no treatment. Suspicion of venous thrombo-embolism (deep vein thrombosis and pulmonary embolism) was confirmed by echo-Doppler examination of the lower limbs and/or by spiral computed tomography scan of the lungs. Bleeding episodes were recorded. Platelet count was measured on days 7 and 14. Survival time from study entry was determined. Main results One venous thrombo-embolism and one major bleeding occurred in the group receiving nadroparin, whereas two minor bleedings occurred in the control group. At 3 months, nine of ten participants had died in the control group vs five of ten in the group receiving nadroparin (P=0.141). Five participants could be discharged home (P=0.141). Conclusions Decision to administer prophylactic nadroparin in hospitalised cancer patients under palliative care remains a challenge. Better mobility score at admission and the likelihood to be discharged home may be useful for practical purposes. The observation of a potential influence of prophylactic nadroparin on survival deserves further studies.	[Weber, Catherine; Merminod, Thierry; Herrmann, Francois R.; Zulian, Gilbert B.] Univ Hosp Geneva, Dept Rehabil & Geriatr, Serv Palliat Med Cesco, CH-1245 Collonge Bellerive, Switzerland		Zulian, GB (corresponding author), Univ Hosp Geneva, Dept Rehabil & Geriatr, Serv Palliat Med Cesco, 11 Chemin de la Savonniere, CH-1245 Collonge Bellerive, Switzerland.	gilbert.zulian@hcuge.ch	HERRMANN, Francois R/B-6710-2011; HERRMANN, Francois/M-7390-2019	HERRMANN, Francois R/0000-0003-1312-1517; HERRMANN, Francois/0000-0003-1312-1517			Agrawal Manish, 2002, J Palliat Med, V5, P729, DOI 10.1089/109662102320880552; Baron JA, 1998, LANCET, V351, P1077, DOI 10.1016/S0140-6736(97)10018-6; Bruera E, 1998, CAN MED ASSOC J, V158, P1717; BRUERA E, 1992, J PAIN SYMPTOM MANAG, V7, P192, DOI 10.1016/0885-3924(92)90074-R; Casarett DJ, 2000, J PAIN SYMPTOM MANAG, V20, P130, DOI 10.1016/S0885-3924(00)00164-0; Deitcher SR, 2004, CANCER-AM CANCER SOC, V101, P439, DOI 10.1002/cncr.20347; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GOODNOUGH LT, 1984, CANCER-AM CANCER SOC, V54, P1264, DOI 10.1002/1097-0142(19841001)54:7<1264::AID-CNCR2820540706>3.0.CO;2-R; Gouin-Thibaut I, 2000, ANN BIOL CLIN-PARIS, V58, P675; Hawryluck L, 2004, CLIN ONCOL-UK, V16, P225, DOI 10.1016/j.clon.2004.02.002; Jacobs LG, 2003, J AM GERIATR SOC, V51, P1472, DOI 10.1046/j.1532-5415.2003.51469.x; Jilma B, 2003, BRIT MED J, V326, P93, DOI 10.1136/bmj.326.7380.93; Kakkar AK, 2004, J CLIN ONCOL, V22, P1944, DOI 10.1200/JCO.2004.10.002; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Klerk CPW, 2005, J CLIN ONCOL, V23, P2130, DOI 10.1200/JCO.2005.03.134; Koedoot CG, 2003, BRIT J CANCER, V89, P2219, DOI 10.1038/sj.bjc.6601445; Lee AYY, 2003, THROMB RES, V110, P167, DOI 10.1016/S0049-3848(03)00347-5; Leizorovicz A, 2004, CIRCULATION, V110, P874, DOI 10.1161/01.CIR.0000138928.83266.24; Mazzocato C, 2001, PALLIATIVE MED, V15, P261, DOI 10.1191/026921601678576275; MERMINOD T, 2007, SUPPORTIVE IN PRESS; PAUTEX S, 2002, MED HYG, V60, P1313; Samama MM, 1999, NEW ENGL J MED, V341, P793, DOI 10.1056/NEJM199909093411103; SAPHNER T, 1991, J CLIN ONCOL, V9, P286, DOI 10.1200/JCO.1991.9.2.286; Trousseau A., 1865, CLIN MED HOTEL DIEU, V3, P94; WILSON CB, 1987, CLIN RADIOL, V38, P95, DOI 10.1016/S0009-9260(87)80425-7; Yancik R, 2005, CANCER J, V11, P437, DOI 10.1097/00130404-200511000-00002	26	43	43	0	2	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0941-4355	1433-7339		SUPPORT CARE CANCER	Support. Care Cancer	JUL	2008	16	7					847	852		10.1007/s00520-007-0339-3			6	Oncology; Health Care Sciences & Services; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Health Care Sciences & Services; Rehabilitation	309QK	WOS:000256475100012	17940809	Green Accepted, Green Submitted			2022-03-04	
J	Chevrier, R; Foufi, V; Gaudet-Blavignac, C; Robert, A; Lovis, C				Chevrier, Raphael; Foufi, Vasiliki; Gaudet-Blavignac, Christophe; Robert, Arnaud; Lovis, Christian			Use and Understanding of Anonymization and De-Identification in the Biomedical Literature: Scoping Review	JOURNAL OF MEDICAL INTERNET RESEARCH			English	Review						anonymization; anonymisation; de-identification; deidentification; pseudonymization; privacy; confidentiality; secondary use; data protection; scoping review	ELECTRONIC HEALTH RECORDS; MEDICAL-RECORDS; PATIENT PRIVACY; PUBLISHING DATA; ANONYMITY; QUALITY; REIDENTIFICATION; DISCLOSURE; STRATEGIES; SECURITY	Background: The secondary use of health data is central to biomedical research in the era of data science and precision medicine. National and international initiatives, such as the Global Open Findable, Accessible, Interoperable, and Reusable (GO FAIR) initiative, are supporting this approach in different ways (eg, making the sharing of research data mandatory or improving the legal and ethical frameworks). Preserving patients' privacy is crucial in this context. De-identification and anonymization are the two most common terms used to refer to the technical approaches that protect privacy and facilitate the secondary use of health data. However, it is difficult to find a consensus on the definitions of the concepts or on the reliability of the techniques used to apply them. A comprehensive review is needed to better understand the domain, its capabilities, its challenges, and the ratio of risk between the data subjects' privacy on one side, and the benefit of scientific advances on the other. Objective: This work aims at better understanding how the research community comprehends and defines the concepts of de-identification and anonymization. A rich overview should also provide insights into the use and reliability of the methods. Six aspects will be studied: (1) terminology and definitions, (2) backgrounds and places of work of the researchers, (3) reasons for anonymizing or de-identifying health data, (4) limitations of the techniques, (5) legal and ethical aspects, and (6) recommendations of the researchers. Methods: Based on a scoping review protocol designed a priori, MEDLINE was searched for publications discussing de-identification or anonymization and published between 2007 and 2017. The search was restricted to MEDLINE to focus on the life sciences community The screening process was performed by two reviewers independently. Results: After searching 7972 records that matched at least one search term, 135 publications were screened and 60 full-text articles were included. (1) Terminology: Definitions of the terms de-identification and anonymization were provided in less than half of the articles (29/60, 48%). When both terms were used (41/60, 68%), their meanings divided the authors into two equal groups (19/60, 32%, each) with opposed views. The remaining articles (3/60, 5%) were equivocal. (2) Backgrounds and locations: Research groups were based predominantly in North America (31/60, 52%) and in the European Union (22/60, 37%). The authors came from 19 different domains; computer science (91/248, 36.7%), biomedical informatics (47/248, 19.0%), and medicine (38/248, 15.3%) were the most prevalent ones. (3) Purpose: The main reason declared for applying these techniques is to facilitate biomedical research. (4) Limitations: Progress is made on specific techniques but, overall, limitations remain numerous. (5) Legal and ethical aspects: Differences exist between nations in the definitions, approaches, and legal practices. (6) Recommendations: The combination of organizational, legal, ethical, and technical approaches is necessary to protect health data. Conclusions: Interest is growing for privacy-enhancing techniques in the life sciences community. This interest crosses scientific boundaries, involving primarily computer science, biomedical informatics, and medicine. The variability observed in the use of the terms de-identification and anonymization emphasizes the need for clearer definitions as well as for better education and dissemination of information on the subject. The same observation applies to the methods. Several legislations, such as the American Health Insurance Portability and Accountability Act (HIPAA) and the European General Data Protection Regulation (GDPR), regulate the domain Using the definitions they provide could help address the variable use of these two concepts in the research community.	[Chevrier, Raphael; Foufi, Vasiliki; Gaudet-Blavignac, Christophe; Robert, Arnaud; Lovis, Christian] Univ Hosp Geneva, Div Med Informat Sci, Rue Gabrielle Perret Gentil 4, CH-1205 Geneva, Switzerland; [Chevrier, Raphael; Foufi, Vasiliki; Gaudet-Blavignac, Christophe; Robert, Arnaud; Lovis, Christian] Univ Geneva, Fac Med, Geneva, Switzerland		Chevrier, R (corresponding author), Univ Hosp Geneva, Div Med Informat Sci, Rue Gabrielle Perret Gentil 4, CH-1205 Geneva, Switzerland.	raphael.chevrier@hcuge.ch	Gaudet-Blavignac, Christophe/M-5334-2015; Foufi, Vasiliki/P-2224-2017; Lovis, Christian/T-5364-2019; Lovis, Christian/D-2634-2012	Gaudet-Blavignac, Christophe/0000-0001-6527-5898; Foufi, Vasiliki/0000-0002-8625-0734; Lovis, Christian/0000-0002-2681-8076; Lovis, Christian/0000-0002-2681-8076			[Anonymous], 2019, BREACH PORT NOT SEC; Arbuckle L, 2017, J CLIN EPIDEMIOL, V89, P168, DOI 10.1016/j.jclinepi.2017.04.016; Baerlocher MO, 2007, J INVEST MED, V55, P174, DOI 10.2310/6650.2007.06044; Bartholomaus S, 2015, STUD HEALTH TECHNOL, V210, P424, DOI 10.3233/978-1-61499-512-8-424; Bierer BE, 2016, NEW ENGL J MED, V374, P2411, DOI 10.1056/NEJMp1605348; Chazard E, 2014, INT J MED INFORM, V83, P303, DOI 10.1016/j.ijmedinf.2013.11.005; Choi HJ, 2015, PEERJ, V3, DOI 10.7717/peerj.1506; Cimino JJ, 2012, APPL CLIN INFORM, V3, P392, DOI 10.4338/ACI-2012-07-RA-0028; Culnane C., 2017, HLTH DATA OPEN WORLD; Dankar FK, 2013, T DATA PRIVACY; Dukes P, 2016, DATA SHARING POLICY; El Emam K, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1139; El Emam K, 2013, J LAW MED ETHICS, V41, P37, DOI 10.1111/jlme.12036; El Emam K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028071; El Emam K, 2009, J AM MED INFORM ASSN, V16, P670, DOI 10.1197/jamia.M3144; Emam Khaled El, 2009, Can J Hosp Pharm, V62, P307; Fernandes AC, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-71; Foufi V, 2017, STUD HEALTH TECHNOL, V244, P23, DOI 10.3233/978-1-61499-824-2-23; Fullerton SM, 2011, BMC MED ETHICS, V12, DOI 10.1186/1472-6939-12-16; Gkoulalas-Divanis A, 2014, J BIOMED INFORM, V50, P4, DOI 10.1016/j.jbi.2014.06.002; Goodman D, 2017, J COMMUN GENET, V8, P173, DOI 10.1007/s12687-017-0300-1; Grouin C, 2009, STUD HEALTH TECHNOL, V150, P735, DOI 10.3233/978-1-60750-044-5-735; Heatherly R, 2016, J AM MED INFORM ASSN, V23, pE131, DOI 10.1093/jamia/ocv154; Heatherly RD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053875; Hrynaszkiewicz I, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-9; Institute of Medicine (IOM), 2015, SHAR CLIN TRIAL DAT; Kayaalp M, 2018, BALK MED J, V35, P8, DOI 10.4274/balkanmedj.2017.0966; Knoppers BM, 2005, NAT BIOTECHNOL, V23, P925, DOI 10.1038/nbt0805-925; Kohlmayer F, 2015, J BIOMED INFORM, V58, P37, DOI 10.1016/j.jbi.2015.09.007; Kohlmayer F, 2014, J BIOMED INFORM, V50, P62, DOI 10.1016/j.jbi.2013.12.002; Kushida CA, 2012, MED CARE, V50, pS82, DOI 10.1097/MLR.0b013e3182585355; Lasko TA, 2010, IEEE T KNOWL DATA EN, V22, P437, DOI 10.1109/TKDE.2009.88; Levac D, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-69; Lin WY, 2016, BMC MED INFORM DECIS, V16, DOI 10.1186/s12911-016-0293-4; Loukides G, 2013, IEEE J BIOMED HEALTH, V17, P60, DOI 10.1109/TITB.2012.2212281; Loukides G, 2010, J AM MED INFORM ASSN, V17, P322, DOI 10.1136/jamia.2009.002725; Loukides G, 2010, P NATL ACAD SCI USA, V107, P7898, DOI 10.1073/pnas.0911686107; Lu Y, 2017, STUD HEALTH TECHNOL, V239, P84, DOI 10.3233/978-1-61499-783-2-84; Fernandez-Aleman JL, 2013, J BIOMED INFORM, V46, P541, DOI 10.1016/j.jbi.2012.12.003; Majeed A, 2017, SENSORS, V17, P1; Malin B, 2011, J AM MED INFORM ASSN, V18, P3, DOI 10.1136/jamia.2010.004622; Malin B, 2010, J INVEST MED, V58, P11, DOI 10.2310/JIM.0b013e3181c9b2ea; Meystre S, 2018, P AMIA 2018 ANN S 20; Meystre SM, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-70; Narayanan A, 2014, NO SILVER BULLET DEI; National Institutes of Health, 2003, FIN NIH STAT SHAR RE; O'Keefe CM, 2017, J AM MED INFORM ASSN, V24, P544, DOI 10.1093/jamia/ocw152; O'Neill L, 2016, ANESTH ANALG, V122, P2017, DOI 10.1213/ANE.0000000000001331; Pantazos K, 2017, HEALTH INFORM J, V23, P291, DOI 10.1177/1460458216647760; Peters MDJ, 2015, INT J EVID-BASED HEA, V13, P141, DOI 10.1097/XEB.0000000000000050; Phillips M, 2017, J BIOETHIC INQ, V14, P527, DOI 10.1007/s11673-017-9806-9; Phillips M, 2016, NAT BIOTECHNOL, V34, P1102, DOI 10.1038/nbt.3696; Pisani E, 2010, LANCET, V375, P703, DOI 10.1016/S0140-6736(09)61486-0; Prasser F, 2018, IEEE J BIOMED HEALTH, V22, P611, DOI 10.1109/JBHI.2017.2676880; Prasser F, 2016, STUD HEALTH TECHNOL, V228, P312, DOI 10.3233/978-1-61499-678-1-312; Prasser F, 2016, METHOD INFORM MED, V55, P347, DOI 10.3414/ME16-01-0012; Prasser F, 2016, BMC MED INFORM DECIS, V16, DOI 10.1186/s12911-016-0287-2; Safran C, 2007, J AM MED INFORM ASSN, V14, P1, DOI 10.1197/jamia.M2273; Sariyar M, 2016, BIOPRESERV BIOBANK, V14, P367, DOI 10.1089/bio.2015.0100; Sengupta S, 2008, J AM MED INFORM ASSN, V15, P569, DOI 10.1197/jamia.M2207; Shaw DM, 2015, EMBO REP, V16, P894, DOI 10.15252/embr.201540943; Shin SY, 2015, J KOREAN MED SCI, V30, P7, DOI 10.3346/jkms.2015.30.1.7; Sinnott R, 2008, STUD HEALTH TECHNOL, V138, P90; Smith C, 2017, STUD HEALTH TECHNOL, V235, P313, DOI 10.3233/978-1-61499-753-5-313; South BR, 2014, J BIOMED INFORM, V50, P162, DOI 10.1016/j.jbi.2014.05.002; Tamersoy Acar, 2010, AMIA Annu Symp Proc, V2010, P782; Tamersoy A, 2012, IEEE T INF TECHNOL B, V16, P413, DOI 10.1109/TITB.2012.2185850; The European Parliament and the Council of the European Union, 2016, OFFICIAL J EUROPEAN, V59; Thorogood A, 2015, J LAW MED ETHICS, V43, P690, DOI 10.1111/jlme.12312; Townend D, 2016, J LAW MED ETHICS, V44, P128, DOI 10.1177/1073110516644204; Tricco AC, 2016, BMC MED RES METHODOL, V16, DOI 10.1186/s12874-016-0116-4; Tucker K, 2016, BMC MED RES METHODOL, V16, DOI 10.1186/s12874-016-0169-4; Vatsalan D, 2013, INFORM SYST, V38, P946, DOI 10.1016/j.is.2012.11.005; Willison DJ, 2008, J MED ETHICS, V34, P308, DOI 10.1136/jme.2006.020032; Xia WY, 2015, J AM MED INFORM ASSN, V22, P1029, DOI 10.1093/jamia/ocv004; Ye Huimin, 2011, AMIA Annu Symp Proc, V2011, P1573	76	19	19	5	13	JMIR PUBLICATIONS, INC	TORONTO	59 WINNERS CIRCLE, TORONTO, ON M4L 3Y7, CANADA	1438-8871			J MED INTERNET RES	J. Med. Internet Res.	MAY 31	2019	21	5							e13484	10.2196/13484			15	Health Care Sciences & Services; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Medical Informatics	IC0QY	WOS:000470666200001	31152528	Green Published, gold, Green Submitted			2022-03-04	
J	Koka, A; Suppan, L; Cottet, P; Carrera, E; Stuby, L; Suppan, M				Koka, Avinash; Suppan, Laurent; Cottet, Philippe; Carrera, Emmanuel; Stuby, Loric; Suppan, Melanie			Teaching the National Institutes of Health Stroke Scale to Paramedics (E-Learning vs Video): Randomized Controlled Trial	JOURNAL OF MEDICAL INTERNET RESEARCH			English	Article						active learning; electronic learning; video; stroke; online learning; e-learning	PREHOSPITAL STROKE; RELIABILITY; GUIDELINE; CARE	Background: Prompt and accurate identification of stroke victims is essential to reduce time from symptom onset to adequate treatment and to improve neurological outcomes. Most neurologists evaluate the extent of neurological deficit according to the National Institutes of Health Stroke Scale (NIHSS), but the use of this scale by paramedics, the first healthcare providers to usually take care of stroke victims, has proven unreliable. This might be, at least in part, due to the teaching method. The video used to teach NIHSS lacks interactivity, while more engaging electronic learning (e-learning) methods might improve knowledge acquisition. Objective: This study was designed to evaluate whether a highly interactive e-learning module could enhance NIHSS knowledge acquisition in paramedics. Methods: A randomized controlled trial comparing a specially designed e-learning module with the original NIHSS video was performed with paramedics working in Geneva, Switzerland. A registration number was not required as our study does not come into the scope of the Swiss federal law on human research. The protocol was nevertheless submitted to the local ethics committee (Project ID 2017-00847), which issued a "Declaration of no objection." Paramedics were excluded if they had prior knowledge of or previous training in the NIHSS, or if they had worked in a neurology or neurosurgery ward. The primary outcome was overall performance in the study quiz, which contained 50 questions. Secondary outcomes were performance by NIHSS item, time to course and quiz completion, user satisfaction regarding the learning method, user perception of the course duration, and probability the user would recommend the course to a colleague. Results: The study was completed by 39 paramedics. There was a better overall median score (36/50 vs 33/50, P=.04) and a higher degree of satisfaction regarding the learning method in the e-learning group (90% vs 37%, P=.002). Users who had followed the e-learning module were more likely to recommend the course to a colleague (95% vs 63%, P=.02). Paramedics in the e-learning group took more time to complete the course (93 vs 59 minutes, P<.001), but considered the duration to be more adequate (75% vs 32%, P=.01). Time to quiz completion was similar between groups (25 vs 38 minutes, P=.12). Conclusions: Use of an e-learning module shows promising results in teaching the NIHSS to paramedics.	[Koka, Avinash; Suppan, Laurent; Cottet, Philippe] Geneva Univ Hosp, Dept Anaesthesiol Clin Pharmacol Intens Care & Em, Div Emergency Med, Rue Gabrielle Perret Gentil 4, CH-1211 Geneva, Switzerland; [Carrera, Emmanuel] Geneva Univ Hosp, Stroke Ctr, Dept Neurol, Geneva, Switzerland; [Stuby, Loric] Geneve TEAM Ambulances, Geneva, Switzerland; [Suppan, Melanie] Geneva Univ Hosp, Dept Anaesthesiol Clin Pharmacol Intens Care & Em, Div Anesthesiol, Geneva, Switzerland		Suppan, L (corresponding author), Geneva Univ Hosp, Dept Anaesthesiol Clin Pharmacol Intens Care & Em, Div Emergency Med, Rue Gabrielle Perret Gentil 4, CH-1211 Geneva, Switzerland.	laurent.suppan@hcuge.ch	Stuby, Loric/AAS-9043-2021; Suppan, Melanie/AAZ-8097-2020; Suppan, Laurent/AAU-1562-2020	Stuby, Loric/0000-0003-1663-5249; Suppan, Melanie/0000-0002-8807-9619; Suppan, Laurent/0000-0001-6989-6421; Koka, Avinash/0000-0002-3911-0528; Cottet, Philippe/0000-0001-6029-8548; Carrera, Emmanuel/0000-0003-0045-5382			Birns J, 2018, CREATIVE ED, V09, P1196, DOI [10.4236/ce.2018.98089, DOI 10.4236/CE.2018.98089]; Chan M, 2020, J CLIN MED, V9, DOI 10.3390/jcm9010238; Chiu SC, 2009, INT J NURS STUD, V46, P1548, DOI 10.1016/j.ijnurstu.2009.05.008; Croxton RA, 2014, MERLOT J ONLINE LEAR, V10, P314; David I, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.2016; Eysenbach G, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1923; Feng JY, 2013, WORLDV EVID-BASED NU, V10, P174, DOI 10.1111/wvn.12005; Freeman S, 2014, P NATL ACAD SCI USA, V111, P8410, DOI 10.1073/pnas.1319030111; GOLDSTEIN LB, 1989, ARCH NEUROL-CHICAGO, V46, P660, DOI 10.1001/archneur.1989.00520420080026; Iguchi Y, 2011, CEREBROVASC DIS, V31, P51, DOI 10.1159/000320854; Jones SP, 2018, NURS EDUC TODAY, V61, P249, DOI 10.1016/j.nedt.2017.11.024; Kang SY, 2018, KOREAN J INTERN MED, V33, P604, DOI 10.3904/kjim.2017.017; Katan M, 2018, SEMIN NEUROL, V38, P208, DOI 10.1055/s-0038-1649503; Kesinger MR, 2015, STROKE, V46, P575, DOI 10.1161/STROKEAHA.114.007850; Knox S, 2014, BMC MED EDUC, V14, DOI 10.1186/1472-6920-14-41; Kothari RU, 1999, ANN EMERG MED, V33, P373, DOI 10.1016/S0196-0644(99)70299-4; Llanes Jennifer N, 2004, Prehosp Emerg Care, V8, P46; LYDEN P, 1994, STROKE, V25, P2220, DOI 10.1161/01.STR.25.11.2220; Lyden P, 2017, STROKE, V48, P513, DOI 10.1161/STROKEAHA.116.015434; McGowan BS, 2015, J CONTIN EDUC NURS, V46, P292, DOI 10.3928/00220124-20150619-11; Meyer BC, 2009, INT J STROKE, V4, P267, DOI 10.1111/j.1747-4949.2009.00294.x; Powers WJ, 2018, STROKE, V49, pE46, DOI 10.1161/STR.0000000000000158; Roe D, 2010, EMERG MED J, V27, P100, DOI 10.1136/emj.2008.064915; Rouleau G, 2019, J MED INTERNET RES, V21, DOI 10.2196/15118; Sherratt FC, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014024; Shin JY, 2017, NURS EDUC TODAY, V57, P60, DOI 10.1016/j.nedt.2017.07.007; Sommer P, 2017, J NEUROL, V264, P131, DOI 10.1007/s00415-016-8330-x; Suppan L, 2020, MENDELEY DATA; Tarpada SP, 2016, J ORTHOP, V13, P425, DOI 10.1016/j.jor.2016.09.004; Vaclavik D, 2018, BRAIN BEHAV, V8, DOI 10.1002/brb3.1087; Vaona A, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011736.pub2; Venkat A, 2018, NEUROEPIDEMIOLOGY, V51, P123, DOI 10.1159/000491635	32	9	9	2	2	JMIR PUBLICATIONS, INC	TORONTO	130 QUEENS QUAY E, STE 1102, TORONTO, ON M5A 0P6, CANADA	1438-8871			J MED INTERNET RES	J. Med. Internet Res.	JUN 9	2020	22	6							e18358	10.2196/18358			8	Health Care Sciences & Services; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Medical Informatics	LW1XN	WOS:000538939600001	32299792	gold, Green Published			2022-03-04	
J	Ehrler, F; Weber, C; Lovis, C				Ehrler, Frederic; Weber, Chloe; Lovis, Christian			Influence of Pedometer Position on Pedometer Accuracy at Various Walking Speeds: A Comparative Study	JOURNAL OF MEDICAL INTERNET RESEARCH			English	Article						frail elderly; mHealth; walking; motor activity	OBSTRUCTIVE PULMONARY-DISEASE; REGULAR PHYSICAL-ACTIVITY; POPULATION; EXERCISE; MOBILITY; HEALTHY; ADULTS	Background: Demographic growth in conjunction with the rise of chronic diseases is increasing the pressure on health care systems in most OECD countries. Physical activity is known to be an essential factor in improving or maintaining good health. Walking is especially recommended, as it is an activity that can easily be performed by most people without constraints. Pedometers have been extensively used as an incentive to motivate people to become more active. However, a recognized problem with these devices is their diminishing accuracy associated with decreased walking speed. The arrival on the consumer market of new devices, worn indifferently either at the waist, wrist, or as a necklace, gives rise to new questions regarding their accuracy at these different positions. Objective: Our objective was to assess the performance of 4 pedometers (iHealth activity monitor, Withings Pulse O2, Misfit Shine, and Garmin vivofit) and compare their accuracy according to their position worn, and at various walking speeds. Methods: We conducted this study in a controlled environment with 21 healthy adults required to walk 100 m at 3 different paces (0.4 m/s, 0.6 m/s, and 0.8 m/s) regulated by means of a string attached between their legs at the level of their ankles and a metronome ticking the cadence. To obtain baseline values, we asked the participants to walk 200 m at their own pace. Results: A decrease of accuracy was positively correlated with reduced speed for all pedometers (12% mean error at self-selected pace, 27% mean error at 0.8 m/s, 52% mean error at 0.6 m/s, and 76% mean error at 0.4 m/s). Although the position of the pedometer on the person did not significantly influence its accuracy, some interesting tendencies can be highlighted in 2 settings: (1) positioning the pedometer at the waist at a speed greater than 0.8 m/s or as a necklace at preferred speed tended to produce lower mean errors than at the wrist position; and (2) at a slow speed (0.4 m/s), pedometers worn at the wrist tended to produce a lower mean error than in the other positions. Conclusions: At all positions, all tested pedometers generated significant errors at slow speeds and therefore cannot be used reliably to evaluate the amount of physical activity for people walking slower than 0.6 m/s (2.16 km/h, or 1.24 mph). At slow speeds, the better accuracy observed with pedometers worn at the wrist could constitute a valuable line of inquiry for the future development of devices adapted to elderly people.	[Ehrler, Frederic; Weber, Chloe; Lovis, Christian] Univ Hosp Geneva, Div Med Informat Sci, Gabrielle Perret Gentil 4, CH-1205 Geneva, Switzerland; [Lovis, Christian] Univ Geneva, Fac Med, Geneva, Switzerland		Ehrler, F (corresponding author), Univ Hosp Geneva, Div Med Informat Sci, Gabrielle Perret Gentil 4, CH-1205 Geneva, Switzerland.	frederic.ehrler@hcuge.ch	Lovis, Christian/D-2634-2012; Ehrler, Frederic/S-5156-2016; Ehrler, Frederic/ABE-8600-2020; Lovis, Christian/T-5364-2019	Lovis, Christian/0000-0002-2681-8076; Ehrler, Frederic/0000-0001-9734-3242; Ehrler, Frederic/0000-0001-9734-3242; Lovis, Christian/0000-0002-2681-8076			Abel MG, 2009, RES Q EXERCISE SPORT, V80, P434; Arif M., 2004, MEAS SCI REV, V4, P29; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1177/096228029900800204; Booth FW, 2012, COMPR PHYSIOL, V2, P1143, DOI 10.1002/cphy.c110025; Buchner D M, 1992, Clin Geriatr Med, V8, P1; CAMPION MA, 1982, ORGAN BEHAV HUM PERF, V30, P265, DOI 10.1016/0030-5073(82)90221-5; Castell MV, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-86; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; CohenMansfield J, 1997, DEMENT GERIATR COGN, V8, P359, DOI 10.1159/000106656; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Garcia-Aymerich J, 2006, THORAX, V61, P772, DOI 10.1136/thx.2006.060145; Garcia-Aymerich J, 2008, ANN EPIDEMIOL, V18, P775, DOI 10.1016/j.annepidem.2008.05.003; Horvath S, 2007, APPL PHYSIOL NUTR ME, V32, P409, DOI 10.1139/H07-001; Jehn M, 2010, INT J SPORTS MED, V31, P186, DOI 10.1055/s-0029-1243641; Kim WS, 2014, ANN REHABIL MED-ARM, V38, P101, DOI 10.5535/arm.2014.38.1.101; Lauritzen J, 2013, STUD HEALTH TECHNOL, V192, P759, DOI 10.3233/978-1-61499-289-9-759; Marschollek M, 2008, IEEE ENG MED BIO, P1319, DOI 10.1109/IEMBS.2008.4649407; Martin J, 2012, INT J THER REHABIL, V19, P387, DOI 10.12968/ijtr.2012.19.7.387; PERRY J, 1995, STROKE, V26, P982, DOI 10.1161/01.STR.26.6.982; Pescatello L. S., 2014, ACSMS GUID EX TEST P; Storm FA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118723; Studenski S, 2011, JAMA-J AM MED ASSOC, V305, P50, DOI 10.1001/jama.2010.1923; Sugihara Naomi, 2011, Hawaii Med J, V70, P116; TUDORLOCKE C, 2002, PRESIDENTS COUNCIL P, V3, P17, DOI DOI 10.HTTP://WWW.ERIC.ED.G0V/ERICWEBP0RTAL/C0NTENTDELIVERY/SERVLET/ERICSERVLET?; Yusuf HR, 1996, ARCH INTERN MED, V156, P1321, DOI 10.1001/archinte.156.12.1321; Zijlstra A, 2008, EUR J APPL PHYSIOL, V104, P427, DOI 10.1007/s00421-008-0795-6	26	15	15	0	9	JMIR PUBLICATIONS, INC	TORONTO	59 WINNERS CIRCLE, TORONTO, ON M4L 3Y7, CANADA	1438-8871			J MED INTERNET RES	J. Med. Internet Res.	OCT	2016	18	10							e268	10.2196/jmir.5916			9	Health Care Sciences & Services; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services; Medical Informatics	EC2WT	WOS:000387985700004	27713114	Green Published, gold			2022-03-04	
J	Combescure, C; Courvoisier, DS; Haller, G; Perneger, TV				Combescure, C.; Courvoisier, D. S.; Haller, G.; Perneger, T. V.			Meta-analysis of two-arm studies: Modeling the intervention effect from survival probabilities	STATISTICAL METHODS IN MEDICAL RESEARCH			English	Article						Meta-analysis; survival data; multiple time points	TO-EVENT OUTCOMES; BONE-MARROW TRANSPLANTATION; GENERALIZED LEAST-SQUARES; INVESTIGATING HETEROGENEITY; PROPORTIONAL-HAZARDS; CLINICAL-TRIALS; AGGREGATE DATA; BREAST-CANCER; TIME; CHEMOTHERAPY	Pooling the hazard ratios is not always feasible in meta-analyses of two-arm survival studies, because the measure of the intervention effect is not systematically reported. An alternative approach proposed by Moodie et al. is to use the survival probabilities of the included studies, all collected at a single point in time: the intervention effect is then summarised as the pooled ratio of the logarithm of survival probabilities (which is an estimator of the hazard ratios when hazards are proportional). In this article, we propose a generalization of this method. By using survival probabilities at several points in time, this generalization allows a flexible modeling of the intervention over time. The method is applicable to partially proportional hazards models, with the advantage of not requiring the specification of the baseline survival. As in Moodie et al.'s method, the study-level factors modifying the survival functions can be ignored as long as they do not modify the intervention effect. The procedures of estimation are presented for fixed and random effects models. Two illustrative examples are presented.	Univ Geneva, CRC, Geneva, Switzerland; Univ Geneva, Div Clin Epidemiol, Dept Hlth & Community Med, Geneva, Switzerland; Univ Hosp Geneva, Geneva, Switzerland		Combescure, C (corresponding author), Div Clin Epidemiol, Rue Gabrielle Perret Gentil 6, CH-1211 Geneva 14, Switzerland.	christophe.combescure@hcuge.ch		haller, guy/0000-0001-7367-7029			ALTMAN DG, 1995, BRIT J CANCER, V72, P511, DOI 10.1038/bjc.1995.364; Arends LR, 2008, STAT MED, V27, P4381, DOI 10.1002/sim.3311; BEGG CB, 1989, EUR J CANCER CLIN ON, V25, P1519, DOI 10.1016/0277-5379(89)90291-5; Bellera CA, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-20; Bennett S, 1983, Stat Med, V2, P273, DOI 10.1002/sim.4780020223; BENNETT S, 1983, J R STAT SOC C-APPL, V32, P165; Berkey CS, 1996, STAT MED, V15, P537, DOI 10.1002/(SICI)1097-0258(19960315)15:5<537::AID-SIM176>3.0.CO;2-S; Berkey CS, 1998, STAT MED, V17, P2537, DOI 10.1002/(SICI)1097-0258(19981130)17:22<2537::AID-SIM953>3.0.CO;2-C; Berrington A, 2003, BIOSTATISTICS, V4, P423, DOI 10.1093/biostatistics/4.3.423; Combescure C, 2011, STAT METHODS MED RES, V20, P10; CONDE E, 1988, BRIT J HAEMATOL, V68, P219, DOI 10.1111/j.1365-2141.1988.tb06193.x; CUTLER S J, 1958, J Chronic Dis, V8, P699, DOI 10.1016/0021-9681(58)90126-7; DEAR KBG, 1994, BIOMETRICS, V50, P989, DOI 10.2307/2533438; DOREY FJ, 1987, STAT MED, V6, P679, DOI 10.1002/sim.4780060605; Fiocco M, 2009, STAT MED, V28, P3782, DOI 10.1002/sim.3752; Guyot P, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-9; Jackson D, 2010, STAT MED, V29, P1282, DOI 10.1002/sim.3602; Katsahian S, 2008, CONTEMP CLIN TRIALS, V29, P220, DOI 10.1016/j.cct.2007.08.002; Lu WL, 2009, BREAST CANCER RES TR, V114, P403, DOI 10.1007/s10549-008-0023-4; Mathoulin-Pelissier S, 2008, J CLIN ONCOL, V26, P3721, DOI 10.1200/JCO.2007.14.1192; Moodie PF, 2004, STAT MED, V23, P1075, DOI 10.1002/sim.1696; O'Quigley J, 2002, STAT MED, V21, P3219, DOI 10.1002/sim.1259; Ouwens MJ, 2010, RES SYNTH METHODS, V1, P24; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Perneger TV, 2008, CONTEMP CLIN TRIALS, V29, P762, DOI 10.1016/j.cct.2008.06.002; Royston P, 2002, STAT MED, V21, P2175, DOI 10.1002/sim.1203; Siannis F, 2010, STAT MED, V29, P3030, DOI 10.1002/sim.4086; Smith CT, 2005, J EVAL CLIN PRACT, V11, P468, DOI 10.1111/j.1365-2753.2005.00559.x; Smith CT, 2005, STAT MED, V24, P1307, DOI 10.1002/sim.2050; Sundaram R, 2009, J STAT PLAN INFER, V139, P1381, DOI 10.1016/j.jspi.2008.08.006; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Trikalinos TA, 2008, STAT MED, V27, P4279, DOI 10.1002/sim.3299; Whitehead A., 2002, METAANALYSIS CONTROL; Williamson PR, 2002, STAT MED, V21, P3337, DOI 10.1002/sim.1303; Yang S, 2011, BIOSTATISTICS, V12, P354, DOI 10.1093/biostatistics/kxq061	35	1	1	1	5	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0962-2802	1477-0334		STAT METHODS MED RES	Stat. Methods Med. Res.	APR	2016	25	2					857	871		10.1177/0962280212469716			15	Health Care Sciences & Services; Mathematical & Computational Biology; Medical Informatics; Statistics & Probability	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services; Mathematical & Computational Biology; Medical Informatics; Mathematics	DK3CH	WOS:000374792800023	23267027				2022-03-04	
J	Taraschi, G; Aguiar, D; Tille, JC; Petignat, P; Abdulcadir, J				Taraschi, Gianmarco; Aguiar, Diego; Tille, Jean Christophe; Petignat, Patrick; Abdulcadir, Jasmine			Clitoral leiomyoma in a premenopausal woman: a case report (vol 20, 89, 2020)	BMC WOMENS HEALTH			English	Correction									[Taraschi, Gianmarco; Petignat, Patrick; Abdulcadir, Jasmine] Geneva Univ Hosp, Dept Obstet & Gynaecol, 30 Bld Cluse, CH-1211 Geneva, Switzerland; [Aguiar, Diego; Tille, Jean Christophe] Geneva Univ Hosp, Div Clin Pathol, 1 Rue Michel Servet, CH-1205 Geneva, Switzerland		Taraschi, G (corresponding author), Geneva Univ Hosp, Dept Obstet & Gynaecol, 30 Bld Cluse, CH-1211 Geneva, Switzerland.	Taraschi@hcuge.ch	Aguiar, Diego/AAH-6260-2021				Taraschi G, 2020, BMC WOMENS HEALTH, V20, DOI 10.1186/s12905-020-00959-x	1	0	0	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1472-6874		BMC WOMENS HEALTH	BMC Womens Health	MAY 20	2020	20	1							110	10.1186/s12905-020-00975-x			3	Public, Environmental & Occupational Health; Obstetrics & Gynecology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Obstetrics & Gynecology	LT4SW	WOS:000537063200002	32434533	Green Published, gold			2022-03-04	
J	Ehrler, F; Lovis, C; Blondon, K				Ehrler, Frederic; Lovis, Christian; Blondon, Katherine			A Mobile Phone App for Bedside Nursing Care: Design and Development Using an Adapted Software Development Life Cycle Model	JMIR MHEALTH AND UHEALTH			English	Article						mHealth; nursing; hospital information systems	ELECTRONIC MEDICAL-RECORDS; USER-CENTERED DESIGN; HEALTH-CARE; INFORMATION-TECHNOLOGY; PATIENT-CARE; USABILITY; TIME; IMPLEMENTATION; DOCUMENTATION; FAILURE	Background: Nurses are increasingly spending time on computers, and providing them with a tailored tool to access clinical information and perform documentation at the bedside could help to improve their efficiency. Designing an app to support nurses' work at the bedside is a challenging task, given the complexity of the care process. Objective: This study aimed to present the design, development, and testing of a smartphone app for nurses guided by an adapted software development life cycle model that takes into consideration the complexity and constraints of a health care setting. Methods: The model drives us through an iterative development process intersected by 3 stages of formative evaluation of growing ecological validity. Results: The initial requirements identification stage included 11 participants who helped us select the most important functionalities to integrate into the tool. Starting with a usability evaluation allowed for the identification of design issues that could have caused misuse. Then, making on-site evaluations under the supervision of an investigator helped to understand the adequacy of the tool with limited risks. Finally, the on-site evaluation allowed us to validate the acceptance of the app by caregivers. Conclusions: The interpretation of the collected evaluation confirms the necessary involvement of end users early in the process to help address the heterogeneity of the nursing workflow processes in the different wards. We also highlight the delicate balance between high-security measures to protect access to patient data and maintaining ease of access for efficiency and usability. Although a close collaboration with clinicians throughout the entire project facilitated the development of a tailored solution, it was also important to involve all stakeholders, in particular, the information technology (IT) security officers.	[Ehrler, Frederic; Lovis, Christian] Univ Hosp Geneva, Div Med Informat Sci, 4 Gabrielle Perret Gentil, CH-1205 Geneva, Switzerland; [Lovis, Christian] Univ Geneva, Fac Med, Geneva, Switzerland; [Blondon, Katherine] Univ Hosp Geneva, Med Directorate, Geneva, Switzerland		Ehrler, F (corresponding author), Univ Hosp Geneva, Div Med Informat Sci, 4 Gabrielle Perret Gentil, CH-1205 Geneva, Switzerland.	frederic.ehrler@hcuge.ch	Lovis, Christian/D-2634-2012; Ehrler, Frederic/ABE-8600-2020; Lovis, Christian/T-5364-2019; Blondon, Katherine S/H-9219-2019	Lovis, Christian/0000-0002-2681-8076; Ehrler, Frederic/0000-0001-9734-3242; Lovis, Christian/0000-0002-2681-8076; Blondon, Katherine S/0000-0002-9407-8516	"Private Foundation of the University Hospitals of Geneva	The authors thank their colleagues from HUG, Pascal Ducloux, Jean-Yves Wojtasikiewicz, Pierre-Andre Berret, and Thomas Weinhold, who provided insight and expertise that greatly assisted the research. The authors also thank Professor Arnaud Perrier, CMO, for his support throughout this project. This research was funded by the "Private Foundation of the University Hospitals of Geneva."	Al Ayubi SU, 2016, JMIR MHEALTH UHEALTH, V4, P446, DOI 10.2196/mhealth.4424; Ammenwerth E, 2009, METHOD INFORM MED, V48, P84, DOI 10.3414/ME0569; Ash JS, 2004, J AM MED INFORM ASSN, V11, P104, DOI 10.1197/jamia.M1471; Barra Daniela Couto Carvalho, 2017, Texto contexto - enferm., V26, pe2260017, DOI 10.1590/0104-07072017002260017; Bendixen RM, 2017, JMIR MHEALTH UHEALTH, V5, DOI 10.2196/mhealth.7136; Borycki EM, 2015, STUD HEALTH TECHNOL, V216, P338, DOI 10.3233/978-1-61499-564-7-338; Boudreaux ED, 2014, TRANSL BEHAV MED, V4, P363, DOI 10.1007/s13142-014-0293-9; Briggs J, 2012, ACM SIGHIT REC, V2, P31; Brooke John, 1996, USABILITY EVALUATION, V189, P4; Carlson E, 2010, J NURS ADMIN, V40, P360, DOI 10.1097/NNA.0b013e3181ee4248; Christino Melissa A, 2013, J Grad Med Educ, V5, P600, DOI 10.4300/JGME-D-12-00377.1; Cresswell K, 2013, INT J MED INFORM, V82, pE73, DOI 10.1016/j.ijmedinf.2012.10.007; Dabbs AD, 2009, CIN-COMPUT INFORM NU, V27, P175, DOI 10.1097/NCN.0b013e31819f7c7c; Duhm J, 2016, JMIR MHEALTH UHEALTH, V4, P155, DOI 10.2196/mhealth.5464; Ehrler F, 2018, STUD HEALTH TECHNOL, V247, P506, DOI 10.3233/978-1-61499-852-5-506; Ehrler F, 2018, JMIR MHEALTH UHEALTH, V6, DOI 10.2196/mhealth.9079; Ehrler F, 2016, STUD HEALTH TECHNOL, V228, P200, DOI 10.3233/978-1-61499-678-1-200; Ehrler F, 2013, JMIR MHEALTH UHEALTH, V1, DOI 10.2196/mhealth.2344; Fahimi F, 2009, ARCH IRAN MED, V12, P173; Fleischmann R, 2015, J NEUROL, V262, P532, DOI 10.1007/s00415-014-7581-7; Gachet D, 2016, P INT C UB COMP APPL; Granja C, 2018, J MED INTERNET RES, V20, DOI 10.2196/10235; Heeks R, 2006, INT J MED INFORM, V75, P125, DOI 10.1016/j.ijmedinf.2005.07.024; Hendrich Ann, 2008, Perm J, V12, P25; Ho WY, 2013, USE IPADS CLIN DOCUM; Holden RJ, 2010, J BIOMED INFORM, V43, P159, DOI 10.1016/j.jbi.2009.07.002; Hughes M, 2011, J CHANG MANAG, V11, P451, DOI 10.1080/14697017.2011.630506; Johnson CM, 2005, J BIOMED INFORM, V38, P75, DOI 10.1016/j.jbi.2004.11.005; Kaplan B, 2009, J AM MED INFORM ASSN, V16, P291, DOI 10.1197/jamia.M2997; Keller JP, 2017, DIGIT MED, V3, P115, DOI [10.4103/digm.digm_20_17, DOI 10.4103/DIGM.DIGM_20_17]; Kim J, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.8128; Kim MO, 2017, J AM MED INFORM ASSN, V24, P246, DOI 10.1093/jamia/ocw154; Koppel R, 2005, JAMA-J AM MED ASSOC, V293, P1197, DOI 10.1001/jama.293.10.1197; Kushniruk AW, 2005, INT J MED INFORM, V74, P519, DOI 10.1016/j.ijmedinf.2005.01.003; Lin AC, 2013, 2007 INT C BIOINF CO, P933, DOI [10.1007/s13142-014-0293-9, DOI 10.1007/S13142-014-0293-9]; Maher M, 2016, BIOL BLOOD MARROW TR, V22, P349, DOI 10.1016/j.bbmt.2015.08.032; Malik S, 2017, INT RES J ENG TECHNO, V4; Martinez-Perez B, 2014, J MED SYST, V38, DOI 10.1007/s10916-013-0004-y; Moody LE, 2004, CIN-COMPUT INFORM NU, V22, P337, DOI 10.1097/00024665-200411000-00009; Motulsky A, 2017, J AM MED INFORM ASSN, V24, pE69, DOI 10.1093/jamia/ocw107; Munassar NMA., 2010, IJCSI INT J COMPUTER, V7, P94; Nawaz A., 2012 10 AS PAC C COM, P583; Nayebi F., 2012, P 2012 25 IEEE CAN C, P1; Oulasvirta A, 2012, PERS UBIQUIT COMPUT, V16, P105, DOI 10.1007/s00779-011-0412-2; Morera EP, 2016, J MED SYST, V40, DOI 10.1007/s10916-016-0513-6; Prgomet M, 2009, J AM MED INFORM ASSN, V16, P792, DOI 10.1197/jamia.M3215; Rastogi V., 2015, INT J COMPUT SCI INF, V6, P168; Samples C, 2014, Int J Nurs Sci, V1, P330, DOI 10.1016/j.ijnss.2014.08.002; Sligo J, 2017, INT J MED INFORM, V97, P86, DOI 10.1016/j.ijmedinf.2016.09.007; Svanaes D, 2010, INT J MED INFORM, V79, pE24, DOI 10.1016/j.ijmedinf.2008.06.014; van Gemert-Pijnen JEWC, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1672; Ventola C Lee, 2014, P T, V39, P356; Wager KA, 2010, CIN-COMPUT INFORM NU, V28, P205, DOI 10.1097/NCN.0b013e3181e1df19; Yee T, 2012, CIN-COMPUT INFORM NU, V30, P287, DOI 10.1097/NXN.0b013e31824af835	54	2	2	1	11	JMIR PUBLICATIONS, INC	TORONTO	59 WINNERS CIRCLE, TORONTO, ON M4L 3Y7, CANADA	2291-5222			JMIR MHEALTH UHEALTH	JMIR mHealth uHealth	APR 11	2019	7	4							e12551	10.2196/12551			15	Health Care Sciences & Services; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Medical Informatics	HU5UR	WOS:000465345500001	30973339	gold, Green Published			2022-03-04	
J	Peters, W; Fleck, SL; Robinson, BL; Stewart, LB; Jefford, CW				Peters, W; Fleck, SL; Robinson, BL; Stewart, LB; Jefford, CW			The chemotherapy of rodent malaria. LX. The importance of formulation in evaluating the blood schizontocidal activity of some endoperoxide antimalarials	ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY			English	Article							DIFLUORINATED 3,3'-SPIROCYCLOPENTANE 1,2,4-TRIOXANE; RO-42-1611 ARTEFLENE; FALCIPARUM-MALARIA; ARTEMISININ; FENOZAN-50F	The activities of artemisinin (QHS) and a number of its semi-synthetic analogues, as well as Fenozan B07 (1307), a synthetic 1,2,4-trioxane, and arteflene (ATF), a synthetic surrogate of yingzhaosu, were compared in mice infected with drug-sensitive Plasmodium berghei or chloroquine-resistant P. yoelii ssp. NS. The studies were stimulated by the observation that B07, in certain aqueous preparations, appears to be equipotent by the subcutaneous (sc) or oral (po) routes in the rodent model but not in a simian model. In the rodent model, B07 was found to undergo rapid alteration (with a half-life of < 24 h) in an aqueous stock solution prepared using dimethyl sulphoxide (DMSO) to pre-dissolve the drug. Therefore, for all later experiments with aqueous preparations, the test material was newly formulated each day. In a carboxymethylcellulose formulation used as a 'standard suspending vehicle' (SSV), B07 and dihydroartemisinin (DIHYD) were found to be, respectively, one sixth and one 10th as active po as when the drugs were pre-dissolved in DMSO and then diluted with water. ATF in DMSO given po was less than one 20th as active as when used sc in the rodent model, and this drug in SSV was almost inactive po. The relatively low oral activity of these three compounds (especially DIHYD and ATF) may be attributable to extensive first-pass metabolism in the mouse. Oral &beta;-artemether (AM) and &beta;-arteether (AE) were highly active when used in SSV. ATF has been found to have low activity in simian models and clinical trials because of its poor absolute bio-availability. In in-vivo studies of the blood schizontocidal action of antimalarials, in rodent malaria models, the data collected on the structure-activity relationships (SAR) of the drugs must be viewed critically when selecting specific compounds from a chemical series for further development. A study of the influence of drug formulation on the activity of other, novel antimalarials is crucial to the evaluation of the drugs, and merits high priority.	Northwick Pk Inst Med Res, Ctr Trop Antiprotozoal Chemotherapy, Harrow HA1 3UJ, Middx, England; MRC Technol, London NW7 1AD, England; Univ Geneva, Dept Organ Chem, CH-1211 Geneva, Switzerland		Peters, W (corresponding author), Northwick Pk Inst Med Res, Ctr Trop Antiprotozoal Chemotherapy, Y Block, Harrow HA1 3UJ, Middx, England.						AVERY MA, 1999, BIOL ACTIVE NATURAL, P121; Binh TQ, 2001, BRIT J CLIN PHARMACO, V51, P541, DOI 10.1046/j.1365-2125.2001.01395.x; Fleck SL, 1997, ANN TROP MED PARASIT, V91, P25, DOI 10.1080/00034983.1997.11813108; GIROMETTA MA, 1994, TROP MED PARASITOL, V45, P272; Haynes RK, 2001, CURR OPIN INFECT DIS, V14, P719, DOI 10.1097/00001432-200112000-00010; JAQUET C, 1994, TROP MED PARASITOL, V45, P266; JEFFORD CW, 1995, HELV CHIM ACTA, V78, P647, DOI 10.1002/hlca.19950780312; Jefford CW, 2001, CURR MED CHEM, V8, P1803, DOI 10.2174/0929867013371608; JEFFORD CW, 1997, ADV DRUG RES, V29, P271; Meshnick SR, 1996, PARASITOL TODAY, V12, P79, DOI 10.1016/0169-4758(96)80660-0; Peters W, 1999, ANN TROP MED PARASIT, V93, P325, DOI 10.1080/00034989958320; PETERS W, 1975, ANN TROP MED PARASIT, V69, P155, DOI 10.1080/00034983.1975.11686997; PETERS W, 1993, ANN TROP MED PARASIT, V87, P111, DOI 10.1080/00034983.1993.11812745; PETERS W, 1998, HDB ANIMAL MODELS IN, P756; POSNER GH, 2000, BIOMEDICAL CHEM APPL, P289; Radloff PD, 1996, AM J TROP MED HYG, V55, P259, DOI 10.4269/ajtmh.1996.55.259; SALAKO LA, 1994, TROP MED PARASITOL, V45, P284; Vroman JA, 1999, CURR PHARM DESIGN, V5, P101	18	32	33	0	3	MANEY PUBLISHING	LEEDS	HUDSON RD, LEEDS LS9 7DL, ENGLAND	0003-4983			ANN TROP MED PARASIT	Ann. Trop. Med. Parasitol.	SEP	2002	96	6					559	573		10.1179/000349802125001744			15	Public, Environmental & Occupational Health; Parasitology; Tropical Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Parasitology; Tropical Medicine	600JQ	WOS:000178387200004	12396319				2022-03-04	
J	Waterhouse, R				Waterhouse, Robert			TOWARDS A COMPLETE CATALOGUE OF FUNCTIONAL GENOMIC ELEMENTS FROM MULTIPLE ANOPHELES GENOMES	PATHOGENS AND GLOBAL HEALTH			English	Meeting Abstract									[Waterhouse, Robert] Univ Geneva, Sch Med, Swiss Inst Bioinformat, CH-1211 Geneva 4, Switzerland; [Waterhouse, Robert] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA				Waterhouse, Robert M/A-1858-2010	Waterhouse, Robert M/0000-0003-4199-9052				0	0	0	0	2	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	2047-7724	2047-7732		PATHOG GLOB HEALTH	Pathog. Glob. Health	DEC	2013	107	8					429	429					1	Public, Environmental & Occupational Health; Parasitology; Tropical Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Parasitology; Tropical Medicine	AF9SZ	WOS:000335056200081					2022-03-04	
J	Siebert, JN; Ehrler, F; Combescure, C; Lacroix, L; Haddad, K; Sanchez, O; Gervaix, A; Lovis, C; Manzano, S				Siebert, Johan N.; Ehrler, Frederic; Combescure, Christophe; Lacroix, Laurence; Haddad, Kevin; Sanchez, Oliver; Gervaix, Alain; Lovis, Christian; Manzano, Sergio			A Mobile Device App to Reduce Time to Drug Delivery and Medication Errors During Simulated Pediatric Cardiopulmonary Resuscitation: A Randomized Controlled Trial	JOURNAL OF MEDICAL INTERNET RESEARCH			English	Article						resuscitation; medication errors; pharmaceutical preparations; pediatrics; biomedical technology	HOSPITAL CARDIAC-ARREST; AMERICAN-HEART-ASSOCIATION; BROSELOW TAPE; SPONTANEOUS CIRCULATION; WEIGHT ESTIMATION; EPIDEMIOLOGY; CHILDREN; STABILITY; OUTCOMES; EMERGENCIES	Background: During pediatric cardiopulmonary resuscitation (CPR), vasoactive drug preparation for continuous infusion is both complex and time-consuming, placing children at higher risk than adults for medication errors. Following an evidence-based ergonomic-driven approach, we developed a mobile device app called Pediatric Accurate Medication in Emergency Situations (PedAMINES), intended to guide caregivers step-by-step from preparation to delivery of drugs requiring continuous infusion. Objective: The aim of our study was to determine whether the use of PedAMINES reduces drug preparation time (TDP) and time to delivery (TDD; primary outcome), as well as medication errors (secondary outcomes) when compared with conventional preparation methods. Methods: The study was a randomized controlled crossover trial with 2 parallel groups comparing PedAMINES with a conventional and internationally used drugs infusion rate table in the preparation of continuous drug infusion. We used a simulation-based pediatric CPR cardiac arrest scenario with a high-fidelity manikin in the shock room of a tertiary care pediatric emergency department. After epinephrine-induced return of spontaneous circulation, pediatric emergency nurses were first asked to prepare a continuous infusion of dopamine, using either PedAMINES (intervention group) or the infusion table (control group), and second, a continuous infusion of norepinephrine by crossing the procedure. The primary outcome was the elapsed time in seconds, in each allocation group, from the oral prescription by the physician to TDD by the nurse. TDD included TDP. The secondary outcome was the medication dosage error rate during the sequence from drug preparation to drug injection. Results: A total of 20 nurses were randomized into 2 groups. During the first study period, mean TDP while using PedAMINES and conventional preparation methods was 128.1 s (95% CI 102-154) and 308.1 s (95% CI 216-400), respectively (180 s reduction, P=. 002). Mean TDD was 214 s (95% CI 171-256) and 391 s (95% CI 298-483), respectively (177.3 s reduction, P=. 002). Medication errors were reduced from 70% to 0% (P<. 001) by using PedAMINES when compared with conventional methods. Conclusions: In this simulation-based study, PedAMINES dramatically reduced TDP, to delivery and the rate of medication errors.	[Siebert, Johan N.; Lacroix, Laurence; Haddad, Kevin; Gervaix, Alain; Manzano, Sergio] Univ Hosp Geneva, Geneva Childrens Hosp, Dept Pediat Emergency Med, Ave Roseraie 47, CH-1205 Geneva, Switzerland; [Ehrler, Frederic; Lovis, Christian] Univ Hosp Geneva, Div Med Informat Sci, Dept Radiol & Med Informat, Geneva, Switzerland; [Combescure, Christophe] Univ Geneva, Div Clin Epidemiol, Dept Hlth & Community Med, Geneva, Switzerland; [Combescure, Christophe] Univ Hosp Geneva, Geneva, Switzerland; [Sanchez, Oliver] Univ Hosp Geneva, Geneva Childrens Hosp, Dept Pediat Surg, Geneva, Switzerland		Siebert, JN (corresponding author), Univ Hosp Geneva, Geneva Childrens Hosp, Dept Pediat Emergency Med, Ave Roseraie 47, CH-1205 Geneva, Switzerland.	Johan.Siebert@hcuge.ch	Ehrler, Frederic/ABE-8600-2020; Manzano, Sergio/ABG-6281-2020; Siebert, Johan/ABF-6115-2020; Lovis, Christian/D-2634-2012; Lacroix, Laurence/ABF-5052-2021; Lovis, Christian/T-5364-2019; Ehrler, Frederic/S-5156-2016	Ehrler, Frederic/0000-0001-9734-3242; Manzano, Sergio/0000-0001-9603-5520; Siebert, Johan/0000-0002-2871-3382; Lovis, Christian/0000-0002-2681-8076; Lacroix, Laurence/0000-0002-6636-3344; Lovis, Christian/0000-0002-2681-8076; Ehrler, Frederic/0000-0001-9734-3242; Gervaix, Alain/0000-0002-8925-5936; Sanchez, Oliver/0000-0003-0008-7436; Combescure, Christophe/0000-0003-2631-4780			Adapa RM, 2012, BRIT J ANAESTH, V109, P729, DOI 10.1093/bja/aes257; ALLEN EM, 1995, ANN PHARMACOTHER, V29, P1095, DOI 10.1177/106002809502901104; Ameer A, 2015, INTEGR PHARM RES NOV, V153, DOI 10.2147/IPRP.S54998; Andersen L, 2015, JAMA-J AM MED ASSOC, V314, P802, DOI 10.1001/jama.2015.9678; Atkins DL, 2009, CIRCULATION, V119, P1484, DOI 10.1161/CIRCULATIONAHA.108.802678; Carr Roxane R, 2014, Can J Hosp Pharm, V67, P197; CDC, 2011, NAT HOSP AMB MED CAR; Chavez H, 2015, AM J EMERG MED, V33, P1364, DOI 10.1016/j.ajem.2015.07.040; Checchia PA, 2003, RESUSCITATION, V57, P131, DOI 10.1016/S0300-9572(03)00003-0; Cheng A, 2014, PEDIATRICS, V133, P1091, DOI 10.1542/peds.2013-3267; Clark MC, 2016, ACAD EMERG MED, V23, P21, DOI 10.1111/acem.12854; de Caen AR, 2015, CIRCULATION, V132, pS526, DOI 10.1161/CIR.0000000000000266; Dix J, 2003, J TOXICOL-CLIN TOXIC, V41, P771, DOI 10.1081/CLT-120025341; Donoghue AJ, 2005, ANN EMERG MED, V46, P512, DOI 10.1016/j.annemergmed.2005.05.028; Ehrler Frederic, 2015, JMIR Hum Factors, V2, pe15, DOI 10.2196/humanfactors.4093; Eysenbach G, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1923; Franklin BD, 2017, BMJ QUAL SAF, V26, P93, DOI 10.1136/bmjqs-2016-005302; Gerein RB, 2006, ACAD EMERG MED, V13, P653, DOI 10.1197/j.aem.2005.12.025; Gonzales K, 2010, J PEDIATR NURS, V25, P555, DOI 10.1016/j.pedn.2010.04.002; Hagberg H, 2016, STUD HEALTH TECHNOL, V225, P656, DOI 10.3233/978-1-61499-658-3-656; Hofer CK, 2002, BRIT J ANAESTH, V88, P283, DOI 10.1093/bja/88.2.283; Hoyle JD, 2012, PREHOSP EMERG CARE, V16, P59, DOI 10.3109/10903127.2011.614043; Hubble MW, 2015, PREHOSP EMERG CARE, V19, P457, DOI 10.3109/10903127.2015.1005262; Jappinen A, 2003, EUR J PHARM SCI, V19, P31, DOI 10.1016/S0928-0987(03)00041-1; Kaufmann J, 2012, DTSCH ARZTEBL INT, V109, P609, DOI 10.3238/arztebl.2012.0609; Kaushal R, 2001, JAMA-J AM MED ASSOC, V285, P2114, DOI 10.1001/jama.285.16.2114; Knight JC, 2011, PEDIATR EMERG CARE, V27, P479, DOI 10.1097/PEC.0b013e31821d8559; Knudson JD, 2012, CRIT CARE MED, V40, P2940, DOI 10.1097/CCM.0b013e31825feb3f; Kozer E, 2004, BMJ-BRIT MED J, V329, P1321, DOI 10.1136/bmj.38244.607083.55; Krug SE, 2007, PEDIATRICS, V120, P1367, DOI 10.1542/peds.2007-2902; KUISMA M, 1995, RESUSCITATION, V30, P141, DOI 10.1016/0300-9572(95)00888-Z; Larsen GY, 2005, PEDIATRICS, V116, pE21, DOI 10.1542/peds.2004-2452; Lehmann CU, 2006, PEDIATR CRIT CARE ME, V7, P225, DOI 10.1097/01.PCC.0000216415.12120.FF; Lopez-Herce J, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0607-9; Luten R, 2002, ACAD EMERG MED, V9, P840, DOI 10.1197/aemj.9.8.840; Lutz N, 2014, PEDIATR EMERG CARE, V30, P699, DOI 10.1097/PEC.0000000000000231; Matos RI, 2013, CIRCULATION, V127, P442, DOI 10.1161/CIRCULATIONAHA.112.125625; Milne WK, 2012, CAN J EMERG MED, V14, P25, DOI 10.2310/8000.2011.110523; Moreira ME, 2015, ANN EMERG MED, V66, P97, DOI 10.1016/j.annemergmed.2014.12.035; Moyen E, 2008, CRIT CARE, V12, DOI 10.1186/cc6813; Nadkarni VM, 2006, JAMA-J AM MED ASSOC, V295, P50, DOI 10.1001/jama.295.1.50; Neumar RW, 2008, CIRCULATION, V118, P2452, DOI 10.1161/CIRCULATIONAHA.108.190652; Nieman CT, 2006, ACAD EMERG MED, V13, P1011, DOI 10.1197/j.aem.2006.06.042; Nolan Jerry P, 2010, Int Emerg Nurs, V18, P8, DOI 10.1016/j.ienj.2009.07.001; Parshuram CS, 2008, CAN MED ASSOC J, V178, P42, DOI 10.1503/cmaj.061743; Peace JM, 2014, RESUSCITATION, V85, P266, DOI 10.1016/j.resuscitation.2013.10.013; Polischuk Emily, 2012, J Pediatr Pharmacol Ther, V17, P166, DOI 10.5863/1551-6776-17.2.166; Porter E, 2014, WEST J EMERG MED, V15, P486, DOI 10.5811/westjem.2014.2.17922; Rinke ML, 2014, PEDIATRICS, V134, P338, DOI 10.1542/peds.2013-3531; Sahu Sandeep, 2010, J Emerg Trauma Shock, V3, P378, DOI 10.4103/0974-2700.70758; Schnock KO, 2017, BMJ QUAL SAF, V26, P131, DOI 10.1136/bmjqs-2015-004465; sealedenvelope, RAND ONL DAT CLIN TR; Shann F, 2014, DRUG DOSES RCH INTEN; SHERRY E, 1993, ANAESTHESIA, V48, P396, DOI 10.1111/j.1365-2044.1993.tb07012.x; Sinha M, 2012, PEDIATR EMERG CARE, V28, P544, DOI 10.1097/PEC.0b013e318258ac2e; Sirbaugh PE, 1999, ANN EMERG MED, V33, P174, DOI 10.1016/S0196-0644(99)70391-4; Topjian AA, 2008, PEDIATRICS, V122, P1086, DOI 10.1542/peds.2007-3313; Topjian AA, 2014, CRIT CARE MED, V42, P1518, DOI 10.1097/CCM.0000000000000216; Walker Scott E, 2010, Can J Hosp Pharm, V63, P113; Wells M, 2013, RESUSCITATION, V84, P227, DOI 10.1016/j.resuscitation.2012.05.028	60	18	18	0	23	JMIR PUBLICATIONS, INC	TORONTO	130 QUEENS QUAY E, STE 1102, TORONTO, ON M5A 0P6, CANADA	1438-8871			J MED INTERNET RES	J. Med. Internet Res.	FEB	2017	19	2							e31	10.2196/jmir.7005			14	Health Care Sciences & Services; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services; Medical Informatics	EK1WA	WOS:000393715300002	28148473	Green Published, Green Submitted, gold			2022-03-04	
J	Ehrler, F; Wipfli, R; Teodoro, D; Sarrey, E; Walesa, M; Lovis, C				Ehrler, Frederic; Wipfli, Rolf; Teodoro, Douglas; Sarrey, Everlyne; Walesa, Magali; Lovis, Christian			Challenges in the Implementation of a Mobile Application in Clinical Practice: Case Study in the Context of an Application that Manages the Daily Interventions of Nurses	JMIR MHEALTH AND UHEALTH			English	Article						hospital information systems; computers; handheld; equipment design; nurses; mobile health; pilot projects; user-computer interface	WEB; DEVICES	Background: Working in a clinical environment requires unfettered mobility. This is especially true for nurses who are always on the move providing patients' care in different locations. Since the introduction of clinical information systems in hospitals, this mobility has often been considered hampered by interactions with computers. The popularity of personal mobile assistants such as smartphones makes it possible to gain easy access to clinical data anywhere. Objective: To identify the challenges involved in the deployment of clinical applications on handheld devices and to share our solutions to these problems. Methods: A team of experts underwent an iterative development process of a mobile application prototype that aimed to improve the mobility of nurses during their daily clinical activities. Through the process, challenges inherent to mobile platforms have emerged. These issues have been classified, focusing on factors related to ensuring information safety and quality, as well as pleasant and efficient user experiences. Results: The team identified five main challenges related to the deployment of clinical mobile applications and presents solutions to overcome each of them: (1) Financial: Equipping every care giver with a new mobile device requires substantial investment that can be lowered if users use their personal device instead, (2) Hardware: The constraints inherent to the clinical environment made us choose the mobile device with the best tradeoff between size and portability, (3) Communication: the connection of the mobile application with any existing clinical information systems (CIS) is insured by a bridge formatting the information appropriately, (4) Security: In order to guarantee the confidentiality and safety of the data, the amount of data stored on the device is minimized, and (5) User interface: The design of our user interface relied on homogeneity, hierarchy, and indexicality principles to prevent an increase in data acquisition errors. Conclusions: The introduction of nomadic computing often raises enthusiastic reactions from users, but several challenges due to specific constraints of mobile platforms must be overcome. The ease of development of mobile applications and their rapid spread should not overshadow the real challenges of clinical applications and the potential threats for patient safety and the liability of people and organizations using them. For example, careful attention must be given to the overall architecture of the system and to user interfaces. If these precautions are not taken, it can easily lead to unexpected failures such as an increased number of input errors, loss of data, or decreased efficiency.	[Ehrler, Frederic; Wipfli, Rolf; Teodoro, Douglas; Walesa, Magali; Lovis, Christian] Univ Hosp Geneva, Div Med Informat Sci, Rue Gabrielle Perret Gentil 4, CH-1232 Geneva, Switzerland; [Teodoro, Douglas; Walesa, Magali; Lovis, Christian] Univ Geneva, Geneva, Switzerland; [Sarrey, Everlyne] Univ Hosp Geneva, Direct Nursing, Geneva, Switzerland		Ehrler, F (corresponding author), Univ Hosp Geneva, Div Med Informat Sci, Rue Gabrielle Perret Gentil 4, CH-1232 Geneva, Switzerland.	frederic.ehrler@hcuge.ch	Lovis, Christian/D-2634-2012; Ehrler, Frederic/S-5156-2016; Lovis, Christian/T-5364-2019; Teodoro, Douglas/AAN-8343-2020; Ehrler, Frederic/ABE-8600-2020; Teodoro, Douglas H/H-5122-2012	Lovis, Christian/0000-0002-2681-8076; Ehrler, Frederic/0000-0001-9734-3242; Lovis, Christian/0000-0002-2681-8076; Teodoro, Douglas/0000-0001-6238-4503; Ehrler, Frederic/0000-0001-9734-3242; Teodoro, Douglas H/0000-0001-6238-4503			Albers M, 2002, TECH COMMUN-STC, V49, P45; Banderker N, 2006, INT J HEALTHCARE DEL; Barkhuus L, 2003, P UBICOMP 2003 5 ANN; Berkowitz Lyle L, 2002, Healthc Inform, V19, P41; Biancalana C, 2013, ACM T INTEL SYST TEC, V4, DOI 10.1145/2414425.2414435; Burdette SD, 2008, CLIN INFECT DIS, V47, P117, DOI 10.1086/588788; Cheverst K., 2000, P SIGCHI C HUM FACT; Crane M, 2003, PERMANENTE J, V7; Dave G, 2010, FACE RECOGNITION MOB; Dmitrienko A., 2013, BIOMEDICAL ENG SYSTE, V273, P365, DOI DOI 10.1007/978-3-642-29752-6_27; Ehrler F, 2011, STUD HEALTH TECHNOL, V169, P83, DOI 10.3233/978-1-60750-806-9-83; Fischer S, 2003, J AM MED INFORM ASSN, V10, P139, DOI 10.1197/jamia.M1180; Geven A, 2006, P 8 C HUM COMP INT M; Guarascio-Howard L, 2011, HERD-HEALTH ENV RES, V4, P109, DOI 10.1177/193758671100400209; Haller G, 2009, J AM MED INFORM ASSN, V16, P651, DOI 10.1197/jamia.M3041; Huang K. Y, 2009, P WORLD C ENG COMP S; Huber M., 2004, THESIS U ZURICH ZURI; Jones M, 1999, COMPUT NETW, V31, P1129, DOI 10.1016/S1389-1286(99)00013-4; Kjeldskov J., 2002, P 4 INT S MOB HUM CO; Kjeldskov J, 2010, ACM T COMPUT-HUM INT, V17, DOI 10.1145/1879831.1879832; Lane Shannon J, 2006, BMC Med Inform Decis Mak, V6, P23, DOI 10.1186/1472-6947-6-23; Larson Czerwinski M., 1998, P ACM C HUM FACT COM; Lee Nam-Ju, 2005, AMIA Annu Symp Proc, P1021; LUFF P, 1998, P 1998 ACM C COMP SU, P305, DOI DOI 10.1145/289444.289505; Marsden Gary, 2002, CHI 02 EXTENDED ABST, P786, DOI [10.1145/506443.506597, DOI 10.1145/506443.506597]; Myers BA, 2004, COMPUTER, V37, P36, DOI 10.1109/MC.2004.258; Noyes JM, 2008, ERGONOMICS, V51, P1352, DOI 10.1080/00140130802170387; Perera G, 2011, INT J MED INFORM, V80, P94, DOI 10.1016/j.ijmedinf.2010.11.005; Porn Louis M, 2002, Healthc Financ Manage, V56, P66; Sears A, 2003, INT J HUM-COMPUT INT, V16, P163, DOI 10.1207/S15327590IJHC1602_03; Tschopp M, 2002, AMIA 2002 SYMPOSIUM, PROCEEDINGS, P806; Tschopp M, 2001, STUD HEALTH TECHNOL, V84, P764; Xiao XY, 2009, ACM T WEB, V3, DOI 10.1145/1462148.1462152; Zhang DS, 2011, INT J HUM-COMPUT INT, V27, P1133, DOI 10.1080/10447318.2011.559876	34	14	14	0	9	JMIR PUBLICATIONS, INC	TORONTO	59 WINNERS CIRCLE, TORONTO, ON M4L 3Y7, CANADA	2291-5222			JMIR MHEALTH UHEALTH	JMIR mHealth uHealth		2013	1	1							e7	10.2196/mhealth.2344			13	Health Care Sciences & Services; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services; Medical Informatics	V46OY	WOS:000209894700003	25100680	gold, Green Published			2022-03-04	
J	Etter, JF; Stapleton, JA				Etter, Jean-Francois; Stapleton, John A.			Nicotine replacement therapy for long-term smoking cessation: a meta-analysis	TOBACCO CONTROL			English	Review							CONTROLLED-TRIAL; RANDOMIZED-TRIAL; NASAL SPRAY; FOLLOW-UP; CHEWING GUM; HEALTH-CARE; 4 MG; PATCH; ABSTINENCE; INTERVENTION	Objective: To assess if the effect of a single treatment episode with nicotine replacement therapy (NRT) enhances smoking cessation over many years. Data sources: Meta-analysis of all randomised controlled trials of NRT with final follow-up more than one year after the start of treatment. Twelve eligible trials were identified, all placebo-controlled, having final follow-ups ranging from 2-8 years. All had earlier follow-ups at 12 months. They comprised 2408 active and 2384 placebo treatment participants. Data synthesis: The odds ratio ( OR) in favour of NRT at final follow-up was 1.99 (95% confidence interval (CI) 1.50 to 2.64). There was no evidence that the effect varied according to length of final follow-up (b = 0.92, p = 0.28) or duration of initial NRT treatment (b = 0.99, p > 0.5). The overall relapse rate between the 12 months and final follow-up was 30.0% (95% CI 23.5% to 37.5%). This rate did not differ between NRT and control groups (OR 1.11, 95% CI 0.78 to 1.59), or length of initial NRT treatment. There was also no evidence that it varied according to length of final follow up. Due to relapse, the overall efficacy of NRT treatment in terms of additional ex-smokers declined from 10.7% over and above placebo (6.6% to 14.8%) after one year to 7.2% (3.8% to 11.3%) at an average of 4.3 years follow up. Conclusions: The relative efficacy of a single course of NRT remains constant over many years. The majority of relapse after 12 months occurs within the first or second year and is not detectable thereafter, suggesting that NRT has a permanent effect on smoking cessation. However, initial relapse after one year has the effect of diminishing the number of ex-smokers that can be ultimately attributed to NRT. Results after only 6-12 months of follow-up, as used in existing reviews and treatment guidelines, will overestimate the lifetime benefit and cost-efficacy of NRT by about 30%. Because the long-term benefit of NRT is modest, tobacco dependence treatment might be better viewed as a chronic disorder, requiring repeated episodes of treatment.	Univ Geneva, CMU, Inst Social & Prevent Med, CH-1211 Geneva 4, Switzerland; Kings Coll London, Inst Psychiat, London WC2R 2LS, England		Etter, JF (corresponding author), Univ Geneva, CMU, Inst Social & Prevent Med, 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland.	Jean-Francois.Etter@imsp.unige.ch	Stapleton, John A/I-6550-2012	ETTER, Jean-Francois/0000-0002-1426-3157			ANTHONISEN NR, 1994, JAMA-J AM MED ASSOC, V272, P1497, DOI 10.1001/jama.272.19.1497; Anthonisen NR, 2005, ANN INTERN MED, V142, P233, DOI 10.7326/0003-4819-142-4-200502150-00005; Blondal T, 1999, BRIT MED J, V318, P285, DOI 10.1136/bmj.318.7179.285; BLONDAL T, 1989, ARCH INTERN MED, V149, P1818, DOI 10.1001/archinte.149.8.1818; Blondal T, 1997, EUR RESPIR J, V10, P1585, DOI 10.1183/09031936.97.10071585; ClavelChapelon F, 1997, PREV MED, V26, P25, DOI 10.1006/pmed.1996.9997; Daughton DM, 1999, PREV MED, V28, P113, DOI 10.1006/pmed.1998.0391; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; FIORE MC, 2000, TREATING TOBACCO USE; Fleiss J L, 1993, Stat Methods Med Res, V2, P121, DOI 10.1177/096228029300200202; Glavas D, 2003, CROAT MED J, V44, P219; HERRERA N, 1995, CHEST, V108, P447, DOI 10.1378/chest.108.2.447; Hughes JR, 2003, TOB CONTROL, V12, P21, DOI 10.1136/tc.12.1.21; Hughes JR, 2004, ADDICTION, V99, P29, DOI 10.1111/j.1360-0443.2004.00540.x; Leandro G, 2005, META ANAL MED RES HD; Leshner AI, 1997, SCIENCE, V278, P45, DOI 10.1126/science.278.5335.45; Mikkelsen K, 1994, J SMOK REL DIS, V5, P95; Richmond RL, 1997, HEART, V78, P617, DOI 10.1136/hrt.78.6.617; Sackett DL, 1991, CLIN EPIDEMIOLOGY BA; Silagy C., 2005, COCHRANE LIB; SMITH GD, 2001, SYSTEMATIC REV HLTH; Stapleton JA, 1999, LANCET, V354, P210, DOI 10.1016/S0140-6736(99)90001-6; Stapleton JA, 1998, BRIT MED J, V316, P830, DOI 10.1136/bmj.316.7134.830; Sterne JAC, 2001, BMJ-BRIT MED J, V323, P101, DOI 10.1136/bmj.323.7304.101; TONNESEN P, 1988, NEW ENGL J MED, V318, P15, DOI 10.1056/NEJM198801073180104; TONNESEN P, 1988, ADDICT BEHAV, V13, P17, DOI 10.1016/0306-4603(88)90021-4; *US DHHS, 1990, HLTH BEN SMOK CESS; Yudkin P, 2003, BRIT MED J, V327, P28, DOI 10.1136/bmj.327.7405.28	29	176	180	1	18	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0964-4563			TOB CONTROL	Tob. Control	AUG	2006	15	4							280	10.1136/tc.2005.015487			6	Substance Abuse; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Substance Abuse; Public, Environmental & Occupational Health	069PA	WOS:000239459500010	16885576	Green Published, Green Submitted			2022-03-04	
J	Islami, D; Chardonnens, D; Campana, A; Bischof, P				Islami, D; Chardonnens, D; Campana, A; Bischof, P			Comparison of the effects of GnRH-I and GnRH-II on HCG synthesis and secretion by first trimester trophoblast	MOLECULAR HUMAN REPRODUCTION			English	Article						GnRH-I; GnRH-II; HCG; placenta; trophoblast	GONADOTROPIN-RELEASING-HORMONE; HUMAN CHORIONIC-GONADOTROPIN; MESSENGER-RNA; 2ND FORM; GENE; EXPRESSION; LHRH; PROGESTERONE; INCREASES; PITUITARY	Gonadotrophin-releasing hormone (GnRH) is an important factor in the regulation of the synthesis and secretion of gonadotrophins from the pituitary gland, An isoform of this decapeptide, GnRH-II, with an amino acid sequence 70% homologous to GnRH-I, has been recently described. Since the physiological effects of GnRH-II are not yet known, we undertook the present study to see whether GnRH-II could be involved in the secretion and synthesis of HCG in first trimester trophoblast. We incubated cytotrophoblastic cells (CTB) with GnRH-I or GnRH-II, for 4 or 96 h and collected the media at different times thereafter. We also performed experiments with placental tissue, where GnRH-I or GnRH-II was added to perifused placental explants, and samples were collected every 3 min. Total amounts of human chorionic gonadotrophin (HCG) were measured in all samples by enzyme-linked immunosorbent assay. GnRH-I was more potent than GnRH-II when incubated for 4 h with CTB, as indicated by increased HCG secretion at 8 h and at 24 h. GnRH-I, but not GnRH-II, down-regulated HCG secretion when incubated for 96 h, GnRH-I significantly increased HCG secretion by the explants, while GnRH-II had a lesser effect. Both induced a pulse of HCG immediately after their injection. Our data show that GnRH-I has more effect than GnRH-II on HCG synthesis and secretion. This difference could be explained by different pathways of GnRH degradation, different receptor affinities, or even by different types of placental GnRH receptor.	Univ Hosp Geneva, WHO Collaborat Ctr Human Reprod, Clin Infertil & Gynaecol Endocrinol, Dept Obstet & Gynaecol, CH-1211 Geneva, Switzerland		Islami, D (corresponding author), Univ Geneva, Hop Cantonal, Clin Sterile & Endocrinol Gynecol, 32 Blvd Cluse, CH-1211 Geneva 14, Switzerland.	dorina.islami@hcuge.ch					BARNEA ER, 1991, HUM REPROD, V6, P1063, DOI 10.1093/oxfordjournals.humrep.a137485; BARNEA ER, 1991, HUM REPROD, V6, P905, DOI 10.1093/oxfordjournals.humrep.a137456; BARNEA ER, 1989, J CLIN ENDOCR METAB, V69, P215, DOI 10.1210/jcem-69-1-215; BARNEA ER, 1992, HUM REPROD, V7, P1022, DOI 10.1093/oxfordjournals.humrep.a137762; BELISLE S, 1984, J CLIN ENDOCR METAB, V59, P119, DOI 10.1210/jcem-59-1-119; BISCHOF P, 1991, AM J OBSTET GYNECOL, V165, P1791, DOI 10.1016/0002-9378(91)90034-O; BOADI WY, 1992, ARCH TOXICOL, V66, P95, DOI 10.1007/BF02342501; Bramley TA, 1996, MOL HUM REPROD, V2, P535, DOI 10.1093/molehr/2.7.535; Bramley TA, 1999, MOL HUM REPROD, V5, P1095, DOI 10.1093/molehr/5.12.1095; Bramley TA, 2000, MOL HUM REPROD, V6, P113, DOI 10.1093/molehr/6.2.113; CANFIELD RE, 1973, RECENT PROG HORM RES, V27, P121; Chen A, 1998, FEBS LETT, V435, P199, DOI 10.1016/S0014-5793(98)01064-3; CURRIE WD, 1993, GNRH, GNRH ANALOGS, GONADOTROPINS AND GONADAL PEPTIDES, P135; CURRIE WD, 1993, RECENT PROG HORM RES, V48, P505; Duello TM, 1997, BIOL REPROD, V56, P553; GAUTRON JP, 1992, MOL CELL ENDOCRINOL, V85, P99, DOI 10.1016/0303-7207(92)90129-T; GAUTRON JP, 1981, MOL CELL ENDOCRINOL, V24, P1, DOI 10.1016/0303-7207(81)90074-5; Gestrin ED, 1999, FEBS LETT, V448, P289, DOI 10.1016/S0014-5793(99)00361-0; Illing N, 1999, P NATL ACAD SCI USA, V96, P2526, DOI 10.1073/pnas.96.5.2526; IWASHITA M, 1993, ENDOCR J, V40, P539, DOI 10.1507/endocrj.40.539; JimenezLinan M, 1997, ENDOCRINOLOGY, V138, P4123, DOI 10.1210/en.138.10.4123; Kasten TL, 1996, GEN COMP ENDOCR, V104, P7, DOI 10.1006/gcen.1996.0135; KING JA, 1995, CELL MOL NEUROBIOL, V15, P5, DOI 10.1007/BF02069556; Lescheid DW, 1997, ENDOCRINOLOGY, V138, P5618, DOI 10.1210/en.138.12.5618; Leung PCK, 1996, BIOL SIGNAL, V5, P63; LI CH, 1987, P NATL ACAD SCI USA, V84, P959, DOI 10.1073/pnas.84.4.959; LI W, 1994, LIFE SCI, V55, P1717, DOI 10.1016/0024-3205(94)00340-8; LOUMAYE E, 1983, J BIOL CHEM, V258, P2002; MATHIALAGAN N, 1986, J BIOSCIENCE, V10, P429, DOI 10.1007/BF02900503; MATHIALAGAN N, 1986, BIOCHEM INT, V13, P757; Morrish DW, 1987, J HISTOCHEM CYTOCHEM, V35, P93, DOI 10.1177/35.1.2432115; NEKDA MV, 1982, SCIENCE, V218, P160; Osathanondh R, 1981, Placenta Suppl, V3, P257; OWENS OM, 1981, J CLIN ENDOCR METAB, V53, P1307, DOI 10.1210/jcem-53-6-1307; PADMANABHAN V, 1989, J CLIN ENDOCR METAB, V69, P968, DOI 10.1210/jcem-69-5-968; POHL CR, 1984, NEUROENDOCRINOLOGY, V39, P256; POPKIN R, 1983, BIOCHEM BIOPH RES CO, V114, P750, DOI 10.1016/0006-291X(83)90844-6; Quanbeck C, 1997, J COMP NEUROL, V380, P293; Raga F, 1999, J CLIN ENDOCR METAB, V84, P636, DOI 10.1210/jc.84.2.636; RISSMAN EF, 1995, J COMP NEUROL, V357, P524, DOI 10.1002/cne.903570404; SHERWOOD NM, 1993, ENDOCR REV, V14, P241, DOI 10.1210/er.14.2.241; SILERKHODR TM, 1979, FERTIL STERIL, V32, P294; SILERKHODR TM, 1987, LHRH ITS ANALOGS C 2, P161; TAN L, 1982, BIOCHEM BIOPH RES CO, V109, P1061, DOI 10.1016/0006-291X(82)92047-2; Urbanski HF, 1999, ENDOCRINOLOGY, V140, P1945, DOI 10.1210/en.140.4.1945; White RB, 1998, P NATL ACAD SCI USA, V95, P305, DOI 10.1073/pnas.95.1.305; Yahalom D, 1999, FEBS LETT, V463, P289, DOI 10.1016/S0014-5793(99)01638-5; YEN SSC, 1986, REPRODUCTIVE ENDOCRI, P3; ZHANG CL, 1991, NEUROENDOCRINOLOGY, V53, P77, DOI 10.1159/000125799	49	29	29	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND		1460-2407		MOL HUM REPROD	Mol. Hum. Reprod.	JAN	2001	7	1					3	9		10.1093/molehr/7.1.3			7	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Science Citation Index Expanded (SCI-EXPANDED)	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	393GL	WOS:000166460800002	11134354	Bronze, Green Submitted			2022-03-04	
J	Leboulanger, B; Aubry, JM; Bondolfi, G; Guy, RH; Delgado-Charro, MB				Leboulanger, B; Aubry, JM; Bondolfi, G; Guy, RH; Delgado-Charro, MB			Reverse iontophoretic monitoring of lithium in vivo	THERAPEUTIC DRUG MONITORING			English	Meeting Abstract	8th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology	SEP 07-11, 2003	BASEL, SWITZERLAND						Univ Geneva, Sch Pharm, CH-1211 Geneva 4, Switzerland; Univ Geneva, Dept Psychiat, CH-1211 Geneva, Switzerland; Ctr Interuniv Rech & Enseignement, Archamps, France				Delgado-Charro, M.B./D-4085-2009	Delgado-Charro, M.B./0000-0002-2233-7654; Guy, Richard/0000-0003-3227-9862				0	3	3	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0163-4356			THER DRUG MONIT	Ther. Drug Monit.	AUG	2003	25	4				53	499	499					1	Medical Laboratory Technology; Pharmacology & Pharmacy; Toxicology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology; Pharmacology & Pharmacy; Toxicology	706GJ	WOS:000184445500066					2022-03-04	
J	Islami, D; Bischof, P; Chardonnens, D				Islami, D; Bischof, P; Chardonnens, D			Modulation of placental vascular endothelial growth factor by leptin and hCG	MOLECULAR HUMAN REPRODUCTION			English	Article						angiogenesis; hCG; leptin; trophoblast; VEGF	TYROSINE KINASE; FACTOR RECEPTOR; CELL MITOGEN; EXPRESSION; ANGIOGENESIS; TROPHOBLAST; HYPOXIA; METALLOPROTEINASES; PROLIFERATION; KDR	Vascular endothelial growth factor ( VEGF) has been identified as an endothelium-specific mitogen and inducer of angiogenesis and endothelial cell survival. Leptin and hCG have also been suggested as possible regulators of angiogenesis in various models. In-vivo and in-vitro assays revealed that leptin has an angiogenic activity and that the vascular endothelium is a target for leptin. Thus, we hypothesized that products of cytotrophoblastic cells may play a role in placental angiogenesis and we therefore investigated the effects of leptin and hCG on cytotrophoblast VEGF secretion. We incubated cytotrophoblastic cells (CTB) with recombinant human leptin (rhLept) ( 0 - 4 pg/ml) or hCG ( 0 - 30 000 IU/ml) for 4 h. rhLept significantly stimulated hCG ( P = 0.0045) and decreased VEGF release ( P = 0.0008) by CTB in a concentration-dependent manner. On the other hand, increasing concentrations of hCG ( 0 - 30 000 IU/ml), induced a significant inhibition of leptin secretion ( P = 0.0028) and a marked dose-dependent stimulation of VEGF(165) secretion ( P < 0.0001). We observed an increase of > 1000-fold in basal trophoblastic VEGF secretion with physiological concentrations of hCG in vitro. An inhibitory effect of hCG on trophoblastic leptin secretion was also observed, suggesting that hCG might exert a possible negative feedback on trophoblastic release of leptin. We hypothesize that trophoblastic products such as hCG and leptin are probably involved in the control of VEGF secretion at the maternal - fetal interface.	Univ Hosp Geneva, Dept Obstet & Gynaecol, Clin Infertil & Gynaecol Endocrinol, WHO Collaborating Ctr Human Reprod, CH-1211 Geneva, Switzerland		Bischof, P (corresponding author), Univ Geneva, Hop Cantonal, Clin Sterilite & Endocrinol Gynecol, 32 Blvd Cluse, CH-1211 Geneva 14, Switzerland.	paul.bischof@hcuge.ch					AHMED A, 1995, GROWTH FACTORS, V12, P235, DOI 10.3109/08977199509036883; Ahmed A, 2000, PLACENTA, V21, pS16, DOI 10.1053/plac.1999.0524; ALON T, 1995, NAT MED, V1, P1024, DOI 10.1038/nm1095-1024; Athanassiades A, 1998, BIOL REPROD, V59, P643, DOI 10.1095/biolreprod59.3.643; BISCHOF P, 1991, AM J OBSTET GYNECOL, V165, P1791, DOI 10.1016/0002-9378(91)90034-O; Cao RH, 2001, P NATL ACAD SCI USA, V98, P6390, DOI 10.1073/pnas.101564798; Chardonnens D, 1999, MOL HUM REPROD, V5, P1077, DOI 10.1093/molehr/5.11.1077; CHARNOCKJONES DS, 1994, BIOL REPROD, V51, P524, DOI 10.1095/biolreprod51.3.524; CONN G, 1990, P NATL ACAD SCI USA, V87, P2628, DOI 10.1073/pnas.87.7.2628; DEVRIES C, 1992, SCIENCE, V255, P989, DOI 10.1126/science.1312256; Esterman A, 1996, PLACENTA, V17, P217, DOI 10.1016/S0143-4004(96)90041-7; Ferrara N, 1999, J MOL MED, V77, P527, DOI 10.1007/s001099900019; Fisher SJ, 2000, SEMIN REPROD MED, V18, P321, DOI 10.1055/s-2000-12569; FOLKMAN J, 1987, SCIENCE, V235, P442, DOI 10.1126/science.2432664; Gerber HP, 1998, J BIOL CHEM, V273, P13313, DOI 10.1074/jbc.273.21.13313; Geva E, 2000, FERTIL STERIL, V74, P429, DOI 10.1016/S0015-0282(00)00670-1; Grosfeld A, 2001, FEBS LETT, V502, P122, DOI 10.1016/S0014-5793(01)02673-4; Henson MC, 2000, BIOL REPROD, V63, P1219, DOI 10.1095/biolreprod63.5.1219; ISLAMI D, 2003, IN PRESS EUR J OBSTE; Lee A, 1997, HUM REPROD, V12, P2756, DOI 10.1093/humrep/12.12.2756; Licht P, 2001, SEMIN REPROD MED, V19, P37, DOI 10.1055/s-2001-13909; Mise H, 1998, J CLIN ENDOCR METAB, V83, P3225, DOI 10.1210/jc.83.9.3225; Park HY, 2001, EXP MOL MED, V33, P95, DOI 10.1038/emm.2001.17; PLOUET J, 1989, EMBO J, V8, P3801, DOI 10.1002/j.1460-2075.1989.tb08557.x; REYNOLDS LP, 1995, J ANIM SCI, V73, P1839; REYNOLDS LP, 1992, FASEB J, V6, P886, DOI 10.1096/fasebj.6.3.1371260; Rizk B, 1997, HUM REPROD UPDATE, V3, P255, DOI 10.1093/humupd/3.3.255; Roberts JM, 1998, SEMIN REPROD ENDOCR, V16, P5, DOI 10.1055/s-2007-1016248; SHARKEY AM, 1993, J REPROD FERTIL, V99, P609; Sharkey AM, 1996, EUR J CLIN INVEST, V26, P1182, DOI 10.1046/j.1365-2362.1996.830605.x; Shore VH, 1997, PLACENTA, V18, P657, DOI 10.1016/S0143-4004(97)90007-2; Sierra-Honigmann MR, 1998, SCIENCE, V281, P1683, DOI 10.1126/science.281.5383.1683; Smith SK, 2000, HUM REPROD, V15, P59; Taylor CM, 1997, PLACENTA, V18, P451, DOI 10.1016/S0143-4004(97)80047-1; TERMAN BI, 1992, BIOCHEM BIOPH RES CO, V187, P1579, DOI 10.1016/0006-291X(92)90483-2; Vuckovic M, 1996, J ANAT, V188, P361; Vuorela P, 1997, BIOL REPROD, V56, P489, DOI 10.1095/biolreprod56.2.489	37	69	72	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND		1460-2407		MOL HUM REPROD	Mol. Hum. Reprod.	JUL	2003	9	7					395	398		10.1093/molehr/gag053			4	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Science Citation Index Expanded (SCI-EXPANDED)	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	697PH	WOS:000183952000004	12802046	Green Published, Bronze			2022-03-04	
J	Bastida-Ruiz, D; Aguilar, E; Ditisheim, A; Yart, L; Cohen, M				Bastida-Ruiz, Daniel; Aguilar, Elizabeth; Ditisheim, Agnes; Yart, Lucile; Cohen, Marie			Endoplasmic reticulum stress responses in placentation - A true balancing act	PLACENTA			English	Article						Endoplasmic reticulum stress; Placenta development; Unfolded protein response; Intrauterine growth restriction; Preeclampsia	UNFOLDED PROTEIN RESPONSE; ER STRESS; GROWTH-FACTOR; VILLOUS CYTOTROPHOBLAST; EXTRAVILLOUS TROPHOBLAST; HYPERTENSIVE DISORDERS; CHEMICAL CHAPERONES; CELL-SURVIVAL; APOPTOSIS; PREECLAMPSIA	The unfolded protein response (UPR) is recognized as a key mechanism to promote protein folding and processing in eukaryotes when endoplasmic reticulum stress (ERS) occurs. Some conditions such as hypoxia or glucose deprivation are factors that may elicit ERS response. Recent literature collectively proposes that ERS response is crucial for mammalian reproduction by allowing decidualization and placentation to occur. However, prolonged ERS and activation of UPR pathways can lead to apoptosis and autophagy, which in turn could pose adverse effects on pregnancy outcomes and placentation. ERS associated pregnancy pathologies include intrauterine growth restriction and early-onset preeclampsia. Given these findings, evidence suggests that overactivation of UPR may lead to harmful reproductive circumstances, whereas physiological regulation of ERS response is essential for mammalian reproduction and placental function. In this review, we discuss the dual role of UPR activation with respect to its contribution to placental development as well as pathologies caused by pathway overactivation. In addition, we suggest potential protein markers associated with the UPR, as circulating C-terminal GRP78 or anti-GRP78 autoantibodies which may prove to be of clinical interest. (C) 2017 Elsevier Ltd. All rights reserved.	[Bastida-Ruiz, Daniel; Aguilar, Elizabeth; Yart, Lucile; Cohen, Marie] Univ Geneva, Fac Med, Dept Obstet Gynecol, Rue Michel Servet 1, CH-1211 Geneva, Switzerland; [Ditisheim, Agnes] HUG, Dept Internal Med Special, Rue Gabrielle Perret Gentil 4, Geneva, Switzerland		Cohen, M (corresponding author), Univ Geneva, Fac Med, Dept Obstet Gynecol, Rue Michel Servet 1, CH-1211 Geneva, Switzerland.	Marie.Cohen@unige.ch		Yart, Lucile/0000-0002-5700-0883; cohen, marie/0000-0003-4621-5464; Bastida-Ruiz, Daniel/0000-0001-6429-1925	Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission [31003A-163395]	This work was supported by the Swiss National Science Foundation [grant number: 31003A-163395].	Aggarwal PK, 2006, KIDNEY INT, V69, P621, DOI 10.1038/sj.ki.5000075; Akaishi R, 2014, PLACENTA, V35, P974, DOI 10.1016/j.placenta.2014.10.009; Allaire AD, 2000, OBSTET GYNECOL, V96, P271, DOI 10.1016/S0029-7844(00)00895-4; Aplin JD, 2000, J CLIN INVEST, V105, P559, DOI 10.1172/JCI9512; Bailey D, 2007, ANTIOXID REDOX SIGN, V9, P2305, DOI 10.1089/ars.2007.1796; Basar M, 2014, FERTIL STERIL, V102, P1777, DOI 10.1016/j.fertnstert.2014.09.004; Bischof P, 2005, INT J BIOCHEM CELL B, V37, P1, DOI 10.1016/j.biocel.2004.05.014; Black S, 2004, CELL DEATH DIFFER, V11, P90, DOI 10.1038/sj.cdd.4401307; Bryson CL, 2003, AM J EPIDEMIOL, V158, P1148, DOI 10.1093/aje/kwg273; Burton GJ, 2017, PLACENTA, V52, P146, DOI 10.1016/j.placenta.2016.04.001; Burton GJ, 2009, PLACENTA, V30, pS43, DOI 10.1016/j.placenta.2008.11.003; Burton GJ, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.07.050; Burton GJ, 2010, INT J DEV BIOL, V54, P303, DOI 10.1387/ijdb.082764gb; Cartwright JE, 2002, PLACENTA, V23, P232, DOI 10.1053/plac.2001.0760; Charnock-Jones DS, 2016, J REPROD IMMUNOL, V114, P81, DOI 10.1016/j.jri.2015.07.004; Choi Jong-Ho, 2012, Clin Exp Reprod Med, V39, P73, DOI 10.5653/cerm.2012.39.2.73; Cui WJ, 2011, ACTA CRYSTALLOGR D, V67, P423, DOI 10.1107/S0907444911006445; Cullinan SB, 2004, J BIOL CHEM, V279, P20108, DOI 10.1074/jbc.M314219200; De Vivo A, 2008, ACTA OBSTET GYN SCAN, V87, P837, DOI 10.1080/00016340802253759; Du L, 2017, J HUM HYPERTENS, V31, P49, DOI 10.1038/jhh.2016.17; Engin F, 2010, DIABETES OBES METAB, V12, P108, DOI 10.1111/j.1463-1326.2010.01282.x; Ghosh R, 2010, PLOS ONE, V5, pA104, DOI 10.1371/journal.pone.0009575; Gong Jin-Sung, 2014, Clin Exp Reprod Med, V41, P97, DOI 10.5653/cerm.2014.41.3.97; Gude NM, 2004, THROMB RES, V114, P397, DOI 10.1016/j.thromres.2004.06.038; Hassler J, 2012, DEV CELL, V23, P921, DOI 10.1016/j.devcel.2012.10.025; Hawdon JM, 2011, BEST PRACT RES CL OB, V25, P91, DOI 10.1016/j.bpobgyn.2010.10.005; Hung TH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083475; Huppertz B, 1998, HISTOCHEM CELL BIOL, V110, P495, DOI 10.1007/s004180050311; Huppertz B, 1999, LAB INVEST, V79, P1687; Huppertz B, 2006, AM J OBSTET GYNECOL, V195, P29, DOI 10.1016/j.ajog.2005.07.039; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Iwawaki T, 2009, P NATL ACAD SCI USA, V106, P16657, DOI 10.1073/pnas.0903775106; Kawakami T, 2014, TOXICOL APPL PHARM, V275, P134, DOI 10.1016/j.taap.2013.12.008; Laverriere A, 2009, MOL HUM REPROD, V15, P569, DOI 10.1093/molehr/gap037; Li G, 2009, J CELL BIOL, V186, P783, DOI 10.1083/jcb.200904060; Ma YJ, 2004, J CHEM NEUROANAT, V28, P51, DOI 10.1016/j.jchemneu.2003.08.007; Michalak Marek, 2015, Clin Exp Reprod Med, V42, P1, DOI 10.5653/cerm.2015.42.1.1; Mizuuchi M, 2016, J PATHOL, V238, P550, DOI 10.1002/path.4678; Moldenhauer JS, 2003, AM J OBSTET GYNECOL, V189, P1173, DOI 10.1067/S0002-9378(03)00576-3; Murakoshi H, 2003, ENDOCR J, V50, P199, DOI 10.1507/endocrj.50.199; Nakashima A, 2013, AUTOPHAGY, V9, P303, DOI 10.4161/auto.22927; Ness RB, 2006, AM J OBSTET GYNECOL, V195, P40, DOI 10.1016/j.ajog.2005.07.049; Newbern D, 2011, CURR OPIN ENDOCRINOL, V18, P409, DOI 10.1097/MED.0b013e32834c800d; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Oakes SA, 2015, ANNU REV PATHOL-MECH, V10, P173, DOI 10.1146/annurev-pathol-012513-104649; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Ott M, 2002, P NATL ACAD SCI USA, V99, P1259, DOI 10.1073/pnas.241655498; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Rezanezhad L, 2013, IRAN J IMMUNOL, V10, P238, DOI IJIv10i4A5; Rinkenberger J, 2000, NAT GENET, V25, P248, DOI 10.1038/76985; Rote NS, 2010, PLACENTA, V31, P89, DOI 10.1016/j.placenta.2009.12.014; Saito S, 2013, PLACENTA, V34, pS79, DOI 10.1016/j.placenta.2012.11.026; Sano R, 2013, BBA-MOL CELL RES, V1833, P3460, DOI 10.1016/j.bbamcr.2013.06.028; Schmidt Markus, 2009, Gynaekologisch-Geburtshilfliche Rundschau, V49, P94, DOI 10.1159/000197908; Senft D, 2015, TRENDS BIOCHEM SCI, V40, P141, DOI 10.1016/j.tibs.2015.01.002; Shamu CE, 1996, EMBO J, V15, P3028, DOI 10.1002/j.1460-2075.1996.tb00666.x; Smith SC, 1997, AM J OBSTET GYNECOL, V177, P57, DOI 10.1016/S0002-9378(97)70438-1; Staff AC, 2013, HYPERTENSION, V61, P932, DOI 10.1161/HYPERTENSIONAHA.111.00250; Stolz A, 2010, BBA-MOL CELL RES, V1803, P694, DOI 10.1016/j.bbamcr.2010.02.005; Straszewski-Chavez SL, 2005, ENDOCR REV, V26, P877, DOI 10.1210/er.2005-0003; Takagi Y, 2004, VIRCHOWS ARCH, V444, P49, DOI 10.1007/s00428-003-0903-2; Tranquilli AL, 2014, PREGNANCY HYPERTENS, V4, P97, DOI [10.1016/j.preghy.2014.02.001, 10.1016/j.preghy.2014.04.007, 10.1016/j.preghy.2014.04.017]; Tranquilli AL, 2013, PREGNANCY HYPERTENS, V3, P44, DOI [10.1016/j.preghy.2012.11.001, 10.1016/j.preghy.2013.04.006]; Tuuli MG, 2011, PLACENTA, V32, pS109, DOI 10.1016/j.placenta.2010.12.013; Upton JP, 2012, SCIENCE, V338, P818, DOI 10.1126/science.1226191; Villar J, 2006, AM J OBSTET GYNECOL, V194, P921, DOI 10.1016/j.ajog.2005.10.813; Vrachnis N, 2013, J MATERN-FETAL NEO M, V26, P995, DOI 10.3109/14767058.2013.766694; Wang M, 2009, ANTIOXID REDOX SIGN, V11, P2307, DOI [10.1089/ars.2009.2485, 10.1089/ARS.2009.2485]; Yamanaka-Tatematsu M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076605; Yang YZ, 2016, CELL TISSUE RES, V363, P589, DOI 10.1007/s00441-015-2212-x; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yung HW, 2012, J PATHOL, V228, P554, DOI 10.1002/path.4068; Yung HW, 2012, FASEB J, V26, P1970, DOI 10.1096/fj.11-190082; Yung HW, 2008, AM J PATHOL, V173, P451, DOI 10.2353/ajpath.2008.071193; Yung HW, 2016, DIABETOLOGIA, V59, P2240, DOI 10.1007/s00125-016-4040-2	76	18	18	2	12	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0143-4004	1532-3102		PLACENTA	Placenta	SEP	2017	57						163	169		10.1016/j.placenta.2017.07.004			7	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Science Citation Index Expanded (SCI-EXPANDED)	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	FH9OL	WOS:000411541500021	28864006				2022-03-04	
J	Cohen, M; Meisser, A; Haenggeli, L; Bischof, P				Cohen, Marie; Meisser, Arielle; Haenggeli, Luise; Bischof, Paul			Involvement of MAPK pathway in TNF-alpha-induced MMP-9 expression in human trophoblastic cells	MOLECULAR HUMAN REPRODUCTION			English	Article						AP-1; cytotrophoblastic cells; Erk1/2; JNK; MMP-9; NF-kappa B; TNF-alpha	TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; MATRIX-METALLOPROTEINASE-9 EXPRESSION; GENE-EXPRESSION; MESSENGER-RNA; MATRIX; PROTEIN; INVASIVENESS; INHIBITION; SECRETION	The aim of this article was to investigate the signalling pathways involved in metalloproteinase-9 (MMP-9) expression induced by tumour necrosis factor-alpha (TNF-alpha) in first-trimester trophoblastic cells. TNF-alpha-induced MMP-9 expression, secretion and activity were completely blocked by stress-activated protein kinase/jun kinase (SAPK/JNK) and Erk inhibitors (SP600 125 and U0126 respectively) but not by p38 mitogen-activated protein kinase (MAPK) inhibitors (SB203 580 and SB202 190). Stimulation of HIPEC 65 cells with TNF-alpha caused phosphorylation of JNK and extracellular signal-regulated kinase 1/2 (Erk1/2), with a peak after 20 min of treatment. Transcription factors nuclear factor-kappa B (NF-kappa B) and activator protein 1 (AP-1)-binding site were identified as the cis-elements involved in TNF-alpha activation as determined by electromobility shift assays. TNF-alpha-induced transactivation of NF-kappa B was inhibited by U0126, whereas TNF-alpha-induced transactivation of AP-1 was inhibited by SP600 125. Taken together, these results indicate that in trophoblastic cells, TNF-alpha probably activates two different pathways leading to MMP-9 expression: (a) Erk1/2 pathway which in turn initiates NF-kappa B activation and (b) SAPK/JNK pathway that activates AP-1.	Univ Geneva, Hormone Lab, Dept Obstet & Gynaecol, Geneva, Switzerland		Bischof, P (corresponding author), Hormonal Lab, 32 Bd Cluse, CH-1211 Geneva 14, Switzerland.	paul.bischof@hcuge.ch		cohen, marie/0000-0003-4621-5464			Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; Bauer S, 2004, J CLIN ENDOCR METAB, V89, P812, DOI 10.1210/jc.2003-031351; Bischof P, 1995, Early Pregnancy, V1, P263; Bischof P, 2003, PLACENTA, V24, P155, DOI 10.1053/plac.2002.0890; Bond M, 2001, CARDIOVASC RES, V50, P556, DOI 10.1016/S0008-6363(01)00220-6; Chakrabarti S, 2006, J LEUKOCYTE BIOL, V79, P214, DOI 10.1189/jlb.0605353; CHEN HL, 1991, AM J PATHOL, V139, P327; Cho A, 2000, ARTERIOSCL THROM VAS, V20, P2527, DOI 10.1161/01.ATV.20.12.2527; Divya, 2002, Placenta, V23, P59; Esteves E, 2002, MATH RES LETT, V9, P1; FISHER SJ, 1989, J CELL BIOL, V109, P891, DOI 10.1083/jcb.109.2.891; FISHER SJ, 1985, J CELL BIOCHEM, V27, P31, DOI 10.1002/jcb.240270105; HAYNES MK, 1993, CELL IMMUNOL, V151, P300, DOI 10.1006/cimm.1993.1240; Holvoet S, 2003, EXP CELL RES, V290, P108, DOI 10.1016/S0014-4827(03)00293-3; HUNT JS, 1992, CYTOKINE, V4, P340, DOI 10.1016/1043-4666(92)90076-4; KING A, 1995, CYTOKINE, V7, P364, DOI 10.1006/cyto.1995.0046; LIBRACH CL, 1991, J CELL BIOL, V113, P437, DOI 10.1083/jcb.113.2.437; MARTELLI M, 1993, J REPROD FERTIL, V98, P67; Meissner A, 1999, MOL HUM REPROD, V5, P252, DOI 10.1093/molehr/5.3.252; Moon SK, 2004, J CELL PHYSIOL, V198, P417, DOI 10.1002/jcp.10435; Nee LE, 2004, KIDNEY INT, V66, P1376, DOI 10.1111/j.1523-1755.2004.00900.x; Pavan L, 2003, CARCINOGENESIS, V24, P1325, DOI 10.1093/carcin/bgg074; Red-Horse K, 2004, J CLIN INVEST, V114, P744, DOI 10.1172/JCI200422991; Renaud SJ, 2005, BIOL REPROD, V73, P237, DOI 10.1095/biolreprod.104.038000; SATO H, 1993, ONCOGENE, V8, P395; Staun-Ram Elsebeth, 2004, Reprod Biol Endocrinol, V2, P59, DOI 10.1186/1477-7827-2-59; TOVEY MG, 1989, EXPERIENTIA, V45, P526, DOI 10.1007/BF01990502; Van den Steen PE, 2002, CRIT REV BIOCHEM MOL, V37, P375, DOI 10.1080/10409230290771546; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Wiehler S, 2004, BIOCHEM BIOPH RES CO, V315, P463, DOI 10.1016/j.bbrc.2004.01.078; Xu P, 2000, BIOL REPROD, V62, P988, DOI 10.1095/biolreprod62.4.988; YANG YP, 1993, J IMMUNOL, V150, P5614	32	94	97	0	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND		1460-2407		MOL HUM REPROD	Mol. Hum. Reprod.	APR	2006	12	4					225	232		10.1093/molehr/gal023			8	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Science Citation Index Expanded (SCI-EXPANDED)	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	042JC	WOS:000237523200002	16520344	Bronze			2022-03-04	
J	Hughes, JR; Peters, EN; Callas, PW; Peasley-Miklus, C; Oga, E; Etter, JF; Morley, N				Hughes, John R.; Peters, Erica N.; Callas, Peter W.; Peasley-Miklus, Catherine; Oga, Emmanuel; Etter, Jean-Francois; Morley, Nicholas			Withdrawal Symptoms From E-Cigarette Abstinence Among Former Smokers: A Pre-Post Clinical Trial	NICOTINE & TOBACCO RESEARCH			English	Article							ELECTRONIC CIGARETTES; DEPENDENCE; TOBACCO; USERS; NICOTINE; SMOKING	Introduction: The major aim of this study was to test whether abstinence from e-cigarettes causes withdrawal symptoms in former smokers. Methods: We conducted an unblinded, within-participants, pre-post clinical trial in which 109 former smokers who were current daily electronic cigarette (e-cigarette) users used their own e-cigarette for 7 days followed by 6 days of biologically confirmed abstinence engendered via an escalating contingency payment system. Participants monitored symptoms of nicotine withdrawal daily via an Interactive Voice Response system.They also attended three laboratory visits per week for carbon monoxide and cotinine testing to verify abstinence. Results: Half of participants completely abstained for a week. All the Diagnostic and Statistical Manual, Fifth Edition (DSM-5) tobacco withdrawal symptoms, craving for e-cigarettes, craving for tobacco cigarettes, and the four possible new withdrawal symptoms (anhedonia, impulsivity, mood swings, and positive affect) increased during abstinence. Weight increased and heart rate decreased with abstinence. Symptoms showed the prototypical inverted U time pattern of a withdrawal state.The magnitude of withdrawal appeared to be somewhat less than that in a prior study of abstinent daily tobacco cigarette smokers. More severe withdrawal on the first 2 days of abstinence did not predict abstinence on the last day of the study. Conclusions: Former smokers who are daily e-cigarette users transfer physical dependence on tobacco cigarettes to dependence on e-cigarettes. The severity of withdrawal from e-cigarettes appears to be only somewhat less than that from daily tobacco cigarette use. Replication tests that include placebo controls, testing for pharmacological specificity, and including never-smokers, non-daily e-cigarette users and dual users are indicated.	[Hughes, John R.; Peasley-Miklus, Catherine; Morley, Nicholas] Univ Vermont, Dept Psychiat, Vermont Ctr Behav & Hlth, Burlington, VT USA; [Hughes, John R.; Peasley-Miklus, Catherine; Morley, Nicholas] Univ Vermont, Dept Psychol Sci, Vermont Ctr Behav & Hlth, Burlington, VT USA; [Peters, Erica N.; Oga, Emmanuel] Battelle Publ Hlth Ctr Tobacco Res, Baltimore, MD USA; [Callas, Peter W.] Univ Vermont, Med Biostat, Burlington, VT USA; [Etter, Jean-Francois] Univ Geneva, Inst Global Hlth, Fac Med, Geneva, Switzerland		Hughes, JR (corresponding author), Univ Vermont, Dept Psychiat, UHC Campus,Mailstop 482 OH4,1 South Prospect St, Burlington, VT 05401 USA.	john.hughes@uvm.edu	Oga, Emmanuel/P-5899-2018	Oga, Emmanuel/0000-0002-0744-5681	National Cancer InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [CA-192940]	This work was supported by a research grant CA-192940 from the National Cancer Institute.	American Psychiatric Association, DIAGN STAT MAN MENT, V4th; Boykan R, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16122135; Browne M, 2018, ADDICT BEHAV, V76, P113, DOI 10.1016/j.addbeh.2017.07.034; Cassidy Rachel N, 2017, Tob Regul Sci, V3, P139, DOI 10.18001/TRS.3.2.2; Corkrey R, 2002, BEHAV RES METH INS C, V34, P342, DOI 10.3758/BF03195462; Etter JF, 2011, EUR RESPIR J, V38, P1219, DOI 10.1183/09031936.00066011; Etter JF, 2018, ADDICTION, V113, P1776, DOI 10.1111/add.13924; Etter JF, 2015, DRUG ALCOHOL DEPEN, V147, P68, DOI 10.1016/j.drugalcdep.2014.12.007; Evans SE, 2014, TOB CONTROL, V23, P23, DOI 10.1136/tobaccocontrol-2013-051489; Feise Ronald J, 2002, BMC Med Res Methodol, V2, P8, DOI 10.1186/1471-2288-2-8; Foulds J, 2015, NICOTINE TOB RES, V17, P186, DOI 10.1093/ntr/ntu204; Hughes JR, 2007, PSYCHOL ADDICT BEHAV, V21, P127, DOI 10.1037/0893-164X.21.2.127; Hughes JR, 2007, NICOTINE TOB RES, V9, P315, DOI 10.1080/14622200701188919; HUGHES JR, 1986, ARCH GEN PSYCHIAT, V43, P289; Hyland A, 2017, TOB CONTROL, V26, P371, DOI 10.1136/tobaccocontrol-2016-052934; Liu GD, 2017, PREV MED, V104, P86, DOI 10.1016/j.ypmed.2017.04.001; Malas M, 2016, NICOTINE TOB RES, V18, P1926, DOI 10.1093/ntr/ntw119; Marrone GF, 2010, HUM PSYCHOPHARM CLIN, V25, P80, DOI 10.1002/hup.1078; McRobbie H, 2015, CANCER PREV RES, V8, P873, DOI 10.1158/1940-6207.CAPR-15-0058; Rostron BL, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3510-2; Schuckit MA, 2006, DRUG ALCOHOL ABUSE C; West R, 2004, PSYCHOPHARMACOLOGY, V177, P195, DOI 10.1007/s00213-004-1923-6; WETTER DW, 1994, J ABNORM PSYCHOL, V103, P801, DOI 10.1037/0021-843X.103.4.801	23	4	4	0	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1462-2203	1469-994X		NICOTINE TOB RES	Nicotine Tob. Res.	MAY	2020	22	5					734	739		10.1093/ntr/ntz129			6	Substance Abuse; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Substance Abuse; Public, Environmental & Occupational Health	MH8KM	WOS:000546970900018	31352486	Green Published			2022-03-04	
J	Hughes, JR; Peters, EN; Callas, PW; Peasley-Miklus, C; Oga, E; Etter, JF; Morley, N				Hughes, John R.; Peters, Erica N.; Callas, Peter W.; Peasley-Miklus, Catherine; Oga, Emmanuel; Etter, Jean-Francois; Morley, Nicholas			Withdrawal Symptoms From E-Cigarette Abstinence Among Adult Never-Smokers: A Pilot Experimental Study	NICOTINE & TOBACCO RESEARCH			English	Article							NICOTINE; TOBACCO	Introduction: Use of e-cigarettes among never-smokers has substantially increased; yet there are few descriptions of the consequences of such use. We assessed whether adult never-smokers can have withdrawal from cessation of e-cigarettes. Methods: In an un-blinded pre-post clinical trial, 30 never-smoker daily e-cigarette users used their own nicotine-containing e-cigarette for 7 days followed by 6 days of biologically confirmed abstinence. Participants monitored symptoms of nicotine withdrawal nightly via an Interactive Voice Response system. They attended three lab visits/week to provide expired carbon monoxide and urine samples to determine compliance. Findings: Abstinence increased all the DSM5 symptoms of tobacco withdrawal and this occurred in the majority of participants.The increase in severity of withdrawal was small and rarely impaired functioning. Conclusions: Our finding suggests that withdrawal symptoms can occur in never-smokers who stop e-cigarettes abruptly. However, the severity of withdrawal appears to be small and may not be of clinical or regulatory significance. Although our sample size was small and thus replication tests of our results are indicated, it may be prudent to warn never-smokers that withdrawal symptoms may occur.	[Hughes, John R.; Peasley-Miklus, Catherine; Morley, Nicholas] Univ Vermont, Dept Psychiat, Vermont Ctr Behav & Hlth, Burlington, VT USA; [Hughes, John R.; Peasley-Miklus, Catherine; Morley, Nicholas] Univ Vermont, Dept Psychol Sci, Vermont Ctr Behav & Hlth, Burlington, VT USA; [Peters, Erica N.; Oga, Emmanuel] Battelle Publ Hlth Ctr Tobacco Res, Baltimore, MD USA; [Callas, Peter W.] Univ Vermont, Med Biostat, Burlington, VT USA; [Etter, Jean-Francois] Univ Geneva, Inst Global Hlth, Fac Med, Geneva, Switzerland		Hughes, JR (corresponding author), Univ Vermont, Dept Psychiat, UHC Campus,Mailstop 482 OH4,1 South Prospect St, Burlington, VT 05401 USA.	john.hughes@uvm.edu	Oga, Emmanuel/P-5899-2018	Oga, Emmanuel/0000-0002-0744-5681	National Cancer InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [CA-192940]	Funded by National Cancer Institute grant CA-192940	Achilihu H, 2019, J ANAL TOXICOL, V43, P149, DOI 10.1093/jat/bky075; Association AP, 2013, DIAGN STAT MAN MENT, Vfifth; Benowitz NL, 2016, TRENDS CARDIOVAS MED, V26, P515, DOI 10.1016/j.tcm.2016.03.001; Cassidy Rachel N, 2017, Tob Regul Sci, V3, P139, DOI 10.18001/TRS.3.2.2; Dar R, 2004, PSYCHOPHARMACOLOGY, V173, P18, DOI 10.1007/s00213-004-1781-2; Duke AN, 2015, PSYCHOPHARMACOLOGY, V232, P4243, DOI 10.1007/s00213-015-4053-4; Dutra LM, 2014, J ADOLESCENT HEALTH, V55, P595, DOI 10.1016/j.jadohealth.2014.08.010; Etter JF, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-159; Evans SE, 2014, TOB CONTROL, V23, P23, DOI 10.1136/tobaccocontrol-2013-051489; Frenk H., 2000, CRITIQUE NICOTINE AD; Gerlach KK, 2008, DRUG ALCOHOL DEPEN, V98, P154, DOI 10.1016/j.drugalcdep.2008.05.001; Glasser AM, 2017, AM J PREV MED, V52, pE33, DOI 10.1016/j.amepre.2016.10.036; Hughes J, NICOTINE TO IN PRESS; Hughes JR, 2007, NICOTINE TOB RES, V9, P315, DOI 10.1080/14622200701188919; HUGHES JR, 1986, JAMA-J AM MED ASSOC, V255, P3277, DOI 10.1001/jama.255.23.3277; HUGHES JR, 1986, ARCH GEN PSYCHIAT, V43, P289; Hyland A, 2017, TOB CONTROL, V26, P371, DOI 10.1136/tobaccocontrol-2016-052934; Kalman D, 2005, NICOTINE TOB RES, V7, P317, DOI 10.1080/14622200500125385; McMillen RC, 2015, NICOTINE TOB RES, V17, P1195, DOI 10.1093/ntr/ntu213; McNeill A, 2019, VAPING ENGLAND EVIDE; Mirbolouk M, 2019, ANN INTERN MED, V170, P76, DOI 10.7326/M18-1826; National Academies o f Sciences E Medicine, 2018, PUBL HLTH CONS E CIG; Perkins KA, 2008, CLIN PHARMACOL THER, V84, P216, DOI 10.1038/clpt.2008.30; Piper ME, 2015, NICOTINE TOB RES, V17, P1405, DOI 10.1093/ntr/ntv048; Sussan TE, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4671-3; Transdisciplinary Tobacco Use Research Center (TTURC) Tobacco Dependence, 2007, Nicotine Tob Res, V9 Suppl 4, pS555, DOI 10.1080/14622200701673480; West R, 2004, PSYCHOPHARMACOLOGY, V177, P195, DOI 10.1007/s00213-004-1923-6	27	3	3	0	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1462-2203	1469-994X		NICOTINE TOB RES	Nicotine Tob. Res.	MAY	2020	22	5					740	746		10.1093/ntr/ntz169			7	Substance Abuse; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Substance Abuse; Public, Environmental & Occupational Health	MH8KM	WOS:000546970900019	31504882	Green Published			2022-03-04	
J	Cengelli, S; O'Loughlin, J; Lauzon, B; Cornuz, J				Cengelli, Semanur; O'Loughlin, Jennifer; Lauzon, Beatrice; Cornuz, Jacques			A systematic review of longitudinal population-based studies on the predictors of smoking cessation in adolescent and young adult smokers	TOBACCO CONTROL			English	Review							SELF-EFFICACY; PREVENTION; MILESTONES; STUDENTS; BEHAVIOR; ONSET	Objective To describe the determinants of self-initiated smoking cessation of duration of at least 6 months as identified in longitudinal population-based studies of adolescent and young adult smokers. Methods A systematic search of the PubMed and EMBASE databases using smoking, tobacco, cessation, quit and stop as keywords was performed. Limits included articles related to humans, in English, published between January 1984 and August 2010, and study population aged 10-29 years. A total of 4502 titles and 871 abstracts were reviewed independently by 2 and 3 reviewers, respectively. Nine articles were retained for data abstraction. Data on study location, timeframe, duration of follow-up, number of data collection points, sample size, age/grade of participants, number of quitters, smoking status at baseline, definition of cessation, covariates and analytic method were abstracted from each article. The number of studies that reported a statistically significant association between each determinant investigated and cessation were tabulated, from among all studies that assessed the determinant. Results Despite heterogeneity in methods across studies, five factors robustly predicted quitting across studies in which the factor was investigated: not having friends who smoke, not having intentions to smoke in the future, resisting peer pressure to smoke, being older at first use of cigarette and having negative beliefs about smoking. Conclusions The literature on longitudinal predictors of cessation in adolescent and young adult smokers is not well developed. Cessation interventions for this population will remain less than optimally effective until there is a solid evidence base on which to develop interventions.	[O'Loughlin, Jennifer; Lauzon, Beatrice] Univ Montreal, Dept Social & Prevent Med, Ctr Rech, CHUM, Montreal, PQ H2W 1V1, Canada; [Cengelli, Semanur; Cornuz, Jacques] Univ Lausanne, Fac Med, Lausanne, Switzerland; [Cornuz, Jacques] Univ Lausanne, Dept Ambulatory Care & Community Med, Lausanne, Switzerland		O'Loughlin, J (corresponding author), Univ Montreal, Dept Social & Prevent Med, Ctr Rech, CHUM, 3875 St Urbain,1st Floor, Montreal, PQ H2W 1V1, Canada.	jennifer.oloughlin@umontreal.ca			Canadian Cancer SocietyCanadian Cancer Society (CCS)	This study was funded by the Canadian Cancer Society. JO'L holds a Canada Research Chair in the Early Determinants of Adult Chronic Disease.	AJZEN I, 1977, PSYCHOL BULL, V84, P888, DOI 10.1037/0033-2909.84.5.888; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Ajzen I, 2005, ATTITUDES PERSONALIT; AKERS RL, 1979, AM SOCIOL REV, V44, P636, DOI 10.2307/2094592; Bancej C, 2007, TOB CONTROL, V16, DOI 10.1136/tc.2006.018853; Bandura A, 2003, J APPL PSYCHOL, V88, P87, DOI 10.1037/0021-9010.88.1.87; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Bandura A.., 1986, SOCIAL FDN THOUGHT A; Bandura A, 1977, SOCIAL LEARNING THEO; Bricker JB, 2009, ADDICTION, V104, P1036, DOI 10.1111/j.1360-0443.2009.02547.x; Camenga DR, 2004, CURR OPIN PEDIATR, V16, P368, DOI 10.1097/01.mop.0000133080.47631.c6; Chang FC, 2006, ADDICTION, V101, P1645, DOI 10.1111/j.1360-0443.2006.01607.x; DiFranza JR, 2007, ARCH PEDIAT ADOL MED, V161, P704, DOI 10.1001/archpedi.161.7.704; ELLICKSON PL, 1993, AM J PUBLIC HEALTH, V83, P856, DOI 10.2105/AJPH.83.6.856; Ellickson PL, 2001, HEALTH PSYCHOL, V20, P186, DOI 10.1037/0278-6133.20.3.186; Ellickson PL, 2001, J ADOLESCENT HEALTH, V29, P101, DOI 10.1016/S1054-139X(00)00199-3; Fishbein M, 1980, UNDERSTANDING ATTITU; Gervais A, 2007, DROGUES SANTE SOC S2, V6, pii1; Gervais A, 2006, CAN MED ASSOC J, V175, P255, DOI 10.1503/cmaj.051235; HANSEN WB, 1985, ADDICT BEHAV, V10, P265, DOI 10.1016/0306-4603(85)90007-3; Hawkins J D, 1985, J Prim Prev, V6, P73, DOI 10.1007/BF01325432; Health Canada, 2007, HLTH SUMM RES 2004 2; Hughes JR, 2004, ADDICTION, V99, P29, DOI 10.1111/j.1360-0443.2004.00540.x; Jessor R., 1977, PROBLEM BEHAV PSYCHO; Mittelmark M B, 1988, Scand J Prim Health Care, V6, P131, DOI 10.3109/02813438809009305; O'Loughlin J, 2009, AM J PUBLIC HEALTH, V99, P499, DOI 10.2105/AJPH.2007.128629; PALLONEN UE, 1990, HEALTH PSYCHOL, V9, P418, DOI 10.1037/0278-6133.9.4.418; Patterson F, 2004, J AM COLL HEALTH, V52, P203, DOI 10.3200/JACH.52.5.203-212; Peterson AV, 2000, JNCI-J NATL CANCER I, V92, P1979, DOI 10.1093/jnci/92.24.1979; Pletcher JR, 2000, CURR OPIN PEDIATR, V12, P444, DOI 10.1097/00008480-200010000-00004; Reid JL, 2011, TOBACCO USE CANADA P; Rohde P, 2004, NICOTINE TOB RES, V6, P509, DOI 10.1080/14622200410001723663; Stanton WR, 2002, J ADOLESCENCE, V25, P427, DOI 10.1006/jado.2002.0486; Sussman S, 1999, SUBST USE MISUSE, V34, P1469, DOI 10.3109/10826089909039411; Sussman S, 2002, Tob Induc Dis, V1, P35, DOI 10.1186/1617-9625-1-1-35; Tucker Joan S, 2002, Nicotine Tob Res, V4, P321; Tucker JS, 2005, PREV MED, V41, P554, DOI 10.1016/j.ypmed.2004.12.002; VELICER WF, 1992, PSYCHOL BULL, V111, P23, DOI 10.1037/0033-2909.111.1.23	38	68	68	0	28	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0964-4563	1468-3318		TOB CONTROL	Tob. Control	MAY	2012	21	3					355	362		10.1136/tc.2011.044149			8	Substance Abuse; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Substance Abuse; Public, Environmental & Occupational Health	939ZA	WOS:000303858500023	21846777	Green Submitted			2022-03-04	
J	Dilo, A; Daali, Y; Desmeules, J; Chalandon, Y; Uppugunduri, CRS; Ansari, M				Dilo, Ana; Daali, Youssef; Desmeules, Jules; Chalandon, Yves; Uppugunduri, Chakradhara R. S.; Ansari, Marc			Comparing Dried Blood Spots and Plasma Concentrations for Busulfan Therapeutic Drug Monitoring in Children	THERAPEUTIC DRUG MONITORING			English	Article						TDM; dried blood spot; busulfan; children; pharmacokinetics	PERFORMANCE LIQUID-CHROMATOGRAPHY; RECEIVING INTRAVENOUS BUSULFAN; CELL TRANSPLANTATION; ASSOCIATION; EXPOSURE; DERIVATIZATION	Background: Busulfan (Bu) is one of the conditioning regimen components for pediatric hematopoietic stem cell transplantation. Bu therapeutic drug monitoring (TDM) is essential for a successful treatment outcome and toxicity evasion. Dried blood spot (DBS) sampling is a rapid and simple method for Bu TDM, compared with conventional plasma sampling. This study evaluated the feasibility of using the DBS method for Bu TDM. The hematocrit (Hct) and conditioning day were also examined for their impact on the DBS method's performance. Methods: Venous blood collected from 6 healthy volunteers was diluted, using their plasma into 4 samples of varying Hct values. Each sample was spiked with Bu calibrators (300, 600, and 1400 ng/mL), prepared using DBS and dried plasma spot (DPS) sampling and analyzed using a validated liquid-chromatography tandem-mass spectrometry method. Clinical blood samples (n = 153) from pediatric patients (n = 15) treated with Bu (mainly from doses 1, 2, 5, and 9) were used to prepare paired volumetric DBS and DPS samples. A Bland-Altman plot and Deming regression were used to define the agreement between the paired DBS and DPS measurements. Passing-Bablok regression analyses investigated the effects of Hct and conditioning day on the linearity between both methods. Results: In vitro analyses showed good agreement between DBS and DPS measurements, with a mean difference of -5.4% and a 95% confidence interval on the limits of agreement of -15.3% to 4.6%. Clinical samples showed good correlation (Pearson correlation coefficient = 0.96; slope = 1.00) between the DBS and DPS methods. The DBS method met the clinical acceptance limits for clinical samples, with a bias <+/- 20%. Bland-Altman plots showed good agreement, with only 5.8% of paired measurements exceeding the limits of agreement (+/- 1.96 SD), although within its 95% confidence interval. Hct observations ranged from 21.7% to 34.7% and did not affect Bu concentrations measured from DBS in either the in vitro or in vivo studies. Conclusions: These results show that DBS is a useful method for Bu TDM, provided samples are analyzed on the collection day. DBS sampling offers advantages over traditional plasma sampling in infants and younger children because only small volumes of blood are required.	[Dilo, Ana; Daali, Youssef; Desmeules, Jules] Univ Geneva, Geneva Univ Hosp, Clin Pharmacol & Toxicol Unit, Geneva, Switzerland; [Chalandon, Yves] Geneva Univ Hosp, Dept Oncol, Div Hematol, Geneva, Switzerland; [Uppugunduri, Chakradhara R. S.; Ansari, Marc] Geneva Univ Hosp, Dept Paediat Gynaecol & Obstet, Oncohematol Unit, Geneva, Switzerland; [Uppugunduri, Chakradhara R. S.; Ansari, Marc] Univ Geneva, Fac Med, Dept Paediat Gynaecol & Obstet, CANSEARCH Res Lab, Ave Roseraie 64, CH-1205 Geneva, Switzerland		Uppugunduri, CRS (corresponding author), Univ Geneva, Fac Med, Dept Paediat Gynaecol & Obstet, CANSEARCH Res Lab, Ave Roseraie 64, CH-1205 Geneva, Switzerland.	Chakradhara.Uppugunduri@unige.ch	Rao, Uppugunduri S Chakradhara/V-3266-2017	Rao, Uppugunduri S Chakradhara/0000-0002-8928-7049; ansari, marc/0000-0002-9649-6498	Cansearch Foundation; Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission [ME9870/320030-153389]	Supported by the Cansearch Foundation and partly supported by the Swiss National Science Foundation (Grant number: ME9870/320030-153389). The technical assistance of Denis Marino, Melanie Kuntzinger, Fabienne Doffey-Lazeyras, and Rodolfo Lo Piccolo is gratefully acknowledged. C. R. S. Uppugunduri and M. Ansari contributed equally to this work.	Ansari M, 2010, BONE MARROW TRANSPL, V45, P261, DOI 10.1038/bmt.2009.143; Ansari M, 2017, ONCOTARGET, V8, P90852, DOI 10.18632/oncotarget.20310; Ansari M, 2014, THER DRUG MONIT, V36, P93, DOI 10.1097/FTD.0b013e3182a04fc7; Ansari M, 2012, RAPID COMMUN MASS SP, V26, P1437, DOI 10.1002/rcm.6241; Bartelink IH, 2016, LANCET HAEMATOL, V3, pE526, DOI 10.1016/S2352-3026(16)30114-4; Bartelink IH, 2009, BIOL BLOOD MARROW TR, V15, P231, DOI 10.1016/j.bbmt.2008.11.022; Bland JM, 2007, J BIOPHARM STAT, V17, P571, DOI 10.1080/10543400701329422; Courtney JB, 2009, THER DRUG MONIT, V31, P489, DOI 10.1097/FTD.0b013e3181a8c99c; Denniff P, 2010, BIOANALYSIS, V2, P1385, DOI [10.4155/bio.10.103, 10.4155/BIO.10.103]; EHRSSON H, 1984, J PHARM PHARMACOL, V36, P694, DOI 10.1111/j.2042-7158.1984.tb04847.x; Emmons G, 2010, BIOANALYSIS, V2, P1791, DOI 10.4155/BIO.10.159; Enderle Y, 2016, J PHARMACEUT BIOMED, V130, P231, DOI 10.1016/j.jpba.2016.06.026; European Medicines Agency, GUID BIOAN METH VAL; Eva C, 2018, THER DRUG MONIT, V40, P84, DOI 10.1097/FTD.0000000000000468; HASSAN M, 1989, EUR J CLIN PHARMACOL, V36, P525, DOI 10.1007/BF00558081; Huezo-Diaz P, 2014, CURR DRUG METAB, V15, P251, DOI 10.2174/1389200215666140202214012; Matsumoto K, 2016, BIOL BLOOD MARROW TR, V22, P1968, DOI 10.1016/j.bbmt.2016.07.008; Peris JE, 1999, J CHROMATOGR B, V730, P33, DOI 10.1016/S0378-4347(99)00214-5; Quernin MH, 1998, J CHROMATOGR B, V709, P47, DOI 10.1016/S0378-4347(98)00019-X; Rifai N, 1997, THER DRUG MONIT, V19, P169, DOI 10.1097/00007691-199704000-00009; Tran H, 2004, BIOL BLOOD MARROW TR, V10, P805, DOI 10.1016/j.bbmt.2004.07.010; Wilhelm AJ, 2014, CLIN PHARMACOKINET, V53, P961, DOI 10.1007/s40262-014-0177-7; Yu SX, 2005, RAPID COMMUN MASS SP, V19, P250, DOI 10.1002/rcm.1777; Zou GY, 2013, STAT METHODS MED RES, V22, P630, DOI 10.1177/0962280211402548	24	6	6	2	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0163-4356	1536-3694		THER DRUG MONIT	Ther. Drug Monit.	FEB	2020	42	1					111	117		10.1097/FTD.0000000000000673			7	Medical Laboratory Technology; Pharmacology & Pharmacy; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology; Pharmacology & Pharmacy; Toxicology	LA1BH	WOS:000523689800013	31348116	hybrid, Green Published			2022-03-04	
J	Solomon, LJ; Hughes, JR; Livingston, A; Naud, S; Callas, PW; Peters, EN; Kamon, J; Etter, JF				Solomon, Laura J.; Hughes, John R.; Livingston, Amy; Naud, Shelly; Callas, Peter W.; Peters, Erica N.; Kamon, Jody; Etter, Jean-Francois			Cognitive barriers to calling a smoking quitline	NICOTINE & TOBACCO RESEARCH			English	Article							CESSATION TREATMENTS; SMOKERS; ASSISTANCE	Introduction: This study examined cognitive barriers that might prevent cigarette smokers who are interested in quitting from calling a smoking quitline. Methods: Using qualitative and quantitative methods, we developed a 53-item inventory of possible cognitive barriers to quitline access. A total of 641 daily smokers who reported high intentions to stop smoking in the next 30 days completed this inventory and were then prompted to call a toll-free smoking quitline (800-QUIT NOW) on 3 occasions. Two months later, they completed a follow-up phone interview to assess use of the quitline, quit attempts, and smoking status. Results: Exploratory and confirmatory factor analysis of the barrier items revealed a 5-factor solution: stigma, low appraisal of the service, no need for assistance, poor fit with the service, and privacy concerns. Endorsements of barrier factors were generally low. Although several barrier factor scores predicted concurrent intentions to call a quitline in the near future, none prospectively predicted calling the quitline by 2-month follow-up. Discussion: Cognitive barriers to use of quitlines remain elusive.	[Solomon, Laura J.; Hughes, John R.; Livingston, Amy; Peters, Erica N.] Univ Vermont, Dept Psychiat, Burlington, VT 05401 USA; [Naud, Shelly; Callas, Peter W.] Univ Vermont, Dept Med Biostat, Burlington, VT 05401 USA; [Kamon, Jody] New England Inst Addict Studies, Burlington, VT USA; [Etter, Jean-Francois] Univ Geneva, Inst Social & Prevent Med, CH-1211 Geneva 4, Switzerland		Solomon, LJ (corresponding author), Univ Vermont, Dept Psychiat, 429 AR4,1 S Prospect St, Burlington, VT 05401 USA.	laura.solomon@uvm.edu	Hughes, John/H-9687-2013	Hughes, John/0000-0002-0092-9309; ETTER, Jean-Francois/0000-0002-1426-3157	National Institute on Drug AbuseUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R01 DA017825, K05 DA000490, T32 DA007242]; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [T32DA007242, K05DA000490, R01DA017825] Funding Source: NIH RePORTER	This study was funded by grant R01 DA017825, Senior Scientist Award K05 DA000490 (JRH), and Institutional Training Grant T32 DA007242 (ENP) of the National Institute on Drug Abuse.	An LC, 2006, AM J HEALTH PROMOT, V20, P267, DOI 10.4278/0890-1171-20.4.267; ARBUCKLE JL, 2003, AMOS GRAPHICS VERSIO; Baker, 2008, TREATING TOBACCO USE; Balmford J, 2008, DRUG ALCOHOL REV, V27, P21, DOI 10.1080/09595230701710829; CARTER S, 2001, FINDING STRENGTH KIL; Cokkinides VE, 2005, AM J PREV MED, V28, P119, DOI 10.1016/j.amepre.2004.09.007; Cummings KM, 2006, J PUBLIC HEALTH MAN, V12, P37; Ellingstad TP, 2006, ADDICT BEHAV, V31, P519, DOI 10.1016/j.addbeh.2005.05.033; Gross B, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-129; Hammond D, 2004, ADDICTION, V99, P1042, DOI 10.1111/j.1360-0443.2004.00754.x; Lichtenstein E, 1996, HEALTH EDUC RES, V11, P243, DOI 10.1093/her/11.2.243; Mariolis P., 2006, Morbidity and Mortality Weekly Report, V55, P1145; Miller CL, 2003, TOB CONTROL, V12, P53, DOI 10.1136/tc.12.suppl_2.ii53; Mohr DC, 2006, ANN BEHAV MED, V32, P254, DOI 10.1207/s15324796abm3203_12; *NAT TOB CESS COLL, 2007, INN BUILD CONS DEM T; NISBETT RE, 1977, PSYCHOL REV, V84, P231, DOI 10.1037/0033-295X.84.3.231; Ossip-Klein DJ, 2003, AM J MED SCI, V326, P201, DOI 10.1097/00000441-200310000-00010; Paul CL, 2004, ADDICTION, V99, P907, DOI 10.1111/j.1360-0443.2004.00773.x; *SAS I INC, 2002, SAS WIND VERS 9; Shiffman S, 2008, AM J PREV MED, V34, P102, DOI 10.1016/j.amepre.2007.09.033; Solomon LJ, 2005, PREV MED, V40, P306, DOI 10.1016/j.ypmed.2004.06.005; Sood A, 2008, AM J HEALTH PROMOT, V22, P176, DOI 10.4278/ajhp.22.3.176; STEAD LF, 2002, COCHRANE LIB; STREINER DL, 2003, HLTH MEASUREMENT SCA; Tucker JA, 2004, J SUBST ABUSE TREAT, V26, P237, DOI 10.1016/S0740-5472(03)00209-5; Zhu SH, 2000, AM J PREV MED, V18, P305, DOI 10.1016/S0749-3797(00)00124-0	26	19	20	0	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1462-2203	1469-994X		NICOTINE TOB RES	Nicotine Tob. Res.	NOV	2009	11	11					1339	1346		10.1093/ntr/ntp143			8	Substance Abuse; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Substance Abuse; Public, Environmental & Occupational Health	518UI	WOS:000271719400011	19793785	Green Published			2022-03-04	
J	Ahoyo, TA; Bankole, HS; Adeoti, FM; Gbohoun, AA; Assavedo, S; Amoussou-Guenou, M; Kinde-Gazard, DA; Pittet, D				Ahoyo, Theodora Angele; Bankole, Honore Sourou; Adeoti, Franck Mansour; Gbohoun, Aime Attolou; Assavedo, Sibylle; Amoussou-Guenou, Marcellin; Kinde-Gazard, Dorothee Akoko; Pittet, Didier			Prevalence of nosocomial infections and anti-infective therapy in Benin: results of the first nationwide survey in 2012	ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL			English	Article						Nosocomial infection; Prevalence; Antimicrobial resistance; Co-morbidity; Antibiotic use; Infection control; National surveillance; Surveillance; Africa; Low-/middle-income countries	DEVELOPING-COUNTRIES; ANTIMICROBIAL RESISTANCE; STAPHYLOCOCCUS-AUREUS; HOSPITAL-CENTER; SURVEILLANCE	Background: Data on nosocomial infections in hospitals in low-income countries are scarce and often inconsistent. The objectives of this study were to estimate the prevalence of nosocomial infections and antimicrobial drug use in Benin hospitals. Methods: All hospitals were invited to participate in the first national point prevalence study conducted between 10-26 October 2012 using the protocol developed by the "Hospitals in Europe Link for Infection Control through Surveillance" (HELICS) project. Infection prevalence rates and the proportion of infected patients and exposure to antimicrobials were assessed. Results: Overall, 87% (39/45) of hospitals participated. Of 3130 inpatients surveyed, 972 nosocomial infections were identified among 597 patients, representing an overall prevalence of infected patients of 19.1%. The most frequent infections were related to the urinary tract (48.2%), vascular catheter use (34.7%), and surgical site (24.7%). 64.6% of patients surveyed were treated with antibiotics, including a significant proportion (30%) of non-infected patients and a high proportion of self-medication (40.8%). Resistance of leading nosocomial pathogens to antimicrobials included methicillin-resistance (52.5%) among Staphylococcus aureus, vancomycin resistance among enterococci (67.5%), cefotaxime resistance among Escherichia coli (67.6%), and ceftazidime resistance among Acinetobacter baumannii (100%) and Pseudomonas aeruginosa (68.2%). Conclusions: Benin has high nosocomial infection rates and calls for the implementation of new national infection control policies. Patient safety education and training of all individuals involved in healthcare delivery will be critical to highlight awareness of the burden of disease. The high use of antimicrobials needs to be addressed, particularly their indiscriminate use in non-infected patients.	[Ahoyo, Theodora Angele; Bankole, Honore Sourou] Univ Abomey Calavi, Ecole Polytech Abomey Calavi, Genie Biol Humaine, Cotonou, Benin; [Adeoti, Franck Mansour] Int Network Planning & Improving Qual & Safety Hl, Reseau Int Planificat & Ameliorat Qualit & Secur, Abidjan, Cote Ivoire; [Gbohoun, Aime Attolou; Assavedo, Sibylle; Amoussou-Guenou, Marcellin] Minist Hlth, Improvement Qual Serv, Cotonou, Benin; [Kinde-Gazard, Dorothee Akoko] Univ Abomey Calavi, Minist Hlth, Cotonou, Benin; [Kinde-Gazard, Dorothee Akoko] Univ Abomey Calavi, Fac Med, Cotonou, Benin; [Pittet, Didier] Univ Hosp Geneva, Infect Control Programme, Geneva, Switzerland; [Pittet, Didier] Univ Hosp Geneva, WHO Collaborating Ctr Patient Safety, Geneva, Switzerland; [Pittet, Didier] Fac Med, Geneva, Switzerland		Ahoyo, TA (corresponding author), Univ Abomey Calavi, Ecole Polytech Abomey Calavi, Genie Biol Humaine, Cotonou, Benin.	taahoyo@yahoo.fr			Benin Ministry of Health	We gratefully thank the individuals who participated in this study and the research assistants that conducted the field work. The support by Dr Clement Agossadou for the technical data collection is highly appreciated. The authors thank Prof. Babacar Ndoye (Senegal) and Malavaud Sandra (Toulouse en France) for their intellectual contributions to the study design. Financial support for this study was provided by the Benin Ministry of Health. The funding source had no influence on study design; in the collection, analysis, and interpretation of the data; in the writing of the manuscript; or in the decision to submit the manuscript for publication.	Ahoyo AT, 2007, MED MALADIES INFECT, V37, P746, DOI 10.1016/j.medmal.2007.03.004; Ahoyo AT, 2006, ARCH PEDIATRIE, V13, P1391, DOI 10.1016/j.arcped.2006.07.004; Ahoyo TA, 2012, J PHARM BIOMED SCI, V24, P35; Allegranzi B, 2011, LANCET, V377, P228, DOI 10.1016/S0140-6736(10)61458-4; Blomberg B, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-45; Cardo D, 2004, AM J INFECT CONTROL, V32, P470, DOI 10.1016/j.ajic.2004.10.001; Coignard B, 2007, ENQUETE NATL PREVALE; FRENEY J, 2000, PRECIS BACTERIOLOGIE; Gastmeier P, 1998, INFECT CONT HOSP EP, V19, P661; Hospitals in Europe Link for Infection Control through Surveillance (HELICS), 2004, PREV SURV NOS INF; Kampf G, 1998, J CLIN MICROBIOL, V36, P2254, DOI 10.1128/JCM.36.8.2254-2257.1998; KUNIN CM, 1993, ANN INTERN MED, V118, P557, DOI 10.7326/0003-4819-118-7-199304010-00011; *NAT COMM CLIN LAB, 2000, PERF STAND ANT DISK; Nauciel C, 2005, BACTERIOLOGIE MED, P49; Nejad SB, 2011, B WORLD HEALTH ORGAN, V89, P757, DOI 10.2471/BLT.11.088179; Okeke IN, 2005, LANCET INFECT DIS, V5, P481, DOI 10.1016/S1473-3099(05)70189-4; Pittet D, 2000, SWISS NOSO, V7, P1; Raza MW, 2004, J HOSP INFECT, V57, P294, DOI 10.1016/j.jhin.2004.03.019; Rebaudet S, 2007, MED TROP, P73; Simon F, 2007, Med Trop (Mars), V67, P197; STJOHN RK, 1982, INFECT CONT HOSP EP, V3, P453, DOI 10.1017/S0195941700056563; Thapar N, 2004, LANCET, V363, P641, DOI 10.1016/S0140-6736(04)15599-2; Trostle J, 1996, SOC SCI MED, V42, P1117, DOI 10.1016/0277-9536(95)00384-3	23	39	41	0	5	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2047-2994			ANTIMICROB RESIST IN	Antimicrob. Resist. Infect. Control	MAY 14	2014	3								17	10.1186/2047-2994-3-17			6	Public, Environmental & Occupational Health; Infectious Diseases; Microbiology; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Infectious Diseases; Microbiology; Pharmacology & Pharmacy	CZ6OI	WOS:000367220200001	24883183	Green Published, gold			2022-03-04	
J	Nica, AC; Ongen, H; Irminger, JC; Bosco, D; Berney, T; Antonarakis, SE; Halban, PA; Dermitzakis, ET				Nica, Alexandra C.; Ongen, Halit; Irminger, Jean-Claude; Bosco, Domenico; Berney, Thierry; Antonarakis, Stylianos E.; Halban, Philippe A.; Dermitzakis, Emmanouil T.			Cell-type, allelic, and genetic signatures in the human pancreatic beta cell transcriptome	GENOME RESEARCH			English	Article							DNA-SEQUENCING DATA; EXPRESSION; ISLETS; ASSOCIATION; DISEASE; POPULATION; ANNOTATION; SECRETION; DISCOVERY; FRAMEWORK	Elucidating the pathophysiology and molecular attributes of common disorders as well as developing targeted and effective treatments hinges on the study of the relevant cell type and tissues. Pancreatic beta cells within the islets of Langerhans are centrally involved in the pathogenesis of both type 1 and type 2 diabetes. Describing the differentiated state of the human beta cell has been hampered so far by technical (low resolution microarrays) and biological limitations (whole islet preparations rather than isolated beta cells). We circumvent these by deep RNA sequencing of purified beta cells from 11 individuals, presenting here the first characterization of the human beta cell transcriptome. We perform the first comparison of gene expression profiles between beta cells, whole islets, and beta cell depleted islet preparations, revealing thus beta-cell-specific expression and splicing signatures. Further, we demonstrate that genes with consistent increased expression in beta cells have neuronal-like properties, a signal previously hypothesized. Finally, we find evidence for extensive allelic imbalance in expression and uncover genetic regulatory variants (eQTLs) active in beta cells. This first molecular blueprint of the human beta cell offers biological insight into its differentiated function, including expression of key genes associated with both major types of diabetes.	[Nica, Alexandra C.; Ongen, Halit; Irminger, Jean-Claude; Antonarakis, Stylianos E.; Halban, Philippe A.; Dermitzakis, Emmanouil T.] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Nica, Alexandra C.; Ongen, Halit; Irminger, Jean-Claude; Antonarakis, Stylianos E.; Halban, Philippe A.; Dermitzakis, Emmanouil T.] Inst Genet & Genom Geneva iGE3, CH-1271 Geneva, Switzerland; [Nica, Alexandra C.; Ongen, Halit; Dermitzakis, Emmanouil T.] Swiss Inst Bioinformat, CH-1211 Geneva, Switzerland; [Bosco, Domenico; Berney, Thierry] Univ Hosp Geneva, Cell Isolat & Transplant Ctr, Dept Surg, CH-1211 Geneva, Switzerland; [Bosco, Domenico; Berney, Thierry] Univ Geneva, CH-1211 Geneva, Switzerland		Halban, PA (corresponding author), Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland.	Philippe.Halban@unige.ch; emmanouil.dermitzakis@unige.ch	Berney, Thierry/ABE-9450-2021; Antonarakis, Stylianos E/N-8866-2014	Berney, Thierry/0000-0002-4230-9378; Antonarakis, Stylianos E/0000-0001-8907-5823; Ongen, Halit/0000-0002-4197-5790; Bosco, Domenico/0000-0003-3453-9613	JDRFJuvenile Diabetes Research Foundation [17-2011-284]; Innovative Medicines Initiative Joint Undertaking [115317]; Louis-Jeantet Foundation	This work was supported by grant number 17-2011-284 from JDRF, the Innovative Medicines Initiative Joint Undertaking under grant agreement no. 115317 (DIRECT), and the Louis-Jeantet Foundation. We thank Stephane Dupuis, Ismael Padioleau, Alexandra Planchon, Luciana Romano, and Alisa Yurovsky for expert technical assistance.	Ahren B, 2000, DIABETOLOGIA, V43, P393, DOI 10.1007/s001250051322; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Danzer C, 2012, J PROTEOME RES, V11, P1598, DOI 10.1021/pr2007895; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Dorrell C, 2011, DIABETOLOGIA, V54, P2832, DOI 10.1007/s00125-011-2283-5; Dorrell C, 2011, MOL CELL ENDOCRINOL, V339, P144, DOI 10.1016/j.mce.2011.04.008; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Fernandez-Alvarez J, 2001, PANCREAS, V22, P69, DOI 10.1097/00006676-200101000-00012; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Gaulton KJ, 2010, NAT GENET, V42, P255, DOI 10.1038/ng.530; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Hardy OT, 2007, MOL ENDOCRINOL, V21, P765, DOI 10.1210/me.2006-0411; Harrow J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s4; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang YP, 2008, BIOCHEM BIOPH RES CO, V377, P474, DOI 10.1016/j.bbrc.2008.09.138; Jiang FX, 2002, J CELL SCI, V115, P753; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Moran I, 2012, CELL METAB, V16, P435, DOI 10.1016/j.cmet.2012.08.010; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nica AC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002003; Nica AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000895; Nicolls MR, 2003, J PROTEOME RES, V2, P199, DOI 10.1021/pr025576x; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Parnaud G, 2008, DIABETOLOGIA, V51, P91, DOI 10.1007/s00125-007-0855-1; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Pisania A, 2010, LAB INVEST, V90, P1661, DOI 10.1038/labinvest.2010.124; Price AL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001317; Rondas D, 2011, DIABETES, V60, P1146, DOI 10.2337/db10-0946; Sakurai Y, 2011, J MOL NEUROSCI, V43, P3, DOI 10.1007/s12031-010-9424-z; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Thomas MF, 2010, METHODS MOL BIOL, V667, P93, DOI 10.1007/978-1-60761-811-9_7; Tisch R, 1996, CELL, V85, P291, DOI 10.1016/S0092-8674(00)81106-X; Villasenor A, 2010, DIS MODEL MECH, V3, P567, DOI 10.1242/dmm.003210; Zhang L, 2012, DIGEST DIS SCI, V57, P2608, DOI 10.1007/s10620-012-2202-8	44	128	130	2	24	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051			GENOME RES	Genome Res.	SEP	2013	23	9					1554	1562		10.1101/gr.150706.112			9	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	213SJ	WOS:000324080000017	23716500	Green Accepted, Green Published, hybrid			2022-03-04	
J	Kuch, U; Sharma, SK; Alirol, E; Chappuis, F				Kuch, Ulrich; Sharma, Sanjib Kumar; Alirol, Emilie; Chappuis, Francois			FATAL NEUROTOXIC ENVENOMATION FROM THE BITE OF A LESSER BLACK KRAIT (BUNGARUS LIVIDUS) IN NEPAL	SOUTHEAST ASIAN JOURNAL OF TROPICAL MEDICINE AND PUBLIC HEALTH			English	Article						Bungarus lividus; envenomation; snake; neurotoxic; antivenom; Nepal	SNAKE BITES	The Lesser Black Krait (Bungarus lividus) is a small, secretive, nocturnal elapid snake inhabiting Nepal, Bangladesh and India. We report a case of B. lividus bite in Nepal resulting in burning sensation at the bite site and over the whole body, abdominal pain, vomiting, slurred speech, ptosis, and progressive generalized neuromuscular paralysis leading to respiratory distress and death. Only one other case of fatal envenomation by this species has been reported previously in India. This demonstrates that B. lividus contributes to snakebite mortality in South Asia. As few snakebite victims in this region kill and bring the snake and because the clinical syndromes appear similar, envenomation by B. lividus may be misdiagnosed as envenomation by Common Kraits (Bungarus caeruleus). External morphology characters that distinguish B. lividus from B. caeruleus and other krait species are illustrated.	[Kuch, Ulrich] Biodivers & Climate Res Ctr BiK F, D-60325 Frankfurt, Germany; [Sharma, Sanjib Kumar] BP Koirala Inst Hlth Sci, Dharan, Nepal; [Alirol, Emilie; Chappuis, Francois] Univ Hosp Geneva, Div Int & Humanitarian Med, Geneva, Switzerland		Kuch, U (corresponding author), Biodivers & Climate Res Ctr BiK F, Senckenberganlage 25, D-60325 Frankfurt, Germany.	Ulrich.Kuch@senckenberg.de; drsanjib@yahoo.com	Kuch, Ulrich/C-6656-2013	Kuch, Ulrich/0000-0002-5091-7752; Sharma, Sanjeev Kumar/0000-0002-3273-0708; Alirol, Emilie/0000-0001-8691-3991	Vereinigung der Freunde und Forderer der Johann Wolfgang Goethe-Universitat Frankfurt am Main; Ministry of Higher Education, Research and the Arts of the State of Hessen, Germany	We thank the Health Assistants of the Nepal Red Cross Society Sub-Chapter Damak-Jhapa, and the patient's family for sharing the circumstantial details of this case of envenomation and consenting to its publication. This case was previously presented at the Global Issues in Clinical Toxinology 2008 Conference in Melbourne, Australia. Research was financially supported by Vereinigung der Freunde und Forderer der Johann Wolfgang Goethe-Universitat Frankfurt am Main and the research funding program "LOEWE - Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz" of the Ministry of Higher Education, Research and the Arts of the State of Hessen, Germany.	Alirol E, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000603; Ariaratnam CA, 2008, AM J TROP MED HYG, V79, P458, DOI 10.4269/ajtmh.2008.79.458; Chappuis F, 2007, AM J TROP MED HYG, V77, P197, DOI 10.4269/ajtmh.2007.77.197; Faiz MA, 2010, BRAIN, V133, P3181, DOI 10.1093/brain/awq265; Harris JB, 2010, T ROY SOC TROP MED H, V104, P320, DOI 10.1016/j.trstmh.2009.12.006; Islam QT, 2011, T ROY SOC TROP MED H, V105, P74, DOI 10.1016/j.trstmh.2010.10.002; Shah K. B., 2004, HERPETOFAUNA NEPAL C; Sharma SK, 2004, AM J TROP MED HYG, V71, P234, DOI 10.4269/ajtmh.2004.71.234; VIRAVAN C, 1992, T ROY SOC TROP MED H, V86, P100, DOI 10.1016/0035-9203(92)90463-M; Wall F., 1910, Journal of the Bombay Natural History Society, V19; Wall F, 1928, POISONOUS TERRESTRIA; Warrell DA, 2010, GUIDELINES MANAGEMEN; Warrell DA, 2010, LANCET, V375, P77, DOI 10.1016/S0140-6736(09)61754-2	13	6	7	0	6	SOUTHEAST ASIAN MINISTERS EDUC ORGANIZATION	BANGKOK	SEAMEO-TROPMED, 420-6 RAJVITHI RD,, BANGKOK 10400, THAILAND	0125-1562			SE ASIAN J TROP MED	Southeast Asian J. Trop. Med. Public Health	JUL	2011	42	4					960	964					5	Public, Environmental & Occupational Health; Infectious Diseases; Tropical Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Infectious Diseases; Tropical Medicine	801JN	WOS:000293434800023	22299479				2022-03-04	
J	Leboulanger, B; Guy, RH; Delgado-Charro, MB				Leboulanger, B; Guy, RH; Delgado-Charro, MB			Reverse iontophoretic monitoring of free phenytoin	THERAPEUTIC DRUG MONITORING			English	Meeting Abstract	8th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology	SEP 07-11, 2003	BASEL, SWITZERLAND						Univ Geneva, Sch Pharm, CH-1211 Geneva 4, Switzerland; Ctr Interuniv Rech & Enseignement, Archamps, France				Delgado-Charro, M.B./D-4085-2009	Delgado-Charro, M.B./0000-0002-2233-7654; Guy, Richard/0000-0003-3227-9862				0	3	3	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0163-4356			THER DRUG MONIT	Ther. Drug Monit.	AUG	2003	25	4				52	499	499					1	Medical Laboratory Technology; Pharmacology & Pharmacy; Toxicology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology; Pharmacology & Pharmacy; Toxicology	706GJ	WOS:000184445500067					2022-03-04	
J	Peters, A; Lotfinejad, N; Guitart, C; Simniceanu, A; Padoveze, MC; Borzykowski, T; Allegranzi, B; Pittet, D				Peters, Alexandra; Lotfinejad, Nasim; Guitart, Chloe; Simniceanu, Alice; Padoveze, Maria Clara; Borzykowski, Tcheun; Allegranzi, Benedetta; Pittet, Didier			"Nurses and midwives: clean care is in your hands": the 5th May 2020 World Health Organization SAVE LIVES: Clean Your Hands campaign	ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL			English	Editorial Material						Infection prevention and control; Infection control; Hand hygiene; Nurses; Midwives; World Health Organization; Healthcare-associated infection		In honor of Florence Nightingale's 200th birthday, the World Health Organization (WHO) has declared 2020 the "Year of the Nurse and Midwife". On May 5th of this year, for the annual celebration of the SAVE LIVES: Clean Your Hands campaign, WHO will focus on the essential role that nurses and midwives play in contributing to saving millions of lives per year. It is necessary to recognize the work and the immense responsibility that nurses and midwives carry since achieving Universal Health Coverage is highly reliant on them.	[Peters, Alexandra; Guitart, Chloe; Borzykowski, Tcheun; Pittet, Didier] Univ Geneva Hosp, Infect Control Program, Geneva, Switzerland; [Peters, Alexandra; Guitart, Chloe; Borzykowski, Tcheun; Pittet, Didier] Fac Med, Geneva, Switzerland; [Lotfinejad, Nasim] Mashhad Univ Med Sci, Dept Res, Fac Med, Mashhad, Razavi Khorasan, Iran; [Simniceanu, Alice] World Hlth Org, Infect Prevent & Control Hub & Antimicrobial Resi, Geneva, Switzerland; [Padoveze, Maria Clara; Allegranzi, Benedetta] World Hlth Org, Infect Prevent & Control Hub, Integrated Hlth Serv, UHC Life Course, Geneva, Switzerland		Pittet, D (corresponding author), Univ Geneva Hosp, Infect Control Program, Geneva, Switzerland.; Pittet, D (corresponding author), Fac Med, Geneva, Switzerland.	didier.pittet@hcuge.ch			WHO, Geneva, SwitzerlandWorld Health Organization; Infection Control Program, University of Geneva Hospitals, Geneva, Switzerland; Infection Control Program, University of Geneva Faculty of Medicine, Geneva, Switzerland; Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission [32003B_163262]	This work is supported by WHO, Geneva, Switzerland, and the Infection Control Program, University of Geneva Hospitals and Faculty of Medicine, Geneva, Switzerland; hand hygiene research activities at the SPCI/WCC are also supported by the Swiss National Science Foundation (grant number 32003B_163262). Potential conflicts of interest.	[Anonymous], 2020, NURS MIDW FACT SHEET; World Health Organization, 2016, GUID COR COMP INF PR; World Health Organization, DEC ACT	3	0	0	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2047-2994			ANTIMICROB RESIST IN	Antimicrob. Resist. Infect. Control	APR 19	2020	9	1							54	10.1186/s13756-020-00717-6			3	Public, Environmental & Occupational Health; Infectious Diseases; Microbiology; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Infectious Diseases; Microbiology; Pharmacology & Pharmacy	LH6PJ	WOS:000528906100001	32306988	Green Published, gold			2022-03-04	
J	Lotfinejad, N; Assadi, R; Aelami, MH; Pittet, D				Lotfinejad, Nasim; Assadi, Reza; Aelami, Mohammad Hassan; Pittet, Didier			Emojis in public health and how they might be used for hand hygiene and infection prevention and control	ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL			English	Review						Infection prevention and control; Infection control; Emoji; Emoticon; Ideograms; Infection prevention; Hand hygiene; World Health Organization; Healthcare-associated infection; Global health; Behavioral change; Alcohol-based handrub; Hand sanitizer	SOCIAL MEDIA; EMOTICONS; MESSAGE; CARE	Emojis are frequently used picture characters known as possible surrogates for non-verbal aspects of behavior. Considering the ability of emojis to enhance and facilitate communication, there has been a growing interest in studying their effects in scientific and health-related topics over the past few years. Infection prevention and control (IPC) is a field of medicine that is directly associated with specific behaviors. These include hand hygiene, which is the cornerstone of the prevention of healthcare-associated infections, and essential in stemming the spread of antimicrobial resistance. This paper aims to provide an overview of how emojis have been used in the medical and public health literature and proposes their possible use in IPC and hand hygiene to put forth a vision for the future research.	[Lotfinejad, Nasim] Mashhad Univ Med Sci, Dept Res, Fac Med, Mashhad, Razavi Khorasan, Iran; [Lotfinejad, Nasim] Imam Reza Hosp, Hand Hyg & Infect Control Res Ctr, Mashhad, Razavi Khorasan, Iran; [Assadi, Reza] Mashhad Univ Med Sci, Sch Med, E Learning Ctr, Mashhad, Razavi Khorasan, Iran; [Aelami, Mohammad Hassan] Imam Reza Hosp, Dept Pediat, Mashhad, Razavi Khorasan, Iran; [Aelami, Mohammad Hassan] Imam Reza Hosp, Hand Hyg & Infect Control Res Ctr, Mashhad, Razavi Khorasan, Iran; [Pittet, Didier] Univ Geneva Hosp, Infect Control Programme, 4 Rue Gabrielle Perret Gentil, CH-1211 Geneva 14, Switzerland; [Pittet, Didier] Univ Geneva Hosp, WHO Collaborating Ctr Patient Safety, 4 Rue Gabrielle Perret Gentil, CH-1211 Geneva 14, Switzerland; [Pittet, Didier] Fac Med, 4 Rue Gabrielle Perret Gentil, CH-1211 Geneva 14, Switzerland		Pittet, D (corresponding author), Univ Geneva Hosp, Infect Control Programme, 4 Rue Gabrielle Perret Gentil, CH-1211 Geneva 14, Switzerland.; Pittet, D (corresponding author), Univ Geneva Hosp, WHO Collaborating Ctr Patient Safety, 4 Rue Gabrielle Perret Gentil, CH-1211 Geneva 14, Switzerland.; Pittet, D (corresponding author), Fac Med, 4 Rue Gabrielle Perret Gentil, CH-1211 Geneva 14, Switzerland.	Didier.pittet@hcuge.ch	assadi, reza/AAI-1124-2021; assadi, reza/AAT-6629-2020	Pittet, Didier/0000-0002-3667-7131	Infection Control Programme and World Health Organization (WHO) Collaborating Centre on Patient Safety (SPCI/WCC), University of Geneva Hospitals and Faculty of Medicine, Geneva, Switzerland; Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission [32003B_163262]	This work is supported by the Infection Control Programme and World Health Organization (WHO) Collaborating Centre on Patient Safety (SPCI/WCC), University of Geneva Hospitals and Faculty of Medicine, Geneva, Switzerland; hand hygiene research activities at the SPCI/WCC are also supported by the Swiss National Science Foundation (grant no. 32003B_163262).	Aldunate N, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00423; Ali PA, 2018, J CLIN NURS, V27, pE1152, DOI 10.1111/jocn.14204; Allegranzi B, 2017, LANCET GLOB HEALTH, V5, pE1178, DOI 10.1016/S2214-109X(17)30427-8; Amano Tatsuya, 2016, PLoS Biol, V14, pe2000933, DOI 10.1371/journal.pbio.2000933; Aronson J, 2005, BMJ-BRIT MED J, V330, P87, DOI [10.1136/bmj.330.7482.87, DOI 10.1136/BMJ.330.7482.87]; Assadi R, MED EMOJI NEW PARADI; Bedoya G, 2017, B WORLD HEALTH ORGAN, V95, P503, DOI 10.2471/BLT.16.179499; Beyfus TA, 2016, AM J INFECT CONTROL, V44, P496, DOI 10.1016/j.ajic.2015.12.021; Bobek E, 2016, COGN RES, V1, DOI 10.1186/s41235-016-0031-6; Butterworth SE, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.00784; Charles-Smith LE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139701; Chertack J, PROPOSAL MOSQUITO EM; Choi S, 2017, METHODS, V129, P50, DOI 10.1016/j.ymeth.2017.07.027; Coviello L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090315; Fernandez-Luque L, 2015, HEALTHC INFORM RES, V21, P67, DOI 10.4258/hir.2015.21.2.67; Filik R, 2016, Q J EXP PSYCHOL, V69, P2130, DOI 10.1080/17470218.2015.1106566; Fung ICH, 2015, WEST PAC SURVEILL RE, V6, P34, DOI [10.5365/WPSAR.2015.6.2.003, 10.5365/wpsar.2015.6.2.003]; Fung ICH, 2015, WEST PAC SURVEILL RE, V6, DOI [10.5365/WPSAR.2015.6.1.019, 10.5365/wpsar.2015.6.1.019]; Gaube S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197465; Gould DJ, 2008, J HOSP INFECT, V68, P193, DOI 10.1016/j.jhin.2007.11.013; Gruzd A, 2011, 2011 44 HAW INT C SY; Jenner EA, 2005, J HOSP INFECT, V60, P218, DOI 10.1016/j.jhin.2004.12.014; Kass-Hout TA, 2013, BRIT MED BULL, V108, P5, DOI 10.1093/bmb/ldt028; Kaye LK, 2017, TRENDS COGN SCI, V21, P66, DOI 10.1016/j.tics.2016.10.007; Kim S, 2012, AM J INFECT CONTROL, V40, P211, DOI 10.1016/j.ajic.2011.03.028; Kummervold PE, 2008, J MED INTERNET RES, V10, DOI 10.2196/jmir.1023; Lee ACK, 2008, INT J NURS STUD, V45, P1081, DOI 10.1016/j.ijnurstu.2007.05.008; Lim K, 2018, AM J INFECT CONTROL, V46, P1218, DOI 10.1016/j.ajic.2018.05.002; Ljubei N, 2016, GLOBAL ANAL EMOJI US; Lo SK, 2008, CYBERPSYCHOL BEHAV, V11, P595, DOI 10.1089/cpb.2007.0132; Lu X, 2016, UBICOMP'16: PROCEEDINGS OF THE 2016 ACM INTERNATIONAL JOINT CONFERENCE ON PERVASIVE AND UBIQUITOUS COMPUTING, P770, DOI 10.1145/2971648.2971724; Marengo D, 2017, PERS INDIV DIFFER, V112, P74, DOI 10.1016/j.paid.2017.02.037; Murray Sally B, 2005, Aust Health Rev, V29, P25; Novak PK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144296; O'Reilly-Shah VN, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k5033; Oxford Dictionaries, 2015, WORD OF THE YEAR; Pan Sung-Ching, 2016, JMIR Public Health Surveill, V2, pe5, DOI 10.2196/publichealth.5101; Pires D, 2017, ANTIMICROB RESIST IN, V6, DOI 10.1186/s13756-017-0218-8; Pittet D, 2005, LANCET, V366, P1246, DOI 10.1016/S0140-6736(05)67506-X; Pittet Didier, 2017, J Infect Prev, V18, P100, DOI 10.1177/1757177417705191; Sax H, 2007, J HOSP INFECT, V67, P9, DOI 10.1016/j.jhin.2007.06.004; Sendall MC, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16061067; Seo DW, 2017, HEALTHC INFORM RES, V23, P343, DOI 10.4258/hir.2017.23.4.343; Siegel RM, 2015, CLIN THER, V37, P1938, DOI 10.1016/j.clinthera.2015.07.016; Skiba DJ, 2016, NURS EDUC PERSPECT, V37, P56, DOI 10.1097/01.NEP.0000476112.24899.a1; Stella SA, 2019, INFECT CONT HOSP EP, V40, P748, DOI 10.1017/ice.2019.103; Troiano G, 2018, J HUM BEHAV SOC ENVI, V28, P528, DOI 10.1080/10911359.2018.1437103; Tyng CM, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01454; Vermeil T, 2019, J HOSP INFECT, V101, P383, DOI 10.1016/j.jhin.2018.09.003; Walther JB, 2001, SOC SCI COMPUT REV, V19, P324, DOI 10.1177/089443930101900307; Weiss M, 2019, PSYCHOPHYSIOLOGY, V56, DOI 10.1111/psyp.13321; Weston D, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5223-1; WHO, GUID HAND HYG HLTH C; Willoughby JF, 2018, COMPUT HUM BEHAV, V79, P75, DOI 10.1016/j.chb.2017.10.031; World Health Organization. Guide to implementation, GUID IMPL GUID IMPL; Wulff HR, 2004, J ROY SOC MED, V97, P187, DOI 10.1258/jrsm.97.4.187; Yuasa M, 2011, ELECTR COMMUN JPN, V94, P17, DOI 10.1002/ecj.10311	57	6	7	1	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2047-2994			ANTIMICROB RESIST IN	Antimicrob. Resist. Infect. Control	FEB 10	2020	9	1							27	10.1186/s13756-020-0692-2			6	Public, Environmental & Occupational Health; Infectious Diseases; Microbiology; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Infectious Diseases; Microbiology; Pharmacology & Pharmacy	KV4DQ	WOS:000520433200001	32041666	gold, Green Published			2022-03-04	
J	Szabo, R; Morvai, J; Bellissimo-Rodrigues, F; Pittet, D				Szabo, Rita; Morvai, Julia; Bellissimo-Rodrigues, Fernando; Pittet, Didier			Use of hand hygiene agents as a surrogate marker of compliance in Hungarian long-term care facilities: first nationwide survey	ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL			English	Article						Hand hygiene; Alcohol-based handrub; Compliance; Long-term care facilities; Hungary	LACTAMASE-PRODUCING ENTEROBACTERIACEAE; RANDOMIZED CONTROLLED-TRIAL; ALCOHOL-BASED HANDRUB; NURSING-HOMES; ANTIMICROBIAL USE; RUB DISPENSERS; INFECTIONS; PREVALENCE; PROGRAM; RESIDENTS	Background: Hand hygiene practice is an important measure for preventing infections in long-term care facilities (LTCFs). However, low compliance with hand hygiene has been reported in a number of studies. The purpose of this study was to provide an overview of the first reference data collected on alcohol-based handrub (ABHR) and antiseptic soap consumption, as surrogate markers for hand hygiene compliance by healthcare workers (HCWs) in Hungarian LTCFs. The objective was to inform stakeholders on the need of hand hygiene improvement in these settings. Methods: Between 5 May and 30 September 2014, we conducted a nationwide, cross-sectional survey using a standardized self-administered questionnaire; all Hungarian LTCFs were eligible. The Statistical Package for Social Sciences (SPSS) version 20.0 was used for data analysis. Results: The questionnaire was completed by 354 LTCFs, representing 24 % of all Hungarian LTCFs. In total, the median consumption of ABHR and antimicrobial soap was 15.5 L (IQR, 0-800 L) and 60 L (IQR, 0-1,680 L) per LTCFs, and 2.2 mL (IQR, 0.4-9.1 mL) and 12.1 mL (IQR, 0.7-32.8 mL) per HCWs in 2013, respectively. The estimated number of hand hygiene actions was 0.6 hygienic handrub/HCW per day (IQR, 0-12.8/HCWs) and 2.4 hygienic handwashing/HCW per day (IQR, 0-21.9/HCWs; P = .001), respectively. Conclusions: This study suggests that non-compliance with hand hygiene is a significant problem in Hungarian LTCFs. Based on our results, there is an urgent need for a nationwide multimodal hand hygiene promotion strategy including education and performance monitoring and feedback in all LTCFs. Furthermore, monitoring of ABHR consumption constitute an additional component of the existing National Nosocomial Surveillance system.	[Szabo, Rita] Natl Ctr Epidemiol, Dept Hosp Epidemiol & Hyg, H-1097 Budapest, Hungary; [Morvai, Julia] Semmelweis Univ, Sch PHD Studies, H-1088 Budapest, Hungary; [Bellissimo-Rodrigues, Fernando; Pittet, Didier] Univ Hosp Geneva, Infect Control Programme, CH-1205 Geneva, Switzerland; [Bellissimo-Rodrigues, Fernando; Pittet, Didier] WHO Collaborating Ctr Patient Safety, Fac Med, CH-1205 Geneva, Switzerland		Szabo, R (corresponding author), Natl Ctr Epidemiol, Dept Hosp Epidemiol & Hyg, Albert Florian Ut 2-6, H-1097 Budapest, Hungary.	szabo.rita@oek.antsz.hu	Bellissimo-Rodrigues, Fernando/E-7349-2012; Morvai, Julia/E-6690-2016	Bellissimo-Rodrigues, Fernando/0000-0002-3736-7127; Pittet, Didier/0000-0002-3667-7131			Arnoldo L, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-124; Ashraf MS, 2010, INFECT CONT HOSP EP, V31, P758, DOI 10.1086/653821; Barrera L, 2011, AM J INFECT CONTROL, V39, P633, DOI 10.1016/j.ajic.2010.11.004; Bischoff WE, 2000, ARCH INTERN MED, V160, P1017, DOI 10.1001/archinte.160.7.1017; Boog MC, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-510; Cassone M, 2015, CURR GERIATR REP, V4, P87, DOI 10.1007/s13670-015-0120-2; Chan BP, 2013, INFECT CONT HOSP EP, V34, P987, DOI 10.1086/671729; Cochard H, 2014, INFECT CONT HOSP EP, V35, P384, DOI 10.1086/675599; Del Rosario-Quintana Cristobal, 2015, Rev Esp Geriatr Gerontol, V50, P232, DOI 10.1016/j.regg.2014.11.006; Eilers R, 2012, Euro Surveill, V17; Heudorf U., 2012, Eurosurveillance, V17, P20256; Ho ML, 2012, INFECT CONT HOSP EP, V33, P761, DOI 10.1086/666740; Huang TT, 2008, J HOSP INFECT, V68, P164, DOI 10.1016/j.jhin.2007.11.020; Hugonnet S, 2002, ARCH INTERN MED, V162, P1037, DOI 10.1001/archinte.162.9.1037; Lim CJ, 2014, J ANTIMICROB CHEMOTH, V69, P1972, DOI 10.1093/jac/dku077; Liu WI, 2014, INT J NURS PRACT, V20, P46, DOI 10.1111/ijn.12120; Marchi M, 2012, INFECTION, V40, P493, DOI 10.1007/s15010-012-0266-1; Mathai E, 2011, J HOSP INFECT, V77, P294, DOI 10.1016/j.jhin.2010.10.012; McGuckin M, 2009, AM J MED QUAL, V24, P205, DOI 10.1177/1062860609332369; Moro M L, 2013, Ann Ig, V25, P109, DOI 10.7416/ai.2013.1912; Ouslander JG, 2011, J AM MED DIR ASSOC, V12, P195, DOI 10.1016/j.jamda.2010.02.015; Pan A, 2008, AM J INFECT CONTROL, V36, P495, DOI 10.1016/j.ajic.2007.10.017; Pittet D, 2000, LANCET, V356, P1307, DOI 10.1016/S0140-6736(00)02814-2; Pittet D, 2001, LANCET, P9; Rita S, 2014, ORVOSI HETILAP, V155, P911, DOI 10.1556/OH.2014.29876; Rummukainen M, 2009, AM J INFECT CONTROL, V37, P168, DOI 10.1016/j.ajic.2008.09.020; Rummukainen ML, 2013, AM J INFECT CONTROL, V41, pE35, DOI 10.1016/j.ajic.2012.09.007; Ruscher C, 2015, BUNDESGESUNDHEITSBLA, V58, P436, DOI 10.1007/s00103-015-2126-5; Schweon SJ, 2013, AM J INFECT CONTROL, V41, P39, DOI 10.1016/j.ajic.2012.02.010; Smith A, 2008, AM J INFECT CONTROL, V36, P492, DOI 10.1016/j.ajic.2007.11.003; Venkatachalam I, 2014, INFECT CONT HOSP EP, V35, P519, DOI 10.1086/675823; Wojkowska-Mach J, 2013, INFECTION, V41, P1, DOI 10.1007/s15010-012-0351-5; World Health Organization, 2012, HAND HYG OUTP HOM BA; World Health Organization, 2009; Yeung WK, 2011, INFECT CONT HOSP EP, V32, P67, DOI 10.1086/657636; Zahar JR, 2012, J HOSP INFECT, V80, P348, DOI 10.1016/j.jhin.2011.10.006	36	3	4	0	11	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	2047-2994			ANTIMICROB RESIST IN	Antimicrob. Resist. Infect. Control	JUL 31	2015	4								32	10.1186/s13756-015-0069-0			7	Public, Environmental & Occupational Health; Infectious Diseases; Microbiology; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Infectious Diseases; Microbiology; Pharmacology & Pharmacy	CZ8SM	WOS:000367369400001	26236475	Green Published, gold			2022-03-04	
J	Pawlowski, J; Lejzerowicz, F; Esling, P; Apotheloz-Perret-Gentil, L; Amorim, JV; Pillet, L; Vivien, R; Cordonier, A				Pawlowski, Jan; Lejzerowicz, Franck; Esling, Philippe; Apotheloz-Perret-Gentil, Laure; Amorim, Joana Visco; Pillet, Loic; Vivien, Regis; Cordonier, Arielle			Inferring biotic indices from metabarcoding data: promises and challenges	GENOME			English	Meeting Abstract									[Pawlowski, Jan; Lejzerowicz, Franck; Apotheloz-Perret-Gentil, Laure; Amorim, Joana Visco; Pillet, Loic; Vivien, Regis] Univ Geneva, Geneva, Switzerland; [Esling, Philippe] Univ Paris, F-75252 Paris, France; [Cordonier, Arielle] Water Ecol Serv, Geneva, Switzerland			jan.pawlowski@unige.ch	Lejzerowicz, Franck/AAG-7812-2021; Vivien, Régis/AAN-2549-2020					0	0	0	1	9	CANADIAN SCIENCE PUBLISHING, NRC RESEARCH PRESS	OTTAWA	65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA	0831-2796	1480-3321		GENOME	Genome	MAY	2015	58	5					265	265					1	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	CQ8MF	WOS:000360861200301					2022-03-04	
J	Wonkam, A; Hurst, S				Wonkam, Ambroise; Hurst, Samia			A Call for Policy Action in Sub-Saharan Africa to Rethink Diagnostics for Pregnancy Affected by Sickle Cell Disease: Differential Views of Medical Doctors, Parents and Adult Patients Predict Value Conflicts in Cameroon	OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY			English	Article							PRENATAL-DIAGNOSIS; FETAL-HEMOGLOBIN; ANEMIA; PHYSICIANS; GENETICS; CHILDREN; STUDENTS; TERMINATION; INITIATION; DISORDERS	Sickle cell disease (SCD) is a debilitating illness that affects the life expectancy of patients. It is possible to test for SCD before birth, to allow for reproductive options to parents. However, under Cameroonian Law, voluntary abortion is a criminal offense and medical abortion is permitted only "... if it is done by an authorized professional and justified by the need to save the mother from grave health jeopardy." The objective of the present study was to compare the views of Cameroonian doctors, parents with at least one living SCD-affected child, and adult SCD patients, regarding prenatal genetic diagnosis and termination of SCD-affected pregnancy. We conducted a quantitative sociological survey of 110 doctors, 130 parents, and 89 adult patients. The majority accepted the prenatal genetic diagnosis for SCD (78.7%, 89.8%, and 89.2%, respectively). Parents (62.5%) were more in favor of termination of SCD-affected pregnancy, than doctors and adults patients (36.1% and 40.9% acceptance, respectively). Parents and patients who found medical abortion acceptable cited fear to have a SCD-affected child (98.1 and 88.9%) and the poor quality of the affected child's health (92.6% and 81.5%). The data underscore the urgency of policy action to place emphasis on: premarital screening, early detection and care of SCD, socio-economic measures to assist SCD-affected families, appropriateness to consider maternal distress due to fetal anomalies in medical abortion legislation. These novel findings signal potential value-based conflicts on the horizon, and can usefully inform the future policy actions in the African continent as OMICS biotechnologies are increasingly employed in global health. To the best of our knowledge, the present study is the first attempt in sub-Saharan Africa to attempt to triangulate the views of multiple stakeholders towards prenatal diagnosis of SCD and termination of an affected pregnancy.	[Wonkam, Ambroise] Univ Cape Town, Div Human Genet, Fac Hlth Sci, ZA-7925 Cape Town, South Africa; [Hurst, Samia] Univ Geneva, IEH2, Geneva, Switzerland		Wonkam, A (corresponding author), Univ Cape Town, Div Human Genet, Fac Hlth Sci, Anzio Rd Observ, ZA-7925 Cape Town, South Africa.	ambroise.wonkam@uct.ac.za	Hurst, Samia A./A-9661-2008	Hurst, Samia A./0000-0002-1980-5226	Commission for Humanitarian Affairs of the Geneva University Hospitals, Geneva, Switzerland; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1UO1HG007459-01]; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [U01HG007459] Funding Source: NIH RePORTER	For their input, we thank the patients' association, "Globule Rouge", and the parents who participated in the survey. This study was supported by the Commission for Humanitarian Affairs of the Geneva University Hospitals, Geneva, Switzerland, and the NIH no. 1UO1HG007459-01.	Animasahun BA, 2012, J PEDIAT HEMATOL ONC, V34, P252, DOI 10.1097/MPH.0b013e31824e3109; Atz AM, 1997, ANESTHESIOLOGY, V87, P988, DOI 10.1097/00000542-199710000-00037; Ballas SK, 2012, SCI WORLD J, DOI 10.1100/2012/949535; Bartolucci P, 2012, CURR OPIN HEMATOL, V19, P149, DOI 10.1097/MOH.0b013e328351c35f; Belisario AR, 2010, HEMOGLOBIN, V34, P516, DOI 10.3109/03630269.2010.526003; Boland R, 2008, INT FAM PLAN PERSPEC, V34, P110, DOI [10.1363/3411008, 10.1363/ifpp.34.110.08]; Brown BJ, 2010, HEALTH SOC CARE COMM, V18, P289, DOI 10.1111/j.1365-2524.2009.00903.x; DUROSINMI MA, 1995, SOC SCI MED, V41, P433, DOI 10.1016/0277-9536(94)00361-V; Edwin AK, 2011, PAN AFR MED J, V10; Garel M, 2002, PRENATAL DIAG, V22, P811, DOI 10.1002/pd.427; Giardiello FM, 1997, NEW ENGL J MED, V336, P823, DOI 10.1056/NEJM199703203361202; Klings ES, 2012, AM J RESP CRIT CARE, V186, P304, DOI 10.1164/rccm.201206-1126ED; Lettre G, 2008, P NATL ACAD SCI USA, V105, P11869, DOI 10.1073/pnas.0804799105; Locatelli F, 2013, BLOOD, V122, P1072, DOI 10.1182/blood-2013-03-489112; Makani J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014699; Mountcastle-Shah E, 2000, AM J MED GENET, V94, P409, DOI 10.1002/1096-8628(20001023)94:5<409::AID-AJMG13>3.0.CO;2-U; Norman BJ, 2011, SOC WORK PUBLIC HLTH, V26, P405, DOI 10.1080/19371918.2011.579488; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; Rahimy MC, 2009, J CLIN PATHOL, V62, P46, DOI 10.1136/jcp.2008.059113; Scott CJ, 2013, J COMMUN GENET, V4, P87, DOI 10.1007/s12687-012-0122-0; Shakespeare T, 1998, DISABIL SOC, V13, P665, DOI 10.1080/09687599826452; Sheth S, 2013, BRIT J HAEMATOL, V162, P455, DOI 10.1111/bjh.12413; Steinberg MH, 2012, AM J HEMATOL, V87, P795, DOI 10.1002/ajh.23232; Thein SL, 2009, HUM MOL GENET, V18, pR216, DOI 10.1093/hmg/ddp401; Ware RE, 2010, BLOOD, V116, P367; Weatherall DJ, 2008, CURR MOL MED, V8, P592, DOI 10.2174/156652408786241375; Weatherall DJ, 2001, B WORLD HEALTH ORGAN, V79, P704; Wertz DC, 2002, AM J MED GENET, V108, P29, DOI 10.1002/ajmg.10212; Wonkam A, 2006, GENET MED, V8, P331, DOI 10.1097/01.gim.0000223542.97262.21; Wonkam A, 2007, LANCET, V369, P1999, DOI 10.1016/S0140-6736(07)60938-6; Wonkam A, 2014, J MED ETHICS, V40, P615, DOI 10.1136/medethics-2013-101392; Wonkam A, 2014, J GENET COUNS, V23, P948, DOI 10.1007/s10897-014-9701-z; Wonkam A, 2014, J GENET COUNS, V23, P192, DOI 10.1007/s10897-013-9630-2; Wonkam A, 2011, PRENATAL DIAG, V31, P1210, DOI 10.1002/pd.2896; Wonkam A, 2011, J GENET COUNS, V20, P476, DOI 10.1007/s10897-011-9372-y; Wonkam A, 2011, EUR J MED GENET, V54, pE399, DOI 10.1016/j.ejmg.2011.03.013; World Bank, 2010, 48373CM WORLD BANK, P1	37	9	9	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1536-2310	1557-8100		OMICS	OMICS	JUL	2014	18	7					472	480		10.1089/omi.2013.0167			9	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biotechnology & Applied Microbiology; Genetics & Heredity	AK8ZK	WOS:000338717100009	24754796	Green Published			2022-03-04	
J	Pethleart, A; Saichua, P; Rhongbutsri, P; Leelawongtawon, R; Aree, K; Tiengtip, R; Nithikathkul, C; Nateeworanart, S; Taylor, WRJ				Pethleart, Aree; Saichua, Prasert; Rhongbutsri, Pochong; Leelawongtawon, Ratree; Aree, Kalaya; Tiengtip, Rattana; Nithikathkul, Choosak; Nateeworanart, Saengchai; Taylor, W. R. J.			PREVALENCE AND RISK FACTORS FOR PINWORM INFECTION IN THE KINDERGARTEN OF THAMMASAT UNIVERSITY, THAILAND	SOUTHEAST ASIAN JOURNAL OF TROPICAL MEDICINE AND PUBLIC HEALTH			English	Article						pinworm; Scotch-tape technique; socioeconomic status	ENTEROBIUS-VERMICULARIS; CHILDREN	We studied the prevalence and risk factors for pinworm infection in children attending the kindergarten of Thammasat University, Pathum Tham, Thailand, using the Scotch-tape technique. Slides were examined by a standard light microscope, 20% of negative slides were reexamined for quality control. Symptoms and risk factor data were collected using a structured questionnaire. Three hundred thirty children age 3 to 6 years old were sampled (males=159). Sixty-five (19.7%) had symptoms consistent with pinworm infection. No pinworm eggs were detected. Most parents (73%) had a good socioeconomic status and 64% were university graduates Pinworm infection may be uncommon in urban Thailand.	[Pethleart, Aree; Saichua, Prasert; Rhongbutsri, Pochong; Aree, Kalaya; Tiengtip, Rattana] Thammasat Univ, Fac Med, Dept Preclin Sci, Pathum Thani, Thailand; [Leelawongtawon, Ratree; Nithikathkul, Choosak] Huachiew Chalermprakiat Univ, Fac Sci & Technol, Samut Prakan, Thailand; [Nateeworanart, Saengchai] Naresuan Univ, Fac Med Sci, Pitsunulok, Thailand; [Taylor, W. R. J.] Univ Hosp Geneva, Div Int & Humanitarian Med, Geneva, Switzerland		Pethleart, A (corresponding author), Thammasat Univ, Fac Med, Dept Parasitol, Klongluang, Pathum Thani, Thailand.				Thammasat University	We are grateful to Thammasat University for financially supporting this study. We wish to thank the director and teachers of the kindergarten of Thammasat University and the parents without whose cooperation and support, this work would not have been possible.	Agbolade Olufemi Moses, 2007, Korean Journal of Parasitology, V45, P233, DOI 10.3347/kjp.2007.45.3.233; Akagi K., 1973, Progress med Parasit Japan, V5, P229; BABEKIR ARE, 1990, E AFR MED J, V67, P599; CABELLO RM, 2003, KOREAN J PARASITOL, V41, P75; Chaisalee Tisak, 2004, MedGenMed, V6, P5; Changsap B, 2002, Southeast Asian J Trop Med Public Health, V33 Suppl 3, P72; CHO S-Y, 1975, Korean Journal of Parasitology, V13, P102, DOI 10.3347/kjp.1975.13.2.102; Carvalho Thaís Batista de, 2006, Rev. Inst. Med. trop. S. Paulo, V48, P269, DOI 10.1590/S0036-46652006000500006; GILMAN RH, 1991, T ROY SOC TROP MED H, V85, P761, DOI 10.1016/0035-9203(91)90448-8; Herrstrom P, 1997, SCAND J PRIM HEALTH, V15, P146, DOI 10.3109/02813439709018505; KAEWKES S, 1983, PARASITOL TROP MED A, P19; KHAN JS, 1981, BRIT J OBSTET GYNAEC, V88, P681, DOI 10.1111/j.1471-0528.1981.tb01230.x; Kim Bong Jin, 2001, Korean Journal of Parasitology, V39, P323, DOI 10.3347/kjp.2001.39.4.323; Mercado R, 1996, Bol Chil Parasitol, V51, P91; Nithikathkul C, 2001, Southeast Asian J Trop Med Public Health, V32 Suppl 2, P133; Nithikathkul Choosak, 2003, Southeast Asian J Trop Med Public Health, V34 Suppl 2, P25; Oezguemues Osman Birol, 2007, Turkiye Parazitoloji Dergisi, V31, P205; Requena Ixora, 2007, Invest. clín, V48, P277; Saksirisampant Wilai, 2004, Journal of the Medical Association of Thailand, V87, pS278; Singh H. Lokhendro, 2004, Journal of Communicable Diseases, V36, P111; Tepmongkol M., 1980, Siriraj Hospital Gazette, V32, P597; TRITEERAPRAPAB S, 2007, COMPUTER ASSISTED IN; Tukaew A, 2002, Southeast Asian J Trop Med Public Health, V33 Suppl 3, P70; VAJARASTHIRA A, 1960, ANN TROP MED PARASIT, V54, P129; Yoon Hyung-Jun, 2000, Korean Journal of Parasitology, V38, P279, DOI 10.3347/kjp.2000.38.4.279	25	0	0	0	0	SOUTHEAST ASIAN MINISTERS EDUC ORGANIZATION	BANGKOK	SEAMEO-TROPMED, 420-6 RAJVITHI RD,, BANGKOK 10400, THAILAND	0125-1562			SE ASIAN J TROP MED	Southeast Asian J. Trop. Med. Public Health	MAR	2010	41	2					306	310					5	Public, Environmental & Occupational Health; Infectious Diseases; Tropical Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Infectious Diseases; Tropical Medicine	583WN	WOS:000276710900006	20578512				2022-03-04	
J	Cheng, PF; Shakhova, O; Widmer, DS; Eichhoff, OM; Zingg, D; Frommel, SC; Belloni, B; Raaijmakers, MIG; Goldinger, SM; Santoro, R; Hemmi, S; Sommer, L; Dummer, R; Levesque, MP				Cheng, Phil F.; Shakhova, Olga; Widmer, Daniel S.; Eichhoff, Ossia M.; Zingg, Daniel; Frommel, Sandra C.; Belloni, Benedetta; Raaijmakers, Marieke I. G.; Goldinger, Simone M.; Santoro, Raffaella; Hemmi, Silvio; Sommer, Lukas; Dummer, Reinhard; Levesque, Mitchell P.			Methylation-dependent SOX9 expression mediates invasion in human melanoma cells and is a negative prognostic factor in advanced melanoma	GENOME BIOLOGY			English	Article							ABERRANT DNA METHYLATION; TRANSCRIPTION FACTOR; CUTANEOUS MELANOMA; GENE-EXPRESSION; DISTINCT SUBPOPULATION; MALIGNANT-MELANOMA; INITIATING CELLS; NEURAL CREST; IN-VITRO; PHENOTYPE	Background: Melanoma is the most fatal skin cancer displaying a high degree of molecular heterogeneity. Phenotype switching is a mechanism that contributes to melanoma heterogeneity by altering transcription profiles for the transition between states of proliferation/differentiation and invasion/stemness. As phenotype switching is reversible, epigenetic mechanisms, like DNA methylation, could contribute to the changes in gene expression. Results: Integrative analysis of methylation and gene expression datasets of five proliferative and five invasion melanoma cell cultures reveal two distinct clusters. SOX9 is methylated and lowly expressed in the highly proliferative group. SOX9 overexpression results in decreased proliferation but increased invasion in vitro. In a B16 mouse model, sox9 overexpression increases the number of lung metastases. Transcriptional analysis of SOX9-overexpressing melanoma cells reveals enrichment in epithelial to mesenchymal transition (EMT) pathways. Survival analysis of The Cancer Genome Atlas melanoma dataset shows that metastatic patients with high expression levels of SOX9 have significantly worse survival rates. Additional survival analysis on the targets of SOX9 reveals that most SOX9 downregulated genes have survival benefit for metastatic patients. Conclusions: Our genome-wide DNA methylation and gene expression study of 10 early passage melanoma cell cultures reveals two phenotypically distinct groups. One of the genes regulated by DNA methylation between the two groups is SOX9. SOX9 induces melanoma cell invasion and metastasis and decreases patient survival. A number of genes downregulated by SOX9 have a negative impact on patient survival. In conclusion, SOX9 is an important gene involved in melanoma invasion and negatively impacts melanoma patient survival.	[Cheng, Phil F.; Widmer, Daniel S.; Eichhoff, Ossia M.; Belloni, Benedetta; Raaijmakers, Marieke I. G.; Goldinger, Simone M.; Dummer, Reinhard; Levesque, Mitchell P.] Univ Zurich Hosp, Fac Med, Dept Dermatol, CH-8952 Zurich, Switzerland; [Cheng, Phil F.; Widmer, Daniel S.; Eichhoff, Ossia M.; Belloni, Benedetta; Raaijmakers, Marieke I. G.; Goldinger, Simone M.; Dummer, Reinhard; Levesque, Mitchell P.] Univ Zurich, CH-8952 Zurich, Switzerland; [Shakhova, Olga; Zingg, Daniel; Sommer, Lukas] Univ Zurich, Inst Anat, Cell & Dev Biol, CH-8952 Zurich, Switzerland; [Frommel, Sandra C.; Santoro, Raffaella] Univ Zurich, Inst Vet Biochem & Mol Biol, CH-8952 Zurich, Switzerland		Levesque, MP (corresponding author), Univ Zurich Hosp, Fac Med, Dept Dermatol, Wagistr 14, CH-8952 Zurich, Switzerland.	mitchellpaul.levesque@usz.ch	Santoro, Raffaella/L-2637-2013; Cheng, Phil/AAN-8567-2021	Cheng, Phil/0000-0003-2940-006X; Zingg, Daniel/0000-0001-6450-2534; Sommer, Lukas/0000-0002-1143-7908	Georg und Bertha Schwyzer-Winiker Stiftung; Forschungskredit [FK-13-042]; Swiss Cancer League; Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission; Promedica Foundation; Verein fur Hautkrebsforschung; Cancer Biology PhD Program of the University/ETH Zurich	This work was financially supported by the Georg und Bertha Schwyzer-Winiker Stiftung (RD), the Forschungskredit FK-13-042 (PFC), the Swiss Cancer League and the Swiss National Science Foundation (LS, MPL), the Promedica Foundation (OS), and the Verein fur Hautkrebsforschung (MPL). The University Research Priority Program (URPP) in translational cancer research at the University of Zurich provided cell lines used in this work. We thank the Cancer Biology PhD Program of the University/ETH Zurich for support and advice. We would also like to thank The Cancer Genome Atlas (TCGA) for providing important clinical and genomic data. Finally, all research on human materials was done according to Swiss law and following the Declaration of Helsinki on medical research. Consenting patients contributed surplus melanoma biopsy material according to IRB approval numbers (Ek.647/800), and cell lines were generated following IRB KEK-ZH-Nr.2014-0425.	Alcazar O, 2012, INT J CANCER, V131, P18, DOI 10.1002/ijc.26320; Aryee MJ, 2014, BIOINFORMATICS, V30, P1363, DOI 10.1093/bioinformatics/btu049; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Bell DM, 1997, NAT GENET, V16, P174, DOI 10.1038/ng0697-174; Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; Bonazzi VF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026121; Carreira S, 2006, GENE DEV, V20, P3426, DOI 10.1101/gad.406406; Cheli Y, 2011, ONCOGENE, V30, P2307, DOI 10.1038/onc.2010.598; Cheung M, 2003, DEVELOPMENT, V130, P5681, DOI 10.1242/dev.00808; Conway K, 2011, PIGM CELL MELANOMA R, V24, P352, DOI 10.1111/j.1755-148X.2011.00828.x; Cook AL, 2005, EXP CELL RES, V308, P222, DOI 10.1016/j.yexcr.2005.04.019; Deng T, 2009, BIOCHEM BIOPH RES CO, V387, P611, DOI 10.1016/j.bbrc.2009.07.093; Dupin E, 2003, ONCOGENE, V22, P3016, DOI 10.1038/sj.onc.1206460; Eichhoff OM, 2011, PIGM CELL MELANOMA R, V24, P631, DOI 10.1111/j.1755-148X.2011.00871.x; Eichhoff OM, 2010, MELANOMA RES, V20, P349, DOI 10.1097/CMR.0b013e32833bd89e; Fraga MF, 2004, CANCER RES, V64, P5527, DOI 10.1158/0008-5472.CAN-03-4061; Freedman JA, 2011, AM J PATHOL, V178, P2513, DOI 10.1016/j.ajpath.2011.02.037; Garbe C, 2009, CLIN DERMATOL, V27, P3, DOI 10.1016/j.clindermatol.2008.09.001; Geertsen RC, 1998, J INVEST DERMATOL, V111, P497, DOI 10.1046/j.1523-1747.1998.00305.x; Goodall J, 2008, CANCER RES, V68, P7788, DOI 10.1158/0008-5472.CAN-08-1053; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Hendrix MJC, 2007, NAT REV CANCER, V7, P246, DOI 10.1038/nrc2108; Hendrix MJC, 2003, ONCOGENE, V22, P3070, DOI 10.1038/sj.onc.1206447; Hoek KS, 2006, PIGM CELL RES, V19, P290, DOI 10.1111/j.1600-0749.2006.00322.x; Hoek KS, 2008, CANCER RES, V68, P650, DOI 10.1158/0008-5472.CAN-07-2491; Hoek KS, 2010, PIGM CELL MELANOMA R, V23, P746, DOI 10.1111/j.1755-148X.2010.00757.x; Kadaja M, 2014, GENE DEV, V28, P328, DOI 10.1101/gad.233247.113; Koga Y, 2009, GENOME RES, V19, P1462, DOI 10.1101/gr.091447.109; Landsberg J, 2012, NATURE, V490, P412, DOI 10.1038/nature11538; Lian CG, 2012, CELL, V150, P1135, DOI 10.1016/j.cell.2012.07.033; MacKie RM, 2009, ANN ONCOL, V20, P1, DOI 10.1093/annonc/mdp252; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; Mihic-Probst D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033571; Molognoni F, 2011, EPIGENETICS-US, V6, P451, DOI 10.4161/epi.6.4.14917; Muthusamy V, 2006, CANCER RES, V66, P11187, DOI 10.1158/0008-5472.CAN-06-1274; Nguyen T, 2011, EPIGENETICS-US, V6, P388, DOI 10.4161/epi.6.3.14056; Passeron T, 2007, P NATL ACAD SCI USA, V104, P13984, DOI 10.1073/pnas.0705117104; Passeron T, 2009, J CLIN INVEST, V119, P954, DOI 10.1172/JCI34015; Perego M, 2010, J INVEST DERMATOL, V130, P1877, DOI 10.1038/jid.2010.69; Peres J, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-117; Plass C, 2002, HUM MOL GENET, V11, P2479, DOI 10.1093/hmg/11.20.2479; Quintana E, 2010, CANCER CELL, V18, P510, DOI 10.1016/j.ccr.2010.10.012; Raaijmakers MIG, 2015, EXP DERMATOL; Rajasekaran K, 2013, NAT IMMUNOL, V14, P1127, DOI 10.1038/ni.2708; Rodriguez M, 2008, CANCER RES, V68, P7872, DOI 10.1158/0008-5472.CAN-08-0301; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Romano E, 2011, LANCET ONCOL, V12, P913, DOI 10.1016/S1470-2045(10)70274-6; Santoro R, 2014, METHODS MOL BIOL, V1094, P319, DOI 10.1007/978-1-62703-706-8_25; Schinke C, 2010, MELANOMA RES, V20, P253, DOI 10.1097/CMR.0b013e328338a35a; Shakhova O, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004877; Sigalotti L, 2002, J IMMUNOTHER, V25, P16, DOI 10.1097/00002371-200201000-00002; Smyth G.K., 2005, LIMMA LINEAR MODELS; Smyth GK., 2004, STAT APPL GENET MOL, V3, P1, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Widmer DS, 2013, J INVEST DERMATOL, V133, P2436, DOI 10.1038/jid.2013.115; Widmer DS, 2012, PIGM CELL MELANOMA R, V25, P343, DOI 10.1111/j.1755-148X.2012.00986.x; Zipser MC, 2011, PIGM CELL MELANOMA R, V24, P326, DOI 10.1111/j.1755-148X.2010.00823.x	57	43	44	0	5	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1465-6906	1474-760X		GENOME BIOL	Genome Biol.	FEB 22	2015	16								42	10.1186/s13059-015-0594-4			16	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	CE4TJ	WOS:000351822800002	25885555	Green Accepted, Green Published, gold			2022-03-04	
J	Thorens, G; Khan, R; Khazaal, Y; Zullino, D				Thorens, Gabriel; Khan, Riaz; Khazaal, Yasser; Zullino, Daniele			Tragic Logic or How Evidence Does Not Change Convictions The Perception of Geneva's Addictology Caregivers Concerning the Utility of Disulfiram	JOURNAL OF ADDICTIONS NURSING			English	Article						alcohol; disufiram; perception	ALCOHOL-USE DISORDERS; SUBSTANCE USE	In December 2007, the Division of Addictology, Department of Psychiatry, Geneva University Hospitals, decided to stop prescribing disulfiram. The healthcare team's perception of this decision was monitored. A self-administered questionnaire (31 questions) was completed by the healthcare team in June 2009 over a 3-month period to evaluate their perception of the utility of disulfiram and of the pertinence of the decision to stop prescribing it. Fifty-five participants responded (61.1%), of whom 54.1% were women (mean age = 43.7 years), 54.8% were nurses, 30.6% were medical doctors, 9.7% were social workers, and 4.8% were psychologists. Of this group, 78.7% were working on the team in December 2007. The results showed that 54.6% did not agree with the decision to stop prescribing disulfiram. Although 72.2% thought that the decision was based on evidence-based medicine (EBM), 69.1% thought that disulfiram works because of the context of administration and 69.1% because of the fear generated by its effects. Among the participants, 75.5% still believed that disulfiram is useful for some patients (76.8% at the time of the decision). Despite the fact that aversive treatment in addictology has failed to demonstrate efficacy through EBM, the perception of its utility is still strong in caregivers. Although most caregivers acknowledge that aversive treatment works mainly through psychological constraints, they do not support the fact that EBM could generate a practice change such as discontinuing the prescription of disulfiram.	[Thorens, Gabriel; Khan, Riaz; Khazaal, Yasser; Zullino, Daniele] Univ Hosp Geneva, Div Addictol, CH-1202 Geneva, Switzerland		Thorens, G (corresponding author), Univ Hosp Geneva, Div Addictol, Rue Grand Pre 70C, CH-1202 Geneva, Switzerland.	gabriel.thorens@hcuge.ch		khazaal, yasser/0000-0002-8549-6599			Buri C, 2007, ALCOHOL ALCOHOLISM, V42, P333, DOI 10.1093/alcalc/agm038; Chick J, 1999, DRUG SAFETY, V20, P427, DOI 10.2165/00002018-199920050-00003; Fornili K, 2005, J ADDICT NURS, V16, P153, DOI 10.1080/10884600500231946; FULLER RK, 1986, JAMA-J AM MED ASSOC, V256, P1449, DOI 10.1001/jama.256.11.1449; Hill Terry E, 2010, Philos Ethics Humanit Med, V5, P11, DOI 10.1186/1747-5341-5-11; Schuckit MA, 2009, LANCET, V373, P492, DOI 10.1016/S0140-6736(09)60009-X; Soyka M, 2008, WORLD J BIOL PSYCHIA, V9, P6, DOI 10.1080/15622970801896390; Work Group on Substance Use Disorders, 2006, Am J Psychiatry, V163, P5	8	0	0	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1088-4602			J ADDICT NURS	J. Addict. Nurs.	DEC	2012	23	4					255	257		10.1097/JAN.0b013e31826f68d9			3	Substance Abuse; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Substance Abuse; Nursing	185LN	WOS:000321969500006	24622495				2022-03-04	
J	Dieudonne, FX; O'Connor, PBF; Gubler-Jaquier, P; Yasrebi, H; Conne, B; Nikolaev, S; Antonarakis, S; Baranov, PV; Curran, J				Dieudonne, Francois-Xavier; O'Connor, Patrick B. F.; Gubler-Jaquier, Pascale; Yasrebi, Haleh; Conne, Beatrice; Nikolaev, Sergey; Antonarakis, Stylianos; Baranov, Pavel V.; Curran, Joseph			The effect of heterogeneous Transcription Start Sites (TSS) on the translatome: implications for the mammalian cellular phenotype	BMC GENOMICS			English	Article						Translatome; Transcriptome; Proteome; 5 ' mRNA heterogeneity; 5 ' transcript leader; Translation; Cancer	OPEN READING FRAMES; TRANSFER-RNA SYNTHETASES; MEDIATED GENE-REGULATION; 5' UNTRANSLATED REGION; MESSENGER-RNA; BREAST-CANCER; EUKARYOTIC RIBOSOMES; MOLECULAR-MECHANISM; OSTEOSARCOMA CELLS; PROTEIN EXPRESSION	Background: The genetic program, as manifested as the cellular phenotype, is in large part dictated by the cell's protein composition. Since characterisation of the proteome remains technically laborious it is attractive to define the genetic expression profile using the transcriptome. However, the transcriptional landscape is complex and it is unclear as to what extent it reflects the ribosome associated mRNA population (the translatome). This is particularly pertinent for genes using multiple transcriptional start sites (TSS) generating mRNAs with heterogeneous 5' transcript leaders (5'TL). Furthermore, the relative abundance of the TSS gene variants is frequently cell-type specific. Indeed, promoter switches have been reported in pathologies such as cancer. The consequences of this 5'TL heterogeneity within the transcriptome for the translatome remain unresolved. This is not a moot point because the 5'TL plays a key role in regulating mRNA recruitment onto polysomes. Results: In this article, we have characterised both the transcriptome and translatome of the MCF7 (tumoural) and MCF10A (non-tumoural) cell lines. We identified similar to 550 genes exhibiting differential translation efficiency (TE). In itself, this is maybe not surprising. However, by focusing on genes exhibiting TSS heterogeneity we observed distinct differential promoter usage patterns in both the transcriptome and translatome. Only a minor fraction of these genes belonged to those exhibiting differential TE. Nonetheless, reporter assays demonstrated that the TSS variants impacted on the translational readout both quantitatively (the overall amount of protein expressed) and qualitatively (the nature of the proteins expressed). Conclusions: The results point to considerable and distinct cell-specific 5'TL heterogeneity within both the transcriptome and translatome of the two cell lines analysed. This observation is in-line with the ribosome filter hypothesis which posits that the ribosomal machine can selectively filter information from within the transcriptome. As such it cautions against the simple extrapolation transcriptome. proteome. Furthermore, polysomal occupancy of specific gene 5'TL variants may also serve as novel disease biomarkers.	[Dieudonne, Francois-Xavier; Gubler-Jaquier, Pascale; Yasrebi, Haleh; Conne, Beatrice; Curran, Joseph] Univ Geneva, Sch Med, Dept Microbiol & Mol Med, CH-1211 Geneva, Switzerland; [O'Connor, Patrick B. F.; Baranov, Pavel V.] Natl Univ Ireland Univ Coll Cork, Sch Biochem & Cell Biol, Cork, Ireland; [Conne, Beatrice; Nikolaev, Sergey; Antonarakis, Stylianos] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Antonarakis, Stylianos; Curran, Joseph] Univ Geneva, Inst Genet & Genom Geneva iGE3, Geneva, Switzerland		Curran, J (corresponding author), Univ Geneva, Sch Med, Dept Microbiol & Mol Med, CH-1211 Geneva, Switzerland.	Joseph.Curran@unige.ch	Baranov, Pavel/A-2782-2011; Antonarakis, Stylianos E/N-8866-2014	Baranov, Pavel/0000-0001-9017-0270; Antonarakis, Stylianos E/0000-0001-8907-5823	Ligue Genevoise Contre le Cancer; Swiss Science FoundationSwiss National Science Foundation (SNSF); University of Geneva; Wellcome TrustWellcome TrustEuropean Commission [094423]	We would also like to acknowledge the assistance of Dr. Stephano Mandriota with the MCF7 and MCF10A cells lines. J.C would like to acknowledge the support of the Ligue Genevoise Contre le Cancer, the Swiss Science Foundation and the University of Geneva. PV.B would like to acknowledge the support of the Wellcome Trust (grant 094423).	Anderson EC, 2007, J GEN VIROL, V88, P3043, DOI 10.1099/vir.0.82463-0; Andreev DE, 2015, ELIFE, V4, DOI 10.7554/eLife.03971; Araud T, 2007, NUCLEIC ACIDS RES, V35, P4649, DOI 10.1093/nar/gkm482; Arce L, 2006, ONCOGENE, V25, P7492, DOI 10.1038/sj.onc.1210056; Arribere JA, 2013, GENOME RES, V23, P977, DOI 10.1101/gr.150342.112; Bicker A, 2014, HUM MOL GENET, V23, P479, DOI 10.1093/hmg/ddt438; Brown CY, 1999, ONCOGENE, V18, P5631, DOI 10.1038/sj.onc.1202949; Brun J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055034; Burkart C, 2012, J BIOL CHEM, V287, P4883, DOI 10.1074/jbc.M111.255570; Bushell M, 2006, MOL CELL, V23, P401, DOI 10.1016/j.molcel.2006.06.012; Calvo SE, 2009, P NATL ACAD SCI USA, V106, P7507, DOI 10.1073/pnas.0810916106; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Casadei R, 2003, GENE, V321, P185, DOI 10.1016/S0378-1119(03)00835-7; Cazzola M, 2000, BLOOD, V95, P3280, DOI 10.1182/blood.V95.11.3280.011k41_3280_3288; Chappell SA, 2006, P NATL ACAD SCI USA, V103, P18077, DOI 10.1073/pnas.0608212103; Churbanov A, 2005, NUCLEIC ACIDS RES, V33, P5512, DOI 10.1093/nar/gki847; Davuluri RV, 2008, TRENDS GENET, V24, P167, DOI 10.1016/j.tig.2008.01.008; Dieudonne FX, 2012, J BONE MINER RES, V27, P2118, DOI 10.1002/jbmr.1650; Dieudonne FX, 2010, CANCER RES, V70, P5399, DOI 10.1158/0008-5472.CAN-10-0090; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Domingo E, 2012, MICROBIOL MOL BIOL R, V76, P159, DOI 10.1128/MMBR.05023-11; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Dutertre M, 2010, CANCER RES, V70, P3760, DOI 10.1158/0008-5472.CAN-09-3988; Dutertre M, 2010, CANCER RES, V70, P896, DOI 10.1158/0008-5472.CAN-09-2703; Eswaran J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00264; Genolet R, 2011, NUCLEIC ACIDS RES, V39, P989, DOI 10.1093/nar/gkq805; Genolet R, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-33; GETZ MJ, 1976, CELL, V7, P255, DOI 10.1016/0092-8674(76)90025-8; Gillis LD, 2013, ONCOGENE, V32, P3598, DOI 10.1038/onc.2012.371; Goossens S, 2007, FASEB J, V21, P647, DOI 10.1096/fj.06-6066com; Gu WJ, 2014, RNA, V20, P1369, DOI 10.1261/rna.044792.114; Guo M, 2010, NAT REV MOL CELL BIO, V11, P668, DOI 10.1038/nrm2956; Hamada T, 2014, ONCOTARGET, V5, P6076, DOI 10.18632/oncotarget.2161; Hinnebusch AG, 2011, MICROBIOL MOL BIOL R, V75, P434, DOI 10.1128/MMBR.00008-11; Huang YM, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001703; Iacono M, 2005, GENE, V349, P97, DOI 10.1016/j.gene.2004.11.041; Ingolia NT, 2014, NAT REV GENET, V15, P205, DOI 10.1038/nrg3645; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Ivanov IP, 2011, NUCLEIC ACIDS RES, V39, P4220, DOI 10.1093/nar/gkr007; Jacot W, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-523; Justenhoven C, 2009, INT J CANCER, V124, P2077, DOI 10.1002/ijc.24198; Kim S, 2011, NAT REV CANCER, V11, P708, DOI 10.1038/nrc3124; Kozak M, 2001, NUCLEIC ACIDS RES, V29, P5226, DOI 10.1093/nar/29.24.5226; KOZAK M, 1987, MOL CELL BIOL, V7, P3438, DOI 10.1128/MCB.7.10.3438; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Legrand N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102890; Lu B, 2005, GENE THER, V12, P330, DOI 10.1038/sj.gt.3302385; Machida RJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101812; Mauro VP, 2007, CELL CYCLE, V6, P2246, DOI 10.4161/cc.6.18.4739; Mauro VP, 2002, P NATL ACAD SCI USA, V99, P12031, DOI 10.1073/pnas.192442499; McDade SS, 2007, HUM MOL GENET, V16, P742, DOI 10.1093/hmg/ddm003; Meijer HA, 2013, SCIENCE, V340, P82, DOI 10.1126/science.1231197; Merrick WC, 2010, J BIOL CHEM, V285, P21197, DOI 10.1074/jbc.R110.111476; Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078; Narla A, 2010, BLOOD, V115, P3196, DOI 10.1182/blood-2009-10-178129; Pal S, 2011, GENOME RES, V21, P1260, DOI 10.1101/gr.120535.111; Pickering BM, 2005, SEMIN CELL DEV BIOL, V16, P39, DOI 10.1016/j.semcdb.2004.11.006; Plank TDM, 2013, NUCLEIC ACIDS RES, V41, P6698, DOI 10.1093/nar/gkt358; Pozner A, 2000, MOL CELL BIOL, V20, P2297, DOI 10.1128/MCB.20.7.2297-2307.2000; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Rahim G, 2012, MOL CELL BIOL, V32, P1745, DOI 10.1128/MCB.06751-11; Rajasekhar VK, 2003, MOL CELL, V12, P889, DOI 10.1016/S1097-2765(03)00395-2; Robert F, 2013, WIRES RNA, V4, P333, DOI 10.1002/wrna.1163; Rojas-Duran MF, 2012, RNA, V18, P2299, DOI 10.1261/rna.035865.112; Saitoh T, 2002, INT J MOL MED, V10, P345; Sauer T, 2005, CYTOPATHOLOGY, V16, P193, DOI 10.1111/j.1365-2303.2005.00257.x; Somers J, 2013, INT J BIOCHEM CELL B, V45, P1690, DOI 10.1016/j.biocel.2013.04.020; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; SUSSMAN M, 1970, NATURE, V225, P1245, DOI 10.1038/2251245a0; Szamecz B, 2008, GENE DEV, V22, P2414, DOI 10.1101/gad.480508; Thorsen K, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-505; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wethmar K, 2010, BIOESSAYS, V32, P885, DOI 10.1002/bies.201000037; Wethmar K, 2010, GENE DEV, V24, P15, DOI 10.1101/gad.557910; Wiesenthal V, 2006, NAT PROTOC, V1, P1531, DOI 10.1038/nprot.2006.274; Yamashita R, 2011, GENOME RES, V21, P775, DOI 10.1101/gr.110254.110	76	13	13	0	6	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2164			BMC GENOMICS	BMC Genomics	NOV 21	2015	16								986	10.1186/s12864-015-2179-8			15	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	CW8YH	WOS:000365284900005	26589636	Green Published, gold			2022-03-04	
J	Saigi-Morgui, N; Vandenberghe, F; Delacretaz, A; Quteineh, L; Gholamrezaee, M; Aubry, JM; von Gunten, A; Kutalik, Z; Conus, P; Eap, CB				Saigi-Morgui, Nuria; Vandenberghe, Frederik; Delacretaz, AurLie; Quteineh, Lina; Gholamrezaee, Mehdi; Aubry, Jean-Michel; von Gunten, Armin; Kutalik, Zoltan; Conus, Philippe; Eap, Chin B.			Association of genetic risk scores with body mass index in Swiss psychiatric cohorts	PHARMACOGENETICS AND GENOMICS			English	Article						body mass index; genetic risk score; psychiatry; psychotropic drugs	11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1; LINEAR MIXED MODELS; COMMON VARIANTS; SUSCEPTIBILITY LOCI; METABOLIC SYNDROME; IDENTIFIES COMMON; ENERGY-BALANCE; FAT MASS; OBESITY; WEIGHT	Objective Weight gain is associated with psychiatric disorders and/or with psychotropic drug treatments. We analyzed in three psychiatric cohorts under psychotropic treatment the association of weighted genetic risk scores (w-GRSs) with BMI by integrating BMI-related polymorphisms from the candidate-gene approach and Genome-Wide Association Studies (GWAS). Materials and methods w-GRS of 32 polymorphisms associated previously with BMI in general population GWAS and 20 polymorphisms associated with antipsychotics-induced weight gain were investigated in three independent psychiatric samples. Results w-GRS of 32 polymorphisms were significantly associated with BMI in the psychiatric sample 1 (n=425) and were replicated in another sample (n=177). Those at the percentile 95 (p95) of the score had 2.26 and 2.99 kg/m(2) higher predicted BMI compared with individuals at the percentile 5 (p5) in sample 1 and in sample 3 (P=0.009 and 0.04, respectively). When combining all samples together (n=750), a significant difference of 1.89 kg/m(2) predicted BMI was found between p95 and p5 individuals at 12 months of treatment. Stronger associations were found among men (difference: 2.91k g/m(2) of predicted BMI between p95 and p5, P=0.0002), whereas no association was found among women. w-GRS of 20 polymorphisms was not associated with BMI. The w-GRS of 52 polymorphisms and the clinical variables (age, sex, treatment) explained 1.99 and 3.15%, respectively, of BMI variability. Conclusion The present study replicated in psychiatric cohorts previously identified BMI risk variants obtained in GWAS analyses from population-based samples. Sex-specific analysis should be considered in further analysis. (C) 2016 Wolters Kluwer Health, Inc. All rights reserved.	[Saigi-Morgui, Nuria; Vandenberghe, Frederik; Delacretaz, AurLie; Quteineh, Lina; Eap, Chin B.] Univ Lausanne Hosp, Ctr Psychiat Neurosci, Dept Psychiat, Unit Pharmacogenet & Clin Psychopharmacol, CH-1008 Prilly, Switzerland; [Gholamrezaee, Mehdi] Univ Lausanne Hosp, Ctr Psychiat Epidemiol & Psychopathol, Dept Psychiat, Prilly, South Korea; [von Gunten, Armin] Univ Lausanne Hosp, Dept Psychiat, Serv Old Age Psychiat, Prilly, South Korea; [Conus, Philippe] Univ Lausanne Hosp, Dept Psychiat, Serv Gen Psychiat, Prilly, South Korea; [Aubry, Jean-Michel] Univ Hosp Geneva, Dept Mental Hlth & Psychiat, Geneva, South Korea; [Eap, Chin B.] Univ Lausanne, Univ Geneva, Sch Pharmaceut Sci, CH-1015 Lausanne, Switzerland; [Kutalik, Zoltan] Univ Lausanne Hosp, Inst Social & Prevent Med IUMSP, Lausanne, Switzerland; [Kutalik, Zoltan] Swiss Inst Bioinformat, Lausanne, Switzerland		Eap, CB (corresponding author), Univ Lausanne Hosp, Ctr Psychiat Neurosci, Dept Psychiat, Unit Pharmacogenet & Clin Psychopharmacol, CH-1008 Prilly, Switzerland.; Eap, CB (corresponding author), Univ Lausanne, Univ Geneva, Sch Pharmaceut Sci, CH-1015 Lausanne, Switzerland.	chin.eap@chuv.ch		Saigi, Nuria/0000-0003-2503-1818; von Gunten, Armin/0000-0001-7852-3803; Eap, Chin/0000-0002-5439-0230; Vandenberghe, Frederik/0000-0002-8964-2047; Conus, Philippe/0000-0002-5832-1910	Swiss National Research FoundationSwiss National Science Foundation (SNSF) [320030-120686, 324730-144064]; Leenaards Foundation; Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission [31003A-143914]	This work has been funded in part by the Swiss National Research Foundation (C.B.E. and P.C.: 320030-120686 and 324730-144064). Z.K. received support from the Leenaards Foundation and the Swiss National Science Foundation (31003A-143914). The funding sources played no role in the writing of the manuscript or in the decision to submit it for publication.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; [Anonymous], 1991, Eur J Clin Pharmacol, V40, P543; Balt SL, 2011, CLIN PHARMACOL THER, V90, P179, DOI 10.1038/clpt.2011.97; Barrett E, 2004, OBES RES, V12, P362; Beale EG, 2007, CELL BIOCHEM BIOPHYS, V48, P89, DOI 10.1007/s12013-007-0025-6; Belsky DW, 2013, BIODEMOGR SOC BIOL, V59, P85, DOI 10.1080/19485565.2013.774628; Berndt SI, 2013, NAT GENET, V45, P501, DOI 10.1038/ng.2606; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Che Ronglin, 2012, Stat Appl Genet Mol Biol, V11, P15, DOI 10.1515/1544-6115.1796; Choong E, 2013, JAMA PSYCHIAT, V70, P1011, DOI 10.1001/jamapsychiatry.2013.187; De Hert M, 2009, EUR PSYCHIAT, V24, P412, DOI 10.1016/j.eurpsy.2009.01.005; Hert M, 2012, NAT REV ENDOCRINOL, V8, P114, DOI 10.1038/nrendo.2011.156; Derks EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037852; Dorajoo R, 2012, INT J OBESITY, V36, P159, DOI 10.1038/ijo.2011.86; Esterbauer H, 1999, GENOMICS, V62, P98, DOI 10.1006/geno.1999.5977; Farooqi IS, 2005, ANNU REV MED, V56, P443, DOI 10.1146/annurev.med.56.062904.144924; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gibson WT, 2004, OBES RES, V12, P743, DOI 10.1038/oby.2004.89; Goumidi L, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-62; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Horne BD, 2005, ANN HUM GENET, V69, P176, DOI 10.1046/j.1529-8817.2005.00155.x; Hung CF, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0334-3; Hung CF, 2014, BRIT J PSYCHIAT, V205, P24, DOI 10.1192/bjp.bp.113.130419; Katzmarzyk PT, 2000, AM J HUM BIOL, V12, P395, DOI 10.1002/(SICI)1520-6300(200005/06)12:3<395::AID-AJHB10>3.0.CO;2-J; Keshavarz P, 2008, MOL GENET METAB, V93, P200, DOI 10.1016/j.ymgme.2007.08.125; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Lett TAP, 2012, MOL PSYCHIATR, V17, P242, DOI 10.1038/mp.2011.109; Lin X, 2009, DIABETOLOGIA, V52, P600, DOI 10.1007/s00125-008-1254-y; Lin XH, 1999, J ROY STAT SOC B, V61, P381, DOI 10.1111/1467-9868.00183; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Lopresti AL, 2013, PROG NEURO-PSYCHOPH, V45, P92, DOI 10.1016/j.pnpbp.2013.05.005; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; Ntalla I, 2013, ANN HUM GENET, V77, P268, DOI 10.1111/ahg.12012; Okada Y, 2012, NAT GENET, V44, P302, DOI 10.1038/ng.1086; Paterson JM, 2004, P NATL ACAD SCI USA, V101, P7088, DOI 10.1073/pnas.0305524101; Pei YF, 2014, HUM MOL GENET, V23, P820, DOI 10.1093/hmg/ddt464; Peterson RE, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-368; Power ML, 2008, BRIT J NUTR, V99, P931, DOI 10.1017/S0007114507853347; Quteineh L, 2015, PHARMACOGENET GENOM, V25, P246, DOI 10.1097/FPC.0000000000000131; R Core Team, 2021, R LANG ENV STAT COMP; Rouskas K, 2012, OBESITY, V20, P389, DOI 10.1038/oby.2011.177; Rui L, 2014, WORLD J DIABETES, V5, P511, DOI 10.4239/wjd.v5.i4.511; Ryu S, 2007, PROG NEURO-PSYCHOPH, V31, P673, DOI 10.1016/j.pnpbp.2006.12.021; Sadagurski M, 2012, CELL METAB, V15, P703, DOI 10.1016/j.cmet.2012.04.011; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Stahl SM., 2013, STAHLS ESSENTIAL PSY; Strobel A, 1998, NAT GENET, V18, P213, DOI 10.1038/ng0398-213; STUNKARD AJ, 1986, NEW ENGL J MED, V314, P193, DOI 10.1056/NEJM198601233140401; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Tomlinson JW, 2004, ENDOCR REV, V25, P831, DOI 10.1210/er.2003-0031; Venables W.N., 2002, MODERN APPL STAT S; Voight BF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002793; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Waalen J, 2014, TRANSL RES, V164, P293, DOI 10.1016/j.trsl.2014.05.010; Wali JA, 2014, DIABETES METAB SYNDR, V7, P331, DOI 10.2147/DMSO.S51432; Wamil M, 2007, DRUG DISCOV TODAY, V12, P504, DOI 10.1016/j.drudis.2007.06.001; Wang YG, 2010, P NATL ACAD SCI USA, V107, P3087, DOI 10.1073/pnas.0914897107; Warrington NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079547; Wen WQ, 2012, NAT GENET, V44, P307, DOI 10.1038/ng.1087; Wheeler E, 2013, NAT GENET, V45, P513, DOI 10.1038/ng.2607; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Winham SJ, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-164; WOLFINGER R, 1993, J STAT COMPUT SIM, V48, P233, DOI 10.1080/00949659308811554; Wood SN, 2006, GEN ADDITIVE MODELS, P319; Yang WJ, 2007, EPIDEMIOL REV, V29, P49, DOI 10.1093/epirev/mxm004; Zhou XY, 2004, NAT MED, V10, P633, DOI 10.1038/nm1050; Zhu JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091442	69	2	2	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1744-6872	1744-6880		PHARMACOGENET GENOM	Pharmacogenet. Genomics	MAY	2016	26	5					208	217		10.1097/FPC.0000000000000210			10	Biotechnology & Applied Microbiology; Genetics & Heredity; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity; Pharmacology & Pharmacy	DK4JV	WOS:000374885000002	26918956	Green Submitted, Green Accepted			2022-03-04	
J	Geertz, M; Maerkl, SJ				Geertz, Marcel; Maerkl, Sebastian J.			Experimental strategies for studying transcription factor-DNA binding specificities	BRIEFINGS IN FUNCTIONAL GENOMICS			English	Article						transcription factor; DNA binding; binding affinity; ChIP; MITOMI; PBM; SELEX	SURFACE-PLASMON RESONANCE; PROTEIN-DNA; GENE-REGULATION; IN-VIVO; REGULATORY NETWORKS; CHROMATIN-IMMUNOPRECIPITATION; SACCHAROMYCES-CEREVISIAE; GEL-ELECTROPHORESIS; ZINC FINGERS; GENOME	Specific binding of transcription factors (TFs) determines in a large part the connectivity of gene regulatory networks as well as the quantitative level of gene expression. A multiplicity of both experimental and computational methods is currently used to discover and characterize the underlying TF-DNA interactions. Experimental methods can be further subdivided into in vitro-and in vivo-based approaches, each accenting different aspects of TF-binding events. In this review we summarize the flexibility and performance of a selection of both types of experimental methods. In conclusion, we argue that a serial combination of methods with different throughput and data type constitutes an optimal experimental strategy.	[Maerkl, Sebastian J.] Ecole Polytech Fed Lausanne, LBNC, Sch Engn, Inst Bioengn, CH-1015 Lausanne, Switzerland; [Geertz, Marcel] Univ Geneva, CH-1211 Geneva 4, Switzerland		Maerkl, SJ (corresponding author), Ecole Polytech Fed Lausanne, LBNC, Sch Engn, Inst Bioengn, CH-1015 Lausanne, Switzerland.	sebastian.maerkl@epfl.ch	Maerkl, Sebastian J. J/C-5438-2008	Maerkl, Sebastian J. J/0000-0003-1917-5268	Swiss SystemsX.ch initiative	This project was financed with a grant from the Swiss SystemsX.ch initiative, evaluated by the Swiss National Science Foundation.	Arda HE, 2010, BRIEF FUNCT GENOMICS, V9, P4, DOI 10.1093/bfgp/elp049; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Badis G, 2008, MOL CELL, V32, P878, DOI 10.1016/j.molcel.2008.11.020; Bailey TL, 1997, J COMPUT BIOL, V4, P45, DOI 10.1089/cmb.1997.4.45; Bates SR, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3211382; Beer MA, 2004, CELL, V117, P185, DOI 10.1016/S0092-8674(04)00304-6; Berger MF, 2006, NAT BIOTECHNOL, V24, P1429, DOI 10.1038/nbt1246; Bintu L, 2005, CURR OPIN GENET DEV, V15, P116, DOI 10.1016/j.gde.2005.02.007; Blancafort P, 2008, COMB CHEM HIGH T SCR, V11, P146, DOI 10.2174/138620708783744453; Bradley RK, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000343; Bulyk ML, 2001, P NATL ACAD SCI USA, V98, P7158, DOI 10.1073/pnas.111163698; Bussemaker HJ, 2007, ANNU REV BIOPH BIOM, V36, P329, DOI 10.1146/annurev.biophys.36.040306.132725; Carlson CD, 2010, P NATL ACAD SCI USA, V107, P4544, DOI 10.1073/pnas.0914023107; Crawford GE, 2006, NAT METHODS, V3, P503, DOI 10.1038/NMETH888; Das MK, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S7-S21; Dejardin J, 2009, CELL, V136, P175, DOI 10.1016/j.cell.2008.11.045; Djordjevic M, 2007, BIOMOL ENG, V24, P179, DOI 10.1016/j.bioeng.2007.03.001; Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z; Einav S, 2008, NAT BIOTECHNOL, V26, P1019, DOI 10.1038/nbt.1490; Elnitski L, 2006, GENOME RES, V16, P1455, DOI 10.1101/gr.4140006; FAGERSTAM LG, 1992, J CHROMATOGR, V597, P397, DOI 10.1016/0021-9673(92)80137-J; Farnham PJ, 2009, NAT REV GENET, V10, P605, DOI 10.1038/nrg2636; Fedorova E, 2008, BBA-MOL CELL RES, V1783, P2174, DOI 10.1016/j.bbamcr.2008.07.018; FRIED M, 1981, NUCLEIC ACIDS RES, V9, P6505, DOI 10.1093/nar/9.23.6505; GARNER MM, 1981, NUCLEIC ACIDS RES, V9, P3047, DOI 10.1093/nar/9.13.3047; Gerber D, 2009, NAT METHODS, V6, P71, DOI [10.1038/NMETH.1289, 10.1038/nmeth.1289]; Gerland U, 2002, P NATL ACAD SCI USA, V99, P12015, DOI 10.1073/pnas.192693599; Gertz J, 2009, NATURE, V457, P215, DOI 10.1038/nature07521; Gordan R, 2009, GENOME RES, V19, P2090, DOI 10.1101/gr.094144.109; Grove CA, 2009, CELL, V138, P314, DOI 10.1016/j.cell.2009.04.058; Hanlon SE, 2004, CURR OPIN GENET DEV, V14, P697, DOI 10.1016/j.gde.2004.09.008; Hesselberth JR, 2009, NAT METHODS, V6, P283, DOI [10.1038/NMETH.1313, 10.1038/nmeth.1313]; Horak CE, 2002, METHOD ENZYMOL, V350, P469, DOI 10.1016/S0076-6879(02)50979-4; Hu SH, 2009, CELL, V139, P610, DOI 10.1016/j.cell.2009.08.037; Jiang CZ, 2009, NAT REV GENET, V10, P161, DOI 10.1038/nrg2522; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Jolma A, 2010, GENOME RES, V20, P861, DOI 10.1101/gr.100552.109; Kasowski M, 2010, SCIENCE, V328, P232, DOI 10.1126/science.1183621; Kim HD, 2009, SCIENCE, V325, P429, DOI 10.1126/science.1171347; Klug A, 2010, ANNU REV BIOCHEM, V79, P213, DOI 10.1146/annurev-biochem-010909-095056; Komeili A, 1999, SCIENCE, V284, P977, DOI 10.1126/science.284.5416.977; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Liu X, 2005, GENOME RES, V15, P421, DOI 10.1101/gr.3256505; Liu XS, 2002, NAT BIOTECHNOL, V20, P835, DOI 10.1038/nbt717; Luscombe NM, 2000, GENOME BIOL, V1; Maerkl SJ, 2007, SCIENCE, V315, P233, DOI 10.1126/science.1131007; Maerkl SJ, 2009, P NATL ACAD SCI USA, V106, P18650, DOI 10.1073/pnas.0907688106; Majka J, 2007, ADV BIOCHEM ENG BIOT, V104, P13, DOI 10.1007/10_026; Massie CE, 2008, EMBO REP, V9, P337, DOI 10.1038/embor.2008.44; Meng X, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm385; Mukherjee S, 2004, NAT GENET, V36, P1331, DOI 10.1038/ng1473; Nilsson MTI, 2004, BIOCHEMISTRY-US, V43, P12038, DOI 10.1021/bi049122k; Noyes MB, 2008, CELL, V133, P1277, DOI 10.1016/j.cell.2008.05.023; Orlando V, 2000, TRENDS BIOCHEM SCI, V25, P99, DOI 10.1016/S0968-0004(99)01535-2; Pabo CO, 2006, NAT BIOTECHNOL, V24, P954, DOI 10.1038/nbt0806-954; Park PJ, 2009, NAT REV GENET, V10, P669, DOI 10.1038/nrg2641; Rando OJ, 2009, ANNU REV BIOCHEM, V78, P245, DOI 10.1146/annurev.biochem.78.071107.134639; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Reinitz John, 2003, ComPlexUs, V1, P54, DOI 10.1159/000070462; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Roth FP, 1998, NAT BIOTECHNOL, V16, P939, DOI 10.1038/nbt1098-939; Roulet E, 1998, In Silico Biol, V1, P21; Sabo PJ, 2006, NAT METHODS, V3, P511, DOI 10.1038/NMETH890; Schmid M, 2004, MOL CELL, V16, P147, DOI 10.1016/j.molcel.2004.09.007; Segal E, 2009, NAT REV GENET, V10, P443, DOI 10.1038/nrg2591; Sera T, 2009, ADV DRUG DELIVER REV, V61, P513, DOI 10.1016/j.addr.2009.03.012; Sharon E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000154; Tanay A, 2006, GENOME RES, V16, P962, DOI 10.1101/gr.5113606; Thorsen T, 2002, SCIENCE, V298, P580, DOI 10.1126/science.1076996; Tompa M, 2005, NAT BIOTECHNOL, V23, P137, DOI 10.1038/nbt1053; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; TZAMARIAS D, 1994, NATURE, V369, P758, DOI 10.1038/369758a0; van Steensel B, 2000, NAT BIOTECHNOL, V18, P424, DOI 10.1038/74487; Walhout AJM, 2006, GENOME RES, V16, P1445, DOI 10.1101/gr.5321506; Warren CL, 2006, P NATL ACAD SCI USA, V103, P867, DOI 10.1073/pnas.0509843102; Wingender E, 1996, NUCLEIC ACIDS RES, V24, P238, DOI 10.1093/nar/24.1.238; WRIGHT WE, 1991, MOL CELL BIOL, V11, P4104, DOI 10.1128/MCB.11.8.4104; Wunderlich Z, 2009, TRENDS GENET, V25, P434, DOI 10.1016/j.tig.2009.08.003; ZHANG XG, 1995, J BIOL CHEM, V270, P11181, DOI 10.1074/jbc.270.19.11181; Zhao Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000590; Zykovich A, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp802	83	46	49	2	16	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	2041-2649	2041-2657		BRIEF FUNCT GENOMICS	Brief. Funct. Genomics	DEC	2010	9	5-6			SI		362	373		10.1093/bfgp/elq023			12	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	712OC	WOS:000286675100002	20864494	Green Published, Bronze, Green Accepted			2022-03-04	
J	Kamma, JJ; Nakou, M; Gmur, R; Baehni, PC				Kamma, JJ; Nakou, M; Gmur, R; Baehni, PC			Microbiological profile of early onset/aggressive periodontitis patients	ORAL MICROBIOLOGY AND IMMUNOLOGY			English	Article						aggressive periodontitis; bacterial associations; culture; early onset periodontitis; indirect immunofluorescence; microbiology; periodontal pathogens	EARLY-ONSET PERIODONTITIS; RAPIDLY PROGRESSIVE PERIODONTITIS; LOCALIZED JUVENILE PERIODONTITIS; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; MONOCLONAL-ANTIBODIES; BACTEROIDES-FORSYTHUS; SUBGINGIVAL PLAQUE; YOUNG-ADULTS; PERIODONTOPATHIC BACTERIA; PORPHYROMONAS-GINGIVALIS	Objectives: The objectives of this study were to characterize the bacterial profile and to seek possible bacterial associations in the subgingival microbiota of early onset periodontitis/aggressive periodontitis patients by using two different techniques, culture and immunofluorescence. Material and methods: The study group consisted of 66 systemically healthy individuals with evidence of early onset periodontitis - 41 females and 25 males aged 23-35 years (mean 31.1 +/- 3.1 years). Bacterial samples were collected from the deepest site in each quadrant, resulting in a total of 264 sites with a mean probing pocket depth of 6.6 +/- 1.5 mm. Samples were cultured anaerobically and in 10% CO2 using selective and nonselective media, and isolates were characterized to species level. Indirect immunofluorescence using monoclonal antibodies was applied to detect Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis, Tannerella forsythia (Bacteroides forsythus, Tannerella forsythensis), Prevotella intermedia/Prevotella nigrescens, Campylobacter rectus, Peptostreptococcus micros and Actinomyces israelii. Results: 93.6% of sampled sites showed bleeding on probing and 23.5% were positive for suppuration. P. intermedia/P. nigrescens, P. gingivalis, and C. rectus were detected in 77.3-85.9% of samples using culture methods and in 85.6-91.3% using immunofluorescence. P. micros and A. actinomycetemcomitans were found, respectively, in 63.3% and 25.0% of all sites using culturing and in 58.7% and 27.7% sites using immunofluorescence. Significantly strong positive associations were observed between T. forsythia and C. rectus (odds ratio 109.46), and T. forsythia and P. gingivalis (odd ratio 90.26), whereas a negative association was seen between P. intermedia/P. nigrescens and A. actinomycetemcomitans (odds ratio 0.42). Coinfection by P. gingivalis, T. forsythia, P. intermedia/P. nigrescens and C. rectus was observed in 62.1% of the test sites, and in 89.4% of the studied subjects. The sensitivity of immunofluorescence for T. forsythia, C. rectus, P. intermedia/P. nigrescens and P. gingivalis was found to be very high (0.99-0.94) using culture as the reference detection method. The agreement between culture and immunofluorescence in detecting the presence or absence of the investigated species was 85.2-88.1% for P. gingivalis, P. intermedia/P. nigrescens, C. rectus, and T. forsythia, 75.9% for A. actinomycetemcomitans and 70.4% for P. micros. Conclusions: The microbial profile of the early onset/aggressive periodontitis population was complex. The agreement between the two detection methods was very high.	Univ Athens, Sch Dent Med, Dept Periodontol, Lab Periodontol, GR-10679 Athens, Greece; Univ Zurich, Inst Oral Microbiol & Gen Immunol, CH-8006 Zurich, Switzerland; Univ Geneva, Fac Med, Sch Dent Med, Dept Prevent Dent Med, CH-1211 Geneva 4, Switzerland		Kamma, JJ (corresponding author), 6-8 Freattidos St, GR-18537 Piraeus, Greece.	j.kamma@periodontology.gr					AGRESTI A, 1990, CATEGORICAL DATA ANA, P54; AINAMO J, 1975, INT DENT J, V25, P229; Albandar JM, 1997, J PERIODONTOL, V68, P973, DOI 10.1902/jop.1997.68.10.973; ALI RW, 1994, J PERIODONTOL, V65, P1053, DOI 10.1902/jop.1994.65.11.1053; American Academy of Periodontology, 1989, P WORLD WORKSH CLIN; American Academy of Periodontology, 1992, GLOSS PER TERMS; Armitage GC, 2004, PERIODONTOL 2000, V34, P9, DOI 10.1046/j.0906-6713.2002.003421.x; ASIKAINEN S, 1986, J PERIODONTOL, V57, P537, DOI 10.1902/jop.1986.57.9.537; ASTEMBORSKI JA, 1989, J PERIODONTOL, V60, P557, DOI 10.1902/jop.1989.60.10.557; BERRY G, 1994, STAT METHODS MED RES; BONTA Y, 1985, J DENT RES, V64, P793, DOI 10.1177/00220345850640050201; BURMEISTER JA, 1984, J CLIN PERIODONTOL, V11, P181, DOI 10.1111/j.1600-051X.1984.tb01322.x; Darby IB, 2000, J CLIN PERIODONTOL, V27, P417, DOI 10.1034/j.1600-051x.2000.027006417.x; DUFFAU F, 2004, PERIO, V1, P67; DZINK JL, 1988, J CLIN PERIODONTOL, V15, P316, DOI 10.1111/j.1600-051X.1988.tb01590.x; EBERSOLE JL, 1986, INFECT IMMUN, V51, P507, DOI 10.1128/IAI.51.2.507-513.1986; GLADEN B, 1979, J AM STAT ASSOC, V74, P278, DOI 10.2307/2286323; GLAVIND LEIF, 1967, J PERIODONTAL RES, V2, P180, DOI 10.1111/j.1600-0765.1967.tb01887.x; GMUR R, 1989, J PERIODONTAL RES, V24, P113, DOI 10.1111/j.1600-0765.1989.tb00865.x; GMUR R, 1983, INFECT IMMUN, V42, P459; GMUR R, 1994, J DENT RES, V73, P1421, DOI 10.1177/00220345940730080501; GMUR R, 1988, ORAL MICROBIOL IMMUN, V3, P181, DOI 10.1111/j.1399-302X.1988.tb00007.x; GMUR R, 1988, ORAL MICROBIOL IMMUN, V3, P187, DOI 10.1111/j.1399-302X.1988.tb00008.x; Gmur R, 1996, MED MICROBIOL LETT, V5, P335; GROSSI SG, 1994, J PERIODONTOL, V65, P260, DOI 10.1902/jop.1994.65.3.260; Haffajee AD, 1997, J CLIN PERIODONTOL, V24, P767, DOI 10.1111/j.1600-051X.1997.tb00195.x; Haffajee AD, 1998, J CLIN PERIODONTOL, V25, P346, DOI 10.1111/j.1600-051X.1998.tb02454.x; HAN NM, 1991, J PERIODONTAL RES, V26, P409, DOI 10.1111/j.1600-0765.1991.tb01730.x; HOLT S C, 1991, Critical Reviews in Oral Biology and Medicine, V2, P177; KAMMA JJ, 1995, J PERIODONTAL RES, V30, P66, DOI 10.1111/j.1600-0765.1995.tb01254.x; Kamma JJ, 2000, J PERIODONTOL, V71, P1862, DOI 10.1902/jop.2000.71.12.1862; Kamma JJ, 2001, J CLIN PERIODONTOL, V28, P879, DOI 10.1034/j.1600-051x.2001.028009879.x; Kamma JJ, 2001, J CLIN PERIODONTOL, V28, P1096, DOI 10.1034/j.1600-051X.2001.281203.x; Kamma JJ, 1999, J PERIODONTAL RES, V34, P25, DOI 10.1111/j.1600-0765.1999.tb02218.x; KOLENBRANDER PE, 1995, INFECT IMMUN, V63, P4584, DOI 10.1128/IAI.63.12.4584-4588.1995; Kuru B, 1999, J CLIN PERIODONTOL, V26, P19, DOI 10.1034/j.1600-051X.1999.260104.x; LANG NP, 1994, P 1 EUR WORKSH PER L; LILJENBERG B, 1980, J CLIN PERIODONTOL, V7, P48, DOI 10.1111/j.1600-051X.1980.tb01948.x; LISTGARTEN MA, 1995, J PERIODONTOL, V66, P158, DOI 10.1902/jop.1995.66.2.158; LOESCHE WJ, 1985, J PERIODONTOL, V56, P447, DOI 10.1902/jop.1985.56.8.447; LOESCHE WJ, 1992, J CLIN MICROBIOL, V30, P418, DOI 10.1128/JCM.30.2.418-426.1992; LOESCHE WJ, 1972, ARCH ORAL BIOL, V17, P1311, DOI 10.1016/0003-9969(72)90164-1; LOTUFO RFM, 1994, ORAL MICROBIOL IMMUN, V9, P154, DOI 10.1111/j.1399-302X.1994.tb00052.x; Michalowicz BS, 2000, J PERIODONTOL, V71, P981, DOI 10.1902/jop.2000.71.6.981; Moore W E, 1994, Periodontol 2000, V5, P66, DOI 10.1111/j.1600-0757.1994.tb00019.x; MOORE WEC, 1982, INFECT IMMUN, V38, P1137, DOI 10.1128/IAI.38.3.1137-1148.1982; Mullally BH, 2000, J PERIODONTAL RES, V35, P232, DOI 10.1034/j.1600-0765.2000.035004232.x; MULLER HP, 1985, J CLIN PERIODONTOL, V12, P113; OLEARY TJ, 1972, J PERIODONTOL, V43, P38, DOI 10.1902/jop.1972.43.1.38; PAGE RC, 1983, J PERIODONTOL, V54, P197, DOI 10.1902/jop.1983.54.4.197; Papapanou PN, 1997, J PERIODONTOL, V68, P651, DOI 10.1902/jop.1997.68.7.651; Ranney R R, 1993, Periodontol 2000, V2, P13, DOI 10.1111/j.1600-0757.1993.tb00216.x; RODENBURG JP, 1990, J CLIN PERIODONTOL, V17, P392, DOI 10.1111/j.1600-051X.1990.tb00036.x; Schei O., 1959, J PERIODONTOL, V30, P7; Schenkein H A, 1994, Periodontol 2000, V6, P7, DOI 10.1111/j.1600-0757.1994.tb00023.x; SINGH S, 1977, J DENT RES, V56, pB200; Slots J, 2000, ORAL MICROBIOL IMMUN, V15, P277, DOI 10.1034/j.1399-302x.2000.150501.x; SLOTS J, 1984, J DENT RES, V63, P412, DOI 10.1177/00220345840630031101; SLOTS J, 1985, J PERIODONTAL RES, V20, P613, DOI 10.1111/j.1600-0765.1985.tb00845.x; SOCRANSKY S S, 1988, Oral Microbiology and Immunology, V3, P1, DOI 10.1111/j.1399-302X.1988.tb00596.x; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; SUZUKI JB, 1988, DENT CLIN N AM, V32, P195; Tanner A C, 1986, Oral Microbiol Immunol, V1, P15; Thurnheer T, 1997, FEMS MICROBIOL LETT, V150, P255, DOI 10.1111/j.1574-6968.1997.tb10378.x; Tonetti M S, 1999, Ann Periodontol, V4, P39, DOI 10.1902/annals.1999.4.1.39; VANDERVELDEN U, 1989, J PERIODONTOL, V60, P604, DOI 10.1902/jop.1989.60.11.604; VANWINKELHOFF AJ, 1992, J PERIODONTOL, V63, P52, DOI 10.1902/jop.1992.63.1.52; WERNERFELMAYER G, 1988, J DENT RES, V67, P548, DOI 10.1177/00220345880670030501; Zambon J J, 1985, J Periodontol, V56, P32, DOI 10.1902/jop.1985.56.11s.32	69	67	72	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0902-0055			ORAL MICROBIOL IMMUN	Oral Microbiol. Immunol.	OCT	2004	19	5					314	321		10.1111/j.1399-302x.2004.00161.x			8	Dentistry, Oral Surgery & Medicine; Immunology; Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine; Immunology; Microbiology	849JK	WOS:000223534500007	15327644				2022-03-04	
J	Maiti, AK; Bouvagnet, P				Maiti, Amit K.; Bouvagnet, Patrice			Assembling and gap filling of unordered genome sequences through gene checking	GENOME BIOLOGY			English	Article							DNA-SEQUENCE; PROJECT		[Maiti, Amit K.; Bouvagnet, Patrice] Univ Lyon 1, Lab Genet Mol Humaine, F Lyon 08, France		Maiti, AK (corresponding author), Univ Geneva, Sch Med, Div Med Genet, 1 Rue Michel Servet, CH-1211 Geneva, Switzerland.	Amit.Maiti@medecine.unige.ch					Deloukas P, 1998, SCIENCE, V282, P744, DOI 10.1126/science.282.5389.744; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Hattori M, 2000, NATURE, V405, P311, DOI 10.1038/35012518; Kuehl PM, 1999, GENOME RES, V9, P189; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; MARSHALL E, 1995, SCIENCE, V267, P783, DOI 10.1126/science.7846520; Nagase T, 1997, DNA Res, V4, P141, DOI 10.1093/dnares/4.2.141; Pennisi E, 2000, SCIENCE, V288, P2304, DOI 10.1126/science.288.5475.2304; Roach JC, 1999, NATURE, V401, P843, DOI 10.1038/44684	10	1	1	0	0	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1474-7596			GENOME BIOL	Genome Biol.		2001	2	9							0008.1				11	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	V12FF	WOS:000207584400004					2022-03-04	
J	Gomes, TLN; Borges, TC; Pichard, C; Pimentel, GD				Gomes, T. L. N.; Borges, T. C.; Pichard, C.; Pimentel, G. D.			Correlation Between SARC-F Score and Ultrasound-Measured Thigh Muscle Thickness in Older Hospitalized Cancer Patients	JOURNAL OF NUTRITION HEALTH & AGING			English	Article						Ultrasound; anthropometry; older; cancer; sarcopenia; muscle mass	SARCOPENIA; DIAGNOSIS; CACHEXIA; TOOL	Background Strength, Assistance for walking, Rise from a chair, Climb stairs, and Falls (SARC-F) score is frequently used for screening the sarcopenia risk in older people. However, the agreement between SARC-F and loss of ultrasound-derived muscle thickness in hospitalized older cancer patients is unexplored. Objective The primary objective was to evaluate the relationship between the SARC-F score and ultrasound-derived muscle thickness of rectus femoris and vastus intermedius in older hospitalised cancer patients. The secondary objective was to identify the presence of sarcopenia. Measurements: A cross-sectional study enrolled forty-one older hospitalised cancer patients ongoing chemotherapy or surgical treatment. Body weight (kg) was measured using a digital scale and height using a portable stadiometer to assess body mass index. SARC-F was performed to assess and classify sarcopenia risk (with (SARC-F: >= 4), without (SARC-F: <4). US-derived muscle thickness of rectus femoris and vastus intermedius was assessed using a portable ultrasound. Relationship between the SARC-F and muscle thickness was tested using Pearson's correlation and Bland-Altman analyses. Results: Approximately, 46.3% of the patients presented sarcopenia and a lower non-significant muscle thickness of rectus femoris and vastus intermedius (SARC-F >= 4: 18.54 +/- 6.28 vs. SARC-F <4: 22.22 +/- 9.16 mm, p=0.07). There was a moderate negative correlation between SARC-F and muscle thickness (r=-0.40, p=0.004). Additionally, Bland-Altman plots no found systematic bias risk between SARC-F and ultrasound-derived muscle thickness. Conclusions: Approximately, 46.3% of older hospitalized cancer patients presented sarcopenia. Additionally, we found a moderate inverse correlation and no systematic bias risk between SARC-F and ultrasound-measured muscle thickness.	[Gomes, T. L. N.; Borges, T. C.; Pimentel, G. D.] Univ Fed Goias, Lab Res Clin Nutr & Sports Labince, Goiania, Go, Brazil; [Pichard, C.] Geneva Univ Hosp, Clin Nutr, Geneva, Switzerland		Pimentel, GD (corresponding author), Univ Fed Goias, Fac Nutr, Rua 227,Quadra 68 S-N,Setor Leste Univ, BR-74605080 Goiania, Go, Brazil.	gupimentel@yahoo.com.br			Brazilian National Council for Scientific and Technological Development (CNPq, Brazil)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) [312252/2019-6]	TLNG and TCB would like to thank the Capes, Brazil. GDP would like to The Brazilian National Council for Scientific and Technological Development (CNPq, Brazil, 312252/2019-6).	Abe T, 2014, GERIATR GERONTOL INT, V14, P837, DOI 10.1111/ggi.12179; Barbosa-Silva TG, 2016, J AM MED DIR ASSOC, V17, P1136, DOI 10.1016/j.jamda.2016.08.004; Blauwhoff-Buskermolen S, 2017, J CACHEXIA SARCOPENI, V8, P615, DOI 10.1002/jcsm.12200; Deutz NEP, 2019, J AM MED DIR ASSOC, V20, P22, DOI 10.1016/j.jamda.2018.11.021; Hendrickson N, 2019, J ORTHOP TRAUMA, V33, P472, DOI 10.1097/BOT.0000000000001498; Lauretani F, 2003, J APPL PHYSIOL, V95, P1851, DOI 10.1152/japplphysiol.00246.2003; Malmstrom TK, 2016, J CACHEXIA SARCOPENI, V7, P28, DOI 10.1002/jcsm.12048; Mateos-Angulo A, 2020, AGING CLIN EXP RES, V32, P1477, DOI 10.1007/s40520-019-01328-x; Miller J, 2018, AM J CLIN NUTR, V108, P1196, DOI 10.1093/ajcn/nqy244; Minetto MA, 2016, PM&R, V8, P453, DOI 10.1016/j.pmrj.2015.09.014; Nijholt W, 2017, J CACHEXIA SARCOPENI, V8, P702, DOI 10.1002/jcsm.12210; Soares JDP, 2019, CLIN NUTR ESPEN, V29, P149, DOI 10.1016/j.clnesp.2018.11.003; Stephens NA, 2011, J CACHEXIA SARCOPENI, V2, P111, DOI 10.1007/s13539-011-0030-x; Stringer HJ, 2018, J FRALITY AGING, V7, P258, DOI 10.14283/jfa.2018.24; Wang BY, 2020, SUPPORT CARE CANCER, V28, P581, DOI 10.1007/s00520-019-04717-0; Woo J, 2014, J AM MED DIR ASSOC, V15, P630, DOI 10.1016/j.jamda.2014.04.021	16	1	1	0	3	SPRINGER FRANCE	PARIS	22 RUE DE PALESTRO, PARIS, 75002, FRANCE	1279-7707	1760-4788		J NUTR HEALTH AGING	J. Nutr. Health Aging	DEC	2020	24	10					1128	1130		10.1007/s12603-020-1524-z		OCT 2020	3	Geriatrics & Gerontology; Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology; Nutrition & Dietetics	PE6FB	WOS:000585045800002	33244572				2022-03-04	
J	Staudt, CB; Kiliaridis, S				Staudt, Christine Bettina; Kiliaridis, Stavros			Association between mandibular asymmetry and occlusal asymmetry in young adult males with class III malocclusion	ACTA ODONTOLOGICA SCANDINAVICA			English	Article							CONDYLAR ASYMMETRY; SUBDIVISION MALOCCLUSION; PANORAMIC RADIOGRAPHY; SKELETAL ASYMMETRY; ANGLES; CROSSBITE; PATTERNS; CHILDREN	Objective. Our aim was to assess the association between mandibular asymmetry and sagittal and transverse occlusal asymmetry in young adult males with class III malocclusion. Our hypotheses were that (1) mandibular asymmetry increases with increasing mandibular length and (2) occlusal asymmetry is correlated with mandibular asymmetry. Material and methods. On lateral cephalograms of 54 subjects, skeletal class and mandibular length were measured. Mandibular asymmetry was evaluated on orthopantomograms as right-left difference between condylar or ramus heights. Occlusal asymmetry was assessed on dental casts by differences between right and left canine and molar relationship, anterior and posterior crossbite as well as midline deviation. Results. Mandibular asymmetry was significantly correlated with sagittal and transverse occlusal asymmetry (p < 0.05), but not with mandibular length (p > 0.05). Condylar asymmetry due to a longer condyle on one side was correlated with asymmetric aggravation of canine and molar class III on the ipsilateral side (r = -0.53 and -0.62, respectively). In contrast, ramus asymmetry was related to contralateral aggravation of canine and molar class III relationships (r = 0.27 and 0.29, respectively). Correlations existed between asymmetry in total height of the condyle and ramus and asymmetric aggravation of anterior crossbite (r = -0.33), posterior crossbite (r = -0.30) and lower midline deviation (r = -0.27) to the contralateral side (p < 0.05). Conclusions. Mandibular asymmetry is associated with occlusal asymmetry, especially in the sagittal plane. Condylar asymmetry had 28% and 38% of variance in common with sagittal canine and molar asymmetry, respectively. Asymmetry in total height of the condyle and ramus was related to transverse occlusal asymmetry.	[Staudt, Christine Bettina] Univ Geneva, Div Orthodont, Sect Med Dent, Fac Med, CH-1205 Geneva, Switzerland		Staudt, CB (corresponding author), Univ Geneva, Div Orthodont, Sect Med Dent, Fac Med, 19 Rue Barthelemy Menn, CH-1205 Geneva, Switzerland.	christine.staudt@unige.ch		Staudt, Christine B./0000-0002-7141-6500	European Orthodontic Society (EOS); Swiss Dental Association (SSO)	The study was supported by a research grant from the European Orthodontic Society (EOS) and a grant for dental research provided by the Swiss Dental Association (SSO). We are grateful to the Swiss Army for logistical help and the fruitful collaboration. We thank Dr. B. Cerutti for his precious help with the threshold values.	Azevedo ARP, 2006, AM J ORTHOD DENTOFAC, V129, P376, DOI 10.1016/j.ajodo.2005.12.002; Caglaroglu M, 2008, AM J ORTHOD DENTOFAC, V134, P270, DOI 10.1016/j.ajodo.2006.07.036; Dahlberg G., 1940, STAT METHODS MED BIO; DIBBETS J M H, 1985, Journal of Pedodontics, V9, P265; HOUSTON WJB, 1983, AM J ORTHOD DENTOFAC, V83, P382, DOI 10.1016/0002-9416(83)90322-6; Hu Wei, 2002, Zhonghua Kou Qiang Yi Xue Za Zhi, V37, P180; Janson G, 2007, AM J ORTHOD DENTOFAC, V131, P57, DOI 10.1016/j.ajodo.2005.02.031; Kiliaridis S, 2007, ANGLE ORTHOD, V77, P607, DOI 10.2319/101105-360; Kilic N, 2008, AM J ORTHOD DENTOFAC, V133, P382, DOI 10.1016/j.ajodo.2006.04.041; KJELLBERG H, 1994, ACTA ODONTOL SCAND, V52, P43, DOI 10.3109/00016359409096375; KOSKI K, 1975, AM J ORTHOD DENTOFAC, V68, P660, DOI 10.1016/0002-9416(75)90100-1; KUROL J, 1995, INTRO ORTHODONTICS, P112; Kurt G, 2008, ANGLE ORTHOD, V78, P32, DOI 10.2319/021507-73.1; Kusayama M, 2003, AM J ORTHOD DENTOFAC, V123, P329, DOI 10.1067/mod.2003.41; LARHEIM TA, 1986, AM J ORTHOD DENTOFAC, V90, P45, DOI 10.1016/0889-5406(86)90026-0; Liukkonen M, 2005, ACTA ODONTOL SCAND, V63, P168, DOI 10.1080/00016350510019928; Miller VJ, 1997, J ORAL REHABIL, V24, P247; Miller VJ, 1996, J ORAL REHABIL, V23, P712; PIRTTINIEMI P, 1991, European Journal of Orthodontics, V13, P441; PIRTTINIEMI PM, 1994, AM J ORTHOD, V106, P629; Saglam AMS, 2003, J ORAL REHABIL, V30, P738, DOI 10.1046/j.1365-2842.2003.01089.x; Sezgin OS, 2007, ANGLE ORTHOD, V77, P803, DOI 10.2319/092506-392; Staudt CB, 2009, AM J ORTHOD DENTOFAC, V136, P715, DOI 10.1016/j.ajodo.2007.10.061; Staudt CB, 2009, AM J ORTHOD DENTOFAC, V135, P323, DOI 10.1016/j.ajodo.2007.03.031; Turpin DL, 2005, AM J ORTHOD DENTOFAC, V128, P555, DOI 10.1016/j.ajodo.2005.09.006; Van Elslande DC, 2008, AM J ORTHOD DENTOFAC, V134, P183, DOI 10.1016/j.ajodo.2007.07.021; Xie Q, 1996, DENTOMAXILLOFAC RAD, V25, P61, DOI 10.1259/dmfr.25.2.9446974	27	9	10	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0001-6357	1502-3850		ACTA ODONTOL SCAND	Acta Odontol. Scand.	MAY	2010	68	3					131	140		10.3109/00016350903460182			10	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	581WC	WOS:000276555000002	20085500				2022-03-04	
J	Dudic, A; Giannopoulou, C; Leuzinger, M; Kiliaridis, S				Dudic, Alexander; Giannopoulou, Catherine; Leuzinger, Michael; Kiliaridis, Stavros			Detection of apical root resorption after orthodontic treatment by using panoramic radiography and cone-beam computed tomography of super-high resolution	AMERICAN JOURNAL OF ORTHODONTICS AND DENTOFACIAL ORTHOPEDICS			English	Article							DIGITAL VOLUME TOMOGRAPHY; MAXILLARY CANINES; ACCURACY; LOCALIZATION; CT	Introduction: Apical root resorption is an adverse side effect of orthodontic treatment. We compared panoramic radiography (OPT) with cone-beam computed tomography (CBCT) in evaluating orthodontically induced apical root resorption. Methods: The study sample comprised 275 teeth in 22 patients near the end of orthodontic treatment with fixed appliances. Two calibrated examiners assessed blindly the presence or absence and the severity of apical root resorption on the OPT images after treatment and the corresponding reconstructed CBCT images. Resorption was evaluated as no, mild, moderate, severe, and extreme. Results: On the OPT images, 17 teeth (6.2%) could not be evaluated. Statistically significant differences were found between the 2 methods: 56.5% and 31% of the teeth showed no resorption by OPT and CBCT, respectively; 33.5% and 49% of the teeth showed mild resorption, whereas 8% and 19% showed moderate resorption by OPT and CBCT, respectively. Severe resorption was found in only 2 teeth by CBCT. Conclusions: Apical root resorption after orthodontic tooth movement is underestimated when evaluated on OPT. CBCT might be a useful complementary diagnostic method to conventional radiography, to be applied when a decision on continuation or modification of the orthodontic treatment is necessary because of orthodontically induced root resorption. (Am J Orthod Dentofacial Orthop 2009; 135:434-7)	[Giannopoulou, Catherine] Univ Geneva, Sch Dent, Dept Periodontol, CH-1205 Geneva, Switzerland; [Dudic, Alexander; Kiliaridis, Stavros] Univ Geneva, Dept Orthodont, CH-1205 Geneva, Switzerland		Giannopoulou, C (corresponding author), Univ Geneva, Sch Dent, Dept Periodontol, Rue Barthelemy Menn 19, CH-1205 Geneva, Switzerland.	ekaterini.giannopoulou@medecine.unige.ch					Apajalahti S, 2007, EUR J ORTHODONT, V29, P408, DOI 10.1093/ejo/cjm016; Armstrong David, 2006, Aust Orthod J, V22, P153; Chan EKM, 2004, EUR J ORAL SCI, V112, P134, DOI 10.1111/j.1600-0722.2004.00118.x; da Silveira HLD, 2007, DENTOMAXILLOFAC RAD, V36, P393, DOI 10.1259/dmfr/13347073; Danforth Robert A, 2003, J Calif Dent Assoc, V31, P814; Dudic A, 2008, EUR J ORAL SCI, V116, P467, DOI 10.1111/j.1600-0722.2008.00559.x; Hatcher DC, 2004, AM J ORTHOD DENTOFAC, V125, P512, DOI 10.1016/j.ajodo.2003.12.009; Holberg Christof, 2005, J Orofac Orthop, V66, P434, DOI 10.1007/s00056-005-0519-z; Lascala C, 2004, DENTOMAXILLOFAC RAD, V33, P291, DOI 10.1259/dmfr/25500850; LEVANDER E, 1988, EUR J ORTHODONT, V10, P30, DOI 10.1093/ejo/10.1.30; Liu DG, 2008, ORAL SURG ORAL MED O, V105, P91, DOI 10.1016/j.tripleo.2007.01.030; Marmulla R, 2005, DENTOMAXILLOFAC RAD, V34, P28, DOI 10.1259/dmfr/31342245; Mussig Eva, 2005, J Orofac Orthop, V66, P241, DOI 10.1007/s00056-005-0444-1; OwmanMoll P, 1995, ANGLE ORTHOD, V65, P395; Peck JL, 2007, ANGLE ORTHOD, V77, P206, DOI 10.2319/0003-3219(2007)077[0206:MRAUPA]2.0.CO;2; Rohlin M, 1991, Dentomaxillofac Radiol, V20, P127; Sameshima GT, 2001, ANGLE ORTHOD, V71, P185; Scarfe WC, 2006, J CAN DENT ASSOC, V72, P75; Sukovic P, 2003, Orthod Craniofac Res, V6 Suppl 1, P31, DOI 10.1034/j.1600-0544.2003.259.x; Walker L, 2005, AM J ORTHOD DENTOFAC, V128, P418, DOI 10.1016/j.ajodo.2004.04.033; Wortche R, 2006, DENTOMAXILLOFAC RAD, V35, P88, DOI 10.1259/dmfr/27536604; Ziegler CM, 2002, DENTOMAXILLOFAC RAD, V31, P126, DOI 10.1038/sj.dmfr.4600680	22	103	118	0	12	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0889-5406	1097-6752		AM J ORTHOD DENTOFAC	Am. J. Orthod. Dentofac. Orthop.	APR	2009	135	4					434	437		10.1016/j.ajodo.2008.10.014			4	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	431DI	WOS:000265041100009	19361727				2022-03-04	
J	Que, ML; Andersen, E; Mombelli, A				Que, ML; Andersen, E; Mombelli, A			Myeloid-related protein (MRP)8/14 (calprotectin) and its subunits MRP8 and MRP14 in plaque-induced early gingival inflammation	JOURNAL OF CLINICAL PERIODONTOLOGY			English	Article						calprotectin; experimental gingivitis; gingival crevicular fluid; L1-protein; myeloid-related protein	CALCIUM-BINDING PROTEIN; HUMAN NEUTROPHIL ACTIVATION; GRAM-NEGATIVE BACTERIA; CREVICULAR FLUID; RHEUMATOID-ARTHRITIS; PERIODONTAL-DISEASE; LEUKOCYTE PROTEIN; TOPOGRAPHIC DISTRIBUTION; CYSTIC-FIBROSIS; S100 FAMILY	Background: The inflammatory myeloid-related protein, MRP8/14, also called calprotectin, and its subunits MRP8 and MRP14 have been detected and identified recently in gingival crevicular fluid (GCF). It has been suggested that the type and phase of inflammation can be discriminated on the basis of differences in the expression of calprotectin and its subunits, released during activation and/or death of granulocytes and monocytes. The purpose of this study was to quantify calprotectin and its subunits (MRPs) simultaneously in the GCF during the initial phase of experimentally induced gingivitis, and to examine their inter- and intra-individual variations. Material and Methods: Fifteen healthy non-smoking subjects, aged 18-30, were involved in this study. An initial hygiene phase (days -11 to 0) was followed by 10 days of undisturbed plaque accumulation. At days -11, -3, 0, 10, 11, clinical parameters were recorded and GCF samples collected with Durapore strips from 12 sites in each subject. Quantitative analyses of total proteins, MRP8/14, MRP14 and MRP8 were performed by ELISA procedures. Results: During the experimental phase with no oral hygiene (days 0-10), the clinical parameters Plaque Index, Gingival Index (GI) and bleeding on probing increased as expected, confirming that plaque accumulation leads to gingival inflammation. Levels of the MRPs were individually variable. They increased with plaque accumulation in one-half of the subjects, and decreased in the other subjects. The levels of MRP8/14 and MRP14 at subject recruitment (day -11) could predict a significant part of the GI at day 10. Only minute amounts of the subunits MRP8 and MRP14 were detected in comparison with the complex MRP8/14 throughout the experiment. Considerable variations were noted among sites within subjects. Conclusion: The expression of calprotectin in the early phase of experimental gingivitis is variable between subjects, and two groups of subjects can be differentiated according to their response patterns. Clinical parameters at the very first visit (day -11) seemed to be different in the two response groups. The results of the present investigation indicate that the inflammatory response to plaque accumulation depends on the initial status of the subjects, which may not be leveled out by the introduction of perfect oral hygiene. Whether these patterns reflect a different susceptibility to periodontal diseases remains to be determined.	Univ Geneva, Sch Dent Med, CH-1211 Geneva 4, Switzerland		Mombelli, A (corresponding author), Univ Geneva, Sch Dent Med, 19 Rue Barthelemy Menn, CH-1211 Geneva 4, Switzerland.	andrea.mombelli@medecine.unige.ch					ABBAS F, 1986, J CLIN PERIODONTOL, V13, P774, DOI 10.1111/j.1600-051X.1986.tb00881.x; Berntzen H B, 1988, Scand J Rheumatol Suppl, V76, P251; BERNTZEN HB, 1991, J RHEUMATOL, V18, P133; BERNTZEN HB, 1989, J RHEUMATOL, V16, P1416; BRUN JG, 1992, J RHEUMATOL, V19, P859; BRUN JG, 1994, SCAND J RHEUMATOL, V23, P114, DOI 10.3109/03009749409103041; Burmeister G., 1995, Inflammopharmacology, V3, P221, DOI 10.1007/BF02659119; CUIDA M, 1995, EUR J ORAL SCI, V103, P8, DOI 10.1111/j.1600-0722.1995.tb00003.x; DALE I, 1983, EUR J BIOCHEM, V134, P1, DOI 10.1111/j.1432-1033.1983.tb07522.x; DUNLOP O, 1991, SCAND J INFECT DIS, V23, P687, DOI 10.3109/00365549109024294; EDGEWORTH J, 1991, J BIOL CHEM, V266, P7706; FAGERHOL MK, 1980, SCAND J HAEMATOL, V24, P393; Golden BE, 1996, ARCH DIS CHILD, V74, P136, DOI 10.1136/adc.74.2.136; Guignard F, 1996, EUR J BIOCHEM, V241, P265, DOI 10.1111/j.1432-1033.1996.0265t.x; HESSIAN PA, 1993, J LEUKOCYTE BIOL, V53, P197, DOI 10.1002/jlb.53.2.197; HOGG N, 1989, EUR J IMMUNOL, V19, P1053, DOI 10.1002/eji.1830190615; HOLT J, 1983, ACTA PAEDIATR SCAND, V72, P615, DOI 10.1111/j.1651-2227.1983.tb09781.x; Hunter MJ, 1998, J BIOL CHEM, V273, P12427, DOI 10.1074/jbc.273.20.12427; JAMBREC H, 1993, THESIS U GENEVA; Johne B, 1997, J CLIN PATHOL-MOL PA, V50, P113; Kerkhoff C, 1999, PATHOBIOLOGY, V67, P230, DOI 10.1159/000028098; Kido J, 1998, J PERIODONTAL RES, V33, P434; Kido J, 1999, J CLIN PERIODONTOL, V26, P653, DOI 10.1034/j.1600-051X.1999.261004.x; KLIGMAN D, 1988, TRENDS BIOCHEM SCI, V13, P437, DOI 10.1016/0968-0004(88)90218-6; Kojima T, 2000, J DENT RES, V79, P740, DOI 10.1177/00220345000790020701; Lamster I B, 1997, Ann Periodontol, V2, P123; LEMARCHAND P, 1992, J BIOL CHEM, V267, P19379; LOE H, 1965, J PERIODONTOL, V36, P177, DOI 10.1902/jop.1965.36.3.177; LOE H, 1967, J PERIODONTOL, V38, P610, DOI 10.1902/jop.1967.38.6.610; LUGERING N, 1995, EUR J CLIN INVEST, V25, P659, DOI 10.1111/j.1365-2362.1995.tb01982.x; LUGERING N, 1995, DIGESTION, V56, P406, DOI 10.1159/000201267; Lundy FT, 2001, J CLIN PERIODONTOL, V28, P1172, DOI 10.1034/j.1600-051X.2001.281213.x; MCNAMARA MP, 1988, LANCET, V2, P1163; Miyasaki KT, 1998, J PERIODONTOL, V69, P879, DOI 10.1902/jop.1998.69.8.879; MOMBELLI A, 1991, J PERIODONTAL RES, V26, P301, DOI 10.1111/j.1600-0765.1991.tb02067.x; MOMBELLI A, 1994, J PERIODONTOL, V65, P820, DOI 10.1902/jop.1994.65.9.820; MOMBELLI A, 1991, J PERIODONTAL RES, V26, P308, DOI 10.1111/j.1600-0765.1991.tb02068.x; Mombelli A, 1990, Schweiz Monatsschr Zahnmed, V100, P154; MULLER F, 1994, J ACQ IMMUN DEF SYND, V7, P931; MULLER F, 1993, CLIN INFECT DIS, V16, P301, DOI 10.1093/clind/16.2.301; Muller H P, 2000, Clin Oral Investig, V4, P212, DOI 10.1007/s007840000078; MURAO S, 1989, J BIOL CHEM, V264, P8356; MURTHY ARK, 1993, J IMMUNOL, V151, P6291; Rammes A, 1997, J BIOL CHEM, V272, P9496; Roseth AG, 1999, SCAND J GASTROENTERO, V34, P50; SANDER J, 1984, SCAND J CLIN LAB INV, V44, P357, DOI 10.3109/00365518409083820; SOHNLE PG, 1991, J INFECT DIS, V163, P187, DOI 10.1093/infdis/163.1.187; STEINBAKK M, 1990, LANCET, V336, P763, DOI 10.1016/0140-6736(90)93237-J; TEIGELKAMP S, 1991, J BIOL CHEM, V266, P13462; THEILADE ELSE, 1966, J PERIODONTAL RES, V1, P1, DOI 10.1111/j.1600-0765.1966.tb01842.x; Tsai CC, 1998, J DENT, V26, P97, DOI 10.1016/S0300-5712(96)00084-X; Tuter G, 2001, J PERIODONTOL, V72, P883, DOI 10.1902/jop.2001.72.7.883; [No title captured]	53	24	25	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0303-6979	1600-051X		J CLIN PERIODONTOL	J. Clin. Periodontol.	NOV	2004	31	11					978	984		10.1111/j.1600-051X.2004.00594.x			7	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	862XV	WOS:000224525700009	15491313				2022-03-04	
J	Baehni, PC; Takeuchi, Y				Baehni, PC; Takeuchi, Y			Anti-plaque agents in the prevention of biofilm-associated oral diseases	ORAL DISEASES			English	Article; Proceedings Paper	Workshop on Antimicrobial Agents in Periodontal Prevention, Therapy and Maintenance	DEC 06, 2002	LYON, FRANCE			anti-plaque; antimicrobials; prevention; dental caries; periodontal diseases	SUBGINGIVAL PLAQUE; IN-VITRO; PERIODONTAL-DISEASE; CETYLPYRIDINIUM CHLORIDE; SUPRAGINGIVAL PLAQUE; ANTIMICROBIAL AGENTS; STREPTOCOCCUS-MUTANS; AMINE FLUORIDES; DENTAL BIOFILM; CHLORHEXIDINE	The prevention of dental caries and periodontal diseases is targeted at the control of dental plaque. In this context, chemical agents could represent a valuable complement to mechanical plaque control. The active agents should prevent biofilm formation without affecting the biological equilibrium within the oral cavity. Depending on the goals of the preventive measures, various strategies may be considered. Anti-plaque agents with properties other than bactericidal or bacteriostatic activities may be used in primary prevention. In this approach, a modest anti-plaque effect may be sufficient or even desirable, as it would decrease the side effects of the active agent. Antimicrobial agents are best indicated in secondary and tertiary prevention, as the objectives are to restore health and to prevent disease recurrence. The rational is to prevent or delay subgingival recolonization by pathogenic micro-organisms. The development of in vitro oral biofilm models certainly represents a major advance for studying and testing oral anti-plaque agents in recent years. The results of these studies have shown that chlorhexidine, hexetidine, delmopinol, amine fluoride/stannous fluoride, triclosan, phenolic compounds, among others, may inhibit biofilm development and maturation as well as affect bacterial metabolism.	Univ Geneva, Sch Dent Med, Dept Prevent Dent Med, CH-1205 Geneva, Switzerland		Baehni, PC (corresponding author), Univ Geneva, Sch Dent Med, Dept Prevent Dent Med, 19 Rue Barthelemy Menn, CH-1205 Geneva, Switzerland.	Pierre.baehni@medecine.unige.ch					Addy M, 1998, PROCEEDINGS OF THE EUROPEAN WORKSHOP ON MECHANICAL PLAQUE CONTROL, P98; ADDY M, 1994, PROCEEDINGS OF THE 1ST EUROPEAN WORKSHOP ON PERIODONTOLOGY, P244; Andersen Ronald, 1995, P307; Arweiler NB, 2002, J CLIN PERIODONTOL, V29, P358, DOI 10.1034/j.1600-051X.2002.290412.x; AXELSSON P, 1981, J CLIN PERIODONTOL, V8, P281, DOI 10.1111/j.1600-051X.1981.tb02039.x; AXELSSON P, 1991, J CLIN PERIODONTOL, V18, P182, DOI 10.1111/j.1600-051X.1991.tb01131.x; AXELSSON P, 1994, PROCEEDINGS OF THE 1ST EUROPEAN WORKSHOP ON PERIODONTOLOGY, P219; Baehni PC, 1998, PROCEEDINGS OF THE EUROPEAN WORKSHOP ON MECHANICAL PLAQUE CONTROL, P19; BANSAL GS, 1990, J CLIN PERIODONTOL, V17, P414, DOI 10.1111/j.1600-051X.1990.tb02339.x; Bradshaw DJ, 1998, CARIES RES, V32, P456, DOI 10.1159/000016487; Bradshawa DJ, 2002, CARIES RES, V36, P81, DOI 10.1159/000057864; BULLOCK S, 1989, J ANTIMICROB CHEMOTH, V23, P59, DOI 10.1093/jac/23.1.59; Burgemeister S, 2001, EUR J ORAL SCI, V109, P425, DOI 10.1034/j.1600-0722.2001.00121.x; Claydon N, 1996, J CLIN PERIODONTOL, V23, P220, DOI 10.1111/j.1600-051X.1996.tb02079.x; Cobb C M, 1996, Ann Periodontol, V1, P443, DOI 10.1902/annals.1996.1.1.443; COLLAERT B, 1993, ORAL MICROBIOL IMMUN, V8, P36, DOI 10.1111/j.1399-302X.1993.tb00540.x; COLLAERT B, 1994, SCAND J DENT RES, V102, P17; CUMMINS D, 1992, J DENT RES, V71, P1439, DOI 10.1177/00220345920710071601; Embleton JV, 2001, ORAL MICROBIOL IMMUN, V16, P182, DOI 10.1034/j.1399-302x.2001.016003182.x; Garmyn P, 1998, PROCEEDINGS OF THE EUROPEAN WORKSHOP ON MECHANICAL PLAQUE CONTROL, P107; Guggenheim B, 2001, J DENT RES, V80, P363, DOI 10.1177/00220345010800011201; Hamilton I R, 1990, J Dent Res, V69 Spec No, P660; Hancock E B, 1996, Ann Periodontol, V1, P223; JENKINS S, 1994, J CLIN PERIODONTOL, V21, P441, DOI 10.1111/j.1600-051X.1994.tb00743.x; JONES CL, 1990, J CLIN PERIODONTOL, V17, P570, DOI 10.1111/j.1600-051X.1990.tb01107.x; KAY HM, 1988, J PERIODONTOL, V59, P266, DOI 10.1902/jop.1988.59.4.266; KEYES PH, 1964, ARCH ORAL BIOL, V9, P377, DOI 10.1016/0003-9969(64)90024-X; Lang N P, 1998, Oral Dis, V4, P105; Lang NP, 1997, PROCEEDINGS OF THE 2ND EUROPEAN WORKSHOP ON PERIODONTOLOGY, P192; Larsen T, 1996, APMIS, V104, P280, DOI 10.1111/j.1699-0463.1996.tb00718.x; LINDHE J, 1973, J PERIODONTAL RES, V8, P1, DOI 10.1111/j.1600-0765.1973.tb00735.x; LISTGARTEN MA, 1999, DENT PLAQUE REVISITE, P187; LOE H, 1970, Journal of Periodontal Research, V5, P79, DOI 10.1111/j.1600-0765.1970.tb00696.x; LOE H, 1965, J PERIODONTOL, V36, P177, DOI 10.1902/jop.1965.36.3.177; LOE H, 1972, SCAND J DENT RES, V80, P1; MANDEL ID, 1988, J CLIN PERIODONTOL, V15, P488, DOI 10.1111/j.1600-051X.1988.tb01020.x; Marsh P D, 1994, Adv Dent Res, V8, P263; Matthijs S, 2002, J CLIN PERIODONTOL, V29, P1, DOI 10.1034/j.1600-051x.2002.290101.x; MAYHEW RR, 1981, J DENT RES, V60, P1809, DOI 10.1177/00220345810600101301; MEURMAN JH, 1988, CARIES RES, V22, P283, DOI 10.1159/000261122; MILLER WD, 1973, MICROORGANISMS HUMAN; Moore W E, 1994, Periodontol 2000, V5, P66, DOI 10.1111/j.1600-0757.1994.tb00019.x; Ogaard B, 1997, J Orofac Orthop, V58, P206, DOI 10.1007/BF02679961; PAPAPANOU PN, 1994, PROCEEDINGS OF THE 1ST EUROPEAN WORKSHOP ON PERIODONTOLOGY, P23; Paster BJ, 2001, J BACTERIOL, V183, P3770, DOI 10.1128/JB.183.12.3770-3783.2001; Pratten J, 1998, J ANTIMICROB CHEMOTH, V42, P453, DOI 10.1093/jac/42.4.453; RentonHarper P, 1996, J PERIODONTOL, V67, P486, DOI 10.1902/jop.1996.67.5.486; Rolla G, 1997, PROCEEDINGS OF THE 2ND EUROPEAN WORKSHOP ON PERIODONTOLOGY, P120; ROLLA G, 1975, J DENT RES, V54, pB57, DOI 10.1177/00220345750540022601; RUNDEGREN J, 1992, J DENT RES, V71, P1792, DOI 10.1177/00220345920710110501; Schou L, 1998, PROCEEDINGS OF THE EUROPEAN WORKSHOP ON MECHANICAL PLAQUE CONTROL, P287; Shani S, 2000, CARIES RES, V34, P260, DOI 10.1159/000016600; Shapira L, 2000, J DENT RES, V79, P1802, DOI 10.1177/00220345000790101201; Shapiro S, 2002, CARIES RES, V36, P93, DOI 10.1159/000057866; SIMONSSON T, 1991, ORAL MICROBIOL IMMUN, V6, P305, DOI 10.1111/j.1399-302X.1991.tb00498.x; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; SOCRANSKY SS, 1992, J PERIODONTOL, V63, P322, DOI 10.1902/jop.1992.63.4s.322; STANLEY A, 1989, J CLIN PERIODONTOL, V16, P259, DOI 10.1111/j.1600-051X.1989.tb01651.x; STEINBERG D, 1992, J DENT RES, V71, P1797, DOI 10.1177/00220345920710110601; STEPHEN KW, 1990, J PERIODONTOL, V61, P674, DOI 10.1902/jop.1990.61.11.674; Svatun B, 1993, Int Dent J, V43, P441; Van Loveren C, 2001, CARIES RES, V35, P65, DOI 10.1159/000049114; Weiger R, 1998, ARCH ORAL BIOL, V43, P559, DOI 10.1016/S0003-9969(98)00032-6; Wilson M, 1996, J MED MICROBIOL, V44, P79, DOI 10.1099/00222615-44-2-79; Zaura-Arite E, 2001, J DENT RES, V80, P1436, DOI 10.1177/00220345010800051001	65	184	191	0	49	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1354-523X	1601-0825		ORAL DIS	Oral Dis.	JUN	2003	9			1			23	29		10.1034/j.1601-0825.9.s1.5.x			7	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Dentistry, Oral Surgery & Medicine	683PP	WOS:000183158300005	12974527				2022-03-04	
J	Cappuyns, I; Giannopoulou, C; Mombelli, A				Cappuyns, I.; Giannopoulou, C.; Mombelli, A.			GCF IL-1 beta, IL-4 and IL-8 levels during experimental gingivitis in smokers and non-smokers.	JOURNAL OF DENTAL RESEARCH			English	Meeting Abstract									Univ Geneva, Geneva, Switzerland									0	0	0	0	0	INT AMER ASSOC DENTAL RESEARCHI A D R/A A D R	ALEXANDRIA	1619 DUKE ST, ALEXANDRIA, VA 22314-3406 USA	0022-0345			J DENT RES	J. Dent. Res.	JUN	2003	82				B	0588	B86	B86					1	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	V42UY	WOS:000202893600585					2022-03-04	
J	Menzel, O; Vellai, T; Takacs-Vellai, K; Reymond, A; Mueller, F; Antonarakis, SE; Guipponi, M				Menzel, O; Vellai, T; Takacs-Vellai, K; Reymond, A; Mueller, F; Antonarakis, SE; Guipponi, M			The Caenorhabditis elegans ortholog of C21orf80, a potential new protein O-fucosyltransferase, is required for normal development	GENOMICS			English	Article							GENE-EXPRESSION; C-ELEGANS; GDP-FUCOSE; HUMAN-CHROMOSOME-21; IDENTIFICATION; DOSAGE; BAC; RNA	Down syndrome (DS), as a phenotypic result of trisomy 2 1, is the most frequent aneuploidy at birth and the most common known genetic cause of mental retardation. DS is also characterized by other phenotypes affecting many organs, including brain, muscle, heart, limbs, gastrointestinal tract, skeleton, and blood. Any of the human chromosome 21 (Hsa21) genes may contribute to some of the DS phenotypes. To determine which of the Hsa21 genes are involved in DS, the effects of disrupting and overexpressing individual human gene orthologs in model organisms, such as the nematode Caenorhabditis elegans, can be analyzed. Here, we isolated and characterized C21orf80 (human chromosome 21 open reading frame 80), a potential novel protein O-fucosyltransferase gene that encodes three alternatively spliced transcripts. Transient expression of tagged C21orf80 proteins suggests a primary intracellular localization in the Golgi apparatus. To gain insight into the biological role of C21orf80 and its potential role in DS, we isolated its C. elegans ortholog, pad-2, and performed RNA interference (RNAi) and overexpression experiments. pad-2(RNAi) embryos showed failure to undergo normal morphogenesis. Transgenic worms with elevated dosage of pad-2 displayed severe body malformations and abnormal neuronal development. These results show that pad-2 is required for normal development and suggest potential roles for C21orf80 in the pathogenesis of DS. (C) 2004 Elsevier Inc. All rights reserved.	Univ Geneva, Sch Med, Div Med Genet, CH-1211 Geneva 4, Switzerland; Univ Fribourg, Inst Zool, CH-1700 Fribourg, Switzerland		Guipponi, M (corresponding author), Univ Geneva, Sch Med, Div Med Genet, 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland.	guipponi@wehi.edu.au	Takacs-Vellai, Krisztina/AAF-9062-2020; Menzel, Olivier/E-8875-2011; Antonarakis, Stylianos E/N-8866-2014; Vellai, Tibor/AAG-2154-2020	Takacs-Vellai, Krisztina/0000-0002-4472-0363; Antonarakis, Stylianos E/0000-0001-8907-5823; Menzel, Olivier/0000-0003-3502-3264; Reymond, Alexandre/0000-0003-1030-8327			BRENNER S, 1974, GENETICS, V77, P71; Davisson MT, 2001, GENOMICS, V78, P99, DOI 10.1006/geno.2001.6639; Epstein C.J., 1995, METABOLIC MOL BASES, P749; FIRE A, 1991, DEVELOPMENT, V113, P503; FIRE A, 1990, GENE, V93, P189, DOI 10.1016/0378-1119(90)90224-F; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gardiner K, 2002, GENOMICS, V79, P833, DOI 10.1006/geno.2002.6782; Gardiner K, 2001, CYTOGENET CELL GENET, V92, P11; Gitton Y, 2002, NATURE, V420, P586, DOI 10.1038/nature01178; Guipponi M, 2000, GENOMICS, V68, P30, DOI 10.1006/geno.2000.6250; Haltiwanger RS, 2002, CURR OPIN STRUC BIOL, V12, P593, DOI 10.1016/S0959-440X(02)00371-8; Hattori M, 2000, NATURE, V405, P311, DOI 10.1038/35012518; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; KLEENE R, 1993, BIOCHIM BIOPHYS ACTA, V1154, P283, DOI 10.1016/0304-4157(93)90003-7; Labouesse M, 1999, TRENDS GENET, V15, P307, DOI 10.1016/S0168-9525(99)01750-3; Lubke T, 1999, J BIOL CHEM, V274, P25986, DOI 10.1074/jbc.274.37.25986; Luhn K, 2001, NAT GENET, V28, P69, DOI 10.1038/ng0501-69; MADURO M, 1995, GENETICS, V141, P977; Magdaleno SM, 1999, NAT GENET, V22, P319, DOI 10.1038/11882; Martinez-Duncker I, 2003, GLYCOBIOLOGY, V13, p1C, DOI 10.1093/glycob/cwg113; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Mohler WA, 1998, CURR BIOL, V8, P1087, DOI 10.1016/S0960-9822(98)70447-6; Mural RJ, 2002, SCIENCE, V296, P1661, DOI 10.1126/science.1069193; Okajima T, 2003, J BIOL CHEM, V278, P42340, DOI 10.1074/jbc.M308687200; Okajima T, 2002, CELL, V111, P893, DOI 10.1016/S0092-8674(02)01114-5; Reymond A, 2002, GENOMICS, V79, P824, DOI 10.1006/geno.2002.6781; Reymond A, 2002, NATURE, V420, P582, DOI 10.1038/nature01178; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Reymond A, 2001, GENOMICS, V78, P46, DOI 10.1006/geno.2001.6640; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Yang XW, 1999, NAT GENET, V22, P327, DOI 10.1038/11896	32	16	19	0	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0888-7543	1089-8646		GENOMICS	Genomics	AUG	2004	84	2					320	330		10.1016/j.ygeno.2004.04.002			11	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	837UA	WOS:000222665200009	15233996	Green Published, Green Submitted			2022-03-04	
J	Tymoshenko, S; Oppenheim, RD; Soldati-Favre, D; Hatzimanikatis, V				Tymoshenko, Stepan; Oppenheim, Rebecca D.; Soldati-Favre, Dominique; Hatzimanikatis, Vassily			Functional genomics of Plasmodium falciparum using metabolic modelling and analysis	BRIEFINGS IN FUNCTIONAL GENOMICS			English	Article						Plasmodium falciparum; central carbon metabolism; systems biology; flux-balance analysis; constraint-based modelling; in silico gene essentiality	CENTRAL CARBON METABOLISM; DRUG TARGETS; NETWORK MODELS; MALARIA; TRANSCRIPTOME; RECONSTRUCTION; INTEGRATION; UNCERTAINTY; GLYCOLYSIS; PROTEOME	Plasmodium falciparum is an obligate intracellular parasite and the leading cause of severe malaria responsible for tremendous morbidity and mortality particularly in sub-Saharan Africa. Successful completion of the P. falciparum genome sequencing project in 2002 provided a comprehensive foundation for functional genomic studies on this pathogen in the following decade. Over this period, a large spectrum of experimental approaches has been deployed to improve and expand the scope of functionally annotated genes. Meanwhile, rapidly evolving methods of systems biology have also begun to contribute to a more global understanding of various aspects of the biology and pathogenesis of malaria. Herein we provide an overview on metabolic modelling, which has the capability to integrate information from functional genomics studies in P. falciparum and guide future malaria research efforts towards the identification of novel candidate drug targets.	[Tymoshenko, Stepan; Hatzimanikatis, Vassily] Ecole Polytech Fed Lausanne, CH-1015 Lausanne, Switzerland; [Oppenheim, Rebecca D.] Univ Geneva, CH-1211 Geneva 4, Switzerland; [Soldati-Favre, Dominique] Univ Geneva, Fac Med, CH-1211 Geneva 4, Switzerland		Tymoshenko, S (corresponding author), Ecole Polytech Fed Lausanne, Inst Chem Engn, Lab Computat Syst Biotechnol, CH-1015 Lausanne, Switzerland.	stepan.tymoshenko@epfl.ch	Hatzimanikatis, Vassily/G-6505-2010	Hatzimanikatis, Vassily/0000-0001-6432-4694; Soldati-Favre, Dominique/0000-0003-4156-2109	Swiss National Science Foundation within initiative SystemsX.ch; SystemsX.ch initiative of the Swiss National Science FoundationSwiss National Science Foundation (SNSF) [441, LipidX-2008/011]	S.T. is supported by an iPhD grant from the Swiss National Science Foundation within the initiative SystemsX.ch; R.O. was supported by the SystemsX.ch initiative of the Swiss National Science Foundation (441 grant LipidX-2008/011).	Alsford S, 2011, GENOME RES, V21, P915, DOI 10.1101/gr.115089.110; Aregawi M, 2010, GLOBAL MALARIA PROGR; Augagneur Y, 2012, P NATL ACAD SCI USA, V109, P6235, DOI 10.1073/pnas.1203516109; Aurrecoechea C, 2007, NUCLEIC ACIDS RES, V35, pD427, DOI 10.1093/nar/gkl880; Bakker BM, 2000, MOL BIOCHEM PARASIT, V106, P1, DOI 10.1016/S0166-6851(99)00197-8; Balu B, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/829210; Balu B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013282; Baum J, 2009, NUCLEIC ACIDS RES, V37, P3788, DOI 10.1093/nar/gkp239; Bazzani S, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-118; Blazier AS, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00299; Bozdech Z, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-17; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Chassagnole C, 2002, BIOTECHNOL BIOENG, V79, P53, DOI 10.1002/bit.10288; Chavali AK, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.15; Chindelevitch L, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r6; Daily JP, 2007, NATURE, V450, P1091, DOI 10.1038/nature06311; Duy SV, 2012, ANAL CHIM ACTA, V739, P47, DOI 10.1016/j.aca.2012.06.016; Fatumo S, 2011, INFECT GENET EVOL, V11, P201, DOI 10.1016/j.meegid.2010.08.012; Fatumo S, 2009, INFECT GENET EVOL, V9, P351, DOI 10.1016/j.meegid.2008.01.007; Feist AM, 2010, CURR OPIN MICROBIOL, V13, P344, DOI 10.1016/j.mib.2010.03.003; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Foth BJ, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006411; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gille C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.62; Ginsburg H, 2006, TRENDS PARASITOL, V22, P238, DOI 10.1016/j.pt.2006.04.008; Hayes CN, 2006, J PESTIC SCI, V31, P263, DOI 10.1584/jpestics.31.263; Hecker N, 2012, NUCLEIC ACIDS RES, V40, pD1113, DOI 10.1093/nar/gkr912; Henry CS, 2007, BIOPHYS J, V92, P1792, DOI 10.1529/biophysj.106.093138; Hung SS, 2010, BIOINFORMATICS, V26, P1690, DOI 10.1093/bioinformatics/btq266; Huthmacher C, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-120; Kim HU, 2012, BIOTECHNOL J, V7, P330, DOI 10.1002/biot.201100159; KUMAR VS, 2009, PLOS COMPUT BIOL, V0005, DOI DOI 10.1371/JOURNAL.PCBI.1000308; Lakshmanan V, 2011, MOL BIOCHEM PARASIT, V175, P104, DOI 10.1016/j.molbiopara.2010.09.008; Lasonder E, 2002, NATURE, V419, P537, DOI 10.1038/nature01111; Le Roch KG, 2004, GENOME RES, V14, P2308, DOI 10.1101/gr.2523904; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Lewis NE, 2012, NAT REV MICROBIOL, V10, P291, DOI 10.1038/nrmicro2737; Lian LY, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-38; Limenitakis J, 2011, FEBS LETT, V585, P1579, DOI 10.1016/j.febslet.2011.05.002; Llinas M, 2006, NUCLEIC ACIDS RES, V34, P1166, DOI 10.1093/nar/gkj517; Mair GR, 2006, SCIENCE, V313, P667, DOI 10.1126/science.1125129; Martin RE, 2007, BLOOD, V109, P2217, DOI 10.1182/blood-2005-11-026963; Mehta M, 2005, FEBS LETT, V579, P6151, DOI 10.1016/j.febslet.2005.09.088; Mehta Monika, 2006, Journal of Vector Borne Diseases, V43, P95; Miskovic L, 2010, TRENDS BIOTECHNOL, V28, P391, DOI 10.1016/j.tibtech.2010.05.003; Nicholls AW, 2012, BIOANALYSIS, V4, P2195, DOI [10.4155/bio.12.209, 10.4155/BIO.12.209]; Nirmalan N, 2004, MOL MICROBIOL, V52, P1187, DOI 10.1111/j.1365-2958.2004.04049.x; Oberhardt MA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001116; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Oikawa A, 2011, PLANT PHYSIOL, V157, P544, DOI 10.1104/pp.111.183772; Olszewski KL, 2009, CELL HOST MICROBE, V5, P191, DOI 10.1016/j.chom.2009.01.004; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Otto TD, 2010, MOL MICROBIOL, V76, P12, DOI 10.1111/j.1365-2958.2009.07026.x; Paglia G, 2012, ANAL BIOANAL CHEM, V402, P1183, DOI 10.1007/s00216-011-5556-4; Palsson B, 2006, SYSTEMS BIOL PROPERT; Pinney JW, 2007, TRENDS PARASITOL, V23, P548, DOI 10.1016/j.pt.2007.08.013; Pinney JW, 2005, NUCLEIC ACIDS RES, V33, P1399, DOI 10.1093/nar/gki285; Plata G, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.60; Prieto JH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004098; Roberts SB, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-52; Sacci JB, 2005, MOL BIOCHEM PARASIT, V142, P177, DOI 10.1016/j.molbiopara.2005.03.018; Saliba KJ, 2006, NATURE, V443, P582, DOI 10.1038/nature05149; Saliba KJ, 2001, J BIOL CHEM, V276, P18115, DOI 10.1074/jbc.M010942200; Scheer M, 2011, NUCLEIC ACIDS RES, V39, pD670, DOI 10.1093/nar/gkq1089; Schuetz R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100162; Soh KC, 2012, FEMS YEAST RES, V12, P129, DOI 10.1111/j.1567-1364.2011.00771.x; Soh KC, 2010, CURR OPIN MICROBIOL, V13, P350, DOI 10.1016/j.mib.2010.03.001; Southworth PM, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-315; Stelling J, 2004, CURR OPIN MICROBIOL, V7, P513, DOI 10.1016/j.mib.2004.08.004; t'Kindt R, 2010, ANAL BIOANAL CHEM, V398, P2059, DOI 10.1007/s00216-010-4139-0; Tang YJ, 2009, MASS SPECTROM REV, V28, P362, DOI 10.1002/mas.20191; Tarun AS, 2008, P NATL ACAD SCI USA, V105, P305, DOI 10.1073/pnas.0710780104; Teng RW, 2009, NMR BIOMED, V22, P292, DOI 10.1002/nbm.1323; Teusink B, 2000, EUR J BIOCHEM, V267, P5313, DOI 10.1046/j.1432-1327.2000.01527.x; Thiele I, 2010, NAT PROTOC, V5, P93, DOI 10.1038/nprot.2009.203; Veenstra TD, 2012, GENOME MED, V4, DOI 10.1186/gm339; Visvesvara GS, 2002, CLIN MICROBIOL REV, V15, P327, DOI 10.1128/CMR.15.3.327-328.2002; Wang LQ, 2006, METAB ENG, V8, P142, DOI 10.1016/j.ymben.2005.11.002; Wang LQ, 2006, METAB ENG, V8, P133, DOI 10.1016/j.ymben.2005.11.003; Wang LQ, 2005, J BIOTECHNOL, V118, pS6; Wang LQ, 2004, BIOPHYS J, V87, P3750, DOI 10.1529/biophysj.104.048090; Wastling JM, 2009, INT J PARASITOL, V39, P135, DOI 10.1016/j.ijpara.2008.10.003; Wiebe MG, 2008, FEMS YEAST RES, V8, P140, DOI 10.1111/j.1567-1364.2007.00234.x; Winter G, 2013, ENVIRON MICROBIOL, V15, P1901, DOI 10.1111/1462-2920.12064; Wishart DS, 2010, METHODS MOL BIOL, V593, P283, DOI 10.1007/978-1-60327-194-3_14; Yeh W, 2004, GENOME RES, V14, P917, DOI 10.1101/gr.2050304; Zomorrodi AR, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-178	87	11	11	0	9	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	2041-2649	2041-2657		BRIEF FUNCT GENOMICS	Brief. Funct. Genomics	JUL	2013	12	4			SI		316	327		10.1093/bfgp/elt017			12	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	204CW	WOS:000323343600004	23793264	Green Published, Green Submitted, Green Accepted, hybrid			2022-03-04	
J	Henchoz, Y; Bula, C; Guessous, I; Santos-Eggimann, B				Henchoz, Yves; Bula, C.; Guessous, I.; Santos-Eggimann, B.			Association between physical frailty and quality of life in a representative sample of community-dwelling Swiss older people	JOURNAL OF NUTRITION HEALTH & AGING			English	Article						Frailty; quality of life; aged; health; socioeconomic factors	ELDERLY-PEOPLE; HEALTH; ADULTS; PREVALENCE; DISABILITY; SARCOPENIA; PHENOTYPE; PREDICTION; DOMAINS; SPEED	Though the association between physical frailty and health is well established, little is known about its association with other domains of quality of life (QoL). This study investigated the association between physical frailty and multiple domains of QoL in community-dwelling older people. Cross-sectional study. Data of the 2011 annual assessment of 927 older people (age 73-77 years) from the Lc65+ cohort study were used. Physical frailty was assessed by Fried's five criteria: 'shrinking'; 'weakness'; 'poor endurance, exhaustion'; 'slowness'; and 'low activity'. QoL was assessed using 28 items yielding a QoL score and seven domain-specific QoL subscores (Feeling of safety; Health and mobility; Autonomy; Close entourage; Material resources; Esteem and recognition; and Social and cultural life). Low QoL (QoL score or QoL subscores in the lowest quintile) was used as dependent variable in logistic regression analyses adjusted for age and sex (model 1), and additionally for socioeconomic (model 2) and health (model 3) covariates. Physical frailty was associated with a low QoL score, as well as decreased QoL subscores in all seven specific domains, even after adjusting for socio-economic covariates. However, when performing additional adjustment for health covariates, only the domain Health and mobility remained significantly associated with physical frailty. Among each specific Fried's criteria, 'slowness' had the strongest association with a low QoL score. Physical frailty is associated with all QoL domains, but these associations are largely explained by poor health characteristics. Longitudinal studies are needed to better understand temporal relationships between physical frailty, health and QoL.	[Henchoz, Yves; Guessous, I.; Santos-Eggimann, B.] Univ Lausanne, Inst Social & Prevent Med IUMSP, Hosp Ctr, CH-1010 Lausanne, Switzerland; [Bula, C.] Univ Lausanne, Serv Geriatr Med & Geriatr Rehabil, Hosp Ctr, Lausanne, Switzerland; [Guessous, I.] Univ Hosp Geneva, Dept Community Med & Primary Care & Emergency Med, Unit Populat Epidemiol, Geneva, Switzerland		Henchoz, Y (corresponding author), Univ Lausanne, Hosp Ctr, Inst Social & Prevent Med IUMSP, Route Corniche 10, CH-1010 Lausanne, Switzerland.	yves.henchoz@chuv.ch	Bula, Christophe J/ABI-1163-2020; Henchoz, Yves/W-5618-2019	Henchoz, Yves/0000-0002-8251-8393; Santos-Eggimann, Brigitte/0000-0001-9115-6147; Bula, Christophe/0000-0002-7501-3442	Leenaards Foundation	This work was supported by a prize awarded by the Leenaards Foundation.	Abizanda P, 2013, MATURITAS, V74, P54, DOI 10.1016/j.maturitas.2012.09.018; Bandeen-Roche K, 2006, J GERONTOL A-BIOL, V61, P262, DOI 10.1093/gerona/61.3.262; Bilotta C, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-56; Calvani R, 2015, J CACHEXIA SARCOPENI, V6, P278, DOI 10.1002/jcsm.12051; Castell MV, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-86; Cesari M, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00192; Chang YW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038079; Clegg A, 2013, LANCET, V381, P752, DOI 10.1016/S0140-6736(12)62167-9; Collard RM, 2012, J AM GERIATR SOC, V60, P1487, DOI 10.1111/j.1532-5415.2012.04054.x; De Vriendt P, 2016, J NUTR HEALTH AGING, V20, P35, DOI 10.1007/s12603-015-0581-1; Ensrud KE, 2008, ARCH INTERN MED, V168, P382, DOI 10.1001/archinternmed.2007.113; Fitten L J, 2015, J Prev Alzheimers Dis, V2, P7, DOI 10.14283/jpad.2015.45; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Fried LP, 2004, J GERONTOL A-BIOL, V59, P255; Gill TM, 2010, NEW ENGL J MED, V362, P1173, DOI 10.1056/NEJMoa0909087; Gobbens RJJ, 2014, QUAL LIFE RES, V23, P2289, DOI 10.1007/s11136-014-0672-1; Gobbens RJ, 2012, J ADV NURS, V68, P2047, DOI 10.1111/j.1365-2648.2011.05896.x; Gobbens RJJ, 2013, QUAL LIFE RES, V22, P2051, DOI 10.1007/s11136-012-0341-1; Henchoz Y, 2015, AGE AGEING, V44, P979, DOI 10.1093/ageing/afv130; Hubbard RE, 2014, ARCH GERONTOL GERIAT, V58, P364, DOI 10.1016/j.archger.2013.12.008; Jurschik P, 2012, ARCH GERONTOL GERIAT, V55, P625, DOI 10.1016/j.archger.2012.07.002; KATZ S, 1970, GERONTOLOGIST, V10, P20, DOI 10.1093/geront/10.1_Part_1.20; Keevil VL, 2015, P NUTR SOC, V74, P337, DOI 10.1017/S0029665115002037; KUYKEN W, 1995, SOC SCI MED, V41, P1403, DOI 10.1016/0277-9536(95)00112-k; LI KH, 1991, STAT SINICA, V1, P65; Lin CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021841; Makizako H, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008462; Masel MC, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-70; Moreno-Aguilar M, 2013, J FRALITY AGING, V2, P2, DOI 10.14283/jfa.2013.1; Mulasso A, 2014, ARCH GERONTOL GERIAT, V59, P542, DOI 10.1016/j.archger.2014.08.012; Peel NM, 2013, J GERONTOL A-BIOL, V68, P39, DOI 10.1093/gerona/gls174; Peters LL, 2012, J AM MED DIR ASSOC, V13, P546, DOI 10.1016/j.jamda.2012.04.007; Rockwood K, 2004, J GERONTOL A-BIOL, V59, P1310, DOI 10.1093/gerona/59.12.1310; Rockwood K, 2011, CLIN GERIATR MED, V27, P17, DOI 10.1016/j.cger.2010.08.008; Santos-Eggimann Brigitte, 2008, BMC Geriatr, V8, P20, DOI 10.1186/1471-2318-8-20; Santos-Eggimann B, 2009, J GERONTOL A-BIOL, V64, P675, DOI 10.1093/gerona/glp012; Veld LPMOH, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0078-0; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Whooley MA, 1997, J GEN INTERN MED, V12, P439, DOI 10.1046/j.1525-1497.1997.00076.x; Wu TY, 2013, ARCH GERONTOL GERIAT, V57, P143, DOI 10.1016/j.archger.2013.03.010	41	11	13	1	15	SPRINGER FRANCE	PARIS	22 RUE DE PALESTRO, PARIS, 75002, FRANCE	1279-7707	1760-4788		J NUTR HEALTH AGING	J. Nutr. Health Aging	MAY	2017	21	5					585	592		10.1007/s12603-016-0772-4			8	Geriatrics & Gerontology; Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology; Nutrition & Dietetics	ET2VZ	WOS:000400134300016	28448091	Green Accepted			2022-03-04	
J	Deutsch, S; Reymond, A				Deutsch, Samuel; Reymond, Alexandre			The future is genome-wide	GENOME BIOLOGY			English	Editorial Material									Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland; Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland		Reymond, A (corresponding author), Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland.	alexandre.reymond@unil.ch		Reymond, Alexandre/0000-0003-1030-8327; Deutsch, Samuel/0000-0001-9456-7101				0	1	1	0	0	BIOMED CENTRAL LTD	LONDON	MIDDLESEX HOUSE, 34-42 CLEVELAND ST, LONDON W1T 4LB, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.		2006	7	8							324	10.1186/gb-2006-7-8-324			3	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	095QN	WOS:000241322800007	16934105	Bronze, Green Published			2022-03-04	
J	Gubbay, O; Curran, J; Kolakofsky, D				Gubbay, O; Curran, J; Kolakofsky, D			Sendai virus genome synthesis and assembly are coupled: a possible mechanism to promote viral RNA polymerase processivity	JOURNAL OF GENERAL VIROLOGY			English	Article							RESPIRATORY SYNCYTIAL VIRUS; MESSENGER-RNA; P-PROTEIN; GENE-EXPRESSION; CELLULAR ACTIN; INVITRO SYSTEM; INFECTED-CELLS; TRANSCRIPTION; ELONGATION; REPLICATION	A cell-free system for studying Sendai virus RNA synthesis was reconstituted from N protein: RNA templates and transfected cell extracts in which the viral N, P and L proteins were expressed. Both transcription (mRNA synthesis) and replication (genome and antigenome synthesis) took place concurrently in these reactions. Viral RNA polymerases engaged in replication (replicases) were found to elongate their chains at a constant speed along the genome (1.7 nt/s), in a highly processive manner. In contrast, viral RNA polymerases engaged in transcription (transcriptases), although capable of synthesizing RNA at a comparable speed to replicases, were poorly processive. In this system, therefore, transcriptases require special reaction conditions to promote processivity that are not required by replicases. In addition, during replication, incomplete nascent genome chains were shown to be assembled with N protein, providing direct evidence that the synthesis and assembly of genomes are concurrent events. The strong processivity of replicases, independent of the reaction conditions, may thus be due to the coupling of genome synthesis and assembly. A model is proposed to explain how pausing of viral polymerase on the template is restricted when assembly and synthesis of the nascent chain are coupled.	Univ Geneva, Sch Med, Dept Genet & Microbiol, CMU, CH-1211 Geneva, Switzerland		Gubbay, O (corresponding author), MRC, Human Reprod Sci Unit, Ctr Reprod Biol, 37 Chalmers St, Edinburgh EH3 9ET, Midlothian, Scotland.	o.gubbay@hrsu.mrc.ac.uk					Burke E, 1998, VIROLOGY, V252, P137, DOI 10.1006/viro.1998.9471; CASTANEDA SJ, 1990, J VIROL, V64, P222, DOI 10.1128/JVI.64.1.222-230.1990; CATTANEO R, 1988, CELL, V55, P255, DOI 10.1016/0092-8674(88)90048-7; CURRAN J, 1992, VIROLOGY, V189, P647, DOI 10.1016/0042-6822(92)90588-G; CURRAN J, 1995, J VIROL, V69, P849, DOI 10.1128/JVI.69.2.849-855.1995; Curran J, 1998, J VIROL, V72, P4274, DOI 10.1128/JVI.72.5.4274-4280.1998; CURRAN J, 1994, VIROLOGY, V202, P875, DOI 10.1006/viro.1994.1409; DE BP, 1990, J VIROL, V64, P1135, DOI 10.1128/JVI.64.3.1135-1142.1990; DE BP, 1991, J VIROL, V65, P3268, DOI 10.1128/JVI.65.6.3268-3275.1991; Fearns R, 1999, J VIROL, V73, P5852, DOI 10.1128/JVI.73.7.5852-5864.1999; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; Guajardo R, 1997, J MOL BIOL, V265, P8, DOI 10.1006/jmbi.1996.0707; Hardy RW, 1999, J VIROL, V73, P170, DOI 10.1128/JVI.73.1.170-176.1999; Hardy RW, 1998, J VIROL, V72, P520, DOI 10.1128/JVI.72.1.520-526.1998; Hausmann S, 1999, J VIROL, V73, P5568, DOI 10.1128/JVI.73.7.5568-5576.1999; Hausmann S, 1999, J VIROL, V73, P343, DOI 10.1128/JVI.73.1.343-351.1999; HOMANN HE, 1990, VIROLOGY, V177, P131, DOI 10.1016/0042-6822(90)90467-6; HORIKAMI SM, 1992, J VIROL, V66, P4901, DOI 10.1128/JVI.66.8.4901-4908.1992; HUANG YT, 1993, VIROLOGY, V193, P862, DOI 10.1006/viro.1993.1195; IVERSON LE, 1981, CELL, V23, P477, DOI 10.1016/0092-8674(81)90143-4; KOLAKOFSKY D, 1975, VIROLOGY, V66, P185, DOI 10.1016/0042-6822(75)90189-0; Komissarova N, 1997, J BIOL CHEM, V272, P15329, DOI 10.1074/jbc.272.24.15329; Komissarova N, 1997, P NATL ACAD SCI USA, V94, P1755, DOI 10.1073/pnas.94.5.1755; Lamb RA., 1996, FUNDAMENTAL VIROLOGY, V1340; Mooney RA, 1999, CELL, V98, P687, DOI 10.1016/S0092-8674(00)81483-X; Mottet G, 1999, J GEN VIROL, V80, P2977, DOI 10.1099/0022-1317-80-11-2977; MOYER SA, 1986, P NATL ACAD SCI USA, V83, P5405, DOI 10.1073/pnas.83.15.5405; MOYER SA, 1990, J GEN VIROL, V71, P775, DOI 10.1099/0022-1317-71-4-775; Nudler E, 1997, CELL, V89, P33, DOI 10.1016/S0092-8674(00)80180-4; Ogino T, 1999, J BIOL CHEM, V274, P35999, DOI 10.1074/jbc.274.50.35999; PORTNER A, 1988, VIROLOGY, V163, P236, DOI 10.1016/0042-6822(88)90257-7; Reeder TC, 1996, CELL, V87, P767, DOI 10.1016/S0092-8674(00)81395-1; Reines D, 1996, TRENDS BIOCHEM SCI, V21, P351, DOI 10.1016/0968-0004(96)10045-1; Shilatifard A, 1998, FASEB J, V12, P1437, DOI 10.1096/fasebj.12.14.1437; Tarbouriech N, 2000, VIROLOGY, V266, P99, DOI 10.1006/viro.1999.0066; Uptain SM, 1997, ANNU REV BIOCHEM, V66, P117, DOI 10.1146/annurev.biochem.66.1.117; VIDAL S, 1989, J VIROL, V63, P1951, DOI 10.1128/JVI.63.5.1951-1958.1989	37	51	52	0	0	MICROBIOLOGY SOC	LONDON	CHARLES DARWIN HOUSE, 12 ROGER ST, LONDON WC1N 2JU, ERKS, ENGLAND	0022-1317	1465-2099		J GEN VIROL	J. Gen. Virol.	DEC	2001	82		12				2895	2903		10.1099/0022-1317-82-12-2895			9	Biotechnology & Applied Microbiology; Virology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Virology	497EJ	WOS:000172442200007	11714964	Bronze			2022-03-04	
J	Slavcheva, S; Krejci, I; Bortolotto, T				Slavcheva, Slavena; Krejci, Ivo; Bortolotto, Tissiana			Luting of ceramic crowns with a self-adhesive cement: Effect of contamination on marginal adaptation and fracture strength	MEDICINA ORAL PATOLOGIA ORAL Y CIRUGIA BUCAL			English	Article						Marginal adaptation; RelyX Unicem; contamination; all-ceramic crowns	MICROTENSILE BOND STRENGTH; INTERFACIAL CHARACTERISTICS; PROVISIONAL CEMENT; HEMOSTATIC AGENT; RESIN CEMENTS; IN-VITRO; DENTIN; COMPOSITE; SYSTEMS; ENAMEL	Objectives: This study evaluated the percentages of continuous margins (%CM) and fracture strength (FS) of crowns made out from blocs of leucite-reinforced ceramic (IPS Empress CAD) and luted with a representative self-adhesive cement (RelyX Unicem) under four contaminating agents: saliva, water, blood, a haemostatic solution containing aluminium chloride (pH=0.8) and a control group with no contamination. Study Design: %CM at both tooth-cement (TC) and cement-crown (CC) interfaces were determined before and after a fatigue test consisting of 600'000 chewing loads and 1'500 temperature cycles changing from 5 degrees C to 50 degrees C. Load to fracture was recorded on fatigued specimens. Kruskal-Wallis test was used to compare %CM and FS between the five groups with a level of confidence of 95%. Results: At the TC interface, no significant differences in marginal adaptation before loading could be detected between groups. After loading, a significant marginal degradation was observed in the group contaminated with aluminium chloride (52 +/- 22 %CM) in respect to the other groups. No significant differences in %CM could be detected between the groups contaminated with saliva, water, blood and the control. At the CC interface, no significant differences in marginal adaptation were observed between the groups. The FS on loaded specimens was around 1637N, with no significant differences between groups as well. Conclusions: An adverse interaction of the highly acidic haemostatic agent with either dentin or the self-adhesive cement could explain the specimens' marginal degradation. The self-adhesive cement tested in this study was no sensitive to moisture contamination either with saliva, water or blood.	[Slavcheva, Slavena; Krejci, Ivo; Bortolotto, Tissiana] Univ Geneva, Sch Dent Med, Div Cariol & Endodont, CH-1205 Geneva, Switzerland		Bortolotto, T (corresponding author), Univ Geneva, Sch Dent Med, Div Cariol & Endodont, Rue Barthelemy Menn 19, CH-1205 Geneva, Switzerland.	Tissiana.Bortolotto@unige.ch	Bortolotto, Tissiana/AAE-2796-2021	Bortolotto, Tissiana/0000-0002-3231-9097			Abo-Hamar SE, 2005, CLIN ORAL INVEST, V9, P161, DOI 10.1007/s00784-005-0308-5; Al-Assaf K, 2007, DENT MATER, V23, P829, DOI 10.1016/j.dental.2006.06.023; Bagis B, 2011, J ADHES DENT, V13, P543, DOI 10.3290/j.jad.a19811; Behr M, 2009, CLIN ORAL INVEST, V13, P459, DOI 10.1007/s00784-009-0255-7; Behr M, 2004, DENT MATER, V20, P191, DOI 10.1016/S0109-5641(03)00091-5; Bindl A, 2006, J ORAL REHABIL, V33, P520, DOI 10.1111/j.1365-2842.2005.01588.x; Bindl A, 2006, DENT MATER, V22, P29, DOI 10.1016/j.dental.2005.02.007; Cheong C, 2003, OPER DENT, V28, P747; Chung CWM, 2009, J DENT, V37, P923, DOI 10.1016/j.jdent.2009.07.007; De Munck J, 2004, DENT MATER, V20, P963, DOI 10.1016/j.dental.2004.03.002; Fabianelli A, 2005, J ADHES DENT, V7, P33; Fleming GJP, 2003, DENT MATER, V19, P69, DOI 10.1016/S0109-5641(02)00006-4; Goracci C, 2006, J ADHES DENT, V8, P327; Hikita K, 2007, DENT MATER, V23, P71, DOI 10.1016/j.dental.2005.12.002; Kaaden Christoph, 2002, Clin Oral Investig, V6, P155, DOI 10.1007/s00784-002-0170-7; Kuphasuk W, 2007, OPER DENT, V32, P399, DOI 10.2341/06-121; Lefever D, 2012, J ADHES DENT, V14, P561, DOI 10.3290/j.jad.a27795; Mormann W, 2009, J PROSTHODONT, V18, P403, DOI 10.1111/j.1532-849X.2009.00461.x; Mohammadi N, 2012, MED ORAL PATOL ORAL, V17, pE841, DOI 10.4317/medoral.17683; Nakamura T, 2010, J PROSTHODONT RES, V54, P59, DOI 10.1016/j.jpor.2009.09.004; Reddy L, 2003, J ORAL MAXIL SURG, V61, P206, DOI 10.1053/joms.2003.50039; Roggendorf MJ, 2012, J DENT, V40, P1068, DOI 10.1016/j.jdent.2012.08.019; ROSENSTIEL SF, 1993, DENT MATER, V9, P274, DOI 10.1016/0109-5641(93)90074-Z; Sailer I, 2012, J PROSTHET DENT, V107, P252, DOI 10.1016/S0022-3913(12)60070-5; Sidhu SK, 1998, J DENT RES, V77, P1749, DOI 10.1177/00220345980770091101; Sornsuwan T, 2012, ACTA BIOMATER, V8, P4426, DOI 10.1016/j.actbio.2012.08.006; Tay FR, 2004, J DENT RES, V83, P644, DOI 10.1177/154405910408300812; Viotti RG, 2009, J PROSTHET DENT, V102, P306, DOI 10.1016/S0022-3913(09)60180-3	28	3	3	0	2	MEDICINA ORAL S L	VALENCIA	CALLE DANIEL BALACIART N 4 PTA 17, VALENCIA, 46020, SPAIN	1698-6946			MED ORAL PATOL ORAL	Med. Oral Patol. Oral Cir. Bucal	SEP	2013	18	5					E799	E803	18544	10.4317/medoral.18544			5	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	249AQ	WOS:000326749300008	23722123	Green Published, Green Submitted, gold			2022-03-04	
J	Terzic, A; Becker, M; Imholz, B; Scolozzi, P				Terzic, Andrej; Becker, Minerva; Imholz, Benoit; Scolozzi, Paolo			Unilateral widening of the inferior alveolar nerve canal: a rare anatomic variant mimicking disease	ORAL RADIOLOGY			English	Article						Widening; Enlargement; Idiopathic; Inferior alveolar nerve; Tractography	NON-HODGKINS-LYMPHOMA; OF-THE-LITERATURE; ARTERIOVENOUS-MALFORMATION; OSTEOGENIC-SARCOMA; MALIGNANT SCHWANNOMA; SHEATH TUMORS; MENTAL NERVE; JAWS; OSTEOSARCOMA; NEUROFIBROMATOSIS	We report a case of an asymptomatic healthy 49-year-old male patient with an incidental finding of enlargement of the right inferior alveolar nerve (IAN) canal (9 vs. 4 mm). After 2 years, follow-up magnetic resonance imaging (MRI) revealed no change in the findings. In addition, MR-based diffusion tensor imaging with tractography of the right and left mandibular nerves showed that the difference in size between the right and left nerves was caused by an increased number of nerve fibers in the right IAN. During the entire follow-up period of 4 years, the patient remained symptom-free. Therefore, we suggest that the enlargement in our patient was a pure anatomic variant. However, a multitude of conditions are known to produce the identical radiological appearance in conventional radiology, including benign and malignant tumors, vascular malformations, and inflammatory disorders. We describe these pathologies in more detail as well as the possibilities for examinations with different MRI sequences.	[Terzic, Andrej; Imholz, Benoit; Scolozzi, Paolo] Univ Hosp Geneva, Dept Surg, Serv Maxillofacial & Oral Surg, CH-1211 Geneva 14, Switzerland; [Becker, Minerva] Univ Hosp Geneva, Dept Radiol, CH-1211 Geneva 14, Switzerland		Terzic, A (corresponding author), Univ Hosp Geneva, Dept Surg, Serv Maxillofacial & Oral Surg, Rue Gabrielle Perret Gentil 4, CH-1211 Geneva 14, Switzerland.	andrej.terzic@hcuge.ch					Apostolidis C, 2001, J ORAL MAXIL SURG, V59, P232, DOI 10.1053/joms.2001.20508; Garcia IA, 2008, MED ORAL PATOL ORAL, V13, pE186; August M, 1997, INT J ORAL MAX SURG, V26, P198, DOI 10.1016/S0901-5027(97)80819-3; Bachaud J. M., 1992, Revue de Stomatologie et de Chirurgie Maxillo-Faciale, V93, P372; BARBER HD, 1992, J ORAL MAXIL SURG, V50, P1334; Becker M, 2008, NEUROIMAG CLIN N AM, V18, P283, DOI 10.1016/j.nic.2007.11.002; Becktor KB, 2002, CLEFT PALATE-CRAN J, V39, P233, DOI 10.1597/1545-1569(2002)039<0233:CADMOP>2.0.CO;2; Bennett JH, 2000, ORAL SURG ORAL MED O, V90, P323, DOI 10.1067/moe.2000.108274; Bertolotto M, 1996, EUR RADIOL, V6, P637; Borges A, 2010, EUR J RADIOL, V74, P323, DOI 10.1016/j.ejrad.2010.02.006; Buric N, 2010, DENTOMAXILLOFAC RAD, V39, P383, DOI 10.1259/dmfr/16059055; BURKES EJ, 1995, J ORAL MAXIL SURG, V53, P65, DOI 10.1016/0278-2391(95)90504-9; Chi AC, 2003, ORAL SURG ORAL MED O, V96, P54, DOI 10.1016/S1079-2104(03)00228-2; CLARK JL, 1983, CANCER, V51, P2311, DOI 10.1002/1097-0142(19830615)51:12<2311::AID-CNCR2820511224>3.0.CO;2-Z; COLMENERO C, 1991, J CRANIO MAXILL SURG, V19, P40, DOI 10.1016/S1010-5182(05)80270-7; Ethunandan M, 1999, J ORAL MAXIL SURG, V57, P84, DOI 10.1016/S0278-2391(99)90642-0; Fujiwara S, 2011, J NEUROIMAGING, V21, pe102, DOI 10.1111/j.1552-6569.2010.00508.x; GARRINGTON GE, 1967, CANCER-AM CANCER SOC, V20, P377, DOI 10.1002/1097-0142(1967)20:3<377::AID-CNCR2820200306>3.0.CO;2-T; Givol N, 1998, DENTOMAXILLOFAC RAD, V27, P313, DOI 10.1038/sj.dmfr.4600383; GUSENBAUER AW, 1990, J ORAL MAXIL SURG, V48, P409, DOI 10.1016/0278-2391(90)90442-5; HALAZONITIS JA, 1982, ORAL SURG ORAL MED O, V53, P454, DOI 10.1016/0030-4220(82)90455-8; HELL B, 1988, J CRANIO MAXILL SURG, V16, P76, DOI 10.1016/S1010-5182(88)80022-2; HORSWELL BB, 1988, AUST NZ J SURG, V58, P73, DOI 10.1111/j.1445-2197.1988.tb00972.x; Ikeda K, 1996, AM J NEURORADIOL, V17, P579; Juodzbalys Gintaras, 2010, J Oral Maxillofac Res, V1, pe3, DOI 10.5037/jomr.2010.1103; Kieser J, 2005, J CRANIOFAC SURG, V16, P6, DOI 10.1097/00001665-200501000-00003; Kohout MP, 1998, PLAST RECONSTR SURG, V102, P643, DOI 10.1097/00006534-199809030-00006; KUNZLER A, 1991, J CRANIO MAXILL SURG, V19, P332, DOI 10.1016/S1010-5182(05)80274-4; Lee HH, 2010, BRIT J RADIOL, V83, pE74, DOI 10.1259/bjr/16531514; LINDQVIST C, 1986, J ORAL MAXIL SURG, V44, P759, DOI 10.1016/0278-2391(86)90149-7; Longo F, 2004, INT J ORAL MAX SURG, V33, P801, DOI 10.1016/j.ijom.2003.12.003; Maeda M, 2005, AM J NEURORADIOL, V26, P1186; Martin-Duverneuil N, 2006, J NEURORADIOLOGY, V33, P237, DOI 10.1016/S0150-9861(06)77269-8; Metwaly H, 2010, ORAL MED PATHOL, V15, P29; Mohammadi H, 1997, ORAL SURG ORAL MED O, V84, P286, DOI 10.1016/S1079-2104(97)90344-9; Mori S, 2008, ORAL SURG ORAL MED O, V106, P270, DOI 10.1016/j.tripleo.2008.03.015; OHNISHI M, 1992, INT J ORAL MAX SURG, V21, P280, DOI 10.1016/S0901-5027(05)80736-2; Olivier E., 1928, BR DENT J, V49, P356; Park YK, 1999, SKELETAL RADIOL, V28, P536, DOI 10.1007/s002560050559; POLAK M, 1989, J ORAL MAXIL SURG, V47, P65, DOI 10.1016/0278-2391(89)90127-4; ROBBINS KT, 1986, HEAD NECK-J SCI SPEC, V8, P192, DOI 10.1002/hed.2890080311; ROBERTSON I, 1983, PATHOLOGY, V15, P421, DOI 10.3109/00313028309085169; Sakkas N, 2007, ANN HEMATOL, V86, P409, DOI 10.1007/s00277-007-0261-2; Salla Juliana Tito, 2009, Braz. oral res., V23, P43, DOI 10.1590/S1806-83242009000100008; SCHENBERG ME, 1992, INT J ORAL MAX SURG, V21, P110, DOI 10.1016/S0901-5027(05)80545-4; Schimming R, 1999, Schweiz Monatsschr Zahnmed, V109, P837; SHAPIRO SD, 1984, ORAL SURG ORAL MED O, V58, P493, DOI 10.1016/0030-4220(84)90350-5; Sidransky D., 2005, PATHOLOGY GENETICS H; Siu WWY, 2001, J VASC INTERV RADIOL, V12, P1095, DOI 10.1016/S1051-0443(07)61597-8; SLOOTWEG PJ, 1985, J MAXILLOFAC SURG, V13, P158, DOI 10.1016/S0301-0503(85)80040-0; Vargas MI, 2010, NEURORADIOLOGY, V52, P237, DOI 10.1007/s00234-009-0643-3; Vartiainen VM, 2008, ORAL SURG ORAL MED O, V106, pE27, DOI 10.1016/j.tripleo.2008.05.063; Vilos GA, 2005, J ORAL MAXIL SURG, V63, P1461, DOI 10.1016/j.joms.2005.06.018; Williams LS, 2003, AM J NEURORADIOL, V24, P1317; YAGAN R, 1985, ORAL SURG ORAL MED O, V60, P56, DOI 10.1016/0030-4220(85)90216-6; Yamazaki H, 2004, ORAL SURG ORAL MED O, V97, P122, DOI 10.1016/S1079-2104(03)00462-1	56	3	3	1	12	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0911-6028	1613-9674		ORAL RADIOL	Oral Radiol.	JUL	2013	29	2					160	165		10.1007/s11282-012-0118-9			6	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	180YS	WOS:000321635800010		Green Submitted, Green Published			2022-03-04	
J	Cionca, N; Giannopoulou, C; Ugolotti, G; Mombelli, A				Cionca, Norbert; Giannopoulou, Catherine; Ugolotti, Giovanni; Mombelli, Andrea			Microbiologic Testing and Outcomes of Full-Mouth Scaling and Root Planing With or Without Amoxicillin/Metronidazole in Chronic Periodontitis	JOURNAL OF PERIODONTOLOGY			English	Article						Actinobacillus actinomycetemcomitans; Aggregatibacter actinomycetemcomitans; amoxicillin; chronic periodontitis; metronidazole; Porphyromonas gingivalis; root planing	ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; SYSTEMIC METRONIDAZOLE; AGGRESSIVE PERIODONTITIS; PORPHYROMONAS-GINGIVALIS; ANTIBIOTIC-THERAPY; AMOXICILLIN; DIAGNOSIS; BACTERIA; ADJUNCT; DISEASE	Background: It has been suggested that use of systemic antibiotics should be limited to patients with specific microbiologic profiles. The main purpose of the present analysis was to study whether microbiologic testing before therapy was of value in predicting which patients would specifically benefit from adjunctive amoxicillin and metronidazole, given in the context of full-mouth scaling and root planing (SRP) within 48 hours. Methods: This was a 6-month, single-center, double-masked, placebo-controlled, randomized longitudinal study. Fifty-one patients received full-mouth periodontal debridement, performed within 48 hours; then, 25 subjects received metronidazole, 500 mg, and amoxicillin, 375 mg, three times a day for 7 days, and 26 received a placebo (control group). Pooled microbiologic samples were taken from the deepest pocket at baseline in each quadrant before and 6 months after treatment. Six periodontal pathogens were quantified by real-time polymerase chain reaction. Results: Forty-seven patients were followed for 6 months. After treatment, test subjects had a substantially lower mean number of persisting sites with probing depth >4 mm and bleeding on probing than did control subjects (0.4 versus 3.0; P=0.005; month 6). Aggregatibacter actinomycetemcomitans (previously Actinobacillus actinomycetemcomitans) could not be detected in the antibiotic group after treatment. However, in the placebo group, three of six subjects positive for A. actinomycetemcomitans continued to be positive. Lower frequencies were also noted in the test group for Porphyromonas gingivalis (P = 0.013) and Tannerella forsythia (previously T. forsythensis) (P = 0.007). However, even subjects testing negative for A. actinomycetemcomitans at baseline had a significantly better primary clinical outcome if they received the active drugs. The presence of six putative periodontal pathogens (A. actinomycetemcomitans, Fusobacterium nucleatum spp., P. gingivalis, Preuotella intermedia, Treponema denticola, and T. forsythia) quantified prior to therapy was not correlated with the outcome of full-mouth SRP with or without amoxicillin and metronidazole. Conclusion: Excellent clinical results in the antibiotics group were obtained regardless of the presence or absence of six classic periodontal periopathogens prior to treatment. J Periodontol 2010;81:15-23.	[Cionca, Norbert; Giannopoulou, Catherine; Ugolotti, Giovanni; Mombelli, Andrea] Univ Geneva, Dept Periodontol, Sch Dent Med, CH-1205 Geneva, Switzerland		Cionca, N (corresponding author), Univ Geneva, Dept Periodontol, Sch Dent Med, Rue Barthelemy Menn 19, CH-1205 Geneva, Switzerland.	Norbert.Cionca@unige.ch			GABA International, Therwil, Switzerland	The authors gratefully acknowledge the support of GABA International, Therwil, Switzerland, which provided the microbiologic analyses free of charge. The authors report no conflicts of interest related to this study.	Berglundh T, 1998, J CLIN PERIODONTOL, V25, P354, DOI 10.1111/j.1600-051X.1998.tb02455.x; Cionca N, 2009, J PERIODONTOL, V80, P364, DOI [10.1902/jop.2009.080540, 10.1902/jop.2009.080540 ]; Dannewitz B, 2007, AM J DENT, V20, P153; Flemmig TF, 1998, J CLIN PERIODONTOL, V25, P380, DOI 10.1111/j.1600-051X.1998.tb02459.x; Flemmig TF, 1998, J CLIN PERIODONTOL, V25, P1, DOI 10.1111/j.1600-051X.1998.tb02356.x; GOENE RJ, 1990, J PERIODONTOL, V61, P61, DOI 10.1902/jop.1990.61.1.61; Haffajee Anne D, 2003, Ann Periodontol, V8, P115, DOI 10.1902/annals.2003.8.1.115; Haubek D, 2008, LANCET, V371, P237, DOI 10.1016/S0140-6736(08)60135-X; Herrera D, 2002, J CLIN PERIODONTOL, V29, P136, DOI 10.1034/j.1600-051X.29.s3.8.x; HERRERA D, 2002, J CLIN PERIODONTO S3, V29, P160; Jervoe-Storm PM, 2007, J CLIN PERIODONTOL, V34, P156, DOI 10.1111/j.1600-051X.2006.01035.x; Jervoe-Storm PM, 2007, J PERIODONTOL, V78, P909, DOI 10.1902/jop.2007.060218; Jervoe-Storm PM, 2005, J CLIN PERIODONTOL, V32, P778, DOI 10.1111/j.1600-051X.2005.00740.x; Kilian M, 2006, PERIODONTOL 2000, V42, P158, DOI 10.1111/j.1600-0757.2006.00159.x; Listgarten Max A, 2003, Ann Periodontol, V8, P182, DOI 10.1902/annals.2003.8.1.182; LOE HARALD, 1963, ACTA ODONTOL SCAND, V21, P533, DOI 10.3109/00016356309011240; Mombelli A, 2002, J CLIN PERIODONTOL, V29, P10, DOI 10.1034/j.1600-051X.29.s3.1.x; Mombelli A, 2002, J CLIN PERIODONTOL, V29, P743, DOI 10.1034/j.1600-051X.2002.290811.x; PAVICIC MJAMP, 1994, J CLIN PERIODONTOL, V21, P107, DOI 10.1111/j.1600-051X.1994.tb00287.x; PAVICIC MJAMP, 1992, ANTIMICROB AGENTS CH, V36, P2634, DOI 10.1128/AAC.36.12.2634; Rooney J, 2002, J CLIN PERIODONTOL, V29, P342, DOI 10.1034/j.1600-051X.2002.290410.x; Shaddox LM, 2009, PERIODONTOL 2000, V50, P25, DOI 10.1111/j.1600-0757.2008.00285.x; SOCRANSKY SS, 2008, CLIN PERIODONTOLOGY, V1, P207; TSAI CC, 1984, INFECT IMMUN, V43, P700, DOI 10.1128/IAI.43.2.700-705.1984; van Winkelhoff AJ, 2009, J PERIODONTOL, V80, P1555, DOI 10.1902/jop.2009.090276; VANWINKELHOFF AJ, 1989, J CLIN PERIODONTOL, V16, P128; VANWINKELHOFF AJ, 1992, J PERIODONTOL, V63, P52, DOI 10.1902/jop.1992.63.1.52; Winkel EG, 2001, J CLIN PERIODONTOL, V28, P296, DOI 10.1034/j.1600-051x.2001.028004296.x; Wolf H., 2002, SWISS DENT, V23, P11	29	70	72	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3492	1943-3670		J PERIODONTOL	J. Periodont.	JAN	2010	81	1					15	23		10.1902/jop.2009.090390			9	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	665FI	WOS:000283020200005	20059413				2022-03-04	
J	Giannopoulou, C; Andersen, E; Brochut, P; Plagnat, D; Mombelli, A				Giannopoulou, C.; Andersen, E.; Brochut, P.; Plagnat, D.; Mombelli, A.			Enamel matrix derivative and systemic antibiotics as adjuncts to non-surgical periodontal treatment: Biologic response	JOURNAL OF PERIODONTOLOGY			English	Article						antibiotics; enamel matrix protein; gingival crevicular fluid; treatment	GINGIVAL CREVICULAR FLUID; INTRABONY DEFECTS; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; HISTOLOGIC EVALUATION; GRANULOCYTE ELASTASE; REGENERATIVE THERAPY; PROTEINS; CALPROTECTIN; EMDOGAIN(R); SMOKING	Background: Short-term clinical observations suggest an anti-inflammatory effect of enamel matrix derivative (EMD). The purpose of this study was to evaluate the anti-inflammatory capacity of EMD, used as an adjunct to non-surgical periodontal treatment of deep lesions in chronic periodontitis patients, by monitoring inflammatory markers in gingival crevicular fluid (GCF). Methods: Sixteen subjects were randomly assigned to treatment with EMD or placebo in contralateral dentition areas. Half of the subjects received 250 mg metronidazole and 375 mg amoxicillin three times a day for 7 days; the other half received a placebo. GCF samples were collected from one interproximal lesion in each of the contralateral quadrants before treatment and after 10 days and 2, 6, and 12 months. Total protein content was determined according to the Bradford method. Myeloid-related protein (MRP) 8/14 and interleukin (IL)-1 beta were analyzed quantitatively by enzyme-linked immunosorbent assay (ELISA), and elastase activity was determined using a low molecular weight fluorogenic substrate. Results: No significant differences were observed between sites treated with or without EMD for any biochemical parameter. Two months after treatment, subjects treated with antibiotics exhibited less clinical signs of inflammation. Furthermore, these subjects had lower MRP 8/14 levels only at day 10 compared to those receiving the placebo. For total protein, IL-1 beta, and elastase, no statistically significant differences were noted for subjects with or without antibiotic therapy at any time point. Conclusions: Improved healing of the soft tissues has been noted clinically in non-surgically treated sites in subjects treated with antibiotics. The expression of inflammatory media tors in GCF corroborated this finding only in part. EMD did not seem to further affect the expression of inflammatory mediators.	Univ Geneva, Sch Dent Med, Dept Periodontol, Geneva, Switzerland		Giannopoulou, C (corresponding author), Univ Geneva, Sch Dent Med, Dept Periodontol, Geneva, Switzerland.	ekaterini.giannopoulou@medecine.unige.ch					Armitage GC, 2004, PERIODONTOL 2000, V34, P109, DOI 10.1046/j.0906-6713.2002.003427.x; Arweiler Nicole Birgit, 2002, Clin Oral Investig, V6, P205, DOI 10.1007/s00784-002-0185-0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CAFFESSE RG, 1986, J CLIN PERIODONTOL, V13, P205, DOI 10.1111/j.1600-051X.1986.tb01461.x; Figueredo CMS, 2004, J CLIN PERIODONTOL, V31, P615, DOI 10.1111/j.1600-051X.2004.00532.x; Gestrelius S, 1997, J CLIN PERIODONTOL, V24, P685, DOI 10.1111/j.1600-051X.1997.tb00250.x; GIANNOPOULOU C, 1992, J DENT RES, V71, P359, DOI 10.1177/00220345920710020301; Giannopoulou C, 2003, J CLIN PERIODONTOL, V30, P996, DOI 10.1034/j.1600-051X.2003.00416.x; Grbic JT, 1999, J PERIODONTOL, V70, P1221, DOI 10.1902/jop.1999.70.10.1221; Gutierrez MA, 2003, J CLIN PERIODONTOL, V30, P739, DOI 10.1034/j.1600-051X.2003.00374.x; Hammarstrom L, 1997, J CLIN PERIODONTOL, V24, P669, DOI 10.1111/j.1600-051X.1997.tb00248.x; Heijl L, 1997, J CLIN PERIODONTOL, V24, P705, DOI 10.1111/j.1600-051X.1997.tb00253.x; Heijl L, 1997, J CLIN PERIODONTOL, V24, P693, DOI 10.1111/j.1600-051X.1997.tb00251.x; Holmlund A, 2004, J CLIN PERIODONTOL, V31, P475, DOI 10.1111/j.1600-051X.2004.00504.x; Jin LJ, 2002, J CLIN PERIODONTOL, V29, P604, DOI 10.1034/j.1600-051X.2002.290704.x; JIN LJ, 1995, J CLIN PERIODONTOL, V22, P240; JIN LJ, 1995, EUR J ORAL SCI, V103, P84, DOI 10.1111/j.1600-0722.1995.tb00121.x; Kaldahl WB, 1996, J PERIODONTOL, V67, P675, DOI 10.1902/jop.1996.67.7.675; Kawase T, 2002, J PERIODONTAL RES, V37, P255, DOI 10.1034/j.1600-0765.2002.01615.x; Kido J, 1999, J CLIN PERIODONTOL, V26, P653, DOI 10.1034/j.1600-051X.1999.261004.x; Kinane DF, 1997, J PERIODONTOL, V68, P467, DOI 10.1902/jop.1997.68.5.467; Kojima T, 2000, J DENT RES, V79, P740, DOI 10.1177/00220345000790020701; Labriola A, 2005, PERIODONTOL 2000, V37, P124, DOI 10.1111/j.1600-0757.2004.03793.x; LOE HARALD, 1963, ACTA ODONTOL SCAND, V21, P533, DOI 10.3109/00016356309011240; Loos BG, 2005, PERIODONTOL 2000, V39, P53, DOI 10.1111/j.1600-0757.2005.00129.x; Lundy FT, 2001, J CLIN PERIODONTOL, V28, P1172, DOI 10.1034/j.1600-051X.2001.281213.x; Mellonig JT, 1999, INT J PERIODONT REST, V19, P9; Mombelli A, 2005, J CLIN PERIODONTOL, V32, P225, DOI 10.1111/j.1600-051X.2005.00664.x; Mombelli A, 2000, J PERIODONTOL, V71, P14, DOI 10.1902/jop.2000.71.1.14; Palmer RM, 1999, J CLIN PERIODONTOL, V26, P158, DOI 10.1034/j.1600-051X.1999.260305.x; Poullis A, 2003, J GASTROEN HEPATOL, V18, P756, DOI 10.1046/j.1440-1746.2003.03014.x; PREISS DS, 1994, J PERIODONTOL, V65, P423, DOI 10.1902/jop.1994.65.5.423; Que ML, 2004, J CLIN PERIODONTOL, V31, P978, DOI 10.1111/j.1600-051X.2004.00594.x; REINHARDT RA, 1993, J CLIN PERIODONTOL, V20, P514, DOI 10.1111/j.1600-051X.1993.tb00400.x; RENVERT S, 1990, J CLIN PERIODONTOL, V17, P345, DOI 10.1111/j.1600-051X.1990.tb00029.x; Sculean A, 1999, INT J PERIODONT REST, V19, P157; Sculean A, 2003, J PERIODONTOL, V74, P153, DOI 10.1902/jop.2003.74.2.153; Sculean A, 1999, J PERIODONTAL RES, V34, P310, DOI 10.1111/j.1600-0765.1999.tb02259.x; Sculean A, 2001, J CLIN PERIODONTOL, V28, P1074, DOI 10.1034/j.1600-051X.2001.281113.x; SILNESS J, 1964, Acta Odontol Scand, V22, P121, DOI 10.3109/00016356408993968; SMITH QT, 1992, J PERIODONTAL RES, V27, P466, DOI 10.1111/j.1600-0765.1992.tb01819.x; Spahr A, 2002, J CLIN PERIODONTOL, V29, P62, DOI 10.1034/j.1600-051x.2002.290110.x; Tonetti MS, 2002, J CLIN PERIODONTOL, V29, P317, DOI 10.1034/j.1600-051X.2002.290407.x; Van der Weijden GA, 2002, J CLIN PERIODONTOL, V29, P55, DOI 10.1034/j.1600-051X.29.s3.3.x; Wennstrom JL, 2002, J CLIN PERIODONTOL, V29, P9, DOI 10.1034/j.1600-051x.2002.290102.x; Yukna RA, 2000, J PERIODONTOL, V71, P752, DOI 10.1902/jop.2000.71.5.752	46	26	27	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3492	1943-3670		J PERIODONTOL	J. Periodont.	APR	2006	77	4					707	713		10.1902/jop.2006.050166			7	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	103IL	WOS:000241878800020	16584354				2022-03-04	
J	Bouillaguet, S				Bouillaguet, S			Biological risks of resin-based materials to the dentin-pulp complex	CRITICAL REVIEWS IN ORAL BIOLOGY & MEDICINE			English	Review						biocompatibility; composites; bonding; acid-etching; microleakage; nanoleakage	POLYMERIZATION CONTRACTION STRESS; IN-VITRO CYTOTOXICITY; TOTAL-ETCH ADHESIVES; COMPOSITE RESIN; BOND STRENGTH; SUBLETHAL CONCENTRATIONS; RESTORATIVE DENTISTRY; SURFACE-AREA; PERMEABILITY; COMPONENTS	Over the past 30 years, restorative dentistry has seen a revolution in materials, restorative techniques, and patient priorities. This revolution has been made possible with the development of new resin-based materials which can be bonded to the tooth structure. Not all of these changes have been without controversy or concern, and some have raised questions about the biological safety of these new materials and techniques. It is the purpose of this review to present recent and relevant information about the biological risks and consequences of resin-tooth bonding and how these risks are affected by the material, its clinical properties, and its manipulation by the practitioner. These biological risks are complex and interactive, and are still incompletely defined. In broad terms, these risks can be divided into those stemming from the toxicological properties of the materials themselves ( direct biological risks) and those stemming from microbiological leakage ( indirect biological risks).	Univ Geneva, Sch Dent Med, Dept Dent Mat, Dept Cariol & Endodont, CH-1205 Geneva, Switzerland		Bouillaguet, S (corresponding author), Univ Geneva, Sch Dent Med, Dept Dent Mat, Dept Cariol & Endodont, 19 Rue Barthelemy Menn, CH-1205 Geneva, Switzerland.	serge.bouillaguet@medecine.unige.ch		Bouillaguet, Serge/0000-0001-5816-6124			Abdalla A I, 1993, Am J Dent, V6, P295; About I, 2001, J DENT, V29, P109, DOI 10.1016/S0300-5712(00)00067-1; *ADA COUNC DENT MA, 1982, 41 ADA COUNC DENT MA, P1; Alster D, 1995, J DENT RES, V74, P1745, DOI 10.1177/00220345950740110501; Alster D, 1997, BIOMATERIALS, V18, P337, DOI 10.1016/S0142-9612(96)00140-8; ASMUSSEN E, 1982, SCAND J DENT RES, V90, P490; Baume L J, 1980, Monogr Oral Sci, V8, P1; Bergenholtz G, 2000, CRIT REV ORAL BIOL M, V11, P467, DOI 10.1177/10454411000110040501; Bouillaguet S, 2000, DENT MATER, V16, P213, DOI 10.1016/S0109-5641(00)00011-7; Bouillaguet S, 1996, J ENDODONT, V22, P244, DOI 10.1016/S0099-2399(06)80141-X; Bouillaguet S, 2001, J DENT, V29, P55, DOI 10.1016/S0300-5712(00)00049-X; Bouillaguet S, 2000, J Adhes Dent, V2, P201; Bouillaguet S, 1998, J ORAL REHABIL, V25, P45; Bouillaguet S, 2001, DENT MATER, V17, P316, DOI 10.1016/S0109-5641(00)00089-0; Bouillaguet Serge, 2002, Schweiz Monatsschr Zahnmed, V112, P1006; Bouschlicher M R, 2000, J Esthet Dent, V12, P328, DOI 10.1111/j.1708-8240.2000.tb00242.x; BRANNSTROM M, 1972, INT DENT J, V22, P219; Burke F M, 1995, Gerodontology, V12, P57, DOI 10.1111/j.1741-2358.1995.tb00132.x; Choi KK, 2000, J DENT RES, V79, P812, DOI 10.1177/00220345000790030501; CIUCCHI B, 1995, J ENDODONT, V21, P191, DOI 10.1016/S0099-2399(06)80564-9; Ciucchi B, 1997, J DENT, V25, P305, DOI 10.1016/S0300-5712(96)00032-2; Ciucchi B, 1997, REV MENS SUISSE ODON, V107, P32; Costa CAD, 2002, DENT MATER, V18, P543, DOI 10.1016/S0109-5641(01)00089-6; Costa CAS, 2001, AM J DENT, V14, P25; Davidson C L, 2000, J Adhes Dent, V2, P167; DAVIDSON CL, 1984, J DENT RES, V63, P1396, DOI 10.1177/00220345840630121101; Davidson CL, 1997, J DENT, V25, P435, DOI 10.1016/S0300-5712(96)00063-2; De Munck J, 2003, J DENT RES, V82, P136, DOI 10.1177/154405910308200212; DEGEE AJ, 1993, DENT MATER, V9, P11, DOI 10.1016/0109-5641(93)90097-A; Eick JD, 1997, CRIT REV ORAL BIOL M, V8, P306, DOI 10.1177/10454411970080030501; Eick JD, 2002, DENT MATER, V18, P413, DOI 10.1016/S0109-5641(01)00071-9; FEILZER AJ, 1987, J DENT RES, V66, P1636, DOI 10.1177/00220345870660110601; FEILZER AJ, 1993, DENT MATER, V9, P2, DOI 10.1016/0109-5641(93)90095-8; FERRACANE JL, 1995, CRIT REV ORAL BIOL M, V6, P302, DOI 10.1177/10454411950060040301; Finger W J, 1999, J Adhes Dent, V1, P311; GARBEROGLIO R, 1976, ARCH ORAL BIOL, V21, P355, DOI 10.1016/S0003-9969(76)80003-9; GOLDSCHMIDT H, 1994, BALLET REV, V22, P25; Gwinnett AJ, 1998, AM J DENT, V11, pS35; HANKS CT, 1988, J ORAL PATHOL MED, V17, P396, DOI 10.1111/j.1600-0714.1988.tb01304.x; HANKS CT, 1991, J DENT RES, V70, P1450, DOI 10.1177/00220345910700111201; HANKS CT, 1994, J ORAL REHABIL, V21, P475, DOI 10.1111/j.1365-2842.1994.tb01162.x; Hanks CT, 1996, DENT MATER, V12, P186, DOI 10.1016/S0109-5641(96)80020-0; Hannig M, 1999, DENT MATER, V15, P275, DOI 10.1016/S0109-5641(99)00047-0; Hashimoto M, 2000, J DENT RES, V79, P1385, DOI 10.1177/00220345000790060601; Hebling J, 1999, J DENT, V27, P557, DOI 10.1016/S0300-5712(99)00034-2; Heyeraas KJ, 1999, CRIT REV ORAL BIOL M, V10, P328, DOI 10.1177/10454411990100030501; Hitmi L, 1999, J Adhes Dent, V1, P219; HOLZ J, 1973, REV MENS SUISSE ODON, V83, P1369; Hume WR, 1996, CRIT REV ORAL BIOL M, V7, P172, DOI 10.1177/10454411960070020501; Imazato S, 2001, DENT MATER, V17, P178, DOI 10.1016/S0109-5641(00)00066-X; Inoue S, 2001, J Adhes Dent, V3, P237; INOUE S, 2000, P 3 INT KUR S ADV AD, P131; *ISO, 1993, 109935 ISO; JONTELL M, 1995, J DENT RES, V74, P1162, DOI 10.1177/00220345950740050401; Kaga M, 2001, DENT MATER, V17, P333, DOI 10.1016/S0109-5641(00)00091-9; Katsuno K, 1996, Dent Mater J, V15, P22; KIDD EAM, 1996, J DENT, V24, P199; Kim S, 1990, DYNAMIC ASPECTS DENT, P167; Krejci I, 2000, Pract Periodontics Aesthet Dent, V12, P727; Labella R, 1999, DENT MATER, V15, P128, DOI 10.1016/S0109-5641(99)00022-6; Lai SCN, 2001, J DENT RES, V80, P1919, DOI 10.1177/00220345010800101101; Lefebvre CA, 1999, J BIOMAT SCI-POLYM E, V10, P1265, DOI 10.1163/156856299X00063; Lutz F, 1992, Quintessence Int, V23, P763; LUTZ F, 2001, ADV OPERATIVE DENT C, V2, P305; Maciel KT, 1996, J DENT RES, V75, P1851, DOI 10.1177/00220345960750110601; MERTZFAIRHURST EJ, 1995, J DENT CHILD, V62, P97; Miyazaki M, 2002, DENT MATER, V18, P576, DOI 10.1016/S0109-5641(01)00093-8; Mjor IA, 2001, QUINTESSENCE INT, V32, P427; Mjor IA, 2002, QUINTESSENCE INT, V33, P35; Mjor IA, 2000, INT DENT J, V50, P361; Murray PE, 2002, J DENT, V30, P29, DOI 10.1016/S0300-5712(01)00055-0; NAKABAYASHI N, 1982, J BIOMED MATER RES, V16, P265, DOI 10.1002/jbm.820160307; NAKABAYASHI N, 1992, DENT MATER, V8, P125, DOI 10.1016/0109-5641(92)90067-M; NAKABAYASHI N, 1998, HYBRIDIZATION DENT H, P1; Nakajima M, 2002, DENT MATER, V18, P603, DOI 10.1016/S0109-5641(02)00004-0; NARHI MVO, 1990, DYNAMIC ASPECTS DENT, P137; Noda M, 2003, DENT MATER, V19, P101, DOI 10.1016/S0109-5641(02)00018-0; Nomura Y, 2002, J BIOMED MATER RES, V63, P209, DOI 10.1002/jbm.10126; Osorio R, 2002, J BIOMED MATER RES, V60, P316, DOI 10.1002/jbm.10074; OUTHWAITE WC, 1976, ARCH ORAL BIOL, V21, P599, DOI 10.1016/0003-9969(76)90029-7; Paphangkorakit J, 2000, ARCH ORAL BIOL, V45, P1033, DOI 10.1016/S0003-9969(00)00090-X; Pashley D H, 1993, Quintessence Int, V24, P618; Pashley D H, 1999, J Adhes Dent, V1, P299; PASHLEY DH, 1993, ARCH ORAL BIOL, V38, P577, DOI 10.1016/0003-9969(93)90122-3; PASHLEY DH, 1985, J DENT RES, V64, P613, DOI 10.1177/002203458506400419; Pashley DH, 1996, CRIT REV ORAL BIOL M, V7, P104, DOI 10.1177/10454411960070020101; PASHLEY DH, 1989, SCANNING MICROSCOPY, V3, P161; Pashley DH, 2000, DENT MATER, V16, P7, DOI 10.1016/S0109-5641(99)00077-9; Pashley DH, 1996, ARCH ORAL BIOL, V41, P1065, DOI 10.1016/S0003-9969(96)00059-3; Paul SJ, 1997, INT J PERIODONT REST, V17, P537; Perdigao J, 2001, QUINTESSENCE INT, V32, P385; Rakich DR, 1999, J ENDODONT, V25, P114, DOI 10.1016/S0099-2399(99)80008-9; RATANASATHIEN S, 1995, J DENT RES, V74, P1602, DOI 10.1177/00220345950740091601; ROULET JF, 2001, ADHESION SILENT REVO, P11; RUEGGEBERG FA, 1990, J DENT RES, V69, P1652, DOI 10.1177/00220345900690100501; RYGE G, 1980, INT DENT J, V30, P347; Sahafi A, 2001, AM J DENT, V14, P295; SANO H, 1994, DENT MATER, V10, P236, DOI 10.1016/0109-5641(94)90067-1; SANO H, 1994, OPER DENT, V19, P59; SANO H, 1995, OPER DENT, V20, P18; Santerre JP, 2001, CRIT REV ORAL BIOL M, V12, P136, DOI 10.1177/10454411010120020401; Schafer TE, 1999, J BIOMED MATER RES, V45, P192, DOI 10.1002/(SICI)1097-4636(19990605)45:3<192::AID-JBM5>3.0.CO;2-A; Schweikl H, 1999, MUTAT RES-GEN TOX EN, V438, P71, DOI 10.1016/S1383-5718(98)00164-8; SILVERSTONE LM, 1975, P INT S ACID ETCH TE, P13; Staehle H J, 1999, J Adhes Dent, V1, P267; Tay F R, 2000, J Adhes Dent, V2, P99; Tay FR, 2001, DENT MATER, V17, P296, DOI 10.1016/S0109-5641(00)00087-7; Tay FR, 2002, J DENT, V30, P371, DOI 10.1016/S0300-5712(02)00064-7; Tay FR, 1996, AM J DENT, V9, P43; TAY FR, 2003, IN PRESS AM J DENT; Tonetti-Eberle B, 2001, Schweiz Monatsschr Zahnmed, V111, P1160; TURNER DF, 1989, J DENT RES, V68, P1262, DOI 10.1177/00220345890680081001; Unemori M, 2001, J DENT, V29, P7, DOI 10.1016/S0300-5712(00)00037-3; Van Meerbeek B, 1998, J DENT, V26, P1, DOI 10.1016/S0300-5712(96)00070-X; Van Meerbeek B, 1998, J DENT RES, V77, P50, DOI 10.1177/00220345980770010501; VANMEERBEEK B, 2001, OPERATIVE DENT S, V6, P119; VERSLUIS A, 2000, ADV ADHESIVE DENT, P31; Williams D.F., 1990, CONCISE ENCY MED DEN, P51; Yoshikawa T, 2001, DENT MATER, V17, P359, DOI 10.1016/S0109-5641(00)00095-6; Yoshikawa T, 1999, J DENT RES, V78, P898, DOI 10.1177/00220345990780041001; Yoshiyama M, 2002, J DENT RES, V81, P556, DOI 10.1177/154405910208100811; Zheng L, 2001, OPER DENT, V26, P97; [No title captured]	123	59	66	2	8	INT AMER ASSOC DENTAL RESEARCHI A D R/A A D R	ALEXANDRIA	1619 DUKE ST, ALEXANDRIA, VA 22314-3406 USA	1045-4411			CRIT REV ORAL BIOL M	Crit. Rev. Oral Biol. Med.	JAN	2004	15	1					47	60		10.1177/154411130401500105			14	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	894LD	WOS:000226792300005	14761899	Green Submitted			2022-03-04	
J	Mombelli, A				Mombelli, A			Microbiology and antimicrobial therapy of peri-implantitis	PERIODONTOLOGY 2000			English	Article							GUIDED TISSUE REGENERATION; OSSEOINTEGRATED TITANIUM FIXTURES; PARTIALLY EDENTULOUS PATIENTS; DENTAL IMPLANTS; SUBGINGIVAL PLAQUE; BONE REGENERATION; IN-VITRO; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; BACTEROIDES-INTERMEDIUS; PERIODONTAL-DISEASE		Univ Geneva, Sch Dent Med, Dept Periodontol, Geneva, Switzerland		Mombelli, A (corresponding author), Univ Geneva, Sch Dent Med, Dept Periodontol, Geneva, Switzerland.						ADELL R, 1986, INT J ORAL MAX SURG, V15, P39, DOI 10.1016/S0300-9785(86)80010-2; ADELL R, 1981, INT J ORAL MAXILLOF, V10, P387, DOI 10.1016/S0300-9785(81)80077-4; Alcoforado G A, 1991, J Parodontol, V10, P11; APSE P, 1989, J PERIODONTAL RES, V24, P96, DOI 10.1111/j.1600-0765.1989.tb00863.x; Apse P, 1991, INT J PERIODONT REST, V11, P95; BAIR RE, 1988, INT J ORAL MAXILLOF, V3, P9; Becker W, 1994, Int J Oral Maxillofac Implants, V9, P31; BECKER W, 1990, International Journal of Oral and Maxillofacial Implants, V5, P31; BOWER RC, 1989, J CLIN PERIODONTOL, V16, P580, DOI 10.1111/j.1600-051X.1989.tb02141.x; BRAGD L, 1987, J CLIN PERIODONTOL, V14, P95, DOI 10.1111/j.1600-051X.1987.tb00949.x; Buser D, 1990, CLIN ORAL IMPLAN RES, V1, P33, DOI 10.1034/j.1600-0501.1990.010105.x; Buser D, 1997, CLIN ORAL IMPLAN RES, V8, P161, DOI 10.1034/j.1600-0501.1997.080302.x; Cox J F, 1987, Int J Oral Maxillofac Implants, V2, P91; Cune MS, 1996, J CLIN PERIODONTOL, V23, P425, DOI 10.1111/j.1600-051X.1996.tb00569.x; DENNISON DK, 1994, J PERIODONTOL, V65, P942, DOI 10.1902/jop.1994.65.10.942; DIETRICH U, 1991, Z ZAHNARZTLICHE IMPL, V7, P221; Dortbudak O, 2001, CLIN ORAL IMPLAN RES, V12, P104, DOI 10.1034/j.1600-0501.2001.012002104.x; EADY EA, 1982, BRIT J DERMATOL, V107, P235; ERICSSON I, 1986, J CLIN PERIODONTOL, V13, P307, DOI 10.1111/j.1600-051X.1986.tb02227.x; Ericsson I, 1996, CLIN ORAL IMPLAN RES, V7, P320, DOI 10.1034/j.1600-0501.1996.070404.x; Esposito M, 1997, J MATER SCI-MATER M, V8, P843, DOI 10.1023/A:1018593403126; Gatewood R R, 1993, Clin Oral Implants Res, V4, P53; GEORGE K, 1994, J PERIODONTOL, V65, P766, DOI 10.1902/jop.1994.65.8.766; GHER ME, 1994, J PERIODONTOL, V65, P881, DOI 10.1902/jop.1994.65.9.881; GOTFREDSEN K, 1993, J ORAL MAXIL SURG, V51, P879, DOI 10.1016/S0278-2391(10)80108-9; Gunay H, 1989, Z ZAHNARZTL IMPLANTO, V5, P162; Haas R, 1997, CLIN ORAL IMPLAN RES, V8, P249, DOI 10.1034/j.1600-0501.1997.080401.x; HAMMERLE CHF, 1995, J PERIODONTOL, V66, P303; Hermann JS, 2000, J PERIODONTOL, V71, P1412, DOI 10.1902/jop.2000.71.9.1412; Hermann JS, 2000, CLIN ORAL IMPLAN RES, V11, P1, DOI 10.1034/j.1600-0501.2000.011001001.x; JOVANOVIC SA, 1993, J PERIODONTOL, V64, P1176, DOI 10.1902/jop.1993.64.11s.1176; Kohal RJ, 1998, J PERIODONTOL, V69, P927, DOI 10.1902/jop.1998.69.8.927; KOHAVI D, 1994, INT J ORAL MAXILLOF, V9, P673; KOKA S, 1993, J PROSTHET DENT, V70, P141, DOI 10.1016/0022-3913(93)90009-D; Lavigne S E, 1994, Int J Oral Maxillofac Implants, V9, P156; Lehmann B, 1992, Clin Oral Implants Res, V3, P42, DOI 10.1034/j.1600-0501.1992.030107.x; LEKHOLM U, 1986, INT J ORAL MAX SURG, V15, P53, DOI 10.1016/S0300-9785(86)80011-4; LEONHARDT A, 1993, CLIN ORAL IMPLAN RES, V4, P113, DOI 10.1034/j.1600-0501.1993.040301.x; Leonhardt A, 1999, CLIN ORAL IMPLAN RES, V10, P339, DOI 10.1034/j.1600-0501.1999.100501.x; Levignac J, 1965, Rev Fr Odontostomatol, V12, P1251; LISTGARTEN MA, 1981, J CLIN PERIODONTOL, V8, P122, DOI 10.1111/j.1600-051X.1981.tb02352.x; MARINELLO CP, 1995, J CLIN PERIODONTOL, V22, P475, DOI 10.1111/j.1600-051X.1995.tb00180.x; Matarasso S, 1996, CLIN ORAL IMPLAN RES, V7, P64, DOI 10.1034/j.1600-0501.1996.070108.x; MATTOUT P, 1995, CLIN ORAL IMPLAN RES, V6, P189, DOI 10.1034/j.1600-0501.1995.060308.x; MCCOLLUM J, 1992, J PERIODONTOL, V63, P802, DOI 10.1902/jop.1992.63.10.802; MERICSKESTERN R, 1994, CLIN ORAL IMPLAN RES, V5, P9, DOI 10.1034/j.1600-0501.1994.050102.x; Mombelli A, 1997, CLIN ORAL IMPLAN RES, V8, P448, DOI 10.1034/j.1600-0501.1997.080602.x; Mombelli A, 1990, CLIN ORAL IMPLAN RES, V1, P1, DOI 10.1034/j.1600-0501.1990.010101.x; Mombelli A, 1997, J CLIN PERIODONTOL, V24, P470, DOI 10.1111/j.1600-051X.1997.tb00214.x; MOMBELLI A, 1988, ORAL MICROBIOL IMMUN, V3, P113, DOI 10.1111/j.1399-302X.1988.tb00095.x; Mombelli A, 1992, Clin Oral Implants Res, V3, P162, DOI 10.1034/j.1600-0501.1992.030402.x; MOMBELLI A, 1995, J CLIN PERIODONTOL, V22, P124; Mombelli A, 1987, Oral Microbiol Immunol, V2, P145, DOI 10.1111/j.1399-302X.1987.tb00298.x; Mombelli A, 2001, CLIN ORAL IMPLAN RES, V12, P287, DOI 10.1034/j.1600-0501.2001.012004287.x; Mombelli A, 1999, PROCEEDINGS OF THE 3RD EUROPEAN WORKSHOP ON PERIODONTOLOGY: IMPLANT DENTISTRY, P281; Mombelli A, 1998, PERIODONTOL 2000, V17, P63, DOI 10.1111/j.1600-0757.1998.tb00124.x; Nowzari H, 1995, Int J Oral Maxillofac Implants, V10, P67; Persson LG, 1999, CLIN ORAL IMPLAN RES, V10, P195, DOI 10.1034/j.1600-0501.1999.100302.x; PITCHER GR, 1980, J CLIN PERIODONTOL, V7, P300, DOI 10.1111/j.1600-051X.1980.tb01972.x; PONTORIERO R, 1994, CLIN ORAL IMPLAN RES, V5, P254, DOI 10.1034/j.1600-0501.1994.050409.x; Quirynen M, 1991, CLIN ORAL IMPLAN RES, V2, P186, DOI 10.1034/j.1600-0501.1991.020405.x; QUIRYNEN M, 1993, J DENT RES, V72, P1304, DOI 10.1177/00220345930720090801; Quirynen M, 1990, CLIN ORAL IMPLAN RES, V1, P8, DOI 10.1034/j.1600-0501.1990.010102.x; RAMS T E, 1983, Journal of Oral Implantology, V11, P93; RAMS TE, 1990, ORAL MICROBIOL IMMUN, V5, P29, DOI 10.1111/j.1399-302X.1990.tb00222.x; RAMS TE, 1984, J PROSTHET DENT, V51, P529, DOI 10.1016/0022-3913(84)90309-3; ROMINGER JW, 1994, J ORAL MAXIL SURG, V52, P106, DOI 10.1016/0278-2391(94)90388-3; SANZ M, 1990, International Journal of Oral and Maxillofacial Implants, V5, P247; Schenk G, 1997, CLIN ORAL IMPLAN RES, V8, P427, DOI 10.1034/j.1600-0501.1997.080510.x; Sennerby L, 1993, Clin Oral Implants Res, V4, P23, DOI 10.1034/j.1600-0501.1993.040103.x; SENNERBY L, 1989, International Journal of Oral and Maxillofacial Implants, V4, P233; Simion M, 1994, INT J PERIODONT REST, V14, P167; SLOTS J, 1986, J CLIN PERIODONTOL, V13, P570, DOI 10.1111/j.1600-051X.1986.tb00849.x; Tillmanns HWS, 1998, INT J ORAL MAX IMPL, V13, P59; van Winkelhoff AJ, 2000, J CLIN PERIODONTOL, V27, P531, DOI 10.1034/j.1600-051x.2000.027007531.x; WOLFF LF, 1988, J PERIODONTAL RES, V23, P170, DOI 10.1111/j.1600-0765.1988.tb01353.x; Zablotsky M, 1992, Clin Oral Implants Res, V3, P189, DOI 10.1034/j.1600-0501.1992.030406.x; ZABLOTSKY M, 1991, INT J ORAL IMPLANTOL, V8, P45	78	169	177	0	28	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0906-6713	1600-0757		PERIODONTOL 2000	Periodontol. 2000		2002	28						177	189		10.1034/j.1600-0757.2002.280107.x			13	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	524VN	WOS:000174033700007	12013341				2022-03-04	
J	Mombelli, A; Almaghlouth, A; Cionca, N; Courvoisier, DS; Giannopoulou, C				Mombelli, Andrea; Almaghlouth, Adnan; Cionca, Norbert; Courvoisier, Delphine S.; Giannopoulou, Catherine			Differential Benefits of Amoxicillin-Metronidazole in Different Phases of Periodontal Therapy in a Randomized Controlled Crossover Clinical Trial	JOURNAL OF PERIODONTOLOGY			English	Article						Amoxicillin; case management; metronidazole; periodontitis; randomized controlled trial	GENERALIZED AGGRESSIVE PERIODONTITIS; 1257-1269. RE EFFECTIVENESS; ANALYSIS. SGOLASTRA F; REVIEW. ZANDBERGEN D; SYSTEMIC AMOXICILLIN/METRONIDAZOLE; NONSURGICAL TREATMENT; ADJUNCTIVE THERAPY; PLUS AMOXICILLIN; COBB CM; GATTO R	Background: The specific advantage of administering systemic antibiotics during initial, non-surgical therapy or in the context of periodontal surgery is unclear. This study assesses the differential outcomes of periodontal therapy supplemented with amoxicillin-metronidazole during either the non-surgical or the surgical treatment phase. Methods: This is a single-center, randomized placebo-controlled crossover clinical trial with a 1-year follow-up. Eighty participants with Aggregatibacter actinomycetemcomitans-associated moderate to advanced periodontitis were randomized into two treatment groups: group A, antibiotics (500 mg metronidazole plus 375 mg amoxicillin three times per day for 7 days) during the first, non-surgical phase of periodontal therapy (T1) and placebo during the second, surgical phase (T2); and group B, placebo during T1 and antibiotics during T2. The number of sites with probing depth (PD) >4 mm and bleeding on probing (BOP) per patient was the primary outcome. Results: A total of 11,212 sites were clinically monitored on 1,870 teeth. T1 with antibiotics decreased the number of sites with PD >4 mm and BOP per patient significantly more than without (group A: from 34.5 to 5.7, 84%; group B: from 28.7 to 8.7, 70%; P < 0.01). Twenty patients treated with antibiotics, but only eight treated with placebo, achieved a 10-fold reduction of diseased sites (P = 0.007). Consequently, fewer patients of group A needed additional therapy, the mean number of surgical interventions was lower, and treatment time in T2 was shorter. Six months after T2, the mean number of residual pockets (group A: 2.8 +/- 5.2; group B: 2.2 +/- 5.0) was not significantly different and was sustained over 12 months in both groups. Conclusion: Giving the antibiotics during T1 or T2 yielded similar long-term outcomes, but antibiotics in T1 resolved the disease quicker and thus reduced the need for additional surgical intervention.	[Mombelli, Andrea; Almaghlouth, Adnan; Cionca, Norbert; Giannopoulou, Catherine] Univ Geneva, Dept Periodontol, CH-1205 Geneva, Switzerland; [Courvoisier, Delphine S.] Univ Geneva, Clin Res Ctr, CH-1205 Geneva, Switzerland; [Courvoisier, Delphine S.] Univ Geneva, Div Clin Epidemiol, CH-1205 Geneva, Switzerland		Mombelli, A (corresponding author), Univ Geneva, Sch Dent Med, Rue Barthelemy Menn 19, CH-1205 Geneva, Switzerland.	Andrea.Mombelli@unige.ch			Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission [320030-122089]; Royal Saudi Arabian Government	This work was supported by Swiss National Science Foundation Grant 320030-122089 and a scholarship from the Royal Saudi Arabian Government (to AA). The Institute for Applied Immunology, Zuchwil, Switzerland, analyzed the microbiologic samples taken for the purpose of screening free of charge. The help of Celine Nicole-Ippolito (Department of Periodontology, University of Geneva, Geneva, Switzerland) in data acquisition is greatly appreciated. The authors report no conflicts of interest related to this study.	Armitage G C, 1999, Ann Periodontol, V4, P1, DOI 10.1902/annals.1999.4.1.1; Armitage GC, 2014, J PERIODONTOL, V85, P369, DOI 10.1902/jop.2014.130700; AXELSSON P, 1981, J CLIN PERIODONTOL, V8, P281, DOI 10.1111/j.1600-051X.1981.tb02039.x; Axelsson P, 2004, J CLIN PERIODONTOL, V31, P749, DOI 10.1111/j.1600-051X.2004.00563.x; Cionca N, 2010, J PERIODONTOL, V81, P15, DOI 10.1902/jop.2009.090390; Cionca N, 2009, J PERIODONTOL, V80, P364, DOI [10.1902/jop.2009.080540, 10.1902/jop.2009.080540 ]; Cortellini P, 2004, J PERIODONTOL, V75, P672, DOI 10.1902/jop.2004.75.5.672; DIX K, 1990, J CLIN MICROBIOL, V28, P319, DOI 10.1128/JCM.28.2.319-323.1990; Eberhard J, 2008, COCHRANE DB SYST REV, V1; Eickholz P, 2004, J PERIODONTOL, V75, P957, DOI 10.1902/jop.2004.75.7.957; Faveri M, 2014, J PERIODONTOL, V85, P581, DOI 10.1902/jop.2013.130278; Feres M, 2012, J CLIN PERIODONTOL, V39, P1149, DOI 10.1111/jcpe.12004; Goodson JM, 2012, J CLIN PERIODONTOL, V39, P526, DOI 10.1111/j.1600-051X.2012.01870.x; Griffiths GS, 2011, J CLIN PERIODONTOL, V38, P43, DOI 10.1111/j.1600-051X.2010.01632.x; Guerrero A, 2014, J CLIN PERIODONTOL, V41, P1080, DOI 10.1111/jcpe.12299; Herrera D, 2008, J CLIN PERIODONTOL, V35, P45, DOI 10.1111/j.1600-051X.2008.01260.x; Hujoel PP, 2004, PERIODONTOL 2000, V36, P196, DOI 10.1111/j.1600-0757.2004.03681.x; Kaner D, 2007, J PERIODONTOL, V78, P1201, DOI 10.1902/jop.2007.060437; LINDHE J, 1984, J CLIN PERIODONTOL, V11, P448, DOI 10.1111/j.1600-051X.1984.tb01344.x; LOE HARALD, 1963, ACTA ODONTOL SCAND, V21, P533, DOI 10.3109/00016356309011240; LOESCHE WJ, 1992, J CLIN PERIODONTOL, V19, P103, DOI 10.1111/j.1600-051X.1992.tb00448.x; Loesche WJ, 2002, J AM DENT ASSOC, V133, P311, DOI 10.14219/jada.archive.2002.0170; Matarazzo F, 2008, J CLIN PERIODONTOL, V35, P885, DOI 10.1111/j.1600-051X.2008.01304.x; Matuliene G, 2008, J CLIN PERIODONTOL, V35, P685, DOI 10.1111/j.1600-051X.2008.01245.x; Mestnik MJ, 2012, J CLIN PERIODONTOL, V39, P955, DOI 10.1111/j.1600-051X.2012.01932.x; Mombelli A, 2002, J CLIN PERIODONTOL, V29, P10, DOI 10.1034/j.1600-051X.29.s3.1.x; Mombelli A, 2013, J PERIODONTOL, V84, P715, DOI 10.1902/jop.2012.120281; Mombelli A, 2012, FRONT ORAL BIOL, V15, P133, DOI 10.1159/000329676; Palmer RM, 1999, J CLIN PERIODONTOL, V26, P158, DOI 10.1034/j.1600-051X.1999.260305.x; Preus HR, 2014, J PERIODONTOL, V85, P374, DOI 10.1902/jop.2014.130379; Robbins J., 2003, NY TIMES; Sgolastra F, 2012, J PERIODONTOL, V83, P1257, DOI 10.1902/jop.2012.110625; Sgolastra F, 2012, J PERIODONTOL, V83, P731, DOI 10.1902/jop.2011.110432; Soares GMS, 2014, J CLIN PERIODONTOL, V41, P366, DOI 10.1111/jcpe.12217; Socransky SS, 2013, J CLIN PERIODONTOL, V40, P771, DOI 10.1111/jcpe.12117; van Winkelhoff AJ, 2005, PERIODONTOL 2000, V39, P40, DOI 10.1111/j.1600-0757.2005.00116.x; Zandbergen D, 2014, J PERIODONTOL, V85, P384, DOI 10.1902/jop.2014.130436; Zandbergen D, 2013, J PERIODONTOL, V84, P332, DOI 10.1902/jop.2012.120040	38	35	35	0	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3492	1943-3670		J PERIODONTOL	J. Periodont.	MAR	2015	86	3					367	375		10.1902/jop.2014.140478			9	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	CE9EO	WOS:000352146900004	25415250	Green Published			2022-03-04	
J	Benbachir, N; Ardu, S; Krejci, I				Benbachir, Nacer; Ardu, Stefano; Krejci, Ivo			Spectrophotometric evaluation of the efficacy of a new in-office bleaching technique	QUINTESSENCE INTERNATIONAL			English	Review						OTC bleaching products; randomized clinical trial; vital bleaching	RANDOMIZED CLINICAL-TRIAL; COLOR	Objective: To quantitatively test the hypothesis that a new paint-on bleaching gel has the potential to lighten tooth color in clinical situations and to evaluate the change of the tooth color six months after the bleaching procedure. Method and Materials: Ten adult subjects requesting tooth bleaching were selected to participate in this randomized clinical trial involving a new in-office bleaching technique using VivaStyle Paint On Plus (Ivoclar Vivadent), originally designed as an over-the-counter bleaching gel. Digital images and CIE L*a*b* spectrophotometric measurements were taken at baseline (I), after the bleaching treatment (PB), and 6 months after bleaching (6M). Differences in L*a*b* values were tested with a repeated measures analysis of variance (ANOVA). Differences in Delta E values were tested with a factorial ANOVA. Results: Significant (P < .05) differences were detected in L*, as well as in a* and b* values, between initial (I) and post-bleaching (PB) and between initial (I) and 6 months post-op (6M). In contrast, there was no significant difference between post-bleaching (PB) and 6 months post-op (6M). Conclusion: This new bleaching technique proved to be efficient over a period of 6 months. It could be a less aggressive and more convenient alternative to traditional bleaching techniques.	[Benbachir, Nacer; Ardu, Stefano; Krejci, Ivo] Univ Geneva, Sch Dent, Div Cariol & Endodontol, CH-1205 Geneva, Switzerland		Benbachir, N (corresponding author), Univ Geneva, Ecole Med Dent, Div Cariol & Endodontol, Rue Barthelemy Menn 19, CH-1205 Geneva, Switzerland.	nacer.benbachir@medecine.unige.ch		ardu, stefano/0000-0003-1641-2168			Brunton PA, 2004, OPER DENT, V29, P623; Chamberlin GJ, 1980, COLOUR ITS MEASUREME; *COMM INT ECL COL, 1976, COMM INT ECL COL P S, V15; Dayan D, 1983, Quintessence Int Dent Dig, V14, P195; Dietschi D, 2006, QUINTESSENCE INT, V37, P515; Douglas RD, 1998, J PROSTHET DENT, V79, P254, DOI 10.1016/S0022-3913(98)70233-1; Farrell Svetlana, 2006, J Clin Dent, V17, P117; Gerlach R W, 2000, Compend Contin Educ Dent Suppl, pS22; Gerlach R W, 2001, J Contemp Dent Pract, V2, P1; Gerlach Robert W, 2003, Compend Contin Educ Dent, V24, P461; Goldstein RE, 1997, J AM DENT ASSOC, V128, pS11, DOI 10.14219/jada.archive.1997.0415; Goldstein RE, 1995, COMPLETE DENT BLEACH; HANKS CT, 1993, J DENT RES, V72, P931, DOI 10.1177/00220345930720051501; Hayes P A, 1986, J Can Dent Assoc, V52, P217; Joiner A, 2004, J DENT, V32, P3, DOI 10.1016/j.jdent.2003.10.013; Joiner A, 2006, J DENT, V34, P412, DOI 10.1016/j.jdent.2006.02.002; KUEHNI RG, 1976, J OPT SOC AM, V66, P497, DOI 10.1364/JOSA.66.000497; Leonard R H Jr, 2000, Compend Contin Educ Dent Suppl, pS18; Leonard R H Jr, 2001, J Esthet Restor Dent, V13, P357, DOI 10.1111/j.1708-8240.2001.tb01021.x; Li Yiming, 2003, Compend Contin Educ Dent, V24, P357; MATA AD, 2005, J DENT RES, V84; Nohl FSA, 2002, BRIT DENT J, V192, P443, DOI 10.1038/sj.bdj.4801396a; Paul S, 2002, J DENT RES, V81, P578, DOI 10.1177/154405910208100815; Ritter Andre V, 2002, J Esthet Restor Dent, V14, P275, DOI 10.1111/j.1708-8240.2002.tb00523.x; SACHS L, 1974, METHODEN MODELLE SPR, P420; da Mata ADP, 2006, INT J ESTHET DENT, V1, P70; TEO C S, 1989, Annals Academy of Medicine Singapore, V18, P585; Watts A, 2001, BRIT DENT J, V190, P309, DOI 10.1038/sj.bdj.4800959; Zantner C, 2006, OPER DENT, V31, P308, DOI 10.2341/05-69; Zantner C, 2006, QUINTESSENCE INT, V37, P695	30	5	6	0	4	QUINTESSENCE PUBLISHING CO INC	HANOVER PARK	4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA	0033-6572	1936-7163		QUINTESSENCE INT	Quintessence Int.	APR	2008	39	4					299	306					8	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	307QN	WOS:000256333500004	19081898				2022-03-04	
J	Belser, U; Buser, D; Higginbottom, F				Belser, U; Buser, D; Higginbottom, F			Consensus statements and recommended clinical procedures regarding esthetics in implant dentistry	INTERNATIONAL JOURNAL OF ORAL & MAXILLOFACIAL IMPLANTS			English	Editorial Material									Univ Geneva, Sch Dent Med, CH-1205 Geneva, Switzerland		Belser, U (corresponding author), Univ Geneva, Sch Dent Med, Rue Barthelemy Menn 19, CH-1205 Geneva, Switzerland.	urs.belser@medicine.unige.ch	Buser, Daniel/D-3971-2011					0	126	133	3	20	QUINTESSENCE PUBL CO INC	CAROL STREAM	551 NORTH KIMBERLY DR, CAROL STREAM, IL 60188-1881 USA	0882-2786			INT J ORAL MAX IMPL	Int. J. Oral Maxillofac. Implants		2004	19			S			73	74					2	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	884QI	WOS:000226100500007	15635947				2022-03-04	
J	Olsburgh, S; Jacoby, T; Krejci, I				Olsburgh, S; Jacoby, T; Krejci, I			Crown fractures in the permanent dentition: pulpal and restorative considerations	DENTAL TRAUMATOLOGY			English	Review						trauma; crown fracture; permanent teeth; histopathology; restoration; treatment; prognosis	MECHANICALLY-EXPOSED PULPS; CALCIUM HYDROXIDE; DENTAL-PULP; ADHESIVE RESINS; ORTHODONTIC EXTRUSION; COMPOSITE RESIN; CAPPING AGENT; TEETH; ROOT; MONKEY	Crown fractures account for the highest percentage of all traumatic injuries in the permanent dentition. This review paper will discuss the different types of crown fracture, from the uncomplicated to complicated, including crown-root fractures. It will focus on two different aspects: the pulp, with an attempt to correlate epidemiological, experimental, histopathological and clinical studies, so that the clinician can better understand the underlying processes accounting for success or failure to maintain pulp vitality. Also, we will consider the restoration: knowledge about bonding to dentin and new material is evolving extremely quickly making it difficult for the clinician to keep up with the developments. If handled properly, prognosis of the pulp, after traumatic crown fracture, is good. Prognosis of the restoration has also improved considerably over the last few years, and it appears that this trend will continue in the future.	Univ Geneva, Dept Operat Dent Endodont & Pedodont, Geneva, Switzerland		Krejci, I (corresponding author), Univ Geneva, Dept Operat Dent Endodont & Pedodont, Geneva, Switzerland.	ivo.kerjci@medecine.unige.ch					ANDREASEN FM, 1993, ENDOD DENT TRAUMATOL, V9, P111; ANDREASEN FM, 1995, QUINTESSENCE INT, V26, P660; ANDREASEN FM, 1994, CROWN FRACTURES TXB, P219; Andreassen JO, 1994, TXB COLOR ATLAS TRAU, P257; BAUME LJ, 1981, INT DENT J, V31, P251; BERGENHOLTZ G, 1982, J ORAL PATHOL MED, V11, P439, DOI 10.1111/j.1600-0714.1982.tb00188.x; BERGENHOLTZ G, 1977, SCAND J DENT RES, V85, P122; Bondemark L, 1997, AM J ORTHOD DENTOFAC, V112, P187, DOI 10.1016/S0889-5406(97)70245-2; BOUILLAGUET S, 1996, ACTA MED DENT HELV, V1, P235; Browning WD, 1996, OPER DENT, V21, P160; Caliskan MK, 1999, INT ENDOD J, V32, P146, DOI 10.1046/j.1365-2591.1999.00199.x; Cavalleri G, 1995, ENDOD DENT TRAUMATOL, V11, P294; Chuang HM, 1996, J FORMOS MED ASSOC, V95, P545; CIUCCHI B, 1995, J ENDODONT, V21, P191, DOI 10.1016/S0099-2399(06)80564-9; Costa CAD, 2000, DENT MATER, V16, P188; COX CF, 1985, J ORAL PATHOL MED, V14, P156, DOI 10.1111/j.1600-0714.1985.tb00479.x; COX CF, 1992, P FINN DENT SOC S1, V88, P81; Cvek M, 1978, J Endod, V4, P232, DOI 10.1016/S0099-2399(78)80153-8; deBlanco LP, 1996, ORAL SURG ORAL MED O, V82, P564, DOI 10.1016/S1079-2104(96)80204-6; DELATTRE JP, 1995, ENDOD DENT TRAUMATOL, V11, P186; Dietschi D, 1995, Pract Periodontics Aesthet Dent, V7, P15; DISHMAN MV, 1994, DENT MATER, V10, P33, DOI 10.1016/0109-5641(94)90019-1; Farik B, 1998, ENDOD DENT TRAUMATOL, V14, P119; Farik B, 1999, EUR J ORAL SCI, V107, P70; Feiglin B, 1995, Dent Clin North Am, V39, P53; FORD TRP, 1991, ORAL SURG ORAL MED O, V71, P338, DOI 10.1016/0030-4220(91)90311-Y; FOREMAN PC, 1990, INT ENDOD J, V23, P283, DOI 10.1111/j.1365-2591.1990.tb00108.x; FUKS A B, 1987, Endodontics and Dental Traumatology, V3, P100; Fuks A B, 1982, Pediatr Dent, V4, P240; Hayashi Y, 1999, J ENDODONT, V25, P225, DOI 10.1016/S0099-2399(99)80147-2; Hebling J, 1999, J ENDODONT, V25, P676, DOI 10.1016/S0099-2399(99)80354-9; Heitmann T, 1995, Quintessence Int, V26, P765; IMAI M, 1993, J ORAL PATHOL MED, V22, P411, DOI 10.1111/j.1600-0714.1993.tb00132.x; Johnson BR, 1997, ENDOD DENT TRAUMATOL, V13, P248; Katebzadeh N, 1998, J ENDODONT, V24, P256, DOI 10.1016/S0099-2399(98)80108-8; Kitasako Y, 1998, OPER DENT, V23, P308; Kitasako Y, 1999, J DENT, V27, P257, DOI 10.1016/S0300-5712(98)00054-2; Kitasako Y, 2000, OPER DENT, V25, P155; Kocadereli I, 1998, AUST DENT J, V43, P28, DOI 10.1111/j.1834-7819.1998.tb00148.x; Koparal E, 1999, J Clin Pediatr Dent, V23, P113; Lovdahl P E, 1995, Dent Clin North Am, V39, P169; Love RM, 1996, ENDOD DENT TRAUMATOL, V12, P289; MACKIE IC, 1992, BR DENT J, V25, P60; MALMGREN O, 1991, ENDOD DENT TRAUMATOL, V7, P49; Mochizuki K, 1998, Bull Tokyo Dent Coll, V39, P31; Niinuma A, 1999, INT ENDOD J, V32, P475, DOI 10.1046/j.1365-2591.1999.00249.x; Olmez A, 1998, ORAL SURG ORAL MED O, V86, P98, DOI 10.1016/S1079-2104(98)90157-3; Pameijer CH, 1998, AM J DENT, V11, pS45; PASHLEY DH, 1987, ARCH ORAL BIOL, V32, P519, DOI 10.1016/S0003-9969(87)80014-6; RAVN JJ, 1981, SCAND J DENT RES, V89, P117; RAVN JJ, 1981, SCAND J DENT RES, V89, P355; RAVN JJ, 1981, SCAND J DENT RES, V89, P213; RAVN JJ, 1982, SCAND J DENT RES, V90, P363; Robertson A, 1997, Int J Paediatr Dent, V7, P217, DOI 10.1046/j.1365-263X.1997.00046.x; Robertson A, 1998, J DENT, V26, P409, DOI 10.1016/S0300-5712(98)00003-7; Schuster GS, 2000, DENT MATER, V16, P297, DOI 10.1016/S0109-5641(00)00022-1; Smales R J, 1992, Am J Dent, V5, P208; SMALES RJ, 1992, DENT MATER, V8, P246, DOI 10.1016/0109-5641(92)90094-S; STAHLANE I, 1975, SWED DENT J, V68, P157; STAVRIDAKIS M, IN PRESS MARGINAL AD; SUBAY RK, 1993, ORAL SURG ORAL MED O, V76, P485, DOI 10.1016/0030-4220(93)90018-Y; Tarim B, 1998, QUINTESSENCE INT, V29, P535; Tarim B, 1998, INT J PERIODONT REST, V18, P87; TEGSJO U, 1987, SWED DENT J, V11, P235; TORNECK CD, 1990, ENDOD DENT TRAUMATOL, V6, P97; TSUNEDA Y, 1995, OPER DENT, V20, P223; Wilson PR, 1997, CLIN J PAIN, V13, P1, DOI 10.1097/00002508-199703000-00001; World Health Organization, 1995, APPL INT CLASS DIS D, V3rd ed; YOSHIMINE Y, 1995, ORAL SURG ORAL MED O, V79, P351, DOI 10.1016/S1079-2104(05)80229-X; Zalkind M, 1989, Isr J Dent Sci, V2, P133; Zerfowski M, 1998, Clin Oral Investig, V2, P120, DOI 10.1007/s007840050056	71	123	135	2	34	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1600-4469	1600-9657		DENT TRAUMATOL	Dent. Traumatol.	JUN	2002	18	3					103	115		10.1034/j.1600-9657.2002.00004.x			13	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	562NW	WOS:000176205800001	12110103	Green Published			2022-03-04	
J	Scolozzi, P				Scolozzi, P.			Applications of 3D orbital computer-assisted surgery (CAS)	JOURNAL OF STOMATOLOGY ORAL AND MAXILLOFACIAL SURGERY			English	Article; Proceedings Paper	53rd SFSCMFCO Congress	OCT 04-07, 2017	Marseille, FRANCE	SFSCMFCO		Navigational system; Computer-assisted surgery; Virtual surgical planning; Computer-aided design/computer-aided manufacturing software (CAD/CAM); Orbital surgery	CRANIOMAXILLOFACIAL SURGERY; INTRAOPERATIVE NAVIGATION; MAXILLOFACIAL SURGERY; AIDED-DESIGN; RECONSTRUCTION; FRACTURES; IMPLANTS	Introduction: The purpose of the present report is to describe the indications for use of 3D orbital computer-assisted surgery (CAS). Patients and methods: We analyzed the clinical and radiological data of all patients with orbital deformities treated using intra-operative navigation and CAD/CAM techniques at the Hopitaux Universitaires de Geneve, Switzerland, between 2009 and 2016. We recorded age and gender, orbital deformity, technical and surgical procedure and postoperative complications. Results: One hundred and three patients were included. Mean age was 39.5 years (range, 5 to 84 years) and 85 (87.5%) were men. Of the 103 patients, 96 had intra-operative navigation (34 for primary and 3 for secondary orbito-zygomatic fractures, 15 for Le Fort fractures, 16 for orbital floor fractures, 10 for combined orbital floor and medial wall fractures, 7 for orbital medial wall fractures, 3 for NOE (naso-orbito-ethmoidal) fractures, 2 for isolated comminuted zygomatic arch fractures, 1 for enophthalmos, 3 for TMJ ankylosis and 2 for fibrous dysplasia bone recontouring), 8 patients had CAD/CAM PEEK-PSI for correction of residual orbital bone contour following craniomaxillofacial trauma, and 1 patient had CAD/CAM surgical splints and cutting guides for correction of orbital hypertelorism. Two patient (1.9%) required revision surgery for readjustment of an orbital mesh. The 1-year follow-up examination showed stable cosmetic and dimensional results in all patients. Conclusion: This study demonstrated that the application of 3D orbital CAS with regards to intra-operative navigation and CAD/CAM techniques allowed for a successful outcome in the patients presented in this series. (C) 2017 Elsevier Masson SAS. All rights reserved.	[Scolozzi, P.] Hop Univ Geneve, Fac Med, Dept Surg, Div Oral & Maxillofacial Surg, CH-1211 Geneva, Switzerland		Scolozzi, P (corresponding author), Hop Univ Geneve, Fac Med, Dept Surg, Div Oral & Maxillofacial Surg, CH-1211 Geneva, Switzerland.	paolo.scolozzi@hcuge.ch					Centenero SAH, 2012, J CRANIO MAXILL SURG, V40, P162, DOI 10.1016/j.jcms.2011.03.014; Austin RE, 2012, ANN PLAS SURG, V69, P271, DOI 10.1097/SAP.0b013e31822a3ec3; Bell RB, 2009, J ORAL MAXIL SURG, V67, P2559, DOI 10.1016/j.joms.2009.07.098; Ernoult C, 2015, REV STOMATOL CHIR, V116, P95, DOI 10.1016/j.revsto.2015.01.010; Gellrich NC, 2002, PLAST RECONSTR SURG, V110, P1417, DOI 10.1097/01.PRS.0000029807.35391.E5; Guevara-Rojas G, 2014, J ORAL MAXIL SURG, V72, P1801, DOI 10.1016/j.joms.2014.02.013; Kim MM, 2009, ARCH FACIAL PLAST S, V11, P53, DOI 10.1001/archfaci.11.1.53; Lauer G, 2006, J CRANIO MAXILL SURG, V34, P299, DOI 10.1016/j.jcms.2006.03.002; Liu TJ, 2016, ANN PLAS SURG, V76, P411, DOI 10.1097/SAP.0000000000000429; Pohlenz P, 2009, J ORAL MAXIL SURG, V67, P515, DOI 10.1016/j.joms.2008.06.086; Scolozzi P, 2015, REV STOMATOL CHIR, V116, P343, DOI 10.1016/j.revsto.2015.09.005; Scolozzi P, 2012, REV STOMATOL CHIR, V113, P115, DOI 10.1016/j.stomax.2012.01.009; Scolozzi P, 2007, J CRANIOFAC SURG, V18, P224, DOI 10.1097/01.scs.0000249359.56417.7e; Scolozzi P, 2012, AESTHET PLAST SURG, V36, P660, DOI 10.1007/s00266-011-9853-2; Scolozzi P, 2011, J ORAL MAXIL SURG, V69, P1697, DOI 10.1016/j.joms.2010.07.049; Gil RS, 2015, BRIT J ORAL MAX SURG, V53, P49, DOI 10.1016/j.bjoms.2014.09.015; Tahiri Y, 2015, J CRANIOFAC SURG, V26, P104, DOI 10.1097/SCS.0000000000001260; Taylor RH, 1998, CLIN ORTHOP RELAT R, P5; Terzic A, 2011, COMPUT AIDED SURG, V16, P170, DOI 10.3109/10929088.2011.581901; Wilde F, 2014, CRANIOMAX TRAUM REC, V7, P158, DOI 10.1055/s-0034-1371356	20	14	14	0	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	2468-7855			J STOMATOL ORAL MAXI	J. Stomatol. Oral Maxillofac. Surg.	SEP	2017	118	4					217	223		10.1016/j.jormas.2017.05.007			7	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Dentistry, Oral Surgery & Medicine	FW0QU	WOS:000425001000004	28642192				2022-03-04	
J	Parisini, P; Braccini, L; Krejci, I				Parisini, Piero; Braccini, Luca; Krejci, Ivo			A new veneer technique with prefabricated composite denture teeth combined with the "Biologically Oriented Preparation Technique" (BOPT) - a case report	INTERNATIONAL JOURNAL OF ESTHETIC DENTISTRY			English	Article							MOUTH ADHESIVE REHABILITATION; SEVERELY ERODED DENTITION; PORCELAIN VENEERS; CLOSING DIASTEMAS; RESIN COMPOSITE; RESTORATIONS; INCISORS; CROWNS	This clinical report describes the step-by-step protocol for novel, 100% non prep, custom-modified, prefabricated composite veneer restorations in the case of an esthetic rehabilitation of a patient presenting peg-shaped lateral incisors and undersized maxillary central incisors. A correct diagnosis, comprehensive treatment plan, and an interdisciplinary approach are necessary to obtain optimal conservative and predictable esthetic results.	[Parisini, Piero; Krejci, Ivo] Univ Geneva, Div Cariol & Endodontol, Sect Dent Med, Geneva, Switzerland		Parisini, P (corresponding author), Rue Henri Veyrassat 8, CH-1202 Geneva, Switzerland.	piero.parisini@gmail.com					Bazos P, 2011, INT J ESTHET DENT, V6, P8; Bazos P, 2014, INT J ESTHET DENT, V9, P330; Beddis Hannah P, 2012, Dent Update, V39, P630; Beddis HP, 2012, DENT UPDATE, V39, P634; Bello A, 1997, J PROSTHET DENT, V78, P437, DOI 10.1016/S0022-3913(97)70056-8; Canullo L, 2012, PERI IMPLANT TISSUE; Castellano V., 2015, QUINTESSENZA ODONTOT, V2, P8; Chiche G, 1989, Quintessence Int, V20, P789; Chu FC, 2001, GEN DENT, V49, P288; Chu Frederick C. S., 2001, General Dentistry, V49, P282; D'Arcangelo C, 2007, J ADHES DENT, V9, P319; De Araujo EM, 2009, J ESTHET RESTOR DENT, V21, P229, DOI 10.1111/j.1708-8240.2009.00267.x; Devoto W, 2010, INT J ESTHET DENT, V5, P102; Dietschi D, 2001, J Adhes Dent, V3, P71; Dietschi D, 2011, INT J ESTHET DENT, V6, P20; Dietschi D, 2011, INT J ESTHET DENT, V6, P178; Dietschi D, 2011, INT J ESTHET DENT, V6, P142; Dunn J, 1994, J Calif Dent Assoc, V22, P73; Dunn J., 1994, J CALIF DENT ASSOC, V22, P80; Dunn J., 1994, J CALIF DENT ASSOC, V22, P78; GARBER DA, 1989, DENT CLIN N AM, V33, P301; Gargari M, 2014, ORAL IMPLANTOL ROME, V6, P99; Gomes G, 2014, J ESTHET RESTOR DENT, V26, P302, DOI 10.1111/jerd.12114; Gresnigt M, 2011, J CAN DENT ASSOC, V77, P1; Gresnigt MMM, 2012, J DENT, V40, P766, DOI 10.1016/j.jdent.2012.05.010; Izgi AD, 2005, J PROSTHET DENT, V93, P526, DOI 10.1016/j.prosdent.2005.03.016; Loi I, 2013, INT J ESTHET DENT, V8, P10; Lowe R A, 2000, Dent Today, V19, P84; Magne P, 2005, J PROSTHET DENT, V94, P511, DOI 10.1016/j.prosdent.2005.10.010; Magne P, 1999, INT J PROSTHODONT, V12, P111; Magne P., 2005, J ESTHET RESTOR DENT, V17, P155; Magne P, 2002, BONDED PORCELAIN RES; Magne Pascal, 2005, J Esthet Restor Dent, V17, P144, DOI 10.1111/j.1708-8240.2005.tb00103.x; Magne P, 2013, INT J ESTHET DENT, V8, P376; Mangani F, 2007, INT J ESTHET DENT, V2, P188; Mante Francis K, 2013, Compend Contin Educ Dent, V34 Spec 9, P2; Miranda ME, 2013, OPER DENT, V38, P567, DOI 10.2341/12-225-T; Nazarian Ara, 2006, Dent Today, V25, P70; Pena CE, 2009, INT J ESTHET DENT, V4, P210; Perdigao J, 2014, J ADHES DENT, V16, P137, DOI [10.3290/j.jad.a30689, 10.3290/j.jad.a31871]; Pinault, 1994, ESTHETICS ANTERIOR F; Raducanu AM, 2010, ROM J MORPHOL EMBRYO, V51, P371; Radz Gary M, 2011, Dent Clin North Am, V55, P353, DOI 10.1016/j.cden.2011.01.006; Scarpelli Ana Carolina, 2008, Gen Dent, V56, P74; Small Bruce W., 2012, General Dentistry, V60, P179; Spreafico RC, 2010, INT J ESTHET DENT, V5, P28; Strassler HE., 2007, GEN DENT, V55, P712; STRASSLER HE, 2007, GEN DENT, V55, P695; Strassler Howard E, 2007, Gen Dent, V55, P686; Vailati F, 2008, INT J ESTHET DENT, V3, P30; Vailati F, 2008, INT J ESTHET DENT, V3, P236; Vailati F, 2008, INT J ESTHET DENT, V3, P128; Wakiaga J, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004347; Wolff D, 2010, J DENT, V38, P1001, DOI 10.1016/j.jdent.2010.08.017	54	1	1	1	16	QUINTESSENCE PUBLISHING CO INC	HANOVER PARK	4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA	2198-591X			INT J ESTHET DENT	Int. J. Esthet. Dent.	SPR	2017	12	1					14	26					13	Dentistry, Oral Surgery & Medicine	Emerging Sources Citation Index (ESCI)	Dentistry, Oral Surgery & Medicine	EQ9EW	WOS:000398388200002	28117852				2022-03-04	
J	Saratti, CM; Del Curto, F; Rocca, GT; Krejci, I				Saratti, C. M.; Del Curto, F.; Rocca, G. T.; Krejci, I.			Vertical dimension augmentation with a full digital approach: a multiple chairside sessions case report	INTERNATIONAL JOURNAL OF COMPUTERIZED DENTISTRY			English	Article						Digital workflow; CAD/CAM; full-mouth rehabilitation; DVO augmentation	MOUTH REHABILITATION; LITHIUM DISILICATE; FRACTURE-RESISTANCE; OCCLUSAL VENEERS; CLINICAL REPORT; WORN DENTITION; DENTAL EROSION; TOOTH WEAR; CAD/CAM; PATIENT	The last few decades have seen an upward trend of the pathologies of abrasion, erosion, and abfraction. These pathologies, especially in combination, can provoke a significant loss of tooth substance. Nowadays, modern digital chairside technologies and new restorative materials allow clinicians to restore the lost tooth structure with a minimally invasive and fully digital approach. This article describes a step-by-step procedure of a full-mouth rehabilitation performed with a total digital chairside approach in several appointments.	[Saratti, C. M.; Del Curto, F.; Rocca, G. T.] Univ Geneva, Div Cariol & Endodont, 24 Rue Gen Dufour, CH-1211 Geneva, Switzerland; [Krejci, I.] Univ Geneva, Cariolol & Endodontol, Geneva, Switzerland		Saratti, CM (corresponding author), Univ Geneva, Div Cariol & Endodont, 24 Rue Gen Dufour, CH-1211 Geneva, Switzerland.	cmsaratti@hotmail.it		Rocca, Giovanni Tommaso/0000-0002-9511-9965; Saratti, Carlo Massimo/0000-0003-3932-2202			Abduo J, 2012, QUINTESSENCE INT, V43, P369; Alqahtani F, 2014, J PROSTHODONT, V23, P50, DOI 10.1111/jopr.12097; Belli R, 2017, DENT MATER, V33, P84, DOI 10.1016/j.dental.2016.10.009; Bindl A, 2003, INT J PROSTHODONT, V16, P653; Bosch G, 2015, INT J COMPUT DENT, V18, P273; Chen CF, 2014, DENT MATER, V30, P954, DOI 10.1016/j.dental.2014.05.018; Diracoglu D, 2011, ARCH ORAL BIOL, V56, P1569, DOI 10.1016/j.archoralbio.2011.06.019; Ergun G, 2014, J PROSTHODONT, V23, P406, DOI 10.1111/jopr.12113; Fradeani M, 2016, INT J ESTHET DENT, V11, P16; Grutter L, 2013, INT J ESTHET DENT, V8, P358; Guth JF, 2014, J PROSTHET DENT, V112, P89, DOI 10.1016/j.prosdent.2013.10.020; Kavoura V, 2005, QUINTESSENCE INT, V36, P501; Lee A, 2012, J ORAL REHABIL, V39, P217, DOI 10.1111/j.1365-2842.2011.02257.x; Lee JJW, 2009, J DENT RES, V88, P224, DOI 10.1177/0022034508330055; Lien W, 2015, DENT MATER, V31, P928, DOI 10.1016/j.dental.2015.05.003; Lussi A, 1996, EUR J ORAL SCI, V104, P191, DOI 10.1111/j.1600-0722.1996.tb00067.x; Ma L, 2013, DENT MATER, V29, P742, DOI 10.1016/j.dental.2013.04.004; Magne Pascal, 2005, J Esthet Restor Dent, V17, P144, DOI 10.1111/j.1708-8240.2005.tb00103.x; Reich S, 2014, CLIN ORAL INVEST, V18, P2171, DOI 10.1007/s00784-014-1191-8; Rocca GT, 2007, QUINTESSENCE INT, V38, P543; Sasse M, 2015, DENT MATER, V31, P907, DOI 10.1016/j.dental.2015.04.017; Schlichting LH, 2016, J PROSTHET DENT, V116, P474, DOI 10.1016/j.prosdent.2016.02.013; Schneider O, 2016, INT J COMPUT DENT, V19, P239; Steiner Marcel, 2010, Schweiz Monatsschr Zahnmed, V120, P1084; Vailati F, 2016, INT J ESTHET DENT, V11, P356; Vailati F, 2008, INT J ESTHET DENT, V3, P30; van Noort R, 2012, DENT MATER, V28, P3, DOI 10.1016/j.dental.2011.10.014; Wiedhahn K, 2007, Int J Comput Dent, V10, P79; Zimmermann M, 2016, J PROSTHET DENT, V116, P309, DOI 10.1016/j.prosdent.2016.02.010	29	4	4	1	2	QUINTESSENCE PUBLISHING CO INC	HANOVER PARK	4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA	1463-4201			INT J COMPUT DENT	Int. J. Comput. Dent.		2017	20	4					423	438					16	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	FR7YW	WOS:000419290800007	29292415				2022-03-04	
J	Giannopoulou, C; Cappuyns, I; Cancela, J; Cionca, N; Mombelli, A				Giannopoulou, Catherine; Cappuyns, Isabelle; Cancela, Jose; Cionca, Norbert; Mombelli, Andrea			Effect of Photodynamic Therapy, Diode Laser, and Deep Scaling on Cytokine and Acute-Phase Protein Levels in Gingival Crevicular Fluid of Residual Periodontal Pockets	JOURNAL OF PERIODONTOLOGY			English	Article						Acute-phase proteins; cytokines; dental scaling; gingival crevicular fluid; lasers; root planing	ROOT SUBSTANCE REMOVAL; DENTIN SENSITIVITY; IN-VITRO; AGGRESSIVE PERIODONTITIS; YAG LASER; ND-YAG; HYPERSENSITIVITY; PREVALENCE; INFLAMMATION; ADJUNCT	Background: There is an ongoing controversy on the benefits of treatment protocols, including dental lasers and photodynamic therapy (PDT). The purpose of this study is to compare the local biologic effects of PDT, diode soft laser (DSL) therapy, and conventional deep scaling and root planing (SRP) in residual pockets. Methods: Thirty-two individuals were included based on a history of previous treatment for periodontitis and the persistence of sites with probing depths >4 mm and bleeding on probing. Residual pockets were debrided with an ultrasonic device and then randomly assigned either to PDT, DSL, or SRP. Gingival crevicular fluid was collected before treatment, after 14 days, and at 2 and 6 months. Levels of 13 cytokines and nine acute-phase proteins were measured using a bead-based multiplexing analysis system. Results: Treatment with PDT, DSL, or SRP led to significant changes in several cytokines and acute-phase proteins: Compared with baseline, levels of interleukin-17, basic fibroblast growth factor, granulocyte colony-stimulating factor, granulocyte macrophage colony-stimulating factor, and macrophage inflammatory protein 1-alpha were lower 14 days and 2 months after treatment. Except for granulocyte colony-stimulating factor, these differences remained significant throughout the observation period. The levels of five acute-phase proteins (alpha-2 macroglobulin, haptoglobin, serum amyloid P, procalcitonin, and tissue plasminogen activator) were significantly higher at 6 months than at baseline. No significant differences were observed among the three treatment modalities at any time point for any biochemical parameter. Conclusions: Levels of several cytokines and acute-phase proteins significantly changed after treatment regardless of treatment modality. There was no evidence for a specific DSL- or PDT-enhanced expression of inflammatory mediators. J Periodontol 2012;83:1018-1027.	[Giannopoulou, Catherine] Univ Geneva, Sch Dent Med, Dept Periodontol, CH-1205 Geneva, Switzerland		Giannopoulou, C (corresponding author), Univ Geneva, Sch Dent Med, Dept Periodontol, Rue Barthelemy Menn 19, CH-1205 Geneva, Switzerland.	Ekaterini.Giannopoulou@unige.ch					[Anonymous], 2011, J PERIODONTOL, V82, P513, DOI 10.1902/jop.2011.114001; Aoki A, 2004, PERIODONTOL 2000, V36, P59, DOI 10.1111/j.1600-0757.2004.03679.x; Aykol G, 2011, J PERIODONTOL, V82, P481, DOI 10.1902/jop.2010.100195; Azarpazhooh A, 2010, J PERIODONTOL, V81, P4, DOI 10.1902/jop.2009.090285; BADERSTEN A, 1984, J CLIN PERIODONTOL, V11, P63, DOI 10.1111/j.1600-051X.1984.tb01309.x; BADERSTEN A, 1981, J CLIN PERIODONTOL, V8, P57, DOI 10.1111/j.1600-051X.1981.tb02024.x; Buduneli N, 2011, J CLIN PERIODONTOL, V38, P85, DOI 10.1111/j.1600-051X.2010.01670.x; Cappuyns I, 2012, LASER MED SCI, V27, P979, DOI 10.1007/s10103-011-1027-6; Chabanski MB, 1997, J ORAL REHABIL, V24, P15, DOI 10.1046/j.1365-2842.1997.00471.x; de Oliveira RR, 2009, J PERIODONTOL, V80, P98, DOI 10.1902/jop.2009.070465 ; Dominguez A, 2010, LASER SURG MED, V42, P24, DOI 10.1002/lsm.20873; Ebersole JL, 2000, PERIODONTOL 2000, V23, P19, DOI 10.1034/j.1600-0757.2000.2230103.x; Fichorova RN, 2008, ANAL CHEM, V80, P4741, DOI 10.1021/ac702628q; FISCHER C, 1992, J DENT, V20, P272, DOI 10.1016/0300-5712(92)90043-C; FISCHER C, 1991, ENDOD DENT TRAUMATOL, V7, P259; Flemmig TF, 1998, J CLIN PERIODONTOL, V25, P158, DOI 10.1111/j.1600-051X.1998.tb02422.x; Hayek RRA, 2005, J PERIODONTOL, V76, P1275, DOI 10.1902/jop.2005.76.8.1275; Ishikawa I, 2004, J PERIODONTAL RES, V39, P275, DOI 10.1111/j.1600-0765.2004.00738.x; Ishikawa I, 2009, PERIODONTOL 2000, V50, P90, DOI 10.1111/j.1600-0757.2008.00283.x; Karlsson MR, 2008, J PERIODONTOL, V79, P2021, DOI [10.1902/jop.2008.080197, 10.1902/jop.2008.080197 ]; KERNS DG, 1991, J PERIODONTOL, V62, P421, DOI 10.1902/jop.1991.62.7.421; Kocher T, 2001, J CLIN PERIODONTOL, V28, P9, DOI 10.1034/j.1600-051x.2001.280102.x; Liu CM, 1999, J PERIODONTOL, V70, P1276, DOI 10.1902/jop.1999.70.11.1276; Luan XL, 2009, LASER MED SCI, V24, P162, DOI 10.1007/s10103-007-0513-3; Miyazaki A, 2003, J PERIODONTOL, V74, P175, DOI 10.1902/jop.2003.74.2.175; Moritz A, 1998, LASER SURG MED, V22, P302; Moritz A, 1997, J Clin Laser Med Surg, V15, P33; ORCHARDSON R, 1994, ARCH ORAL BIOL, V39, pS113, DOI 10.1016/0003-9969(94)90197-X; Preshaw PM, 2011, J CLIN PERIODONTOL, V38, P60, DOI 10.1111/j.1600-051X.2010.01671.x; Qadri T, 2007, LASER MED SCI, V22, P245, DOI 10.1007/s10103-006-0439-1; Qadri T, 2005, J CLIN PERIODONTOL, V32, P714, DOI 10.1111/j.1600-051X.2005.00749.x; RITZ L, 1991, J CLIN PERIODONTOL, V18, P643, DOI 10.1111/j.1600-051X.1991.tb00104.x; Schwarz F, 2008, J CLIN PERIODONTOL, V35, P29, DOI 10.1111/j.1600-051X.2008.01259.x; Soukos NS, 2011, PERIODONTOL 2000, V55, P143, DOI 10.1111/j.1600-0757.2010.00346.x; Tammaro S, 2000, J CLIN PERIODONTOL, V27, P690, DOI 10.1034/j.1600-051x.2000.027009690.x; Teles RP, 2010, J CLIN PERIODONTOL, V37, P313, DOI 10.1111/j.1600-051X.2010.01534.x; Thunell DH, 2010, J PERIODONTAL RES, V45, P148, DOI 10.1111/j.1600-0765.2009.01204.x; Van der Weijden GA, 2002, J CLIN PERIODONTOL, V29, P55, DOI 10.1034/j.1600-051X.29.s3.3.x; von Troil B, 2002, J CLIN PERIODONTOL, V29, P173, DOI 10.1034/j.1600-051X.29.s3.10.x; WILSON M, 1993, ORAL MICROBIOL IMMUN, V8, P182, DOI 10.1111/j.1399-302X.1993.tb00663.x; ZAPPA U, 1991, J PERIODONTOL, V62, P750, DOI 10.1902/jop.1991.62.12.750	41	63	65	0	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3492	1943-3670		J PERIODONTOL	J. Periodont.	AUG	2012	83	8					1018	1027		10.1902/jop.2011.110281			10	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	987KQ	WOS:000307416200007	22181685				2022-03-04	
J	Bortolotto, T; Onisor, I; Krejci, I				Bortolotto, T.; Onisor, I.; Krejci, I.			Proximal direct composite restorations and chairside CAD/CAM inlays: Marginal adaptation of a two-step self-etch adhesive with and without selective enamel conditioning	CLINICAL ORAL INVESTIGATIONS			English	Article						slot; marginal adaptation; veramic inlay; layering technique; wall flexibility	TUNNEL RESTORATIONS; RESIN-COMPOSITES; STRESS DISTRIBUTIONS; SHRINKAGE STRESS; POSTERIOR TEETH; PERMANENT; DENTISTRY; SURVIVAL; MOLARS; DAMAGE	The aim of this study was to evaluate the marginal adaptation of CEREC ceramic inlays, CEREC composite inlays and direct composite restorations in unbeveled proximal slot cavities under artificial aging conditions. Two groups of each restoration type were prepared (n = 6), one group with a self-etch adhesive, the other group with H3PO4 enamel etching before the self-etch adhesive application. Replicas were generated before and after long-term thermo-mechanical loading under dentinal fluid simulation and margins were evaluated at x200 magnification in the scanning electron miscroscope (SEM). Statistically, significant differences were found before and after loading with respect to the percentages of "continuous margins", the direct composite filling with H3PO4 enamel etching giving the lowest percentages of "continuous margins" after loading (p < 0.05). The highest percentage of "continuous margin" was attained by composite inlays without H3PO4 enamel etching. However, these results were not significantly different from ceramic inlays after stressing. Polymerization shrinkage is still one critical property of composite restorative materials. The marginal adaptation of indirect adhesive proximal slot restorations without enamel bevels both fabricated out of composite and ceramic is better than that of directly placed composite restorations.	Univ Geneva, Sch Dent Med, Div Cariol & Endodontol, CH-1205 Geneva, Switzerland		Krejci, I (corresponding author), Univ Geneva, Sch Dent Med, Div Cariol & Endodontol, 19,Rue Barthelemy Menn, CH-1205 Geneva, Switzerland.	Ivo.Krejci@medecine.unige.ch	Bortolotto, Tissiana/AAE-2796-2021	Bortolotto, Tissiana/0000-0002-3231-9097			Ausiello P, 2004, DENT MATER, V20, P862, DOI 10.1016/j.dental.2004.05.001; Blatz MB, 2003, J PROSTHET DENT, V89, P268, DOI 10.1067/mpr.2003.50; BUONOCORE MG, 1955, J DENT RES, V34, P849, DOI DOI 10.1177/00220345550340060801; Burgess John O, 2002, Compend Contin Educ Dent, V23, P889; BURKE FJ, 1991, BR DENT J, V7, P269; FETT H, 1991, P INT S COMP REST ZU, P393; Frencken JE, 1996, J PUBLIC HEALTH DENT, V56, P135, DOI 10.1111/j.1752-7325.1996.tb02423.x; Frencken JE, 1998, CARIES RES, V32, P119, DOI 10.1159/000016441; Friedl K H, 1997, Clin Oral Investig, V1, P163; Goehring TN, 2001, J PROSTHET DENT, V86, P81, DOI 10.1067/mpr.2001.115072; HASSELROT L, 1993, SWED DENT J, V17, P173; Hickel R, 2001, J Adhes Dent, V3, P45; Hilton T J, 1997, Quintessence Int, V28, P135; Houpt M, 1994, Quintessence Int, V25, P155; Hugo B, 2001, Schweiz Monatsschr Zahnmed, V111, P19; Hugo B, 1992, Schweiz Monatsschr Zahnmed, V102, P1181; Hunt P R, 1984, Quintessence Int Dent Dig, V15, P1011; Hunt P R, 1994, J Esthet Dent, V6, P245, DOI 10.1111/j.1708-8240.1994.tb00865.x; JINKS GM, 1963, J DENT CHILD, V30, P87; Kaaden Christoph, 2002, Clin Oral Investig, V6, P155, DOI 10.1007/s00784-002-0170-7; KNIGHT GM, 1984, AUST DENT J, V29, P324, DOI 10.1111/j.1834-7819.1984.tb05294.x; Krejci I, 1990, Schweiz Monatsschr Zahnmed, V100, P1445; Krejci I, 1990, Schweiz Monatsschr Zahnmed, V100, P953; KREJCI I, 1993, J DENT RES, V72, P490, DOI 10.1177/00220345930720020401; Krejci I, 1990, Schweiz Monatsschr Zahnmed, V100, P1164; KREJCI I, 1995, ZAHNARZTLICHE WELT, V104, P781; Lu H, 2004, J MATER SCI-MATER M, V15, P1097, DOI 10.1023/B:JMSM.0000046391.07274.e6; Lussi A, 2003, J DENT, V31, P291, DOI 10.1016/S0300-5712(03)00029-0; LUSSI A, 1995, SCHWEIZ MONATSSCHR Z, V10, P1259; LUTZ F, 1991, DENT MATER, V7, P107, DOI 10.1016/0109-5641(91)90055-4; LUTZ F, 1999, COMPEND CONTIN ED DE, V12, P1138; Manhart J, 2004, OPER DENT, V29, P481; Manhart J, 2001, OPER DENT, V26, P357; Mehl A, 1999, Int J Comput Dent, V2, P9; Mertz-Fairhurst EJ, 1998, J AM DENT ASSOC, V129, P55, DOI 10.14219/jada.archive.1998.0022; Mormann WH, 2000, QUINTESSENCE INT, V31, P699; MOUNT GJ, 1986, J PROSTHET DENT, V55, P682, DOI 10.1016/0022-3913(86)90442-7; MUNECHIKA T, 1984, J DENT RES, V63, P1079, DOI 10.1177/00220345840630081501; NORDBO H, 1993, J PROSTHET DENT, V69, P155, DOI 10.1016/0022-3913(93)90134-A; Opdam NJM, 2002, AM J DENT, V15, P317; Peutzfeldt A, 2004, J DENT, V32, P109, DOI 10.1016/j.jdent.2003.08.008; Pyk N, 1999, ACTA ODONTOL SCAND, V57, P195, DOI 10.1080/000163599428779; Reiss B, 2000, Int J Comput Dent, V3, P9; ROULET JF, 1991, DENT MATER, V7, P44, DOI 10.1016/0109-5641(91)90026-U; Rusin R P, 2001, Compend Contin Educ Dent, V22, P35; Sarrett DC, 2005, DENT MATER, V21, P9, DOI 10.1016/j.dental.2004.10.001; SCHMALZ G, 1995, J PROSTHET DENT, V73, P392, DOI 10.1016/S0022-3913(05)80337-3; Shimada Y, 2003, OPER DENT, V28, P20; SIDHU SK, 1995, AM J DENT, V8, P59; Simonsen R J, 1989, Quintessence Int, V20, P75; STAEHLE HJ, 1999, J ADHES DENT, V3, P267; Stavridakis MM, 2003, AM J DENT, V16, P431; Strand GV, 1996, EUR J ORAL SCI, V104, P384, DOI 10.1111/j.1600-0722.1996.tb00096.x; Tyas MJ, 2000, INT DENT J, V50, P1, DOI 10.1111/j.1875-595X.2000.tb00540.x; Van Landuyt KL, 2006, J DENT, V34, P77, DOI 10.1016/j.jdent.2005.04.001; Versluis A, 2004, DENT MATER, V20, P554, DOI 10.1016/j.dental.2003.05.007; Weinmann W, 2005, DENT MATER, V21, P68, DOI 10.1016/j.dental.2004.10.007; WELBURY RR, 1990, BRIT DENT J, V169, P361, DOI 10.1038/sj.bdj.4807385; WILDER A, 1999, J ESTHET DENT, V3, P135; Willems G, 1993, Quintessence Int, V24, P641; Yip H K, 1998, Clin Oral Investig, V2, P148, DOI 10.1007/s007840050062; [No title captured]	62	41	42	0	8	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1432-6981	1436-3771		CLIN ORAL INVEST	Clin. Oral Investig.	MAR	2007	11	1					35	43		10.1007/s00784-006-0076-x			9	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	135XB	WOS:000244186100004	17031673	Green Submitted, Green Published			2022-03-04	
J	Spreafico, RC; Krejci, N; Dietschi, D				Spreafico, RC; Krejci, N; Dietschi, D			Clinical performance and marginal adaptation of class II direct and semidirect composite restorations over 3.5 years in vivo	JOURNAL OF DENTISTRY			English	Article						posterior composite; class II restorations; direct-semidirect techniques; clinical trial; marginal adaptation	DENTIN BOND STRENGTH; CERAMIC INLAYS; RESIN; TEETH	Objective. The study evaluated the clinical performance and marginal adaptation of direct and semi-direct class 11 composite restorations in a split-mouth design over 3.5 years. Design. 44 upper posterior teeth in 11 adults with primary carious lesions were treated with 22 direct and 22 semi-direct restorations. Conventional cavities were prepared for both types of restorations. A fine fine hybrid composite (APH) and a multifunctional adhesive system (Prisma universal bond 3) were used for all restorations. The incremental '3-sited light curing' technique was applied to direct restorations. Semi-direct inlays were prefabricated on silicone casts and post-cured using tight and heat. Clinical performance was evaluated using modified USPHS parameters, while marginal adaptation was judged on replicas, using SEM and a standardized evaluation technique. Results. Clinical results after 3.5 years revealed a 100% retention rate with no fractures, sensitivity or recurrent caries for both types of restorations. SEM-evaluation of the occlusal margins showed at the tooth -restoration interface relatively Low rates of marginal openings over the observation period (4-8%). Marginal restoration fractures ranged between 1 and 2%, marginal tooth fractures between 3 and 9%. Differences between the restorative techniques and after the different time observation periods were not statistically significant. Proportions of marginal fractures and openings at the restoration - luting composite interface were less than 10% after 3.5 years. Conclusion. The results indicated no significant differences for direct and semi-direct fine hybrid composite restorations in medium size cavities in posterior teeth with respect to clinical performance and marginal adaptation over 3.5 years. (C) 2005 Elsevier Ltd. All rights reserved.	Univ Geneva, Fac Med, Sch Dent,Sect Med Dent, Dept Cariol & Endodontol, CH-1205 Geneva, Switzerland		Dietschi, D (corresponding author), Univ Geneva, Fac Med, Sch Dent,Sect Med Dent, Dept Cariol & Endodontol, 19 Rue Barthelemy Menn, CH-1205 Geneva, Switzerland.	didier.dietschi@medecine.unige.ch					Boretti R, 1997, J DENT RES, V76, P222; BOWEN RL, 1983, J AM DENT ASSOC, V106, P475, DOI 10.14219/jada.archive.1983.0078; DAVIDSON CL, 1984, J DENT RES, V63, P1396, DOI 10.1177/00220345840630121101; DAVIDSON CL, 1984, J DENT RES, V63, P146, DOI 10.1177/00220345840630021001; DEGEE AJ, 1993, DENT MATER, V9, P11, DOI 10.1016/0109-5641(93)90097-A; Dietschi D, 1989, Quintessence Int, V20, P641; Dietschi D, 1990, Quintessence Int, V21, P965; Dietschi D, 1998, EUR J ORAL SCI, V106, P1033, DOI 10.1046/j.0909-8836.1998.eos106609.x; Dietschi D, 1995, Quintessence Int, V26, P127; Dietschi D, 1997, ADHESIVE METAL FREE; Donly KJ, 1999, QUINTESSENCE INT, V30, P163; Douglas WH, 1995, POSTERIOR COMPOSITE, P433; FEILZER AJ, 1987, J DENT RES, V66, P1636, DOI 10.1177/00220345870660110601; Frankenberger R, 1999, OPER DENT, V24, P147; Fullemann J, 1992, Schweiz Monatsschr Zahnmed, V102, P292; FULLEMANN J, 1998, SCHWEIZ MSCHR ZAHNME, V98, P758; HANNIG M, 1996, DTSCH ZAHNARZTL Z, V51, P595; Hayashi M, 2003, EUR J ORAL SCI, V111, P155, DOI 10.1034/j.1600-0722.2003.00020.x; Hickel R, 2001, J Adhes Dent, V3, P45; KILDAL KK, 1994, ACTA ODONTOL SCAND, V52, P315, DOI 10.3109/00016359409029044; KRAMER N, 1996, DTSCH ZAHNARZTLICHE, V51, P342; Krejci I, 1994, Quintessence Int, V25, P403; Krejci I, 2000, Pract Periodontics Aesthet Dent, V12, P727; Krejci I, 1994, Schweiz Monatsschr Zahnmed, V104, P1351; KREJCI I, 1992, ZAHNFARBENE STAT PLA, P38; LEUNG RL, 1983, J DENT RES, V62, P219; Liebenberg WH, 2000, QUINTESSENCE INT, V31, P153; LUESCHER B, 1977, J PROSTHET DENT, V37, P300, DOI 10.1016/0022-3913(77)90072-5; Lutz F, 1999, Compend Contin Educ Dent, V20, P1138; Lutz F, 1980, Quintessenz, V31, P125; Lutz F, 1986, Quintessence Int, V17, P659; Lutz F, 1980, SSO Schweiz Monatsschr Zahnheilkd, V90, P455; Mair LH, 1998, QUINTESSENCE INT, V29, P483; Manhart J, 2000, Clin Oral Investig, V4, P192, DOI 10.1007/s007840000086; Manhart J, 2000, J PROSTHET DENT, V84, P289, DOI 10.1067/mpr.2000.108774; Mjor IA, 2000, ACTA ODONTOL SCAND, V58, P97; Mormann W H, 1982, Quintessenz, V33, P1891; Pallesen U, 2000, EUR J ORAL SCI, V108, P239, DOI 10.1034/j.1600-0722.2000.108003239.x; Pallesen U, 1998, J DENT RES, V77, P914; Roulet J F, 1987, Quintessence Int, V18, P543; ROULET JF, 1993, CURRENT OPINION ESTH, V1, P41; SACHS L, 1974, ANGEW STAT PLANUNG A, P420; Scheibenbogen A, 1998, J PROSTHET DENT, V80, P410, DOI 10.1016/S0022-3913(98)70004-6; SCHMALZ G, 1995, J PROSTHET DENT, V73, P392, DOI 10.1016/S0022-3913(05)80337-3; Sorensen JA, 1996, J PROSTHET DENT, V76, P472, DOI 10.1016/S0022-3913(96)90003-7; STAVRIDAKIS M, 2000, ODONTOSTOMATOLOGIKI, V54, P213; Taylor DF, 1989, J DENT RES, V68, P186; THORDRUP M, 1994, SCAND J DENT RES, V102, P186; van Dijken JWV, 1998, J DENT, V26, P219, DOI 10.1016/S0300-5712(97)00005-5; van Dijken JWV, 2000, J DENT, V28, P299, DOI 10.1016/S0300-5712(00)00010-5; VANDIJKEN JWV, 1994, ACTA ODONTOL SCAND, V52, P368, DOI 10.3109/00016359409029034; vanDijken JWV, 1996, J DENT, V24, P389, DOI 10.1016/0300-5712(95)00098-4; WASSELL RW, 1995, BRIT DENT J, V179, P343, DOI 10.1038/sj.bdj.4808919; Wassell RW, 1998, J DENT RES, V77, P913; Wendt S L Jr, 1992, Am J Dent, V5, P258; WIEDMER CS, 1997, ACTA MED DENT HELVET, V106, P301; [No title captured]	57	51	53	0	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0300-5712	1879-176X		J DENT	J. Dent.	JUL	2005	33	6					499	507		10.1016/j.jdent.2004.11.009			9	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	941RE	WOS:000230231100007	15935270				2022-03-04	
J	Magne, P; Belser, UC				Magne, P; Belser, UC			Porcelain versus composite inlays/onlays: Effects of mechanical loads on stress distribution. Adhesion, and crown flexure	INTERNATIONAL JOURNAL OF PERIODONTICS & RESTORATIVE DENTISTRY			English	Article							THERMAL-EXPANSION COEFFICIENT; CRACKED-TOOTH SYNDROME; VENEER RESTORATIONS; DENTAL COMPOSITES; POSTERIOR TEETH; FINITE-ELEMENT; CERAMIC INLAYS; HYGROSCOPIC EXPANSION; CLINICAL-PERFORMANCE; MARGINAL ADAPTATION	This study used 2-D finite element modeling to simulate cuspal flexure and stresses at the surface and tooth-restoration interface of a restored maxillary molar using three restorative materials; the influence of four inlay/onlay preparation configurations on stress distribution within the complex was also investigated. A buccolinqual cross-section of an intact molar was digitized and used to create 2-D models restored with different restorative materials (feldspathic porcelain, high- and low-elastic modulus composites) and tooth preparations (small and large inlays small and large onlays). Two simulated 25-N oblique loads were applied to the cusps. The tangential stress for each finite element node located at the tooth surface, interfacial stress, and relative cuspal flexure were analyzed. All materials and tooth preparations exhibited similar surface tangential stress patterns, with a definite compressive area at the external cusp ridges, a tensile zone at the occlusal surface, and compression stress peaks at the CEJ. The low-elastic modulus composite showed reduced tensile stresses at its surface but increased tension at the dentin-adhesive interface when compared to ceramics. All types of onlays demonstrated a majority of compressive interfacial stresses, while inlays showed a majority of tensile stresses. The interfacial tension at the dentin level increased with the flexibility of the restorative material. Only the large ceramic onlay displayed almost pure compression at the interface. Composite-restored teeth exhibited increased crown flexure, while porcelain-restored teeth showed increased crown stiffness. Porcelain inlays/onlays featured more detrimental stresses at the occlusal surface but better potential protection against debonding at the dentin-restoration interface compared to composite inlays/onlays. Ceramic onlays/overlays seem to represent an effective answer to restore severely damaged posterior teeth.	Univ Geneva, Sch Dent Med, Dept Prosthodont, CH-1211 Geneva 4, Switzerland		Magne, P (corresponding author), 19 Rue Barthelemy Menn, CH-1205 Geneva, Switzerland.	Pascal.Magne@medecine.unige.ch	Buser, Daniel/D-3971-2011				ANUSAVICE KJ, 1988, J DENT RES, V67, P1371, DOI 10.1177/00220345880670110201; ASSIF D, 1990, J PROSTHET DENT, V63, P258, DOI 10.1016/0022-3913(90)90191-E; Bertschinger C, 1996, AM J DENT, V9, P115; Bremer BD, 2001, AM J DENT, V14, P216; CAMERON CE, 1976, J AM DENT ASSOC, V93, P971, DOI 10.14219/jada.archive.1976.0034; CAMERON CE, 1964, J AM DENT ASSOC, V68, P405, DOI 10.14219/jada.archive.1964.0108; CAVEL WT, 1985, J PROSTHET DENT, V53, P38, DOI 10.1016/0022-3913(85)90061-7; Cotert HS, 2001, INT J PROSTHODONT, V14, P374; CRAIG RG, 1980, RESTORATIVE DENT MAT, P76; Dietschi D, 1999, J Adhes Dent, V1, P41; Dietschi D, 1997, ADHESIVE METAL FREE; Douglas WH, 1996, DENT MATER, V12, P203, DOI 10.1016/S0109-5641(96)80023-6; DOUGLAS WH, 1985, INT S POST COMP RES, P433; Dumfahrt H, 2000, INT J PROSTHODONT, V13, P9; ELDIWANY M, 1993, AM J DENT, V6, P22; FEILZER AJ, 1990, J DENT RES, V69, P36, DOI 10.1177/00220345900690010501; Fradeani M, 1998, INT J PERIODONT REST, V18, P217; Frankenberger R, 1999, OPER DENT, V24, P147; Friedman M J, 1998, Compend Contin Educ Dent, V19, P625; Fuzzi M, 1999, J Adhes Dent, V1, P71; GERE JM, 1990, MECH MATER, P378; HANSEN EK, 1989, DENT MATER, V5, P122, DOI 10.1016/0109-5641(89)90142-5; HOOD JAA, 1985, INT S POST COMP RES, P443; Jantarat J, 2001, J DENT, V29, P75, DOI 10.1016/S0300-5712(00)00040-3; KOIKE T, 1990, DENT MATER, V6, P178, DOI 10.1016/0109-5641(90)90025-A; Korioth TWP, 1997, CRIT REV ORAL BIOL M, V8, P90, DOI 10.1177/10454411970080010501; Kreulen CM, 1998, J DENT, V26, P345, DOI 10.1016/S0300-5712(97)00023-7; LACY AM, 1992, J PROSTHET DENT, V67, P7, DOI 10.1016/0022-3913(92)90038-C; MACPHERSON LC, 1995, BRIT DENT J, V178, P341, DOI 10.1038/sj.bdj.4808760; Magne P, 2000, INT J PERIODONT REST, V20, P441; Magne P, 1999, INT J PROSTHODONT, V12, P111; Magne P, 2002, INT J PERIODONT REST, V22, P425; Magne P, 1996, INT J PERIODONT REST, V16, P105; Magne P, 1999, J PROSTHET DENT, V81, P345, DOI 10.1016/S0022-3913(99)70279-9; Magne P, 2002, BONDED PORCELAIN RES; Manhart J, 2001, AM J DENT, V14, P95; MCCABE JF, 1994, BRIT DENT J, V176, P333, DOI 10.1038/sj.bdj.4808447; MCCULLOCK AJ, 1986, BRIT DENT J, V161, P450, DOI 10.1038/sj.bdj.4806005; Meijering AC, 1998, J DENT, V26, P563, DOI 10.1016/S0300-5712(97)00032-8; Meijering AC, 1997, J DENT, V25, P493, DOI 10.1016/S0300-5712(96)00067-X; MISRA DN, 1977, J DENT RES, V56, P603, DOI 10.1177/00220345770560060801; MORIN D, 1984, J DENT RES, V63, P1075, DOI 10.1177/00220345840630081401; MORIN DL, 1988, DENT MATER, V4, P41, DOI 10.1016/S0109-5641(88)80087-3; MORIN DL, 1988, DENT MATER, V4, P77, DOI 10.1016/S0109-5641(88)80095-2; Otto T, 2002, INT J PROSTHODONT, V15, P122; Paul SJ, 1997, INT J PERIODONT REST, V17, P537; PAUL SJ, 1997, ADHESIVE LUTING PROC, P89; Peumans M, 1998, QUINTESSENCE INT, V29, P211; REEH ES, 1989, J DENT RES, V68, P1540, DOI 10.1177/00220345890680111401; REEH ES, 1989, J ENDODONT, V15, P512, DOI 10.1016/S0099-2399(89)80191-8; REEH ES, 1994, DENT MATER, V10, P247, DOI 10.1016/0109-5641(94)90069-8; RUCKER LM, 1990, J AM DENT ASSOC, V121, P594, DOI 10.14219/jada.archive.1990.0225; Versluis A, 1996, J DENT RES, V75, P871, DOI 10.1177/00220345960750030301; Versluis A, 1996, DENT MATER, V12, P290, DOI 10.1016/S0109-5641(96)80036-4; WALLS AWG, 1988, J ORAL REHABIL, V15, P439, DOI 10.1111/j.1365-2842.1988.tb00180.x; WATTS DC, 1987, J DENT RES, V66, P29, DOI 10.1177/00220345870660010601; WILLEMS G, 1992, DENT MATER, V8, P310, DOI 10.1016/0109-5641(92)90106-M; XU HC, 1989, AUST DENT J, V34, P530	58	101	109	1	18	QUINTESSENCE PUBLISHING CO INC	HANOVER PARK	4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA	0198-7569	1945-3388		INT J PERIODONT REST	Int. J. Periodontics Restor. Dent.	DEC	2003	23	6					543	555					13	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	758JK	WOS:000187630700003	14703758				2022-03-04	
J	Cattani-Lorente, M; Bouillaguet, S; Godin, C; Meyer, JM				Cattani-Lorente, M; Bouillaguet, S; Godin, C; Meyer, JM			Effect of food simulating liquids (FSL) on mechanical properties of dental composites	JOURNAL OF DENTAL RESEARCH			English	Meeting Abstract									Univ Geneva, Sch Dent, CH-1211 Geneva 4, Switzerland									0	0	0	0	0	INT AMER ASSOC DENTAL RESEARCHI A D R/A A D R	ALEXANDRIA	1619 DUKE ST, ALEXANDRIA, VA 22314-3406 USA	0022-0345			J DENT RES	J. Dent. Res.	APR	2001	80	4					1237	1237					1	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	497VL	WOS:000172476102050					2022-03-04	
J	Denes, BJ; Lagou, A; Kiliaridis, S				Denes, Balazs J.; Lagou, Aikaterini; Kiliaridis, Stavros			Monitoring Overeruption Pattern of Young vs Adult Unopposed Molars in the Rat	INTERNATIONAL JOURNAL OF PROSTHODONTICS			English	Article							CONTINUOUS TOOTH ERUPTION; ALVEOLAR BONE TURNOVER; AND/OR ADJACENT TOOTH; PERIODONTAL-LIGAMENT; SINGLE IMPLANTS; CREST HEIGHT; POSITION; TEETH; EXPRESSION; AGE	Purpose: To investigate the overeruption of unopposed molars and the adaptation of alveolar bone height in young and adult rats. Materials and Methods: A total of 56 4-week-old (young) and 26-week-old (adult) male Wistar rats were followed up longitudinally. In each age group (n = 28), 16 rats were included in the experimental subgroup, in which all the maxillary right molars were extracted, and 12 rats were included in the control subgroup. All rats were scanned at regular intervals with in vivo microcomputed tomography for a 12-week period, and the eruption rate of the mandibular first molars and the surrounding bone were measured, with the reference point at the mandibular canal. The molar categories were unopposed right molars and overloaded left molars in the experimental group and control molars in the control group. Results: The young unopposed molars had the highest mean eruption rate (172 +/- 67 mu m/day). The overeruption was most marked during the first 3 weeks postextraction, thereafter gradually returning to a level comparable to controls (12.9 +/- 6.8 mu m/day). The overloaded adult molars did not erupt during the experimental period. Alveolar bone height also increased in young unopposed molars, but at a slower pace than overeruption, causing an increase in clinical crown height. Conclusion: Unopposed young molars overerupt at a higher pace than adult molars during the first weeks postextraction. The alveolar bone grows in response to the tooth eruption but to a lesser extent, which leads to a constant increase in clinical crown height at the same rate in young and adult rats. The increase of clinical crown height was 4.5-fold higher in young unopposed molars compared to control molars.	[Denes, Balazs J.; Lagou, Aikaterini; Kiliaridis, Stavros] Univ Geneva, Univ Clin Dent Med, Univ Med Ctr, Dept Orthodont, Geneva, Switzerland		Denes, BJ (corresponding author), Univ Geneva, Dept Orthodont, CUMD, 1 Rue Michel Servet, CH-1201 Geneva 4, Switzerland.	balazs.denes@unige.ch			Swiss National Science Foundation (FNS)Swiss National Science Foundation (SNSF) [31003A_176131]	This study was financed by the Swiss National Science Foundation (FNS), grant no. 31003A_176131. The authors would like to kindly thank Dr Domna Dorotheou for her valuable assistance with the animal experimentation. The authors declare that there is no conflict of interest.	Bernard JP, 2004, J CLIN PERIODONTOL, V31, P1024, DOI 10.1111/j.1600-051X.2004.00574.x; Christou P, 2007, EUR J ORTHODONT, V29, P543, DOI 10.1093/ejo/cjm036; Craddock Helen L, 2007, J Prosthodont, V16, P485, DOI 10.1111/j.1532-849X.2007.00212.x; Craddock HL, 2004, BRIT DENT J, V196, P341, DOI 10.1038/sj.bdj.4811082; DANENBERG PJ, 1991, AM J PHYS ANTHROPOL, V85, P305, DOI 10.1002/ajpa.1330850309; Denes BJ, 2018, LAB ANIM-UK, V52, P394, DOI 10.1177/0023677217750410; Dorotheou D, 2018, J INT MED RES, V46, P2423, DOI 10.1177/0300060518769545; Dorotheou D, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00075; Faggion CM, 2011, J DENT, V39, P108, DOI 10.1016/j.jdent.2010.11.002; Fujita T, 2009, ARCH ORAL BIOL, V54, P40, DOI 10.1016/j.archoralbio.2008.07.010; Heij DGO, 2006, INT J ORAL MAX IMPL, V21, P867; HOFFMAN MM, 1940, AM J ORTHOD ORAL SUR, V26, P854; HOUSTON WJB, 1983, AM J ORTHOD DENTOFAC, V83, P382, DOI 10.1016/0002-9416(83)90322-6; Kiliaridis S, 2000, INT J PROSTHODONT, V13, P480; KING GJ, 1995, ANAT REC, V242, P321, DOI 10.1002/ar.1092420305; LEVERS BGH, 1983, ARCH ORAL BIOL, V28, P401, DOI 10.1016/0003-9969(83)90135-8; Lindskog-Stokland B, 2012, J ORAL REHABIL, V39, P136, DOI 10.1111/j.1365-2842.2011.02252.x; Lindskog-Stokland B, 2013, SWED DENT J, V37, P97; Misawa Y, 2007, ARCH ORAL BIOL, V52, P44, DOI 10.1016/j.archoralbio.2006.06.012; NEWMAN HN, 1979, J ROY SOC MED, V72, P341; NISHIMOTO SK, 1985, CALCIFIED TISSUE INT, V37, P617, DOI 10.1007/BF02554919; PICTON DCA, 1984, ARCH ORAL BIOL, V29, P425, DOI 10.1016/0003-9969(84)90022-0; Proffit WR, 2009, ORTHOD CRANIOFAC RES, V12, P59, DOI 10.1111/j.1601-6343.2009.01438.x; Rohila Ajit K, 2012, Indian J Dent Res, V23, P726, DOI 10.4103/0970-9290.111247; Theytaz GA, 2011, AM J ORTHOD DENTOFAC, V139, pS129, DOI 10.1016/j.ajodo.2010.05.017; Thilander B, 1999, CLIN ORAL IMPLAN RES, V10, P346, DOI 10.1034/j.1600-0501.1999.100502.x; Thilander B, 2001, EUR J ORTHODONT, V23, P715, DOI 10.1093/ejo/23.6.715; Volchansky A, 2001, J CLIN PERIODONTOL, V28, P1085, DOI 10.1034/j.1600-051X.2001.281201.x; WHITTAKER DK, 1985, ARCH ORAL BIOL, V30, P493, DOI 10.1016/0003-9969(85)90096-2; WHITTAKER DK, 1990, ARCH ORAL BIOL, V35, P81, DOI 10.1016/0003-9969(90)90167-9; Wise GE, 2008, J DENT RES, V87, P414, DOI 10.1177/154405910808700509	31	0	0	0	0	QUINTESSENCE PUBLISHING CO INC	HANOVER PARK	4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA	0893-2174	1942-4426		INT J PROSTHODONT	Int. J. Prosthodont.	NOV-DEC	2020	33	6					663	670		10.11607/ijp.6644			8	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	PB4WM	WOS:000596322900010	33284909				2022-03-04	
J	Nerushay, I; Krejci, I; Ryabova, A; Bortolotto, T				Nerushay, Izabella; Krejci, Ivo; Ryabova, Anastasia; Bortolotto, Tissiana			Influence of pulse duration when performing Er:YAG laser irradiation on dental tissues	AMERICAN JOURNAL OF DENTISTRY			English	Article							ER-YAG-LASER; TENSILE BOND STRENGTH; CAVITY PREPARATION; MARGINAL QUALITY; SECONDARY CARIES; TOOTH STRUCTURE; ER/YAG LASER; SELF-ETCH; BUR-CUT; ENAMEL	Purpose: To evaluate the marginal adaptation of mixed Class V composite restorations in cavities prepared with the Quantum Square Pulse (QSP) mode Er:YAG laser, compared to Super Short Pulse (SSP) and diamond bur. The impact of Er:YAG laser finishing with low pulse energy and two irradiation distances was also evaluated. Methods: Class V cavities were prepared in enamel and dentin by varying the above parameters, and then restored with Clearfil SE Bond and Clearfil AP-X composite under dentin fluid simulation. The control groups were prepared and finished using conventional diamond burs (80 and 25 mu m respectively). Scanning electron microscope (SEM) marginal adaptation analysis at x200 magnification was performed on replicas before and after thermo-mechanical cyclic loading in order to determine the percentage of continuous margins (i.e. from 0 to 100% of gap free margins). The differences between groups were analyzed with one-way ANOVA and Duncan post hoc test. Results: Dentin treated with SSP showed significantly lower percentages of "continuous margin" than the QSP and control groups. QSP was as effective as bur preparation.	[Nerushay, Izabella; Krejci, Ivo; Ryabova, Anastasia; Bortolotto, Tissiana] Univ Geneva, Fac Med, Univ Clin Dent Med, Div Cariol & Endodontol, Rue Barthelemy Menn 19, CH-1205 Geneva, Switzerland		Nerushay, I (corresponding author), Univ Geneva, Fac Med, Univ Clin Dent Med, Div Cariol & Endodontol, Rue Barthelemy Menn 19, CH-1205 Geneva, Switzerland.	izabella.nerushay@unige.ch	Ryabova, Anastasia V/I-7911-2014; Bortolotto, Tissiana/AAE-2796-2021	Ryabova, Anastasia V/0000-0003-3488-1128; Bortolotto, Tissiana/0000-0002-3231-9097			Akin M, 2016, J OROFAC ORTHOP, V77, P151, DOI 10.1007/s00056-016-0019-3; Aoki A, 1998, J DENT RES, V77, P1404, DOI 10.1177/00220345980770060501; Bader C, 2006, AM J DENT, V19, P337; Bader C, 2006, AM J DENT, V19, P178; Bahrami B, 2011, LASER MED SCI, V26, P187, DOI 10.1007/s10103-010-0767-z; Baraba A, 2016, PHOTOMED LASER SURG, V34, P215, DOI 10.1089/pho.2015.4078; Baraba A, 2013, PHOTOMED LASER SURG, V31, P116, DOI 10.1089/pho.2012.3286; Baraba A, 2012, PHOTOMED LASER SURG, V30, P301, DOI 10.1089/pho.2011.3190; Barceleiro MO, 2005, OPER DENT, V30, P304; Bortolotto T, 2012, CLIN ORAL INVEST, V16, P1125, DOI 10.1007/s00784-011-0623-y; Camerlingo C, 2004, J DENT, V32, P399, DOI 10.1016/j.jdent.2004.01.011; Ceballos L, 2002, J DENT RES, V81, P119, DOI 10.1177/154405910208100207; Ceballos L, 2001, AM J DENT, V14, P46; Ceballos L, 2001, DENT MATER, V17, P340, DOI 10.1016/S0109-5641(00)00092-0; Chimello-Sousa DT, 2006, J DENT, V34, P245, DOI 10.1016/j.jdent.2005.06.009; Corona SAM, 2008, J BIOMED MATER RES A, V84A, P569, DOI 10.1002/jbm.a.31335; Correa-Afonso AM, 2010, J DENT, V38, P534, DOI 10.1016/j.jdent.2010.03.009; de Carvalho RC., 2005, J ORAL LASER APPL, V5, P237; De Moor R.J., 2006, J ORAL LASER APPL, V6, P7; De Moor RJG, 2009, J ADHES DENT, V11, P427, DOI [10.3290/j.jad.a17528, 10.3290/j.jad.a18136]; De Munck J, 2002, EUR J ORAL SCI, V110, P322, DOI 10.1034/j.1600-0722.2002.21281.x; Decup F, 2014, BRIT DENT J, V216, P393, DOI 10.1038/sj.bdj.2014.246; Delme K., 2006, J ORAL LASER APPL, V6, P43; Delme KIM, 2007, PHOTOMED LASER SURG, V25, P393, DOI 10.1089/pho.2006.2069; Esteves-Oliveira M, 2007, PHOTOMED LASER SURG, V25, P373, DOI 10.1089/pho.2007.2044; Firat E, 2012, LASER MED SCI, V27, P15, DOI 10.1007/s10103-010-0830-9; Frankenberger R, 2003, J BIOMED MATER RES B, V67B, P712, DOI 10.1002/jbm.b.10052; Frankenberger R, 2005, DENT MATER, V21, P397, DOI 10.1016/j.dental.2004.07.005; Freitas PM, 2007, MICROSC RES TECHNIQ, V70, P803, DOI 10.1002/jemt.20470; Gimbel C B, 2000, Dent Clin North Am, V44, P931; HIBST R, 1989, LASER SURG MED, V9, P338, DOI 10.1002/lsm.1900090405; Hibst R, 2002, J ORAL LASER APPL, V2, P203; Hossain M, 2003, J CLIN LASER MED SUR, V21, P29, DOI 10.1089/10445470360516716; Jokstad A, 2016, DENT MATER, V32, P11, DOI 10.1016/j.dental.2015.09.006; Jukic Krmek S, 2010, LASER MED SCI, V25, P823, DOI 10.1007/s10103-009-0707-y; Kallis A, 2019, LASER MED SCI, V34, P23, DOI 10.1007/s10103-018-2575-9; Karaarslan ES, 2012, J DENT, V40, P793, DOI 10.1016/j.jdent.2012.05.013; Kataumi M, 1998, DENT MATER J, V17, P125; Krejci I, 1990, Schweiz Monatsschr Zahnmed, V100, P953; KREJCI I, 1993, J DENT RES, V72, P490, DOI 10.1177/00220345930720020401; Lin M, 2010, DENT MATER, V26, P501, DOI 10.1016/j.dental.2010.02.009; Lopes RM, 2015, PHOTOMED LASER SURG, V33, P393, DOI 10.1089/pho.2015.3892; Luka M., 2004, J ORAL LASER APPL, V4, P171; Lukac N, 2016, J BIOMED OPT, V21; Majaron B, 1998, APPL PHYS B-LASERS O, V66, P479, DOI 10.1007/s003400050423; Majd H, 2012, J DENT RES, V91, P894, DOI 10.1177/0022034512455800; Malta DAMP, 2008, LASER PHYS LETT, V5, P144, DOI 10.1002/lapl.200710089; Moretto SG, 2011, MICROSC RES TECHNIQ, V74, P720, DOI 10.1002/jemt.20949; Parker S, 2007, BRIT DENT J, V202, P445, DOI 10.1038/bdj.2007.294; Perhavec T, 2008, J ORAL LASER APPL, V8, P87; Rizcalla N, 2012, QUINTESSENCE INT, V43, P153; Sagir S, 2013, ANGLE ORTHOD, V83, P973, DOI 10.2319/111412-872.1; Schein MT, 2003, J DENT, V31, P127, DOI 10.1016/S0300-5712(03)00003-4; Shirani Farzaneh, 2014, Dent Res J (Isfahan), V11, P689; Staninec M, 2009, DENT MATER, V25, P520, DOI 10.1016/j.dental.2008.10.004; Trevelin LT, 2015, MICROSC RES TECHNIQ, V78, P472, DOI 10.1002/jemt.22496	56	0	0	0	1	MOSHER & LINDER, INC	WESTON	318 INDIAN TRACE SUITE 500, WESTON, FL 33326 USA	0894-8275			AM J DENT	Am. J. Dent.	APR	2019	32	2					61	68					8	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	HX8PM	WOS:000467667800002	31094139				2022-03-04	
J	Martinelli-Klay, CP; Lombardi, T				Martinelli-Klaey, C. -P.; Lombardi, T.			Unusual location of mucous extravasation cyst: Report of two cases	REVUE DE STOMATOLOGIE DE CHIRURGIE MAXILLO-FACIALE ET DE CHIRURGIE ORALE			French	Article						Mucocele/diagnosis; Minor salivary glands/pathology; Salivary gland neoplasm	ORAL MUCOCELES	Introduction. The most common location of mucous extravasation cyst is the lower lip followed by buccal mucosa and ventral surface of the tongue. It very rarely occurs on the upper lip. Observation. A 17-year-old man consulted for a firm sub-mucosal nodule of the upper lip. The nodule was removed and the histological examination identified a pseudocyst characterized by a mucus pool without any epithelial lining, surrounded by granulation tissue. A similar observation was made in a 58-year-old woman who consulted for a recurrent translucent vesicle of the upper lip. There was no recurrence in either case. Discussion. The clinical presentation of mucous extravasation cysts of the upper lip is similar to that of others lesions especially salivary gland or connective tissue tumors, or sometimes traumatic fibroma. Histological examination is mandatory to prove a definitive diagnosis and rule out a neoplasm requiring a more aggressive treatment. (C) 2012 Elsevier Masson SAS. All rights reserved.	[Martinelli-Klaey, C. -P.; Lombardi, T.] Univ Geneva, Div Stomatol & Chirurg Orale, Lab Histopathol Buccale & Maxillofaciale, CH-1205 Geneva, Switzerland		Lombardi, T (corresponding author), Univ Geneva, Div Stomatol & Chirurg Orale, Lab Histopathol Buccale & Maxillofaciale, 79 Rue Barthelemy Menn, CH-1205 Geneva, Switzerland.	tommaso.lombardi@unige.ch					Barcker BF, 1997, DIFFERENTIAL DIAGNOS, P561; Baurmash HD, 2003, J ORAL MAXIL SURG, V61, P369, DOI 10.1053/joms.2003.50074; Cecconi DR, 2010, MED ORAL PATOL ORAL, V15, pE551, DOI 10.4317/medoral.15.e551; CHAUDHRY A. P., 1960, JOUR DENTAL RES, V39, P1253, DOI 10.1177/00220345600390062001; Chi AC, 2011, J ORAL MAXIL SURG, V69, P1086, DOI 10.1016/j.joms.2010.02.052; Dent C D, 1997, Va Dent J, V74, P8; Granholm C, 2009, SWED DENT J, V33, P125; HARRISON JD, 1975, ORAL SURG ORAL MED O, V39, P268, DOI 10.1016/0030-4220(75)90228-5; Koudelka BM, 1991, SURG PATHOLOGY SALIV, P26; Mustapha Indra Z, 2004, J Can Dent Assoc, V70, P318	10	0	0	0	4	ELSEVIER	BRIDGEWATER	685 ROUTE 202-206, BRIDGEWATER, NJ 08807 USA	2213-6533			REV STOMATOL CHIR	Rev. Stomatol. Chir. Maxillo-Facil.	NOV	2012	113	5					375	377		10.1016/j.stomax.2012.05.004			3	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	074XX	WOS:000313849500005	22789629				2022-03-04	
J	Schimmel, M; Muller, F				Schimmel, Martin; Mueller, Frauke			Masticatory function in prosthodontically restored edentulous patients	IMPLANTOLOGIE			German	Article						chewing efficiency; maximum voluntary occlusal force; edentulism; implant-supported overdentures; implant-supported fixed dental prostheses; conventional complete dentures; mandibular movement; nutrition	IMPLANT-SUPPORTED OVERDENTURES; QUALITY-OF-LIFE; 2-COLOR CHEWING GUM; OLDER-ADULTS; ORAL-HEALTH; CONSENSUS STATEMENT; NUTRITIONAL-STATUS; COMPLETE DENTURES; MIXING ABILITY; OCCLUSAL FORCE	The capacity to comminute food decreases with the loss of teeth-masticatory efficiency deteriorates. Conventionally restored complete denture wearers show the severest handicap, which often impairs their diet and oral health-related quality of life. Masticatory efficiency of edentulous patients can be improved through use of implant-supported removable or fixed dental prostheses but can never fully compensate for the loss of natural teeth. The loss of periodontal mechanoreceptors results in a decline in tactile sensitivity and thus impairment in fine motor control during mastication. Masticatory function is a complex interaction between tooth- and denture-related factors as well as central and peripheral control of the muscles and other oral structures. In mal- or undernourished elderly individuals, a prosthodontic restoration is not sufficient to change long-established nutritional habits and should therefore be accompanied by dietary counseling.	[Schimmel, Martin; Mueller, Frauke] Univ Genf, Fak Med, Abt Rehabil & Geriatrie, CH-1205 Geneva, Switzerland; [Schimmel, Martin; Mueller, Frauke] Univ Genf, Fak Med, Abt Alterszahnheilkunde & Abnehmbare Prothet, CH-1205 Geneva, Switzerland		Schimmel, M (corresponding author), Univ Genf, Fak Med, Abt Rehabil & Geriatrie, 19 Rue Barthelemy Menn, CH-1205 Geneva, Switzerland.	martin.schimmel@unige.ch	Schimmel, Martin/F-5694-2011; Müller, Frauke/C-3835-2014	Schimmel, Martin/0000-0001-9700-5534; Müller, Frauke/0000-0003-3981-0134			Anastassiadou V, 2001, Gerodontology, V18, P79, DOI 10.1111/j.1741-2358.2001.00079.x; [Anonymous], 2005, J PROSTHET DENT, V94, P10; Benzing U, 1994, Int J Oral Maxillofac Implants, V9, P207; Boumendjel N, 2000, LANCET, V356, P563, DOI 10.1016/S0140-6736(00)02583-6; Bourdiol P, 2000, ARCH ORAL BIOL, V45, P691, DOI 10.1016/S0003-9969(00)00027-3; Bradbury J, 2006, J DENT RES, V85, P463, DOI 10.1177/154405910608500513; Brennan M, 2010, INT J ORAL MAX IMPL, V25, P791; Carlsson G E, 1994, Int J Prosthodont, V7, P448; CARLSSON GE, 1984, INT DENT J, V34, P93; Chang CC, 2008, J CLIN NURS, V17, P2266, DOI 10.1111/j.1365-2702.2007.02275.x; Dormenval V, 1995, Gerodontology, V12, P73, DOI 10.1111/j.1741-2358.1995.tb00134.x; Emami E, 2009, CLIN ORAL IMPLAN RES, V20, P533, DOI 10.1111/j.1600-0501.2008.01693.x; FEINE JS, 1994, J DENT RES, V73, P1646, DOI 10.1177/00220345940730101001; Ferrario VF, 2004, CLIN ORAL IMPLAN RES, V15, P219, DOI 10.1111/j.1600-0501.2004.00974.x; Fueki K, 2007, J PROSTHET DENT, V98, P470, DOI 10.1016/S0022-3913(07)60147-4; Grigoriadis A, 2011, CLIN ORAL IMPLAN RES, V22, P1057; Grigoriadis A, 2011, J CLIN PERIODONTOL, V38, P395, DOI 10.1111/j.1600-051X.2010.01697.x; HARALDSON T, 1983, ACTA ODONTOL SCAND, V41, P203, DOI 10.3109/00016358309162325; HEATH MR, 1982, INT DENT J, V32, P345; Heckmann SM, 2009, CLIN ORAL IMPLAN RES, V20, P1200, DOI 10.1111/j.1600-0501.2009.01722.x; Ikebe K, 2006, INT J PROSTHODONT, V19, P475; Ikebe K, 2010, INT J PROSTHODONT, V23, P521; Ikeda M, 2002, J NEUROL NEUROSUR PS, V73, P371, DOI 10.1136/jnnp.73.4.371; Kerschbaum T., 2006, VIERTE DTSCHE MUNDGE, P354; Kikutani T, 2009, ODONTOLOGY, V97, P38, DOI 10.1007/s10266-008-0094-z; Kinsel RP, 2009, J PROSTHET DENT, V101, P388, DOI 10.1016/S0022-3913(09)60083-4; Klineberg I, 2005, CLIN EXP PHARMACOL P, V32, P145, DOI 10.1111/j.1440-1681.2005.04144.x; LIEDBERG B, 1991, Dysphagia, V6, P211, DOI 10.1007/BF02493529; Lobbezoo F, 2002, J OROFAC PAIN, V16, P9; Luraschi I, 2011, CLIN ORAL IMPLAN RES, DOI [10.1111/j.600-0501.2011.02283, DOI 10.1111/J.600-0501.2011.02283]; MANLY RS, 1950, J DENT RES, V29, P448, DOI 10.1177/00220345500290040701; Mazari A, 2007, DYSPHAGIA, V22, P117, DOI 10.1007/s00455-006-9062-3; Millwood J, 2000, Gerodontology, V17, P25, DOI 10.1111/j.1741-2358.2000.00025.x; Mistry S, 2008, PHYS MED REH CLIN N, V19, P709, DOI 10.1016/j.pmr.2008.05.002; Miura H, 2003, J ORAL REHABIL, V30, P808, DOI 10.1046/j.1365-2842.2003.01124.x; Miura Hiroko, 2005, Gerodontology, V22, P200; Muller F, 2005, Z GERONTOL GERIATR, V38, P334, DOI 10.1007/s00391-005-0329-3; Muller F, 2001, Gerodontology, V18, P58, DOI 10.1111/j.1741-2358.2001.00058.x; MULLER F, 1995, J ORAL REHABIL, V22, P759, DOI 10.1111/j.1365-2842.1995.tb00220.x; Muller F, 2011, CLIN ORAL IMPLAN RES, DOI [10.1111/j.600-0501.2011.02213.x, DOI 10.1111/J.600-0501.2011.02213.X]; Muller F, 2006, CURRICULUM ORALE PHY, P35; NAKAMURA Y, 1995, NEUROSCI RES, V23, P1, DOI 10.1016/0168-0102(95)00925-J; Newton J P, 1993, Gerodontology, V10, P16, DOI 10.1111/j.1741-2358.1993.tb00074.x; Newton James P, 2004, Gerodontology, V21, P37, DOI 10.1111/j.1741-2358.2004.00002.x; Nordstrom G, 1990, Aging (Milano), V2, P371; Palmer JB, 2007, PHYSIOL BEHAV, V91, P66, DOI 10.1016/j.physbeh.2007.01.018; Prinz JF, 1999, J ORAL REHABIL, V26, P243, DOI 10.1046/j.1365-2842.1999.00362.x; Rashid F, 2011, J ORAL REHABIL, V38, P176, DOI 10.1111/j.1365-2842.2010.02143.x; Rosin P., 1933, ZEMENT, V31, P427; Sanchez-Ayala A, 2010, IMPLANT DENT, V19, P196, DOI 10.1097/ID.0b013e3181d46903; Schimmel M, 2007, J ORAL REHABIL, V34, P671, DOI 10.1111/j.1365-2842.2007.01773.x; Schimmel M, 2011, J DENT RES, V90, P230, DOI 10.1177/0022034510383860; Schimmel M, 2008, GERODONTOLOGY, V25, P107, DOI 10.1111/j.1741-2358.2007.00212.x; Schimmel M, 2011, GERODONTOLOGY, V28, P3, DOI 10.1111/j.1741-2358.2009.00330.x; Schimmel M, 2010, INT J PROSTHODONT, V23, P418; Schindler HJ., 2006, CURRICULUM ORALE PHY, P113; Sheiham A, 2001, PUBLIC HEALTH NUTR, V4, P797, DOI 10.1079/PHN2000116; Speksnijder CM, 2009, EUR J ORAL SCI, V117, P580, DOI 10.1111/j.1600-0722.2009.00675.x; Stenman U, 2011, GERODONTOLOGY, DOI [10.1111/j.741-2358.011.00495.x, DOI 10.1111/J.741-2358.011.00495.X]; Thomason JM, 2009, BRIT DENT J, V207, P185, DOI 10.1038/sj.bdj.2009.728; van der Bilt A, 2006, EUR J ORAL SCI, V114, P191, DOI 10.1111/j.1600-0722.2006.00356.x; van der Bilt A, 2010, J ORAL REHABIL, V37, P79, DOI 10.1111/j.1365-2842.2009.02040.x; van der Bilt A, 2010, CLIN ORAL IMPLAN RES, V21, P1209, DOI 10.1111/j.1600-0501.2010.01915.x; van Kampen FMC, 2004, J DENT RES, V83, P708, DOI 10.1177/154405910408300910; Weijenberg RAF, 2011, NEUROSCI BIOBEHAV R, V35, P483, DOI 10.1016/j.neubiorev.2010.06.002; Wostmann B, 2008, J DENT, V36, P816, DOI 10.1016/j.jdent.2008.05.017; Wostmann B, 2011, J DENT RES, V90, P1598	67	1	1	0	17	QUINTESSENZ VERLAGS-GMBH	BERLIN	IFENPFAD 2-4, BERLIN, 12107, GERMANY	0943-9692			IMPLANTOLOGIE	Implantologie	MAR	2012	20	1					55	62					8	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	944DD	WOS:000304177700006					2022-03-04	
J	Katsoulis, J; Richter, M				Katsoulis, J.; Richter, M.			Efficiency of specific physiotherapy for temporomandibular joint dysfunction of muscular origin	REVUE DE STOMATOLOGIE ET DE CHIRURGIE MAXILLO-FACIALE			French	Article						temporomandibular joint dysfunction syndrome; physical therapy modalities; self-care; occlusal	PHYSICAL-THERAPY; PAIN; DISORDERS	Introduction. Little explanation is given to patients with tempor-omandibular disorders and muscles dysfunction on the mechanism and the expected results of conservative treatment. The purpose of this prospective study was to evaluate the efficacy of specific physical therapy prescribed after this explanation was given and also after using a flat occlusal splint adapted only if muscle pain remained after physical therapy. Material and method. Twenty-seven patients with temporomandibular joint dysfunction of muscular origin were evaluated after a mean of six sessions of specialized physical therapy with professionals. Patients were treated by oral and facial massages and were trained for self-reeducation. They were also trained for a specific exercise named the "propulsive/opening maneuver". Every patient was questioned on the subjective evolution of pain and the current maximal pain was evaluated with the Visual Analogical Scale (VAS). Clinical evaluation focused on tenderness of masticator muscles and also assessed the changes in the amplitude of mouth opening. Results. Ninety-three percent of the patients treated by specific physical therapy had a significant reduction of their maximal pain feeling (p < 0.05). The recovery of an optimal mouth opening without deviation was also improved as was the protrusion. For 33% of the patients a flat nighttime occlusal splint was necessary as a complementary treatment. Twenty-two percent of the patients decided to change their treatment for alternative therapies (osteopathy, acupuncture, etc.). Fifty percent of the patients were convinced of the efficacy of the prescribed treatment. Discussion. Patients who undertake the specific physical therapy and who regularly practice self-physical therapy succeed in relaxing their masticator muscles and in decreasing the level of pain. Explanations given by the doctor concerning the etiology of pain, during temporomandibular joint dysfunction of muscular origin, and the purpose of specific physical therapy increase the capacity of self-relaxation. A flat occlusal splint is indicated for patients who grind their teeth and for those whose pain resists to physical therapy. (C) 2008 Elsevier Masson SAS. All rights reserved.	[Katsoulis, J.; Richter, M.] Hop Univ Geneve, Serv Chirurg Maxillofaciale & Chirurg Buccale, Dept Chirurg, CH-1211 Geneva 14, Switzerland		Richter, M (corresponding author), Hop Univ Geneve, Serv Chirurg Maxillofaciale & Chirurg Buccale, Dept Chirurg, 24 Rue Micheli Crest, CH-1211 Geneva 14, Switzerland.	michel.richter@hcuge.ch					Conti PCR, 2001, J ORAL REHABIL, V28, P534, DOI 10.1046/j.1365-2842.2001.00727.x; Cros P, 1976, Rev Stomatol Chir Maxillofac, V77, P237; De Laat A, 2003, J OROFAC PAIN, V17, P42; de Leeuw R, 2005, ORAL SURG ORAL MED O, V99, P168, DOI 10.1016/j.tripleo.2004.03.001; Delaire J, 1975, Rev Stomatol Chir Maxillofac, V76, P331; Delcanho RE, 1996, ARCH ORAL BIOL, V41, P585, DOI 10.1016/0003-9969(96)00009-X; Feine JS, 1997, PAIN, V71, P5, DOI 10.1016/S0304-3959(96)03287-3; Geering A H, 1978, SSO Schweiz Monatsschr Zahnheilkd, V88, P32; Gola R., 1995, Revue de Stomatologie et de Chirurgie Maxillo-Faciale, V96, P177; Kopp S, 2001, J OROFAC PAIN, V15, P9; Manfredini D, 2003, MINERVA STOMATOL, V52, P327, DOI DOI 10.1136/BMJ.H444; Stohler CS, 1997, ORAL SURG ORAL MED O, V83, P77, DOI 10.1016/S1079-2104(97)90095-0	12	6	10	0	8	ELSEVIER	BRIDGEWATER	685 ROUTE 202-206, BRIDGEWATER, NJ 08807 USA	0035-1768			REV STOMATOL CHIR	Rev. Stomatol. Chir. Maxillo-Facil.	FEB	2008	109	1					9	14		10.1016/j.stomax.2007.08.007			6	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	288AO	WOS:000254958800004	18082232				2022-03-04	
J	Dojcinovic, I; Hugentobler, M; Richter, M				Dojcinovic, I.; Hugentobler, M.; Richter, M.			Needle breakage: a rare and potentially dangerous complication during local anaesthesia	REVUE DE STOMATOLOGIE DE CHIRURGIE MAXILLO-FACIALE ET DE CHIRURGIE ORALE			French	Article						mandible nerve; local anesthesia; complications	PTERYGOMANDIBULAR SPACE; BROKEN NEEDLE	Introduction. Needle breakage is a rare complication during local oral anesthesia administration. The authors describe the surgical procedure used to remove a broken dental needle and how to prevent this complication. Case report. The authors present the case of a 52-year-old man who was referred by his general dental practitioner for needle breakage during an inferior alveolar nerve block. Surgical management involved localizing the broken needle using radioscopy and removing it under general atomax00041nesthesia. Discussion. Today, needle breakage during local anesthesia is mainly attributed to an incorrect anesthetic injection technique. The prevention, investigation, and management of such complication are discussed. (c) 2007 Elsevier Masson SAS. All rights reserved.	[Dojcinovic, I.; Hugentobler, M.; Richter, M.] Hop Cantonal Geneva, Dept Chirurg, Serv Chirurg Maxillofaciale & Chirurg Buccale, CH-1211 Geneva, Switzerland		Dojcinovic, I (corresponding author), Hop Cantonal Geneva, Dept Chirurg, Serv Chirurg Maxillofaciale & Chirurg Buccale, 24 Rue Micheli du Crest, CH-1211 Geneva, Switzerland.	ivan.dojcinovic@hcuge.ch					Bedrock RD, 1999, J AM DENT ASSOC, V130, P685, DOI 10.14219/jada.archive.1999.0278; Brown LJ, 1963, J DENT ASS S AFR, V18, P74; FRASERMOODIE W, 1958, BR DENT J, V105, P79; FULLER NP, 1979, J AM DENT ASSOC, V99, P822, DOI 10.14219/jada.archive.1979.0384; MARKS RB, 1984, J AM DENT ASSOC, V109, P263, DOI 10.14219/jada.archive.1984.0355; van der Bijl P, 1995, Compend Contin Educ Dent, V16, P1116; VANDERBIJL P, 1995, COMPEND CONTIN ED DE, V16, P1116; VANDERBIJL P, 1995, COMPEND CONTIN ED DE, V16, P1110; VANDERBIJL P, 1995, COMPEND CONTIN ED DE, V16, P1112; Zeltser Rephael, 2002, Pediatr Dent, V24, P153	10	6	7	0	1	ELSEVIER	BRIDGEWATER	685 ROUTE 202-206, BRIDGEWATER, NJ 08807 USA	2213-6533			REV STOMATOL CHIR	Rev. Stomatol. Chir. Maxillo-Facil.	JUN	2007	108	3					222	224		10.1016/j.stomax.2006.10.005			3	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	283BZ	WOS:000254612900011	17400265				2022-03-04	
J	Bader, C; Krejci, I				Bader, Carl; Krejci, Ivo			Marginal quality in enamel and dentin after preparation and finishing with an Er : YAG laser	AMERICAN JOURNAL OF DENTISTRY			English	Article							RESIN COMPOSITE RESTORATIONS; CLASS-V RESTORATIONS; ETCH-AND-RINSE; IN-VITRO; BOND STRENGTH; AIR-ABRASION; ASSESSING MICROLEAKAGE; IRRADIATED SURFACE; CAVITY PREPARATION; SELF-ETCH	Purpose: To find the most appropriate Er:YAG laser parameters for an optimal marginal adaptation of Class V restorations in enamel and dentin. Methods: Six saucer-shaped mixed Class V cavities were prepared in each of the eight experimental groups with an Erbium:YAG hard laser (Opus Duo) on extracted human molars in near contact mode with a conical 800 mu m sapphire tip under continuous water spray by using different pulse energy and pps (pulse per second) parameters. The cavities were restored under the simulation of dentin fluid with Clearfil SE Bond and Clearfil APX PLT composite applied in two layers and light-cured. Marginal adaptation in enamel and dentin was quantified before and after simultaneous thermal (5-50-5 degrees C, 2 minutes each) and mechanical (max. 49N; 1,200,000 cycles) stresses by using the replica technique in a SEM under x200 magnification. Results: With the exception of dentin margins before loading, significant differences for percentages of "continuous margin" and "enamel fractures" were detected before and after loading (P< 0.05, ANOVA, Student's t-test). A pulse energy of 100 mJ both on dentin and enamel was found optimal for finishing and smoothing the preparation margins after cavity preparation with 500 mJ or more.	Univ Geneva, Div Cariol & Endodontol, Sch Dent, CH-1205 Geneva, Switzerland		Krejci, I (corresponding author), Univ Geneva, Div Cariol & Endodontol, Sch Dent, Rue Barthelemy Menn 19, CH-1205 Geneva, Switzerland.	ivo.krejci@medecine.unige.ch					Araujo RM, 2001, J CLIN LASER MED SUR, V19, P325, DOI 10.1089/104454701753342785; ARCURI MR, 1993, J PROSTHET DENT, V69, P483, DOI 10.1016/0022-3913(93)90157-J; Armengol V, 2002, LASER MED SCI, V17, P93, DOI 10.1007/s101030200016; Bedran-De-Castro AKB, 2004, AM J DENT, V17, P337; Borsatto MC, 2001, J CLIN LASER MED SUR, V19, P83, DOI 10.1089/104454701750285403; BORTHOLOTTO T, 2005, DENT S AFRICA, V7, P446; BRAEM M, 1994, J DENT, V22, P97, DOI 10.1016/0300-5712(94)90010-8; BURKES EJ, 1992, J PROSTHET DENT, V67, P847, DOI 10.1016/0022-3913(92)90599-6; Burnett LH, 2001, J CLIN LASER MED SUR, V19, P199, DOI 10.1089/104454701316918970; Ceballos L, 2002, J DENT RES, V81, P119, DOI 10.1177/154405910208100207; Ceballos L, 2001, AM J DENT, V14, P46; Ceballos L, 2001, DENT MATER, V17, P340, DOI 10.1016/S0109-5641(00)00092-0; Corona SAM, 2003, J ORAL REHABIL, V30, P1008, DOI 10.1046/j.1365-2842.2003.01173.x; Corona SAM, 2001, OPER DENT, V26, P491; Cozean C, 1997, J AM DENT ASSOC, V128, P1080, DOI 10.14219/jada.archive.1997.0364; Curti M, 2004, J CLIN LASER MED SUR, V22, P119, DOI 10.1089/104454704774076172; DAVIDSON CL, 1984, J DENT RES, V63, P146, DOI 10.1177/00220345840630021001; Dibb RGP, 2002, J CLIN LASER MED SUR, V20, P129, DOI 10.1089/104454702760090209; Dostalova T, 1998, J CLIN LASER MED SUR, V16, P273, DOI 10.1089/clm.1998.16.273; Eguro T, 2002, LASER SURG MED, V30, P267, DOI 10.1002/lsm.10043; Eguro T, 2001, LASER SURG MED, V28, P365, DOI 10.1002/lsm.1063; Ferracane JL, 2003, AM J DENT, V16, P239; Frankenberger R, 2005, DENT MATER, V21, P397, DOI 10.1016/j.dental.2004.07.005; Frentzen M, 1996, Eur J Prosthodont Restor Dent, V4, P99; Gohring TN, 2003, AM J DENT, V16, P275; Groth E B, 2001, Eur J Prosthodont Restor Dent, V9, P73; HASSAN R, 1981, J DENT RES, V60, P820, DOI 10.1177/00220345810600040901; Hibst R, 2002, J ORAL LASER APPL, V2, P203; Hossain M, 2003, LASER MED SCI, V18, P25, DOI 10.1007/s10103-002-0235-5; Hossain M, 1999, J CLIN LASER MED SUR, V17, P105, DOI 10.1089/clm.1999.17.105; Kameyama A, 2000, J Adhes Dent, V2, P297; KAYANO T, 1989, Journal of the Stomatological Society Japan, V56, P381; Kohara EK, 2002, J CLIN LASER MED SUR, V20, P141, DOI 10.1089/104454702760090227; Krejci I, 1990, Schweiz Monatsschr Zahnmed, V100, P953; KREJCI I, 1993, J DENT RES, V72, P490, DOI 10.1177/00220345930720020401; KREJCI I, 1994, DENT MATER, V10, P331, DOI 10.1016/0109-5641(94)90042-6; Lupi-Pegurier Laurence, 2003, J Dent Child (Chic), V70, P134; MAITA E, 1991, ARCH ORAL BIOL, V36, P103, DOI 10.1016/0003-9969(91)90072-3; Manhart J, 2001, OPER DENT, V26, P357; Martinez-Insua A, 2000, J PROSTHET DENT, V84, P280, DOI 10.1067/mpr.2000.108600; Matson JR, 2002, J CLIN LASER MED SUR, V20, P27, DOI 10.1089/104454702753474986; Mehl A, 1997, DENT MATER, V13, P246, DOI 10.1016/S0109-5641(97)80036-X; Moll K, 2004, QUINTESSENCE INT, V35, P845; Moritz A, 1996, J Clin Laser Med Surg, V14, P133; Otsuki M, 2002, LASER SURG MED, V30, P351, DOI 10.1002/lsm.10049; PASHLEY DH, 1981, ARCH ORAL BIOL, V26, P703, DOI 10.1016/0003-9969(81)90185-0; RASMUSSEN ST, 1976, J DENT RES, V55, P154, DOI 10.1177/00220345760550010901; Roebuck E M, 2001, Int J Paediatr Dent, V11, P49, DOI 10.1046/j.1365-263x.2001.00230.x; Setien VJ, 2001, AM J DENT, V14, P157; Spears IR, 1997, J DENT RES, V76, P1690, DOI 10.1177/00220345970760101101; STRASSL M, 2004, J ORAL LASER APPL, V4, P263; Trajtenberg CP, 2004, AM J DENT, V17, P331; Van Meerbeek B, 2003, OPER DENT, V28, P647	53	16	16	0	1	MOSHER & LINDER, INC	WESTON	318 INDIAN TRACE SUITE 500, WESTON, FL 33326 USA	0894-8275			AM J DENT	Am. J. Dent.	DEC	2006	19	6					337	342					6	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	114QY	WOS:000242681900004	17212074				2022-03-04	
J	Dudic, A; Kiliaridis, S; Mombelli, A; Giannopoulou, C				Dudic, Alexander; Kiliaridis, Stavros; Mombelli, Andrea; Giannopoulou, Catherine			Composition changes in gingival crevicular fluid during orthodontic tooth movement: comparisons between tension and compression sides	EUROPEAN JOURNAL OF ORAL SCIENCES			English	Article						children; crevicular fluid; orthodontic movement	NECROSIS-FACTOR-ALPHA; LACTATE-DEHYDROGENASE ACTIVITY; PERIODONTAL-LIGAMENT; ALKALINE-PHOSPHATASE; PROSTAGLANDIN E-2; INTERLEUKIN-1-BETA; SMOKING; FORCE; BETA	The aim of this study was to evaluate whether the application of tension or compression forces exerted on the periodontium during the early phase of orthodontic tooth movement is reflected by differences in the composition of the gingival crevicular fluid (GCF), at the level of interleukin-1 beta (IL-1 beta), substance P (SP), and prostaglandin E-2 (PGE(2)). Eighteen children (mean age 10.8 yr) starting orthodontic treatment were included in the study. Molar elastic separators were inserted mesially to two first upper or lower molars. One of the antagonist molars served as the control. GCF was collected from the mesial and distal sites of each molar, before (-7 d, 0 d) and immediately after (1 min, 1 h, 1 d, and 7 d) the placement of separators. The levels of IL-1 beta, SP, and PGE(2) were determined by enzme-linked immunosorbent assay. At the orthodontically moved teeth, the GCF levels of IL-1 beta, SP, and PGE(2) were significantly higher than at the control teeth in both tension and compression sides, and at almost all occasions after insertion of separators. The increase, relative to baseline values, was generally higher in tension sides. For the control teeth, the three mediators remained at baseline levels throughout the experiment. The results suggest that IL-1 beta, SP, and PGE(2) levels in the GCF reflect the biologic activity in the periodontium during orthodontic tooth movement.	Univ Geneva, Sch Dent Med, Dept Periodont, CH-1205 Geneva, Switzerland; Univ Geneva, Dept Orthodont, CH-1205 Geneva, Switzerland		Giannopoulou, C (corresponding author), Univ Geneva, Sch Dent Med, Dept Periodont, Rue Barthelemy Menn 19, CH-1205 Geneva, Switzerland.	Ekaterini.Giannopoulou@medecine.unige.ch					Apajalahti S, 2003, J DENT RES, V82, P1018, DOI 10.1177/154405910308201216; Baldwin PD, 1999, EUR J ORTHODONT, V21, P481, DOI 10.1093/ejo/21.5.481; Bourauel C, 2000, J Orofac Orthop, V61, P266, DOI 10.1007/s000560050012; Champagne CME, 2003, PERIODONTOL 2000, V31, P167, DOI 10.1034/j.1600-0757.2003.03110.x; DAVIDOVITCH Z, 1988, DENT CLIN N AM, V32, P411; Giannopoulou C, 2003, J CLIN PERIODONTOL, V30, P996, DOI 10.1034/j.1600-051X.2003.00416.x; Giannopoulou C, 2003, J CLIN PERIODONTOL, V30, P145, DOI 10.1034/j.1600-051X.2003.300201.x; Giannopoulou C, 2006, J PAIN, V7, P367, DOI 10.1016/j.jpain.2005.12.008; Gonzales JR, 2001, J CLIN PERIODONTOL, V28, P544, DOI 10.1034/j.1600-051x.2001.028006544.x; GRIEVE WG, 1994, AM J ORTHOD DENTOFAC, V105, P369, DOI 10.1016/S0889-5406(94)70131-8; HEASMAN PA, 1993, J PERIODONTAL RES, V28, P241, DOI 10.1111/j.1600-0765.1993.tb02090.x; Hill P A, 1998, Br J Orthod, V25, P101; Hofbauer LC, 1999, BONE, V25, P255, DOI 10.1016/S8756-3282(99)00162-3; HUSER MC, 1990, AM J ORTHOD DENTOFAC, V97, P213, DOI 10.1016/S0889-5406(05)80054-X; Kavadia-Tsatala Smaro, 2002, Int J Adult Orthodon Orthognath Surg, V17, P191; Kawarizadeh A, 2005, J DENT RES, V84, P902, DOI 10.1177/154405910508401006; Kawarizadeh A, 2003, EUR J ORTHODONT, V25, P569, DOI 10.1093/ejo/25.6.569; KINANE DF, 1992, ARCH ORAL BIOL, V37, P153, DOI 10.1016/0003-9969(92)90011-V; LAST KS, 1988, ARCH ORAL BIOL, V33, P907, DOI 10.1016/0003-9969(88)90021-0; Lee KJ, 2004, AM J ORTHOD DENTOFAC, V125, P168, DOI 10.1016/j.ajodo.2003.03.006; Lekic P, 1996, ANAT REC, V245, P327; Linden GJ, 1997, J CLIN PERIODONTOL, V24, P799; LOE H, 1967, J PERIODONTOL, V38, P610, DOI 10.1902/jop.1967.38.6.610; LUNDSTROM A, 1980, EUR J ORTHODONT, V2, P65, DOI 10.1093/ejo/2.2.65; LUNDSTROM F, 1980, SCAND J DENT RES, V88, P53; Lundy FT, 2004, CRIT REV ORAL BIOL M, V15, P82, DOI 10.1177/154411130401500203; NAKASHIMA K, 1994, J CLIN PERIODONTOL, V21, P327, DOI 10.1111/j.1600-051X.1994.tb00721.x; Perinetti G, 2005, J PERIODONTOL, V76, P411, DOI 10.1902/jop.2005.76.3.411; Perinetti G, 2004, J CLIN PERIODONTOL, V31, P60, DOI 10.1111/j.0303-6979.2004.00450.x; Sallum EJ, 2004, AM J ORTHOD DENTOFAC, V126, P363, DOI 10.1016/j.ajodo.2004.04.017; SAMUELS RHA, 1993, J CLIN PERIODONTOL, V20, P371, DOI 10.1111/j.1600-051X.1993.tb00375.x; SANDY JR, 1993, AM J ORTHOD DENTOFAC, V103, P212, DOI 10.1016/0889-5406(93)70002-6; Serra E, 2003, AM J ORTHOD DENTOFAC, V124, P206, DOI 10.1016/S0889-5406(03)00407-4; SILNESS J, 1964, Acta Odontol Scand, V22, P121, DOI 10.3109/00016356408993968; STYLIANOU E, 1988, INT J BIOCHEM CELL B, V30, P1075; Tsai CC, 1998, J DENT, V26, P97, DOI 10.1016/S0300-5712(96)00084-X; Tzannetou S, 1999, AM J ORTHOD DENTOFAC, V115, P686, DOI 10.1016/S0889-5406(99)70295-7; Uematsu S, 1996, J DENT RES, V75, P562, DOI 10.1177/00220345960750010801; Voller A., 1976, HDB CLIN IMMUNOLOGY, P506	39	47	47	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0909-8836	1600-0722		EUR J ORAL SCI	Eur. J. Oral Sci.	OCT	2006	114	5					416	422		10.1111/j.1600-0722.2006.00387.x			7	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	091MW	WOS:000241034000009	17026508				2022-03-04	
J	Mombelli, A				Mombelli, A			Periodontitis as an infectious disease: specific features and their implications	ORAL DISEASES			English	Article; Proceedings Paper	Workshop on Antimicrobial Agents in Periodontal Prevention, Therapy and Maintenance	DEC 06, 2002	LYON, FRANCE			periodontitis; infection; biofilm; antimicrobial therapy	LOCALIZED JUVENILE PERIODONTITIS; GRAM-NEGATIVE BACTERIA; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; PORPHYROMONAS-GINGIVALIS; BACTEROIDES-INTERMEDIUS; ADULT PERIODONTITIS; MICROBIOLOGICAL EVALUATION; TOPOGRAPHIC DISTRIBUTION; SUBGINGIVAL MICROBIOTA; SYSTEMIC TETRACYCLINE	Periodontitis may be viewed as an infectious disease with a number of specific characteristics. Pathogens of the subgingival microbiota can interact with host tissues even without direct tissue penetration. Hence, antimicrobial agents must be available at a sufficiently high concentration not only within the periodontal tissues, but also outside, in the environment of the periodontal pocket. The subgingival microbiota accumulate on the root surface to form an adherent layer of plaque with the characteristics of a biofilm. Several mechanisms, such as diffusion barriers, and selective inactivation of agents lead to an increased resistance of bacteria in biofilms. Mechanical supragingival plaque control is indispensable to prevent the re-emergence of periodontal pathogens and the re-establishment of a biofilm in treated sites. Since specific features have important implications for the use of antimicrobial agents in periodontal therapy, extrapolations from experiences made in the therapy of other infections are only partially valid. The ultimate evidence for the efficacy of systemic or local chemotherapy must be obtained from treatment studies in humans with adequate follow-up.	Univ Geneva, Sch Dent Med, CH-1205 Geneva, Switzerland		Mombelli, A (corresponding author), Univ Geneva, Sch Dent Med, 19 Rue Barthelemy Menn, CH-1205 Geneva, Switzerland.						ALLENSPACHPETRZILKA GE, 1983, J CLIN PERIODONTOL, V10, P609, DOI 10.1111/j.1600-051X.1983.tb01299.x; ANWAR H, 1990, ANTIMICROB AGENTS CH, V34, P2043, DOI 10.1128/AAC.34.11.2043; ANWAR H, 1992, ANTIMICROB AGENTS CH, V36, P1347, DOI 10.1128/AAC.36.7.1347; BRAGD L, 1987, J CLIN PERIODONTOL, V14, P95, DOI 10.1111/j.1600-051X.1987.tb00949.x; CARRANZA FA, 1983, J PERIODONTOL, V54, P598, DOI 10.1902/jop.1983.54.10.598; CHRISTERSSON LA, 1985, J CLIN PERIODONTOL, V12, P465, DOI 10.1111/j.1600-051X.1985.tb01382.x; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Dahlen G, 1996, J PERIODONTOL, V67, P879, DOI 10.1902/jop.1996.67.9.879; EAKLE WS, 1986, J CLIN PERIODONTOL, V13, P39, DOI 10.1111/j.1600-051X.1986.tb01412.x; FINE DH, 1994, J CLIN PERIODONTOL, V21, P98, DOI 10.1111/j.1600-051X.1994.tb00286.x; Fives-Taylor PM, 1999, PERIODONTOL 2000, V20, P136, DOI 10.1111/j.1600-0757.1999.tb00161.x; GOODSON JM, 1989, J DENT RES, V68, P1625; HAFFAJEE AD, 1988, J CLIN PERIODONTOL, V15, P255, DOI 10.1111/j.1600-051X.1988.tb01579.x; Holt SC, 1999, PERIODONTOL 2000, V20, P168, DOI 10.1111/j.1600-0757.1999.tb00162.x; KORNMAN KS, 1994, J PERIODONTOL, V65, P848, DOI 10.1902/jop.1994.65.9.848; KORNMAN KS, 1985, J PERIODONTOL, V56, P443, DOI 10.1902/jop.1985.56.8.443; LISTGARTEN MA, 1965, J PERIODONTOL, V36, P328, DOI 10.1902/jop.1965.36.4.328; LISTGARTEN MA, 1973, J PERIODONTOL, V44, P85, DOI 10.1902/jop.1973.44.2.85; LOE H, 1965, J PERIODONTOL, V36, P177, DOI 10.1902/jop.1965.36.3.177; MAGNUSSON I, 1984, J CLIN PERIODONTOL, V11, P193, DOI 10.1111/j.1600-051X.1984.tb01323.x; MCNABB H, 1992, ORAL MICROBIOL IMMUN, V7, P267, DOI 10.1111/j.1399-302X.1992.tb00586.x; MOMBELLI A, 1991, J PERIODONTAL RES, V26, P301, DOI 10.1111/j.1600-0765.1991.tb02067.x; MOMBELLI A, 1994, J PERIODONTOL, V65, P827, DOI 10.1902/jop.1994.65.9.827; MOMBELLI A, 1994, J PERIODONTOL, V65, P820, DOI 10.1902/jop.1994.65.9.820; Mombelli A, 1997, J CLIN PERIODONTOL, V24, P470, DOI 10.1111/j.1600-051X.1997.tb00214.x; MOMBELLI A, 1991, J PERIODONTAL RES, V26, P308, DOI 10.1111/j.1600-0765.1991.tb02068.x; Mombelli A, 2002, J CLIN PERIODONTOL, V29, P743, DOI 10.1034/j.1600-051X.2002.290811.x; Mombelli A, 2000, J PERIODONTOL, V71, P14, DOI 10.1902/jop.2000.71.1.14; Mombelli A, 1998, ORAL MICROBIOL IMMUN, V13, P231, DOI 10.1111/j.1399-302X.1998.tb00701.x; Mombelli A, 1999, J CLIN PERIODONTOL, V26, P505, DOI 10.1034/j.1600-051X.1999.260803.x; MULLER HP, 1995, J CLIN PERIODONTOL, V22, P413, DOI 10.1111/j.1600-051X.1995.tb00169.x; MULLER HP, 1993, J CLIN PERIODONTOL, V20, P498, DOI 10.1111/j.1600-051X.1993.tb00397.x; Noyan U, 1997, J CLIN PERIODONTOL, V24, P158, DOI 10.1111/j.1600-051X.1997.tb00485.x; NYMAN S, 1977, J CLIN PERIODONTOL, V4, P240, DOI 10.1111/j.1600-051X.1977.tb01896.x; OOSTERWAAL PJM, 1990, J CLIN PERIODONTOL, V17, P613, DOI 10.1111/j.1600-051X.1990.tb01681.x; PAQUETTE D, 1994, J DENT RES, V73, P305; PAVICIC MJAMP, 1994, J CLIN PERIODONTOL, V21, P107, DOI 10.1111/j.1600-051X.1994.tb00287.x; PITCHER GR, 1980, J CLIN PERIODONTOL, V7, P300, DOI 10.1111/j.1600-051X.1980.tb01972.x; Rams TE, 1996, J CLIN PERIODONTOL, V23, P346, DOI 10.1111/j.1600-051X.1996.tb00556.x; RODENBURG JP, 1990, J CLIN PERIODONTOL, V17, P392, DOI 10.1111/j.1600-051X.1990.tb00036.x; Rooney J, 2002, J CLIN PERIODONTOL, V29, P342, DOI 10.1034/j.1600-051X.2002.290410.x; ROSLING B, 1976, Journal of Clinical Periodontology, V3, P233, DOI 10.1111/j.1600-051X.1976.tb00042.x; ROVIN SHELDON, 1966, J PERIODONTAL RES, V1, P193, DOI 10.1111/j.1600-0765.1966.tb01860.x; SAGLIE FR, 1982, J PERIODONTAL RES, V17, P452, DOI 10.1111/j.1600-0765.1982.tb02024.x; SAGLIE R, 1982, J PERIODONTOL, V53, P217, DOI 10.1902/jop.1982.53.4.217; SLOTS J, 1983, J CLIN PERIODONTOL, V10, P465, DOI 10.1111/j.1600-051X.1983.tb02179.x; SLOTS J, 1988, J CLIN PERIODONTOL, V15, P85, DOI 10.1111/j.1600-051X.1988.tb00999.x; SLOTS J, 1986, J CLIN PERIODONTOL, V13, P570, DOI 10.1111/j.1600-051X.1986.tb00849.x; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Stoller NH, 1998, J PERIODONTOL, V69, P1085, DOI 10.1902/jop.1998.69.10.1085; STOLTZE K, 1995, J CLIN PERIODONTOL, V22, P185; THEILADE ELSE, 1966, J PERIODONTAL RES, V1, P1, DOI 10.1111/j.1600-0765.1966.tb01842.x; Van Winkelhoff A J, 1988, Oral Microbiol Immunol, V3, P83; VANDERVELDEN U, 1997, CLIN PERIODONTOLOGY, P794; VanWinkelhoff AJ, 1996, PERIODONTOL 2000, V10, P45; VERNIMOULIN P, 1995, J DENT RES, V74, P481; Wennstrom J L, 1987, Oral Microbiol Immunol, V2, P158, DOI 10.1111/j.1399-302X.1987.tb00300.x; ZAMBON JJ, 1981, INFECT IMMUN, V32, P198, DOI 10.1128/IAI.32.1.198-203.1981	58	22	29	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1354-523X	1601-0825		ORAL DIS	Oral Dis.	JUN	2003	9			1			6	10		10.1034/j.1601-0825.9.s1.2.x			5	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Dentistry, Oral Surgery & Medicine	683PP	WOS:000183158300002	12974524				2022-03-04	
J	Ardiet, DL; Graz, B; Szeless, T; Mauris, A; Falquet, J; Doumbo, OK; Dolo, A; Guindo, O; Sissoko, MS; Konare, M; Motamed, S; Rougemont, AC				Ardiet, Denis-Luc; Graz, Bertrand; Szeless, Thomas; Mauris, Anne; Falquet, Jacques; Doumbo, Ogobara K.; Dolo, Amagana; Guindo, Ousmane; Sissoko, Mahamadou S.; Konare, Moussa; Motamed, Sandrine; Rougemont, Andre C.			Patterns of malaria indices across three consecutive seasons in children in a highly endemic area of West Africa: a three times-repeated cross-sectional study	MALARIA JOURNAL			English	Article						Plasmodium infection; Malaria disease; Season; Endemicity; Malaria indices; Epidemics; Epidemiology; Diagnosis	PARASITE DENSITY; FALCIPARUM-MALARIA; CASE DEFINITIONS; YOUNG-CHILDREN; RURAL AREA; ANEMIA; TRANSMISSION; DYNAMICS; MALI; EPIDEMIOLOGY	Objectives: To study the manifestations of Plasmodium infection, and its relations with the malaria disease, especially when comparing dry and rainy seasons in a hyperendemic area of West Africa. Methods: The study was carried out in an area where malaria transmission is high, showing important seasonal variations. One thousand children, representing the total child population (1-12 year old), were observed transversally at the end of three consecutive seasons (dry/rainy/dry). The usual indicators, such as parasite density, splenomegaly, anaemia, or febrile disease were recorded and analysed. Results: The prevalence of Plasmodium falciparum was high in all age groups and seasons, constantly around 60%. The high transmission season (rainy) showed higher rates of anaemia and spleen enlargement and, in the youngest children only, higher parasite densities. There were also differences between the two dry seasons: in the first one, there was a higher rate of fever than in the second one (p < 0.001). Low parasite density (< 2,000 p/mu l) was never associated with fever during any season, raising some concern with regard to the usefulness of parasite detection. The possible origins of fever are discussed, together with the potential usefulness of analyzing these indices on a population sample, at a time when fever incidence rises and malaria is one potential cause among others. The distinction to be made between the Plasmodium infection and the malaria disease is highlighted. Conclusions: These data confirm previous hypotheses of a strong difference in malaria infection and disease between dry and rainy seasons. The most relevant seasonal indicator was not mainly parasite rate and density but anaemia, spleen enlargement, prevalence and possible origin of fever. Recommendations: In any situation (i.e. fever or not) and especially during the dry season, one must consider that detection of parasites in the blood is only evidence of a Plasmodium infection and not necessarily of a malaria disease. In such a situation, it seems suitable to obtain, through national malaria teams, a well-defined situation of transmission and prevalence of Plasmodium infection following zones and seasons, in order to adapt control strategies. For researchers, a systematic management of data separately for dry and rainy season appears mandatory.	[Graz, Bertrand; Szeless, Thomas; Mauris, Anne; Motamed, Sandrine; Rougemont, Andre C.] CMU, Inst Sante Globale, IMSP Inst Med Sociale & Prevent, CH-1211 Geneva, Switzerland; [Ardiet, Denis-Luc; Graz, Bertrand; Falquet, Jacques; Rougemont, Andre C.] Community Hlth Geneva, Assoc Mali Geneve, CH-1206 Geneva, Switzerland; [Doumbo, Ogobara K.; Dolo, Amagana; Guindo, Ousmane; Sissoko, Mahamadou S.; Konare, Moussa] Univ Sci Tech & Technol, Fac Med Pharm & Odontostomatol, Malaria Res & Training Ctr, Bamako, Mali		Rougemont, AC (corresponding author), CMU, Inst Sante Globale, IMSP Inst Med Sociale & Prevent, Rue Michel Servet 1, CH-1211 Geneva, Switzerland.	Andre.Rougemont@unige.ch					Berkley JA, 2005, BMJ-BRIT MED J, V330, P995, DOI 10.1136/bmj.38408.471991.8F; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bloland PB, 1999, AM J TROP MED HYG, V60, P635, DOI 10.4269/ajtmh.1999.60.635; Boisier P, 2002, AM J TROP MED HYG, V67, P137, DOI 10.4269/ajtmh.2002.67.137; Bouvier P, 1997, AM J EPIDEMIOL, V145, P850, DOI 10.1093/oxfordjournals.aje.a009179; Breman JG, 2001, AM J TROP MED HYG, V64, P1; Cornet M, 1998, AM J TROP MED HYG, V58, P606, DOI 10.4269/ajtmh.1998.58.606; COX MJ, 1994, T ROY SOC TROP MED H, V88, P191, DOI 10.1016/0035-9203(94)90292-5; DAVIS TME, 1990, J CLIN INVEST, V86, P793, DOI 10.1172/JCI114776; Delley V, 2000, TROP MED INT HEALTH, V5, P404, DOI 10.1046/j.1365-3156.2000.00566.x; Dicko A, 2005, TROP MED INT HEALTH, V10, P550, DOI 10.1111/j.1365-3156.2005.01418.x; Ehrhardt S, 2006, J INFECT DIS, V194, P108, DOI 10.1086/504688; Ekvall Hakan, 2001, American Journal of Tropical Medicine and Hygiene, V64, P58; Farnert A, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-241; Graz B, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-136; GREENWOOD BM, 1987, T ROY SOC TROP MED H, V81, P478, DOI 10.1016/0035-9203(87)90170-2; Guyatt HL, 2001, AM J TROP MED HYG, V64, P36, DOI 10.4269/ajtmh.2001.64.36; Koram KA, 2000, AM J TROP MED HYG, V62, P670, DOI 10.4269/ajtmh.2000.62.670; Korenromp EL, 2004, TROP MED INT HEALTH, V9, P1050, DOI 10.1111/j.1365-3156.2004.01317.x; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; MORET AL, 1989, ACCES FIEVRE PALUDIS; Mwangi TW, 2005, J INFECT DIS, V191, P1932, DOI 10.1086/430006; Ouedraogo A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050036; Perneger TV, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-81; Price RN, 2001, AM J TROP MED HYG, V65, P614, DOI 10.4269/ajtmh.2001.65.614; Righetti AA, 2013, J INFECT DIS, V207, P1604, DOI 10.1093/infdis/jit066; Roucher C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046188; ROUGEMONT A, 1991, LANCET, V338, P1292, DOI 10.1016/0140-6736(91)92592-P; Rougemont A, 2000, LANCET, V356, P251, DOI 10.1016/S0140-6736(05)74501-3; ROUGEMONT A, 1977, B SOC PATHOL EXOT, V70, P265; SMITH T, 1994, STAT MED, V13, P2345, DOI 10.1002/sim.4780132206; Vinnemeier CD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036678; Willcox ML, 2009, ANN TROP MED PARASIT, V103, P3, DOI 10.1179/136485909X384983	33	4	4	1	3	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	MAY 28	2014	13								199	10.1186/1475-2875-13-199			8	Infectious Diseases; Parasitology; Tropical Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Infectious Diseases; Parasitology; Tropical Medicine	AL2JH	WOS:000338951400002	24885107	gold, Green Published			2022-03-04	
J	Houstis, O; Kiliaridis, S				Houstis, Odyssia; Kiliaridis, Stavros			Gender and age differences in facial expressions	EUROPEAN JOURNAL OF ORTHODONTICS			English	Article							SOFT-TISSUE; MOVEMENT; RECONSTRUCTION; SHAPE; FACE; LIP; SEX	It was evident that the ability to produce certain facial expressions differs between groups of individuals due to gender and age. Males had a greater upward vertical movement capacity in the studied facial expressions than females. Females had a more pronounced horizontal component in the posed smile. There was a trend from childhood to adulthood showing an increase in the percentage change in most vertical movements. This trend was present in both genders, though more pronounced in males. Using a robust quantitative method for collecting and analysing facial expressions, gender differences in adults were detected as well as differences between adults and children. The trend toward increasing vertical movements in adults compared with children suggests the possibility that the mimic musculature is developmentally regulated.	[Houstis, Odyssia] Univ Geneva, Dept Orthodont, Sch Dent, CH-1205 Geneva, Switzerland		Houstis, O (corresponding author), Univ Geneva, Dept Orthodont, Sch Dent, 19 Rue Barthelemy Menn, CH-1205 Geneva, Switzerland.	odyssia@gmail.com					BJORKQVIST K, 1994, SEX ROLES, V30, P177, DOI 10.1007/BF01420988; BRAND RW, 1998, ANATOMY OROFACIAL ST; Darrah Johanna, 2007, Phys Occup Ther Pediatr, V27, P5, DOI 10.1300/J006v27n03_02; Dulguerov P, 2003, ARCH OTOLARYNGOL, V129, P960, DOI 10.1001/archotol.129.9.960; EKMAN P, 1991, J NONVERBAL BEHAV, V15, P125, DOI 10.1007/BF00998267; FREY M, 1994, PLAST RECONSTR SURG, V93, P1334, DOI 10.1097/00006534-199406000-00002; Friesen E, 1978, MANUAL FACIAL ACTION, V3; HOUSTON WJB, 1983, AM J ORTHOD DENTOFAC, V83, P382, DOI 10.1016/0002-9416(83)90322-6; Johnston DJ, 2003, CLEFT PALATE-CRAN J, V40, P291, DOI 10.1597/1545-1569(2003)040<0291:AFER>2.0.CO;2; Miyakawa T, 2006, J ORAL REHABIL, V33, P202, DOI 10.1111/j.1365-2842.2005.01548.x; Neiva F C, 1996, Int J Orofacial Myology, V22, P8; OTTO E, 1998, PSYCHOL REP, V83, P907; PALETZ JL, 1994, PLAST RECONSTR SURG, V93, P784, DOI 10.1097/00006534-199404000-00020; Rasheed S A, 1996, J Clin Pediatr Dent, V20, P305; Santrock J.W ., 1999, LIFE SPAN DEV, Vseventh; Trotman CA, 2004, J ORAL MAXIL SURG, V62, P1372, DOI 10.1016/j.joms.2004.03.014; Trotman CA, 1998, CLEFT PALATE-CRAN J, V35, P16, DOI 10.1597/1545-1569(1998)035<0016:MOFSTM>2.3.CO;2; Trotman CA, 2000, PLAST RECONSTR SURG, V105, P1273, DOI 10.1097/00006534-200004040-00003; Weeden JC, 2001, ANGLE ORTHOD, V71, P132; Yamaguchi K, 2000, J ORAL REHABIL, V27, P893, DOI 10.1046/j.1365-2842.2000.00596.x	20	42	42	0	8	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0141-5387			EUR J ORTHODONT	Eur. J. Orthodont.	OCT	2009	31	5					459	466		10.1093/ejo/cjp019			8	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Dentistry, Oral Surgery & Medicine	499KB	WOS:000270217900001	19541798	Bronze, Green Published			2022-03-04	
J	Cionca, N; Giannopoulou, C; Ugolotti, G; Mombelli, A				Cionca, Norbert; Giannopoulou, Catherine; Ugolotti, Giovanni; Mombelli, Andrea			Amoxicillin and Metronidazole as an Adjunct to Full-Mouth Scaling and Root Planing of Chronic Periodontitis	JOURNAL OF PERIODONTOLOGY			English	Article						Amoxicillin; chronic periodontitis; metronidazole; root planing	ACTINOMYCETEMCOMITANS-ASSOCIATED PERIODONTITIS; GENERALIZED AGGRESSIVE PERIODONTITIS; CONTROLLED CLINICAL-TRIAL; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; ANTIBIOTIC-RESISTANCE; SYSTEMIC ANTIBIOTICS; ULTRASONIC DEBRIDEMENT; THERAPY; INFECTIONS; DISEASE	Background: It has been suggested that scaling and root planing of all pockets within a few hours and chlorhexidine treatments (full-mouth disinfection) may reduce the need for supplementary therapies. The aim of this study was to evaluate the clinical benefit of amoxicillin and metronidazole administered immediately after completion of full-mouth periodontal debridement in patients with chronic periodontitis. Methods: This was a single-center, double-masked, placebo-controlled, randomized longitudinal study of 6 months' duration. Fifty-one patients received full-mouth periodontal debridement, performed within 48 hours. Twenty-five subjects received metronidazole, 500 mg, and amoxicillin, 375 mg, three times a day for 7 days; 26 subjects received a placebo. Results: Forty-seven patients could be followed up to month 6. No differences in clinical parameters were noted before treatment. The overall mean probing depth decreased from 4.3 +/- 0.4 mm to 3.0 +/- 0.2 mm in the test group and from 4.4 +/- 0.4 mm to 3.1 +/- 0.3 mm in the control group (P=0.05, difference between groups). More importantly, test subjects had a significantly lower mean number of persisting pockets >4 mm and bleeding on probing that required further treatment (P=0.005): 6 months after full-mouth debridement plus antibiotics, only 0.4 +/- 0.8 persisting pockets were still present, whereas 3.0 4.3 persisting pockets were still present in the control group. The protective risk of the antibiotics for having more than one pocket deeper than 4 mm and bleeding on probing per subject after 6 months was 8.85. Conclusion: Systemic metronidazole and amoxicillin significantly improved the 6-month clinical outcomes of full-mouth non-surgical periodontal debridement, thus significantly reducing the need for additional therapy. J Periodontol 2009;80:364-371.	[Cionca, Norbert; Giannopoulou, Catherine; Ugolotti, Giovanni; Mombelli, Andrea] Univ Geneva, Dept Periodontol, Sch Dent Med, CH-1205 Geneva, Switzerland		Cionca, N (corresponding author), Univ Geneva, Dept Periodontol, Sch Dent Med, Rue Barthelemy Menn 19, CH-1205 Geneva, Switzerland.	norbert.cionca@unige.ch					Apatzidou DA, 2004, J CLIN PERIODONTOL, V31, P132, DOI 10.1111/j.0303-6979.2004.00461.x; Axelsson P, 2004, J CLIN PERIODONTOL, V31, P749, DOI 10.1111/j.1600-051X.2004.00563.x; Berglundh T, 1998, J CLIN PERIODONTOL, V25, P354, DOI 10.1111/j.1600-051X.1998.tb02455.x; Cortellini P, 2004, J PERIODONTOL, V75, P672, DOI 10.1902/jop.2004.75.5.672; D'Aiuto F, 2005, J DENT RES, V84, P269, DOI 10.1177/154405910508400312; D'Aiuto F, 2004, J PERIODONTAL RES, V39, P236, DOI 10.1111/j.1600-0765.2004.00731.x; Dannewitz B, 2007, AM J DENT, V20, P153; Eberhard J, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004622.pub2; Eickholz P, 2004, J PERIODONTOL, V75, P957, DOI 10.1902/jop.2004.75.7.957; Feres M, 2002, J CLIN PERIODONTOL, V29, P724, DOI 10.1034/j.1600-051X.2002.290809.x; Feres M, 1999, J CLIN PERIODONTOL, V26, P784, DOI 10.1111/j.1600-051X.1999.tb02521.x; Feres EJ, 2006, J CLIN PERIODONTOL, V33, P936, DOI 10.1111/j.1600-051X.2006.01018.x; Flemmig TF, 1998, J CLIN PERIODONTOL, V25, P380, DOI 10.1111/j.1600-051X.1998.tb02459.x; GOENE RJ, 1990, J PERIODONTOL, V61, P61, DOI 10.1902/jop.1990.61.1.61; Guerrero A, 2005, J CLIN PERIODONTOL, V32, P1096, DOI 10.1111/j.1600-051X.2005.00814.x; Haffajee AD, 2006, J CLIN PERIODONTOL, V33, P359, DOI 10.1111/j.1600-051X.2006.00916.x; Haffajee Anne D, 2003, Ann Periodontol, V8, P115, DOI 10.1902/annals.2003.8.1.115; Heitz-Mayfield LJA, 2002, J CLIN PERIODONTOL, V29, P92, DOI 10.1034/j.1600-051X.29.s3.5.x; Herrera D, 2002, J CLIN PERIODONTOL, V29, P136, DOI 10.1034/j.1600-051X.29.s3.8.x; Jervoe-Storm PM, 2006, J CLIN PERIODONTOL, V33, P209, DOI 10.1111/j.1600-051X.2005.00890.x; Kaner D, 2007, J CLIN PERIODONTOL, V34, P880, DOI 10.1111/j.1600-051X.2007.01122.x; Kaner D, 2007, J PERIODONTOL, V78, P1201, DOI 10.1902/jop.2007.060437; Koshy G, 2005, J CLIN PERIODONTOL, V32, P734, DOI 10.1111/j.1600-051X.2005.00775.x; LOE HARALD, 1963, ACTA ODONTOL SCAND, V21, P533, DOI 10.3109/00016356309011240; Mombelli A, 2006, J CLIN PERIODONTOL, V33, P661, DOI 10.1111/j.1600-051X.2006.00976.x; Noack B, 2001, J PERIODONTOL, V72, P1221, DOI 10.1902/jop.2000.72.9.1221; PAVICIC MJAMP, 1994, J CLIN PERIODONTOL, V21, P107, DOI 10.1111/j.1600-051X.1994.tb00287.x; PAVICIC MJAMP, 1992, ANTIMICROB AGENTS CH, V36, P2634, DOI 10.1128/AAC.36.12.2634; Quirynen M, 1999, J PERIODONTOL, V70, P646, DOI 10.1902/jop.1999.70.6.646; QUIRYNEN M, 1995, J DENT RES, V74, P1459, DOI 10.1177/00220345950740080501; Sedlacek MJ, 2007, ORAL MICROBIOL IMMUN, V22, P333, DOI 10.1111/j.1399-302X.2007.00366.x; Van der Weijden GA, 2002, J CLIN PERIODONTOL, V29, P55, DOI 10.1034/j.1600-051X.29.s3.3.x; van Winkelhoff AJ, 1999, J CLIN PERIODONTOL, V26, P764; VANWINKELHOFF AJ, 1989, J CLIN PERIODONTOL, V16, P128; VANWINKELHOFF AJ, 1992, J PERIODONTOL, V63, P52, DOI 10.1902/jop.1992.63.1.52; Walker CB, 1996, PERIODONTOL 2000, V10, P12, DOI 10.1111/j.1600-0757.1996.tb00066.x; Walter C, 2006, J CLIN PERIODONTOL, V33, P938, DOI 10.1111/j.1600-051X.2006.01019.x; Wennstrom JL, 2005, J CLIN PERIODONTOL, V32, P851, DOI 10.1111/j.1600-051X.2005.00776.x; Zanatta GM, 2006, J PERIODONTOL, V77, P498, DOI 10.1902/jop.2006.050154	39	121	127	1	19	AMER ACAD PERIODONTOLOGY	CHICAGO	737 NORTH MICHIGAN AVENUE, SUITE 800, CHICAGO, IL 60611-2690 USA	0022-3492	1943-3670		J PERIODONTOL	J. Periodont.	MAR	2009	80	3					364	371		10.1902/jop.2009.080540			8	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	419YX	WOS:000264256700002	19254119				2022-03-04	
J	Rocca, GT; Krejci, I				Rocca, Giovanni Tommaso; Krejci, I.			Bonded indirect restorations for posterior teeth: The luting appointment	QUINTESSENCE INTERNATIONAL			English	Article						adhesive luting; indirect restoration; resin composite	PROVISIONAL CEMENTS; CURING UNITS; COMPOSITE; STRENGTH; PORCELAIN; ENAMEL; RESIN; AGENTS; CURE	Classic bonded indirect restorations are laboratory fabricated and require 2 appointments: one for provisionalization and one for luting. This article describes the adhesive luting procedure, from try-in of the workpiece to finishing and polishing after the adhesive cementation, and it represents the second part of an updated technique for bonded inlays and onlays. The clinical sequence is described step by step with 2 cases. Particular attention is given to the adhesive treatment of the restoration and the cavity as well as the choice of the resin cement. Following the adhesive philosophy and due to improvements in materials and techniques, the simplified approach described may provide predictable luting restoration of the posterior dentition.	Univ Geneva, Sch Dent Med, Div Cariol & Endodontol, CH-1205 Geneva, Switzerland		Rocca, GT (corresponding author), Univ Geneva, Sch Dent Med, Div Cariol & Endodontol, Rue Barthelemy Menn 19, CH-1205 Geneva, Switzerland.	Giovanni.Rocca@medecine.unige.ch		Rocca, Giovanni Tommaso/0000-0002-9511-9965			AIDA M, 1995, J PROSTHET DENT, V73, P464, DOI 10.1016/S0022-3913(05)80076-9; Asmussen E, 2006, J ADHES DENT, V8, P299; Barghi N, 2000, J ORAL REHABIL, V27, P407, DOI 10.1046/j.1365-2842.2000.00508.x; Bouillaguet S, 2005, J BIOMED MATER RES B, V72B, P260, DOI 10.1002/jbm.b.30143; De Munck J, 2004, DENT MATER, V20, P963, DOI 10.1016/j.dental.2004.03.002; Ernst CP, 2004, J ADHES DENT, V6, P141; Fonseca RB, 2005, J ADHES DENT, V7, P225; Hannig C, 2003, OPER DENT, V28, P800; Hikita K, 2007, DENT MATER, V23, P71, DOI 10.1016/j.dental.2005.12.002; Kato H, 2000, J ORAL REHABIL, V27, P103, DOI 10.1046/j.1365-2842.2000.00489.x; KERN M, 1994, J PROSTHET DENT, V71, P453, DOI 10.1016/0022-3913(94)90182-1; Magne P, 2006, J PROSTHET DENT, V96, P354, DOI 10.1016/j.prosdent.2006.09.007; Monticelli F, 2006, DENT MATER, V22, P1024, DOI 10.1016/j.dental.2005.11.024; Park SH, 2004, OPER DENT, V29, P627; Paul SJ, 1997, J ORAL REHABIL, V24, P8, DOI 10.1046/j.1365-2842.1997.00484.x; Peumans M, 1999, DENT MATER, V15, P105, DOI 10.1016/S0109-5641(99)00020-2; Peutzfeldt A, 2001, OPER DENT, P153; Rocca GT, 2007, QUINTESSENCE INT, V38, P371; ROULET JF, 1995, J DENT RES, V74, P381, DOI 10.1177/00220345950740011501; Shen CY, 2004, J PROSTHET DENT, V91, P453, DOI 10.1016/j.prosdent..2004.03.007; Terry Douglas A, 2004, Pract Proced Aesthet Dent, V16, P720	21	26	27	0	3	QUINTESSENCE PUBLISHING CO INC	HANOVER PARK	4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA	0033-6572	1936-7163		QUINTESSENCE INT	Quintessence Int.	JUL-AUG	2007	38	7					543	553					11	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	188NT	WOS:000247927300002	17694210				2022-03-04	
J	Kamma, JJ; Baehni, PC				Kamma, JJ; Baehni, PC			Five-year maintenance follow-up of early-onset periodontitis patients	JOURNAL OF CLINICAL PERIODONTOLOGY			English	Article						early-onset periodontitis; aggressive periodontitis; supportive periodontal care; microbiology; periodontal pathogens; clinical attachment level	NON-SURGICAL TREATMENT; SYSTEMIC ANTIBIOTIC-THERAPY; PARTIAL-MOUTH DISINFECTION; PROBING ATTACHMENT LOSS; LONG-TERM MAINTENANCE; STAGE FULL-MOUTH; ADULT PERIODONTITIS; PLAQUE CONTROL; YOUNG-ADULTS; TOOTH LOSS	Objectives: The purpose of this study was to evaluate the clinical and microbiological status of patients with early-onset or aggressive periodontitis (EOP) who had received supportive periodontal care (SPC) every 3-6 months for a period of 5 years, following active periodontal treatment. Material & Methods: The study population consisted of 25 individuals with early-onset periodontitis. Clinical examination and recordings of probing pocket depth (PPD) and clinical attachment level (CAL) were performed at baseline prior to treatment (T0), 3 months following the termination of active periodontal treatment (T1) and annually at the SPC appointments (T2,T3,T4,T5). Microbiological samples were obtained at the 5-year SPC (T5). Subgingival plaque samples for each individual were collected from one deep pocket (>5 mm), based on pretreatment measurements, randomly selected in each quadrant. The levels of Actinobacillus actinomycetemcomitans, Bacteroides forsythus, Porphyromonas gingivalis and Treponema denticola were determined using oligonucleotide probe hybridization. Results: During the 5-year period, the mean of SPC/patient was 12.7 sessions. A significant improvement was observed in PPD, CAL, gingival bleeding index and suppuration following treatment. However, between T1 and T5, 134 sites in 20 patients deteriorated with a CAL loss ofgreater than or equal to2 mm. Out of these 134 sites showing disease progression, microbial samples were randomly obtained in 13 sites (9.7%) from 8 patients. Among other factors, smoking and stress were found to have significant predictive value on the future attachment loss. P. gingivalis, T. denticola and total bacterial load were statistically significantly higher in patients who experienced disease progression during the 5-year maintenance period. Conclusions: For most EOP patients, regular SPC was effective in maintaining clinical and microbiological improvements attained after active periodontal therapy. However, a small percentage of sites was identified as progressive in 20 patients. Variables found to be related to periodontal progression were the presence of as well as the high bacterial counts of P. gingivalis, T. denticola and total bacterial load, number of acute episodes, number of teeth lost, smoking and stress.	Univ Geneva, Sch Dent Med, Dept Prevent Dent, CH-1211 Geneva 4, Switzerland		Kamma, JJ (corresponding author), 6-8 Freattidos St, GR-18537 Piraeus, Greece.	j.kamma@periodontology.gr					AINAMO J, 1975, INT DENT J, V25, P229; Albandar JM, 1997, J PERIODONTOL, V68, P973, DOI 10.1902/jop.1997.68.10.973; American Academy of Periodontology, 1989, P WORLD WORKSH CLIN; BADERSTEN A, 1984, J CLIN PERIODONTOL, V11, P63, DOI 10.1111/j.1600-051X.1984.tb01309.x; BADERSTEN A, 1985, J CLIN PERIODONTOL, V12, P432, DOI 10.1111/j.1600-051X.1985.tb01379.x; Baehni PC, 1997, CURR OPIN PERIODONT, V4, P151; BERRY G, 1994, STAT METHODS MED RES; BRAGGER U, 1992, J CLIN PERIODONTOL, V19, P659, DOI 10.1111/j.1600-051X.1992.tb01715.x; Breivik T, 2000, EUR J ORAL SCI, V108, P115, DOI 10.1034/j.1600-0722.2000.00774.x; CLAFFEY N, 1990, J CLIN PERIODONTOL, V17, P108, DOI 10.1111/j.1600-051X.1990.tb01071.x; Cugini MA, 2000, J CLIN PERIODONTOL, V27, P30, DOI 10.1034/j.1600-051x.2000.027001030.x; DASILVA AMM, 1995, J CLIN PERIODONTOL, V22, P516; Genco R J, 1998, Ann Periodontol, V3, P288, DOI 10.1902/annals.1998.3.1.288; Genco RJ, 1999, J PERIODONTOL, V70, P711, DOI 10.1902/jop.1999.70.7.711; GLAVIND LEIF, 1967, J PERIODONTAL RES, V2, P180, DOI 10.1111/j.1600-0765.1967.tb01887.x; GOLDMAN MJ, 1986, J PERIODONTOL, V57, P347, DOI 10.1902/jop.1986.57.6.347; GRBIC JT, 1992, J PERIODONTOL, V63, P262, DOI 10.1902/jop.1992.63.4.262; GUNSOLLEY JC, 1994, J PERIODONTOL, V65, P274, DOI 10.1902/jop.1994.65.3.274; Haffajee A D, 1994, Periodontol 2000, V5, P78, DOI 10.1111/j.1600-0757.1994.tb00020.x; Haffajee AD, 1997, J CLIN PERIODONTOL, V24, P324, DOI 10.1111/j.1600-051X.1997.tb00765.x; Haffajee AD, 1998, J CLIN PERIODONTOL, V25, P346, DOI 10.1111/j.1600-051X.1998.tb02454.x; Haffajee AD, 2001, J CLIN PERIODONTOL, V28, P283, DOI 10.1034/j.1600-051x.2001.028004283.x; HIRSCHFELD L, 1978, J PERIODONTOL, V49, P225, DOI 10.1902/jop.1978.49.5.225; Kaldahl WB, 1996, J PERIODONTOL, V67, P93, DOI 10.1902/jop.1996.67.2.93; Kaldahl WB, 1996, J PERIODONTOL, V67, P103, DOI 10.1902/jop.1996.67.2.103; KAMMA JJ, 1995, J PERIODONTAL RES, V30, P66, DOI 10.1111/j.1600-0765.1995.tb01254.x; Kamma JJ, 2000, J PERIODONTOL, V71, P1862, DOI 10.1902/jop.2000.71.12.1862; Kamma JJ, 1999, J PERIODONTAL RES, V34, P25, DOI 10.1111/j.1600-0765.1999.tb02218.x; KAMMA JJ, 1999, ANALECTA PERIODONTOL, V10, P138; LANG NP, 1994, P 1 EUR WORKSH PER L; LINDHE J, 1984, J CLIN PERIODONTOL, V11, P448, DOI 10.1111/j.1600-051X.1984.tb01344.x; LINDHE J, 1984, J CLIN PERIODONTOL, V11, P504, DOI 10.1111/j.1600-051X.1984.tb00902.x; LINN MW, 1986, J CONSULT CLIN PSYCH, V54, P507, DOI 10.1037/0022-006X.54.4.507; LOESCHE WJ, 1985, J PERIODONTOL, V56, P447, DOI 10.1902/jop.1985.56.8.447; Lowenguth RA, 1995, PERIODONTOL 2000, V9, P14, DOI 10.1111/j.1600-0757.1995.tb00052.x; Machtei EE, 1997, J CLIN PERIODONTOL, V24, P102, DOI 10.1111/j.1600-051X.1997.tb00474.x; MCFALL WT, 1982, J PERIODONTOL, V53, P539, DOI 10.1902/jop.1982.53.9.539; MCFALL WT, 1989, P WORLD WORKSH CLIN; MENDOZA AR, 1991, J PERIODONTOL, V62, P731, DOI 10.1902/jop.1991.62.12.731; MOMBELLI A, 1994, J PERIODONTOL, V65, P827, DOI 10.1902/jop.1994.65.9.827; MONCLA BJ, 1990, J CLIN MICROBIOL, V28, P324, DOI 10.1128/JCM.28.2.324-327.1990; Mongardini C, 1999, J PERIODONTOL, V70, P632, DOI 10.1902/jop.1999.70.6.632; Montgomery DC., 2001, INTRO LINEAR REGRESS, V3; Mullally BH, 2000, J PERIODONTAL RES, V35, P232, DOI 10.1034/j.1600-0765.2000.035004232.x; NABERS CL, 1988, J PERIODONTOL, V59, P297, DOI 10.1902/jop.1988.59.5.297; OLEARY TJ, 1972, J PERIODONTOL, V43, P38, DOI 10.1902/jop.1972.43.1.38; Palmer RM, 1996, J CLIN PERIODONTOL, V23, P670, DOI 10.1111/j.1600-051X.1996.tb00592.x; PIHLSTROM BL, 1983, J CLIN PERIODONTOL, V10, P524, DOI 10.1111/j.1600-051X.1983.tb02182.x; Pinheiro J, 2006, MIXED EFFECTS MODELS; Quirynen M, 1999, J PERIODONTOL, V70, P646, DOI 10.1902/jop.1999.70.6.646; RAMFJORD SP, 1987, J CLIN PERIODONTOL, V14, P445, DOI 10.1111/j.1600-051X.1987.tb02249.x; Rosling B, 2001, J CLIN PERIODONTOL, V28, P241, DOI 10.1034/j.1600-051x.2001.028003241.x; Schei O., 1959, J PERIODONTOL, V30, P7; Serino G, 2001, J CLIN PERIODONTOL, V28, P910, DOI 10.1034/j.1600-051x.2001.028010910.x; Shiloah J, 1996, J PERIODONTOL, V67, P130, DOI 10.1902/jop.1996.67.2.130; SINGH S, 1977, J DENT RES, V56, pB200; Slots J, 1996, J PERIODONTOL, V67, P831; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Tonetti M S, 1999, Ann Periodontol, V4, P39, DOI 10.1902/annals.1999.4.1.39; VANOOTEGHEM R, 1987, J CLIN PERIODONTOL, V14, P226, DOI 10.1111/j.1600-051X.1987.tb00971.x; vanWinkelhoff AJ, 1997, CURR OPIN PERIODONT, V4, P35; VanWinkelhoff AJ, 1996, PERIODONTOL 2000, V10, P45; WENNSTROM A, 1986, J CLIN PERIODONTOL, V13, P869, DOI 10.1111/j.1600-051X.1986.tb02245.x; Westfelt E, 1998, J CLIN PERIODONTOL, V25, P536, DOI 10.1111/j.1600-051X.1998.tb02484.x; WESTFELT E, 1983, J CLIN PERIODONTOL, V10, P148, DOI 10.1111/j.1600-051X.1983.tb02203.x; Wilson TG, 1996, PERIODONTOL 2000, V12, P11, DOI 10.1111/j.1600-0757.1996.tb00074.x; WOOD WR, 1989, J PERIODONTOL, V60, P516, DOI 10.1902/jop.1989.60.9.516; Zambon JJ, 1996, J PERIODONTOL, V67, P1050, DOI 10.1902/jop.1996.67.10s.1050	68	61	65	0	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0303-6979	1600-051X		J CLIN PERIODONTOL	J. Clin. Periodontol.	JUN	2003	30	6					562	572		10.1034/j.1600-051X.2003.00289.x			11	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	688NR	WOS:000183442600012	12795796				2022-03-04	
J	Bonnafous, F; Krejci, I; Bortolotto, T				Bonnafous, Francois; Krejci, Ivo; Bortolotto, Tissiana			Coating of enamel and dentin with bioactive materials: Effect on adhesive interface of class V restorations	AMERICAN JOURNAL OF DENTISTRY			English	Article							ETCH-AND-RINSE; BOND STRENGTH; RESIN; REMINERALIZATION; HYDROXYAPATITE; PRETREATMENT; CEMENT; AGENTS; FLUID	Purpose: To evaluate the effect of coating enamel and dentin with a calcium phosphate powder, a calcium fluoride silicon polymer, an oxalate and a functionalized tricalcium phosphate, on marginal adaptation of class V cavities restored with a universal adhesive containing the adhesive monomer with chemical bonding potential 10-MDP (Clearfil Universal Bond) and a hybrid composite (Clearfil APX). Methods: Class V cavities with margins located in enamel and dentin were coated with the different bioactive materials prior to the application of the adhesive and composite. After restoration polishing, the samples were subjected to a thermo-mechanical fatigue test. Gold coated resin-based replicas were readied to analyze the percentages of continuous margins (%CM) before and after loading to evidence differences between different enamel/dentin pre-treatments (Kruskal-Wallis, Duncan post hoc test). Results: The highest %CM was observed in the group in which enamel and dentin were coated with calcium phosphate powder prior to the application of the 10-MDP-containing adhesive. This was also the most stress-resistant group.	[Bonnafous, Francois; Krejci, Ivo; Bortolotto, Tissiana] Univ Geneva, Div Cariol & Endodontol, Univ Clin Dent Med, Fac Med, 19 Rue Lombard, CH-1205 Geneva, Switzerland		Bortolotto, T (corresponding author), Univ Geneva, Div Cariol & Endodontol, Univ Clin Dent Med, Fac Med, 19 Rue Lombard, CH-1205 Geneva, Switzerland.	Tissiana.Bortolotto@unige.ch	Bortolotto, Tissiana/AAE-2796-2021	Bortolotto, Tissiana/0000-0002-3231-9097			Arisu HD, 2011, OPER DENT, V36, P153, DOI 10.2341/09-381-L; Armstrong SR, 2004, OPER DENT, V29, P705; Baldassarri M, 2008, J DENT RES, V87, P645, DOI 10.1177/154405910808700711; Bortolotto T, 2007, AM J DENT, V20, P83; Bortolotto T, 2015, CLIN ORAL INVEST, V19, P1881, DOI 10.1007/s00784-015-1402-y; Bortolotto T, 2012, CLIN ORAL INVEST, V16, P1125, DOI 10.1007/s00784-011-0623-y; Cao CY, 2015, INT J MOL SCI, V16, P4615, DOI 10.3390/ijms16034615; Carrilho MRO, 2007, J DENT RES, V86, P529, DOI 10.1177/154405910708600608; Chow LC, 2009, DENT MATER J, V28, P1; Chow LC, 2001, J RES NATL INST STAN, V106, P1029, DOI 10.6028/jres.106.053; Borges BCD, 2013, ACTA ODONTOL SCAND, V71, P271, DOI 10.3109/00016357.2012.671364; Frankenberger R, 2007, J ADHES DENT, V9, P381; FUKASE Y, 1990, J DENT RES, V69, P1852, DOI 10.1177/00220345900690121201; Fukegawa D, 2006, J DENT RES, V85, P941, DOI 10.1177/154405910608501014; Gandolfi M, 2010, CLIN ORAL INVEST, V14, P659, DOI 10.1007/s00784-009-0356-3; Gupta T, 2017, CONTEMP CLIN DENT, V8, P244, DOI 10.4103/ccd.ccd_155_17; Han LL, 2015, AM J DENT, V28, P90; Jefferies SR, 2015, J ESTHET RESTOR DENT, V27, P155, DOI 10.1111/jerd.12133; KREJCI I, 1993, J DENT RES, V72, P490, DOI 10.1177/00220345930720020401; KREJCI I, 1994, DENT MATER, V10, P331, DOI 10.1016/0109-5641(94)90042-6; Liang KN, 2018, DENT MATER, V34, P607, DOI 10.1016/j.dental.2018.01.001; Mazzoni A, 2013, J DENT RES, V92, P82, DOI 10.1177/0022034512467034; Nakabayashi N, 1998, HYBRIDIZATION DENT H; Pashley E L, 1993, Am J Dent, V6, P116; Saffarpour Anna, 2015, J Dent (Tehran), V12, P807; Scotti N, 2016, EUR J ORAL SCI, V124, P504, DOI 10.1111/eos.12289; Seseogullari-Dirihan R, 2017, DENT MATER, V33, pE62, DOI 10.1016/j.dental.2016.09.036; Silva SMA, 2012, OPER DENT, V37, P356, DOI 10.2341/09-228-L; TAO L, 1989, DENT MATER, V5, P181, DOI 10.1016/0109-5641(89)90010-9; Taubock TT, 2014, DENT MATER, V30, P868, DOI 10.1016/j.dental.2014.05.029; Tay FR, 2003, J DENT RES, V82, P537, DOI 10.1177/154405910308200710; Tay FR, 2008, BIOMATERIALS, V29, P1127, DOI 10.1016/j.biomaterials.2007.11.001; Tay FR, 2007, J ENDODONT, V33, P1347, DOI 10.1016/j.joen.2007.07.008; Thanatvarakorn O, 2013, J BIOMED MATER RES B, V101B, P303, DOI 10.1002/jbm.b.32840; Wang ZJ, 2014, J BIOMAT SCI-POLYM E, V25, P679, DOI 10.1080/09205063.2014.891926; Yoshida Y, 2004, J DENT RES, V83, P454, DOI 10.1177/154405910408300604; Yoshida Y, 2001, J DENT RES, V80, P1565, DOI 10.1177/00220345010800061701; Zhao J, 2011, CHEM CENT J, V5, DOI 10.1186/1752-153X-5-40	38	0	0	0	2	MOSHER & LINDER, INC	WESTON	318 INDIAN TRACE SUITE 500, WESTON, FL 33326 USA	0894-8275			AM J DENT	Am. J. Dent.	DEC	2019	32	6					281	287					7	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	KB8FN	WOS:000506724800004	31920053				2022-03-04	
J	De Rose, L; Krejci, I; Bortolotto, T				De Rose, Luca; Krejci, I.; Bortolotto, T.			Immediate endodontic access cavity sealing: fundamentals of a new restorative technique	ODONTOLOGY			English	Article						Endodontic treatment; Endodontic irrigation; Immediate dentin sealing; Sodium hypochlorite; Coronal leakage	SODIUM-HYPOCHLORITE; BOND STRENGTHS; DENTIN; MICROLEAKAGE; ADAPTATION; INTERFACE; IRRIGANTS; ADHESION; QUALITY; ETCH	Endodontic access cavity sealing is conventionally performed after endodontic irrigation, referred to as delayed endodontic sealing (DES). Evidence shows that endodontic irrigation with NaOCl decreases dentinal bond quality and could cause coronal leakage. Access cavity sealing before endodontic irrigation is a new restorative approach, referred to as immediate endodontic sealing (IES). The primary aim of this in vitro study was to investigate whether IES improved internal adaptation. The secondary aim was to investigate the influence of the viscosity of the composite used to seal the dentine, on the internal adaptation in both IES and DES groups. Third molars (n = 40) with fully developed apices were used. The teeth were prepared into standard Class II MO cavities, and divided in 4 groups according to the approach, and composite viscosity was used for sealing. Group 1: IES + low viscosity composite; group 2: IES + high viscosity composite; group 3: DES + low viscosity composite; and group 4: DES + high viscosity composite. Samples were then sectioned axially for observation using scanning electron microscopy. Outcome was evaluated by determining the internal adaptation of the samples, which was judged based on the percentage of a continuous margin at the tooth-composite interface. The results were analyzed using a two-way analysis of variance and Mann-Whitney test. IES groups exhibited significantly greater internal adaptation (p = 0.000) as compared with DES groups. Composite viscosity did not significantly affect internal adaptation in either IES or DES groups (p > 0.005).	[De Rose, Luca; Krejci, I.; Bortolotto, T.] Univ Geneva, Sch Dent, Div Cariol & Endodontol, 11 Rue Barthelemy Menn, CH-1205 Geneva, Switzerland		De Rose, L (corresponding author), Univ Geneva, Sch Dent, Div Cariol & Endodontol, 11 Rue Barthelemy Menn, CH-1205 Geneva, Switzerland.	Luca.derose@unige.ch	Bortolotto, Tissiana/AAE-2796-2021	Bortolotto, Tissiana/0000-0002-3231-9097			Belli S, 2001, J ENDODONT, V27, P527, DOI 10.1097/00004770-200108000-00007; Bortolotto T, 2010, DENT MATER, V26, P242, DOI 10.1016/j.dental.2009.11.001; Buck RA, 2001, J ENDODONT, V27, P206, DOI 10.1097/00004770-200103000-00017; Carson KR, 2005, J ENDODONT, V31, P471, DOI 10.1097/01.don.0000148868.72833.62; Chiaraputt S, 2011, DENT MATER J, V30, P814, DOI 10.4012/dmj.2011-080; De Munck J, 2005, J DENT RES, V84, P118, DOI 10.1177/154405910508400204; Dietschi D, 2002, J DENT, V30, P259, DOI 10.1016/S0300-5712(02)00041-6; Duarte S, 2009, J PROSTHET DENT, V102, P1, DOI 10.1016/S0022-3913(09)00073-0; Dunavant TR, 2006, J ENDODONT, V32, P527, DOI 10.1016/j.joen.2005.09.001; Ebert J, 2009, J ADHES DENT, V11, P311; Fedorowicz Z, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008948.pub2; Gillen BM, 2011, J ENDODONT, V37, P895, DOI 10.1016/j.joen.2011.04.002; GUTMANN JL, 1992, J PROSTHET DENT, V67, P458, DOI 10.1016/0022-3913(92)90073-J; Heling I, 2002, J PROSTHET DENT, V87, P674, DOI 10.1067/mpr.2002.124453; Jaju S, 2011, INT J DENT, V2011, DOI 10.1155/2011/851359; Koagel SO, 2008, J ENDODONT, V34, P442, DOI 10.1016/j.joen.2008.01.009; Krejci I, 1990, Schweiz Monatsschr Zahnmed, V100, P1445; Li XH, 2012, J ADHES DENT, V14, P129, DOI 10.3290/j.jad.a22090; Lost C, 2006, INT ENDOD J, V39, P921, DOI 10.1111/j.1365-2591.2006.01180.x; Magne P, 2005, J PROSTHET DENT, V94, P511, DOI 10.1016/j.prosdent.2005.10.010; Magne P, 2007, J PROSTHET DENT, V98, pA12, DOI 10.1016/S0022-3913(07)60052-3; Magne Pascal, 2005, J Esthet Restor Dent, V17, P144, DOI 10.1111/j.1708-8240.2005.tb00103.x; MAGURA ME, 1991, J ENDODONT, V17, P324, DOI 10.1016/S0099-2399(06)81700-0; Marending M, 2007, INT ENDOD J, V40, P786, DOI 10.1111/j.1365-2591.2007.01287.x; Marshall GW, 1997, J DENT, V25, P441, DOI 10.1016/S0300-5712(96)00065-6; Moharnmadi Z, 2008, INT DENT J, V58, P329, DOI 10.1922/IDJ_1961Mohammadi13; Nikaido T, 1999, AM J DENT, V12, P177; PASHLEY EL, 1992, OPER DENT, V17, P13; Shokati B, 2010, J BIOMED MATER RES B, V94B, P230, DOI 10.1002/jbm.b.31645; Sim TPC, 2001, INT ENDOD J, V34, P120, DOI 10.1046/j.1365-2591.2001.00357.x; Stavridakis MM, 2005, OPER DENT, V30, P747, DOI 10.2341/04-151; Ten Nanci A, 2008, CATES ORAL HISTOLOGY; Van Meerbeek B, 2003, OPER DENT, V28, P215; Van Meerbeek B, 2010, DENT MATER, V26, pE100, DOI 10.1016/j.dental.2009.11.148	34	2	3	0	15	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1618-1247	1618-1255		ODONTOLOGY	Odontology	SEP	2015	103	3					280	285		10.1007/s10266-014-0174-1			6	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	DE0SG	WOS:000370334000005	25183493	Green Published			2022-03-04	
J	Srinivasan, M; Vazquez, L; Rieder, P; Moraguez, O; Bernard, JP; Belser, UC				Srinivasan, Murali; Vazquez, Lydia; Rieder, Philippe; Moraguez, Osvaldo; Bernard, Jean-Pierre; Belser, Urs C.			Efficacy and Predictability of Short Dental Implants (< 8 mm): A Critical Appraisal of the Recent Literature	INTERNATIONAL JOURNAL OF ORAL & MAXILLOFACIAL IMPLANTS			English	Article						dental implant; implant length (< 8 mm); literature review; short dental implants; treatment outcomes	LIFE-TABLE ANALYSIS; PARTIALLY EDENTULOUS PATIENTS; MULTICENTER CLINICAL-TRIAL; MACHINED-SURFACE IMPLANTS; LONG-TERM EVALUATION; ITI IMPLANTS; FOLLOW-UP; SUPPORTED RESTORATIONS; SURVIVAL RATES; FAILURE RATES	Purpose: This review of literature was conducted to evaluate the predictability of treatment outcomes with short dental implants (SDI), ie, implants shorter than 8 mm. Materials and Methods: The review included studies, published between January 1990 and July 2011, that (1) involved SDI (< 8 mm) placed in human jaws, (2) had a minimum of 20 SDI in their analysis, (3) provided data on survival rates, and (4) reported a minimum observation period of at least 3 months after placement. Results: Forty-one studies fulfilled the above criteria; only 17 of these studies reported outcomes with micro rough surface SDI. Six different lengths (4, 5, 6. 6.5, 7 and 7.5 mm) of microrough surface SDI with varying diameters (3.5 to 6 mm) were identified in the studies. A total of 1,828 microrough surface SDI were inserted and 45 failures were reported. Observation periods ranged from 3 months to 9 years. The reported survival rates for SDI ranged from 92.2% to 100%. From a total of 1,123 SDI inserted in specified jaw locations, failures were observed more often in the maxilla (n = 297, failed = 13) than in the mandible (n = 826, failed = 19). The review did not identify any correlation between implant diameter and survival for the microrough SDI. Conclusions: Microrough surface short implants (6 to 7.5 mm) appear to provide favorable survival rates and, therefore, can be predictably employed for simplification of implant therapy in situations of reduced alveolar heights in the posterior jaw segments. INT J ORAL MAXILLOFAC IMPLANTS 2012;27:1429-1437	[Srinivasan, Murali] Univ Geneva, Dept Fixed Prosthodont & Occlus, Sch Dent Med, Dept Stomatol & Oral Surg, CH-1205 Geneva, Switzerland; [Srinivasan, Murali] Univ Geneva, Div Gerodontol & Removable Prosthodont, Sch Dent Med, CH-1205 Geneva, Switzerland; [Vazquez, Lydia] Univ Geneva, Div Maxillofacial & Dent Radiol, Sch Dent Med, CH-1205 Geneva, Switzerland		Srinivasan, M (corresponding author), Univ Geneva, Dept Fixed Prosthodont & Occlus, Sch Dent Med, Dept Stomatol & Oral Surg, Rue Barthelemy Menn 19, CH-1205 Geneva, Switzerland.	murali.srinivasan@unige.ch	Vazquez, Lydia/AAX-8097-2020; Srinivasan, Murali/B-5159-2013; Buser, Daniel/D-3971-2011	Vazquez, Lydia/0000-0003-1871-4178; Srinivasan, Murali/0000-0003-3365-576X; 			Anitua E, 2010, J PERIODONTOL, V81, P819, DOI 10.1902/jop.2010.090637; Arlin ML, 2006, INT J ORAL MAX IMPL, V21, P769; Bahat O, 1993, Int J Oral Maxillofac Implants, V8, P151; Becker W, 1999, J PERIODONTOL, V70, P896, DOI 10.1902/jop.1999.70.8.896; Behat O, 2000, INT J ORAL MAX IMPL, V15, P646; Bischof M, 2006, CLIN ORAL IMPLAN RES, V17, P512, DOI 10.1111/j.1600-0501.2006.01271.X; BLOCK MS, 1990, J ORAL MAXIL SURG, V48, P174, DOI 10.1016/S0278-2391(10)80206-X; BRANEMARK PI, 1995, CLIN ORAL IMPLAN RES, V6, P227, DOI 10.1034/j.1600-0501.1995.060405.x; Brocard D, 2000, INT J ORAL MAX IMPL, V15, P691; Buser D, 1997, CLIN ORAL IMPLAN RES, V8, P161, DOI 10.1034/j.1600-0501.1997.080302.x; Cochran DL, 1999, J PERIODONTOL, V70, P1523, DOI 10.1902/jop.1999.70.12.1523; Combescure C, 2011, STAT METHODS MED RES, V20, P531, DOI 10.1177/0962280210379172; Davarpanah M, 2002, INT J ORAL MAX IMPL, V17, P820; Deporter D, 2001, INT J ORAL MAX IMPL, V16, P653; Deporter D, 2000, INT J PERIODONT REST, V20, P477; Ekfeldt A, 1994, Int J Oral Maxillofac Implants, V9, P179; Esposito M., 2007, COCHRANE DB SYST REV, V17; Esposito M, 2011, EUR J ORAL IMPLANTOL, V4, P21; Etoz OA, 2010, IMPLANT DENT, V19, P394, DOI 10.1097/ID.0b013e3181ed0798; Feldman Sylvan, 2004, Clin Implant Dent Relat Res, V6, P16, DOI 10.1111/j.1708-8208.2004.tb00023.x; Felice P, 2009, EUR J ORAL IMPLANTOL, V2, P7; Friberg B, 2000, Clin Implant Dent Relat Res, V2, P184; FRIBERG B, 1991, International Journal of Oral and Maxillofacial Implants, V6, P142; Fugazzotto PA, 2004, J PERIODONTOL, V75, P327, DOI 10.1902/jop.2004.75.2.327; Fugazzotto PA, 2008, INT J ORAL MAX IMPL, V23, P487; Gentile MA, 2005, INT J ORAL MAX IMPL, V20, P930; Griffin TJ, 2004, J PROSTHET DENT, V92, P139, DOI 10.1016/j.prosdent.2004.05.010; Gunne J, 1999, INT J PROSTHODONT, V12, P216; Hagi D, 2004, J PERIODONTOL, V75, P798, DOI 10.1902/jop.2004.75.6.798; Herrmann I, 2005, INT J ORAL MAX IMPL, V20, P220; HIGUCHI KW, 1995, J ORAL MAXIL SURG, V53, P264, DOI 10.1016/0278-2391(95)90222-8; Ivanoff CJ, 1999, INT J ORAL MAX IMPL, V14, P173; Ivanoff CJ, 1997, INT J ORAL MAX SURG, V26, P141, DOI 10.1016/S0901-5027(05)80837-9; JAFFIN RA, 1991, J PERIODONTOL, V62, P2, DOI 10.1902/jop.1991.62.1.2; JEMT T, 1992, International Journal of Oral and Maxillofacial Implants, V7, P40; JEMT T, 1993, CLIN ORAL IMPLAN RES, V4, P187, DOI 10.1034/j.1600-0501.1993.040404.x; Jemt T, 1995, Int J Oral Maxillofac Implants, V10, P303; JEMT T, 1994, CLIN ORAL IMPLAN RES, V5, P142, DOI 10.1034/j.1600-0501.1994.050304.x; Jemt T, 1993, Int J Oral Maxillofac Implants, V8, P635; Koo KT, 2010, J PERIODONTOL, V81, P1242, DOI 10.1902/jop.2010.100064; Kotsovilis S, 2009, J PERIODONTOL, V80, P1700, DOI 10.1902/jop.2009.090107; Lekholm U, 1999, INT J ORAL MAX IMPL, V14, P639; Lekholm U., 1985, TISSUE INTEGRATED PR, P199, DOI DOI 10.1111/J.1708-8208.2002.TB00174.X; Lum L. B., 1991, J ORAL IMPLANTOL, V17, P121; Mahon J M, 2000, Implant Dent, V9, P310, DOI 10.1097/00008505-200009040-00006; Malo P, 2007, CLIN IMPLANT DENT R, V9, P15, DOI 10.1111/j.1708-8208.2006.00027.x; Mericske-Stern R, 2001, CLIN ORAL IMPLAN RES, V12, P309, DOI 10.1034/j.1600-0501.2001.012004309.x; Misch Carl E, 2005, Dent Today, V24, P64; Mombelli A, 1999, PROCEEDINGS OF THE 3RD EUROPEAN WORKSHOP ON PERIODONTOLOGY: IMPLANT DENTISTRY, P281; Morgan M J, 1993, Int J Oral Maxillofac Implants, V8, P409; NAERT I, 1992, J PROSTHET DENT, V67, P236, DOI 10.1016/0022-3913(92)90461-I; Naert I, 2002, CLIN ORAL IMPLAN RES, V13, P381, DOI 10.1034/j.1600-0501.2002.130406.x; Naert I, 2002, CLIN ORAL IMPLAN RES, V13, P390, DOI 10.1034/j.1600-0501.2002.130407.x; Nedir R, 2004, CLIN ORAL IMPLAN RES, V15, P150, DOI 10.1111/j.1600-0501.2004.00978.x; Neldam CA, 2010, CLIN IMPLANT DE 1026; Nevins M, 1993, Int J Oral Maxillofac Implants, V8, P428; Pierrisnard Laurent, 2003, Clin Implant Dent Relat Res, V5, P254, DOI 10.1111/j.1708-8208.2003.tb00208.x; Pjetursson BE, 2009, CLIN ORAL IMPLAN RES, V20, P667, DOI 10.1111/j.1600-0501.2009.01704.x; Polizzi G, 2000, Clin Implant Dent Relat Res, V2, P93, DOI 10.1111/j.1708-8208.2000.tb00111.x; Pommer B, 2011, J CLIN PERIODONTOL, V38, P856, DOI 10.1111/j.1600-051X.2011.01750.x; Quirynen M, 1992, Clin Oral Implants Res, V3, P104, DOI 10.1034/j.1600-0501.1992.030302.x; Renouard F, 2005, CLIN IMPLANT DENT R, V7, pS104, DOI 10.1111/j.1708-8208.2005.tb00082.x; Renouard F, 2006, CLIN ORAL IMPLAN RES, V17, P35, DOI 10.1111/j.1600-0501.2006.01349.x; Roccuzzo M, 2001, CLIN ORAL IMPLAN RES, V12, P572, DOI 10.1034/j.1600-0501.2001.120604.x; Roos-Jansaker AM, 2006, J CLIN PERIODONTOL, V33, P290, DOI 10.1111/j.1600-051X.2006.00906.x; Rossi F, 2010, CLIN ORAL IMPLAN RES, V21, P937, DOI 10.1111/j.1600-0501.2010.01942.x; Slotte C, 2012, CLIN IMPLANT DENT R, V14, pe46, DOI 10.1111/j.1708-8208.2011.00346.x; Sohn DS, 2010, IMPLANT DENT, V19, P409, DOI 10.1097/ID.0b013e3181ed2cee; Tawil G, 2003, INT J ORAL MAX IMPL, V18, P894; Teixeira ER, 1997, J PROSTHET DENT, V78, P166, DOI 10.1016/S0022-3913(97)70121-5; Telleman G, 2011, J CLIN PERIODONTOL, V38, P667, DOI 10.1111/j.1600-051X.2011.01736.x; ten Bruggenkate CM, 1998, INT J ORAL MAX IMPL, V13, P791; Testori T, 2001, INT J ORAL MAX IMPL, V16, P193; Van Assche N, 2012, CLIN ORAL IMPLAN RES, V23, P567, DOI 10.1111/j.1600-0501.2011.02235.x; van Steenberghe D, 1990, Int J Oral Maxillofac Implants, V5, P272; Weng D, 2003, INT J ORAL MAX IMPL, V18, P417; Winkler S, 2000, Ann Periodontol, V5, P22, DOI 10.1902/annals.2000.5.1.22; Wyatt CCL, 1998, INT J ORAL MAX IMPL, V13, P204; Yi YS, 2011, IMPLANT DENT, V20, P125, DOI 10.1097/ID.0b013e31820fb67e	79	45	46	0	9	QUINTESSENCE PUBLISHING CO INC	HANOVER PARK	4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA	0882-2786	1942-4434		INT J ORAL MAX IMPL	Int. J. Oral Maxillofac. Implants	NOV-DEC	2012	27	6					1429	1437					9	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	054OE	WOS:000312352300014	23189293				2022-03-04	
J	Scolozzi, P				Scolozzi, P.			A combined transcaruncular transconjunctival approach to orbital medial wall fractures. Surgical technique	REVUE DE STOMATOLOGIE ET DE CHIRURGIE MAXILLO-FACIALE			French	Article						Orbital fractures	ENOPHTHALMOS; REPAIR	Introduction. The ideal approach to orbital medial wall fractures remains controversial. Only the corona! approach exposes the medial wall completely. The transcaruncular approach enables a clear and wide view of the medial wall without any visible scar compared to usual transcutaneous techniques. This approach can be combined with a transconjunctival approach, thus providing an extended exposure of the whole medial wall and the orbital floor. Technical note. The conjunctival incision is performed with a needle electrocautery in the groove between the plica semilunaris and the caruncle. It is extended laterally within the inferior conjunctival fornix for 20 mm to the lateral palpebral commissure. The subconjunctival dissection to the posterior lacrimal crest is performed with Stevens scissors through an avascular plane along the medial wall behind Homer's muscle. The periosteum is incised behind the posterior lacrimal crest. The sub-periosteal periorbital dissection is continued medially thus exposing the insertion of the inferior oblique muscle which is coagulated and cut over the inferior orbital rim. Reconstruction is performed after exposing the complete fracture after freeing the periorbital tissue. The periorbita is sutured with interrupted 5-0 Vicryl stitches. The inferior conjunctiva and the caruncle are closed with a continuous 6-0 Maxon suture. (C) 2010 Elsevier Masson SAS. All rights reserved.	Hop Cantonal Univ Geneva, Fac Med, Serv Chirurg Maxillofaciale & Chirurg Buccale, Dept Chirurg, CH-1211 Geneva 14, Switzerland		Scolozzi, P (corresponding author), Hop Cantonal Univ Geneva, Fac Med, Serv Chirurg Maxillofaciale & Chirurg Buccale, Dept Chirurg, Rue Gabrielle Perret Gentil 4, CH-1211 Geneva 14, Switzerland.	paolo.scolozzi@hcuge.ch					Burm JS, 1999, PLAST RECONSTR SURG, V103, P1839, DOI 10.1097/00006534-199906000-00005; Edgin WA, 2007, J ORAL MAXIL SURG, V65, P2345, DOI 10.1016/j.joms.2006.06.270; Ellis E, 2006, SURG APPROACHES FACI, P41; Garcia G H, 1998, J Craniomaxillofac Trauma, V4, P7; HAMMER B, 1995, DIAGNOSIS OPERATIVE, P2; HOLTMANN B, 1981, PLAST RECONSTR SURG, V67, P731, DOI 10.1097/00006534-198106000-00003; Lee CS, 2009, ARCH OPHTHALMOL-CHIC, V127, P291, DOI 10.1001/archophthalmol.2009.5; Lynch R.C., 1921, LARYNGOSCOPE, V31, P1, DOI 10.1288/00005537-192101000-00001; Malhotra R, 2007, J CRANIOFAC SURG, V18, P420, DOI 10.1097/scs.0b013e31803384c2; MANSON PN, 1986, PLAST RECONSTR SURG, V77, P193, DOI 10.1097/00006534-198602000-00004; MANSON PN, 1986, PLAST RECONSTR SURG, V77, P203, DOI 10.1097/00006534-198602000-00005	11	2	2	0	1	ELSEVIER	BRIDGEWATER	685 ROUTE 202-206, BRIDGEWATER, NJ 08807 USA	0035-1768			REV STOMATOL CHIR	Rev. Stomatol. Chir. Maxillo-Facil.	NOV-DEC	2010	111	5-6					302	307		10.1016/j.stomax.2010.10.010			6	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	711FP	WOS:000286572800011	21111433				2022-03-04	
J	Mavropoulos, A; Cattani-Lorente, M; Krejci, I; Staudt, CB				Mavropoulos, Anestis; Cattani-Lorente, Maria; Krejci, Ivo; Staudt, Christine Bettina			Kinetics of light-cure bracket bonding: Power density vs exposure duration	AMERICAN JOURNAL OF ORTHODONTICS AND DENTOFACIAL ORTHOPEDICS			English	Article							CURING TIME REDUCTION; RESIN COMPOSITE; ENERGY DENSITY; POLYMERIZATION; INTENSITY; STRENGTH; CONVERSION; UNITS	Introduction: Recent technologic advances make it possible to increase the light power density to reduce the necessary exposure duration. The kinetics of polymerization are complex. The special case of indirectly curing the thin layler of composite below the metallic bracket base further increases this complexity. It was hypothesized that the concept of "total energy,"-the reciprocity between power density and exposure duration-does not hold for orthodontic light-cure bracket bonding. Methods: Stainless steel brackets were bonded on deciduous bovine incisors with a standard light-cured composite. A calibrated, powerful halogen lamp allowed for modification of power density from 300 to 3000 mW/cm(2). Metallic brackets were bonded in 8 groups of 20 incisors each with various combinations of power densities and exposure durations to obtain 3 levels of energy density (6000, 12000, and 24000 mJ/cm(2)). Another group of 20 incisors served as the positive control with a conventional powerful halogen lamp (1000 mW/cm(2)) for 40 seconds. After storage for 24 hours at 37 degrees C in water, the bracket shear bond strength (SBS) and the adhesive remnant index (ARI) were measured. Results: It was confirmed that bracket SBS mainly depends on the energy density of the light cure. All groups with an energy density of 6000 mJ/cm(2) had significantly lower SBS than the groups with higher energy densities (P <0.01). The dependence of SBS on exposure duration for the same energy density followed an exponential model of nonlinear regression (r(2) = 0.98). Conclusions: The concept of "total energy" does not hold for orthodontic light-cure bracket bonding. An exposure time of less than 4 seconds, irrespective of the power density, cannot guarantee sufficient bracket bond strength. There seems to be an advantage of power density over exposure duration in the context of metallic bracket bonding. These results show that, for an efficient light-cure bracket bonding, there is an absolute lower limit of exposure duration (4 seconds) and an upper limit of useful power density (3000 mW/cm(2)). (Am J Orthod Dentofacial Orthop 2008;134:543-7)	[Mavropoulos, Anestis] Univ Geneva, Dept Orthodont, Div Orthodont, CH-1205 Geneva, Switzerland; [Cattani-Lorente, Maria] Univ Geneva, Div Prosthet, CH-1205 Geneva, Switzerland; [Krejci, Ivo] Univ Geneva, Div Cardiol & Endodontol, CH-1205 Geneva, Switzerland		Mavropoulos, A (corresponding author), Univ Geneva, Dept Orthodont, Div Orthodont, Barthelemy Menn 19, CH-1205 Geneva, Switzerland.	anestis.mavropoulos@medecine.unige.ch		Staudt, Christine B./0000-0002-7141-6500			ARTUN J, 1984, AM J ORTHOD DENTOFAC, V85, P333, DOI 10.1016/0002-9416(84)90190-8; Bouillaguet S, 2005, J BIOMED MATER RES B, V72B, P260, DOI 10.1002/jbm.b.30143; Eliades T, 2000, EUR J ORTHODONT, V22, P13, DOI 10.1093/ejo/22.1.13; Emami N, 2003, J DENT, V31, P189, DOI 10.1016/S0300-5712(03)00015-0; Ferracane JL, 1997, J DENT RES, V76, P1508, DOI 10.1177/00220345970760081401; FERRACANE JL, 1986, J BIOMED MATER RES, V20, P121, DOI 10.1002/jbm.820200111; Halvorson RH, 2002, DENT MATER, V18, P463, DOI 10.1016/S0109-5641(01)00069-0; Kauppi MR, 2003, AM J ORTHOD DENTOFAC, V124, P316, DOI 10.1016/S0889-5406(03)00402-5; Lindberg A, 2005, CLIN ORAL INVEST, V9, P71, DOI 10.1007/s00784-005-0312-9; Lovell LG, 2003, DENT MATER, V19, P458, DOI 10.1016/S0109-5641(02)00090-8; Mavropoulos A, 2005, EUR J ORTHODONT, V27, P408, DOI 10.1093/ejo/cji021; Musanje L, 2003, DENT MATER, V19, P531, DOI 10.1016/S0109-5641(02)00101-X; Nomoto R, 1994, Dent Mater J, V13, P198; Peutzfeldt A, 2005, J DENT RES, V84, P659, DOI 10.1177/154405910508400715; Rueggeberg F A, 1993, Am J Dent, V6, P91; RUEGGEBERG FA, 1994, OPER DENT, V19, P26; Sakaguchi R L, 2001, J Esthet Restor Dent, V13, P121, DOI 10.1111/j.1708-8240.2001.tb00434.x; Staudt CB, 2005, AM J ORTHOD DENTOFAC, V128, P749, DOI 10.1016/j.ajodo.2004.08.020; Staudt CB, 2006, J DENT, V34, P498, DOI 10.1016/j.jdent.2005.11.006; Vandewalle KS, 2004, DENT MATER, V20, P96, DOI 10.1016/S0109-5641(03)00124-6; Yap AUJ, 2001, OPER DENT, V26, P460; Yoon TH, 2002, J ORAL REHABIL, V29, P1165, DOI 10.1046/j.1365-2842.2002.00970.x	22	7	9	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0889-5406			AM J ORTHOD DENTOFAC	Am. J. Orthod. Dentofac. Orthop.	OCT	2008	134	4					543	547		10.1016/j.ajodo.2006.09.068			5	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	361FD	WOS:000260112000019	18929272				2022-03-04	
J	Scolozzi, P; Richter, M				Scolozzi, P; Richter, M			Treatment of severe mandibular fractures using AO reconstruction plates	JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Article							INTERNAL-FIXATION; ANGLE FRACTURES; RIGID FIXATION; COMPLICATIONS; INFECTION	Purpose: The goal of this study was to retrospectively evaluate the use of 2.4-mm- AO titanium reconstruction plates for mandibular fractures. Patients and Methods: We analyzed the clinical and radiologic data of 63 patients with 63 single fractures (53 comminuted, 5 dislocated, and 5 with bone loss) and 2 patients with double fractures. Fracture location was symphysis in 37 patients (56.9%), body in 13 (20%), and angle in 15 (23.1%). We recorded the mechanism of injury, tithe between injury and surgery, gender and age, temporary maxillomandibular fixation (MMF) and its duration, and surgical approach. Follow-up examinations were performed at 1, 3, 6, and 12 months, at which time we noted the status of healing and any complications. Results: Fifty patients (77%) had a successful treatment outcome without complications; 13 patients (20%) developed minor complications; and 2 patients (3%) developed nonunion with infection requiring hardware removal and reosteosynthesis with bone graft. Conclusions: We found that 2.4-mm AO titanium reconstruction plates can be used to treat severe mandibular fractures with a low rate of major complications (3%) and a high success rate. (C) 2003 American Association of Oral and Maxillofacial Surgeons.	Univ Hosp Geneva, Div Reconstruct Surg, Oral & Maxillofacial Surg Unit, CH-1211 Geneva 14, Switzerland		Scolozzi, P (corresponding author), Univ Hosp Geneva, Div Reconstruct Surg, Oral & Maxillofacial Surg Unit, 24 Micheli du Crest, CH-1211 Geneva 14, Switzerland.						Bromige M R, 1971, Br J Oral Surg, V9, P29, DOI 10.1016/S0007-117X(71)80005-7; CANNELL H, 1985, J MAXILLOFAC SURG, V13, P121, DOI 10.1016/S0301-0503(85)80030-8; CONIGLIO JU, 1989, ARCH OTOLARYNGOL, V115, P699; EID K, 1976, J TRAUMA, V16, P658; ELLIS E, 1993, J ORAL MAXIL SURG, V51, P250, DOI 10.1016/S0278-2391(10)80166-1; IIZUKA T, 1991, J ORAL MAXIL SURG, V49, P585, DOI 10.1016/0278-2391(91)90340-R; JAMES RB, 1981, J ORAL SURG, V39, P275; Jaques B, 1997, J ORAL MAXIL SURG, V55, P1402, DOI 10.1016/S0278-2391(97)90637-6; KAZANJIAN VH, 1942, AM J ORTHOD ORAL SUR, V28, P265; KAZANJIAN VH, 1942, AM J ORTHOD ORAL SUR, V28, P551; KEARNS GJ, 1994, J ORAL MAXIL SURG, V52, P226, DOI 10.1016/0278-2391(94)90287-9; Kuriakose MA, 1996, BRIT J ORAL MAX SURG, V34, P315, DOI 10.1016/S0266-4356(96)90010-8; MALONEY PL, 1991, J ORAL MAXIL SURG, V49, P698, DOI 10.1016/S0278-2391(10)80230-7; NEUPERT EA, 1991, ORAL SURG ORAL MED O, V72, P383, DOI 10.1016/0030-4220(91)90544-M; PASSERI LA, 1993, J ORAL MAXIL SURG, V51, P22, DOI 10.1016/S0278-2391(10)80383-0; Potter J, 1999, J ORAL MAXIL SURG, V57, P288, DOI 10.1016/S0278-2391(99)90674-2; Preim J, 1998, MANUAL INTERNAL FIXA, P57; Prein J, 1990, ORAL MAXILLOFAC SURG, V2, P187; SMITH BR, 1993, J ORAL MAXIL SURG, V51, P1320, DOI 10.1016/S0278-2391(10)80135-1; Spiessl B, 1989, INTERNAL FIXATION MA, P235; STONE IE, 1993, PLAST RECONSTR SURG, V91, P64, DOI 10.1097/00006534-199301000-00008	21	33	35	0	3	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0278-2391			J ORAL MAXIL SURG	J. Oral Maxillofac. Surg.	APR	2003	61	4					458	461		10.1053/joms.2003.50087			4	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	662BG	WOS:000181925400009	12684963				2022-03-04	
J	Byloff, FK; Mossaz, CF				Byloff, FK; Mossaz, CF			Skeletal and dental changes following surgically assisted rapid palatal expansion	EUROPEAN JOURNAL OF ORTHODONTICS			English	Article							TRANSVERSE MAXILLARY DEFICIENCY; TRANSPALATAL DISTRACTION; ORTHODONTIC EXPANSION; MIDPALATAL SUTURE; STABILITY; MANAGEMENT; OSTEOTOMY; ADULTS	The purpose of this study was to analyse the changes produced by surgically assisted rapid palatal expansion (SARPE) longitudinally on 14 patients aged between 18 and 41 years. A pre-fabricated Hyrax appliance was cemented prior to the surgical intervention, which consisted of a maxillary buccal corticotomy with pterygoid separation. Models and postero-anterior (PA) headfilms were taken before expansion (T1), at the end of expansion (T2), at the end of retention (T3) and at least 1 year post-surgery (T4). Overall expansion and relapse were measured directly on the casts. Transverse distances increased more at the first molars (8.7 mm) and premolars (8.1 and 8.3 mm) than in the canine (5.2 mm) and second molar (5.5 mm) region. Minimal relapse occurred during the retention phase. The arch width decreased more during the post-retention period, with more pronounced reduction at the teeth used as anchorage during the expansion procedure (-2.0 mm for the first premolars and -2.6 mm for the first molars). The mean total dental relapse was 28 per cent. PA radiographic analysis for angular changes showed 9.6 degrees of lateral tipping per side during expansion. One-third of this movement relapsed during the retention period (-3.3 degrees) and this trend (-6.0 degrees) continued during the post-retention phase to reach practically the original value at T1. Skeletal changes monitored on the PA headfilms were minimal with great individual variation. The mean expansion measured in the proximity of the osteotomy site was only 1.3 mm. From this amount, 0.4 mm was lost during the retention and post-retention periods. Based on these findings, it appears that maxillary skeletal expansion by SARPE is mainly a lateral rotation of the two maxillary halves with only minimal horizontal translation.	Univ Geneva, Sch Dent, Dept Orthodont, CH-1211 Geneva, Switzerland		Mossaz, CF (corresponding author), Univ Geneva, Sch Dent, Dept Orthodont, Rue Barthelemy Menn 19, CH-1211 Geneva, Switzerland.						ALPERN MC, 1987, ANGLE ORTHOD, V57, P245; Bailey LT, 1997, J ORAL MAXIL SURG, V55, P728, DOI 10.1016/S0278-2391(97)90588-7; Basciftci FA, 2002, ANGLE ORTHOD, V72, P118; BAYS RA, 1992, J ORAL MAXIL SURG, V50, P110, DOI 10.1016/0278-2391(92)90352-Z; BELL WH, 1976, AM J ORTHOD DENTOFAC, V70, P517, DOI 10.1016/0002-9416(76)90276-1; Berger JL, 1998, AM J ORTHOD DENTOFAC, V114, P638, DOI 10.1016/S0889-5406(98)70195-7; Betts N J, 1995, Int J Adult Orthodon Orthognath Surg, V10, P75; Braun S, 2000, AM J ORTHOD DENTOFAC, V118, P257, DOI 10.1067/mod.2000.108254; Cameron CG, 2002, AM J ORTHOD DENTOFAC, V121, P129, DOI 10.1067/mod.2002.120685; Capelozza Filho L, 1996, Int J Adult Orthodon Orthognath Surg, V11, P57; Cureton SL, 1999, AM J ORTHOD DENTOFAC, V116, P46, DOI 10.1016/S0889-5406(99)70302-1; Dahlberg G., 1940, STAT METHODS MEDICAL, P122; EPKER BN, 1986, DENTOFACIAL DEFORMIT, V2, P818; GLASSMAN AS, 1984, AM J ORTHOD DENTOFAC, V86, P207, DOI 10.1016/0002-9416(84)90372-5; Handelman CS, 2000, ANGLE ORTHOD, V70, P129; Isaacson R. J., 1964, ANGLE ORTHOD, V34, P261; KENNEDY JW, 1976, AM J ORTHOD DENTOFAC, V70, P123, DOI 10.1016/S0002-9416(76)90313-4; KRAUT RA, 1984, J ORAL MAXIL SURG, V42, P651, DOI 10.1016/0278-2391(84)90207-6; KREBS A, 1958, T EUR ORTHOD SOC, P163; LEHMAN JA, 1984, PLAST RECONSTR SURG, V73, P62, DOI 10.1097/00006534-198401000-00013; LINES PA, 1975, AM J ORTHOD DENTOFAC, V67, P44, DOI 10.1016/0002-9416(75)90128-1; Matteini C, 2001, AM J ORTHOD DENTOFAC, V120, P498, DOI 10.1067/mod.2001.118401; Mommaerts MY, 1999, BRIT J ORAL MAX SURG, V37, P268, DOI 10.1054/bjom.1999.0127; MOSS JP, 1968, J PRACT ORTHOD, V11, P215; MOSSAZ C F, 1992, European Journal of Orthodontics, V14, P110; MOSSAZJOELSON K, 1989, EUR J ORTHODONT, V11, P67, DOI 10.1093/oxfordjournals.ejo.a035967; Northway WM, 1997, ANGLE ORTHOD, V67, P309; Phillips C, 1992, Int J Adult Orthodon Orthognath Surg, V7, P139; POGREL M A, 1992, International Journal of Adult Orthodontics and Orthognathic Surgery, V7, P37; SHETTY V, 1994, J ORAL MAXIL SURG, V52, P742, DOI 10.1016/0278-2391(94)90492-8; Silverstein K, 1997, J ORAL MAXIL SURG, V55, P725, DOI 10.1016/S0278-2391(97)90587-5; SKIELLER V, 1964, T EUR ORTHOD SOC, P143; TURVEY TA, 1985, J MAXILLOFAC SURG, V13, P51, DOI 10.1016/S0301-0503(85)80016-3; Vanardsdall R.L., 1994, ORTHODONTICS CURRENT, P712; WARREN DW, 1987, AM J ORTHOD DENTOFAC, V91, P111, DOI 10.1016/0889-5406(87)90467-7; WERTZ RA, 1968, ANGLE ORTHOD, V38, P1; WERTZ RA, 1970, AMER J ORTHODONTICS, V58, P41, DOI 10.1016/0002-9416(70)90127-2	37	98	110	0	12	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0141-5387	1460-2210		EUR J ORTHODONT	Eur. J. Orthodont.	AUG	2004	26	4					403	409		10.1093/ejo/26.4.403			7	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	842IP	WOS:000222997400008	15366385	Bronze, Green Published			2022-03-04	
J	Giannopoulou, C; Kamma, J; Mombelli, A				Giannopoulou, C; Kamma, J; Mombelli, A			Crevicular fluid IL-1 beta, IL4, IL-6 and IL-8 levels in association to inflammation, smoking and stress.	JOURNAL OF DENTAL RESEARCH			English	Meeting Abstract	37th Annual Meeting of the International-Association-for-Dental-Research	SEP 05-08, 2001	ROME, ITALY	Int Assoc Dent Res					Univ Geneva, Fac Dent, Dept Periodont, CH-1211 Geneva 4, Switzerland									0	0	0	0	1	INT AMER ASSOC DENTAL RESEARCHI A D R/A A D R	ALEXANDRIA	1619 DUKE ST, ALEXANDRIA, VA 22314-3406 USA	0022-0345			J DENT RES	J. Dent. Res.	DEC	2002	81				B		B235	B235					1	Dentistry, Oral Surgery & Medicine	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	632HM	WOS:000180217901672					2022-03-04	
J	Stergiopulos, O; Houstis, O; Kiliaridis, S; Antonarakis, GS				Stergiopulos, Ourania; Houstis, Odyssia; Kiliaridis, Stavros; Antonarakis, Gregory S.			Changes in facial expressions following functional orthopaedic treatment for Class II division 1 malocclusion: a prospective controlled study	EUROPEAN JOURNAL OF ORTHODONTICS			English	Article							EXTRAORAL TRACTION; DYNAMIC-ANALYSIS; SMILE; ATTRACTIVENESS; APPEARANCE; APPLIANCES; AESTHETICS; MOVEMENT	Objective: The aim of this study was to quantify changes in facial expressions in children with Class II division 1 malocclusion treated with functional appliances. Materials and methods: A prospective controlled study was carried out evaluating 20 children with Class II division 1 malocclusion (ages 9-13) treated with a functional appliance for 12 months (treatment group). Age- and gender-matched children without immediate orthodontic treatment need were followed up without treatment for 12 months (control group). A frame-mode video sequence was taken of each subject at the beginning and end of the 12-month study period, during which 5 distinct facial expressions (posed smile, spontaneous smile, aggressive smile, lip pucker, and maximal mouth opening) were recorded. Frames at which each facial expression was at its peak were analysed. Changes in horizontal and vertical facial anthropometric distances brought about by performing each facial expression were measured. Intragroup differences following treatment were assessed using paired t-tests, whereas intergroup differences were assessed using unpaired t-tests. Results: All treated children showed an improvement in dentoalveolar relationships. Initial facial expressions differed between groups, with the treatment group showing less marked changes during lip pucker and more marked changes during maximal mouth opening. In contrast, no statistically significant differences were found between groups for the final facial expressions. Conclusions: This study suggests that functional appliance use in growing children with Class II division 1 malocclusion tends to normalize soft-tissue movements during facial expressions.	[Stergiopulos, Ourania; Kiliaridis, Stavros; Antonarakis, Gregory S.] Univ Geneva, Univ Clin Dent Med, Div Orthodont, 1 Rue Michel Servet, CH-1205 Geneva, Switzerland		Antonarakis, GS (corresponding author), Univ Geneva, Univ Clin Dent Med, Div Orthodont, 1 Rue Michel Servet, CH-1205 Geneva, Switzerland.	gregory.antonarakis@unige.ch	Antonarakis, Gregory/ABA-1855-2020	Antonarakis, Gregory/0000-0001-6741-6922			ALBINO JE, 1981, J DENT RES, V60, P1661, DOI 10.1177/00220345810600090501; Antonarakis GS, 2007, ANGLE ORTHOD, V77, P907, DOI 10.2319/061706-244; Badran SA, 2010, EUR J ORTHODONT, V32, P638, DOI 10.1093/ejo/cjq014; BALDWIN DC, 1980, COMMUNITY DENT ORAL, V8, P244, DOI 10.1111/j.1600-0528.1980.tb01296.x; Campbell CM, 2012, EUR J ORTHODONT, V34, P640, DOI 10.1093/ejo/cjr077; Chetan P, 2013, ANGLE ORTHOD, V83, P90, DOI 10.2319/040112-268.1; Dahlberg G., 1940, STAT METHODS MED BIO; Desai S, 2009, AM J ORTHOD DENTOFAC, V136, DOI 10.1016/j.ajodo.2009.04.013; Friesen E, 1978, MANUAL FACIAL ACTION, V3; Houstis O, 2010, J ORAL MAXIL SURG, V68, P1498, DOI 10.1016/j.joms.2009.09.013; Houstis O, 2009, EUR J ORTHODONT, V31, P459, DOI 10.1093/ejo/cjp019; Islam R, 2009, ANGLE ORTHOD, V79, P256, DOI 10.2319/030308-125.1; Johnston C, 2010, ANGLE ORTHOD, V80, P361, DOI 10.2319/051209-252.1; Koretsi V, 2015, EUR J ORTHODONT, V37, P418, DOI 10.1093/ejo/cju071; Mah M, 2014, EUR J ORTHODONT, V36, P657, DOI 10.1093/ejo/cjt041; Marill KA, 2004, ACAD EMERG MED, V11, P87, DOI 10.1197/S1069-6563(03)00600-6; Nooreyazdan M, 2004, J ORAL MAXIL SURG, V62, P1380, DOI 10.1016/j.joms.2004.03.015; O'Brien K, 2009, AM J ORTHOD DENTOFAC, V135, P580, DOI 10.1016/j.ajodo.2008.02.020; PFEIFFER JP, 1975, AM J ORTHOD DENTOFAC, V68, P499, DOI 10.1016/0002-9416(75)90084-6; PFEIFFER JP, 1982, AM J ORTHOD DENTOFAC, V81, P185, DOI 10.1016/0002-9416(82)90052-5; Santamaria-Villegas A, 2017, BMC ORAL HEALTH, V17, DOI 10.1186/s12903-017-0339-8; Sarver DM, 2003, AM J ORTHOD DENTOFAC, V124, P116, DOI 10.1016/S0889-5406(03)00307-X; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SHAW WC, 1985, AM J ORTHOD DENTOFAC, V87, P21, DOI 10.1016/0002-9416(85)90170-8; Singh B, 2013, ANGLE ORTHOD, V83, P468, DOI 10.2319/061212-488.1; Trotman CA, 2004, J ORAL MAXIL SURG, V62, P1372, DOI 10.1016/j.joms.2004.03.014; Tsichlaki A, 2014, AM J ORTHOD DENTOFAC, V146, P279, DOI 10.1016/j.ajodo.2014.05.022; Uysal T, 2012, EUR J ORTHODONT, V34, P96, DOI 10.1093/ejo/cjq169	28	1	1	1	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0141-5387	1460-2210		EUR J ORTHODONT	Eur. J. Orthodont.	JUN	2019	41	3					231	237		10.1093/ejo/cjy047			7	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	JI5LK	WOS:000493508500003	29982371				2022-03-04	
J	Sailer, I; Fehmer, V				Sailer, Irena; Fehmer, Vincent			EXCELLENCE IN DENTAL ESTHETICS	INTERNATIONAL JOURNAL OF ESTHETIC DENTISTRY			English	Editorial Material									[Sailer, Irena; Fehmer, Vincent] Univ Geneva, Clin Dent Med, Div Fixed Prosthodont & Biomat, 19 Rue Barthelemy Menn, CH-1205 Geneva, Switzerland		Sailer, I (corresponding author), Univ Geneva, Clin Dent Med, Div Fixed Prosthodont & Biomat, 19 Rue Barthelemy Menn, CH-1205 Geneva, Switzerland.	irena.sailer@unige.ch; Vincent.fehmer@unige.ch						0	0	0	0	0	QUINTESSENCE PUBLISHING CO INC	HANOVER PARK	4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA	2198-591X			INT J ESTHET DENT	Int. J. Esthet. Dent.	SUM	2018	13	2					143	144	PMID 29687094				2	Dentistry, Oral Surgery & Medicine	Emerging Sources Citation Index (ESCI)	Dentistry, Oral Surgery & Medicine	GX8RM	WOS:000448057600002	29687094				2022-03-04	
J	Bruneau, S; Scolozzi, P				Bruneau, S.; Scolozzi, P.			Preseptal transconjunctival approach to the orbital floor fractures. Surgical technique	REVUE DE STOMATOLOGIE DE CHIRURGIE MAXILLO-FACIALE ET DE CHIRURGIE ORALE			English	Article						Orbital fractures; Operative surgical procedures; Maxillofacial surgery	CONJUNCTIVAL APPROACH; REPAIR	Introduction. Orbital floor fractures may be reached through 2 types of conjunctival approaches, the preseptal one and the retroseptal one. While the retroseptal approach offers a more direct and easier route to the orbital rim and floor, it is associated with a significantly higher rate of lower lid complications compared to the preseptal approach. We will focus on the preseptal transconjunctival approach. Technical note. The conjunctival incision is performed with a guarded needle-tip electrocautery or with a long-handled scalpel (blade No. 15) from the inferior extremity of the semilunar fold to the lateral canthal region. The subconjunctival plane is divided with Stevens scissors medially and laterally. This plane, located between the preseptal cranial conjunctival flap covered by the orbital septum and the caudal conjunctival flap covered by the orbicular muscle's fascia, is opened with the scissors toward the inferior orbital rim. The periosteum over the inferior orbital rim is incised and reflected. The subperiosteal dissection is continued toward the orbital floor. The incarcerated periorbital tissues are repositioned to expose the stable bone margins of the fracture before orbital reconstruction. The closure of the periorbita is performed with uninterrupted 5-0 Vicryl sutures. The conjunctiva is closed with a running 6-0 Maxon suture. Discussion. Although technically more demanding than the retroseptal approach, the preseptal approach enables a large and safe access to the entire orbital floor by passing through an anatomical bloodless plane. This approach can also be combined with a lateral canthotomy/cantholysis and with a medial caruncular transconjunctival incision, thus providing extended exposure of the entire orbit. (C) 2015 Elsevier Masson SAS. All rights reserved.	[Bruneau, S.; Scolozzi, P.] Univ Hosp, Fac Med, Serv Maxillofacial & Oral Surg, Dept Surg, Geneva, Switzerland		Scolozzi, P (corresponding author), Univ Hosp, Fac Med, Serv Maxillofacial & Oral Surg, Dept Surg, Geneva, Switzerland.	paolo.scolozzi@hcuge.ch					Baumann A, 2001, J ORAL MAXIL SURG, V59, P287, DOI 10.1053/joms.2001.20997; Bourguet J., 1924, B ACAD MED, P1270; CONVERSE JM, 1973, PLAST RECONSTR SURG, V52, P656, DOI 10.1097/00006534-197312000-00010; Garcia G H, 1998, J Craniomaxillofac Trauma, V4, P7; Kushner GM, 2006, J ORAL MAXIL SURG, V64, P108, DOI 10.1016/j.joms.2005.09.019; MCCORD CD, 1979, OPHTHALMIC SURG LAS, V10, P53; Mullins JB, 1997, ARCH OTOLARYNGOL, V123, P385; Ridgway EB, 2009, PLAST RECONSTR SURG, V124, P1578, DOI 10.1097/PRS.0b013e3181babb3d; Scolozzi P, 2010, REV STOMATOL CHIR, V111, P302, DOI 10.1016/j.stomax.2010.10.010; TENZEL RR, 1971, AM J OPHTHALMOL, V71, P1141, DOI 10.1016/0002-9394(71)90592-7; Tessier P, 1973, J Maxillofac Surg, V1, P3, DOI 10.1016/S0301-0503(73)80005-0	11	9	9	0	3	ELSEVIER	BRIDGEWATER	685 ROUTE 202-206, BRIDGEWATER, NJ 08807 USA	2213-6533			REV STOMATOL CHIR	Rev. Stomatol. Chir. Maxillo-Facil.	DEC	2015	116	6					362	367		10.1016/j.revsto.2015.10.004			6	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	CY7CD	WOS:000366564700008	26586596				2022-03-04	
J	Schimmel, M; Loup, A; Duvernay, E; Gaydarov, N; Muller, F				Schimmel, Martin; Loup, Angelica; Duvernay, Elena; Gaydarov, Nikolay; Mueller, Frauke			The Effect of Mandibular Denture Abstention on Masseter Muscle Thickness in a 97-Year-Old Patient: A Case Report	INTERNATIONAL JOURNAL OF PROSTHODONTICS			English	Article								This case report describes the effect of complete denture abstention and subsequent rehabilitation with mandibular implant-supported overdentures (IOD) on masseter muscle thickness (MMT) in a 97-year-old patient. MMT was measured bilaterally using an ultrasound scanner during 1 year of wearing a conventional denture, after 101 days of voluntary denture abstention, and 3, 6, and 12 months after delivery of the IOD. MMT decreased by 17% during denture abstention following repeated implant surgery, and returned to 100% during the 12 months with the mandibular IOD. This case suggests that muscle bulk may be related to denture function. Int J Prosthodont 2010; 23: 418-420.	[Schimmel, Martin; Loup, Angelica; Duvernay, Elena; Mueller, Frauke] Univ Geneva, Sch Dent, Dept Gerodontol & Removable Prosthodont, CH-1205 Geneva, Switzerland; [Gaydarov, Nikolay] Univ Geneva, Sch Dent, Dept Oral Surg & Stomatol, CH-1205 Geneva, Switzerland		Schimmel, M (corresponding author), Univ Geneva, Sch Dent, Dept Gerodontol & Removable Prosthodont, 19 Rue Barthelemy Menn, CH-1205 Geneva, Switzerland.	Martin.Schimmel@unige.ch	Müller, Frauke/C-3835-2014; Schimmel, Martin/F-5694-2011; Morosolli, Aline/P-1984-2014	Müller, Frauke/0000-0003-3981-0134; Schimmel, Martin/0000-0001-9700-5534; 	ITI Foundation [458_2006]	This study was funded by the ITI Foundation (grant 458_2006). The contributions of Prof J.P. Bernard and Dr M. Imsand to the larger study are acknowledged.	Assuncao WG, 2010, GERODONTOLOGY, V27, P154, DOI 10.1111/j.1741-2358.2009.00299.x; KILIARIDIS S, 1991, J DENT RES, V70, P1262, DOI 10.1177/00220345910700090601; Meijer HJA, 2001, INT J ORAL MAX IMPL, V16, P522; Newton James P, 2004, Gerodontology, V21, P37, DOI 10.1111/j.1741-2358.2004.00002.x; Tokmakidis SP, 2009, CLIN PHYSIOL FUNCT I, V29, P316, DOI 10.1111/j.1475-097X.2009.00866.x	5	13	13	0	0	QUINTESSENCE PUBLISHING CO INC	HANOVER PARK	4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA	0893-2174			INT J PROSTHODONT	Int. J. Prosthodont.	SEP-OCT	2010	23	5					418	420					3	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	653BJ	WOS:000282057300006	20859556				2022-03-04	
J	Morel-Verdebout, C; Botteron, S; Kiliaridis, S				Morel-Verdebout, Catherine; Botteron, Sebastien; Kiliaridis, Stavros			Dentofacial characteristics of growing patients with Duchenne muscular dystrophy: a morphological study	EUROPEAN JOURNAL OF ORTHODONTICS			English	Article							NEUROMUSCULAR DISEASE; CRANIOFACIAL MORPHOLOGY; MYOTONIC-DYSTROPHY; MUSCLE; CHILDREN; DISORDERS; EXERCISE	Occlusal traits and craniofacial morphology were studied in growing patients with Duchenne muscular dystrophy (DMD). Sixteen patients from 6 to 20 years of age were examined and compared with 16 healthy male individuals matched according to age. The dental arches and occlusal traits of both groups were analysed on dental casts and compared with the norms of healthy individuals from the literature. Lateral cephalograms of the patients were compared with normal individuals by using scored values based on standard deviations in order to compensate for heterogeneity in the age of the subjects. Statistical analysis was undertaken for continuous variables with a paired Student's t-test and non-continuous variables with a chi-square test. Linear regressions were used to evaluate the influence of age. A high prevalence of malocclusions was found, including posterior crossbites, anterior and lateral open bites, a tendency towards mesio-occlusion due to a skeletal Class III malocclusion, and dental compensations of the Class III relationship by retrusion of the lower incisors. Both upper and lower arches were widened posteriorly. The lower arches were even wider than the upper arches, resulting in frequent posterior crossbites. No signficant skeletal vertical deviations were observed in this group of DMD patients, except for the maxillary plane angle (NL/NSL) that was larger than normal, while the anterior upper face height (NSp) was smaller. However, no difference was found in lower face height. The posterior enlargement of the dental arches and the dentoalveolar development towards an Angle Class III relationship were significantly related to age and found more frequently among the older subjects.	Univ Geneva, Dept Orthodont, CH-1211 Geneva 4, Switzerland		Kiliaridis, S (corresponding author), Univ Geneva, Sect Med Dent, Div Orthodont, Geneve 4, CH-1211 Geneva, Switzerland.	stavros.kiliaridis@unige.ch					Campbell MJ, 1999, MED STAT COMMONSENSE; Denti MA, 2006, P NATL ACAD SCI USA, V103, P3758, DOI 10.1073/pnas.0508917103; Droschl H, 1977, Inf Orthod Kieferorthop, V9, P241; Eckardt L, 1996, AM J ORTHOD DENTOFAC, V110, P185, DOI 10.1016/S0889-5406(96)70107-5; Erturk N, 1991, Quintessence Int, V22, P317; FARDEAU M, 2005, HOMME CHAIR; FOWLER WM, 1982, ARCH PHYS MED REHAB, V63, P322; GHAFARI J, 1988, AM J ORTHOD DENTOFAC, V93, P126, DOI 10.1016/0889-5406(88)90289-2; Goyenvalle A, 2004, SCIENCE, V306, P1796, DOI 10.1126/science.1104297; Grimby Gunnar, 2004, Lakartidningen, V101, P2008; HARA A, 2002, ORTHODONTIC WAVES, V61, P1; HASUND B, 1977, CLIN CEPHALOMETRY BE, P120; HECKMATT JZ, 1982, J PEDIATR-US, V101, P656, DOI 10.1016/S0022-3476(82)80286-2; Jennekens F G, 1991, Neuromuscul Disord, V1, P389, DOI 10.1016/0960-8966(91)90001-9; KAWAZOE Y, 1982, J NEUROL NEUROSUR PS, V45, P343, DOI 10.1136/jnnp.45.4.343; KILIARIDIS S, 1989, EUR J ORTHODONT, V11, P131, DOI 10.1093/oxfordjournals.ejo.a035975; Kiliaridis S, 1998, ACTA ODONTOL SCAND, V56, P369, DOI 10.1080/000163598428347; KILIARIDIS S, 1995, ACTA ODONTOL SCAND, V53, P196, DOI 10.3109/00016359509005972; KILMER DD, 1994, ARCH PHYS MED REHAB, V75, P560; Kinali M, 2002, NEUROMUSCULAR DISORD, V12, pS169, DOI 10.1016/S0960-8966(02)00097-4; Kulkarni M L, 1995, Indian Pediatr, V32, P700; LATEUR BJD, 1979, AM J PHYS MED REHAB, V58, P26; Matsumoto Shinichi, 2002, J Clin Pediatr Dent, V27, P53; Matsuyuki T, 2006, EUR J ORTHODONT, V28, P42, DOI 10.1093/ejo/cji074; MCLEAN WG, 1988, 1 MOMENTS CENTROIDS; MORIMOTO T, 1981, J NEUROL SCI, V49, P285, DOI 10.1016/0022-510X(81)90085-X; Morinushi T, 1986, Spec Care Dentist, V6, P117, DOI 10.1111/j.1754-4505.1986.tb00972.x; Moyers RE, 1976, MONOGRAPH CRANIOFACI, V5; ONIMUS M, 1999, MALADIES NEUROMUSCUL, P1; Pillen S, 2003, MUSCLE NERVE, V27, P699, DOI 10.1002/mus.10385; REIMERS K, 1993, J ULTRAS MED, V12, P73; Scholten RR, 2003, MUSCLE NERVE, V27, P693, DOI 10.1002/mus.10384; STENVIK A, 1986, J DENT CHILD, V53, P215; Symons A L, 2002, ASDC J Dent Child, V69, P277; WILLIG TN, 1994, ARCH PHYS MED REHAB, V75, P1175, DOI 10.1016/0003-9993(94)90001-9; [No title captured]	36	32	32	0	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0141-5387	1460-2210		EUR J ORTHODONT	Eur. J. Orthodont.	OCT	2007	29	5					500	507		10.1093/ejo/cjm045			8	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	227SA	WOS:000250676900014	17974540	Bronze, Green Published			2022-03-04	
J	Mavropoulos, A; Staudt, CB; Kiliaridis, S; Krejci, I				Mavropoulos, A; Staudt, CB; Kiliaridis, S; Krejci, I			Light curing time reduction: in vitro evaluation of new intensive light-emitting diode curing units	EUROPEAN JOURNAL OF ORTHODONTICS			English	Article							SHEAR BOND STRENGTH; ORTHODONTIC RESIN; DENTAL COMPOSITES; CERAMIC BRACKETS; ARGON-LASER; POLYMERIZATION; HALOGEN; CEMENT; ENAMEL; DEPTH	The aim of the present in vitro study was to establish the minimum necessary curing time to bond stainless steel brackets (Mini Diamond Twin (TM)) using new, intensive, light-emitting diode (LED) curing units. Seventy-five bovine primary incisors were divided into five equal groups. A standard light curing adhesive (Transbond (TM) XT) was used to bond the stainless steel brackets using different lamps and curing times. Two groups were bonded using an intensive LED curing lamp (Ortholux (TM) LED) for 5 and 10 seconds. Two more groups were bonded using another intensive LED curing device (Ultra-Lume (TM) LED 5) also for 5 and 10 seconds. Finally, a high-output halogen lamp (Optilux (TM) 501) was used for 40 seconds to bond the final group, which served as a positive control. All teeth were fixed in hard acrylic and stored for 24 hours in water at 37 degrees C. Shear bond strength (SBS) was measured using an Instron testing machine. Weibull distribution and analysis of variance were used to test for significant differences. The SBS values obtained were significantly different between groups (P < 0.001). When used for 10 seconds, the intensive LED curing units achieved sufficient SBS, comparable with the control. In contrast, 5 seconds resulted in significantly lower SBS. The adhesive remnant index (ARI) was not significantly affected. A curing time of 10 seconds was found to be sufficient to bond metallic brackets to incisors using intensive LED curing units. These new, comparatively inexpensive, curing lamps seem to be an advantageous alternative to conventional halogen lamps for bonding orthodontic brackets.	Univ Geneva, Sch Dent Med, Dept Orthodont, CH-1205 Geneva, Switzerland; Univ Geneva, Sch Dent Med, Dept Cariol & Endodontol, CH-1205 Geneva, Switzerland		Mavropoulos, A (corresponding author), Univ Geneva, Sch Dent Med, Dept Orthodont, Barthelemy Menn 19, CH-1205 Geneva, Switzerland.	anestis.mavropoulos@medecine.unige.ch		Staudt, Christine B./0000-0002-7141-6500			ARTUN J, 1984, AM J ORTHOD DENTOFAC, V85, P333, DOI 10.1016/0002-9416(84)90190-8; BASSIOUNY MA, 1978, BRIT DENT J, V145, P327, DOI 10.1038/sj.bdj.4804176; Bishara SE, 2003, ANGLE ORTHOD, V73, P431; Dunn WJ, 2002, AM J ORTHOD DENTOFAC, V122, P236, DOI 10.1067/mod.2002.123949; Eliades T, 2000, EUR J ORTHODONT, V22, P13, DOI 10.1093/ejo/22.1.13; Fox N A, 1994, Br J Orthod, V21, P33; HAITZ RH, 1995, HDB OPTICS, P1; Ishikawa H, 2001, AM J ORTHOD DENTOFAC, V120, P58, DOI 10.1067/mod.2001.115148; Jandt KD, 2000, DENT MATER, V16, P41, DOI 10.1016/S0109-5641(99)00083-4; Kleverlaan CJ, 2004, EUR J ORAL SCI, V112, P84, DOI 10.1111/j.0909-8836.2004.00101.x; Klocke A, 2003, AM J ORTHOD DENTOFAC, V124, P309, DOI 10.1016/S0889-5406(03)00310-X; Lalani N, 2000, ANGLE ORTHOD, V70, P28; Mills RW, 1999, BRIT DENT J, V186, P388, DOI 10.1038/sj.bdj.4800120a; Mitton BA, 2001, BRIT DENT J, V191, P82, DOI 10.1038/sj.bdj.4801103a; Miyazaki M, 1998, OPER DENT, V23, P50; NAKAMICHI I, 1983, J DENT RES, V62, P1076, DOI 10.1177/00220345830620101501; Nomoto R, 1997, Dent Mater J, V16, P60; Oberholzer TG, 2003, BIOMATERIALS, V24, P3593, DOI 10.1016/S0142-9612(03)00211-4; Oesterle LJ, 1998, AM J ORTHOD DENTOFAC, V114, P514, DOI 10.1016/S0889-5406(98)70171-4; Oesterle LJ, 2001, ANGLE ORTHOD, V71, P307; Pettemerides A P, 2001, J Orthod, V28, P237, DOI 10.1093/ortho/28.3.237; Read M J, 1984, Br J Orthod, V11, P16; Reynolds I.R., 1975, BRIT J ORTHODONT, V2, P171, DOI [10.1080/0301228X.1975.11743666, DOI 10.1080/0301228X.1975.11743666]; RUEGGEBERG FA, 1996, J DENT RES, V75, P380; Stahl F, 2000, BIOMATERIALS, V21, P1379, DOI 10.1016/S0142-9612(00)00029-6; STAUDT CB, 2005, IN PRESS AM J ORTHOD; Tavas M A, 1984, Br J Orthod, V11, P33; WANG WN, 1992, AM J ORTHOD DENTOFAC, V101, P350, DOI 10.1016/S0889-5406(05)80328-2; Weinberger SJ, 1997, ANGLE ORTHOD, V67, P173	29	15	20	0	4	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0141-5387			EUR J ORTHODONT	Eur. J. Orthodont.	AUG	2005	27	4					408	412		10.1093/ejo/cji021			5	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	950GX	WOS:000230846700011	15961571	Green Published, Bronze			2022-03-04	
J	Bernard, JP; Schatz, JP; Christou, P; Belser, U; Kiliaridis, S				Bernard, JP; Schatz, JP; Christou, P; Belser, U; Kiliaridis, S			Long-term vertical changes of the anterior maxillary teeth adjacent to single implants in young and mature adults - A retrospective study	JOURNAL OF CLINICAL PERIODONTOLOGY			English	Article						adult patients; alveolar and skeletal growth; ankylosis; implants; tooth eruption	OSSEOINTEGRATED TITANIUM IMPLANTS; ERUPTION; INCISOR; GROWTH; ADOLESCENTS; ANCHORAGE	Aim: To evaluate the effects of the tooth eruption process on the position of teeth adjacent to implant-borne restorations in adult patients compared to patients in their late adolescence. Subject and Methods: The sample included 28 patients divided into two groups. A "young adult" group consisting of 14 patients, aged from 15.5 to 21 years, and a "mature adult" group consisting of 14 patients, aged from 40 to 55 years. All patients presented missing anterior teeth, requiring insertion of 40 implant fixtures (16 central incisors, 12 lateral incisors, 12 canines). The implants were of the Straumann Dental Implant System, clinically and radiologically re-evaluated 1 year or more after the surgical procedure (mean interval=4.2 years). Assessment of the eruption of the adjacent teeth was performed using the implant as a stable point of reference: measurements of the different reference points were compared after implant placement and at follow-up examination. Results: In the "young adult" group, all patients showed infra-occlusion of the implant-supported crowns: the vertical step measured on radiographs varied between 0.1 and 1.65 mm. In the "mature adult" group, all patients showed a vertical difference between the teeth adjacent to the implant-supported crown and the implant: the measured step ranged from 0.12 to 1.86 mm. No difference was found in the amount of vertical eruption between male and female patients, nor according to localization of the implant. Conclusion: Mature adults can exhibit major vertical steps after anterior restorations with osseointegrated fixtures to the same extent as adolescents or "young adult" individuals with residuous growth potential.	Univ Geneva, Sch Dent Med, Dept Oral Surg, Geneva, Switzerland; Univ Geneva, Sch Dent Med, Dept Orthodont, Geneva, Switzerland; Univ Geneva, Sch Dent Med, Dept Prosthodont, Geneva, Switzerland		Schatz, JP (corresponding author), Univ Geneva, Sch Dent, Dept Orthodont, 19 Rue Barthelemy Menn, CH-1205 Geneva, Switzerland.	jean-paul.schatz@medecine.unige.ch	Buser, Daniel/D-3971-2011				ALBREKTSSON T, 1981, ACTA ORTHOP SCAND, V52, P155, DOI 10.3109/17453678108991776; BERKOVITZ BK, 1971, ARCH ORAL BIOL, V16, P1033, DOI 10.1016/0003-9969(71)90208-1; BJORK A, 1983, EUR J ORTHODONT, V5, P1; Branemark P I, 1977, Scand J Plast Reconstr Surg Suppl, V16, P1; Cochran DL, 2002, CLIN ORAL IMPLAN RES, V13, P144, DOI 10.1034/j.1600-0501.2002.130204.x; Cronin R J Jr, 1994, Int J Oral Maxillofac Implants, V9, P55; Dietschi D, 1997, Quintessence Int, V28, P231; FORSBERG CM, 1991, EUR J ORTHODONT, V13, P249, DOI 10.1093/ejo/13.4.249; Iseri H, 1996, EUR J ORTHODONT, V18, P245; Mombelli A, 1987, Oral Microbiol Immunol, V2, P145, DOI 10.1111/j.1399-302X.1987.tb00298.x; NORDQUIST GG, 1975, J PERIODONTOL, V46, P139, DOI 10.1902/jop.1975.46.3.139; ODMAN J, 1988, EUR J ORTHODONT, V10, P98, DOI 10.1093/ejo/10.2.98; ODMAN J, 1991, EUR J ORTHODONT, V13, P279, DOI 10.1093/ejo/13.4.279; ODMAN J, 1994, EUR J ORTHODONT, V16, P187, DOI 10.1093/ejo/16.3.187; Oesterle LJ, 2000, INT J ORAL MAX IMPL, V15, P252; SARNAS K-V, 1980, European Journal of Orthodontics, V2, P1; Sennerby L, 1993, Clin Oral Implants Res, V4, P65; SLAGSVOLD O, 1978, AM J ORTHOD DENTOFAC, V74, P410, DOI 10.1016/0002-9416(78)90063-5; Thilander B, 1999, CLIN ORAL IMPLAN RES, V10, P346, DOI 10.1034/j.1600-0501.1999.100502.x; THILANDER B, 1994, EUR J ORTHODONT, V16, P84, DOI 10.1093/ejo/16.2.84; Thilander B, 2001, EUR J ORTHODONT, V23, P715, DOI 10.1093/ejo/23.6.715; THILANDER B, 1992, European Journal of Orthodontics, V14, P99; THILANDER B, 1995, ACTA ODONTOL SCAND, V53, P144, DOI 10.3109/00016359509005964	23	125	128	0	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0303-6979	1600-051X		J CLIN PERIODONTOL	J. Clin. Periodontol.	NOV	2004	31	11					1024	1028		10.1111/j.1600-051X.2004.00574.x			5	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	862XV	WOS:000224525700017	15491321				2022-03-04	
J	Dudic, A; Giannopoulou, C; Kiliaridisc, S				Dudic, Alexander; Giannopoulou, Catherine; Kiliaridisc, Stavros			Factors related to the rate of orthodontically induced tooth movement	AMERICAN JOURNAL OF ORTHODONTICS AND DENTOFACIAL ORTHOPEDICS			English	Article							BONE; FORCE; ROOT; OSTEOPOROSIS; MAGNITUDE; CASTS; YOUNG; DOGS	Introduction: The purpose of this study was to investigate the variations of orthodontically induced tooth movement in the maxillary and mandibular arches between patients and the factors such as age, sex, and presence of an interference that might influence the amount of tooth displacement. Methods: By using a standardized experimental orthodontic tooth movement in 30 subjects, 57 premolars were moved buccally during 8 weeks with the application of a 1-N force. Forty-four contralateral premolars not subjected to orthodontic tooth movement served as the controls. Plaster models from before and after the experimental tooth movement were digitized and superimposed to evaluate the amounts of tooth movement. Differences in tooth movement between the experimental and control groups were tested by an unpaired t test. For the experimental teeth, subject-related factors (age and sex) and tooth-related factors (location in the maxillary or mandibular dental arch, and the presence or absence of an intra-arch or interarch obstacle such as neighboring touching teeth or teeth interfering with the occlusion) were examined with analysis of variance. Multiple linear regression analysis was performed to determine correlations between tooth displacement, age, sex, tooth location, and presence of an interference. Results: Each subject contributed at least 2 experimental premolars and 1 control premolar. The displacement of the orthodontically moved teeth was 2.42 mm (range, 0.3-5.8 mm). Younger subjects (<16 years; n = 19; number of teeth, 36) had significantly greater amounts of tooth displacement compared with older subjects (>= 16 years; n = 11; number of teeth, 21): 2.6 +/- 1.3 mm vs 1.8 +/- 0.8 mm; P < 0.01. When an interarch or intra-arch obstacle was present, the amount of tooth movement was significantly less (2.6 +/- 1.3 mm vs 1.8 +/- 0.8 mm) (P < 0.05). Neither sex nor the location of the experimental teeth in the mandible or the maxilla had any effect. Conclusions: Younger patients showed greater tooth movement velocity than did older ones. An interarch or intra-arch obstacle decreased the amount of tooth displacement. (Am J Orthod Dentofacial Orthop 2013;143:616-21)	[Dudic, Alexander; Kiliaridisc, Stavros] Univ Geneva, Dept Orthodont, CH-1205 Geneva, Switzerland; [Giannopoulou, Catherine] Univ Geneva, Dept Periodontol, CH-1205 Geneva, Switzerland		Giannopoulou, C (corresponding author), Univ Geneva, Sch Dent, Dept Periodontol, Rue Barthelemy Menn 19, CH-1205 Geneva, Switzerland.	ekaterini.giannopoulou@unige.ch			Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission [3200-127539]	Supported by the Swiss National Science Foundation (grant 3200-127539).	Ashizawa Y, 1998, ARCH ORAL BIOL, V43, P473, DOI 10.1016/S0003-9969(98)00017-X; BOESTER CH, 1974, ANGLE ORTHOD, V44, P113; Choy K, 2000, AM J ORTHOD DENTOFAC, V117, P98, DOI 10.1016/S0889-5406(00)70254-X; Costalos PA, 2005, AM J ORTHOD DENTOFAC, V128, P624, DOI 10.1016/j.ajodo.2004.08.017; Deguchi T, 2008, AM J ORTHOD DENTOFAC, V133, P889, DOI 10.1016/j.ajodo.2006.12.013; HELLSING E, 1991, EUR J ORTHODONT, V13, P223, DOI 10.1093/ejo/13.3.223; HOUSTON WJB, 1983, AM J ORTHOD DENTOFAC, V83, P382, DOI 10.1016/0002-9416(83)90322-6; Kawasaki K, 2006, Orthod Craniofac Res, V9, P137, DOI 10.1111/j.1601-6343.2006.00368.x; King GJ, 1998, AM J ORTHOD DENTOFAC, V114, P692, DOI 10.1016/S0889-5406(98)70202-1; Krishnan V, 2006, AM J ORTHOD DENTOFAC, V129, DOI DOI 10.1016/J.AJ0D0.2005.10.007; Krishnan V, 2009, BIOL MECH TOOTH MOVE, P143; Lerner UH, 2006, J DENT RES, V85, P584, DOI 10.1177/154405910608500703; Mok CW, 2007, ACTA ODONTOL SCAND, V65, P362, DOI 10.1080/00016350701771850; Owman-Moll P, 1995, Swed Dent J Suppl, V105, P1; OwmanMoll P, 1995, ANGLE ORTHOD, V65, P395; Pilon JJGM, 1996, AM J ORTHOD DENTOFAC, V110, P16, DOI 10.1016/S0889-5406(96)70082-3; Proffit WR., 2007, CONT ORTHODONTICS, P331; Raisz LG, 2005, J CLIN INVEST, V115, P3318, DOI 10.1172/JCI27071; Reid IR, 2004, CALCIFIED TISSUE INT, V74, P313, DOI 10.1007/s00223-002-0015-z; REITAN K, 1967, AMER J ORTHODONTICS, V53, P721, DOI 10.1016/0002-9416(67)90118-2; REITAN KAARE, 1961, ACTA ODONTOL SCAND, V19, P443, DOI 10.3109/00016356109043400; Ren Y, 2003, J DENT RES, V82, P38, DOI 10.1177/154405910308200109; Ren YJ, 2005, ARCH ORAL BIOL, V50, P1032, DOI 10.1016/j.archoralbio.2005.04.005; Ren YJ, 2003, ANGLE ORTHOD, V73, P86; Ren YJ, 2002, J CLIN PERIODONTOL, V29, P757, DOI 10.1034/j.1600-051X.2002.290813.x; Shimpo S, 2003, EUR J ORTHODONT, V25, P1, DOI 10.1093/ejo/25.1.1; van Leeuwen EJ, 1999, EUR J ORAL SCI, V107, P468, DOI 10.1046/j.0909-8836.1999.eos107608.x; Verna C, 2003, Orthod Craniofac Res, V6, P155; Verna C, 1999, BONE, V25, P577, DOI 10.1016/S8756-3282(99)00206-9; Walker JB, 2001, ANN PHARMACOTHER, V35, P113, DOI 10.1345/aph.10185; Zahrowski JJ, 2007, AM J ORTHOD DENTOFAC, V131, P311, DOI 10.1016/j.ajodo.2006.09.035	31	29	29	0	9	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0889-5406	1097-6752		AM J ORTHOD DENTOFAC	Am. J. Orthod. Dentofac. Orthop.	MAY	2013	143	5					616	621		10.1016/j.ajodo.2012.12.009			6	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	132KB	WOS:000318065300006	23631963	Green Published			2022-03-04	
J	Fabre, M; Mossaz, C; Christou, P; Kiliaridis, S				Fabre, M.; Mossaz, C.; Christou, P.; Kiliaridis, S.			Orthodontists' and laypersons' aesthetic assessment of Class III subjects referred for orthognathic surgery	EUROPEAN JOURNAL OF ORTHODONTICS			English	Article							FACIAL ATTRACTIVENESS; PROFILE; PERCEPTIONS	Lateral headfilms and coloured profile photographs of 18 skeletal Class III Caucasian adult patients (10 males, 8 females with a mean age of 24.5 years) prior to surgery, and nine adult Caucasian patients (four males, five females with a mean age of 27.4 years) with a dental Class I occlusion and no major skeletal discrepancy were included in the study. The headfilms were hand traced and digitized. Various cephalometric variables were calculated by computer software. Each printed profile photograph was evaluated aesthetically by 18 laypersons and 18 orthodontists using a 10-graded visual analogue scale (VAS) and a standard profile for calibration. Intra-observer reliability was tested and no significant error was found. Paired and unpaired t-tests were used to compare the scores. The association between various cephalometric variables and the PAS was tested. In general, compared with orthodontists, laypersons were less critical in their evaluation of the Class III profiles (+0.3 grade on the VAS) as well as the reference profiles (+0.7). The reference profiles were found to be more attractive than the Class III profiles by both laypersons and orthodontists (+2.3 grades). The degree of facial concavity had a negatively predictive value for the orthodontists' and laypersons' evaluations. The degree of facial concavity together with the steepness of the mandibular plane were negatively predictive factors for the PAS given by the orthodontists.	[Fabre, M.; Mossaz, C.; Christou, P.; Kiliaridis, S.] Univ Geneva, Dept Orthodont, Sch Dent Med, CH-1205 Geneva, Switzerland		Kiliaridis, S (corresponding author), Univ Geneva, Dept Orthodont, Sch Dent Med, Barthelemy Menn 19, CH-1205 Geneva, Switzerland.	stavros.kiliaridis@medecine.unige.ch					ARNETT GW, 1993, AM J ORTHOD DENTOFAC, V103, P395; Bishara SE, 1997, AM J ORTHOD DENTOFAC, V112, P639, DOI 10.1016/S0889-5406(97)70229-4; BURCAL RG, 1987, J ORAL MAXIL SURG, V45, P666, DOI 10.1016/0278-2391(87)90304-1; Cochrane S M, 1999, Int J Adult Orthodon Orthognath Surg, V14, P291; DESMIT A, 1984, AM J ORTHOD DENTOFAC, V86, P67, DOI 10.1016/0002-9416(84)90278-1; HOUSTON WJB, 1983, AM J ORTHOD DENTOFAC, V83, P382, DOI 10.1016/0002-9416(83)90322-6; Johnston C, 2005, EUR J ORTHODONT, V27, P129, DOI 10.1093/ejo/cjh093; Johnston DJ, 2005, EUR J ORTHODONT, V27, P349, DOI 10.1093/ejo/cji023; Kerr W J, 1990, Br J Orthod, V17, P299; LINES PA, 1978, AM J ORTHOD DENTOFAC, V73, P648, DOI 10.1016/0002-9416(78)90225-7; Maple JR, 2005, AM J ORTHOD DENTOFAC, V128, P690, DOI 10.1016/j.ajodo.2004.09.030; Michiels G, 1994, Int J Adult Orthodon Orthognath Surg, V9, P95; Phillips C, 1995, Int J Adult Orthodon Orthognath Surg, V10, P127; Powell N, 1984, PROPORTIONS AESTHETI; PRAHLANDERSEN B, 1979, J AM DENT ASSOC, V98, P209, DOI 10.14219/jada.archive.1979.0456; Ricketts RM, 1960, AM J ORTHOD, V46, P330, DOI 10.1016/0002-9416(60)90047-6; Shelly AD, 2000, AM J ORTHOD DENTOFAC, V117, P630, DOI 10.1016/S0889-5406(00)70171-5; TUCKEY JW, 1977, EXPLORATORY DATA ANA, P506; WORMS FW, 1976, ANGLE ORTHOD, V46, P1	19	21	22	0	5	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0141-5387	1460-2210		EUR J ORTHODONT	Eur. J. Orthodont.	AUG	2009	31	4					443	448		10.1093/ejo/cjp002			6	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	478KH	WOS:000268586600018	19395371	Bronze, Green Published			2022-03-04	
J	Cappuyns, I; Gugerli, P; Mombelli, A				Cappuyns, I; Gugerli, P; Mombelli, A			Viruses in periodontal disease - a review	ORAL DISEASES			English	Review						human immunodeficiency virus; cytomegalovirus; Epstein-Barr virus; herpes simplex virus; periodontitis/pathogenesis	HERPES-SIMPLEX-VIRUS; EPSTEIN-BARR-VIRUS; ORAL HAIRY LEUKOPLAKIA; NECROTIZING ULCERATIVE PERIODONTITIS; ACQUIRED-IMMUNODEFICIENCY-SYNDROME; LOCALIZED JUVENILE PERIODONTITIS; VARICELLA-ZOSTER VIRUS; HIV-INFECTION; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; AGGRESSIVE PERIODONTITIS	The purpose of this review was to evaluate the evidence supporting the hypothesis that viral infection plays a role in the development of periodontitis. An involvement in periodontal diseases has been suspected specifically for human immunodeficiency virus (HIV) and herpes viruses. An association has been demonstrated between HIV infection and some distinct forms of periodontal infection, i.e. necrotizing lesions. Furthermore, reports of increased prevalence and severity of chronic periodontitis in HIV-positive subjects suggests that HIV infection predispose to chronic periodontitis. Several studies, most of them from the same research group, have demonstrated an association of herpesviruses with periodontal disease. Viral DNA have been detected in gingival tissue, gingival cervicular fluid (GCF) and subgingival plaque from periodontaly diseased sites. In addition markers of herpesviral activation have been demonstrated in the GCF from periodontal lesions. Active human cytomegalovirus (HCMV) replication in periodontal sites may suggest that HCMV re-activation triggers periodontal disease activity. Concerns regarding sampling, methods and interpretation cast doubts on the role of viruses as causes of periodontal disease.	Univ Geneva, Sch Dent Med, CH-1205 Geneva, Switzerland		Cappuyns, I (corresponding author), Univ Geneva, Sch Dent Med, 19 rue Barthelemy Menn, CH-1205 Geneva, Switzerland.	isabella.cappuyns@medecine.unige.ch					ALYAHFOUFI Z, 1994, MICROB ECOL HEALTH D, V7, P217, DOI 10.3109/08910609409141357; Amir J, 2001, Paediatr Drugs, V3, P593, DOI 10.2165/00128072-200103080-00004; Amir J, 1999, PEDIATR DERMATOL, V16, P259, DOI 10.1046/j.1525-1470.1999.00072.x; AMIT R, 1992, J PERIODONTOL, V63, P502, DOI 10.1902/jop.1992.63.6.502; Arikawa J, 2004, INT J DERMATOL, V43, P136, DOI 10.1111/j.1365-4632.2004.01837.x; Arvin AM, 1996, CLIN MICROBIOL REV, V9, P361, DOI 10.1128/CMR.9.3.361; Babcock GJ, 1998, IMMUNITY, V9, P395, DOI 10.1016/S1074-7613(00)80622-6; BAELUM V, 1986, J PERIODONTAL RES, V21, P221, DOI 10.1111/j.1600-0765.1986.tb01454.x; Baelum V, 1996, J PERIODONTAL RES, V31, P17, DOI 10.1111/j.1600-0765.1996.tb00459.x; BERGSTROM J, 1989, COMMUNITY DENT ORAL, V17, P245, DOI 10.1111/j.1600-0528.1989.tb00626.x; BIRX DL, 1986, NEW ENGL J MED, V314, P874, DOI 10.1056/NEJM198604033141403; Brochut P F, 1997, Schweiz Monatsschr Zahnmed, V107, P672; BROCHUT PF, 1997, REV MENSUELLE SUISSE, V107, P771; Burkardt HJ, 2000, CLIN CHEM LAB MED, V38, P87, DOI 10.1515/CCLM.2000.014; Buxbaum S, 2003, MED MICROBIOL IMMUN, V192, P177, DOI 10.1007/s00430-003-0183-0; Cate T R, 1998, Semin Respir Infect, V13, P17; CHOO PW, 1995, J INFECT DIS, V172, P706, DOI 10.1093/infdis/172.3.706; CIANCIO SG, 1980, J PERIODONTOL, V51, P530, DOI 10.1902/jop.1980.51.9.530; CIANCIO SG, 1982, J PERIODONTOL, V53, P557, DOI 10.1902/jop.1982.53.9.557; Cobb CM, 2003, J PERIODONTAL RES, V38, P147, DOI 10.1034/j.1600-0765.2003.02011.x; Cohen JI, 1997, JAMA-J AM MED ASSOC, V278, P510, DOI 10.1001/jama.278.6.510; Contreras A, 1999, ORAL MICROBIOL IMMUN, V14, P206, DOI 10.1034/j.1399-302X.1999.140402.x; Contreras A, 1999, J PERIODONTOL, V70, P478, DOI 10.1902/jop.1999.70.5.478; Contreras A, 1998, ORAL MICROBIOL IMMUN, V13, P225, DOI 10.1111/j.1399-302X.1998.tb00700.x; Contreras A, 2000, ORAL MICROBIOL IMMUN, V15, P15, DOI 10.1034/j.1399-302x.2000.150103.x; Contreras A, 1996, ORAL MICROBIOL IMMUN, V11, P381, DOI 10.1111/j.1399-302X.1996.tb00199.x; Contreras A, 2001, J CLIN PERIODONTOL, V28, P96, DOI 10.1034/j.1600-051x.2001.280115.x; Corbet E F, 1997, Oral Dis, V3, P9; CORBET EF, 1997, SECONDARY TITEL, V76, P54; CROEN KD, 1991, ANNU REV MED, V42, P61, DOI 10.1146/annurev.med.42.1.61; DAHLEN G, 1989, J CLIN PERIODONTOL, V16, P305, DOI 10.1111/j.1600-051X.1989.tb01660.x; De Araujo T, 2002, DERMATOL CLIN, V20, P301, DOI 10.1016/S0733-8635(01)00008-0; EHRLICH J, 1983, J PERIODONTOL, V54, P357, DOI 10.1902/jop.1983.54.6.357; EISENMANN AC, 1983, J PERIODONTOL, V54, P712, DOI 10.1902/jop.1983.54.12.712; EPSTEIN JB, 1991, ORAL SURG ORAL MED O, V71, P38, DOI 10.1016/0030-4220(91)90517-G; Fleming DT, 1997, NEW ENGL J MED, V337, P1105, DOI 10.1056/NEJM199710163371601; GLICK M, 1994, J PERIODONTOL, V65, P393, DOI 10.1902/jop.1994.65.5.393; GMUR R, 1994, J DENT RES, V73, P1421, DOI 10.1177/00220345940730080501; Goncalves LD, 2004, ORAL SURG ORAL MED O, V97, P196, DOI 10.1016/j.tripleo.2003.08.023; GOODSON JM, 1982, J CLIN PERIODONTOL, V9, P472, DOI 10.1111/j.1600-051X.1982.tb02108.x; GRBIC JT, 1995, J PERIODONTOL, V66, P30, DOI 10.1902/jop.1995.66.1.30; GREENSPAN JS, 1994, COMPEND S, V18, pS714; GREENSPAN JS, 1994, COMPENDIUM, V18, pS694; HAFFAJEE AD, 1991, J PERIODONTAL RES, V26, P293, DOI 10.1111/j.1600-0765.1991.tb01662.x; Hanookai D, 2000, J PERIODONTOL, V71, P376, DOI 10.1902/jop.2000.71.3.376; Hausler M, 2002, J NEUROL SCI, V195, P111, DOI 10.1016/S0022-510X(02)00017-5; Herrera D, 2002, J CLIN PERIODONTOL, V29, P136, DOI 10.1034/j.1600-051X.29.s3.8.x; Holmes HK, 2002, ORAL DIS, V8, P40, DOI 10.1034/j.1601-0825.2002.00010.x; Holmstrup P, 1998, PERIODONTOL 2000, V18, P37, DOI 10.1111/j.1600-0757.1998.tb00137.x; HOLMSTRUP P, 1994, J CLIN PERIODONTOL, V21, P270, DOI 10.1111/j.1600-051X.1994.tb00317.x; Jenson H, 1999, J INFECT DIS, V179, P1395, DOI 10.1086/314764; Kamma JJ, 2003, J CLIN PERIODONTOL, V30, P420, DOI 10.1034/j.1600-051X.2003.20002.x; Kamma JJ, 2001, J CLIN PERIODONTOL, V28, P879, DOI 10.1034/j.1600-051x.2001.028009879.x; KLEIN RS, 1991, J PERIODONTOL, V62, P535, DOI 10.1902/jop.1991.62.8.535; Kolokotronis A, 2001, J Clin Pediatr Dent, V25, P107; Kornman KS, 1997, PERIODONTOL 2000, V14, P33, DOI 10.1111/j.1600-0757.1997.tb00191.x; Kubar A, 2004, J PERIODONTAL RES, V39, P81, DOI 10.1111/j.1600-0765.2004.00707.x; KUZUSHIMA K, 1991, PEDIATRICS, V87, P152; Lamster I B, 1997, Oral Dis, V3 Suppl 1, pS141; Lamster I B, 1998, Ann Periodontol, V3, P62; Landolfo S, 2003, PHARMACOL THERAPEUT, V98, P269, DOI 10.1016/S0163-7258(03)00034-2; Langford A, 1994, Quintessence Int, V25, P375; LASKARIS G, 1992, ORAL SURG ORAL MED O, V74, P168, DOI 10.1016/0030-4220(92)90377-3; LEIGH IM, 1988, AM J MED, V85, P34; LOE H, 1965, J PERIODONTOL, V36, P177, DOI 10.1902/jop.1965.36.3.177; Lowhagen GB, 2002, SCAND J INFECT DIS, V34, P664, DOI 10.1080/00365540210147732; MADINIER I, 1992, J PERIODONTOL, V63, P667, DOI 10.1902/jop.1992.63.8.667; Margiotta V, 1999, J ORAL PATHOL MED, V28, P173; MCMILLAN JA, 1993, PEDIATR INFECT DIS J, V12, P280, DOI 10.1097/00006454-199304000-00004; MCNABB H, 1992, ORAL MICROBIOL IMMUN, V7, P267, DOI 10.1111/j.1399-302X.1992.tb00586.x; Mombelli A, 1999, J CLIN PERIODONTOL, V26, P505, DOI 10.1034/j.1600-051X.1999.260803.x; Nikkels AF, 1999, BRIT J DERMATOL, V140, P343; Nowzari H, 2001, J PERIODONTOL, V72, P1601, DOI 10.1902/jop.2001.72.11.1601; NUMAZAKI K, 1995, SERODIAGN IMMUNOTHER, V7, P70; OLEARY GJS, 1962, SO CALIFORNIAN DENT; Papapanou P N, 1996, Ann Periodontol, V1, P1, DOI 10.1902/annals.1996.1.1.1; Parra B, 1996, ORAL MICROBIOL IMMUN, V11, P289, DOI 10.1111/j.1399-302X.1996.tb00183.x; PASS RF, 1985, J INFECT DIS, V152, P243, DOI 10.1093/infdis/152.2.243; Patton L L, 1998, Oral Dis, V4, P164; Patton LL, 2002, ORAL DIS, V8, P98, DOI 10.1034/j.1601-0825.2002.00020.x; Patton LL, 1999, INFECT DIS CLIN N AM, V13, P879, DOI 10.1016/S0891-5520(05)70114-8; Patton LL, 1999, AIDS, V13, P2174, DOI 10.1097/00002030-199910220-00026; PORTER SR, 1989, J ORAL PATHOL MED, V18, P47, DOI 10.1111/j.1600-0714.1989.tb00732.x; Rabenau HF, 2002, MED MICROBIOL IMMUN, V190, P153, DOI 10.1007/s00430-001-0102-1; Ranganathan K, 2000, ORAL DIS, V6, P152, DOI 10.1111/j.1601-0825.2000.tb00326.x; Reichart PA, 2003, MED MICROBIOL IMMUN, V192, P157, DOI 10.1007/s00430-002-0168-4; Rivera-Hidalgo F, 1999, PERIODONTOL 2000, V21, P106, DOI 10.1111/j.1600-0757.1999.tb00171.x; Robinson P G, 1996, Oral Dis, V2, P45; Robinson PG, 2002, ORAL DIS, V8, P91, DOI 10.1034/j.1601-0825.2002.00019.x; Roizman B, 1996, FIELDS VIROLOGY, V2, P2231; ROIZMANN B, 1992, ARCH VIROL, V123, P425, DOI 10.1007/BF01317276; Rozenberg F, 2002, PATHOL BIOL, V50, P414, DOI 10.1016/S0369-8114(02)00326-7; Ryder MI, 2002, J PERIODONTOL, V73, P1071, DOI 10.1902/jop.2002.73.9.1071; Salvi GE, 1997, PERIODONTOL 2000, V14, P173, DOI 10.1111/j.1600-0757.1997.tb00197.x; Saygun I, 2004, ORAL MICROBIOL IMMUN, V19, P83, DOI 10.1046/j.0902-0055.2002.00118.x; Saygun I, 2002, J PERIODONTOL, V73, P1437, DOI 10.1902/jop.2002.73.12.1437; Schei O., 1959, J PERIODONTOL, V30, P7; SCHIODT M, 1987, ORAL SURG ORAL MED O, V64, P716, DOI 10.1016/0030-4220(87)90174-5; SCHIODT M, 1987, AIDS, V1, P191; Schuman P, 1998, AM J MED, V104, P559, DOI 10.1016/S0002-9343(98)00110-7; SCHURCH E, 1988, COMMUNITY DENT ORAL, V16, P181, DOI 10.1111/j.1600-0528.1988.tb00570.x; Scully C, 1998, Dent Update, V25, P478; Sethi S, 2002, GERIATRICS-US, V57, P56; Shiboski CH, 2001, J ADOLESCENT HEALTH, V29, P109, DOI 10.1016/S1054-139X(01)00280-4; SLOTS J, 1991, J CLIN PERIODONTOL, V18, P411, DOI 10.1111/j.1600-051X.1991.tb02309.x; Slots J, 2002, ORAL MICROBIOL IMMUN, V17, P369, DOI 10.1034/j.1399-302X.2002.170606.x; SMITH S, 1984, ORAL SURG ORAL MED O, V57, P388, DOI 10.1016/0030-4220(84)90156-7; STAGNO S, 1985, NEW ENGL J MED, V313, P1270, DOI 10.1056/NEJM198511143132006; Teo CG, 2002, ORAL DIS, V8, P88, DOI 10.1034/j.1601-0825.2002.00018.x; Thorley-Lawson DA, 2004, NEW ENGL J MED, V350, P1328, DOI 10.1056/NEJMra032015; Ting M, 2000, J PERIODONTAL RES, V35, P17, DOI 10.1034/j.1600-0765.2000.035001017.x; Triantos D, 1997, CLIN INFECT DIS, V25, P1392, DOI 10.1086/516131; WAAL IV, 1997, ORAL DIS S1, V3, pS197; Whitley RJ, 2001, LANCET, V357, P1513, DOI 10.1016/S0140-6736(00)04638-9; WINKLER JR, 1988, CLIN DESCRIPTION ETI; Xu FJ, 2002, J INFECT DIS, V185, P1019, DOI 10.1086/340041; YAO QY, 1985, CHINESE MED J-PEKING, V98, P191; Yapar M, 2003, J PERIODONTOL, V74, P1634, DOI 10.1902/jop.2003.74.11.1634; YEUNG SCH, 1993, J PERIODONTOL, V64, P651, DOI 10.1902/jop.1993.64.7.651; YOUNG TB, 1988, AM J EPIDEMIOL, V127, P612, DOI 10.1093/oxfordjournals.aje.a114837; ZAKAYRONES Z, 1982, J PERIODONTOL, V53, P42, DOI 10.1902/jop.1982.53.1.42	121	43	47	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1354-523X	1601-0825		ORAL DIS	Oral Dis.	JUL	2005	11	4					219	229		10.1111/j.1601-0825.2005.01123.x			11	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	940KF	WOS:000230142700002	15984953				2022-03-04	
J	Bouillaguet, S; Duroux, B; Cattani-Lorrente, M; Delaloye, M; Meyer, JM				Bouillaguet, S; Duroux, B; Cattani-Lorrente, M; Delaloye, M; Meyer, JM			Ability of adhesive systems to seal dentin surfaces: An in vitro study.	JOURNAL OF DENTAL RESEARCH			English	Meeting Abstract									Univ Geneva, Sch Dent, Geneva, Switzerland									0	0	0	0	0	INT AMER ASSOC DENTAL RESEARCHI A D R/A A D R	ALEXANDRIA	1619 DUKE ST, ALEXANDRIA, VA 22314-3406 USA	0022-0345			J DENT RES	J. Dent. Res.	APR	2001	80	4					1204	1204					1	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	497VL	WOS:000172476101782					2022-03-04	
J	Hugentobler, M; Scolozzi, P				Hugentobler, Max; Scolozzi, Paolo			Severe dental malocclusion: a rare and insidious complication of mandibular advancement devices for obstructive sleep apnea syndrome treatment	ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY			English	Article							ORAL APPLIANCES	Objectives. Severe dental malocclusion resulting from mandibular advancement devices (MADs) for obstructive sleep apnea syndrome (OSAS) is extremely rare. Reporting of such situations is therefore useful for clinicians managing OSAS. Study design. We report the unusual cases of 4 patients who developed a severe circular dental open bite related to the use of a MAD. These bite changes were related to molar extrusion in two patients, whereas in the other two patients no obvious etiology was found. Results. In all patients, the MAD was immediately discontinued as early as the malocclusion was detected and continuous positive airway pressure proposed. Conclusion. Mandibular advancement devices may be associated with a severe dental malocclusion. Failure to recognize and promptly treat this complication may lead to irreversible dentoskeletal changes. Therefore, follow-up to survey dental occlusion is mandatory in all patients wearing a MAD. (Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010; 109: e28-e32)	[Scolozzi, Paolo] Hop Univ Geneve, Dept Surg, Serv Oral & Maxillofacial Surg, Fac Med Geneve, CH-1211 Geneva, Switzerland		Scolozzi, P (corresponding author), Hop Univ Geneve, Dept Surg, Serv Oral & Maxillofacial Surg, Fac Med Geneve, CH-1211 Geneva, Switzerland.	scolozzi-paolo@diogenes.hcuge.ch					Battagel JM, 2005, CLIN OTOLARYNGOL, V30, P149, DOI 10.1111/j.1365-2273.2004.00944.x; Clark G T, 1998, Sleep Med Rev, V2, P163, DOI 10.1016/S1087-0792(98)90019-3; de Almeida FR, 2006, AM J ORTHOD DENTOFAC, V129, P195, DOI 10.1016/j.ajodo.2005.10.001; de Almeida FR, 2006, AM J ORTHOD DENTOFAC, V129, P205, DOI 10.1016/j.ajodo.2005.04.034; Ferguson KA, 2006, SLEEP, V29, P244, DOI 10.1093/sleep/29.2.244; Fritsch KM, 2001, AM J RESP CRIT CARE, V164, P813, DOI 10.1164/ajrccm.164.5.2003078; GOODDAY RHB, 2009, ORAL MAXILLOFACIAL S, P316; Kushida CA, 2006, SLEEP, V29, P240, DOI 10.1093/sleep/29.2.240; Marklund M, 2006, AM J ORTHOD DENTOFAC, V129, P214, DOI 10.1016/j.ajodo.2005.10.004; Pantin CC, 1999, SLEEP, V22, P237, DOI 10.1093/sleep/22.2.237; Petit FX, 2002, AM J RESP CRIT CARE, V166, P274, DOI 10.1164/rccm.2008167; Robertson CJ, 2001, SLEEP, V24, P531, DOI 10.1093/sleep/24.5.531	12	2	2	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	1079-2104	1528-395X		ORAL SURG ORAL MED O	Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod.	MAR	2010	109	3					E28	E32		10.1016/j.tripleo.2009.10.040			5	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	561DT	WOS:000274956600029	20219582				2022-03-04	
J	Rocca, GT				Rocca, Giovanni Tommaso			Bonded indirect restorations for posterior teeth: From cavity preparation to provisionalization	QUINTESSENCE INTERNATIONAL			English	Article						adhesive sealing; esthetics; indirect reslorations	INTERNAL ADAPTATION; POLYMERIZATION SHRINKAGE; COMPOSITE RESTORATIONS; DENTIN; IMMEDIATE; ADHESIVES; STRENGTH; ENAMEL	Classic bonded indirect ceramic or resin composite restorations necessitate at least 2 appointments. The present article describes an updated technique for the first appointment comprising cavity preparation, dentin sealing, impression, and provisionalization. Two clinical cases are presented to illustrate the procedures step by step.	Univ Geneva, Sch Dent Med, Div Cariol & Endodontol, CH-1205 Geneva, Switzerland		Rocca, GT (corresponding author), Univ Geneva, Sch Dent Med, Div Cariol & Endodontol, Rue Barthelemy Menn 19, CH-1205 Geneva, Switzerland.	Giovanni.Rocca@medecine.unige.ch		Rocca, Giovanni Tommaso/0000-0002-9511-9965			Ardu S, 2006, QUINTESSENCE INT, V37, P423; Bertschinger C, 1996, AM J DENT, V9, P115; Black A., 1912, NW DENT J, V10, P60; BORTOLOTTO T, 2003, J DENT RES, P82; Broadbent JM, 2006, J CLIN PERIODONTOL, V33, P803, DOI 10.1111/j.1600-051X.2006.00988.x; CARVALHO RM, 2000, J ADHES DENT, V2, P252; De Munck J, 2005, OPER DENT, V30, P39; De Munck J, 2005, EUR J ORAL SCI, V113, P77, DOI 10.1111/j.1600-0722.2004.00185.x; Dietschi D, 2003, EUR J ORAL SCI, V111, P73, DOI 10.1034/j.1600-0722.2003.00004.x; Dietschi D, 2002, J DENT, V30, P259, DOI 10.1016/S0300-5712(02)00041-6; Dietschi D, 1998, Pract Periodontics Aesthet Dent, V10, P47; Dietschi D, 1998, EUR J ORAL SCI, V106, P1033, DOI 10.1046/j.0909-8836.1998.eos106609.x; Edelhoff D, 2002, INT J PERIODONT REST, V22, P241; Frankenberger R, 1999, Clin Oral Investig, V3, P208, DOI 10.1007/s007840050103; Hofmann N, 1998, Clin Oral Investig, V2, P77, DOI 10.1007/s007840050049; Ito S, 2005, BIOMATERIALS, V26, P6449, DOI 10.1016/j.biomaterials.2005.04.052; KREJCI I, 2001, P AC DENT MAT OCT 20, V5, P31; Labella R, 1999, DENT MATER, V15, P128, DOI 10.1016/S0109-5641(99)00022-6; Lutz F, 1999, Compend Contin Educ Dent, V20, P1138; Magne P, 2005, J PROSTHET DENT, V94, P511, DOI 10.1016/j.prosdent.2005.10.010; Manhart J, 2004, OPER DENT, V29, P481; MOERMANN W, 1982, QUINTESSENZ, V33, P1891; Paolantonio M, 2004, J CLIN PERIODONTOL, V31, P200, DOI 10.1111/j.0303-6979.2004.00472.x; Peumans M, 2005, DENT MATER, V21, P864, DOI 10.1016/j.dental.2005.02.003; Schulte AG, 2005, J DENT, V33, P433, DOI 10.1016/j.jdent.2004.10.026; SMALES RJ, 1993, BRIT DENT J, V174, P330, DOI 10.1038/sj.bdj.4808167; Soh MS, 2003, OPER DENT, V28, P707; Stavridakis MM, 2005, OPER DENT, V30, P747, DOI 10.2341/04-151; Stavridakis MM, 2005, OPER DENT, V30, P118; Van Meerbeek B, 2003, OPER DENT, V28, P215; Yap AUJ, 2001, OPER DENT, V26, P556	31	32	32	0	5	QUINTESSENCE PUBLISHING CO INC	HANOVER PARK	4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA	0033-6572	1936-7163		QUINTESSENCE INT	Quintessence Int.	MAY	2007	38	5					371	379					9	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	168RS	WOS:000246542300002	17568835				2022-03-04	
J	Brochut, PF; Marin, I; Baehni, P; Mombelli, A				Brochut, PF; Marin, I; Baehni, P; Mombelli, A			Predictive value of clinical and microbiological parameters for the treatment outcome of scaling and root planing	JOURNAL OF CLINICAL PERIODONTOLOGY			English	Article						A. actinomycetemcomitans; clinical outcome; P. gingivalis; predictive value; scaling and root planing	ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; BACTEROIDES-INTERMEDIUS; PERIODONTAL THERAPY; GINGIVALIS; IDENTIFICATION; SURGERY; DISEASE	Objectives: To compare the clinical and microbiological outcome of non-surgical periodontal therapy after 6 months with data obtained after hygienic phase or 6 weeks after completion of non-surgical therapy, in order to evaluate the value of clinical and microbiological parameters to predict treatment success. Materials and Methods: Clinical and microbiological data were available from 271 sites in 10 systemically healthy non-smokers with moderate-to-advanced chronic periodontal disease (24-32 sites per individual). Subgingival plaque samples were tested for the presence of Porphyromonas gingivalis, Actinobacillus actinomycetemcomitans, Tannerella forsythensis and Treponema denticola using RNA probes. Results: Stepwise multiple linear regression analysis revealed a significant impact of the number of sites with visible plaque index > 1 after hygienic phase on the bleeding tendency of a subject at month 6 (p < 0.01). Furthermore, an association could be demonstrated between the number of residual pockets (PD > 3 mm) 6 months after therapy and the number of bleeding sites and suppurating sites after hygienic phase (p=0.016). Six weeks after therapy, the mean total bacterial loads had a significant impact on the bleeding tendency of a subject at month 6 (p < 0.01). Although the average numbers of sites with persisting P. gingivalis, A. actinomycetemcomitans, T. forsythensis and T. denticola seemed to be very similar 6 weeks and 6 months after therapy, large variations were noted between subjects, and therefore the microbiological status of a subject at week 6 could not predict the status at month 6. Conclusions: The present study showed a limited potential of microbiological tests, performed after hygienic phase or shortly after non-surgical periodontal therapy, to predict the clinical outcome 6 months later, but confirmed the importance of an establishment of perfect oral hygiene before non-surgical therapy.	Univ Geneva, Sch Dent Med, CH-1211 Geneva, Switzerland		Brochut, PF (corresponding author), Univ Geneva, Sch Dent Med, 19 Rue Barthelemy Menn, CH-1211 Geneva, Switzerland.	patrick.brochut@medecine.unige.ch					BRAGD L, 1987, J CLIN PERIODONTOL, V14, P95, DOI 10.1111/j.1600-051X.1987.tb00949.x; CHRISTERSSON LA, 1985, J CLIN PERIODONTOL, V12, P465, DOI 10.1111/j.1600-051X.1985.tb01382.x; DIX K, 1990, J CLIN MICROBIOL, V28, P319, DOI 10.1128/JCM.28.2.319-323.1990; DUFFAU F, 2004, PERIO, V1, P67; FINE DH, 1994, J CLIN PERIODONTOL, V21, P98, DOI 10.1111/j.1600-051X.1994.tb00286.x; HAFFAJEE AD, 1988, J CLIN PERIODONTOL, V15, P255, DOI 10.1111/j.1600-051X.1988.tb01579.x; JOSS A, 1994, J CLIN PERIODONTOL, V21, P402, DOI 10.1111/j.1600-051X.1994.tb00737.x; Kaldahl WB, 1996, J PERIODONTOL, V67, P93, DOI 10.1902/jop.1996.67.2.93; KORNMAN KS, 1985, J PERIODONTOL, V56, P443, DOI 10.1902/jop.1985.56.8.443; LANG NP, 1990, J CLIN PERIODONTOL, V17, P714, DOI 10.1111/j.1600-051X.1990.tb01059.x; MOMBELLI A, 1989, J CLIN PERIODONTOL, V16, P434, DOI 10.1111/j.1600-051X.1989.tb01672.x; Mombelli A, 2000, J PERIODONTOL, V71, P14, DOI 10.1902/jop.2000.71.1.14; NYMAN S, 1977, J CLIN PERIODONTOL, V4, P240, DOI 10.1111/j.1600-051X.1977.tb01896.x; Rams TE, 1996, J CLIN PERIODONTOL, V23, P346, DOI 10.1111/j.1600-051X.1996.tb00556.x; Rees TD, 2003, PERIODONTOL 2000, V32, P9, DOI 10.1046/j.0906-6713.2002.03201.x; Renvert S, 2002, J CLIN PERIODONTOL, V29, P82, DOI 10.1034/j.1600-051X.29.s-3.2.x; RODENBURG JP, 1990, J CLIN PERIODONTOL, V17, P392, DOI 10.1111/j.1600-051X.1990.tb00036.x; ROSLING B, 1976, Journal of Clinical Periodontology, V3, P233, DOI 10.1111/j.1600-051X.1976.tb00042.x; SILNESS J, 1964, Acta Odontol Scand, V22, P121, DOI 10.3109/00016356408993968; SLOTS J, 1983, J CLIN PERIODONTOL, V10, P465, DOI 10.1111/j.1600-051X.1983.tb02179.x; SLOTS J, 1988, J CLIN PERIODONTOL, V15, P85, DOI 10.1111/j.1600-051X.1988.tb00999.x; SLOTS J, 1986, J CLIN PERIODONTOL, V13, P570, DOI 10.1111/j.1600-051X.1986.tb00849.x; Van der Weijden GA, 2002, J CLIN PERIODONTOL, V29, P55, DOI 10.1034/j.1600-051X.29.s3.3.x; vanSteenbergen TJM, 1996, J CLIN PERIODONTOL, V23, P955, DOI 10.1111/j.1600-051X.1996.tb00518.x	24	26	29	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0303-6979	1600-051X		J CLIN PERIODONTOL	J. Clin. Periodontol.	JUL	2005	32	7					695	701		10.1111/j.1600-051X.2005.00730.x			7	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	937WI	WOS:000229956300002	15966873				2022-03-04	
J	Najm, SA; Lombardi, T; Samson, J; Vazquez, L				Najm, SA; Lombardi, T; Samson, J; Vazquez, L			"Unusual calcareous periapical tumor": A brief communication	ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY			English	Editorial Material									Univ Geneva, Sch Dent Med, Dept Oral Surg Oral Med & Oral Maxillofacial Radi, Head Oral & Maxillofacial Pathol Lab, CH-1205 Geneva, Switzerland		Vazquez, L (corresponding author), Univ Geneva, Sch Dent Med, Dept Oral Surg Oral Med & Oral Maxillofacial Radi, Head Oral & Maxillofacial Pathol Lab, Barthelemy Menn 19, CH-1205 Geneva, Switzerland.	lydia.vazquez@medecine.unige.ch	Vazquez, Lydia/AAX-8097-2020	Vazquez, Lydia/0000-0003-1871-4178			Pillai K, 2001, ORAL SURG ORAL MED O, V92, P365, DOI 10.1067/moe.2001.116822; SHAFFER EL, 1983, ORAL SURG ORAL MED O, V56, P564, DOI 10.1016/0030-4220(83)90112-3	2	1	1	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	1079-2104	1528-395X		ORAL SURG ORAL MED O	Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod.	JAN	2005	99	1					106	106		10.1016/j.tripleo.2004.04.019			1	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	882GQ	WOS:000225927800016	15599356				2022-03-04	
J	Lefebvre-Legendre, L; Merendino, L; Rivier, C; Goldschmidt-Clermont, M				Lefebvre-Legendre, Linnka; Merendino, Livia; Rivier, Cristian; Goldschmidt-Clermont, Michel			On the Complexity of Chloroplast RNA Metabolism: psaA Trans-splicing Can be Bypassed in Chlamydomonas	MOLECULAR BIOLOGY AND EVOLUTION			English	Article						chloroplast; RNA processing; splicing; constructive neutral evolution; Chlamydomonas; synthetic biology	GROUP-II INTRON; PENTATRICOPEPTIDE REPEAT PROTEINS; ORGANELLE GENE-EXPRESSION; SITE-DIRECTED MUTAGENESIS; MESSENGER-RNA; IRON-DEFICIENCY; PHOTOSYSTEM-I; NUCLEAR GENES; PPR PROTEINS; PSBA-GENE	In the chloroplast, the posttranscriptional steps of gene expression are remarkably complex. RNA maturation and translation rely on a large cohort of nucleus-encoded proteins that act specifically on a single target transcript or a small set of targets. For example in the chloroplast of Chlamydomonas, trans-splicing of the two split introns of psaA requires at least 14 nucleus-encoded proteins. To investigate the functional significance of this complex trans-splicing pathway, we have introduced an intron-less copy of psaA in the chloroplast genomes of three mutants deficient in trans-splicing and of the wild type. We find that the intron-less psaA gene rescues the mutant phenotypes. The growth of strains with the intron-less psaA is indistinguishable from the wild type under the set of different experimental conditions that were investigated. Thus, the trans-splicing factors do not appear to have any other essential function and trans-splicing of psaA can be bypassed. We discuss how these observations support the hypothesis that complex RNA metabolism in the chloroplast may in part be the result of a nonadaptive evolutionary ratchet. Genetic drift may lead to the accumulation of chloroplast mutations and the recruitment of compensatory nuclear suppressors from large preexisting pools of genes encoding RNA-binding proteins.	[Lefebvre-Legendre, Linnka; Merendino, Livia; Rivier, Cristian; Goldschmidt-Clermont, Michel] Univ Geneva, Dept Bot & Plant Biol, Geneva, Switzerland; [Lefebvre-Legendre, Linnka; Merendino, Livia; Rivier, Cristian; Goldschmidt-Clermont, Michel] Univ Geneva, Dept Mol Biol, CH-1211 Geneva, Switzerland		Goldschmidt-Clermont, M (corresponding author), Univ Geneva, Dept Bot & Plant Biol, Geneva, Switzerland.	michel.goldschmidt-clermont@unige.ch			Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission [31003A_146300, 3100A0-117712]	This work was supported by the Swiss National Science Foundation (grants 31003A_146300 and 3100A0-117712). The authors thank Jean-David Rochaix and Geoffrey Fucile for their comments on the manuscript, and Nicolas Roggli for preparing the figures.	AKINS RA, 1987, CELL, V50, P331, DOI 10.1016/0092-8674(87)90488-0; Auchincloss AH, 2002, J CELL BIOL, V157, P953, DOI 10.1083/jcb.200201060; Ausubel FA, 1998, CURRENT PROTOCOLS IN; Balczun C, 2005, PLANT J, V43, P636, DOI 10.1111/j.1365-313X.2005.02478.x; Barkan A, 2000, BIOCHIMIE, V82, P559, DOI 10.1016/S0300-9084(00)00602-7; Barkan A, 2014, ANNU REV PLANT BIOL, V65, P415, DOI 10.1146/annurev-arplant-050213-040159; Barkan A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002910; Barkan A, 2011, PLANT PHYSIOL, V155, P1520, DOI 10.1104/pp.110.171231; Boudreau E, 2000, EMBO J, V19, P3366, DOI 10.1093/emboj/19.13.3366; Cao MQ, 2009, PROTOPLASMA, V235, P107, DOI 10.1007/s00709-009-0036-9; Choquet Y, 2002, FEBS LETT, V529, P39, DOI 10.1016/S0014-5793(02)03260-X; CHOQUET Y, 1988, CELL, V52, P903, DOI 10.1016/0092-8674(88)90432-1; Choquet Y, 2009, THE CHLAMYDOMONAS SO, V2, P1027; COVELLO PS, 1993, TRENDS GENET, V9, P265, DOI 10.1016/0168-9525(93)90011-6; de Longevialle AF, 2010, MOL PLANT, V3, P691, DOI 10.1093/mp/ssq025; Drager RG, 1998, PLANT J, V13, P85, DOI 10.1046/j.1365-313X.1998.00016.x; Eberhard S, 2002, PLANT J, V31, P149, DOI 10.1046/j.1365-313X.2002.01340.x; Eberhard S, 2008, ANNU REV GENET, V42, P463, DOI 10.1146/annurev.genet.42.110807.091452; Eberhard S, 2011, PLANT J, V67, P1055, DOI 10.1111/j.1365-313X.2011.04657.x; Ghulam MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078265; GIRARDBASCOU J, 1992, CURR GENET, V22, P47, DOI 10.1007/BF00351741; Glanz S, 2012, PLANT J, V69, P421, DOI 10.1111/j.1365-313X.2011.04801.x; Glanz S, 2009, BIOESSAYS, V31, P921, DOI 10.1002/bies.200900036; GOLDSCHMIDTCLERMONT M, 1991, CELL, V65, P135, DOI 10.1016/0092-8674(91)90415-U; GOLDSCHMIDTCLERMONT M, 1991, NUCLEIC ACIDS RES, V19, P4083, DOI 10.1093/nar/19.15.4083; GOLDSCHMIDTCLERMONT M, 1990, MOL GEN GENET, V223, P417, DOI 10.1007/BF00264448; Gray MW, 2010, SCIENCE, V330, P920, DOI 10.1126/science.1198594; Greiner S, 2011, MOL ECOL, V20, P671, DOI 10.1111/j.1365-294X.2010.04984.x; Hahn D, 1998, PLANT J, V15, P575, DOI 10.1046/j.1365-313X.1998.00234.x; Hammani K, 2014, BIOCHIMIE, V100, P141, DOI 10.1016/j.biochi.2013.08.031; Hohner R, 2013, MOL CELL PROTEOMICS, V12, P2774, DOI 10.1074/mcp.M113.029991; Holloway SP, 1998, PLANT CELL, V10, P1193; Jacobs J, 2013, MOL CELL PROTEOMICS, V12, P1912, DOI 10.1074/mcp.M112.026583; Jenkins BD, 2001, EMBO J, V20, P872, DOI 10.1093/emboj/20.4.872; JOHANNINGMEIER U, 1993, PLANT MOL BIOL, V22, P91, DOI 10.1007/BF00038998; Johnson X, 2010, PLANT CELL, V22, P234, DOI 10.1105/tpc.109.066266; Ke JY, 2013, NAT STRUCT MOL BIOL, V20, P1377, DOI 10.1038/nsmb.2710; Kleinknecht L, 2014, PLANT CELL, V26, P777, DOI 10.1105/tpc.114.122853; KUCHKA MR, 1989, CELL, V58, P869, DOI 10.1016/0092-8674(89)90939-2; KUCK U, 1987, EMBO J, V6, P2185, DOI 10.1002/j.1460-2075.1987.tb02489.x; Lambowitz AM, 2004, ANNU REV GENET, V38, P1, DOI 10.1146/annurev.genet.38.072902.091600; Loizeau K, 2014, NUCLEIC ACIDS RES, V42, P3286, DOI 10.1093/nar/gkt1272; Lukes J, 2011, IUBMB LIFE, V63, P528, DOI 10.1002/iub.489; Lynch M, 2007, THE ORIGINS OF GENOM; Lynch M, 2011, ANNU REV GENOM HUM G, V12, P347, DOI 10.1146/annurev-genom-082410-101412; Lyska D, 2013, PLANTA, V237, P413, DOI 10.1007/s00425-012-1752-5; Maier UG, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-36; Merendino L, 2006, NUCLEIC ACIDS RES, V34, P262, DOI 10.1093/nar/gkj429; Millar AH, 2005, TRENDS PLANT SCI, V10, P36, DOI 10.1016/j.tplants.2004.12.002; MINAGAWA J, 1994, PHOTOSYNTH RES, V42, P121, DOI 10.1007/BF02187123; MONOD C, 1992, MOL GEN GENET, V231, P449, DOI 10.1007/BF00292715; Moseley JL, 2002, EMBO J, V21, P6709, DOI 10.1093/emboj/cdf666; Naumann B, 2005, J BIOL CHEM, V280, P20431, DOI 10.1074/jbc.M414486200; Nickelsen J, 1999, PLANT CELL, V11, P957, DOI 10.1105/tpc.11.5.957; Peeters NM, 2002, RNA, V8, P497, DOI 10.1017/S1355838202029424; Perron K, 1999, EMBO J, V18, P6481, DOI 10.1093/emboj/18.22.6481; Petersen K, 2011, NUCLEIC ACIDS RES, V39, P5181, DOI 10.1093/nar/gkr105; Pfalz J, 2009, EMBO J, V28, P2042, DOI 10.1038/emboj.2009.121; Rahire M, 2012, PLANT J, V72, P652, DOI 10.1111/j.1365-313X.2012.05111.x; Raynaud C, 2007, P NATL ACAD SCI USA, V104, P9093, DOI 10.1073/pnas.0703162104; Redding K, 1998, EMBO J, V17, P50, DOI 10.1093/emboj/17.1.50; Rivier C, 2001, EMBO J, V20, P1765, DOI 10.1093/emboj/20.7.1765; Rivier C, 2000, THESIS; ROCHAIX JD, 1989, EMBO J, V8, P1013, DOI 10.1002/j.1460-2075.1989.tb03468.x; Rochaix JD, 1988, PLANT MOLECULAR BIOL; Schmitz-Linneweber C, 2005, PLANT CELL, V17, P1815, DOI 10.1105/tpc.105.032474; Schmitz-Linneweber C, 2008, TRENDS PLANT SCI, V13, P663, DOI 10.1016/j.tplants.2008.10.001; SERAPHIN B, 1987, P NATL ACAD SCI USA, V84, P6810, DOI 10.1073/pnas.84.19.6810; Shikanai T, 2013, RNA BIOL, V10, P1446, DOI 10.4161/rna.25207; SPREITZER RJ, 1983, PLANT PHYSIOL, V71, P35, DOI 10.1104/pp.71.1.35; Stern DB, 2010, ANNU REV PLANT BIOL, V61, P125, DOI 10.1146/annurev-arplant-042809-112242; Terauchi AM, 2010, PHOTOSYNTH RES, V105, P39, DOI 10.1007/s11120-010-9562-8; Tourasse NJ, 2013, RNA BIOL, V10, P1526, DOI 10.4161/rna.26127; Vaistij FE, 2000, PLANT J, V21, P469, DOI 10.1046/j.1365-313x.2000.00700.x; Vaistij FE, 2000, P NATL ACAD SCI USA, V97, P14813, DOI 10.1073/pnas.97.26.14813; Watkins KP, 2007, PLANT CELL, V19, P2606, DOI 10.1105/tpc.107.053736; Wei LL, 2014, PLANT CELL, V26, P353, DOI 10.1105/tpc.113.120121; Wostrikoff K, 2007, P NATL ACAD SCI USA, V104, P6466, DOI 10.1073/pnas.0610586104; Yagi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057286; Yin P, 2013, NATURE, V504, P168, DOI 10.1038/nature12651; ZHANG HT, 1994, PLANT MOL BIOL, V24, P663, DOI 10.1007/BF00023562	81	9	9	1	12	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0737-4038	1537-1719		MOL BIOL EVOL	Mol. Biol. Evol.	OCT	2014	31	10					2697	2707		10.1093/molbev/msu215			11	Biochemistry & Molecular Biology; Evolutionary Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Evolutionary Biology; Genetics & Heredity	AR2GQ	WOS:000343402200013	25053803	Bronze			2022-03-04	
J	Cionca, N; Hashim, D; Mombelli, A				Cionca, Norbert; Hashim, Dena; Mombelli, Andrea			Zirconia dental implants: where are we now, and where are we heading?	PERIODONTOLOGY 2000			English	Review							ONE-PIECE ZIRCONIA; SURFACE-MODIFIED ZIRCONIA; LONG-TERM EVALUATION; CRESTAL BONE CHANGES; ALL-CERAMIC CROWNS; TITANIUM IMPLANTS; IN-VITRO; SUBMERGED IMPLANTS; 2-PIECE ZIRCONIA; TISSUE-RESPONSE		[Cionca, Norbert; Hashim, Dena] Univ Geneva, Div Periodontol, Geneva, Switzerland; [Mombelli, Andrea] Univ Geneva, Sch Dent Med, Div Periodontol, Geneva, Switzerland		Cionca, N (corresponding author), Univ Geneva, Div Periodontol, Geneva, Switzerland.						Aboushelib M, 2006, EUR PAT APPL; Aboushelib MN, 2013, J ORAL IMPLANTOL, V39, P583, DOI 10.1563/AAID-JOI-D-11-00075; Al-Amleh B, 2010, J ORAL REHABIL, V37, P641, DOI 10.1111/j.1365-2842.2010.02094.x; Al-Radha ASD, 2012, J DENT, V40, P146, DOI 10.1016/j.jdent.2011.12.006; Allain J, 1999, J BONE JOINT SURG BR, V81B, P835, DOI 10.1302/0301-620X.81B5.9454; Andreiotelli M, 2009, CLIN IMPLANT DENT R, V11, P158, DOI 10.1111/j.1708-8208.2008.00105.x; Becker J, 2017, CLIN ORAL IMPLAN RES, V28, P29, DOI 10.1111/clr.12610; Bianco PD, 1996, J BIOMED MATER RES, V31, P227; Blaschke C, 2006, NEUROENDOCRINOL LETT, V27, P69; Borgonovo AE, 2013, INT J DENT, V2013, DOI 10.1155/2013/463073; Bormann KH, 2012, CLIN ORAL IMPLAN RES, V23, P1210, DOI 10.1111/j.1600-0501.2011.02291.x; BRANEMARK P I, 1969, Scandinavian Journal of Plastic and Reconstructive Surgery, V3, P81; Brull F, 2014, INT J ORAL MAX IMPL, V29, P914, DOI 10.11607/jomi.3293; Buser D, 1997, CLIN ORAL IMPLAN RES, V8, P161, DOI 10.1034/j.1600-0501.1997.080302.x; Cannizzaro G, 2010, EUR J ORAL IMPLANTOL, V3, P111; Chappuis V, 2016, CLIN IMPLANT DENT R, V18, P686, DOI 10.1111/cid.12375; Chung SH, 2013, J CLIN PERIODONTOL, V40, P404, DOI 10.1111/jcpe.12073; Cionca N, 2016, J DENT RES, V95, P995; Cionca N, 2016, CLIN ORAL INVEST, V20, P2285, DOI 10.1007/s00784-016-1729-z; Cionca N, 2015, CLIN ORAL IMPLAN RES, V26, P413, DOI 10.1111/clr.12370; Covacci V, 1999, BIOMATERIALS, V20, P371, DOI 10.1016/S0142-9612(98)00182-3; d'Hoedt B, 1988, INT J ORAL MAXILLOF, V4, P95; Degidi M, 2006, J PERIODONTOL, V77, P73, DOI 10.1902/jop.2006.77.1.73; Derks J, 2015, J CLIN PERIODONTOL, V42, pS158, DOI 10.1111/jcpe.12334; DEWIJS FLJA, 1994, J ORAL REHABIL, V21, P11, DOI 10.1111/j.1365-2842.1994.tb01120.x; do Nascimento C, 2016, DENT MATER, V32, P93, DOI 10.1016/j.dental.2015.10.014; do Nascimento C, 2014, CLIN ORAL IMPLAN RES, V25, P337, DOI 10.1111/clr.12093; Fartash B, 1997, CLIN ORAL IMPLAN RES, V8, P58, DOI 10.1111/j.1600-0501.1997.tb00008.x; Gahlert M, 2007, CLIN ORAL IMPLAN RES, V18, P662, DOI 10.1111/j.1600-0501.2007.01401.x; Gahlert M, 2012, CLIN ORAL IMPLAN RES, V23, P287, DOI 10.1111/j.1600-0501.2011.02206.x; Han JM, 2014, DENT MATER J, V33, P210, DOI 10.4012/dmj.2013-188; Hartman GA, 2004, J PERIODONTOL, V75, P572, DOI 10.1902/jop.2004.75.4.572; Hashim D, 2016, CLIN ORAL INVEST, V20, P1403, DOI 10.1007/s00784-016-1853-9; Hempel U, 2010, CLIN ORAL IMPLAN RES, V21, P174, DOI 10.1111/j.1600-0501.2009.01797.x; Hermann JS, 1997, J PERIODONTOL, V68, P1117, DOI 10.1902/jop.1997.68.11.1117; Hermann JS, 2001, CLIN ORAL IMPLAN RES, V12, P559, DOI 10.1034/j.1600-0501.2001.120603.x; Hermann JS, 2001, J PERIODONTOL, V72, P1372, DOI 10.1902/jop.2001.72.10.1372; ICHIKAWA Y, 1992, J PROSTHET DENT, V68, P322, DOI 10.1016/0022-3913(92)90338-B; Igarashi K, 2015, DENT MATER J, V34, P692, DOI 10.4012/dmj.2014-361; Kelly JR, 2008, DENT MATER, V24, P289, DOI 10.1016/j.dental.2007.05.005; Keuper M, 2014, ACTA BIOMATER, V10, P951, DOI 10.1016/j.actbio.2013.09.033; Koch FP, 2010, CLIN ORAL IMPLAN RES, V21, P350, DOI 10.1111/j.1600-0501.2009.01832.x; Kohal RJ, 2011, CLIN ORAL IMPLAN RES, V22, P808, DOI 10.1111/j.1600-0501.2010.02067.x; Kohal RJ, 2006, CLIN ORAL IMPLAN RES, V17, P565, DOI 10.1111/j.1600-0501.2006.01252.X; Kohal RJ, 2010, CLIN ORAL IMPLAN RES, V21, P1345, DOI 10.1111/j.1600-0501.2010.01954.x; Kohal RJ, 2013, J CLIN PERIODONTOL, V40, P553, DOI 10.1111/jcpe.12093; Kohal RJ, 2012, J CLIN PERIODONTOL, V39, P590, DOI 10.1111/j.1600-051X.2012.01876.x; Kohal RJ, 2009, CLIN IMPLANT DENT R, V11, P323, DOI 10.1111/j.1708-8208.2008.00116.x; Kohal RJ, 2004, J PERIODONTOL, V75, P1262, DOI 10.1902/jop.2004.75.9.1262; Korsch M, 2015, CLIN IMPLANT DENT R, V17, pE45, DOI 10.1111/cid.12122; Korsch M, 2015, INT J PROSTHODONT, V28, P11, DOI 10.11607/ijp.4043; KOTH DL, 1988, J PROSTHET DENT, V60, P226, DOI 10.1016/0022-3913(88)90321-6; Linares A, 2016, J CLIN PERIODONTOL, V43, P538, DOI 10.1111/jcpe.12543; Linkevicius T, 2013, CLIN ORAL IMPLAN RES, V24, P71, DOI 10.1111/j.1600-0501.2012.02453.x; Lughi V, 2010, DENT MATER, V26, P807, DOI 10.1016/j.dental.2010.04.006; Manzano G, 2014, INT J ORAL MAX IMPL, V29, P311, DOI 10.11607/jomi.2817; Meyer S, 2017, CLIN ORAL IMPLAN RES, V28, P1005, DOI 10.1111/clr.12912; Meyer U, 2006, CLIN ORAL IMPLAN RES, V17, P206, DOI 10.1111/j.1600-0501.2005.01184.x; Moller B, 2012, INT J ORAL MAX SURG, V41, P638, DOI 10.1016/j.ijom.2012.02.004; Mombelli A, 2012, CLIN ORAL IMPLAN RES, V23, P67, DOI 10.1111/j.1600-0501.2012.02541.x; Mombelli A, 2011, J CLIN PERIODONTOL, V38, P203, DOI 10.1111/j.1600-051X.2010.01666.x; Montero J, 2015, INT J ORAL MAX IMPL, V30, P773, DOI 10.11607/jomi.3668; Muller K, 2006, NEUROENDOCRINOL LETT, V27, P31; Nakamura K, 2010, INT J PROSTHODONT, V23, P299; Nawa M, 1998, CERAM INT, V24, P497, DOI 10.1016/S0272-8842(97)00048-5; Nickenig HJ, 2012, INT J ORAL MAX IMPL, V27, P671; Noro A, 2013, J BIOMED MATER RES B, V101B, P355, DOI 10.1002/jbm.b.32846; Oliva J, 2010, INT J ORAL MAX IMPL, V25, P336; Olmedo DG, 2013, J PERIODONTOL, V84, P78, DOI 10.1902/jop.2012.110757; Olmedo DG, 2012, J PERIODONTOL, V83, P973, DOI 10.1902/jop.2011.110392; Osman RB, 2014, CLIN ORAL IMPLAN RES, V25, P1366, DOI 10.1111/clr.12272; Osman RB, 2013, CLIN ORAL IMPLAN RES, V24, P592, DOI 10.1111/j.1600-0501.2011.02411.x; Payer M, 2015, CLIN ORAL IMPLAN RES, V26, P371, DOI 10.1111/clr.12342; Payer M, 2013, CLIN ORAL IMPLAN RES, V24, P569, DOI 10.1111/j.1600-0501.2012.02425.x; Pirker W, 2009, INT J ORAL MAX SURG, V38, P1127, DOI 10.1016/j.ijom.2009.07.008; PONTORIERO R, 1994, CLIN ORAL IMPLAN RES, V5, P254, DOI 10.1034/j.1600-0501.1994.050409.x; Preis V, 2016, DENT MATER, V32, P765, DOI 10.1016/j.dental.2016.03.028; Rimondini L, 2002, INT J ORAL MAX IMPL, V17, P793; Roehling S, 2016, CLIN IMPLANT DENT R, V18, P545, DOI 10.1111/cid.12323; Rompen E, 2006, CLIN ORAL IMPLAN RES, V17, P55, DOI 10.1111/j.1600-0501.2006.01367.x; Salihoglu U, 2011, INT J ORAL MAX IMPL, V26, P101; Salvi GE, 2012, CLIN ORAL IMPLAN RES, V23, P182, DOI 10.1111/j.1600-0501.2011.02220.x; Sandhaus S., 1967, INF ODONTOSTOMATOL, V4, P19; Sanon C, 2015, DENT MATER, V31, P15, DOI 10.1016/j.dental.2014.09.002; Saulacic N, 2014, CLIN IMPLANT DENT R, V16, P313, DOI 10.1111/cid.12070; Scarano A, 2004, J PERIODONTOL, V75, P292, DOI 10.1902/jop.2004.75.2.292; Schliephake H, 2010, J CLIN PERIODONTOL, V37, P818, DOI 10.1111/j.1600-051X.2010.01549.x; Schneider GB, 2003, J DENT RES, V82, P372, DOI 10.1177/154405910308200509; Schroeder A, 1976, SSO Schweiz Monatsschr Zahnheilkd, V86, P713; Schwarz F, 2015, J CLIN PERIODONTOL, V42, P783, DOI 10.1111/jcpe.12439; Sennerby L, 2005, CLIN IMPLANT DENT R, V7, pS13, DOI 10.1111/j.1708-8208.2005.tb00070.x; Sicilia A, 2008, CLIN ORAL IMPLAN RES, V19, P823, DOI 10.1111/j.1600-0501.2008.01544.x; Siddiqi A, 2016, CLIN ORAL IMPLAN RES, V27, P288, DOI 10.1111/clr.12536; Sollazzo V, 2008, DENT MATER, V24, P357, DOI 10.1016/j.dental.2007.06.003; Spies BC, 2016, J MECH BEHAV BIOMED, V53, P1, DOI 10.1016/j.jmbbm.2015.07.005; Spies BC, 2016, CLIN ORAL IMPLAN RES, V27, P481, DOI 10.1111/clr.12560; Sridhar S, 2015, CLIN IMPLANT DENT R, V17, pE562, DOI 10.1111/cid.12285; Steflik D, 1994, J ORAL IMPLANTOL, V21, P8; Stejskal Jenny, 1999, Neuro Endocrinol Lett, V20, P351; Sundfeldt M, 2006, ACTA ORTHOP, V77, P177, DOI 10.1080/17453670610045902; Takano T, 2012, J DENT RES, V91, P800, DOI 10.1177/0022034512452277; Tete S, 2009, INT J ORAL MAX IMPL, V24, P52; Thoma DS, 2016, CLIN ORAL IMPLAN RES, V27, P412, DOI 10.1111/clr.12595; ToumelinChemla F, 1996, J DENT, V24, P109, DOI 10.1016/0300-5712(95)00033-X; van Brakel R, 2011, CLIN ORAL IMPLAN RES, V22, P1172, DOI 10.1111/j.1600-0501.2010.02082.x; Vanhakendover S, 1987, Actual Odontostomatol (Paris), V41, P627; WEINGART D, 1994, INT J ORAL MAX SURG, V23, P450, DOI 10.1016/S0901-5027(05)80045-1; Welander M, 2008, CLIN ORAL IMPLAN RES, V19, P635, DOI 10.1111/j.1600-0501.2008.01543.x; Wenz HJ, 2008, INT J PROSTHODONT, V21, P27; Wilson TG, 2009, J PERIODONTOL, V80, P1388, DOI 10.1902/jop.2009.090115; Wittneben JG, 2014, INT J ORAL MAX IMPL, V29, P84, DOI 10.11607/jomi.2014suppl.g2.1; Yamano S, 2011, INT J ORAL MAX IMPL, V26, P1247; Yamashita D, 2009, DENT MATER J, V28, P461, DOI 10.4012/dmj.28.461; Yildirim M, 2003, J PROSTHET DENT, V90, P325, DOI 10.1016/S0022-3913(03)00514-6; Zembic A, 2012, CLIN ORAL IMPLAN RES, V23, P49, DOI 10.1111/j.1600-0501.2011.02174.x; Zinelis S, 2010, DENT MATER, V26, P295, DOI 10.1016/j.dental.2009.11.079; Zitzmann NU, 2001, J CLIN PERIODONTOL, V28, P517, DOI 10.1034/j.1600-051x.2001.028006517.x	117	101	104	6	32	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0906-6713	1600-0757		PERIODONTOL 2000	Periodontol. 2000	FEB	2017	73	1					241	258		10.1111/prd.12180			18	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	EI9KT	WOS:000392827600017	28000266	Green Published, hybrid			2022-03-04	
J	Imholz, B; Lombardi, T; Scolozzi, P				Imholz, B.; Lombardi, T.; Scolozzi, P.			Toothache: At what point has a pontocerebellar angle tumor to be evoked?	REVUE DE STOMATOLOGIE DE CHIRURGIE MAXILLO-FACIALE ET DE CHIRURGIE ORALE			French	Article						Toothache; Cerebellopontine angle; Facial pain; Neurilemmoma; Epidermal cyst	CEREBELLOPONTINE ANGLE; OROFACIAL PAIN	Introduction. Dental pain may have another origin than teeth. It may be caused by myofascial, neurovascular, cardiac, neurological, sinusal or psychological factors. We will discuss 2 rare cases of patients who presented with a cerebellopontine tumor, who initially manifested with symptoms of dental pain. Observation. The first patient, male, 44 years of age presented to his dentist with toothache (47), which led to its extraction. Five months later, a second painful episode, more characteristic, revealed the presence of a vestibular schwannoma, which was successfully treated and led to the disappearance of the pain. The second case, a 43-year-old female presented to her dentist with toothache (46), which lead the dentist perform a root filling. Two years later, with a 3rd episode of dental pain, more relevant of a trigeminal nevralgia, a epidermoid cyst of the right cerebellopontine angle was identified and successfully treated leading to the disappearance of the pain. Discussion. Cerebellopontine tumors of this type may lead, in exceptional cases to symptoms of dental pain. Therefore, in face of atypical tooth or facial pain, both a detailed medical history and a detailed examination are necessary, in order to investigate any neurological signs and symptoms, before undertaking any nonessential dental treatment, which may be detrimental for the patients. (C) 2015 Elsevier Masson SAS. All rights reserved.	[Imholz, B.; Lombardi, T.; Scolozzi, P.] Hop Cantonal Univ Geneva, Dept Chirurg, Unite Med & Pathol Orale, Serv Chirurg Maxillofaciale & Chirurg Buccale, CH-1211 Geneva 14, Switzerland		Imholz, B (corresponding author), Hop Cantonal Univ Geneva, Dept Chirurg, Unite Med & Pathol Orale, Serv Chirurg Maxillofaciale & Chirurg Buccale, 4 Rue Gabrielle Perret Gentil, CH-1211 Geneva 14, Switzerland.	benoit.imholz@hcuge.ch					FERGUSON JW, 1990, ORAL SURG ORAL MED O, V69, P672, DOI 10.1016/0030-4220(90)90345-S; Israel HA, 2000, J AM DENT ASSOC, V131, P919, DOI 10.14219/jada.archive.2000.0310; Lagares A, 2010, NEUROSURGERY, V66, pE841, DOI 10.1227/01.NEU.0000367550.30165.A7; LIPTON JA, 1993, J AM DENT ASSOC, V124, P115, DOI 10.14219/jada.archive.1993.0200; Moazzam AA, 2012, OR SURG OR MED OR PA, V114, P749, DOI 10.1016/j.oooo.2012.06.017; Nixdorf DR, 2010, J ENDODONT, V36, P1494, DOI 10.1016/j.joen.2010.06.020; Okeson J P, 2000, Tex Dent J, V117, P64; Roz TM, 2005, J AM DENT ASSOC, V136, P1556, DOI 10.14219/jada.archive.2005.0086; Uehara M, 2007, J ORAL MAXIL SURG, V65, P560, DOI 10.1016/j.joms.2005.12.035; Zakrzewska JM, 2013, BRIT J ANAESTH, V111, P95, DOI 10.1093/bja/aet125	10	0	0	0	1	ELSEVIER	BRIDGEWATER	685 ROUTE 202-206, BRIDGEWATER, NJ 08807 USA	2213-6533			REV STOMATOL CHIR	Rev. Stomatol. Chir. Maxillo-Facil.	JUN	2015	116	3					161	165		10.1016/j.revsto.2015.04.002			5	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	CM8JD	WOS:000357945000008	26001346				2022-03-04	
J	Scolozzi, P; Herzog, G				Scolozzi, Paolo; Herzog, Georges			Total Mandibular Subapical Osteotomy and Le Fort I Osteotomy Using Piezosurgery and Computer-Aided Designed and Manufactured Surgical Splints: A Favorable Combination of Three Techniques in the Management of Severe Mouth Asymmetry in Parry-Romberg Syndrome	JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Article							HEMIFACIAL ATROPHY; ORTHOGNATHIC SURGERY; ORTHODONTIC TREATMENT; AESTHETIC TREATMENT; DISEASE; EXPERIENCE; RECONSTRUCTION; SOFT	Although its pathogenesis remains obscure, Parry-Romberg syndrome (PRS) has been associated with the linear scleroderma en coup de sabre. PRS is characterized by unilateral facial atrophy of the skin, subcutaneous tissue, muscles, and bones with at least 1 dermatome supplied by the trigeminal nerve. Facial asymmetry represents the most common sequela and can involve the soft tissues, craniomaxillofacial skeleton, dentoalveolar area, and temporomandibular joint. Although orthognathic procedures have been reported for skeletal reconstruction, treatment of facial asymmetry has been directed to augmentation of the soft tissue volume on the atrophic side using different recontouring or volumetric augmentation techniques. Total mandibular subapical osteotomy has been used in the management of dentofacial deformities, such as open bite and mandibular dentoalveolar retrusion or protrusion associated with an imbalance between the lower lip and the chin. Management of orthognathic procedures has been improved by the recent introduction of stereolithographic surgical splints using computer-aided design (CAD) and computer-aided manufacturing (CAM) technology and piezosurgery. Piezosurgery has increased security during surgery, especially for delicate procedures associated with a high risk of nerve injury. The present report describes a combined total mandibular subapical osteotomy and Le Fort I osteotomy using piezosurgery and surgical splints fabricated using CAD and CAM for the correction of severe mouth asymmetry related to vertical dentoalveolar disharmony in a patient with PRS. (C) 2014 American Association of Oral and Maxillofacial Surgeons	[Scolozzi, Paolo] Univ Hosp Geneva, Fac Med, Dept Surg, Div Oral & Maxillofacial Surg, CH-1211 Geneva, Switzerland		Scolozzi, P (corresponding author), Univ Hosp Geneva, Fac Med, Dept Surg, Div Oral & Maxillofacial Surg, CH-1211 Geneva, Switzerland.	paolo.scolozzi@hcuge.ch					Centenero SAH, 2012, J CRANIO MAXILL SURG, V40, P162, DOI 10.1016/j.jcms.2011.03.014; ABYHOLM FE, 1995, PLAST RECONSTR SURG, V96, P71, DOI 10.1097/00006534-199507000-00011; Bell RB, 2011, J ORAL MAXIL SURG, V69, P592, DOI 10.1016/j.joms.2009.06.030; Carvalho MD, 2010, J CRANIOFAC SURG, V21, P436, DOI 10.1097/SCS.0b013e3181cfe917; Colquhoun AN, 2000, BRIT J ORAL MAX SURG, V38, P533, DOI 10.1054/bjom.2000.0461; El-Kehdy J, 2012, J AM ACAD DERMATOL, V67, P769, DOI 10.1016/j.jaad.2012.01.019; FAYAD S, 1994, J ENDODONT, V20, P299, DOI 10.1016/S0099-2399(06)80821-6; FOSTER TD, 1979, BRIT DENT J, V146, P148, DOI 10.1038/sj.bdj.4804213; Geha HJ, 2006, PLAST RECONSTR SURG, V118, P1598, DOI 10.1097/01.prs.0000232360.08768.de; Grippaudo C, 2004, CLEFT PALATE-CRAN J, V41, P95, DOI 10.1597/02-066; Guerrerosantos J, 2007, AESTHET PLAST SURG, V31, P424, DOI 10.1007/s00266-006-0215-4; Hoehnke C, 2007, J PLAST RECONSTR AES, V60, P1138, DOI 10.1016/j.bjps.2007.01.068; Hu JT, 2011, J CRANIOFAC SURG, V22, P937, DOI 10.1097/SCS.0b013e31820fe27d; INIGO F, 1993, BRIT J PLAST SURG, V46, P194; Inigo F, 2000, MICROSURG, V20, P167, DOI 10.1002/1098-2752(2000)20:4<167::AID-MICR4>3.0.CO;2-D; Labanca M, 2008, BRIT J ORAL MAX SURG, V46, P265, DOI 10.1016/j.bjoms.2007.12.007; MacIntosh R B, 1974, J Maxillofac Surg, V2, P210; McCormick SU, 2011, J ORAL MAXIL SURG, V69, P638, DOI 10.1016/j.joms.2010.10.047; O'Flynn S, 2006, INT J PAEDIATR DENT, V16, P297, DOI 10.1111/j.1365-263X.2006.00730.x; Pagnoni M, 2012, J CRANIOFAC SURG, V23, pE621, DOI 10.1097/SCS.0b013e318270f9cb; Pavlikova G, 2011, INT J ORAL MAX SURG, V40, P451, DOI 10.1016/j.ijom.2010.11.013; RONCEVIC R, 1994, BRIT J PLAST SURG, V47, P230, DOI 10.1016/0007-1226(94)90003-5; Schaeren S, 2008, J ORAL MAXIL SURG, V66, P593, DOI 10.1016/j.joms.2007.03.025; Troulis MJ, 2004, J ORAL MAXIL SURG, V62, P824, DOI 10.1016/j.joms.2003.12.021; Widmann G, 2009, ORAL SURG ORAL MED O, V107, P701, DOI 10.1016/j.tripleo.2009.02.011; You KH, 2011, J CRANIOFAC SURG, V22, P970, DOI 10.1097/SCS.0b013e31820fe339; Zinser MJ, 2012, OR SURG OR MED OR PA, V113, P673, DOI 10.1016/j.oooo.2011.11.009	28	10	11	0	13	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-2391	1531-5053		J ORAL MAXIL SURG	J. Oral Maxillofac. Surg.	MAY	2014	72	5					991	999		10.1016/j.joms.2013.09.044			9	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	AF1YX	WOS:000334510900024	24280170				2022-03-04	
J	Ardu, S				Ardu, Stefano			Shade correction technique for freehand bonded restorations	QUINTESSENCE INTERNATIONAL			English	Article						bonded restorations; chroma; color; esthetics; hue; shade; value	RESIN COMPOSITE; STRENGTH	Objective: The aim of this short communication is to describe an easy technique illustrating how to correct an esthetic mismatch between a natural tooth and a freehand bonded restoration. Method and Materials: The proposed technique is based on a case report showing the procedures required to perform a shade correction of an unesthetic anterior composite resin restoration. Results: The clinical case shows an easy and minimally invasive procedure which allows for color correction of anterior freehand bonded restorations, avoiding the complete removal of a class IV composite resin. Conclusion: This technique is suitable especially for anterior restorations whenever an imperfect color match is detected.	[Ardu, Stefano] Univ Geneva, Sch Dent, Treatment Plan Unit, CH-1205 Geneva, Switzerland; [Ardu, Stefano] Univ Geneva, Sch Dent, Div Operat Dent, CH-1205 Geneva, Switzerland		Ardu, S (corresponding author), Univ Geneva, Ecole Med Dent, Rue Barthelemy Menn 19, CH-1205 Geneva, Switzerland.	stefano.ardu@unige.ch		ardu, stefano/0000-0003-1641-2168			Ardu Stefano, 2008, Pract Proced Aesthet Dent, V20, P426; Fawzy AS, 2008, J DENT, V36, P969, DOI 10.1016/j.jdent.2008.07.014; Fondriest J, 2003, INT J PERIODONT REST, V23, P467; Papacchini F, 2007, J ADHES DENT, V9, P391; Shinchi MJ, 2000, DENT MATER, V16, P324, DOI 10.1016/S0109-5641(00)00024-5	5	0	0	0	1	QUINTESSENCE PUBLISHING CO INC	HANOVER PARK	4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA	0033-6572	1936-7163		QUINTESSENCE INT	Quintessence Int.	JAN	2014	45	1					53	55		10.3290/j.qi.a30771			3	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	297XE	WOS:000330287600007	24392495				2022-03-04	
J	Lefever, D; Gregor, L; Bortolotto, T; Krejci, I				Lefever, Dorien; Gregor, Ladislav; Bortolotto, Tissiana; Krejci, Ivo			Supragingival Relocation of Subgingivally Located Margins for Adhesive Inlays/Onlays with Different Materials	JOURNAL OF ADHESIVE DENTISTRY			English	Article						subgingival; marginal adaptation; silorane; relocation; inlays; onlays; resin composite; resin coating	BONDED INDIRECT RESTORATIONS; RESIN COMPOSITE; SELF-ETCH; DENTAL COMPOSITES; SILORANE COMPOSITE; POSTERIOR TEETH; ONE-STEP; SHRINKAGE; STABILITY; STRESS	Purpose: This study evaluated the marginal adaptation of supragingivally relocated cervical margins. Newly developed and reference materials were compared. Materials and Methods: Eighty-eight extracted human teeth were divided into 11 groups. A standardized box-shaped cavity (4.0 mm mesiodistal width, 1.5 mm axial depth) was prepared on each tooth with the cervical margin 1.3 mm below the cementoenamel junction. Seven different restorative materials (Filtek Silorane [Sill, Clearfil AP-X [APX], Clearfil Majesty Posterior [CMP], Clearfil Majesty Flow [CMFlow], RelyX Unicem [RelyX], SDR [SDR], Vertise Flow [Vert Flow]) were applied in a layer of 1.5 mm, combined with different adhesive systems (Filtek Silorane Primer + Bond [SiIPB], Clearfil Profect Bond [ClePB], Filtek Silorane Bond [SilB]). No indirect restorations (ie, inlays/onlays) were placed on these restorations. SEM analysis was performed to evaluate marginal adaptation in enamel and dentin. The results were subjected to statistical analysis by Kruskal Wallis and Duncan post-hoc tests. Results: In both dentin and enamel, statistically significant differences were present between groups (p < 0.001). In enamel, the lowest percentage of continuous margin was observed for SilPB/CMP, SilPB/APX, and ClePB/SDR, while SilPB/Sil exhibited the highest percentage of continuous margin, although this was not statistically different from other groups except for SilPB/CMP, SilPB/APX, and ClePB/SDR. In dentin, a higher percentage of continuous margin was observed for all materials than in enamel (p < 0.002). Statistically significant differences were found between ClePB/SilB/Sil, ClePB/SDR, and RelyX, SilPB/APX, ClePB/APX, and ClePB/Sil. ClePB/Sil showed the lowest marginal adaptation. Considering the overall marginal length, the best marginal adaptation was exhibited by ClePB/SilB/Sil, followed by SilPB/Sil, ClePB/SDR, and ClePB/CMP. Conclusion: Marginal adaptation of supragingivally relocated cervical margins is significantly influenced by the materials used.	[Lefever, Dorien; Gregor, Ladislav; Bortolotto, Tissiana; Krejci, Ivo] Univ Geneva, Div Cariolog & Endodontol, CH-1205 Geneva, Switzerland		Lefever, D (corresponding author), Univ Geneva, Div Cariolog & Endodontol, Rue Barthelemy Menn 19, CH-1205 Geneva, Switzerland.	dorien.lefever@unige.ch	Bortolotto, Tissiana/AAE-2796-2021	Bortolotto, Tissiana/0000-0002-3231-9097			Bagis YH, 2009, OPER DENT, V34, P578, DOI 10.2341/08-073-LR; Bouillaguet S, 2006, DENT MATER, V22, P896, DOI 10.1016/j.dental.2005.11.017; De Munck J, 2005, J DENT RES, V84, P118, DOI 10.1177/154405910508400204; De Munck J, 2003, AM J DENT, V16, P414; Dietschi D, 2003, EUR J ORAL SCI, V111, P73, DOI 10.1034/j.1600-0722.2003.00004.x; Dietschi D, 1998, Pract Periodontics Aesthet Dent, V10, P47; Dietschi D, 1998, PRAC PERIODONTICS AE, V10, P56; Duarte S, 2009, DENT MATER, V25, P589, DOI 10.1016/j.dental.2008.10.012; El-Korashy DI, 2010, OPER DENT, V35, P172, DOI 10.2341/09-072-L; FEILZER AJ, 1987, J DENT RES, V66, P1636, DOI 10.1177/00220345870660110601; Ferracane JL, 2008, OPER DENT, V33, P247, DOI 10.2341/07-BL2; Frankenberger R, 2005, DENT MATER, V21, P397, DOI 10.1016/j.dental.2004.07.005; Furuse AY, 2008, J DENT, V36, P945, DOI 10.1016/j.jdent.2008.08.001; Hikita K, 2007, DENT MATER, V23, P71, DOI 10.1016/j.dental.2005.12.002; Ilie N, 2009, DENT MATER, V25, P810, DOI 10.1016/j.dental.2009.02.005; Inoue S, 2001, J Adhes Dent, V3, P237; Leprince J, 2010, J ORAL REHABIL, V37, P364, DOI 10.1111/j.1365-2842.2010.02066.x; Lien W, DENT MAT, V26, P337; Loguercio AD, 2010, OPER DENT, V35, P265, DOI 10.2341/09-241-C; Luhrs AK, 2010, CLIN ORAL INVEST, V14, P193, DOI 10.1007/s00784-009-0279-z; Mine A, 2010, DENT MATER, V26, P524, DOI 10.1016/j.dental.2010.01.010; Palin WM, 2005, DENT MATER, V21, P852, DOI 10.1016/j.dental.2005.01.004; Park J, 2008, DENT MATER, V24, P1501, DOI 10.1016/j.dental.2008.03.013; Peumans M, 2005, DENT MATER, V21, P864, DOI 10.1016/j.dental.2005.02.003; Poggio C, 2009, INT J ARTIF ORGANS, V32, P671, DOI 10.1177/039139880903200917; Radovic I, 2008, J ADHES DENT, V10, P251; Rocca GT, 2007, QUINTESSENCE INT, V38, P371; Rocca GT, 2007, QUINTESSENCE INT, V38, P543; Santini A, 2008, J DENT, V36, P683, DOI 10.1016/j.jdent.2008.04.016; Tezvergil-Mutluay A, 2008, J DENT, V36, P560, DOI 10.1016/j.jdent.2008.03.008; Van Ende A, DENT MAT, V26, P215; Walter R, 2009, QUINTESSENCE INT, V40, P843; Weinmann W, 2005, DENT MATER, V21, P68, DOI 10.1016/j.dental.2004.10.007	33	13	15	0	3	QUINTESSENCE PUBLISHING CO INC	HANOVER PARK	4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA	1461-5185			J ADHES DENT	J. Adhes. Dent.	DEC	2012	14	6					561	567		10.3290/j.jad.a27795			7	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	056DJ	WOS:000312468300009	22724114				2022-03-04	
J	Antonarakis, GS; Kiliaridis, S				Antonarakis, Gregory Stylianos; Kiliaridis, Stavros			Maxillary Molar Distalization with Noncompliance Intramaxillary Appliances in Class II Malocclusion	ANGLE ORTHODONTIST			English	Review						Class II malocclusion; Noncompliance; Molar distalization	PENDULUM APPLIANCE; DISTAL MOVEMENT; 2ND MOLARS; 1ST; EFFICIENCY; ERUPTION; COILS	Objective: To use published data to evaluate quantitatively the dental effects of noncompliance intramaxillary appliances in individuals with Class II malocclusion. Materials and Methods: A literature search was carried out identifing 13 prospective or retrospective clinical studies matching inclusion criteria. Only appliances with conventional anchorage designs were considered for the review. The data provided in these publications were grouped and analyzed in terms of molar distalization, tipping and vertical movements, and incisor and premolar mesialization, tipping, and vertical movements. Results: Maxillary first molars showed distal crown movement and tipping greater than the mesial crown movement and tipping shown by incisors and premolars. Vertical movements of incisors and premolars were in general extrusive, but molars were intrusive or extrusive, depending on the study and the type of appliance used. Appliances that acted palatally seemed to display a smaller distal tipping movement, as well as smaller incisor and premolar mesial tipping movements, when compared with those that acted buccally. Friction-free appliances, namely the pendulum, produced a large amount of mesiodistal movement and tipping, if no therapeutic uprighting activation was applied. Conclusions: Noncompliance intramaxillary molar distalization appliances all act by distalizing molars with a concomitant and unavoidable loss of anchorage, as revealed by incisor and premolar mesial movement. Buccal acting and palatal acting appliances demonstrate almost similar results, with palatal acting appliances showing less tipping. Friction-free palatal acting appliances appear to produce better molar distalizing effects, but with a concomitant notable loss of anchorage.	[Antonarakis, Gregory Stylianos; Kiliaridis, Stavros] Univ Geneva, Sch Dent, Dept Orthodont, CH-1205 Geneva, Switzerland		Antonarakis, GS (corresponding author), Univ Geneva, Sch Dent, Dept Orthodont, 19 Rue Barthelemy Menn, CH-1205 Geneva, Switzerland.	Gregory.Antonarakis@medecine.unige.ch	Antonarakis, Gregory/ABA-1855-2020	Antonarakis, Gregory/0000-0001-6741-6922			BONDEMARK L, 1994, ANGLE ORTHOD, V64, P189; Bondemark L, 2005, ANGLE ORTHOD, V75, P699; Bondemark L, 1992, Eur J Orthod, V14, P264; Bondemark L, 1998, J Orofac Orthop, V59, P127, DOI 10.1007/BF01317174; Bondemark L, 2000, EUR J ORTHODONT, V22, P683, DOI 10.1093/ejo/22.6.683; Byloff FK, 1997, ANGLE ORTHOD, V67, P261; Byloff FK, 1997, ANGLE ORTHOD, V67, P249; Carano A, 1996, J Clin Orthod, V30, P374; Chaques-Asensi J, 2001, J Clin Orthod, V35, P254; Dahlberg G., 1940, STAT METHODS MEDICAL, P122; Erverdi N, 1997, Br J Orthod, V24, P47; Ferguson Donald J, 2005, World J Orthod, V6, P382; Ghosh J, 1996, AM J ORTHOD DENTOFAC, V110, P639, DOI 10.1016/S0889-5406(96)80041-2; GIANELLY AA, 1991, AM J ORTHOD DENTOFAC, V99, P564, DOI 10.1016/S0889-5406(05)81633-6; Hilgers J J, 1992, J Clin Orthod, V26, P706; JOSEPH AA, 2000, SEMIN ORTHOD, V6, P129; Karlsson I, 2006, ANGLE ORTHOD, V76, P923, DOI 10.2319/110805-390; Kinzinger GSM, 2007, EUR J ORTHODONT, V29, P1, DOI 10.1093/ejo/cjl028; Kinzinger GSM, 2005, ANGLE ORTHOD, V75, P558; Kinzinger GSM, 2005, AM J ORTHOD DENTOFAC, V127, P314, DOI 10.1016/j.ajodo.2004.09.014; Kinzinger GSM, 2004, AM J ORTHOD DENTOFAC, V125, P8, DOI 10.1016/j.ajodo.2003.02.002; Mavropoulos A, 2005, ANGLE ORTHOD, V75, P532; Mavropoulos A, 2003, AM J ORTHOD DENTOFAC, V124, P30, DOI 10.1016/S0889-5406(03)00199-9; Ngantung V, 2001, AM J ORTHOD DENTOFAC, V120, P178, DOI 10.1067/mod.2001.114645; Papadopoulos M A, 2003, Orthod Craniofac Res, V6, P112; Papadopoulos Moschos A, 2004, J Orofac Orthop, V65, P123, DOI 10.1007/s00056-004-0317-z; Sayinsu K, 2006, EUR J ORTHODONT, V28, P361, DOI 10.1093/ejo/cji118; STONDRINI MF, 2002, ORTHOD CRANIOFAC RES, V5, P114; Toro&gbreve;lu Ms, 2001, Clin Orthod Res, V4, P15, DOI 10.1034/j.1600-0544.2001.040103.x	29	50	54	0	9	E H ANGLE EDUCATION RESEARCH FOUNDATION, INC	NEWTON N	1615 BEACON ST, NEWTON N, MA 02468-1507 USA	0003-3219	1945-7103		ANGLE ORTHOD	Angle Orthod.	NOV	2008	78	6					1133	1140		10.2319/101507-406.1			8	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	369XT	WOS:000260727900028	18947282	gold			2022-03-04	
J	Ardu, S; Stavridakis, M; Krejci, I				Ardu, Stefano; Stavridakis, Minos; Krejci, Ivo			A minimally invasive treatment of severe dental fluorosis	QUINTESSENCE INTERNATIONAL			English	Article						fluorosis; microabrasion; micromorphology; minimally invasive treatment	FLUORIDE	This article describes a minimally invasive technique to treat a severe case of enamel fluorosis using microabrasion to eliminate the hypermineralized, white-colored, superficial enamel layer, followed by home bleaching treatment and chairside re-creation of superficial enamel microstructure. The proposed technique may improve the esthetics of fluorotic teeth without requiring other restorative procedures. Microabrasion followed by home bleaching may be an interesting alternative for the restorative treatment of teeth affected by fluorosis.	Univ Geneva, Div Cardiol & Endodontol, Sch Dent, CH-1205 Geneva, Switzerland; Univ Geneva, Dept Operat Dent, Sch Dent, CH-1205 Geneva, Switzerland; Univ Geneva, Div Cariol & Endodontol, Sch Dent, CH-1205 Geneva, Switzerland		Ardu, S (corresponding author), Univ Geneva, Div Cardiol & Endodontol, Sch Dent, Rue Barthelemy Menn 19, CH-1205 Geneva, Switzerland.	stefano.ardu@medecine.unige.ch		ardu, stefano/0000-0003-1641-2168			Akpata ES, 2001, INT DENT J, V51, P325, DOI 10.1002/j.1875-595X.2001.tb00845.x; Browne D, 2005, J DENT, V33, P177, DOI 10.1016/j.jdent.2004.10.003; Buzalaf MAR, 2001, J DENT CHILD, V68, P37; Croll T P, 1989, Quintessence Int, V20, P395; Croll T P, 1994, Quintessence Int, V25, P811; DEAN H. T., 1941, PUBL HEALTH REPTS, V56, P761, DOI 10.2307/4583693; Dean HT, 1942, PUBLIC HEALTH REP, V57, P1155, DOI 10.2307/4584182; Fejerskov O.M.F., 1988, HDB HLTH WORKERS; Robinson C, 2004, CARIES RES, V38, P268, DOI 10.1159/000077766; Scherer W, 1992, Pract Periodontics Aesthet Dent, V4, P11; Segura A, 1997, Quintessence Int, V28, P463; Whelton H, 2004, Community Dent Health, V21, P37; Whelton HP, 2004, COMMUNITY DENT ORAL, V32, P9, DOI 10.1111/j.1600-0528.2004.00134.x	13	22	22	0	8	QUINTESSENCE PUBLISHING CO INC	HANOVER PARK	4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA	0033-6572	1936-7163		QUINTESSENCE INT	Quintessence Int.	JUN	2007	38	6					455	458					4	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	188NS	WOS:000247927200002	17625627				2022-03-04	
J	Ardu, S; Perroud, R; Krejci, I				Ardu, Stefano; Perroud, Reymond; Krejci, Ivo			Extended sealing of interproximal caries lesions	QUINTESSENCE INTERNATIONAL			English	Article						caries lesion; caries risk; fluoride; minimally invasive dentistry; proximal lesion; resin composite	MINIMAL INTERVENTION DENTISTRY; TUNNEL RESTORATIONS	In recent years the concept of minimally invasive dentistry has offered a more conservative approach to restoration of teeth with caries lesions. Several techniques have been suggested for treatment of proximal lesions, but their results have been less than ideal. The aim of this article is to present a new technique for ultraconservative restoration of small interproximal caries lesions that avoids the disadvantages of both the tunnel and the proximal slot restorative techniques. Two cases, of patients with high and low caries risk, are presented to illustrate the technique. The proposed technique can be considered the most conservative alternative to conventional Class 2 or slot-cavity treatment approaches.	Univ Geneva, Ecole Med Dent, Sch Dent, Div Cariol & Endodontol, CH-1205 Geneva, Switzerland		Ardu, S (corresponding author), Univ Geneva, Ecole Med Dent, Sch Dent, Div Cariol & Endodontol, Rue Barthelemy Merin 19, CH-1205 Geneva, Switzerland.	stefano.ardu@medecine.unige.ch		ardu, stefano/0000-0003-1641-2168			Aranha ACC, 2004, AM J DENT, V17, P99; BLACK GV, 1892, DENT COSMOS, V33, P1; Hirt T, 1987, Schweiz Monatsschr Zahnmed, V97, P1260; Hunt P R, 1984, Quintessence Int Dent Dig, V15, P1011; KNIGHT GM, 1984, DENT OUTLOOK, V10, P53; Mount GJ, 2003, OPER DENT, V28, P92; Nicolaisen S, 2000, J DENT, V28, P383, DOI 10.1016/S0300-5712(00)00024-5; REEH ES, 1989, J ENDODONT, V15, P512, DOI 10.1016/S0099-2399(89)80191-8; Strand GV, 1996, EUR J ORAL SCI, V104, P384, DOI 10.1111/j.1600-0722.1996.tb00096.x; Strand GV, 2000, QUINTESSENCE INT, V31, P453; Strobel WO, 2005, J ORAL REHABIL, V32, P606, DOI 10.1111/j.1365-2842.2005.01459.x; Tyas MJ, 2000, INT DENT J, V50, P1, DOI 10.1111/j.1875-595X.2000.tb00540.x	12	12	12	0	2	QUINTESSENCE PUBLISHING CO INC	HANOVER PARK	4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA	0033-6572			QUINTESSENCE INT	Quintessence Int.	JUN	2006	37	6					423	427					5	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	080NM	WOS:000240254600002	16752697				2022-03-04	
J	Grand, E; Burgener, E; Samson, J; Lombardi, T				Grand, Emmanuel; Burgener, Emmanuel; Samson, Jacky; Lombardi, Tommaso			Post-traumatic development of a peripheral giant cell granuloma in a child	DENTAL TRAUMATOLOGY			English	Article							MAXILLARY BROWN TUMOR; SECONDARY HYPERPARATHYROIDISM; MANIFESTATION; GINGIVA; LESIONS	The peripheral giant cell granuloma (PGCG) is a benign hyperplastic gingival lesion of unknown aetiology occurring mostly in adults. A few cases have been described in children where a more aggressive clinical behaviour has been observed. In this paper, we report a case of PGCG localized in the anterior region of the maxilla of a 6-year-old boy which developed 6 months following a traumatic event. Early detection and treatment of PGCG is important to reduce possible dento-alveolar complications such as bone loss or displacement of dental germs or teeth.	[Grand, Emmanuel; Samson, Jacky; Lombardi, Tommaso] Univ Geneva, Sch Dent Med, Div Stomatol & Oral Surg, Fac Med, CH-1205 Geneva, Switzerland		Grand, E (corresponding author), Univ Geneva, Sch Dent Med, Div Stomatol & Oral Surg, Fac Med, 19 Rue Barthelemy Menn, CH-1205 Geneva, Switzerland.	grand@medicine.unige.ch					ANNEROTH G, 1983, ACTA ODONTOL SCAND, V41, P75, DOI 10.3109/00016358309162306; ATTIE J N, 1960, Oral Surg Oral Med Oral Pathol, V13, P482, DOI 10.1016/0030-4220(60)90353-4; BAER P N, 1985, Journal of Pedodontics, V9, P351; BERGDAHL L, 1975, AM SURGEON, V41, P650; Bhat S S, 1999, J Indian Soc Pedod Prev Dent, V17, P93; BURKES EJ, 1989, J AM DENT ASSOC, V118, P62, DOI 10.14219/jada.archive.1989.0005; CHADWICK BL, 1989, BRIT DENT J, V167, P279, DOI 10.1038/sj.bdj.4806999; Eronat N, 2000, J Clin Pediatr Dent, V24, P245; Flaitz Catherine M., 2000, Pediatric Dentistry, V22, P232; GURUMURTHY K, 1982, J PEDIATR-US, V100, P245, DOI 10.1016/S0022-3476(82)80647-1; KATSIKERIS N, 1988, INT J ORAL MAX SURG, V17, P94, DOI 10.1016/S0901-5027(88)80158-9; KFIR Y, 1980, J PERIODONTOL, V51, P655, DOI 10.1902/jop.1980.51.11.655; LEVIN LA, 1984, INFORM CONTROL, V61, P15, DOI 10.1016/S0019-9958(84)80060-1; LEVINE N, 1984, ONT DENT, V61, P17; Mortellaro C, 2005, J CRANIOFAC SURG, V16, P45, DOI 10.1097/00001665-200501000-00010; Pandolfi P J, 1999, J Clin Pediatr Dent, V23, P353; Shields J A, 1994, J Ir Dent Assoc, V40, P39; STRATAKIS CA, 1995, J PEDIATR-US, V127, P444, DOI 10.1016/S0022-3476(95)70081-1; WEISS RR, 1980, JAMA-J AM MED ASSOC, V243, P1929, DOI 10.1001/jama.243.19.1929; WOLFSON L, 1989, AM J ORTHOD DENTOFAC, V96, P519, DOI 10.1016/0889-5406(89)90120-0	20	6	7	0	2	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	1600-4469			DENT TRAUMATOL	Dent. Traumatol.	FEB	2008	24	1					124	126		10.1111/j.1600-9657.2006.00504.x			3	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	242PV	WOS:000251738700028	18173683				2022-03-04	
J	Jonasson, G; Kiliaridis, S				Jonasson, G; Kiliaridis, S			Prediction of osteoporosis using simple oral variables.	JOURNAL OF DENTAL RESEARCH			English	Meeting Abstract									Univ Geneva, Geneva, Switzerland									0	0	0	0	0	INT AMER ASSOC DENTAL RESEARCHI A D R/A A D R	ALEXANDRIA	1619 DUKE ST, ALEXANDRIA, VA 22314-3406 USA	0022-0345			J DENT RES	J. Dent. Res.	MAR	2002	81				SI	1286	A178	A178					1	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	559KE	WOS:000176024701272					2022-03-04	
J	Huyghe, A; Francois, P; Mombelli, A; Tangomo, M; Girard, M; Baratti-Mayer, D; Bolivar, I; Pittet, D; Schrenzel, J				Huyghe, Antoine; Francois, Patrice; Mombelli, Andrea; Tangomo, Manuela; Girard, Myriam; Baratti-Mayer, Denise; Bolivar, Ignacio; Pittet, Didier; Schrenzel, Jacques		Geneva Study Grp Noma GESNOMA	Microarray Analysis of Microbiota of Gingival Lesions in Noma Patients	PLOS NEGLECTED TROPICAL DISEASES			English	Article							PREVOTELLA-INTERMEDIA; CANCRUM ORIS; ANAEROBIC MICROBIOLOGY; BACTERIAL DIVERSITY; CHILDREN; INFECTIONS; AMPLIFICATION; PERIODONTITIS; ENDODONTALIS; NIGRESCENS	Noma (cancrum oris) is a gangrenous disease of unknown etiology affecting the maxillo-facial region of young children in extremely limited resource countries. In an attempt to better understand the microbiological events occurring during this disease, we used phylogenetic and low-density microarrays targeting the 16S rRNA gene to characterize the gingival flora of acute noma and acute necrotizing gingivitis (ANG) lesions, and compared them to healthy control subjects of the same geographical and social background. Our observations raise doubts about Fusobacterium necrophorum, a previously suspected causative agent of noma, as this species was not associated with noma lesions. Various oral pathogens were more abundant in noma lesions, notably Atopobium spp., Prevotella intermedia, Peptostreptococcus spp., Streptococcus pyogenes and Streptococcus anginosus. On the other hand, pathogens associated with periodontal diseases such as Aggregatibacter actinomycetemcomitans, Capnocytophaga spp., Porphyromonas spp. and Fusobacteriales were more abundant in healthy controls. Importantly, the overall loss of bacterial diversity observed in noma samples as well as its homology to that of ANG microbiota supports the hypothesis that ANG might be the immediate step preceding noma.	[Huyghe, Antoine; Francois, Patrice; Tangomo, Manuela; Girard, Myriam; Schrenzel, Jacques] Univ Hosp Geneva, Infect Dis Serv, Genom Res Lab, Geneva, Switzerland; [Huyghe, Antoine] Univ Geneva, Dept Plant Biol, Microbiol Unit, Geneva, Switzerland; [Mombelli, Andrea] Univ Geneva, Sch Dent Med, Dept Periodontol, Geneva, Switzerland; [Baratti-Mayer, Denise] Fac Med, Geneva, Switzerland; [Bolivar, Ignacio] Inst Angew Immunol, Geneva, Switzerland; [Pittet, Didier] Univ Geneva, Fac Med, Infect Control Program, Geneva, Switzerland		Huyghe, A (corresponding author), Univ Hosp Geneva, Infect Dis Serv, Genom Res Lab, Geneva, Switzerland.	patrice.francois@genomic.ch	francois, patrice/AAL-5583-2020; Schrenzel, Jacques/P-8525-2017; Schrenzel, Jacques/AAC-5685-2021	Schrenzel, Jacques/0000-0001-5464-7764; Schrenzel, Jacques/0000-0001-5464-7764; francois, patrice/0000-0002-0540-750X	GESNOMA research program; Hirzel Foundation	The study was supported by the GESNOMA research program. The GESNOMA research program is funded by the Hirzel Foundation. The funding source had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1986, B WORLD HEALTH ORGAN, V64, P929; Aziz RK, 2008, EMERG INFECT DIS, V14, P1511, DOI 10.3201/eid1410.071660; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; Baratti-Mayer D, 2003, LANCET INFECT DIS, V3, P419, DOI 10.1016/S1473-3099(03)00670-4; Baratti-Mayer D, 2013, LANCET GLOBAL HLTH; Barmes DE, 1997, TROP MED INT HEALTH, V2, P1111, DOI 10.1046/j.1365-3156.1997.d01-220.x; Bisno AL, 1996, NEW ENGL J MED, V334, P240, DOI 10.1056/NEJM199601253340407; Blackwood CB, 2005, APPL ENVIRON MICROB, V71, P6193, DOI 10.1128/AEM.71.10.6193-6198.2005; Bolivar I, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001556; Bourgeois DM, 1999, ORAL DIS, V5, P172; Brook I, 1997, J ANTIMICROB CHEMOTH, V39, P763, DOI 10.1093/jac/39.6.763; Brook I, 2000, OTOLARYNG HEAD NECK, V122, P696, DOI 10.1016/S0194-5998(00)70199-9; BROOK I, 1991, J PEDIATR SURG, V26, P207, DOI 10.1016/0022-3468(91)90912-D; Brook I, 2004, ANN OTO RHINOL LARYN, V113, P830, DOI 10.1177/000348940411301010; Brook I, 2004, EUR J PEDIATR SURG, V14, P265, DOI 10.1055/s-2004-817895; Brook I, 2004, PEDIATR DERMATOL, V21, P113, DOI 10.1111/j.0736-8046.2004.21204.x; BROOK I, 1995, INT J PEDIATR OTORHI, V31, P23, DOI 10.1016/0165-5876(94)01063-4; Brook I, 1998, J ACCID EMERG MED, V15, P162; Brook I, 2001, ANN OTO RHINOL LARYN, V110, P844, DOI 10.1177/000348940111000908; Brook I, 2001, PEDIATRICS, V108, part. no., DOI 10.1542/peds.108.1.e17; Brook I, 1998, ARCH OTOLARYNGOL, V124, P35, DOI 10.1001/archotol.124.1.35; Brook I, 2000, PEDIATR NEUROSURG, V32, P20, DOI 10.1159/000028892; Charbonnier Y, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-95; Cole JR, 2005, NUCLEIC ACIDS RES, V33, pD294, DOI 10.1093/nar/gki038; Colombo APV, 2009, J PERIODONTOL, V80, P1421, DOI 10.1902/jop.2009.090185; Dahlen G, 2011, EXPERT REV ANTI-INFE, V9, P227, DOI [10.1586/eri.10.172, 10.1586/ERI.10.172]; DODDS B, 1988, LARYNGOSCOPE, V98, P956; ENWONWU CO, 1972, ARCH ORAL BIOL, V17, P1357, DOI 10.1016/0003-9969(72)90169-0; Enwonwu CO, 1999, ORAL DIS, V5, P144; ENWONWU CO, 1995, B WORLD HEALTH ORGAN, V73, P541; Enwonwu CO, 2000, CRIT REV ORAL BIOL M, V11, P159, DOI 10.1177/10454411000110020201; Enwonwu CO, 2006, LANCET, V368, P147, DOI 10.1016/S0140-6736(06)69004-1; Falkler WA, 1999, AM J TROP MED HYG, V60, P150, DOI 10.4269/ajtmh.1999.60.150; Falkler WW, 2000, ORAL DIS, V6, P103, DOI 10.1111/j.1601-0825.2000.tb00109.x; Francois P, 2007, J MICROBIOL METH, V68, P385, DOI 10.1016/j.mimet.2006.09.022; FRANDSEN EVG, 1995, ORAL MICROBIOL IMMUN, V10, P291, DOI 10.1111/j.1399-302X.1995.tb00157.x; GHARBIA SE, 1994, J PERIODONTOL, V65, P56, DOI 10.1902/jop.1994.65.1.56; Horning G M, 1996, Compend Contin Educ Dent, V17, P951; Huyghe A, 2008, APPL ENVIRON MICROB, V74, P1876, DOI 10.1128/AEM.01722-07; Isenbarger TA, 2008, APPL ENVIRON MICROB, V74, P840, DOI 10.1128/AEM.01933-07; Lazarevic V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067699; Loy A, 2007, NUCLEIC ACIDS RES, V35, pD800, DOI 10.1093/nar/gkl856; Parahitiyawa NB, 2010, ORAL DIS, V16, P136, DOI 10.1111/j.1601-0825.2009.01607.x; Paster BJ, 2001, J BACTERIOL, V183, P3770, DOI 10.1128/JB.183.12.3770-3783.2001; Paster BJ, 2002, J CLIN MICROBIOL, V40, P2187, DOI 10.1128/JCM.40.6.2187-2191.2002; Phillips RS, 1995, EUR CYTOKINE NETW, V16, P70; Preza D, 2008, J CLIN MICROBIOL, V46, P2015, DOI 10.1128/JCM.02411-07; Rautio M, 2000, PEDIATR INFECT DIS J, V19, P1078, DOI 10.1097/00006454-200011000-00010; Rocas IN, 2008, J CLIN MICROBIOL, V46, P3599, DOI 10.1128/JCM.00431-08; SLOTS J, 1986, J CLIN PERIODONTOL, V13, P912, DOI 10.1111/j.1600-051X.1986.tb01426.x; Srour ML, 2008, AM J TROP MED HYG, V78, P539, DOI 10.4269/ajtmh.2008.78.539; Tan Pei-Ti, 2001, Journal of Microbiology Immunology and Infection, V34, P287; Tomazinho LF, 2007, ORAL SURG ORAL MED O, V103, P285, DOI 10.1016/j.tripleo.2006.05.010; VANWINKELHOFF AJ, 1985, INFECT IMMUN, V49, P494, DOI 10.1128/IAI.49.3.494-497.1985; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Wennstrom J L, 1987, Oral Microbiol Immunol, V2, P158, DOI 10.1111/j.1399-302X.1987.tb00300.x; WHILEY RA, 1990, J CLIN MICROBIOL, V28, P1497, DOI 10.1128/JCM.28.7.1497-1501.1990	57	16	16	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	SEP	2013	7	9							e2453	10.1371/journal.pntd.0002453			11	Infectious Diseases; Parasitology; Tropical Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Infectious Diseases; Parasitology; Tropical Medicine	224WA	WOS:000324920800052	24086784	Green Submitted, Green Published, gold			2022-03-04	
J	Graz, B; Kitua, AY; Malebo, HM				Graz, Bertrand; Kitua, Andrew Y.; Malebo, Hamisi M.			To what extent can traditional medicine contribute a complementary or alternative solution to malaria control programmes?	MALARIA JOURNAL			English	Review							SULFADOXINE-PYRIMETHAMINE; NATURAL-PRODUCTS; ARTEMISININ; RESISTANCE; DRUGS	Recent studies on traditional medicine (TM) have begun to change perspectives on TM effects and its role in the health of various populations. The safety and effectiveness of some TMs have been studied, paving the way to better collaboration between modern and traditional systems. Traditional medicines still remain a largely untapped health resource: they are not only sources of new leads for drug discoveries, but can also provide lessons and novel approaches that may have direct public-health and economic impact. To optimize such impact, several interventions have been suggested, including recognition of TM's economic and medical worth at academic and health policy levels; establishing working relationships with those prescribing TM; providing evidence for safety and effectiveness of local TM through appropriate studies with malaria patients; spreading results for clinical recommendations and health policy development; implementing and evaluating results of new health policies that officially integrate TM.	[Graz, Bertrand] Univ Geneva, IMSP CMU, CH-1211 Geneva 4, Switzerland; [Kitua, Andrew Y.] Special Programme Res & Training Trop Dis WHO IDR, CH-1211 Geneva 27, Switzerland; [Malebo, Hamisi M.] Natl Inst Med Res, Dar Es Salaam, Tanzania		Graz, B (corresponding author), Univ Geneva, IMSP CMU, 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland.	Bertrand.Graz@chuv.ch	Malebo, Hamisi/AAX-1833-2021	Malebo, Hamisi Masanja/0000-0001-6081-9120			[Anonymous], 1979, CHINESE MED J-PEKING, V92, P811; Appelbaum D, 2006, ACAD MED, V81, P1098, DOI 10.1097/01.ACM.0000246681.34207.a7; Enosse S, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-115; Gomes MF, 2009, LANCET, V373, P557, DOI 10.1016/S0140-6736(08)61734-1; Graz B, 2010, EVID-BASED COMPL ALT, V7, P471, DOI 10.1093/ecam/nen022; Graz B, 2010, T ROY SOC TROP MED H, V104, P33, DOI 10.1016/j.trstmh.2009.07.005; HIEN TT, 1993, LANCET, V341, P603; Hirt HM, 2008, NATURAL MED TROPICS, VThirdth; Hopkins H, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-134; Hsu E., 2010, PLANTS HLTH HEALING; Karou D, 2007, MED AROMATIC PLANT S, V1, P1; Kayser O, 2003, PARASITOL RES, V90, pS55, DOI 10.1007/s00436-002-0768-3; KLAYMAN DL, 1985, SCIENCE, V228, P1049, DOI 10.1126/science.3887571; KLAYMAN DL, 1984, J NAT PROD, V47, P715, DOI 10.1021/np50034a027; Kong JM, 2003, ACTA PHARMACOL SIN, V24, P7; Mandi G, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-58; Mueller MS, 2004, T ROY SOC TROP MED H, V98, P318, DOI 10.1016/j.trstmh.2003.09.001; Munier A, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-83; Newman DJ, 2000, NAT PROD REP, V17, P215, DOI 10.1039/a902202c; Phillipson JD, 1999, PHYTOTHER RES, V13, P2, DOI 10.1002/(SICI)1099-1573(199902)13:1&lt;2::AID-PTR471&gt;3.0.CO;2-K; Phillipson JD, 2001, PHYTOCHEMISTRY, V56, P237, DOI 10.1016/S0031-9422(00)00456-8; Some AF, 2010, ANTIMICROB AGENTS CH, V54, P1949, DOI 10.1128/AAC.01413-09; Ssegawa Paul, 2007, Journal of Ethnobiology, V27, P110, DOI 10.2993/0278-0771(2007)27[110:PFMTIS]2.0.CO;2; WHO, 2010, GUID TREATM MAL, P2; WHO, 2004, GUID SAF MON HERB ME; WHO, 2003, SUBST COUNT MED; WHO, 2000, GEN GUID METH RES EV; Willcox M, 2004, TRADITIONAL MED PLAN; Willcox M, 2009, J ALTERN COMPLEM MED, V15, P101, DOI 10.1089/acm.2008.0327; Willcox ML, 2004, BMJ-BRIT MED J, V329, P1156, DOI 10.1136/bmj.329.7475.1156; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	41	15	15	0	6	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1475-2875		MALARIA J	Malar. J.	MAR 15	2011	10			1					S6	10.1186/1475-2875-10-S1-S6			7	Infectious Diseases; Parasitology; Tropical Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Infectious Diseases; Parasitology; Tropical Medicine	759GW	WOS:000290229700006	21411017	gold, Green Published			2022-03-04	
J	Legaz, J; Karasan, D; Fehmer, V; Sailer, I				Legaz, Juan; Karasan, Duygu; Fehmer, Vincent; Sailer, Irena			The 3D-printed prototype: a new protocol for the evaluation and potential adaptation of monolithic all-ceramic restorations before finalization	QUINTESSENCE INTERNATIONAL			English	Article						CAD/CAM; ceramics; diagnostic procedure; digital workflow; prosthodontics	GRINDING DAMAGE ASSESSMENT; SURFACE-ROUGHNESS; DENTAL PROSTHESES; ZIRCONIA; ACCURACY; SURVIVAL; ENAMEL; WEAR	The prototyping protocol to evaluate and make the potential adjustments prior to finalization of the monolithic restorations was described by two clinical situations. In the first case report, following the digital impressions using an intraoral scanner (3ShapeTrios, 3Shape) for an implant-supported four-unit fixed dental prosthesis, a digital design (3Shape Dental System, 3Shape) was performed and a prototype using subtractive CAM (milling) (PMMA, Telio CAD, Ivoclar Vivadent) was fabricated. The second case highlights the 3D-printed prototyping (additive CAM) (Sheraprint Model Plus UV, Shera) following digital impressions using an intraoral scanner and digital design in a patient requiring two opposing open-end three-unit fixed dental prostheses. By means of prototyping, the esthetic, fitting, and functional properties could be tested and the adjustments were completed on the prototypes. It is suggested that prototyping is an efficient tool that minimizes the clinical adjustment need for the final restoration while improving the communication between the dental practitioner and the technician.	[Legaz, Juan; Karasan, Duygu; Fehmer, Vincent; Sailer, Irena] Univ Geneva, Ctr Dent Med, Div Fixed Prosthodont & Biomat, 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland		Legaz, J (corresponding author), Univ Geneva, Ctr Dent Med, Div Fixed Prosthodont & Biomat, 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland.	Juan.Legaz@unige.ch					Barazanchi A, 2017, J PROSTHODONT, V26, P156, DOI 10.1111/jopr.12510; Bukhari S, 2018, J PROSTHET DENT, V119, P530, DOI 10.1016/j.prosdent.2017.07.008; Canneto JJ, 2016, DENT MATER, V32, P171, DOI 10.1016/j.dental.2015.11.028; Curran P, 2017, DENT MATER, V33, P294, DOI 10.1016/j.dental.2016.12.004; Di Giacomo Giovanni, 2014, Eur J Dent, V8, P100, DOI 10.4103/1305-7456.126257; Di Giacomo GA, 2012, J PERIODONTOL, V83, P410, DOI 10.1902/jop.2011.110115; Di Giacomo GDP, 2016, J PROSTHET DENT, V116, P874, DOI 10.1016/j.prosdent.2016.04.018; Flugge T, 2018, CLIN ORAL IMPLAN RES, V29, P374, DOI 10.1111/clr.13273; Gou M, 2019, J PROSTHET DENT, V121, P598, DOI 10.1016/j.prosdent.2018.06.005; Hammerle CHF, 2015, CLIN ORAL IMPLAN RES, V26, P97, DOI 10.1111/clr.12648; Kois DE, 2008, J ESTHET RESTOR DENT, V20, P239, DOI 10.1111/j.1708-8240.2008.00186.x; Lawson NC, 2014, J DENT, V42, P1586, DOI 10.1016/j.jdent.2014.09.008; Lee DH, 2019, J ADV PROSTHODONT, V11, P41, DOI 10.4047/jap.2019.11.1.41; Magne P, 1996, INT J PERIODONT REST, V16, P561; MIETTINEN T, 2016, J MED ENG, V2016; Nakamura Y, 2010, DENT MATER J, V29, P30, DOI 10.4012/dmj.2009-059; Passos SP, 2014, J PROSTHODONT, V23, P593, DOI 10.1111/jopr.12167; Pjetursson BE, 2015, DENT MATER, V31, P624, DOI 10.1016/j.dental.2015.02.013; Sailer I, 2018, CLIN ORAL IMPLAN RES, V29, P184, DOI 10.1111/clr.13277; Salmi M, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0203; Sancho-Puchades M, 2015, INT J ESTHET DENT, V10, P374; Schweiger J, 2016, BRIT DENT J, V221, P555, DOI 10.1038/sj.bdj.2016.815; Tahayeri A, 2018, DENT MATER, V34, P192, DOI 10.1016/j.dental.2017.10.003; van Noort R, 2012, DENT MATER, V28, P3, DOI 10.1016/j.dental.2011.10.014; Zhang Y, 2013, J DENT, V41, P1135, DOI 10.1016/j.jdent.2013.10.007	25	0	0	2	5	QUINTESSENCE PUBLISHING CO INC	HANOVER PARK	4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA	0033-6572	1936-7163		QUINTESSENCE INT	Quintessence Int.	JUL-AUG	2020	51	7					538	544		10.3290/j.qi.a44635			7	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	MA4UX	WOS:000541911400003	32500861				2022-03-04	
J	Ardu, S; Castioni, NV; Benbachir, N; Krejci, I				Ardu, Stefano; Castioni, Nathalie Vivien; Benbachir, Nacer; Krejci, Ivo			Minimally invasive treatment of white spot enamel lesions	QUINTESSENCE INTERNATIONAL			English	Article						CCP-ACP; microabrasion; minimally invasive treatment; white spot lesions	AMORPHOUS CALCIUM-PHOSPHATE; FREE CHEWING GUM; CASEIN PHOSPHOPEPTIDE; SUBSURFACE LESIONS; STREPTOCOCCUS-MUTANS; REMINERALIZATION; CHEESE; CARIES; PLAQUE; RATS	This article describes a technique used to treat superficial white spot lesions by a Minimally invasive approach. The proposed technique is based on reactivation of enamel by elimination of its hypermineralized external layer through microabrasion, followed by daily home application of casein phosphopeptide-amorphous calcium phosphate complexes (CCP-ACP). The technique may allow elimination of white spot lesions without involving restorative procedures. Microabrasion followed by long-term daily home application of CCP-ACP may be considered an interesting alternative to the restorative approach for treatment of white spot lesions.	Univ Geneva, Sch Dent, Div Cardiol & Endodontol, CH-1205 Geneva, Switzerland; Univ Geneva, Sch Dent, Div Prevent Med, CH-1205 Geneva, Switzerland		Ardu, S (corresponding author), Univ Geneva, Ecole Med Dentaire, Rue Barthelemy Menn 19, CH-1205 Geneva, Switzerland.	stefano.ardu@medecine.unige.ch		ardu, stefano/0000-0003-1641-2168			BERLAND LF, 1998, DENT TODAY, V17, P54; BERLAND LF, 1998, DENT TODAY, V17, P50; Cai F, 2003, AUST DENT J, V48, P240, DOI 10.1111/j.1834-7819.2003.tb00037.x; Croll T P, 1989, Quintessence Int, V20, P395; HARPER DS, 1986, CARIES RES, V20, P123, DOI 10.1159/000260931; Holt C, 1996, BIOCHEM J, V314, P1035, DOI 10.1042/bj3141035; Iijima Y, 2004, CARIES RES, V38, P551, DOI 10.1159/000080585; KROBICKA A, 1987, J DENT RES, V66, P1116, DOI 10.1177/00220345870660060501; Malterud Mark I, 2006, Pract Proced Aesthet Dent, V18, P409; REYNOLDS EC, 1987, J DENT RES, V66, P1120, DOI 10.1177/00220345870660060601; Reynolds EC, 1997, J DENT RES, V76, P1587, DOI 10.1177/00220345970760091101; Reynolds EC, 2003, J DENT RES, V82, P206, DOI 10.1177/154405910308200311; REYNOLDS EC, 1995, J DENT RES, V74, P1272, DOI 10.1177/00220345950740060601; REYNOLDS EC, 1998, REV SPEC CARE DENTIS, V18, P8; Rose RK, 2000, CARIES RES, V34, P427, DOI 10.1159/000016618; ROSEN S, 1984, J DENT RES, V63, P894, DOI 10.1177/00220345840630061601; Schupbach P, 1996, J DENT RES, V75, P1779, DOI 10.1177/00220345960750101101; Shen P, 2001, J DENT RES, V80, P2066, DOI 10.1177/00220345010800120801; SILVA MFD, 1987, J DENT RES, V66, P38, DOI 10.1177/00220345870660010801; Staufer Kirsten, 2004, J Orofac Orthop, V65, P13, DOI 10.1007/s00056-004-0207-4; VANCROONENBURG EJ, 1986, J BIOL BUCCALE, V14, P177; Wilson R M, 2001, Pediatr Dent, V23, P255	22	42	43	0	7	QUINTESSENCE PUBLISHING CO INC	HANOVER PARK	4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA	0033-6572			QUINTESSENCE INT	Quintessence Int.	SEP	2007	38	8					633	636					4	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	199WU	WOS:000248726700015	17823680				2022-03-04	
J	Bortolotto, T; Krejci, I				Bortolotto, T.; Krejci, I.			Marginal adaptation of direct and CAD/CAM proximal slot restorations using a self-etching adhesive system.	JOURNAL OF DENTAL RESEARCH			English	Meeting Abstract									Univ Geneva, Geneva, Switzerland				Bortolotto, Tissiana/AAE-2796-2021	Bortolotto, Tissiana/0000-0002-3231-9097				0	2	3	0	0	INT AMER ASSOC DENTAL RESEARCHI A D R/A A D R	ALEXANDRIA	1619 DUKE ST, ALEXANDRIA, VA 22314-3406 USA	0022-0345			J DENT RES	J. Dent. Res.	JUN	2003	82				B	1293	B173	B173					1	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	V42UY	WOS:000202893601504					2022-03-04	
J	Pescia, R; Kiliaridis, S; Antonarakis, GS				Pescia, Raji; Kiliaridis, Stavros; Antonarakis, Gregory S.			Spontaneous eruption of impacted maxillary incisors after surgical extraction of supernumerary teeth: a systematic review and meta-analysis	CLINICAL ORAL INVESTIGATIONS			English	Review						Impacted teeth; Spontaneous eruption; Supernumerary teeth; Systematic review; Mesiodens; Meta-analysis	COMPLICATIONS; PREVALENCE; REMOVAL	Objectives To evaluate the spontaneous eruption potential of impacted human permanent teeth localized in the anterior part of the maxilla, after the surgical extraction of obstacles in their eruption pathway, by means of a systematic review and meta-analysis. Materials and methods A systematic literature search was carried out to locate studies reporting on the percentage of anterior permanent teeth erupting after surgical removal of the obstacle, without other interventions. Eruption potential of impacted teeth was calculated using a random-effects meta-analysis. Information about the sex proportion, follow-up duration, age and years during which the study was carried out was used for subgroup analyses. Results A total of twelve studies were included, with a total sample size of 960 cases and a follow-up period of up to 36 months. The results show that more than 65.5% of impacted teeth erupt spontaneously following surgical extraction of the obstacle, with an odds ratio of 4 (95% CI 1.9, 8.2) (p < 0.001) favouring spontaneous eruption. Conclusions When faced with an impacted maxillary anterior tooth, surgical extraction of the obstacle can lead to spontaneous eruption of the impacted tooth in the majority of cases, with better success with a longer follow-up for up to 3 years.	[Pescia, Raji; Kiliaridis, Stavros; Antonarakis, Gregory S.] Univ Geneva, Univ Clin Dent Med, Fac Med, Dept Orthodont, 1 Rue Michel Servet, CH-1205 Geneva, Switzerland		Pescia, R (corresponding author), Univ Geneva, Univ Clin Dent Med, Fac Med, Dept Orthodont, 1 Rue Michel Servet, CH-1205 Geneva, Switzerland.	raji.pescia@gmail.com	Antonarakis, Gregory/ABA-1855-2020	Antonarakis, Gregory/0000-0001-6741-6922; Pescia, Raji/0000-0001-5790-7226			Aktan AM, 2010, EUR J ORTHODONT, V32, P575, DOI 10.1093/ejo/cjp151; Anthonappa RP, 2012, DENTOMAXILLOFAC RAD, V41, P444, DOI 10.1259/dmfr/19442214; Betts A, 1999, Int J Paediatr Dent, V9, P285, DOI 10.1111/j.1365-263X.1999.00147.x; Bodenham R S, 1967, Br Dent J, V123, P173; Bryan R A, 2005, Eur J Paediatr Dent, V6, P84; Celikoglu M, 2010, J ORAL MAXIL SURG, V68, P1001, DOI 10.1016/j.joms.2009.09.006; Fardi A, 2011, MED ORAL PATOL ORAL, V16, pE56, DOI 10.4317/medoral.16.e56; Foley J, 2004, Eur J Paediatr Dent, V5, P35; GROVER PS, 1985, ORAL SURG ORAL MED O, V59, P420, DOI 10.1016/0030-4220(85)90070-2; Higgins JPT, 2019, COCHRANE HDB SYSTEMA, V2; HOGSTROM A, 1987, J DENT CHILD, V54, P341; HUMERFELT D, 1985, J DENT CHILD, V52, P121; Jung YH, 2016, IMAGNG SCI DENT, V46, P251, DOI 10.5624/isd.2016.46.4.251; KRAMER RM, 1970, ORAL SURG ORAL MED O, V29, P237, DOI 10.1016/0030-4220(70)90091-5; Leyland Leila, 2006, J Clin Pediatr Dent, V30, P225; Mason C, 2000, BRIT J ORAL MAX SURG, V38, P62, DOI 10.1054/bjom.1999.0210; Mitchell L, 1992, Br J Orthod, V19, P41; Moher D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000097; Patchett C L, 2001, Int J Paediatr Dent, V11, P259, DOI 10.1046/j.1365-263X.2001.00282.x; Ravn J J, 1971, Tandlaegebladet, V75, P1; Russell Kathleen A, 2003, J Can Dent Assoc, V69, P362; Smailiene Dalia, 2006, Stomatologija, V8, P103; SOLARES R, 1990, J DENT CHILD, V57, P209; Sterne JAC, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i4919; Topkara A, 2012, EUR J PAEDIATR DENT, V13, P311; VONARX T, 1992, AUST DENT J, V37, P189; Wedrychowska-Szulc Barbara, 2007, Roczniki Pomorskiej Akademii Medycznej w Szczecinie, V53, P107; WITSENBURG B, 1981, INT J ORAL MAXILLOF, V10, P423, DOI 10.1016/S0300-9785(81)80079-8	28	1	1	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1432-6981	1436-3771		CLIN ORAL INVEST	Clin. Oral Investig.	NOV	2020	24	11					3749	3759		10.1007/s00784-020-03369-3		JUN 2020	11	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	NY1ZZ	WOS:000537380800001	32488485				2022-03-04	
J	Mombelli, A				Mombelli, Andrea			Microbial colonization of the periodontal pocket and its significance for periodontal therapy	PERIODONTOLOGY 2000			English	Review							GINGIVAL CREVICULAR FLUID; ADJUNCTIVE ANTIMICROBIAL THERAPY; ACTINOMYCETEMCOMITANS-ASSOCIATED PERIODONTITIS; GENERALIZED AGGRESSIVE PERIODONTITIS; RANDOMIZED CLINICAL-TRIAL; ROOT SUBSTANCE REMOVAL; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; PHOTODYNAMIC THERAPY; SUBGINGIVAL MICROBIOTA; SYSTEMIC AMOXICILLIN/METRONIDAZOLE		[Mombelli, Andrea] Univ Geneva, Univ Clin Dent Med, Div Periodontol, Geneva, Switzerland		Mombelli, A (corresponding author), Univ Geneva, Univ Clin Dent Med, Div Periodontol, Geneva, Switzerland.						ABBAS F, 1986, J CLIN PERIODONTOL, V13, P774, DOI 10.1111/j.1600-051X.1986.tb00881.x; Arweiler NB, 2014, CLIN ORAL INVEST, V18, P2129, DOI 10.1007/s00784-014-1193-6; Atieh MA, 2010, LASER MED SCI, V25, P605, DOI 10.1007/s10103-009-0744-6; Azarpazhooh A, 2010, J PERIODONTOL, V81, P4, DOI 10.1902/jop.2009.090285; Berglundh T, 1998, J CLIN PERIODONTOL, V25, P354, DOI 10.1111/j.1600-051X.1998.tb02455.x; BERNIMOULIN JP, 1995, J DENT RES, V74, P481; BRAGD L, 1987, J CLIN PERIODONTOL, V14, P95, DOI 10.1111/j.1600-051X.1987.tb00949.x; Brochut PF, 2005, J CLIN PERIODONTOL, V32, P695, DOI 10.1111/j.1600-051X.2005.00730.x; Campanile VSM, 2015, LASER MED SCI, V30, P27, DOI 10.1007/s10103-013-1337-y; Cappuyns I, 2005, ORAL DIS, V11, P219, DOI 10.1111/j.1601-0825.2005.01123.x; Cappuyns I, 2012, LASER MED SCI, V27, P979, DOI 10.1007/s10103-011-1027-6; CARLOS JP, 1988, J DENT RES, V67, P1510, DOI 10.1177/00220345880670121301; Charalampakis G, 2013, EUR J ORAL SCI, V121, P394, DOI 10.1111/eos.12080; Chaves ES, 2000, J CLIN PERIODONTOL, V27, P897, DOI 10.1034/j.1600-051x.2000.027012897.x; Cionca N, 2010, J PERIODONTOL, V81, P15, DOI 10.1902/jop.2009.090390; Cionca N, 2009, J PERIODONTOL, V80, P364, DOI [10.1902/jop.2009.080540, 10.1902/jop.2009.080540 ]; Contreras A, 2014, PERIODONTOL 2000, V64, P40, DOI 10.1111/j.1600-0757.2012.00448.x; Dahlen G, 1996, J PERIODONTOL, V67, P879, DOI 10.1902/jop.1996.67.9.879; DANIELSEN B, 1989, J PERIODONTAL RES, V24, P254, DOI 10.1111/j.1600-0765.1989.tb01790.x; Dannewitz B, 2007, AM J DENT, V20, P153; Drisko CH, 1996, PERIODONTOL 2000, V12, P90, DOI 10.1111/j.1600-0757.1996.tb00085.x; Dudic VB, 1999, J CLIN PERIODONTOL, V26, P341, DOI 10.1034/j.1600-051X.1999.260602.x; Ehmke B, 2005, J PERIODONTOL, V76, P749, DOI 10.1902/jop.2005.76.5.749; Ellen RP, 1996, PERIODONTOL 2000, V10, P29, DOI 10.1111/j.1600-0757.1996.tb00067.x; Eyre DW, 2013, NEW ENGL J MED, V369, P1195, DOI 10.1056/NEJMoa1216064; Feres M, 2015, PERIODONTOL 2000, V67, P131, DOI 10.1111/prd.12075; Mostajo MFY, 2011, EUR J ORAL SCI, V119, P259, DOI 10.1111/j.1600-0722.2011.00828.x; Flemmig TF, 1998, J CLIN PERIODONTOL, V25, P158, DOI 10.1111/j.1600-051X.1998.tb02422.x; Flemmig TF, 1998, J CLIN PERIODONTOL, V25, P1, DOI 10.1111/j.1600-051X.1998.tb02356.x; Flemmig TF, 2012, J PERIODONTOL, V83, P444, DOI 10.1902/jop.2011.110367; Fullmer SC, 2009, J DENT RES, V88, P524, DOI 10.1177/0022034509338676; Giannopoulou C, 2003, J CLIN PERIODONTOL, V30, P996, DOI 10.1034/j.1600-051X.2003.00416.x; Giannopoulou C, 2012, J PERIODONTOL, V83, P1018, DOI 10.1902/jop.2011.110281; GOENE RJ, 1990, J PERIODONTOL, V61, P61, DOI 10.1902/jop.1990.61.1.61; Goodson J M, 1994, Periodontol 2000, V5, P142, DOI 10.1111/j.1600-0757.1994.tb00022.x; Goodson JM, 2012, J CLIN PERIODONTOL, V39, P526, DOI 10.1111/j.1600-051X.2012.01870.x; Grenier G, 2009, ORAL MICROBIOL IMMUN, V24, P506, DOI 10.1111/j.1399-302X.2009.00542.x; GROSSI SG, 1994, J PERIODONTOL, V65, P260, DOI 10.1902/jop.1994.65.3.260; Guerrero A, 2005, J CLIN PERIODONTOL, V32, P1096, DOI 10.1111/j.1600-051X.2005.00814.x; GUSBERTI FA, 1990, J CLIN PERIODONTOL, V17, P685, DOI 10.1111/j.1600-051X.1990.tb01054.x; Haffajee A D, 1994, Periodontol 2000, V5, P78, DOI 10.1111/j.1600-0757.1994.tb00020.x; HAFFAJEE AD, 1991, J CLIN PERIODONTOL, V18, P744, DOI 10.1111/j.1600-051X.1991.tb00066.x; Haubek D, 2008, LANCET, V371, P237, DOI 10.1016/S0140-6736(08)60135-X; Heasman PA, 2011, PERIODONTOL 2000, V55, P217, DOI 10.1111/j.1600-0757.2010.00341.x; Huyghe A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002453; Kaner D, 2007, J CLIN PERIODONTOL, V34, P880, DOI 10.1111/j.1600-051X.2007.01122.x; Kilian M, 2006, PERIODONTOL 2000, V42, P158, DOI 10.1111/j.1600-0757.2006.00159.x; Kroes I, 1999, P NATL ACAD SCI USA, V96, P14547, DOI 10.1073/pnas.96.25.14547; Li YH, 2014, J CLIN MICROBIOL, V52, P1400, DOI 10.1128/JCM.02954-13; LISTGARTEN MA, 1988, J CLIN PERIODONTOL, V15, P485, DOI 10.1111/j.1600-051X.1988.tb01019.x; LISTGARTEN MA, 1986, J CLIN PERIODONTOL, V13, P418, DOI 10.1111/j.1600-051X.1986.tb01485.x; LOE H, 1965, J PERIODONTOL, V36, P177, DOI 10.1902/jop.1965.36.3.177; MAGNUSSON I, 1984, J CLIN PERIODONTOL, V11, P193, DOI 10.1111/j.1600-051X.1984.tb01323.x; Mahanonda R, 2011, PERIODONTOL 2000, V56, P143, DOI 10.1111/j.1600-0757.2010.00378.x; Marsh PD, 2011, J CLIN PERIODONTOL, V38, P28, DOI 10.1111/j.1600-051X.2010.01673.x; MCNABB H, 1992, J CLIN PERIODONTOL, V19, P348, DOI 10.1111/j.1600-051X.1992.tb00658.x; Moene R, 2010, J PERIODONTOL, V81, P79, DOI 10.1902/jop.2009.090394; MOMBELLI A, 1991, J PERIODONTAL RES, V26, P301, DOI 10.1111/j.1600-0765.1991.tb02067.x; MOMBELLI A, 1995, J CLIN PERIODONTOL, V22, P300, DOI 10.1111/j.1600-051X.1995.tb00152.x; MOMBELLI A, 1994, J PERIODONTOL, V65, P820, DOI 10.1902/jop.1994.65.9.820; Mombelli A, 1997, J CLIN PERIODONTOL, V24, P470, DOI 10.1111/j.1600-051X.1997.tb00214.x; MOMBELLI A, 1990, J CLIN PERIODONTOL, V17, P48, DOI 10.1111/j.1600-051X.1990.tb01047.x; Mombelli A, 2002, J CLIN PERIODONTOL, V29, P10, DOI 10.1034/j.1600-051X.29.s3.1.x; Mombelli A, 2002, J CLIN PERIODONTOL, V29, P743, DOI 10.1034/j.1600-051X.2002.290811.x; MOMBELLI A, 1992, CLEFT PALATE-CRAN J, V29, P463, DOI 10.1597/1545-1569(1992)029<0463:MAWRCA>2.3.CO;2; MOMBELLI A, 1990, J PERIODONTAL RES, V25, P331, DOI 10.1111/j.1600-0765.1990.tb00924.x; Mombelli A, 1990, Schweiz Monatsschr Zahnmed, V100, P154; Mombelli A, 2015, ITI TREAT GUIDE, V8, P131; Mombelli A, 2013, J PERIODONTOL, V84, P715, DOI 10.1902/jop.2012.120281; Mombelli A, 2011, J CLIN PERIODONTOL, V38, P203, DOI 10.1111/j.1600-051X.2010.01666.x; Mombelli A, 2011, PERIODONTOL 2000, V55, P205, DOI 10.1111/j.1600-0757.2010.00356.x; Muller N, 2014, J CLIN PERIODONTOL, V41, P883, DOI 10.1111/jcpe.12289; Muller H P, 2000, Clin Oral Investig, V4, P212, DOI 10.1007/s007840000078; MULLER HP, 1995, J CLIN PERIODONTOL, V22, P413, DOI 10.1111/j.1600-051X.1995.tb00169.x; MULLER HP, 1993, J CLIN PERIODONTOL, V20, P498, DOI 10.1111/j.1600-051X.1993.tb00397.x; Noyan U, 1997, J CLIN PERIODONTOL, V24, P158, DOI 10.1111/j.1600-051X.1997.tb00485.x; PAQUETTE D, 1994, J DENT RES, V73, P305; Paster BJ, 2001, J BACTERIOL, V183, P3770, DOI 10.1128/JB.183.12.3770-3783.2001; PAVICIC MJAMP, 1994, J CLIN PERIODONTOL, V21, P107, DOI 10.1111/j.1600-051X.1994.tb00287.x; PAVICIC MJAMP, 1992, ANTIMICROB AGENTS CH, V36, P2634, DOI 10.1128/AAC.36.12.2634; Petersilka GJ, 2002, PERIODONTOL 2000, V28, P56, DOI 10.1034/j.1600-0757.2002.280103.x; Pratten J, 2001, MICROBES INFECT, V3, P633, DOI 10.1016/S1286-4579(01)01418-6; Preus HR, 2014, J PERIODONTOL, V85, P374, DOI 10.1902/jop.2014.130379; Que ML, 2004, J CLIN PERIODONTOL, V31, P978, DOI 10.1111/j.1600-051X.2004.00594.x; Rams TE, 1996, J CLIN PERIODONTOL, V23, P346, DOI 10.1111/j.1600-051X.1996.tb00556.x; Sampaio E, 2011, J CLIN PERIODONTOL, V38, P838, DOI 10.1111/j.1600-051X.2011.01766.x; SBORDONE L, 1990, J PERIODONTOL, V61, P579, DOI 10.1902/jop.1990.61.9.579; Sgolastra F, 2012, J PERIODONTOL, V83, P1257, DOI 10.1902/jop.2012.110625; Sgolastra F, 2012, J PERIODONTOL, V83, P731, DOI 10.1902/jop.2011.110432; Sgolastra F, 2013, LASER MED SCI, V28, P669, DOI 10.1007/s10103-011-1002-2; Silva MP, 2011, J CLIN PERIODONTOL, V38, P828, DOI 10.1111/j.1600-051X.2011.01763.x; Skurnik D, 2013, P NATL ACAD SCI USA, V110, P20747, DOI 10.1073/pnas.1221552110; Slots J, 2002, PERIODONTOL 2000, V28, P106, DOI 10.1034/j.1600-0757.2002.280106.x; Slots J, 2002, POLYMICROBIAL DIS; Slots J, 2015, PERIODONTOL 2000, V69, P28, DOI 10.1111/prd.12085; Slots J, 2012, PERIODONTOL 2000, V60, P110, DOI 10.1111/j.1600-0757.2011.00429.x; Soares GMS, 2014, J CLIN PERIODONTOL, V41, P366, DOI 10.1111/jcpe.12217; Socransky SS, 2005, PERIODONTOL 2000, V38, P135, DOI 10.1111/j.1600-0757.2005.00107.x; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Sunde PT, 2008, J CLIN VIROL, V42, P176, DOI 10.1016/j.jcv.2008.01.007; Takasaki AA, 2009, PERIODONTOL 2000, V51, P109, DOI 10.1111/j.1600-0757.2009.00302.x; Teles R, 2010, J PERIODONTOL, V81, P89, DOI 10.1902/jop.2009.090397; Teles RP, 2010, J CLIN PERIODONTOL, V37, P313, DOI 10.1111/j.1600-051X.2010.01534.x; THEILADE ELSE, 1966, J PERIODONTAL RES, V1, P1, DOI 10.1111/j.1600-0765.1966.tb01842.x; TSAI CC, 1984, INFECT IMMUN, V43, P700, DOI 10.1128/IAI.43.2.700-705.1984; Van der Weijden GA, 2002, J CLIN PERIODONTOL, V29, P55, DOI 10.1034/j.1600-051X.29.s3.3.x; Van Winkelhoff A J, 1988, Oral Microbiol Immunol, V3, P83; van Winkelhoff AJ, 2005, PERIODONTOL 2000, V39, P40, DOI 10.1111/j.1600-0757.2005.00116.x; van Winkelhoff AJ, 2009, J PERIODONTOL, V80, P1555, DOI 10.1902/jop.2009.090276; VANWINKELHOFF AJ, 1989, J CLIN PERIODONTOL, V16, P128; VANWINKELHOFF AJ, 1992, J PERIODONTOL, V63, P52, DOI 10.1902/jop.1992.63.1.52; VanWinkelhoff AJ, 1996, PERIODONTOL 2000, V10, P45; Vayssier-Taussat M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081439; Wennstrom JL, 2011, J CLIN PERIODONTOL, V38, P820, DOI 10.1111/j.1600-051X.2011.01751.x; Wennstrom J L, 1987, Oral Microbiol Immunol, V2, P158, DOI 10.1111/j.1399-302X.1987.tb00300.x; Wilson M, 1994, Int Dent J, V44, P181; Wilson TG, 2009, J PERIODONTOL, V80, P1388, DOI 10.1902/jop.2009.090115; ZAMBON JJ, 1981, INFECT IMMUN, V32, P198, DOI 10.1128/IAI.32.1.198-203.1981; ZAPPA U, 1991, J PERIODONTOL, V62, P750, DOI 10.1902/jop.1991.62.12.750	119	95	100	1	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0906-6713	1600-0757		PERIODONTOL 2000	Periodontol. 2000	FEB	2018	76	1					85	96		10.1111/prd.12147			12	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	FQ1CZ	WOS:000418095200007	29193304	hybrid			2022-03-04	
J	Lefever, D; Krejci, I; Ardu, S				Lefever, Dorien; Krejci, Ivo; Ardu, Stefano			Laboratory evaluation of the effect of toothbrushing on surface gloss of resin composites	AMERICAN JOURNAL OF DENTISTRY			English	Article							DENTAL MATERIALS; ROUGHNESS; SYSTEMS; TIME; WEAR	Purpose: To determine changes in surface gloss of different composite materials after laboratory toothbrushing simulation. Methods: 40 specimens were fabricated for each material (Filtek Supreme XTE, Renamel, Empress Direct, Gradia Direct, Edelweiss, G-aenial, Venus Pearl and Venus Diamond) and polished with 120-, 220-, 500-, 1200-, 2400- and 4000- grit SiC abrasive paper, respectively. Gloss measurements were made with a glossmeter prior to testing procedures and then subjected to simulated toothbrushing for 5, 15, 30 and 60 minutes by means of an electrical toothbrush with a pressure of 2N while being immersed in a 50 RDA toothpaste slurry. Four samples per group were analyzed under SEM immediately after polishing procedures and four samples after 60 minutes simulated toothbrushing in order to evaluate the causes of the gloss decrease. Human enamel was the control group. Statistical analysis was performed using Kruskal Wallis and Tukey's post-hoc test (P< 0.05). Results: Resin composite initial gloss values ranged from 78.2 to 100.5 at baseline to 13.8 to 62.4 after 1 hour of brushing. Highest gloss values were obtained by Filtek Supreme XTE and Renamel (P< 0.05), followed by Empress Direct. Lowest values were obtained with Venus Diamond, Venus Pearl, G-aenial and Edelweiss. Human enamel was the only material which maintained its gloss throughout the brushing procedure (110.4 after 00 minutes). SEM analysis revealed different patterns of surface degradation dependant on the material.	[Lefever, Dorien; Krejci, Ivo] Univ Geneva, Sch Dent, Div Cariol & Endodont, CH-1205 Geneva, Switzerland; [Ardu, Stefano] Univ Geneva, Sch Dent, Unit Treatment Planning, CH-1205 Geneva, Switzerland		Lefever, D (corresponding author), Univ Geneva, Div Cariol & Endodont, 19 Rue Barthelemy MENN, CH-1205 Geneva, Switzerland.	Dorien.Lefever@unige.ch		ardu, stefano/0000-0003-1641-2168			Ardu S, 2010, COLLEGIUM ANTROPOL, V34, P1045; Ardu S, 2009, AM J DENT, V22, P264; Da Costa J, 2007, J ESTHET RESTOR DENT, V19, P214, DOI 10.1111/j.1708-8240.2007.00104.x; Dos Santos PH, 2003, AM J DENT, V16, P197; GOLDSTEIN GR, 1991, J PROSTHET DENT, V66, P498, DOI 10.1016/0022-3913(91)90511-T; Heintze SD, 2010, DENT MATER, V26, P306, DOI 10.1016/j.dental.2009.11.152; Heintze SD, 2006, DENT MATER, V22, P146, DOI 10.1016/j.dental.2005.04.013; Heintze SD, 2005, OPER DENT, V30, P617; Hoelscher DC, 1998, OPER DENT, V23, P36; Kaplan BA, 1996, J PROSTHET DENT, V76, P34, DOI 10.1016/S0022-3913(96)90343-1; Keyf F, 2004, DENT MATER, V20, P244, DOI 10.1016/S0109-5641(03)00099-X; Lee YK, 2005, J PROSTHET DENT, V94, P370, DOI 10.1016/j.prosdent.2005.08.006; Lefever D, 2012, AM J DENT, V25, P54; Lu Huan, 2005, J Esthet Restor Dent, V17, P102, DOI 10.1111/j.1708-8240.2005.tb00094.x; Lu Huan, 2003, J Esthet Restor Dent, V15, P297, DOI 10.1111/j.1708-8240.2003.tb00300.x; MACGREGOR IDM, 1985, COMMUNITY DENT ORAL, V13, P121, DOI 10.1111/j.1600-0528.1985.tb00423.x; Neme AL, 2003, OPER DENT, V28, P808; Neme AL, 2002, OPER DENT, V27, P50; Peutzfeldt A, 1997, EUR J ORAL SCI, V105, P97, DOI 10.1111/j.1600-0722.1997.tb00188.x; Roeder LB, 2004, AM J DENT, V17, P109; Saxer UP, 1998, J CLIN DENT, V9, P49; Tanoue N, 2000, J PROSTHET DENT, V84, P93, DOI 10.1067/mpr.2000.107560; Tate WH, 1996, OPER DENT, V21, P53; VANDIJKEN JWV, 1987, ACTA ODONTOL SCAND, V45, P337, DOI 10.3109/00016358709096356; Vanini L, 1996, Pract Periodontics Aesthet Dent, V8, P673; Vanini L., 1996, PRACT PERIODONTICS A, V8, P684; Wakefield CW, 2007, J ESTHET RESTOR DENT, V19, P225, DOI 10.1111/j.1708-8240.2007.00105.x; WICTORIN L, 1972, ACTA ODONTOL SCAND, V30, P383, DOI 10.3109/00016357209004605; Wilder AD, 2000, J DENT, V28, P367, DOI 10.1016/S0300-5712(99)00075-5	29	13	15	0	7	MOSHER & LINDER, INC	WESTON	318 INDIAN TRACE SUITE 500, WESTON, FL 33326 USA	0894-8275			AM J DENT	Am. J. Dent.	FEB	2014	27	1					42	46					5	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	AD2MF	WOS:000333069100008	24902404				2022-03-04	
J	Mombelli, A; Moene, R; Decaillet, F				Mombelli, Andrea; Moene, Raphael; Decaillet, Fabien			Surgical treatments of peri-implantitis	EUROPEAN JOURNAL OF ORAL IMPLANTOLOGY			English	Review						peri-implantitis; review; surgical treatment	ANTIINFECTIVE MECHANICAL THERAPY; 3-YEAR CLINICAL-TRIAL; SHAPED ORAL IMPLANTS; 12-MONTH FOLLOW-UP; AUTOGENOUS BONE; NANOCRYSTALLINE HYDROXYAPATITE; RESECTIVE SURGERY; COLLAGEN MEMBRANE; DEFECTS; LESIONS	Purpose: To review the literature on the surgical treatment of peri-implantitis. Materials and methods: The potentially relevant literature was preliminarily assessed via scoping searches to find the most appropriate search terms and the most efficient Boolean search algorithm. The present authors identified 33 reports on subjects with osseointegrated implants, with a pathological condition compatible with the definition of 'peri-implantitis', describing the surgical treatment with a follow-up of at least 6 months. Results and conclusions: The 14 case reports, 10 case series and 9 papers on 6 comparative studies illustrate the diversity of approaches and the current uncertainties concerning the surgical treatment of peri-implantitis. All current approaches include the elevation of a mucoperiosteal flap and the removal of the pen-implant inflammatory granulation tissue. Surfaces have been subjected to cleaning with carbon or plastic curettes, ultrasonic scalers, air-polishing devices using sodium bicarbonate or glycine powder, to irradiation with hard or soft laser light, implantoplasty and/or the application of acids or various antimicrobial agents. The majority of protocols include the systemic administration of an antibiotic and chlorhexidine rinses. Autogenous bone, allogenic decalcified freeze-dried bone, xenogenic bone mineral, phytogenic calcium carbonate, hydroxyapatite or tri-calcium phosphate have been used in an attempt to fill pen-implant defects and regenerate bone. Expanded polytetrafluoroethylene, collagen, and resorbable synthetic membranes have been placed to cover the area. The currently available evidence does not allow any firm specific recommendations for the surgical therapy of peri-implantitis. The following elements of therapy seem to be beneficial: surgical access by a full-thickness flap, thorough cleaning of the contaminated implant surfaces, systemic administration of an antibiotic and oral chlorhexidine rinse. The stabilisation of the defect with a bone substitute may also be advantageous.	[Mombelli, Andrea; Moene, Raphael; Decaillet, Fabien] Univ Geneva, Sch Dent Med, Div Periodontol & Oral Pathophysiol, CH-1205 Geneva, Switzerland		Mombelli, A (corresponding author), Univ Geneva, Sch Dent Med, Div Periodontol & Oral Pathophysiol, Rue Barthelemy Menn 19, CH-1205 Geneva, Switzerland.	andrea.mombelli@unige.ch			School of Dental Medicine, Division of Periodontology and Oral Pathophysiology, University of Geneva	The authors declare that they have no conflict of interest. The study was funded by the authors and the School of Dental Medicine, Division of Periodontology and Oral Pathophysiology, University of Geneva.	ALBREKTSSON T, 1994, PROCEEDINGS OF THE 1ST EUROPEAN WORKSHOP ON PERIODONTOLOGY, P365; AUGTHUN M, 1992, Z ZAHNARZTL IMPLANTO, V8, P246; Azzeh MA, 2008, J PERIODONTOL, V79, P2000, DOI [10.1902/jop.2008.080045, 10.1902/jop.2008.080045 ]; Bassetti Renzo, 2011, Schweiz Monatsschr Zahnmed, V121, P325; Behneke A, 2000, INT J ORAL MAX IMPL, V15, P125; Buchter A, 2004, BRIT J ORAL MAX SURG, V42, P454, DOI 10.1016/j.bjoms.2004.06.008; Charalampakis G, 2011, J CLIN PERIODONTOL, V38, P864, DOI 10.1111/j.1600-051X.2011.01759.x; Chen S, 2003, AUST DENT J, V48, P212, DOI 10.1111/j.1834-7819.2003.tb00034.x; Claffey N, 2008, J CLIN PERIODONTOL, V35, P316, DOI 10.1111/j.1600-051X.2008.01277.x; de Mendonca AC, 2009, J PERIODONTOL, V80, P693, DOI 10.1902/jop.2009.080521; Deppe H, 2007, INT J ORAL MAX IMPL, V22, P79; Emanuelli S, 1991, Dent Cadmos, V59, P68; Emanuelli SLozadaJ, 1991, DENT CADMOS, V59, P75; GAMMAGE D D, 1989, Journal of Oral Implantology, V15, P124; Haas R, 2000, INT J ORAL MAX IMPL, V15, P374; Hammerle CHF, 1996, CLIN ORAL IMPLAN RES, V7, P111, DOI 10.1034/j.1600-0501.1996.070204.x; HAMMERLE CHF, 1995, J PERIODONTOL, V66, P303; Khoury F, 2001, J PERIODONTOL, V72, P1498, DOI 10.1902/jop.2001.72.11.1498; Leonhardt A, 2003, J PERIODONTOL, V74, P1415, DOI 10.1902/jop.2003.74.10.1415; Levignac J, 1965, Rev Fr Odontostomatol, V12, P1251; Lindhe J, 2008, J CLIN PERIODONTOL, V35, P282, DOI 10.1111/j.1600-051X.2008.01283.x; LOE H, 1965, J PERIODONTOL, V36, P177, DOI 10.1902/jop.1965.36.3.177; LOZADA J L, 1990, Journal of Oral Implantology, V16, P42; MELLONIG JT, 1995, INT J PERIODONT REST, V15, P385; Mombelli A, 1992, Clin Oral Implants Res, V3, P162, DOI 10.1034/j.1600-0501.1992.030402.x; Mombelli A, 1987, Oral Microbiol Immunol, V2, P145, DOI 10.1111/j.1399-302X.1987.tb00298.x; MOMBELLI A, 1994, PROCEEDINGS OF THE 1ST EUROPEAN WORKSHOP ON PERIODONTOLOGY, P317; Mombelli A, 1999, PROCEEDINGS OF THE 3RD EUROPEAN WORKSHOP ON PERIODONTOLOGY: IMPLANT DENTISTRY, P281; Muller E, 1999, Implant Dent, V8, P247, DOI 10.1097/00008505-199903000-00006; PONTORIERO R, 1994, CLIN ORAL IMPLAN RES, V5, P254, DOI 10.1034/j.1600-0501.1994.050409.x; Renvert S, 2008, J CLIN PERIODONTOL, V35, P305, DOI 10.1111/j.1600-051X.2008.01276.x; Roccuzzo M, 2011, J CLIN PERIODONTOL, V38, P738, DOI 10.1111/j.1600-051X.2011.01742.x; Romeo E, 2005, CLIN ORAL IMPLAN RES, V16, P9, DOI 10.1111/j.1600-0501.2004.01084.x; Romeo E, 2007, CLIN ORAL IMPLAN RES, V18, P179, DOI 10.1111/j.1600-0501.2006.01318.x; Roos-Jansaker AM, 2007, J CLIN PERIODONTOL, V34, P723, DOI 10.1111/j.1600-051X.2007.01098.x; Roos-Jansaker AM, 2007, J CLIN PERIODONTOL, V34, P625, DOI 10.1111/j.1600-051X.2007.01102.x; Roos-Jansaker AM, 2011, J CLIN PERIODONTOL, V38, P590, DOI 10.1111/j.1600-051X.2011.01729.x; Santos Vanessa Renata, 2009, General Dentistry, V57, P230; Schwarz F, 2008, J CLIN PERIODONTOL, V35, P80, DOI 10.1111/j.1600-051X.2007.01168.x; Schwarz F, 2011, J CLIN PERIODONTOL, V38, P276, DOI 10.1111/j.1600-051X.2010.01690.x; Schwarz F, 2010, J CLIN PERIODONTOL, V37, P449, DOI 10.1111/j.1600-051X.2010.01540.x; Schwarz F, 2009, J CLIN PERIODONTOL, V36, P807, DOI 10.1111/j.1600-051X.2009.01443.x; Serino G, 2011, CLIN ORAL IMPLAN RES, V22, P1214, DOI 10.1111/j.1600-0501.2010.02098.x; Suh Jong-Jin, 2003, Implant Dent, V12, P277, DOI 10.1097/01.ID.0000091139.04246.BC; Tarnow DP, 2000, J PERIODONTOL, V71, P546, DOI 10.1902/jop.2000.71.4.546; Tinti C, 2001, INT J ORAL MAX IMPL, V16, P572; Tozum Tolga Fikret, 2008, N Y State Dent J, V74, P52; Wiltfang J, 2010, CLIN IMPLANT DE 0203; Zitzmann NU, 2008, J CLIN PERIODONTOL, V35, P286, DOI 10.1111/j.1600-051X.2008.01274.x; Zitzmann NU, 2001, J CLIN PERIODONTOL, V28, P517, DOI 10.1034/j.1600-051x.2001.028006517.x	50	10	10	0	14	QUINTESSENCE PUBLISHING CO INC	HANOVER PARK	4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA	1756-2406	1756-2414		EUR J ORAL IMPLANTOL	Eur. J. Oral Implant.		2012	5			S			S61	S70					10	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	928FG	WOS:000302968000007	22834395				2022-03-04	
J	Theytaz, GA; Christou, P; Kiliaridis, S				Theytaz, Georges Andre; Christou, Panagiotis; Kiliaridis, Stavros			Gingival changes and secondary tooth eruption in adolescents and adults: A longitudinal retrospective study	AMERICAN JOURNAL OF ORTHODONTICS AND DENTOFACIAL ORTHOPEDICS			English	Article							HEIGHT; SULCUS	Introduction: Our aim was to investigate 8 years of vertical changes of the gingival margin and tooth displacement of maxillary molars and incisors in adolescents and adults. Methods: Twenty-five adolescents and 10 adults were included in this study, with dental casts taken 2 and 10 years after orthodontic treatment. The gingival contour of the teeth was traced digitally using calibrated photographs of the 2 dental casts, and gingival changes were measured on crown superimposition. Eruption of the central incisors and first molar were measured on dental casts after scanning and superimposition on the palatal vault. Results: Adults and adolescents presented a mean molar eruption of 0.27 and 0.34 mm and a mean incisor eruption of 0.39 and 0.73 mm, respectively. Adults and adolescents presented a mean molar gingival displacement of respectively 0.34 and 0.77 mm, and the adolescents a mean incisor gingival displacement of 0.44 mm. Correlation between secondary tooth eruption and gingival displacement was obtained only for the incisors in the adolescent group. Conclusions: Adolescents and adults presented apical displacement of the gingival contour of the maxillary first molars, as was the case for maxillary incisors in adolescents. Secondary eruption of maxillary first molars and central incisors continues in adolescents and adults. (Am J Orthod Dentofacial Orthop 2011; 139:S129-32)	[Theytaz, Georges Andre; Christou, Panagiotis; Kiliaridis, Stavros] Univ Geneva, Sch Dent, Dept Orthodont, CH-1205 Geneva, Switzerland		Theytaz, GA (corresponding author), Univ Geneva, Sch Dent, Dept Orthodont, 19 Rue Barthelemy Menn, CH-1205 Geneva, Switzerland.	Georges-Andre.Theytaz@unige.ch					BIMSTEIN E, 1988, J CLIN PERIODONTOL, V15, P175, DOI 10.1111/j.1600-051X.1988.tb01565.x; Christou P, 2007, EUR J ORTHODONT, V29, P543, DOI 10.1093/ejo/cjm036; FORSBERG CM, 1991, EUR J ORTHODONT, V13, P249, DOI 10.1093/ejo/13.4.249; HOUSTON WJB, 1983, AM J ORTHOD DENTOFAC, V83, P382, DOI 10.1016/0002-9416(83)90322-6; Morrow LA, 2000, J DENT, V28, P469, DOI 10.1016/S0300-5712(00)00023-3; SMITH RG, 1982, J PERIODONTAL RES, V17, P427, DOI 10.1111/j.1600-0765.1982.tb01173.x; Theytaz GA, 2008, J CLIN PERIODONTOL, V35, P825, DOI 10.1111/j.1600-051X.2008.01297.x; VEHKALAHTI M, 1989, J PERIODONTOL, V60, P599, DOI 10.1902/jop.1989.60.11.599; VOLCHANSKY A, 1981, J DENT, V9, P150	9	3	3	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0889-5406			AM J ORTHOD DENTOFAC	Am. J. Orthod. Dentofac. Orthop.	APR	2011	139	4		1			S129	S132		10.1016/j.ajodo.2010.05.017			4	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	739GG	WOS:000288701900009	21435530	Green Published			2022-03-04	
J	Grutter, L; Belser, UC				Gruetter, Linda; Belser, Urs C.			Implant Loading Protocols for the Partially Edentulous Esthetic Zone	INTERNATIONAL JOURNAL OF ORAL & MAXILLOFACIAL IMPLANTS			English	Article; Proceedings Paper	4th Consensus Conference on International Team for Implantology	AUG, 2008	Stuttgart, GERMANY			anterior mandible; anterior maxilla; dental implants; esthetics; fixed dental prostheses; loading protocol; partial edentulism; single crown; systematic review	SINGLE-TOOTH IMPLANTS; IMMEDIATE PROVISIONAL RESTORATION; 4-YEAR FOLLOW-UP; RESTORED 3 WEEKS; ANTERIOR MAXILLA; DENTAL IMPLANTS; TITANIUM IMPLANTS; 1-STAGE SURGERY; CLINICAL REPORT; EXTRACTION	Purpose: The scientific evidence related to different or novel implant loading (primary objective) and directly associated implant placement (secondary objective) protocols developed for the anterior maxillae of partially edentulous patients was reviewed. Materials and Methods: A comprehensive search of electronic databases and a hand search of six relevant journals was performed. The principal outcome variables were implant survival, implant success, and esthetic appearance. Concerning esthetic treatment outcomes, articles were specifically screened for the presence of objective evaluation parameters and patient satisfaction assessment. Results: The analysis of the literature on immediately restored or conventionally loaded implants in the esthetic zone revealed an initial survival rate of 97.3% after 1 year (10 prospective cohort studies and one case series). For periods of 1 to 5 years, the survival rate was 96.7%. These survival rates are consistent with previous reports on more traditional loading modalities. However, for immediately placed implants with immediate restoration and occlusal loading, the survival rate dropped by approximately 10% (four studies). Success criteria such as stable crestal bone levels, soft tissue recession, and probing depth could not be evaluated on the basis of the available literature. Conclusion: There is a paucity of prospective cohort studies addressing patient-centered outcomes. No parameters specific to immediate loading protocols were available for evaluation. In order to validate or reject such implant protocols for use in the esthetically sensitive anterior maxilla, long-term clinical trials should routinely include objective esthetic criteria that comprehensively embrace the pertinent elements of "pink and white esthetics" in the form of readily used indices. INT J ORAL MAXILLOFAC IMPLANTS 2009;24(SUPPL):169-179	[Gruetter, Linda; Belser, Urs C.] Univ Geneva, Sch Dent Med, Dept Fixed Prosthodont & Occlus, CH-1205 Geneva, Switzerland		Grutter, L (corresponding author), Univ Geneva, Sch Dent Med, Dept Fixed Prosthodont & Occlus, Rue Barthelemy Menn 19, CH-1205 Geneva, Switzerland.	linda.gruetter@unige.ch	song, ke/B-4885-2012; Buser, Daniel/D-3971-2011				Andersen E, 2002, CLIN ORAL IMPLAN RES, V13, P281, DOI 10.1034/j.1600-0501.2002.130307.x; Barone A, 2006, J PERIODONTOL, V77, P1914, DOI 10.1902/jop.2006.060072; Belser UC, 2009, J PERIODONTOL, V80, P140, DOI [10.1902/jop.2009.080435, 10.1902/jop.2009.080435 ]; Bornstein MM, 2003, INT J ORAL MAX IMPL, V18, P659; Bornstein MM, 2005, CLIN ORAL IMPLAN RES, V16, P631, DOI 10.1111/j.1600-0501.2005.01209.x; Buser D, 2008, J PERIODONTOL, V79, P1773, DOI [10.1902/jop.2008.080071, 10.1902/jop.2008.080071 ]; Buser D, 2009, J PERIODONTOL, V80, P152, DOI [10.1902/jop.2009.080360, 10.1902/jop.2009.080360 ]; Chaushu G, 2001, INT J ORAL MAX IMPL, V16, P267; Chen ST, 2007, CLIN ORAL IMPLAN RES, V18, P552, DOI 10.1111/j.1600-0501.2007.01388.x; Cooper L, 2001, INT J ORAL MAX IMPL, V16, P182; Cooper LF, 2007, INT J ORAL MAX IMPL, V22, P791; Cornelini R, 2005, INT J PERIODONT REST, V25, P439; Cornelini Roberto, 2008, Pract Proced Aesthet Dent, V20, P337; De Kok IJ, 2006, INT J ORAL MAX IMPL, V21, P405; Degidi M, 2005, INT J ORAL MAX IMPL, V20, P99; Degidi M, 2003, J PERIODONTOL, V74, P225, DOI 10.1902/jop.2003.74.2.225; Degidi Marco, 2006, J Oral Implantol, V32, P277, DOI 10.1563/0.795.1; Drago CJ, 2004, INT J ORAL MAX IMPL, V19, P534; Dvursuter L, 2000, CLIN IMPLANT DENT R, V2, P138, DOI 10.1111/j.1708-8208.2000.tb00004.x; Ericsson I, 2000, CLIN ORAL IMPLAN RES, V11, P26, DOI 10.1034/j.1600-0501.2000.011001026.x; Esposito M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003878.pub4; Evans CDJ, 2008, CLIN ORAL IMPLAN RES, V19, P73, DOI 10.1111/j.1600-0501.2007.01413.x; Ferrara A, 2006, INT J PERIODONT REST, V26, P371; Furhauser R, 2005, CLIN ORAL IMPLAN RES, V16, P639, DOI 10.1111/j.1600-0501.2005.01193.x; Ganeles J, 2004, INT J ORAL MAX IMPL, V19, P92; Glauser Roland, 2003, Clin Implant Dent Relat Res, V5 Suppl 1, P47, DOI 10.1111/j.1708-8208.2003.tb00015.x; Gotfredsen Klaus, 2004, Clin Implant Dent Relat Res, V6, P1, DOI 10.1111/j.1708-8208.2004.tb00021.x; Groisman Mario, 2003, Pract Proced Aesthet Dent, V15, P115; Hall JAG, 2007, CLIN IMPLANT DENT R, V9, P34, DOI 10.1111/j.1708-8208.2007.00029.x; Harvey BV, 2007, J PERIODONTOL, V78, P770, DOI 10.1902/jop.2007.060278; Hui E, 2001, Clin Implant Dent Relat Res, V3, P79, DOI 10.1111/j.1708-8208.2001.tb00235.x; Ioannidou E, 2005, J PERIODONTOL, V76, P1252, DOI 10.1902/jop.2005.76.8.1252; Jemt T, 1997, INT J PERIODONT REST, V17, P327; Juodzbalys G, 2007, CLIN ORAL IMPLAN RES, V18, P237, DOI 10.1111/j.1600-0501.2006.01312.x; Kan JYK, 2003, INT J ORAL MAX IMPL, V18, P31; Lindeboom JA, 2006, J ORAL MAXIL SURG, V64, P936, DOI 10.1016/j.joms.2006.02.015; Locante William M, 2004, J Oral Implantol, V30, P369, DOI 10.1563/0710.1; Lorenzoni M, 2003, CLIN ORAL IMPLAN RES, V14, P180, DOI 10.1034/j.1600-0501.2003.140207.x; Malo Paulo, 2003, Clin Implant Dent Relat Res, V5 Suppl 1, P37, DOI 10.1111/j.1708-8208.2003.tb00014.x; Noelken R, 2007, INT J PERIODONT REST, V27, P277; Norton MR, 2004, INT J ORAL MAX IMPL, V19, P274	41	44	46	0	9	QUINTESSENCE PUBLISHING CO INC	HANOVER PARK	4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA	0882-2786	1942-4434		INT J ORAL MAX IMPL	Int. J. Oral Maxillofac. Implants		2009	24			S			169	179					11	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Dentistry, Oral Surgery & Medicine	508DR	WOS:000270908400014	19885444				2022-03-04	
J	Mombelli, A				Mombelli, A			Antimicrobial profiles of periodontal pathogens and systemic antimicrobial therapy	JOURNAL OF CLINICAL PERIODONTOLOGY			English	Editorial Material									Univ Geneva, Sch Dent Med, CH-1211 Geneva, Switzerland		Mombelli, A (corresponding author), Univ Geneva, Sch Dent Med, 19 Rue Barthelemy Menn, CH-1211 Geneva, Switzerland.	Andrea.Mombelli@medecine.unige.ch					Listgarten Max A, 2003, Ann Periodontol, V8, P182, DOI 10.1902/annals.2003.8.1.182; Rooney J, 2002, J CLIN PERIODONTOL, V29, P342, DOI 10.1034/j.1600-051X.2002.290410.x; van Winkelhoff AJ, 2005, J CLIN PERIODONTOL, V32, P893, DOI 10.1111/j.1600-051X.2005.00782.x	3	14	16	0	2	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DG, OXON, ENGLAND	0303-6979			J CLIN PERIODONTOL	J. Clin. Periodontol.	AUG	2005	32	8					891	892		10.1111/j.1600-051X.2005.00807.x			2	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	942NX	WOS:000230290200009	15998274				2022-03-04	
J	Perakis, N; Belser, UC; Magne, P				Perakis, N; Belser, UC; Magne, P			Final impressions: A review of material properties and description of a current technique	INTERNATIONAL JOURNAL OF PERIODONTICS & RESTORATIVE DENTISTRY			English	Review							ELASTOMERIC IMPRESSION; RHEOLOGICAL PROPERTIES; DIMENSIONAL STABILITY; DETAIL REPRODUCTION; POLYETHER; ACCURACY; GLOVES	Esthetic rehabilitations are characterized by a sequence of well-structured clinical and laboratory steps, during which different kinds of impressions are required. T is review presents a survey of the most clinically relevant physical properties that characterize final impression materials and their interactions with the products they are commonly in contact with. The principal steps of an esthetic rehabilitation involving a diagnostic phase, together with a rational step-by-step approach to final impressions, are described. The one-stepldouble-mix impression using polyvinyl siloxane materials associated with a "double cord" gingival displacement is explained.	Univ Geneva, Sch Dent Med, Dept Prosthodont, CH-1211 Geneva 4, Switzerland		Perakis, N (corresponding author), 19 Rue Barthelemy Menn, CH-1205 Geneva, Switzerland.	nperakis@libero.it	Buser, Daniel/D-3971-2011				ABADO GL, 1999, J PROSTHET DENT, V81, P621; [Anonymous], 1996, J AM DENT ASSOC, V127, P672; [Anonymous], 1990, J AM DENT ASSOC; Anusavice K J, 1988, Adv Dent Res, V2, P65; AZZI R, 1983, J PROSTHET DENT, V50, P561, DOI 10.1016/0022-3913(83)90581-4; BAUMANN MA, 1995, BRIT DENT J, V179, P130, DOI 10.1038/sj.bdj.4808854; Bertschinger C, 1996, AM J DENT, V9, P115; Bindra B, 1997, J ORAL REHABIL, V24, P63, DOI 10.1046/j.1365-2842.1997.00458.x; Chai J, 1998, INT J PROSTHODONT, V11, P219; Chong Y H, 1989, Int J Prosthodont, V2, P323; COOK WD, 1986, AUST DENT J, V31, P140, DOI 10.1111/j.1834-7819.1986.tb02577.x; Corso M, 1998, J PROSTHET DENT, V79, P626, DOI 10.1016/S0022-3913(98)70068-X; Craig R G, 1988, Adv Dent Res, V2, P51; CULLEN DR, 1991, J PROSTHET DENT, V66, P261, DOI 10.1016/S0022-3913(05)80058-7; DECAMARGO LM, 1993, J PROSTHET DENT, V70, P114, DOI 10.1016/0022-3913(93)90003-7; Di Felice Roberto, 2002, Schweiz Monatsschr Zahnmed, V112, P12; Hondrum S O, 1994, Int J Prosthodont, V7, P517; Johnson GH, 1998, J PROSTHET DENT, V79, P446, DOI 10.1016/S0022-3913(98)70160-X; Kahn R L, 1989, Int J Prosthodont, V2, P128; Kahn R L, 1989, Int J Prosthodont, V2, P342; KECK SC, 1985, J PROSTHET DENT, V54, P479, DOI 10.1016/0022-3913(85)90417-2; KOPP FR, 1982, ESTHETIC GUIDELINES, P187; LACY AM, 1981, J PROSTHET DENT, V45, P329, DOI 10.1016/0022-3913(81)90400-5; Laufer B Z, 1994, Int J Prosthodont, V7, P247; Laufer BZ, 1996, J PROSTHET DENT, V76, P466, DOI 10.1016/S0022-3913(96)90002-5; Lepe X, 1997, J PROSTHET DENT, V78, P245, DOI 10.1016/S0022-3913(97)70021-0; LEUNG RL, 1983, J PROSTHET DENT, V49, P210, DOI 10.1016/0022-3913(83)90503-6; Magne P, 1999, J Adhes Dent, V1, P81; Magne P, 1996, INT J PERIODONT REST, V16, P561; Magne P, 1993, J Esthet Dent, V5, P161, DOI 10.1111/j.1708-8240.1993.tb00773.x; MAGNE P, 2002, BONDED PORCELAIN RES, P57; Magne P., 2002, BONDED PORCELAIN RES, P270; Matis B A, 1997, J Prosthodont, V6, P189, DOI 10.1111/j.1532-849X.1997.tb00089.x; MCCABE JF, 1989, J DENT RES, V68, P1218, DOI 10.1177/00220345890680080101; McCabe JF, 1998, J DENT RES, V77, P1874, DOI 10.1177/00220345980770110301; NEMETZ H, 1984, J PROSTHET DENT, V51, P647, DOI 10.1016/0022-3913(84)90410-4; Paul SJ, 1997, INT J PERIODONT REST, V17, P537; PELZNER RB, 1978, J PROSTHET DENT, V39, P287, DOI 10.1016/S0022-3913(78)80098-5; Purk JH, 1998, J AM DENT ASSOC, V129, P1014, DOI 10.14219/jada.archive.1998.0356; Ragain JC, 2000, INT J PROSTHODONT, V13, P214; RAMADAN FA, 1968, LINEAR EFFECTIVENESS; Rios MD, 1996, J PROSTHET DENT, V76, P356, DOI 10.1016/S0022-3913(96)90538-7; RUEL J, 1980, J PROSTHET DENT, V44, P508, DOI 10.1016/0022-3913(80)90069-4; TJAN AHL, 1986, J PROSTHET DENT, V56, P4, DOI 10.1016/0022-3913(86)90272-6; WEIR DJ, 1984, J PROSTHET DENT, V51, P326, DOI 10.1016/0022-3913(84)90214-2	45	44	47	0	13	QUINTESSENCE PUBLISHING CO INC	HANOVER PARK	4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA	0198-7569	1945-3388		INT J PERIODONT REST	Int. J. Periodontics Restor. Dent.	APR	2004	24	2					109	117					9	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	816NY	WOS:000221117800002	15119881				2022-03-04	
J	Rivera-Rivera, CJ; Montoya-Burgos, JI				Rivera-Rivera, Carlos; Montoya-Burgos, Juan, I			Back to the roots: Reducing evolutionary rate heterogeneity among sequences gives support for the early morphological hypothesis of the root of Siluriformes (Teleostei: Ostariophysi)	MOLECULAR PHYLOGENETICS AND EVOLUTION			English	Article							MAJOR GROUPS; CATFISHES; FISHES; BIOGEOGRAPHY; ORIGIN; GENES	Catfishes (Teleostei: Siluriformes) are a highly diverse order within Ostariophysi that is distributed worldwide. At the base of this Glade emerge three lineages with well-defined monophylies: Diplomystidae, Loricarioidei, and Siluroidei. Morphological phylogeny studies place the Diplomystidae as the earliest branching of these three lineages, but studies based on molecular phylogenetics consistently find the fast-evolving Loricarioidei instead. The high lineage evolutionary rate heterogeneity in this order and the fact that the lineage placed closest to the root in the molecular phylogenies is fast evolving, including many long branches, raises the possibility that the discrepancy between morphological and molecular phylogenies may be the result of a long branch attraction inference artifact. We test this hypothesis by using a 10-gene dataset to evaluate the arrangement of the three main siluriform lineages, and apply the LS(3 )and LS4 taxon sequence subsampling methods to reduce evolutionary rate heterogeneity among lineages. The initial and complete dataset supports the basal branching of Loricarioidei as in all previous molecular phylogenies, but once lineage rate heterogeneity is reduced with LS3 or LS4 through the removal of sequences disrupting homogeneity, the phylogeny shows Diplomystidae as the earliest branching group, with high supports, as proposed by morphological phylogeny. The result obtained with LS3, however, introduces the misplacement of one of the species with the highest amount of missing data, Scoloplax sp. Because the sequence sub-selection criterion of LS4 has been optimized to reduce data removal, the phylogeny resulting from the LS4-processed data is in agreement with the known intra-lineage relationships in addition to supporting the morphologically-based roofing hypothesis. Our results are the first instance in which a consensus between molecular and morphological phylogeny is reached concerning the root of this order.	[Montoya-Burgos, Juan, I] Univ Geneva, Dept Genet & Evolut, 30 Quai Ernest Ansermet, CH-1211 Geneva, Switzerland; Univ Geneva, iGE3, Geneva, Switzerland		Montoya-Burgos, JI (corresponding author), Univ Geneva, Dept Genet & Evolut, 30 Quai Ernest Ansermet, CH-1211 Geneva, Switzerland.	juan.montoya@unige.ch		Montoya-Burgos, Juan/0000-0001-9080-9820	Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission [31003A_141233]; Institute of Genetics and Genomics in Geneva (iGE3)	We would like to thank Raphael Covain and Sonia Fisch-Muller from the Museum of Natural History of Geneva for making the tissue samples available for us. We are also grateful to Ilham Bahechar and Juan Carrillo de Albornoz for their help in sequencing and aligning the new data. This research was funded by the Swiss National Science Foundation (grant 31003A_141233 to JIMB) and the Institute of Genetics and Genomics in Geneva (iGE3).	Arcila D, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-016-0020; Armbruster JW, 2011, AM FISH S S, V77, P15; Arratia G, 1987, BONN ZOOL MONOGR; Arratia G, 1992, BONN ZOOL MONOGR, V32; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; Minh BQ, 2013, MOL BIOL EVOL, V30, P1188, DOI 10.1093/molbev/mst024; Chen WJ, 2013, EVOLUTION, V67, P2218, DOI 10.1111/evo.12104; Chiari Y, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-65; Collins TM, 2005, SYST BIOL, V54, P493, DOI 10.1080/10635150590947339; Covain R, 2008, MOL PHYLOGENET EVOL, V46, P986, DOI 10.1016/j.ympev.2007.12.015; de Pinna Mario C.C., 1998, P279; Diogo R, 2004, ANIM BIOL, V54, P331, DOI 10.1163/1570756042729546; Diogo R, 2007, ORIGIN HIGHER TAXA, DOI [10.1093/acprof:oso/9780199691883.001.0001, DOI 10.1093/ACPROF:OSO/9780199691883.001.0001]; Diogo R, 2010, SER TELEOST FISH BIO, P465, DOI 10.1201/b10194-13; Dornburg A, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0837-3; Fedrigo O, 2005, J EXP ZOOL PART B, V304B, P119, DOI 10.1002/jez.b.21032; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; FINK SV, 1981, ZOOL J LINN SOC-LOND, V72, P297, DOI 10.1111/j.1096-3642.1981.tb01575.x; Grande L., 1987, Journal of Vertebrate Paleontology, V7, P24; Greenwood P. H., 1966, Bulletin of the American Museum of Natural History, V131, P339; Howes G.J., 1983, Bulletin of the British Museum (Natural History) Zoology, V45, P309; Irisarri I, 2016, SYST BIOL, V65, P1057, DOI 10.1093/sysbio/syw057; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kumar S, 2012, BIOINFORMATICS, V28, P2685, DOI 10.1093/bioinformatics/bts507; Liu L, 2015, MOL BIOL EVOL, V32, P791, DOI 10.1093/molbev/msu331; Lopez-Giraldez F, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-152; Lundberg J.G., 1969, American Museum Novitates, VNo. 2398, P1; Lundberg JG, 2000, ANN MO BOT GARD, V87, P26, DOI 10.2307/2666207; Massingham T, 2000, BIOINFORMATICS, V16, P294, DOI 10.1093/bioinformatics/16.3.294; Nakatani M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-177; Philippe H, 2005, ANNU REV ECOL EVOL S, V36, P541, DOI 10.1146/annurev.ecolsys.35.112202.130205; Philippe H, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-91; Plazzi F, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-209; Popescu AA, 2012, BIOINFORMATICS, V28, P1536, DOI 10.1093/bioinformatics/bts184; Rivera-Rivera C. J, 2017, BIORXIV, DOI [10.1101/220053, DOI 10.1101/220053]; Rivera-Rivera CJ, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.1831; Rivera-Rivera CJ, 2016, MOL BIOL EVOL, V33, P1625, DOI 10.1093/molbev/msw043; Romiguier J, 2013, MOL BIOL EVOL, V30, P2134, DOI 10.1093/molbev/mst116; SCHAEFER SA, 1990, P ACAD NAT SCI PHILA, V142, P167; St Amand TR, 2000, DEV BIOL, V217, P323, DOI 10.1006/dbio.1999.9547; Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815; Su Z, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0364-7; Sullivan JP, 2006, MOL PHYLOGENET EVOL, V41, P636, DOI 10.1016/j.ympev.2006.05.044; Sullivan JP, 2013, P ACAD NAT SCI PHILA, V162, P89, DOI 10.1635/053.162.0106; Team RC, 2016, R LANG ENV STAT COMP; Tianpei M, 1991, ANATOMY RELATIONSHIP; Townsend JP, 2012, SYST BIOL, V61, P835, DOI 10.1093/sysbio/sys036; White WT, 2007, MOL BIOL EVOL, V24, P2029, DOI 10.1093/molbev/msm139	48	3	3	0	9	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1055-7903	1095-9513		MOL PHYLOGENET EVOL	Mol. Phylogenet. Evol.	OCT	2018	127						272	279		10.1016/j.ympev.2018.06.004			8	Biochemistry & Molecular Biology; Evolutionary Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Evolutionary Biology; Genetics & Heredity	GV3UB	WOS:000446021300023	29885935				2022-03-04	
J	Megally, A; Zekeridou, A; Cancela, J; Giannopoulou, C; Mombelli, A				Megally, Andrew; Zekeridou, Alkisti; Cancela, Jose; Giannopoulou, Catherine; Mombelli, Andrea			Short ultrasonic debridement with adjunctive low-concentrated hypochlorite/amino acid gel during periodontal maintenance: randomized clinical trial of 12 months	CLINICAL ORAL INVESTIGATIONS			English	Article						Maintenance; Subgingival plaque removal; Hypochlorite; amino acid gel; Clinical trial	SUPRAGINGIVAL PLAQUE CONTROL; SUBGINGIVAL DEBRIDEMENT; TOOTH SUBSTANCE; REMOVAL; THERAPY; SMOKING; CARIES; INSTRUMENTS; EFFICACY	Objectives The objective of this study was to evaluate the benefit of repeated subgingival cleaning with a low-concentrated hypochlorite/amino acid gel in subjects in maintenance care with residual pockets >= 5 mm. Material and methods Examiner masked, randomized two-arm parallel design. Thirty-two adult periodontal patients in maintenance phase, > 3 months after periodontal therapy, with at least one residual periodontal pocket >= 5 mm, were randomly assigned to treatment by subgingival ultrasonic debridement with the gel or ultrasonic debridement only. At months 0, 4, and 8, all sites presenting with a probing depth (PD) >= 5 mm were treated. Six sites were monitored on each tooth. The primary end point was the presence or absence of PD >= 5 mm after 12 months. Secondary clinical outcomes were oral tissue safety; patient acceptance; changes in PD; bleeding on probing; recession after 4, 8, and 12 months; and the presence or absence of six target microorganisms in treated pockets at baseline, after 7 days and 4 months. Results A total of 365 sites in 32 patients with PD >= 5 mm were treated at baseline. At the final evaluation at month 12, 47% of these sites in the test and 49% in the control group were still in this PD category. The difference between baseline and month 12 was significant in both groups (p < 0.01), whereas the difference between groups was not. Repeated short ultrasonic instrumentation with adjunctive administration of the test product resulted in a clinical attachment level (CAL) gain of 1.02 mm (p < 0.01) and led to - 0.97 mm of pocket reduction (p < 0.01) without inducing further recession. However, repeated short ultrasonic debridement without the gel led to a similar clinical outcome (p < 0.01). No adverse events were recorded. Conclusions Short ultrasonic instrumentation of residual pockets with PD >= 5 mm during maintenance visits resulted in a clinically relevant CAL gain and PD reduction in the order of 1 mm in 1 year, without inducing further recession.	[Megally, Andrew; Zekeridou, Alkisti; Cancela, Jose; Giannopoulou, Catherine; Mombelli, Andrea] Univ Geneva, Univ Clin Dent Med, Div Periodontol, 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland		Mombelli, A (corresponding author), Univ Geneva, Univ Clin Dent Med, Div Periodontol, 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland.	andrea.mombelli@unige.ch			CSRD VA [1] Funding Source: Medline		Axelsson P, 2004, J CLIN PERIODONTOL, V31, P749, DOI 10.1111/j.1600-051X.2004.00563.x; Azaripour A, 2018, LASER MED SCI, V33, P407, DOI 10.1007/s10103-017-2383-7; Beeley JA, 2000, BRIT DENT J, V188, P427, DOI 10.1038/sj.bdj.4800501a; BELTRAMI M, 1987, J CLIN PERIODONTOL, V14, P161, DOI 10.1111/j.1600-051X.1987.tb00960.x; BOWER RC, 1979, J PERIODONTOL, V50, P366, DOI 10.1902/jop.1979.50.7.366; CAFFESSE RG, 1986, J CLIN PERIODONTOL, V13, P205, DOI 10.1111/j.1600-051X.1986.tb01461.x; Campanile VSM, 2015, LASER MED SCI, V30, P27, DOI 10.1007/s10103-013-1337-y; Carter GP, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.02000-17; Gottardi W, 2013, ANTIMICROB AGENTS CH, V57, P1107, DOI 10.1128/AAC.02132-12; Gottardi W, 2010, J ANTIMICROB CHEMOTH, V65, P399, DOI 10.1093/jac/dkp466; Guarnelli ME, 2015, MINERVA STOMATOL, V64, P158; Heasman PA, 2002, J CLIN PERIODONTOL, V29, P163, DOI 10.1034/j.1600-051X.29.s3.9.x; Hosoya Y, 2005, J DENT, V33, P283, DOI 10.1016/j.jdent.2004.09.004; Jurczyk K, 2016, CLIN ORAL INVEST, V20, P2165, DOI 10.1007/s00784-016-1711-9; KHO P, 1985, J CLIN PERIODONTOL, V12, P676, DOI 10.1111/j.1600-051X.1985.tb00939.x; Kotsakis GA, 2015, J PERIODONTOL, V86, P254, DOI 10.1902/jop.2014.140452; Kozarov E, 2006, MICROBES INFECT, V8, P687, DOI 10.1016/j.micinf.2005.09.004; Labriola A, 2005, PERIODONTOL 2000, V37, P124, DOI 10.1111/j.1600-0757.2004.03793.x; LOOS B, 1988, J CLIN PERIODONTOL, V15, P211, DOI 10.1111/j.1600-051X.1988.tb01572.x; Matesanz-Perez P, 2013, J CLIN PERIODONTOL, V40, P227, DOI 10.1111/jcpe.12026; Matuliene G, 2008, J CLIN PERIODONTOL, V35, P685, DOI 10.1111/j.1600-051X.2008.01245.x; MCNABB H, 1992, J CLIN PERIODONTOL, V19, P348, DOI 10.1111/j.1600-051X.1992.tb00658.x; Moene R, 2010, J PERIODONTOL, V81, P79, DOI 10.1902/jop.2009.090394; Mombelli A, 2018, PERIODONTOL 2000, V76, P85, DOI 10.1111/prd.12147; Mombelli A, 2017, J PERIODONTOL, V88, P1253, DOI 10.1902/jop.2017.170286; Mombelli A, 2015, J PERIODONTOL, V86, P367, DOI 10.1902/jop.2014.140478; Muller N, 2014, J CLIN PERIODONTOL, V41, P883, DOI 10.1111/jcpe.12289; Nadanovsky P, 2001, CARIES RES, V35, P384, DOI 10.1159/000047478; Obeid P, 2005, CLIN ORAL INVEST, V9, P118, DOI 10.1007/s00784-005-0309-4; Patel RA, 2012, J PERIODONTOL, V83, P143, DOI 10.1902/jop.2011.110130; RABBANI GM, 1981, J PERIODONTOL, V52, P119, DOI 10.1902/jop.1981.52.3.119; Schmidlin RR, 2001, J CLIN PERIODONTOL, V28, P1058; Shelburne CE, 2000, J MICROBIOL METH, V39, P97, DOI 10.1016/S0167-7012(99)00106-2; SILNESS J, 1964, Acta Odontol Scand, V22, P121, DOI 10.3109/00016356408993968; Van der Weijden GA, 2002, J CLIN PERIODONTOL, V29, P55, DOI 10.1034/j.1600-051X.29.s3.3.x; Williamson Deborah A, 2017, Clin Microbiol Rev, V30, P827, DOI 10.1128/CMR.00112-16; ZAPPA U, 1991, J PERIODONTOL, V62, P750, DOI 10.1902/jop.1991.62.12.750	37	6	6	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1432-6981	1436-3771		CLIN ORAL INVEST	Clin. Oral Investig.	JAN	2020	24	1					201	209		10.1007/s00784-019-02949-2			9	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	KL2DI	WOS:000513239100020	31079243				2022-03-04	
J	Epars, JF; Mavropoulos, A; Kiliaridis, S				Epars, Jean-Francois; Mavropoulos, Anestis; Kiliaridis, Stavros			Changes in the location of the human mandibular foramen as a function of growth and vertical facial type	ACTA ODONTOLOGICA SCANDINAVICA			English	Article						anesthesia; facial morphology; inferior alveolar nerve block; lateral cephalometric radiograph; occlusal plane	FACE SYNDROME; ADULTS	Objective. A previous cross-sectional investigation showed that the mandibular foramen location depends on the age and the vertical facial pattern of growing individuals. The aim of the present longitudinal study was to explain how these factors influence the distance between the foramen and the occlusal plane. It is known that a certain distance is necessary for a successful inferior alveolar nerve block in clinical dentistry. Materials and methods. This distance, as well as another four cephalometric variables, were measured on both pre-treatment and 10-year post-treatment lateral cephalometric radiographs collected from 50 patients who underwent orthodontic treatment. The changes between these two sets of measurements were also calculated. Results. A multiple regression analysis was performed using the pre-treatment age, the pre-treatment intermaxillary angle, the rotation of the occlusal plane and the change in mandibular ramus height as independent variables and the change of foramen-occlusal plane distance as a dependent variable. The independent variables under investigation were found to account for more than half of the variability of the foramen-occlusal plane distance (r = 0.732; p < 0.001). Conclusion. In very young individuals the mandibular foramen is located approximately at the level of the occlusal plane. With age it moves upwards relative to the occlusal plane and more so for those individuals with a low anterior facial height (short-face vertical facial type). These observations are, at least, partially explained by the differential growth of the various elements of the maxillo-mandibular complex and the change of the inclination of the occlusal plane.	[Epars, Jean-Francois; Mavropoulos, Anestis; Kiliaridis, Stavros] Univ Geneva, Sch Dent, Dept Orthodont, CH-1205 Geneva, Switzerland		Epars, JF (corresponding author), Univ Geneva, Sch Dent, Dept Orthodont, 19 Barthelemy Menn, CH-1205 Geneva, Switzerland.	jfepars@gmail.com					Bennett CR, 1978, MONHEIMS LOCAL ANEST; Epars JF, 2013, PEDIATR DENT, V35, P369; FIELDS HW, 1984, AM J ORTHOD DENTOFAC, V85, P217, DOI 10.1016/0002-9416(84)90061-7; HOUSTON WJB, 1983, AM J ORTHOD DENTOFAC, V83, P382, DOI 10.1016/0002-9416(83)90322-6; Hwang T J, 1990, Zhonghua Ya Yi Xue Hui Za Zhi, V9, P98; ISAACSON JR, 1971, ANGLE ORTHOD, V41, P219; KILIARIDIS S, 1993, ACTA ODONTOL SCAND, V51, P323, DOI 10.3109/00016359309040583; Malamed SF, 2004, HDB LOCAL ANESTHESIA; ODEGAARD J, 1970, AMER J ORTHODONTICS, V58, P448, DOI 10.1016/0002-9416(70)90021-7; OPDEBEECK H, 1978, AM J ORTHOD DENTOFAC, V73, P499, DOI 10.1016/0002-9416(78)90240-3; PROFFIT WR, 1983, J DENT RES, V62, P566, DOI 10.1177/00220345830620051201; SCHENDEL SA, 1976, AM J ORTHOD DENTOFAC, V70, P398, DOI 10.1016/0002-9416(76)90112-3; Steiner RB, 1977, ORAL SURG ANESTHESIA; Suzumura N, 1989, Nihon Kyosei Shika Gakkai Zasshi, V48, P404; Thoma KH, 1958, ORAL SURG; van der Linden FPGM, 2008, EUR J ORTHODONT, V30, P449, DOI 10.1093/ejo/cjn048; WONG MKS, 1992, J AM DENT ASSOC, V123, P69, DOI 10.14219/jada.archive.1992.0004	17	7	7	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0001-6357	1502-3850		ACTA ODONTOL SCAND	Acta Odontol. Scand.	JUL	2015	73	5					375	379		10.3109/00016357.2014.968871			5	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	CI2VX	WOS:000354606800009	25330162				2022-03-04	
J	Pecie, R; Onisor, I; Krejci, I; Bortolotto, T				Pecie, R.; Onisor, I.; Krejci, I.; Bortolotto, T.			Marginal Adaptation of Direct Class II Composite Restorations with Different Cavity Liners	OPERATIVE DENTISTRY			English	Article								The aim of this study was to evaluate how cavity linings with different elastic modulus can influence the marginal adaptation (MA) of Class II composite restorations before and after thermo-mechanical loading. Materials and Methods: Forty Class II cavities with margins extending 1 mm below the cement-enamel junction were prepared in extracted human third molars. In each group except the control group, a lining material of 1-mm thickness was applied to the bottom of the cavity and polymerized before placing the resin composite Herculite XRV Ultra (group A: control; group B: Premise Flowable lining; group C: Herculite XRV Ultra lining; and group D: Optibond FL lining). MA was evaluated (with a scanning electron microscope) before and after loading (200,000 loading cycles). Statistical analysis was done using the Shapiro-Wilks test, the analysis of variance test, and Duncan post hoc test at p<0.05. Results: Before loading, the percentages of continuous margins in dentin were superior (p<0.05) for groups C and D (71.1% and 87.2%, respectively) compared to groups A and B (55.7% and 48.3%, respectively). After loading, group D (79.8%) was statistically superior in dentin compared to all of the other groups (43.6%, 35.9%, and 54.4%, respectively). In occlusal enamel, no significant difference was found between groups. The percentage of enamel fractures and the percentage of non-continuous margins in proximal enamel were high, with no significant difference between liners. It can be concluded that for the materials used in this study, a 1-mm-thick lining with an extremely low elastic modulus (2-3 GPa) could redistribute shrinkage stress. The use of a flowable composite did not significantly improve MA.	[Pecie, R.; Onisor, I.; Krejci, I.; Bortolotto, T.] Univ Geneva, Div Cariol & Endodontol, Rue Barthelemy Menn 19, CH-1205 Geneva, Switzerland		Pecie, R (corresponding author), Univ Geneva, Div Cariol & Endodontol, Rue Barthelemy Menn 19, CH-1205 Geneva, Switzerland.	raluca.pecie@unige.ch	Bortolotto, Tissiana/AAE-2796-2021	Bortolotto, Tissiana/0000-0002-3231-9097			Alomari QD, 2001, OPER DENT, V26, P406; Asmussen E, 2008, DENT MATER, V24, P600, DOI 10.1016/j.dental.2007.06.019; Attar N, 2004, OPER DENT, V29, P162; Attar Nuray, 2003, J Can Dent Assoc, V69, P516; Ausiello P, 2002, DENT MATER, V18, P295, DOI 10.1016/S0109-5641(01)00042-2; Ausiello P, 2001, J BIOMECH, V34, P1269, DOI 10.1016/S0021-9290(01)00098-7; Blunck U, 1989, Quintessence Int, V20, P407; Bortolotto T, 2005, INT DENTISTRY S AFRI, V5, P21; Bouillaguet S, 2006, DENT MATER, V22, P896, DOI 10.1016/j.dental.2005.11.017; BOWEN RL, 1967, J AM DENT ASSOC, V74, P439, DOI 10.14219/jada.archive.1967.0078; Braga RR, 2002, J DENT RES, V81, P114, DOI 10.1177/154405910208100206; Braga RR, 2004, CRIT REV ORAL BIOL M, V15, P176, DOI 10.1177/154411130401500306; Braga RR, 2003, J AM DENT ASSOC, V134, P721, DOI 10.14219/jada.archive.2003.0258; Cara RR, 2007, J DENT, V35, P482, DOI 10.1016/j.jdent.2007.01.005; Chiang YC, 2010, DENT MATER, V26, P223, DOI 10.1016/j.dental.2009.09.013; Choi KK, 2000, J DENT RES, V79, P812, DOI 10.1177/00220345000790030501; Chuang SF, 2004, OPER DENT, V29, P301; da Silva EM, 2007, OPER DENT, V32, P356, DOI 10.2341/06-104; DAVIDSON CL, 1984, J DENT RES, V63, P146, DOI 10.1177/00220345840630021001; De Munck J, 2005, J DENT RES, V84, P118, DOI 10.1177/154405910508400204; Dewaele M, 2006, EUR J ORAL SCI, V114, P535, DOI 10.1111/j.1600-0722.2006.00407.x; Goncalves F, 2010, DENT MATER, V26, P704, DOI 10.1016/j.dental.2010.03.015; Gow Alex M, 2002, Eur J Prosthodont Restor Dent, V10, P101; GRUNDY JR, 1971, BRIT DENT J, V130, P113, DOI 10.1038/sj.bdj.4802634; Gueders AM, 2006, OPER DENT, V31, P450, DOI 10.2341/05-55; Heintze SD, 2007, J ADHES DENT, V9, P77; Hemmings KW, 2000, J PROSTHET DENT, V83, P287, DOI 10.1016/S0022-3913(00)70130-2; Hilton TJ, 2002, AM J DENT, V15, P279; Ichim IP, 2007, DENT MATER, V23, P1562, DOI 10.1016/j.dental.2007.02.002; Ilie N, 2006, DENT MATER, V22, P593, DOI 10.1016/j.dental.2005.05.014; Irie M, 2002, DENT MATER, V18, P203, DOI 10.1016/S0109-5641(01)00083-5; Jain P, 2000, AM J DENT, V13, P235; Kanca J, 1999, AM J DENT, V12, P107; KEMPSCHOLTE CM, 1990, J PROSTHET DENT, V64, P658, DOI 10.1016/0022-3913(90)90291-J; KEMPSCHOLTE CM, 1990, J DENT RES, V69, P1240, DOI 10.1177/00220345900690060301; Kinomoto Y, 1998, J DENT, V26, P165, DOI 10.1016/S0300-5712(96)00083-8; Korkmaz Y, 2007, J ADHES DENT, V9, P189; Kowalczyk P, 2009, DENT MATER, V25, pE83, DOI 10.1016/j.dental.2009.07.014; Kubo S, 2006, J DENT, V34, P97, DOI 10.1016/j.jdent.2005.04.003; Labella R, 1999, DENT MATER, V15, P128, DOI 10.1016/S0109-5641(99)00022-6; Leevailoj C, 2001, OPER DENT, V26, P302; Lindberg A, 2005, CLIN ORAL INVEST, V9, P77, DOI 10.1007/s00784-005-0311-x; LUTZ F, 1991, DENT MATER, V7, P107, DOI 10.1016/0109-5641(91)90055-4; Marchesi G, 2010, DENT MATER, V26, P947, DOI 10.1016/j.dental.2010.05.007; Oliveira LCA, 2010, DENT MATER, V26, pE159, DOI 10.1016/j.dental.2009.11.076; Olmez A, 2004, OPER DENT, V29, P713; Peumans M, 2005, DENT MATER, V21, P864, DOI 10.1016/j.dental.2005.02.003; Poyser NJ, 2007, J ORAL REHABIL, V34, P361, DOI 10.1111/j.1365-2842.2006.01702.x; Redman CDJ, 2003, BRIT DENT J, V194, P566, DOI 10.1038/sj.bdj.4810209; Schmidlin PR, 2007, OPER DENT, V32, P291, DOI 10.2341/06-84; Schmidlin PR, 2009, OPER DENT, V34, P102, DOI 10.2341/08-11; SEGURA A, 1993, J ORAL REHABIL, V20, P495, DOI 10.1111/j.1365-2842.1993.tb01636.x; Shono Y, 1999, J DENT RES, V78, P699, DOI 10.1177/00220345990780021001; Smales RJ, 2007, EUR J PROSTHODONT RE, V15, P2; Stavridakis MM, 2005, OPER DENT, V30, P118; SULIMAN AA, 1993, DENT MATER, V9, P6, DOI 10.1016/0109-5641(93)90096-9; Tantbirojn D, 2004, DENT MATER, V20, P535, DOI 10.1016/j.dental.2003.05.008; Tredwin CJ, 2005, OPER DENT, V30, P32; Unterbrink GL, 1999, QUINTESSENCE INT, V30, P249; van Dijken JWV, 2008, DENT MATER, V24, P915, DOI 10.1016/j.dental.2007.11.008; van Dijken JWV, 2007, DENT MATER, V23, P1101, DOI 10.1016/j.dental.2006.10.005; VANMEERBEEK B, 1993, J DENT RES, V72, P1434, DOI 10.1177/00220345930720101401; Versluis A, 2004, DENT MATER, V20, P554, DOI 10.1016/j.dental.2003.05.007; Ziskind D, 2005, Int J Paediatr Dent, V15, P349, DOI 10.1111/j.1365-263X.2005.00663.x	64	13	16	0	5	OPERATIVE DENTISTRY INC	INDIANAPOLIS	INDIANA UNIV SCHOOL DENTISTRY, ROOM S411, 1121 WEST MICHIGAN ST, INDIANAPOLIS, IN 46202-5186 USA	0361-7734	1559-2863		OPER DENT	Oper. Dent.	NOV-DEC	2013	38	6					E210	E220		10.2341/12-229-L			11	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	VH3OT	WOS:000452915800002	23713806				2022-03-04	
J	Bortolotto, T; Dagon, C; Krejci, I				Bortolotto, Tissiana; Dagon, Christel; Krejci, Ivo			Light polymerization during cavity filling: Effect of 'exposure reciprocity law' and the resulted shrinkage forces on restoration margins	ACTA ODONTOLOGICA SCANDINAVICA			English	Article						curing protocol; irradiance; linear shrinkage; polymerization force; marginal integrity	SHORT IRRADIATION TIME; RESIN COMPOSITE; DENTAL COMPOSITES; POWER-DENSITY; CONTRACTION STRESS; ENERGY DENSITY; CURE; CONVERSION; INTENSITY; INTEGRITY	Objective. To evaluate shrinkage development and marginal integrity of a micro hybrid restorative composite as a function of irradiance. Materials and methods. Linear displacement and shrinkage were measured with custom-made devices for irradiances of 100, 200, 400, 800 and 1600 mW/cm(2) at a constant radiant exposure of 16 J/cm(2). Marginal adaptation (MA) of composite restorations performed with a self-etch adhesive (Syntac Classic, Ivoclar Vivadent) and a micro hybrid composite (Tetric, Ivoclar Vivadent) was evaluated before and after mechanical loading with 300,000 cycles at 70 N. Results. The highest percentage of MA was attained by the group light cured with an irradiance of 100 mW/cm(2) for 160 s. No significant differences were observed between the rest of the groups. Shrinkage development was similar in all groups. Conclusions. For the material tested in this study, the reciprocal relationship between irradiance and time of exposure had no significant effect on restoration margins and shrinkage stress development within the range of 200-1600 mW/cm(2) with a constant radiant exposure of 16 J/cm(2).	[Bortolotto, Tissiana; Dagon, Christel; Krejci, Ivo] Univ Geneva, Sch Dent Med, Div Cariol & Endodont, CH-1205 Geneva, Switzerland		Bortolotto, T (corresponding author), Univ Geneva, Sch Dent Med, Div Cariol & Endodont, 19 Rue Barthelemy Menn, CH-1205 Geneva, Switzerland.	tissiana.bortolotto@unige.ch	Bortolotto, Tissiana/AAE-2796-2021	Bortolotto, Tissiana/0000-0002-3231-9097			Alonso RCB, 2006, ACTA ODONTOL SCAND, V64, P306, DOI 10.1080/00016350600791744; Braga RR, 2004, CRIT REV ORAL BIOL M, V15, P176, DOI 10.1177/154411130401500306; da Silva Segalin Aline, 2005, J Esthet Restor Dent, V17, P303, DOI 10.1111/j.1708-8240.2005.tb00135.x; DAVIDSON CL, 1984, J DENT RES, V63, P146, DOI 10.1177/00220345840630021001; Emami N, 2003, EUR J ORAL SCI, V111, P536, DOI 10.1111/j.0909-8836.2003.00082.x; Emami N, 2003, J DENT, V31, P189, DOI 10.1016/S0300-5712(03)00015-0; FEILZER AJ, 1995, EUR J ORAL SCI, V103, P322, DOI 10.1111/j.1600-0722.1995.tb00033.x; FEILZER AJ, 1988, J PROSTHET DENT, V59, P297, DOI 10.1016/0022-3913(88)90176-X; Feng L, 2009, DENT MATER, V25, P283, DOI 10.1016/j.dental.2008.07.007; Ferracane JL, 2003, AM J DENT, V16, P239; Friedl KH, 2000, OPER DENT, V25, P26; Gritsch K, 2008, EUR J ORAL SCI, V116, P77, DOI 10.1111/j.1600-0722.2007.00506.x; Halvorson RH, 2002, DENT MATER, V18, P463, DOI 10.1016/S0109-5641(01)00069-0; Leprince JG, 2011, DENT MATER, V27, P157, DOI 10.1016/j.dental.2010.09.011; Manga R K, 1995, Gen Dent, V43, P241; Musanje L, 2003, DENT MATER, V19, P531, DOI 10.1016/S0109-5641(02)00101-X; Neves AD, 2005, J BIOMED MATER RES B, V72B, P393, DOI 10.1002/jbm.b.30179; Nomoto R, 1997, Dent Mater J, V16, P60; Peutzfeldt A, 2005, J DENT RES, V84, P659, DOI 10.1177/154405910508400715; Price RBT, 2004, BIOMATERIALS, V25, P4465, DOI 10.1016/j.biomaterials.2003.11.032; RUEGGEBERG FA, 1994, OPER DENT, V19, P26; Rueggeberg FA, 2011, DENT MATER, V27, P39, DOI 10.1016/j.dental.2010.10.021; Sakaguchi R L, 2001, J Esthet Restor Dent, V13, P121, DOI 10.1111/j.1708-8240.2001.tb00434.x; Sakaguchi RL, 2004, DENT MATER, V20, P402, DOI 10.1016/j.dental.2003.11.004; Sato T, 2004, EUR J ORAL SCI, V112, P538, DOI 10.1111/j.1600-0722.2004.00179.x; Scotti N, 2011, QUINTESSENCE INT, V42, pE89; Stavridakis MM, 2003, AM J DENT, V16, P431; Taubock TT, 2010, EUR J ORAL SCI, V118, P423, DOI 10.1111/j.1600-0722.2010.00746.x; Vandewalle KS, 2004, DENT MATER, V20, P96, DOI 10.1016/S0109-5641(03)00124-6	29	6	6	0	2	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0001-6357			ACTA ODONTOL SCAND	Acta Odontol. Scand.	SEP	2013	71	5					1296	1302		10.3109/00016357.2012.762988			7	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	216CH	WOS:000324258100041	23796309				2022-03-04	
J	Rocca, GT; Bonnafous, F; Rizcalla, N; Krejci, I				Rocca, Giovanni Tommaso; Bonnafous, Francois; Rizcalla, Nicolas; Krejci, Ivo			A TECHNIQUE TO IMPROVE THE ESTHETIC ASPECTS OF CAD/CAM COMPOSITE RESIN RESTORATIONS	JOURNAL OF PROSTHETIC DENTISTRY			English	Article								Bonded indirect computer-aided design/computer-aided manufacturing (CAD/CAM) restorations are increasingly gaining popularity for the restoration of large defects in posterior teeth. In addition to ceramic blocks, composite resin blocks have been developed. Composite resins blocks may have improved mechanical properties, but have poor esthetics. Thus, an esthetic modification of the restoration after machine milling may be necessary. A step-by-step procedure for the external esthetic layering of a composite CAD/CAM restoration is described. This technique can be used to repair or modify any composite resin restoration. (J Prosthet Dent 2010; 104:273-275)	[Rocca, Giovanni Tommaso; Rizcalla, Nicolas; Krejci, Ivo] Univ Geneva, Sch Dent Med, Div Cariol & Endodontol, CH-1205 Geneva, Switzerland; [Bonnafous, Francois] Univ Geneva, Sch Dent Med, Div Prevent Dent Med, CH-1205 Geneva, Switzerland		Rocca, GT (corresponding author), Univ Geneva, Sch Dent Med, Div Cariol & Endodontol, Rue Barthelemy Menn 19, CH-1205 Geneva, Switzerland.	Giovanni.rocca@unige.ch		Rocca, Giovanni Tommaso/0000-0002-9511-9965			Akbar Jaber Hussain, 2006, J Prosthodont, V15, P155, DOI 10.1111/j.1532-849X.2006.00095.x; Attia A, 2006, J PROSTHET DENT, V95, P117, DOI 10.1016/j.prosdent.2005.11.014; Ausiello P, 2004, DENT MATER, V20, P862, DOI 10.1016/j.dental.2004.05.001; Giordano R, 2006, J AM DENT ASSOC, V137, p14S, DOI 10.14219/jada.archive.2006.0397; Jiang W, 2010, J PROSTHET DENT, V103, P6, DOI 10.1016/S0022-3913(09)60206-7; Junior SAR, 2009, DENT MATER, V25, P442, DOI 10.1016/j.dental.2008.09.009; Lin CL, 2008, J DENT, V36, P194, DOI 10.1016/j.jdent.2007.11.016; Magne P, 2009, QUINTESSENCE INT, V40, P125; Mormann W H, 1989, Quintessence Int, V20, P329; Reiss B, 2003, Int J Comput Dent, V6, P333; Sato K, 2002, J ORAL REHABIL, V29, P24, DOI 10.1046/j.1365-2842.2002.00798.x; Soares Carlos Jose, 2005, J Esthet Restor Dent, V17, P224, DOI 10.1111/j.1708-8240.2005.tb00119.x	12	41	42	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-3913	1097-6841		J PROSTHET DENT	J. Prosthet. Dent.	OCT	2010	104	4					273	275		10.1016/S0022-3913(10)60138-2			3	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	670GN	WOS:000283409300008	20875532				2022-03-04	
J	Moene, R; Decaillet, F; Andersen, E; Mombelli, A				Moene, Raphael; Decaillet, Fabien; Andersen, Elene; Mombelli, Andrea			Subgingival Plaque Removal Using a New Air-Polishing Device	JOURNAL OF PERIODONTOLOGY			English	Article						Air abrasion, dental; dental plaque; randomized controlled trial; root planing; visual analog scale	NONSURGICAL PERIODONTAL THERAPY; CERVICAL DENTIN SENSITIVITY; POWDER ABRASIVE SYSTEM; ROOT SUBSTANCE REMOVAL; REAL-TIME PCR; IN-VITRO; CLINICAL-EVALUATION; CALCULUS REMOVAL; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; ADULT PERIODONTITIS	Background: The purpose of this study is to evaluate the safety, patient acceptance, and short-term microbiologic effect of a new air-polishing device in subjects in maintenance care with residual pockets >= 5 mm. Methods: This was an examiner-masked, randomized, split-mouth clinical trial. A new disposable nozzle, allowing the subgingival application of amino acid glycine powder at a limited pressure, was compared to scaling and root planing (SRP) in 50 subjects with residual pockets during the maintenance phase. After removing supragingival deposits, the spray was applied for 4 to 5 seconds in all sites >= 5mm in the test quadrant, whereas SRP was used in the control quadrant. Microbiologic samples were taken from one treated test and one control site 2 days before and 7 days after treatment. Total bacterial counts and the counts of six periodontal pathogens were determined by real-time polymerase chain reaction. Results: No adverse event was noted in any subject for the test or control treatment. Using a visual analog scale, the patients perceived the test treatment to be significantly less painful/uncomfortable than the hand instrumentation (P < 0.001). Significantly less time was used by the operator for the test procedure (P < 0.001). The reduction in bleeding on probing was significant for the treated sites in the test and control quadrants (P = 0.019 and P < 0.001, respectively), but traditional SRP reduced the bleeding tendency significantly more than air polishing (P = 0.045). The differences in the total bacterial load and the counts of six periodontal pathogens between the test and control sites did not reach statistical significance. The longitudinal reduction was significant in control sites for total bacteria load (P < 0.001), Porphyromonas gingivalis (P = 0.01), Treponema denticola (P < 0.001), and Tannerella forsythia (previously T. forsythensis) (P < 0.001). Conclusion: Subgingival air polishing with a new device was safe (no adverse events were noted), perceived to be more acceptable by the patients, and was more time-efficient than SRP; however, on a microbiologic level, it was not superior to conventional SRP. J Periodontol 2010;81:79-88.	[Moene, Raphael; Decaillet, Fabien; Andersen, Elene; Mombelli, Andrea] Univ Geneva, Dept Periodontol, Sch Dent Med, CH-1205 Geneva, Switzerland		Moene, R (corresponding author), Univ Geneva, Dept Periodontol, Sch Dent Med, Rue Barthelemy Menn 19, CH-1205 Geneva, Switzerland.	Raphael.Moene@unige.ch			EMS Electro Medical System, Nyon, Switzerland; GABA International, Therwil, Switzerland	This study was supported by EMS Electro Medical System, Nyon, Switzerland. The modified air-polishing device was developed and provided by the company. The authors gratefully acknowledge the support of GABA International, Therwil, Switzerland, for providing the microbiologic analyses free of charge. The authors report no conflicts of interest related to this study.	Aquilina Peter, 2004, Emerg Med Australas, V16, P244, DOI 10.1111/j.1742-6723.2004.00574.x; ARAGON SB, 1986, J ORAL MAXIL SURG, V44, P141, DOI 10.1016/0278-2391(86)90198-9; ATKINSON DR, 1984, J PERIODONTOL, V55, P13, DOI 10.1902/jop.1984.55.1.13; AXELSSON P, 1981, J CLIN PERIODONTOL, V8, P281, DOI 10.1111/j.1600-051X.1981.tb02039.x; Axelsson P, 2004, J CLIN PERIODONTOL, V31, P749, DOI 10.1111/j.1600-051X.2004.00563.x; BADERSTEN A, 1984, J CLIN PERIODONTOL, V11, P114, DOI 10.1111/j.1600-051X.1984.tb00839.x; BADERSTEN A, 1984, J CLIN PERIODONTOL, V11, P63, DOI 10.1111/j.1600-051X.1984.tb01309.x; BADERSTEN A, 1981, J CLIN PERIODONTOL, V8, P57, DOI 10.1111/j.1600-051X.1981.tb02024.x; BARNES CM, 1990, AM J ORTHOD DENTOFAC, V97, P74, DOI 10.1016/S0889-5406(05)81712-3; BERKSTEIN S, 1987, J PERIODONTOL, V58, P327, DOI 10.1902/jop.1987.58.5.327; BUCHANAN SA, 1987, J PERIODONTOL, V58, P159, DOI 10.1902/jop.1987.58.3.159; Chabanski MB, 1997, J ORAL REHABIL, V24, P15, DOI 10.1046/j.1365-2842.1997.00471.x; Chabanski MB, 1997, J ORAL REHABIL, V24, P666, DOI 10.1046/j.1365-2842.1997.00552.x; Darby IB, 2001, J CLIN PERIODONTOL, V28, P796, DOI 10.1034/j.1600-051X.2001.280812.x; FINLAYSON RS, 1988, J PERIODONTOL, V59, P315, DOI 10.1902/jop.1988.59.5.315; FISCHER C, 1992, J DENT, V20, P272, DOI 10.1016/0300-5712(92)90043-C; FISCHER C, 1991, ENDOD DENT TRAUMATOL, V7, P259; Flemmig TF, 1998, J CLIN PERIODONTOL, V25, P158, DOI 10.1111/j.1600-051X.1998.tb02422.x; Flemmig TF, 2007, J PERIODONTOL, V78, P1002, DOI 10.1902/jop.2007.060420; FURUICHI Y, 1992, J CLIN PERIODONTOL, V19, P423, DOI 10.1111/j.1600-051X.1992.tb00673.x; GOODSON JM, 1985, J PERIODONTOL, V56, P265, DOI 10.1902/jop.1985.56.5.265; HAFFAJEE AD, 1995, J CLIN PERIODONTOL, V22, P618, DOI 10.1111/j.1600-051X.1995.tb00815.x; Haffajee AD, 1997, J CLIN PERIODONTOL, V24, P324, DOI 10.1111/j.1600-051X.1997.tb00765.x; Heyman S N, 1995, Quintessence Int, V26, P535; Jervoe-Storm PM, 2007, J CLIN PERIODONTOL, V34, P156, DOI 10.1111/j.1600-051X.2006.01035.x; Jervoe-Storm PM, 2007, J PERIODONTOL, V78, P909, DOI 10.1902/jop.2007.060218; Jervoe-Storm PM, 2005, J CLIN PERIODONTOL, V32, P778, DOI 10.1111/j.1600-051X.2005.00740.x; Josephson GD, 2001, OTOLARYNG HEAD NECK, V124, P170, DOI 10.1067/mhn.2001.113144; Jost-Brinkmann P G, 1998, J Orofac Orthop, V59, P1, DOI 10.1007/BF01321551; Karras Spiro C., 1996, Journal of Emergency Medicine, V14, P9, DOI 10.1016/0736-4679(95)02037-3; KERNS DG, 1991, J PERIODONTOL, V62, P421, DOI 10.1902/jop.1991.62.7.421; Kocher T, 2001, J CLIN PERIODONTOL, V28, P9, DOI 10.1034/j.1600-051x.2001.280102.x; KORNMAN KS, 1994, J PERIODONTOL, V65, P848, DOI 10.1902/jop.1994.65.9.848; Kozlovsky A, 2005, J CLIN PERIODONTOL, V32, P329, DOI 10.1111/j.1600-051X.2005.00678.x; Levy RM, 1999, INT J PERIODONT REST, V19, P555; Liebenberg W H, 1997, Quintessence Int, V28, P31; LISTGARTEN MA, 1978, J CLIN PERIODONTOL, V5, P246, DOI 10.1111/j.1600-051X.1978.tb01918.x; MAGNUSSON I, 1984, J CLIN PERIODONTOL, V11, P193, DOI 10.1111/j.1600-051X.1984.tb01323.x; MAIDEN MFJ, 1991, J PERIODONTAL RES, V26, P452, DOI 10.1111/j.1600-0765.1991.tb01735.x; MOMBELLI A, 1994, J PERIODONTOL, V65, P827, DOI 10.1902/jop.1994.65.9.827; MOMBELLI A, 1994, J PERIODONTOL, V65, P820, DOI 10.1902/jop.1994.65.9.820; NYMAN S, 1977, J CLIN PERIODONTOL, V4, P240, DOI 10.1111/j.1600-051X.1977.tb01896.x; ORCHARDSON R, 1994, ARCH ORAL BIOL, V39, pS113, DOI 10.1016/0003-9969(94)90197-X; Petersilka GJ, 2003, J PERIODONTOL, V74, P307, DOI 10.1902/jop.2003.74.3.307; Petersilka GJ, 2003, J CLIN PERIODONTOL, V30, P328, DOI 10.1034/j.1600-051X.2003.00290.x; Petersilka GJ, 2003, J CLIN PERIODONTOL, V30, P165, DOI 10.1034/j.1600-051X.2003.300204.x; Petersilka GJ, 2003, J CLIN PERIODONTOL, V30, P9, DOI 10.1034/j.1600-051X.2003.300102.x; Petersilka G, 2008, J CLIN PERIODONTOL, V35, P324, DOI 10.1111/j.1600-051X.2007.01195.x; PYNN BR, 1992, J CAN DENT ASSOC, V56, P496; RABBANI GM, 1981, J PERIODONTOL, V52, P119, DOI 10.1902/jop.1981.52.3.119; Ramaglia L, 1999, EUR J ORTHODONT, V21, P423, DOI 10.1093/ejo/21.4.423; Rawlinson A, 1995, Eur J Prosthodont Restor Dent, V3, P155; RITZ L, 1991, J CLIN PERIODONTOL, V18, P643, DOI 10.1111/j.1600-051X.1991.tb00104.x; ROSLING B, 1976, Journal of Clinical Periodontology, V3, P233, DOI 10.1111/j.1600-051X.1976.tb00042.x; SATO K, 1993, J CLIN PERIODONTOL, V20, P359, DOI 10.1111/j.1600-051X.1993.tb00373.x; Sekine J, 2000, INT J ORAL MAX SURG, V29, P355, DOI 10.1016/S0901-5027(00)80051-X; SHARAWY AM, 1966, J PERIODONTOL, V37, P495, DOI 10.1902/jop.1966.37.6.495; SILNESS J, 1964, Acta Odontol Scand, V22, P121, DOI 10.3109/00016356408993968; SIMONSON LG, 1992, J PERIODONTOL, V63, P270, DOI 10.1902/jop.1992.63.4.270; SLOTS J, 1983, J CLIN PERIODONTOL, V10, P465, DOI 10.1111/j.1600-051X.1983.tb02179.x; Tammaro S, 2000, J CLIN PERIODONTOL, V27, P690, DOI 10.1034/j.1600-051x.2000.027009690.x; Tunkel J, 2002, J CLIN PERIODONTOL, V29, P72, DOI 10.1034/j.1600-051X.29.s3.4.x; Van der Weijden GA, 2002, J CLIN PERIODONTOL, V29, P55, DOI 10.1034/j.1600-051X.29.s3.3.x; von Troil B, 2002, J CLIN PERIODONTOL, V29, P173, DOI 10.1034/j.1600-051X.29.s3.10.x; WEAKS LM, 1984, J PERIODONTOL, V55, P486, DOI 10.1902/jop.1984.55.8.486; Yukna RA, 1997, J PERIODONTOL, V68, P436, DOI 10.1902/jop.1997.68.5.436; ZAPPA U, 1991, J PERIODONTOL, V62, P750, DOI 10.1902/jop.1991.62.12.750	67	85	90	0	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3492	1943-3670		J PERIODONTOL	J. Periodont.	JAN	2010	81	1					79	88		10.1902/jop.2009.090394			10	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	665FI	WOS:000283020200012	20059420				2022-03-04	
J	Mombelli, A				Mombelli, Andrea			Heresy? Treatment of chronic periodontitis with systemic antibiotics only	JOURNAL OF CLINICAL PERIODONTOLOGY			English	Editorial Material									Univ Geneva, Sch Dent Med, CH-1211 Geneva 4, Switzerland		Mombelli, A (corresponding author), Univ Geneva, Sch Dent Med, 19 Rue Barthelemy Menn, CH-1211 Geneva 4, Switzerland.						Herrera D, 2002, J CLIN PERIODONTOL, V29, P136, DOI 10.1034/j.1600-051X.29.s3.8.x; Lopez NJ, 2006, J CLIN PERIODONTOL, V33, P648, DOI 10.1111/j.1600-051X.2006.00957.x; SHINN DLS, 1962, LANCET, V1, P1191	3	12	12	0	2	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	0303-6979			J CLIN PERIODONTOL	J. Clin. Periodontol.	SEP	2006	33	9					661	662		10.1111/j.1600-051X.2006.00976.x			2	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	069NE	WOS:000239453800008	16918990				2022-03-04	
J	Covani, U; Barone, A; Cornelini, R; Crespi, R				Covani, Ugo; Barone, Antonio; Cornelini, Roberto; Crespi, Roberto			Clinical outcome of implants placed immediately after implant removal	JOURNAL OF PERIODONTOLOGY			English	Article						bone regeneration; dental implants	FRESH EXTRACTION SITES; DENTAL IMPLANTS	Background: The purpose of this study was to evaluate the clinical success of implants placed immediately after the explantation of failed implants due to fracture at 12 months. Methods: Nine immediate implants were placed in nine patients following explantation of nine fractured implants. Five experimental implants did not require any regenerative procedures; the remaining four immediate implants were grafted with deproteinized porcine bone particles and covered with bioabsorbable membranes. All implants were restored with flxed prostheses. The follow-up period was 12 months. Results: No residual bone defects were observed or probed around any implant at the second-stage surgery, and all implants were asymptomatic and stable. All the implants were successful after prosthetic rehabilitation showing no mobility, pain, suppuration, or absence of peri-implant radiolucency. The radiographic measurements showed no signiflcant bone loss pattern at the 12-month follow-up visit. Conclusion: The findings of this study suggested that implants placed immediately after implant explantation due to biomechanical fracture could be performed with results that are similar to results obtained with implants placed immediately after tooth extraction.	Univ Genoa, Sch Med, Dept Biophys Med & Dent Sci & Technol, Geneva, Switzerland		Barone, A (corresponding author), Univ Genoa, Sch Med, Dept Biophys Med & Dent Sci & Technol, Geneva, Switzerland.	barosurg@libero.it	Barone, Antonio/O-2738-2013	Barone, Antonio/0000-0003-1226-7565; COVANI, UGO/0000-0002-1267-6345			ADELL R, 1981, INT J ORAL MAXILLOF, V10, P387, DOI 10.1016/S0300-9785(81)80077-4; ADELL R, 1990, International Journal of Oral and Maxillofacial Implants, V5, P347; Albrektsson T, 1986, Int J Oral Maxillofac Implants, V1, P11; Alliot B, 1999, INT J ORAL MAX IMPL, V14, P841; ATWOOD DA, 1963, J PROSTHET DENT, V13, P810, DOI 10.1016/0022-3913(63)90225-7; Buser D, 1990, CLIN ORAL IMPLAN RES, V1, P33, DOI 10.1034/j.1600-0501.1990.010105.x; Buser D, 1997, CLIN ORAL IMPLAN RES, V8, P161, DOI 10.1034/j.1600-0501.1997.080302.x; CARLSSON GE, 1967, ACTA ODONTOL SCAND, V25, P21, DOI 10.3109/00016356709072521; Covani U, 2004, INT J ORAL MAX IMPL, V19, P549; Covani U, 2004, J PERIODONTOL, V75, P982, DOI 10.1902/jop.2004.75.7.982; Evian CI, 2004, INT J ORAL MAX IMPL, V19, P393; Isidor F, 1996, CLIN ORAL IMPLAN RES, V7, P143, DOI 10.1034/j.1600-0501.1996.070208.x; JAFFIN RA, 1991, J PERIODONTOL, V62, P2, DOI 10.1902/jop.1991.62.1.2; Paolantonio M, 2001, J PERIODONTOL, V72, P1560, DOI 10.1902/jop.2001.72.11.1560; SBORDONE L, 1995, J PERIODONTOL, V66, P69, DOI 10.1902/jop.1995.66.1.69; Sbordone L, 1999, J PERIODONTOL, V70, P1322, DOI 10.1902/jop.1999.70.11.1322; Schliephake H, 1997, INT J ORAL MAX IMPL, V12, P325; Schwartz-Arad D, 2000, J PERIODONTOL, V71, P923, DOI 10.1902/jop.2000.71.6.923; SchwartzArad D, 1997, J PERIODONTOL, V68, P915, DOI 10.1902/jop.1997.68.10.915; SchwartzArad D, 1997, J PERIODONTOL, V68, P1110, DOI 10.1902/jop.1997.68.11.1110; Scurria MS, 1998, INT J ORAL MAX IMPL, V13, P400; Tonetti M S, 1994, Periodontol 2000, V4, P127, DOI 10.1111/j.1600-0757.1994.tb00013.x; ZARB GA, 1990, J PROSTHET DENT, V63, P451, DOI 10.1016/0022-3913(90)90237-7	23	20	23	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3492	1943-3670		J PERIODONTOL	J. Periodont.	APR	2006	77	4					722	727		10.1902/jop.2006.040414			6	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	103IL	WOS:000241878800022	16584356				2022-03-04	
J	Urech, K; Neumayr, A; Blum, J				Urech, Karin; Neumayr, Andreas; Blum, Johannes			Sleeping Sickness in Travelers - Do They Really Sleep?	PLOS NEGLECTED TROPICAL DISEASES			English	Article							HUMAN AFRICAN TRYPANOSOMIASIS; RHODESIENSE TRYPANOSOMIASIS; BRUCEI-RHODESIENSE; CLINICAL-ASPECTS; LATE-STAGE; GAMBIENSE; DIAGNOSIS; INVOLVEMENT; DYSFUNCTION; INFECTION	The number of imported Human African Trypanosomiasis (HAT) cases in non-endemic countries has increased over the last years. The objective of this analysis is to describe the clinical presentation of HAT in Caucasian travelers. Literature was screened (MEDLINE, Pubmed) using the terms "Human African Trypanosomiasis", "travelers" and "expatriates"; all European languages except Slavic ones were included. Publications without clinical description of patients were only included in the epidemiological analysis. Forty-five reports on Caucasians with T.b. rhodesiense and 15 with T.b. gambiense infections were included in the analysis of the clinical parameters. Both species have presented with fever (T.b. rhodesiense 97.8% and T.b. gambiense 93.3%), headache (50% each) and a trypanosomal chancre (T.b. rhodesiense 84.4%, T.b. gambiense 46.7%). While sleeping disorders dominate the clinical presentation of HAT in endemic regions, there have been only rare reports in travelers: insomnia (T.b. rhodesiense 7.1%, T.b. gambiense 21.4%), diurnal somnolence (T.b. rhodesiense 4.8%, T.b. gambiense none). Surprisingly, jaundice has been seen in 24.2% of the Caucasian T.b. rhodesiense patients, but has never been described in HAT patients in endemic regions. These results contrast to the clinical presentation of T.b. gambiense and T.b. rhodesiense HAT in Africans in endemic regions, where the presentation of chronic T.b. gambiense and acute T.b. rhodesiense HAT is different. The analysis of 14 reports on T.b. gambiense HAT in Africans living in a non-endemic country shows that neurological symptoms such as somnolence (46.2%), motor deficit (64.3%) and reflex anomalies (14.3%) as well as psychiatric symptoms such as hallucinations (21.4%) or depression (21.4%) may dominate the clinical picture. Often, the diagnosis has been missed initially: some patients have even been hospitalized in psychiatric clinics. In travelers T.b. rhodesiense and gambiense present as acute illnesses and chancres are frequently seen. The diagnosis of HAT in Africans living outside the endemic region is often missed or delayed, leading to presentation with advanced stages of the disease.	[Urech, Karin; Neumayr, Andreas; Blum, Johannes] Swiss Trop & Publ Heath Inst, Basel, Switzerland; [Urech, Karin] Univ Basel, Fac Med, Basel, Switzerland		Urech, K (corresponding author), Swiss Trop & Publ Heath Inst, Basel, Switzerland.	karin.urech@stud.unibas.ch					ANTOINE P, 1977, ANN SOC BELG MED TR, V57, P227; Bertrand E, 1973, MED AFRIQUE NOIRE MED AFRIQUE NOIRE, V20, P303; Bisser S, 1997, B SOC PATHOL EXOT, V90, P321; Blum J, 2006, ACTA TROP, V97, P55, DOI 10.1016/j.actatropica.2005.08.001; Blum J, 2005, T ROY SOC TROP MED H, V99, P795, DOI 10.1016/j.trstmh.2005.04.010; Blum J, 2002, SWISS MED WKLY, V132, P51; Blum J, 2001, TROP MED INT HEALTH, V6, P390, DOI 10.1046/j.1365-3156.2001.00710.x; Blum JA, 2008, LANCET INFECT DIS, V8, P631, DOI 10.1016/S1473-3099(08)70230-5; Blum JA, 2007, TROP MED INT HEALTH, V12, P1422, DOI 10.1111/j.1365-3156.2007.01948.x; Blum JA, 2007, ACTA TROP, V104, P16, DOI 10.1016/j.actatropica.2007.07.004; Blum JA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000383; BOA YF, 1988, B SOC PATHOL EXOT, V81, P427; BOATIN BA, 1986, B WORLD HEALTH ORGAN, V64, P389; Brun R, 2010, LANCET, V375, P148, DOI 10.1016/S0140-6736(09)60829-1; BUYST H, 1977, ANN SOC BELG MED TR, V57, P349; Chappuis F, 2005, CLIN MICROBIOL REV, V18, P133, DOI 10.1128/CMR.18.1.133-146.2005; Checchi F, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-16; Croft A M, 2006, J R Army Med Corps, V152, P156; DAMIAN MS, 1994, DEUT MED WOCHENSCHR, V119, P1690, DOI 10.1055/s-2008-1058888; Deborggraeve S, 2010, LANCET INFECT DIS, V10, P433, DOI 10.1016/S1473-3099(10)70077-3; DEBROISE A, 1968, ARCH FR PEDIATR, V25, P703; DUGGAN AJ, 1966, J TROP MED HYG, V69, P124; DUPONT B, 1979, NOUV PRESSE MED, V8, P1579; Edan G, 1979, Med Trop (Mars), V39, P499; Ezzedine K, 2007, J TRAVEL MED, V14, P192, DOI 10.1111/j.1708-8305.2007.00114.x; Ginoux P Y, 1982, Med Trop (Mars), V42, P281; HEPPNER C, 1995, T ROY SOC TROP MED H, V89, P65, DOI 10.1016/0035-9203(95)90662-2; Jelinek T, 2002, EMERG INFECT DIS, V8, P634, DOI 10.3201/eid0806.010432; KOUCHNER G, 1979, B SOC PATHOL EXOT, V72, P131; Kuepfer I, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000968; Le Bras J., 1977, Medecine Tropicale, V37, P51; MacLean LM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000906; Mbulamberi DB, 1987, CLIN ANAL 3151 CASES, P188; NGANDUKABEYA G, 1976, ANN SOC BELG MED TR, V56, P85; QUINN TC, 1983, ARCH INTERN MED, V143, P1021, DOI 10.1001/archinte.143.5.1021; Reincke M, 1998, ANN NY ACAD SCI, V840, P809, DOI 10.1111/j.1749-6632.1998.tb09619.x; REINCKE M, 1993, CLIN ENDOCRINOL, V39, P455, DOI 10.1111/j.1365-2265.1993.tb02393.x; Simarro PP, 2008, PLOS MED, V5, P174, DOI 10.1371/journal.pmed.0050055; Simarro PP, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001007; Truc P, 1998, T ROY SOC TROP MED H, V92, P537, DOI 10.1016/S0035-9203(98)90904-X; WELLDE BT, 1989, ANN TROP MED PARASIT, V83, P1; World Health Organization, 1998, CONTR SURV AFR TRYP	42	35	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	NOV	2011	5	11							e1358	10.1371/journal.pntd.0001358			9	Infectious Diseases; Parasitology; Tropical Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Infectious Diseases; Parasitology; Tropical Medicine	863AA	WOS:000298134000007	22069503	Green Published, Green Submitted, gold			2022-03-04	
J	Saratti, CM; Merheb, C; Franchini, L; Rocca, GT; Krejci, I				Saratti, Carlo Massimo; Merheb, Carl; Franchini, Leonardo; Rocca, Giovanni Tommaso; Krejci, Ivo			Full-mouth rehabilitation of a severe tooth wear case: a digital, esthetic and functional approach	INTERNATIONAL JOURNAL OF ESTHETIC DENTISTRY			English	Article							DIRECT COMPOSITE RESTORATIONS; VERTICAL DIMENSION; WORN DENTITION; CAD/CAM; MANAGEMENT; RESIN; PERFORMANCE; EROSION	The proliferation of digital technology is progressively changing dentistry. Thanks to continual improvements in CAD/CAM devices and dental materials, it is possible nowadays to carry out a treatment plan for oral rehabilitations with fully digital approaches and noninvasive concepts. The availability of digital resources allows clinicians to increase the predictability of enhanced esthetics and good functional results. There is an increasing number of patients today who are affected by excessive tooth wear and may benefit from these kinds of treatments. This article provides a step-by-step documentation of a full-mouth rehabilitation performed with a digital approach and additive CAD/CAM composite resin restorations. An innovative functional evaluation is also documented and discussed. The initial situation was assessed and compared with the rehabilitation project through a snap-on device. After the intraoral adjustment and validation, the final rehabilitation was performed according to the information obtained in the provisional phase and digitally transmitted to the laboratory.	[Saratti, Carlo Massimo; Merheb, Carl; Rocca, Giovanni Tommaso; Krejci, Ivo] Univ Geneva, Div Cariol & Endodontol, Univ Clin Dent Med, Rue Lombard 19, CH-1735 Geneva, Switzerland		Saratti, CM (corresponding author), Univ Geneva, Div Cariol & Endodontol, Univ Clin Dent Med, Rue Lombard 19, CH-1735 Geneva, Switzerland.	carlo.saratti@unige.ch		Saratti, Carlo Massimo/0000-0003-3932-2202; Rocca, Giovanni Tommaso/0000-0002-9511-9965			Abduo J, 2012, QUINTESSENCE INT, V43, P369; Ammannato R, 2015, INT J ESTHET DENT, V10, P68; Belli R, 2017, DENT MATER, V33, P84, DOI 10.1016/j.dental.2016.10.009; Del Curto F, 2018, INT J ESTHET DENT, V13, P50; Dietschi D, 2011, INT J ESTHET DENT, V6, P20; Dietschi D, 2011, INT J ESTHET DENT, V6, P142; Fradeani M, 2016, INT J ESTHET DENT, V11, P16; Hamburger JT, 2011, J ADHES DENT, V13, P585, DOI 10.3290/j.jad.a22094; Flores-Orozco EI, 2016, ACTA ODONTOL SCAND, V74, P103, DOI 10.3109/00016357.2015.1048996; Loomans B, 2017, J ADHES DENT, V19, P111, DOI 10.3290/j.jad.a38102; Lussi A, 2014, EROSIVE TOOTH WEAR D; Magne P, 2017, INT J ESTHET DENT, V12, P134; Mesko ME, 2016, J DENT, V48, P9, DOI 10.1016/j.jdent.2016.03.003; Milosevic A, 2016, J DENT, V44, P13, DOI 10.1016/j.jdent.2015.10.015; Mormann WH, 2013, J MECH BEHAV BIOMED, V20, P113, DOI 10.1016/j.jmbbm.2013.01.003; Papini A., 2017, J ORAL SCI REHABIL, V3, P60; Pickles MJ, 2006, MG ORAL SCI, V19, P86, DOI 10.1159/000090587; Rocca GT, 2010, J PROSTHET DENT, V104, P273, DOI 10.1016/S0022-3913(10)60138-2; Saratti CM, 2017, INT J COMPUT DENT, V20, P423; Sen N, 2018, J PROSTHET DENT, V119, P593, DOI 10.1016/j.prosdent.2017.06.012; Spreafico RC, 2010, INT J ESTHET DENT, V5, P28; Stawarczyk B, 2016, J MECH BEHAV BIOMED, V55, P1, DOI 10.1016/j.jmbbm.2015.10.004; TURNER KA, 1984, J PROSTHET DENT, V52, P467, DOI 10.1016/0022-3913(84)90326-3; Vailati F, 2008, INT J ESTHET DENT, V3, P30; Vailati F, 2010, INT J PERIODONT REST, V30, P559; Vailati F, 2008, INT J ESTHET DENT, V3, P236; Vailati F, 2008, INT J ESTHET DENT, V3, P128; Wendler M, 2018, DENT MATER, V34, P910, DOI 10.1016/j.dental.2018.03.024; Wendler M, 2017, DENT MATER, V33, P99, DOI 10.1016/j.dental.2016.10.008; Wetselaar P, 2016, J ORAL REHABIL, V43, P69, DOI 10.1111/joor.12340	30	0	0	1	2	QUINTESSENCE PUBLISHING CO INC	HANOVER PARK	4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA	2198-591X			INT J ESTHET DENT	Int. J. Esthet. Dent.	FAL	2020	15	3					242	262					21	Dentistry, Oral Surgery & Medicine	Emerging Sources Citation Index (ESCI)	Dentistry, Oral Surgery & Medicine	NY0TK	WOS:000576112100003	32760922				2022-03-04	
J	Kuijpers, MA				Kuijpers, Mette A.			ORTHODONTIC BRACKETS Response	JOURNAL OF THE AMERICAN DENTAL ASSOCIATION			English	Letter							SALIVA CONTAMINATION; CLINICAL-TRIAL		Univ Geneva, Fac Med Dent, Div Orthodontie, CH-1211 Geneva 4, Switzerland		Kuijpers, MA (corresponding author), Univ Geneva, Fac Med Dent, Div Orthodontie, CH-1211 Geneva 4, Switzerland.		Kuijpers, Mette/H-3308-2015	Kuijpers, Mette/0000-0001-6462-9789			Maia SRC, 2010, AM J ORTHOD DENTOFAC, V138, P79, DOI 10.1016/j.ajodo.2008.08.035; Campoy MD, 2010, AM J ORTHOD DENTOFAC, V137, P679, DOI 10.1016/j.ajodo.2008.06.032; Ponduri S, 2007, AM J ORTHOD DENTOFAC, V132, P663, DOI 10.1016/j.ajodo.2006.10.022	3	0	0	0	1	AMER DENTAL ASSOC	CHICAGO	211 E CHICAGO AVE, CHICAGO, IL 60611 USA	0002-8177			J AM DENT ASSOC	J. Am. Dent. Assoc.	JAN	2011	142	1					18	18		10.14219/jada.archive.2011.0007			1	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	715FY	WOS:000286867300007					2022-03-04	
J	Ardu, S; Perroud, R				Ardu, Stefano; Perroud, Raymond			A NONTRAUMATIC METHOD FOR CERAMIC CROWN REMOVAL	JOURNAL OF PROSTHETIC DENTISTRY			English	Editorial Material									[Ardu, Stefano] Univ Geneva, Sch Dent, Ecole Med Dent, Div Prevent Med, CH-1205 Geneva, Switzerland		Ardu, S (corresponding author), Univ Geneva, Sch Dent, Ecole Med Dent, Div Prevent Med, Rue Barthelemy Menn 19, CH-1205 Geneva, Switzerland.	stefano.ardu@unige.ch		ardu, stefano/0000-0003-1641-2168			CHAING BKP, 1984, J DENT, V12, P203, DOI 10.1016/0300-5712(84)90063-0; GRANT BE, 1988, J PROSTHET DENT, V59, P165, DOI 10.1016/0022-3913(88)90009-1; Lane DA, 2003, J PROSTHET DENT, V89, P141, DOI 10.1067/mpr.2003.25	3	0	0	1	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-3913			J PROSTHET DENT	J. Prosthet. Dent.	APR	2009	101	4					285	285		10.1016/S0022-3913(09)60056-1			1	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	435AQ	WOS:000265316000010	19328283				2022-03-04	
J	Dudic, A; Giannopoulou, C; Martinez, M; Montet, X; Kiliaridis, S				Dudic, Alexander; Giannopoulou, Catherine; Martinez, Manuela; Montet, Xavier; Kiliaridis, Stavros			Diagnostic accuracy of digitized periapical radiographs validated against micro-computed tomography scanning in evaluating orthodontically induced apical root resorption	EUROPEAN JOURNAL OF ORAL SCIENCES			English	Article						apical root resorption; digitized periapical radiographs; micro-CT scanner; orthodontic movement	DIGITAL SUBTRACTION RADIOGRAPHY; PHYSICAL-PROPERTIES; TOOTH MOVEMENT; VOLUMETRIC-ANALYSIS; ELECTRON-MICROSCOPY; MAXILLARY INCISORS; CEMENTUM; FORCE; CRATERS; COMPRESSION	The aim of this study was to validate the use of digitized periapical radiographs in evaluating orthodontically induced apical root resorption against micro-computed tomography (micro-CT) scanning as a criterion standard test. In a standardized experimental protocol, 29 premolars in 16 subjects were tipped buccally for 8 wk. Nineteen contralateral premolars not subjected to orthodontic movement served as controls. Standardized periapical radiographs were taken before and after the experimental period (Rx method). These teeth were extracted and scanned using a micro-CT technique with a 9 mu m resolution. Two calibrated examiners assessed blindly the presence or absence of apical root resorption on digitized radiographs and three-dimensional reconstructions of the scans. Significant differences were detected between the orthodontically moved teeth and controls: 86% of the orthodontically moved teeth and 21% of the control teeth showed apical root resorption when using micro-CT as a validation method. A total of 55% of the experimental teeth and 5% of the control teeth showed resorption when assessed using Rx method. The Rx method showed a specificity of 78% and a sensitivity of 44%, which means that less than half of the cases with root resorption identified using a CT scanner were identified by radiography. Nearly all the orthodontically moved teeth showed apical root resorption. Apical root resorption may be underestimated when evaluated using digitized periapical radiographs.	[Giannopoulou, Catherine] Univ Geneva, Sch Dent, Dept Periodontol, CH-1205 Geneva, Switzerland; [Dudic, Alexander; Martinez, Manuela; Kiliaridis, Stavros] Univ Geneva, Dept Orthodont, CH-1205 Geneva, Switzerland; [Montet, Xavier] Univ Geneva, Dept Cell Physiol & Metab, CH-1205 Geneva, Switzerland		Giannopoulou, C (corresponding author), Univ Geneva, Sch Dent, Dept Periodontol, Rue Barthelemy Menn 19, CH-1205 Geneva, Switzerland.	ekaterini.giannopoulo@medecine.unige.ch		Montet, Xavier/0000-0003-2442-5866	Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission [3200-06480.01]	The present work was supported by the Swiss National Science Foundation (grant no. 3200-06480.01).	Acar A, 1999, ANGLE ORTHOD, V69, P159; ANDREASEN JO, 1987, ENDOD DENT TRAUMATOL, V3, P269; Borg E, 1998, ORAL SURG ORAL MED O, V86, P110, DOI 10.1016/S1079-2104(98)90159-7; Butcher JT, 2007, DEV DYNAM, V236, P802, DOI 10.1002/dvdy.20962; Chan E, 2006, AM J ORTHOD DENTOFAC, V129, P504, DOI 10.1016/j.ajodo.2004.12.018; Chan E, 2005, AM J ORTHOD DENTOFAC, V127, P186, DOI 10.1016/j.ajodo.2003.11.026; Chan E K M, 2004, Orthod Craniofac Res, V7, P64, DOI 10.1111/j.1601-6343.2004.00280.x; Chan EKM, 2004, EUR J ORAL SCI, V112, P134, DOI 10.1111/j.1600-0722.2004.00118.x; CHAPNICK L, 1989, ORAL SURG ORAL MED O, V67, P578, DOI 10.1016/0030-4220(89)90276-4; Chappard C, 2006, OSTEOARTHR CARTILAGE, V14, P215, DOI 10.1016/j.joca.2005.09.008; Eraso FE, 2007, DENTOMAXILLOFAC RAD, V36, P130, DOI 10.1259/dmfr/97564373; FELDKAMP LA, 1984, J OPT SOC AM A, V1, P612, DOI 10.1364/JOSAA.1.000612; Foo M, 2007, AM J ORTHOD DENTOFAC, V131, P34, DOI 10.1016/j.ajodo.2005.02.030; Guldberg Robert E, 2004, Birth Defects Res C Embryo Today, V72, P250, DOI 10.1002/bdrc.20016; Harris DA, 2006, AM J ORTHOD DENTOFAC, V130, P639, DOI 10.1016/j.ajodo.2005.01.029; HARRY MR, 1982, ANGLE ORTHOD, V52, P235; Heo MS, 2001, ORAL SURG ORAL MED O, V91, P369, DOI 10.1067/moe.2001.113592; HINTZE H, 1992, ENDOD DENT TRAUMATOL, V8, P149; HOLLENDER L, 1980, EUR J ORTHODONT, V2, P197; Holmes JP, 2001, DENTOMAXILLOFAC RAD, V30, P249, DOI 10.1038/sj.dmfr.4600626; Janhom A, 2000, DENTOMAXILLOFAC RAD, V29, P20, DOI 10.1038/sj.dmfr.4600488; Jonsson A, 2007, EUR J ORTHODONT, V29, P482, DOI 10.1093/ejo/cjm047; Kurol J, 1996, AM J ORTHOD DENTOFAC, V110, P303, DOI 10.1016/S0889-5406(96)80015-1; Kurol J, 1998, ANGLE ORTHOD, V68, P161; KVAM E, 1972, SCAND J DENT RES, V80, P357, DOI 10.1111/j.1600-0722.1972.tb00303.x; Laux M, 2000, INT ENDOD J, V33, P483, DOI 10.1046/j.1365-2591.2000.00338.x; LEVANDER E, 1994, EUR J ORTHODONT, V16, P223, DOI 10.1093/ejo/16.3.223; Levander E, 1998, EUR J ORTHODONT, V20, P57, DOI 10.1093/ejo/20.1.57; Long A, 1996, ARCH ORAL BIOL, V41, P799, DOI 10.1016/S0003-9969(96)00057-X; MALMGREN O, 1982, AM J ORTHOD DENTOFAC, V82, P487, DOI 10.1016/0002-9416(82)90317-7; Malueg LA, 1996, ORAL SURG ORAL MED O, V82, P89, DOI 10.1016/S1079-2104(96)80383-0; McNab S, 2000, ANGLE ORTHOD, V70, P227; MIRABELLA AD, 1995, EUR J ORTHODONT, V17, P93, DOI 10.1093/ejo/17.2.93; Owman-Moll P, 1995, Swed Dent J Suppl, V105, P1; OwmanMoll P, 1995, ANGLE ORTHOD, V65, P395; Parker WS, 1997, AM J ORTHOD DENTOFAC, V112, P119, DOI 10.1016/S0889-5406(97)70235-X; PASLER FA, 1985, DEUT ZAHNAERZTL Z, V40, P707; Perona G, 1996, DENTOMAXILLOFAC RAD, V25, P179, DOI 10.1259/dmfr.25.4.9084270; PROFFIT WR, 2000, CONT ORTHODONTICS, P296; Reukers E, 1998, DENTOMAXILLOFAC RAD, V27, P25, DOI 10.1038/sj.dmfr.4600313; Sameshima GT, 2001, ANGLE ORTHOD, V71, P185; SHARPE W, 1987, AM J ORTHOD DENTOFAC, V91, P252, DOI 10.1016/0889-5406(87)90455-0; TAYLOR NG, 1995, BR DENT J, V25, P377; Versteeg CH, 1997, J DENT, V25, P215, DOI 10.1016/S0300-5712(96)00026-7; Weiland F, 2003, EUR J ORTHODONT, V25, P335, DOI 10.1093/ejo/25.4.335; Westphalen VPD, 2004, DENTOMAXILLOFAC RAD, V33, P233, DOI 10.1259/dmfr/65487937	46	33	37	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0909-8836	1600-0722		EUR J ORAL SCI	Eur. J. Oral Sci.	OCT	2008	116	5					467	472		10.1111/j.1600-0722.2008.00559.x			6	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	345VA	WOS:000259024100012	18821990				2022-03-04	
J	Gugerli, P; Secci, G; Mombelli, A				Gugerli, Patrick; Secci, Graziella; Mombelli, Andrea			Evaluation of the benefits of using a power toothbrush during the initial phase of periodontal therapy	JOURNAL OF PERIODONTOLOGY			English	Article						controlled clinical trial; plaque; therapy; toothbrushing	SUPRAGINGIVAL PLAQUE CONTROL; SUBGINGIVAL MICROFLORA; EFFICACY; PARAMETERS/	Background: Studies evaluating the efficiency of oral hygiene procedures typically focus on prevention or maintenance after periodontal therapy. Little is known about the specific benefit of a power toothbrush during therapy. The objective of this study was to evaluate the clinical efficacy of power toothbrushing compared to manual toothbrushing in patients undergoing the initial phase of periodontal therapy. Methods: This was an examiner-masked, randomized, two-arm parallel study involving 70 adults (range, 23 to 81 years) with untreated periodontitis. After and initial supragingival debridement, subjects were assigned to toothbrushing with a manual (group M) or power (group P) toothbrush. Subjects returned for evaluation after 7, 14, and 28 days. Results: At day 28, the mean plaque index (PI) was significantly lower for subjects in group P than for those in group M (P = 0.006). The mean number of sites with PI > 1 at days 14 and 28 and the mean number of sites with bleeding on probing at days 14 and 28 also were significantly lower in these subjects (P = 0.018 and P = 0.005, respectively, and P = 0.017 and P = 0.034, respectively). Differences in the mean gingival index, the number of sites with a gingival index > 1, mean recession, mean probing depth, and the number of pockets > 4 mm were not significant. Conclusion: Subjects using a power toothbrush during initial treatment reduced supragingival plaque to lower levels and showed significantly less bleeding on probing than subjects using a manual brush.	Univ Geneva, Sch Dent Med, Dept Periodontol, CH-1211 Geneva 4, Switzerland		Gugerli, P (corresponding author), Univ Geneva, Sch Dent Med, Dept Periodontol, 19 Rue Barthelemy Menn, CH-1211 Geneva 4, Switzerland.	patrick.gugerli@medicine.unige.ch					Altman DG, 2005, BRIT MED J, V330, P843, DOI 10.1136/bmj.330.7495.843; Armitage G C, 1999, Ann Periodontol, V4, P1, DOI 10.1902/annals.1999.4.1.1; BELTRAMI M, 1987, J CLIN PERIODONTOL, V14, P161, DOI 10.1111/j.1600-051X.1987.tb00960.x; EGELBERG J, 1999, ORAL HYGIENE METHODS, P67; Haffajee AD, 2001, J CLIN PERIODONTOL, V28, P937, DOI 10.1034/j.1600-051x.2001.028010937.x; Haffajee AD, 2001, J CLIN PERIODONTOL, V28, P947, DOI 10.1034/j.1600-051x.2001.028010947.x; KHO P, 1985, J CLIN PERIODONTOL, V12, P676, DOI 10.1111/j.1600-051X.1985.tb00939.x; LOE HARALD, 1963, ACTA ODONTOL SCAND, V21, P533, DOI 10.3109/00016356309011240; LOOS B, 1988, J CLIN PERIODONTOL, V15, P211, DOI 10.1111/j.1600-051X.1988.tb01572.x; MAGNUSSON I, 1984, J CLIN PERIODONTOL, V11, P193, DOI 10.1111/j.1600-051X.1984.tb01323.x; NYMAN S, 1977, J CLIN PERIODONTOL, V4, P240, DOI 10.1111/j.1600-051X.1977.tb01896.x; OBeirne G, 1996, J PERIODONTOL, V67, P900, DOI 10.1902/jop.1996.67.9.900; Robinson P, 2005, COCHRANE DB SYST REV, V2; ROSLING B, 1976, Journal of Clinical Periodontology, V3, P38, DOI 10.1111/j.1600-051X.1976.tb01849.x; ROSLING B, 1976, Journal of Clinical Periodontology, V3, P233, DOI 10.1111/j.1600-051X.1976.tb00042.x; SILNESS J, 1964, Acta Odontol Scand, V22, P121, DOI 10.3109/00016356408993968; YUKNA RA, 1993, J PERIODONTOL, V64, P859, DOI 10.1902/jop.1993.64.9.859	17	7	7	0	6	AMER ACAD PERIODONTOLOGY	CHICAGO	737 NORTH MICHIGAN AVENUE, SUITE 800, CHICAGO, IL 60611-2690 USA	0022-3492			J PERIODONTOL	J. Periodont.	APR	2007	78	4					654	660		10.1902/jop.2007.060279			7	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	157MS	WOS:000245724800010	17397312				2022-03-04	
J	Brochut, PF; Marin, I; Baehni, P; Mombelli, A				Brochut, P. F.; Marin, I.; Baehni, P.; Mombelli, A.			Can microbiological tests 6 weeks after scaling and root planing predict its clinical outcome after 6 months?	JOURNAL OF DENTAL RESEARCH			English	Meeting Abstract									Univ Geneva, Geneva, Switzerland									0	0	0	0	0	INT AMER ASSOC DENTAL RESEARCHI A D R/A A D R	ALEXANDRIA	1619 DUKE ST, ALEXANDRIA, VA 22314-3406 USA	0022-0345			J DENT RES	J. Dent. Res.	JUN	2003	82				B	0577	B84	B84					1	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	V42UY	WOS:000202893600574					2022-03-04	
J	Burki, F; Pawlowski, J				Burki, Fabien; Pawlowski, Jan			Monophyly of Rhizaria and multigene phylogeny of unicellular bikonts	MOLECULAR BIOLOGY AND EVOLUTION			English	Article						eukaryotes; unicellular bikonts; Rhizaria; multigene phylogeny	LONG-BRANCH ATTRACTION; RIBOSOMAL-RNA; EVOLUTIONARY HISTORY; ACTIN PHYLOGENY; EUKARYOTE TREE; COMMON ORIGIN; GENE; FORAMINIFERA; CERCOZOA; POSITION	Reconstructing a global phylogeny of eukaryotes is an ongoing challenge of molecular phylogenetics. The availability of genomic data from a broad range of eukaryotic phyla helped in resolving the eukaryotic tree into a topology with a rather small number of large assemblages, but the relationships between these "supergroups" are yet to be confirmed. Rhizaria is the most recently recognized "supergroup," but, in spite of this important position within the tree of life, their representatives are still missing in global phylogenies of eukaryotes. Here, we report the first large-scale analysis of eukaryote phylogeny including data for 2 rhizarian species, the foraminiferan Reticulomyxa filosa and the chlorarachniophyte Bigelowiella natans. Our results confirm the monophyly of Rhizaria (Foraminifera + Cercozoa), with very high bootstrap supports in all analyses. The overall topology of our trees is in agreement with the current view of eukaryote phylogeny with basal division into "unikonts" (Opisthokonts and Ameobozoa) and "bikonts" (Plantae, alveolates, stramenopiles, and excavates). As expected, Rhizaria branch among bikonts; however, their phylogenetic position is uncertain. Depending on the data set and the type of analysis, Rhizaria branch as sister group to either stramenopiles or excavates. Overall, the relationships between the major groups of unicellular bikonts are poorly resolved, despite the use of 85 proteins and the largest taxonomic sampling for this part of the tree available to date. This may be due to an acceleration of evolutionary rates in some bikont phyla or be related to their rapid diversification in the early evolution of eukaryotes.	Univ Geneva, Dept Zool & Anim Biol, Geneva, Switzerland		Burki, F (corresponding author), Univ Geneva, Dept Zool & Anim Biol, Geneva, Switzerland.	fabien.burki@zoo.unige.ch	Burki, Fabien/F-4818-2010				Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Adl SM, 2005, J EUKARYOT MICROBIOL, V52, P399, DOI 10.1111/j.1550-7408.2005.00053.x; Archibald JM, 2003, P NATL ACAD SCI USA, V100, P7678, DOI 10.1073/pnas.1230951100; Archibald JM, 2003, MOL BIOL EVOL, V20, P62, DOI 10.1093/molbev/msg006; Arisue N, 2005, MOL BIOL EVOL, V22, P409, DOI 10.1093/molbev/msi023; Baldauf SL, 2000, SCIENCE, V290, P972, DOI 10.1126/science.290.5493.972; BALDAUF SL, 1993, P NATL ACAD SCI USA, V90, P11558, DOI 10.1073/pnas.90.24.11558; Bapteste E, 2002, P NATL ACAD SCI USA, V99, P1414, DOI 10.1073/pnas.032662799; Bass D, 2005, PROTIST, V156, P149, DOI 10.1016/j.protis.2005.03.001; Berney C, 2003, J MOL EVOL, V57, pS120, DOI 10.1007/s00239-003-0015-2; BHATTACHARYA D, 1995, J EUKARYOT MICROBIOL, V42, P65, DOI 10.1111/j.1550-7408.1995.tb01541.x; Brinkmann H, 2005, SYST BIOL, V54, P743, DOI 10.1080/10635150500234609; Burki F, 2002, PROTIST, V153, P251, DOI 10.1078/1434-4610-00102; BURKI F, 2006, UNPUB GENOME; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cavalier-Smith T, 1998, BIOL REV, V73, P203, DOI 10.1017/S0006323198005167; Cavalier-Smith T, 2002, INT J SYST EVOL MICR, V52, P297, DOI 10.1099/00207713-52-2-297; Cavalier-Smith T, 1999, J EUKARYOT MICROBIOL, V46, P347, DOI 10.1111/j.1550-7408.1999.tb04614.x; Cavalier-Smith T, 2003, PROTIST, V154, P341, DOI 10.1078/143446103322454112; CavalierSmith T, 1997, ARCH PROTISTENKD, V147, P227, DOI 10.1016/S0003-9365(97)80050-4; CAVALIERSMITH T, 1993, MICROBIOL REV, V57, P953, DOI 10.1128/MMBR.57.4.953-994.1993; DEKONIG A, 2005, PROTIST, V15, P181; Fast NM, 2002, J EUKARYOT MICROBIOL, V49, P30, DOI 10.1111/j.1550-7408.2002.tb00336.x; Fast NM, 2001, MOL BIOL EVOL, V18, P418, DOI 10.1093/oxfordjournals.molbev.a003818; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Felsenstein J., 2005, PHYLIP PHYLOGENY INF; Flakowski J, 2005, J FORAMIN RES, V35, P93, DOI 10.2113/35.2.93; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hampl V, 2005, MOL BIOL EVOL, V22, P2508, DOI 10.1093/molbev/msi245; Harper JT, 2005, INT J SYST EVOL MICR, V55, P487, DOI 10.1099/ijs.0.63216-0; Harper JT, 2003, MOL BIOL EVOL, V20, P1730, DOI 10.1093/molbev/msg195; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jeffroy O, 2006, TRENDS GENET, V22, P225, DOI 10.1016/j.tig.2006.02.003; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Keeling PJ, 2005, TRENDS ECOL EVOL, V20, P670, DOI 10.1016/j.tree.2005.09.005; Keeling PJ, 2001, P NATL ACAD SCI USA, V98, P10745, DOI 10.1073/pnas.191337098; Keeling PJ, 2001, MOL BIOL EVOL, V18, P1551, DOI 10.1093/oxfordjournals.molbev.a003941; Kumar S, 1996, J MOL EVOL, V42, P183, DOI 10.1007/BF02198844; LEANDER B, 2003, TRENDS ECOL EVOL, V18, P498; Leander BS, 2004, J PHYCOL, V40, P341, DOI 10.1111/j.1529-8817.2004.03129.x; Longet D, 2004, ACTA PROTOZOOL, V43, P303; Longet D, 2003, INT J SYST EVOL MICR, V53, P1735, DOI 10.1099/ijs.0.02597-0; Moreira D, 1999, MOL BIOL EVOL, V16, P234, DOI 10.1093/oxfordjournals.molbev.a026105; Morin L, 2000, J EUKARYOT MICROBIOL, V47, P167, DOI 10.1111/j.1550-7408.2000.tb00028.x; Nikolaev SI, 2004, P NATL ACAD SCI USA, V101, P8066, DOI 10.1073/pnas.0308602101; Pawlowski J, 1996, MOL BIOL EVOL, V13, P445, DOI 10.1093/oxfordjournals.molbev.a025605; Philippe H, 2000, P ROY SOC B-BIOL SCI, V267, P1213, DOI 10.1098/rspb.2000.1130; Philippe H, 2005, MOL BIOL EVOL, V22, P1246, DOI 10.1093/molbev/msi111; Philippe H, 2000, MOL BIOL EVOL, V17, P830, DOI 10.1093/oxfordjournals.molbev.a026362; Philippe H, 2004, MOL BIOL EVOL, V21, P1740, DOI 10.1093/molbev/msh182; Philippe H, 1998, SYST ASSOC SPEC VOL, V56, P25; Philippe H, 2000, PROTIST, V151, P307, DOI 10.1078/S1434-4610(04)70029-2; Polet S, 2004, PROTIST, V155, P53, DOI 10.1078/1434461000164; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Rodriguez-Ezpeleta N, 2005, CURR BIOL, V15, P1325, DOI 10.1016/j.cub.2005.06.040; Rogers MB, 2004, J EUKARYOT MICROBIOL, V51, P529, DOI 10.1111/j.1550-7408.2004.tb00288.x; Rokas A, 2005, SCIENCE, V310, P1933, DOI 10.1126/science.1116759; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Simpson AGB, 2002, J EUKARYOT MICROBIOL, V49, P239, DOI 10.1111/j.1550-7408.2002.tb00529.x; Simpson AGB, 2006, MOL BIOL EVOL, V23, P615, DOI 10.1093/molbev/msj068; Simpson AGB, 2002, MOL BIOL EVOL, V19, P1782, DOI 10.1093/oxfordjournals.molbev.a004000; Sogin ML, 1991, CURR OPIN GENET DEV, V1, P457, DOI 10.1016/S0959-437X(05)80192-3; Sogin ML, 1998, INT J PARASITOL, V28, P11, DOI 10.1016/S0020-7519(97)00181-1; SOGIN ML, 1989, SCIENCE, V243, P75, DOI 10.1126/science.2911720; Stechmann A, 2003, CURR BIOL, V13, pR665, DOI 10.1016/S0960-9822(03)00602-X; Stechmann A, 2002, SCIENCE, V297, P89, DOI 10.1126/science.1071196; Steenkamp ET, 2006, MOL BIOL EVOL, V23, P93, DOI 10.1093/molbev/msj011; Stiller JW, 1999, MOL BIOL EVOL, V16, P1270, DOI 10.1093/oxfordjournals.molbev.a026217; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Yamamoto A, 1997, J MOL EVOL, V44, P98, DOI 10.1007/PL00006127; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yoon HS, 2004, MOL BIOL EVOL, V21, P809, DOI 10.1093/molbev/msh075; Yoon HS, 2002, P NATL ACAD SCI USA, V99, P15507, DOI 10.1073/pnas.242379899	76	37	39	0	17	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0737-4038	1537-1719		MOL BIOL EVOL	Mol. Biol. Evol.	OCT	2006	23	10					1922	1930		10.1093/molbev/msl055			9	Biochemistry & Molecular Biology; Evolutionary Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Evolutionary Biology; Genetics & Heredity	085EQ	WOS:000240586600012	16829542	Bronze			2022-03-04	
J	Antonarakis, GS; Kiliaridis, S				Antonarakis, Gregory S.; Kiliaridis, Stavros			Class II functional appliance treatment and dynamic three-dimensional mimic muscle evaluation	JOURNAL OF ORAL REHABILITATION			English	Article						Angle Class II malocclusion; facial expression; facial muscles; functional orthodontic appliances; prospective studies; smiling	MODELING FACIAL MOVEMENT; EXTRAORAL TRACTION; CLEFT-LIP; MALOCCLUSION; QUANTIFICATION; DISPLACEMENT; SYMMETRY	Background Functional appliances have skeletal and dentoalveolar treatment effects, but knowledge on their effect on facial expressions is limited. Objective To analyse changes in facial expressions, using three-dimensional (3D) mimic muscle evaluation, in growing children with Class II malocclusion and large overjet, undergoing functional appliance treatment. Methods Fifteen growing children with Class II division 1 malocclusion, selected prospectively, had dynamic 3D recordings of facial expressions prior to and 12 months after commencing functional appliance treatment. Facial expressions recorded were smile and lip pucker, and the movements of the oral commissures were analysed, as well as mouth width and its symmetry. A control group of fifteen age- and sex-matched growing children without immediate need for orthodontic treatment had similar recordings prior to and after a 12-month observation period. Results In the treatment group, the Class II malocclusion in all children improved after 12 months of functional appliance wear. With regard to movements of the oral commissures, the initial recordings of the treatment group did not show any significant differences to the control group for neither smile nor lip pucker. Differences were noted however when looking at mouth width asymmetry, where this tended to become more symmetrical in the functional appliance treatment group, during rest and during smiling, while it became more asymmetrical in the untreated control group. Conclusion The use of removable functional appliances in children with Class II division 1 malocclusion may have a positive effect on mouth width symmetry when smiling, making it more symmetrical.	[Antonarakis, Gregory S.; Kiliaridis, Stavros] Univ Geneva, Univ Clin Dent Med, Div Orthodont, 1 Rue Michel Servet, CH-1206 Geneva, Switzerland		Antonarakis, GS (corresponding author), Univ Geneva, Univ Clin Dent Med, Div Orthodont, 1 Rue Michel Servet, CH-1206 Geneva, Switzerland.	gregory.antonarakis@unige.ch	Antonarakis, Gregory/ABA-1855-2020	Antonarakis, Gregory/0000-0001-6741-6922	Swiss Dental Association Research Foundation [284-14]	Swiss Dental Association Research Foundation, Grant/Award Number: 284-14	Antonarakis GS, 2007, ANGLE ORTHOD, V77, P907, DOI 10.2319/061706-244; Baccetti T., 2005, SEMIN ORTHOD, V11, P119, DOI 10.1053/j.sodo.2005.04.005; Badran SA, 2010, EUR J ORTHODONT, V32, P638, DOI 10.1093/ejo/cjq014; Coulson SE, 2000, ANN OTO RHINOL LARYN, V109, P478, DOI 10.1177/000348940010900507; Coulson SE, 2002, OTOL NEUROTOL, V23, P999, DOI 10.1097/00129492-200211000-00032; Duran GS, 2017, ANGLE ORTHOD, V87, P96, DOI 10.2319/020916-112.1; Guo H, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00202; Houstis O, 2010, J ORAL MAXIL SURG, V68, P1498, DOI 10.1016/j.joms.2009.09.013; Houstis O, 2009, EUR J ORTHODONT, V31, P459, DOI 10.1093/ejo/cjp019; Islam R, 2009, ANGLE ORTHOD, V79, P256, DOI 10.2319/030308-125.1; Koretsi V, 2015, EUR J ORTHODONT, V37, P418, DOI 10.1093/ejo/cju071; Nagy E, 2012, CORTEX, V48, P1064, DOI 10.1016/j.cortex.2011.04.002; Nooreyazdan M, 2004, J ORAL MAXIL SURG, V62, P1380, DOI 10.1016/j.joms.2004.03.015; PFEIFFER JP, 1975, AM J ORTHOD DENTOFAC, V68, P499, DOI 10.1016/0002-9416(75)90084-6; PFEIFFER JP, 1982, AM J ORTHOD DENTOFAC, V81, P185, DOI 10.1016/0002-9416(82)90052-5; Popat H, 2008, ORTHOD CRANIOFAC RES, V11, P216, DOI 10.1111/j.1601-6343.2008.00433.x; Popat H, 2013, J ORAL REHABIL, V40, P348, DOI 10.1111/joor.12037; Popat H, 2012, J CRANIO MAXILL SURG, V40, P36, DOI 10.1016/j.jcms.2010.12.005; Ritter K, 2002, CLEFT PALATE-CRAN J, V39, P587, DOI 10.1597/1545-1569(2002)039<0587:VOSEFT>2.0.CO;2; Santamaria-Villegas A, 2017, BMC ORAL HEALTH, V17, DOI 10.1186/s12903-017-0339-8; Sawyer AR, 2010, J PLAST RECONSTR AES, V63, P65, DOI 10.1016/j.bjps.2008.08.062; Schimmel M, 2011, J ORAL REHABIL, V38, P800, DOI 10.1111/j.1365-2842.2011.02219.x; Schimmel M, 2010, AM J ORTHOD DENTOFAC, V137, DOI 10.1016/j.ajodo.2009.03.039; Sjogreen L, 2011, J ORAL REHABIL, V38, P410, DOI 10.1111/j.1365-2842.2010.02168.x; Stergiopulos O, 2019, EUR J ORTHODONT, V41, P231, DOI 10.1093/ejo/cjy047; Tanikawa C, 2010, CLEFT PALATE-CRAN J, V47, P611, DOI 10.1597/09-099; Trotman CA, 2004, J ORAL MAXIL SURG, V62, P1372, DOI 10.1016/j.joms.2004.03.014; Trotman CA, 2000, PLAST RECONSTR SURG, V105, P1273, DOI 10.1097/00006534-200004040-00003; Trotman CA, 2007, CLEFT PALATE-CRAN J, V44, P607, DOI 10.1597/06-125.1; Trotman CA, 2013, CLEFT PALATE-CRAN J, V50, P684, DOI 10.1597/12-191; Trotman CA, 2011, AM J ORTHOD DENTOFAC, V140, P895, DOI 10.1016/j.ajodo.2011.07.014; Trotman CAE, 2013, CLEFT PALATE-CRAN J, V50, P315, DOI 10.1597/12-080	32	2	2	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0305-182X	1365-2842		J ORAL REHABIL	J. Oral Rehabil.	SEP	2019	46	9					813	819		10.1111/joor.12819			7	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	IP7ZL	WOS:000480266600005	31081283				2022-03-04	
J	Mombelli, A				Mombelli, Andrea			Maintenance therapy for teeth and implants	PERIODONTOLOGY 2000			English	Review						cumulative interceptive supportive therapy; implant maintenance; long-term results; maintenance guidelines; mechanical instrumentation; patient role; periodontal maintenance; risk factors; supportive therapy	GINGIVAL CREVICULAR FLUID; SUPRAGINGIVAL PLAQUE CONTROL; INDUCED PERI-IMPLANTITIS; ROOT SUBSTANCE REMOVAL; LONG-TERM; PERIODONTAL-DISEASE; PHOTODYNAMIC THERAPY; TOOTH LOSS; BONE LOSS; SYSTEMIC AMOXICILLIN/METRONIDAZOLE		[Mombelli, Andrea] Univ Geneva, Sch Dent Med, Div Periodontol, Geneva, Switzerland		Mombelli, A (corresponding author), Univ Geneva, Sch Dent Med, Div Periodontol, Geneva, Switzerland.	andrea.mombelli@unige.ch					AH MKB, 1994, J CLIN PERIODONTOL, V21, P91; Albrektsson T, 1986, Int J Oral Maxillofac Implants, V1, P11; American Dental Association (ADA), 2012, DENT RAD EX REC PAT; Andersen E, 2010, J PERIODONTAL RES, V45, P458, DOI 10.1111/j.1600-0765.2009.01257.x; Atieh MA, 2010, LASER MED SCI, V25, P605, DOI 10.1007/s10103-009-0744-6; AXELSSON P, 1981, J CLIN PERIODONTOL, V8, P281, DOI 10.1111/j.1600-051X.1981.tb02039.x; Axelsson P, 2004, J CLIN PERIODONTOL, V31, P749, DOI 10.1111/j.1600-051X.2004.00563.x; AXELSSON P, 1981, J CLIN PERIODONTOL, V8, P239, DOI 10.1111/j.1600-051X.1981.tb02035.x; Azarpazhooh A, 2010, J PERIODONTOL, V81, P4, DOI 10.1902/jop.2009.090285; BADERSTEN A, 1987, J CLIN PERIODONTOL, V14, P425, DOI 10.1111/j.1600-051X.1987.tb01548.x; Baelum V, 2004, J PERIODONTOL, V75, P1404, DOI 10.1902/jop.2004.75.10.1404; BECKER W, 1984, J PERIODONTOL, V55, P505, DOI 10.1902/jop.1984.55.9.505; BELTRAMI M, 1987, J CLIN PERIODONTOL, V14, P161, DOI 10.1111/j.1600-051X.1987.tb00960.x; Bergstrom J, 2004, J CLIN PERIODONTOL, V31, P260, DOI 10.1111/j.1600-051X.2004.00475.x; Bergstrom J, 2000, J PERIODONTOL, V71, P1338, DOI 10.1902/jop.2000.71.8.1338; Bonito AJ, 2005, J PERIODONTOL, V76, P1227, DOI 10.1902/jop.2005.76.8.1227; Bragger U, 2005, CLIN ORAL IMPLAN RES, V16, P326, DOI 10.1111/j.1600-0501.2005.01105.x; Brochut PF, 2005, J CLIN PERIODONTOL, V32, P695, DOI 10.1111/j.1600-051X.2005.00730.x; Campanile VSM, 2015, LASER MED SCI, V30, P27, DOI 10.1007/s10103-013-1337-y; Cappuyns I, 2012, LASER MED SCI, V27, P979, DOI 10.1007/s10103-011-1027-6; Cekici A, 2014, PERIODONTOL 2000, V64, P57, DOI 10.1111/prd.12002; Chambrone L, 2010, J CLIN PERIODONTOL, V37, P675, DOI 10.1111/j.1600-051X.2010.01587.x; Charalampakis G, 2013, EUR J ORAL SCI, V121, P394, DOI 10.1111/eos.12080; Chaves ES, 2000, J CLIN PERIODONTOL, V27, P897, DOI 10.1034/j.1600-051x.2000.027012897.x; Cohen JT, 2008, NEW ENGL J MED, V358, P661, DOI 10.1056/NEJMp0708558; Cortellini P, 2004, J PERIODONTOL, V75, P672, DOI 10.1902/jop.2004.75.5.672; Dereka X, 2012, CLIN ORAL IMPLAN RES, V23, P775, DOI 10.1111/j.1600-0501.2011.02329.x; DEVORE CH, 1986, J PERIODONTOL, V57, P354, DOI 10.1902/jop.1986.57.6.354; Diehl SR, 2015, J AM DENT ASSOC, V146, P164, DOI 10.1016/j.adaj.2014.12.018; Dierens M, 2012, CLIN ORAL IMPLAN RES, V23, P197, DOI 10.1111/j.1600-0501.2011.02212.x; Dudic VB, 1999, J CLIN PERIODONTOL, V26, P341, DOI 10.1034/j.1600-051X.1999.260602.x; Eickholz P, 2004, J PERIODONTOL, V75, P957, DOI 10.1902/jop.2004.75.7.957; Fiorini T, 2014, J PERIODONTOL, V85, P83, DOI 10.1902/jop.2013.130047; Flemmig TF, 1998, J CLIN PERIODONTOL, V25, P158, DOI 10.1111/j.1600-051X.1998.tb02422.x; Giannobile WV, 2013, J DENT RES, V92, P694, DOI 10.1177/0022034513492336; Giannopoulou C, 2003, J CLIN PERIODONTOL, V30, P145, DOI 10.1034/j.1600-051X.2003.300201.x; Giannopoulou C, 2012, J PERIODONTOL, V83, P1018, DOI 10.1902/jop.2011.110281; GOLDMAN L, 1991, JAMA-J AM MED ASSOC, V265, P1145, DOI 10.1001/jama.265.9.1145; GROSSI SG, 1994, J PERIODONTOL, V65, P260, DOI 10.1902/jop.1994.65.3.260; GROSSI SG, 1995, J PERIODONTOL, V66, P23, DOI 10.1902/jop.1995.66.1.23; Hajishengallis G, 2012, MOL ORAL MICROBIOL, V27, P409, DOI 10.1111/j.2041-1014.2012.00663.x; Hanes Philip J, 2003, Ann Periodontol, V8, P79, DOI 10.1902/annals.2003.8.1.79; Heasman L, 2006, J CLIN PERIODONTOL, V33, P241, DOI 10.1111/j.1600-051X.2006.00902.x; Heitz-Mayfield LJA, 2014, INT J ORAL MAX IMPL, V29, P325, DOI 10.11607/jomi.2014suppl.g5.3; Heitz-Mayfield LJA, 2009, INT J ORAL MAX IMPL, V24, P39; HICKEY JS, 1991, J PERIODONTOL, V62, P548, DOI 10.1902/jop.1991.62.9.548; ISIDOR F, 1986, J PERIODONTAL RES, V21, P462, DOI 10.1111/j.1600-0765.1986.tb01482.x; Jacobi-Gresser E, 2013, INT J ORAL MAX SURG, V42, P537, DOI 10.1016/j.ijom.2012.07.018; Kaldahl WB, 1996, J PERIODONTOL, V67, P103, DOI 10.1902/jop.1996.67.2.103; KERR NW, 1981, BRIT DENT J, V150, P222, DOI 10.1038/sj.bdj.4804579; KHO P, 1985, J CLIN PERIODONTOL, V12, P676, DOI 10.1111/j.1600-051X.1985.tb00939.x; KNOWLES JW, 1979, J PERIODONTOL, V50, P225, DOI 10.1902/jop.1979.50.5.225; Kocher T, 2001, J CLIN PERIODONTOL, V28, P9, DOI 10.1034/j.1600-051x.2001.280102.x; Koide M, 2010, PERIODONTOL 2000, V54, P235, DOI 10.1111/j.1600-0757.2010.00355.x; Koldsland OC, 2010, J PERIODONTOL, V81, P231, DOI 10.1902/jop.2009.090269; KORNMAN KS, 1981, J PERIODONTAL RES, V16, P363, DOI 10.1111/j.1600-0765.1981.tb00987.x; Korsch M, 2014, CLIN ORAL IMPLAN RES, V25, P797, DOI 10.1111/clr.12173; Kotsakis GA, 2015, J PERIODONTOL, V86, P254, DOI 10.1902/jop.2014.140452; Labriola A, 2005, PERIODONTOL 2000, V37, P124, DOI 10.1111/j.1600-0757.2004.03793.x; Laine ML, 2012, PERIODONTOL 2000, V58, P37, DOI 10.1111/j.1600-0757.2011.00415.x; Lang Niklaus P, 2003, Oral Health Prev Dent, V1, P7; Lang NP, 2015, CLIN PERIODONTOL IMP, V2, P1348; Lee CT, 2015, J DENT RES, V94, P777, DOI 10.1177/0022034515578910; Leininger M, 2010, J CLIN PERIODONTOL, V37, P427, DOI 10.1111/j.1600-051X.2010.01553.x; Leppilahti JM, 2015, J PERIODONTOL, V86, P777, DOI 10.1902/jop.2015.140421; Leppilahti JM, 2014, J CLIN PERIODONTOL, V41, P348, DOI 10.1111/jcpe.12223; Leppilahti JM, 2014, J PERIODONTOL, V85, P250, DOI 10.1902/jop.2013.130156; LINDHE J, 1984, J CLIN PERIODONTOL, V11, P448, DOI 10.1111/j.1600-051X.1984.tb01344.x; LINDHE J, 1984, J CLIN PERIODONTOL, V11, P504, DOI 10.1111/j.1600-051X.1984.tb00902.x; LOE H, 1965, J PERIODONTOL, V36, P177, DOI 10.1902/jop.1965.36.3.177; LOOS B, 1988, J CLIN PERIODONTOL, V15, P211, DOI 10.1111/j.1600-051X.1988.tb01572.x; MAGNUSSON I, 1984, J CLIN PERIODONTOL, V11, P193, DOI 10.1111/j.1600-051X.1984.tb01323.x; Matesanz-Perez P, 2013, J CLIN PERIODONTOL, V40, P227, DOI 10.1111/jcpe.12026; Matuliene G, 2008, J CLIN PERIODONTOL, V35, P685, DOI 10.1111/j.1600-051X.2008.01245.x; MCNABB H, 1992, J CLIN PERIODONTOL, V19, P348, DOI 10.1111/j.1600-051X.1992.tb00658.x; Michalowicz BS, 2000, J PERIODONTOL, V71, P1699, DOI 10.1902/jop.2000.71.11.1699; Moene R, 2010, J PERIODONTOL, V81, P79, DOI 10.1902/jop.2009.090394; MOMBELLI A, 1991, J PERIODONTAL RES, V26, P301, DOI 10.1111/j.1600-0765.1991.tb02067.x; Mombelli A, 2002, PERIODONTOL 2000, V28, P177, DOI 10.1034/j.1600-0757.2002.280107.x; Mombelli A, 1987, Oral Microbiol Immunol, V2, P145, DOI 10.1111/j.1399-302X.1987.tb00298.x; Mombelli A, 1999, PROCEEDINGS OF THE 3RD EUROPEAN WORKSHOP ON PERIODONTOLOGY: IMPLANT DENTISTRY, P281; Mombelli A, 2015, ITI TREAT GUIDE, V8, P131; Mombelli A, 2018, PERIODONTOL 2000, V76, P85, DOI 10.1111/prd.12147; Mombelli A, 2015, J PERIODONTOL, V86, P367, DOI 10.1902/jop.2014.140478; Mombelli A, 2012, CLIN ORAL IMPLAN RES, V23, P67, DOI 10.1111/j.1600-0501.2012.02541.x; Mombelli A, 2011, J CLIN PERIODONTOL, V38, P203, DOI 10.1111/j.1600-051X.2010.01666.x; Monje A, 2016, J DENT RES, V95, P372, DOI 10.1177/0022034515622432; Muller N, 2014, J CLIN PERIODONTOL, V41, P883, DOI 10.1111/jcpe.12289; Nociti FH, 2001, CLIN ORAL IMPLAN RES, V12, P295, DOI 10.1034/j.1600-0501.2001.012004295.x; NYMAN S, 1979, J PERIODONTOL, V50, P163, DOI 10.1902/jop.1979.50.4.163; NYMAN S, 1975, Journal of Clinical Periodontology, V2, P80, DOI 10.1111/j.1600-051X.1975.tb01728.x; NYMAN S, 1977, J CLIN PERIODONTOL, V4, P240, DOI 10.1111/j.1600-051X.1977.tb01896.x; Page RC, 2003, J CLIN PERIODONTOL, V30, P819, DOI 10.1034/j.1600-051X.2003.00370.x; Parthan A, 2013, PHARMACOECONOMICS, V31, P519, DOI 10.1007/s40273-013-0054-5; Patel RA, 2012, J PERIODONTOL, V83, P143, DOI 10.1902/jop.2011.110130; PIHLSTROM BL, 1983, J CLIN PERIODONTOL, V10, P524, DOI 10.1111/j.1600-051X.1983.tb02182.x; PONTORIERO R, 1994, CLIN ORAL IMPLAN RES, V5, P254, DOI 10.1034/j.1600-0501.1994.050409.x; Pratten J, 2001, MICROBES INFECT, V3, P633, DOI 10.1016/S1286-4579(01)01418-6; Que ML, 2004, J CLIN PERIODONTOL, V31, P978, DOI 10.1111/j.1600-051X.2004.00594.x; RAESTE AM, 1981, J CLIN PERIODONTOL, V8, P415, DOI 10.1111/j.1600-051X.1981.tb00890.x; RAMFJORD SP, 1975, J PERIODONTOL, V46, P522, DOI 10.1902/jop.1975.46.9.522; Ramseier CA, 2015, J CLIN PERIODONTOL, V42, pS47, DOI 10.1111/jcpe.12351; Rinke S, 2011, CLIN ORAL IMPLAN RES, V22, P826, DOI 10.1111/j.1600-0501.2010.02061.x; RITZ L, 1991, J CLIN PERIODONTOL, V18, P643, DOI 10.1111/j.1600-051X.1991.tb00104.x; Roccuzzo M, 2012, CLIN ORAL IMPLAN RES, V23, P389, DOI 10.1111/j.1600-0501.2011.02309.x; Rodrigo D, 2012, CLIN ORAL IMPLAN RES, V23, P1224, DOI 10.1111/j.1600-0501.2011.02294.x; Roos-Jansaker AM, 2006, J CLIN PERIODONTOL, V33, P290, DOI 10.1111/j.1600-051X.2006.00906.x; ROSLING B, 1976, Journal of Clinical Periodontology, V3, P233, DOI 10.1111/j.1600-051X.1976.tb00042.x; Rutar A, 2001, CLIN ORAL IMPLAN RES, V12, P189, DOI 10.1034/j.1600-0501.2001.012003189.x; Safii SH, 2010, CLIN IMPLANT DENT R, V12, P165, DOI 10.1111/j.1708-8208.2009.00162.x; SBORDONE L, 1990, J PERIODONTOL, V61, P579, DOI 10.1902/jop.1990.61.9.579; Sgolastra F, 2012, J PERIODONTOL, V83, P1257, DOI 10.1902/jop.2012.110625; Sgolastra F, 2012, J PERIODONTOL, V83, P731, DOI 10.1902/jop.2011.110432; Sgolastra F, 2013, LASER MED SCI, V28, P669, DOI 10.1007/s10103-011-1002-2; Shi BC, 2015, MBIO, V6, DOI 10.1128/mBio.01926-14; SOCRANSKY SS, 1988, J CLIN PERIODONTOL, V15, P440, DOI 10.1111/j.1600-051X.1988.tb01598.x; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Soskolne WA, 2003, J PERIODONTOL, V74, P420, DOI 10.1902/jop.2003.74.4.420; Teles R, 2010, J PERIODONTOL, V81, P89, DOI 10.1902/jop.2009.090397; Tonetti MS, 2015, J CLIN PERIODONTOL, V42, pS5, DOI 10.1111/jcpe.12368; Trombelli L, 2009, Minerva Stomatol, V58, P277; Van der Weijden GA, 2002, J CLIN PERIODONTOL, V29, P55, DOI 10.1034/j.1600-051X.29.s3.3.x; WESTFELT E, 1983, J CLIN PERIODONTOL, V10, P148, DOI 10.1111/j.1600-051X.1983.tb02203.x; WILSON M, 1993, ORAL MICROBIOL IMMUN, V8, P182, DOI 10.1111/j.1399-302X.1993.tb00663.x; Wilson M, 1994, Int Dent J, V44, P181; Wilson TG, 2009, J PERIODONTOL, V80, P1388, DOI 10.1902/jop.2009.090115; Zandbergen D, 2013, J PERIODONTOL, V84, P332, DOI 10.1902/jop.2012.120040; ZAPPA U, 1991, J PERIODONTOL, V62, P750, DOI 10.1902/jop.1991.62.12.750; Zitzmann NU, 2001, J CLIN PERIODONTOL, V28, P517, DOI 10.1034/j.1600-051x.2001.028006517.x	129	25	26	2	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0906-6713	1600-0757		PERIODONTOL 2000	Periodontol. 2000	FEB	2019	79	1					190	199		10.1111/prd.12255			10	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	HP6TW	WOS:000461820100012	30892766				2022-03-04	
J	Muller, F; Schimmel, M				Mueller, Frauke; Schimmel, Martin			Management of preventative care for an ageing population	INTERNATIONAL DENTAL JOURNAL			English	Article						prevention; older adults; dentures; ageing; gerodontology	METAANALYSIS; DENTURES; IMPLANTS	With the world's population ageing, the challenges to the dental profession in coming years will be greater in providing oral care to people in the older age groups. Not only will elderly adults have retained more teeth, their expectations will be greater at a time in their lives when their adaptability and general health will be increasingly challenged and diminished. Those charged with oral care will need to be skilled technical, as well as empathetic, practitioners whose role will be not only in oral health but in issues involving the general health and well being of their patients.	Univ Geneva, Div Gerodontol & Removable Prosthodont, CH-1205 Geneva, Switzerland		Muller, F (corresponding author), Univ Geneva, Div Gerodontol & Removable Prosthodont, 19 Rue Barthelemy Menn, CH-1205 Geneva, Switzerland.	frauke.mueller@medecine.unige.ch	Schimmel, Martin/F-5694-2011; Müller, Frauke/C-3835-2014	Schimmel, Martin/0000-0001-9700-5534; Müller, Frauke/0000-0003-3981-0134			Arora A, 2005, AGE AGEING, V34, P519, DOI 10.1093/ageing/afi124; BudtzJorgensen E, 1996, PERIODONTOL 2000, V10, P89, DOI 10.1111/j.1600-0757.1996.tb00070.x; Burger M, 1960, ALTERN KRANKHEIT PRO; Chapman L, 2006, AGE AGEING, V35, P205, DOI 10.1093/ageing/afj034; CORAZZO V, 2006, STERBLICHKEIT SCHWEI; Douglass CW, 2002, J PROSTHET DENT, V87, P5, DOI 10.1067/mpr.2002.121203; FARELL JH, 1956, BRIT DENT J, V100, P149; Feine J S, 2002, Int J Prosthodont, V15, P413; Feine J S, 2002, Gerodontology, V19, P3; Hugoson A, 2005, SWED DENT J, V29, P125; Imsand M, 2002, Gerodontology, V19, P66, DOI 10.1111/j.1741-2358.2002.00066.x; Janket SJ, 2003, ORAL SURG ORAL MED O, V95, P559, DOI 10.1067/moe.2003.107; Khader YS, 2006, J DIABETES COMPLICAT, V20, P59, DOI 10.1016/j.jdiacomp.2005.05.006; KRAUSE KH, 2007, IN PRESS EXP GERONTO; Micheelis W, 2006, VIERTE DTSCH MUNDGES; Muller F, 1994, Gerodontology, V11, P7, DOI 10.1111/j.1741-2358.1994.tb00096.x; NITSCHKE I, 1996, ZAHNMEDIZINISCHE VOR; Nitschke Ina, 2004, Gerodontology, V21, P123, DOI 10.1111/j.1741-2358.2004.00031.x; Psillakis Jason J, 2004, J Prosthodont, V13, P244; Schonknecht P, 2005, AM J PSYCHIAT, V162, P2071, DOI 10.1176/appi.ajp.162.11.2071; Suominen-Taipale AL, 1999, COMMUNITY DENT ORAL, V27, P353, DOI 10.1111/j.1600-0528.1999.tb02032.x; *UN, 2006, POP AG; Walton JN, 2005, INT J PROSTHODONT, V18, P483; Wismeijer D, 1997, INT J ORAL MAX SURG, V26, P263, DOI 10.1016/S0901-5027(97)80864-8	24	2	2	0	1	F D I WORLD DENTAL PRESS LTD	LOWESTOFT	5 BATTERY GREEN RD, LOWESTOFT NR32 1 DE, SUFFOLK, ENGLAND	0020-6539			INT DENT J	Int. Dent. J.	JUN	2007	57	3		1			215	220					6	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	183IQ	WOS:000247566900002					2022-03-04	
J	Kazandjian, S; Kiliaridis, S; Mavropoulos, A				Kazandjian, Serge; Kiliaridis, Stavros; Mavropoulos, Anestis			Validity and reliability of a new edge-based computerized method for identification of cephalometric landmarks	ANGLE ORTHODONTIST			English	Article						cephalometric landmark identification; cephalometric software; edge-based automatic landmark identification	CEPHALOGRAMS; ERROR	Objective: To evaluate the validity and inter- and intraexaminer reliability when on-screen landmarks are digitized manually or when these are computer-assisted by means of a new cephalometric software feature. Materials and Methods: Twenty radiographs were digitized four times by two experienced orthodontists using a manual method and an edge-based algorithm that helps landmark identification by detecting the edges of anatomical structures. Results: The computer-assisted method did not agree with manual digitization in 7 of 13 landmarks and 5 of 10 variables. With a tolerance of 0.5 mm or degrees, the two methods did not agree in cephalometric variables. Intraoperator reliability was improved for B point (x-axis), and Menton (x- and y-axis). It got worse for point A (y-axis). Interoperator reliability was improved for B point (x- and y-axis), Soft Labrale Inferior (x- and y-axis), Soft Pogonion (x-axis), and Menton (y-axis). It decreased for point A (y-axis). Intra- and interoperator reliability got better for only one cephalometric variable under study (SNB). Conclusions: The edge-locking feature seems to be a promising tool for increasing the reliability of on-screen cephalometric analysis. There seem to be difficulties in locating the appropriate edges when artifacts or soft tissue edges are located near the targeted landmark. The existence of very small, but systematic differences between the two digitization methods manifests the need for further improvement.	Univ Geneva, Dept Orthodont, Sch Dent Med, CH-1205 Geneva, Switzerland		Kazandjian, S (corresponding author), Univ Geneva, Dept Orthodont, Sch Dent Med, Rue Barthelemy Menn 19, CH-1205 Geneva, Switzerland.	serge.kazandjian@medecine.unige.ch					BAUMRIND S, 1971, AMER J ORTHODONTICS, V60, P111, DOI 10.1016/0002-9416(71)90028-5; BROCH J, 1981, EUR J ORTHODONT, V3, P9, DOI 10.1093/ejo/3.1.9; CARDILLO J, 1994, IEEE T MED IMAGING, V13, P275, DOI 10.1109/42.293920; CHAKRABARTTY S, 2003, P 2003 INT C ACC PRE, V2, P825; Chen YJ, 2000, ANGLE ORTHOD, V70, P387; Cohen A M, 1984, Br J Orthod, V11, P143; Davis D N, 1991, Br J Orthod, V18, P105; Hutton TJ, 2000, EUR J ORTHODONT, V22, P499, DOI 10.1093/ejo/22.5.499; INNES A, 2003, P 2003 INT C IM SCI, V2, P456; Kamoen A, 2001, EUR J ORTHODONT, V23, P569, DOI 10.1093/ejo/23.5.569; LEVYMANDEL AD, 1986, COMPUT BIOMED RES, V19, P282, DOI 10.1016/0010-4809(86)90023-6; Major PW, 1996, ANGLE ORTHOD, V66, P51; Ongkosuwito EM, 2002, EUR J ORTHODONT, V24, P655, DOI 10.1093/ejo/24.6.655; PARTHASARATHY S, 1989, COMPUT BIOMED RES, V22, P248, DOI 10.1016/0010-4809(89)90005-0; Perillo M, 2000, Clin Orthod Res, V3, P29, DOI 10.1034/j.1600-0544.2000.030106.x; RICHARDSON A, 1981, EUR J ORTHODONT, V3, P15, DOI 10.1093/ejo/3.1.15; Rudolph DJ, 1998, AM J ORTHOD DENTOFAC, V113, P173, DOI 10.1016/S0889-5406(98)70289-6; STABRUN AE, 1982, EUR J ORTHODONT, V4, P185, DOI 10.1093/ejo/4.3.185; TANIKAWA C, 2003, P 81 GEN SESS INT AS, P1233; Turner P J, 2001, J Orthod, V28, P221; Yagi M, 2004, ADV NEUR IN, V16, P1035	21	14	14	0	1	E H ANGLE EDUCATION RESEARCH FOUNDATION, INC	NEWTON N	1615 BEACON ST, NEWTON N, MA 02468-1507 USA	0003-3219	1945-7103		ANGLE ORTHOD	Angle Orthod.	JUL	2006	76	4					619	624					6	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	063KJ	WOS:000239016800012	16808568				2022-03-04	
J	Ardu, S; Krejci, I				Ardu, Stefano; Krejci, Ivo			Biomimetic direct composite stratification technique for the restoration of anterior teeth	QUINTESSENCE INTERNATIONAL			English	Article						biomimetic approach; composite restorations; layering technique	RESIN COMPOSITES	The aim of this article is to describe a simplified layering technique based on a biomimetic approach for large anterior Class 4 restorations. The proposed layering technique is based on a modified layering technique where palatal enamel and dentin masses are replaced with the same quantity of a microhybrid enamel and dentin shade composites, respectively, while for the thin buccal enamel layer a microfilled resin composite is used. Transparencies and, whenever necessary, white spot characterizations, are created by interposing blue and white effect masses between dentin mamelons, under buccal enamel. The combination of a microfilled composite with a microhybrid composite substituting the same quantity of lost enamel and dentin better mimics the physical and optical characteristics of the natural tooth. The biomimetic composite restoration may be considered an interesting alternative to ceramics, minimizing invasiveness, chair time, and costs for patients.	Univ Geneva, Ecole Med Dent, Dept Cariol & Endodontol, Sch Dent, CH-1205 Geneva, Switzerland		Ardu, S (corresponding author), Univ Geneva, Ecole Med Dent, Dept Cariol & Endodontol, Sch Dent, Rue Barthelemy Menn 19, CH-1205 Geneva, Switzerland.	stefano.ardu@medecine.unige.ch		ardu, stefano/0000-0003-1641-2168			Brosh T, 1999, DENT MATER, V15, P174, DOI 10.1016/S0109-5641(99)00029-9; CHUNG KH, 1990, J DENT RES, V69, P852, DOI 10.1177/00220345900690030401; Dietschi D, 2001, J Adhes Dent, V3, P71; Dietschi D, 1997, J Esthet Dent, V9, P156, DOI 10.1111/j.1708-8240.1997.tb00936.x; Felippe Luis Antonio, 2005, J Esthet Restor Dent, V17, P11, DOI 10.1111/j.1708-8240.2005.tb00077.x; Frankenberger R, 2005, AM J DENT, V18, P23; Kramer N, 2005, AM J DENT, V18, P75; Krejci I, 1999, QUINTESSENCE INT, V30, P490; SMALES RJ, 1993, BRIT DENT J, V174, P330, DOI 10.1038/sj.bdj.4808167; Vanini L, 1996, Pract Periodontics Aesthet Dent, V8, P673	10	31	33	0	11	QUINTESSENCE PUBLISHING CO INC	HANOVER PARK	4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA	0033-6572			QUINTESSENCE INT	Quintessence Int.	MAR	2006	37	3					167	174					8	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	080NK	WOS:000240254400002	16536143				2022-03-04	
J	Staudt, CB; Mavropoulos, A; Bouillaguet, S; Kiliaridis, S; Krejci, I				Staudt, CB; Mavropoulos, A; Bouillaguet, S; Kiliaridis, S; Krejci, I			Light-curing time reduction with a new high-power halogen lamp	AMERICAN JOURNAL OF ORTHODONTICS AND DENTOFACIAL ORTHOPEDICS			English	Article							SHEAR BOND STRENGTH; EMITTING DIODE; ARGON-LASER; ORTHODONTIC BRACKETS; CERAMIC BRACKETS; RESIN; PLASMA; POLYMERIZATION; COMPOSITE	Orthodontic brackets are routinely bonded with light-cured adhesives. Conventional halogen lights used in bonding have the disadvantage of a long curing time, and the available alternatives (laser and plasma lights) are expensive. Our aim was to investigate the minimum time necessary to bond brackets with a new, relatively low-priced, high-power halogen light. Methods: Five groups of 15 deciduous bovine incisors were bonded with stainless steel brackets (Mini Diamond Twin, Ormco, Orange, Calif) by using different lamps and curing times. Three of the groups were bonded by using a high-power halogen light (Swiss Master Light, Electro Medical Systems, Nyon, Switzerland) for 2, 3, and 6 seconds, respectively. The fourth group, bonded with a fast halogen light (Optilux 501, Sybron Dental Specialties, Danbury, Conn) for 40 seconds, served as the positive control group. The fifth group, the comparison group, was bonded with a plasma light (Remecure, Remedent, Deurle, Belgium) for 4 seconds. After storage for 24 hours in the dark at 37 degrees C in water, shear bond strength was measured with a universal testing machine. Results: A curing time of 2 seconds with the high-power halogen light negatively affected the bond strength and the probability of bond survival. The adhesive remnant index scores were not significantly different among the groups. Most failures (> 60%) occurred at the bracket base/adhesive interface. Conclusions: The high-power halogen light seems to be a cost-effective solution to reducing curing time. The recommended curing times to bond stainless steel brackets are 6 seconds and, with caution, even 3 seconds.	Univ Geneva, Fac Med, Sect Med Dent, Div Orthodontie,Dept Orthodont, CH-1205 Geneva, Switzerland; Univ Geneva, Dept Cariol & Endodontol, CH-1205 Geneva, Switzerland		Staudt, CB (corresponding author), Univ Geneva, Fac Med, Sect Med Dent, Div Orthodontie,Dept Orthodont, 19 Rue Barthelemy Menn, CH-1205 Geneva, Switzerland.	christine.staudt@medecine.unige.ch		Staudt, Christine B./0000-0002-7141-6500; Bouillaguet, Serge/0000-0001-5816-6124			Althoff O, 2000, AM J DENT, V13, p77D; ARTUN J, 1984, AM J ORTHOD DENTOFAC, V85, P333, DOI 10.1016/0002-9416(84)90190-8; Bishara SE, 2003, ANGLE ORTHOD, V73, P431; Blankenau R J, 1991, Am J Dent, V4, P40; Dietschi D, 2003, DENT MATER, V19, P493, DOI 10.1016/S0109-5641(02)00095-7; Dunn WJ, 2002, AM J ORTHOD DENTOFAC, V122, P236, DOI 10.1067/mod.2002.123949; Eliades T, 2000, EUR J ORTHODONT, V22, P13, DOI 10.1093/ejo/22.1.13; Fox N A, 1994, Br J Orthod, V21, P33; Ishikawa H, 2001, AM J ORTHOD DENTOFAC, V120, P58, DOI 10.1067/mod.2001.115148; Klocke A, 2003, AM J ORTHOD DENTOFAC, V124, P309, DOI 10.1016/S0889-5406(03)00310-X; Klocke A, 2002, AM J ORTHOD DENTOFAC, V122, P643, DOI 10.1067/mod.2002.126897; Kurchak M, 1997, J Clin Orthod, V31, P371; Lalani N, 2000, ANGLE ORTHOD, V70, P28; Munksgaard EC, 2000, EUR J ORAL SCI, V108, P341, DOI 10.1034/j.1600-0722.2000.108004341.x; Murray SD, 2003, AM J ORTHOD DENTOFAC, V123, P2, DOI 10.1067/mod.2003.49; Musanje L, 2003, DENT MATER, V19, P531, DOI 10.1016/S0109-5641(02)00101-X; Oesterle LJ, 1998, AM J ORTHOD DENTOFAC, V114, P514, DOI 10.1016/S0889-5406(98)70171-4; Oesterle LJ, 2002, AM J ORTHOD DENTOFAC, V122, P242, DOI 10.1067/mod.2002.126728; Oesterle LJ, 2001, AM J ORTHOD DENTOFAC, V119, P610, DOI 10.1067/mod.2001.113652; Pettemerides A P, 2001, J Orthod, V28, P237, DOI 10.1093/ortho/28.3.237; Reynolds I.R., 1975, BRIT J ORTHODONT, V2, P171, DOI [10.1080/0301228X.1975.11743666, DOI 10.1080/0301228X.1975.11743666]; Sfondrini M F, 2002, J Orthod, V29, P45, DOI 10.1093/ortho/29.1.45; Sfondrini MF, 2001, AM J ORTHOD DENTOFAC, V119, P30, DOI 10.1067/mod.2001.111399; Swanson T, 2004, AM J ORTHOD DENTOFAC, V125, P337, DOI 10.1016/j.ajodo.2003.04.011; Talbot TQ, 2000, AM J ORTHOD DENTOFAC, V118, P274, DOI 10.1067/mod.2000.106069; Usumez S, 2004, ANGLE ORTHOD, V74, P259; Weinberger SJ, 1997, ANGLE ORTHOD, V67, P173; Yoon TH, 2002, J ORAL REHABIL, V29, P1165, DOI 10.1046/j.1365-2842.2002.00970.x	28	16	20	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0889-5406	1097-6752		AM J ORTHOD DENTOFAC	Am. J. Orthod. Dentofac. Orthop.	DEC	2005	128	6					749	754		10.1016/j.ajodo.2004.08.020			6	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	995IP	WOS:000234094300015	16360916	Green Published			2022-03-04	
J	Gallucci, GO; Bernard, JP; Bertosa, M; Belser, UC				Gallucci, GO; Bernard, JP; Bertosa, M; Belser, UC			Immediate loading with fixed screw-retained provisional restorations in edentulous jaws: The pickup technique	INTERNATIONAL JOURNAL OF ORAL & MAXILLOFACIAL IMPLANTS			English	Article						dental implants; immediate loading; pickup technique; provisional template; surgical guide; titanium copings	LONGITUDINAL CLINICAL EFFECTIVENESS; OSSEOINTEGRATED DENTAL IMPLANTS; TORONTO; INTERFACE; PATIENT; ARCHES	Purpose: This article describes (a) an immediate loading technique in the treatment of edentulous arches with screw-retained provisional restorations and (b) the effort to determine whether the described technique is compatible with the predictable achievement of osseointegration. Materials and Methods: Eight patients with either 1 or 2 edentulous arches were treated. A diagnostic tooth arrangement was carried out for each patient and was then duplicated twice to fabricate a provisional template and a surgical guide. Six to 10 solid-screw ITI implants were placed around the dental arch to reach the first molar regions. On the same day, all patients received splinted metal-free screw-retained provisional restorations according to the pickup technique. The provisional prostheses were retrieved every 2 weeks during the healing phase. Results: Seventy-eight implants were placed in 11 edentulous arches. Two implants were not immediately loaded because of inadequate primary stability. In an 8- to 20-month follow-up period (mean 14 months), two 8-mm implants were lost after 5 weeks of functional loading, resulting in an overall survival rate of 97.4%. All implants were assessed by resonance frequency analysis. After 4 months of functional loading, the mean implant stability quotient was 60 4.1 units (range 51 to 72 ISQ units) for maxillary implants and 65 +/- 6.5 units (range 47 to 74 ISQ units) for mandibular implants. Discussion and Conclusion: The immediate loading of implants placed in edentulous arches with screw-retained 1-piece (cross-arch) provisional restorations does not appear to jeopardize the achievement of osseointegration. Neither the metal-free design of the provisional prostheses nor the removal of the provisional prostheses during the healing phase adversely affected osseointegration. The pickup technique for immediate provisionalization represents a reproducible treatment option.	Univ Geneva, Sch Dent Med, Dept Prosthodont, CH-1205 Geneva, Switzerland; Univ Geneva, Sch Dent Med, Dept Stomatol & Oral Surg, CH-1205 Geneva, Switzerland		Gallucci, GO (corresponding author), Univ Geneva, Sch Dent Med, Dept Prosthodont, 19 Rue Barthelemy Menn, CH-1205 Geneva, Switzerland.	german.gallucci@medecine.unige.ch	Buser, Daniel/D-3971-2011; Gallucci, German/H-4505-2011				ADELL R, 1990, International Journal of Oral and Maxillofacial Implants, V5, P347; BABBUSH CA, 1986, J ORAL MAXIL SURG, V44, P274, DOI 10.1016/0278-2391(86)90078-9; Balleri Piero, 2002, Clin Implant Dent Relat Res, V4, P128, DOI 10.1111/j.1708-8208.2002.tb00162.x; BALSHI TJ, 1997, IMPLANT DENT, V6, P683; Branemark P I, 1977, Scand J Plast Reconstr Surg Suppl, V16, P1; BRUNSKI J B, 1992, Clinical Materials, V10, P153, DOI 10.1016/0267-6605(92)90049-Y; Brunski J B, 1999, Adv Dent Res, V13, P99; Chiapasco M, 1997, CLIN ORAL IMPLAN RES, V8, P48, DOI 10.1111/j.1600-0501.1997.tb00007.x; Cooper LF, 2002, INT J ORAL MAX IMPL, V17, P517; Degidi Marco, 2002, Clin Implant Dent Relat Res, V4, P110, DOI 10.1111/j.1708-8208.2002.tb00160.x; Ganeles J, 2001, INT J ORAL MAX IMPL, V16, P418; Grunder U, 2001, INT J PERIODONT REST, V21, P545; HORIUCHI K, 2000, INT J ORAL MAXILLOF, V15, P8204; Ivanoff CJ, 1997, INT J ORAL MAX SURG, V26, P310, DOI 10.1016/S0901-5027(97)80878-8; Jaffin RA, 2000, J PERIODONTOL, V71, P833, DOI 10.1902/jop.2000.71.5.833; Kammeyer G, 2002, J PROSTHET DENT, V87, P473, DOI 10.1067/mpr.2002.123985; Mericske-Stern RD, 2000, CLIN ORAL IMPLAN RES, V11, P108; Piattelli A, 1993, J Oral Implantol, V19, P303; PILLIAR RM, 1991, BONE-BIOMATERIAL INTERFACE, P380; Romanos GE, 2002, INT J ORAL MAX IMPL, V17, P44; SALAMA H, 1995, INT J PERIODONT REST, V15, P345; SCHNITMAN P A, 1990, Journal of Oral Implantology, V16, P96; Schroeder A, 1983, SSO Schweiz Monatsschr Zahnheilkd, V93, P720; Spiekermann H, 1995, Int J Oral Maxillofac Implants, V10, P231; Szmukler-Moncler S, 1998, J BIOMED MATER RES, V43, P192, DOI 10.1002/(SICI)1097-4636(199822)43:2<192::AID-JBM14>3.0.CO;2-K; Tarnow DP, 1997, INT J ORAL MAX IMPL, V12, P319; Testori T, 2001, INT J PERIODONT REST, V21, P451; Weingart D, 2000, CLIN ORAL IMPLAN RES, V11, P69, DOI 10.1034/j.1600-0501.2000.011S1069.x; ZARB GA, 1990, J PROSTHET DENT, V64, P185, DOI 10.1016/0022-3913(90)90177-E; ZARB GA, 1995, J ORAL REHABIL, V22, P661, DOI 10.1111/j.1365-2842.1995.tb01064.x; ZARB GA, 1990, J PROSTHET DENT, V64, P53, DOI 10.1016/0022-3913(90)90153-4; ZARB GA, 1990, J PROSTHET DENT, V63, P451, DOI 10.1016/0022-3913(90)90237-7; ZARB GA, 1991, BRIT DENT J, V170, P439, DOI 10.1038/sj.bdj.4807583; Zubery Y, 1999, INT J PERIODONT REST, V19, P343	34	78	80	0	1	QUINTESSENCE PUBLISHING CO INC	HANOVER PARK	4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA	0882-2786	1942-4434		INT J ORAL MAX IMPL	Int. J. Oral Maxillofac. Implants	JUL-AUG	2004	19	4					524	533					10	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	844JJ	WOS:000223153900006	15346749				2022-03-04	
J	Del Curto, F; Rocca, GT; Krejci, I				Del Curto, Filippo; Rocca, Giovanni Tommaso; Krejci, Ivo			Restoration of discolored endodontically treated anterior teeth: a minimally invasive chemo-mechanical approach	INTERNATIONAL JOURNAL OF ESTHETIC DENTISTRY			English	Article							SODIUM PERBORATE; HYDROGEN-PEROXIDE; IN-VITRO; POSTERIOR TEETH; BOND STRENGTH; HUMAN ENAMEL; COMPOSITE; ADHESION; LEAKAGE; RESIN	In the case of discolored devitalized anterior teeth, several treatments are available to enhance the esthetic outcome, from noninvasive external/internal bleaching to freehand resin composites and more complex prosthetic solutions such as veneers or full crowns. Innovative computer-aided design/computer-aided manufacturing (CAD/CAM) chair-side technologies and the introduction of new industrially polymerized composite resin blocks coupled with modern adhesive strategies have reduced both biological and financial costs compared to the classic post-core-crown approach. The aim of this article is to show how these new materials can be used in association with noninvasive internal and external tooth bleaching to restore a discolored, fractured, non-vital central incisor.	[Del Curto, Filippo] Univ Geneva, Univ Clin Dent Med, Div Cariol & Endodontol, 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland; [Rocca, Giovanni Tommaso] Univ Geneva, Univ Clin Dent Med, Div Cariol & Endodontol, Clin Sci, Geneva, Switzerland; [Krejci, Ivo] Univ Geneva, Univ Clin Dent Med, Geneva, Switzerland; [Krejci, Ivo] Univ Geneva, Div Prevent Dent Med & Primary Dent Care, Geneva, Switzerland; [Krejci, Ivo] Univ Geneva, Div Cariol & Endodontol, Geneva, Switzerland		Del Curto, F (corresponding author), Univ Geneva, Univ Clin Dent Med, Div Cariol & Endodontol, 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland.	filippo.delcurto@gmail.com		Rocca, Giovanni Tommaso/0000-0002-9511-9965			Ari H, 2002, INT ENDOD J, V35, P433, DOI 10.1046/j.1365-2591.2002.00497.x; Arrihed HM, 2012, INT ENDOD J, V45, P83; Attin T, 2004, DENT MATER, V20, P852, DOI 10.1016/j.dental.2004.04.002; Balkenhol M, 2007, J DENT, V35, P50, DOI 10.1016/j.jdent.2006.04.004; Berg RA, 2017, PROC SPIE, V10044, DOI 10.1117/12.2256745; Bittencourt ME, 2010, J AM DENT ASSOC, V141, P300, DOI 10.14219/jada.archive.2010.0164; COSTAS FL, 1991, J ENDODONT, V17, P365, DOI 10.1016/S0099-2399(06)81986-2; CULLEN DR, 1993, J PROSTHET DENT, V69, P247, DOI 10.1016/0022-3913(93)90100-3; Dietschi D, 1998, Pract Periodontics Aesthet Dent, V10, P47; DISHMAN MV, 1994, DENT MATER, V10, P33, DOI 10.1016/0109-5641(94)90019-1; Fokkinga WA, 2007, J DENT, V35, P778, DOI 10.1016/j.jdent.2007.07.006; Gregor L, 2014, J PROSTHET DENT, V112, P942, DOI 10.1016/j.prosdent.2014.02.008; Jimenez-Rubio A, 1998, J ENDODONT, V24, P229, DOI 10.1016/S0099-2399(98)80101-5; LEWINSTEIN I, 1994, J ENDODONT, V20, P61, DOI 10.1016/S0099-2399(06)81181-7; Plotino G, 2008, J ENDODONT, V34, P394, DOI 10.1016/j.joen.2007.12.020; Rocca GT, 2016, DENT MATER, V32, pE338, DOI 10.1016/j.dental.2016.09.024; Rocca GT, 2013, INT J ESTHET DENT, V8, P156; Rocca GT, 2007, QUINTESSENCE INT, V38, P543; Rocca GT, 2015, INT J ESTHET DENT, V10, P392; ROTSTEIN I, 1993, J ENDODONT, V19, P567, DOI 10.1016/S0099-2399(06)81288-4; ROTSTEIN I, 1992, J ENDODONT, V18, P114, DOI 10.1016/S0099-2399(06)81310-5; Rotstein I., 2001, BLEACHING TECHNIQUES; Salvas J. C., 1938, J AM DENT ASS DENT C, V25, P324; Shinohara Mirela Sanae, 2005, J Esthet Restor Dent, V17, P22, DOI 10.1111/j.1708-8240.2005.tb00078.x; SMITH JJ, 1992, J ENDODONT, V18, P476, DOI 10.1016/S0099-2399(06)81346-4; Spasser HF, 1961, NY STATE DENT J, V27, P332; Steiner DR, 1994, J ENDODONT, V20, P304; Sulieman MAM, 2008, PERIODONTOL 2000, V48, P148, DOI 10.1111/j.1600-0757.2008.00258.x; TITLEY KC, 1993, J ENDODONT, V19, P112, DOI 10.1016/S0099-2399(06)80504-2; TORNECK CD, 1991, J ENDODONT, V17, P156, DOI 10.1016/S0099-2399(06)82008-X; WEIGER R, 1994, J ENDODONT, V20, P338, DOI 10.1016/S0099-2399(06)80096-8	31	0	1	0	4	QUINTESSENCE PUBLISHING CO INC	HANOVER PARK	4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA	2198-591X			INT J ESTHET DENT	Int. J. Esthet. Dent.	FAL	2018	13	3					302	317	PMID 30073215				16	Dentistry, Oral Surgery & Medicine	Emerging Sources Citation Index (ESCI)	Dentistry, Oral Surgery & Medicine	GX8RU	WOS:000448058600002	30073215				2022-03-04	
J	Tsanidis, N; Antonarakis, GS; Kiliaridis, S				Tsanidis, N.; Antonarakis, G. S.; Kiliaridis, S.			Functional changes after early treatment of unilateral posterior cross-bite associated with mandibular shift: a systematic review	JOURNAL OF ORAL REHABILITATION			English	Review						systematic review; unilateral posterior cross-bite; maxillary expansion; bite force; electromyography; ultrasound; masticatory cycle; chewing cycle	MASTICATORY MUSCLE; CHILDREN; FORCE; THICKNESS; SKELETAL; QUALITY; TRIALS	The objective of this systematic review was to investigate whether oral functional asymmetry in children treated for unilateral functional posterior cross-bite disappears after orthodontic treatment with a resulting normalisation of oral functions. A literature search was carried out using PubMed, Web of Science and the Cochrane Library to locate longitudinal studies reporting on clinical oral functional changes, recorded by methods including masseter muscle thickness, bite force, masticatory/chewing cycle or electromyographic masticatory muscle activity, following the treatment of unilateral functional posterior cross-bite. All potential articles were initially screened according to their title and abstract, the full text of selected articles was evaluated, and the final study selection was made based on the pre-defined criteria. Data extraction was subsequently carried out. The initial literature search identified 736 articles, with 12 articles fulfilling pre-defined criteria. Although there was a lack of high-quality prospective studies, based on the available evidence, results suggest that the abnormal masticatory cycle associated with functional posterior unilateral cross-bite tends to normalise following early cross-bite treatment. Masticatory muscle activity shows an increase after early functional unilateral posterior cross-bite treatment, and this activity approaches normal levels. Insufficient evidence was available to conclude on maximal molar bite force or masticatory muscle thickness changes following early treatment of functional unilateral posterior cross-bite. Results should be interpreted with caution due to the lack of high-quality controlled studies. Well-designed prospective studies with large patient samples and long-term follow-up are necessary before making reliable conclusions concerning change in functional asymmetry following unilateral functional posterior cross-bite correction.	[Tsanidis, N.; Antonarakis, G. S.; Kiliaridis, S.] Univ Geneva, Div Orthodont, CH-1205 Geneva, Switzerland		Tsanidis, N (corresponding author), Univ Geneva, Div Orthodont, 19 Rue Barthelemy Menn, CH-1205 Geneva, Switzerland.	niktsanidis@gmail.com	Antonarakis, Gregory/ABA-1855-2020	Antonarakis, Gregory/0000-0001-6741-6922			Andradea AD, 2009, ANGLE ORTHOD, V79, P380, DOI 10.2319/030708-137.1; ANTCZAK AA, 1986, J PERIODONTAL RES, V21, P305, DOI 10.1111/j.1600-0765.1986.tb01464.x; Ben-Bassat Y, 1993, Eur J Orthod, V15, P57; Brin I, 1996, AM J ORTHOD DENTOFAC, V109, P173, DOI 10.1016/S0889-5406(96)70178-6; Castelo PM, 2007, EUR J ORTHODONT, V29, P149, DOI 10.1093/ejo/cjl089; Castelo PM, 2010, J CLIN PEDIATR DENT, V34, P369, DOI 10.17796/jcpd.34.4.656rh557093373k4; De Rossi M, 2009, AM J ORTHOD DENTOFAC, V136, P355, DOI 10.1016/j.ajodo.2007.08.027; EGERMARKERIKSSON I, 1990, EUR J ORTHODONT, V12, P399, DOI 10.1093/ejo/12.4.399; INGERVALL B, 1975, ANGLE ORTHOD, V45, P249; Iodice G, 2013, EUR J ORTHODONT, V35, P737, DOI 10.1093/ejo/cjt024; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Kecik D, 2007, AM J ORTHOD DENTOFAC, V131, P202, DOI 10.1016/j.ajodo.2005.03.030; KILIARIDIS S, 1995, AM J ORTHOD DENTOFAC, V107, P372, DOI 10.1016/S0889-5406(95)70089-7; KILIARIDIS S, 1988, ARCH ORAL BIOL, V33, P187, DOI 10.1016/0003-9969(88)90044-1; Kiliaridis S, 2007, ANGLE ORTHOD, V77, P607, DOI 10.2319/101105-360; KUROL J, 1992, European Journal of Orthodontics, V14, P173; KUTIN G, 1969, AMER J ORTHODONTICS, V56, P491, DOI 10.1016/0002-9416(69)90210-3; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Maffei C, 2014, ACTA ODONTOL SCAND, V72, P298, DOI 10.3109/00016357.2013.824606; Martin C, 2012, J ELECTROMYOGR KINES, V22, P620, DOI 10.1016/j.jelekin.2012.01.002; Piancino Maria G, 2010, Prog Orthod, V11, P138, DOI 10.1016/j.pio.2010.09.006; Piancino MG, 2006, EUR J ORTHODONT, V28, P480, DOI 10.1093/ejo/cjl014; Pignataro G, 2007, AM J ORTHOD DENTOFAC, V131, P464, DOI 10.1016/j.ajodo.2005.06.030; SCHRODER U, 1984, EUR J ORTHODONT, V6, P65, DOI 10.1093/ejo/6.1.65; Sonnesen L, 2001, EUR J ORTHODONT, V23, P741, DOI 10.1093/ejo/23.6.741; Sonnesen L, 2007, EUR J ORTHODONT, V29, P310, DOI 10.1093/ejo/cjl082; THILANDER B, 1984, EUR J ORTHODONT, V6, P25, DOI 10.1093/ejo/6.1.25; Throckmorton GS, 2001, AM J ORTHOD DENTOFAC, V120, P521, DOI 10.1067/mod.2001.118626	28	20	20	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0305-182X	1365-2842		J ORAL REHABIL	J. Oral Rehabil.	JAN	2016	43	1					59	68		10.1111/joor.12335			10	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	DA7XT	WOS:000368019600008	26257271				2022-03-04	
J	Bortolotto, T; Prando, F; Dietschi, D; Krejci, I				Bortolotto, Tissiana; Prando, Federico; Dietschi, Didier; Krejci, Ivo			Light polymerization during cavity filling: influence of total energy density on shrinkage and marginal adaptation	ODONTOLOGY			English	Article						Curing protocol; Radiant exposure; Linear shrinkage; Polymerization force; Marginal integrity	RESIN COMPOSITE; DENTAL COMPOSITES; CONTRACTION STRESS; CURE; IRRADIANCE; RESTORATIONS; TIME	The aim of the study was to evaluate the marginal adaptation and shrinkage stress development of a micro hybrid restorative composite as a function of energy density. Linear displacement and shrinkage forces were measured with custom-made devices for energies of 4,000, 8,000, 16,000 and 32,000 mJ/cm(2) at a constant power density of 800 mW/cm(2). Marginal adaptation of composite restorations cured with the same energy density was evaluated before and after mechanical loading with 300,000 cycles at 70 N. The group "4,000 mJ/cm(2)" showed the lowest shrinkage force [2.9(0.2) kg] and linear displacement [23.5(0.7) mu m] but led to the worst marginal adaptation after loading [46.4(23.5) %CM] probably due to under-curing. When the maximum energy of 32,000 mJ/cm(2) was applied, a slight increase in shrinkage forces [3.6(0.2) kg and 29.2(0.8) mu m], and a slight decrease in marginal adaptation after loading [75.4(11.5) %CM] were observed, but these changes were not significantly different in comparison to groups cured with energies of 8,000 and 16,000 mJ/cm(2). For the resin composite tested in this study, no differences in marginal adaptation could be detected above the energy threshold of 8,000 mJ/cm(2).	[Bortolotto, Tissiana; Prando, Federico; Dietschi, Didier; Krejci, Ivo] Univ Geneva, Sch Dent Med, Div Cariol & Endodont, CH-1205 Geneva, Switzerland		Bortolotto, T (corresponding author), Univ Geneva, Sch Dent Med, Div Cariol & Endodont, 19 Rue Barthelemy Menn, CH-1205 Geneva, Switzerland.	tissiana.bortolotto@unige.ch	Bortolotto, Tissiana/AAE-2796-2021	Bortolotto, Tissiana/0000-0002-3231-9097			Asmussen E, 2005, EUR J ORAL SCI, V113, P417, DOI 10.1111/j.1600-0722.2005.00239.x; Cadenaro M, 2008, DENT MATER, V24, P681, DOI 10.1016/j.dental.2007.06.031; Cadenaro M, 2009, DENT MATER, V25, P649, DOI 10.1016/j.dental.2008.11.010; DEGEE AJ, 1993, DENT MATER, V9, P11, DOI 10.1016/0109-5641(93)90097-A; Dewaele M, 2006, EUR J ORAL SCI, V114, P535, DOI 10.1111/j.1600-0722.2006.00407.x; Dietschi D., 2003, THESIS U GENEVA SWIT; Emami N, 2003, EUR J ORAL SCI, V111, P536, DOI 10.1111/j.0909-8836.2003.00082.x; Feng L, 2009, DENT MATER, V25, P283, DOI 10.1016/j.dental.2008.07.007; Ferracane JL, 2003, AM J DENT, V16, P239; FERRACANE JL, 1995, J DENT RES, V74, P1418, DOI 10.1177/00220345950740071501; Halvorson RH, 2002, DENT MATER, V18, P463, DOI 10.1016/S0109-5641(01)00069-0; Koplin C, 2009, DENT MATER, V25, P331, DOI 10.1016/j.dental.2008.08.007; Lovell LG, 2001, POLYM ADVAN TECHNOL, V12, P335, DOI 10.1002/pat.115; Lovell LG, 2001, DENT MATER, V17, P504, DOI 10.1016/S0109-5641(01)00010-0; Peutzfeldt A, 2005, J DENT RES, V84, P659, DOI 10.1177/154405910508400715; Pfeifer CS, 2008, J DENT RES, V87, P1043, DOI 10.1177/154405910808701114; RUEGGEBERG FA, 1994, OPER DENT, V19, P26; Sakaguchi R L, 2001, J Esthet Restor Dent, V13, P121, DOI 10.1111/j.1708-8240.2001.tb00434.x; Sakaguchi RL, 2004, DENT MATER, V20, P402, DOI 10.1016/j.dental.2003.11.004; Stavridakis MM, 2003, AM J DENT, V16, P431; Vandewalle KS, 2004, DENT MATER, V20, P96, DOI 10.1016/S0109-5641(03)00124-6; Yap AUJ, 2001, OPER DENT, V26, P460	22	7	8	1	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1618-1247	1618-1255		ODONTOLOGY	Odontology	JUL	2014	102	2					184	188		10.1007/s10266-013-0123-4			5	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	AN6BZ	WOS:000340680000008	23832391	Green Published, Green Submitted			2022-03-04	
J	Alharbi, A; Rocca, GT; Dietschi, D; Krejci, I				Alharbi, Amal; Rocca, Giovanni Tommaso; Dietschi, Didier; Krejci, Ivo			Semidirect Composite Onlay With Cavity Sealing: A Review of Clinical Procedures	JOURNAL OF ESTHETIC AND RESTORATIVE DENTISTRY			English	Article							BONDED INDIRECT RESTORATIONS; POSTERIOR TEETH; MECHANICAL-PROPERTIES; INTERNAL ADAPTATION; HYBRID RESIN; STRENGTH; CONVERSION	The evolution in adhesive dentistry has broadened the indication of esthetic restorative procedures especially with the use of resin composite material. Depending on the clinical situation, some restorative techniques are best indicated. As an example, indirect adhesive restorations offer many advantages over direct techniques in extended cavities. In general, the indirect technique requires two appointments and a laboratory involvement, or it can be prepared chairside in a single visit either conventionally or by the use of computer-aided design/computer-aided manufacturing systems. In both cases, there will be an extra cost as well as the need of specific materials. This paper describes the clinical procedures for the chairside semidirect technique for composite onlay fabrication without the use of special equipments. The use of this technique combines the advantages of the direct and the indirect restoration. Clinical Significance The semidirect technique for composite onlays offers the advantages of an indirect restoration and low cost, and can be the ideal treatment option for extended cavities in case of financial limitations.	[Alharbi, Amal; Rocca, Giovanni Tommaso; Dietschi, Didier; Krejci, Ivo] Univ Geneva, Dept Cariol & Endodont, CH-1205 Geneva, Switzerland		Alharbi, A (corresponding author), Univ Geneva, Div Cariol & Endodontie, Sect Med Dent, 19 Rue Barthelemy Menn, CH-1205 Geneva, Switzerland.	amal.alharbi@unige.ch		Rocca, Giovanni Tommaso/0000-0002-9511-9965			ASMUSSEN E, 1990, SCAND J DENT RES, V98, P564; Bertschinger C, 1996, AM J DENT, V9, P115; Blankenau R J, 1984, Quintessence Int Dent Dig, V15, P515; Carvalho RM, 2000, J DENT RES, V79, P442; COOK WD, 1987, J BIOMED MATER RES, V21, P979, DOI 10.1002/jbm.820210804; Devoto W, 2010, INT J ESTHET DENT, V5, P102; Dietschi D, 1998, EUR J ORAL SCI, V106, P1033, DOI 10.1046/j.0909-8836.1998.eos106609.x; Dietschi D, 1995, Quintessence Int, V26, P127; Dietschi D, 1997, ADHESIVE METAL FREE; Douglas WH, 1995, POSTERIOR COMPOSITE, P433; FEILZER AJ, 1987, J DENT RES, V66, P1636, DOI 10.1177/00220345870660110601; Ferracane JL, 2011, DENT MATER, V27, P29, DOI 10.1016/j.dental.2010.10.020; FERRACANE JL, 1992, DENT MATER, V8, P290, DOI 10.1016/0109-5641(92)90102-I; Fullemann J, 1988, Schweiz Monatsschr Zahnmed, V98, P758; James D F, 1983, Quintessence Int Dent Dig, V14, P725; Junior SAR, 2009, DENT MATER, V25, P442, DOI 10.1016/j.dental.2008.09.009; KILDAL KK, 1994, ACTA ODONTOL SCAND, V52, P315, DOI 10.3109/00016359409029044; Krejci I, 2000, Pract Periodontics Aesthet Dent, V12, P727; Lovell LG, 2001, DENT MATER, V17, P504, DOI 10.1016/S0109-5641(01)00010-0; Lutz E, 1986, Quintessence Int, V17, P777; Magne P, 2005, J PROSTHET DENT, V94, P511, DOI 10.1016/j.prosdent.2005.10.010; Magne P, 1996, INT J PERIODONT REST, V16, P105; Mormann W H, 1989, Quintessence Int, V20, P329; Mormann W H, 1982, Quintessenz, V33, P1891; Papacchini F, 2007, J ADHES DENT, V9, P25; Park SH, 1996, J PROSTHET DENT, V76, P613, DOI 10.1016/S0022-3913(96)90439-4; PEUTZFELDT A, 1990, OPER DENT, V15, P129; Rickman LJ, 2011, BRIT DENT J, V211, P63, DOI 10.1038/sj.bdj.2011.571; Rocca GT, 2007, QUINTESSENCE INT, V38, P371; Rocca GT, 2007, QUINTESSENCE INT, V38, P543; Rocca GT, 2012, CLIN ORAL INVEST, V16, P1385, DOI 10.1007/s00784-011-0632-x; Sarrett DC, 2005, DENT MATER, V21, P9, DOI 10.1016/j.dental.2004.10.001; SCHMALZ G, 1995, J PROSTHET DENT, V73, P392, DOI 10.1016/S0022-3913(05)80337-3; SHORTALL AC, 1991, J DENT, V19, P307, DOI 10.1016/0300-5712(91)90080-I; Spreafico R, 1996, DIRECT SEMIDIRECT PO; Spreafico RC, 2005, J DENT, V33, P499, DOI 10.1016/j.jdent.2004.11.009; van Dijken JWV, 2000, J DENT, V28, P299, DOI 10.1016/S0300-5712(00)00010-5; vanDijken JWV, 1996, J DENT, V24, P389, DOI 10.1016/0300-5712(95)00098-4; Versluis A, 1996, DENT MATER, V12, P290, DOI 10.1016/S0109-5641(96)80036-4; WASSELL RW, 1992, J DENT, V20, P294, DOI 10.1016/0300-5712(92)90052-E; Wendt S L Jr, 1987, Quintessence Int, V18, P351; Wendt S L Jr, 1987, Quintessence Int, V18, P265; Wendt S L Jr, 1991, Am J Dent, V4, P10	43	12	12	0	19	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1496-4155	1708-8240		J ESTHET RESTOR DENT	J. Esthet. Restor. Dent.	APR	2014	26	2					97	106		10.1111/jerd.12067			10	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	AE2KD	WOS:000333800800004	24341472				2022-03-04	
J	Oliveira, R; El Hage, M; Carrel, JP; Lombardi, T; Bernard, JP				Oliveira, Rita; El Hage, Marc; Carrel, Jean-Pierre; Lombardi, Tommaso; Bernard, Jean-Pierre			Rehabilitation of the Edentulous Posterior Maxilla After Sinus Floor Elevation Using Deproteinized Bovine Bone: A 9-Year Clinical Study	IMPLANT DENTISTRY			English	Article						dental implant; sinus elevation; biomaterial	BIO-OSS; DENTAL IMPLANTS; AUTOGENOUS BONE; FOLLOW-UP; AUGMENTATION; HYDROXYAPATITE; SURFACE; PLACEMENT; CULTURE; 5-YEAR	Objectives: To evaluate the long-term survival rate of rough-surfaced implants placed in maxillary sinuses augmented with deproteinized bovine bone (Bio-Oss; Geistlich Pharma AG, Wolhusen, Switzerland). Materials and Methods: Thirteen maxillary sinuses were augmented in 10 patients with Bio-Oss. After an average healing period of 13.8 months, 24 implants were placed. In 4 cases, biopsies were performed and submitted to histological analysis. Clinical and radiographic evaluation was performed 9 years after implant placement and minimum 8 years after functional loading. Results: At the 9-year control, all the 24 implants were still functional. Thus, the implant survival rate was 100%. Conclusions: Bio-Oss is an acceptable substitute to the autogenous bone, and it can be used as a unique material for sinus floor elevation. Rough-surfaced implants placed in 100% Bio-Oss grafts showed a high survival rate (100%) on the long term. Larger clinical trials are necessary to confirm our results. (Implant Dent 2012;21:422-426)	[Lombardi, Tommaso] Univ Geneva, Dept Oral Surg Oral Med Oral & Maxillofacial Radi, Sch Dent Med, Lab Oral & Maxillofacial Pathol, Geneva, Switzerland		Oliveira, R (corresponding author), Chemin Ruisselet 15, CH-1009 Pully, Switzerland.	oliveiragrbavac@gmail.com	Oliveira, Camila CCO/K-4279-2016				Artzi Z, 2005, J CLIN PERIODONTOL, V32, P193, DOI 10.1111/j.1600-051X.2005.00656.x; Asai S, 2002, CLIN ORAL IMPLAN RES, V13, P405, DOI 10.1034/j.1600-0501.2002.130409.x; Astrand P, 2008, CLIN IMPLANT DENT R, V10, P207, DOI 10.1111/j.1708-8208.2007.00081.x; Boyan BD, 2002, CALCIFIED TISSUE INT, V71, P519, DOI 10.1007/s00223-001-1114-y; BOYNE PJ, 1980, J ORAL SURG, V38, P613; Buser D, 1997, CLIN ORAL IMPLAN RES, V8, P161, DOI 10.1034/j.1600-0501.1997.080302.x; Cochran DL, 2002, CLIN ORAL IMPLAN RES, V13, P144, DOI 10.1034/j.1600-0501.2002.130204.x; Cochran DL, 1999, J PERIODONTOL, V70, P1523, DOI 10.1902/jop.1999.70.12.1523; Del Fabbro M, 2004, INT J PERIODONT REST, V24, P565; Esposito M, 2010, EUR J ORAL IMPLANTOL, V3, P3; Fugazzotto PA, 2007, IMPLANT DENT, V16, P369, DOI 10.1097/ID.0b013e318157086c; Haas R, 1998, CLIN ORAL IMPLAN RES, V9, P107, DOI 10.1034/j.1600-0501.1998.090206.x; Haas R, 1998, CLIN ORAL IMPLAN RES, V9, P117, DOI 10.1034/j.1600-0501.1998.090207.x; Hallman M, 2002, INT J ORAL MAX IMPL, V17, P635; Hising P, 2001, INT J ORAL MAX IMPL, V16, P90; JAFFIN RA, 1991, J PERIODONTOL, V62, P2, DOI 10.1902/jop.1991.62.1.2; Javed F, 2011, IMPLANT DENT, V20, P40, DOI 10.1097/ID.0b013e31820867da; John HD, 2004, INT J ORAL MAX IMPL, V19, P199; Kaptein MLA, 1998, CLIN ORAL IMPLAN RES, V9, P321, DOI 10.1034/j.1600-0501.1998.090505.x; Merkx MAW, 2003, INT J ORAL MAX SURG, V32, P1, DOI 10.1054/ijom.2002.0346; Misch C E, 1993, Implant Dent, V2, P158, DOI 10.1097/00008505-199309000-00003; Peetz M., 1997, OSSEOUS RECONSTRUCTI, P87; Piattelli M, 1999, INT J ORAL MAX IMPL, V14, P835; Sartori S, 2003, CLIN ORAL IMPLAN RES, V14, P369, DOI 10.1034/j.1600-0501.2003.140316.x; Scarano A, 2007, IMPLANT DENT, V16, P195, DOI 10.1097/ID.0b013e3180587ad8; Schlegel KA, 2003, INT J ORAL MAX IMPL, V18, P53; Solar P, 1999, CLIN ORAL IMPLAN RES, V10, P34, DOI 10.1034/j.1600-0501.1999.100105.x; Steigenga Jennifer T, 2003, Implant Dent, V12, P306, DOI 10.1097/01.ID.0000091140.76130.A1; Tarnow DP, 2000, INT J PERIODONT REST, V20, P117; TATUM H, 1986, DENT CLIN N AM, V30, P207; Valentini P, 2000, INT J PERIODONT REST, V20, P245; Viornery C, 2002, J BIOMED MATER RES, V62, P149, DOI 10.1002/jbm.10205; Wallace SS, 2005, INT J PERIODONT REST, V25, P551; Xu H, 2004, CLIN ORAL IMPLAN RES, V15, P126, DOI 10.1111/j.1600-0501.2004.01003.x	34	25	26	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1056-6163			IMPLANT DENT	Implant Dent.	OCT	2012	21	5					422	426		10.1097/ID.0b013e3182691873			5	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	007CG	WOS:000308865800014	22968571	Green Published			2022-03-04	
J	Theytaz, GA; Kiliaridis, S				Theytaz, Georges-Andre; Kiliaridis, Stavros			Gingival and dentofacial changes in adolescents and adults 2 to 10 years after orthodontic treatment	JOURNAL OF CLINICAL PERIODONTOLOGY			English	Article						gingival changes; gingival shape; lower facial height; tooth eruption; upper central incisors	CLINICAL CROWN HEIGHT; TOOTH ERUPTION; ANTERIOR TEETH; LENGTH; AGE; DENTITION; IMPLANT; SULCUS; DEPTH	Background: Information about long-term changes of the shape of the gingival margin is missing. Aim: To monitor 8 year changes of the gingival contour occurring in adolescents and adults and relate these changes to dentofacial growth. Subjects and method: Forty adolescents (mean age 16.3), and 14 adults (mean age 29.7) were included in the study with photographs, radiographs and casts taken 2 and 10 years after orthodontic treatment. The gingival contour of upper central incisors and the midline passing through the contact surface of both teeth were traced digitally using calibrated photographs. Changes were measured on seven standardized lines of the gingival contour. Lower facial height changes and tooth eruption were measured using lateral cephalograms. Results: Adolescents and adults showed a central mean apical displacement of the gingival margin of 0.51 mm (SD 0.4 mm) and 0.13 mm (SD 0.17 mm), respectively. This displacement decreased by moving away from the centre. The gingival displacement was associated to the individual's lower facial height augmentation, r=0.63 (p < 0.001). Conclusions: Apical displacement of the gingival contour of the upper central incisors takes place during adolescence following a semi-lunar shape. Growth explains parts of these changes.	[Theytaz, Georges-Andre; Kiliaridis, Stavros] Univ Geneva, Sch Dent, Dept Orthodont, CH-1205 Geneva, Switzerland		Theytaz, GA (corresponding author), Univ Geneva, Sch Dent, Dept Orthodont, 19 Rue Barthelemy Menn, CH-1205 Geneva, Switzerland.	Georges-Andre.Theytaz@medecine.unige.ch					ABDELKADER HM, 1986, AM J ORTHOD DENTOFAC, V89, P246, DOI 10.1016/0002-9416(86)90040-0; AINAMO J, 1976, J PERIODONTAL RES, V11, P182, DOI 10.1111/j.1600-0765.1976.tb00069.x; Bassey I E, 1991, Afr Dent J, V5, P8; Bernard JP, 2004, J CLIN PERIODONTOL, V31, P1024, DOI 10.1111/j.1600-051X.2004.00574.x; BIMSTEIN E, 1988, J CLIN PERIODONTOL, V15, P175, DOI 10.1111/j.1600-051X.1988.tb01565.x; BJORK A, 1972, AMER J ORTHODONTICS, V62, P339, DOI 10.1016/S0002-9416(72)90277-1; Christou P, 2008, AM J ORTHOD DENTOFAC, V133, P81, DOI 10.1016/j.ajodo.2007.07.009; FORSBERG CM, 1991, EUR J ORTHODONT, V13, P249, DOI 10.1093/ejo/13.4.249; HOUSTON WJB, 1983, AM J ORTHOD DENTOFAC, V83, P382, DOI 10.1016/0002-9416(83)90322-6; Kokich V, 1993, J Esthet Dent, V5, P174, DOI 10.1111/j.1708-8240.1993.tb00774.x; Kokich V., 1993, J ESTHET DENT, V5, P19; KOKICH VG, 1984, AM J ORTHOD DENTOFAC, V86, P89, DOI 10.1016/0002-9416(84)90300-2; Kuijpers-Jagtman A M, 2002, Ned Tijdschr Tandheelkd, V109, P42; Larsson E, 1981, Br J Orthod, V8, P171; Morrow LA, 2000, J DENT, V28, P469, DOI 10.1016/S0300-5712(00)00023-3; OLSSON M, 1993, J CLIN PERIODONTOL, V20, P570, DOI 10.1111/j.1600-051X.1993.tb00773.x; Op Heij DG, 2003, PERIODONTOL 2000, V33, P172, DOI 10.1046/j.0906-6713.2003.03314.x; RONNERMAN A, 1977, ACTA ODONTOL SCAND, V35, P229, DOI 10.3109/00016357709019797; Ronnerman A, 1982, Swed Dent J Suppl, V15, P215; Sarver DM, 2004, AM J ORTHOD DENTOFAC, V126, P749, DOI 10.1016/j.ajodo.2004.07.034; Serio F G, 1989, J Esthet Dent, V1, P177, DOI 10.1111/j.1708-8240.1989.tb00499.x; SMITH RG, 1982, J PERIODONTAL RES, V17, P427, DOI 10.1111/j.1600-0765.1982.tb01173.x; SOLOW B, 1976, AM J PHYS ANTHROPOL, V44, P417, DOI 10.1002/ajpa.1330440306; Spear FM, 2006, J AM DENT ASSOC, V137, P160, DOI 10.14219/jada.archive.2006.0140; Sterrett JD, 1999, J CLIN PERIODONTOL, V26, P153, DOI 10.1034/j.1600-051X.1999.260304.x; Volchansky A, 1976, J Dent, V4, P116, DOI 10.1016/0300-5712(76)90011-7; VOLCHANSKY A, 1981, J DENT, V9, P150; VOLCHANSKY A, 1979, J CLIN PERIODONTOL, V6, P231, DOI 10.1111/j.1600-051X.1979.tb01925.x; Volchansky A, 2001, J CLIN PERIODONTOL, V28, P1085, DOI 10.1034/j.1600-051X.2001.281201.x; ZACHRISSON BU, 1973, ANGLE ORTHOD, V43, P402	30	6	6	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0303-6979	1600-051X		J CLIN PERIODONTOL	J. Clin. Periodontol.	SEP	2008	35	9					825	830		10.1111/j.1600-051X.2008.01297.x			6	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	337NC	WOS:000258441800012	18680508				2022-03-04	
J	Bader, C; Krejci, I				Bader, Carl; Krejci, Ivo			Indications and limitations of Er : YAG laser applications in dentistry	AMERICAN JOURNAL OF DENTISTRY			English	Review							TENSILE BOND STRENGTH; ROOT SUBSTANCE REMOVAL; DENTAL HARD-TISSUE; IN-VITRO; COMPOSITE RESTORATIONS; HUMAN ENAMEL; PERIODONTAL TREATMENT; SUBGINGIVAL CALCULUS; CAVITY PREPARATION; AIR-ABRASION	Purpose : To describe the development, indications, and limitations of Er:YAG lasers in the dental field. Methods: A review based on the literature search in PubMed and completed by other documents was performed. Results: Based on the synthesis of the reviewed literature different topics concerning the Er:YAG effects and applications in dentistry are discussed and recommendations for the use of this type of laser are given.	Univ Geneva, Sch Dent, Dept Cariol & Endodontol, CH-1205 Geneva, Switzerland		Krejci, I (corresponding author), Univ Geneva, Sch Dent, Dept Cariol & Endodontol, Rue Barthelemy Menn 19, CH-1205 Geneva, Switzerland.	ivo.krejci@medecine.unige.ch					Altshuler GB, 2001, LASER SURG MED, V28, P435; Ando Y, 1996, LASER SURG MED, V19, P190; Aoki A, 1998, J DENT RES, V77, P1404, DOI 10.1177/00220345980770060501; AOKI A, 1994, J PERIODONTOL, V65, P1097, DOI 10.1902/jop.1994.65.12.1097; Aoki A, 2000, J PERIODONTAL RES, V35, P266, DOI 10.1034/j.1600-0765.2000.035005266.x; Apel C, 2004, PHOTOMED LASER SURG, V22, P312; Apel C, 2005, CARIES RES, V39, P65, DOI 10.1159/000081659; Apel C, 2003, CARIES RES, V37, P34, DOI 10.1159/000068228; Apel C, 2002, LASER MED SCI, V17, P246, DOI 10.1007/s101030200036; Apel C, 2002, LASER MED SCI, V17, P253, DOI 10.1007/s101030200037; Apel C, 2002, LASER SURG MED, V30, P337, DOI 10.1002/lsm.10058; Armengol V, 2000, J ENDODONT, V26, P138, DOI 10.1097/00004770-200003000-00002; Armengol V, 2002, LASER MED SCI, V17, P93, DOI 10.1007/s101030200016; Attrill DC, 2004, J DENT, V32, P35, DOI 10.1016/S0300-5712(03)00137-4; Borsatto MC, 2001, J CLIN LASER MED SUR, V19, P83, DOI 10.1089/104454701750285403; Burnett LH, 2001, J CLIN LASER MED SUR, V19, P199, DOI 10.1089/104454701316918970; Burnett LH, 2004, PHOTOMED LASER SURG, V22, P351, DOI 10.1089/pho.2004.22.351; Camerlingo C, 2004, J DENT, V32, P399, DOI 10.1016/j.jdent.2004.01.011; Cavalcanti BN, 2003, J PROSTHET DENT, V90, P447, DOI 10.1016/j.prosdent.2003.08.022; Ceballos L, 2002, J DENT RES, V81, P119, DOI 10.1177/154405910208100207; Ceballos L, 2001, AM J DENT, V14, P46; Ceballos L, 2001, DENT MATER, V17, P340, DOI 10.1016/S0109-5641(00)00092-0; Corona SAM, 2003, J ORAL REHABIL, V30, P1008, DOI 10.1046/j.1365-2842.2003.01173.x; Corona SAM, 2001, OPER DENT, V26, P491; de Souza AE, 2004, J DENT, V32, P269, DOI 10.1016/j.jdent.2003.12.003; Delbem ACB, 2003, J CLIN LASER MED SUR, V21, P197, DOI 10.1089/104454703768247765; Dostalova T, 1997, J Clin Laser Med Surg, V15, P117; Dostalova T, 2002, J CLIN LASER MED SUR, V20, P135, DOI 10.1089/104454702760090218; Eberhard J, 2003, J CLIN PERIODONTOL, V30, P511, DOI 10.1034/j.1600-051X.2003.00052.x; Eguro T, 2002, LASER SURG MED, V30, P267, DOI 10.1002/lsm.10043; Eguro T, 2001, LASER SURG MED, V28, P365, DOI 10.1002/lsm.1063; Feist IS, 2003, J PERIODONTOL, V74, P1368, DOI 10.1902/jop.2003.74.9.1368; Folwaczny M, 2001, J CLIN PERIODONTOL, V28, P220, DOI 10.1034/j.1600-051x.2001.028003220.x; Folwaczny M, 2003, J PERIODONTOL, V74, P360, DOI 10.1902/jop.2003.74.3.360; Folwaczny M, 2000, J PERIODONTOL, V71, P147, DOI 10.1902/jop.2000.71.2.147; Glockner K, 1998, J CLIN LASER MED SUR, V16, P153, DOI 10.1089/clm.1998.16.153; Goncalves M, 2003, J CLIN LASER MED SUR, V21, P105, DOI 10.1089/104454703765035538; Goncalves M, 2002, J CLIN LASER MED SUR, V20, P89, DOI 10.1089/104454702753768070; Groth E B, 2001, Eur J Prosthodont Restor Dent, V9, P73; HIBST R, 1989, LASER SURG MED, V9, P338, DOI 10.1002/lsm.1900090405; Hibst R, 2002, J ORAL LASER APPL, V2, P203; Hoke J A, 1990, J Laser Appl, V2, P61, DOI 10.2351/1.4745270; Hossain M, 2000, J CLIN LASER MED SUR, V18, P61, DOI 10.1089/clm.2000.18.61; Hossain M, 2003, LASER MED SCI, V18, P25, DOI 10.1007/s10103-002-0235-5; Hossain M, 2003, J CLIN LASER MED SUR, V21, P29, DOI 10.1089/10445470360516716; Hossain M, 1999, J CLIN LASER MED SUR, V17, P105, DOI 10.1089/clm.1999.17.105; Inoue H, 2004, ORAL SURG ORAL MED O, V97, P246, DOI 10.1016/S1079-2104(03)00474-8; Ishizaka Y, 2002, LASER SURG MED, V31, P171, DOI 10.1002/lsm.10061; Jayawardena JA, 2001, ORAL SURG ORAL MED O, V91, P222, DOI 10.1067/moe.2001.111943; Jelinkova H, 1999, J CLIN LASER MED SUR, V17, P267, DOI 10.1089/clm.1999.17.267; Kameyama A, 2000, Bull Tokyo Dent Coll, V41, P43, DOI 10.2209/tdcpublication.41.43; Kameyama A, 2002, J ORAL REHABIL, V29, P749, DOI 10.1046/j.1365-2842.2002.00954.x; Kameyama A, 2000, J Adhes Dent, V2, P297; Keller U, 1997, LASER SURG MED, V20, P32, DOI 10.1002/(SICI)1096-9101(1997)20:1<32::AID-LSM5>3.0.CO;2-#; Keller U, 1998, J DENT, V26, P649, DOI 10.1016/S0300-5712(97)00036-5; Kesler G, 2002, J CLIN LASER MED SUR, V20, P269, DOI 10.1089/10445470260420786; Khan MFR, 1998, J CLIN LASER MED SUR, V16, P305, DOI 10.1089/clm.1998.16.305; Kim ME, 2003, J CLIN LASER MED SUR, V21, P139, DOI 10.1089/104454703321895581; Kimura Y, 2003, J CLIN LASER MED SUR, V21, P345, DOI 10.1089/104454703322650149; Kimura Y, 2001, J ENDODONT, V27, P567, DOI 10.1097/00004770-200109000-00003; Kohara EK, 2002, J CLIN LASER MED SUR, V20, P141, DOI 10.1089/104454702760090227; Kreisler M, 2002, J PERIODONTOL, V73, P1292, DOI 10.1902/jop.2002.73.11.1292; Krejci I, 1992, Schweiz Monatsschr Zahnmed, V102, P693; Lee BS, 2003, ANGLE ORTHOD, V73, P565; Lizarelli RDZ, 2003, LASER SURG MED, V33, P132, DOI 10.1002/lsm.10196; Lizarelli RFZ, 2004, J CLIN LASER MED SUR, V22, P51, DOI 10.1089/104454704773660976; Luka M., 2004, J ORAL LASER APPL, V4, P171; Lupi-Pegurier Laurence, 2003, J Dent Child (Chic), V70, P134; LUTZ F, 1976, ADHESIVE DENT; Martinez-Insua A, 2000, J PROSTHET DENT, V84, P280, DOI 10.1067/mpr.2000.108600; Matson JR, 2002, J CLIN LASER MED SUR, V20, P27, DOI 10.1089/104454702753474986; Matsumoto K, 1996, J Clin Laser Med Surg, V14, P123; Matsuoka E, 1998, J CLIN LASER MED SUR, V16, P255, DOI 10.1089/clm.1998.16.255; Mehl A, 1999, J ENDODONT, V25, P490, DOI 10.1016/S0099-2399(99)80288-X; Mercer CE, 2003, BRIT DENT J, V194, P99, DOI 10.1038/sj.bdj.4809883; Moritz A, 1999, J CLIN LASER MED SUR, V17, P161, DOI 10.1089/clm.1999.17.161; Moritz A, 1996, J Clin Laser Med Surg, V14, P133; Nair PNR, 2003, LASER SURG MED, V32, P203, DOI 10.1002/lsm.10155; Niu WD, 1998, J CLIN LASER MED SUR, V16, P227, DOI 10.1089/clm.1998.16.227; Oelgiesser D, 2003, AM J DENT, V16, P96; Otsuki M, 2002, LASER SURG MED, V30, P351, DOI 10.1002/lsm.10049; Pecora JD, 2000, LASER SURG MED, V26, P277, DOI 10.1002/(SICI)1096-9101(2000)26:3<277::AID-LSM5>3.0.CO;2-M; Perin Fernanda M, 2004, Aust Endod J, V30, P20; Pioch T, 1998, EUR J ORAL SCI, V106, P600, DOI 10.1046/j.0909-8836..t01-3-.x; Quo BC, 2002, J DENT, V30, P141, DOI 10.1016/S0300-5712(02)00011-8; Ramos RP, 2002, LASER SURG MED, V31, P164, DOI 10.1002/lsm.10106; Roebuck E M, 2001, Int J Paediatr Dent, V11, P49, DOI 10.1046/j.1365-263x.2001.00230.x; ROTH KKF, 1991, THESIS U HAMBURG HAM, P118; Sasaki KM, 2002, LASER SURG MED, V31, P79, DOI 10.1002/lsm.10074; Schoop U, 2004, LASER SURG MED, V35, P111, DOI 10.1002/lsm.20026; Schoop U, 2002, LASER SURG MED, V30, P360, DOI 10.1002/lsm.10054; Schwarz F, 2002, J CLIN PERIODONTOL, V29, P211, DOI 10.1034/j.1600-051x.2002.290305.x; Schwarz F, 2003, LASER SURG MED, V33, P140, DOI 10.1002/lsm.10201; Schwarz F, 2003, LASER SURG MED, V32, P359, DOI 10.1002/lsm.10179; Schwarz F, 2003, J CLIN PERIODONTOL, V30, P26, DOI 10.1034/j.1600-051X.2003.300105.x; Schwarz F, 2001, J PERIODONTOL, V72, P361, DOI 10.1902/jop.2001.72.3.361; Schwarz F, 2003, J PERIODONTOL, V74, P590, DOI 10.1902/jop.2003.74.5.590; Setien VJ, 2001, AM J DENT, V14, P157; Shigetani Y, 2002, DENT MATER J, V21, P238, DOI 10.4012/dmj.21.238; Staninec M, 2003, LASER SURG MED, V33, P264, DOI 10.1002/lsm.10229; Stiesch-Scholz M, 2000, J Adhes Dent, V2, P213; STRASSL M, 2004, J ORAL LASER APPL, V4, P263; Swift Edward J Jr, 2004, Compend Contin Educ Dent, V25, P95; Takamori K, 2003, LASER SURG MED, V32, P25, DOI 10.1002/lsm.10140; Takeda FH, 1998, J CLIN LASER MED SUR, V16, P117, DOI 10.1089/clm.1998.16.117; Takeda FH, 1999, INT ENDOD J, V32, P32, DOI 10.1046/j.1365-2591.1999.00182.x; Takeda FH, 1998, ENDOD DENT TRAUMATOL, V14, P270; Tokonabe H, 1999, J CLIN LASER MED SUR, V17, P7, DOI 10.1089/clm.1999.17.7; Van Meerbeek B, 2003, OPER DENT, V28, P647; Visuri SR, 1996, J DENT RES, V75, P599, DOI 10.1177/00220345960750011401; Visuri SR, 1996, LASER SURG MED, V18, P294, DOI 10.1002/(SICI)1096-9101(1996)18:3<294::AID-LSM11>3.0.CO;2-6; WALSH JT, 1994, LASER SURG MED, V15, P295, DOI 10.1002/lsm.1900150310; Yamada Y, 2002, Eur J Paediatr Dent, V3, P39; Yamasaki T., 2000, Materials Physics and Mechanics, V1, P127; Ying D, 2004, J DENT, V32, P41, DOI 10.1016/S0300-5712(03)00138-6; Zharikov E. V., 1975, Soviet Journal of Quantum Electronics, V4, P1039, DOI 10.1070/QE1975v004n08ABEH011147	116	72	72	2	17	MOSHER & LINDER, INC	WESTON	318 INDIAN TRACE SUITE 500, WESTON, FL 33326 USA	0894-8275			AM J DENT	Am. J. Dent.	JUN	2006	19	3					178	186					9	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	057FR	WOS:000238582200011	16838484				2022-03-04	
J	Mombelli, A; Brochut, P; Plagnat, D; Casagni, F; Giannopoulou, C				Mombelli, A; Brochut, P; Plagnat, D; Casagni, F; Giannopoulou, C			Enamel matrix proteins and systemic antibiotics as adjuncts to non-surgical periodontal treatment: clinical effects	JOURNAL OF CLINICAL PERIODONTOLOGY			English	Article						amoxicillin; chronic periodontitis; enamel matrix proteins; metronidazole; non-surgical periodontal treatment	ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; PARALLELING INSTRUMENT; DERIVATIVE EMDOGAIN(R); REGENERATIVE THERAPY; INTRABONY DEFECTS; DEBRIDEMENT; GINGIVALIS	Objectives: The purpose of the present study was to evaluate the clinical effects of non-surgical periodontal treatment, supplemented with enamel matrix derivative (EMD) and/or systemic antibiotics, in deep periodontal pockets of patients with chronic periodontitis. Methods: This was a randomized, placebo-controlled longitudinal clinical trial of 12 months duration. Using a split-mouth design, 16 subjects were randomly assigned to scaling and root planing (SRP) with EMD or placebo in contra-lateral dentition areas. One half of the subjects received 250 mg metronidazole and 375 mg amoxicillin three times a day for 7 days and the other half received a placebo. One inter-proximal periodontal lesion was chosen as study site in each of the contra-lateral quadrants. Results: Subjects treated with systemic antibiotics yielded significantly better clinical results than those treated with placebo. In these cases, probing pocket depth was reduced significantly more after 6 months (3.0 +/- 2.1 mm versus 1.6 +/- 1.4 mm, p=0.05), and the mean clinical attachment gain was significantly greater after 6 months (2.3 +/- 1.9 mm versus 0.7 +/- 1.6 mm, p=0.02) and 12 months (2.3 +/- 3.5 mm versus 0.4 +/- 3.8 mm, p=0.02). Sites treated with the antibiotics plus EMD gained the largest amount of clinical attachment. There was no significant benefit of EMD adjunctive to SRP in subjects not treated with antibiotics. Conclusions: The present study supports the notion that optimal repair and regeneration of the periodontium requires suppression of the microbiota causing periodontal disease.	Univ Geneva, Sch Dent Med, CH-1211 Geneva, Switzerland		Mombelli, A (corresponding author), Univ Geneva, Sch Dent Med, 19 Rue Barthelemy Menn, CH-1211 Geneva, Switzerland.	Andrea.mombelli@medecine.unige.ch					Arweiler Nicole Birgit, 2002, Clin Oral Investig, V6, P205, DOI 10.1007/s00784-002-0185-0; BLOMLOF J, 1995, EUR J ORAL SCI, V103, P17, DOI 10.1111/j.1600-0722.1995.tb00005.x; Blomlof JPS, 1996, J PERIODONTOL, V67, P841, DOI 10.1902/jop.1996.67.9.841; CAFFESSE RG, 1986, J CLIN PERIODONTOL, V13, P205, DOI 10.1111/j.1600-051X.1986.tb01461.x; DIX K, 1990, J CLIN MICROBIOL, V28, P319, DOI 10.1128/JCM.28.2.319-323.1990; Dornier C, 2004, DENTOMAXILLOFAC RAD, V33, P220, DOI 10.1259/dmfr/71716997; DUBREZ B, 1995, ORAL SURG ORAL MED O, V80, P358, DOI 10.1016/S1079-2104(05)80395-6; GRAF JM, 1988, ORAL SURG ORAL MED O, V66, P502, DOI 10.1016/0030-4220(88)90278-2; Gutierrez MA, 2003, J CLIN PERIODONTOL, V30, P739, DOI 10.1034/j.1600-051X.2003.00374.x; Hammarstrom L, 1997, J CLIN PERIODONTOL, V24, P669, DOI 10.1111/j.1600-051X.1997.tb00248.x; Heijl L, 1997, J CLIN PERIODONTOL, V24, P705, DOI 10.1111/j.1600-051X.1997.tb00253.x; Heijl L, 1997, J CLIN PERIODONTOL, V24, P693, DOI 10.1111/j.1600-051X.1997.tb00251.x; Herrera D, 2002, J CLIN PERIODONTOL, V29, P136, DOI 10.1034/j.1600-051X.29.s3.8.x; LOE HARALD, 1963, ACTA ODONTOL SCAND, V21, P533, DOI 10.3109/00016356309011240; Mellonig JT, 1999, INT J PERIODONT REST, V19, P9; MOMBELLI A, 1994, J PERIODONTOL, V65, P820, DOI 10.1902/jop.1994.65.9.820; Mombelli A, 2000, J PERIODONTOL, V71, P14, DOI 10.1902/jop.2000.71.1.14; RENVERT S, 1990, J CLIN PERIODONTOL, V17, P345, DOI 10.1111/j.1600-051X.1990.tb00029.x; Rooney J, 2002, J CLIN PERIODONTOL, V29, P342, DOI 10.1034/j.1600-051X.2002.290410.x; Sculean A, 1999, INT J PERIODONT REST, V19, P157; Sculean A, 1999, J PERIODONTAL RES, V34, P310, DOI 10.1111/j.1600-0765.1999.tb02259.x; Sculean A, 2001, J CLIN PERIODONTOL, V28, P1074, DOI 10.1034/j.1600-051X.2001.281113.x; SILNESS J, 1964, Acta Odontol Scand, V22, P121, DOI 10.3109/00016356408993968; Spahr A, 2002, J CLIN PERIODONTOL, V29, P62, DOI 10.1034/j.1600-051x.2002.290110.x; Tonetti MS, 2002, J CLIN PERIODONTOL, V29, P317, DOI 10.1034/j.1600-051X.2002.290407.x; Van der Weijden GA, 2002, J CLIN PERIODONTOL, V29, P55, DOI 10.1034/j.1600-051X.29.s3.3.x; WAERHAUG J, 1978, J PERIODONTOL, V49, P119, DOI 10.1902/jop.1978.49.3.119; Yukna RA, 2000, J PERIODONTOL, V71, P752, DOI 10.1902/jop.2000.71.5.752	28	48	50	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0303-6979	1600-051X		J CLIN PERIODONTOL	J. Clin. Periodontol.	MAR	2005	32	3					225	230		10.1111/j.1600-051X.2005.00664.x			6	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	904YH	WOS:000227534000002	15766363				2022-03-04	
J	de Courten, A; Kuffer, R; Samson, J; Lombardi, T				de Courten, A; Kuffer, R; Samson, J; Lombardi, T			Anterior lingual mandibular salivary gland defect (Stafne defect) presenting as a residual cyst	ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS			English	Article							BONE CAVITY; CONCAVITY; TISSUE	Lingual mandibular salivary gland inclusion (Stafne defect) is a developmental anomaly represented by a bone concavity usually containing submandibular gland tissue. The posterior mandible region, particularly at the angle and below the mandibular canal, is the common location, and the anterior mandibular variants occur rather seldom. The latter is usually observed in the premolar and cuspid region, or more rarely in the symphysis, as a round or ovoid radiolucency sometimes appearing superimposed over the teeth's apices, resembling a true cystic lesion or an odontogenic tumor. We report an additional case of anterior lingual mandibular salivary gland defect occurring in a 42-year-old white man. It presented as an asymptomatic radiolucency located on the left side of the mandible, in the region of an absent second premolar and first molar, above the alveolar canal, mimicking a residual cyst. Histopathologic examination of the "cyst" content revealed the absence of a cyst lining and the presence of normal sublingual gland tissue.	Univ Geneva, Sch Dent Med, Div Stomatol & Oral Surg, Lab Oral Histopathol,Fac Med, CH-1211 Geneva 4, Switzerland		Lombardi, T (corresponding author), Univ Geneva, Sch Dent Med, Div Stomatol & Oral Surg, Lab Oral Histopathol,Fac Med, 19,Rue Barthelemy Menn, CH-1211 Geneva 4, Switzerland.						ABRAMSON AS, 1966, J AM DENT ASSOC, V73, P1114, DOI 10.14219/jada.archive.1966.0335; ANNEROTH G, 1990, INT J ORAL MAX SURG, V19, P74, DOI 10.1016/S0901-5027(05)80198-5; Apruzzese D, 1999, J ORAL MAXIL SURG, V57, P333, DOI 10.1016/S0278-2391(99)90684-5; ARAICHE M, 1959, Oral Surg Oral Med Oral Pathol, V12, P727, DOI 10.1016/0030-4220(59)90119-7; BARAK S, 1993, BRIT J ORAL MAX SURG, V31, P318, DOI 10.1016/0266-4356(93)90070-D; BERGENHOLTZ A, 1963, Oral Surg Oral Med Oral Pathol, V16, P703, DOI 10.1016/0030-4220(63)90077-X; Bouquot JE, 2000, ORAL SURG ORAL MED O, V90, P205, DOI 10.1067/moe.2000.107058; Branstetter BF, 1999, AM J NEURORADIOL, V20, P587; BUCHNER A, 1991, ORAL SURG ORAL MED O, V71, P131, DOI 10.1016/0030-4220(91)90452-I; Camilleri G, 1963, BR DENT J, V114, P515; CHILDERS ELB, 1990, J AM DENT ASSOC, V121, P759, DOI 10.14219/jada.archive.1990.0263; CHOUKAS N C, 1960, J Oral Surg Anesth Hosp Dent Serv, V18, P16; CONNOR MS, 1979, ORAL SURG ORAL MED O, V48, P413, DOI 10.1016/0030-4220(79)90069-0; FORREST WR, 1974, ORAL SURG ORAL MED O, V37, P653, DOI 10.1016/0030-4220(74)90299-0; FRIEDMAN JEROME, 1964, ORAL SURG ORAL MED ORAL PATHOL, V18, P219, DOI 10.1016/0030-4220(64)90430-X; GOSNEY MBE, 1981, BRIT DENT J, V151, P381, DOI 10.1038/sj.bdj.4804711; GRELLNER TJ, 1990, J ORAL MAXIL SURG, V48, P288, DOI 10.1016/0278-2391(90)90396-J; HAYASHI Y, 1984, ORAL SURG ORAL MED O, V57, P139, DOI 10.1016/0030-4220(84)90199-3; Katz J, 2001, J ENDODONT, V27, P304, DOI 10.1097/00004770-200104000-00020; LAYNE EL, 1981, J ORAL SURG, V39, P599; Malkin M, 1974, N Y State Dent J, V40, P17; MILLER AS, 1971, ORAL SURG ORAL MED O, V31, P790, DOI 10.1016/0030-4220(71)90135-6; MILLER AS, 1986, GEN DENT, V6, P491; MIZUNO A, 1983, INT J ORAL MAXILLOF, V12, P64, DOI 10.1016/S0300-9785(83)80083-0; PALLADINO VS, 1965, J AM DENT ASSOC, V70, P388, DOI 10.14219/jada.archive.1965.0280; PLEZIA RA, 1977, ORAL SURG ORAL MED O, V43, P979, DOI 10.1016/0030-4220(77)90092-5; RICHARD E L, 1957, Oral Surg Oral Med Oral Pathol, V10, P1086, DOI 10.1016/0030-4220(57)90059-2; SALMAN L, 1986, J ORAL MED, V1, P239; Salman L, 1991, COMPENDIUM, V12, P42; SAMSON J, 1982, REV STOMATOL CHIR, V83, P13; Samson J, 1983, SSO Schweiz Monatsschr Zahnheilkd, V93, P1138; SANDY JR, 1981, BRIT J ORAL SURG, V19, P223, DOI 10.1016/0007-117X(81)90008-1; Seward G.R., 1960, BRIT DENT J, V108, P321; Stafne E. C., 1942, JOUR AMER DENTAL ASSOC, V29, P1969; STENE T, 1977, ORAL SURG ORAL MED O, V44, P72, DOI 10.1016/0030-4220(77)90246-8; STROM C, 1987, ORAL SURG ORAL MED O, V64, P159, DOI 10.1016/0030-4220(87)90082-X; THOMA K. H., 1955, ORAL SURG ORAL MED AND ORAL PATHOL, V8, P963, DOI 10.1016/0030-4220(55)90296-6; Tominaga K, 1990, Dentomaxillofac Radiol, V19, P28	38	37	39	0	3	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	1079-2104			ORAL SURG ORAL MED O	Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod.	OCT	2002	94	4					460	464		10.1067/moe.2002.125196			5	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	602KF	WOS:000178503900013	12374920				2022-03-04	
J	Dietschi, D; Krejci, I				Dietschi, D; Krejci, I			Adhesive restorations in posterior teeth: Rationale for the application of direct techniques	OPERATIVE DENTISTRY			English	Article; Proceedings Paper	International Symposium on Management Alternatives of the Carious Lesion	SEP 15-17, 2000	CHARLESTON, SC	Dentsply Int, ESPE, Procter & Gamble, Heraneus Kulzer, 3M, BISCO, GC, Ivoclar, Kerr Corp, Shofu, Ultradent			POLYMERIZATION CONTRACTION STRESS; RESIN COMPOSITE RESTORATIONS; BOND STRENGTHS; DENTAL COMPOSITES; SYSTEMS; ADAPTATION; LIGHT	Material properties as well as the clinician's ability to control the development of detrimental polymerization shrinkage stresses govern the behavior and quality of direct composite restorations in posterior teeth. In addition to the use of a strong adhesive, many other compensatory factors can help to achieve a good adaptation. Among the most important ones may be the application of a thick bonding resin layer or the application of a "soft" base-liner, the use of multilayer techniques and the application of the "selective" bonding concept. Understanding the principles of composite polymerization and stress development in the tooth-restoration complex is a prerequisite for achieving optimal results.	Univ Geneva, Sch Dent, Dept Cardiol Endodont & Pedodont, CH-1205 Geneva, Switzerland		Dietschi, D (corresponding author), Univ Geneva, Sch Dent, Dept Cardiol Endodont & Pedodont, 19 Rue Barthelemy Menn, CH-1205 Geneva, Switzerland.						BINDI G, 1998, THESIS U GENEVA GENE; BOWEN RL, 1983, J AM DENT ASSOC, V106, P475, DOI 10.14219/jada.archive.1983.0078; Choi KK, 2000, J DENT RES, V79, P812, DOI 10.1177/00220345000790030501; Davidson C L, 1994, J Esthet Dent, V6, P223, DOI 10.1111/j.1708-8240.1994.tb00863.x; DAVIDSON CL, 1984, J DENT RES, V63, P1396, DOI 10.1177/00220345840630121101; DAVIDSON CL, 1984, J DENT RES, V63, P146, DOI 10.1177/00220345840630021001; DEGEE AJ, 1993, DENT MATER, V9, P11, DOI 10.1016/0109-5641(93)90097-A; Dietschi D, 1998, EUR J ORAL SCI, V106, P1033, DOI 10.1046/j.0909-8836.1998.eos106609.x; Dietschi D, 1997, ADHESIVE METAL FREE, P60; FEILZER AJ, 1987, J DENT RES, V66, P1636, DOI 10.1177/00220345870660110601; Friedl KH, 1997, OPER DENT, V22, P21; Hannig M, 1997, J DENT RES, V76, P2403; KEMPSCHOLTE CM, 1990, J PROSTHET DENT, V64, P658, DOI 10.1016/0022-3913(90)90291-J; KEMPSCHOLTE CM, 1990, J DENT RES, V69, P1240, DOI 10.1177/00220345900690060301; Krejci I, 2000, Pract Periodontics Aesthet Dent, V12, P727; Krejci I, 1993, Schweiz Monatsschr Zahnmed, V103, P973; LEUNG RL, 1983, J DENT RES, V62, P219; Lutz F, 1986, Quintessence Int, V17, P659; Lutz F, 1980, SSO Schweiz Monatsschr Zahnheilkd, V90, P455; May KN, 1997, AM J DENT, V10, P195; Myers M L, 1994, J Prosthodont, V3, P149; OLSBURGH S, 2000, THESIS U GENEVA GENE; Rueggeberg F A, 1993, Am J Dent, V6, P91; Rueggeberg F A, 1993, Int J Prosthodont, V6, P364; Rueggeberg F A, 1994, Int J Prosthodont, V7, P159; Rueggeberg F A, 1999, J Esthet Dent, V11, P197, DOI 10.1111/j.1708-8240.1999.tb00399.x; RUEGGEBERG FA, 1994, OPER DENT, V19, P26; Simonsen R J, 1985, Quintessence Int, V16, P15; STAVRIDAKIS M, IN PRESS ODONTOSTOMA; Tanumiharja M, 2000, DENT MATER, V16, P180, DOI 10.1016/S0109-5641(00)00007-5; Versluis A, 1998, J DENT RES, V77, P1435, DOI 10.1177/00220345980770060801; Versluis A, 1997, J DENT RES, V76, P1298, DOI 10.1177/00220345970760061001; Wakefield CW, 1998, OPER DENT, V23, P69; Weaver W S, 1988, Gen Dent, V36, P236; Wilder AD, 1998, AM J DENT, V11, P114; [No title captured]	36	6	6	0	4	OPERATIVE DENTISTRY INC	INDIANAPOLIS	INDIANA UNIV SCHOOL DENTISTRY, ROOM S411, 1121 WEST MICHIGAN ST, INDIANAPOLIS, IN 46202-5186 USA	0361-7734	1559-2863		OPER DENT	Oper. Dent.	AUG	2001				6			191	197					7	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Dentistry, Oral Surgery & Medicine	467VP	WOS:000170724700018					2022-03-04	
J	Zekeridou, A; Mombelli, A; Cancela, J; Courvoisier, D; Giannopoulou, C				Zekeridou, Alkisti; Mombelli, Andrea; Cancela, Jose; Courvoisier, Delphine; Giannopoulou, Catherine			Systemic inflammatory burden and local inflammation in periodontitis: What is the link between inflammatory biomarkers in serum and gingival crevicular fluid?	CLINICAL AND EXPERIMENTAL DENTAL RESEARCH			English	Article						cytokines; periodontal disease; periodontal treatment; serum	C-REACTIVE PROTEIN; NECROSIS-FACTOR-ALPHA; CYTOKINE LEVELS; VISFATIN CONCENTRATION; TNF-ALPHA; THERAPY; ASSOCIATION; HEALTH; DISEASE; MARKERS	In periodontitis patients, high levels of several inflammatory markers may be expressed in serum, reflecting the effect of local disease on the general health. The objective of the present analysis was to compare cytokine levels assessed in peripheral blood with those in the gingival crevicular fluid (GCF) and evaluate the impact of nonsurgical periodontal therapy on the incidence of high levels of 12 biomarkers in serum. Twenty-four patients with chronic periodontitis (Group P) contributed with serum and GCF samples at baseline (BL) and 1 and 3 months after periodontal treatment (M1 and M3). Samples were assessed for 12 cytokines using the Bio-Plex bead array multianalyte detection system. For each analyte, peak values were calculated as greater than the mean + 2SD of the one found in 60 periodontally healthy participants. Significant correlations between serum and GCF values were obtained in the periodontitis group for interleukin (IL) 1ra, IL-6, and interferon gamma at BL and for macrophage inflammatory protein 1 beta at M3 after treatment. Periodontitis subjects were found to exhibit high peaks for several inflammatory markers in serum. The highest incidence of peaks at BL was found for interferon gamma (37.5% of the periodontitis subjects). For the four biomarkers with a detection frequency of >75% at BL (IL-1ra, IL-8, macrophage inflammatory protein 1 beta, and vascular endothelial growth factor), no significant difference was observed over time for the P group or between the two groups at BL. The significant correlation found between the serum and the GCF for certain cytokines and the fact that periodontitis subjects exhibit high peaks for several inflammatory markers in serum may support the hypothesis that the inflammatory reaction due to periodontitis is not restricted to the diseased sites. Within the limitations of the study, periodontal therapy did not seem to have any significant impact on the systemic cytokine levels.	[Zekeridou, Alkisti; Mombelli, Andrea; Cancela, Jose; Courvoisier, Delphine; Giannopoulou, Catherine] Univ Geneva, Univ Clin Dent Med, Div Periodontol, 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland		Zekeridou, A (corresponding author), Univ Geneva, Univ Clin Dent Med, Div Periodontol, 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland.	alkisti.zekeridou@unige.ch					Almaghlouth A, 2011, J DENT RES, V90, P2982; Almaghlouth AA, 2014, CLIN ORAL INVEST, V18, P2113, DOI 10.1007/s00784-014-1187-4; Armitage G C, 1999, Ann Periodontol, V4, P1, DOI 10.1902/annals.1999.4.1.1; Baltacioglu E, 2008, ARCH ORAL BIOL, V53, P716, DOI 10.1016/j.archoralbio.2008.02.002; Behle JH, 2009, J CLIN PERIODONTOL, V36, P287, DOI 10.1111/j.1600-051X.2009.01382.x; Bretz WA, 2005, J AM GERIATR SOC, V53, P1532, DOI 10.1111/j.1532-5415.2005.53468.x; Buduneli N, 2011, J CLIN PERIODONTOL, V38, P85, DOI 10.1111/j.1600-051X.2010.01670.x; Chapple ILC, 2013, J CLIN PERIODONTOL, V40, pS106, DOI [10.1902/jop.2013.1340011, 10.1111/jcpe.12077]; Chen L, 2012, J PERIODONTOL, V83, P435, DOI 10.1902/jop.2011.110327; D'Aiuto F, 2005, J DENT RES, V84, P269, DOI 10.1177/154405910508400312; D'Aiuto F, 2004, J DENT RES, V83, P156, DOI 10.1177/154405910408300214; Dave S, 2008, ORAL DIS, V14, P95, DOI 10.1111/j.1601-0825.2007.01438.x; Elshal MF, 2006, METHODS, V38, P317, DOI 10.1016/j.ymeth.2005.11.010; Fell Robert A, 2013, J Int Acad Periodontol, V15, P20; Figueredo CM, 2011, J PERIODONTAL RES, V46, P141, DOI 10.1111/j.1600-0765.2010.01303.x; Fiorini T, 2013, J PERIODONTAL RES, V48, P126, DOI 10.1111/j.1600-0765.2012.01513.x; Fiorini T, 2012, CYTOKINE, V58, P34, DOI 10.1016/j.cyto.2011.12.015; Geisinger ML, 2016, J PERIODONTOL, V87, P900, DOI 10.1902/jop.2016.150727; Giannopoulou C, 2016, J DENT RES, V95, P349, DOI 10.1177/0022034515618949; Gokul Kalpana, 2012, Indian J Dent Res, V23, P348, DOI 10.4103/0970-9290.102221; Hayes C, 1998, Ann Periodontol, V3, P257, DOI 10.1902/annals.1998.3.1.257; Ide M, 2004, J PERIODONTOL, V75, P420, DOI 10.1902/jop.2004.75.3.420; Ioannidou E, 2006, J PERIODONTOL, V77, P1635, DOI 10.1902/jop.2006.050443; Kinane DF, 2001, PERIODONTOL 2000, V25, P8, DOI 10.1034/j.1600-0757.2001.22250102.x; Leng SX, 2008, J GERONTOL A-BIOL, V63, P879, DOI 10.1093/gerona/63.8.879; LOE H, 1967, J PERIODONTOL, V38, P610, DOI 10.1902/jop.1967.38.6.610; Loos BG, 2000, PERIODONTOL, V2005, P39; Michalowicz BS, 2009, J PERIODONTOL, V80, P1731, DOI 10.1902/jop.2009.090236; Mombelli A., 2015, PARONDONTOLOGIE, V26, P123; Morozumi T, 2018, J PERIODONTAL RES, V53, P536, DOI 10.1111/jre.12543; Noack B, 2017, J PERIODONTAL RES, V52, P824, DOI 10.1111/jre.12450; Offenbacher S, 1996, J PERIODONTOL, V67, P1103, DOI 10.1902/jop.1996.67.10s.1103; Passoja A, 2010, J CLIN PERIODONTOL, V37, P881, DOI 10.1111/j.1600-051X.2010.01602.x; Perunovic ND, 2016, J PERIODONTOL, V87, P248, DOI 10.1902/jop.2015.150364; Pradeep AR, 2011, J PERIODONTOL, V82, P1314, DOI 10.1902/jop.2011.100690; Pradeep AR, 2011, CYTOKINE, V54, P200, DOI 10.1016/j.cyto.2011.02.010; Raghavendra NM, 2012, DIS MARKERS, V32, P383, DOI [10.3233/DMA-2012-0897, 10.1155/2012/828049]; Raj SC, 2018, CONTEMP CLIN DENT, V9, P293, DOI 10.4103/ccd.ccd_51_18; Robati M, 2011, IRAN J IMMUNOL, V8, P170, DOI IJIv8i3A4; Satpathy A, 2015, OBES RES CLIN PRACT, V9, P513, DOI 10.1016/j.orcp.2015.01.005; Teeuw WJ, 2014, J CLIN PERIODONTOL, V41, P70, DOI 10.1111/jcpe.12171; Teeuw WJ, 2010, DIABETES CARE, V33, P421, DOI 10.2337/dc09-1378; Thorat M, 2010, INT J ORAL SCI, V2, P198, DOI 10.4248/IJOS10077; Turer CC, 2017, J PERIODONTOL, V88, P493, DOI 10.1902/jop.2016.160279; Wytrykowska A, 2016, J ORAL SCI, V58, P509, DOI 10.2334/josnusd.16-0278; Yamazaki K, 2005, J PERIODONTAL RES, V40, P53, DOI 10.1111/j.1600-0765.2004.00772.x; Zekeridou A, 2017, CLIN EXP DENT RES, V3, P62, DOI 10.1002/cre2.61; Zheng P, 2006, J CLIN PERIODONTOL, V33, P797, DOI 10.1111/j.1600-051X.2006.00987.x; Zhou SY, 2013, CHIN J DENT RES, V16, P145; Zhu HH, 2015, INT J CLIN EXP PATHO, V8, P2214	50	14	16	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2057-4347			CLIN EXP DENT RES	CLIN. EXP. DENT. RES.	APR	2019	5	2					128	135		10.1002/cre2.162			8	Dentistry, Oral Surgery & Medicine	Emerging Sources Citation Index (ESCI)	Dentistry, Oral Surgery & Medicine	HX1MU	WOS:000467157200005	31049215	gold, Green Published			2022-03-04	
J	Douillard, T; Martinelli-Klay, CP; Lombardi, T				Douillard, T.; Martinelli-Klay, C. P.; Lombardi, Tommaso			Nerve Growth Factor Expression and Its Receptors TrkA and p75NTR in Peri-Implantitis Lesions	IMPLANT DENTISTRY			English	Article						nerve growth factor; TrkA; p75NTR; peri-implantitis; immunohistochemistry	MESSENGER-RNAS; NEUROTROPHINS; CELLS; NGF; P75(NTR); ESTROGEN; AFFINITY	Background: Nerve growth factor (NGF) can, through its receptors TrkA and p75NTR, convey signals for cell survival or cell differentiation. These proteins are also involved in inflammation and in bone resorption. The aim of this study is to evaluate, for the first time, the expression of NGF and its receptors TrkA and p75NTR in peri-implantitis lesions. Materials and Methods: Fifteen biopsy specimens from patients with chronic peri-implantitis and 4 of healthy oral mucosa were immunostained with antibodies against NGF, TrkA, and p75NTR. The staining intensity and percentage of stained cells were semi-quantitatively evaluated and results were compared between the 2 groups. Results: In the peri-implant pocket epithelium and gingival epithelium, NGF and TrkA expressions were similar to the healthy oral mucosa, however, a decreased expression of p75NTR was observed. In all cases, more than 75% of the inflammatory cells stained positively for NGF and TrkA, and p75NTR was negatively expressed. Conclusion: The intense expression of NGF and TrkA in the inflammatory cell infiltrate associated with decreased expression of p75NTR in both gingival and pocket epithelium suggests that these proteins may have a role in peri-implantitis lesions.	[Douillard, T.] Geneva Univ Hosp HUG, Div Oral Maxillofacial Surg, Dept Surg, Oral Med Lab,Oral Maxillofacial Pathol Unit,Oral, CH-1205 Geneva, Switzerland; [Martinelli-Klay, C. P.; Lombardi, Tommaso] Geneva Univ Hosp HUG, Div Oral Maxillofacial Surg, Dept Surg, Oral Med Lab,Oral Maxillofacial Pathol Unit, 19 Rue Barthelemy Menn, CH-1205 Geneva, Switzerland		Lombardi, T (corresponding author), Geneva Univ Hosp HUG, Div Oral Maxillofacial Surg, Dept Surg, Oral Med Lab,Oral Maxillofacial Pathol Unit, 19 Rue Barthelemy Menn, CH-1205 Geneva, Switzerland.	Tommaso.Lombardi@unige.ch	Douillard, Thierry/G-9808-2014	Douillard, Thierry/0000-0001-7113-889X			Aiga A, 2006, ACTA MED OKAYAMA, V60, P267; ALBREKTSSON T, 1994, PROCEEDINGS OF THE 1ST EUROPEAN WORKSHOP ON PERIODONTOLOGY, P365; Allen J, 2005, EXP CELL RES, V304, P69, DOI 10.1016/j.yexcr.2004.10.020; ALOE L, 1994, AUTOIMMUNITY, V19, P141, DOI 10.3109/08916939409009542; Asaumi K, 2000, BONE, V26, P625, DOI 10.1016/S8756-3282(00)00281-7; Barker PA, 2007, NEURON, V53, P1, DOI 10.1016/j.neuron.2006.12.018; Berglundh T, 2011, J CLIN PERIODONTOL, V38, P188, DOI 10.1111/j.1600-051X.2010.01672.x; Cochran DL, 2008, J PERIODONTOL, V79, P1569, DOI 10.1902/jop.2008.080233; Copray S, 2004, J NEUROIMMUNOL, V148, P41, DOI 10.1016/j.jneuroim.2003.11.008; Dechant G, 2001, CELL TISSUE RES, V305, P229, DOI 10.1007/s004410100378; Freund V, 2004, PROG BRAIN RES, V146, P335; Gaspersic R, 2010, J DENT RES, V89, P515, DOI 10.1177/0022034510363108; GIBBS RB, 1994, EXP NEUROL, V129, P70, DOI 10.1006/exnr.1994.1148; Grills BL, 1998, ACTA ORTHOP SCAND, V69, P415, DOI 10.3109/17453679808999059; Groneberg DA, 2005, J NEUROIMMUNOL, V161, P87, DOI 10.1016/j.jneuroim.2004.12.019; Hayashi K, 2008, J ORAL PATHOL MED, V37, P241, DOI 10.1111/j.1600-0714.2007.00627.x; Hayashi K, 2007, EUR J ORAL SCI, V115, P344, DOI 10.1111/j.1600-0722.2007.00480.x; Hemingway F, 2011, BONE, V48, P938, DOI 10.1016/j.bone.2010.12.023; Hermes B, 2003, BRIT J DERMATOL, V148, P411, DOI 10.1046/j.1365-2133.2003.05167.x; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Jin HF, 2007, NEOPLASIA, V9, P471, DOI 10.1593/neo.07175; Jin HF, 2007, MOL CANCER RES, V5, P423, DOI 10.1158/1541-7786.MCR-06-0407; Khwaia FS, 2008, MOL CANCER THER, V7, P3539, DOI 10.1158/1535-7163.MCT-08-0512; Kovacic U, 2013, ARCH ORAL BIOL, V58, P788, DOI 10.1016/j.archoralbio.2013.01.006; Kurihara H, 2003, J PERIODONTOL, V74, P76, DOI 10.1902/jop.2003.74.1.76; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lang NP, 2011, J CLIN PERIODONTOL, V38, P178, DOI 10.1111/j.1600-051X.2010.01674.x; Matsuda H, 1998, J EXP MED, V187, P297, DOI 10.1084/jem.187.3.297; O'Hara AH, 2009, ARCH ORAL BIOL, V54, P871, DOI 10.1016/j.archoralbio.2009.06.003; Oddiah D, 1998, NEUROREPORT, V9, P1455, DOI 10.1097/00001756-199805110-00038; Pincelli C, 1997, JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS, VOL 2, NO 1, AUGUST 1997, P31, DOI 10.1038/jidsymp.1997.8; Rankin SL, 2005, NEUROSCI LETT, V383, P305, DOI 10.1016/j.neulet.2005.04.043; Raychaudhuri SP, 1998, ACTA DERM-VENEREOL, V78, P84; Rezaee F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009690; Shi ZQ, 2006, BIOL REPROD, V74, P850, DOI 10.1095/biolreprod.105.044917; Shikata A, 2000, MED PEDIATR ONCOL, V34, P394, DOI 10.1002/(SICI)1096-911X(200006)34:6<394::AID-MPO3>3.3.CO;2-X; Skaper SD, 2001, MOL NEUROBIOL, V24, P183, DOI 10.1385/MN:24:1-3:183; Stefanato CM, 2003, J CUTAN PATHOL, V30, P351, DOI 10.1034/j.1600-0560.2003.00065.x; Teng KK, 2004, CELL MOL LIFE SCI, V61, P35, DOI 10.1007/s00018-003-3099-3; Vega JA, 2003, J ANAT, V203, P1, DOI 10.1046/j.1469-7580.2003.00203.x; Wang L, 2006, J ORTHOP RES, V24, P2238, DOI 10.1002/jor.20269; Wiesmann C, 2001, CELL MOL LIFE SCI, V58, P748, DOI 10.1007/PL00000898; ZHOU J, 1995, J NEUROCHEM, V65, P1146	43	2	4	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1056-6163			IMPLANT DENT	Implant Dent.	JUN	2016	25	3					373	379		10.1097/ID.0000000000000418			7	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	DN5WI	WOS:000377142000013	27064695	Green Published			2022-03-04	
J	Bortolotto, T; Melian, K; Krejci, I				Bortolotto, Tissiana; Melian, Karla; Krejci, Ivo			Effect of dual-cure composite resin as restorative material on marginal adaptation of Class 2 restorations	QUINTESSENCE INTERNATIONAL			English	Article						amalgam substitute; bulk filling; Class 2 restoration; dual cure; marginal adaptation; self cure	OPEN-SANDWICH RESTORATIONS; POLYMERIZATION SHRINKAGE; CONTRACTION STRESS; FILLING TECHNIQUE; BOND STRENGTHS; IN-VIVO; ADHESIVE; SYSTEMS; ENAMEL; DENTIN	Objective: The present study attempted to find a simple direct adhesive restorative technique for the restoration of Class 2 cavities. Method and Materials: A self-etch adhesive system with a dual-cured core buildup composite resin (paste 1 + paste 2) was evaluated in its ability to restore proximo-occlusal cavities with margins located on enamel and dentin. The groups were: A, cavity filling (cf) with paste 1 (light-curing component) by using a layering technique; B, cf by mixing both pastes, bulk insertion, and dual curing; and C, cf by mixing both pastes, bulk insertion, and chemical curing. Two control groups (D, negative, bulk; and E, positive, layering technique) were included by restoring cavities with a classic three-step etch-and-rinse adhesive and a universal restorative composite resin. SEM margin analysis was performed before and after thermomechanical loading in a chewing simulator. Results: Percentages (mean +/- SD) of "continuous margins" were improved by applying the material in bulk and letting it self cure (54 +/- 6) or dual cure (59 +/- 9), and no significant differences were observed between these two groups and the positive control (44 +/- 19). Conclusion: The present study showed that the dual-cured composite resin tested has the potential to be used as bulk filling material for Class 2 restorations. Clinical relevance: When used as filling materials, dual-cure composite resins placed in bulk can provide marginal adaptation similar to light-cured composites applied with a complex stratification technique.	[Bortolotto, Tissiana; Melian, Karla; Krejci, Ivo] Univ Geneva, Sch Dent, Div Cariol & Endodontol, Rue Barthelemy Menn 19, CH-1205 Geneva, Switzerland		Bortolotto, T (corresponding author), Univ Geneva, Sch Dent, Div Cariol & Endodontol, Rue Barthelemy Menn 19, CH-1205 Geneva, Switzerland.	Tissiana.Bortolotto@unige.ch	Bortolotto, Tissiana/AAE-2796-2021	Bortolotto, Tissiana/0000-0002-3231-9097			Aksornmuang J, 2006, AM J DENT, V19, P51; Andersson-Wenckert IE, 2004, AM J DENT, V17, P43; Atlas AM, 2009, QUINTESSENCE INT, V40, P471; Bolhuis P, 2004, QUINTESSENCE INT, V35, P657; Bolhuis PB, 2006, DENT MATER, V22, P223, DOI 10.1016/j.dental.2005.03.016; Bortolotto T, 2007, CLIN ORAL INVEST, V11, P35, DOI 10.1007/s00784-006-0076-x; Bortolotto T, 2007, AM J DENT, V20, P83; Bortolotto T, 2009, CLIN ORAL INVEST, V13, P409, DOI 10.1007/s00784-008-0242-4; CAUGHMAN WF, 1991, BIOMATERIALS, V12, P737, DOI 10.1016/0142-9612(91)90022-3; Dietschi D, 2002, J DENT, V30, P259, DOI 10.1016/S0300-5712(02)00041-6; Dietschi D, 2001, OPER DENT, P191; Feng L, 2006, J BIOMED MATER RES B, V76B, P196, DOI 10.1002/jbm.b.30355; FERRACANE JL, 1986, J BIOMED MATER RES, V20, P121, DOI 10.1002/jbm.820200111; Giachetti Luca, 2006, J Contemp Dent Pract, V7, P79; Koubi S, 2009, OPER DENT, V34, P150, DOI 10.2341/08-29; KREJCI I, 1993, J DENT RES, V72, P490, DOI 10.1177/00220345930720020401; Kuijs RH, 2003, J DENT RES, V82, P967, DOI 10.1177/154405910308201206; Loguercio AD, 2004, J DENT, V32, P459, DOI 10.1016/j.jdent.2004.02.010; Loher H, 2009, CLIN ORAL INVEST, V13, P217, DOI 10.1007/s00784-008-0215-7; Lutz F, 1999, COMPEND CONTIN ED DE, V20, P1146; Opdam NJM, 1998, J DENT, V26, P555, DOI 10.1016/S0300-5712(97)00042-0; Park J, 2008, DENT MATER, V24, P1501, DOI 10.1016/j.dental.2008.03.013; Peutzfeldt A, 1997, EUR J ORAL SCI, V105, P97, DOI 10.1111/j.1600-0722.1997.tb00188.x; Ritter AV, 2009, J DENT, V37, P59, DOI 10.1016/j.jdent.2008.09.006; Shimada Y, 2003, OPER DENT, V28, P20; Taubock TT, 2010, EUR J ORAL SCI, V118, P423, DOI 10.1111/j.1600-0722.2010.00746.x; van Dijken JWV, 1998, AM J DENT, V11, P165	27	2	2	2	13	QUINTESSENCE PUBLISHING CO INC	HANOVER PARK	4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA	0033-6572	1936-7163		QUINTESSENCE INT	Quintessence Int.	OCT	2013	44	9					663	672		10.3290/j.qi.a29751			10	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	287DI	WOS:000329520000003	23757460				2022-03-04	
J	Solano-Hernandez, B; Antonarakis, GS; Scolozzi, P; Kiliaridis, S				Solano-Hernandez, Belen; Antonarakis, Gregory Stylianos; Scolozzi, Paolo; Kiliaridis, Stavros			Combined Orthodontic and Orthognathic Surgical Treatment for the Correction of Skeletal Anterior Open-Bite Malocclusion: A Systematic Review on Vertical Stability	JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Review							LE-FORT-I; LONG-TERM STABILITY; SAGITTAL SPLIT; FOLLOW-UP; DENTOALVEOLAR STABILITY; AMELOGENESIS IMPERFECTA; BIMAXILLARY OSTEOTOMIES; MAXILLARY OSTEOTOMY; INTERNAL-FIXATION; BONE PLATE	Purpose: To evaluate vertical stability after combined orthodontic surgical treatment of skeletal anterior open-bite malocclusion. Materials and Methods: A literature search was performed to locate studies pertaining to vertical stability after combined orthodontic surgical treatment of skeletal anterior open-bite malocclusion. Data from the identified studies were extracted and assessed for quality. Short-term and long-term changes in the following variables were evaluated: overbite; mandibular plane, palatal plane, and intermaxillary angles; and anterior facial height. Results: Nine studies, all retrospective, were appropriate for inclusion after review. The postoperative follow-up period ranged from 1 to 18 years. A wide variation was present for post-treatment changes and relapse. Dentally, overbite changes showed a wide variation, with more long-term relapse observed in patients after Le Fort I osteotomy. Skeletally, the mandibular plane and intermaxillary angles showed greater long-term relapse after bimaxillary surgery than after Le Fort I osteotomy. The same trend was seen for the post-treatment increase in anterior facial height. In contrast, the palatal plane seemed to remain rather stable. Conclusions: Vertical relapse is a characteristic in a certain number of patients after combined orthodontic surgical treatments regardless of surgery type. This can be observed dentally by an opening of the bite and skeletally by an increase in the mandibular plane and intermaxillary angles during long-term follow-up. Long-term skeletal relapse seems to be more common after bimaxillary surgery. (C) 2013 American Association of Oral and Maxillofacial Surgeons J Oral Maxillofac Surg 71: 98-109, 2013	[Solano-Hernandez, Belen] Univ Geneva, Dept Orthodont, Sch Dent, CH-1205 Geneva, Switzerland		Solano-Hernandez, B (corresponding author), Univ Geneva, Dept Orthodont, Sch Dent, 19 Rue Barthelemy Menn, CH-1205 Geneva, Switzerland.	belensolanohernandez@gmail.com	Antonarakis, Gregory/ABA-1855-2020	Antonarakis, Gregory/0000-0001-6741-6922			Arpornmaeklong P, 2000, Aust Orthod J, V16, P69; Bailey L J, 2001, Int J Adult Orthodon Orthognath Surg, V16, P280; Bailey L J, 1994, Int J Adult Orthodon Orthognath Surg, V9, P163; Behrents R G, 1985, Prog Clin Biol Res, V187, P307; Bianchi Alberto, 2009, Prog Orthod, V10, P26; BISHARA SE, 1988, AM J ORTHOD DENTOFAC, V94, P184, DOI 10.1016/0889-5406(88)90027-3; Bondemark L, 2007, ANGLE ORTHOD, V77, P181, DOI 10.2319/011006-16R.1; Christou P, 2007, EUR J ORTHODONT, V29, P543, DOI 10.1093/ejo/cjm036; Claudia R, 2005, J CRANIOFAC SURG, V16, P716, DOI 10.1097/01.SCS.0000157203.19557.B7; Cozza P, 2005, ANGLE ORTHOD, V75, P707; DATTILO DJ, 1985, J ORAL MAXIL SURG, V43, P440, DOI 10.1016/S0278-2391(85)80052-5; DEEKS J, 2001, 4 CRD NHS CTR REV DI; DENISON TF, 1989, ANGLE ORTHOD, V59, P5; Ding Y, 2007, J OROFAC ORTHOP, V68, P245, DOI 10.1007/s00056-007-0632-2; ELLIS E, 1984, AM J ORTHOD DENTOFAC, V86, P277, DOI 10.1016/0002-9416(84)90138-6; Ermel T, 1999, J Orofac Orthop, V60, P236, DOI 10.1007/BF01299782; Espeland L, 2008, EUR J ORTHODONT, V30, P24, DOI 10.1093/ejo/cjm081; Fischer K, 2000, EUR J ORTHODONT, V22, P711, DOI 10.1093/ejo/22.6.711; GREEBE RB, 1987, ORAL SURG ORAL MED O, V63, P158, DOI 10.1016/0030-4220(87)90304-5; HAYMOND CS, 1991, INT J ORAL MAX SURG, V20, P223, DOI 10.1016/S0901-5027(05)80180-8; HENNES J A, 1988, International Journal of Adult Orthodontics and Orthognathic Surgery, V3, P127; Hoppenreijs T J, 1996, Int J Adult Orthodon Orthognath Surg, V11, P29; Hoppenreijs T J, 1998, Int J Adult Orthodon Orthognath Surg, V13, P7; Hoppenreijs TJM, 1998, J CRANIO MAXILL SURG, V26, P286, DOI 10.1016/S1010-5182(98)80056-5; Hoppenreijs TJM, 1998, INT J ORAL MAX SURG, V27, P81, DOI 10.1016/S0901-5027(98)80301-9; Hoppenreijs TJM, 1997, INT J ORAL MAX SURG, V26, P161, DOI 10.1016/S0901-5027(97)80813-2; Hoppenreijs TJM, 1998, J CRANIO MAXILL SURG, V26, P260, DOI 10.1016/S1010-5182(98)80023-1; Huang GJ., 2002, SEMIN ORTHOD, V8, P162; Iannetti G, 2007, J CRANIOFAC SURG, V18, P350, DOI 10.1097/01.scs.0000248658.38158.d2; Joss CU, J ORAL MAXILLOFAC SU, V68, P201; KAHNBERG KE, 1994, J CRANIO MAXILL SURG, V22, P250, DOI 10.1016/S1010-5182(05)80566-9; KREKMANOV L, 1988, INT J ORAL MAX SURG, V17, P363, DOI 10.1016/S0901-5027(88)80065-1; Kuroda S, 2007, AM J ORTHOD DENTOFAC, V132, P599, DOI 10.1016/j.ajodo.2005.11.046; LANSLEY CV, 1986, BRIT J ORAL MAX SURG, V24, P391, DOI 10.1016/0266-4356(86)90052-5; LARSEN AJ, 1989, AM J ORTHOD DENTOFAC, V95, P334, DOI 10.1016/0889-5406(89)90167-4; Lawry D M, 1990, Aust Orthod J, V11, P147; LELLO GE, 1987, J CRANIO MAXILL SURG, V15, P132, DOI 10.1016/S1010-5182(87)80037-9; Lo F M, 1998, Int J Adult Orthodon Orthognath Surg, V13, P23; MCCANCE A M, 1992, European Journal of Orthodontics, V14, P198; Miguel J A, 1995, Int J Adult Orthodon Orthognath Surg, V10, P235; Moldez M A, 2000, Int J Adult Orthodon Orthognath Surg, V15, P309; NHS Centres for Review and Dissemination, 2001, UND SYST REV RES EFF; Oliveira J A, 1997, Int J Adult Orthodon Orthognath Surg, V12, P101; Proffit W R, 1998, Int J Adult Orthodon Orthognath Surg, V13, P97; Proffit WR, 2000, ANGLE ORTHOD, V70, P112; REITZIK M, 1990, AM J ORTHOD DENTOFAC, V97, P52, DOI 10.1016/S0889-5406(05)81709-3; Reyneke Johan P, 2007, Oral Maxillofac Surg Clin North Am, V19, P321, DOI 10.1016/j.coms.2007.04.004; RITTERSMA J, 1981, J ORAL SURG, V39, P671; RONDAHL US, 1988, INT J ORAL MAX SURG, V17, P165, DOI 10.1016/S0901-5027(88)80023-7; ROSEN HM, 1986, PLAST RECONSTR SURG, V78, P748, DOI 10.1097/00006534-198678060-00006; Sarver DM, 1995, AM J ORTHOD DENTOFAC, V108, P651, DOI 10.1016/S0889-5406(95)70011-0; SCHENDEL SA, 1980, J ORAL SURG, V38, P265; SINGER RS, 1985, J ORAL MAXIL SURG, V43, P444, DOI 10.1016/S0278-2391(85)80053-7; Stansbury CD, 2010, J ORAL MAXIL SURG, V68, P149, DOI 10.1016/j.joms.2009.07.105; Swinnen K, 2001, EUR J ORTHODONT, V23, P547, DOI 10.1093/ejo/23.5.547; VANSICKELS JE, 1988, ORAL SURG ORAL MED O, V66, P2, DOI 10.1016/0030-4220(88)90055-2; Wriedt S, 2009, J OROFAC ORTHOP, V70, P318, DOI 10.1007/s00056-009-9912-3	57	27	30	2	51	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-2391	1531-5053		J ORAL MAXIL SURG	J. Oral Maxillofac. Surg.	JAN	2013	71	1					98	109		10.1016/j.joms.2012.03.016			12	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	068EH	WOS:000313347400028	22695022	Green Published			2022-03-04	
J	Pham, D; Kiliaridis, S				Pham, Diane; Kiliaridis, Stavros			Evaluation of changes in trabecular alveolar bone during growth using conventional panoramic radiographs	ACTA ODONTOLOGICA SCANDINAVICA			English	Article						assessment; alveolar trabecular bone; growth; panoramic radiographs	MINERAL DENSITY; RISK-FACTORS; MINI-IMPLANTS; PATTERN; SITES; ASSESSMENTS; THICKNESS; STABILITY; FAILURE; AGE	Objective. To assess changes of the alveolar trabecular bone during growth using panoramic radiographs and to detect possible differences in trabecular bone patterns when comparing individuals of various ages and genders. Materials and methods. Conventional panoramic radiographs of 18 young (eight females, 10 males) and 21 adult (12 females, nine males) subjects were taken at 2 years (T1) and 10 years (T2) after the end of orthodontic treatment. At T1, mean ages were 15.6 +/- 0.9 years and 31.3 +/- 9.7 years in the young and the adult groups, respectively. A three-scale visual analysis was used to evaluate bilaterally the alveolar bone trabeculation in the interdental spaces, from the distal side of the first mandibular premolar to the mesial side of the second lower molar. An analysis of variance (ANOVA), associated with t-tests whenever significance was found, was used to appraise the role of the age, the extent of the follow-up period and the gender on trabecular bone structure. Results. The adult group had a denser alveolar bone trabeculation, compared to the young group. This was also observed in the 8 years follow-up recordings among the adults, but no statistically significant differences were found in the growing individuals. No gender discrepancy was detected. Conclusions. From puberty to the middle age adulthood, denser alveolar bone trabeculation in the mandible seems to be related to the age. No differences were found between male and female subjects in the sample.	[Pham, Diane; Kiliaridis, Stavros] Univ Geneva, Dept Orthodont, CH-1205 Geneva, Switzerland		Pham, D (corresponding author), Univ Geneva, Dept Orthodont, 19 Rue Barthelemy Menn, CH-1205 Geneva, Switzerland.	diane.pham@unige.ch					Amling M, 1996, J BONE MINER RES, V11, P36, DOI 10.1002/jbmr.5650110107; Bonjour JP, 2009, SALUD PUBLICA MEXICO, V51, pS5; BRIDGES T, 1988, AM J ORTHOD DENTOFAC, V93, P245, DOI 10.1016/S0889-5406(88)80010-6; Carlsson Gunnar E, 2004, Gerodontology, V21, P65, DOI 10.1111/j.1741-2358.2004.00005.x; Chen YJ, 2007, CLIN ORAL IMPLAN RES, V18, P768, DOI 10.1111/j.1600-0501.2007.01405.x; Cheng SJ, 2004, INT J ORAL MAX IMPL, V19, P100; Choi JH, 2009, AM J ORTHOD DENTOFAC, V136, DOI 10.1016/j.ajodo.2009.04.019; Chun YS, 2009, ORTHOD CRANIOFAC RES, V12, P25, DOI 10.1111/j.1601-6343.2008.01434.x; Doundoulakis JH, 2003, J AM DENT ASSOC, V134, P1455, DOI 10.14219/jada.archive.2003.0073; de Oliveira RCG, 2008, ORAL SURG ORAL MED O, V105, P231, DOI 10.1016/j.tripleo.2007.08.007; Hoste S, 2008, AUST ORTHOD J, V24, P140; Jonasson G, 2001, ORAL SURG ORAL MED O, V92, P346, DOI 10.1067/moe.2001.116494; Jonasson G, 2006, BONE, V38, P714, DOI 10.1016/j.bone.2005.10.008; KILIARIDIS S, 1993, ACTA ODONTOL SCAND, V51, P323, DOI 10.3109/00016359309040583; Kim YH, 2010, AM J ORTHOD DENTOFAC, V137, P66, DOI 10.1016/j.ajodo.2007.11.036; Klein-Nulend J, 2005, PATHOL BIOL, V53, P576, DOI 10.1016/j.patbio.2004.12.005; Miyawaki S, 2003, AM J ORTHOD DENTOFAC, V124, P373, DOI 10.1016/S0889-5406(03)00565-1; Molly L, 2006, CLIN ORAL IMPLAN RES, V17, P124, DOI 10.1111/j.1600-0501.2006.01356.x; Moon HS, 2004, SURG RADIOL ANAT, V26, P466, DOI 10.1007/s00276-004-0247-x; Nackaerts O, 2007, CLIN ORAL INVEST, V11, P225, DOI 10.1007/s00784-007-0107-2; Park HS, 2008, AM J ORTHOD DENTOFAC, V133, P30, DOI 10.1016/j.ajodo.2006.01.044; Park HS, 2006, AM J ORTHOD DENTOFAC, V130, P18, DOI 10.1016/j.ajodo.2004.11.032; Pham D, 2010, ACTA ODONTOL SCAND, V68, P91, DOI 10.3109/00016350903468235; Raadsheer MC, 1996, ARCH ORAL BIOL, V41, P323, DOI 10.1016/0003-9969(95)00136-0; Reynders R, 2009, AM J ORTHOD DENTOFAC, V135, P564, DOI 10.1016/j.ajodo.2009.02.003; Rothe LE, 2006, AM J ORTHOD DENTOFAC, V130, P476, DOI 10.1016/j.ajodo.2005.03.023; Seeman E, 2008, RHEUMATOLOGY, V47, P2, DOI 10.1093/rheumatology/ken177; Taguchi A, 1997, DENTOMAXILLOFAC RAD, V26, P85, DOI 10.1038/sj.dmfr.4600209; Turkyilmaz I, 2007, J ORAL REHABIL, V34, P267, DOI 10.1111/j.1365-2842.2006.01689.x; Turner C H, 1998, J Orthop Sci, V3, P346, DOI 10.1007/s007760050064; Turner CH, 1998, BONE, V23, P399, DOI 10.1016/S8756-3282(98)00118-5; Ulm C, 1999, CLIN ORAL IMPLAN RES, V10, P459, DOI 10.1034/j.1600-0501.1999.100604.x; Wang QJ, 2008, BEST PRACT RES CL EN, V22, P687, DOI 10.1016/j.beem.2008.07.008; White SC, 2002, DENTOMAXILLOFAC RAD, V31, P84, DOI 10.1038/sj.dmfr.4600674	34	4	4	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0001-6357	1502-3850		ACTA ODONTOL SCAND	Acta Odontol. Scand.	MAR	2012	70	2					127	132		10.3109/00016357.2011.600706			6	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	894UH	WOS:000300452000007	21793639	Green Published			2022-03-04	
J	Rizcalla, N; Bader, C; Bortolotto, T; Krejci, I				Rizcalla, Nicolas; Bader, Carl; Bortolotto, Tissiana; Krejci, Ivo			Improving the efficiency of an Er:YAG laser on enamel and dentin	QUINTESSENCE INTERNATIONAL			English	Article						air pressure; efficiency; Er:YAG laser; morphology; water spray	ER-YAG LASER; WATER-LAYER; ABLATION; TEETH	Objective: To evaluate the influence of air pressure, water flow rate, and pulse frequency on the removal speed of enamel and dentin as well as on their surface morphology. Method and Materials: Twenty-four bovine incisors were horizontally cut in slices. Each sample was mounted on an experimental assembly, allowing precise orientation. Eighteen cavities were prepared, nine in enamel and nine in dentin. Specific parameters for frequency, water flow rate, and air pressure were applied for each experimental group. Three groups were randomly formed according to the air pressure settings. Cavity depth was measured using a digital micrometer gauge, and surface morphology was checked by means of scanning electron microscopy. Data was analyzed with ANOVA and Duncan post hoc test. Results: Irradiation at 25 Hz for enamel and 30 Hz for dentin provided the best ablation rates within this study, but efficiency decreased if the frequency was raised further. Greater tissue ablation was found with water flow rate set to low and dropped with higher values. Air pressure was found to have an interaction with the other settings, since ablation rates varied with different air pressure values. Conclusion: Fine-tuning of all parameters to get a good ablation rate with minimum surface damage seems to be key in achieving optimal efficiency for cavity preparation with an Er:YAG laser. (Quintessence lot 2012;42:153-160)	[Rizcalla, Nicolas; Bader, Carl; Bortolotto, Tissiana; Krejci, Ivo] Univ Geneva, Dept Cariol & Endodontol, Sch Dent, CH-1205 Geneva, Switzerland		Rizcalla, N (corresponding author), Univ Geneva, Ecole Med Dent, Rue Barthelemy Menn 19, CH-1205 Geneva, Switzerland.	nicolas.rizcalla@unige.ch	Bortolotto, Tissiana/AAE-2796-2021	Bortolotto, Tissiana/0000-0002-3231-9097			Bader C, 2006, AM J DENT, V19, P178; Brugnera A, 2001, PROC SPIE, V4249, P175, DOI 10.1117/12.424506; BURKES EJ, 1992, J PROSTHET DENT, V67, P847, DOI 10.1016/0022-3913(92)90599-6; Corona SAM, 2008, J BIOMED MATER RES A, V84A, P569, DOI 10.1002/jbm.a.31335; George R., 2007, J ORAL LASER APPL, V7, p225 ; KELLER U, 1991, P SOC PHOTO-OPT INS, V1424, P127, DOI 10.1117/12.43999; Kim ME, 2003, J CLIN LASER MED SUR, V21, P139, DOI 10.1089/104454703321895581; LI ZZ, 1992, LASER SURG MED, V12, P625, DOI 10.1002/lsm.1900120610; Mehl A, 1997, DENT MATER, V13, P246, DOI 10.1016/S0109-5641(97)80036-X; Meister J, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2204028; Mir M, 2008, LASER MED SCI, V23, P451, DOI 10.1007/s10103-007-0508-0; Olivi G., 2007, SCIENCE, V7, P27; Staninec M, 2003, LASER SURG MED, V33, P264, DOI 10.1002/lsm.10229; Staninec M, 2009, DENT MATER, V25, P520, DOI 10.1016/j.dental.2008.10.004	14	7	10	0	3	QUINTESSENCE PUBLISHING CO INC	HANOVER PARK	4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA	0033-6572	1936-7163		QUINTESSENCE INT	Quintessence Int.	FEB	2012	43	2					153	160					8	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	889ZK	WOS:000300114700011	22257878				2022-03-04	
J	Vailati, F; Vaglio, G; Belser, UC				Vailati, Francesca; Vaglio, Giovanna; Belser, Urs Christoph			Full-mouth Minimally Invasive Adhesive Rehabilitation to Treat Severe Dental Erosion: A Case Report	JOURNAL OF ADHESIVE DENTISTRY			English	Article						dental erosion; palatal veneers; full-mouth adhesive rehabilitation	FIXED PARTIAL DENTURES; ALL-CERAMIC CROWNS; SINGLE CROWNS; TOOTH WEAR; CLINICAL-EVALUATION; SURVIVAL RATES; BOND STRENGTH; ORAL-HEALTH; TEETH; RESTORATION	Dental erosion is increasing, and only recently are clinicians starting to acknowledge the problem. A prospective clinical trial investigating which therapeutic approach must be undertaken to treat erosion and when is under way at the University of Geneva (Geneva Erosion Study). All patients affected by dental erosion who present with signs of dentin exposure are immediately treated using only adhesive techniques. In this article, the full-mouth adhesive rehabilitation of one of these patients affected by severe dental erosion (ACE class IV) is illustrated. By the end of the therapy, a very pleasing esthetic outcome had been achieved (esthetic success), all of the patient's teeth maintained their vitality, and the amount of tooth structure sacrificed to complete the adhesive full-mouth rehabilitation was negligible (biological success).	[Vailati, Francesca; Vaglio, Giovanna; Belser, Urs Christoph] Univ Geneva, Dept Fixed Prosthodont & Occlus, Sch Dent Med, CH-1205 Geneva, Switzerland		Vailati, F (corresponding author), Univ Geneva, Dept Fixed Prosthodont & Occlus, Sch Dent Med, Rue Barthelemy Menn 19, CH-1205 Geneva, Switzerland.	Francesca.vailati@unige.ch	Buser, Daniel/D-3971-2011				Aranha Ana Cecilia Correa, 2008, J Contemp Dent Pract, V9, P89; Aranha Ana Cecilia Correa, 2008, J Contemp Dent Pract, V9, P73; Arnadottir IB, 2010, COMMUNITY DENT ORAL, V38, P521, DOI 10.1111/j.1600-0528.2010.00559.x; Auad SM, 2009, PEDIATR DENT, V31, P229; Bader James D., 2009, General Dentistry, V57, P74; Bartlett D, 2008, CLIN ORAL INVEST, V12, pS27, DOI 10.1007/s00784-007-0177-1; Bartlett D, 2006, MG ORAL SCI, V20, P119, DOI 10.1159/000093359; Bartlett D, 2007, J AM DENT ASSOC, V138, p21S, DOI 10.14219/jada.archive.2007.0356; Belser U C, 1997, J Esthet Dent, V9, P197; Bertschinger C, 1996, AM J DENT, V9, P115; De Backer H, 2006, INT J PROSTHODONT, V19, P136; Dietschi D, 2008, QUINTESSENCE INT, V39, P117; El Aidi H, 2008, J DENT RES, V87, P731, DOI 10.1177/154405910808700813; Glantz POJ, 2002, ACTA ODONTOL SCAND, V60, P213, DOI 10.1080/000163502760147972; Hinds K, 1995, NATL DIET NUTR SURVE, V2; Imfeld T, 1996, EUR J ORAL SCI, V104, P151, DOI 10.1111/j.1600-0722.1996.tb00063.x; Lussi A, 2008, CLIN ORAL INVEST, V12, pS5, DOI 10.1007/s00784-007-0179-z; LUSSI A, 1991, COMMUNITY DENT ORAL, V19, P286, DOI 10.1111/j.1600-0528.1991.tb00169.x; LYNCH JB, 1947, BRIT J IND MED, V4, P84; Magne P, 2000, INT J PERIODONT REST, V20, P441; Magne P, 2005, J PROSTHET DENT, V94, P511, DOI 10.1016/j.prosdent.2005.10.010; Magne P, 1999, INT J PROSTHODONT, V12, P111; Magne P, 1999, J Adhes Dent, V1, P81; Magne P, 2007, J PROSTHET DENT, V98, pA12, DOI 10.1016/S0022-3913(07)60052-3; Magne Pascal, 2004, J Esthet Restor Dent, V16, P7, DOI 10.1111/j.1708-8240.2004.tb00444.x; Magne Pascal, 2005, J Esthet Restor Dent, V17, P144, DOI 10.1111/j.1708-8240.2005.tb00103.x; Mannocci F, 2009, INT ENDOD J, V42, P399; Mannocci F, 2009, INT ENDOD J, V42, P401, DOI 10.1111/j.1365-2591.2009.01559.x; Marquardt P, 2006, QUINTESSENCE INT, V37, P253; McGuire J, 2009, INT J PAEDIATR DENT, V19, P91, DOI 10.1111/j.1365-263X.2008.00952.x; McLaren EA, 2000, J PROSTHET DENT, V83, P216, DOI 10.1016/S0022-3913(00)80015-3; Mejare I, 2001, CARIES RES, V35, P178, DOI 10.1159/000047453; Milosevic Alex, 2008, Prim Dent Care, V15, P11, DOI 10.1308/135576108783328337; Milosevic Alex, 2008, Evid Based Dent, V9, P54, DOI 10.1038/sj.ebd.6400586; Napankangas R, 2008, INT J PROSTHODONT, V21, P307; Nunn JH, 1996, EUR J ORAL SCI, V104, P156, DOI 10.1111/j.1600-0722.1996.tb00064.x; OBrien M., 1994, CHILDRENS DENT HLTH; Palmqvist S, 1993, Int J Prosthodont, V6, P279; Paul SJ, 1997, INT J PERIODONT REST, V17, P537; Piovesan EM, 2007, INT J PROSTHODONT, V20, P633; Pjetursson BE, 2007, CLIN ORAL IMPLAN RES, V18, P73, DOI 10.1111/j.1600-0501.2007.01467.x; Salvi GE, 2007, INT ENDOD J, V40, P209, DOI 10.1111/j.1365-2591.2007.01218.x; Shaughnessy BE, 2008, J CLIN PEDIATR DENT, V33, P87, DOI 10.17796/jcpd.33.2.d0kwj02t525t8177; Signore A, 2009, J DENT, V37, P115, DOI 10.1016/j.jdent.2008.10.007; Sorensen J A, 1998, J Calif Dent Assoc, V26, P130; Sundh B, 1997, INT J PROSTHODONT, V10, P513; Taskonak B, 2006, DENT MATER, V22, P1008, DOI 10.1016/j.dental.2005.11.028; Vailati F, 2008, INT J ESTHET DENT, V3, P30; Vailati F, 2010, INT J PERIODONT REST, V30, P559; Vailati F, 2008, INT J ESTHET DENT, V3, P236; Vailati F, 2008, INT J ESTHET DENT, V3, P128; Valderhaug J, 1997, J DENT, V25, P97, DOI 10.1016/S0300-5712(96)00008-5; Van't Spijker A, 2009, INT J PROSTHODONT, V22, P35; von der Fehr F R, 1994, Int Dent J, V44, P371; Wegner PK, 2006, J ENDODONT, V32, P928, DOI 10.1016/j.joen.2006.06.001; Yip HK, 2002, QUINTESSENCE INT, V33, P516	56	21	21	1	16	QUINTESSENCE PUBLISHING CO INC	HANOVER PARK	4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA	1461-5185	1757-9988		J ADHES DENT	J. Adhes. Dent.		2012	14	1					83	92		10.3290/j.jad.a21852			10	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	894XH	WOS:000300460300013	21734973				2022-03-04	
J	Christou, P; Kiliaridis, S				Christou, Panagiotis; Kiliaridis, Stavros			Vertical growth-related changes in the positions of palatal rugae and maxillary incisors	AMERICAN JOURNAL OF ORTHODONTICS AND DENTOFACIAL ORTHOPEDICS			English	Article							TOOTH MOVEMENT; DENTAL CASTS; LANDMARKS; STABILITY	Introduction: With 3-dimensional scanning, the image of 1 digital dental cast can be superimposed on another to observe growth or treatment changes; however, this requires stable references. The palatal rugae were considered reliable points for detecting dental changes on the cast's occlusal plane, but is this the case in the vertical plane? Our aims were to assess the long-term stability of the palatal rugae in the vertical dimension, relate them to possible maxillary incisor posteruptive movements, and validate them as references for the evaluation of longitudinal dental changes. Methods: Four-year longitudinal lateral cephalograms and dental casts of 10 adults and 13 adolescents were used. The median palatal contour of each cast and marks corresponding to each ruga were superimposed on the palate of the cephalograms. Changes in rugae positions during the observation period were measured with respect to the palatal plane. Results: Vertical changes were greater for the first rugae (closest to the incisors), less for the second, and even less for the third (farthest from the incisors). The adolescents showed greater vertical changes in rugae position than the adults. There were no statistically significant differences in the anteroposterior changes between the groups. The maxillary central incisor and the first ruga had vertical displacements proportional to the increase of the subject's lower anterior facial height. Conclusions: We found vertical displacement of the maxillary incisor and the rugae during the 4 years of observation in adolescents and adults. The third ruga, the farthest from the incisors, can be used as a reliable reference to assess longitudinal dental changes mainly when growth changes are less prominent.	[Christou, Panagiotis] Univ Geneva, Sch Dent, Dept Orthodont, CH-1205 Geneva, Switzerland; [Kiliaridis, Stavros] Univ Geneva, Sch Dent, Dept Chair, CH-1205 Geneva, Switzerland		Christou, P (corresponding author), Univ Geneva, Sch Dent, Dept Orthodont, 19 Rue Barthelemy Menn, CH-1205 Geneva, Switzerland.	Panayiotis.Christou@medecine.unige.ch					ALMEIDA MA, 1995, ANGLE ORTHOD, V65, P43; Bailey LJ, 1996, ANGLE ORTHOD, V66, P73; Bernard JP, 2004, J CLIN PERIODONTOL, V31, P1024, DOI 10.1111/j.1600-051X.2004.00574.x; CHRISTOU P, 2007, EUR J ORTHOD    0801; Dahlberg G., 1940, STAT METHODS MEDICAL, P122; ENGLISH WR, 1988, J FORENSIC SCI, V33, P718; Hoggan BR, 2001, AM J ORTHOD DENTOFAC, V119, P482, DOI 10.1067/mod.2001.113001; HOUSTON WJB, 1983, AM J ORTHOD DENTOFAC, V83, P382, DOI 10.1016/0002-9416(83)90322-6; Limson K S, 2004, J Forensic Odontostomatol, V22, P1; Mavropoulos A, 2006, ANGLE ORTHOD, V76, P382; PEAVY DC, 1967, J PROSTHET DENT, V18, P536, DOI 10.1016/0022-3913(67)90219-3	11	46	47	2	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0889-5406			AM J ORTHOD DENTOFAC	Am. J. Orthod. Dentofac. Orthop.	JAN	2008	133	1					81	86		10.1016/j.ajodo.2007.07.009			6	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	266MT	WOS:000253440800027	18174076				2022-03-04	
J	Benbachir, N				Benbachir, Nacer			Indications and limits of the microabrasion technique	QUINTESSENCE INTERNATIONAL			English	Article						enamel dysplasia; home bleaching; megabrasion; microabrasion; minimally invasive treatment; white spot lesion	TEETH	This clinical report illustrates with clinical cases the indications and limits of microabrasion in patients with discolored anterior teeth. The proposed techniques are based on the elimination of the dysplastic external enamel layer through microabrasion, completed by home bleaching and the use of modern adhesive restorative techniques, if necessary. In specific cases, the proposed technique may eliminate dysplastic enamel lesions without being invasive. The use of minimally invasive techniques based on microabrasion allows for treatment of slight enamel defects. In more severe cases, megabrasion combined with a minimally invasive adhesive resin composite restoration may present a valuable alternative to microabrasion.	Univ Geneva, Ecole Med Dent, Div Cariol & Endodontol, Sch Dent, CH-1205 Geneva, Switzerland		Benbachir, N (corresponding author), Univ Geneva, Ecole Med Dent, Div Cariol & Endodontol, Sch Dent, Rue Barthelemy Menn 19, CH-1205 Geneva, Switzerland.	nacer.benbachir@medecine.unige.ch		ardu, stefano/0000-0003-1641-2168			Alaluusua S, 1996, EUR J ORAL SCI, V104, P493, DOI 10.1111/j.1600-0722.1996.tb00131.x; Ardu S, 2006, QUINTESSENCE INT, V37, P167; Croll T P, 1989, Quintessence Int, V20, P395; Croll T P, 2000, J Esthet Dent, V12, P64, DOI 10.1111/j.1708-8240.2000.tb00202.x; CROSS T, 1991, ENAMEL MICROABSRASIO, P27; Donly K J, 1992, Quintessence Int, V23, P175; Heymann H O, 1997, J Am Dent Assoc, V128 Suppl, p1S; Magne P, 1997, Pract Periodontics Aesthet Dent, V9, P389; Nohl FSA, 2002, BRIT DENT J, V192, P443, DOI 10.1038/sj.bdj.4801396a; Price RBT, 2003, J AM DENT ASSOC, V134, P1066, DOI 10.14219/jada.archive.2003.0320; Weerheijm KL, 2001, CARIES RES, V35, P390, DOI 10.1159/000047479; Wray A, 2001, Int J Paediatr Dent, V11, P309, DOI 10.1046/j.1365-263X.2001.00300.x	12	13	16	0	7	QUINTESSENCE PUBLISHING CO INC	HANOVER PARK	4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA	0033-6572			QUINTESSENCE INT	Quintessence Int.	NOV-DEC	2007	38	10					811	815					5	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	279WB	WOS:000254384800002	18197319				2022-03-04	
J	Antonarakis, GS; Kiliaridis, S				Antonarakis, Gregory S.; Kiliaridis, Stavros			Predictive value of masseter muscle thickness and bite force on Class II functional appliance treatment: a prospective controlled study	EUROPEAN JOURNAL OF ORTHODONTICS			English	Article							TWIN-BLOCK APPLIANCE; RANDOMIZED CLINICAL-TRIAL; FACIAL MORPHOLOGY; HERBST APPLIANCE; ACTIVATOR TREATMENT; TOOTH MOVEMENT; ORTHODONTIC TREATMENT; EXTRAORAL TRACTION; FIXED APPLIANCES; MALOCCLUSION	To prospectively evaluate the functional capacity of the masticatory musculature as a predictive variable in determining functional appliance treatment outcomes in Class II/1 malocclusion children. Twenty Class II/1 malocclusion children (11.4 +/- 1.7 years) were treated with functional appliances during 1 year. Masseter muscle thickness and maximal molar bite force measurements, lateral cephalograms, and study casts were taken before and after treatment. Twenty age- and gender-matched untreated children were included as a control group. Regression analyses were used to identify correlations between pre-treatment muscle characteristics and treatment outcomes. All treated patients showed dentoalveolar sagittal improvement. Maximal molar bite force and masseter muscle thickness decreased during the treatment period in the experimental group but increased in the control group. Children with lower pre-treatment maximal molar bite force showed more mesial movement of mandibular first molars, distal movement of maxillary first molars, and larger change in molar class during treatment. Children with thinner pre-treatment masseter muscles demonstrated more mandibular first molar mesialisation, mandibular incisor proclination, and opening of the gonial angle during treatment. The initial condition of the masticatory muscles may partly determine treatment outcomes. Children with thinner preaEuroEtreatment masseter muscles or weaker bite force show greater dentoalveolar changes.	[Antonarakis, Gregory S.; Kiliaridis, Stavros] Univ Geneva, Dept Orthodont, CH-1205 Geneva, Switzerland		Antonarakis, GS (corresponding author), Univ Geneva, Sch Dent, Dept Orthodont, 19 Rue Barthelemy Menn, CH-1205 Geneva, Switzerland.	gregory.Antonarakis@unige.ch	Antonarakis, Gregory/ABA-1855-2020	Antonarakis, Gregory/0000-0001-6741-6922			Al-Khateeb SN, 2015, EUR J ORTHODONT, V37, P142, DOI 10.1093/ejo/cju025; Antonarakis GS, 2012, EUR J ORTHODONT, V34, P244, DOI 10.1093/ejo/cjq184; Antonarakis GS, 2007, ANGLE ORTHOD, V77, P907, DOI 10.2319/061706-244; Asmussen E., 1973, HUMAN GROWTH DEV, P60; ATCHLEY WR, 1991, BIOL REV, V66, P101, DOI 10.1111/j.1469-185X.1991.tb01138.x; BAKKE M, 1980, SCAND J DENT RES, V88, P67; Benington PCM, 1999, EUR J ORTHODONT, V21, P659, DOI 10.1093/ejo/21.6.659; BISHARA SE, 1989, AM J ORTHOD DENTOFAC, V95, P250, DOI 10.1016/0889-5406(89)90055-3; BJORK A, 1983, EUR J ORTHODONT, V5, P1; Braun S, 1996, ANGLE ORTHOD, V66, P261; BRAUN S, 1995, ANGLE ORTHOD, V65, P367; BRIDGES T, 1988, AM J ORTHOD DENTOFAC, V93, P245, DOI 10.1016/S0889-5406(88)80010-6; Dahlberg G., 1940, STAT METHODS MED BIO; Dudic A, 2013, AM J ORTHOD DENTOFAC, V143, P616, DOI 10.1016/j.ajodo.2012.12.009; Ehmer U, 1999, J Orofac Orthop, V60, P392, DOI 10.1007/BF01388192; Franchi L, 2006, ANGLE ORTHOD, V76, P950, DOI 10.2319/110205-385; Ghafari J, 1998, AM J ORTHOD DENTOFAC, V113, P51, DOI 10.1016/S0889-5406(98)70276-8; Greco PM, 1999, ANGLE ORTHOD, V69, P141; Hansen K, 1992, Eur J Orthod, V14, P285; Hashimoto M, 2013, ANGLE ORTHOD, V83, P766, DOI 10.2319/111312-869.1; INGERVALL B, 1979, ANGLE ORTHOD, V49, P131; INGERVALL B, 1978, ARCH ORAL BIOL, V23, P203, DOI 10.1016/0003-9969(78)90217-0; Ingervall B, 1997, ANGLE ORTHOD, V67, P415; INGERVALL B, 1986, EUR J ORTHODONT, V8, P172, DOI 10.1093/ejo/8.3.172; JAKOBSSON SO, 1990, EUR J ORTHODONT, V12, P174, DOI 10.1093/ejo/12.2.174; Jonasson G, 2004, ARCH ORAL BIOL, V49, P1001, DOI 10.1016/j.archoralbio.2004.07.005; Keeling SD, 1998, AM J ORTHOD DENTOFAC, V113, P40, DOI 10.1016/S0889-5406(98)70275-6; KILIARIDIS S, 1991, J DENT RES, V70, P1262, DOI 10.1177/00220345910700090601; Kiliaridis S, 2010, ORTHOD CRANIOFAC RES, V13, P203, DOI 10.1111/j.1601-6343.2010.01496.x; KILIARIDIS S, 1993, ACTA ODONTOL SCAND, V51, P323, DOI 10.3109/00016359309040583; Kiliaridis S., 1998, FUTURE ORTHODONTICS, P97; Koretsi V, 2015, EUR J ORTHODONT, V37, P418, DOI 10.1093/ejo/cju071; LAUWERYNS I, 1995, J CRAN GENET DEV BIO, V15, P26; Lund DL, 1998, AM J ORTHOD DENTOFAC, V113, P104, DOI 10.1016/S0889-5406(98)70282-3; Macey-Dare L V, 1999, Dent Update, V26, P240; Manfredi C, 2001, ANGLE ORTHOD, V71, P170; Mavropoulos A, 2004, EUR J ORAL SCI, V112, P259, DOI 10.1111/j.1600-0722.2004.00129.x; Mills CM, 1998, AM J ORTHOD DENTOFAC, V114, P15, DOI 10.1016/S0889-5406(98)70232-X; NAKATSUKA K, 2006, NIHON KYOSEI SHIKA G, V65, P336; O'Brien K, 2003, AM J ORTHOD DENTOFAC, V124, P128, DOI 10.1016/S0889-5406(03)00345-7; O'Brien K, 2003, AM J ORTHOD DENTOFAC, V124, P234, DOI 10.1016/S0889-5406(03)00352-4; PANCHERZ H, 1982, EUR J ORTHODONT, V4, P37, DOI 10.1093/ejo/4.1.37; PANCHERZ H, 1980, AM J ORTHOD DENTOFAC, V78, P321, DOI 10.1016/0002-9416(80)90277-8; PFEIFFER JP, 1975, AM J ORTHOD DENTOFAC, V68, P499, DOI 10.1016/0002-9416(75)90084-6; PFEIFFER JP, 1982, AM J ORTHOD DENTOFAC, V81, P185, DOI 10.1016/0002-9416(82)90052-5; RAADSHEER MC, 1994, ARCH ORAL BIOL, V39, P1079, DOI 10.1016/0003-9969(94)90061-2; Raadsheer MC, 1996, ARCH ORAL BIOL, V41, P323, DOI 10.1016/0003-9969(95)00136-0; SHI CS, 1991, J ORAL REHABIL, V18, P253; Staudt CB, 2010, ACTA ODONTOL SCAND, V68, P131, DOI 10.3109/00016350903460182; TULLOCH JFC, 1990, AM J ORTHOD DENTOFAC, V98, P340, DOI 10.1016/S0889-5406(05)81491-X; Tulloch JFC, 1997, AM J ORTHOD DENTOFAC, V111, P533, DOI 10.1016/S0889-5406(97)70290-7; Tulloch JFC, 1997, AM J ORTHOD DENTOFAC, V111, P391, DOI 10.1016/S0889-5406(97)80021-2; VARGERVIK K, 1985, AM J ORTHOD DENTOFAC, V88, P242, DOI 10.1016/S0002-9416(85)90219-2; Wheeler TT, 2002, AM J ORTHOD DENTOFAC, V121, P9, DOI 10.1067/mod.2002.120159; White SC, 2002, DENTOMAXILLOFAC RAD, V31, P84, DOI 10.1038/sj.dmfr.4600674; WIESLANDER L, 1993, AM J ORTHOD DENTOFAC, V104, P319, DOI 10.1016/S0889-5406(05)81328-9; Woodside DG, 1998, AM J ORTHOD DENTOFAC, V113, P11, DOI 10.1016/S0889-5406(98)70270-7	57	11	12	0	7	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0141-5387	1460-2210		EUR J ORTHODONT	Eur. J. Orthodont.	DEC	2015	37	6					570	577		10.1093/ejo/cju089			8	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	CY5ZI	WOS:000366486200002	25582592	Bronze, Green Published			2022-03-04	
J	Scolozzi, P				Scolozzi, P.			Computer-aided design and computer-aided modeling (CAD/CAM) generated surgical splints, cutting guides and custom-made implants: Which indications in orthognathic surgery?	REVUE DE STOMATOLOGIE DE CHIRURGIE MAXILLO-FACIALE ET DE CHIRURGIE ORALE			English	Article						Computer-assisted surgery; Virtual surgical planning; Computer-aided design/computer-aided manufacturing software (CAD/CAM); Orthognathic surgery	DISTRACTION OSTEOGENESIS; CLEFT-LIP; SIMULATION; ACCURACY; RECONSTRUCTION; PRECISION	Introduction. The purpose of the present report was to describe our indications, results and complications of computer-aided design and computer-aided modeling CAD/CAM surgical splints, cutting guides and custom-made implants in orthognathic surgery. Patients and methods. We analyzed the clinical and radiological data of ten consecutive patients with dentofacial deformities treated using a CAD/CAM technique. Four patients had surgical splints and cutting guides for correction of maxillomandibular asymmetries, three had surgical cutting guides and customized internal distractors for correction of severe maxillary deficiencies and three had custommade implants for additional chin contouring and/or mandibular defects following bimaxillary osteotomies and sliding genioplasty. We recorded age, gender, dentofacial deformity, surgical procedure and intra-and postoperative complications. Results. All of the patients had stable cosmetic results with a high rate of patient satisfaction at the 1-year follow-up examination. No intra-and/ or postoperative complications were encountered during any of the different steps of the procedure. Discussion. This study demonstrated that the application of CAD/CAM patient-specific surgical splints, cutting guides and custom- made implants in orthognathic surgery allows for a successful outcome in the ten patients presented in this series. (C) 2015 Elsevier Masson SAS. All rights reserved.	[Scolozzi, P.] Hop Univ Geneve, Fac Med, Dept Surg, Div Oral & Maxillofacial Surg, CH-1211 Geneva, Switzerland		Scolozzi, P (corresponding author), Hop Univ Geneve, Fac Med, Dept Surg, Div Oral & Maxillofacial Surg, CH-1211 Geneva, Switzerland.	paolo.scolozzi@hcuge.ch					Centenero SAH, 2012, J CRANIO MAXILL SURG, V40, P162, DOI 10.1016/j.jcms.2011.03.014; Bai SZ, 2010, ORAL SURG ORAL MED O, V110, pE1, DOI 10.1016/j.tripleo.2010.05.052; Benassarou M, 2013, REV STOMATOL CHIR, V114, P219, DOI 10.1016/j.revsto.2013.06.004; Bouchard C, 2013, INT J ORAL MAX SURG, V42, P592, DOI 10.1016/j.ijom.2012.10.034; Ernoult C, 2015, REV STOMATOL CHIR, V116, P95, DOI 10.1016/j.revsto.2015.01.010; Gateno J, 2003, J ORAL MAXIL SURG, V61, P814, DOI 10.1016/S0278-2391(03)00240-4; Gil JN, 2007, INT J ORAL MAX SURG, V36, P296, DOI 10.1016/j.ijom.2006.10.015; Guevara-Rojas G, 2014, J ORAL MAXIL SURG, V72, P1801, DOI 10.1016/j.joms.2014.02.013; Hoarau R, 2014, REV STOMATOL CHIR, V115, P353, DOI 10.1016/j.revsto.2014.07.006; Hsu SSP, 2013, J ORAL MAXIL SURG, V71, P128, DOI 10.1016/j.joms.2012.03.027; Huang CS, 2007, CLEFT PALATE-CRAN J, V44, P274, DOI 10.1597/06-104; Kim MM, 2009, ARCH FACIAL PLAST S, V11, P53, DOI 10.1001/archfaci.11.1.53; Kumar A, 2006, PLAST RECONSTR SURG, V117, P1499, DOI 10.1097/01.prs.0000206308.86089.86; Metzger MC, 2008, ORAL SURG ORAL MED O, V105, pE1, DOI 10.1016/j.tripleo.2007.07.040; Mischkowski RA, 2006, J CRANIO MAXILL SURG, V34, P478, DOI 10.1016/j.jcms.2006.07.862; Olszewski R, 2004, Rev Stomatol Chir Maxillofac, V105, P165; Polley JW, 2013, J ORAL MAXIL SURG, V71, P911, DOI 10.1016/j.joms.2012.11.004; Rachmiel A, 2005, INT J ORAL MAX SURG, V34, P473, DOI 10.1016/j.ijom.2005.01.004; Schneider M, 2005, J CRANIO MAXILL SURG, V33, P8, DOI 10.1016/j.jcms.2004.05.010; Schouman T, 2015, HEAD FACE MED, V11, DOI 10.1186/s13005-015-0082-9; Scolozzi P, 2008, J CRANIOFAC SURG, V19, P1199, DOI 10.1097/SCS.0b013e318184365d; Scolozzi P, 2012, AESTHET PLAST SURG, V36, P660, DOI 10.1007/s00266-011-9853-2; Swennen GRJ, 2009, J ORAL MAXIL SURG, V67, P2080, DOI 10.1016/j.joms.2009.06.007; Terzic A, 2013, REV STOMATOL CHIR, V114, P276, DOI 10.1016/j.revsto.2013.06.007; White Jr R.P, 2003, COMBINING SURG ORTHO, P245; Xia JJ, 2011, J ORAL MAXIL SURG, V69, P2014, DOI 10.1016/j.joms.2011.02.018; Zinser MJ, 2012, OR SURG OR MED OR PA, V113, P673, DOI 10.1016/j.oooo.2011.11.009	27	20	20	0	11	ELSEVIER	BRIDGEWATER	685 ROUTE 202-206, BRIDGEWATER, NJ 08807 USA	2213-6533			REV STOMATOL CHIR	Rev. Stomatol. Chir. Maxillo-Facil.	DEC	2015	116	6					343	349		10.1016/j.revsto.2015.09.005			7	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	CY7CD	WOS:000366564700004	26598243				2022-03-04	
J	Antonarakis, GS; Kiliaridis, S				Antonarakis, G. S.; Kiliaridis, S.			Treating Class II malocclusion in children. Vertical skeletal effects of high-pull or low-pull headgear during comprehensive orthodontic treatment and retention	ORTHODONTICS & CRANIOFACIAL RESEARCH			English	Article						angle Class II; cephalometry; extraoral traction appliances; malocclusion	MASSETER MUSCLE THICKNESS; CERVICAL HEADGEAR; CRANIOFACIAL MORPHOLOGY; GROWTH; FORCES; DIMENSION; FACE	ObjectivesTo evaluate, in Class II malocclusion children, vertical skeletal changes occurring with high- and low-pull headgear during non-extraction comprehensive orthodontic treatment, and retention. Setting and sample populationTwo groups of thirty Class II malocclusion children (mean age 10.8years) who had undergone non-extraction comprehensive orthodontic treatment with either high- or low-pull headgear and fixed appliances. Material and MethodsRetrospective longitudinal study, where pre-treatment, post-treatment and at least 2year post-retention lateral cephalometric radiographs were analyzed. Comparisons were made concerning changes during treatment and retention in high- or low-pull headgear-treated children. Correlation analyses were carried out investigating changes in vertical cephalometric parameters and pre-treatment vertical facial pattern or type of headgear used. ResultsDuring treatment, sagittal relationships improved in all children and remained stable during retention. Vertically, in both high- and low-pull headgear groups, the intermaxillary angle as well as the maxillary and mandibular plane angles did not show statistically significant changes during treatment or retention, and large variation was seen between patients. When pooling the whole patient sample, change in the vertical facial pattern was independent of the pre-treatment vertical facial pattern or type of headgear used. ConclusionWhen treating Class II malocclusion children non-extraction with high- or low-pull headgear and fixed appliances, changes in vertical skeletal relationships demonstrate wide variation, both during treatment and retention. Dentoalveolar changes brought about by these appliancesmay not be able to make a predictable difference in vertical skeletal patterns of growing patients.	[Antonarakis, G. S.; Kiliaridis, S.] Univ Geneva, Sch Dent, Dept Orthodont, CH-1205 Geneva, Switzerland		Antonarakis, GS (corresponding author), Univ Geneva, Sch Dent, Dept Orthodont, 19 Rue Barthelemy Menn, CH-1205 Geneva, Switzerland.	gregory.antonarakis@unige.ch	Antonarakis, Gregory/ABA-1855-2020	Antonarakis, Gregory/0000-0001-6741-6922			BARTON JJ, 1972, AMER J ORTHODONTICS, V62, P517, DOI 10.1016/0002-9416(72)90027-9; BAUMRIND S, 1978, AM J ORTHOD DENTOFAC, V74, P32, DOI 10.1016/0002-9416(78)90043-X; Baumrind S, 1999, Semin Orthod, V5, P96, DOI 10.1016/S1073-8746(99)80029-2; BAUMRIND S, 1981, AM J ORTHOD DENTOFAC, V80, P17, DOI 10.1016/0002-9416(81)90193-7; BISHARA SE, 1985, AM J ORTHOD DENTOFAC, V88, P466, DOI 10.1016/S0002-9416(85)80046-4; BJORK A, 1983, EUR J ORTHODONT, V5, P1; BOECLER PR, 1989, ANGLE ORTHOD, V59, P263; BURKE M, 1992, AM J ORTHOD DENTOFAC, V102, P501, DOI 10.1016/0889-5406(92)70066-J; Charalampidou M, 2008, ACTA ODONTOL SCAND, V66, P23, DOI 10.1080/00016350701884604; COOK AH, 1994, AM J ORTHOD DENTOFAC, V106, P376, DOI 10.1016/S0889-5406(94)70059-1; CREEKMORE TD, 1967, ANGLE ORTHOD, V37, P285; Dahlberg G., 1940, STAT METHODS MED BIO; DUTERLOO HS, 1985, AM J ORTHOD DENTOFAC, V88, P297, DOI 10.1016/0002-9416(85)90128-9; FIROUZ M, 1992, AM J ORTHOD DENTOFAC, V102, P197, DOI 10.1016/S0889-5406(05)81053-4; FOTIS V, 1985, AM J ORTHOD DENTOFAC, V88, P288, DOI 10.1016/0002-9416(85)90127-7; Gautam P, 2009, AM J ORTHOD DENTOFAC, V135, P507, DOI 10.1016/j.ajodo.2007.02.059; Gkantidis N, 2011, AM J ORTHOD DENTOFAC, V140, P346, DOI 10.1016/j.ajodo.2011.05.015; Haralabakis NB, 2004, AM J ORTHOD DENTOFAC, V126, P310, DOI 10.1016/j.ajodo.2003.08.028; KILIARIDIS S, 1991, J DENT RES, V70, P1262, DOI 10.1177/00220345910700090601; KILIARIDIS S, 1993, ACTA ODONTOL SCAND, V51, P323, DOI 10.3109/00016359309040583; KILIARIDIS S, 1995, ACTA ODONTOL SCAND, V53, P196, DOI 10.3109/00016359509005972; Kim KR, 2001, AM J ORTHOD DENTOFAC, V119, P522, DOI 10.1067/mod.2001.113407; Melsen B, 2003, AM J ORTHOD DENTOFAC, V123, P374, DOI 10.1067/mod.2003.72; MERRIFIE.LL, 1970, AMER J ORTHODONTICS, V57, P435, DOI 10.1016/0002-9416(70)90164-8; POULTON DR, 1967, AMER J ORTHODONTICS, V53, P8, DOI 10.1016/0002-9416(67)90135-2; Proffit W.R., 2007, CONT ORTHODONTICS; PROFFIT WR, 1983, J DENT RES, V62, P566, DOI 10.1177/00220345830620051201; Raadsheer MC, 1996, ARCH ORAL BIOL, V41, P323, DOI 10.1016/0003-9969(95)00136-0; SCHUDY F F, 1965, Angle Orthod, V35, P36; Schudy FF, 1964, ANGLE ORTHOD, V34, P75; Sfondrini M F, 2002, Orthod Craniofac Res, V5, P114, DOI 10.1034/j.1600-0544.2002.01155.x; van der Linden FPGM, 2008, EUR J ORTHODONT, V30, P449, DOI 10.1093/ejo/cjn048; WATSON WG, 1972, AM J ORTHOD DENTOFAC, V62, P561, DOI 10.1016/0002-9416(72)90001-2; WIESLANDER L, 1974, AM J ORTHOD DENTOFAC, V65, P531, DOI 10.1016/0002-9416(74)90034-7	34	5	7	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1601-6335	1601-6343		ORTHOD CRANIOFAC RES	Orthod. Craniofac. Res.	MAY	2015	18	2					86	95		10.1111/ocr.12062			10	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	CF4ND	WOS:000352525000003	25545335				2022-03-04	
J	Bovali, E; Kiliaridis, S; Cornelis, MA				Bovali, Efstathia; Kiliaridis, Stavros; Cornelis, Marie A.			Indirect vs direct bonding of mandibular fixed retainers in orthodontic patients: A single-center randomized controlled trial comparing placement time and failure over a 6-month period	AMERICAN JOURNAL OF ORTHODONTICS AND DENTOFACIAL ORTHOPEDICS			English	Article							FOLLOW-UP; LINGUAL RETAINERS; STABILITY; SURVIVAL	Introduction: The objective of this 2-armparallel single-center trial was to compare placement time and numbers of failures of mandibular lingual retainers bonded with an indirect procedure vs a direct bonding procedure. Methods: Sixty-four consecutive patients at the postgraduate orthodontic clinic of the University of Geneva in Switzerland scheduled for debonding and mandibular fixed retainer placement were randomly allocated to either an indirect bonding procedure or a traditional direct bonding procedure. Eligibility criteria were the presence of the 4 mandibular incisors and the 2 mandibular canines, and no active caries, restorations, fractures, or periodontal disease of these teeth. The patients were randomized in blocks of 4; the randomization sequence was generated using an online randomization service (www.randomization.com). Allocation concealment was secured by contacting the sequence generator for treatment assignment; blinding was possible for outcome assessment only. Bonding time was measured for each procedure. Unpaired t tests were used to assess differences in time. Patients were recalled at 1, 2, 4, and 6 months after bonding. Mandibular fixed retainers having at least 1 composite pad debonded were considered as failures. The log-rank test was used to compare the Kaplan-Meier survival curves of both procedures. A test of proportion was applied to compare the failures at 6 months between the treatment groups. Results: Sixty-four patients were randomized in a 1: 1 ratio. One patient dropped out at baseline after the bonding procedure, and 3 patients did not attend the recalls at 4 and 6 months. Bonding time was significantly shorter for the indirect procedure (321 +/- 31 seconds, mean +/- SD) than for the direct procedure (401 +/- 40 seconds) (per protocol analysis of 63 patients: mean difference = 80 seconds; 95% CI = 62.4-98.1; P < 0.001). The 6-month numbers of failures were 10 of 31 (32%) with the indirect technique and 7 of 29 (24%) with the direct technique (log rank: P 5 0.35; test of proportions: risk difference = 0.08; 95% CI = -0.15 to 0.31; P = 0.49). No serious harm was observed except for plaque accumulation. Conclusions: Indirect bonding was statistically significantly faster than direct bonding, with both techniques showing similar risks of failure.	[Bovali, Efstathia; Kiliaridis, Stavros; Cornelis, Marie A.] Univ Geneva, Sch Dent, Dept Orthodont, CH-1205 Geneva, Switzerland		Bovali, E (corresponding author), Univ Geneva, Dept Orthodont, Rue Barthelemy Menn 19, CH-1205 Geneva, Switzerland.	Efstathia.Bovali@unige.ch		Cornelis, Marie/0000-0001-8050-2868	Clinical Research Center, University of Geneva; Geneva University Hospitals	Methodologic support was provided by the Clinical Research Center, University of Geneva, and Geneva University Hospitals (Dr Delphine Courvoisier). We thank Dr Gregory S. Antonarakis for rereading the manuscript and Ivor Leahy, our laboratory technician.	Al Yami EA, 1999, AM J ORTHOD DENTOFAC, V115, P300, DOI 10.1016/S0889-5406(99)70333-1; Artun J, 1997, EUR J ORTHODONT, V19, P501, DOI 10.1093/ejo/19.5.501; BEARN DR, 1995, AM J ORTHOD DENTOFAC, V108, P207, DOI 10.1016/S0889-5406(95)70085-4; Blake M, 1998, AM J ORTHOD DENTOFAC, V114, P299, DOI 10.1016/S0889-5406(98)70212-4; Booth FA, 2008, AM J ORTHOD DENTOFAC, V133, P70, DOI 10.1016/j.ajodo.2006.10.023; Dahl E H, 1991, J Clin Orthod, V25, P619; Foek DJLS, 2008, EUR J ORTHODONT, V30, P199, DOI 10.1093/ejo/cjm117; Haydar B, 2001, J Clin Orthod, V35, P608; Karaman AL, 2003, AM J ORTHOD DENTOFAC, V124, P327, DOI 10.1016/S0889-5406(03)00451-7; KNIERIM RW, 1973, ANGLE ORTHOD, V43, P218; Kramer N, 2008, AM J DENT, V21, P135; Lumsden K W, 1999, Br J Orthod, V26, P191; Machin D, 1997, SAMPLE SIZE TABLES C, P24; Pandis N, 2007, EUR J ORTHODONT, V29, P471, DOI 10.1093/ejo/cjm042; Pandis N, 2013, AM J ORTHOD DENTOFAC, V144, P169, DOI 10.1016/j.ajodo.2013.02.030; Renkema AM, 2011, AM J ORTHOD DENTOFAC, V139, P614, DOI 10.1016/j.ajodo.2009.06.041; Schulz KF, 2010, OBSTET GYNECOL, V115, P1063, DOI [10.1097/AOG.0b013e3181d9d421, 10.1016/j.ijsu.2011.09.004, 10.7326/0003-4819-152-11-201006010-00232]; Schulz KF, 2010, J CLIN EPIDEMIOL, V63, P834, DOI [10.1016/j.jclinepi.2010.02.005, 10.1136/bmj.c332, 10.1136/bmj.c869, 10.1016/j.jclinepi.2010.03.004, 10.4103/0976-500X.72352, 10.1186/1741-7015-8-18, 10.1016/j.ijsu.2011.09.004, 10.1016/j.ijsu.2011.10.001]; Segner D, 2000, J Orofac Orthop, V61, P352, DOI 10.1007/PL00001905; SINCLAIR PM, 1983, AM J ORTHOD DENTOFAC, V83, P114, DOI 10.1016/S0002-9416(83)90296-8; Tacken MPE, 2010, EUR J ORTHODONT, V32, P117, DOI 10.1093/ejo/cjp100; Taner T, 2012, EUR J ORTHODONT, V34, P470, DOI 10.1093/ejo/cjr038; Thilander B, 2009, EUR J ORTHODONT, V31, P109, DOI 10.1093/ejo/cjn124; ZACHRISSON BU, 1977, AM J ORTHOD DENTOFAC, V71, P440, DOI 10.1016/0002-9416(77)90247-0	24	21	21	0	13	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0889-5406	1097-6752		AM J ORTHOD DENTOFAC	Am. J. Orthod. Dentofac. Orthop.	DEC	2014	146	6					701	708		10.1016/j.ajodo.2014.08.015			8	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	AU5PQ	WOS:000345659600006	25432250				2022-03-04	
J	Scolozzi, P; Becker, M; Lombardi, T				Scolozzi, Paolo; Becker, Minerva; Lombardi, Tommaso			Mandibular Condylar Metastasis Mimicking Acute Internal Derangement of the Temporomandibular Joint	JOURNAL OF THE CANADIAN DENTAL ASSOCIATION			English	Article							CLASSIFICATION; TUMORS	Metastasis of a tumour to the mandibular condyle is rare. We describe a case in which a patient presented with isolated condylar metastasis mimicking acute internal derangement of the temporomandibular joint (TMJ). Open biopsy revealed a lesion seated within the condylar head and extending through the bony cortex to the infratemporal fossa. Histopathology confirmed the diagnosis of metastatic large-cell lung carcinoma. TMJ dysfunction may be associated with any pathologic entity involving the mandibular condyle. A panoramic radiograph should be considered in patients who do not respond to conventional therapy or whose clinical symptoms worsen. Particular attention must be paid to osteolytic jaw lesions, which can be the "tip of the iceberg" indicating widespread metastatic disease.	[Scolozzi, Paolo] Hop Univ Geneva, Dept Surg, Div Oral & Maxillofacial Surg, Fac Med, CH-1211 Geneva, Switzerland; [Becker, Minerva] Hop Univ Geneva, Div Radiol, CH-1211 Geneva, Switzerland; [Lombardi, Tommaso] Hop Univ Geneva, Lab Oral Histopathol, Div Stomatol & Oral Surg, Fac Med, CH-1211 Geneva, Switzerland		Scolozzi, P (corresponding author), Hop Univ Geneva, Dept Surg, Div Oral & Maxillofacial Surg, Fac Med, CH-1211 Geneva, Switzerland.	paolo.scolozzi@hcuge.ch					Brambilla E, 2001, EUR RESPIR J, V18, P1059, DOI 10.1183/09031936.01.00275301; Freudenberg Lutz S, 2010, Thorac Surg Clin, V20, P25, DOI 10.1016/j.thorsurg.2009.12.003; Helkimo M, 1974, Sven Tandlak Tidskr, V67, P101; Hirshberg A, 2008, ORAL ONCOL, V44, P743, DOI 10.1016/j.oraloncology.2007.09.012; Shintaku WH, 2009, ORAL SURG ORAL MED O, V107, pE37, DOI 10.1016/j.tripleo.2009.02.027; Stegenga B, 2010, J ORAL REHABIL, V37, P760, DOI 10.1111/j.1365-2842.2010.02146.x; THOMA KH, 1947, AM J ORTHOD ORAL SUR, V33, P344	7	8	8	0	0	CANADIAN DENTAL ASSOC	OTTAWA	1815 ALTA VISTA DRIVE, OTTAWA, ON K1G 3Y6, CANADA	1488-2159			J CAN DENT ASSOC	J. Can. Dent. Assoc.	JUL 9	2012	78								c77				3	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	987ZS	WOS:000307458400001	22889503				2022-03-04	
J	Christou, P; Kiliaridis, S				Christou, Panagiotis; Kiliaridis, S.			Three-dimensional changes in the position of unopposed molars in adults	EUROPEAN JOURNAL OF ORTHODONTICS			English	Article							TEETH; IMPLANTS; TOOTH; ADOLESCENTS; ANTAGONISTS	The aim of this study was to longitudinally examine, in adults, changes of position in the three dimensions of maxillary molars unopposed for more than 10 years. Twelve healthy mature adults (six males, six females; mean age 45 years 11 months) with unopposed molars were followed-up for a mean period of 10 years 7 months. Plaster casts were made at the first and last examination. The patients presented 22 unopposed maxillary molars at both recordings and 14 posterior teeth with antagonists, at least one in each subject, without significant modifications during the study period. On three-dimensional scanned plaster casts, changes in the centroid of the occlusal surface were measured in the three dimensions. The changes observed on both occasions were compared with a t-test. Vertical displacement of unopposed molars [0.8 mm, standard deviation (SD) 0.65 mm] and controls (0.4 mm, SD 0.2 mm) was noted. The unopposed teeth overerupted more than the controls (P <= 0.06); periodontally affected molars erupted more than periodontally healthy molars ( P <= 0.01). There was significant mesial displacement of unopposed molars without mesially adjacent teeth when compared with their respective controls ( P <= 0.04). Palatal movement was observed in the unopposed teeth (0.9 mm, SD 0.6 mm) and was significantly greater than that in the controls (0.5 mm, SD 0.3 mm; P <= 0.02). There is displacement of unopposed teeth in the three dimensions in the long term, although this is clinically insignificant in periodontally healthy adults. The observed changes are either the result of late growth remodelling or a consequence of altered dental equilibrium following antagonist tooth loss.	Univ Geneva, Sch Dent, Dept Orthodont, CH-1205 Geneva, Switzerland		Christou, P (corresponding author), Univ Geneva, Sch Dent, Dept Orthodont, 19 Rue Barthelemy Menn, CH-1205 Geneva, Switzerland.	panayiotis.christou@medecine.unige.ch					Bernard JP, 2004, J CLIN PERIODONTOL, V31, P1024, DOI 10.1111/j.1600-051X.2004.00574.x; COMPAGNON D, 1991, J PROSTHET DENT, V66, P29, DOI 10.1016/0022-3913(91)90347-Y; Craddock HL, 2004, BRIT DENT J, V196, P341, DOI 10.1038/sj.bdj.4811082; DAHLBERG E, 1940, STAT METHODS MED BIO; Duke P, 2000, J PROSTHET DENT, V83, P466, DOI 10.1016/S0022-3913(00)70043-6; FORSBERG CM, 1991, EUR J ORTHODONT, V13, P249, DOI 10.1093/ejo/13.4.249; HOUSTON WJB, 1983, AM J ORTHOD DENTOFAC, V83, P382, DOI 10.1016/0002-9416(83)90322-6; Kiliaridis S, 2003, EUR J ORTHODONT, V25, P259, DOI 10.1093/ejo/25.3.259; Kiliaridis S, 2000, INT J PROSTHODONT, V13, P480; LOVE WD, 1971, J PROSTHET DENT, V25, P271, DOI 10.1016/0022-3913(71)90188-0; Lyka I, 2001, SWED DENT J, V25, P67; PROFFIT WR, 1978, ANGLE ORTHOD, V48, P175; PROFFIT WR, 2000, CONT ORTHODONTICS, P113; Shugars DA, 2000, J AM DENT ASSOC, V131, P1317, DOI 10.14219/jada.archive.2000.0385; Smith R, 1996, Br J Orthod, V23, P109; TALLGREN A, 1991, EUR J ORTHODONT, V13, P149, DOI 10.1093/ejo/13.2.149; TENCATE AR, 2003, TENCATES ORAL HISTOL, P275; THILANDER B, 1994, EUR J ORTHODONT, V16, P84, DOI 10.1093/ejo/16.2.84; Thilander B, 2001, EUR J ORTHODONT, V23, P715, DOI 10.1093/ejo/23.6.715; Yonezu Takuro, 1997, Bulletin of Tokyo Dental College, V38, P201	20	28	29	1	4	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0141-5387			EUR J ORTHODONT	Eur. J. Orthodont.	DEC	2007	29	6					543	549		10.1093/ejo/cjm036			7	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	239GF	WOS:000251506100001	17670802	Green Published, Bronze			2022-03-04	
J	Crespi, R; Barone, A; Covani, U				Crespi, R; Barone, A; Covani, U			Effect of Er : YAG laser on diseased root surfaces: An in vivo study	JOURNAL OF PERIODONTOLOGY			English	Article						lasers/therapeutic use; periodontal pockets/surgery; scaling; tooth root/surgery	SUBSTANCE REMOVAL; VITRO; RADIATION; CALCULUS; IRRADIATION; ERBIUM	Background: The aim of the present study was to observe in vivo the effects of two different power settings of an Er:YAG laser on pockets of periodontally involved root surfaces using a scanning electron microscope (SEM). Methods: Thirty-two teeth with severe periodontal disease scheduled for extraction were divided into three groups: group A was irradiated with an energy of 140 mJ, 10 Hz; group B with 160 mJ 10 Hz; group C was used as controls. Morphological changes on the treated root surfaces were evaluated using SEM observations to assess laser-induced ultrastructural changes. Results: All surfaces treated in both groups showed a homogeneous and smooth root surface morphology. The surface alterations were very similar with both energy values used. Conclusion: Er:YAG laser irradiation performed with two different power settings of root surfaces in vivo showed at the SEM observation a complete absence of debris and smooth root surfaces.	Univ Geneva, Sch Med, Dept Biophys Med & Odontostomatol Sci & Technol, CH-1211 Geneva, Switzerland		Crespi, R (corresponding author), Via Busto Arsizio 50,Busto Garolfo, I-20020 Milan, Italy.	robcresp@libero.it	Barone, Antonio/O-2738-2013	Barone, Antonio/0000-0003-1226-7565; COVANI, UGO/0000-0002-1267-6345			AOKI A, 1994, J PERIODONTOL, V65, P1097, DOI 10.1902/jop.1994.65.12.1097; AXELSSON P, 1991, J CLIN PERIODONTOL, V18, P182, DOI 10.1111/j.1600-051X.1991.tb01131.x; Feist IS, 2003, J PERIODONTOL, V74, P1368, DOI 10.1902/jop.2003.74.9.1368; Folwaczny M, 2001, J CLIN PERIODONTOL, V28, P220, DOI 10.1034/j.1600-051x.2001.028003220.x; Folwaczny M, 2003, J PERIODONTOL, V74, P360, DOI 10.1902/jop.2003.74.3.360; Folwaczny M, 2000, J PERIODONTOL, V71, P147, DOI 10.1902/jop.2000.71.2.147; Frentzen M, 2002, J PERIODONTOL, V73, P524, DOI 10.1902/jop.2002.73.5.524; Fujii T, 1998, J PERIODONTOL, V69, P1283, DOI 10.1902/jop.1998.69.11.1283; Israel M, 1997, J CLIN PERIODONTOL, V24, P595, DOI 10.1111/j.1600-051X.1997.tb00235.x; KATHIBLOU FA, 1983, J PERIODONTOL, V54, P365; KELLEWR U, 1995, LASER SURG MED, V2623, P189; KEPIC TJ, 1990, J PERIODONTOL, V61, P16, DOI 10.1902/jop.1990.61.1.16; Oberholzer R, 1996, J CLIN PERIODONTOL, V23, P326, DOI 10.1111/j.1600-051X.1996.tb00553.x; OLEARY TJ, 1986, J PERIODONTOL, V57, P69, DOI 10.1902/jop.1986.57.2.69; Schwarz F, 2001, LASER SURG MED, V29, P328, DOI 10.1002/lsm.1125; SHERMAN PR, 1990, J PERIODONTOL, V61, P3, DOI 10.1902/jop.1990.61.1.3; Theodoro LH, 2003, J PERIODONTOL, V74, P838, DOI 10.1902/jop.2003.74.6.838; Yamaguchi H, 1997, J PERIODONTOL, V68, P1151, DOI 10.1902/jop.1997.68.12.1151	18	21	21	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3492	1943-3670		J PERIODONTOL	J. Periodont.	AUG	2005	76	8					1386	1390		10.1902/jop.2005.76.8.1386			5	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	957VG	WOS:000231400800021	16101373				2022-03-04	
J	Mombelli, A				Mombelli, A			Antimicrobial agents in periodontal prevention, therapy and maintenance: GABA Forum 2002	ORAL DISEASES			English	Editorial Material									Univ Geneva, Sch Dent Med, CH-1205 Geneva, Switzerland		Mombelli, A (corresponding author), Univ Geneva, Sch Dent Med, 19 Rue Barthelemy Menn, CH-1205 Geneva, Switzerland.							0	0	0	0	0	BLACKWELL MUNKSGAARD	COPENHAGEN	35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK	1354-523X			ORAL DIS	Oral Dis.	JUN	2003	9			1			5	5		10.1034/j.1601-0825.9.s1.1.x			1	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	683PP	WOS:000183158300001					2022-03-04	
J	Cionca, N; Hashim, D; Cancela, J; Giannopoulou, C; Mombelli, A				Cionca, Norbert; Hashim, Dena; Cancela, Jose; Giannopoulou, Catherine; Mombelli, Andrea			Pro-inflammatory cytokines at zirconia implants and teeth. A cross-sectional assessment	CLINICAL ORAL INVESTIGATIONS			English	Article						Zirconia; Dental implants; Cytokines	GINGIVAL CREVICULAR FLUID; PERI-IMPLANTITIS; PROINFLAMMATORY CYTOKINES; TNF-ALPHA; FOLLOW-UP; TITANIUM; IL-1-BETA; SEVERITY; DISEASE; MARKERS	The aim of this study was to compare the expression of host-derived markers in peri-implant/gingival crevicular fluid (PCF/GCF) and clinical conditions at ceramic implants and contralateral natural teeth. As a secondary objective, we compared zirconia implants with titanium implants. One zirconia implant (ZERAMEXA (R) Implant System) and one contralateral natural tooth were examined in 36 systemically healthy subjects (21 males, 15 females, mean age 58). The levels of Il-1 beta, Il-1RA, Il-6, Il-8, Il-17, b-FGF, G-CSF, GM-CSF, IFNE pound, MIP-1 beta, TNF-alpha, and VEGF were assessed in PCF/GCF using the Bio-Plex 200 Suspension Array System. The plaque index (PI), gingival index (GI), probing depth (PD), and bleeding on probing (BOP) were assessed at six sites around each implant or tooth. Titanium implants were also assessed when present (n = 9). The zirconia implants were examined after a loading period of at least 1.2 years (average 2.2 years). The mean PI was significantly lower at zirconia implants compared to teeth (p = 0.003), while the mean GI, PD, and BOP were significantly higher (p < 0.001). A correlation was found in the expression of Il-1RA, Il-8, G-CSF, MIP-1 beta, and TNF-alpha at zirconia implants and teeth. The levels of IL-1 beta and TNF-alpha were significantly higher at zirconia implants than at teeth. No significant differences were found between zirconia and titanium implants. A correlation was found between the levels of IL-1RA, IL-8, GM-CSF, and MIP-1 beta at zirconia and titanium implants. The correlation in the expression of five biomarkers at zirconia implants and teeth, and of four biomarkers at zirconia and titanium implants, is compatible with the existence of a patient-specific inflammatory response pattern. Higher mean GI, PD, and BOP around implants suggests that the peri-implant mucosa may be mechanically more fragile than the gingiva. Similar expression of selected biomarkers at zirconia implants and teeth and at zirconia and titanium implants reflects existence of patient-specific inflammatory response patterns.	[Cionca, Norbert; Hashim, Dena; Cancela, Jose; Giannopoulou, Catherine; Mombelli, Andrea] Univ Geneva, Sch Dent Med, Div Periodontol, Rue Barthelemy Menn 19, CH-1205 Geneva, Switzerland		Cionca, N (corresponding author), Univ Geneva, Sch Dent Med, Div Periodontol, Rue Barthelemy Menn 19, CH-1205 Geneva, Switzerland.	Norbert.Cionca@unige.ch		Hashim, Dena/0000-0002-0490-028X	Dentalpoint AG, Zurich, Switzerland	The patients investigated here took part in a longitudinal study supported by a grant from Dentalpoint AG, Zurich, Switzerland. The costs of the biochemical analyses were assumed by research funds of the division.	Andreiotelli M, 2009, CLIN ORAL IMPLAN RES, V20, P32, DOI 10.1111/j.1600-0501.2009.01785.x; Baelum V, 2004, J PERIODONTOL, V75, P1404, DOI 10.1902/jop.2004.75.10.1404; Barwacz CA, 2015, CLIN ORAL IMPLAN RES, V26, pe35, DOI 10.1111/clr.12326; Campanile VSM, 2015, LASER MED SCI, V30, P27, DOI 10.1007/s10103-013-1337-y; CIMASONI G, 1983, CREVICULAR FLUID UPD; Cionca N, 2015, CLIN ORAL IMPLAN RES, V26, P413, DOI 10.1111/clr.12370; Degidi M, 2006, J PERIODONTOL, V77, P73, DOI 10.1902/jop.2006.77.1.73; Depprich R, 2014, CLIN IMPLANT DENT R, V16, P124, DOI 10.1111/j.1708-8208.2012.00454.x; Dierens M, 2012, CLIN ORAL IMPLAN RES, V23, P197, DOI 10.1111/j.1600-0501.2011.02212.x; do Nascimento C, 2014, CLIN ORAL IMPLAN RES, V25, P337, DOI 10.1111/clr.12093; Duarte PM, 2009, CLIN ORAL IMPLAN RES, V20, P514, DOI 10.1111/j.1600-0501.2008.01680.x; Gallucci GO, 2011, J CLIN PERIODONTOL, V38, P293, DOI 10.1111/j.1600-051X.2010.01686.x; Giannopoulou C, 2012, J PERIODONTOL, V83, P1018, DOI 10.1902/jop.2011.110281; Jacobi-Gresser E, 2013, INT J ORAL MAX SURG, V42, P537, DOI 10.1016/j.ijom.2012.07.018; Javed F, 2011, CYTOKINE, V53, P8, DOI 10.1016/j.cyto.2010.08.013; KINANE DF, 1992, ARCH ORAL BIOL, V37, P153, DOI 10.1016/0003-9969(92)90011-V; Koldsland OC, 2010, J PERIODONTOL, V81, P231, DOI 10.1902/jop.2009.090269; LOE H, 1967, J PERIODONTOL, V38, P610, DOI 10.1902/jop.1967.38.6.610; Mombelli A, 1987, Oral Microbiol Immunol, V2, P145, DOI 10.1111/j.1399-302X.1987.tb00298.x; Mombelli A, 2012, CLIN ORAL IMPLAN RES, V23, P67, DOI 10.1111/j.1600-0501.2012.02541.x; Nowzari H, 2012, CLIN IMPLANT DENT R, V14, P546, DOI 10.1111/j.1708-8208.2010.00299.x; Petkovic AB, 2010, INT J ORAL MAX SURG, V39, P478, DOI 10.1016/j.ijom.2010.01.014; Plagnat D, 2002, CLIN ORAL IMPLAN RES, V13, P227, DOI 10.1034/j.1600-0501.2002.130301.x; Ramseier CA, 2016, CLIN ORAL IMPLAN RES, V27, P211, DOI 10.1111/clr.12566; Recker EN, 2015, J PERIODONTOL, V86, P264, DOI 10.1902/jop.2014.140354; Roos-Jansaker AM, 2006, J CLIN PERIODONTOL, V33, P290, DOI 10.1111/j.1600-051X.2006.00906.x; Rutar A, 2001, CLIN ORAL IMPLAN RES, V12, P189, DOI 10.1034/j.1600-0501.2001.012003189.x; Salvi GE, 2012, CLIN ORAL IMPLAN RES, V23, P182, DOI 10.1111/j.1600-0501.2011.02220.x; Schierano G, 2008, J CLIN PERIODONTOL, V35, P532, DOI 10.1111/j.1600-051X.2008.01224.x; Sicilia A, 2008, CLIN ORAL IMPLAN RES, V19, P823, DOI 10.1111/j.1600-0501.2008.01544.x; Sun X, 2014, JAMA-J AM MED ASSOC, V311, P405, DOI 10.1001/jama.2013.285063	31	25	25	0	4	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1432-6981	1436-3771		CLIN ORAL INVEST	Clin. Oral Investig.	NOV	2016	20	8					2285	2291		10.1007/s00784-016-1729-z			7	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	EA3KS	WOS:000386501800050	26832782	Green Published, hybrid			2022-03-04	
J	Moraguez, OD; Wiskott, HWA; Scherrer, SS				Moraguez, Osvaldo D.; Wiskott, H. W. Anselm; Scherrer, Susanne S.			Three- to nine-year survival estimates and fracture mechanisms of zirconia- and alumina-based restorations using standardized criteria to distinguish the severity of ceramic fractures	CLINICAL ORAL INVESTIGATIONS			English	Article						All-ceramic restoration; Zirconia; Alumina; Survival; Chipping; Fracture; Fractography	FIXED DENTAL PROSTHESES; PROCERA ALLCERAM CROWNS; IMPLANT-SUPPORTED ABUTMENTS; CONTROLLED CLINICAL-TRIAL; 3-YEAR FOLLOW-UP; SINGLE CROWNS; FAILURE ANALYSIS; COMPLICATION RATES; OBSERVATION PERIOD; PARTIAL DENTURES	The aims of this study were set as follows: To provide verifiable criteria to categorize the ceramic fractures into non-critical (i.e., amenable to polishing) or critical (i.e., in need of replacement) To establish the corresponding survival rates for alumina and zirconia restorations To establish the mechanism of fracture using fractography Fifty-eight patients restored with 115 alumina-/zirconia-based crowns and 26 zirconia-based fixed dental prostheses (FDPs) were included. Ceramic fractures were classified into four types and further subclassified into "critical" or "non-critical." Kaplan-Meier survival estimates were calculated for "critical fractures only" and "all fractures." Intra-oral replicas were taken for fractographic analyses. Kaplan-Meier survival estimates for "critical fractures only" and "all fractures" were respectively: Alumina single crowns: 90.9 and 68.3 % after 9.5 years (mean 5.71 +/- 2.6 years). Zirconia single crowns: 89.4 and 80.9 % after 6.3 years (mean 3.88 +/- 1.2 years). Zirconia FDPs: 68.6 % (critical fractures) and 24.6 % (all fractures) after 7.2 and 4.6 years respectively (FDP mean observation time 3.02 +/- 1.4 years). No core/framework fractures were detected. Survival estimates varied significantly depending on whether "all" fractures were considered as failures or only those deemed as "critical". For all restorations, fractographic analyses of failed veneering ceramics systematically demonstrated heavy occlusal wear at the failure origin. Therefore, the relief of local contact pressures on unsupported ceramic is recommended. Occlusal contacts on mesial or distal ridges should systematically be eliminated. A classification standard for ceramic fractures into four categories with subtypes "critical" and "non-critical" provides a differentiated view of the survival of ceramic restorations.	[Moraguez, Osvaldo D.; Wiskott, H. W. Anselm; Scherrer, Susanne S.] Univ Geneva, Sch Dent Med, Div Fixed Prosthodont & Biomat, CH-1205 Geneva, Switzerland		Moraguez, OD (corresponding author), Univ Geneva, Sch Dent Med, Div Fixed Prosthodont & Biomat, Rue Barthelemy Menn 19, CH-1205 Geneva, Switzerland.	Osvaldo.Moraguez@unige.ch; Anselm.Wiskott@unige.com; Susanne.Scherrer@unige.ch					Aboushelib MN, 2013, DENT MATER, V29, P252, DOI 10.1016/j.dental.2012.10.009; Al-Amleh B, 2010, J ORAL REHABIL, V37, P641, DOI 10.1111/j.1365-2842.2010.02094.x; Anusavice KJ, 2012, DENT MATER, V28, P102, DOI 10.1016/j.dental.2011.09.012; Baldassarri M, 2011, J DENT, V39, P489, DOI 10.1016/j.jdent.2011.04.006; Beuer F, 2010, QUINTESSENCE INT, V41, P631; Beuer F, 2009, CLIN ORAL INVEST, V13, P445, DOI 10.1007/s00784-009-0249-5; California Dental Association, 1977, QUAL EV DENT CAR GUI; Cehreli MC, 2009, J APPL ORAL SCI, V17, P49, DOI 10.1590/S1678-77572009000100010; Cvar JF, 2005, CLIN ORAL INVEST, V9, P215, DOI 10.1007/s00784-005-0018-z; Fradeani M, 2005, QUINTESSENCE INT, V36, P105; Guess PC, 2012, CLIN IMPLANT DENT R, V14, P633, DOI 10.1111/j.1708-8208.2010.00317.x; Heintze SD, 2010, INT J PROSTHODONT, V23, P493; Hickel R, 2010, CLIN ORAL INVEST, V14, P349, DOI 10.1007/s00784-010-0432-8; Hsueh CH, 2008, DENT MATER, V24, P9, DOI 10.1016/j.dental.2006.12.009; Kokubo Y, 2009, J ORAL REHABIL, V36, P786, DOI 10.1111/j.1365-2842.2009.01995.x; Larsson C, 2013, ACTA ODONTOL SCAND, V71, P1118, DOI 10.3109/00016357.2012.749518; Molin MK, 2008, INT J PROSTHODONT, V21, P223; Mundt T, 2013, ACTA ODONTOL SCAND, V71, P1326, DOI 10.3109/00016357.2013.764003; Odman P, 2001, INT J PROSTHODONT, V14, P504; Ortorp A, 2012, J DENT, V40, P527, DOI 10.1016/j.jdent.2012.02.011; Ortorp A, 2009, J DENT, V37, P731, DOI 10.1016/j.jdent.2009.06.002; Pelaez J, 2012, INT J PROSTHODONT, V25, P451; Pjetursson BE, 2007, CLIN ORAL IMPLAN RES, V18, P73, DOI 10.1111/j.1600-0501.2007.01467.x; Raigrodski AJ, 2006, J PROSTHET DENT, V96, P237, DOI 10.1016/j.prosdent.2006.08.010; Raigrodski AJ, 2012, J PROSTHET DENT, V107, P170, DOI 10.1016/S0022-3913(12)60051-1; Rosentritt M, 2009, J DENT, V37, P978, DOI 10.1016/j.jdent.2009.08.003; Sailer I, 2007, INT J PROSTHODONT, V20, P383; Sailer I, 2007, CLIN ORAL IMPLAN RES, V18, P86, DOI 10.1111/j.1600-0501.2007.01468.x; Sailer I, 2009, INT J PROSTHODONT, V22, P553; Sax C, 2011, Int J Comput Dent, V14, P183; Scherrer SS, 2006, INT J PROSTHODONT, V19, P185; Scherrer SS, 2008, DENT MATER, V24, P1107, DOI 10.1016/j.dental.2008.01.002; Scherrer SS, 2007, DENT MATER, V23, P1397, DOI 10.1016/j.dental.2006.12.002; Schley JS, 2010, EUR J ORAL SCI, V118, P443, DOI 10.1111/j.1600-0722.2010.00767.x; Schmitt J, 2010, INT J PROSTHODONT, V23, P107; Schmitter M, 2012, J ORAL REHABIL, V39, P552, DOI 10.1111/j.1365-2842.2012.02311.x; Schwarz S, 2012, CLIN IMPLANT DENT R, V14, pe119, DOI 10.1111/j.1708-8208.2011.00388.x; Sorrentino R, 2012, CLIN ORAL INVEST, V16, P977, DOI 10.1007/s00784-011-0575-2; Sorrentino R, 2012, CLIN IMPLANT DENT R, V14, P184, DOI 10.1111/j.1708-8208.2009.00251.x; Sundh A, 2005, DENT MATER, V21, P476, DOI 10.1016/j.dental.2004.07.013; Tartaglia GM, 2011, CLINICS, V12, P2063; Tinschert J, 2008, INT J PROSTHODONT, V21, P217; Walter MH, 2006, INT J PROSTHODONT, V19, P162; Wang XD, 2012, INT J PROSTHODONT, V25, P441; Wolfart S, 2009, EUR J ORAL SCI, V117, P741, DOI 10.1111/j.1600-0722.2009.00693.x; Worni A, 2015, CLIN IMPLANT DENT R, V17, P1073, DOI 10.1111/cid.12214; Zarone F, 2005, CLIN IMPLANT DENT R, V7, pS95, DOI 10.1111/j.1708-8208.2005.tb00081.x; Zarone F, 2011, DENT MATER, V27, P83, DOI 10.1016/j.dental.2010.10.024; Zitzmann NU, 2007, INT J PROSTHODONT, V20, P239	49	18	18	1	12	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1432-6981	1436-3771		CLIN ORAL INVEST	Clin. Oral Investig.	DEC	2015	19	9					2295	2307		10.1007/s00784-015-1455-y			13	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	CX2IG	WOS:000365519800015	25986462	Green Published, Green Submitted			2022-03-04	
J	Tapia, MTR; Ardu, S; Daeniker, L; Krejci, I				Tapia, Maria Teresa Rodriguez; Ardu, Stefano; Daeniker, Laurent; Krejci, Ivo			Evaluation of marginal adaptation, seal and resistance against fatigue cracks of different pit and fissure sealants under laboratory load	AMERICAN JOURNAL OF DENTISTRY			English	Article							IN-VITRO; ENAMEL; MICROLEAKAGE; PENETRATION; SURFACE; CARIES; WEAR; ASSOCIATION; ADOLESCENTS; ADHESIVES	Purpose: To evaluate, in the laboratory, five light-cured pit and fissure sealants (ClinPro Sealant, Grandio Seal, Delton Seal-N-Go Illuminating, Embrace Wet Bond, Delton LC) and a filled bonding resin (Optibond FL Adhesive) used as a sealant in respect to their marginal adaptation before and after simultaneous thermal cycling and occlusal loading and their seal and failure cracks after loading. Methods: 60 caries-free upper molars were mechanically and thermally loaded after sealant application. Marginal adaptation was evaluated in the SEM before and after loading and a dye penetration test was performed after loading. In addition, micro-morphology of the occlusal contact area was qualitatively assessed. Results: Percentages of "continuous margin" ranged from 97.5 to 72.3% before, and from 92.2 to 56.6% after loading. Loading significantly influenced marginal quality (ANOVA, P< 0.05). Dye penetration after loading ranged from 0.05 to 1.21, with significant differences between groups (Kruskal-Wallis, P< 0.05). Different degrees of disintegration were observed in the occlusal contact area of all materials after loading. (Am J Dent 2011;24:367-371).	[Tapia, Maria Teresa Rodriguez; Ardu, Stefano; Daeniker, Laurent; Krejci, Ivo] Univ Geneva, Sch Dent, Div Cariol & Endodontol, Pediat Unit, CH-1205 Geneva, Switzerland		Krejci, I (corresponding author), Univ Geneva, Sch Dent, Div Cariol & Endodontol, Pediat Unit, 19 Rue Barthelemy Menn, CH-1205 Geneva, Switzerland.	ivo.krejci@unige.ch		ardu, stefano/0000-0003-1641-2168	Cariology and Pediatric Dentistry staff; Ivonne Chaskelis	To the Cariology and Pediatric Dentistry staff; especially, to Ivonne Chaskelis, for their unconditional support and help, to Marie-Claude Reymond for her excellent assistance in the preparation of the SEM samples, and to Cecile Delhumeau for her assistance in statistics.	Aguiar Flávio Henrique Baggio, 2005, Braz. oral res., V19, P302, DOI 10.1590/S1806-83242005000400012; AHOUOSALORRANTA A, 2008, COCHRANE DB SYST REV; Armas-Vega AC, 2007, QUINTESSENCE INT, V38, pE321; Azarpazhooh A, 2008, J CAN DENT ASSOC, V74, P171; Beauchamp J, 2008, J AM DENT ASSOC, V139, P257, DOI 10.14219/jada.archive.2008.0155; Bergmann P, 1991, Quintessence Int, V22, P739; Boksman L, 1993, Quintessence Int, V24, P131; Burrow MF, 2001, AUST DENT J, V46, P258, DOI 10.1111/j.1834-7819.2001.tb00289.x; Cehreli ZC, 2008, J ADHES DENT, V10, P379; Celiberti P, 2005, J DENT, V33, P163, DOI 10.1016/j.jdent.2004.08.010; Celiberti P, 2007, J DENT, V35, P59, DOI 10.1016/j.jdent.2006.04.007; Courson F, 2003, J ADHES DENT, V5, P313; COURSON F, 2001, REV ODONT STOMAT, V32, P231; DIJKMAN AG, 1982, J BIOL BUCCALE, V10, P63; Duangthip D, 2003, Pediatr Dent, V25, P527; Duangthip D, 2003, OPER DENT, V28, P756; Feigal RJ, 2000, J DENT RES, V79, P1850, DOI 10.1177/00220345000790110601; Gray G B, 2006, J Prosthodont, V15, P2, DOI 10.1111/j.1532-849X.2006.00062.x; Handelman SL, 1996, J DENT RES, V75, P529, DOI 10.1177/00220345960750010401; Hannig M, 2004, J DENT, V32, P75, DOI 10.1016/j.jdent.2003.08.005; Hatibovic-Kofman S, 2001, Int J Paediatr Dent, V11, P409, DOI 10.1046/j.0960-7439.2001.00303.x; Hevinga MA, 2007, J DENT, V35, P909, DOI 10.1016/j.jdent.2007.09.001; Kantovitz KR, 2008, AM J DENT, V21, P377; Kersten S, 2001, AM J DENT, V14, P127; KREJCI I, 1994, J PROSTHET DENT, V72, P233, DOI 10.1016/0022-3913(94)90335-2; KREJCI I, 1993, J PROSTHET DENT, V69, P425, DOI 10.1016/0022-3913(93)90192-Q; KREJCI I, 1993, J DENT RES, V72, P490, DOI 10.1177/00220345930720020401; Kusgoz A, 2010, J MECH BEHAV BIOMED, V3, P594, DOI 10.1016/j.jmbbm.2010.07.008; LEKKA MP, 1989, J ORAL REHABIL, V16, P287, DOI 10.1111/j.1365-2842.1989.tb01344.x; Lupi-Pegurier L, 2004, J ADHES DENT, V6, P43; Lussi A, 1999, CARIES RES, V33, P261, DOI 10.1159/000016527; MERTZFAIRHURST EJ, 1986, J AM DENT ASSOC, V112, P194, DOI 10.14219/jada.archive.1986.0340; Meyer-Lueckel H, 2006, DENT MATER, V22, P22, DOI 10.1016/j.dental.2005.03.005; Momeni A, 2007, INT J PUBLIC HEALTH, V52, P393, DOI 10.1007/s00038-007-6094-x; Mount GJ, 2007, AUST DENT J, V52, P264, DOI 10.1111/j.1834-7819.2007.tb00500.x; Mouradian WE, 2000, JAMA-J AM MED ASSOC, V284, P2625, DOI 10.1001/jama.284.20.2625; Onisor I, 2007, J ADHES DENT, V9, P297; Peumans M, 2005, DENT MATER, V21, P864, DOI 10.1016/j.dental.2005.02.003; PINTADO MR, 1991, J DENT, V19, P33, DOI 10.1016/0300-5712(91)90034-V; Reggiardo Paul, 2010, J Calif Dent Assoc, V38, P722; ROCK WP, 1989, BRIT DENT J, V167, P395, DOI 10.1038/sj.bdj.4807037; RUYTER IE, 1981, ACTA ODONTOL SCAND, V39, P27, DOI 10.3109/00016358109162255; Simonsen Richard J, 2002, Pediatr Dent, V24, P393; Stavridakis MM, 2003, OPER DENT, V28, P403; Symons AL, 1996, J ORAL REHABIL, V23, P791, DOI 10.1046/j.1365-2842.1996.d01-202.x; Vandewalle Kraig S, 2005, J Esthet Restor Dent, V17, P244, DOI 10.1111/j.1708-8240.2005.tb00122.x; WILSON NHF, 2008, MINIMALLY INVASIVE D; Zervou C, 2000, J Clin Pediatr Dent, V24, P279	48	4	4	0	4	MOSHER & LINDER, INC	WESTON	318 INDIAN TRACE SUITE 500, WESTON, FL 33326 USA	0894-8275			AM J DENT	Am. J. Dent.	DEC	2011	24	6					367	371					5	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	867HU	WOS:000298446300008	22263335				2022-03-04	
